PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kristiansen, G; Hu, JM; Wichmann, D; Stiehl, DP; Rose, M; Gerhardt, J; Bohnert, A; ten Haaf, A; Moch, H; Raleigh, J; Varia, MA; Subarsky, P; Scandurra, FM; Gnaiger, E; Gleixner, E; Bicker, A; Gassmann, M; Hankeln, T; Dahl, E; Gorr, TA				Kristiansen, Glen; Hu, Junmin; Wichmann, Daniela; Stiehl, Daniel P.; Rose, Michael; Gerhardt, Josefine; Bohnert, Annette; ten Haaf, Anette; Moch, Holger; Raleigh, James; Varia, Mahesh A.; Subarsky, Patrick; Scandurra, Francesca M.; Gnaiger, Erich; Gleixner, Eva; Bicker, Anne; Gassmann, Max; Hankeln, Thomas; Dahl, Edgar; Gorr, Thomas A.			Endogenous Myoglobin in Breast Cancer Is Hypoxia-inducible by Alternative Transcription and Functions to Impair Mitochondrial Activity A ROLE IN TUMOR SUPPRESSION?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; HUMAN SKELETAL-MUSCLE; SMOOTH-MUSCLE; EXPRESSION; OXYGEN; CELLS; RESPIRATION; GENE; PHOSPHORYLATION; FIBROBLASTS	Recently, immunohistochemical analysis of myoglobin (MB) in human breast cancer specimens has revealed a surprisingly widespread expression of MB in this nonmuscle context. The positive correlation with hypoxia-inducible factor 2 alpha (HIF-2 alpha) and carbonic anhydrase IX suggested that oxygen regulates myoglobin expression in breast carcinomas. Here, we report that MB mRNA and protein levels are robustly induced by prolonged hypoxia in breast cancer cell lines, in part via HIF-1/2-dependent transactivation. The hypoxia-induced MB mRNA originated from a novel alternative transcription start site 6 kb upstream of the ATG codon. MB regulation in normal and tumor tissue may thus be fundamentally different. Functionally, the knockdown of MB in MDA-MB468 breast cancer cells resulted in an unexpected increase of O-2 uptake and elevated activities of mitochondrial enzymes during hypoxia. Silencing of MB transcription attenuated proliferation rates and motility capacities of hypoxic cancer cells and, surprisingly, also fully oxygenated breast cancer cells. Endogenous MB in cancer cells is apparently involved in controlling oxidative cell energy metabolism, contrary to earlier findings on mouse heart, where the targeted disruption of the Mb gene did not effect myocardial energetics and O-2 consumption. This control function of MB seemingly impacts mitochondria and influences cell proliferation and motility, but it does so in ways not directly related to the facilitated diffusion or storage of O-2. Hypothetically, the mitochondrion-impairing role of MB in hypoxic cancer cells is part of a novel tumor-suppressive function.	[Kristiansen, Glen] Univ Hosp Bonn, Inst Pathol, D-53127 Bonn, Germany; [Hu, Junmin; Wichmann, Daniela; Gassmann, Max; Gorr, Thomas A.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Vetsuisse Fac, Inst Vet Physiol, CH-8057 Zurich, Switzerland; [Stiehl, Daniel P.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Rose, Michael; ten Haaf, Anette; Dahl, Edgar] Univ Hosp RWTH, Inst Pathol, D-52074 Aachen, Germany; [Gerhardt, Josefine; Bohnert, Annette; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Raleigh, James; Varia, Mahesh A.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Subarsky, Patrick; Scandurra, Francesca M.; Gnaiger, Erich] Med Univ Innsbruck, D Swarovski Res Lab, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria; [Gleixner, Eva; Bicker, Anne; Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55099 Mainz, Germany; [Gorr, Thomas A.] Univ Med Ctr Freiburg, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany	University of Bonn; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; RWTH Aachen University; RWTH Aachen University Hospital; University of Zurich; University Zurich Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Medical University of Innsbruck; Johannes Gutenberg University of Mainz; University of Freiburg	Kristiansen, G (corresponding author), Univ Hosp Bonn UKB, Inst Pathol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	glen.kristiansen@ukb.uni-bonn.de	Stiehl, Daniel/A-3622-2008	Gassmann, Max/0000-0003-2750-8878; Stiehl, Daniel/0000-0002-0076-4874; Gorr, Thomas/0000-0002-6023-4234; Gnaiger, Erich/0000-0003-3647-5895; Bicker, Anne/0000-0003-4364-9777	Swiss National Science Foundation; Faculty of Medicine, RWTH Aachen (START network)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Medicine, RWTH Aachen (START network)	This work was supported in part by grants from the Swiss National Science Foundation (to M. G.), a grant from the Faculty of Medicine, RWTH Aachen (START network) (to E. D.), and by contributions from K-Regio Project Mito-Com Tyrol (to E. G.). Parts of this paper have been presented at the International Congress of Respiratory Science, August 9-13, 2009, Bad Honnef, Germany.	Aguirre E, 2010, BBA-BIOENERGETICS, V1797, P557, DOI 10.1016/j.bbabio.2010.01.033; Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; Arcasoy MO, 2002, LAB INVEST, V82, P911, DOI 10.1097/01.LAB.0000020415.72863.40; BLANCHETOT A, 1986, EUR J BIOCHEM, V159, P469, DOI 10.1111/j.1432-1033.1986.tb09909.x; Brown JM, 1999, CANCER RES, V59, P5863; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chang H, 2003, CLIN SCI, V105, P447, DOI 10.1042/CS20030088; Enoki Y., 1988, Advances in Experimental Medicine and Biology, V222, P709; EUSEBI V, 1984, AM J SURG PATHOL, V8, P51, DOI 10.1097/00000478-198401000-00005; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Flogel U, 2004, FASEB J, V18, P1156, DOI 10.1096/fj.03-1382fje; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Fordel E, 2004, IUBMB LIFE, V56, P681, DOI 10.1080/15216540500037406; Fraser J, 2006, P NATL ACAD SCI USA, V103, P2977, DOI 10.1073/pnas.0508270103; Galluzzo M, 2009, J CLIN INVEST, V119, P865, DOI 10.1172/JCI36579; Garry DJ, 1998, NATURE, V395, P905, DOI 10.1038/27681; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; Gorr TA, 2011, ACTA PHYSIOL, V202, P563, DOI 10.1111/j.1748-1716.2010.02205.x; Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; ISEKI M, 1990, AM J SURG PATHOL, V14, P395, DOI 10.1097/00000478-199004000-00014; JURGENS KD, 1994, P NATL ACAD SCI USA, V91, P3829, DOI 10.1073/pnas.91.9.3829; Kanatous SB, 2009, AM J PHYSIOL-CELL PH, V296, pC393, DOI 10.1152/ajpcell.00428.2008; Khan KK, 1998, EUR J BIOCHEM, V257, P547, DOI 10.1046/j.1432-1327.1998.2570547.x; Kristiansen G, 2010, BRIT J CANCER, V102, P1736, DOI 10.1038/sj.bjc.6605702; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; Nitta T, 2003, J SURG RES, V110, P322, DOI 10.1016/S0022-4804(02)00066-5; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; Pesta D, 2011, MITOCHONDRIAL BIOENE; Qiu Y, 1998, J BIOL CHEM, V273, P23426, DOI 10.1074/jbc.273.36.23426; REYNAFARJE B, 1962, J APPL PHYSIOL, V17, P301, DOI 10.1152/jappl.1962.17.2.301; Roesner A, 2008, FEBS J, V275, P3633, DOI 10.1111/j.1742-4658.2008.06508.x; Rosman DS, 2008, CANCER RES, V68, P1319, DOI 10.1158/0008-5472.CAN-07-5424; Scandurra FM, 2010, ADV EXP MED BIOL, V662, P7, DOI 10.1007/978-1-4419-1241-1_2; Schenkman KA, 2001, AM J PHYSIOL-HEART C, V281, pH2463, DOI 10.1152/ajpheart.2001.281.6.H2463; SMITH TW, 1984, CANCER, V54, P323, DOI 10.1002/1097-0142(19840715)54:2<323::AID-CNCR2820540225>3.0.CO;2-5; Smolkova K, 2010, J BIOENERG BIOMEMBR, V42, P55, DOI 10.1007/s10863-009-9267-x; Sriram R, 2008, FEBS LETT, V582, P3643, DOI 10.1016/j.febslet.2008.09.047; SteinlechnerMaran R, 1996, AM J PHYSIOL-CELL PH, V271, pC2053, DOI 10.1152/ajpcell.1996.271.6.C2053; Thews O, 1998, BRIT J CANCER, V78, P752, DOI 10.1038/bjc.1998.572; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tomita A, 2010, J EXP BIOL, V213, P2748, DOI 10.1242/jeb.042994; VAUPEL P, 1991, CANCER RES, V51, P3316; Vogt M, 2001, J APPL PHYSIOL, V91, P173, DOI 10.1152/jappl.2001.91.1.173; WELLER P, 1984, EMBO J, V3, P439, DOI 10.1002/j.1460-2075.1984.tb01825.x; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1092, DOI 10.1167/iovs.04-0043; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wirthner R, 2008, CARCINOGENESIS, V29, P2306, DOI 10.1093/carcin/bgn231; WITTENBERG BA, 1975, J BIOL CHEM, V250, P9038; Wittenberg BA, 2009, AM J PHYSIOL-CELL PH, V296, pC390, DOI 10.1152/ajpcell.00002.2009; WITTENBERG JB, 1970, PHYSIOL REV, V50, P559, DOI 10.1152/physrev.1970.50.4.559; Wystub S, 2004, CYTOGENET GENOME RES, V105, P65, DOI 10.1159/000078011; Zhang PJ, 2003, MODERN PATHOL, V16, P229, DOI 10.1097/01.MP.0000056630.76035.F3	57	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43417	43428		10.1074/jbc.M111.227553	http://dx.doi.org/10.1074/jbc.M111.227553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21930697	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000298351300061
J	Purcell, DJ; Jeong, KW; Bittencourt, D; Gerke, DS; Stallcup, MR				Purcell, Daniel J.; Jeong, Kwang Won; Bittencourt, Danielle; Gerke, Daniel S.; Stallcup, Michael R.			A Distinct Mechanism for Coactivator versus Corepressor Function by Histone Methyltransferase G9a in Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; PROTEIN METHYLTRANSFERASE; NUCLEAR RECEPTORS; DNA METHYLATION; H3; GENES; BETA; RECRUITMENT; PROMOTER; REPEATS	Histone methyltransferase G9a has been understood primarily as a corepressor of gene expression, but we showed previously that G9a positively regulates nuclear receptor-mediated transcription in reporter gene assays. Here, we show that endogenous G9a contributes to the estradiol (E-2)-dependent induction of some endogenous target genes of estrogen receptor (ER)alpha in MCF-7 breast cancer cells while simultaneously limiting the E-2-induced expression of other ER alpha target genes. Thus, G9a has a dual and selective role as a coregulator for ER alpha target genes. The ER alpha binding regions associated with the pS2 gene, which requires G9a for E-2-induced expression, are transiently occupied by G9a at 15 min after beginning E-2 treatment, suggesting that G9a coactivator function is by direct interaction with ER alpha target genes. Transient reporter gene assays with deletion mutants of G9a demonstrated that domains previously associated with the corepressor functions of G9a (C-terminal methyltransferase domain, ankyrin repeat domain, and cysteine-rich domain) were unnecessary for G9a coactivator function in ER alpha mediated transcription. In contrast, the N-terminal domain of G9a was necessary and sufficient for enhancement of ER alpha-mediated transcription and for E-2-induced occupancy of G9a on ER alpha binding sites associated with endogenous target genes of ER alpha. In addition to a previously identified activation domain, this region contains a previously uncharacterized ligand-dependent ER alpha binding function, indicating how G9a is recruited to the target genes. Therefore, the coactivator and corepressor functions of G9a involve different G9a domains and different molecular mechanisms.	[Purcell, Daniel J.; Jeong, Kwang Won; Bittencourt, Danielle; Gerke, Daniel S.; Stallcup, Michael R.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California	Stallcup, MR (corresponding author), Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, NOR 6316,1441 Eastlake Ave, Los Angeles, CA 90089 USA.	stallcup@usc.edu			National Institutes of Health [R01 DK055274]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK055274 (to M. R. S.).	Chaturvedi CP, 2009, P NATL ACAD SCI USA, V106, P18303, DOI 10.1073/pnas.0906769106; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Glass CK, 2000, GENE DEV, V14, P121; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Lehnertz B, 2010, J EXP MED, V207, P915, DOI 10.1084/jem.20100363; Ma H, 1999, MOL CELL BIOL, V19, P6164; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; MILNER CM, 1993, BIOCHEM J, V290, P811, DOI 10.1042/bj2900811; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315	28	57	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41963	41971		10.1074/jbc.M111.298463	http://dx.doi.org/10.1074/jbc.M111.298463			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21984853	Green Published, hybrid			2022-12-27	WOS:000298180900007
J	Li, K; Yao, J; Shi, LY; Sawada, N; Chi, Y; Yan, QJ; Matsue, H; Kitamura, M; Takeda, M				Li, Kai; Yao, Jian; Shi, Liye; Sawada, Norifumi; Chi, Yuan; Yan, Qiaojing; Matsue, Hiroyuki; Kitamura, Masanori; Takeda, Masayuki			Reciprocal Regulation between Proinflammatory Cytokine-induced Inducible NO Synthase (iNOS) and Connexin43 in Bladder Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; NF-KAPPA-B; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; UROPATHOGENIC ESCHERICHIA-COLI; NITRIC-OXIDE SYNTHASE; GAP-JUNCTIONS; URINARY-BLADDER; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; HUMAN DETRUSOR	Gap junctions (GJs) play an important role in the control of bladder contractile response and in the regulation of various immune inflammatory processes. Here, we investigated the possible interaction between inflammation and GJs in bladder smooth muscle cells (BSMCs). Stimulation of BSMCs with IL1 beta and TNF alpha increased connexin43 (Cx43) expression and function, which was associated with increased phosphorylation of vasodilator-stimulated phosphoprotein. Inhibition of PKA with H89 or down-regulation of CREB with specific siRNAs largely abolished the Cx43-elevating effect. Further analysis revealed that IL1 beta/TNF alpha induced NF kappa B-dependent inducible NO synthase (iNOS) expression. Inhibition of iNOS with G-nitro-L-arginine methyl ester abrogated and an exogenous NO donor mimicked the effect of the cytokines on Cx43. Intraperitoneal injection of LPS into mice also induced bladder Cx43 expression, which was largely blocked by an iNOS inhibitor. Finally, the elevated Cx43 was found to negatively regulate iNOS expression. Dysfunction of GJs with various blockers or down-regulation of Cx43 with siRNA significantly potentiated the expression of iNOS. Fibroblasts from Cx43 knock-out (Cx43(-/-)) mice also displayed a significantly higher response to the cytokine-induced iNOS expression than cells from Cx43 wild-type (Cx43(+/+)) littermates. Collectively, our study revealed a previously unrecognized reciprocal regulation loop between cytokine-induced NO and GJs. Our findings may provide an important molecular mechanism for the symptoms of bladder infection. In addition, it may further our understanding of the roles of GJs in inflammatory diseases.	[Li, Kai; Yao, Jian; Chi, Yuan; Yan, Qiaojing; Kitamura, Masanori] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Yamanashi 4093898, Japan; [Li, Kai; Sawada, Norifumi; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Yamanashi 4093898, Japan; [Matsue, Hiroyuki] Chiba Univ, Grad Sch Med, Dept Dermatol, Chiba 2608670, Japan; [Li, Kai] China Med Univ, Affiliated Hosp 1, Dept Oncol, Shenyang 110001, Peoples R China; [Shi, Liye] China Med Univ, Affiliated Hosp 1, Dept Cardiol, Shenyang 110001, Peoples R China	University of Yamanashi; University of Yamanashi; Chiba University; China Medical University; China Medical University	Yao, J (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Yamanashi 4093898, Japan.	yao@yamanashi.ac.jp		Yao, Jian/0000-0003-2622-0215	Ministry of Education, Culture, Sports, Science and Technology, Japan [23591187, 20590953]; University of Yamanashi; Grants-in-Aid for Scientific Research [23591187] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Yamanashi(University of Yamanashi); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 23591187 and 20590953 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to). Y.), and a strategic project grant from the University of Yamanashi.	Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; Billips BK, 2007, INFECT IMMUN, V75, P5353, DOI 10.1128/IAI.00922-07; Bouchelouche K, 2006, UROLOGY, V67, P214, DOI 10.1016/j.urology.2005.07.049; BUTT E, 1994, J BIOL CHEM, V269, P14509; Christ GJ, 2003, AM J PHYSIOL-REG I, V284, pR1241, DOI 10.1152/ajpregu.00030.2002; Civitelli R, 1998, J CELL BIOCHEM, V68, P8, DOI 10.1002/(SICI)1097-4644(19980101)68:1<8::AID-JCB2>3.0.CO;2-#; Cronier L, 2003, BIOL REPROD, V69, P1472, DOI 10.1095/biolreprod.103.016360; Dowling-Warriner CV, 2000, NEUROSCIENCE, V95, P859; Drake MJ, 2003, J UROLOGY, V170, P276, DOI 10.1097/01.ju.0000069722.35137.e0; Ehrlich HP, 2000, J CELL PHYSIOL, V184, P86, DOI 10.1002/(SICI)1097-4652(200007)184:1<86::AID-JCP9>3.0.CO;2-5; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Eugenin EA, 2007, CELL IMMUNOL, V247, P103, DOI 10.1016/j.cellimm.2007.08.001; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Fernandez-Cobo M, 1998, SHOCK, V10, P97, DOI 10.1097/00024382-199808000-00003; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Haferkamp A, 2004, EUR UROL, V46, P799, DOI 10.1016/j.eururo.2004.08.020; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Jimenez-Feltstrom J, 2005, CELL TISSUE RES, V319, P221, DOI 10.1007/s00441-004-1013-4; Kasper CA, 2010, IMMUNITY, V33, P804, DOI 10.1016/j.immuni.2010.10.015; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Li LK, 2007, AM J PHYSIOL-CELL PH, V293, pC1627, DOI 10.1152/ajpcell.00122.2007; Liao CK, 2010, INT J BIOCHEM CELL B, V42, P762, DOI 10.1016/j.biocel.2010.01.016; Matsue H, 2006, J IMMUNOL, V176, P181, DOI 10.4049/jimmunol.176.1.181; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Neuhaus J, 2002, WORLD J UROL, V20, P250, DOI 10.1007/s00345-002-0289-9; Neuhaus J, 2009, EUR UROL, V55, P491, DOI 10.1016/j.eururo.2008.03.090; Okamoto T, 2011, EXP CELL RES, V317, P348, DOI 10.1016/j.yexcr.2010.10.018; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Paulson AF, 2000, J CELL SCI, V113, P3037; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; Sawada N, 2008, LAB INVEST, V88, P553, DOI 10.1038/labinvest.2008.21; Scheckenbach KEL, 2011, J VASC RES, V48, P91, DOI 10.1159/000316942; Simon AM, 2004, J VASC RES, V41, P323, DOI 10.1159/000079614; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; TAKENSKWAK BR, 1992, AM J PHYSIOL, V262, pC1531, DOI 10.1152/ajpcell.1992.262.6.C1531; Veliz LP, 2008, AM J PHYSIOL-HEART C, V295, pH1056, DOI 10.1152/ajpheart.00266.2008; Wang XC, 2000, J UROLOGY, V163, P993, DOI 10.1016/S0022-5347(05)67870-6; Wein AJ, 2002, UROLOGY, V60, P7, DOI 10.1016/S0090-4295(02)01784-3; Weng TI, 2009, INFECT IMMUN, V77, P3312, DOI 10.1128/IAI.00013-09; Wu F, 2008, J CELL PHYSIOL, V217, P207, DOI 10.1002/jcp.21495; Yao J, 2007, BRIT J PHARMACOL, V151, P457, DOI 10.1038/sj.bjp.0707255; Yao J, 2006, AM J PHYSIOL-RENAL, V290, pF1083, DOI 10.1152/ajprenal.00134.2005; Yao J, 2002, J AM SOC NEPHROL, V13, P2018, DOI 10.1097/01.ASN.0000023436.71816.56; Yao JA, 2010, BRIT J PHARMACOL, V160, P2055, DOI 10.1111/j.1476-5381.2010.00860.x; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Yao JJ, 2005, J AM SOC NEPHROL, V16, P1300, DOI 10.1681/ASN.2004110991; Zhao Y, 2006, GLIA, V54, P775, DOI 10.1002/glia.20418	50	29	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41552	41562		10.1074/jbc.M111.274449	http://dx.doi.org/10.1074/jbc.M111.274449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965676	Green Published, hybrid			2022-12-27	WOS:000298057500041
J	Marbaix, AY; Noel, G; Detroux, AM; Vertommen, D; Van Schaftingen, E; Linster, CL				Marbaix, Alexandre Y.; Noel, Gaetane; Detroux, Aline M.; Vertommen, Didier; Van Schaftingen, Emile; Linster, Carole L.			Extremely Conserved ATP- or ADP-dependent Enzymatic System for Nicotinamide Nucleotide Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED DIPHOSPHOPYRIDINE NUCLEOTIDE; I BINDING-PROTEIN; ADENINE-DINUCLEOTIDE; SACCHAROMYCES-CEREVISIAE; NADH; DEHYDROGENASE; GENOME; ACID	The reduced forms of NAD and NADP, two major nucleotides playing a central role in metabolism, are continuously damaged by enzymatic or heat-dependent hydration. We report the molecular identification of the eukaryotic dehydratase that repairs these nucleotides and show that this enzyme (Carkd in mammals, YKL151C in yeast) catalyzes the dehydration of the S form of NADHX and NADPHX, at the expense of ATP, which is converted to ADP. Surprisingly, the Escherichia coli homolog, YjeF, a bidomain protein, catalyzes a similar reaction, but using ADP instead of ATP. The latter reaction is ascribable to the C-terminal domain of YjeF. This represents an unprecedented example of orthologous enzymes using either ADP or ATP as phosphoryl donor, We also show that eukaryotic proteins homologous to the N-terminal domain of YjeF (apolipoprotein A-1-binding protein (AIBP) in mammals, YNL200C in yeast) catalyze the epimerization of the S and R forms of NAD(P)HX, thereby allowing, in conjunction with the energy-dependent dehydratase, the repair of both epimers of NAD(P)HX. Both enzymes are very widespread in eukaryotes, prokaryotes, and archaea, which together with the ADP dependence of the dehydratase in some species indicates the ancient origin of this repair system.	[Marbaix, Alexandre Y.; Noel, Gaetane; Detroux, Aline M.; Van Schaftingen, Emile; Linster, Carole L.] Catholic Univ Louvain, Duve Inst, WELBIO, B-1200 Brussels, Belgium; [Marbaix, Alexandre Y.; Noel, Gaetane; Detroux, Aline M.; Van Schaftingen, Emile; Linster, Carole L.] Catholic Univ Louvain, Physiol Chem Lab, B-1200 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, Hormone & Metab Res Unit, Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; Universite Catholique Louvain	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Duve Inst, WELBIO, BCHM 7539,Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be; carole.linster@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Vertommen, Didier/0000-0001-7648-8282; Van Schaftingen, Emile/0000-0002-6199-7647; Linster, Carole/0000-0001-7143-0719	Fonds de la Recherche Scientifique (FRS-FNRS); European Union [276814]; Welbio (Walloon region)	Fonds de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); European Union(European Commission); Welbio (Walloon region)(WELBIO)	This work was supported by the Fonds de la Recherche Scientifique (FRS-FNRS), by the European Union Seventh Framework Programme (Grant FP7/2007-2013) under Grant Agreement 276814, and by Welbio (Walloon region).	ACHESON SA, 1988, BIOCHEMISTRY-US, V27, P7371, DOI 10.1021/bi00419a030; Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; CHAYKIN S, 1956, J BIOL CHEM, V220, P811; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Jha KN, 2008, ENDOCRINOLOGY, V149, P2108, DOI 10.1210/en.2007-0582; Linster CL, 2011, J BIOL CHEM, V286, P42992, DOI 10.1074/jbc.M111.281527; Linster CL, 2003, J BIOL CHEM, V278, P36328, DOI 10.1074/jbc.M306593200; MEINHART JO, 1956, J BIOL CHEM, V220, P821; MIKSIC JR, 1978, BIOCHEMISTRY-US, V17, P2234, DOI 10.1021/bi00604a034; OPPENHEIMER NJ, 1974, BIOCHEMISTRY-US, V13, P4675, DOI 10.1021/bi00720a001; OPPENHEIMER NJ, 1974, BIOCHEMISTRY-US, V13, P4685, DOI 10.1021/bi00720a002; Prabhakar P, 1998, ARCH BIOCHEM BIOPHYS, V360, P195, DOI 10.1006/abbi.1998.0939; RAFTER GW, 1954, J BIOL CHEM, V208, P799; Ritter M, 2002, GENOMICS, V79, P693, DOI 10.1006/geno.2002.6761; Treger JM, 1998, J BIOL CHEM, V273, P26875, DOI 10.1074/jbc.273.41.26875; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; YOSHIDA A, 1975, ARCH BIOCHEM BIOPHYS, V169, P298, DOI 10.1016/0003-9861(75)90344-6	21	85	97	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41246	41252		10.1074/jbc.C111.310847	http://dx.doi.org/10.1074/jbc.C111.310847			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994945	Green Published, hybrid			2022-12-27	WOS:000298057500012
J	Heinen, CD; Cyr, JL; Cook, C; Punja, N; Sakato, M; Forties, RA; Lopez, JM; Hingorani, MM; Fishel, R				Heinen, Christopher D.; Cyr, Jennifer L.; Cook, Christopher; Punja, Nidhi; Sakato, Miho; Forties, Robert A.; Lopez, Juana Martin; Hingorani, Manju M.; Fishel, Richard			Human MSH2 (hMSH2) Protein Controls ATP Processing by hMSH2-hMSH6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH REPAIR PROTEIN; SACCHAROMYCES-CEREVISIAE MSH2-MSH6; DNA MISMATCH; MOLECULAR SWITCH; HMUTS-ALPHA; RECOGNITION COMPLEX; BINDING ACTIVITIES; LYNCH-SYNDROME; SLIDING CLAMP; MUTS	The mechanics of hMSH2-hMSH6 ATP binding and hydrolysis are critical to several proposed mechanisms for mismatch repair (MMR), which in turn rely on the detailed coordination of ATP processing between the individual hMSH2 and hMSH6 subunits. Here we show that hMSH2-hMSH6 is strictly controlled by hMSH2 and magnesium in a complex with ADP (hMSH2(magnesium-ADP)-hMSH6). Destabilization of magnesium results in ADP release from hMSH2 that allows high affinity ATP binding by hMSH6, which then enhances ATP binding by hMSH2. Both subunits must be ATP-bound to efficiently form a stable hMSH2-hMSH6 hydrolysis-independent sliding clamp required for MMR. In the presence of magnesium, the ATP-bound sliding clamps remain on the DNA for similar to 8 min. These results suggest a precise stepwise kinetic mechanism for hMSH2-hMSH6 functions that appears to mimic G protein switches, severely constrains models for MMR, and may partially explain the MSH2 allele frequency in Lynch syndrome or hereditary nonpolyposis colorectal cancer.	[Heinen, Christopher D.; Cyr, Jennifer L.] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT 06030 USA; [Cook, Christopher; Punja, Nidhi; Lopez, Juana Martin; Fishel, Richard] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Heinen, Christopher D.; Cyr, Jennifer L.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA; [Sakato, Miho; Hingorani, Manju M.] Wesleyan Univ, Mol Biol & Biochem Dept, Middletown, CT 06459 USA; [Forties, Robert A.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Cook, Christopher; Punja, Nidhi; Lopez, Juana Martin; Fishel, Richard] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University of Connecticut; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Connecticut; Wesleyan University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Heinen, CD (corresponding author), Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, 263 Farmington Ave,ML3101, Farmington, CT 06030 USA.	cheinen@uchc.edu; rfishel@osu.edu	MARTIN-LOPEZ, JUANA VICTORIA/AAB-2367-2021	MARTIN-LOPEZ, JUANA VICTORIA/0000-0003-2777-2740	National Institutes of Health [CA115783, CA67007]; National Science Foundation [MCB 1022203]; NATIONAL CANCER INSTITUTE [R01CA067007, R01CA115783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA115783 (to C. D. H.) and CA67007 (to R. F.). This work was also supported by National Science Foundation Grant MCB 1022203 (to M. M. H.).	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Antony E, 2004, BIOCHEMISTRY-US, V43, P13115, DOI 10.1021/bi049010t; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Bjornson KP, 2003, J BIOL CHEM, V278, P18557, DOI 10.1074/jbc.M301101200; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Cheng JQ, 1998, BIOCHEMISTRY-US, V37, P5288, DOI 10.1021/bi972742j; Cyr JL, 2008, J BIOL CHEM, V283, P31641, DOI 10.1074/jbc.M806018200; de la Chapelle A, 2005, FAM CANCER, V4, P233, DOI 10.1007/s10689-004-5811-3; Drotschmann K, 2002, DNA REPAIR, V1, P743, DOI 10.1016/S1568-7864(02)00081-2; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; HABER LT, 1988, J BACTERIOL, V170, P197, DOI 10.1128/jb.170.1.197-202.1988; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Heinen CD, 2002, CANCER CELL, V1, P469, DOI 10.1016/S1535-6108(02)00073-9; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Jacobs-Palmer E, 2007, J MOL BIOL, V366, P1087, DOI 10.1016/j.jmb.2006.11.092; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Jiang JJ, 2005, MOL CELL, V20, P771, DOI 10.1016/j.molcel.2005.10.014; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kolodner RD, 2007, P NATL ACAD SCI USA, V104, P12953, DOI 10.1073/pnas.0705698104; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lebbink JHG, 2010, J BIOL CHEM, V285, P13131, DOI 10.1074/jbc.M109.066001; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nitta R, 2008, NAT STRUCT MOL BIOL, V15, P1067, DOI 10.1038/nsmb.1487; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Wang HX, 2002, J BIOL CHEM, V277, P26136, DOI 10.1074/jbc.M200357200; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	38	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40287	40295		10.1074/jbc.M111.297523	http://dx.doi.org/10.1074/jbc.M111.297523			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937421	Green Published, hybrid			2022-12-27	WOS:000296925700060
J	Liu, ZY; Swindall, AF; Kesterson, RA; Schoeb, TR; Bullard, DC; Bellis, SL				Liu, Zhongyu; Swindall, Amanda F.; Kesterson, Robert A.; Schoeb, Trenton R.; Bullard, Daniel C.; Bellis, Susan L.			ST6Gal-I Regulates Macrophage Apoptosis via alpha 2-6 Sialylation of the TNFR1 Death Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOID FIBRONECTIN RECEPTORS; NECROSIS-FACTOR-ALPHA; CELL-DEATH; DENDRITIC CELLS; LEUKEMIA CELLS; U937 CELLS; SURFACE; SIALYLTRANSFERASE; GLYCOSYLATION; ACTIVATION	Macrophages play a central role in innate immunity, however mechanisms regulating macrophage survival are not fully understood. Herein we describe a novel apoptotic pathway involving alpha 2-6 sialylation of the TNFR1 death receptor by the ST6Gal-I sialyltransferase. Variant glycosylation of TNFR1 has not previously been implicated in TNFR1 function, and little is known regarding the TNFR1 glycan composition. To study sialylation in macrophages, we treated U937 monocytic cells with PMA, which stimulates both macrophage differentiation and apoptosis. Interestingly, macrophage differentiation induces ST6Gal-I down-regulation, leading to reduced alpha 2-6 sialylation of selected receptors. To prevent loss of alpha 2-6 sialylation, we forced constitutive expression of ST6Gal-I, and found that this strongly inhibited PMA-induced apoptosis. Given that PMA-mediated apoptosis is thought to result from up-regulation of TNF alpha, which then activates TNFR1, we next evaluated the alpha 2-6 sialylation of TNFR1. U937 cells with forced ST6Gal-I displayed TNFR1 with elevated alpha 2-6 sialylation, and this was associated with diminished TNF alpha-stimulated apoptosis. Correspondingly, removal of alpha 2-6 sialylation from TNFR1 through either neuraminidase treatment or expression of ST6Gal-I shRNA markedly enhanced TNF alpha-mediated apoptosis. To confirm the physiologic importance of TNFR1 sialylation, we generated over-expressing ST6Gal-I transgenic mice. Peritoneal macrophages from transgenic lines displayed TNFR1 with elevated alpha 2-6 sialylation, and these cells were significantly protected against TNF alpha-stimulated apoptosis. Moreover, greater numbers of thioglycollate-induced peritoneal cells were observed in transgenic mice. These collective results highlight a new mechanism of TNFR1 regulation, and further intimate that loss of alpha 2-6 sialylation during macrophage differentiation may limit macrophage lifespan by sensitizing cells to TNF alpha-stimulated apoptosis.	[Liu, Zhongyu; Swindall, Amanda F.; Bellis, Susan L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Kesterson, Robert A.; Schoeb, Trenton R.; Bullard, Daniel C.] Univ Alabama, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), 1918 Univ Blvd,982A MCLM, Birmingham, AL 35294 USA.	bellis@uab.edu	Swindall, Amanda/F-3935-2012		National Institutes of Health [R01 CA84248, P30AR48311]; UAB Rheumatic Diseases Core Center; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA084248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Rheumatic Diseases Core Center; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by Grants R01 CA84248 (to S. L. B.) and P30AR48311 from the National Institutes of Health, the UAB Rheumatic Diseases Core Center, and the American Heart Association (Grant-in-Aid to S.L.B.).	Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Cartee L, 2002, MOL PHARMACOL, V61, P1313, DOI 10.1124/mol.61.6.1313; Chan J, 1998, BLOOD, V92, P1423, DOI 10.1182/blood.V92.4.1423.416k31_1423_1431; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; CORTI A, 1995, J INTERF CYTOK RES, V15, P143, DOI 10.1089/jir.1995.15.143; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; DEVENTE J, 1995, CELL GROWTH DIFFER, V6, P371; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Greenlee MC, 2009, INFLAMM RES, V58, P909, DOI 10.1007/s00011-009-0064-0; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Keppler OT, 1999, GLYCOBIOLOGY, V9, P557, DOI 10.1093/glycob/9.6.557; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Kohne C, 1999, J CELL BIOCHEM, V75, P446; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Marino JH, 2008, GLYCOBIOLOGY, V18, P719, DOI 10.1093/glycob/cwn051; Meesmann HM, 2010, J CELL SCI, V123, P3347, DOI 10.1242/jcs.066696; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; O'Sullivan AW, 2009, J SURG RES, V151, P138, DOI 10.1016/j.jss.2008.02.031; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; PETER ME, 1995, CELL DEATH DIFFER, V2, P163; Rahmani M, 2002, EXP CELL RES, V277, P31, DOI 10.1006/excr.2002.5548; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Takada Y, 1999, J BIOL CHEM, V274, P28286, DOI 10.1074/jbc.274.40.28286; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Taniguchi A, 1998, FEBS LETT, V441, P191, DOI 10.1016/S0014-5793(98)01548-8; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Videira PA, 2008, GLYCOCONJUGATE J, V25, P259, DOI 10.1007/s10719-007-9092-6; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Zhang J, 2008, BIOCHEM BIOPH RES CO, V366, P579, DOI 10.1016/j.bbrc.2007.12.011; Zhang LS, 2010, HUM MOL GENET, V19, P2754, DOI 10.1093/hmg/ddq172; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	43	66	68	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39654	39662		10.1074/jbc.M111.276063	http://dx.doi.org/10.1074/jbc.M111.276063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930713	Green Published, hybrid			2022-12-27	WOS:000296759800082
J	Nam, HK; Liu, J; Li, Y; Kragor, A; Hatch, NE				Nam, Hwa Kyung; Liu, Jin; Li, Yan; Kragor, Andrew; Hatch, Nan E.			Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) Protein Regulates Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; CELL MEMBRANE GLYCOPROTEIN-1; INORGANIC PYROPHOSPHATE GENERATION; NONSPECIFIC ALKALINE-PHOSPHATASE; NUCLEOTIDE PYROPHOSPHATASE; PATHOLOGICAL CALCIFICATION; DEFICIENT MICE; MOUSE MODEL; PC-1; EXPRESSION	ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase-1) is an established regulator of tissue mineralization. Previous studies demonstrated that ENPP1 is expressed in differentiated osteoblasts and that ENPP1 influences matrix mineralization by increasing extracellular levels of inorganic pyrophosphate. ENPP1 is also expressed in osteoblastic precursor cells when stimulated with FGF2, but the role of ENPP1 in preosteoblastic and other precursor cells is unknown. Here we investigate the function of ENPP1 in preosteoblasts. We find that ENPP1 expression is critical for osteoblastic differentiation and that this effect is not mediated by changes in extracellular concentration levels of phosphate or pyrophosphate or ENPP1 catalytic activity. MC3T3E1(C4) preosteoblastic cells, in which ENPP1 expression was suppressed by ENPP1-specific shRNA, and calvarial cells isolated from Enpp1 knock-out mice show defective osteoblastic differentiation upon stimulation with ascorbate, as indicated by a lack of cellular morphological change, a lack of osteoblast marker gene expression, and an inability to mineralize matrix. Additionally, MC3T3E1(C4) cells, in which wild type or catalytic inactive ENPP1 expression was increased, exhibited an increased tendency to differentiate, as evidenced by increased osteoblast marker gene expression and increased mineralization. Notably, treatment of cells with inorganic phosphate or pyrophosphate inhibited, as opposed to enhanced, expression of multiple genes that are expressed in association with osteoblast differentiation, matrix deposition, and mineralization. Our results indicate that ENPP1 plays multiple and distinct roles in the development of mineralized tissues and that the influence of ENPP1 on osteoblast differentiation and gene expression may include a mechanism that is independent of its catalytic activity.	[Nam, Hwa Kyung; Liu, Jin; Kragor, Andrew; Hatch, Nan E.] Univ Michigan, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA; [Li, Yan] Univ Michigan, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hatch, NE (corresponding author), Univ Michigan, Dept Orthodont & Pediat Dent, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	nhatch@umich.edu	Hatch, Nan/AAQ-8465-2020; Hatch, Nan/ABC-9177-2020	Hatch, Nan/0000-0002-2632-0841; 				Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Anderson HC, 2005, AM J PATHOL, V166, P1711, DOI 10.1016/S0002-9440(10)62481-9; Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; Babij P, 2009, J BONE MINER RES, V24, P1552, DOI [10.1359/JBMR.090417, 10.1359/jbmr.090417]; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; BELLI SI, 1995, EUR J BIOCHEM, V228, P669, DOI 10.1111/j.1432-1033.1995.tb20308.x; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Cohen MM, 1996, INT J ORAL MAX SURG, V25, P45; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; EVANS WH, 1973, BIOCHEM J, V135, P819, DOI 10.1042/bj1350819; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; FLEISCH H, 1966, AM J PHYSIOL, V211, P821, DOI 10.1152/ajplegacy.1966.211.3.821; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; GRUPE A, 1995, J BIOL CHEM, V270, P22085, DOI 10.1074/jbc.270.38.22085; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Hatch NE, 2009, J BONE MINER RES, V24, P652, DOI 10.1359/JBMR.081213; Hatch NE, 2005, CONNECT TISSUE RES, V46, P184, DOI 10.1080/03008200500237203; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hirakawa H, 2004, J ORTHOP SCI, V9, P591, DOI 10.1007/s00776-004-0823-2; Hosoda Y, 1981, Ryumachi, V21 Suppl, P157; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; James MJ, 2006, J BONE MINER RES, V21, P1034, DOI 10.1359/JBMR.060413; Johnson K, 1999, ARTHRITIS RHEUM-US, V42, P1986, DOI 10.1002/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O; Johnson K, 2005, FRONT BIOSCI-LANDMRK, V10, P988, DOI 10.2741/1593; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Johnson K, 2001, ARTHRITIS RHEUM, V44, P1071, DOI 10.1002/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO;2-3; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; Johnson K, 1999, J BONE MINER RES, V14, P883, DOI 10.1359/jbmr.1999.14.6.883; Johnson K, 2001, J RHEUMATOL, V28, P2681; Johnson KA, 2000, AM J PHYSIOL-REG I, V279, pR1365, DOI 10.1152/ajpregu.2000.279.4.R1365; Koshizuka Y, 2001, CYTOGENET CELL GENET, V94, P163, DOI 10.1159/000048809; Koshizuka Y, 2002, J BONE MINER RES, V17, P138, DOI 10.1359/jbmr.2002.17.1.138; Kreiborg S, 1981, Scand J Plast Reconstr Surg Suppl, V18, P1; Li Y, 2010, J CELL BIOCHEM, V111, P1346, DOI 10.1002/jcb.22861; Liang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000882; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Nakamura I, 1999, HUM GENET, V104, P492, DOI 10.1007/s004390050993; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Okawa A, 1999, CALCIFIED TISSUE INT, V64, P239, DOI 10.1007/s002239900610; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; Polewski MD, 2010, BONE, V46, P81, DOI 10.1016/j.bone.2009.08.055; REGISTER TC, 1985, BONE, V6, P307, DOI 10.1016/8756-3282(85)90320-5; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Ruf Nico, 2005, Hum Mutat, V25, P98, DOI 10.1002/humu.9297; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; SAKAMOTO M, 1994, PATHOL INT, V44, P420, DOI 10.1111/j.1440-1827.1994.tb01705.x; Sali A.F.J.M., 1999, ECTO ATPASES RELATED, P267; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Terkeltaub Robert, 2006, Purinergic Signal, V2, P371, DOI 10.1007/s11302-005-5304-3; Yoshiko Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011782; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	55	49	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39059	39071		10.1074/jbc.M111.221689	http://dx.doi.org/10.1074/jbc.M111.221689			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930712	hybrid, Green Published			2022-12-27	WOS:000296759800025
J	Sarma, NJ; Yaseen, NR				Sarma, Nayan J.; Yaseen, Nabeel R.			Amino-terminal Enhancer of Split (AES) Interacts with the Oncoprotein NUP98-HOXA9 and Enhances Its Transforming Ability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; NUCLEAR-PORE COMPLEX; HEMATOPOIETIC-CELLS; NUCLEOPORIN NUP98; DROSOPHILA-ENHANCER; KAPPA-B; MEDIATED TRANSCRIPTION; MYELOGENOUS LEUKEMIA; ONCOGENE NUP98-HOXA9; COREPRESSOR GROUCHO	NUP98-HOXA9 is the prototype of NUP98 fusion oncoproteins that cause acute myeloid leukemia. It consists of an N-terminal FG-rich portion of the nucleoporin NUP98 fused to the homeodomain region of the homeobox protein HOXA9, and acts as an aberrant transcription factor. To identify interacting partners of NUP98-HOXA9, we used a cytoplasmic yeast two-hybrid assay to avoid the nonspecific trans-activation that would occur with the traditional yeast two-hybrid assay due to the transactivating properties of NUP98-HOXA9. We identified amino-terminal enhancer of split (AES), a transcriptional regulator of the transducin-like enhancer/Groucho family as a novel interaction partner of NUP98-HOXA9. The interaction was confirmed by in vitro pulldown and co-immunoprecipitation assays and was shown to require the FG repeat region of NUP98-HOXA9. Immunofluorescence analysis showed that AES localizes primarily to the interior of the nucleus. AES also showed a strong interaction with wild-type NUP98. AES augmented the transcriptional activity of NUP98-HOXA9. In the presence of NUP98-HOXA9, AES caused an increase in long-term proliferation of primary human CD34+ cells with a marked increase in the numbers of primitive cells. These effects of AES were not observed in the absence of NUP98-HOXA9. AES knockdown diminished the transcriptional and proliferative effects of NUP98-HOXA9. AES caused a shift away from the erythroid lineage in cells expressing NUP98-HOXA9. These data establish AES as an interacting partner of NUP98-HOXA9 and show that it cooperates with NUP98-HOXA9 in transcriptional regulation and cell transformation.	[Sarma, Nayan J.; Yaseen, Nabeel R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Yaseen, NR (corresponding author), 660 S Euclid Ave,Campus Box 8118, St Louis, MO 63110 USA.	nyaseen@wustl.edu		Yaseen, Nabeel/0000-0001-6902-5116	National Institutes of Health [R01 HL082549, K02 HL084179]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082549, K02HL084179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL082549 and K02 HL084179 (to N. R. Y.).	Abdul-Nabi AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012464; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; Bei L, 2005, J BIOL CHEM, V280, P12359, DOI 10.1074/jbc.M408138200; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Courey AJ, 2001, GENE DEV, V15, P2786; Dayyani F, 2008, BLOOD, V111, P4338, DOI 10.1182/blood-2007-07-103291; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Fraga MF, 2008, CANCER RES, V68, P4116, DOI 10.1158/0008-5472.CAN-08-0085; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Gorello P, 2008, HAEMATOL-HEMATOL J, V93, P1398, DOI 10.3324/haematol.12945; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Guiral M, 2001, J BIOL CHEM, V276, P2961, DOI 10.1074/jbc.M004948200; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; Ishikawa M, 2007, INT J HEMATOL, V86, P238, DOI 10.1007/BF03006927; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Kaltenbach S, 2010, BLOOD, V116, P2332, DOI 10.1182/blood-2010-04-277806; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Liu JJ, 2003, J BIOL CHEM, V278, P19534, DOI 10.1074/jbc.M212278200; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; MIYASAKA H, 1993, EUR J BIOCHEM, V216, P343, DOI 10.1111/j.1432-1033.1993.tb18151.x; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Nebral K, 2005, CLIN CANCER RES, V11, P6489, DOI 10.1158/1078-0432.CCR-05-0150; Oka M, 2010, MOL BIOL CELL, V21, P1885, DOI 10.1091/mbc.E09-12-1041; Pan Q, 2008, ONCOGENE, V27, P3414, DOI 10.1038/sj.onc.1210999; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Petit A, 2010, LEUKEMIA, V24, P654, DOI 10.1038/leu.2009.241; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Reader JC, 2007, LEUKEMIA, V21, P842, DOI 10.1038/sj.leu.2404579; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Slape Christopher, 2008, J Natl Cancer Inst Monogr, P64, DOI 10.1093/jncimonographs/lgn014; Steffen B, 2011, BLOOD, V117, P4328, DOI 10.1182/blood-2009-09-242545; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Takeda A, 2010, J BIOL CHEM, V285, P16248, DOI 10.1074/jbc.M109.048785; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Tolkunova EN, 1998, MOL CELL BIOL, V18, P2804, DOI 10.1128/MCB.18.5.2804; Tosi S, 2005, GENE CHROMOSOME CANC, V44, P225, DOI 10.1002/gcc.20233; van Zutven LJCM, 2006, GENE CHROMOSOME CANC, V45, P437, DOI 10.1002/gcc.20308; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang JCW, 2000, J BIOL CHEM, V275, P18418, DOI 10.1074/jbc.M910211199; Wang WF, 2004, DEV BIOL, V270, P364, DOI 10.1016/j.ydbio.2004.03.003; Yamamoto M, 2005, CANCER GENET CYTOGEN, V157, P104, DOI 10.1016/j.cancergencyto.2004.06.014; Yassin ER, 2010, LEUKEMIA, V24, P1001, DOI 10.1038/leu.2010.42; Yassin ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006719; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zhang H, 2002, GENETICS, V160, P799; Zhang MY, 1998, BLOOD, V91, P4136, DOI 10.1182/blood.V91.11.4136.411k26_4136_4144; Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200	69	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38989	39001		10.1074/jbc.M111.297952	http://dx.doi.org/10.1074/jbc.M111.297952			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937451	Green Published, hybrid			2022-12-27	WOS:000296759800018
J	Zhang, YX				Zhang, Yunxin			Growth and Shortening of Microtubules A TWO-STATE MODEL APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE-VELOCITY RELATION; MOLECULAR MOTORS; GROWING MICROTUBULES; DYNAMIC INSTABILITY; BIASED DIFFUSION; RING COMPLEX; DAM1 RING; MODEL; KINETOCHORES; DEPOLYMERIZATION	In this study, a two-state mechanochemical model is presented to describe the dynamic instability of microtubules (MTs) in cells. The MT switches between two states, the assembly and disassembly states. In assembly state, the growth of MTs includes two processes: free GTP-tubulin binding to the tip of protofilament (PF) and conformation change of PF, during which the first tubulin unit that curls outwards is rearranged onto the MT surface, using the energy released from the hydrolysis of GTP in the penultimate tubulin unit. In the disassembly state, the shortening of MTs also includes two processes, the release of GDP-tubulin from the tip of PF and the curling of one new tubulin unit out of the MT surface. Switches between these two states, which are usually called rescue and catastrophe, happen stochastically with external force-dependent rates. Using this two-state model with parameters obtained by fitting the recent experimental data, detailed properties of MT growth are obtained. I find that MT is mainly in the assembly state, its mean growth velocity increases with both the external force and the GTP-tubulin concentration, and an MT will shorten on average without an external force. To know more about the external force and GTP-tubulin concentration-dependent properties of MT growth, and for future experimental verification of this two-state model, 11 critical forces are defined and discussed numerically.	Fudan Univ, Sch Math Sci, Shanghai Key Lab Contemporary Appl Math, Lab Math Nonlinear Sci,Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Fudan University	Zhang, YX (corresponding author), Fudan Univ, Sch Math Sci, Shanghai Key Lab Contemporary Appl Math, Lab Math Nonlinear Sci,Ctr Computat Syst Biol, Shanghai 200433, Peoples R China.	xyz@fudan.edu.cn			Natural Science Foundation of Shanghai [11ZR1403700]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by the Natural Science Foundation of Shanghai (Grant 11ZR1403700).	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Armond JW, 2010, BIOPHYS J, V98, P1598, DOI 10.1016/j.bpj.2010.01.004; Asbury CL, 2011, TRENDS CELL BIOL, V21, P38, DOI 10.1016/j.tcb.2010.09.003; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bray D, 2001, CELL MOVEMENTS MOL M; Cooper GM, 2000, CELL MOL APPROACH; DERRIDA B, 1983, J STAT PHYS, V31, P433, DOI 10.1007/BF01019492; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gao Q, 2010, P NATL ACAD SCI USA, V107, P13330, DOI 10.1073/pnas.1004887107; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; Howard J., 2001, MECH MOTOR PROTEINS; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; Joglekar AP, 2002, BIOPHYS J, V83, P42, DOI 10.1016/S0006-3495(02)75148-5; JULICHER F, 1995, PHYS REV LETT, V75, P2618, DOI 10.1103/PhysRevLett.75.2618; Kolomeisky AB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031902; Kolomeisky AB, 2001, BIOPHYS J, V80, P149, DOI 10.1016/S0006-3495(01)76002-X; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Pury PA, 2003, J PHYS A-MATH GEN, V36, P2695, DOI 10.1088/0305-4470/36/11/304; Redner S, 2001, GUIDE 1 PASSAGE PROC; Salmon ED, 2005, CURR BIOL, V15, pR299, DOI 10.1016/j.cub.2005.04.005; SCHLIWA M, 2003, MOL MOTORS; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sperry A. O., 2007, MOL MOTORS METHODS P, V392; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; WALKER RA, 1991, J CELL BIOL, V114, P73, DOI 10.1083/jcb.114.1.73; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Zhang YX, 2009, PHYS LETT A, V373, P2629, DOI 10.1016/j.physleta.2009.05.061; Zhang YX, 2009, PHYSICA A, V388, P3465, DOI 10.1016/j.physa.2009.04.039	45	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39439	39449		10.1074/jbc.M111.260208	http://dx.doi.org/10.1074/jbc.M111.260208			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21903577	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000296759800061
J	Lee, SG; Haakenson, W; McCarter, JP; Williams, DJ; Hresko, MC; Jez, JM				Lee, Soon Goo; Haakenson, William; McCarter, James P.; Williams, D. Jeremy; Hresko, Michelle C.; Jez, Joseph M.			Thermodynamic Evaluation of Ligand Binding in the Plant-like Phosphoethanolamine Methyltransferases of the Parasitic Nematode Haemonchus contortus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE N-METHYLTRANSFERASE; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; CAENORHABDITIS-ELEGANS; CRYSTAL-STRUCTURE; KINETIC-ANALYSIS; DRUG DISCOVERY; RAT-LIVER; METHYLATION; PATHWAY	Nematodes are a major cause of disease and the discovery of new pathways not found in hosts is critical for development of therapeutic targets. Previous studies suggest that Caenorhabditis elegans synthesizes phosphocholine via two S-adenosylmethionine (AdoMet)-dependent phosphoethanolamine methyltransferases (PMT). Here we examine two PMT from the parasitic nematode Haemonchus contortus. Sequence analysis suggests that HcPMT1 contains a methyltransferase domain in the N-terminal half of the protein and that HcPMT2 encodes a C-terminal methyltransferase domain, as in the C. elegans proteins. Kinetic analysis demonstrates that HcPMT1 catalyzes the conversion of phosphoethanolamine to phosphomonomethylethanolamine (pMME) and that HcPMT2 methylates pMME to phosphodimethylethanolamine (pDME) and pDME to phosphocholine. The IC50 values for miltefosine, sinefungin, amodiaquine, diphenhydramine, and tacrine suggest differences in the active sites of these two enzymes. To examine the interaction of AdoMet and S-adenosylhomocysteine (AdoCys), isothermal titration calorimetry confirmed the presence of a single binding site in each enzyme. Binding of AdoMet and AdoCys is tight (K-d similar to 2-25 mu M) over a range of temperatures (5-25 degrees C) and NaCl concentrations (0.05-0.5 M). Heat capacity changes for AdoMet and AdoCys binding suggests that each HcPMT differs in interaction surface area. Nonlinear van't Hoff plots also indicate a possible conformational change upon AdoMet/AdoCys binding. Functional analysis of the PMT from a parasitic nematode provides new insights on inhibitor and AdoMet/AdoCys binding to these enzymes.	[Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Haakenson, William; McCarter, James P.; Williams, D. Jeremy; Hresko, Michelle C.] Divergence Inc, St Louis, MO 63141 USA	Washington University (WUSTL)	Jez, JM (corresponding author), 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu		McCarter, James/0000-0001-7646-810X; Lee, Soon Goo/0000-0002-1541-8587	United States Environmental Protection Agency [X-83228201]; Department of Agriculture [2005-33610-16465]	United States Environmental Protection Agency(United States Environmental Protection Agency); Department of Agriculture	This work was supported by United States Environmental Protection Agency Grant X-83228201 (to J. P. M., D. J. W., M. C. H., and J. M. J.) and Department of Agriculture Grant 2005-33610-16465 (to M. C. H.).	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; DATKO AH, 1988, PLANT PHYSIOL, V88, P854, DOI 10.1104/pp.88.3.854; DATKO AH, 1988, PLANT PHYSIOL, V88, P1338, DOI 10.1104/pp.88.4.1338; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Gilleard JS, 2006, INT J PARASITOL, V36, P1227, DOI 10.1016/j.ijpara.2006.06.010; GRENFELL BT, 1988, PHILOS T ROY SOC B, V321, P541, DOI 10.1098/rstb.1988.0107; Horn JR, 2002, BIOCHEMISTRY-US, V41, P7501, DOI 10.1021/bi025626b; Horton JR, 2005, J MOL BIOL, V353, P334, DOI 10.1016/j.jmb.2005.08.040; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Hunter WN, 2009, J BIOL CHEM, V284, P11749, DOI 10.1074/jbc.R800072200; Jez J.M., 2007, CURR ENZYM INHIB, V3, P133, DOI [10.2174/157340807780598378, DOI 10.2174/157340807780598378]; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kent C., 1995, ANNU REV BIOCHEM, V64, P314; Komoto J, 2002, J MOL BIOL, V320, P223, DOI 10.1016/S0022-2836(02)00448-5; Kumaran S, 2003, P NATL ACAD SCI USA, V100, P14828, DOI 10.1073/pnas.2432867100; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Lee Soon Goo, 2011, Curr Chem Biol, V5, P183, DOI 10.2174/2212796811105030183; Montange RK, 2010, J MOL BIOL, V396, P761, DOI 10.1016/j.jmb.2009.12.007; MUDD SH, 1986, PLANT PHYSIOL, V82, P126, DOI 10.1104/pp.82.1.126; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; O'Brien R, 1998, J MOL BIOL, V279, P117, DOI 10.1006/jmbi.1998.1743; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Redmond DL, 2001, MOL BIOCHEM PARASIT, V117, P107, DOI 10.1016/S0166-6851(01)00331-0; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Ridley M., 2004, EVOLUTION; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; WALSH CT, 1979, ENZYMATIC REACTION M; Wu Q, 2005, J MED CHEM, V48, P7243, DOI 10.1021/jm050568o; Zajac AM, 2006, VET CLIN N AM-FOOD A, V22, P529, DOI 10.1016/j.cvfa.2006.07.006	42	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38060	38068		10.1074/jbc.M111.290619	http://dx.doi.org/10.1074/jbc.M111.290619			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914812	Green Published, hybrid			2022-12-27	WOS:000296594200018
J	Alalouf, O; Balazs, Y; Volkinshtein, M; Grimpel, Y; Shoham, G; Shoham, Y				Alalouf, Onit; Balazs, Yael; Volkinshtein, Margarita; Grimpel, Yael; Shoham, Gil; Shoham, Yuval			A New Family of Carbohydrate Esterases Is Represented by a GDSL Hydrolase/Acetylxylan Esterase from Geobacillus stearothermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-ARABINOFURANOSIDASE; DETAILED KINETIC-ANALYSIS; ACETYLXYLAN ESTERASE; GLYCOSIDE HYDROLASE; CATALYTIC RESIDUES; CRYSTAL-STRUCTURE; BETA-XYLOSIDASE; BIOCHEMICAL-CHARACTERIZATION; THERMOSTABLE XYLANASE; SUBSTRATE-SPECIFICITY	Acetylxylan esterases hydrolyze the ester linkages of acetyl groups at positions 2 and/or 3 of the xylose moieties in xylan and play an important role in enhancing the accessibility of xylanases to the xylan backbone. The hemicellulolytic system of the thermophilic bacterium Geobacillus stearothermophilus T-6 comprises a putative acetylxylan esterase gene, axe2. The gene product belongs to the GDSL hydrolase family and does not share sequence homology with any of the carbohydrate esterases in the CAZy Database. The axe2 gene is induced by xylose, and the purified gene product completely deacetylates xylobiose peracetate (fully acetylated) and hydrolyzes the synthetic substrates 2-naphthyl acetate, 4-nitrophenyl acetate, 4-methylumbelliferyl acetate, and phenyl acetate. The pH profiles for k(cat) and k(cat)/K-m suggest the existence of two ionizable groups affecting the binding of the substrate to the enzyme. Using NMR spectroscopy, the regioselectivity of Axe2 was directly determined with the aid of one-dimensional selective total correlation spectroscopy. Methyl 2,3,4-tri-O-acetyl-beta-D-xylopyranoside was rapidly deacetylated at position 2 or at positions 3 and 4 to give either diacetyl or monoacetyl intermediates, respectively; methyl 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranoside was initially deacetylated at position 6. In both cases, the complete hydrolysis of the intermediates occurred at a much slower rate, suggesting that the preferred substrate is the peracetate sugar form. Site-directed mutagenesis of Ser-15, His-194, and Asp-191 resulted in complete inactivation of the enzyme, consistent with their role as the catalytic triad. Overall, our results show that Axe2 is a serine acetylxylan esterase representing a new carbohydrate esterase family.	[Alalouf, Onit; Volkinshtein, Margarita; Grimpel, Yael; Shoham, Yuval] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel; [Balazs, Yael] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel; [Shoham, Gil] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Hebrew University of Jerusalem	Shoham, Y (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.	yshoham@technion.ac.il	Shoham, Yuval/M-4409-2013; Balazs, Amber/AAO-5408-2021	Balazs, Amber/0000-0002-5556-6795	Israel Science Foundation [500/10]; United States-Israel Binational Science Foundation (BSF; Jerusalem, Israel) [96-178]; Technion-Israel Institute of Technology Otto Meyerhof Center for Biotechnology	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation (BSF; Jerusalem, Israel)(US-Israel Binational Science Foundation); Technion-Israel Institute of Technology Otto Meyerhof Center for Biotechnology	This work was supported by Israel Science Foundation Grant 500/10 (to Y. S.), United States-Israel Binational Science Foundation (BSF; Jerusalem, Israel) Grant 96-178 (to Y. S.), and the Technion-Israel Institute of Technology Otto Meyerhof Center for Biotechnology, established by the Minerva Foundation (Munich, Germany).	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Bakshy K, 2009, BBA-PROTEINS PROTEOM, V1794, P324, DOI 10.1016/j.bbapap.2008.10.007; Bar M, 2004, ACTA CRYSTALLOGR D, V60, P545, DOI 10.1107/S0907444903029305; Ben-David A, 2007, CHEMBIOCHEM, V8, P2145, DOI 10.1002/cbic.200700414; BENDER M L, 1973, Critical Reviews in Biochemistry, V1, P149, DOI 10.3109/10409237309102546; Biely P, 1996, FEBS LETT, V396, P257, DOI 10.1016/0014-5793(96)01080-0; Biely P, 1996, BBA-PROTEIN STRUCT M, V1298, P209, DOI 10.1016/S0167-4838(96)00132-X; Biely P, 2011, J BIOTECHNOL, V151, P137, DOI 10.1016/j.jbiotec.2010.10.074; Bravman T, 2003, BIOCHEMISTRY-US, V42, P10528, DOI 10.1021/bi034505o; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GAT O, 1994, APPL ENVIRON MICROB, V60, P1889, DOI 10.1128/AEM.60.6.1889-1896.1994; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Golan G, 2004, J BIOL CHEM, V279, P3014, DOI 10.1074/jbc.M310098200; Hakulinen N, 2000, J STRUCT BIOL, V132, P180, DOI 10.1006/jsbi.2000.4318; Harris RK, 2008, MAGN RESON CHEM, V46, P582, DOI 10.1002/mrc.2225; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; JOHNSON KG, 1988, HEMICELLULOSE; KESSLER H, 1986, J MAGN RESON, V70, P106, DOI 10.1016/0022-2364(86)90366-5; KHASIN A, 1993, APPL ENVIRON MICROB, V59, P1725, DOI 10.1128/AEM.59.6.1725-1730.1993; Lapidot A, 1996, J BIOTECHNOL, V51, P259, DOI 10.1016/S0168-1656(96)01604-5; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Lo YC, 2003, J MOL BIOL, V330, P539, DOI 10.1016/S0022-2836(03)00637-5; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; Shallom D, 2004, J BACTERIOL, V186, P6928, DOI 10.1128/JB.186.20.6928-6937.2004; Shallom D, 2002, FEBS LETT, V514, P163, DOI 10.1016/S0014-5793(02)02343-8; Shallom D, 2002, J BIOL CHEM, V277, P43667, DOI 10.1074/jbc.M208285200; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Teplitsky A, 1997, ACTA CRYSTALLOGR D, V53, P608, DOI 10.1107/S0907444997002734; Topakas E, 2010, FEBS LETT, V584, P543, DOI 10.1016/j.febslet.2009.11.095; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; WHARTON CW, 1998, SERINE PROTEINASES; Zaide G, 2001, EUR J BIOCHEM, V268, P3006, DOI 10.1046/j.1432-1327.2001.02193.x	46	46	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41993	42001		10.1074/jbc.M111.301051	http://dx.doi.org/10.1074/jbc.M111.301051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994937	Green Published, hybrid			2022-12-27	WOS:000298180900010
J	Jayaraman, T; Tejero, J; Chen, BB; Blood, AB; Frizzell, S; Shapiro, C; Tiso, M; Hood, BL; Wang, XD; Zhao, XJ; Conrads, TP; Mallampalli, RK; Gladwin, MT				Jayaraman, Thottala; Tejero, Jesus; Chen, Bill B.; Blood, Arlin B.; Frizzell, Sheila; Shapiro, Calli; Tiso, Mauro; Hood, Brian L.; Wang, Xunde; Zhao, Xuejun; Conrads, Thomas P.; Mallampalli, Rama K.; Gladwin, Mark T.			14-3-3 Binding and Phosphorylation of Neuroglobin during Hypoxia Modulate Six-to-Five Heme Pocket Coordination and Rate of Nitrite Reduction to Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; INDUCIBLE FACTOR-1-ALPHA; GLOBIN; ACTIVATION; CYTOGLOBIN; EXPRESSION; REACTIVITY; INHIBITOR; PROTECTS; SURVIVAL	Neuroglobin protects neurons from hypoxia in vitro and in vivo; however, the underlying mechanisms for this effect remain poorly understood. Most of the neuroglobin is present in a hexacoordinate state with proximal and distal histidines in the heme pocket directly bound to the heme iron. At equilibrium, the concentration of the five-coordinate neuroglobin remains very low (0.1-5%). Recent studies have shown that post-translational redox regulation of neuroglobin surface thiol disulfide formation increases the open probability of the heme pocket and allows nitrite binding and reaction to form NO. We hypothesized that the equilibrium between the six-and five-coordinate states and secondary reactions with nitrite to form NO could be regulated by other hypoxia-dependent post-translational modification(s). Protein sequence models identified candidate sites for both 14-3-3 binding and phosphorylation. In both in vitro experiments and human SH-SY5Y neuronal cells exposed to hypoxia and glucose deprivation, we observed that 1) neuroglobin phosphorylation and protein-protein interactions with 14-3-3 increase during hypoxic and metabolic stress; 2) neuroglobin binding to 14-3-3 stabilizes and increases the half-life of phosphorylation; and 3) phosphorylation increases the open probability of the heme pocket, which increases ligand binding (CO and nitrite) and accelerates the rate of anaerobic nitrite reduction to form NO. These data reveal a series of hypoxia-dependent post-translational modifications to neuroglobin that regulate the six-to-five heme pocket equilibrium and heme access to ligands. Hypoxia-regulated reactions of nitrite and neuroglobin may contribute to the cellular adaptation to hypoxia.	[Hood, Brian L.; Conrads, Thomas P.; Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA; [Jayaraman, Thottala; Tejero, Jesus; Frizzell, Sheila; Shapiro, Calli; Tiso, Mauro; Zhao, Xuejun; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Jayaraman, Thottala; Chen, Bill B.; Mallampalli, Rama K.; Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Med, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA; [Wang, Xunde] NHLBI, NIH, Bethesda, MD 20892 USA; [Blood, Arlin B.] Loma Linda Univ, Sch Med, Dept Pediat, Div Neonatol, Loma Linda, CA 92354 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Loma Linda University	Gladwin, MT (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA.	gladwinmt@upmc.edu	Tejero, Jesus/G-3953-2017; Blood, Arlin/AAG-8897-2020	Tejero, Jesus/0000-0003-3245-9978; Blood, Arlin/0000-0002-4803-5021	National Institutes of Health [R01 HL098032, R01 HL096973, P01 HL103455, R01 HL096376, R01 HL097376, R01 HL098174]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098032, R01HL097376, R01HL095973, R01HL096376, R01HL096973, R01HL098174, P01HL103455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL098032, R01 HL096973, and P01 HL103455 (to M. T. G.) and R01 HL096376, R01 HL097376, and R01 HL098174 (to R. K. M.). This work was also supported by the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania (to M. T. G.). M. Tiso and M. T. Gladwin are listed as co-inventors on a patent application entitled "Neuroglobin as a Six-to-Five Coordinate-regulated Nitrite Reductase."	Abbruzzetti S, 2009, P NATL ACAD SCI USA, V106, P18984, DOI 10.1073/pnas.0905433106; Arany I, 2005, KIDNEY INT, V68, P1573, DOI 10.1111/j.1523-1755.2005.00569.x; Ascenzi P, 2004, BIOCHEM MOL BIOL EDU, V32, P305, DOI 10.1002/bmb.2004.494032050386; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Fago A, 2006, J INORG BIOCHEM, V100, P1339, DOI 10.1016/j.jinorgbio.2006.03.009; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; Jayaraman T, 2000, J BIOL CHEM, V275, P6417, DOI 10.1074/jbc.275.9.6417; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Li J, 2008, J PHYS CHEM B, V112, P8715, DOI 10.1021/jp711919f; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Liu XH, 2002, J BIOL CHEM, V277, P50081, DOI 10.1074/jbc.M201095200; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Milton SL, 2006, J BIOMED SCI, V13, P509, DOI 10.1007/s11373-006-9084-8; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Nadra AD, 2008, PROTEINS, V71, P695, DOI 10.1002/prot.21814; Nicolis S, 2007, BIOCHEM J, V407, P89, DOI 10.1042/BJ20070372; Nienhaus K, 2007, IUBMB LIFE, V59, P490, DOI 10.1080/15216540601188538; Nienhaus K, 2010, CHEMPHYSCHEM, V11, P119, DOI 10.1002/cphc.200900637; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Saurin AT, 2000, FASEB J, V14, P2237, DOI 10.1096/fj.99-0671com; Shang AJ, 2006, BRAIN RES, V1078, P219, DOI 10.1016/j.brainres.2006.01.064; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vos MH, 2008, BIOCHEMISTRY-US, V47, P5718, DOI 10.1021/bi800288z; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Watanabe S, 2008, BIOCHEM BIOPH RES CO, V369, P695, DOI 10.1016/j.bbrc.2008.02.089; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Ye SQ, 2009, ACTA PHARMACOL SIN, V30, P913, DOI 10.1038/aps.2009.70; Yu ZY, 2009, NEUROL RES, V31, P122, DOI 10.1179/174313209X389866; Zhu YH, 2002, BLOOD, V100, P2494, DOI 10.1182/blood-2002-01-0280	48	59	61	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42679	42689		10.1074/jbc.M111.271973	http://dx.doi.org/10.1074/jbc.M111.271973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965683	hybrid, Green Published			2022-12-27	WOS:000298180900075
J	Magliano, P; Flipphi, M; Arpat, BA; Delessert, S; Poirier, Y				Magliano, Pasqualina; Flipphi, Michel; Arpat, Bulak A.; Delessert, Syndie; Poirier, Yves			Contributions of the Peroxisome and beta-Oxidation Cycle to Biotin Synthesis in Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA COLI K-12; ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; 8-AMINO-7-OXONONANOATE SYNTHASE; BACILLUS-SUBTILIS; GENE-CLUSTER; FATTY-ACIDS; BIOSYNTHESIS; SEQUENCE; IDENTIFICATION	The first step in the synthesis of the bicyclic rings of D-biotin is mediated by 8-amino-7-oxononanoate (AON) synthase, which catalyzes the decarboxylative condensation of L-alanine and pimelate thioester. We found that the Aspergillus nidulans AON synthase, encoded by the bioF gene, is a peroxisomal enzyme with a type 1 peroxisomal targeting sequence (PTS1). Localization of AON to the peroxisome was essential for biotin synthesis because expression of a cytosolic AON variant or deletion of pexE, encoding the PTS1 receptor, rendered A. nidulans a biotin auxotroph. AON synthases with PTS1 are found throughout the fungal kingdom, in ascomycetes, basidiomycetes, and members of basal fungal lineages but not in representatives of the Saccharomyces species complex, including Saccharomyces cerevisiae. A. nidulans mutants defective in the peroxisomal acyl-CoA oxidase AoxA or the multifunctional protein FoxA showed a strong decrease in colonial growth rate in biotin-deficient medium, whereas partial growth recovery occurred with pimelic acid supplementation. These results indicate that pimeloyl-CoA is the in vivo substrate of AON synthase and that it is generated in the peroxisome via the beta-oxidation cycle in A. nidulans and probably in a broad range of fungi. However, the beta-oxidation cycle is not essential for biotin synthesis in S. cerevisiae or Escherichia coli. These results suggest that alternative pathways for synthesis of the pimelate intermediate exist in bacteria and eukaryotes and that Saccharomyces species use a pathway different from that used by the majority of fungi.	[Poirier, Yves] Univ Lausanne, DBMV, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Flipphi, Michel] CSIC, Inst Agroquim & Tecnol Alimentos, E-46100 Valencia, Spain	University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Poirier, Y (corresponding author), Univ Lausanne, DBMV, Dept Plant Mol Biol, Biophore Bldg, CH-1015 Lausanne, Switzerland.	yves.poirier@unil.ch	Arpat, Alaaddin Bulak/C-1336-2008	Arpat, Alaaddin Bulak/0000-0002-7749-3793	Fonds National Suisse de la Recherche Scientifique [3100A0-122493]; Ministerio de Ciencia e Innovacion (MCINN) [BIO2008-00228]; Spanish Ministerio de Ciencia e Innovacion [RYC-2004-003005]	Fonds National Suisse de la Recherche Scientifique; Ministerio de Ciencia e Innovacion (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported in part by Fonds National Suisse de la Recherche Scientifique Grant 3100A0-122493 (to Y. P.). Work at the Instituto de Agroquimica y Tecnologia de Alimentos was supported by Ministerio de Ciencia e Innovacion (MCINN) Grant BIO2008-00228.; Supported by Ramon y Cajal Postdoctoral Contract RYC-2004-003005 from the Spanish Ministerio de Ciencia e Innovacion.	Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bower S, 1996, J BACTERIOL, V178, P4122, DOI 10.1128/jb.178.14.4122-4130.1996; CLEARY PP, 1972, J BACTERIOL, V112, P830, DOI 10.1128/JB.112.2.830-839.1972; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; DELCAMPI.A, 1967, J BACTERIOL, V94, P2065, DOI 10.1128/JB.94.6.2065-2066.1967; Engh I, 2007, EUKARYOT CELL, V6, P831, DOI 10.1128/EC.00269-06; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; Han KH, 2003, J MICROBIOL, V41, P34; Hynes MJ, 2008, GENETICS, V178, P1355, DOI 10.1534/genetics.107.085795; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Lin S, 2011, MOL BIOSYST, V7, P1811, DOI 10.1039/c1mb05022b; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Magliano P, 2011, FUNGAL GENET BIOL, V48, P208, DOI 10.1016/j.fgb.2010.08.004; Magliano P, 2010, BBA-MOL CELL BIOL L, V1801, P1386, DOI 10.1016/j.bbalip.2010.08.008; McDonald T, 2005, MOL PLANT MICROBE IN, V18, P539, DOI 10.1094/MPMI-18-0539; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Phalip V, 1999, GENE, V232, P43, DOI 10.1016/S0378-1119(99)00117-1; Poggeler S., 2008, FUNGAL GENET REP, V55, P8, DOI [10.4148/1941-4765.1083, DOI 10.4148/1941-4765.1083]; Pokorska A, 2000, J MOL BIOL, V298, P585, DOI 10.1006/jmbi.2000.3666; Reiser K, 2010, CURR GENET, V56, P139, DOI 10.1007/s00294-009-0286-2; Rodionov DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r90; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; ROLFE B, 1968, J BACTERIOL, V96, P515, DOI 10.1128/JB.96.2.515-524.1968; Ruprich-Robert G, 2002, GENETICS, V161, P1089; Stok JE, 2000, ARCH BIOCHEM BIOPHYS, V384, P351, DOI 10.1006/abbi.2000.2067; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Tanabe Y, 2011, J BIOL CHEM, V286, P30455, DOI 10.1074/jbc.M111.247338; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Wu H, 2005, APPL ENVIRON MICROB, V71, P6845, DOI 10.1128/AEM.71.11.6845-6855.2005; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	38	27	34	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42133	42140		10.1074/jbc.M111.279687	http://dx.doi.org/10.1074/jbc.M111.279687			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21998305	hybrid, Green Published			2022-12-27	WOS:000298180900024
J	Wong, W; Wijeyewickrema, LC; Kennan, RM; Reeve, SB; Steer, DL; Reboul, C; Smith, AI; Pike, RN; Rood, JI; Whisstock, JC; Porter, CJ				Wong, Wilson; Wijeyewickrema, Lakshmi C.; Kennan, Ruth M.; Reeve, Shane B.; Steer, David L.; Reboul, Cyril; Smith, A. Ian; Pike, Robert N.; Rood, Julian I.; Whisstock, James C.; Porter, Corrine J.			S1 Pocket of a Bacterially Derived Subtilisin-like Protease Underpins Effective Tissue Destruction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGEN DICHELOBACTER-NODOSUS; MOLECULAR-GRAPHICS PROJECT; OVINE FOOTROT PATHOGEN; BACTEROIDES-NODOSUS; SERINE PROTEASES; BASIC PROTEASE; AMINO-ACID; IDENTIFICATION; ELASTASE; VIRULENT	The ovine footrot pathogen, Dichelobacter nodosus, secretes three subtilisin-like proteases that play an important role in the pathogenesis of footrot through their ability to mediate tissue destruction. Virulent and benign strains of D. nodosus secrete the basic proteases BprV and BprB, respectively, with the catalytic domain of these enzymes having 96% sequence identity. At present, it is not known how sequence variation between these two putative virulence factors influences their respective biological activity. We have determined the high resolution crystal structures of BprV and BprB. These data reveal that that the S1 pocket of BprV is more hydrophobic but smaller than that of BprB. We show that BprV is more effective than BprB in degrading extracellular matrix components of the host tissue. Mutation of two residues around the S1 pocket of BprB to the equivalent residues in BprV dramatically enhanced its proteolytic activity against elastin substrates. Application of a novel approach for profiling substrate specificity, the Rapid Endopeptidase Profiling Library (REPLi) method, revealed that both enzymes prefer cleaving after hydrophobic residues (and in particular P1 leucine) but that BprV has more restricted primary substrate specificity than BprB. Furthermore, for P1 Leu-containing substrates we found that BprV is a significantly more efficient enzyme than BprB. Collectively, these data illuminate how subtle changes in D. nodosus proteases may significantly influence tissue destruction as part of the ovine footrot pathogenesis process.	[Kennan, Ruth M.; Rood, Julian I.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Wong, Wilson; Kennan, Ruth M.; Reeve, Shane B.; Steer, David L.; Reboul, Cyril; Smith, A. Ian; Rood, Julian I.; Whisstock, James C.; Porter, Corrine J.] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia; [Wong, Wilson; Wijeyewickrema, Lakshmi C.; Reeve, Shane B.; Steer, David L.; Reboul, Cyril; Smith, A. Ian; Pike, Robert N.; Whisstock, James C.; Porter, Corrine J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University	Rood, JI (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	julian.rood@monash.edu; james.whisstock@monash.edu	Rood, Julian I/A-4858-2008; Wijeyewickrema, Lakshmi/A-9676-2015	Rood, Julian I/0000-0003-2126-7209; Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Smith, Ian/0000-0002-4143-2892; Reboul, Cyril/0000-0002-6258-2697; Pike, Robert/0000-0002-2083-0269; Wong, Wilson/0000-0003-1335-8047; Whisstock, James/0000-0003-4200-5611	Australian Research Council; Department of Biochemistry and Molecular Biology at Monash University; Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics	Australian Research Council(Australian Research Council); Department of Biochemistry and Molecular Biology at Monash University; Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council)	This research was supported by the Australian Research Council through funding to the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics.; Supported by a Faculty scholarship provided by the Department of Biochemistry and Molecular Biology at Monash University and previously supported by a scholarship from the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics.	Androulakis S, 2008, ACTA CRYSTALLOGR D, V64, P810, DOI 10.1107/S0907444908015540; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Billington SJ, 1996, FEMS MICROBIOL LETT, V145, P147, DOI 10.1111/j.1574-6968.1996.tb08570.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEPIAZZI LJ, 1979, AUST VET J, V55, P25, DOI 10.1111/j.1751-0813.1979.tb09541.x; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Green LE, 2008, VET J, V175, P173, DOI 10.1016/j.tvjl.2007.01.014; Kennan RM, 2011, VET MICROBIOL, V153, P59, DOI 10.1016/j.vetmic.2011.04.005; Kennan RM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001210; KORTT AA, 1994, BIOCHEM J, V299, P521, DOI 10.1042/bj2990521; LILLEY GG, 1992, EUR J BIOCHEM, V210, P13, DOI 10.1111/j.1432-1033.1992.tb17385.x; LILLEY GG, 1995, BIOCHEM MOL BIOL INT, V36, P101; LIU D, 1993, RES VET SCI, V55, P124, DOI 10.1016/0034-5288(93)90046-I; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers GSA, 2007, NAT BIOTECHNOL, V25, P569, DOI 10.1038/nbt1302; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RIFFKIN MC, 1993, GENE, V137, P259, DOI 10.1016/0378-1119(93)90017-W; Riffkin MC, 1995, GENE, V167, P279, DOI 10.1016/0378-1119(95)00664-8; ROBERTS DS, 1969, J COMP PATHOL, V79, P217, DOI 10.1016/0021-9975(69)90008-5; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Stewart D. J., 1989, Footrot and foot abscess of ruminants., P5; STEWART DJ, 1979, RES VET SCI, V27, P99, DOI 10.1016/S0034-5288(18)32866-2; Thomas DA, 2006, PROTEOMICS, V6, P2112, DOI 10.1002/pmic.200500153; Wani SA, 2006, VET J, V171, P421, DOI 10.1016/j.tvjl.2005.02.017; Wong W, 2010, ACTA CRYSTALLOGR F, V66, P289, DOI 10.1107/S1744309110000333	33	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42180	42187		10.1074/jbc.M111.298711	http://dx.doi.org/10.1074/jbc.M111.298711			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21990366	Green Published, hybrid			2022-12-27	WOS:000298180900028
J	Convertino, M; Vitalis, A; Caflisch, A				Convertino, Marino; Vitalis, Andreas; Caflisch, Amedeo			Disordered Binding of Small Molecules to A beta(12-28)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; A-BETA-PEPTIDE; ALPHA-SYNUCLEIN AGGREGATION; ALZHEIMERS-DISEASE; IN-VITRO; PROTEIN AGGREGATION; INTRINSIC DISORDER; CONGO RED; INHIBITORS; OLIGOMERS	In recent years, an increasing number of small molecules and short peptides have been identified that interfere with aggregation and/or oligomerization of the Alzheimer beta-amyloid peptide (A beta). Many of them possess aromatic moieties, suggesting a dominant role for those in interacting with A beta along various stages of the aggregation process. In this study, we attempt to elucidate whether interactions of such aromatic inhibitors with monomeric A beta(12-28) point to a common mechanism of action by performing atomistic molecular dynamics simulations at equilibrium. Our results suggest that, independently of the presence of inhibitors, monomeric A beta(12-28) populates a partially collapsed ensemble that is largely devoid of canonical secondary structure at 300 K and neutral pH. The small molecules have different affinities for A beta(12-28) that can be partially rationalized by the balance of aromatic and charged moieties constituting the molecules. There are no predominant binding modes, although aggregation inhibitors preferentially interact with the N-terminal portion of the fragment (residues 13-20). Analysis of the free energy landscape of A beta(12-28) reveals differences highlighted by altered populations of a looplike conformer in the presence of inhibitors. We conclude that intrinsic disorder of AB persists at the level of binding small molecules and that inhibitors can significantly alter properties of monomeric AB via multiple routes of differing specificity.	[Convertino, Marino; Vitalis, Andreas; Caflisch, Amedeo] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Vitalis, A (corresponding author), Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland.	a.vitalis@bioc.uzh.ch; caflisch@bioc.uzh.ch	Caflisch, Amedeo/I-3459-2012		Swiss National Science Foundation; UZH Forschungskredit	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UZH Forschungskredit	This work was supported by a grant of the Swiss National Science Foundation (to A. C.) and a grant of the UZH Forschungskredit (to A. V.).	Armstrong AH, 2011, BIOCHEMISTRY-US, V50, P4058, DOI 10.1021/bi200268w; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Baumketner A, 2008, P NATL ACAD SCI USA, V105, P6027, DOI 10.1073/pnas.0708193105; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Chebaro Y, 2009, PROTEINS, V75, P442, DOI 10.1002/prot.22254; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cohen T, 2006, BIOCHEMISTRY-US, V45, P4727, DOI 10.1021/bi051525c; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Convertino M, 2009, PROTEIN SCI, V18, P792, DOI 10.1002/pro.87; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Evers F, 2009, J AM CHEM SOC, V131, P9516, DOI 10.1021/ja8097417; Fawzi NL, 2007, J MOL BIOL, V365, P535, DOI 10.1016/j.jmb.2006.10.011; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; FIELDS GB, 1992, J PHYS CHEM-US, V96, P3974, DOI 10.1021/j100189a013; Frydman-Marom A, 2009, ANGEW CHEM INT EDIT, V48, P1981, DOI 10.1002/anie.200802123; Frydman-Marorn A., 2011, ACS CHEM BI IN PRESS; Gervais F, 2007, NEUROBIOL AGING, V28, P537, DOI 10.1016/j.neurobiolaging.2006.02.015; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Hawkes CA, 2009, DRUG DEVELOP RES, V70, P111, DOI 10.1002/ddr.20290; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hillmer AS, 2010, BIOCHEM BIOPH RES CO, V391, P461, DOI 10.1016/j.bbrc.2009.11.080; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Jiang P, 2011, BIOPHYS J, V100, P1550, DOI 10.1016/j.bpj.2011.02.010; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanapathipillai M, 2005, FEBS LETT, V579, P4775, DOI 10.1016/j.febslet.2005.07.057; Kim J, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-20; Kim S, 2011, BIOPHYS J, V100, P2024, DOI 10.1016/j.bpj.2011.02.044; Kim S, 2010, BIOPHYS J, V99, P1949, DOI 10.1016/j.bpj.2010.07.008; Kokkoni N, 2006, BIOCHEMISTRY-US, V45, P9906, DOI 10.1021/bi060837s; Krivov SV, 2006, J PHYS CHEM B, V110, P12689, DOI 10.1021/jp060039b; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Latawiec D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009234; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Mishra R, 2008, ANGEW CHEM INT EDIT, V47, P4679, DOI 10.1002/anie.200705372; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; Pappu RV, 2008, ARCH BIOCHEM BIOPHYS, V469, P132, DOI 10.1016/j.abb.2007.08.033; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pellarin R, 2006, J MOL BIOL, V360, P882, DOI 10.1016/j.jmb.2006.05.033; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Re F, 2010, CURR MED CHEM, V17, P2990, DOI 10.2174/092986710791959729; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Schafer L, 1999, EXCLUDED VOLUME EFFE; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Schutz AK, 2011, ANGEW CHEM INT EDIT, V50, P5956, DOI 10.1002/anie.201008276; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Stempler S, 2011, J COMPUT AID MOL DES, V25, P135, DOI 10.1007/s10822-010-9405-x; Straub JE, 2002, ACCOUNTS CHEM RES, V35, P473, DOI 10.1021/ar010031e; Szegedi V, 2006, FASEB J, V20, P1191, DOI 10.1096/fj.05-4891fje; Takeda T, 2010, J PHYS CHEM B, V114, P15394, DOI 10.1021/jp107955v; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tarus B, 2005, J MOL BIOL, V345, P1141, DOI 10.1016/j.jmb.2004.11.022; Tarus B, 2008, J MOL BIOL, V379, P815, DOI 10.1016/j.jmb.2008.04.028; TERRY RD, 1994, PROG BRAIN RES, V101, P383; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tran HT, 2006, BIOPHYS J, V91, P1868, DOI 10.1529/biophysj.106.086264; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; Vitalis A, 2010, J MOL BIOL, V403, P148, DOI 10.1016/j.jmb.2010.08.003; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu C, 2011, CURR OPIN STRUC BIOL, V21, P209, DOI 10.1016/j.sbi.2011.02.002; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Zagrovic B, 2006, PROTEINS, V63, P210, DOI 10.1002/prot.20872; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288; Zhang SS, 1998, FOLD DES, V3, P413, DOI 10.1016/S1359-0278(98)00054-6; Zhou WB, 2009, J MOL BIOL, V388, P597, DOI 10.1016/j.jmb.2009.03.053	104	45	45	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41578	41588		10.1074/jbc.M111.285957	http://dx.doi.org/10.1074/jbc.M111.285957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969380	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000298057500043
J	Joseph, B; Jeschke, G; Goetz, BA; Locher, KP; Bordignon, E				Joseph, Benesh; Jeschke, Gunnar; Goetz, Birke A.; Locher, Kaspar P.; Bordignon, Enrica			Transmembrane Gate Movements in the Type II ATP-binding Cassette (ABC) Importer BtuCD-F during Nucleotide Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; ESCHERICHIA-COLI; MALTOSE TRANSPORTER; VITAMIN-B12 TRANSPORT; CRYSTAL-STRUCTURE; PROTEIN; MECHANISM; DYNAMICS; MUTANTS; IDENTIFICATION	ATP-binding cassette (ABC) transporters are ubiquitous integral membrane proteins that translocate substrates across cell membranes. The alternating access of their transmembrane domains to opposite sides of the membrane powered by the closure and reopening of the nucleotide binding domains is proposed to drive the translocation events. Despite clear structural similarities, evidence for considerable mechanistic diversity starts to accumulate within the importers subfamily. We present here a detailed study of the gating mechanism of a ABC importer, the BtuCD-F vitamin B-12 importer from Escherichia coli, elucidated by EPR spectroscopy. Distance changes at key positions in the translocation gates in the nucleotide-free, ATP- and ADP-bound conformations of the transporter were measured in detergent micelles and liposomes. The translocation gates of the BtuCD-F complex undergo conformational changes in line with a "two-state" alternating access model. We provide the first direct evidence that binding of ATP drives the gates to an inward-facing conformation, in contrast to type I importers specific for maltose, molybdate, or methionine. Following ATP hydrolysis, the translocation gates restore to an apo-like conformation. In the presence of ATP, an excess of vitamin B-12 promotes the reopening of the gates toward the periplasm and the dislodgment of BtuF from the transporter. The EPR data allow a productive translocation cycle of the vitamin B-12 transporter to be modeled.	[Joseph, Benesh; Jeschke, Gunnar; Bordignon, Enrica] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Goetz, Birke A.; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bordignon, E (corresponding author), ETH, Phys Chem Lab, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	enrica.bordignon@phys.chem.ethz.ch	JOSEPH, BENESH/K-4628-2016; Joseph, Benesh/AAK-9039-2020	JOSEPH, BENESH/0000-0003-4968-889X; Joseph, Benesh/0000-0003-4968-889X; Jeschke, Gunnar/0000-0001-6853-8585; Bordignon, Enrica/0000-0003-2450-5161	ETH [ETH-21 09-1]; Swiss National Science Foundation (SNF) [31003A-131075/1]	ETH(ETH Zurich); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by the ETH Research Grant ETH-21 09-1 (to G. J. and E. B.) and by Grant Swiss National Science Foundation (SNF) 31003A-131075/1 (to K. P. L.).	AUFRERE R, 1986, MOL GEN GENET, V205, P358, DOI 10.1007/BF00430451; BASSFORD PJ, 1976, J BACTERIOL, V128, P242, DOI 10.1128/JB.128.1.242-247.1976; BASSFORD PJ, 1977, J BACTERIOL, V132, P796, DOI 10.1128/JB.132.3.796-805.1977; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; Cadieux N, 2002, J BACTERIOL, V184, P706, DOI 10.1128/JB.184.3.706-717.2002; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; DIGIROLA.PM, 1971, J BACTERIOL, V106, P751, DOI 10.1128/JB.106.3.751-757.1971; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Grote M, 2008, BIOPHYS J, V95, P2924, DOI 10.1529/biophysj.108.132456; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; James KJ, 2009, BIOCHEMISTRY-US, V48, P9212, DOI 10.1021/bi900722p; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MERINO G, 1995, J THEOR BIOL, V177, P171, DOI 10.1006/jtbi.1995.0236; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; TAYLOR RT, 1972, ARCH BIOCHEM BIOPHYS, V148, P366, DOI 10.1016/0003-9861(72)90154-3; Tschaggelar R, 2009, J MAGN RESON, V200, P81, DOI 10.1016/j.jmr.2009.06.007; Van Bibber M, 1999, J BACTERIOL, V181, P5539, DOI 10.1128/JB.181.17.5539-5541.1999; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; WHITE JC, 1973, J BIOL CHEM, V248, P3978; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	39	48	49	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41008	41017		10.1074/jbc.M111.269472	http://dx.doi.org/10.1074/jbc.M111.269472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21953468	hybrid, Green Published			2022-12-27	WOS:000297315400060
J	Bin, BH; Fukada, T; Hosaka, T; Yamasaki, S; Ohashi, W; Hojyo, S; Miyai, T; Nishida, K; Yokoyama, S; Hirano, T				Bin, Bum-Ho; Fukada, Toshiyuki; Hosaka, Toshiaki; Yamasaki, Satoru; Ohashi, Wakana; Hojyo, Shintaro; Miyai, Tomohiro; Nishida, Keigo; Yokoyama, Shigeyuki; Hirano, Toshio			Biochemical Characterization of Human ZIP13 Protein A HOMO-DIMERIZED ZINC TRANSPORTER INVOLVED IN THE SPONDYLOCHEIRO DYSPLASTIC EHLERS-DANLOS SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIV-1 SUBFAMILY; SECRETORY PATHWAY; MEMBER; ARCHITECTURE; SYMPORTER; COMPLEXES; REVEALS; GROWTH; CELLS; CTR1	The human SLC39A13 gene encodes ZIP13, a member of the LZT (LIV-1 subfamily of ZIP zinc transporters) family. The ZIP13 protein is important for connective tissue development, and its loss of function is causative for the spondylocheiro dysplastic form of Ehlers-Danlos syndrome. However, this protein has not been characterized in detail. Here we report the first detailed biochemical characterization of the human ZIP13 protein using its ectopic expressed and the purified recombinant protein. Protease accessibility, microscopic, and computational analyses demonstrated that ZIP13 contains eight putative transmembrane domains and a unique hydrophilic region and that it resides with both its N and C termini facing the luminal side on the Golgi. Analyses including cross-linking, immunoprecipitation, Blue Native-PAGE, and size-exclusion chromatography experiments indicated that the ZIP13 protein may form a homodimer. We also demonstrated that ZIP13 mediates zinc influx, as assessed by monitoring the expression of the metallothionein gene and by detecting the intracellular zinc level with a zinc indicator, FluoZin-3. Our data indicate that ZIP13 is a homodimerized zinc transporter that possesses some domains that are not found in other LZT family members. This is the first biochemical characterization of the physiologically important protein ZIP13 and the demonstration of homo-dimerization for a mammalian ZIP zinc transporter family member. This biochemical characterization of the human ZIP13 protein provides important information for further investigations of its structural characteristics and function.	[Bin, Bum-Ho; Fukada, Toshiyuki; Yamasaki, Satoru; Ohashi, Wakana; Hojyo, Shintaro; Miyai, Tomohiro; Nishida, Keigo; Hirano, Toshio] RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Yokohama, Kanagawa 2300045, Japan; [Fukada, Toshiyuki] Osaka Univ, Grad Sch Med, Dept Allergy & Immunol, Suita, Osaka 5650871, Japan; [Bin, Bum-Ho; Miyai, Tomohiro; Nishida, Keigo; Hirano, Toshio] Osaka Univ, Grad Sch Med, Japan Sci & Technol Agcy Core Res Evolut Sci & Te, Lab Dev Immunol,Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Bin, Bum-Ho; Miyai, Tomohiro; Nishida, Keigo; Hirano, Toshio] Osaka Univ, Grad Sch Med, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Hosaka, Toshiaki; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; [Bin, Bum-Ho] AmorePacific Corp R&D Ctr, Biosci Inst, Yongin 446729, Gyeounggi Do, South Korea	RIKEN; Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University; RIKEN; University of Tokyo	Fukada, T (corresponding author), 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	fukada@rcai.riken.jp	Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Miyai, Tomohiro/0000-0003-1952-0228	KAKENHI; Japan Science and Technology Agency; Naito Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation)	This work was supported by KAKENHI and the Japan Science and Technology Agency-Core Research for Evolutional Science and Technology program and the Naito Foundation (to T. F.).	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bi YY, 2004, BIOCHEM J, V380, P695, DOI 10.1042/BJ20031677; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Foster M, 2010, ATHEROSCLEROSIS, V210, P344, DOI 10.1016/j.atherosclerosis.2009.11.038; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukada T, 2011, J ORAL BIOSCI, V53, P1, DOI 10.2330/joralbiosci.53.1; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Hershfinkel M, 2007, MOL MED, V13, P331, DOI 10.2119/2006-00038.Hershfinkel; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Liu Z, 2008, BIOCHEM BIOPH RES CO, V365, P814, DOI 10.1016/j.bbrc.2007.11.067; Lopez V, 2011, CANCER LETT, V304, P41, DOI 10.1016/j.canlet.2011.01.027; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishida K, 2009, J EXP MED, V206, P1351, DOI 10.1084/jem.20082533; Nose Y, 2006, TRENDS BIOCHEM SCI, V31, P604, DOI 10.1016/j.tibs.2006.09.003; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Pawa S, 2008, AM J MED SCI, V336, P430, DOI 10.1097/MAJ.0b013e31815f2c05; PRASAD AS, 1995, NUTRITION, V11, P93; Stout JG, 1996, BIOCHEMISTRY-US, V35, P8289, DOI 10.1021/bi960563g; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	41	107	111	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40255	40265		10.1074/jbc.M111.256784	http://dx.doi.org/10.1074/jbc.M111.256784			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21917916	Green Published, hybrid			2022-12-27	WOS:000296925700057
J	Orebaugh, CD; Fye, JM; Harvey, S; Hollis, T; Perrino, FW				Orebaugh, Clinton D.; Fye, Jason M.; Harvey, Scott; Hollis, Thomas; Perrino, Fred W.			The TREX1 Exonuclease R114H Mutation in Aicardi-Goutieres Syndrome and Lupus Reveals Dimeric Structure Requirements for DNA Degradation Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL CHILBLAIN LUPUS; MEDIATED CELL-DEATH; DOMINANT MUTATIONS; AUTOIMMUNE-DISEASE; 3' TERMINI; GENE; SUSCEPTIBILITY; IDENTIFICATION; ERYTHEMATOSUS; EXPRESSION	Mutations in the TREX1 gene cause Aicardi-Goutieres syndrome (AGS) and are linked to the autoimmune disease systemic lupus erythematosus. The TREX1 protein is a dimeric 3' DNA exonuclease that degrades DNA to prevent inappropriate immune activation. One of the most common TREX1 mutations, R114H, causes AGS as a homozygous and compound heterozygous mutation and is found as a heterozygous mutation in systemic lupus erythematosus. The TREX1 proteins containing R114H and the insertion mutations aspartate at position 201 (D201ins) and alanine at position 124 (A124ins), found in compound heterozygous AGS with R114H, were prepared and the DNA degradation activities were tested. The homodimer TREX1(R114H/R114H) exhibits a 23-fold reduced single-stranded DNA (ssDNA) exonuclease activity relative to TREX1(WT). The TREX1(D201ins/D201ins) and TREX1(A124ins/A124ins) exhibit more than 10,000-fold reduced ssDNA degradation activities. However, the TREX1(R114H/D201ins) and TREX1(R114H/A124ins) compound heterodimers exhibit activities 10-fold greater than the TREX1(R114H/R114H) homodimer during ssDNA and double-stranded DNA (dsDNA) degradation. These higher levels of activities measured in the TREX1(R114H/D201ins) and TREX1(R114H/A124ins) compound heterodimers are attributed to Arg-114 residues of TREX1(D201ins) and TREX1(A124ins) positioned at the dimer interface contributing to the active sites of the opposing TREX1(R114H) protomer. This interpretation is further supported by exonuclease activities measured for TREX1 enzymes containing R114A and R114K mutations. These biochemical data provide direct evidence for TREX1 residues in one protomer contributing to DNA degradation catalyzed in the opposing protomer and help to explain the dimeric TREX1 structure required for full catalytic competency.	[Orebaugh, Clinton D.; Fye, Jason M.; Harvey, Scott; Hollis, Thomas; Perrino, Fred W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Perrino, FW (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu			National Institutes of Health [GM069962]; Alliance for Lupus Research Grant [179222]; American Heart Association [10GRNT3650033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research Grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069962 (to F. W. P.), Alliance for Lupus Research Grant 179222 (to F. W. P.), and American Heart Association Grant 10GRNT3650033 (to T. H.).	Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Gunther C, 2009, DERMATOLOGY, V219, P162, DOI 10.1159/000222430; Haaxma CA, 2010, AM J MED GENET A, V152A, P2612, DOI 10.1002/ajmg.a.33620; Higuchi R., 1990, PCR PROTOCOLS GUIDE; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Kolivras A, 2008, J CUTAN PATHOL, V35, P774, DOI 10.1111/j.1600-0560.2007.00900.x; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Parra D, 2009, CANCER RES, V69, P6676, DOI 10.1158/0008-5472.CAN-09-1208; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	28	33	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40246	40254		10.1074/jbc.M111.297903	http://dx.doi.org/10.1074/jbc.M111.297903			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937424	Green Published, hybrid			2022-12-27	WOS:000296925700056
J	Wang, Y; Robertson, JD; Walcheck, B				Wang, Yue; Robertson, John D.; Walcheck, Bruce			Different Signaling Pathways Stimulate a Disintegrin and Metalloprotease-17 (ADAM17) in Neutrophils during Apoptosis and Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; L-SELECTIN; CONVERTING-ENZYME; TNF-ALPHA; PROTEIN-KINASE; INTRACELLULAR MATURATION; POTENTIAL ROLE; GROWTH-FACTOR; RECEPTOR; CLEAVAGE	ADAM17 is a membrane-associated metalloprotease that cleaves proteins from the surface of neutrophils and modulates the density of various receptors and adhesion molecules. The protease activity of ADAM17 is highly inducible and occurs upon neutrophil activation as well as apoptosis. At this time, little is known about the signal transduction pathway that promotes ADAM17 activity in neutrophils upon the induction of apoptosis. We show that caspase-8 activation, Bid cleavage, and the release of mitochondrial reactive oxygen species are sequential transduction components of the Fas signaling cascade that induces ADAM17. This is different from ADAM17 stimulation upon overt neutrophil activation, which requires MAPK p38 or ERK, but not caspases and reactive oxygen species. ADAM17 activity in apoptotic neutrophils may serve to inactivate select effector molecules that promote the pro-inflammatory activity of recruited neutrophils. For instance, TNF alpha receptors TNF-RI and TNF-RII are substrates of ADAM17, and we show that they are shed during apoptosis, decreasing neutrophil sensitivity to TNF alpha. Altogether, our findings provide significant new insights into the signal transduction pathway that stimulates ADAM17 during induced neutrophil apoptosis. ADAM17 induction during apoptosis may rapidly diminish neutrophil sensitivity to the inflammatory environment, complementing other anti-inflammatory activities by these cells during inflammation resolution.	[Wang, Yue; Walcheck, Bruce] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Robertson, John D.] Univ Kansas, Med Ctr, Kansas Univ Canc Ctr, Kansas City, KS 66160 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Walcheck, B (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, 295J AS-VM Bldg,1988 Fitch Ave, St Paul, MN 55108 USA.	walch003@umn.edu			National Institutes of Health [HL61613, AI083521, AI082291]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI082291, R21AI083521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL61613, AI083521, and AI082291 (to B. W.).	Akgul C, 2003, CELL MOL LIFE SCI, V60, P2402, DOI 10.1007/s00018-003-3110-z; Alvarado-Kristensson M, 2005, J BIOL CHEM, V280, P6238, DOI 10.1074/jbc.M409718200; Arndt PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019938; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Budd RC, 2002, J CLIN INVEST, V109, P437, DOI 10.1172/JC1200215077; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Long CM, 2010, J LEUKOCYTE BIOL, V87, P1097, DOI 10.1189/jlb.1109763; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maianski NA, 2003, ACTA HAEMATOL-BASEL, V111, P56, DOI 10.1159/000074486; Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408; Mattila PE, 2005, AM J PHYSIOL-CELL PH, V289, pC323, DOI 10.1152/ajpcell.00603.2004; Melley DD, 2005, CLIN SCI, V108, P413, DOI 10.1042/CS20040228; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ott GR, 2008, BIOORG MED CHEM LETT, V18, P1577, DOI 10.1016/j.bmcl.2008.01.075; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Rizoli SB, 1999, J BIOL CHEM, V274, P22072, DOI 10.1074/jbc.274.31.22072; Rosendahl MS, 1997, J BIOL CHEM, V272, P24588, DOI 10.1074/jbc.272.39.24588; Ryan JG, 2009, ARTHRITIS RHEUM, V60, P8, DOI 10.1002/art.24145; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shawgo ME, 2009, J BIOL CHEM, V284, P33447, DOI 10.1074/jbc.M109.032359; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; van Raam BJ, 2006, INT J HEMATOL, V84, P199, DOI 10.1532/IJH97.06131; Walcheck B, 2006, EUR J IMMUNOL, V36, P968, DOI 10.1002/eji.200535257; Wang Y, 2010, J IMMUNOL, V184, P4447, DOI 10.4049/jimmunol.0902925; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Watson RWG, 1999, FEBS LETT, V453, P67, DOI 10.1016/S0014-5793(99)00688-2; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Woska JR, 2003, J IMMUNOL METHODS, V277, P101, DOI 10.1016/S0022-1759(03)00176-5; Zhang ZL, 2000, J BIOL CHEM, V275, P15839, DOI 10.1074/jbc.M000604200; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC	61	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38980	38988		10.1074/jbc.M111.277087	http://dx.doi.org/10.1074/jbc.M111.277087			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949123	Green Published, hybrid			2022-12-27	WOS:000296759800017
J	Carpenter, S; Wochal, P; Dunne, A; O'Neill, LAJ				Carpenter, Susan; Wochal, Paulina; Dunne, Aisling; O'Neill, Luke A. J.			Toll-like Receptor 3 (TLR3) Signaling Requires TLR4 Interactor with Leucine-rich Repeats (TRIL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE-RECEPTOR-4; RECOGNITION; ACTIVATION; COMPLEX; PRAT4A; RP105; CD14	Toll-like receptors (TLRs) are a family of proteins that act as the primary sensors of microbial products. Many TLRs require accessory molecules in order to recognize these microbial products and initiate signal transduction cascades. We have identified TRIL (TLR4 interactor with leucine-rich repeats) as a novel modulator of TLR4 signaling showing high expression in the brain. We now show that TRIL also plays a role in TLR3 signaling. TRIL is expressed intracellularly in the astrocytoma cell line U373 and in the monocytic cell line THP1. TRIL co-localizes with the endosomal compartment. These data are consistent with a role for TRIL in TLR3 signaling and endosomal TLR4 signaling. TRIL was induced by the TLR3 ligand poly(I: C). Overexpression of TRIL enhanced cytokine production and interferon-stimulated response element (ISRE) luciferase activity following poly(I: C) stimulation in U373. TRIL interacted with TLR3, and this interaction was enhanced following poly(I: C) stimulation. Transient knockdown of TRIL with siRNA or stable knockdown using shRNA in U373 cells inhibited TLR3 signaling, reducing ISRE luciferase, RANTES, and type I interferon production. Knockdown of TRIL did not affect TLR2 signaling. Most accessory molecules identified to date, such as CD14, gp96, PRAT4a, and Unc93B, all play roles in multiple TLR signaling pathways, and we now show that this is also the case for TRIL.	[O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748; dunne, aisling/0000-0002-2342-9518	Science Foundation Ireland; FP7 Marie Curie Initial Training Network TranSIVR; Health Research Board; Marie Curie actions	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); FP7 Marie Curie Initial Training Network TranSIVR; Health Research Board; Marie Curie actions(European Commission)	This work is supported by Science Foundation Ireland, FP7 Marie Curie Initial Training Network TranSIVR, and the Health Research Board and Marie Curie actions. L. A. J. O'Neill is a cofounder, minority shareholder, and member of the scientific advisory board of Opsona Therapeutics Ltd., a University Start-up company involved in the development of anti-inflammatory therapeutics.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Carpenter S, 2009, J IMMUNOL, V183, P3989, DOI 10.4049/jimmunol.0901518; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Wakabayashi Y, 2006, J IMMUNOL, V177, P1772, DOI 10.4049/jimmunol.177.3.1772; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	18	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38795	38804		10.1074/jbc.M111.255893	http://dx.doi.org/10.1074/jbc.M111.255893			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911501	Green Published, hybrid			2022-12-27	WOS:000296594200090
J	Guo, XE; Chen, CF; Wang, DDH; Modrek, AS; Phan, VH; Lee, WH; Chen, PL				Guo, Xuning Emily; Chen, Chi-Fen; Wang, Dennis Ding-Hwa; Modrek, Aram Sandaldjian; Vy Hoai Phan; Lee, Wen-Hwa; Chen, Phang-Lang			Uncoupling the Roles of the SUV3 Helicase in Maintenance of Mitochondrial Genome Stability and RNA Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED DODECAMER SEQUENCE; INTRON-ENCODED PROTEIN; ESCHERICHIA-COLI; MESSENGER-RNA; POLYNUCLEOTIDE PHOSPHORYLASE; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; POSTTRANSCRIPTIONAL PROCESSES; RIBONUCLEASE-E; IN-VIVO	Yeast SUV3 is a nuclear encoded mitochondrial RNA helicase that complexes with an exoribonuclease, DSS1, to function as an RNA degradosome. Inactivation of SUV3 leads to mitochondrial dysfunctions, such as respiratory deficiency; accumulation of aberrant RNA species, including excised group I introns; and loss of mitochondrial DNA (mtDNA). Although intron toxicity has long been speculated to be the major reason for the observed phenotypes, direct evidence to support or refute this theory is lacking. Moreover, it remains unknown whether SUV3 plays a direct role in mtDNA maintenance independently of its degradosome activity. In this paper, we address these questions by employing an inducible knockdown system in Saccharomyces cerevisiae with either normal or intronless mtDNA background. Expressing mutants defective in ATPase (K245A) or RNA binding activities (V272L or Delta CC, which carries an 8-amino acid deletion at the C-terminal conserved region) resulted in not only respiratory deficiencies but also loss of mtDNA under normal mtDNA background. Surprisingly, V272L, but not other mutants, can rescue the said deficiencies under intronless background. These results provide genetic evidence supporting the notion that the functional requirements of SUV3 for degradosome activity and maintenance of mtDNA stability are separable. Furthermore, V272L mutants and wild-type SUV3 associated with an active mtDNA replication origin and facilitated mtDNA replication, whereas K245A and Delta CC failed to support mtDNA replication. These results indicate a direct role of SUV3 in maintaining mitochondrial genome stability that is independent of intron turnover but requires the intact ATPase activity and the CC conserved region.	[Lee, Wen-Hwa; Chen, Phang-Lang] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, 124 Sprague Hall, Irvine, CA 92697 USA.	whlee@uci.edu; plchen@uci.edu	Lee, Wen-Hwa/C-2519-2014; Chen, Phang-Lang/J-5031-2013	Chen, Phang-Lang/0000-0002-0357-9017; Modrek, Aram/0000-0001-7586-9833; Chen, Chi-Fen/0000-0002-6391-821X	National Institutes of Health (NIH) [AG027877]; NIH, NIGMS (University of California, Irvine); Department of Defense [W81XWH-06-1-0767]; National Science Foundation (University of California, Irvine); NATIONAL CANCER INSTITUTE [T32CA113265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027877] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIGMS (University of California, Irvine)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)University of California System); Department of Defense(United States Department of Defense); National Science Foundation (University of California, Irvine)(National Science Foundation (NSF)University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant AG027877 (to W. H. L. and P. L. C.) and the NIH, NIGMS, Medical Scientist Training Program (University of California, Irvine) (to D.-H. W). W. H. L. serves as a member of the board of directors for GeneTex Inc. The term of this arrangement has been reviewed and approved by University of California, Irvine according to its conflict of interest policy.; Supported by Department of Defense Predoctoral Traineeship Award W81XWH-06-1-0767.; Supported by a National Science Foundation Lifechips Integrative Graduate Education and Research fellowship (University of California, Irvine).	Ahmed KM, 2010, J BIOL CHEM, V285, P4464, DOI 10.1074/jbc.M109.062265; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; BABITZKE P, 1991, P NATL ACAD SCI USA, V88, P1, DOI 10.1073/pnas.88.1.1; Bessarab DA, 1998, P NATL ACAD SCI USA, V95, P3157, DOI 10.1073/pnas.95.6.3157; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; BOULET A, 1990, CURR GENET, V17, P537, DOI 10.1007/BF00313085; Briani F, 2007, BIOCHIMIE, V89, P145, DOI 10.1016/j.biochi.2006.09.020; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; BUTOW RA, 1989, GENOME, V31, P757, DOI 10.1139/g89-134; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200; Cheng X, 2007, MITOCHONDRION, V7, P211, DOI 10.1016/j.mito.2006.11.023; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; CONRADWEBB H, 1990, NUCLEIC ACIDS RES, V18, P1369, DOI 10.1093/nar/18.6.1369; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; DMOCHOWSKA A, 1995, CURR GENET, V28, P108, DOI 10.1007/BF00315775; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; Fan HY, 1996, GENETICS, V142, P749; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; KALMAN M, 1991, NEW BIOL, V3, P886; Khidr L, 2008, J BIOL CHEM, V283, P27064, DOI 10.1074/jbc.M802991200; Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4; MACREADIE IG, 1985, CELL, V41, P395, DOI 10.1016/S0092-8674(85)80012-X; Malecki M, 2007, J MOL BIOL, V372, P23, DOI 10.1016/j.jmb.2007.06.074; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; MORTIMER RK, 1986, GENETICS, V113, P35; PY B, 1994, MOL MICROBIOL, V14, P717, DOI 10.1111/j.1365-2958.1994.tb01309.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Rogowska AT, 2006, MOL BIOL CELL, V17, P1184, DOI 10.1091/mbc.E05-08-0796; Sarkar D, 2006, CELL CYCLE, V5, P1080, DOI 10.4161/cc.5.10.2741; SERAPHIN B, 1987, P NATL ACAD SCI USA, V84, P6810, DOI 10.1073/pnas.84.19.6810; Shu ZY, 2004, BIOCHEMISTRY-US, V43, P4781, DOI 10.1021/bi0356449; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; STEPIEN PP, 1992, P NATL ACAD SCI USA, V89, P6813, DOI 10.1073/pnas.89.15.6813; STEPIEN PP, 1995, CURR GENET, V27, P234, DOI 10.1007/BF00326154; Turk EM, 2010, J BIOL CHEM, V285, P8585, DOI 10.1074/jbc.M109.090761; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580; Zhong Q, 2002, J BIOL CHEM, V277, P28641, DOI 10.1074/jbc.M200748200; ZHU H, 1989, MOL CELL BIOL, V9, P1507, DOI 10.1128/MCB.9.4.1507; ZINN AR, 1985, CELL, V40, P887, DOI 10.1016/0092-8674(85)90348-4	56	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38783	38794		10.1074/jbc.M111.257956	http://dx.doi.org/10.1074/jbc.M111.257956			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911497	Green Published, hybrid			2022-12-27	WOS:000296594200089
J	O'Toole, KK; Jenkins, A				O'Toole, Kate K.; Jenkins, Andrew			Discrete M3-M4 Intracellular Loop Subdomains Control Specific Aspects of gamma-Aminobutyric Acid Type A Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; NICOTINIC ACETYLCHOLINE-RECEPTORS; MEMBRANE-SPANNING SEGMENT; CELL-SURFACE STABILITY; LARGE CYTOPLASMIC LOOP; GABA(A) RECEPTOR; 5-HYDROXYTRYPTAMINE TYPE-3; STRUCTURAL DETERMINANTS; CHARGED RESIDUES; 5-HT3A RECEPTOR	The GABA type A receptor (GABA(A)R) is a member of the pentameric ligand gated ion channel (pLGIC) family that mediates ionotropic neurotransmission. Residues in the intracellular loop domain (ILD) have recently been shown to define part of the ion permeation pathway in several closely related members of the pentameric ligand gated ion channel family. In this study, we investigated the role the ILD of the GABA(A)R alpha 1 subunit plays in channel function. Deletion of the alpha 1 ILD resulted in a significant increase in GABA EC50 and maximal current amplitude, suggesting that the ILD must be intact for proper receptor function. To test this hypothesis, we conducted a mutagenic screen of all amino acids harboring ionizable side chains within this domain to investigate the contribution of individual charged residues to ion permeation. Using macroscopic and single channel voltage-clamp recording techniques, we found that mutations within a subdomain of the alpha 1 ILD near M3 altered GABA apparent affinity; interestingly, alpha 1(K312E) exhibited reduced partial agonist efficacy. We introduced point mutations near M4, including alpha 1(K383E) and alpha 1(K384E), that enhanced receptor desensitization. Mutation of 5 charged residues within a 39-residue span contiguous with M4 reduced relative anion permeability of the channel and may represent a weak intracellular selectivity filter. Within this subdomain, the alpha 1(K378E) mutation induced a significant reduction in single channel conductance, consistent with our hypothesis that the GABA(A)R alpha 1 ILD contributes directly to the permeation pathway.	Emory Univ, Dept Anesthesiol, Atlanta, GA 30322 USA; Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University; Emory University	Jenkins, A (corresponding author), 1510 Clifton Rd,5013 O Wayne Rollins Res Ctr, Atlanta, GA 30322 USA.	ajenki2@emory.edu			National Institutes of Health [GM073959]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073959.	Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brandon NJ, 1999, BIOCHEM SOC T, V27, P527, DOI 10.1042/bst0270527; Breitinger HG, 2002, J NEUROCHEM, V83, P30, DOI 10.1046/j.1471-4159.2002.01109.x; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jensen ML, 2005, J NEUROCHEM, V92, P962, DOI 10.1111/j.1471-4159.2004.02970.x; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kash TL, 2004, BIOCHEM SOC T, V32, P540, DOI 10.1042/BST0320540; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2006, J PHYSIOL-LONDON, V575, P11, DOI 10.1113/jphysiol.2005.102756; Kuo YP, 2005, J PHARMACOL EXP THER, V314, P455, DOI 10.1124/jpet.105.084954; LEIDENHEIMER NJ, 1991, TRENDS PHARMACOL SCI, V12, P84, DOI 10.1016/0165-6147(91)90509-Q; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Mukerjee J., 2010, NEUR M PLANN SOC NEU; NODA M, 1983, NATURE, V302, P528, DOI 10.1038/302528a0; Nymann-Andersen J, 2002, J NEUROCHEM, V83, P1164, DOI 10.1046/j.1471-4159.2002.01222.x; Peran M, 2006, CELL MOTIL CYTOSKEL, V63, P747, DOI 10.1002/cm.20156; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Wotring VE, 1999, J PHYSIOL-LONDON, V521, P327, DOI 10.1111/j.1469-7793.1999.00327.x; Wotring VE, 2008, J GEN PHYSIOL, V131, P87, DOI 10.1085/jgp.200609701; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	48	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37990	37999		10.1074/jbc.M111.258012	http://dx.doi.org/10.1074/jbc.M111.258012			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21903587	Green Published, hybrid			2022-12-27	WOS:000296594200011
J	Weinman, EJ; Steplock, D; Shenolikar, S; Biswas, R				Weinman, Edward J.; Steplock, Deborah; Shenolikar, Shirish; Biswas, Rajatsubhra			Fibroblast Growth Factor-23-mediated Inhibition of Renal Phosphate Transport in Mice Requires Sodium-Hydrogen Exchanger Regulatory Factor-1 (NHERF-1) and Synergizes with Parathyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; DOMINANT HYPOPHOSPHATEMIC RICKETS; TUMOR-INDUCED OSTEOMALACIA; FGF23; IIA; PHOSPHORYLATION; EXPRESSION; DOPAMINE; KIDNEY; MEDIA	Fibroblast growth factor-23 (FGF-23) inhibits sodium-dependent phosphate transport in brush border membrane vesicles derived from hormone-treated kidney slices of the mouse and in mouse proximal tubule cells by processes involving mitogen-activated protein kinase (MAPK) but not protein kinase A (PKA) or protein kinase C (PKC). By contrast, phosphate transport in brush border membrane vesicles and proximal tubule cells from sodium-hydrogen exchanger regulatory factor-1 (NHERF-1)-null mice were resistant to the inhibitory effect of FGF-23 (10(-9) M). Infection of NHERF-1-null proximal tubule cells with wild-type adenovirus-GFP-NHERF-1 increased basal phosphate transport and restored the inhibitory effect of FGF-23. Infection with adenovirus-GFP-NHERF-1 containing a S77A or T95D mutation also increased basal phosphate transport, but the cells remained resistant to FGF-23 (10(-9) M). Low concentrations of FGF-23 (10(-13) M) and PTH (10(-11) M) individually did not inhibit phosphate transport or activate PKA, PKC, or MAPK. When combined, however, these hormones markedly inhibited phosphate transport associated with activation of PKC and PKA but not MAPK. These studies indicate that FGF-23 inhibits phosphate transport in the mouse kidney by processes that involve the scaffold protein NHERF-1. In addition, FGF-23 synergizes with PTH to inhibit phosphate transport by facilitating the activation of the PTH signal transduction pathway.	[Weinman, Edward J.; Steplock, Deborah; Biswas, Rajatsubhra] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Weinman, Edward J.] Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD 21201 USA; [Shenolikar, Shirish] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorders, Singapore 169857, Singapore	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National University of Singapore	Weinman, EJ (corresponding author), Univ Maryland Hosp, Div Nephrol, Rm N3W143,22 S Greene St, Baltimore, MD 21201 USA.	eweinman1440@yahoo.com			National Institutes of Health [DK55881]; Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55881 (to E. J. W.). This work was also supported by the Research Service, Department of Veterans Affairs (to E. J. W.).	Baum M, 2005, KIDNEY INT, V68, P1148, DOI 10.1111/j.1523-1755.2005.00506.x; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Geller JL, 2007, J BONE MINER RES, V22, P931, DOI 10.1359/JBMR.070304; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Seiler S, 2009, KIDNEY INT, V76, pS34, DOI 10.1038/ki.2009.405; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Weinman EJ, 2010, J BIOL CHEM, V285, P13454, DOI 10.1074/jbc.M109.094359; Weinman EJ, 2003, AM J PHYSIOL-RENAL, V285, pF1225, DOI 10.1152/ajprenal.00215.2003; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Yu XJ, 2005, CYTOKINE GROWTH F R, V16, P221, DOI 10.1016/j.cytogfr.2005.01.002	21	43	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37216	37221		10.1074/jbc.M111.288357	http://dx.doi.org/10.1074/jbc.M111.288357			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908609	hybrid, Green Published			2022-12-27	WOS:000296542400022
J	Colbert, JD; Matthews, SP; Kos, J; Watts, C				Colbert, Jeff D.; Matthews, Stephen P.; Kos, Janko; Watts, Colin			Internalization of Exogenous Cystatin F Supresses Cysteine Proteases and Induces the Accumulation of Single-chain Cathepsin L by Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINYL ENDOPEPTIDASE; PROTEINASE-INHIBITOR; LYSOSOMAL PROTEASES; MAMMALIAN LEGUMAIN; INVARIANT CHAIN; MACROPHAGES; EXPRESSION; DISEASE; CANCER; ROLES	Cystatin F is an unusual member of the cystatin family of protease inhibitors, which is made as an inactive dimer and becomes activated by proteolysis in the endo/lysosome pathway of the immune cells that produce it. However a proportion is secreted and can be taken up and activated by other cells. We show here that cystatin F acquired in this way induces a dramatic accumulation of the single-chain form of cathepsin L (CatL). Cystatin F was observed in the same cellular compartments as CatL and was tightly complexed with CatL as determined by co-precipitation studies. The observed accumulation of single-chain CatL was partly due to cystatin F-mediated inhibition of the putative single-chain to two-chain CatL convertase AEP/legumain and partly to general suppression of cathepsin activity. Thus, cystatin F stabilizes CatL leading to the dramatic accumulation of an inactive complex composed either of the single-chain or two-chain form depending on the capacity of cystatin F to inhibit AEP. Cross-transfer of cystatin F from one cell to another may therefore attenuate potentially harmful effects of excessive CatL activity while paradoxically, inducing accumulation of CatL protein. Finally, we confirmed earlier data (Beers, C., Honey, K., Fink, S., Forbush, K., and Rudensky, A. (2003) J. Exp. Med. 197, 169-179) showing a loss of CatL activity, but not of CatL protein, in macrophages activated with IFN gamma. However, we found equivalent loss of CatL activity in wild type and cystatin F-null macrophages suggesting that an inhibitory activity other than cystatin F quenches CatL activity in activated macrophages.	[Colbert, Jeff D.; Matthews, Stephen P.; Watts, Colin] Univ Dundee, Coll Life Sci, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland; [Kos, Janko] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia	University of Dundee; University of Ljubljana	Watts, C (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk		Matthews, Stephen/0000-0003-3556-962X; Watts, Colin/0000-0001-6183-2087	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Programme grant (to C. W.).	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; Bogyo M, 2004, CURR PROTOC PROTEIN; Buhling F, 2004, AM J PATHOL, V164, P2203, DOI 10.1016/S0002-9440(10)63777-7; Cappello F, 2004, EXP CELL RES, V297, P607, DOI 10.1016/j.yexcr.2004.03.048; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Colbert JD, 2009, EUR J IMMUNOL, V39, P2955, DOI 10.1002/eji.200939650; Colbert JD, 2009, TRAFFIC, V10, P425, DOI 10.1111/j.1600-0854.2009.00881.x; Fiebiger E, 2002, J EXP MED, V196, P1263, DOI 10.1084/jem.20020762; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Halfon S, 1998, J BIOL CHEM, V273, P16400, DOI 10.1074/jbc.273.26.16400; Hamilton G, 2008, EMBO J, V27, P499, DOI 10.1038/sj.emboj.7601979; Honey K, 2002, NAT IMMUNOL, V3, P1069, DOI 10.1038/ni844; KOS J, 1995, BIOL CHEM H-S, V376, P401, DOI 10.1515/bchm3.1995.376.7.401; Langerholc T, 2005, FEBS J, V272, P1535, DOI 10.1111/j.1742-4658.2005.04594.x; Lennon-Dumenil AM, 2001, EMBO J, V20, P4055, DOI 10.1093/emboj/20.15.4055; Li W, 2009, ATHEROSCLEROSIS, V202, P92, DOI 10.1016/j.atherosclerosis.2008.03.027; Loak K, 2003, BIOL CHEM, V384, P1239, DOI 10.1515/BC.2003.136; Matthews SP, 2010, J IMMUNOL, V184, P2423, DOI 10.4049/jimmunol.0901486; Mattock KL, 2010, ATHEROSCLEROSIS, V208, P83, DOI 10.1016/j.atherosclerosis.2009.07.022; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nathanson CM, 2002, EUR J BIOCHEM, V269, P5502, DOI 10.1046/j.1432-1033.2002.03252.x; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Ni J, 1998, J BIOL CHEM, V273, P24797, DOI 10.1074/jbc.273.38.24797; Ni J, 1997, J BIOL CHEM, V272, P10853; Olafsson I, 2000, AMYLOID, V7, P70, DOI 10.3109/13506120009146827; Petermann I, 2006, FASEB J, V20, P1266, DOI 10.1096/fj.05-5517fje; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P16570, DOI 10.1074/jbc.M601033200; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Zeeuwen PLJM, 2002, HUM MOL GENET, V11, P2867, DOI 10.1093/hmg/11.23.2867; Zeeuwen PLJM, 2001, J INVEST DERMATOL, V116, P693, DOI 10.1046/j.1523-1747.2001.01309.x	44	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42082	42090		10.1074/jbc.M111.253914	http://dx.doi.org/10.1074/jbc.M111.253914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21956111	Green Published, hybrid			2022-12-27	WOS:000298180900018
J	Yang, X; Teng, Y; Hou, N; Fan, XW; Cheng, X; Li, J; Wang, LJ; Wang, YL; Wu, XS; Yang, X				Yang, Xue; Teng, Yan; Hou, Ning; Fan, Xiongwei; Cheng, Xuan; Li, Jun; Wang, Lijuan; Wang, Youliang; Wu, Xiushan; Yang, Xiao			Delayed Re-epithelialization in Ppm1a Gene-deficient Mice Is Mediated by Enhanced Activation of Smad2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; TRANSGENIC MICE; ACCELERATED REEPITHILIALIZATION; WOUND REPAIR; SKIN WOUNDS; PHOSPHATASE; MOUSE; TGF-BETA-1; INDUCTION; REEPITHELIALIZATION	Protein phosphatase magnesium-dependent 1A (PPM1A), a protein serine/threonine phosphatase, controls several signal pathways through cleavage of phosphate from its substrates. However, the in vivo function of Ppm1a in mammals remains unknown. Here we reported that mice lacking Ppm1a developed normally but were impaired in re-epithelialization process during cutaneous wound healing. Specifically, complete or keratinocyte-specific deletion of Ppm1a led to delayed re-epithelialization with reduced keratinocyte migration upon wounding. We showed that this effect was the result of an increase in Smad2/3 phosphorylation in keratinocytes. Keratinocyte-specific Smad2 deficient mice displayed accelerated re-epithelialization with enhanced keratinocyte migration. Importantly, Smad2 and Ppm1a double mutant mice also exhibited accelerated re-epithelialization, demonstrating that the effect of Ppm1a on promoting re-epithelialization is mediated by Smad2 signaling. Furthermore, the decreased expression of specific integrins and matrix metalloproteinases (MMPs) may contribute to the retarded re-epithelialization in Ppm1a mutant mice. These data indicate that Ppm1a, through suppressing Smad2 signaling, plays a critical role in re-epithelialization during wound healing.	[Yang, Xue; Teng, Yan; Hou, Ning; Fan, Xiongwei; Cheng, Xuan; Li, Jun; Wang, Lijuan; Wang, Youliang; Yang, Xiao] Inst Biotechnol, State Key Lab Prote Genet Lab Dev & Dis, Beijing 100071, Peoples R China; [Yang, Xue; Yang, Xiao] Shanghai Jiao Tong Univ, E Inst Shanghai Univ, Model Organism Div, Shanghai 200025, Peoples R China; [Wu, Xiushan] Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China	Shanghai Jiao Tong University; Hunan Normal University	Teng, Y (corresponding author), Inst Biotechnol, State Key Lab Prote Genet Lab Dev & Dis, 20 Dongdajie, Beijing 100071, Peoples R China.	tengyan0919@tom.com; yangx@nic.bmi.ac.cn	Yang, xue/G-3626-2016; XIAO, YANG/GPW-5529-2022	Yang, Xiao/0000-0002-0298-9831	Chinese National Key Program on Basic Research [2011CB504200, 2012CB945100, 2011CB910601]; National Natural Science Foundation of China [31030040, 30871396, 31171249, 30700423]; Beijing Natural Science Foundation of China [5082018]	Chinese National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work was supported by Grants 2011CB504200, 2012CB945100, and 2011CB910601 from the Chinese National Key Program on Basic Research, Grants 31030040, 30871396, 31171249, and 30700423 from the National Natural Science Foundation of China, and Grant 5082018 from the Beijing Natural Science Foundation of China.	Amendt C, 2002, J CELL SCI, V115, P2189; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Chan T, 2002, WOUND REPAIR REGEN, V10, P177, DOI 10.1046/j.1524-475X.2002.11101.x; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; GARLICK JA, 1994, J INVEST DERMATOL, V103, P554, DOI 10.1111/1523-1747.ep12396847; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Hosokawa R, 2005, J INVEST DERMATOL, V125, P1302, DOI 10.1111/j.0022-202X.2005.23963.x; Kaiser S, 1998, J INVEST DERMATOL, V111, P1145, DOI 10.1046/j.1523-1747.1998.00407.x; KOKABU S, J BONE MINER RES, V25, P653; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lifschitz-Mercer B, 2001, HISTOCHEM CELL BIOL, V116, P31; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; Owens P, 2010, AM J PATHOL, V176, P122, DOI 10.2353/ajpath.2010.090081; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Reynolds LE, 2008, J CLIN INVEST, V118, P965, DOI 10.1172/JCI33538; Schilling SH, 2006, CELL, V125, P838, DOI 10.1016/j.cell.2006.05.015; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; Strovel ET, 2000, J BIOL CHEM, V275, P2399, DOI 10.1074/jbc.275.4.2399; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Teng Y, 2006, CANCER RES, V66, P6972, DOI 10.1158/0008-5472.CAN-06-0507; Tredget EB, 2005, WOUND REPAIR REGEN, V13, P61, DOI 10.1111/j.1067-1927.2005.130108.x; Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200; Zhang BH, 2009, HISTOCHEM CELL BIOL, V132, P169, DOI 10.1007/s00418-009-0601-5; Zhou J, 2002, SCI CHINA SER C, V45, P129, DOI 10.1360/02yc9015	37	20	21	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42267	42273		10.1074/jbc.M111.292284	http://dx.doi.org/10.1074/jbc.M111.292284			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21990361	Green Published, hybrid			2022-12-27	WOS:000298180900036
J	Ikushima, H; Todo, T; Ino, Y; Takahashi, M; Saito, N; Miyazawa, K; Miyazono, K				Ikushima, Hiroaki; Todo, Tomoki; Ino, Yasushi; Takahashi, Masamichi; Saito, Nobuhito; Miyazawa, Keiji; Miyazono, Kohei			Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER STEM-CELLS; SELF-RENEWAL; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; MICE LACKING; GLIOBLASTOMA; COMPLEX; IDENTIFICATION; TUMORS; DIFFERENTIATION	Although the concept of cancer stem cells or cancer-initiating cells had created a new paradigm for the treatment of malignant tumors, it remains unclear how cancer-initiating cells can be eradicated. We have previously reported that the transforming growth factor-beta (TGF-beta)-Sox4-Sox2 pathway is essential for glioma-initiating cells to retain their sternness, and inhibition of TGF-beta signaling may lead to differentiation of glioma-initiating cells (Ikushima, H., Todo, T., Ino, Y., Takahashi, M., Miyazawa, K., and Miyazono, K. (2009) Cell Stem Cell 5, 504-514). Here we demonstrate that Oct4 plays essential roles in retention of the sternness properties of glioma-initiating cells through positive regulation of Sox2 expression. We also show that, in glioma-initiating cells, Oct4 is associated with Sox4 and that Oct4-Sox4 complexes cooperatively activate the enhancer activity of the SOX2 gene. In contrast, in fetal neural progenitor cells, Sox2 expression is enhanced by transcriptional complex containing Sox2 protein itself, and this self-reinforcing loop of Sox2 appears to be disrupted in glioma-initiating cells, suggesting that Sox2 expression in glioma-initiating cells is differently regulated from that in neural progenitor cells. Our findings reveal differences between glioma-initiating cells and fetal neural progenitor cells and may open the way to depriving glioma-initiating cells of tumorigenic activity without affecting normal tissues.	[Ikushima, Hiroaki; Miyazawa, Keiji; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Todo, Tomoki; Ino, Yasushi; Takahashi, Masamichi; Saito, Nobuhito] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Tokyo 1130033, Japan; [Todo, Tomoki; Ino, Yasushi] Univ Tokyo, Grad Sch Med, Translat Res Ctr, Tokyo 1130033, Japan; [Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Yamanashi 4093898, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Yamanashi	Miyazono, K (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	MIYAZAWA, KEIJI/I-9713-2014; Takahashi, Masamichi/GRJ-2866-2022	Todo, Tomoki/0000-0003-0523-8010; Takahashi, Masamichi/0000-0001-8792-1993	KAKENHI; Ministry of Education, Culture, Sports, Science, and Technology of Japan; University of Tokyo; Antisense Pharma GmbH (Germany); Grants-in-Aid for Scientific Research [21390404] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Tokyo; Antisense Pharma GmbH (Germany); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI (grant-in-aid for scientific research) and the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a grant-in-aid for Cancer Research for the Third-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour, and Welfare of Japan.; Supported by a Tetsumon scholarship for the Ph.D.-M.D. program of the University of Tokyo.; Supported by a research grant from Antisense Pharma GmbH (Germany).	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Cheng L, 2007, J PATHOL, V211, P1, DOI 10.1002/path.2105; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Jones TD, 2004, CLIN CANCER RES, V10, P8544, DOI 10.1158/1078-0432.CCR-04-0688; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sato A, 2010, NEUROSCI LETT, V470, P115, DOI 10.1016/j.neulet.2009.12.067; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka M, 2005, LANCET ONCOL, V6, P953, DOI 10.1016/S1470-2045(05)70395-8; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	41	112	118	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41434	41441		10.1074/jbc.M111.300863	http://dx.doi.org/10.1074/jbc.M111.300863			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987575	hybrid, Green Published			2022-12-27	WOS:000298057500030
J	Kuang, ES; Fu, BS; Liang, QM; Myoung, J; Zhu, FX				Kuang, Ersheng; Fu, Bishi; Liang, Qiming; Myoung, Jinjong; Zhu, Fanxiu			Phosphorylation of Eukaryotic Translation Initiation Factor 4B (EIF4B) by Open Reading Frame 45/p90 Ribosomal S6 Kinase (ORF45/RSK) Signaling Axis Facilitates Protein Translation during Kaposi Sarcoma-associated Herpesvirus (KSHV) Lytic Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; PRIMARY EFFUSION LYMPHOMA; FACTOR EIF-4B; TUBEROUS SCLEROSIS; HELICASE ACTIVITY; GENE-EXPRESSION; VACCINIA VIRUS; MAPK PATHWAYS; ENTRY SITE; IN-VITRO	Open reading frame 45 (ORF45) of Kaposi sarcoma-associated herpesvirus (KSHV) causes sustained activation of p90 ribosomal 56 kinase (RSK), which is crucial for KSHV lytic replication, but the exact functional roles remain to be determined. To characterize the biological consequence of persistent RSK activation by ORF45, we screened known cellular substrates of RSK. We found that ORF45 induced phosphorylation of eukaryotic translation initiation factor 4B (eIF4B), increased its assembly into translation initiation complex, and subsequently facilitated protein translation. The ORF45/RSK-mediated eIF4B phosphorylation was distinguishable from that caused by the canonical AKT/mammalian target of rapamycin/ribosomal S6 kinase and MEK/ERK/RSK pathways because it was resistant to both rapamycin (an mammalian target of rapamycin inhibitor) and U1026 (an MEK inhibitor). The rapamycin and U1026 doubly insensitive eIF4B phosphorylation was induced during KSHV reactivation but was abolished if either ORF45 or RSK1/2 were ablated by siRNA, a pattern that is correlated with reduced lytic gene expression as we observed previously. Ectopic expression of eIF4B but not its phosphorylation-deficient mutant form increased KSHV lytic gene expression and production of progeny viruses. Together, these results indicated that ORF45/RSK axis-induced eIF4B phosphorylation is involved in translational regulation and is required for optimal KSHV lytic replication.	[Kuang, Ersheng; Fu, Bishi; Liang, Qiming; Zhu, Fanxiu] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Myoung, Jinjong] Novartis Inst Biomed Res, Emeryville, CA 94608 USA	State University System of Florida; Florida State University; Novartis	Zhu, FX (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	fzhu@bio.fsu.edu			National Institutes of Health [R01DE016680]; Bankhead-Coley bridge; Florida State University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley bridge; Florida State University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE016680 (to F. Z.). This work was also supported by a Bankhead-Coley bridge grant, a Florida State University setup fund, and a Florida State University planning grant (to F. Z.).	Angenstein F, 1998, P NATL ACAD SCI USA, V95, P15078, DOI 10.1073/pnas.95.25.15078; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arias C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000334; BAGLIONI C, 1978, NATURE, V275, P240, DOI 10.1038/275240a0; Bais C, 2003, CANCER CELL, V3, P131, DOI 10.1016/S1535-6108(03)00024-2; Bechtel JT, 2003, J VIROL, V77, P6474, DOI 10.1128/JVI.77.11.6474-6481.2003; Boulanger E, 2008, AM J TRANSPLANT, V8, P707, DOI 10.1111/j.1600-6143.2007.02110.x; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chaisuparat R, 2008, CANCER RES, V68, P8361, DOI 10.1158/0008-5472.CAN-08-0878; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Dioum EM, 2009, CELL, V139, P462, DOI 10.1016/j.cell.2009.10.007; Doepker RC, 2004, J VIROL, V78, P4684, DOI 10.1128/JVI.78.9.4684-4699.2004; Dowling RJO, 2009, BIODRUGS, V23, P77, DOI 10.2165/00063030-200923020-00002; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; FERRARI S, 1991, J BIOL CHEM, V266, P22770; Ford PW, 2006, J GEN VIROL, V87, P1139, DOI 10.1099/vir.0.81628-0; FUERST TR, 1989, J MOL BIOL, V206, P333, DOI 10.1016/0022-2836(89)90483-X; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Glaunsinger B, 2004, MOL CELL, V13, P713, DOI 10.1016/S1097-2765(04)00091-7; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; Kuang E, 2008, J VIROL, V82, P1838, DOI 10.1128/JVI.02119-07; Kuang E, 2009, J BIOL CHEM, V284, P13958, DOI 10.1074/jbc.M900025200; KWONG AD, 1988, J VIROL, V62, P912, DOI 10.1128/JVI.62.3.912-921.1988; Lambert PJ, 2007, EXPERT OPIN THER TAR, V11, P589, DOI 10.1517/14728222.11.5.589; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; LAWSON TG, 1989, BIOCHEMISTRY-US, V28, P4729, DOI 10.1021/bi00437a033; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Li XJ, 2009, J VIROL, V83, P2531, DOI 10.1128/JVI.02209-08; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, MOL CELL BIOL, V16, P5328; MEYER K, 1995, J VIROL, V69, P2819, DOI 10.1128/JVI.69.5.2819-2824.1995; Mizutani T, 2007, ANN NY ACAD SCI, V1102, P86, DOI 10.1196/annals.1408.006; MOHR IJ, 2007, TRANSLATIONAL CONTRO, P545; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; NARANDA T, 1994, J BIOL CHEM, V269, P14465; Nguyen TL, 2008, ANTI-CANCER AGENT ME, V8, P710, DOI 10.2174/187152008785914770; Nichols LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014535; Ochs K, 2002, J VIROL, V76, P2113, DOI 10.1128/JVI.76.5.2113-2122.2002; Ochs K, 1999, J VIROL, V73, P7505, DOI 10.1128/JVI.73.9.7505-7514.1999; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Panteva M, 2003, VIRUS RES, V92, P131, DOI 10.1016/S0168-1702(02)00356-8; Pleschka S, 2008, BIOL CHEM, V389, P1273, DOI 10.1515/BC.2008.145; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Rust RC, 1999, J VIROL, V73, P6111, DOI 10.1128/JVI.73.7.6111-6113.1999; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092; Smith RWP, 2008, BIOCHEM SOC T, V36, P701, DOI 10.1042/BST0360701; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tominaga Y, 2005, MOL CELL BIOL, V25, P8465, DOI 10.1128/MCB.25.19.8465-8475.2005; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; van Gorp AGM, 2009, ONCOGENE, V28, P95, DOI 10.1038/onc.2008.367; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Walsh D, 2006, GENE DEV, V20, P461, DOI 10.1101/gad.1375006; Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wang LJ, 2001, J BIOL CHEM, V276, P32670, DOI 10.1074/jbc.M102776200; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002; Zhu FX, 2006, J VIROL, V80, P12187, DOI 10.1128/JVI.01275-06; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999	83	48	49	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41171	41182		10.1074/jbc.M111.280982	http://dx.doi.org/10.1074/jbc.M111.280982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994950	Green Published, hybrid			2022-12-27	WOS:000298057500006
J	Ogawa, M; Yamaji, R; Higashimura, Y; Harada, N; Ashida, H; Nakano, Y; Inui, H				Ogawa, Masahiro; Yamaji, Ryoichi; Higashimura, Yasuki; Harada, Naoki; Ashida, Hitoshi; Nakano, Yoshihisa; Inui, Hiroshi			17 beta-Estradiol Represses Myogenic Differentiation by Increasing Ubiquitin-specific Peptidase 19 through Estrogen Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE ATROPHY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BREAST-CANCER; ER-BETA; ANDROGEN RECEPTOR; GENE-EXPRESSION; CELLS; PROTEASOME; SYSTEM; RATS	Skeletal muscles express estrogen receptor (ER) alpha and ER beta. However, the roles of estrogens acting through the ERs in skeletal muscles remain unclear. The effects of 17 beta-estradiol (E2) on myogenesis were studied in C2C12 myoblasts. E2 and an ER alpha-selective agonist propylpyrazole-triol depressed myosin heavy chain (MHC), tropomyosin, and rnyogenin levels and repressed the fusion of myoblasts into myotubes. ER antagonist ICI 182,780 cancelled E2-repressed myogenesis. E2 induced ubiquitin-specific peptidase 19 (USP19) expression during myogenesis. E2 replacement increased USP19 expression in the gastrocnemius and soleus muscles of ovariectomized mice. Knockdown of USP19 inhibited E2-repressed myogenesis. Mutant forms of USP19 lacking deubiquitinating activity increased MHC and tropomyosin levels. E2 decreased ubiquitinated proteins during rnyogenesis, and the E2-decreased ubiquitinated proteins were increased by knockdown of USP19. Propylpyrazole-triol increased USP19 expression, and ICI 182,780 inhibited E2-increased USP19 expression. Overexpression of ER alpha or knockdown of ER beta enhanced the effects of E2 on the levels of USP19, MHC, and tropomyosin, whereas knockdown of ER alpha, overexpression of ER beta, or an ER beta-selective agonist diarylpropionitrile abolished their effects. A mutant form of ER alpha that is constitutively localized in the nucleus increased USP19 expression and decreased MHC and tropomyosin expression in the presence of E2. Furthermore, in skeletal muscle satellite cells, E2 inhibited myogenesis and increased USP19 expression, and diarylpropionitrile repressed E2-increased USP19 expression. These results demonstrate that (i) E2 induces USP19 expression through nuclear ER alpha, (ii) increased USP19-mediated deubiquitiunating activity represses myogenesis, and (iii) ER beta inhibits ER alpha-activated USP19 expression.	[Ogawa, Masahiro; Yamaji, Ryoichi; Higashimura, Yasuki; Harada, Naoki; Inui, Hiroshi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan; [Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan; [Nakano, Yoshihisa] Osaka Womens Jr Coll, Osaka 5838558, Japan	Osaka Metropolitan University; Kobe University	Yamaji, R (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan.	yamaji@biochem.osakafu-u.ac.jp	Harada, Naoki/AAP-2868-2020	Harada, Naoki/0000-0003-3846-388X; Ogawa, Masahiro/0000-0002-8347-5268	Japan Society for the Promotion of Science [23580182]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid 23580182 for scientific research (to R. Y.) from the Japan Society for the Promotion of Science.	Allen RE, 1997, METHOD CELL BIOL, V52, P155, DOI 10.1016/S0091-679X(08)60378-7; Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Charbonnier F, 2002, J BIOL CHEM, V277, P1139, DOI 10.1074/jbc.M107018200; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, pE693, DOI 10.1152/ajpendo.00281.2004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Harada N, 2008, BIOCHEM BIOPH RES CO, V373, P373, DOI 10.1016/j.bbrc.2008.06.024; Harada N, 2007, J BIOL CHEM, V282, P22651, DOI 10.1074/jbc.M610724200; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayashi SI, 2003, ENDOCR-RELAT CANCER, V10, P193, DOI 10.1677/erc.0.0100193; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; IHEMELANDU EC, 1981, ACTA ANAT, V110, P311; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005; McCormick KM, 2004, J MUSCLE RES CELL M, V25, P21, DOI 10.1023/B:JURE.0000021398.78327.39; MEDINA R, 1991, BIOMED BIOCHIM ACTA, V50, P347; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Nakopoulou L, 2004, J CLIN PATHOL, V57, P523, DOI 10.1136/jcp.2003.008599; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Picotto G, 1996, MOL CELL ENDOCRINOL, V119, P129, DOI 10.1016/0303-7207(96)03799-9; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Sundaram P, 2009, AM J PHYSIOL-ENDOC M, V297, pE1283, DOI 10.1152/ajpendo.00409.2009; Tsai WJA, 2007, EXP BIOL MED, V232, P1314, DOI 10.3181/0704-RM-92; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Wiik A, 2009, HISTOCHEM CELL BIOL, V131, P181, DOI 10.1007/s00418-008-0512-x; Yamaji R, 2003, BBA-MOL CELL RES, V1593, P269, DOI 10.1016/S0167-4889(02)00397-X; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013	37	45	49	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41455	41465		10.1074/jbc.M111.276824	http://dx.doi.org/10.1074/jbc.M111.276824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971047	hybrid, Green Published			2022-12-27	WOS:000298057500032
J	Bruel, L; Sulzenbacher, G; Tison, MC; Pujol, A; Nicoletti, C; Perrier, J; Galinier, A; Ropartz, D; Fons, M; Pompeo, F; Giardina, T				Bruel, Laetitia; Sulzenbacher, Gerlind; Tison, Marine Cervera; Pujol, Ange; Nicoletti, Cendrine; Perrier, Josette; Galinier, Anne; Ropartz, David; Fons, Michel; Pompeo, Frederique; Giardina, Thierry			alpha-Galactosidase/Sucrose Kinase (AgaSK), a Novel Bifunctional Enzyme from the Human Microbiome Coupling Galactosidase and Kinase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUT MICROBIOME; LACTOBACILLUS; SUBSTRATE; GALACTOOLIGOSACCHARIDES; PURIFICATION; NOMENCLATURE; SEQUENCES; ECOLOGY; OBESITY; CLONING	alpha-Cialactosides are non-digestible carbohydrates widely distributed in plants. They are a potential source of energy in our daily food, and their assimilation by microbiota may play a role in obesity. In the intestinal tract, they are degraded by microbial glycosidases, which are often modular enzymes with catalytic domains linked to carbohydrate-binding modules. Here we introduce a bifunctional enzyme from the human intestinal bacterium Ruminococcus gnavus E1, alpha-galactosidase/sucrose kinase (AgaSK). Sequence analysis showed that AgaSK is composed of two domains: one closely related to alpha-galactosidases from glycoside hydrolase family GH36 and the other containing a nucleotide-binding motif. Its biochemical characterization showed that AgaSK is able to hydrolyze melibiose and raffinose to galactose and either glucose or sucrose, respectively, and to specifically p hosphorylate sucrose on the C6 position of glucose in the presence of ATP. The production of sucrose-6-P directly from raffinose points toward a glycolytic pathway in bacteria, not described so far. The crystal structures of the galactosidase domain in the apo form and in complex with the product shed light onto the reaction and substrate recognition mechanisms and highlight an oligorneric state necessary for efficient substrate binding and suggesting a cross-talk between the galactose and kinase domains.	[Bruel, Laetitia; Tison, Marine Cervera; Pujol, Ange; Nicoletti, Cendrine; Perrier, Josette; Fons, Michel; Giardina, Thierry] Univ Paul Cezanne, Fac Sci & Tech St Jerome, ISM2 BiosCiences, CNRS,UMR 6263,Serv 342, F-13397 Marseille 20, France; [Sulzenbacher, Gerlind] Univ Aix Marseille, CNRS, UMR 6098, F-13288 Marseille 09, France; [Bruel, Laetitia; Galinier, Anne; Pompeo, Frederique] CNRS, UPR 9043, IMM, Chim Bacterienne Lab, F-13402 Marseille 20, France; [Ropartz, David] INRA, Lab Spectrometrie Masse, UR Biopolymeres Interact Assemblages 1268, F-44316 Nantes 3, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE	Giardina, T (corresponding author), Univ Paul Cezanne, Fac Sci & Tech St Jerome, ISM2 BiosCiences, CNRS,UMR 6263,Serv 342, F-13397 Marseille 20, France.	thierry.giardina@univ-cezanne.fr	Pompeo, Frederique/Q-5772-2017; Sulzenbacher, Gerlind/A-6801-2018; Giardina, Thierry/AAA-4003-2020	Sulzenbacher, Gerlind/0000-0003-4844-2820; Ropartz, David/0000-0003-4767-6940; Fons, Michel/0000-0001-8263-3669	CNRS; Agence Nationale de la Recherche (ANR); Ministere de l'Enseignement Superieur	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur	This work was supported by the CNRS, the Agence Nationale de la Recherche (ANR) contract "P-loop proteins," and the "Ministere de l'Enseignement Superieur."	Ademark P, 2001, ENZYME MICROB TECH, V29, P441, DOI 10.1016/S0141-0229(01)00415-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; ASLANIDIS C, 1989, J BACTERIOL, V171, P6753, DOI 10.1128/jb.171.12.6753-6763.1989; Barrangou R, 2006, P NATL ACAD SCI USA, V103, P3816, DOI 10.1073/pnas.0511287103; Blaut Michael, 2002, European Journal of Nutrition, V41, P11; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CAPUTTO R, 1949, J BIOL CHEM, V179, P497; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dore J, 1998, SYST APPL MICROBIOL, V21, P65, DOI 10.1016/S0723-2020(98)80009-X; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forouhar F, 2008, J BIOL CHEM, V283, P11832, DOI 10.1074/jbc.M710352200; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Goulas T, 2009, APPL MICROBIOL BIOT, V82, P471, DOI 10.1007/s00253-008-1750-5; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; HASHIMOTO H, 1995, BIOSCI BIOTECH BIOCH, V59, P619, DOI 10.1271/bbb.59.619; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hugouvieux-Cotte-Pattat N, 2009, J BACTERIOL, V191, P6960, DOI 10.1128/JB.00594-09; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 1992, PROTEIN CRYSTALLOGR, V26, P27; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai H, 2010, FEBS J, V277, P3538, DOI 10.1111/j.1742-4658.2010.07763.x; Neyrinck AM, 2010, CURR OPIN CLIN NUTR, V13, P722, DOI 10.1097/MCO.0b013e32833ec3fb; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Reid SJ, 2005, APPL MICROBIOL BIOT, V67, P312, DOI 10.1007/s00253-004-1885-y; Rigden DJ, 2002, FEBS LETT, V523, P17, DOI 10.1016/S0014-5793(02)02879-X; SILVERSTEIN R, 1967, J BIOL CHEM, V242, P1338; Spangenberg P, 2000, CARBOHYD RES, V329, P65, DOI 10.1016/S0008-6215(00)00170-1; Tison MC, 2009, BBA-PROTEINS PROTEOM, V1794, P438, DOI 10.1016/j.bbapap.2008.11.024; TRUGO LC, 1995, FOOD CHEM, V52, P385, DOI 10.1016/0308-8146(95)93286-Z; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tzortzis G, 2004, APPL MICROBIOL BIOT, V64, P106, DOI 10.1007/s00253-003-1427-z; Tzortzis G, 2003, APPL MICROBIOL BIOT, V63, P286, DOI 10.1007/s00253-003-1426-0; Van Laere KMJ, 1999, APPL MICROBIOL BIOT, V52, P681, DOI 10.1007/s002530051579; Venema K, 2010, CURR OPIN CLIN NUTR, V13, P432, DOI 10.1097/MCO.0b013e32833a8b60; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Zhao H, 2008, FEMS MICROBIOL LETT, V285, P278, DOI 10.1111/j.1574-6968.2008.01246.x	55	27	28	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40814	40823		10.1074/jbc.M111.286039	http://dx.doi.org/10.1074/jbc.M111.286039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21931163	Green Published, hybrid			2022-12-27	WOS:000297315400042
J	Chen, B; Dores, MR; Grinnsey, N; Canto, I; Barker, BL; Trejo, J				Chen, Buxin; Dores, Michael R.; Grinnsey, Neil; Canto, Isabel; Barker, Breann L.; Trejo, JoAnn			Adaptor Protein Complex-2 (AP-2) and Epsin-1 Mediate Protease-activated Receptor-1 Internalization via Phosphorylation- and Ubiquitination-dependent Sorting Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 NEF; RNA INTERFERENCE; THROMBIN RECEPTORS; BETA-ARRESTINS; LIQUID FACETS; CLATHRIN; ENDOCYTOSIS; BINDING; TRAFFICKING; TERMINATION	Signaling by protease-activated receptor-1 (PAR1), a G protein-coupled receptor (GPCR) for thrombin, is regulated by desensitization and internalization. PAR1 desensitization is mediated by beta-arrestins, like most classic GPCRs. In contrast, internalization of PAR1 occurs through a clathrin- and dynamin-dependent pathway independent of beta-arrestins. PAR1 displays two modes of internalization. Constitutive internalization of unactivated PAR1 is mediated by the clathrin adaptor protein complex-2 (AP-2), where the mu 2-adaptin subunit binds directly to a tyrosine-based motif localized within the receptor C-tail domain. However, AP-2 depletion only partially inhibits agonist-induced internalization of PAR!, suggesting a function for other clathrin adaptors in this process. Here, we now report that AP-2 and epsin-1 are both critical mediators of agonist-stimulated PAR1 internalization, We show that ubiquitination of PAR1 and the ubiquitin-interacting motifs of epsin-1 are required for epsin-l-dependent internalization of activated PAR1. In addition, activation of PAR1 promotes epsin-1 de-ubiquitination, which may increase its endocytic adaptor activity to facilitate receptor internalization. AP-2 also regulates activated PAR1 internalization via recognition of distal C-tail phosphorylation sites rather than the canonical tyrosine-based motif. Thus, AP-2 and epsin-1 are both required to promote efficient internalization of activated PAR1 and recognize discrete receptor sorting signals. This study defines a new pathway for internalization of mammalian GPCRs.	[Chen, Buxin; Dores, Michael R.; Grinnsey, Neil; Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Canto, Isabel] Univ Calif San Diego, Biomed Sci Grad Program, Sch Med, La Jolla, CA 92093 USA; [Barker, Breann L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Jefferson University	Trejo, J (corresponding author), 9500 Gilman Dr,BSB Rm 3044A, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Grimsey, Neil/B-1634-2015	Grimsey, Neil/0000-0002-0481-4920; Dores, Michael/0000-0001-9243-0582; TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [HL073328]; University of California; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007444, R01HL073328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL073328 (to IT.) and a University of California Tobacco related Disease Research Program Exploratory Award (to J. T.).; Supported by an American Heart Association Postdoctoral Fellowship Award.	Aguilar RC, 2003, J BIOL CHEM, V278, P10737, DOI 10.1074/jbc.M211622200; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P2486, DOI 10.1021/bi982527i; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; HEIN L, 1994, J BIOL CHEM, V269, P27719; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; ISHII K, 1994, J BIOL CHEM, V269, P1125; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Oldham W. M., 2008, NAT REV, V9, P60; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98	35	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40760	40770		10.1074/jbc.M111.299776	http://dx.doi.org/10.1074/jbc.M111.299776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965661	Green Published, hybrid			2022-12-27	WOS:000297315400037
J	Fei, YR; Xiao, LP; Doetschman, T; Coffin, DJ; Hurley, MM				Fei, Yurong; Xiao, Liping; Doetschman, Thomas; Coffin, Douglas J.; Hurley, Marja M.			Fibroblast Growth Factor 2 Stimulation of Osteoblast Differentiation and Bone Formation Is Mediated by Modulation of the Wnt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRIZZLED-RELATED PROTEIN-1; BETA-CATENIN; NEGATIVE REGULATOR; MISSENSE MUTATIONS; IN-VIVO; MASS; MICE; GENE; LRP5; RECEPTOR	Fibroblast growth factor 2 (FGT2) positively modulates osteoblast differentiation and bone formation. However, the mechanism(s) is not fully understood. Because the Wnt canonical pathway is important for bone homeostasis, this study focuses on modulation of Wnt/beta-catenin signaling using Fgf2(-/-) mice (FGF2 all isoforms ablated), both in the absence of endogenous FGF2 and in the presence of exogenous FGF2. This study demonstrates a role of endogenous FGF2 in bone formation through Wnt signaling. Specifically, mRNA expression for the canonical Wnt genes Wnt10b, Lrp6, and beta-catenin was decreased significantly in Fgf2(-/-) bone marrow stromal cells during osteoblast differentiation. In addition, a marked reduction of Wnt10b and p-catenin protein expression was observed in Fgf2(-/-) mice. Furthermore, Fgf2(-/-) osteoblasts displayed marked reduction of inactive phosphorylated glycogen synthase kinase-3 beta, a negative regulator of Wnt/beta-catenin pathway as well as a significant decrease of Dkk2 mRNA, which plays a role in terminal osteoblast differentiation. Addition of exogenous FGF2 promoted p-catenin nuclear accumulation and further partially rescued decreased mineralization in Fgf2(-/-) bone marrow stromal cell cultures, Collectively, our findings suggest that FGF2 stimulation of osteoblast differentiation and bone formation is mediated in part by modulating the Wnt pathway.	[Hurley, Marja M.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA; [Doetschman, Thomas] Univ Arizona, Tucson, AZ 85724 USA; [Coffin, Douglas J.] Univ Montana, Missoula, MT 59812 USA	University of Connecticut; University of Arizona; University of Montana System; University of Montana	Hurley, MM (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA.	hurley@nso1.uchc.edu			National Institutes of Health [AG021189]; NATIONAL INSTITUTE ON AGING [R01AG021189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, National Institutes of Health Grant AG021189 (to M. M. H.).	Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Cho HY, 2010, BONE, V47, P263, DOI 10.1016/j.bone.2010.05.010; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; Fei YR, 2010, BIOCHEM BIOPH RES CO, V391, P335, DOI 10.1016/j.bbrc.2009.11.059; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Hurley M. M., 2002, PRINCIPLES BONE BIOL, P627; Hurley MM, 1999, J BONE MINER RES, V14, P776, DOI 10.1359/jbmr.1999.14.5.776; HURLEY MM, 1994, J BIOL CHEM, V269, P9392; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Karsenty G, 2008, HUM GENET, V9, P183; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawaguchi H, 2010, J BONE MINER RES, V25, P2459, DOI 10.1002/jbmr.146; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616; Kitamura M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002611; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; MAYAHARA H, 1993, GROWTH FACTORS, V9, P73, DOI 10.3109/08977199308991583; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Naganawa T, 2006, BIOCHEM BIOPH RES CO, V339, P490, DOI 10.1016/j.bbrc.2005.10.215; Nakamura K, 1998, INT ORTHOP, V22, P49, DOI 10.1007/s002640050207; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Nakanishi R, 2006, J BONE MINER RES, V21, P1713, DOI 10.1359/JBMR.060719; Okada Y, 2003, J BIOL CHEM, V278, P21258, DOI 10.1074/jbc.M302113200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piters E, 2008, ARCH BIOCHEM BIOPHYS, V473, P112, DOI 10.1016/j.abb.2008.03.006; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Quarto N, 2010, J BONE MINER RES, V25, P1680, DOI 10.1359/jbmr.091116; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Spellman PT, 2002, GENOME BIOL, V3; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wang XH, 2004, AM J PHYSIOL-HEART C, V287, pH2376, DOI 10.1152/ajpheart.01173.2003; Xiao LP, 2010, BONE, V47, P360, DOI 10.1016/j.bone.2010.05.021; Xiao LP, 2009, J BIOL CHEM, V284, P3170, DOI 10.1074/jbc.M804900200; Yao W, 2010, J BONE MINER RES, V25, P190, DOI 10.1359/jbmr.090719; Zhou M, 1998, NAT MED, V4, P201, DOI 10.1038/nm0298-201	66	74	81	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40575	40583		10.1074/jbc.M111.274910	http://dx.doi.org/10.1074/jbc.M111.274910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21987573	Green Published, hybrid			2022-12-27	WOS:000297315400017
J	Kaiser, HJ; Surma, MA; Mayer, F; Levental, I; Grzybek, M; Klemm, RW; Da Cruz, S; Meisinger, C; Muller, V; Simons, K; Lingwood, D				Kaiser, Hermann-Josef; Surma, Michal A.; Mayer, Florian; Levental, Ilya; Grzybek, Michal; Klemm, Robin W.; Da Cruz, Sandrine; Meisinger, Chris; Mueller, Volker; Simons, Kai; Lingwood, Daniel			Molecular Convergence of Bacterial and Eukaryotic Surface Order	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOTGUN MASS-SPECTROMETRY; ALPHA-HELICAL PEPTIDES; MODEL MEMBRANES; LIPID RAFTS; HOMEOVISCOUS ADAPTATION; BIOLOGICAL-MEMBRANES; SECRETORY VESICLES; BILAYER THICKNESS; PLASMA-MEMBRANES; PHASE-DIAGRAMS	The conservation of fluidity is a theme common to all cell membranes. In this study, an analysis of lipid packing was conducted via C-laurdan spectroscopy of cell surface membranes prepared from representative species of Bacteria and Eukarya. We found that despite their radical differences in composition (namely the presence and absence of membrane-rigidifying sterol) the membrane order of all taxa converges on a remarkably similar level, To understand how this similarity is constructed, we reconstituted membranes with either bacterial or eukaryotic components. We found that transmembrane segments of proteins have an important role in buffering lipid-mediated packing. This buffering ensures that sterol-free and sterol-containing membranes exhibit similar barrier properties.	[Kaiser, Hermann-Josef; Surma, Michal A.; Levental, Ilya; Grzybek, Michal; Simons, Kai; Lingwood, Daniel] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Mayer, Florian; Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60438 Frankfurt, Germany; [Klemm, Robin W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Da Cruz, Sandrine] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Da Cruz, Sandrine] Univ Calif San Diego, Ludwig Inst, La Jolla, CA 92093 USA; [Meisinger, Chris] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Meisinger, Chris] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany	Max Planck Society; Goethe University Frankfurt; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Freiburg; University of Freiburg	Lingwood, D (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	daniel.lingwood@nih.gov	Surma, Michal/B-1955-2016; Meisinger, Chris/J-1110-2014; Mueller, Volker/ABE-4305-2021; Levental, Ilya/F-4707-2011; Klemm, Robin/C-5463-2014; Grzybek, Michal/D-3802-2017; Klemm, Robin/ABA-2252-2020	Surma, Michal/0000-0001-7833-2214; Meisinger, Chris/0000-0002-8326-3548; Mueller, Volker/0000-0001-7955-5508; Levental, Ilya/0000-0002-1206-9545; Klemm, Robin/0000-0003-2313-8240; Grzybek, Michal/0000-0003-2083-0506; Klemm, Robin/0000-0003-2313-8240; Simons, Kai/0000-0002-9231-9996	Max Planck Institute for Molecular Cell Biology and Genetics; Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereiche [807]; DFG Schwerpunktprogramm1175 [SI459/2-1]; DFG Transregio [TRR83 TP02]; European Science Foundation LIPIDPROD [SI459/3-1]; Bundesministerium fur Bildung und Forschung ForMaT [03FO1212]; Klaus Tschira Foundation	Max Planck Institute for Molecular Cell Biology and Genetics; Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereiche(German Research Foundation (DFG)); DFG Schwerpunktprogramm1175; DFG Transregio(German Research Foundation (DFG)); European Science Foundation LIPIDPROD; Bundesministerium fur Bildung und Forschung ForMaT(Federal Ministry of Education & Research (BMBF)); Klaus Tschira Foundation	This work was supported by a Max Planck Institute for Molecular Cell Biology and Genetics stipend (to D. L.), by Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereiche Grant 807 (to V. M.), and by DFG Schwerpunktprogramm1175 Grant SI459/2-1, DFG Transregio 83 Grant TRR83 TP02; European Science Foundation LIPIDPROD Grant SI459/3-1; Bundesministerium fur Bildung und Forschung ForMaT Grant 03FO1212, and The Klaus Tschira Foundation (to K. S.).	BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; Castanho MARB, 1997, EUR BIOPHYS J BIOPHY, V26, P253, DOI 10.1007/s002490050078; Chintalapati S, 2004, CELL MOL BIOL, V50, P631; de Planque MRR, 1998, BIOCHEMISTRY-US, V37, P9333, DOI 10.1021/bi980233r; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dupuy AD, 2008, P NATL ACAD SCI USA, V105, P2848, DOI 10.1073/pnas.0712379105; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Fastenberg ME, 2003, BIOCHEMISTRY-US, V42, P12376, DOI 10.1021/bi034718d; Feigenson GW, 2009, BBA-BIOMEMBRANES, V1788, P47, DOI 10.1016/j.bbamem.2008.08.014; Ge MT, 2003, BIOPHYS J, V85, P1278, DOI 10.1016/S0006-3495(03)74563-9; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0; HUSCHILT JC, 1989, BIOCHIM BIOPHYS ACTA, V979, P139, DOI 10.1016/0005-2736(89)90534-8; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; JAHNIG F, 1981, BIOPHYS J, V36, P329, DOI 10.1016/S0006-3495(81)84735-2; Kaiser HJ, 2011, P NATL ACAD SCI USA, V108, P16628, DOI 10.1073/pnas.1103742108; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kalvodova L, 2009, J VIROL, V83, P7996, DOI 10.1128/JVI.00635-09; Killian JA, 2006, CURR OPIN STRUC BIOL, V16, P473, DOI 10.1016/j.sbi.2006.06.007; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; LEWIS BA, 1983, J MOL BIOL, V166, P203, DOI 10.1016/S0022-2836(83)80006-0; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lonnfors M, 2011, BIOPHYS J, V100, P2633, DOI 10.1016/j.bpj.2011.03.066; Lundbaek JA, 2003, BIOPHYS J, V84, P2080, DOI 10.1016/S0006-3495(03)75015-2; MacDonald A.G., 1985, Symposia of the Society for Experimental Biology, P301; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; MOURITSEN OG, 1993, ANNU REV BIOPH BIOM, V22, P145, DOI 10.1146/annurev.bb.22.060193.001045; Mykytczuk NCS, 2007, PROG BIOPHYS MOL BIO, V95, P60, DOI 10.1016/j.pbiomolbio.2007.05.001; NEZIL FA, 1992, BIOPHYS J, V61, P1176, DOI 10.1016/S0006-3495(92)81926-4; Niemela PS, 2009, BBA-BIOMEMBRANES, V1788, P122, DOI 10.1016/j.bbamem.2008.08.018; Noireaux V, 2011, P NATL ACAD SCI USA, V108, P3473, DOI 10.1073/pnas.1017075108; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Ren JH, 1999, BIOCHEMISTRY-US, V38, P5905, DOI 10.1021/bi982942a; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Sajbidor J, 1997, CRIT REV BIOTECHNOL, V17, P87, DOI 10.3109/07388559709146608; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; SEELIG J, 1980, Q REV BIOPHYS, V13, P19, DOI 10.1017/S0033583500000305; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Smith WL, 2001, J BIOL CHEM, V276, P32393, DOI 10.1074/jbc.R100044200; Surma MA, 2011, TRAFFIC, V12, P1139, DOI 10.1111/j.1600-0854.2011.01221.x; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101	51	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40631	40637		10.1074/jbc.M111.276444	http://dx.doi.org/10.1074/jbc.M111.276444			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965671	Green Published, hybrid			2022-12-27	WOS:000297315400024
J	Sue, XE; Hansen, BG; Hedstrom, L				Sue, Xin E.; Hansen, Bjarne Gram; Hedstrom, Lizbeth			Kinetically Controlled Drug Resistance HOW PENICILLIUM BREVICOMPACTUM SURVIVES MYCOPHENOLIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE MONOPHOSPHATE DEHYDROGENASE; IMP DEHYDROGENASE; 5'-MONOPHOSPHATE DEHYDROGENASE; MOLECULAR-BASIS; MECHANISM; IMMUNOSUPPRESSANT; 5-MONOPHOSPHATE; INHIBITION; BINDING; COMPLEX	The filamentous fungus Penicillium brevicompactum produces the immunosuppressive drug mycophenolic acid (MPA), which is a potent inhibitor of eukaryotic IMP dehydrogenases (IMPDHs). IMPDH catalyzes the conversion of IMP to XMP via a covalent enzyme intermediate, E-XMP*; MPA inhibits by trapping E-XMP*. P. brevicompactum (Pb) contains two MPA-resistant IMPDHs, PbIMPDH-A and PhIMPDH-B, which are 17- and 10(3)-fold more resistant to MPA than typically observed. Surprisingly, the active sites of these resistant enzymes are essentially identical to those of MPA-sensitive enzymes, so the mechanistic basis of resistance is not apparent. Here, we show that, unlike MPA-sensitive IMPDHs, formation of E-XMP* is rate-limiting for both PbIMPDH-A and PbIMPDH-B. Therefore, MPA resistance derives from the failure to accumulate the drug-sensitive intermediate.	[Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02453 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02453 USA; [Sue, Xin E.] Brandeis Univ, Grad Program Biochem, Waltham, MA 02453 USA; [Hansen, Bjarne Gram] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Kongens Lyngby, Denmark	Brandeis University; Brandeis University; Brandeis University; Technical University of Denmark	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biol, MS009,415 South St, Waltham, MA 02453 USA.	hedstrom@brandeis.edu			National Institutes of Health [GM54403, P41 RR001081]; Danish Council for Independent Research, Technology and Product Sciences [09-064240, 09-064967]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596, R01GM054403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Technology and Product Sciences(Det Frie Forskningsrad (DFF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54403 (to L. H.). The work performed by B. G. H. was supported by Grants 09-064240 and 09-064967 from the Danish Council for Independent Research, Technology and Product Sciences.; Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081).	Bentley R, 2000, CHEM REV, V100, P3801, DOI 10.1021/cr990097b; Bruzzese FJ, 1997, BIOCHEMISTRY-US, V36, P10428, DOI 10.1021/bi9708040; Digits JA, 1999, BIOCHEMISTRY-US, V38, P2295, DOI 10.1021/bi982305k; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Hansen B.G., 2011, BIOCH J IN PRESS; Hansen BG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-202; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; HERMES JD, 1984, BIOCHEMISTRY-US, V23, P5479, DOI 10.1021/bi00318a016; Jenks MH, 2005, YEAST, V22, P1181, DOI 10.1002/yea.1300; Kohler GA, 2005, J BIOL CHEM, V280, P11295, DOI 10.1074/jbc.M409847200; Link JO, 1996, J AM CHEM SOC, V118, P2091, DOI 10.1021/ja9534056; MacPherson IS, 2010, J AM CHEM SOC, V132, P1230, DOI 10.1021/ja909947a; Min DH, 2008, PLOS BIOL, V6, P1802, DOI 10.1371/journal.pbio.0060206; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; NOTO T, 1969, J ANTIBIOT, V22, P165, DOI 10.7164/antibiotics.22.165; Regueira TB, 2011, APPL ENVIRON MICROB, V77, P3035, DOI 10.1128/AEM.03015-10; Riera TV, 2008, BIOCHEMISTRY-US, V47, P8689, DOI 10.1021/bi800674a; Schlippe YVG, 2004, BIOCHEMISTRY-US, V43, P4511, DOI 10.1021/bi035823q; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Wang W, 1996, BIOCHEMISTRY-US, V35, P95, DOI 10.1021/bi951499q; Wang W, 1997, BIOCHEMISTRY-US, V36, P8479, DOI 10.1021/bi970226n	21	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40595	40600		10.1074/jbc.M111.305235	http://dx.doi.org/10.1074/jbc.M111.305235			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21979957	hybrid, Green Published			2022-12-27	WOS:000297315400019
J	Erokhova, L; Horner, A; Kugler, P; Pohl, P				Erokhova, Liudmila; Horner, Andreas; Kuegler, Philipp; Pohl, Peter			Monitoring Single-channel Water Permeability in Polarized Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; RENAL PRINCIPAL CELLS; EPITHELIAL-CELLS; DIFFUSION-COEFFICIENTS; TIGHT JUNCTIONS; MDCK CELLS; AQUAPORINS; TRANSPORT; PHOSPHORYLATION; RECONSTITUTION	So far the determination of unitary permeability (p(f)) of water channels that are expressed in polarized cells is subject to large errors because the opening of a single water channel does not noticeably increase the water permeability of a membrane patch above the background. That is, in contrast to the patch clamp technique, where the single ion channel conductance may be derived from a single experiment, two experiments separated in time and/or space are required to obtain the single-channel water permeability p(f) as a function of the incremental water permeability (p(f, c)) and the number (n) of water channels that contributed to p(f, c). Although the unitary conductance of ion channels is measured in the native environment of the channel, p(f) is so far derived from reconstituted channels or channels expressed in oocytes. To determine the p(f) of channels from live epithelial monolayers, we exploit the fact that osmotic volume flow alters the concentration of aqueous reporter dyes adjacent to the epithelia. We measure these changes by fluorescence correlation spectroscopy, which allows the calculation of both p(f, c) and osmolyte dilution within the unstirred layer. Shifting the focus of the laser from the aqueous solution to the apical and basolateral membranes allowed the FCS-based determination of n. Here we validate the new technique by determining the p(f) of aquaporin 5 in Madin-Darby canine kidney cell monolayers. Because inhibition and subsequent activity rescue are monitored on the same sample, drug effects on exocytosis or endocytosis can be dissected from those on p(f).	[Erokhova, Liudmila; Horner, Andreas; Pohl, Peter] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Kuegler, Philipp] Austrian Acad Sci, Radon Inst Computat & Appl Math, A-4040 Linz, Austria	Johannes Kepler University Linz; Austrian Academy of Sciences	Pohl, P (corresponding author), Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	peter.pohl@jku.at	Horner, Andreas/F-6427-2013; Pohl, Peter/A-5361-2008; Kügler, Philipp/B-4444-2015	Horner, Andreas/0000-0002-5328-1745; Pohl, Peter/0000-0002-1792-2314; Kügler, Philipp/0000-0002-1041-9265	Austrian Science Fund (FWF) [W1201, P23466]; Austrian Science Fund (FWF) [P 23466] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grants W1201 and P23466 from the Austrian Science Fund (FWF) (to P. P.).	Chou CL, 2008, AM J PHYSIOL-RENAL, V295, pF192, DOI 10.1152/ajprenal.00011.2008; Eto K, 2010, J BIOL CHEM, V285, P40777, DOI 10.1074/jbc.M110.151928; Gendron PO, 2008, J FLUORESC, V18, P1093, DOI 10.1007/s10895-008-0357-7; Heo J, 2008, ANAL CHEM, V80, P6974, DOI 10.1021/ac8008498; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Hub JS, 2010, BIOPHYS J, V99, pL97, DOI 10.1016/j.bpj.2010.11.003; Kovbasnjuk O, 1998, P NATL ACAD SCI USA, V95, P6526, DOI 10.1073/pnas.95.11.6526; Lorenz D, 2003, EMBO REP, V4, P88, DOI 10.1038/sj.embor.embor711; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Maric K, 2001, BIOPHYS J, V80, P1783, DOI 10.1016/S0006-3495(01)76148-6; Matsui H, 2000, J CLIN INVEST, V105, P1419, DOI 10.1172/JCI4546; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Mollajew R, 2010, BIOPHYS J, V99, P3647, DOI 10.1016/j.bpj.2010.10.021; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Pohl P, 2001, P NATL ACAD SCI USA, V98, P9624, DOI 10.1073/pnas.161299398; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; STRANGE K, 1987, SCIENCE, V235, P1068, DOI 10.1126/science.3823867; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Tsunoda SP, 2004, J BIOL CHEM, V279, P11364, DOI 10.1074/jbc.M310881200; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; VANHOEK AN, 1992, J BIOL CHEM, V267, P18267; VONBONSDORFF CH, 1985, EMBO J, V4, P2781, DOI 10.1002/j.1460-2075.1985.tb04004.x; Wan XC, 2004, J EXP BOT, V55, P411, DOI 10.1093/jxb/erh051; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; ZAMPIGHI GA, 1995, J MEMBRANE BIOL, V148, P65; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002	32	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39926	39932		10.1074/jbc.M111.291864	http://dx.doi.org/10.1074/jbc.M111.291864			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21940624	Green Published, hybrid			2022-12-27	WOS:000296925700026
J	Ma, XY; Yu, JM; Zhang, SZ; Liu, XY; Wu, BH; Wei, XL; Yan, JQ; Sun, HL; Yan, HT; Zheng, JQ				Ma, Xiao-Yun; Yu, Jin-Mei; Zhang, Shu-Zhuo; Liu, Xiao-Yan; Wu, Bao-Hong; Wei, Xiao-Li; Yan, Jia-Qing; Sun, Hong-Liang; Yan, Hai-Tao; Zheng, Jian-Quan			External Ba2(+) Block of the Two-pore Domain Potassium Channel TREK-1 Defines Conformational Transition in Its Selectivity Filter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; FUNCTIONAL EXPRESSION; XENOPUS OOCYTES; OUTER PORE; INACTIVATION; CONDUCTANCE; MECHANISM; BA2+; LOCALIZATION; BARIUM	TREK-1 is a member of the two-pore domain potassium channel family that is known as a leak channel and plays a key role in many physiological and pathological processes. The conformational transition of the selectivity filter is considered as an effective strategy for potassium channels to control the course of potassium efflux. It is well known that TREK-1 is regulated by a large volume of extracellular and intracellular signals. However, until now, little was known about the selectivity filter gating mechanism of the channel. In this research, it was found that Ba2+ blocked the TREK-1 channel in a concentration-and time-dependent manner. A mutagenesis analysis showed that overlapped binding of Ba2+ at the assumed K+ binding site 4 (S4) within the selectivity filter was responsible for the inhibitory effects on TREK-1. Then, Ba2+ was used as a probe to explore the conformational transition in the selectivity filter of the channel. It was confirmed that collapsed conformations were induced by extracellular K+-free and acidification at the selectivity filters, leading to nonconductive to permeable ions. Further detailed characterization demonstrated that the two conformations presented different properties. Additionally, the N-terminal truncated isoform (Delta N41), a product derived from alternative translation initiation, was identified as a constitutively nonconductive variant. Together, these results illustrate the important role of selectivity filter gating in the regulation of TREK-1 by the extracellular K+ and proton.	[Ma, Xiao-Yun; Yu, Jin-Mei; Zhang, Shu-Zhuo; Liu, Xiao-Yan; Wu, Bao-Hong; Wei, Xiao-Li; Yan, Jia-Qing; Sun, Hong-Liang; Yan, Hai-Tao; Zheng, Jian-Quan] Beijing Inst Pharmacol & Toxicol, Dept Biochem Pharmacol, Beijing 100850, Peoples R China	Academy of Military Medical Sciences - China	Zheng, JQ (corresponding author), 27 Taiping Rd, Beijing 100850, Peoples R China.	zhengjq@bmi.ac.cn	Yan, Jia-qing/AAI-1974-2020		National Program on Key Basic Research Project of China [2007CB512307]	National Program on Key Basic Research Project of China(National Basic Research Program of China)	This work was supported by National Program on Key Basic Research Project of China Grant 2007CB512307.	Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bhate MP, 2010, J MOL BIOL, V401, P155, DOI 10.1016/j.jmb.2010.06.031; Bruening-Wright A, 2007, J GEN PHYSIOL, V130, P601, DOI 10.1085/jgp.200709828; Chang HK, 2009, BBA-BIOMEMBRANES, V1788, P500, DOI 10.1016/j.bbamem.2008.10.016; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chatelain FC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007496; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Cheng YM, 2008, BIOPHYS J, V95, P4456, DOI 10.1529/biophysj.108.133165; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Domene C, 2008, J AM CHEM SOC, V130, P9474, DOI 10.1021/ja801792g; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Es-Salah-Lamoureux Z, 2010, TRENDS PHARMACOL SCI, V31, P587, DOI 10.1016/j.tips.2010.09.001; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Gibor G, 2004, J GEN PHYSIOL, V124, P83, DOI 10.1085/jgp.200409068; Gibor G, 2007, BIOPHYS J, V93, P4159, DOI 10.1529/biophysj.107.107987; Harris RE, 1998, BIOPHYS J, V74, P1808, DOI 10.1016/S0006-3495(98)77891-9; Inglis SK, 2007, AM J PHYSIOL-LUNG C, V292, pL1304, DOI 10.1152/ajplung.00424.2006; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Kim SJ, 2006, CARDIOVASC RES, V69, P13, DOI 10.1016/j.cardiores.2005.10.013; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; O'Connell AD, 2005, J PHYSIOL-LONDON, V562, P687, DOI 10.1113/jphysiol.2004.079020; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Shieh RC, 1998, BIOPHYS J, V75, P2313, DOI 10.1016/S0006-3495(98)77675-1; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105; Vergara C, 1999, J GEN PHYSIOL, V114, P365, DOI 10.1085/jgp.114.3.365; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; Yuill KH, 2007, PFLUG ARCH EUR J PHY, V455, P333, DOI 10.1007/s00424-007-0282-7; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7; Zuniga L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016141	43	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39813	39822		10.1074/jbc.M111.264788	http://dx.doi.org/10.1074/jbc.M111.264788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965685	Green Published, hybrid			2022-12-27	WOS:000296925700015
J	Steiner, LA; Schulz, VP; Maksimova, Y; Wong, C; Gallagher, PG				Steiner, Laurie A.; Schulz, Vincent P.; Maksimova, Yelena; Wong, Clara; Gallagher, Patrick G.			Patterns of Histone H3 Lysine 27 Monomethylation and Erythroid Cell Type-specific Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT ANNOTATION SYSTEM; HUMAN GENOME; METHYLTRANSFERASE ACTIVITY; MAMMALIAN CHROMATIN; STEM-CELLS; METHYLATION; POLYCOMB; DROSOPHILA; COMPLEXES; EPIGENETICS	Post-translational histone modifications, acting alone or in a context-dependent manner, influence numerous cellular processes via their regulation of gene expression. Monomethylation of histone H3 lysine 27 (K27me1) is a poorly understood histone modification. Some reports describe depletion of K27Me1 at promoters and transcription start sites (TSS), implying its depletion at TSS is necessary for active transcription, while others have associated enrichment of H3K27me1 at TSS with increased levels of mRNA expression. Tissue- and gene-specific patterns of H3K27me1 enrichment and their correlation with gene expression were determined via chromatin immunoprecipitation on chip microarray (ChIP-chip) and human mRNA expression array analyses. Results from erythroid cells were compared with those in neural and muscle cells. H3K27me1 enrichment varied depending on levels of cell-type specific gene expression, with highest enrichment over transcriptionally active genes. Over individual genes, the highest levels of H3K27me1 enrichment were found over the gene bodies of highly expressed genes. In contrast to H3K4me3, which was highly enriched at the TSS of actively transcribing genes, H3K27me1 was selectively depleted at the TSS of actively transcribed genes. There was markedly decreased to no H3K27me1 enrichment in genes with low expression. At some locations, H3K27 monomethylation was also found to be associated with chromatin signatures of gene enhancers.	[Steiner, Laurie A.; Schulz, Vincent P.; Maksimova, Yelena; Wong, Clara; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Gallagher, PG (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	patrick.gallagher@yale.edu		Schulz, Vincent/0000-0001-6333-4284; Steiner, Laurie/0000-0002-2923-4105	National Institutes of Health [K12HD000850, HL65448, DK62039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062039, K08DK090153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants K12HD000850, HL65448, and DK62039 from the National Institutes of Health.	Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Gallagher PG, 1997, J BIOL CHEM, V272, P19220, DOI 10.1074/jbc.272.31.19220; Gallagher PG, 1998, J BIOL CHEM, V273, P1339, DOI 10.1074/jbc.273.3.1339; Goecks J., GENOME BIOL, V11, pR86; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jacob Y, 2009, EPIGENETICS-US, V4, P266, DOI 10.4161/epi.4.6.9713; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Steiner LA, 2009, MOL CELL BIOL, V29, P5399, DOI 10.1128/MCB.00777-09; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	40	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39457	39465		10.1074/jbc.M111.243006	http://dx.doi.org/10.1074/jbc.M111.243006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937433	hybrid, Green Published			2022-12-27	WOS:000296759800063
J	Li, LT; Jia, X; Ward, DM; Kaplan, J				Li, Liangtao; Jia, Xuan; Ward, Diane M.; Kaplan, Jerry			Yap5 Protein-regulated Transcription of the TYW1 Gene Protects Yeast from High Iron Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SULFUR CLUSTER; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAY; MITOCHONDRIAL; REGULON; TRANSPORT; IDENTIFICATION; BIOSYNTHESIS; TRAFFICKING	The budding yeast Saccharomyces cerevisiae responds to high cytosolic iron by inducing Yap5-mediated transcription. We identified genes regulated by Yap5 in response to iron and show that one of the genes induced is TYW1, which encodes an iron-sulfur cluster enzyme that participates in the synthesis of wybutosine-modified tRNA. Strains deleted for TYW1 do not show a phenotype in standard yeast medium. In contrast, overexpression of TYW1 results in decreased cell growth and induction of the iron regulon, leading to increased expression of the high affinity iron transporters. We identified a minimal domain of S. cerevisiae Tyw1 that is sufficient to induce the iron regulon. CCC1, a vacuolar iron importer, is a Yap5-regulated gene, and deletion of either CCC1 or YAP5 resulted in high iron sensitivity. Deletion of TYW1 in a Delta ccc1 strain led to increased iron sensitivity. The increased iron sensitivity of Delta ccc1 Delta tyw1 could be suppressed by overexpression of iron-sulfur cluster enzymes. We conclude that the Yap5-mediated induction of TYW1 provides protection from high iron toxicity by the consumption of free cytosolic iron through the formation of protein-bound iron-sulfur clusters.	[Li, Liangtao; Jia, Xuan; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu			National Institutes of Health from NIDDK [030534]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 030534 from NIDDK.	ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Kumanovics A, 2006, J BIOL CHEM, V281, P22566, DOI 10.1074/jbc.M604730200; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li LT, 1997, J BIOL CHEM, V272, P28485, DOI 10.1074/jbc.272.45.28485; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Moreno-Cermeno A, 2010, J BIOL CHEM, V285, P41653, DOI 10.1074/jbc.M110.149443; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Radisky DC, 1997, P NATL ACAD SCI USA, V94, P5662, DOI 10.1073/pnas.94.11.5662; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	24	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38488	38497		10.1074/jbc.M111.286666	http://dx.doi.org/10.1074/jbc.M111.286666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917924	hybrid, Green Published			2022-12-27	WOS:000296594200063
J	Tomita, T; Kuzuyama, T; Nishiyama, M				Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto			Structural Basis for Leucine-induced Allosteric Activation of Glutamate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERINSULINISM/HYPERAMMONEMIA SYNDROME; REGULATORY MUTATIONS; CRYSTAL-STRUCTURE; MECHANISM; CHILDREN; INSIGHTS; REVEALS; DOMAIN; GENE	Glutamate dehydrogenase (GDH) catalyzes reversible conversion between glutamate and 2-oxoglutarate using NAD(P)(H) as a coenzyme. Although mammalian GDH is regulated by GTP through the antenna domain, little is known about the mechanism of allosteric activation by leucine. An extremely thermophilic bacterium, Thermus thermophilus, possesses GDH with a unique subunit configuration composed of two different subunits, GdhA (regulatory subunit) and GdhB (catalytic subunit). T. thermophilus GDH is unique in that the enzyme is subject to allosteric activation by leucine. To elucidate the structural basis for leucine-induced allosteric activation of GDH, we determined the crystal structures of the GdhB-Glu and GdhA-GdhB-Leu complexes at 2.1 and 2.6 angstrom resolution, respectively. The GdhB-Glu complex is a hexamer that binds 12 glutamate molecules: six molecules are bound at the substrate-binding sites, and the remaining six are bound at subunit interfaces, each composed of three subunits. The GdhA-GdhB-Leu complex is crystallized as a heterohexamer composed of four GdhA subunits and two GdhB subunits. In this complex, six leucine molecules are bound at subunit interfaces identified as glutamate-binding sites in the GdhB-Glu complex. Consistent with the structure, replacement of the amino acid residues of T. thermophilus GDH responsible for leucine binding made T. thermophilus GDH insensitive to leucine. Equivalent amino acid replacement caused a similar loss of sensitivity to leucine in human GDH2, suggesting that human GDH2 also uses the same allosteric site for regulation by leucine.	[Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Nishiyama, Makoto] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	University of Tokyo; RIKEN	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Nishiyama, Makoto/0000-0001-8143-8052; Kuzuyama, Tomohisa/0000-0002-7221-5858	Ministry of Education, Culture, Sports, Science and Technology of Japan; Asahi Glass Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Asahi Glass Foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hamza MA, 2008, FEBS LETT, V582, P1816, DOI 10.1016/j.febslet.2008.04.049; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kawakami R, 2007, J BACTERIOL, V189, P5626, DOI 10.1128/JB.00496-07; Kelly A, 2001, J CLIN ENDOCR METAB, V86, P3724, DOI 10.1210/jc.86.8.3724; Knapp S, 1997, J MOL BIOL, V267, P916, DOI 10.1006/jmbi.1996.0900; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li M, 2007, BIOCHEMISTRY-US, V46, P15089, DOI 10.1021/bi7018783; Li M, 2009, J BIOL CHEM, V284, P22988, DOI 10.1074/jbc.M109.020222; Lu CD, 2001, J BACTERIOL, V183, P490, DOI 10.1128/JB.183.2.490-499.2001; MacMullen C, 2001, J CLIN ENDOCR METAB, V86, P1782, DOI 10.1210/jc.86.4.1782; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minambres B, 2000, J BIOL CHEM, V275, P39529, DOI 10.1074/jbc.M005136200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noor S, 2005, MICROBIOL-SGM, V151, P1409, DOI 10.1099/mic.0.27751-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; RICE DW, 1987, BIOCHEM J, V242, P789, DOI 10.1042/bj2420789; Smith TJ, 2008, TRENDS BIOCHEM SCI, V33, P557, DOI 10.1016/j.tibs.2008.07.007; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Stillman TJ, 1999, J MOL BIOL, V285, P875, DOI 10.1006/jmbi.1998.2335; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; Tomita T, 2010, MICROBIOL-SGM, V156, P3801, DOI 10.1099/mic.0.042721-0; WEST DJ, 1967, J BIOL CHEM, V242, P2134; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9	31	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37406	37413		10.1074/jbc.M111.260265	http://dx.doi.org/10.1074/jbc.M111.260265			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900230	Green Published, hybrid			2022-12-27	WOS:000296542400041
J	Marom, M; Dayan, D; Demishtein-Zohary, K; Mokranjac, D; Neupert, W; Azem, A				Marom, Milit; Dayan, Dana; Demishtein-Zohary, Keren; Mokranjac, Dejana; Neupert, Walter; Azem, Abdussalam			Direct Interaction of Mitochondrial Targeting Presequences with Purified Components of the TIM23 Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; PRECURSOR PROTEINS; IMPORT MOTOR; PREPROTEIN TRANSLOCASE; TIM50; HSP70; BINDING; OUTER; SITE; SPECIFICITY	Precursor proteins that are imported from the cytosol into the matrix of mitochondria carry positively charged amphipathic presequences and cross the inner membrane with the help of vital components of the TIM23 complex. It is currently unclear which subunits of the TIM23 complex recognize and directly bind to presequences. Here we analyzed the binding of presequence peptides to purified components of the TIM23 complex. The interaction of three different presequences with purified soluble domains of yeast Tim50 (Tim50(IMS)), Tim23 (Tim23(IMS)), and full-length Tim44 was examined. Using chemical cross-linking and surface plasmon resonance we demonstrate, for the first time, the ability of purified Tim50IMS and Tim44 to interact directly with the yeast Hsp60 presequence. We also analyzed their interaction with presequences derived from precursors of yeast mitochondrial 70-kDa heat shock protein (mHsp70) and of bovine cytochrome P450(SCC). Moreover, we characterized the nature of the interactions and determined their K(D)s. On the basis of our results, we suggest a mechanism of translocation where stronger interactions of the presequences on the trans side of the channel support the import of precursor proteins through TIM23 into the matrix.	[Marom, Milit; Dayan, Dana; Demishtein-Zohary, Keren; Azem, Abdussalam] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Neupert, Walter] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Mokranjac, Dejana] Univ Munich, Inst Physiol Chem, D-81377 Munich, Germany	Tel Aviv University; Max Planck Society; University of Munich	Azem, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	azema@tauex.tau.ac.il		Mokranjac, Dejana/0000-0002-4005-6979	German-Israeli Foundation for Scientific Research and Development [GIF-1012/08, SFB594]; Israel Science Foundation [452/09]; Tel-Aviv University; Ori Foundation	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Tel-Aviv University; Ori Foundation	This work was supported by the German-Israeli Foundation for Scientific Research and Development Grant GIF-1012/08, SFB594 and Israel Science Foundation Grant 452/09. This work was also supported by the Argentinean Friends of Tel-Aviv University and by the Ori Foundation in Memory of Ori Levi (to D. D.).	Alder NN, 2008, MOL BIOL CELL, V19, P159, DOI 10.1091/mbc.E07-07-0669; Azem A, 1997, J BIOL CHEM, V272, P20901, DOI 10.1074/jbc.272.33.20901; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; BLOM J, 1993, MOL CELL BIOL, V13, P7364, DOI 10.1128/MCB.13.12.7364; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; de la Cruz L, 2010, PROTEIN SCI, V19, P2045, DOI 10.1002/pro.482; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gevorkyan-Airapetov L, 2009, J BIOL CHEM, V284, P4865, DOI 10.1074/jbc.M807041200; Gruhler A, 1997, J BIOL CHEM, V272, P17410, DOI 10.1074/jbc.272.28.17410; Kanamori T, 1997, P NATL ACAD SCI USA, V94, P485, DOI 10.1073/pnas.94.2.485; Komiya T, 1997, EMBO J, V16, P4267, DOI 10.1093/emboj/16.14.4267; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Marom M, 2011, BBA-BIOMEMBRANES, V1808, P990, DOI 10.1016/j.bbamem.2010.07.011; Marom M, 2009, BIOCHEMISTRY-US, V48, P11185, DOI 10.1021/bi900998v; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Merlin A, 1999, J CELL BIOL, V145, P961, DOI 10.1083/jcb.145.5.961; Mokranjac D, 2005, BIOCHEM SOC T, V33, P1019, DOI 10.1042/BST0331019; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Mokranjac D, 2010, BBA-BIOENERGETICS, V1797, P1045, DOI 10.1016/j.bbabio.2010.01.026; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; SCHERER PE, 1992, P NATL ACAD SCI USA, V89, P11930, DOI 10.1073/pnas.89.24.11930; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Slutsky-Leiderman O, 2007, J BIOL CHEM, V282, P33935, DOI 10.1074/jbc.M704435200; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; van der Laan M, 2005, MOL CELL BIOL, V25, P7449, DOI 10.1128/MCB.25.17.7449-7458.2005; van der Laan M, 2006, FEMS YEAST RES, V6, P849, DOI 10.1111/j.1567-1364.2006.00134.x; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X; Yamamoto H, 2011, P NATL ACAD SCI USA, V108, P91, DOI 10.1073/pnas.1014918108; Yosef E, 2009, J MOL BIOL, V385, P1470, DOI 10.1016/j.jmb.2008.09.053	38	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43809	43815		10.1074/jbc.M111.261040	http://dx.doi.org/10.1074/jbc.M111.261040			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21969381	Green Published, hybrid			2022-12-27	WOS:000298402300023
J	Cao, JS; Zhou, YJ; Peng, HB; Huang, XY; Stahler, S; Suri, V; Qadri, A; Gareski, T; Jones, J; Hahm, S; Perreault, M; Mckew, J; Shi, MX; Xu, X; Tobin, JF; Gimeno, RE				Cao, Jingsong; Zhou, Yingjiang; Peng, Haibing; Huang, Xinyi; Stahler, Shannon; Suri, Vipin; Qadri, Ariful; Gareski, Tiffany; Jones, Juli; Hahm, Seung; Perreault, Mylene; McKew, John; Shi, Mengxiao; Xu, Xin; Tobin, James F.; Gimeno, Ruth E.			Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME ADIACYLGLYCEROL ACYLTRANSFERASE; COA-DIACYLGLYCEROL ACYLTRANSFERASE-1; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SYNTHESIS; HEPATIC STEATOSIS; ADIPOSE-TISSUE; KEY ENZYME; MICE	Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) is one of two known DGAT enzymes that catalyze the final step in triglyceride synthesis. Findings from genetically modified mice as well as pharmacological studies suggest that inhibition of DGAT1 is a promising strategy for the treatment of obesity and type 2 diabetes. Here we characterize a tool DGAT1 inhibitor compound, T863. We found that T863 is a potent inhibitor for both human and mouse DGAT1 in vitro, which acts on the acyl-CoA binding site of DGAT1 and inhibits DGAT1-mediated triacylglycerol formation in cells. In an acute lipid challenge model, oral administration of 1863 significantly delayed fat absorption and resulted in lipid accumulation in the distal small intestine of mice, mimicking the effects of genetic ablation of DGAT1. In diet-induced obese mice, oral administration of T863 for 2 weeks caused weight loss, reduction in serum and liver triglycerides, and improved insulin sensitivity. In addition to the expected triglyceride-lowering activity, T863 also lowered serum cholesterol. Hepatic IRS2 protein was dramatically up-regulated in mice treated with T863, possibly contributing to improved insulin sensitivity. In differentiated 3T3-L1 adipocytes, T863 enhanced insulin-stimulated glucose uptake, suggesting a possible role for adipocytes to improve insulin sensitivity upon DGAT1 inhibition. These results reveal novel mechanistic insights into the insulin-sensitizing effects of DGAT1 inhibition in mouse models. Taken together, our study provides a comprehensive evaluation of a small molecule inhibitor for DGAT1 and suggests that pharmacological inhibition of DGAT1 holds promise in treating diverse metabolic disorders.	[Cao, Jingsong; Zhou, Yingjiang; Peng, Haibing; Suri, Vipin; Qadri, Ariful; Gareski, Tiffany; Jones, Juli; Hahm, Seung; Perreault, Mylene; Tobin, James F.; Gimeno, Ruth E.] Pfizer, Biocorrect Res Unit, Cambridge, MA 02140 USA; [McKew, John] Pfizer, Exploratory Med Chem, Cambridge, MA 02140 USA; [Huang, Xinyi; Stahler, Shannon] Pfizer, Screening Sci, Collegeville, PA 19426 USA; [Shi, Mengxiao; Xu, Xin] Pfizer, Discovery Pharmacokinet, Andover, MA 01810 USA	Pfizer; Pfizer; Pfizer; Pfizer	Cao, JS (corresponding author), Pfizer, Biocorrect Res Unit, Cambridge, MA 02140 USA.	jingsong.cao@novartis.com; gimeno_ruth@lilly.com						Bagnato C, 2003, J BIOL CHEM, V278, P52203, DOI 10.1074/jbc.M305760200; Bello AA, 1996, BIOCHEM PHARMACOL, V51, P413, DOI 10.1016/0006-2952(95)02186-8; Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; Birch AM, 2009, J MED CHEM, V52, P1558, DOI 10.1021/jm801507v; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad; Chen HC, 2004, DIABETES, V53, P1445, DOI 10.2337/diabetes.53.6.1445; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chen N, 2005, DIABETES, V54, P3379, DOI 10.2337/diabetes.54.12.3379; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; Chiari A, 1995, PHARMACOL RES, V32, P189, DOI 10.1016/S1043-6618(05)80022-2; Chung CC, 2008, ASSAY DRUG DEV TECHN, V6, P361, DOI 10.1089/adt.2007.105; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Fox B.M., 2004, U.S. Patent, Patent No. [US 2004/0209871 A1, 20040209871, 2004/0209871 A1]; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; King AJ, 2009, J PHARMACOL EXP THER, V330, P526, DOI 10.1124/jpet.109.154047; Kohjima M, 2007, INT J MOL MED, V20, P351; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Okawa M, 2009, BIOCHEM BIOPH RES CO, V390, P377, DOI 10.1016/j.bbrc.2009.08.167; Ramharack R.R., 2002, Diacylglycerol acyltransferase (DGAT) assay, Patent No. [US20020127627, 20020127627]; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Seethala R, 2008, ANAL BIOCHEM, V383, P144, DOI 10.1016/j.ab.2008.09.013; Shih MYS, 2009, J BIOL CHEM, V284, P4292, DOI 10.1074/jbc.M807503200; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Tan CH, 2010, ANAL BIOCHEM, V401, P144, DOI 10.1016/j.ab.2010.02.021; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Zhang JH, 2010, J BIOMOL SCREEN, V15, P695, DOI 10.1177/1087057110370210; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	36	105	108	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41838	41851		10.1074/jbc.M111.245456	http://dx.doi.org/10.1074/jbc.M111.245456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990351	Green Published, hybrid			2022-12-27	WOS:000298057500066
J	Geng, Z; Xu, FY; Huang, SH; Chen, ZY				Geng, Zhao; Xu, Feng-Yi; Huang, Shu-Hong; Chen, Zhe-Yu			Sorting Protein-related Receptor SorLA Controls Regulated Secretion of Glial Cell Line-derived Neurotrophic Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; DENSITY-LIPOPROTEIN RECEPTOR; INTRACELLULAR TRAFFICKING; DOPAMINERGIC-NEURONS; CYTOPLASMIC DOMAIN; PARKINSON-DISEASE; VPS10P DOMAIN; LIVING CELLS; GOLGI PH; GDNF	Ghat cell line-derived neurotrophic factor (GDNF), after secreted from cells, plays a critical role in central and peripheral neuron survival and function. The secretion of GDNF can be either constitutive or regulated by physiological stimuli; however, the detailed mechanism driving GDNF secretion is still unknown. Here, we report that sorting protein-related receptor with A-type repeats (SorLA), a member of the mammal Vps10p domain receptor, interacts with GDNF and is localized to GDNF-containing vesicles. Overexpression of SorLA significantly increases, and knockdown of SorLA by siRNA decreases, the regulated secretion of GDNF in PC12 and MN9D cells but has no effect on GDNF constitutive secretion. In addition, overexpression of a truncated form of SorLA also impairs GDNF-regulated secretion. Finally, we found that the prodomain of GDNF mediates the interaction of GDNF with SorLA under acidic conditions. Moreover, overexpression of SorLA could enhance the regulated secretion of the GDNF prodomain-GFP fusion protein, suggesting that the prodomain of GDNF is responsible for its regulated secretion. Together, these findings will advance our understanding of the molecular mechanism underlying GDNF-regulated secretion.	[Geng, Zhao; Xu, Feng-Yi; Huang, Shu-Hong; Chen, Zhe-Yu] Shandong Univ, Dept Neurobiol, Sch Med, Shandong Prov Key Lab Mental Disorders, Jinan 250012, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Dept Neurobiol, Sch Med, Shandong Prov Key Lab Mental Disorders, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn	Huang, Shuhong/AAI-4151-2021		National Natural Science Foundation of China [30725020, 30900717, 31071254, 31130026]; National 973 Basic Research Program of China [2012CB911004, 2009CB941403]; National Natural Science Foundation of China for Innovative Research Group [81021001]; Foundation for Excellent Young Scientists of Shandong Province [BS2010SW022]; Research Fund for the Doctoral Program of Higher Education of China [200804221070]; Independent Innovation Foundation of Shandong University [2011DX001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scientists of Shandong Province; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Innovation Foundation of Shandong University	This study was supported by the National Natural Science Foundation of China (No. 30725020, 30900717, 31071254, 31130026), the National 973 Basic Research Program of China (No. 2012CB911004, 2009CB941403), the State Program of National Natural Science Foundation of China for Innovative Research Group (No.81021001), the Foundation for Excellent Young Scientists of Shandong Province (BS2010SW022), Research Fund for the Doctoral Program of Higher Education of China (200804221070), and Independent Innovation Foundation of Shandong University (2011DX001).	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Baudet C, 2008, J NEUROSCI, V28, P963, DOI 10.1523/JNEUROSCI.4489-07.2008; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; CHOI HK, 1992, P NATL ACAD SCI USA, V89, P8943, DOI 10.1073/pnas.89.19.8943; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Kawamoto Y, 2000, NEUROSCIENCE, V100, P701, DOI 10.1016/S0306-4522(00)00326-2; Kim T, 2009, EMBO J, V28, P1612, DOI 10.1038/emboj.2009.118; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lonka-Nevalaita L, 2010, J NEUROSCI, V30, P11403, DOI 10.1523/JNEUROSCI.5888-09.2010; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nilsson SK, 2008, J BIOL CHEM, V283, P25920, DOI 10.1074/jbc.M802721200; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Oh-hashi K, 2009, MOL CELL BIOCHEM, V323, P1, DOI 10.1007/s11010-008-9958-3; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Saavedra A, 2008, PROG NEUROBIOL, V86, P186, DOI 10.1016/j.pneurobio.2008.09.006; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Soderstrom K, 2006, CELL TRANSPLANT, V15, P251, DOI 10.3727/000000006783982025; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Verity AN, 1998, J NEUROCHEM, V70, P531; Wang Y, 2008, BRAIN RES, V1226, P1, DOI 10.1016/j.brainres.2008.05.087; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761	41	11	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41871	41882		10.1074/jbc.M111.246413	http://dx.doi.org/10.1074/jbc.M111.246413			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994944	Green Published, hybrid			2022-12-27	WOS:000298057500069
J	Mao, YF; Shang, YL; Pham, VC; Ernst, JA; Lill, JR; Scales, SJ; Zha, JP				Mao, Yifan; Shang, Yonglei; Pham, Victoria C.; Ernst, James A.; Lill, Jennie R.; Scales, Suzie J.; Zha, Jiping			Polyubiquitination of Insulin-like Growth Factor I Receptor (IGF-IR) Activation Loop Promotes Antibody-induced Receptor Internalization and Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; INSULIN-LIKE-GROWTH-FACTOR-1 RECEPTOR; MULTIUBIQUITIN CHAIN; ANTITUMOR-ACTIVITY; UBIQUITIN CHAINS; KINASE DOMAIN; TUMOR-GROWTH; DEGRADATION; PROTEIN; CANCER	Ubiquitination has been implicated in negatively regulating insulin-like growth factor I receptor (IGF-IR) activity. Because of the relative stability of IGF-IR in the presence of ligand stimulation, IGF-IR ubiquitination sites have yet to be mapped and characterized, thus preventing a direct demonstration of how the receptor ubiquitination contributes to downstream molecular cascades. We took advantage of an anti-IGF-IR antibody (h10H5) that induces more efficient receptor down-regulation to show that IGF-IR is promptly and robustly ubiquitinated. The ubiquitination sites were mapped to the two lysine residues in the IGF-IR activation loop (Lys-1138 and Lys-1141) and consisted of polyubiquitin chains formed through both Lys-48 and Lys-29 linkages. Mutation of these ubiquitinated lysine residues resulted in decreased h10H5-induced IGF-IR internalization and down-regulation as well as a reduced cellular response to h10H5 treatment. We have therefore demonstrated that IGF-IR ubiquitination contributes critically to the down-regulating and antiproliferative activity of h10H5. This finding is physiologically relevant because insulin-like growth factor I appears to mediate ubiquitination of the same major sites as h10H5 (albeit to a lesser extent), and ubiquitination is facilitated by pre-existing phosphorylation of the receptor in both cases. Furthermore, identification of a breast cancer cell line with a defect in IGF-IR ubiquitination suggests that this could be an important tumor resistance mechanism to evade down-regulation-mediated negative regulation of IGF-IR activity in cancer.	[Scales, Suzie J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Mao, Yifan; Shang, Yonglei; Zha, Jiping] Genentech Inc, Dept Pathol Res, San Francisco, CA 94080 USA; [Pham, Victoria C.; Ernst, James A.; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Scales, SJ (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	sscales@gene.com; jzha@crownbio.com	Scales, Suzie J./H-4507-2019	Scales, Suzie J./0000-0003-2544-0283				Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Broussas M, 2009, INT J CANCER, V124, P2281, DOI 10.1002/ijc.24186; Burtrum D, 2003, CANCER RES, V63, P8912; Carelli S, 2006, J CELL PHYSIOL, V208, P354, DOI 10.1002/jcp.20670; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; GREGORI L, 1990, J BIOL CHEM, V265, P8354; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LI SW, 1994, J BIOL CHEM, V269, P32558; Maloney EK, 2003, CANCER RES, V63, P5073; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Munshi S, 2003, ACTA CRYSTALLOGR D, V59, P1725, DOI 10.1107/S0907444903015415; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Shang YL, 2008, MOL CANCER THER, V7, P2599, DOI 10.1158/1535-7163.MCT-07-2401; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang Y, 2005, MOL CANCER THER, V4, P1214, DOI 10.1158/1535-7163.MCT-05-0048; Wu JH, 2008, EMBO J, V27, P1985, DOI 10.1038/emboj.2008.116; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yee D, 2006, BRIT J CANCER, V94, P465, DOI 10.1038/sj.bjc.6602963; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426	43	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41852	41861		10.1074/jbc.M111.288514	http://dx.doi.org/10.1074/jbc.M111.288514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994939	hybrid, Green Published			2022-12-27	WOS:000298057500067
J	Timm, T; von Kries, JP; Li, XY; Zennpel, H; Mandelkow, E; Mandelkow, EM				Timm, Thomas; von Kries, Jens Peter; Li, Xiaoyu; Zennpel, Hans; Mandelkow, Eckhard; Mandelkow, Eva-Maria			Microtubule Affinity Regulating Kinase Activity in Living Neurons Was Examined by a Genetically Encoded Fluorescence Resonance Energy Transfer/Fluorescence Lifetime Imaging-based Biosensor INHIBITORS WITH THERAPEUTIC POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE MOUSE MODELS; DETERMINES AGGREGATION; TAU-PHOSPHORYLATION; REPEAT DOMAIN; PAR PROTEINS; POLARITY; MARK; ESTABLISHMENT; DOUBLECORTIN; MARK/PAR-1	Protein kinases of the microtubule affinity regulating kinase (MARK)/Par-1 family play important roles in the establishment of cellular polarity, cell cycle control, and intracellular signal transduction. Disturbance of their function is linked to cancer and brain diseases, e.g. lissencephaly and Alzheimer disease. To understand the biological role of MARK family kinases, we searched for specific inhibitors and a biosensor for MARK activity. A screen of the ChemBioNet library containing similar to 18,000 substances yielded several compounds with inhibitory activity in the low micromolar range and capable of inhibiting MARK activity in cultured cells and primary neurons, as judged by MARK-dependent phosphorylation of microtubule-associated proteins and its consequences for microtubule integrity. Four of the compounds share a 9-oxo-9H-acridin-10-yl structure as a basis that will serve as a lead for optimization of inhibition efficiency. To test these inhibitors, we developed a cellular biosensor for MARK activity based on a MARK target sequence attached to the 14-3-3 scaffold protein and linked to enhanced cyan or teal and yellow fluorescent protein as FRET donor and acceptor pairs. Transfection of the teal/yellow fluorescent protein sensor into neurons and imaging by fluorescence lifetime imaging revealed that MARK was particularly active in the axons and growth cones of differentiating neurons.	[Timm, Thomas; Li, Xiaoyu; Zennpel, Hans; Mandelkow, Eckhard; Mandelkow, Eva-Maria] DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; [von Kries, Jens Peter] Forschungsinst Fuer Mol Pharmakol, FMP, D-13125 Berlin, Germany; [Zennpel, Hans; Mandelkow, Eckhard; Mandelkow, Eva-Maria] DZNE German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany; [Zennpel, Hans; Mandelkow, Eckhard; Mandelkow, Eva-Maria] CAESAR, D-53175 Bonn, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR)	Mandelkow, EM (corresponding author), DESY, Max Planck Unit Struct Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	mandelkow@dzne.de			Institute for the Study of Aging (ISOA, New York); Deutsche Forschungsgemeinschaft; EU	Institute for the Study of Aging (ISOA, New York); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission)	This work was supported by grants from the Institute for the Study of Aging (ISOA, New York), the Deutsche Forschungsgemeinschaft, and the EU-FP7 (Memosad project).	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Buee L, 2010, BIOCHEM SOC T, V38, P967, DOI 10.1042/BST0380967; Chin JY, 2000, J NEUROPATH EXP NEUR, V59, P966, DOI 10.1093/jnen/59.11.966; Clegg RM, 2003, METHOD ENZYMOL, V360, P509; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Eckermann K, 2007, J BIOL CHEM, V282, P31755, DOI 10.1074/jbc.M705282200; Esterman AL, 2006, GENET ENG NEWS, V26, P26; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hutchins JRA, 2004, CELL CYCLE, V3, P41; Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Lisurek M, 2010, MOL DIVERS, V14, P401, DOI 10.1007/s11030-009-9187-z; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matenia D, 2005, MOL BIOL CELL, V16, P4410, DOI 10.1091/mbc.E05-01-0081; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Meijer L, 2000, CHEM BIOL, V7, P51, DOI 10.1016/S1074-5521(00)00063-6; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sapir T, 2008, J NEUROSCI, V28, P13008, DOI 10.1523/JNEUROSCI.2363-08.2008; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	44	31	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41711	41722		10.1074/jbc.M111.257865	http://dx.doi.org/10.1074/jbc.M111.257865			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984823	Green Published, hybrid			2022-12-27	WOS:000298057500055
J	Chung, J; Grant, RI; Kaplan, DR; Irwin, MS				Chung, Jacky; Grant, R. Ian; Kaplan, David R.; Irwin, Meredith S.			Special AT-rich Binding Protein-2 (SATB2) Differentially Affects Disease-causing p63 Mutant Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 HOMOLOG; SAM DOMAIN; ECTODERMAL DYSPLASIAS; TETRAMERIZATION DOMAIN; EPITHELIAL DEVELOPMENT; GENE-EXPRESSION; CLEFT-PALATE; AEC SYNDROME; PERP; P73	p63, a p53 family member, is critical for proper skin and limb development and directly regulates gene expression in the ectoderm. Mice lacking p63 exhibit skin and craniofacial defects including cleft palate. In humans p63 mutations are associated with several distinct developmental syndromes. p63 sterile-alpha-motif domain, AEC (ankyloblepharon-ectodermal dysplasiaclefting)-associated mutations are associated with a high prevalence of orofacial clefting disorders, which are less common in EEC (ectrodactyly-ectoderrnal dysplasia-defting) patients with DNA binding domain p63 mutations. However, the mechanisms by which these mutations differentially influence p63 function remain unclear, and interactions with other proteins implicated in craniofacial development have not been identified. Here, we show that AEC p63 mutations affect the ability of the p63 protein to interact with special AT-rich binding protein-2 (SATB2), which has recently also been implicated in the development of cleft palate. p63 and SATB2 are co-expressed early in development in the ectoderm of the first and second branchial arches, two essential sites where signaling is required for craniofacial patterning. SATB2 attenuates p63-mediated gene expression of perp (p53 apoptosis effector related to PMP-22), a critical downstream target gene during development, and specifically decreases p63 perp promoter binding. Interestingly, AEC but not EEC p63 mutations affect the ability of p63 to interact with SATB2 and the inhibitory effects of SATB2 on p63 transactivation of perp are most pronounced for AEC-associated p63 mutations. Our findings reveal a novel gain-of-function property of AEC-causing p63 mutations and identify SATB2 as the first p63 binding partner that differentially influences AEC and EEC p63 mutant proteins.	[Chung, Jacky; Kaplan, David R.; Irwin, Meredith S.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Irwin, Meredith S.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Irwin, Meredith S.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Chung, Jacky; Grant, R. Ian; Kaplan, David R.] Hosp Sick Children, Res Inst, Cell Biol Program, Div Hemato Oncol, Toronto, ON M5G 1L7, Canada; [Irwin, Meredith S.] Hosp Sick Children, Res Inst, Dept Paediat, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Irwin, MS (corresponding author), MaRS Ctr TMDT E Tower, Rm 12-601C,101 Coll St, Toronto, ON M5G 1L7, Canada.	meredith.irwin@sickkids.ca			Canadian Cancer Society [018054]; Canadian Institutes of Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Cancer Society Grant 018054.; Recipient of a doctoral Canada graduate scholarship from the Canadian Institutes of Health Research.	Attardi LD, 2000, GENE DEV, V14, P704; Beaudry VG, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001168; Beaudry VG, 2009, AM J MED GENET A, V149A, P1952, DOI 10.1002/ajmg.a.32760; Bellomaria A, 2010, CELL CYCLE, V9, P3730, DOI 10.4161/cc.9.18.12933; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Browne G, 2011, J CELL SCI, V124, P2200, DOI 10.1242/jcs.079327; Brunner HG, 2002, J MED GENET, V39, P377, DOI 10.1136/jmg.39.6.377; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Chi SW, 1999, EMBO J, V18, P4438, DOI 10.1093/emboj/18.16.4438; Chung J, 2010, EMBO REP, V11, P777, DOI 10.1038/embor.2010.125; Cicero DO, 2006, CELL BIOCHEM BIOPHYS, V44, P475, DOI 10.1385/CBB:44:3:475; Coutandin D, 2009, CELL DEATH DIFFER, V16, P1582, DOI 10.1038/cdd.2009.139; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Deutsch GB, 2011, CELL, V144, P566, DOI 10.1016/j.cell.2011.01.013; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Dugani CB, 2009, J NEUROSCI, V29, P6710, DOI 10.1523/JNEUROSCI.5878-08.2009; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Kaustov L, 2007, J BIOL CHEM, V282, P11300, DOI 10.1074/jbc.M611297200; Laptenko O, 2011, P NATL ACAD SCI USA, V108, P10385, DOI 10.1073/pnas.1105680108; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; Lopardo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002715; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Radoja N, 2007, DEVELOPMENT, V134, P13, DOI 10.1242/dev.02703; Reczek EE, 2003, MOL CANCER RES, V1, P1048; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Sathyamurthy A, 2011, FEBS J, V278, P2680, DOI 10.1111/j.1742-4658.2011.08194.x; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Thomason HA, 2008, DEV BIOL, V321, P273, DOI 10.1016/j.ydbio.2008.06.030; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	49	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40671	40680		10.1074/jbc.M111.271189	http://dx.doi.org/10.1074/jbc.M111.271189			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965674	hybrid, Green Published			2022-12-27	WOS:000297315400028
J	Navadgi-Patil, VM; Kumar, S; Burgers, PM				Navadgi-Patil, Vasundhara M.; Kumar, Sandeep; Burgers, Peter M.			The Unstructured C-terminal Tail of Yeast Dpb11 (Human TopBP1) Protein Is Dispensable for DNA Replication and the S Phase Checkpoint but Required for the G(2)/M Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINT; BUDDING YEAST; DAMAGE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION; ACTIVATION; COMPLEX; KINASE; POLYMERASE; PATHWAY	Budding yeast Dpb11 (human TopBP1, fission yeast Cut5) is an essential protein required for replisome assembly and for the DNA damage checkpoint. Previous studies with the temperature-sensitive dpb11-1 allele, truncated at amino acid 583 of the 764-amino acid protein, have suggested the model that Dpb11 couples DNA replication to the replication checkpoint. However, the dpb11-1 allele shows distinct replication defects even at permissive temperatures. Here, we determine that the 1-600-amino acid domain of DPB11 is both required and sufficient for full replication function of Dpb11 but that this domain is defecfive for activation of the principal checkpoint kinase Mec1 (human ataxia telarigiectasia and Rad3-related) in vitro and in vivo. Remarkably, mutants of DPB11 that leave its replication function intact but abrogate its ability to activate Mec1 are proficient for the replication checkpoint, but they are compromised for the G(2)/M DNA damage checkpoint. These data suggest that replication checkpoint defects may result indirectly from defects in replisome assembly. Two conserved aromatic amino acids in the C terminus of Dpb11 are critical for Mec1 activation in vitro and for the G(2)/M checkpoint in yeast. Together with aromatic motifs identified previously in the Ddc1 subunit of 9-1-1, another activator of Mec1 kinase, they define a consensus structure for Mec1 activation.	[Navadgi-Patil, Vasundhara M.; Kumar, Sandeep; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021	Kumar, Sandeep/0000-0003-1249-1743	National Institutes of Health [GM032431, GM083970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083970, R01GM032431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM032431 and GM083970.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Cobb JA, 2004, CURR OPIN GENET DEV, V14, P292, DOI 10.1016/j.gde.2004.04.001; DURSO G, 1995, J CELL SCI, V108, P3109; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kondo T, 1999, MOL CELL BIOL, V19, P1136; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Longhese MP, 1997, EMBO J, V16, P5216, DOI 10.1093/emboj/16.17.5216; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2011, BIOCHEM SOC T, V39, P600, DOI 10.1042/BST0390600; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2009, DNA REPAIR, V8, P996, DOI 10.1016/j.dnarep.2009.03.011; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ogiwara H, 2006, NUCLEIC ACIDS RES, V34, P3389, DOI 10.1093/nar/gkl411; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Puddu F, 2008, MOL CELL BIOL, V28, P4782, DOI 10.1128/MCB.00330-08; Puddu F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002022; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Sugimoto K, 1997, MOL CELL BIOL, V17, P5905, DOI 10.1128/MCB.17.10.5905; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Taricani L, 2006, MOL BIOL CELL, V17, P3456, DOI 10.1091/mbc.E06-01-0056; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Wang H, 2002, GENETICS, V160, P1295; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	43	28	28	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40999	41007		10.1074/jbc.M111.283994	http://dx.doi.org/10.1074/jbc.M111.283994			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956112	Green Published, hybrid			2022-12-27	WOS:000297315400059
J	Olmedo-Verd, E; Santamaria-Gomez, J; de Alda, JAGO; de Pouplana, LR; Luque, I				Olmedo-Verd, Elvira; Santamaria-Gomez, Javier; Ochoa de Alda, Jesus A. G.; Ribas de Pouplana, Lluis; Luque, Ignacio			Membrane Anchoring of Aminoacyl-tRNA Synthetases by Convergent Acquisition of a Novel Protein Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-I; SEQUENCE; COMPLEX; EVOLUTION; REVEALS; EXPRESSION; PREDICTION; TRNA(ILE); TRNA(VAL); MECHANISM	Four distinct aminoacyl-tRNA synthetases (aaRSs) found in some cyanobacterial species contain a novel protein domain that bears two putative transmembrane helices. This CAAD domain is present in glutamyl-, isoleucyl-, leucyl-, and valyl-tRNA synthetases, the latter of which has probably recruited the domain more than once during evolution. Deleting the CAAD domain from the valyl-tRNA synthetase of Anabaena sp. PCC 7120 did not significantly modify the catalytic properties of this enzyme, suggesting that it does not participate in its canonical tRNA-charging function. Multiple lines of evidence suggest that the function of the CAAD domain is structural, mediating the membrane anchorage of the enzyme, although membrane localization of aaRSs has not previously been described in any living organism. Synthetases containing the CAAD domain were localized in the intracytoplasmic thylakoid membranes of cyanobacteria and were largely absent from the plasma membrane. The CAAD domain was necessary and apparently sufficient for protein targeting to membranes. Moreover, localization of aaRSs in thylakoids was important under nitrogen limiting conditions. In Anabaena, a multicellular filamentous cyanobacterium often used as a model for prokaryotic cell differentiation, valyl-tRNA synthetase underwent subcellular relocation at the cell poles during heterocyst differentiation, a process also dependent on the CAAD domain.	[Olmedo-Verd, Elvira; Santamaria-Gomez, Javier; Luque, Ignacio] CSIC, Inst Bioquim Vegetal & Fotosintesis, E-41092 Seville, Spain; [Olmedo-Verd, Elvira; Santamaria-Gomez, Javier; Luque, Ignacio] Univ Seville, E-41092 Seville, Spain; [Ochoa de Alda, Jesus A. G.] IE Univ, Sch Biol, E-40003 Segovia, Spain; [Ribas de Pouplana, Lluis] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Ribas de Pouplana, Lluis] ICREA, Barcelona 08010, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); University of Sevilla; IE University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Luque, I (corresponding author), CSIC, Inst Bioquim Vegetal & Fotosintesis, Avda Americo Vespucio 49, E-41092 Seville, Spain.	ignacio.luque@ibvf.csic.es	de Alda, Jesús A. G. Ochoa/I-7613-2012; de Pouplana, Lluis Ribas/AAA-4738-2019; Luque, Inmaculada/K-9464-2014; Luque, Ignacio/D-5060-2009; Santamaría Gómez, Javier/F-3080-2015; Olmedo-Verd, Elvira/G-2549-2015	de Alda, Jesús A. G. Ochoa/0000-0002-4688-2470; de Pouplana, Lluis Ribas/0000-0002-2087-0359; Luque, Inmaculada/0000-0003-1838-2636; Luque, Ignacio/0000-0002-0336-5094; Santamaría Gómez, Javier/0000-0002-4379-1020; Olmedo-Verd, Elvira/0000-0003-0687-5767	Ministerio de Ciencia e Innovacion and Fondo Social Europeo [BFU2007-66589/BMC, BFU2010-19544/BMC]; Junta de Castilla y Leon [IEU002A10-2]; Proyectos de Excelencia, Junta de Andalucia y FEDER [P07-CVI-03167]; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion and Fondo Social Europeo(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Proyectos de Excelencia, Junta de Andalucia y FEDER; ICREA(ICREA)	This work was supported by Ministerio de Ciencia e Innovacion and Fondo Social Europeo Grants BFU2007-66589/BMC and BFU2010-19544/BMC, Junta de Castilla y Leon Grant IEU002A10-2, and Proyectos de Excelencia, Junta de Andalucia y FEDER Grant P07-CVI-03167.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel FM, 2010, CURRENT PROTOCOLS MO; Banerjee R, 2010, FEBS LETT, V584, P387, DOI 10.1016/j.febslet.2009.11.013; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; Cusack S., 1997, MANY FACES RNA, P55; de Pouplana LR, 2000, CELL MOL LIFE SCI, V57, P865, DOI 10.1007/PL00000729; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; Eddy SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000069; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Facey SJ, 2004, BBA-MOL CELL RES, V1694, P55, DOI 10.1016/j.bbamcr.2004.03.012; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Fukai S, 2003, RNA, V9, P100, DOI 10.1261/rna.2760703; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Hansson M, 2003, MOL CELL PROTEOMICS, V2, P550, DOI 10.1074/mcp.M300050-MCP200; Herrero A, 2004, FEMS MICROBIOL REV, V28, P469, DOI 10.1016/j.femsre.2004.04.003; Hsu JL, 2008, J MOL BIOL, V376, P482, DOI 10.1016/j.jmb.2007.11.065; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANG NJ, 1971, PROC R SOC SER B-BIO, V178, P193, DOI 10.1098/rspb.1971.0061; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Liberton Michelle, 2008, P271; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Luque I, 2008, MOL BIOL EVOL, V25, P2369, DOI 10.1093/molbev/msn197; Luque I, 2006, MOL MICROBIOL, V60, P1276, DOI 10.1111/j.1365-2958.2006.05170.x; MacKinney G, 1941, J BIOL CHEM, V140, P315; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Merino-Puerto V, 2010, MOL MICROBIOL, V75, P1159, DOI 10.1111/j.1365-2958.2009.07031.x; Mirande M, 2010, FEBS LETT, V584, P443, DOI 10.1016/j.febslet.2009.11.027; Mullineaux CW, 2008, EMBO J, V27, P1299, DOI 10.1038/emboj.2008.66; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; ORR J, 1981, J BIOL CHEM, V256, P3099; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Raczniak G, 2001, J BIOL CHEM, V276, P45862, DOI 10.1074/jbc.M109494200; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; STEWART WDP, 1975, BIOCHEM BIOPH RES CO, V65, P846, DOI 10.1016/S0006-291X(75)80463-3; Ting CS, 2007, J BACTERIOL, V189, P4485, DOI 10.1128/JB.01948-06; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Trifonov EN, 2009, CURR OPIN STRUC BIOL, V19, P335, DOI 10.1016/j.sbi.2009.03.007; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolf YI, 1999, GENOME RES, V9, P689; Wong FC, 2003, J BIOL CHEM, V278, P52857, DOI 10.1074/jbc.M309627200; Xu Xudong, 2008, P383; Yuan JJ, 2010, CELL MOL LIFE SCI, V67, P179, DOI 10.1007/s00018-009-0160-x	81	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41057	41068		10.1074/jbc.M111.242461	http://dx.doi.org/10.1074/jbc.M111.242461			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965654	hybrid, Green Published			2022-12-27	WOS:000297315400065
J	Santangelo, MD; Gest, PM; Guerin, ME; Coincon, M; Pham, H; Ryan, G; Puckett, SE; Spencer, JS; Gonzalez-Juarrero, M; Daher, R; Lenaerts, AJ; Schnappinger, D; Therisod, M; Ehrt, S; Sygusch, J; Jackson, M				de la Paz Santangelo, Maria; Gest, Petra M.; Guerin, Marcelo E.; Coincon, Mathieu; Ha Pham; Ryan, Gavin; Puckett, Susan E.; Spencer, John S.; Gonzalez-Juarrero, Mercedes; Daher, Racha; Lenaerts, Anne J.; Schnappinger, Dirk; Therisod, Michel; Ehrt, Sabine; Sygusch, Jurgen; Jackson, Mary			Glycolytic and Non-glycolytic Functions of Mycobacterium tuberculosis Fructose-1,6-bisphosphate Aldolase, an Essential Enzyme Produced by Replicating and Non-replicating Bacilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTOSE-BISPHOSPHATE ALDOLASES; CLASS-II; SELECTIVE INHIBITORS; MOLECULAR-CLONING; PROTEOME ANALYSIS; CANDIDA-ALBICANS; BOVIS BCG; PERSISTENCE; EXPRESSION; GROWTH	The search for antituberculosis drugs active against persistent bacilli has led to our interest in metallodependent class II fructose-1,6-bisphosphate aldolase (FBA-tb), a key enzyme of gluconeogenesis absent from mammalian cells. Knock-out experiments at the fba-tb locus indicated that this gene is required for the growth of Mycobacterium tuberculosis on gluconeogenetic substrates and in glucose-containing medium. Surface labeling and enzymatic activity measurements revealed that this enzyme was exported to the cell surface of M. tuberculosis and produced under various axenic growth conditions including oxygen depletion and hence by non-replicating bacilli. Importantly, FBA-tb was also produced in vivo in the lungs of infected guinea pigs and mice. FBA-tb bound human plasmin(ogen) and protected FBA-tb-bound plasmin from regulation by alpha(2)-antiplasmin, suggestive of an involvement of this enzyme in host/pathogen interactions. The crystal structures of FBA-tb in the native form and in complex with a hydroxamate substrate analog were determined to 2.35- and 1.9-angstrom resolution, respectively. Whereas inhibitor attachment had no effect on the plasminogen binding activity of FBA-tb, it competed with the natural substrate of the enzyme, fructose 1,6-bisphosphate, and substantiated a previously unknown reaction mechanism associated with metallodependent aldolases involving recruitment of the catalytic zinc ion by the substrate upon active site binding. Altogether, our results highlight the potential of FBA-tb as a novel therapeutic target against both replicating and non-replicating bacilli.	[de la Paz Santangelo, Maria; Gest, Petra M.; Ha Pham; Ryan, Gavin; Spencer, John S.; Gonzalez-Juarrero, Mercedes; Lenaerts, Anne J.; Jackson, Mary] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Guerin, Marcelo E.] Univ Basque Country, Unidad Biofis, Ctr Mixto, CSIC,EHU, Leioa 48940, Bizkaia, Spain; [Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain; [Guerin, Marcelo E.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain; [Coincon, Mathieu; Sygusch, Jurgen] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Puckett, Susan E.; Schnappinger, Dirk; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Daher, Racha; Therisod, Michel] Univ Paris 11, Lab Chim Bioorgan & Bioinorgan, Inst Chim Mol & Mat Orsay, UMR 8182, F-91405 Orsay, France; [de la Paz Santangelo, Maria] Inst Nacl Tecnol Agropecuaria, Inst Biotecnol, Ctr Invest Ciencias Vet & Agron, RA-1686 Buenos Aires, DF, Argentina	Colorado State University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Universite de Montreal; Cornell University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Jackson, M (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu	Spencer, John S/G-6968-2017; Ehrt, Sabine/AAU-6449-2020; Guerin, Marcelo M/N-7245-2016; Jackson, Mary/D-5345-2017	Spencer, John S/0000-0002-8051-3038; Guerin, Marcelo M/0000-0001-9524-3184; Jackson, Mary/0000-0002-9212-0258; gonzalez-juarrero, mercedes/0000-0002-4045-2365; Santangelo, Maria de la Paz/0000-0001-7865-7035	National Institutes of Health from the NIAID [AI078126]; National Institutes of Health from the NINDS [NS066438 from the]; Natural Science and Engineering Research Council (Canada); Canadian Institutes for Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066438] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health from the NINDS; Natural Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI078126 from the NIAID and NS066438 from the NINDS.; Supported by the Natural Science and Engineering Research Council (Canada) and Canadian Institutes for Health Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAI NJ, 1982, METHOD ENZYMOL, V90, P241; BAI NJ, 1974, FEBS LETT, V45, P68, DOI 10.1016/0014-5793(74)80812-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Blau K, 2007, J INFECT DIS, V195, P1828, DOI 10.1086/518038; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; Blumenthal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015667; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Daher R, 2010, J MED CHEM, V53, P7836, DOI 10.1021/jm1009814; Dax C, 2006, J MED CHEM, V49, P1499, DOI 10.1021/jm050237b; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Elkington PT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001847; Fonvielle M, 2008, CHEM-EUR J, V14, P8521, DOI 10.1002/chem.200800857; Galkin A, 2007, J BIOL CHEM, V282, P4859, DOI 10.1074/jbc.M609534200; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gerber SS, 2010, CELL MOL LIFE SCI, V67, P1505, DOI 10.1007/s00018-010-0264-3; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; HUECK CJ, 1995, MOL MICROBIOL, V15, P395, DOI 10.1111/j.1365-2958.1995.tb02252.x; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; JAGANNATHAN V, 1956, BIOCHEM J, V63, P94, DOI 10.1042/bj0630094; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jungblut PR, 1999, MOL MICROBIOL, V33, P1103, DOI 10.1046/j.1365-2958.1999.01549.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Labbe G., 2011, PROTEIN EXP IN PRESS; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; MARSH JJ, 1992, TRENDS BIOCHEM SCI, V17, P110, DOI 10.1016/0968-0004(92)90247-7; MARSH JJ, 1989, PLANT PHYSIOL, V91, P1393, DOI 10.1104/pp.91.4.1393; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Moritz B, 2000, EUR J BIOCHEM, V267, P3442, DOI 10.1046/j.1432-1327.2000.01354.x; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; ORTALOMAGNE A, 1995, MICROBIOL-UK, V141, P1609, DOI 10.1099/13500872-141-7-1609; Owen BB, 1938, J AM CHEM SOC, V60, P3074, DOI 10.1021/ja01279a068; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pegan SD, 2009, J MOL BIOL, V386, P1038, DOI 10.1016/j.jmb.2009.01.003; Ramsaywak PC, 2004, PROTEIN EXPRES PURIF, V37, P220, DOI 10.1016/j.pep.2004.05.011; Rellos P, 2000, J BIOL CHEM, V275, P1145, DOI 10.1074/jbc.275.2.1145; RICHARDS OC, 1961, J BIOL CHEM, V236, P3177; Rodaki A, 2006, EUKARYOT CELL, V5, P1371, DOI 10.1128/EC.00115-06; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; SINGER M, 1991, J BACTERIOL, V173, P6249, DOI 10.1128/jb.173.19.6249-6257.1991; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wehmeier UF, 2001, FEMS MICROBIOL LETT, V197, P53, DOI 10.1111/j.1574-6968.2001.tb10582.x; *WHO, 2009, WHO REP 2009 GLOB TU; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200; Wu ZF, 2008, FEMS IMMUNOL MED MIC, V53, P52, DOI 10.1111/j.1574-695X.2008.00401.x; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	70	60	61	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40219	40231		10.1074/jbc.M111.259440	http://dx.doi.org/10.1074/jbc.M111.259440			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949126	hybrid, Green Published			2022-12-27	WOS:000296925700054
J	Deng, Y; Fong, SS				Deng, Yu; Fong, Stephen S.			Laboratory Evolution and Multi-platform Genome Re-sequencing of the Cellulolytic Actinobacterium Thermobifida fusca	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA HYDROLASE; PEPTIDYL-TRANSFER-RNA; FATTY ACYL-COENZYME; AMINO-ACID-RESIDUES; ESCHERICHIA-COLI; ADAPTIVE EVOLUTION; THERMOMONOSPORA-FUSCA; 10,000-GENERATION EXPERIMENT; BACTERIAL-POPULATIONS; CELLULOSIC BIOMASS	Biological utilization of cellulose is a complex process involving the coordinated expression of different cellulases, often in a synergistic manner. One possible means of inducing an organism-level change in cellulase activity is to use laboratory adaptive evolution. In this study, evolved strains of the cellulolytic actinobacterium, Thermobifida fusca, were generated for two different scenarios: continuous exposure to cellobiose (strain muC) or alternating exposure to cellobiose and glucose (strain muS). These environmental conditions produced a phenotype specialized for growth on cellobiose (muC) and an adaptable, generalist phenotype (muS). Characterization of cellular phenotypes and whole genome re-sequencing were conducted for both the muC and muS strains. Phenotypically, the muC strain showed decreased cell yield over the course of evolution concurrent with decreased cellulase activity, increased intracellular ATP concentrations, and higher end-product secretions. The muS strain increased its cell yield for growth on glucose and exhibited a more generalist phenotype with higher cellulase activity and growth capabilities on different substrates. Whole genome re-sequencing identified 48 errors in the reference genome and 18 and 14 point mutations in the muC and muS strains, respectively. Among these mutations, the site mutation of Tfu_1867 was found to contribute the specialist phenotype and the site mutation of Tfu_0423 was found to contribute the generalist phenotype. By conducting and characterizing evolution experiments on Thermobifida fusca, we were able to show that evolutionary changes balance ATP energetic considerations with cellulase activity. Increased cellulase activity is achieved in stress environments (switching carbon sources), otherwise cellulase activity is minimized to conserve ATP.	[Deng, Yu; Fong, Stephen S.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA; [Deng, Yu] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA	Virginia Commonwealth University; Dartmouth College	Fong, SS (corresponding author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.	ssfong@vcu.edu	Deng, Yu/F-7066-2012	Deng, Yu/0000-0003-3101-5160				Ai YC, 2003, ENZYME MICROB TECH, V32, P331, DOI 10.1016/S0141-0229(02)00276-4; Babu MM, 2006, TRENDS MICROBIOL, V14, P11, DOI 10.1016/j.tim.2005.11.005; Bevillard E, 2004, J BACTERIOL, V186, P136, DOI 10.1128/JB.186.1.136-145.2004; Black PN, 1997, J BIOL CHEM, V272, P4896, DOI 10.1074/jbc.272.8.4896; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SL, 2007, J BACTERIOL, V189, P6260, DOI 10.1128/JB.00584-07; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Deng Y, 2011, METAB ENG, V13, P570, DOI 10.1016/j.ymben.2011.06.007; Deng Y, 2010, APPL ENVIRON MICROB, V76, P2098, DOI 10.1128/AEM.02626-09; Deng Y, 2010, APPL MICROBIOL BIOT, V85, P965, DOI 10.1007/s00253-009-2155-9; Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; FERCHAK JD, 1983, BIOTECHNOL BIOENG, V25, P2855, DOI 10.1002/bit.260251204; FERCHAK JD, 1983, BIOTECHNOL BIOENG, V25, P2865, DOI 10.1002/bit.260251205; Ferenci T, 2008, HEREDITY, V100, P446, DOI 10.1038/sj.hdy.6801077; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542; Fong SS, 2003, J BACTERIOL, V185, P6400, DOI 10.1128/JB.185.21.6400-6408.2003; Gowen CM, 2010, CHEM BIODIVERS, V7, P1086, DOI 10.1002/cbdv.200900314; Heidenreich E, 2007, CRIT REV BIOCHEM MOL, V42, P285, DOI 10.1080/10409230701507773; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Igarashi K, 1999, J BIOL CHEM, V274, P3338, DOI 10.1074/jbc.274.6.3338; Irwin DC, 2000, EUR J BIOCHEM, V267, P4988, DOI 10.1046/j.1432-1327.2000.01546.x; Jeoh T, 2002, BIOTECHNOL PROGR, V18, P760, DOI 10.1021/bp0200402; Jung H, 2003, BIOTECHNOL BIOENG, V84, P151, DOI 10.1002/bit.10743; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; MENNINGER JR, 1979, J BACTERIOL, V137, P694, DOI 10.1128/JB.137.1.694-696.1979; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; Papadopoulos D, 1999, P NATL ACAD SCI USA, V96, P3807, DOI 10.1073/pnas.96.7.3807; Singh NS, 2004, NUCLEIC ACIDS RES, V32, P6028, DOI 10.1093/nar/gkh924; Spector MP, 1999, MICROBIOL-SGM, V145, P15, DOI 10.1099/13500872-145-1-15; Spiridonov NA, 1999, J BIOL CHEM, V274, P13127, DOI 10.1074/jbc.274.19.13127; Spiridonov NA, 2001, CURR MICROBIOL, V42, P295, DOI 10.1007/s002840010220; Suto M, 2001, J BIOSCI BIOENG, V92, P305, DOI 10.1263/jbb.92.305; Watson DL, 2002, APPL BIOCHEM BIOTECH, V101, P97, DOI 10.1385/ABAB:101:2:097; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x; Xiao ZZ, 2004, BIOTECHNOL BIOENG, V88, P832, DOI 10.1002/bit.20286; Zhang YH, 2003, ANAL CHEM, V75, P219, DOI 10.1021/ac020271n; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n	48	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39958	39966		10.1074/jbc.M111.239616	http://dx.doi.org/10.1074/jbc.M111.239616			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21914801	Green Published, hybrid			2022-12-27	WOS:000296925700029
J	Hilser, VJ; Thompson, EB				Hilser, Vincent J.; Thompson, E. Brad			Structural Dynamics, Intrinsic Disorder, and Allostery in Nuclear Receptors as Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DNA-BINDING DOMAIN; ESTROGEN RESPONSE ELEMENTS; HUMAN GLUCOCORTICOID-RECEPTOR; PROTEIN-PROTEIN INTERACTIONS; CO-REGULATORY PROTEINS; TERMINAL EXTENSION CTE; HORMONE-RECEPTORS; CONFORMATIONAL-CHANGES; UNSTRUCTURED PROTEINS; MOLECULAR CHAPERONES	Steroid hormone receptors (SHRs) and nuclear receptors (NRs) in general are flexible, allosterically regulated transcription factors. The classic model is inadequate to explain all their behavior. Keys to function are their regions of intrinsic disorder (ID). Data show the dynamic structure and allosteric interactions of the three classic SHR domains: ligand-binding (LBD), DNA-binding (DBD), and N-terminal (NTD). Each responds to its ligands by stabilizing its structure. The LBD responds to classic steroidal and nonsteroidal small ligands; both may selectively modify SHR activity. The DBD responds differentially to the DNA sequences of its response elements. The NTD, with its high ID content and AF1, interacts allosterically with the LBD and DBD. Each domain binds heterologous proteins, potential allosteric ligands. An ensemble framework improves the classic model, shows how ID regions poise the SHR/NR family for optimal allosteric response, and provides a basis for quantitative evaluation of SHR/NR actions.	[Thompson, E. Brad] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Hilser, Vincent J.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Thompson, E. Brad] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA	University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University; University of Houston System; University of Houston	Thompson, EB (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	bthompso@utmb.edu			National Institutes of Health [R01-GM63747]; National Science Foundation [MCB-0446050]; Sealy Foundation at the University of Texas Medical Branch; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Sealy Foundation at the University of Texas Medical Branch; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM63747 and National Science Foundation Grant MCB-0446050 (to V. J. H.). This work was also supported by the Sealy Foundation at the University of Texas Medical Branch (to E. B. T.).	ALLAN GF, 1992, J BIOL CHEM, V267, P19513; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; Bain DL, 2000, J BIOL CHEM, V275, P7313, DOI 10.1074/jbc.275.10.7313; Bain DL, 2001, J BIOL CHEM, V276, P23825, DOI 10.1074/jbc.M102611200; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; BAUMANN H, 1993, BIOCHEMISTRY-US, V32, P13463, DOI 10.1021/bi00212a011; BERGLUND H, 1992, BIOCHEMISTRY-US, V31, P12001, DOI 10.1021/bi00163a007; Berglund H, 1997, BIOCHEMISTRY-US, V36, P11188, DOI 10.1021/bi970343i; Bhasin S, 2009, CURR OPIN CLIN NUTR, V12, P232, DOI 10.1097/MCO.0b013e32832a3d79; Bolen D W, 2001, Methods Mol Biol, V168, P17; Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; Chen JW, 2006, J PROTEOME RES, V5, P879, DOI 10.1021/pr060048x; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; CINTRA A, 1994, NEUROSCIENCE, V62, P843, DOI 10.1016/0306-4522(94)90481-2; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Cutler TA, 2007, J MOL BIOL, V371, P308, DOI 10.1016/j.jmb.2007.05.077; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fischer K, 2010, MOL ENDOCRINOL, V24, P1935, DOI 10.1210/me.2010-0005; Freiburger LA, 2011, NAT STRUCT MOL BIOL, V18, P288, DOI 10.1038/nsmb.1978; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Geserick C, 2005, MOL CELL ENDOCRINOL, V236, P1, DOI 10.1016/j.mce.2005.03.007; Gessi S, 2010, CURR PHARM DESIGN, V16, P3540, DOI 10.2174/138161210793797915; Gorski J, 1968, Recent Prog Horm Res, V24, P45; Gu J, 2008, STRUCTURE, V16, P1627, DOI 10.1016/j.str.2008.08.016; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hilser VJ, 2006, CHEM REV, V106, P1545, DOI 10.1021/cr040423+; Hilser VJ, 2010, SCIENCE, V327, P653, DOI 10.1126/science.1186121; Hol T, 1997, J WOMENS HEALTH, V6, P523, DOI 10.1089/jwh.1997.6.523; Ikeda M, 1996, J BIOL CHEM, V271, P23096, DOI 10.1074/jbc.271.38.23096; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Johnson BA, 2000, J MOL BIOL, V298, P187, DOI 10.1006/jmbi.2000.3636; Joseph JD, 2009, P NATL ACAD SCI USA, V106, P12178, DOI 10.1073/pnas.0900185106; Katzenellenbogen BS, 1997, BREAST CANCER RES TR, V44, P23, DOI 10.1023/A:1005835428423; Kazmin D, 2006, MOL ENDOCRINOL, V20, P1201, DOI 10.1210/me.2005-0309; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Krasowski MD, 2008, J PROTEOME RES, V7, P4359, DOI 10.1021/pr8003024; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; Le Gall T, 2007, J BIOMOL STRUCT DYN, V24, P325; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; Lieberman BA, 1997, J BIOL CHEM, V272, P1061, DOI 10.1074/jbc.272.2.1061; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Loven MA, 2001, J BIOL CHEM, V276, P45282, DOI 10.1074/jbc.M106211200; Loven MA, 2001, MOL CELL ENDOCRINOL, V181, P151, DOI 10.1016/S0303-7207(01)00491-9; Lu NZ, 2004, ANN NY ACAD SCI, V1024, P102, DOI 10.1196/annals.1321.008; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; McEwan IJ, 2004, ENDOCR-RELAT CANCER, V11, P281, DOI 10.1677/erc.0.0110281; McMaster A, 2007, EXP PHYSIOL, V92, P299, DOI 10.1113/expphysiol.2006.036194; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Melvin VS, 2004, J BIOL CHEM, V279, P14763, DOI 10.1074/jbc.M313335200; Melvin VS, 2002, J BIOL CHEM, V277, P25115, DOI 10.1074/jbc.M110400200; Miller AL, 2007, STEROIDS, V72, P673, DOI 10.1016/j.steroids.2007.05.004; Nardulli AM, 1996, MOL ENDOCRINOL, V10, P694, DOI 10.1210/me.10.6.694; O'Brien JE, 2006, J BIOL CHEM, V281, P26683, DOI 10.1074/jbc.M601522200; O'Malley BW, 2008, CURR OPIN CELL BIOL, V20, P310, DOI 10.1016/j.ceb.2008.04.005; Paramanik V, 2011, MOL BIOL REP, V38, P4657, DOI 10.1007/s11033-010-0600-6; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pfaff SJ, 2010, J BIOL CHEM, V285, P15256, DOI 10.1074/jbc.M110.108118; Pickar JH, 2010, MATURITAS, V67, P129, DOI 10.1016/j.maturitas.2010.05.009; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Reed JC, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.30155; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Scarpin Katherine M, 2009, Nucl Recept Signal, V7, pe009, DOI 10.1621/nrs.07009; Schultz-Norton JR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-97; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; SCHWABE JWR, 1995, STRUCTURE, V3, P201, DOI 10.1016/S0969-2126(01)00150-2; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Sugiyama N, 2009, MOL PSYCHIATR, V14, P223, DOI 10.1038/mp.2008.118; Sugiyama N, 2010, TRENDS ENDOCRIN MET, V21, P545, DOI 10.1016/j.tem.2010.05.001; Takayama Y, 2010, BIOCHEMISTRY-US, V49, P7998, DOI 10.1021/bi100962h; Thakur MK, 2009, HORM RES, V71, P194, DOI 10.1159/000201107; Thompson EB, 2003, BIOCHEM BIOPH RES CO, V306, P1, DOI 10.1016/S0006-291X(03)00877-5; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; VANTILBORG MAA, 1995, J MOL BIOL, V247, P689, DOI 10.1016/S0022-2836(05)80148-2; Veleiro AS, 2010, CHEMMEDCHEM, V5, P649, DOI 10.1002/cmdc.201000014; Wood JR, 2001, MOL ENDOCRINOL, V15, P1114, DOI 10.1210/me.15.7.1114; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367; Younes M, 2011, ARCH PATHOL LAB MED, V135, P63, DOI 10.1043/2010-0448-RAR.1; Yu EW, 2001, P NATL ACAD SCI USA, V98, P9517, DOI 10.1073/pnas.161239298	101	56	56	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39675	39682		10.1074/jbc.R111.278929	http://dx.doi.org/10.1074/jbc.R111.278929			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937423	hybrid, Green Published			2022-12-27	WOS:000296925700001
J	Valdes, JL; Tang, JR; McDermott, MI; Kuo, JC; Zimmerman, SP; Wincovitch, SM; Waterman, CM; Milgram, SL; Playford, MP				Valdes, Julie L.; Tang, Jingrong; McDermott, Mark I.; Kuo, Jean-Cheng; Zimmerman, Seth P.; Wincovitch, Stephen M.; Waterman, Clare M.; Milgram, Sharon L.; Playford, Martin P.			Sorting Nexin 27 Protein Regulates Trafficking of a p21-activated Kinase (PAK) Interacting Exchange Factor (beta-Pix)-G Protein-coupled Receptor Kinase Interacting Protein (GIT) Complex via a PDZ Domain Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; BETA-PIX; CELL-MIGRATION; MEMBRANE; FAMILY; IDENTIFICATION; ACTIVATION; BINDING; ROLES; ACTIN	Sorting nexin 27 (SNX27) is a 62-kDa protein localized to early endosomes and known to regulate the intracellular trafficking of ion channels and receptors. In addition to a PX domain, SNX27 is the only sorting family member that contains a PDZ domain. To identify novel SNX27-PDZ binding partners, we performed a proteomic screen in mouse principal kidney cortical collecting duct cells using a GST-SNX27 fusion construct as bait. We found that beta-Pix (p21-activated kinase-interactive exchange factor), a guanine nucleotide exchange factor for the Rho family of small GTPases known to regulate cell motility directly interacted with SNX27. The association of beta-Pix and SNX27 is specific for beta-Pix isoforms terminating in the type-1 PDZ binding motif (ETNL). In the same screen we also identified Git1/2 as a potential SNX27 interacting protein. The interaction between SNX27 and Git1/2 is indirect and mediated by beta-Pix. Furthermore, we show recruitment of the beta-Pix.Git complex to endosomal sites in a SNX27-dependent manner. Finally, migration assays revealed that depletion of SNX27 from HeLa and mouse principal kidney cortical collecting duct cells significantly decreases cell motility. We propose a model by which SNX27 regulates trafficking of beta-Pix to focal adhesions and thereby influences cell motility.	[Valdes, Julie L.; Tang, Jingrong; McDermott, Mark I.; Kuo, Jean-Cheng; Zimmerman, Seth P.; Wincovitch, Stephen M.; Waterman, Clare M.; Milgram, Sharon L.; Playford, Martin P.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20982 USA; [Kuo, Jean-Cheng] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Yang Ming Chiao Tung University	Playford, MP (corresponding author), NIH, Bldg 10,Rm 6N256,9000 Rockville Pike, Bethesda, MD 20892 USA.	playfordmp@nhlbi.nih.gov		Waterman, Clare/0000-0001-6142-6775	National Institutes of Health; NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005108, ZIAHL005105, ZIAHL005104] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by a National Institutes of Health grant from the NHLBI.	Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Botrugno OA, 2006, EUR J CELL BIOL, V85, P35, DOI 10.1016/j.ejcb.2005.09.018; Cai L, 2011, MOL CELL BIOL, V31, P1734, DOI 10.1128/MCB.01044-10; Campa F, 2006, CELL RES, V16, P759, DOI 10.1038/sj.cr.7310091; Chao WT, 2010, MOL CELL BIOL, V30, P4463, DOI 10.1128/MCB.01207-09; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hsu RM, 2010, MOL BIOL CELL, V21, P287, DOI 10.1091/mbc.E09-03-0232; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jones NP, 2007, MOL CELL BIOL, V27, P5790, DOI 10.1128/MCB.00778-07; Joubert L, 2004, J CELL SCI, V117, P5367, DOI 10.1242/jcs.01379; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Koh CG, 2001, J CELL SCI, V114, P4239; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Lamorte L, 2003, MOL BIOL CELL, V14, P2818, DOI 10.1091/mbc.E02-08-0497; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lee J, 2005, EXP CELL RES, V307, P315, DOI 10.1016/j.yexcr.2005.03.028; Lee SH, 2001, J BIOL CHEM, V276, P25066, DOI 10.1074/jbc.M010892200; Liu FM, 2010, MOL CELL BIOL, V30, P1971, DOI 10.1128/MCB.01247-09; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; MacNeil AJ, 2007, BIOCHEM BIOPH RES CO, V359, P848, DOI 10.1016/j.bbrc.2007.05.162; Manabe R, 2002, J CELL SCI, V115, P1497; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Matafora V, 2001, J CELL SCI, V114, P4509; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996	44	32	34	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39403	39416		10.1074/jbc.M111.260802	http://dx.doi.org/10.1074/jbc.M111.260802			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21926430	hybrid, Green Published			2022-12-27	WOS:000296759800058
J	Pandey, A; Yoon, H; Lyver, ER; Dancis, A; Pain, D				Pandey, Alok; Yoon, Heeyong; Lyver, Elise R.; Dancis, Andrew; Pain, Debkumar			Isd11p Protein Activates the Mitochondrial Cysteine Desulfurase Nfs1p Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOGENESIS; FE-S CLUSTER; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; YEAST NFS1P; IRON; BIOSYNTHESIS; LOCALIZATION; NIFS	Cysteine desulfurases perform pyridoxal phosphate (PLP)-dependent desulfuration of cysteine. The key steps of the enzymatic cycle include substrate binding to PLP, formation of a covalent persulfide intermediate at the active site cysteine, and transfer of sulfur to recipients for use in various metabolic pathways. In Saccharomyces cerevisiae, the cysteine desulfurase Nfs1p and an accessory protein, Isd11p, are found primarily in mitochondria, and both are essential for cell viability. Although cysteine desulfurases are conserved from bacteria to humans, Isd11p is found only in eukaryotes and not in prokaryotes. Here we show that Isd11p activates Nfs1p. The enzyme without Isd11p was inactive and did not form the [S-35]persulfide intermediate from the substrate [S-35]cysteine. Addition of Isd11p to inactive Nfs1p induced formation of the persulfide. Remarkably, in a two-step assay, [S-35]cysteine could be bound to the inactive Nfs1p in a PLP-dependent manner, and the enzyme could be subsequently induced to form the persulfide by addition of Isd11p. A mutant form of Isd11p with the (LYK17)-L-15 motif changed to (15)AAA(17) was able to bind but failed to activate Nfs1p, thus separating these two functions of Isd11p. Finally, compared with Nfs1p with or without the bound Isd11p mutant, the Nfs1p.Isd11p complex was more resistant to inactivation by an alkylating agent. On the basis of these novel findings, we propose that interaction of Isd11p with Nfs1p activates the enzyme by inducing a conformational change, thereby promoting formation of the persulfide intermediate at the active site cysteine. Such a conformational change may protect the active site cysteine from alkylating agents.	[Pandey, Alok; Pain, Debkumar] Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, New Jersey Med Sch, Newark, NJ 07101 USA; [Yoon, Heeyong; Lyver, Elise R.; Dancis, Andrew] Univ Penn, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania	Pain, D (corresponding author), Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, New Jersey Med Sch, 185 S Orange Ave,MSB I-669, Newark, NJ 07101 USA.	painde@umdnj.edu			National Institutes of Health from NIGMS [GM087965]; NIA [AG030504]; American Heart Association [09GRNT2260364];  [R37DK053953]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056953, R37DK053953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030504] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087965 from NIGMS (to D. P. and A. D.), Grant AG030504 from NIA (to D. P.), and Grant R37DK053953 (to A. D). This work was also supported by American Heart Association Grant 09GRNT2260364 (to D. P.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Amutha B, 2003, BIOCHEM J, V370, P805, DOI 10.1042/BJ20021415; Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Amutha B, 2009, METHOD ENZYMOL, V456, P247, DOI 10.1016/S0076-6879(08)04414-5; Beinert H, 2000, EUR J BIOCHEM, V267, P5657, DOI 10.1046/j.1432-1327.2000.01637.x; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Fosset C, 2006, J BIOL CHEM, V281, P25398, DOI 10.1074/jbc.M602979200; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Lauhon CT, 2004, J BIOL CHEM, V279, P19551, DOI 10.1074/jbc.M401261200; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Naamati A, 2009, J BIOL CHEM, V284, P30200, DOI 10.1074/jbc.M109.034694; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Paris Z, 2010, J BIOL CHEM, V285, P22394, DOI 10.1074/jbc.M109.083774; Rawat S, 2011, CHEM-EUR J, V17, P746, DOI 10.1002/chem.201002143; Richards TA, 2006, MOL BIOL EVOL, V23, P1341, DOI 10.1093/molbev/msl001; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Strain J, 1998, J BIOL CHEM, V273, P31138, DOI 10.1074/jbc.273.47.31138; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	39	10	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38242	38252		10.1074/jbc.M111.288522	http://dx.doi.org/10.1074/jbc.M111.288522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908622	Green Published, hybrid			2022-12-27	WOS:000296594200038
J	Sheng, L; Cho, KW; Zhou, YJ; Shen, H; Rui, LY				Sheng, Liang; Cho, Kae Won; Zhou, Yingjiang; Shen, Hong; Rui, Liangyou			Lipocalin 13 Protein Protects against Hepatic Steatosis by Both Inhibiting Lipogenesis and Stimulating Fatty Acid beta-Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; ELEMENT-BINDING PROTEIN; SKELETAL-MUSCLE; LIVER-DISEASE; MICE; DEFICIENCY; EXPRESSION; OBESITY; RETINOL-BINDING-PROTEIN-4; IDENTIFICATION	Obesity is associated with hepatic steatosis, partially due to increased lipogenesis and decreased fatty acid beta-oxidation in the liver; however, the underlying mechanism of abnormal lipid metabolism is not fully understood. We reported previously that obesity is associated with LCN13 (lipocalin 13) deficiency. LCN13 is a lipocalin family member involved in glucose metabolism, and LCN13 deficiency appears to contribute to hyperglycemia in obese mice. Here, we show that LCN13 is also an important regulator of lipogenesis and beta-oxidation in the liver. In primary hepatocytes, recombinant LCN13 directly suppressed lipogenesis and increased fatty acid beta-oxidation, whereas neutralization of endogenous LCN13 had an opposite effect. Transgenic overexpression of LCN13 protected against hepatic steatosis in mice with either dietary or genetic (ob/ob) obesity. LCN13 transgenic overexpression also improved hyperglycemia, glucose intolerance, and insulin resistance in ob/ob mice. Short-term LCN13 overexpression via an adenovirus-mediated gene transfer similarly attenuated hepatic steatosis in db/db mice. LCN13 inhibited the expression of important lipogenic genes and stimulated the genes that promote beta-oxidation. These results suggest that LCN13 decreases liver lipid levels by both inhibiting hepatic lipogenesis and stimulating beta-oxidation. LCN13 deficiency is likely to contribute to fatty liver disease in obese mice.	[Sheng, Liang; Cho, Kae Won; Zhou, Yingjiang; Shen, Hong; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	shen, hong/I-6179-2016	SHEN, HONG/0000-0002-1559-3633	National Institutes of Health [R01 DK065122, R01 DK073601, 5P60 DK20572, 5P30 CA46592, P30 AG013283, DK34933]; American Diabetes Association [1-09-RA-156]; Michigan Diabetes Research and Training Center; University of Michigan Cancer Center; University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, P60DK020572, R01DK073601, R01DK065122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Michigan Diabetes Research and Training Center; University of Michigan Cancer Center(University of Michigan System); University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK065122 and R01 DK073601. This work was also supported by American Diabetes Association Research Award 1-09-RA-156. This work utilized the cores supported by the Michigan Diabetes Research and Training Center (funded by National Institutes of Health Grant 5P60 DK20572), the University of Michigan Cancer Center (funded by National Institutes of Health Grant 5P30 CA46592), the University of Michigan Nathan Shock Center (funded by National Institutes of Health Grant P30 AG013283), and the University of Michigan Gut Peptide Research Center (funded by National Institutes of Health Grant DK34933).	Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Caldwell S, 2010, J HEPATOL, V53, P719, DOI 10.1016/j.jhep.2010.04.031; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cho KW, 2011, MOL CELL BIOL, V31, P450, DOI 10.1128/MCB.00459-10; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim YB, 2002, J BIOL CHEM, V277, P32915, DOI 10.1074/jbc.M204710200; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Mendez-Sanchez N, 2007, LIVER INT, V27, P423, DOI 10.1111/j.1478-3231.2007.01483.x; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; More L, 2006, CHEM SENSES, V31, P393, DOI 10.1093/chemse/bjj043; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Schlehuber S, 2005, DRUG DISCOV TODAY, V10, P23, DOI 10.1016/S1359-6446(04)03294-5; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Suzuki K, 2004, GENE, V339, P49, DOI 10.1016/j.gene.2004.06.027; Taube A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1004, DOI 10.1152/ajpendo.00241.2009; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	38	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38128	38135		10.1074/jbc.M111.256677	http://dx.doi.org/10.1074/jbc.M111.256677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908604	hybrid, Green Published			2022-12-27	WOS:000296594200026
J	Staron, P; Forchhammer, K; Maldener, I				Staron, Peter; Forchhammer, Karl; Maldener, Iris			Novel ATP-driven Pathway of Glycolipid Export Involving TolC Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-7120; MULTIDRUG EFFLUX SYSTEM; BLUE-GREEN-ALGA; ABC-TRANSPORTER; ESCHERICHIA-COLI; HETEROCYST GLYCOLIPIDS; CRYSTAL-STRUCTURE; BACTERIAL LIPOPROTEINS; PERIPLASMIC COMPONENT; SIGNAL-TRANSDUCTION	Upon depletion of combined nitrogen, N-2-fixing heterocysts are formed from vegetative cells in the case of the filamentous cyanobacterium Anabaena sp. strain PCC 7120. A heterocyst-specific layer composed of glycolipids (heterocyst envelope glycolipids (HGLs)) that functions as an O-2 diffusion barrier is deposited over the heterocyst outer membrane and is surrounded by an outermost heterocyst polysaccharide envelope. Mutations in any gene of the devBCA operon or tolC result in the absence of the HGL layer, preventing growth on N-2 used as the sole nitrogen source. However, those mutants do not have impaired HGL synthesis. In this study, we show that DevBCA and TolC form an ATP-driven efflux pump required for the export of HGLs across the Gram-negative cell wall. By performing protein-protein interaction studies (in vivo formaldehyde cross-linking, surface plasmon resonance, and isothermal titration calorimetry), we determined the kinetics and stoichiometric relations for the transport process. For sufficient glycolipid export, the membrane fusion protein DevB had to be in a hexameric form to connect the inner membrane factor DevC and the outer membrane factor TolC. A mutation that impaired the ability of DevB to form a hexameric arrangement abolished the ability of DevC to recognize its substrate. The physiological relevance of a hexameric DevB is shown in complementation studies. We provide insights into a novel pathway of glycolipid export across the Gram-negative cell wall.	[Staron, Peter; Forchhammer, Karl; Maldener, Iris] Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen, Dept Microbiol Organism Interact, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Maldener, I (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen, Dept Microbiol Organism Interact, Morgenstelle 28, D-72076 Tubingen, Germany.	iris.maldener@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [DFG-Ma1359/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG-Ma1359/5-1).	Awai K, 2007, FEMS MICROBIOL LETT, V266, P98, DOI 10.1111/j.1574-6968.2006.00512.x; Bauersachs T, 2009, PHYTOCHEMISTRY, V70, P2034, DOI 10.1016/j.phytochem.2009.08.014; BLACK K, 1995, J BACTERIOL, V177, P6440, DOI 10.1128/jb.177.22.6440-6448.1995; Campbell EL, 1997, ARCH MICROBIOL, V167, P251, DOI 10.1007/s002030050440; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; CARDEMIL L, 1976, J BIOL CHEM, V251, P2967; Deininger KNW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018960; Eckford PDW, 2010, BIOCHEM J, V429, P195, DOI 10.1042/BJ20100144; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Fan Q, 2005, MOL MICROBIOL, V58, P227, DOI 10.1111/j.1365-2958.2005.04818.x; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Ferhat M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007732; Fiedler G, 1998, BBA-BIOMEMBRANES, V1375, P140, DOI 10.1016/S0005-2736(98)00147-3; Fiedler G, 1998, MOL MICROBIOL, V27, P1193, DOI 10.1046/j.1365-2958.1998.00762.x; Fokina O, 2010, J MOL BIOL, V399, P410, DOI 10.1016/j.jmb.2010.04.018; Gambacorta A, 1998, PHYTOCHEMISTRY, V48, P801, DOI 10.1016/S0031-9422(97)00954-0; Garti-Levi S, 2008, MOL MICROBIOL, V69, P1018, DOI 10.1111/j.1365-2958.2008.06340.x; Hantke K, 2011, J BACTERIOL, V193, P1086, DOI 10.1128/JB.01399-10; HAURY JF, 1978, J BACTERIOL, V136, P688, DOI 10.1128/JB.136.2.688-692.1978; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kaul G, 2011, INDIAN J BIOCHEM BIO, V48, P7; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Maldener I, 2003, FEMS MICROBIOL LETT, V224, P205, DOI 10.1016/S0378-1097(03)00444-0; Martins M, 2011, IN VIVO, V25, P171; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Moslavac S, 2007, J BACTERIOL, V189, P7887, DOI 10.1128/JB.00750-07; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; Narita S, 2010, METHODS MOL BIOL, V619, P117, DOI 10.1007/978-1-60327-412-8_7; Nicolalsen K, 2009, J BASIC MICROB, V49, P5, DOI 10.1002/jobm.200800300; Olmedo-Verd E, 2006, J BACTERIOL, V188, P6694, DOI 10.1128/JB.00509-06; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; Ramirez ME, 2005, J BACTERIOL, V187, P2326, DOI 10.1128/JB.187.7.2326-2331.2005; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Schultze M, 2009, BBA-BIOENERGETICS, V1787, P1479, DOI 10.1016/j.bbabio.2009.06.010; Shi L, 2007, J BACTERIOL, V189, P5075, DOI 10.1128/JB.00323-07; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Tikhonova EB, 2009, P NATL ACAD SCI USA, V106, P16416, DOI 10.1073/pnas.0906601106; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; WINKENBACH F, 1972, PLANTA, V107, P69, DOI 10.1007/BF00398015; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; WOLK CP, 1984, P NATL ACAD SCI-BIOL, V81, P1561, DOI 10.1073/pnas.81.5.1561; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Xu Y, 2009, BIOCHEMISTRY-US, V48, P5218, DOI 10.1021/bi900415t; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048	59	28	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38202	38210		10.1074/jbc.M111.269332	http://dx.doi.org/10.1074/jbc.M111.269332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917923	Green Published, hybrid			2022-12-27	WOS:000296594200034
J	Wade, R; Brimer, N; Lyons, C; Vande Pol, S				Wade, Ramon; Brimer, Nicole; Lyons, Charles; Vande Pol, Scott			Paxillin Enables Attachment-independent Tyrosine Phosphorylation of Focal Adhesion Kinase and Transformation by RAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSFORMATION; PAPILLOMAVIRUS E6 ONCOPROTEIN; RECEPTOR COACTIVATOR; PROTEIN PAXILLIN; CELL-SURVIVAL; LIM PROTEIN; NUDE MICE; PTP-PEST; HIC-5; MOTIF	Paxillin and HIC5 are closely related adapter proteins that regulate cell migration and are tyrosine-phosphorylated by focal adhesion kinase (FAK). Paxillin, HIC5, and FAK tyrosine phosphorylation increase upon cell attachment and decrease upon detachment from extracellular matrix. Unexpectedly, we found that although FAK tyrosine phosphorylation in attached cells did not require paxillin, in detached fibroblasts there was remaining FAK tyrosine phosphorylation that required expression of paxillin and was not supported by HIC5. The support of attachment-independent FAK tyrosine phosphorylation required the paxillin LIM domains and suggested that paxillin might facilitate oncogenic transformation. Paxillin but not HIC5 augmented anchorage-independent cell proliferation induced by RAS. Both anchorage-independent FAK tyrosine phosphorylation and RAS-induced colony formation required multiple docking sites on paxillin, including LD4 (docking sites for FAK-Src and GIT1/2-PIX-NCK-PAK complex), LD5, and all four carboxyl-terminal LIM domains (that bind tubulin and PTP-PEST). Analysis using paxillin mutants dissociated domains of paxillin that are required for regulation of cell migration from domains that are required for anchorage-independent cell proliferation and demonstrated essential functions of the paxillin LIM domains that are not found in HIC5 LIM domains. These results highlight the role of paxillin in facilitating attachment-independent signal transduction implicated in cancer.	[Wade, Ramon; Brimer, Nicole; Lyons, Charles; Vande Pol, Scott] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Vande Pol, S (corresponding author), Univ Virginia, Dept Pathol, POB 800904, Charlottesville, VA 22908 USA.	vandepol@virginia.edu			National Institutes of Health [CA-69292, CA-120352]; University of Virginia; NATIONAL CANCER INSTITUTE [R01CA069292, R01CA120352, R29CA069292, R01CA134737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-69292 and CA-120352 (to S. V.). This work was also supported by the University of Virginia.	Avraamides C, 2007, AM J PHYSIOL-HEART C, V293, pH193, DOI 10.1152/ajpheart.00728.2006; Bohl J, 2000, VIROLOGY, V271, P163, DOI 10.1006/viro.2000.0316; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Dong JM, 2009, BIOCHEM J, V418, P173, DOI 10.1042/BJ20080170; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Heitzer MD, 2006, CANCER RES, V66, P7326, DOI 10.1158/0008-5472.CAN-05-2379; Ili D, 1995, NATURE, V377, P539, DOI 10.1038/377539a07566154; Jamieson JS, 2005, J CELL SCI, V118, P5835, DOI 10.1242/jcs.02693; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Renshaw MW, 1999, J CELL BIOL, V147, P611, DOI 10.1083/jcb.147.3.611; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; STOKER M, 1968, INT J CANCER, V3, P683, DOI 10.1002/ijc.2910030517; Tong XA, 1997, P NATL ACAD SCI USA, V94, P4412, DOI 10.1073/pnas.94.9.4412; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Valles AM, 2004, J BIOL CHEM, V279, P44490, DOI 10.1074/jbc.M405144200; Vande Pol SB, 1998, ONCOGENE, V16, P43, DOI 10.1038/sj.onc.1201504; Wade R, 2006, BIOCHEM J, V393, P565, DOI 10.1042/BJ20051241; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; Wade R, 2008, J VIROL, V82, P5962, DOI 10.1128/JVI.02747-07; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	46	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37932	37944		10.1074/jbc.M111.294504	http://dx.doi.org/10.1074/jbc.M111.294504			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900245	Green Published, hybrid			2022-12-27	WOS:000296594200006
J	Dunlop, MH; Dray, E; Zhao, WX; Tsai, MS; Wiese, C; Schild, D; Sung, P				Dunlop, Myun Hwa; Dray, Eloise; Zhao, Weixing; Tsai, Miaw-Sheue; Wiese, Claudia; Schild, David; Sung, Patrick			RAD51-associated Protein 1 (RAD51AP1) Interacts with the Meiotic Recombinase DMC1 through a Conserved Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; BINDING PROTEIN; MEIOSIS; DNA; COMPLEXES; PROMOTES; ROLES; RAD54; MECHANISM	Homologous recombination (HR) reactions mediated by the RAD51 recombinase are essential for DNA and replication fork repair, genome stability, and tumor suppression. RAD51-associated protein 1 (RAD51AP1) is an important HR factor that associates with and stimulates the recombinase activity of RAD51. We have recently shown that RAD51AP1 also partners with the meiotic recombinase DMC1, displaying isoform-specific interactions with DMC1. Here, we have characterized the DMC1 interaction site in RAD51AP1 by a series of truncations and point mutations to uncover a highly conserved WVPP motif critical for DMC1 interaction but dispensable for RAD51 association. This RAD51AP1 motif is reminiscent of the FVPP motif in the tumor suppressor protein BRCA2 that mediates DMC1 interaction. These results further implicate RAD51AP1 in meiotic HR via RAD51 and DMC1.	[Dunlop, Myun Hwa; Dray, Eloise; Zhao, Weixing; Sung, Patrick] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA; [Tsai, Miaw-Sheue; Wiese, Claudia; Schild, David] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Yale University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Sung, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Sch Med, 333 Cedar St,SHM C-130, New Haven, CT 06520 USA.	patrick.sung@yale.edu	Dray, Eloise/E-3938-2012; Dray, Eloise/AAD-5147-2021; zhao, weixing/H-3154-2013; Classen, Scott/AAY-8176-2020	Dray, Eloise/0000-0001-6793-9838; zhao, weixing/0000-0001-5746-3696	National Institutes of Health [RO1 ES015252, RO1 ES015632, RO1 ES07061, PO1 CA092584, PO1 CA129186, R01 CA120315]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA120315, P01CA129186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061, R01ES015632, R01ES015252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES015252, RO1 ES015632, RO1 ES07061, PO1 CA092584, PO1 CA129186, and R01 CA120315.	ADZUMA K, 1992, GENE DEV, V6, P1679, DOI 10.1101/gad.6.9.1679; Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chi P, 2009, DNA REPAIR, V8, P279, DOI 10.1016/j.dnarep.2008.10.012; Dray E, 2011, P NATL ACAD SCI USA, V108, P3560, DOI 10.1073/pnas.1016454108; Dresser ME, 1997, GENETICS, V147, P533; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; FERRIN LJ, 1991, SCIENCE, V254, P1494, DOI 10.1126/science.1962209; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Kagawa W, 2010, FEBS J, V277, P590, DOI 10.1111/j.1742-4658.2009.07503.x; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Klein HL, 1997, GENETICS, V147, P1533; Kovalenko OV, 2006, NUCLEIC ACIDS RES, V34, P5081, DOI 10.1093/nar/gkl665; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Sheridan S, 2006, GENE DEV, V20, P1685, DOI 10.1101/gad.1447606; Shinohara A, 2004, CYTOGENET GENOME RES, V107, P201, DOI 10.1159/000080598; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 1997, GENETICS, V147, P1545; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Tempest HG, 2011, SYST BIOL REPROD MED, V57, P93, DOI 10.3109/19396368.2010.504879; TERASAWA M, 1995, GENE DEV, V9, P925, DOI 10.1101/gad.9.8.925; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027	42	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37328	37334		10.1074/jbc.M111.290015	http://dx.doi.org/10.1074/jbc.M111.290015			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903585	hybrid, Green Published			2022-12-27	WOS:000296542400033
J	Haig, NA; Guan, ZQ; Li, DM; McMichael, A; Raetz, CRH; Xu, XN				Haig, Neil A.; Guan, Ziqiang; Li, Demin; McMichael, Andrew; Raetz, Christian R. H.; Xu, Xiao-Ning			Identification of Self-lipids Presented by CD1c and CD1d Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECOGNITION; ANTIGEN PRESENTATION; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; ENDOPLASMIC-RETICULUM; MEMBRANE DIGESTION; BINDING GROOVE; MOUSE CD1D; NKT CELLS; MOLECULES	The CD1 family consists of five proteins that are related to the peptide-presenting MHC class I family. T cells can recognize the presentation of both foreign and self-derived lipids on four CD1 family members. The identities of the self-lipids capable of stimulating autoreactive T cell responses remain elusive or controversial. Here, we employed mass spectrometry to analyze the lipid content of highly purified CD1c and CD1d protein samples. We report the identification of 11 novel self-lipids presented by CD1c and nine by CD1d. Rigorous controls provide strong evidence that the identified lipids were specifically loaded into the lipid-binding site of the CD1 molecules. The diverse but distinct population of lipids identified from each CD1 family member implies each present a different subset of self-lipids, and the enrichment of particular motifs indicates that the lipids that are presented by CD1 family members could be predicted. Finally, our results imply the CD1 system surveys the endoplasmic reticulum, Golgi apparatus, and/or secretory compartments, in addition to its well characterized surveillance of the endocytic and lysosomal compartments.	[Haig, Neil A.; Li, Demin; McMichael, Andrew; Xu, Xiao-Ning] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Guan, Ziqiang; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of Oxford; Duke University	McMichael, A (corresponding author), Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	andrew.mcmichael@ndm.ox.ac.uk	Li, Demin/O-4065-2019; Guan, Ziqiang/AAE-5110-2019	Li, Demin/0000-0002-7118-3401; 	Medical Research Council; National Institutes of Health [GM-069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; Medical Research Council [G1000800j, MC_U137884177] Funding Source: researchfish; MRC [MC_U137884177] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (to N. A. H., D. L., X.-N. X., and A. M.). This work was also supported by LIPID MAPS Large Scale Collaborative Grant GM-069338 from the National Institutes of Health (to Z. G. and C. R. H. R.).	Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Batuwangala T, 2004, J IMMUNOL, V172, P2382, DOI 10.4049/jimmunol.172.4.2382; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2006, J IMMUNOL, V176, P3625, DOI 10.4049/jimmunol.176.6.3625; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Chen DLN, 2008, J IMMUNOL METHODS, V330, P57, DOI 10.1016/j.jim.2007.10.018; Christiansen D, 2008, PLOS BIOL, V6, P1527, DOI 10.1371/journal.pbio.0060172; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; de Jong A, 2007, CHEM BIOL, V14, P1232, DOI 10.1016/j.chembiol.2007.09.010; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; De Libero G, 2005, NAT REV IMMUNOL, V5, P485, DOI 10.1038/nri1631; De Libero G, 2005, IMMUNITY, V22, P763, DOI 10.1016/j.immuni.2005.04.013; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Dias BR, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-116; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Gadola SD, 2006, J EXP MED, V203, P2293, DOI 10.1084/jem.20060921; Garcia-Alles LF, 2006, EMBO J, V25, P3684, DOI 10.1038/sj.emboj.7601244; Giabbai B, 2005, J IMMUNOL, V175, P977, DOI 10.4049/jimmunol.175.2.977; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Guiard J, 2009, J IMMUNOL, V182, P7030, DOI 10.4049/jimmunol.0804044; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kolter T, 2005, J BIOL CHEM, V280, P41125, DOI 10.1074/jbc.R500015200; Li DM, 2009, J IMMUNOL, V182, P1033, DOI 10.4049/jimmunol.182.2.1033; Li YS, 2008, GLYCOBIOLOGY, V18, P158, DOI 10.1093/glycob/cwm129; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Moody D. B, 2007, T CELL ACTIVATION CD; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Muindi K, 2010, P NATL ACAD SCI USA, V107, P3052, DOI 10.1073/pnas.0915056107; Park JJ, 2004, P NATL ACAD SCI USA, V101, P1022, DOI 10.1073/pnas.0307847100; Paul W. E, 2008, FUNDAMENTAL IMMUNOLO, P518; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Scharf L, 2010, IMMUNITY, V33, P853, DOI 10.1016/j.immuni.2010.11.026; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Silk JD, 2008, J IMMUNOL, V180, P6452, DOI 10.4049/jimmunol.180.10.6452; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; Sugita M, 2000, TRAFFIC, V1, P295, DOI 10.1034/j.1600-0854.2000.010401.x; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Sullivan BA, 2005, TRENDS IMMUNOL, V26, P282, DOI 10.1016/j.it.2005.03.002; Van Rhijn I, 2009, J EXP MED, V206, P1409, DOI 10.1084/jem.20082480; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Wu D, 2006, P NATL ACAD SCI USA, V103, P3972, DOI 10.1073/pnas.0600285103; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2008, P NATL ACAD SCI USA, V105, P17925, DOI 10.1073/pnas.0809814105; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	63	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37692	37701		10.1074/jbc.M111.267948	http://dx.doi.org/10.1074/jbc.M111.267948			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900247	Green Published, hybrid			2022-12-27	WOS:000296542400065
J	Hinds, TD; Stechschulte, LA; Cash, HA; Whisler, D; Banerjee, A; Yong, WD; Khuder, SS; Kaw, MK; Shou, WN; Najjar, SM; Sanchez, ER				Hinds, Terry D., Jr.; Stechschulte, Lance A.; Cash, Harrison A.; Whisler, Donald; Banerjee, Ananya; Yong, Weidong; Khuder, Saja S.; Kaw, Meenakshi K.; Shou, Weinian; Najjar, Sonia M.; Sanchez, Edwin R.			Protein Phosphatase 5 Mediates Lipid Metabolism through Reciprocal Control of Glucocorticoid Receptor and Peroxisome Proliferator-activated Receptor-gamma (PPAR gamma)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; HEAT-SHOCK-PROTEIN; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; ADIPOSE-TISSUE; SERINE/THREONINE PHOSPHATASE; IMMUNOPHILIN FKBP51; STEROID-RECEPTORS; SQUIRREL-MONKEY; MESSENGER-RNA	Background: The glucocorticoid (GR) and peroxisome proliferator-activated (PPAR gamma) receptors are antagonists of lipid metabolism. Results: Protein phosphatase 5 (PP5) dephosphorylates GR and PPAR gamma to reciprocally control their activities. Conclusion: PP5 is a switch point in nuclear receptor control of lipid metabolism. Significance: PP5 is a potential new drug target in the treatment of obesity.	[Hinds, Terry D., Jr.; Stechschulte, Lance A.; Cash, Harrison A.; Whisler, Donald; Banerjee, Ananya; Khuder, Saja S.; Kaw, Meenakshi K.; Najjar, Sonia M.; Sanchez, Edwin R.] Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Hinds, Terry D., Jr.; Stechschulte, Lance A.; Cash, Harrison A.; Whisler, Donald; Banerjee, Ananya; Khuder, Saja S.; Kaw, Meenakshi K.; Najjar, Sonia M.; Sanchez, Edwin R.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Yong, Weidong; Shou, Weinian] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Pediat Cardiol Sect, Indianapolis, IN 46202 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Indiana University System; Indiana University Bloomington	Sanchez, ER (corresponding author), Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, 3035 Arlington Ave, Toledo, OH 43614 USA.	edwin.sanchez@utoledo.edu	Najjar, Sonia M/GXW-2217-2022; Hinds, Terry/B-8495-2015	Stechschulte, Lance/0000-0001-9783-6194; Hinds, Terry/0000-0002-7599-1529	National Institutes of Health [DK70127, DK73402, DK054254, DK083850, F31DK84958]; national research service award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK084958, R01DK073402, R01DK054254, R01DK070127, R01DK083850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); national research service award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK70127 (to E. R. S.), DK73402 (to W. S.), DK054254 and DK083850 (to S. M. N.), and F31DK84958, a national research service award (to T. D. H.).	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Banerjee A, 2008, BIOCHEMISTRY-US, V47, P10471, DOI 10.1021/bi8011862; BECKER W, 1994, J BIOL CHEM, V269, P22586; Blind RD, 2008, J STEROID BIOCHEM, V109, P150, DOI 10.1016/j.jsbmb.2008.01.002; Bodwell JE, 1998, J STEROID BIOCHEM, V65, P91, DOI 10.1016/S0960-0760(97)00185-4; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Camp HS, 1997, J BIOL CHEM, V272, P10811; Campbell JE, 2009, METABOLISM, V58, P651, DOI 10.1016/j.metabol.2009.01.002; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; CHINKERS M, 1994, P NATL ACAD SCI USA, V91, P11075, DOI 10.1073/pnas.91.23.11075; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Dean DA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-6; DEFRANCO DB, 1991, MOL ENDOCRINOL, V5, P1215, DOI 10.1210/mend-5-9-1215; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Galigniana MD, 2002, BIOCHEMISTRY-US, V41, P13602, DOI 10.1021/bi020399z; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Heuvel JPV, 2003, TOXICOL APPL PHARM, V188, P185, DOI 10.1016/S0041-008X(03)00015-2; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Jan HJ, 2009, CANCER LETT, V277, P141, DOI 10.1016/j.canlet.2008.11.033; Kang H, 2001, BIOCHEMISTRY-US, V40, P10485, DOI 10.1021/bi010999i; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Lazar MA, 2005, BIOCHIMIE, V87, P9, DOI 10.1016/j.biochi.2004.10.021; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; Ni L, 2007, ASSAY DRUG DEV TECHN, V5, P645, DOI 10.1089/adt.2007.079; Nye C, 2008, TRENDS ENDOCRIN MET, V19, P356, DOI 10.1016/j.tem.2008.08.003; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ramsey AJ, 2002, BIOCHEMISTRY-US, V41, P5625, DOI 10.1021/bi016090h; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; SLAVIN BG, 1994, J LIPID RES, V35, P1535; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sumanasekera WK, 2003, BIOCHEMISTRY-US, V42, P10726, DOI 10.1021/bi0347353; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Swingle Mark, 2007, V365, P23; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Wan ZX, 2010, AM J PHYSIOL-CELL PH, V299, pC1162, DOI 10.1152/ajpcell.00188.2010; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wolf IM, 2009, J STEROID BIOCHEM, V113, P36, DOI 10.1016/j.jsbmb.2008.11.006; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhang Y, 2009, J BIOL CHEM, V284, P24542, DOI 10.1074/jbc.M109.021469; Zuo Z, 1999, BIOCHEMISTRY-US, V38, P8849, DOI 10.1021/bi990842e; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	75	66	70	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42911	42922		10.1074/jbc.M111.311662	http://dx.doi.org/10.1074/jbc.M111.311662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21994940	hybrid, Green Published			2022-12-27	WOS:000298351300013
J	Bhat, UG; Jagadeeswaran, R; Halasi, M; Gartel, AL				Bhat, Uppoor G.; Jagadeeswaran, Ramasamy; Halasi, Marianna; Gartel, Andrei L.			Nucleophosmin Interacts with FOXM1 and Modulates the Level and Localization of FOXM1 in Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXM1; GENE-EXPRESSION PROFILES; TUMOR-CELLS; HEPATOCELLULAR CARCINOMAS; MICROARRAY ANALYSIS; INDUCE APOPTOSIS; CDNA MICROARRAY; IDENTIFICATION; PROLIFERATION; PROGRESSION	Using mass spectrometric analysis we found that oncogenic transcription factor FOXM1 that is overexpressed in a majority of human cancers interacts with multifunctional protein NPM, which is also overexpressed in a variety of human tumors. Coimmunoprecipitation and glutathione S-transferase pull-down experiments demonstrated that NPM forms a complex with FOXM1 and also identified the regions responsible for their interaction. Immunofluorescence microscopy confirmed the interaction between FOXM1 and NPM in cancer and immortal cells. Furthermore, knockdown of NPM in immortal and cancer cells led to significant down-regulation of FOXM1 similar to its levels in normal cells, suggesting that NPNI might modulate FOXM1 level. In addition, in OCI/AMI.3 leukemia cells where mutant NPM is localized in the cytoplasm we found that typically nuclear FOXM1 was predominantly co-localized with NPM in the cytoplasm, while NPM knockdown led to the disappearance of FOXM1 from the cytoplasm, suggesting that NPM may also determine intracellular localization of FOXM1. Knockdown of FOXM1 or NPM in MIA PaCa-2 pancreatic cancer cells inhibited anchorage-dependent and independent growth in cell culture, and tumor growth in nude mice. In addition, over-expression of FOXM1 reversed the effect of NPM knockdown in vitro. Our data suggest that in cancer cells NPM interacts with Foxm1 and their interaction is required for sustaining the level and localization of FOXM1. Targeting the interaction between FOXM1 and NPM by peptides or small molecules may represent a novel therapeutic strategy against cancer.	[Bhat, Uppoor G.; Jagadeeswaran, Ramasamy; Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Gartel, Andrei L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gartel, AL (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,Room 1041, Chicago, IL 60612 USA.	agartel@uic.edu	Jagadeeswaran, Ramasamy/C-9987-2013	Ramasamy, Jagadeesh/0000-0002-7906-4239	National Institutes of Health [1R01 CA1294414, 1R21 CA134615]; NATIONAL CANCER INSTITUTE [R01CA129414, R01CA124414, R21CA134615, R01CA194414, R01CA129444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01 CA1294414 and 1R21 CA134615 (to A. L. G.).	Ahmad A., 2009, BREAST CANC TREATMEN; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Douard R, 2006, SURGERY, V139, P665, DOI 10.1016/j.surg.2005.10.012; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nozawa Y, 1996, J PATHOL, V178, P48; Okabe H, 2001, CANCER RES, V61, P2129; Pandit B, 2009, CELL CYCLE, V8, P3425, DOI 10.4161/cc.8.20.9628; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Penzo M, 2009, J CELL PHYSIOL, V218, P215, DOI 10.1002/jcp.21596; Pianta A, 2011, ENDOCR PATHOL, V22, P18, DOI 10.1007/s12022-011-9147-x; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Radhakrishnan Senthil K, 2008, Nat Rev Cancer, V8, pc2, DOI 10.1038/nrc2223-c1; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Romagnoli S, 2009, AM J PATHOL, V174, P762, DOI 10.2353/ajpath.2009.080721; Subong ENP, 1999, PROSTATE, V39, P298; TANAKA M, 1992, CANCER RES, V52, P3372; Teh MT, 2002, CANCER RES, V62, P4773; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Wang HF, 2011, CANCER RES, V71, P68, DOI 10.1158/0008-5472.CAN-10-0030; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wu HW, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-125; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626	46	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41425	41433		10.1074/jbc.M111.270843	http://dx.doi.org/10.1074/jbc.M111.270843			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21979956	Green Published, hybrid			2022-12-27	WOS:000298057500029
J	Brandes, N; Reichmann, D; Tienson, H; Leichert, LI; Jakob, U				Brandes, Nicolas; Reichmann, Dana; Tienson, Heather; Leichert, Lars I.; Jakob, Ursula			Using Quantitative Redox Proteomics to Dissect the Yeast Redoxome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; DISULFIDE FORMATION; HYDROGEN-PEROXIDE; CELLULAR THIOL; PROTEINS; CYSTEINE; DAMAGE; PK(A); LOCALIZATION	To understand and eventually predict the effects of changing redox conditions and oxidant levels on the physiology of an organism, it is essential to gain knowledge about its redoxome: the proteins whose activities are controlled by the oxidation status of their cysteine thiols. Here, we applied the quantitative redox proteomic method OxICAT to Saccharomyces cerevisiae and determined the in vivo thiol oxidation status of almost 300 different yeast proteins distributed among various cellular compartments. We found that a substantial number of cytosolic and mitochondrial proteins are partially oxidized during exponential growth. Our results suggest that prevailing redox conditions constantly control central cellular pathways by fine-tuning oxidation status and hence activity of these proteins. Treatment with sublethal H2O2 concentrations caused a subset of 41 proteins to undergo substantial thiol modifications, thereby affecting a variety of different cellular pathways, many of which are directly or indirectly involved in increasing oxidative stress resistance. Classification of the identified protein thiols according to their steady-state oxidation levels and sensitivity to peroxide treatment revealed that redox sensitivity of protein thiols does not predict peroxide sensitivity. Our studies provide experimental evidence that the ability of protein thiols to react to changing peroxide levels is likely governed by both thermodynamic and kinetic parameters, making predicting thiol modifications challenging and de novo identification of peroxide sensitive protein thiols indispensable.	[Brandes, Nicolas; Reichmann, Dana; Tienson, Heather; Leichert, Lars I.; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Nat Sci Bldg,Rm 4041,830 N Univ, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Nat Sci Bldg,Rm 4041,830 N Univ, Ann Arbor, MI 48109 USA.	ujakob@umich.edu	Leichert, Lars I./B-4762-2009; Reichmann, Dana/J-4999-2019	Leichert, Lars I./0000-0002-5666-9681; Reichmann, Dana/0000-0003-0315-5334	National Institutes of Health, NIA [AG027349]; NIA [AG000114]; European Molecular Biology Organization and Human Frontiers; Michigan Life Sciences Corridor; NATIONAL INSTITUTE ON AGING [T32AG000114, Z01AG000114, R01AG027349] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Molecular Biology Organization and Human Frontiers; Michigan Life Sciences Corridor; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health, NIA Grant AG027349 (to U. J.) and by Postdoctoral Fellowship NIA Training Grant AG000114 (to H. T.). This work was also supported by the European Molecular Biology Organization and Human Frontiers postdoctoral fellowship (to D. R.). The Michigan Proteome was supported in part by funds from the Michigan Life Sciences Corridor.	Allen S, 2003, J BIOL CHEM, V278, P38505, DOI 10.1074/jbc.M306027200; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Baty JW, 2005, BIOCHEM J, V389, P785, DOI 10.1042/BJ20050337; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; Colgreave I. A., 2002, METHOD ENZYMOL, V348, P175; Cook JA, 2004, SEMIN RADIAT ONCOL, V14, P259, DOI 10.1016/j.semradonc.2004.04.001; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dixon BM, 2008, ANTIOXID REDOX SIGN, V10, P963, DOI 10.1089/ars.2007.1869; Dove JE, 1998, METHOD CELL BIOL, V53, P33; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Garcia-Santamarina S., 2011, J PROTEOMICS; Gerstein M, 2001, INT TABLES CRYSTALLO, V22, P531; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kumsta C, 2011, ANTIOXID REDOX SIGN, V14, P1023, DOI 10.1089/ars.2010.3203; Le Moan N, 2006, J BIOL CHEM, V281, P10420, DOI 10.1074/jbc.M513346200; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leichert LI, 2006, ANTIOXID REDOX SIGN, V8, P763, DOI 10.1089/ars.2006.8.763; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Magherini F, 2009, CELL MOL LIFE SCI, V66, P933, DOI 10.1007/s00018-009-8574-z; Marino SM, 2010, BIOCHEMISTRY-US, V49, P7709, DOI 10.1021/bi100677a; MATTIASSON B, 1982, EUR J APPL MICROBIOL, V16, P52, DOI 10.1007/BF01008243; McDonagh B, 2009, J PROTEOMICS, V72, P677, DOI 10.1016/j.jprot.2009.01.023; Mehta R, 2010, ADV EXP MED BIOL, V694, P14; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Minard KI, 2007, FREE RADICAL BIO MED, V42, P106, DOI 10.1016/j.freeradbiomed.2006.09.024; Poole Leslie B., 2007, V44, P61; Reichmann D, 2008, BIOCHEMISTRY-US, V47, P1051, DOI 10.1021/bi7019639; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Rhee S G, 2000, Sci STKE, V2000, ppe1; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; Shenton D, 2003, BIOCHEM J, V374, P513, DOI 10.1042/BJ20030414; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; Tajc SG, 2004, J AM CHEM SOC, V126, P10508, DOI 10.1021/ja047929u; Thamsen M, 2011, CURR OPIN CHEM BIOL, V15, P113, DOI 10.1016/j.cbpa.2010.11.013; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; ZHANG RM, 1989, J BIOL CHEM, V264, P18472; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012	53	81	82	0	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41893	41903		10.1074/jbc.M111.296236	http://dx.doi.org/10.1074/jbc.M111.296236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21976664	Green Published, hybrid			2022-12-27	WOS:000298057500071
J	Holz-Schietinger, C; Matje, DM; Harrison, MF; Reich, NO				Holz-Schietinger, Celeste; Matje, Douglas M.; Harrison, Madeleine Flexer; Reich, Norbert O.			Oligomerization of DNMT3A Controls the Mechanism of de Novo DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLTRANSFERASE 3A; ECORV ENDONUCLEASE; PROCESSIVITY; MUTATIONS; TRANSCRIPTION; MAINTENANCE; BINDING; PATTERNS; REVEALS; FAMILY	DNMT3A is one of two human de novo DNA methyltransferases essential for regulating gene expression through cellular development and differentiation. Here we describe the consequences of single amino acid mutations, including those implicated in the development of acute myeloid leukemia (AML) and myelodysplastic syndromes, at the DNMT3A.DNMT3A homotetramer and DNMT3A.DNMT3L heterotetramer interfaces. A model for the DNMT3A homotetramer was developed via computational interface scanning and tested using light scattering and electrophoretic mobility shift assays. Distinct oligomeric states were functionally characterized using fluorescence anisotropy and steady-state kinetics. Replacement of residues that result in DNMT3A dimers, including those identified in AML patients, show minor changes in methylation activity but lose the capacity for processive catalysis on multisite DNA substrates, unlike the highly processive wild-type enzyme. Our results are consistent with the bimodal distribution of DNA methylation in vivo and the loss of clustered methylation in AML patients. Tetramerization with the known interacting partner DNMT3L, rescues processive catalysis, demonstrating that protein binding at the DNMT3A tetramer interface can modulate methylation patterning. Our results provide a structural mechanism for the regulation of DNMT3A activity and epigenetic imprinting.	[Holz-Schietinger, Celeste; Reich, Norbert O.] Univ Calif Santa Barbara, Interdept Program Biomol Sci Engn, Santa Barbara, CA 93106 USA; [Matje, Douglas M.; Harrison, Madeleine Flexer; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Interdept Program Biomol Sci Engn, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu						Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fersht A., 1999, STRUCTURE MECH PROTE, Vxxi, P103; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Hata K, 2002, DEVELOPMENT, V129, P1983; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hiller DA, 2003, BIOCHEMISTRY-US, V42, P14375, DOI 10.1021/bi035520w; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Lindstrom WM, 2000, J BIOL CHEM, V275, P4912, DOI 10.1074/jbc.275.7.4912; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Malygin EG, 2009, BIOL CHEM, V390, P835, DOI 10.1515/BC.2009.082; Matje DM, 2011, BIOCHEMISTRY-US, V50, P1465, DOI 10.1021/bi101446g; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Shah MY, 2011, NAT GENET, V43, P289, DOI 10.1038/ng0411-289; Sharma V, 2005, J BIOMOL STRUCT DYN, V22, P533, DOI 10.1080/07391102.2005.10507023; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P14977, DOI 10.1021/bi050988f; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Van Emburgh BO, 2011, NUCLEIC ACIDS RES, V39, P4984, DOI 10.1093/nar/gkr116; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	54	45	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41479	41488		10.1074/jbc.M111.284687	http://dx.doi.org/10.1074/jbc.M111.284687			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21979949	hybrid, Green Published			2022-12-27	WOS:000298057500034
J	Luo, HY; Charpentier, T; Wang, XH; Qi, SJ; Han, B; Wu, T; Terra, R; Lamarre, A; Wu, JP				Luo, Hongyu; Charpentier, Tania; Wang, Xuehai; Qi, Shijie; Han, Bing; Wu, Tao; Terra, Rafik; Lamarre, Alain; Wu, Jiangping			Efnb1 and Efnb2 Proteins Regulate Thymocyte Development Peripheral T Cell Differentiation, and Antiviral Immune Responses and Are Essential for Interleukin-6 (IL-6) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; STIMULATES MIGRATION; EPHA RECEPTORS; ACTIVATION; MICE; HOMEOSTASIS; EPHRIN-B1; COSTIMULATION; LYMPHOCYTES; SELECTION	Erythropoietin-producing hepatocellular kinases (Eph kinases) constitute the largest family of cell membrane receptor tyrosine kinases, and their ligand ephrins are also cell surface molecules. Because of promiscuous interaction between Ephs and ephrins, there is considerable redundancy in this system, reflecting the essential roles of these molecules in the biological system through evolution. In this study, both Efnb1 and Efnb2 were null-mutated in the T cell compartment of mice through loxP-mediated gene deletion. Mice with this double conditional mutation (double KO mice) showed reduced thymus and spleen size and cellularity. There was a significant decrease in the DN4, double positive, and single positive thymocyte subpopulations and mature CD4 and CD8 cells in the periphery. dKO thymocytes and peripheral T cells failed to compete with their WT counterparts in irradiated recipients, and the T cells showed compromised ability of homeostatic expansion. dKO naive T cells were inferior in differentiating into Th1 and Th17 effectors in vitro. The dKO mice showed diminished immune response against LCMV infection. Mechanistic studies revealed that IL-6 signaling in dKO T cells was compromised, in terms of abated induction of STAT3 phosphorylation upon IL-6 stimulation. This defect likely contributed to the observed in vitro and in vivo phenotype in dKO mice. This study revealed novel roles of Efnb1 and Efnb2 in T cell development and function.	[Luo, Hongyu; Wang, Xuehai; Qi, Shijie; Han, Bing; Wu, Tao; Terra, Rafik; Wu, Jiangping] Notre Dame Hosp, CHUM, Res Ctr, Immunol Lab, Montreal, PQ H2L 4M1, Canada; [Wu, Jiangping] Notre Dame Hosp, CHUM, Res Ctr, Serv Nephrol, Montreal, PQ H2L 4M1, Canada; [Charpentier, Tania; Lamarre, Alain] Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada; [Wu, Tao] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Cardiol, Hangzhou 310003, Zhejiang, Peoples R China	Universite de Montreal; Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS); Zhejiang University	Wu, JP (corresponding author), Notre Dame Hosp, CHUM, Res Ctr, Immunol Lab, Rm Y-5616,1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	jianping.wu@umontreal.ca			Canadian Institutes of Health Research [MOP57697, MOP69089, IMH 79565, MOP97829, MOP89797]; Heart and Stroke Foundation of Quebec; Quebec Ministry of Economic Development, Innovation, and Exportation [PSR-SIIRI-069]; J.-Louis Levesque Foundation; Fonds de la Recherche en Sante du Quebec; Zhejiang Provincial Natural Science Foundation of China [Y2080374]; National Natural Sciences Foundation of China [30800999]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Quebec Ministry of Economic Development, Innovation, and Exportation; J.-Louis Levesque Foundation; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Canadian Institutes of Health Research Grants MOP57697 and MOP69089 (to J. W.), IMH 79565 and MOP97829 to H. L.), and MOP89797 (to A. L.), by grants from the Heart and Stroke Foundation of Quebec, the Quebec Ministry of Economic Development, Innovation, and Exportation Grant PSR-SIIRI-069, by The J.-Louis Levesque Foundation (to J. W.), a group grant from the Fonds de la Recherche en Sante du Quebec for Transfusional and Hemovigilance Medical Research (to J. W.), and a J.-Louis Levesque Foundation grant (to A. L.).; Supported in part by Zhejiang Provincial Natural Science Foundation of China Grant Y2080374 and National Natural Sciences Foundation of China (Projects for Young Scientists Grant 30800999).	Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; [Anonymous], 1997, Cell, V90, P403; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bong YS, 2007, P NATL ACAD SCI USA, V104, P17305, DOI 10.1073/pnas.0702337104; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Foster KE, 2010, P NATL ACAD SCI USA, V107, P13414, DOI 10.1073/pnas.1003747107; Freywald A, 2002, J BIOL CHEM, V277, P3823, DOI 10.1074/jbc.M108011200; Freywald A, 2006, J IMMUNOL, V176, P4066, DOI 10.4049/jimmunol.176.7.4066; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; Holen HL, 2010, J LEUKOCYTE BIOL, V87, P1059, DOI 10.1189/jlb.0709497; Kalo MS, 2001, J BIOL CHEM, V276, P38940, DOI 10.1074/jbc.M105815200; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; Lee HS, 2006, NAT CELL BIOL, V8, P55, DOI 10.1038/ncb1344; Luo HY, 2002, J CLIN INVEST, V110, P1141, DOI 10.1172/JCI200215883; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Sharfe N, 2002, EUR J IMMUNOL, V32, P3745, DOI 10.1002/1521-4141(200212)32:12<3745::AID-IMMU3745>3.0.CO;2-M; Smith LM, 2004, EXP CELL RES, V292, P295, DOI 10.1016/j.yexcr.2003.08.021; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wohlfahrt JG, 2004, J IMMUNOL, V172, P843, DOI 10.4049/jimmunol.172.2.843; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200; Yu G, 2003, J IMMUNOL, V171, P106, DOI 10.4049/jimmunol.171.1.106; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200; Zaragoza B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017423; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	53	46	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41135	41152		10.1074/jbc.M111.302596	http://dx.doi.org/10.1074/jbc.M111.302596			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21976681	Green Published, hybrid			2022-12-27	WOS:000298057500003
J	Mitra, D; Das, PM; Huynh, FC; Jones, FE				Mitra, Doyel; Das, Partha M.; Huynh, Felicia C.; Jones, Frank E.			Jumonji/ARID1 B (JARID1B) Protein Promotes Breast Tumor Cell Cycle Progression through Epigenetic Repression of MicroRNA let-7e	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; GENE-EXPRESSION; MAMMARY-GLAND; CANCER; PROLIFERATION; RECEPTOR; PLU-1; DIFFERENTIATION; ACTIVATION; RESISTANCE	MicroRNAs (miRs) function as tumor suppressors or oncogenes in multiple tumor types. Although miR expression is tightly regulated, the molecular basis of miR regulation is poorly understood. Here, we investigated the influence of the histone demethylase Junionji/ARID1 B (JARID1B) on miR regulation in breast tumor cells. In MCF-7 cells with stable RNAi-mediated suppression of JARID1B expression we identified altered regulation of multiple miRs including let-7e, a member of the let-7 family of tumor suppressor miRs. Chromatin immunoprecipitation analysis demonstrated JARID1B binding to the let-7e promoter region as well as removal of the of H3K4me3 histone mark associated with active gene expression. These results suggest that JARID1B epigenetically represses let-7e expression. JARID1B stimulates tumor cell proliferation by promoting the G, to S transition. As predicted, suppression of JARID1B resulted in an accumulation of MCF-7 cells in G We confirmed that cyclin D1, which also promotes G, progression, is a direct target of let-7e, and we show that cydin D1 expression is suppressed in JARID1B knockdown cells. Cyclin D1 expression and cell cycle progression were restored following inhibition of let-7e, suggesting that JARID1B repression of let-7e contributes to cydin D1 expression and JARID1B-mediated cell cycle progression. Our results indicate that the JARID1B demethylase contributes to tumor cell proliferation through the epigenetic repression of a tumor suppressor miR.	[Mitra, Doyel] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; [Das, Partha M.; Huynh, Felicia C.; Jones, Frank E.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Tulane University	Jones, FE (corresponding author), 6400 Freret St, New Orleans, LA 70118 USA.	fjones3@tulane.edu	Das, Partha/C-6898-2012		United States Army Medical Research and Materiel Command [W81XWH-08-1-0506]	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by United States Army Medical Research and Materiel Command Grant W81XWH-08-1-0506 (to D. M. and F. E. J.).	Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Barrett A, 2007, INT J CANCER, V121, P265, DOI 10.1002/ijc.22673; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Cittelly DM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-317; Cittelly DM, 2010, CARCINOGENESIS, V31, P2049, DOI 10.1093/carcin/bgq192; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Lan FF, 2011, INT J CANCER, V128, P319, DOI 10.1002/ijc.25336; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Verghese ET, 2008, J PATHOL, V215, P214, DOI 10.1002/path.2359; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	33	63	67	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40531	40535		10.1074/jbc.M111.304865	http://dx.doi.org/10.1074/jbc.M111.304865			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969366	Green Published, hybrid			2022-12-27	WOS:000297315400012
J	Ryan, CM; Mehlert, A; Richardson, JM; Ferguson, MAJ; Johnson, PJ				Ryan, Christopher M.; Mehlert, Angela; Richardson, Julia M.; Ferguson, Michael A. J.; Johnson, Patricia J.			Chemical Structure of Trichomonas vaginalis Surface Lipoglycan A ROLE FOR SHORT GALACTOSE (beta 1-4/3) N-ACETYLGLUCOSAMINE REPEATS IN HOST CELL INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRITRICHOMONAS-FETUS; EPITHELIAL-CELLS; LIPOPHOSPHOGLYCAN; SACCHARIDES; STRAINS; ANTIBODIES; PROTEINS; ENZYMES; RISK	The extracellular parasite Trichomonas vaginalis contains a surface glycoconjugate that appears to mediate parasite-host cell interaction via binding to human galectin-1. This glycoconjugate also elicits cytokine production from human vaginal epithelial cells, implicating its role in modulation of host immune responses. We have analyzed the structure of this glycoconjugate, previously described to contain the sugars rhamnose (Rha), N-acetylglucosamine (GlcNAc), galactose (Gal), xylose (Xyl), N-acetylgalactosamine (GalNAc), and glucose (Glc), using gas chromatograph mass spectrometry (GC-MS), matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF), electrospray MS/MS, and nuclear magnetic resonance (NMR), combined with chemical and enzymatic digestions. Our data reveal a complex structure, named T. vaginalis lipoglycan (TvLG), that differs markedly from Leishmania lipophosphoglycan and Entamoeba lipopeptidophosphoglycan and is devoid of phosphosaccharide repeats. TvLG is composed of an alpha 1-3 linked polyrhamnose core, where Rha residues are substituted at the 2-position with either beta-Xyl or chains of, on average, five N-acetyllactosamine (-3Gal beta 1-4GlcNAc beta 1-) (LacNAc) units and occasionally lacto-N-biose (-3Gal beta 1-3GlcNAc beta 1-) (LNB). These chains are themselves periodically substituted at the Gal residues with Xyl-Rha. These structural analyses led us to test the role of the poly-LacNAc/LNB chains in parasite binding to host cells. We found that reduction of poly-LacNAc/LNB chains decreased the ability of TvLG to compete parasite binding to host cells. In summary, our data provide a new model for the structure of TvLG, composed of a polyrhamnose backbone with branches of Xyl and poly-LacNAc/LNB. Furthermore, the poly-LacNAc side chains are shown to be involved in parasite-host cell interaction.	[Mehlert, Angela; Ferguson, Michael A. J.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 4HN, Scotland; [Ryan, Christopher M.; Johnson, Patricia J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Richardson, Julia M.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland	University of Dundee; University of California System; University of California Los Angeles; University of Edinburgh	Ferguson, MAJ (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 4HN, Scotland.	m.a.j.ferguson@dundee.ac.uk; johnsonp@ucla.edu	Richardson, Julia/D-1808-2013	Richardson, Julia/0000-0002-1547-3009; Ferguson, Michael/0000-0003-1321-8714	National Institutes of Health [R01 AI069058]; American Cancer Society; Boehringer Ingelheim Fonds; Wellcome Trust [083481, 085622]; Medical Research Council, United Kingdom; MRC [G0500923] Funding Source: UKRI; Medical Research Council [G0500923] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI069058 (to P. J. J.). This work was also supported by a postdoctoral fellowship from the American Cancer Society and a travel grant from Boehringer Ingelheim Fonds (to C. M. R.). The Mass Spectrometry facility at the College of Life Sciences, University of Dundee, is supported by Wellcome Trust Strategic Award 083481.; Supported by Wellcome Trust Grant 085622 and a grant from the Medical Research Council, United Kingdom.	AKHER MA, 1953, NATURE, V171, P474; Alderete JF, 2001, CELL MICROBIOL, V3, P359, DOI 10.1046/j.1462-5822.2001.00126.x; Bastida-Corcuera FD, 2005, EUKARYOT CELL, V4, P1951, DOI 10.1128/EC.4.11.1951-1958.2005; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; CHOROMANSKI L, 1985, Z PARASITENKD, V71, P443, DOI 10.1007/BF00928347; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; COSTELLO CE, 1993, GLYCOBIOLOGY, V3, P261, DOI 10.1093/glycob/3.3.261; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; de Miguel N, 2010, MOL CELL PROTEOMICS, V9, P1554, DOI 10.1074/mcp.M000022-MCP201; Ferguson M. A. J., 1992, LIPID MODIFICATION P, P191; FERGUSON MAJ, 1993, BIOCHEM J, V291, P51, DOI 10.1042/bj2910051; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; GARDNER WA, 1986, ARCH PATHOL LAB MED, V110, P430; Gilbert RO, 2000, INFECT IMMUN, V68, P4200, DOI 10.1128/IAI.68.7.4200-4206.2000; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hirt RP, 2007, TRENDS PARASITOL, V23, P540, DOI 10.1016/j.pt.2007.08.020; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Lloyd GL, 2003, J UROLOGY, V170, P924, DOI 10.1097/01.ju.0000080375.18547.cc; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; MCCONVILLE MJ, 1987, P NATL ACAD SCI USA, V84, P8941, DOI 10.1073/pnas.84.24.8941; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MCCONVILLE MJ, 1995, BIOCHEM J, V310, P807, DOI 10.1042/bj3100807; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; MINKOFF H, 1984, AM J OBSTET GYNECOL, V150, P965, DOI 10.1016/0002-9378(84)90392-2; Moody-Haupt S, 2000, J MOL BIOL, V297, P409, DOI 10.1006/jmbi.2000.3577; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; Singh BN, 2009, GLYCOCONJUGATE J, V26, P3, DOI 10.1007/s10719-008-9157-1; SINGH BN, 1994, ARCH BIOCHEM BIOPHYS, V309, P273, DOI 10.1006/abbi.1994.1113; SINGH BN, 1993, MOL BIOCHEM PARASIT, V57, P281, DOI 10.1016/0166-6851(93)90204-B; SINGH BN, 1994, PARASITOL TODAY, V10, P152, DOI 10.1016/0169-4758(94)90267-4; Singh BN, 1999, INFECT IMMUN, V67, P3847, DOI 10.1128/IAI.67.8.3847-3854.1999; Soper D, 2004, AM J OBSTET GYNECOL, V190, P281, DOI 10.1016/j.ajog.2003.08.023; Sorvillo F, 1998, LANCET, V351, P213, DOI 10.1016/S0140-6736(05)78181-2; Sutcliffe S, 2006, CANCER EPIDEM BIOMAR, V15, P939, DOI 10.1158/1055-9965.EPI-05-0781; TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.mi.46.100192.000433; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; WARTON A, 1983, Z PARASITENKD, V69, P149, DOI 10.1007/BF00926951; WARTON A, 1988, J ELECTRON MICROSC, V37, P134; WARTON A, 1980, J PROTOZOOL, V27, P410, DOI 10.1111/j.1550-7408.1980.tb05386.x; Wilson IBH, 2004, CELL MOL LIFE SCI, V61, P794, DOI 10.1007/s00018-003-3278-2; World Health Organization, 1996, SEX TRANSM DIS STDS; YAP EH, 1995, GENITOURIN MED, V71, P402; ZHANG ZF, 1994, INT J EPIDEMIOL, V23, P682, DOI 10.1093/ije/23.4.682	46	28	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40494	40508		10.1074/jbc.M111.280578	http://dx.doi.org/10.1074/jbc.M111.280578			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21900246	Green Published, hybrid			2022-12-27	WOS:000297315400009
J	Gorleku, OA; Barns, AM; Prescott, GR; Greaves, J; Chamberlain, LH				Gorleku, Oforiwa A.; Barns, Anna-Marie; Prescott, Gerald R.; Greaves, Jennifer; Chamberlain, Luke H.			Endoplasmic Reticulum Localization of DHHC Palmitoyltransferases Mediated by Lysine-based Sorting Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; PROTEIN PALMITOYLATION; SACCHAROMYCES-CEREVISIAE; MEMBRANE INTERACTIONS; STRING PROTEIN; TRANSFERASES; RAS; PATHWAY; SNAP25; YEAST	Intracellular palmitoylation dynamics are regulated by a family of 24 DHHC (aspartate-histidine-histidine-cysteine) palmitoyltransferases, which are localized in a compartment-specific manner. The majority of DHHC proteins localize to endoplasmic reticulum (ER) and Golgi membranes, and a small number target to post-Golgi membranes. To date, there are no reports of the fine mapping of sorting signals in mammalian DHHC proteins; thus, it is unclear how spatial distribution of the DHHC family is achieved. Here, we have identified and characterized lysine-based sorting signals that determine the restricted localization of DHHC4 and DHHC6 to ER membranes. The ER targeting signal in DHHC6 conforms to a KKXX motif, whereas the signal in DHHC4 is a distinct KXX motif. The identified dilysine signals are sufficient to specify ER localization as adding the C-terminal pentapeptide sequences from DHHC4 or DHHC6, which contain these KXX and KKXX motifs, to the C terminus of DHHC3, redistributes this palmitoyltransferase from Golgi to ER membranes. Recent work proposed that palmitoylation of newly synthesized peripheral membrane proteins occurs predominantly at the Golgi. Indeed, previous analyses of the peripheral membrane proteins, SNAP25 and cysteine string protein, are fully consistent with their initial palmitoylation being mediated by Golgi-localized DHHC proteins. Interestingly, ER-localized DHHC3 is able to palmitoylate SNAP25 and cysteine string protein to a similar level as wild-type Golgi-localized DHHC3 in co-expression studies. These results suggest that targeting of intrinsically active DHHC proteins to defined membrane compartments is an important factor contributing to spatially restricted patterns of substrate palmitoylation.	[Gorleku, Oforiwa A.; Barns, Anna-Marie; Greaves, Jennifer; Chamberlain, Luke H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland; [Prescott, Gerald R.] Univ St Andrews, Sch Biol, St Andrews KY16 9TF, Fife, Scotland	University of Strathclyde; University of St Andrews	Chamberlain, LH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	Luke.Chamberlain@strath.ac.uk		Greaves, Jennifer/0000-0001-8445-789X	United Kingdom Medical Research Council; MRC [G0601597] Funding Source: UKRI; Medical Research Council [G0601597] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a senior non-clinical fellowship award from the United Kingdom Medical Research Council (to L. H. C.).	Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Girotti M, 1996, J CELL SCI, V109, P2915; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Greaves J, 2011, MOL BIOL CELL, V22, P1887, DOI 10.1091/mbc.E10-11-0924; Greaves J, 2011, J CELL SCI, V124, P1351, DOI 10.1242/jcs.079095; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Hannoush AN, 2010, NAT CHEM BIOL, V6, P498, DOI [10.1038/NCHEMBIO.388, 10.1038/nchembio.388]; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Lemale J, 2008, BBA-MOL CELL RES, V1783, P2234, DOI 10.1016/j.bbamcr.2008.07.023; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Palmer ZJ, 2008, BIOCHEM J, V413, P479, DOI 10.1042/BJ20080069; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200	38	50	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39573	39584		10.1074/jbc.M111.272369	http://dx.doi.org/10.1074/jbc.M111.272369			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21926431	Green Published, hybrid			2022-12-27	WOS:000296759800074
J	Kinlough, CL; Poland, PA; Gendler, SJ; Mattila, PE; Mo, D; Weisz, OA; Hughey, RP				Kinlough, Carol L.; Poland, Paul A.; Gendler, Sandra J.; Mattila, Polly E.; Mo, Di; Weisz, Ora A.; Hughey, Rebecca P.			Core-glycosylated Mucin-like Repeats from MUC1 Are an Apical Targeting Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED MDCK CELLS; BIOSYNTHETIC-PATHWAY; EPITHELIAL-CELLS; BREAST-CANCER; TANDEM REPEAT; O-GLYCAN; HT-29 CELLS; MEMBRANE; PROTEINS; LOCALIZATION	MUC1 is efficiently delivered to the apical surface of polarized Madin-Darby canine kidney (MDCK) cells by transit through apical recycling endosomes, a route associated with delivery of apical proteins with glycan-dependent targeting signals. However, a role for glycans in MUC1 sorting has not been established. A key feature of MUC1 is a heavily O-glycosylated mucin-like domain with a variable number of nearly perfect tandem repeats and adjacent imperfect repeats. Metabolic labeling, cell surface biotinylation, immobilized lectins, and confocal immunofluorescence microscopy were used to characterize the polarized delivery of MUC1 mutants and chimeras in MDCK cells to identify the apical targeting signal. Both the interleukin-2 receptor alpha subunit (Tac) and a chimera where the Tac ectodomain replaced that of MUC1 were delivered primarily to the basolateral surface. Attachment of the MUC1 mucin-like domain to the N terminus of Tac enhanced apical but not basolateral delivery when compared with Tac. Conversely, deletions within the mucin-like domain in MUC1 reduced apical but not basolateral delivery when compared with MUC1. In pull-down assays with lectins, we found a notable difference in the presence of core 1 O-glycans, but not poly-N-acetyllactosamine, in apically targeted MUC1 and chimeras when compared with Tac. Consistent with these data, we found no effect on MUC1 targeting when galectin-3, with preference for poly-N-acetyllactosamine, was depleted from polarized MDCK cells. However, we did block the apical targeting activity of the mucin-like repeats when we over expressed CMP-Neu5Ac:GalNAc-R alpha 2,6-sialyltransferase-1 to block core O-glycan synthesis. The cumulative data indicate that the core-glycosylated mucin-like repeats of MUC1 constitute an apical targeting signal.	[Kinlough, Carol L.; Poland, Paul A.; Mattila, Polly E.; Mo, Di; Weisz, Ora A.; Hughey, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Gendler, Sandra J.] Mayo Clin Scottsdale, Mayo Clin Coll Med, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; [Gendler, Sandra J.] Mayo Clin Scottsdale, Mayo Clin Coll Med, Tumor Biol Program, Scottsdale, AZ 85259 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Hughey, RP (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, S933 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hugheyr@pitt.edu			National Institutes of Health [DK54787, DK054407, CA64389, P30 DK079307]; Genzyme Renal Innovations Program; NRSA [F32DK082109]; NATIONAL CANCER INSTITUTE [R01CA064389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054787, P30DK079307, F32DK082109, R01DK054407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Renal Innovations Program(Sanofi-AventisGenzyme Corporation); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54787 (to R. P. H.), DK054407 (to O. A. W.), CA64389 (to S. J. G.) and P30 DK079307 (Pittsburgh Center for Kidney Research Core C). This work was also supported by the Genzyme Renal Innovations Program (to R. P. H.).; Supported by individual NRSA F32DK082109.	Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Cramm-Behrens CI, 2008, TRAFFIC, V9, P2206, DOI 10.1111/j.1600-0854.2008.00829.x; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2003, J BIOL CHEM, V278, P37799, DOI 10.1074/jbc.M305755200; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Folsch H, 2009, TRAFFIC, V10, P972, DOI 10.1111/j.1600-0854.2009.00927.x; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Guerriero CJ, 2008, J BIOL CHEM, V283, P18040, DOI 10.1074/jbc.M802048200; Hanisch FG, 2000, GLYCOBIOLOGY, V10, P439, DOI 10.1093/glycob/10.5.439; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Huet G, 1998, J CELL BIOL, V141, P1311, DOI 10.1083/jcb.141.6.1311; Jacob R, 2000, J BIOL CHEM, V275, P6566, DOI 10.1074/jbc.275.9.6566; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; Kinlough CL, 2006, J BIOL CHEM, V281, P12112, DOI 10.1074/jbc.M512996200; Kinlough CL, 2004, J BIOL CHEM, V279, P53071, DOI 10.1074/jbc.M409360200; Kohlgraf KG, 2003, CANCER RES, V63, P5011; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee SH, 2010, J BIOL CHEM, V285, P37683, DOI 10.1074/jbc.M110.162735; Marcos Nuno T, 2011, Front Biosci (Elite Ed), V3, P1443; Mattila PE, 2009, BIOL CHEM, V390, P551, DOI 10.1515/BC.2009.088; MCGUCKIN MA, 1995, HUM PATHOL, V26, P432, DOI 10.1016/0046-8177(95)90146-9; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Mo D, 2010, AM J PHYSIOL-RENAL, V299, pF1178, DOI 10.1152/ajprenal.00152.2010; Muller S, 1997, J BIOL CHEM, V272, P24780, DOI 10.1074/jbc.272.40.24780; Muller S, 1999, J BIOL CHEM, V274, P18165, DOI 10.1074/jbc.274.26.18165; PARCZYK K, 1991, FEBS LETT, V278, P267, DOI 10.1016/0014-5793(91)80132-M; Pemberton LF, 1996, J BIOL CHEM, V271, P2332, DOI 10.1074/jbc.271.4.2332; Poland PA, 1997, GLYCOCONJUGATE J, V14, P89, DOI 10.1023/A:1018569100438; Poland PA, 2011, J BIOL CHEM, V286, P6780, DOI 10.1074/jbc.M110.179002; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Potter BA, 2004, MOL BIOL CELL, V15, P1407, DOI 10.1091/mbc.E03-08-0550; Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929	44	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39072	39081		10.1074/jbc.M111.289504	http://dx.doi.org/10.1074/jbc.M111.289504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937430	Green Published, hybrid			2022-12-27	WOS:000296759800026
J	Morgan, JL; Song, YJ; Barbar, E				Morgan, Jessica L.; Song, Yujuan; Barbar, Elisar			Structural Dynamics and Multiregion Interactions in Dynein-Dynactin Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN BINDS; CYTOPLASMIC DYNEIN; INTERMEDIATE-CHAIN; SECONDARY STRUCTURE; GENETIC-ANALYSIS; PROTEIN; LC8; PREDICTION; COMPLEX; DROSOPHILA	Cytoplasmic dynein is a 1.2-MDa multisubunit motor protein complex that, together with its activator dynactin, is responsible for the majority of minus end microtubule-based motility. Dynactin targets dynein to specific cellular locations, links dynein to cargo, and increases dynein processivity. These two macromolecular complexes are connected by a direct interaction between dynactin's largest subunit, p150(Glued), and dynein intermediate chain (IC) subunit. Here, we demonstrate using NMR spectroscopy and isothermal titration calorimetry that the binding footprint of p150(Glued) on IC involves two noncontiguous recognition regions, and both are required for full binding affinity. In apo-IC, the helical structure of region 1, the nascent helix of region 2, and the disorder in the rest of the chain are determined from coupling constants, amide-amide sequential NOEs, secondary chemical shifts, and various dynamics measurements. When bound to p150(Glued), different patterns of spectral exchange broadening suggest that region 1 forms a coiled-coil and region 2 a packed stable helix, with the intervening residues remaining disordered. In the 150-kDa complex of p150(Glued), IC, and two light chains, the noninterface segments remain disordered. The multiregion IC binding interface, the partial disorder of region 2 and its potential for post-translational modification, and the modulation of the length of the longer linker by alternative splicing may provide a basis for elegant and multifaceted regulation of binding between IC and p150(Glued). The long disordered linker between the p150(Glued) binding segments and the dynein light chain consensus sequences could also provide an attractive recognition platform for diverse cargoes.	[Morgan, Jessica L.; Song, Yujuan; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu		Barbar, Elisar/0000-0003-4892-5259; Morgan, Jessica/0000-0001-5532-9864	National Science Foundation [MCB 0818896]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 0818896.	Barbar E, 2001, BIOCHEMISTRY-US, V40, P1596, DOI 10.1021/bi002278+; Benison G, 2007, J MAGN RESON, V189, P173, DOI 10.1016/j.jmr.2007.09.009; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Boylan K, 2000, MOL BIOL CELL, V11, P3791, DOI 10.1091/mbc.11.11.3791; Boylan KLM, 2002, GENETICS, V162, P1211; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COLLINS CA, 1989, CELL MOTIL CYTOSKEL, V14, P491, DOI 10.1002/cm.970140407; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103	51	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39349	39359		10.1074/jbc.M111.296277	http://dx.doi.org/10.1074/jbc.M111.296277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21931160	hybrid, Green Published			2022-12-27	WOS:000296759800053
J	Hashizume, R; Maki, Y; Mizutani, K; Takahashi, N; Matsubara, H; Sugita, A; Sato, K; Yamaguchi, S; Mikami, B				Hashizume, Ryota; Maki, Yukiko; Mizutani, Kimihiko; Takahashi, Nobuyuki; Matsubara, Hiroyuki; Sugita, Akiko; Sato, Kimihiko; Yamaguchi, Shotaro; Mikami, Bunzo			Crystal Structures of Protein Glutaminase and Its Pro Forms Converted into Enzyme-Substrate Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRYSEOBACTERIUM-PROTEOLYTICUM; FUNCTIONAL-PROPERTIES; SECONDARY-STRUCTURE; FOOD PROTEINS; DEAMIDATION; PROGRAM; TRANSGLUTAMINASE; MOLSCRIPT	Protein glutaminase, which converts a protein glutamine residue to a glutamate residue, is expected to be useful as a new food-processing enzyme. The crystal structures of the mature and pro forms of the enzyme were refined at 1.15 and 1.73 angstrom resolution, respectively. The overall structure of the mature enzyme has a weak homology to the core domain of human transglutaminase-2. The catalytic triad (Cys-His-Asp) common to transglutaminases and cysteine proteases is located in the bottom of the active site pocket. The structure of the recombinant pro form shows that a short loop between S2 and S3 in the proregion covers and interacts with the active site of the mature region, mimicking the protein substrate of the enzyme. Ala-47 is located just above the pocket of the active site. Two mutant structures (A47Q-1 and A47Q-2) refined at 1.5 angstrom resolution were found to correspond to the enzyme-substrate complex and an S-acyl intermediate. Based on these structures, the catalytic mechanism of protein glutaminase is proposed.	[Hashizume, Ryota; Maki, Yukiko; Mizutani, Kimihiko; Takahashi, Nobuyuki; Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Div Appl Life Sci, Grad Sch Agr, Kyoto 6110011, Japan; [Matsubara, Hiroyuki; Sugita, Akiko; Sato, Kimihiko; Yamaguchi, Shotaro] Amano Enzyme Inc, Gifu R&D Ctr, Gifu 5090108, Japan	Kyoto University	Mikami, B (corresponding author), Kyoto Univ, Lab Appl Struct Biol, Div Appl Life Sci, Grad Sch Agr, Kyoto 6110011, Japan.	mikami@kais.kyoto-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; GILL BP, 1985, IRISH J FOOD SCI TEC, V9, P33; Gu YS, 2001, J AGR FOOD CHEM, V49, P5999, DOI 10.1021/jf010287z; HAMADA JS, 1994, CRIT REV FOOD SCI, V34, P283, DOI 10.1080/10408399409527664; HAMADA JS, 1988, J FOOD SCI, V53, P671, DOI 10.1111/j.1365-2621.1988.tb07788.x; HAMADA JS, 1992, J AGR FOOD CHEM, V40, P719, DOI 10.1021/jf00017a003; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAMPHUIS IG, 1985, J MOL BIOL, V182, P317, DOI 10.1016/0022-2836(85)90348-1; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; Katona G, 2002, J BIOL CHEM, V277, P21962, DOI 10.1074/jbc.M200676200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumeta H, 2010, J BIOMOL NMR, V46, P251, DOI 10.1007/s10858-010-9399-7; LARRE C, 1994, J FOOD BIOCHEM, V17, P267; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEDERSEN LC, 1994, PROTEIN SCI, V3, P1131, DOI 10.1002/pro.5560030720; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Riha WE, 1996, CRIT REV FOOD SCI, V36, P225, DOI 10.1080/10408399609527724; Scheuplein RJ, 2007, REGUL TOXICOL PHARM, V49, P79, DOI 10.1016/j.yrtph.2007.06.001; Schwenke K.D., 2017, FOOD PROTEINS THEIR, P393; SHELDRICK G, 1984, ACTA CRYSTALLOGR A, V40, pC440, DOI 10.1107/S010876738408702X; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Tanabe S, 1996, BIOCHEM BIOPH RES CO, V219, P290, DOI 10.1006/bbrc.1996.0225; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Thornton J. M., 1993, J APPL CRYSTALLOGR, V26, P283; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Yamaguchi S, 2001, EUR J BIOCHEM, V268, P1410, DOI 10.1046/j.1432-1327.2001.02019.x; Yamaguchi S, 2000, APPL ENVIRON MICROB, V66, P3337, DOI 10.1128/AEM.66.8.3337-3343.2000; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yong YH, 2004, J AGR FOOD CHEM, V52, P7094, DOI 10.1021/jf040133u; Yong YH, 2006, J AGR FOOD CHEM, V54, P6034, DOI 10.1021/jf060344u; Zayas J.F.., 1997, FUNCTIONALITY PROTEI, DOI [10.1007/978-3-642-59116-7_2, DOI 10.1007/978-3-642-59116-7_2]	43	19	20	9	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38691	38702		10.1074/jbc.M111.255133	http://dx.doi.org/10.1074/jbc.M111.255133			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21926168	hybrid, Green Published			2022-12-27	WOS:000296594200081
J	Jankowitsch, F; Kuhm, C; Kellner, R; Kalinowski, J; Pelzer, S; Macheroux, P; Mack, M				Jankowitsch, Frank; Kuehm, Christian; Kellner, Roland; Kalinowski, Joern; Pelzer, Stefan; Macheroux, Peter; Mack, Matthias			A Novel N,N-8-Amino-8-demethyl-D-riboflavin Dimethyltransferase (RosA) Catalyzing the Two Terminal Steps of Roseoflavin Biosynthesis in Streptomyces davawensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC ROSEOFLAVIN; BACILLUS-SUBTILIS; CONJUGAL TRANSFER; RIBOFLAVIN; DNA; METHYLTRANSFERASES; METHYLATION; EXPRESSION; RESISTANCE	Streptomyces davawensis synthesizes the antibiotic roseoflavin (RoF) (8-dimethylamino-8-demethyl-D-riboflavin). It was postulated that RoF is synthesized from riboflavin via 8-amino( AF) and 8-methylamino-8-demethyl-D-riboflavin (MAF). In a cell-free extract of S. davawensis, an S-adenosyl methionine-dependent conversion of AF into MAF and RoF was observed. The corresponding N,N-8-amino-8-demethyl-D-riboflavin dimethyltransferase activity was enriched by column chromatography. The final most active fraction still contained at least five different proteins that were analyzed by enzymatic digestion and concomitant de novo sequencing by MS/MS. One of the sequences matched a hypothetical peptide fragment derived from an as yet uncharacterized open reading frame (sda77220) located in the middle of a (putative) gene cluster within the S. davawensis genome. Expression of ORF sda77220 in Escherichia coli revealed that the corresponding gene product had N,N-8-amino-8-demethyl-D-riboflavin dimethyltransferase activity. Inactivation of ORF sda77220 led to a S. davawensis strain that synthesized AF but not MAF or RoF. Accordingly, as the first identified gene of RoF biosynthesis, ORF sda77220 was named rosA. RosA (347 amino acids; 38 kDa) was purified from a recombinant E. coli strain (as a His(6)-tagged protein) and was biochemically characterized (apparent K-m for AF = 57.7 +/- 9.2 mu M; apparent K-D for AF = 10.0 mu M; k(cat) = 0.37 +/- 0.02 s(-1)). RosA is a unique enzyme and may be useful for a variety of applications.	[Jankowitsch, Frank; Kuehm, Christian; Mack, Matthias] Mannheim Univ Appl Sci, Inst Tech Microbiol, Dept Biotechnol, D-68163 Mannheim, Germany; [Kellner, Roland] Merck Serono, Dept Prot & Cell Sci, D-64271 Darmstadt, Germany; [Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol CeBiTec, D-33615 Bielefeld, Germany; [Pelzer, Stefan] BRAIN AG, D-64723 Zwingenberg, Germany; [Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Merck KGaA; EMD Serono Inc.; University of Bielefeld; Graz University of Technology	Mack, M (corresponding author), Mannheim Univ Appl Sci, Inst Tech Microbiol, Dept Biotechnol, Paul Wittsack Str 10, D-68163 Mannheim, Germany.	m.mack@hs-mannheim.de	Macheroux, Peter/AAB-5157-2019; Mack, Matthias/AAB-8660-2022	Macheroux, Peter/0000-0002-0242-454X; Mack, Matthias/0000-0002-7753-2422	Anneliese Konanz-Stiftung; German Federal Ministry of Education and Research	Anneliese Konanz-Stiftung; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Anneliese Konanz-Stiftung and the German Federal Ministry of Education and Research.	Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Blaesing F, 2005, J BIOTECHNOL, V120, P146, DOI [10.1016/j.jbiotec.2005.06.023, 10.1016/j.biotec.2005.06.023]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen HW, 2002, BIOCHEMISTRY-US, V41, P9165, DOI 10.1021/bi020245j; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Grill S, 2008, J BACTERIOL, V190, P1546, DOI 10.1128/JB.01586-07; Grill S, 2007, ARCH MICROBIOL, V188, P377, DOI 10.1007/s00203-007-0258-1; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; JURI N, 1987, J BIOCHEM-TOKYO, V101, P705, DOI 10.1093/jb/101.3.705; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kieser T, 2000, PRACTICAL STREPTOMYC, P168; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; Lee ER, 2009, RNA BIOL, V6, P187, DOI 10.4161/rna.6.2.7727; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; MANSJO M, 2011, RNA BIOL IN PRESS, V8; Mast YJ, 2011, J BIOTECHNOL, V155, P63, DOI 10.1016/j.jbiotec.2010.12.001; MATSUI K, 1979, J BIOCHEM-TOKYO, V86, P167; Ostash B, 2009, BIOCHEMISTRY-US, V48, P8830, DOI 10.1021/bi901018q; OTANI S, 1974, J ANTIBIOT, V27, P88, DOI 10.7164/antibiotics.27.88; Otani S, 1980, Methods Enzymol, V66, P235; Otani Shohei, 1997, Osaka City Medical Journal, V43, P107; Ott E, 2009, RNA BIOL, V6, P276, DOI 10.4161/rna.6.3.8342; Sambrook J., 2002, MOL CLONING LAB MANU; STROHL WR, 1992, NUCLEIC ACIDS RES, V20, P961, DOI 10.1093/nar/20.5.961; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; Vogl C, 2007, J BACTERIOL, V189, P7367, DOI 10.1128/JB.00590-07; WALSH C, 1978, BIOCHEMISTRY-US, V17, P1942, DOI 10.1021/bi00603a022; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199; ZALACAIN M, 1989, J BACTERIOL, V171, P4254, DOI 10.1128/JB.171.8.4254-4260.1989	33	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38275	38285		10.1074/jbc.M111.292300	http://dx.doi.org/10.1074/jbc.M111.292300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911488	Green Published, hybrid			2022-12-27	WOS:000296594200041
J	Kawai, F; Grass, S; Kim, Y; Choi, KJ; St Geme, JW; Yeo, HJ				Kawai, Fumihiro; Grass, Susan; Kim, Youngchang; Choi, Kyoung-Jae; St Geme, Joseph W., III; Yeo, Hye-Jeong			Structural Insights into the Glycosyltransferase Activity of the Actinobacillus pleuropneumoniae HMW1C-like Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; O-GLCNAC TRANSFERASE; 2-PARTNER SECRETION; CRYSTAL-STRUCTURE; HMW1 ADHESIN; GLYCOGEN-SYNTHASE; SUBSTRATE-BINDING; FAMILY; GLYCOSYLATION; IDENTIFICATION	Glycosylation of proteins is a fundamental process that influences protein function. The Haemophilus influenzae HMW1 adhesin is an N-linked glycoprotein that mediates adherence to respiratory epithelium, an essential early step in the pathogenesis of H. influenzae disease. HMW1 is glycosylated by HMW1C, a novel glycosyltransferase in the GT41 family that creates N-glycosidic linkages with glucose and galactose at asparagine residues and di-glucose linkages at sites of glucose modification. Here we report the crystal structure of Actinobacillus pleuropneumoniae HMW1C (ApHMW1C), a functional homolog of HMW1C. The structure of ApHMW1C contains an N-terminal all alpha-domain (AAD) fold and a C-terminal GT-B fold with two Rossmann-like domains and lacks the tetratricopeptide repeat fold characteristic of the GT41 family. The GT-B fold harbors the binding site for UDP-hexose, and the interface of the AAD fold and the GT-B fold forms a unique groove with potential to accommodate the acceptor protein. Structure-based functional analyses demonstrated that the HMW1C protein shares the same structure as ApHMW1C and provided insights into the unique bi-functional activity of HMW1C and ApHMW1C, suggesting an explanation for the similarities and differences of the HMW1C-like proteins compared with other GT41 family members.	[Kawai, Fumihiro; Choi, Kyoung-Jae; Yeo, Hye-Jeong] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Grass, Susan; St Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Grass, Susan; St Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Kim, Youngchang] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	University of Houston System; University of Houston; Duke University; Duke University; United States Department of Energy (DOE); Argonne National Laboratory	Yeo, HJ (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	hyeo@uh.edu	Kawai, Fumihiro/O-2712-2018	Kim, Youngchang/0000-0002-1610-4889; Choi, Kyoungjae/0000-0001-9541-4182; Kawai, Fumihiro/0000-0003-0909-0789	National Institutes of Health from the Welch Foundation [AI068943, E-1616]; National Institutes of Health [R01-DC02873]; U.S. Dept. of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002873] Funding Source: NIH RePORTER	National Institutes of Health from the Welch Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant AI068943 and Grant E-1616 from the Welch Foundation (to H.-J. Y.) and by National Institutes of Health Grant R01-DC02873 (to J. W. S.).; Results shown in this report are derived from work performed at the Argonne National Laboratory, Structural Biology Center (19ID) at the Advanced Photon Source. Argonne is operated by the University of Chicago, Argonne, LLC, for the U.S. Dept. of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; BARENKAMP SJ, 1994, INFECT IMMUN, V62, P3320, DOI 10.1128/IAI.62.8.3320-3328.1994; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Buscher AZ, 2006, MOL MICROBIOL, V61, P470, DOI 10.1111/j.1365-2958.2006.05236.x; Buscher AZ, 2004, J BACTERIOL, V186, P4209, DOI 10.1128/JB.186.13.4209-4217.2004; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Charbonneau ME, 2007, J BACTERIOL, V189, P8880, DOI 10.1128/JB.00969-07; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleckenstein JM, 2006, INFECT IMMUN, V74, P2245, DOI 10.1128/IAI.74.4.2245-2258.2006; Geme JWS, 2009, TRENDS MICROBIOL, V17, P355, DOI 10.1016/j.tim.2009.06.002; Geme JWS, 1998, MOL MICROBIOL, V27, P617; Grass S, 2000, MOL MICROBIOL, V36, P55, DOI 10.1046/j.1365-2958.2000.01812.x; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Liu F, 2006, J BIOL CHEM, V281, P20902, DOI 10.1074/jbc.M602972200; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Murray BW, 1997, BIOCHEMISTRY-US, V36, P823, DOI 10.1021/bi962284z; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nelson KM, 2001, INFECT IMMUN, V69, P6201, DOI 10.1128/IAI.69.10.6201-6208.2001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Ruane KM, 2008, PROTEINS, V73, P784, DOI 10.1002/prot.22171; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; STGEME JW, 1993, P NATL ACAD SCI USA, V90, P2875, DOI 10.1073/pnas.90.7.2875; STGEME JW, 1993, INFECT AGENT DIS, V2, P1; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195	44	42	43	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38546	38557		10.1074/jbc.M111.237602	http://dx.doi.org/10.1074/jbc.M111.237602			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908603	hybrid, Green Published			2022-12-27	WOS:000296594200068
J	Montalbetti, N; Denis, MFL; Pignataro, OP; Kobatake, E; Lazarowski, ER; Schwarzbaum, PJ				Montalbetti, Nicolas; Denis, Maria F. Leal; Pignataro, Omar P.; Kobatake, Eiry; Lazarowski, Eduardo R.; Schwarzbaum, Pablo J.			Homeostasis of Extracellular ATP in Human Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEYDIG-CELL STEROIDOGENESIS; SIGNAL-TRANSDUCTION PATHWAY; RED-BLOOD-CELLS; PROTEIN A-LUCIFERASE; GOLDFISH HEPATOCYTES; RECEPTOR SUBTYPES; ADENINE-NUCLEOTIDES; ENDOTHELIAL-CELLS; P2X(7) RECEPTOR; VOLUME CHANGES	We explored the intra- and extracellular processes governing the kinetics of extracellular ATP (ATPe) in human erythrocytes stimulated with agents that increase cAMP. Using the luciferin-luciferase reaction in off-line luminometry we found both direct adenylyl cyclase activation by forskolin and indirect activation through beta-adrenergic stimulation with isoproterenol-enhanced [ATP]e in a concentration-dependent manner. A mixture (3V) containing a combination of these agents and the phosphodiesterase inhibitor papaverine activated ATP release, leading to a 3-fold increase in [ATP]e, and caused increases in cAMP concentration (3-fold for forskolin + papaverine, and 10-fold for 3V). The pannexin 1 inhibitor carbenoxolone and a pannexin 1 blocking peptide ((10)Panx1) decreased [ATP]e by 75-84%. The residual efflux of ATP resulted from unavoidable mechanical perturbations stimulating a novel, carbenoxolone-insensitive pathway. In real-time luminometry experiments using soluble luciferase, addition of 3V led to an acute increase in [ATP]e to a constant value of similar to 1 pmol x (10(6) cells)(-1). A similar treatment using a surface attached luciferase (proA-luc) triggered a rapid accumulation of surface ATP levels to a peak concentration of 2.4 pmol x (10(6) cells)(-1), followed by a slower exponential decay (t(1/2) = 3.7 min) to a constant value of 1.3 pmol x (10(6) cells)(-1). Both for soluble luciferase and proA-luc, ATP efflux was fully blocked by carbenoxolone, pointing to a 3V-induced mechanism of ATP release mediated by pannexin 1. Ecto-ATPase activity was extremely low (similar to 28 fmol x (10(6) cells min)(-1)), but nevertheless physiologically relevant considering the high density of erythrocytes in human blood.	[Schwarzbaum, Pablo J.] Univ Buenos Aires, Fac Farm & Bioquim, Sch Pharm & Biochem, Dept Biol Chem,IQUIFIB, Buenos Aires, DF, Argentina; [Pignataro, Omar P.] Univ Buenos Aires, Sch Sci, Dept Biol Chem, Buenos Aires, DF, Argentina; [Pignataro, Omar P.] Inst Biol & Expt Med CONICET, Lab Mol Endocrinol & Signal Transduct, RA-1428 Buenos Aires, DF, Argentina; [Kobatake, Eiry] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Lazarowski, Eduardo R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Tokyo Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill	Schwarzbaum, PJ (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Sch Pharm & Biochem, Dept Biol Chem,IQUIFIB, Junin 956,C1113AAD, Buenos Aires, DF, Argentina.	pjs@qb.ffyb.uba.ar	Montalbetti, Nicolas/T-4212-2019	Montalbetti, Nicolas/0000-0003-2897-9540; schwarzbaum, pablo/0000-0002-5176-089X; Leal Denis, Florencia/0000-0002-6209-4378	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 1187]; Secretaria de Ciencia y Tecnica; Universidad de Buenos Aires [20020100100090]; Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina [0151]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina(ANPCyT)	This work was supported in part by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant PIP 1187, Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires Grant 20020100100090, and Agencia Nacional de Promocion Cientifica y Tecnologica Grant 0151 of Argentina.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Bencic DC, 1997, PHYSIOL ZOOL, V70, P621, DOI 10.1086/515873; Brown A. M, 1980, RED CELL MEMBRANES M, P223; Burnstock G, 2008, PHARMACOL REP, V60, P12; Chara O, 2009, B MATH BIOL, V71, P1025, DOI 10.1007/s11538-008-9392-4; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; DelPunta K, 1996, ENDOCRINOLOGY, V137, P5337, DOI 10.1210/en.137.12.5337; Ebihara T, 2002, BIOTECHNOL LETT, V24, P147, DOI 10.1023/A:1013858814175; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; EYLAR EH, 1962, J BIOL CHEM, V237, P1992; Gheorghiu M, 2004, EUR BIOPHYS J BIOPHY, V33, P412, DOI 10.1007/s00249-003-0375-y; Gorman MW, 2007, CLIN CHEM, V53, P318, DOI 10.1373/clinchem.2006.076364; Gorman MW, 2003, LUMINESCENCE, V18, P173, DOI 10.1002/bio.721; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hanson MS, 2009, MICROCIRCULATION, V16, P424, DOI 10.1080/10739680902855218; Hategan A, 2004, BIOPHYS J, V87, P3547, DOI 10.1529/biophysj.104.041475; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; Joseph SM, 2003, J BIOL CHEM, V278, P23331, DOI 10.1074/jbc.M302680200; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Kunapuli SP, 1998, BIOCHEM J, V336, P513, DOI 10.1042/bj3360513; KWANT W O, 1970, Journal of General Physiology, V55, P208, DOI 10.1085/jgp.55.2.208; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lecklin T, 2000, J EXP BIOL, V203, P3025; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTHJE J, 1988, EUR J BIOCHEM, V173, P241, DOI 10.1111/j.1432-1033.1988.tb13990.x; Misiti F, 2008, BIOCHEM CELL BIOL, V86, P501, DOI 10.1139/O08-139; Mondillo C, 2005, BIOL REPROD, V73, P899, DOI 10.1095/biolreprod.105.041285; Mondillo C, 2009, BIOL REPROD, V80, P144, DOI 10.1095/biolreprod.108.069484; Olearczyk J J, 2001, Med Sci Monit, V7, P669; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V287, pH748, DOI 10.1152/ajpheart.00161.2004; Olearczyk JJ, 2004, J PHARMACOL EXP THER, V309, P1079, DOI 10.1124/jpet.103.064709; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V286, pH940, DOI 10.1152/ajpheart.00677.2003; Pafundo DE, 2008, AM J PHYSIOL-REG I, V294, pR220, DOI 10.1152/ajpregu.00522.2007; Pafundo DE, 2010, J BIOL CHEM, V285, P6134, DOI 10.1074/jbc.M109.078246; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pirotton S, 1996, J AUTON PHARMACOL, V16, P353, DOI 10.1111/j.1474-8673.1996.tb00052.x; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; REMALEY AT, 1991, J BIOL CHEM, V266, P24176; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Schwarzbaum PJ, 1998, AM J PHYSIOL-REG I, V274, pR1031, DOI 10.1152/ajpregu.1998.274.4.R1031; SCHWARZBAUM PJ, 1995, BBA-BIOMEMBRANES, V1233, P33, DOI 10.1016/0005-2736(94)00229-I; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sevigny J, 1997, BBA-GEN SUBJECTS, V1334, P73, DOI 10.1016/S0304-4165(96)00079-7; SMITH RM, 1991, PURE APPL CHEM, V63, P1015, DOI 10.1351/pac199163071015; Sprague RS, 2008, MICROCIRCULATION, V15, P461, DOI 10.1080/10739680701833804; Sprague RS, 2007, TRENDS ENDOCRIN MET, V18, P350, DOI 10.1016/j.tem.2007.08.008; Sprague RS, 2001, AM J PHYSIOL-CELL PH, V281, pC1158, DOI 10.1152/ajpcell.2001.281.4.C1158; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; STEINER AL, 1969, P NATL ACAD SCI USA, V64, P367, DOI 10.1073/pnas.64.1.367; Strehler B L, 1968, Methods Biochem Anal, V16, P99, DOI 10.1002/9780470110348.ch2; VAZQUEZ A, 1991, J BIOCHEM BIOPH METH, V23, P45, DOI 10.1016/0165-022X(91)90049-3; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Zhang XM, 2000, ANAL BIOCHEM, V282, P65, DOI 10.1006/abio.2000.4584	60	54	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38397	38407		10.1074/jbc.M111.221713	http://dx.doi.org/10.1074/jbc.M111.221713			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21921036	Green Published, hybrid			2022-12-27	WOS:000296594200054
J	Suman, SK; Mishra, A; Ravindra, D; Yeramala, L; Sharma, Y				Suman, Shashi Kumar; Mishra, Amita; Ravindra, Daddali; Yeramala, Lahari; Sharma, Yogendra			Evolutionary Remodeling of beta gamma-Crystallins for Domain Stability at Cost of Ca2+ Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORE COAT PROTEIN; VERTEBRATE EYE LENS; X-RAY-ANALYSIS; MYXOCOCCUS-XANTHUS; GENETICS; RESOLUTION	The topologically similar beta gamma-crystallins that are prevalent in all kingdoms of life have evolved for high innate domain stability to perform their specialized functions. The evolution of stability and its control in beta gamma-crystallins that possess either a canonical (mostly from microorganisms) or degenerate (principally found in vertebrate homologues) Ca2+-binding motif is not known. Using equilibrium unfolding of beta gamma-crystallin domains (26 wildtype domains and their mutants) in apo- and holo-forms, we demonstrate the presence of a stability gradient across these members, which is attained by the choice of residues in the (N/D)(N/D)XX(S/T)S Ca2+-binding motif. The occurrence of a polar, hydrophobic, or Ser residue at the 1st, 3rd, or 5th position of the motif is likely linked to a higher domain stability. Partial conversion of a microbe-type domain (with a canonical Ca2+-binding motif) to a vertebrate-type domain (with a degenerate Ca2+-binding motif) by mutating serine to arginine/lysine disables the Ca2+-binding but significantly augments its stability. Conversely, stability is compromised when arginine (in a vertebrate-type disabled domain) is replaced by serine (as a microbe type). Our results suggest that such conversions were acquired as a strategy for desired stability in vertebrate members at the cost of Ca2+-binding. In a physiological context, we demonstrate that a mutation such as an arginine to serine (R77S) mutation in this motif of gamma-crystallin (partial conversion to microbe-type), implicated in cataracts, decreases the domain stability. Thus, this motif acts as a "central tuning knob" for innate as well as Ca2+-induced gain in stability, incorporating a stability gradient across beta gamma-crystallin members critical for their specialized functions.	[Suman, Shashi Kumar; Mishra, Amita; Ravindra, Daddali; Yeramala, Lahari; Sharma, Yogendra] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sharma, Y (corresponding author), CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	yogendra@ccmb.res.in		SUMAN, Shashi Kumar/0000-0002-7668-5515	Department of Science and Technology (Science and Engineering Research Council); Department of Biotechnology; Department of Biotechnology, India	Department of Science and Technology (Science and Engineering Research Council)(Department of Science & Technology (India)); Department of Biotechnology; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported in part by grants from Department of Science and Technology (Science and Engineering Research Council) and Department of Biotechnology (to Y. S.).; Supported by a postdoctoral fellowship of the Department of Biotechnology, India.	Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Aravind P, 2009, J MOL BIOL, V385, P163, DOI 10.1016/j.jmb.2008.10.035; BAGBY S, 1994, P NATL ACAD SCI USA, V91, P4308, DOI 10.1073/pnas.91.10.4308; Barnwal RP, 2009, J MOL BIOL, V386, P675, DOI 10.1016/j.jmb.2008.12.058; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BLUNDELL T, 1981, NATURE, V289, P771, DOI 10.1038/289771a0; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; Clout NJ, 2000, J MOL BIOL, V304, P253, DOI 10.1006/jmbi.2000.4197; Das P, 2010, PROTEIN SCI, V19, P131, DOI 10.1002/pro.296; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hung HC, 2003, B MATH BIOL, V65, P553, DOI 10.1016/S0092-8240(03)00024-7; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; JAENICKE R, 1994, NATURWISSENSCHAFTEN, V81, P423; KAISER D, 1979, ANNU REV MICROBIOL, V33, P595, DOI 10.1146/annurev.mi.33.100179.003115; Kannabiran C, 2000, Indian J Ophthalmol, V48, P5; Kappe G, 2010, J MOL EVOL, V71, P219, DOI 10.1007/s00239-010-9379-2; Kong FR, 2011, PROTEIN SCI, V20, P513, DOI 10.1002/pro.583; Kretschmar W, 1999, J MOL BIOL, V289, P701, DOI 10.1006/jmbi.1999.2833; LAPATTO R, 1991, J MOL BIOL, V222, P1067, DOI 10.1016/0022-2836(91)90594-V; LUBSEN NH, 1988, PROG BIOPHYS MOL BIO, V51, P47, DOI 10.1016/0079-6107(88)90010-7; Mishra A, 2012, J MOL BIOL, V415, P75, DOI 10.1016/j.jmb.2011.10.037; Pace C N, 1986, Methods Enzymol, V131, P266; Palme S, 1997, PROTEIN SCI, V6, P1529; Roshan M, 2010, MOL VIS, V16, P887; Shimeld SM, 2005, CURR BIOL, V15, P1684, DOI 10.1016/j.cub.2005.08.046; Srivastava AK, 2010, BIOCHEMISTRY-US, V49, P9746, DOI 10.1021/bi101000m; Wenk M, 1999, J MOL BIOL, V293, P117, DOI 10.1006/jmbi.1999.3146; Wenk M, 1998, EUR J BIOCHEM, V255, P604, DOI 10.1046/j.1432-1327.1998.2550604.x; WISTOW G, 1983, J MOL BIOL, V170, P175, DOI 10.1016/S0022-2836(83)80232-0; WISTOW G, 1985, NATURE, V315, P771, DOI 10.1038/315771a0; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403	32	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43891	43901		10.1074/jbc.M111.247890	http://dx.doi.org/10.1074/jbc.M111.247890			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21949186	Green Published, hybrid			2022-12-27	WOS:000298402300030
J	Fujitani, N; Takegawa, Y; Ishibashr, Y; Araki, K; Furukawa, J; Mitsutake, S; Igarashi, Y; Ito, M; Shinohara, Y				Fujitani, Naoki; Takegawa, Yasuhiro; Ishibashr, Yohei; Araki, Kayo; Furukawa, Jun-ichi; Mitsutake, Susumu; Igarashi, Yasuyuki; Ito, Makoto; Shinohara, Yasuro			Qualitative and Quantitative Cellular Glycomics of Glycosphingolipids Based on Rhodococcal Endoglycosylceramidase-assisted Glycan Cleavage, Glycoblotting-assisted Sample Preparation, and Matrix-assisted Laser Desorption Ionization Tandem Time-of-flight Mass Spectrometry Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; SIALIC-ACID; EXPRESSION; TERATOCARCINOMA; ENDOGLYCOCERAMIDASE; ANTIGENS; SERIES; DIFFERENTIATION; SPHINGOLIPIDS; GANGLIOSIDES	Glycosphingolipids (GSLs) are crucially important components of the cellular membrane, where they comprise microdomains with many critical biological functions. Despite this fact, qualitative and quantitative techniques for the analysis of GSLs still lag behind the needs of researchers. In this study, a reliable procedure for the elucidation of cellular GSL-glycomes was established based on (a) enzymatic glycan cleavage by endoglycosylceramidases derived from Rhodococcus sp. in combination with (b) glycoblotting-assisted sample preparation. The mixture of endoglycosylce-ramidase I and II was employed to maximize the release of glycan moieties from the major classes of GSLs (i.e. ganglio-, (neo)lacto- and globo-series GSLs). The glycoblotting technique enabled the quantitative detection of GSL-glycans using as few as 2 x 10(5) cells. Thirty-seven different kinds of cellular GSL glycans were successfully observed in 11 kinds of cells, including Chinese hamster ovary cells and their lectin-resistant mutants as well as murine and human embryonic carcinoma cells. Furthermore, in-depth structural clarification in terms of discrimination of isomers was achieved by MALDI-TOF/TOF mass spectrometry analysis and/or linkage-specific glycosidase digestion. These novel analytical techniques were shown to be capable of delineating cell-specific GSL-glycomes. Thus, they are anticipated to have a broad range of applications for the characterization, description, and comparison of various cellular/tissue samples in the fields of drug discovery and regenerative medicine.	[Fujitani, Naoki; Takegawa, Yasuhiro; Araki, Kayo; Furukawa, Jun-ichi; Shinohara, Yasuro] Hokkaido Univ, Lab Med & Funct Glyc, Grad Sch Adv Life Sci, Sapporo, Hokkaido 0010021, Japan; [Mitsutake, Susumu; Igarashi, Yasuyuki] Hokkaido Univ, Lab Biomembrane & Biofunct Chem, Grad Sch Adv Life Sci, Sapporo, Hokkaido 0010021, Japan; [Mitsutake, Susumu; Igarashi, Yasuyuki] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0010021, Japan; [Ishibashr, Yohei; Ito, Makoto] Kyushu Univ, Lab Marine Resource Chem, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Kyushu University	Shinohara, Y (corresponding author), Hokkaido Univ, Lab Med & Funct Glyc, Grad Sch Adv Life Sci, Sapporo, Hokkaido 0010021, Japan.	yshinohara@sci.hokudai.ac.jp	Ito, Makoto/Q-6164-2019; Mitsutake, Susumu/A-4082-2012; Fujitani, Naoki/A-4072-2012	ito, Makoto/0000-0003-3159-7818; Fujitani, Naoki/0000-0002-4035-7317	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23780344] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	BRILES EB, 1977, J BIOL CHEM, V252, P1107; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; HAKOMORI SI, 1966, J LIPID RES, V7, P789; ITO M, 1989, J BIOL CHEM, V264, P9510; ITO M, 1993, EUR J BIOCHEM, V218, P637, DOI 10.1111/j.1432-1033.1993.tb18417.x; Izu H, 1997, J BIOL CHEM, V272, P19846, DOI 10.1074/jbc.272.32.19846; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KANNAGI R, 1983, BLOOD, V62, P1230; Kawazoe S, 2009, DEV GROWTH DIFFER, V51, P81, DOI 10.1111/j.1440-169X.2008.01082.x; KRUPNICK JG, 1994, INT J CANCER, V59, P692, DOI 10.1002/ijc.2910590518; Lanctot PM, 2007, CURR OPIN CHEM BIOL, V11, P373, DOI 10.1016/j.cbpa.2007.05.032; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; MACHER BA, 1980, J BIOL CHEM, V255, P2092; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Miura Y, 2007, CHEM-EUR J, V13, P4797, DOI 10.1002/chem.200601872; Nakashima N, 2004, BIOTECHNOL BIOENG, V86, P136, DOI 10.1002/bit.20024; Naven TJP, 1996, RAPID COMMUN MASS SP, V10, P1361, DOI 10.1002/(SICI)1097-0231(199608)10:11<1361::AID-RCM642>3.0.CO;2-A; NOJIRI H, 1984, BLOOD, V64, P534; Parry S, 2007, GLYCOBIOLOGY, V17, P646, DOI 10.1093/glycob/cwm024; Rosales, 1997, BIOCHIM BIOPHYS ACTA, V1354, P153; STANLEY P, 1980, ACS SYM SER, V128, P213; Stroud MR, 1996, BIOCHEMISTRY-US, V35, P758, DOI 10.1021/bi951600r; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Uematsu R, 2005, MOL CELL PROTEOMICS, V4, P1977, DOI 10.1074/mcp.M500203-MCP200; Visco V, 2000, HISTOCHEM CELL BIOL, V113, P43, DOI 10.1007/s004180050006; WIEGANDT H, 1970, EUR J BIOCHEM, V15, P287, DOI 10.1111/j.1432-1033.1970.tb01006.x; WILLISON KR, 1982, J IMMUNOL, V129, P603; WILLISON KR, 1978, CELL, V14, P785, DOI 10.1016/0092-8674(78)90334-3; YOGEESWARAN G, 1972, J BIOL CHEM, V247, P5146; Yowler BC, 2001, J LIPID RES, V42, P659; ZHOU B, 1989, J BIOL CHEM, V264, P12272	35	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41669	41679		10.1074/jbc.M111.301796	http://dx.doi.org/10.1074/jbc.M111.301796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965662	Green Published, hybrid			2022-12-27	WOS:000298057500051
J	Schmidt, J; Guillaume, P; Irving, M; Baunngaertner, P; Speiser, D; Luescher, IF				Schmidt, Julien; Guillaume, Philippe; Irving, Melita; Baunngaertner, Petra; Speiser, Daniel; Luescher, Immanuel F.			Reversible Major Histocompatibility Complex I-Peptide Multimers Containing Ni2+-Nitrilotriacetic Acid Peptides and Histidine Tags Improve Analysis and Sorting of CD8(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLED LIPID INTERFACES; TAGGED PROTEINS; MHC-PEPTIDE; CHELATOR-LIPIDS; CD8+T CELLS; AFFINITY; BINDING; MOLECULES; TCR; IMMOBILIZATION	MHC-peptide multimers containing biotinylated MHC-peptide complexes bound to phycoerythrin (PE) streptavidin (SA) are widely used for analyzing and sorting antigen-specific T cells. Here we describe alternative T cell-staining reagents that are superior to conventional reagents. They are built on reversible chelate complexes of Ni2+-nitrilotriacetic acid (NTA) with oligohistidines. We synthesized biotinylated linear mono-, di-, and tetra-NTA compounds using conventional solid phase peptide chemistry and studied their interaction with HLA-A 0201-peptide complexes containing a His(6), His(12), or 2 x His(6) tag by surface plasmon resonance on SA-coated sensor chips and equilibrium dialysis. The binding avidity increased in the order His(6) < His(12) < 2 x His(6) and NTA(1) < NTA(2) < NTA(4), respectively, depending on the configuration of the NTA moieties and increased to picomolar K-D for the combination of a 2 x His(6) tag and a 2 x Ni2+-NTA(2). We demonstrate that HLA-A2-2 x His(6)-peptide multimers containing either Ni2+-NTA(4)-biotin and PE-SA- or PE-NTA(4)-stained influenza and Melan A-specific CD8+ T cells equal or better than conventional multimers. Although these complexes were highly stable, they very rapidly dissociated in the presence of imidazole, which allowed sorting of bona fide antigen-specific CD8+ T cells without inducing T cell death as well as assessment of HLA-A2-peptide monomer dissociation kinetics on CD8+ T cells.	[Schmidt, Julien; Guillaume, Philippe; Luescher, Immanuel F.] Univ Lausanne, Ludwig Ctr, CH-1066 Epalinges, Switzerland; [Irving, Melita] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Baunngaertner, Petra; Speiser, Daniel] Univ Lausanne, Div Clin Oncoimmunol, Ludwig Ctr, CH-7011 Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne	Luescher, IF (corresponding author), 155 Chemin Boveresses, CH-1066 Epalinges, Switzerland.	immanuel.luescher@unil.ch	Speiser, Daniel E./F-2173-2013		Swiss National Science Foundation [310030_12533/1]; Cancer Research Institute	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research Institute	This work was supported by grants from the Swiss National Science Foundation (310030_12533/1) and from the Cancer Research Institute.	Andre T, 2009, CHEMBIOCHEM, V10, P1878, DOI 10.1002/cbic.200900001; Angelov GS, 2006, J IMMUNOL, V176, P3356, DOI 10.4049/jimmunol.176.6.3356; Brellier M, 2009, CHEM-EUR J, V15, P12689, DOI 10.1002/chem.200901213; Cao HP, 2009, BIOTECHNOL PROGR, V25, P461, DOI 10.1002/btpr.121; Cebecauer M, 2005, J IMMUNOL, V174, P6809, DOI 10.4049/jimmunol.174.11.6809; DIETRICH C, 1995, P NATL ACAD SCI USA, V92, P9014, DOI 10.1073/pnas.92.20.9014; Dorn IT, 1998, J AM CHEM SOC, V120, P2753, DOI 10.1021/ja9735620; Dutoit V, 2002, EUR J IMMUNOL, V32, P3285, DOI 10.1002/1521-4141(200211)32:11<3285::AID-IMMU3285>3.0.CO;2-9; Ge Q, 2002, P NATL ACAD SCI USA, V99, P13729, DOI 10.1073/pnas.212515299; Guillaume P, 2003, J BIOL CHEM, V278, P4500, DOI 10.1074/jbc.M208863200; Guillaume P, 2006, J IMMUNOL, V177, P3903, DOI 10.4049/jimmunol.177.6.3903; Guillaume P, 2010, INT J CANCER, V127, P910, DOI 10.1002/ijc.25099; Guillaume Philippe, 2009, Cancer Immun, V9, P7; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huang ZH, 2006, BIOCONJUGATE CHEM, V17, P1592, DOI 10.1021/bc0602228; Huang ZH, 2009, BIOCONJUGATE CHEM, V20, P1667, DOI 10.1021/bc900309n; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; June RK, 2010, J AM CHEM SOC, V132, P10680, DOI 10.1021/ja1040418; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Khan F, 2006, ANAL CHEM, V78, P3072, DOI 10.1021/ac060184l; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Knecht S, 2009, J MOL RECOGNIT, V22, P270, DOI 10.1002/jmr.941; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; Lata S, 2006, J AM CHEM SOC, V128, P2365, DOI 10.1021/ja0563105; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Neudorfer J, 2007, J IMMUNOL METHODS, V320, P119, DOI 10.1016/j.jim.2007.01.001; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; SCHMITT L, 1994, J AM CHEM SOC, V116, P8485, DOI 10.1021/ja00098a008; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Stayton PS, 1999, BIOMOL ENG, V16, P39, DOI 10.1016/S1050-3862(99)00042-X; Steinhauer C, 2006, PROTEOMICS, V6, P4227, DOI 10.1002/pmic.200600036; Tareste D, 2005, J AM CHEM SOC, V127, P3879, DOI 10.1021/ja043525q; Tinazli A, 2005, CHEM-EUR J, V11, P5249, DOI 10.1002/chem.200500154; Wooldridge L, 2005, J BIOL CHEM, V280, P27491, DOI 10.1074/jbc.M500555200; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9	37	24	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41723	41735		10.1074/jbc.M111.283127	http://dx.doi.org/10.1074/jbc.M111.283127			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990358	Green Published, hybrid			2022-12-27	WOS:000298057500056
J	Wen, KK; McKane, M; Stokasirnov, E; Rubenstein, PA				Wen, Kuo-Kuang; McKane, Melissa; Stokasirnov, Ema; Rubenstein, Peter A.			Mutant Profilin Suppresses Mutant Actin-dependent Mitochondrial Phenotype in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE; YEAST ACTIN; BUDDING YEAST; ANGSTROM RESOLUTION; MASS-SPECTROMETRY; STRUCTURAL BASIS; NONMUSCLE CELLS; BETA-ACTIN; ATP-ACTIN; ADP-ACTIN	In the Saccharomyces cerevisiae actin-profilin interface, Ala(167) of the actin barbed end W-loop and His(372) near the C terminus form a clamp around a profilin segment containing residue Arg(81) and Tyr(79). Modeling suggests that altering steric packing in this interface regulates actin activity. An actin A167E mutation could increase interface crowding and alter actin regulation, and A167E does cause growth defects and mitochondrial dysfunction. We assessed whether a profilin Y79S mutation with its decreased mass could compensate for actin A167E crowding and rescue the mutant phenotype. Y79S profilin alone caused no growth defect in WT actin cells under standard conditions in rich medium and rescued the mitochondrial phenotype resulting from both the A167E and H372R actin mutations in vivo consistent with our model. Rescue did not result from effects of profilin on actin nucleotide exchange or direct effects of profilin on actin polymerization. Polymerization of A167E actin was less stimulated by formin Bni1 FH1-FH2 fragment than was WT actin. Addition of WT profilin to mixtures of A167E actin and formin fragment significantly altered polymerization kinetics from hyperbolic to a decidedly more sigmoidal behavior. Substitution of Y79S profilin in this system produced A167E behavior nearly identical to that of WT actin. A167E actin caused more dynamic actin cable behavior in vivo than observed with WT actin. Introduction of Y79S restored cable movement to a more normal phenotype. Our studies implicate the importance of the actin-profilin interface for formin-dependent actin and point to the involvement of formin and profilin in the maintenance of mitochondrial integrity and function.	[Wen, Kuo-Kuang; McKane, Melissa; Stokasirnov, Ema; Rubenstein, Peter A.] Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM33689, DC8803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008803, R55DC008803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33689 and DC8803 (to P. A. R.).	BABCOCK G, 1993, CELL MOTIL CYTOSKEL, V24, P179, DOI 10.1002/cm.970240305; Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; Bettinger BT, 2007, GENETICS, V175, P1637, DOI 10.1534/genetics.106.063370; BLOMBERG A, 1992, ADV MICROB PHYSIOL, V33, P145, DOI 10.1016/S0065-2911(08)60217-9; Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chesarone M, 2009, DEV CELL, V16, P292, DOI 10.1016/j.devcel.2008.12.001; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Christensen HEM, 1996, PLANT J, V10, P269, DOI 10.1046/j.1365-313X.1996.10020269.x; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Fortsch J, 2011, J CELL BIOL, V194, P473, DOI 10.1083/jcb.201012088; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; GOLDSCHMIDTCLERMONT PJ, 1991, J CELL BIOL, V113, P1081, DOI 10.1083/jcb.113.5.1081; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; GREER C, 1982, MOL CELL BIOL, V2, P1270, DOI 10.1128/MCB.2.10.1270; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Hales KG, 2004, MITOCHONDRION, V4, P285, DOI 10.1016/j.mito.2004.05.007; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; Kim T, 2010, J MOL BIOL, V404, P794, DOI 10.1016/j.jmb.2010.10.017; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2001, J CELL SCI, V114, P4293; Kudryashov DS, 2010, J BIOL CHEM, V285, P25591, DOI 10.1074/jbc.M110.123869; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paavilainen VO, 2007, P NATL ACAD SCI USA, V104, P3113, DOI 10.1073/pnas.0608725104; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Stark BC, 2011, J BIOL CHEM, V286, P30384, DOI 10.1074/jbc.M111.262899; Stokasimov E, 2009, J BIOL CHEM, V284, P25421, DOI 10.1074/jbc.M109.013078; Stokasimov E, 2008, J BIOL CHEM, V283, P34844, DOI 10.1074/jbc.M804419200; Ti SC, 2011, J BIOL CHEM, V286, P5784, DOI 10.1074/jbc.M110.199794; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Yarmola EG, 2001, J BIOL CHEM, V276, P45555, DOI 10.1074/jbc.M105723200; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	56	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41745	41757		10.1074/jbc.M110.217661	http://dx.doi.org/10.1074/jbc.M110.217661			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21956104	hybrid, Green Published			2022-12-27	WOS:000298057500058
J	Wycisk, AI; Lin, JC; Loch, S; Hobohm, K; Funke, J; Wieneke, R; Koch, J; Skach, WR; Mayerhofer, PU; Tampe, R				Wycisk, Agnes I.; Lin, Jiacheng; Loch, Sandra; Hobohm, Kathleen; Funke, Jessica; Wieneke, Ralph; Koch, Joachim; Skach, William R.; Mayerhofer, Peter U.; Tampe, Robert			Epstein-Barr Viral BNLF2a Protein Hijacks the Tail-anchored Protein Insertion Machinery to Block Antigen Processing by the Transport Complex TAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PEPTIDE-LOADING COMPLEX; MOLECULAR-MECHANISM; ER MEMBRANE; VIRUS; GLYCOPROTEIN; INTEGRATION; TRANSLOCATION; BINDING; ICP47	Virus-infected cells are eliminated by cytotoxic T lymphocytes, which recognize viral epitopes displayed on major histocompatibility complex class I molecules at the cell surface. Herpesviruses have evolved sophisticated strategies to escape this immune surveillance. During the lytic phase of EBV infection, the viral factor BNLF2a interferes with antigen processing by preventing peptide loading of major histocompatibility complex class I molecules. Here we reveal details of the inhibition mechanism of this EBV protein. We demonstrate that BNLF2a acts as a tail-anchored protein, exploiting the mammalian Asna-1/WRB (Get3/Get1) machinery for posttranslational insertion into the endoplasmic reticulum membrane, where it subsequently blocks antigen translocation by the transporter associated with antigen processing (TAP). BNLF2a binds directly to the core TAP complex arresting the ATP-binding cassette transporter in a transport-incompetent conformation. The inhibition mechanism of EBV BNLF2a is distinct and mutually exclusive of other viral TAP inhibitors.	[Wycisk, Agnes I.; Lin, Jiacheng; Loch, Sandra; Hobohm, Kathleen; Funke, Jessica; Wieneke, Ralph; Koch, Joachim; Mayerhofer, Peter U.; Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany; [Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Goethe University Frankfurt; Oregon Health & Science University	Tampe, R (corresponding author), Goethe Univ Frankfurt, Bioctr, Inst Biochem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Hartmann, Jessica/AAL-8849-2021; Tampé, Robert/H-2953-2015	Hartmann, Jessica/0000-0001-9372-8954; Tampé, Robert/0000-0002-0403-2160; Wieneke, Ralph/0000-0002-0767-4679	German Research Foundation [SFB 807]; Transport and Communication across Biological Membranes; European Drug Initiative on Channels and Transporters (EDICT) [TA157/7]; European Commission; National Institutes of Health [GM53457, DK51818]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Transport and Communication across Biological Membranes; European Drug Initiative on Channels and Transporters (EDICT); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by German Research Foundation Grants SFB 807, Transport and Communication across Biological Membranes, and TA157/7 (to R.T.), by a grant from the European Drug Initiative on Channels and Transporters (EDICT) funded by the European Commission Seventh Framework Program to R. T.). This work was also supported, in whole or in part, by National Institutes of Health Grants GM53457 and DK51818 (to W. R. S.).	Abele R, 2009, CURR OPIN CELL BIOL, V21, P508, DOI 10.1016/j.ceb.2009.04.008; Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Aisenbrey C, 2006, J BIOL CHEM, V281, P30365, DOI 10.1074/jbc.M603000200; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Boname JM, 2005, EUR J IMMUNOL, V35, P171, DOI 10.1002/eji.200425459; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Horst D, 2011, J IMMUNOL, V186, P3594, DOI 10.4049/jimmunol.1002656; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Horst D, 2009, J IMMUNOL, V182, P2313, DOI 10.4049/jimmunol.0803218; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Koch J, 2006, CELL MOL LIFE SCI, V63, P653, DOI 10.1007/s00018-005-5462-z; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Koppers-Lalic D, 2005, P NATL ACAD SCI USA, V102, P5144, DOI 10.1073/pnas.0501463102; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Kyritsis C, 2001, J BIOL CHEM, V276, P48031, DOI 10.1074/jbc.M108528200; Lacaille VG, 1998, J BIOL CHEM, V273, P17386, DOI 10.1074/jbc.273.28.17386; Loch S, 2008, J BIOL CHEM, V283, P13428, DOI 10.1074/jbc.M800226200; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Saksena S, 2004, P NATL ACAD SCI USA, V101, P12537, DOI 10.1073/pnas.0404934101; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; SKACH WR, 1993, J BIOL CHEM, V268, P23552; STAM NJ, 1986, J IMMUNOL, V137, P2299; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	49	29	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41402	41412		10.1074/jbc.M111.237784	http://dx.doi.org/10.1074/jbc.M111.237784			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984826	Green Published, hybrid			2022-12-27	WOS:000298057500027
J	Xu, D; Young, J; Song, DY; Esko, JD				Xu, Ding; Young, Jeffrey; Song, Danyin; Esko, Jeffrey D.			Heparan Sulfate Is Essential for High Mobility Group Protein 1 (HMGB1) Signaling by the Receptor for Advanced Glycation End Products (RAGE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; GROUP BOX-1 PROTEIN; CELL-SURFACE; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; IN-VIVO; BINDING; DANGER; ANGIOGENESIS; DOMAIN	In a proteomic search for heparan sulfate-binding proteins on monocytes, we identified HMGB1 (high mobility group protein B1). The extracellular role of HMGB1 as a cytokine has been studied intensively and shown to be important as a danger-associated molecular pattern protein. Here, we report that the activity of HMGB1 depends on heparan sulfate. Binding and competition studies demonstrate that HMGB1 interacts with CHO and endothelial cell heparan sulfate. By site-directed mutagenesis, we identified a loop region that connects the A-box and B-box domains of HMGB1 as responsible for heparan sulfate binding. HMGB1-induced Erk1/2 and p38 phosphorylation is abolished when endothelial heparan sulfate is removed or blocked pharmacologically, resulting in decreased HMGB1-induced endothelial sprouting. However, mutated HMGB1 that lacks the heparan sulfate-binding site retained its signaling activity. We show the major receptor for HMGB1, receptor for advanced glycation end products (RAGE), also binds to heparan sulfate and that RAGE and heparan sulfate forms a complex. Our data establishes that the functional receptor for HMGB1 consists of a complex of RAGE and cell surface heparan sulfate.	[Xu, Ding; Young, Jeffrey; Song, Danyin; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Xu, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dxu@ucsd.edu; jesko@ucsd.edu	Xu, Ding/B-2493-2009	Xu, Ding/0000-0001-9380-2712	National Institutes of Health [HL57345]; American Heart Association [0825274F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345, P01HL107150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL57345 (to J. D. E.). This work was also supported by Postdoctoral Fellowship 0825274F from the American Heart Association (to D. X.).	Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025; Brandt R, 2004, BBA-GEN SUBJECTS, V1670, P132, DOI 10.1016/j.bbagen.2003.11.003; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; JORDAN P, 1994, BIOCHEMISTRY-US, V33, P14696, DOI 10.1021/bi00253a007; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; McArthur C, 2002, ARCH ORAL BIOL, V47, P443, DOI 10.1016/S0003-9969(02)00025-0; Menoret A, 2000, J IMMUNOL METHODS, V237, P119, DOI 10.1016/S0022-1759(00)00137-X; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Rauvala H., 2011, BIOCHIM BIOPHYS ACTA, V1799, P164; SALMIVIRTA M, 1992, EXP CELL RES, V200, P444, DOI 10.1016/0014-4827(92)90194-D; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; Stros M, 2000, J BIOL CHEM, V275, P35699, DOI 10.1074/jbc.M007167200; Taudte S, 2000, BIOCHEM J, V347, P807, DOI 10.1042/0264-6021:3470807; Wang CH, 2011, BIOCHEM J, V433, P127, DOI 10.1042/BJ20100589; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9	39	60	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41736	41744		10.1074/jbc.M111.299685	http://dx.doi.org/10.1074/jbc.M111.299685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990362	Green Published, hybrid			2022-12-27	WOS:000298057500057
J	Begriche, K; Levasseur, PR; Zhang, JY; Rossi, J; Skorupa, D; Solt, LA; Young, B; Burris, TP; Marks, DL; Mynatt, RL; Butler, AA				Begriche, Karima; Levasseur, Peter R.; Zhang, Jingying; Rossi, Jari; Skorupa, Danielle; Solt, Laura A.; Young, Brandon; Burris, Thomas P.; Marks, Daniel L.; Mynatt, Randall L.; Butler, Andrew A.			Genetic Dissection of the Functions of the Melanocortin-3 Receptor, a Seven-transmembrane G-protein-coupled Receptor, Suggests Roles for Central and Peripheral Receptors in Energy Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C57BL/6J MICE LACKING; FOOD-INTAKE; METABOLIC DISEASE; BODY-WEIGHT; SYSTEM; LEPTIN; BALANCE; OBESITY; EXPENDITURE; NEURONS	The melanocortin-3 receptor (MC3R) gene is pleiotropic, influencing body composition, natriuresis, immune function, and entrainment of circadian rhythms to nutrient intake. MC3Rs are expressed in hypothalamic and limbic regions of the brain and in peripheral tissues. To investigate the roles of central MC3Rs, we inserted a "lox-stop-lox" (LoxTB) 5' of the translation initiation codon of the mouse Mc3r gene and reactivated transcription using neuron-specific Cre transgenic mice. As predicted based on earlier observations of Mc3r knock-out mice, Mc3r(TB/TB) mice displayed reduced lean mass, increased fat mass, and accelerated diet-induced obesity. Surprisingly, rescuing Mc3r expression in the nervous system using the Nestin-Cre transgene only partially rescued obesity in chow-fed conditions and had no impact on the accelerated diet-induced obesity phenotype. The ventromedial hypothalamus (VMH), a critical node in the neural networks regulating feeding-related behaviors and metabolic homeostasis, exhibits dense Mc3r expression relative to other brain regions. To target VMH MC3R expression, we used the steroidogenic factor-1 Cre transgenic mouse. Although restoring VMH MC3R signaling also had a modest impact on obesity, marked improvements in metabolic homeostasis were observed. VMH MC3R signaling was not sufficient to rescue the lean mass phenotype or the regulation of behaviors anticipating food anticipation. These results suggest that actions of MC3Rs impacting on energy homeostasis involve both central and peripheral sites of action. The impact of central MC3Rs on behavior and metabolism involves divergent pathways; VMH MC3R signaling improves metabolic homeostasis but does not significantly impact on the expression of behaviors anticipating nutrient availability.	[Begriche, Karima; Rossi, Jari; Skorupa, Danielle; Butler, Andrew A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Solt, Laura A.; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Young, Brandon] Scripps Res Inst, Dept Genom Core, Jupiter, FL 33458 USA; [Levasseur, Peter R.; Marks, Daniel L.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA; [Zhang, Jingying; Mynatt, Randall L.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Oregon Health & Science University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Butler, AA (corresponding author), 130 Scripps Way, Jupiter, FL 33458 USA.	AButler@Scripps.edu	Marks, Daniel/C-3712-2009; Begriche, Karima/Y-9444-2019; zhang, jingying R/R-4262-2018; Burris, Thomas/H-5078-2011; Mynatt, Randall L/N-1980-2017; Burris, Thomas P/B-3886-2016	Mynatt, Randall L/0000-0003-4399-0019; Burris, Thomas P/0000-0003-2922-4449; Begriche, Karima/0000-0002-6378-3861; Butler, Andrew/0000-0001-7196-0170; Rossi, Jari/0000-0002-3728-9800	National Institutes of Health [DK073189]; Pennington Biomedical Research Foundation; Clinical Nutrition Research Unit Center [1P30 DK072476]; National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073189, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennington Biomedical Research Foundation; Clinical Nutrition Research Unit Center; National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK073189 (to A. A. B.). This work was also supported by a grant from the Pennington Biomedical Research Foundation (to A. A. B. and R. L. M.).; Supported by the Clinical Nutrition Research Unit Center Grant 1P30 DK072476 entitled "Nutritional Programming: Environmental and Molecular Interactions" sponsored by the National Institutes of Health through the NIDDK (Eric Ravussin, principal investigator).	Albarado DC, 2004, ENDOCRINOLOGY, V145, P243, DOI 10.1210/en.2003-0452; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Begriche K, 2011, PHYSIOL BEHAV, V104, P546, DOI 10.1016/j.physbeh.2011.04.007; Blum I.D., 2011, NEUROSCI BI IN PRESS; Briancon N, 2010, DIABETES, V59, P3074, DOI 10.2337/db10-0481; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Butler AA, 2006, PEPTIDES, V27, P281, DOI 10.1016/j.peptides.2005.02.029; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; ELIA M, 1988, AM J CLIN NUTR, V47, P591, DOI 10.1093/ajcn/47.4.591; Ellacott KLJ, 2007, ENDOCRINOLOGY, V148, P6186, DOI 10.1210/en.2007-0699; Farooqi IS, 2008, NAT CLIN PRACT ENDOC, V4, P569, DOI 10.1038/ncpendmet0966; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Getting SJ, 2006, PHARMACOL THERAPEUT, V111, P1, DOI 10.1016/j.pharmthera.2005.06.022; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gutierrez-Juarez R, 2004, J BIOL CHEM, V279, P49704, DOI 10.1074/jbc.M408665200; Hatzileremia S, 2007, RAPID COMMUN MASS SP, V21, P2431, DOI 10.1002/rcm.3106; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Humphreys MH, 2011, EUR J PHARMACOL, V660, P43, DOI 10.1016/j.ejphar.2010.10.102; Irani BG, 2011, EUR J PHARMACOL, V660, P80, DOI 10.1016/j.ejphar.2010.10.101; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kim KW, 2011, P NATL ACAD SCI USA, V108, P10673, DOI 10.1073/pnas.1102364108; Kim KW, 2011, MOL CELL ENDOCRINOL, V336, P219, DOI 10.1016/j.mce.2010.11.019; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kumar KG, 2009, PEPTIDES, V30, P1892, DOI 10.1016/j.peptides.2009.07.012; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee M, 2008, PEPTIDES, V29, P440, DOI 10.1016/j.peptides.2007.11.005; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Marks DL, 2006, PEPTIDES, V27, P259, DOI 10.1016/j.peptides.2005.01.025; Marks DL, 2003, ENDOCRINOLOGY, V144, P1513, DOI 10.1210/en.2002-221099; Marsh DJ, 1999, BRAIN RES, V848, P66, DOI 10.1016/S0006-8993(99)01962-9; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Navarro M, 2011, ALCOHOL CLIN EXP RES, V35, P1058, DOI 10.1111/j.1530-0277.2011.01438.x; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Perez-Tilve D, 2010, NAT NEUROSCI, V13, P877, DOI 10.1038/nn.2569; Perlemuter G, 2007, NAT CLIN PRACT ENDOC, V3, P458, DOI 10.1038/ncpendmet0505; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Scarlett JM, 2007, ENDOCRINOLOGY, V148, P4217, DOI 10.1210/en.2007-0017; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Sutton GM, 2010, FASEB J, V24, P862, DOI 10.1096/fj.09-142000; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Trivedi P, 2003, BRAIN RES, V977, P221, DOI 10.1016/S0006-8993(03)02683-0; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Zhang YB, 2005, FASEB J, V19, P1482, DOI 10.1096/fj.05-3851com	57	45	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40771	40781		10.1074/jbc.M111.278374	http://dx.doi.org/10.1074/jbc.M111.278374			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21984834	Green Published, hybrid			2022-12-27	WOS:000297315400038
J	Lambertz, C; Leidel, N; Havelius, KGV; Noth, J; Chernev, P; Winkler, M; Happe, T; Haumann, M				Lambertz, Camilla; Leidel, Nils; Havelius, Kajsa G. V.; Noth, Jens; Chernev, Petko; Winkler, Martin; Happe, Thomas; Haumann, Michael			O-2 Reactions at the Six-iron Active Site (H-cluster) in [FeFe]-Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION SPECTROSCOPY; IRON-SULFUR CLUSTER; DRIVEN HYDROGEN-PRODUCTION; RALSTONIA-EUTROPHA H16; FE-ONLY HYDROGENASE; DESULFOVIBRIO-DESULFURICANS; MANGANESE COMPLEX; NIFE HYDROGENASE; REGULATORY HYDROGENASE; OXYGEN	Irreversible inhibition by molecular oxygen (09) complicates the use of [FeFe] -hydrogenases (HydA) for biotechnological hydrogen (H-2) production. Modification by O-2 of the active site six-iron complex denoted as the H-cluster ([4Fe4S]-2Fe(H)) of HydA1 from the green alga Chlamydomonas reinhardtii was characterized by x-ray absorption spectroscopy at the iron K-edge. In a time-resolved approach, HydA1 protein samples were prepared after increasing O-2 exposure periods at 0 degrees C. A kinetic analysis of changes in their x-ray absorption near edge structure and extended X-ray absorption fine structure spectra revealed three phases of O-2 reactions. The first phase (tau(1) <= 4 s) is characterized by the formation of an increased number of Fe-O,C bonds, elongation of the Fe-Fe distance in the binuclear unit (2Fe(H)), and oxidation of one iron ion. The second phase (tau(2) approximate to 15 s) causes a similar to 50% decrease of the number of similar to 2.7-parallel to Fe-Fe distances in the [4Fe4S] subcluster and the oxidation of one more iron ion. The final phase (tau(3) <= 1000 s) leads to the disappearance of most Fe-Fe and Fe-S interactions and further iron oxidation. These results favor a reaction sequence, which involves 1) oxygenation at 2Fe(H+) leading to the formation of a reactive oxygen species-like superoxide (O-2(-)), followed by 2) H-cluster inactivation and destabilization due to ROS attack on the [4Fe4S] cluster to convert it into an apparent [3Fe4S](+) unit, leading to 3) complete O-2-induced degradation of the remainders of the H-cluster. This mechanism suggests that blocking of ROS diffusion paths and/or altering the redox potential of the [4Fe4S] cubane by genetic engineering may yield improved O-2 tolerance in [FeFe]-hydrogenase.	[Lambertz, Camilla; Noth, Jens; Winkler, Martin; Happe, Thomas] Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, D-44780 Bochum, Germany; [Leidel, Nils; Havelius, Kajsa G. V.; Chernev, Petko; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany	Ruhr University Bochum; Free University of Berlin	Happe, T (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, D-44780 Bochum, Germany.	thomas.happe@rub.de	MS-Powder+MS-Surfdiff+Micro-XAS+Super-XAS, SLS/M-1551-2019; Chernev, Petko/F-9964-2018; MIchael, Haumann/A-7087-2013	Chernev, Petko/0000-0002-2836-838X; Sigfridsson Clauss, Kajsa/0000-0002-7604-251X; Happe, Thomas/0000-0003-1206-5234	EU; Deutsche Forschungsgemeinschaft (DFG) [Ha3265/3-1]; Unicat Cluster of Excellence Berlin; "Stiftelsen Bengt Lundgvist minne"; Wenner-Gren Foundation; Bundesministerium fur Bildung und Forschung (BMBF, Design Cells Consortium); Volkswagen Foundation [Lig H2t]	EU(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Unicat Cluster of Excellence Berlin; "Stiftelsen Bengt Lundgvist minne"; Wenner-Gren Foundation; Bundesministerium fur Bildung und Forschung (BMBF, Design Cells Consortium)(Federal Ministry of Education & Research (BMBF)); Volkswagen Foundation(Volkswagen)	This work was supported by the EU-SolarH2 program, (to M. H.) and by Deutsche Forschungsgemeinschaft (DFG) Grant Ha3265/3-1, and the Unicat Cluster of Excellence Berlin.; Recipient of "Stiftelsen Bengt Lundgvist minne" and Wenner-Gren Foundation fellowships.; Supported by the Bundesministerium fur Bildung und Forschung (BMBF, Design Cells Consortium) and by Volkswagen Foundation Grant Lig H2t. To whom correspondence may be addressed. Tel.: 49-234-32-27026; E-mail: thomas.happe@rub.de.; Recipient of a DFG Heisenberg-Fellowship. To whom correspondence may be addressed. Tel.: 49-30-8385-6101; E-mail: michaeLhaurnann@fu-berlin.de.	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Albracht SPJ, 2003, BBA-BIOENERGETICS, V1557, P41, DOI 10.1016/S0005-2728(02)00393-6; Baffert C, 2008, ANGEW CHEM INT EDIT, V47, P2052, DOI 10.1002/anie.200704313; Baffert C, 2011, J AM CHEM SOC, V133, P2096, DOI 10.1021/ja110627b; Barra M, 2006, BIOCHEMISTRY-US, V45, P14523, DOI 10.1021/bi061842z; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruschi M, 2008, INORG CHEM, V47, P6056, DOI 10.1021/ic8006298; Brzoska K, 2006, ACTA BIOCHIM POL, V53, P685; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Czech I, 2011, FEBS LETT, V585, P225, DOI 10.1016/j.febslet.2010.11.052; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; DOUGLAS E, 1964, J PHYS CHEM-US, V68, P169, DOI 10.1021/j100783a028; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Duche O, 2005, FEBS J, V272, P3899, DOI 10.1111/j.1742-4658.2005.04806.x; Fiedler AT, 2005, INORG CHEM, V44, P9322, DOI 10.1021/ic050946f; Friedrich B, 2011, CURR OPIN BIOTECH, V22, P358, DOI 10.1016/j.copbio.2011.01.006; Fritsch J, 2011, BIOCHEMISTRY-US, V50, P5858, DOI 10.1021/bi200367u; Ghirardi ML, 2005, BIOCHEM SOC T, V33, P70, DOI 10.1042/BST0330070; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; HATCHIKIAN EC, 1992, EUR J BIOCHEM, V209, P357, DOI 10.1111/j.1432-1033.1992.tb17297.x; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imsande J, 1999, PLANT PHYSIOL BIOCH, V37, P87, DOI 10.1016/S0981-9428(99)80070-9; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; Kuchenreuther JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020346; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Lautier T, 2011, FARADAY DISCUSS, V148, P385, DOI 10.1039/c004099c; Liebgott PP, 2011, J AM CHEM SOC, V133, P986, DOI 10.1021/ja108787s; Loscher S, 2010, CHEMPHYSCHEM, V11, P1297, DOI 10.1002/cphc.200901007; Loscher S, 2007, INORG CHEM, V46, P11094, DOI 10.1021/ic701255p; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Lubitz W, 2007, CHEM REV, V107, P3900, DOI 10.1021/cr050200z; Lubner CE, 2010, BIOCHEMISTRY-US, V49, P10264, DOI 10.1021/bi1016167; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Nicolet Y, 2000, TRENDS BIOCHEM SCI, V25, P138, DOI 10.1016/S0968-0004(99)01536-4; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Pospisil P, 2003, BIOPHYS J, V84, P1370, DOI 10.1016/S0006-3495(03)74952-2; Roseboom W, 2006, J BIOL INORG CHEM, V11, P102, DOI 10.1007/s00775-005-0040-2; Ryde U, 2010, J AM CHEM SOC, V132, P4512, DOI 10.1021/ja909194f; Saggu M, 2010, PHYS CHEM CHEM PHYS, V12, P2139, DOI 10.1039/b922236g; Salomone-Stagni M, 2010, DALTON T, V39, P3057, DOI 10.1039/b922557a; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Stiebritz MT, 2009, INORG CHEM, V48, P7127, DOI 10.1021/ic9002127; Stripp S, 2009, BIOCHEMISTRY-US, V48, P5042, DOI 10.1021/bi900010b; Stripp ST, 2009, DALTON T, P9960, DOI 10.1039/b916246a; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Tye JW, 2008, INORG CHEM, V47, P2380, DOI 10.1021/ic7013732; van der Linden E, 2004, EUR J BIOCHEM, V271, P801, DOI 10.1111/j.1432-1033.2004.03984.x; VanderSpek TM, 1996, EUR J BIOCHEM, V237, P629; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Winkler M, 2011, BIORESOURCE TECHNOL, V102, P8493, DOI 10.1016/j.biortech.2011.05.019; Xu XM, 2008, CHEMBIOCHEM, V9, P2355, DOI 10.1002/cbic.200800384; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995	79	76	77	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40614	40623		10.1074/jbc.M111.283648	http://dx.doi.org/10.1074/jbc.M111.283648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21930709	Green Published, hybrid			2022-12-27	WOS:000297315400022
J	Moss, ML; Powell, G; Miller, MA; Edwards, L; Qi, B; Sang, QXA; De Strooper, B; Tesseur, I; Lichtenthaler, SF; Taverna, M; Zhong, JL; Dingwall, C; Ferdous, T; Schlomann, U; Zhou, P; Griffith, LG; Lauffenburger, DA; Petrovich, R; Bartsch, JW				Moss, Marcia L.; Powell, Gary; Miller, Miles A.; Edwards, Lori; Qi, Bin; Sang, Qing-Xiang Amy; De Strooper, Bart; Tesseur, Ina; Lichtenthaler, Stefan F.; Taverna, Mara; Zhong, Julia Li; Dingwall, Colin; Ferdous, Taheera; Schlomann, Uwe; Zhou, Pei; Griffith, Linda G.; Lauffenburger, Douglas A.; Petrovich, Robert; Bartsch, Joerg W.			ADAM9 Inhibition Increases Membrane Activity of ADAM10 and Controls alpha-Secretase Processing of Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CONVERTING-ENZYME TACE; DISINTEGRIN-METALLOPROTEINASE; RHEUMATOID-ARTHRITIS; SELECTIVE-INHIBITION; SOLUBLE NEUROPILIN-2; THERAPEUTIC TARGET; TISSUE INHIBITOR; RECEPTOR CD23; CANCER	Prodomains of A disintegrin and metalloproteinase (ADAM) metallopeptidases can act as highly specific intra- and intermolecular inhibitors of ADAM catalytic activity. The mouse ADAM9 prodomain (proA9; amino acids 24-204), expressed and characterized from Escherichia coli, is a competitive inhibitor of human ADAM9 catalyticidisintegrin domain with an overall inhibition constant of 280 +/- 34 nM and high specificity toward ADAM9. In SY5Y neuroblastoma cells overexpressing amyloid precursor protein, proA9 treatment reduces the amount of endogenous ADAM 10 enzyme in the medium while increasing membrane-bound ADAM10, as shown both by Western and activity assays with selective fluorescent peptide substrates using proteolytic activity matrix analysis. An increase in membrane-bound ADAM 10 generates higher levels of soluble amyloid precursor protein alpha in the medium, whereas soluble amyloid precursor protein beta levels are decreased, demonstrating that inhibition of ADAM9 increases alpha-secretase activity on the cell membrane. Quantification of physiological ADAM10 substrates by a proteomic approach revealed that substrates, such as epidermal growth factor (EGF), HER2, osteoactivin, and CD40-ligand, are increased in the medium of BT474 breast tumor cells that were incubated with proA9, demonstrating that the regulation of ADAM10 by ADAM9 applies for many ADAM10 substrates. Taken together, our results demonstrate that ADAM 10 activity is regulated by inhibition of ADAM9, and this regulation may be used to control shedding of amyloid precursor protein by enhancing alpha-secretase activity, a key regulatory step in the etiology of Alzheimer disease.	[Moss, Marcia L.] BioZyme Inc, Apex, NC 27523 USA; [Powell, Gary; Edwards, Lori; Petrovich, Robert] NIEHS, NIH, Durham, NC 27709 USA; [Miller, Miles A.; Griffith, Linda G.; Lauffenburger, Douglas A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Qi, Bin; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [De Strooper, Bart; Tesseur, Ina] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Lichtenthaler, Stefan F.; Taverna, Mara] DZNE German Ctr Neurodegenerat Dis, D-80336 Munich, Germany; [Dingwall, Colin; Ferdous, Taheera; Schlomann, Uwe; Bartsch, Joerg W.] Kings Coll London, Inst Pharm, London SE1 9NH, England; [Zhong, Julia Li] Chongqing Univ, Coll Bioengn, Chongqing 400044, Peoples R China; [Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Bartsch, Joerg W.] Univ Marburg, Univ Hosp, Dept Neurosurg, D-35053 Marburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Massachusetts Institute of Technology (MIT); State University System of Florida; Florida State University; Universite Catholique Louvain; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of London; King's College London; Chongqing University; Duke University; Philipps University Marburg	Bartsch, JW (corresponding author), Univ Hosp, Dept Neurosurg, Baldingerstr, D-35033 Marburg, Germany.	jbartsch@med.uni-marburg.de	De Strooper, Bart/F-6507-2012; Wyss-Coray, Tony/AAF-3380-2019; Bartsch, Joerg Walter/AAB-2951-2020; Zhou, Pei/O-6704-2019; de+Strooper, Bart/Z-1638-2019; Lichtenthaler, Stefan F/B-6587-2016; Schlomann, Uwe/F-6419-2012	De Strooper, Bart/0000-0001-5455-5819; Wyss-Coray, Tony/0000-0001-5893-0831; Zhou, Pei/0000-0002-7823-3416; Lichtenthaler, Stefan F/0000-0003-2211-2575; Bartsch, Prof. Joerg Walter/0000-0002-2773-3357; Griffith, Linda/0000-0002-1801-5548; Miller, Miles/0000-0001-7638-8898	National Institutes of Health [R01EB010246, R01GM081336]; Heptagon Fund London; Cancer Research Technology UK; Whitehead Foundation; Duke Bridge Fund for Research Resources; Bundesministerium fur Bildung und Forschung: Krankheitsbezogene Kompetenznetz Degenerative Demenzen; Chinese Scholarship Council, People's Republic of China; Florida State University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heptagon Fund London; Cancer Research Technology UK; Whitehead Foundation; Duke Bridge Fund for Research Resources; Bundesministerium fur Bildung und Forschung: Krankheitsbezogene Kompetenznetz Degenerative Demenzen(Federal Ministry of Education & Research (BMBF)); Chinese Scholarship Council, People's Republic of China; Florida State University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EB010246 (to L. G. G.) and R01GM081336 (to D. A. L.). This work was also supported by the Heptagon Fund London and Cancer Research Technology UK (to J. W. B.), the Whitehead Foundation and the Duke Bridge Fund for Research Resources (to P. Z.), the Bundesministerium fur Bildung und Forschung: Krankheitsbezogene Kompetenznetz Degenerative Demenzen (to S. F. L.), a National Fellowship from the Chinese Scholarship Council, People's Republic of China (to B. Q.), and grants from Florida State University (to Q. X. A. S.).	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Bartsch JW, 2010, J NEUROSCI, V30, P12210, DOI 10.1523/JNEUROSCI.1520-10.2010; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fassold A, 2009, ARTHRITIS RHEUM-US, V60, P2892, DOI 10.1002/art.24860; Geretti E, 2010, MOL CANCER RES, V8, P1063, DOI 10.1158/1541-7786.MCR-10-0157; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; GRAY PW, 1989, J BIOL CHEM, V264, P9505; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Hirahashi J, 2009, CIRCULATION, V120, P1255, DOI 10.1161/CIRCULATIONAHA.109.873695; Koller G, 2009, CURR PHARM DESIGN, V15, P2272, DOI 10.2174/138161209788682361; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kveiborg M, 2010, BIOCHEM J, V430, P79, DOI 10.1042/BJ20100649; Lee D C, 1992, Cancer Treat Res, V63, P233; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; Leon F, 2006, J IMMUNOL, V177, P6974, DOI 10.4049/jimmunol.177.10.6974; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Liu XD, 2006, CANCER BIOL THER, V5, P648, DOI 10.4161/cbt.5.6.2707; Matei D, 2006, ONCOGENE, V25, P2060, DOI 10.1038/sj.onc.1209232; Miller MA, 2011, INTEGR BIOL-UK, V3, P422, DOI 10.1039/c0ib00083c; Morrison TE, 2008, J VIROL, V82, P11263, DOI 10.1128/JVI.01352-08; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, CANCER, V8, P929; Nasarre C, 2009, CELL ADHES MIGR, V3, P383, DOI 10.4161/cam.3.4.9934; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Nous S, 2010, AM J RESP CRIT CARE, V181, P1318, DOI 10.1164/rccm.200909-1396OC; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Rose AAN, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1791; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Turner SL, 2009, BRIT J BIOMED SCI, V66, P117, DOI 10.1080/09674845.2009.11730257; Turtinen LW, 2005, IMMUNOPHARM IMMUNOT, V27, P85, DOI [10.1081/IPH-200051749, 10.1081/IPH-51749]; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou BBS, 2005, EXPERT OPIN INV DRUG, V14, P591, DOI 10.1517/13543784.14.6.591; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	52	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40443	40451		10.1074/jbc.M111.280495	http://dx.doi.org/10.1074/jbc.M111.280495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956108	Green Published, hybrid			2022-12-27	WOS:000297315400004
J	Colinet, D; Cazes, D; Belghazi, M; Gatti, JL; Poirie, M				Colinet, Dominique; Cazes, Dominique; Belghazi, Maya; Gatti, Jean-Luc; Poirie, Marylene			Extracellular Superoxide Dismutase in Insects CHARACTERIZATION, FUNCTION, AND INTERSPECIFIC VARIATION IN PARASITOID WASP VENOM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR IMMUNE-RESPONSE; PTEROMALUS-PUPARUM HYMENOPTERA; DROSOPHILA-MELANOGASTER; LEPTOPILINA-BOULARDI; HONEY-BEE; INVERTEBRATE IMMUNITY; PROTEOMIC ANALYSIS; PROTEIN; PHENOLOXIDASE; VIRULENCE	Endoparasitoid wasps inject venom proteins with their eggs to protect them from the host immune response and ensure successful parasitism. Here we report identification of Cu,Zn superoxide dismutase (SOD) transcripts for both intracellular SOD1 and extracellular SOD3 in the venom apparatus of two Leptopilina species, parasitoids of Drosophila. Leptopilina SODs show sequence and structure similarity to human SODs, but phylogenetic analyses indicate that the extracellular SODs are more related to cytoplasmic vertebrate SODs than to extracellular SODs, a feature shared by predicted insect extracellular SODs. We demonstrate that L. boulardi SOD3 is indeed secreted and active as monomeric glycosylated forms in venom. Our results also evidence quantitative variation in SOD3 venom contents between closely related parasitoid species, as sod3 is 100-fold less expressed in Leptopilina heterotoma venom apparatus and no protein and SOD activity are detected in its venom. Leptopilina recombinant SOD3s as well as a mammalian SOD in vitro inhibit the Drosophila phenoloxidase activity in a dose-dependent manner, demonstrating that SODs may interfere with the Drosophila melanization process and, therefore, with production of cytotoxic compounds. Although the recombinant L. boulardi SOD3 quantity needed to observe this effect precludes a systemic effect of the wasp venom SOD3, it is still consistent with a local action at oviposition. This work provides the first demonstration that insect extracellular SODs are indeed secreted and active in an insect fluid and can be used as virulence factors to counteract the host immune response, a strategy largely used by bacterial and fungal pathogens but also protozoan parasites during infection.	[Colinet, Dominique; Cazes, Dominique; Gatti, Jean-Luc; Poirie, Marylene] INRA PACA, UMR Biot Interact & Plant Hlth 1301, Inst Natl Rech Agron, F-06903 Sophia Antipolis, France; [Colinet, Dominique; Cazes, Dominique; Gatti, Jean-Luc; Poirie, Marylene] CNRS, UMR 6243, F-06903 Sophia Antipolis, France; [Colinet, Dominique; Cazes, Dominique; Gatti, Jean-Luc; Poirie, Marylene] Univ Nice Sophia Antipolis, UFR Sci, F-06903 Sophia Antipolis, France; [Belghazi, Maya] Univ Aix Marseille 2, Ctr Anal Prote Marseille, IFR Jean Roche, Fac Med Secteur Nord, F-13344 Marseille, France	INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Aix-Marseille Universite	Colinet, D (corresponding author), INRA PACA, UMR Biot Interact & Plant Hlth 1301, Inst Natl Rech Agron, 400 Route Chappes, F-06903 Sophia Antipolis, France.	Dominique.Colinet@sophia.inra.fr	Gatti, jean-luc/ABB-3294-2020; Colinet, Dominique/C-8738-2012	Gatti, jean-luc/0000-0001-7683-718X; Colinet, Dominique/0000-0001-5122-5072	French National Agency for Research [ANR-08-BLAN-0231, ANR-09-BLAN-0243-01]; Department of Plant Health and Environment from the French National Institute for Agricultural Research	French National Agency for Research(French National Research Agency (ANR)); Department of Plant Health and Environment from the French National Institute for Agricultural Research	This work was supported by Grants CLIMEVOL (ANR-08-BLAN-0231) and PARATOXOSE (ANR-09-BLAN-0243-01) from the French National Agency for Research and grants from the Department of Plant Health and Environment from the French National Institute for Agricultural Research.	Ammendola S, 2008, J BIOL CHEM, V283, P13688, DOI 10.1074/jbc.M710499200; Antonyuk SV, 2009, J MOL BIOL, V388, P310, DOI 10.1016/j.jmb.2009.03.026; Asgari S, 2002, INSECT MOL BIOL, V11, P477, DOI 10.1046/j.1365-2583.2002.00356.x; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; Colinet D, 2007, PLOS PATHOG, V3, P2029, DOI 10.1371/journal.ppat.0030203; Colinet D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001206; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Crawford AM, 2008, INSECT MOL BIOL, V17, P313, DOI 10.1111/j.1365-2583.2008.00802.x; de Graaf DC, 2010, INSECT MOL BIOL, V19, P11, DOI 10.1111/j.1365-2583.2009.00914.x; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Dubuffet A, 2009, ADV PARASIT, V70, P147, DOI 10.1016/S0065-308X(09)70006-5; Dupas S, 1998, J HERED, V89, P306, DOI 10.1093/jhered/89.4.306; Dupas S, 2003, HEREDITY, V90, P84, DOI 10.1038/sj.hdy.6800182; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Ghosh S, 2003, BIOCHEM J, V369, P447, DOI 10.1042/BJ20021684; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kohler LJ, 2007, ARCH INSECT BIOCHEM, V66, P64, DOI 10.1002/arch.20199; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Labrosse C, 2005, INSECT BIOCHEM MOLEC, V35, P93, DOI 10.1016/j.ibmb.2004.10.004; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; Nam HJ, 2008, MOL CELLS, V26, P606; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nappi AJ, 2010, ISJ-INVERT SURVIV J, V7, P198; Nappi AJ, 1998, J PARASITOL, V84, P1150, DOI 10.2307/3284664; Nappi AJ, 1995, EUR J CELL BIOL, V68, P450; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Narasipura SD, 2003, MOL MICROBIOL, V47, P1681, DOI 10.1046/j.1365-2958.2003.03393.x; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Parker JD, 2004, INSECT MOL BIOL, V13, P587, DOI 10.1111/j.0962-1075.2004.00515.x; Parkinson N, 2001, INSECT BIOCHEM MOLEC, V31, P57, DOI 10.1016/S0965-1748(00)00105-3; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Petersen SV, 2003, P NATL ACAD SCI USA, V100, P13875, DOI 10.1073/pnas.2436143100; Poirie M, 2009, CR BIOL, V332, P311, DOI 10.1016/j.crvi.2008.09.004; Price DRG, 2009, INSECT MOL BIOL, V18, P195, DOI 10.1111/j.1365-2583.2009.00864.x; Reumer A, 2010, ISJ-INVERT SURVIV J, V7, P32; Stenlund P, 2002, BIOCHEMISTRY-US, V41, P3168, DOI 10.1021/bi011454r; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Vincent B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-693; Vinchon S, 2010, INSECT BIOCHEM MOLEC, V40, P38, DOI 10.1016/j.ibmb.2009.12.007; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Werren J.H., 2009, CSH PROTOC; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Xie XQ, 2010, APPL MICROBIOL BIOT, V86, P1543, DOI 10.1007/s00253-010-2437-2; Zhang GM, 2006, DEV COMP IMMUNOL, V30, P756, DOI 10.1016/j.dci.2005.11.001; Zhu JY, 2008, TOXICON, V51, P1391, DOI 10.1016/j.toxicon.2008.03.008; Zhu JY, 2010, ARCH INSECT BIOCHEM, V75, P28, DOI 10.1002/arch.20380; Zufelato MS, 2004, INSECT BIOCHEM MOLEC, V34, P1257, DOI 10.1016/j.ibmb.2004.08.005	59	64	67	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40110	40121		10.1074/jbc.M111.288845	http://dx.doi.org/10.1074/jbc.M111.288845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937434	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000296925700044
J	McMillan, DGG; Ferguson, SA; Dey, D; Schroder, K; Aung, HL; Carbone, V; Attwood, GT; Ronimus, RS; Meier, T; Janssen, PH; Cook, GM				McMillan, Duncan G. G.; Ferguson, Scott A.; Dey, Debjit; Schroeder, Katja; Aung, Htin Lin; Carbone, Vincenzo; Attwood, Graeme T.; Ronimus, Ron S.; Meier, Thomas; Janssen, Peter H.; Cook, Gregory M.			A(1)A(o)-ATP Synthase of Methanobrevibacter ruminantium Couples Sodium Ions for ATP Synthesis under Physiological Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOSARCINA-MAZEI GO1; NA+-TRANSLOCATING F1F0-ATPASE; PROPIONIGENIUM-MODESTUM; ESCHERICHIA-COLI; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOGENIC ARCHAEA; ROTOR RING; ILYOBACTER-TARTARICUS; ACETOBACTERIUM-WOODII; METHANOCOCCUS-VOLTAE	An unresolved question in the bioenergetics of methanogenic archaea is how the generation of proton-motive and sodium-motive forces during methane production is used to synthesize ATP by the membrane-bound A(1)A(o)-ATP synthase, with both proton- and sodium-coupled enzymes being reported in methanogens. To address this question, we investigated the biochemical characteristics of the A(1)A(o)-ATP synthase (MbbrA(1)A(o)) of Methanobrevibacter ruminantium M1, a predominant methanogen in the rumen. Growth of M. ruminantium M1 was inhibited by protonophores and sodium ionophores, demonstrating that both ion gradients were essential for growth. To study the role of these ions in ATP synthesis, the ahaHIKECFABD operon encoding the MbbrA1Ao was expressed in Escherichia coli strain DK8 (Delta atp) and purified yielding a 9-subunit protein with an SDS-stable c oligomer. Analysis of the c subunit amino acid sequence revealed that it consisted of four transmembrane helices, and each hairpin displayed a complete Na+-binding signature made up of identical amino acid residues. The purified MbbrA(1)A(o) was stimulated by sodium ions, and Na+ provided pH-dependent protection against inhibition by dicyclohexylcarbodiimide but not tributyltin chloride. ATP synthesis in inverted membrane vesicles lacking sodium ions was driven by a membrane potential that was sensitive to cyanide m-chlorophenylhydrazone but not to monensin. ATP synthesis could not be driven by a chemical gradient of sodium ions unless a membrane potential was imposed. ATP synthesis under these conditions was sensitive to monensin but not cyanide m-chlorophenylhydrazone. These data suggest that the M. ruminantium M1 A(1)A(o-)ATP synthase exhibits all the properties of a sodium-coupled enzyme, but it is also able to use protons to drive ATP synthesis under conditions that favor proton coupling, such as low pH and low levels of sodium ions.	[McMillan, Duncan G. G.; Ferguson, Scott A.; Schroeder, Katja; Aung, Htin Lin; Cook, Gregory M.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin 9054, New Zealand; [Dey, Debjit; Carbone, Vincenzo; Attwood, Graeme T.; Ronimus, Ron S.; Janssen, Peter H.] AgResearch, Grasslands Res Ctr, Palmerston North 4442, New Zealand; [Meier, Thomas] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	University of Otago; AgResearch - New Zealand; Max Planck Society	Cook, GM (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, POB 56, Dunedin 9054, New Zealand.	gregory.cook@otago.ac.nz	McMillan, Duncan/AAT-7415-2021; Ferguson, Scott/AAB-4142-2019; Meier, Thomas/AAV-6912-2021; Cook, Gregory/E-5665-2011	McMillan, Duncan/0000-0001-6614-4494; Ferguson, Scott/0000-0001-7937-8273; Meier, Thomas/0000-0003-3364-3320; Ronimus, Ron/0000-0001-8669-5840; Janssen, Peter/0000-0002-1022-3502; carbone, vincenzo/0000-0003-4231-2785; Attwood, Graeme Trevor/0000-0002-6443-8760	Pastoral Greenhouse Gas Research Consortium; University of Otago; AgResearch-University	Pastoral Greenhouse Gas Research Consortium; University of Otago; AgResearch-University	This work was supported by a contract from the Pastoral Greenhouse Gas Research Consortium and in part by a University of Otago research grant and by the AgResearch-University of Otago Collaborative Research Fund.	BECHER B, 1994, J BACTERIOL, V176, P2543, DOI 10.1128/JB.176.9.2543-2550.1994; CRIDER BP, 1985, P NATL ACAD SCI USA, V82, P6793, DOI 10.1073/pnas.82.20.6793; de Jonge MR, 2007, PROTEINS, V67, P971, DOI 10.1002/prot.21376; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; Deppenmeier U, 1999, FEBS LETT, V457, P291, DOI 10.1016/S0014-5793(99)01026-1; Deppenmeier Uwe, 2008, V45, P123, DOI 10.1007/400_2006_026; Dmitriev OY, 2004, FEBS LETT, V556, P35, DOI 10.1016/S0014-5793(03)01360-7; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; DYBAS M, 1992, J BACTERIOL, V174, P5575, DOI 10.1128/JB.174.17.5575-5583.1992; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson SA, 2006, J BACTERIOL, V188, P5045, DOI 10.1128/JB.00128-06; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; KAESLER B, 1988, EUR J BIOCHEM, V174, P189, DOI 10.1111/j.1432-1033.1988.tb14081.x; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; KLUGE C, 1993, BIOCHEMISTRY-US, V32, P10378, DOI 10.1021/bi00090a013; KLUGE C, 1993, J BIOL CHEM, V268, P14557; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANCASTER JR, 1989, J BIOENERG BIOMEMBR, V21, P717, DOI 10.1007/BF00762689; LAUBINGER W, 1988, BIOCHEMISTRY-US, V27, P7531, DOI 10.1021/bi00419a053; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Lemker T, 2001, EUR J BIOCHEM, V268, P3744, DOI 10.1046/j.1432-1327.2001.02284.x; Lingl A, 2003, EXTREMOPHILES, V7, P249, DOI 10.1007/s00792-003-0318-7; Linnett P E, 1979, Methods Enzymol, V55, P472; LUNDIN A, 1975, APPL MICROBIOL, V30, P713, DOI 10.1128/AEM.30.5.713-721.1975; Matthey UH, 1997, EUR J BIOCHEM, V247, P820, DOI 10.1111/j.1432-1033.1997.t01-1-00820.x; McMillan DGG, 2007, J BIOL CHEM, V282, P17395, DOI 10.1074/jbc.M611709200; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Muller V, 2005, J MOL MICROB BIOTECH, V10, P167, DOI 10.1159/000091563; Muller V, 2005, J BIOENERG BIOMEMBR, V37, P455, DOI 10.1007/s10863-005-9491-y; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Neumann S, 1998, J BACTERIOL, V180, P3312, DOI 10.1128/JB.180.13.3312-3316.1998; Pisa KY, 2007, FEMS MICROBIOL LETT, V277, P56, DOI 10.1111/j.1574-6968.2007.00939.x; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; REIDLINGER J, 1994, FEBS LETT, V356, P17, DOI 10.1016/0014-5793(94)01222-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Saum R, 2009, FEMS MICROBIOL LETT, V300, P230, DOI 10.1111/j.1574-6968.2009.01785.x; Schafer G, 1999, MICROBIOL MOL BIOL R, V63, P570; SCHONHEIT P, 1985, EUR J BIOCHEM, V148, P545, DOI 10.1111/j.1432-1033.1985.tb08874.x; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; SMIGAN P, 1994, FEBS LETT, V349, P424, DOI 10.1016/0014-5793(94)00716-0; SMIGAN P, 1995, FEBS LETT, V371, P119, DOI 10.1016/0014-5793(95)00866-8; SMITH PH, 1958, J BACTERIOL, V75, P713, DOI 10.1128/JB.75.6.713-718.1958; SPARLING R, 1993, CAN J MICROBIOL, V39, P742, DOI 10.1139/m93-109; SPRUTH M, 1995, BBA-BIOENERGETICS, V1229, P96, DOI 10.1016/0005-2728(94)00192-8; Surin S, 2006, FOLIA MICROBIOL, V51, P313, DOI 10.1007/BF02931822; Surin S, 2007, FEMS MICROBIOL LETT, V269, P301, DOI 10.1111/j.1574-6968.2007.00655.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; von Ballmoos C, 2002, EUR J BIOCHEM, V269, P5581, DOI 10.1046/j.1432-1033.2002.03264.x; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Vorburger T, 2008, FEBS J, V275, P2137, DOI 10.1111/j.1742-4658.2008.06368.x; Wedlock DN, 2010, NEW ZEAL VET J, V58, P29, DOI 10.1080/00480169.2010.65058; Wiedenmann A, 2009, MOL MICROBIOL, V72, P479, DOI 10.1111/j.1365-2958.2009.06658.x; Wilms R, 1996, J BIOL CHEM, V271, P18843, DOI 10.1074/jbc.271.31.18843; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	69	32	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39882	39892		10.1074/jbc.M111.281675	http://dx.doi.org/10.1074/jbc.M111.281675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953465	Green Published, hybrid			2022-12-27	WOS:000296925700022
J	Pan, LF; Chen, J; Yu, J; Yu, HY; Zhang, MJ				Pan, Lifeng; Chen, Jia; Yu, Jiang; Yu, Haoyue; Zhang, Mingjie			The Structure of the PDZ3-SH3-GuK Tandem of ZO-1 Protein Suggests a Supramodular Organization of the Membrane-associated Guanylate Kinase (MAGUK) Family Scaffold Protein Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION; DOMAINS; MECHANISM; BINDING; TIGHT	Membrane-associated guanylate kinases (MAGUKs) are a large family of scaffold proteins that play essential roles in tethering membrane receptors, adhesion molecules, and macromolecular signaling complexes for tissue developments, cell-cell communications, and intracellular signal transductions. The defining feature of the MAGUK family scaffolds is that each member contains a conserved core consisting of a PSD-95/Dlg/ZO-1 (PDZ) domain, an Src homology 3 (SH3) domain, and a catalytically inactive guanylate kinase (GuK) domain arranged in tandem, although the structural features and functional implications of the PDZ-SH3-GuK tandem arrangement are unclear. The structure of the ZO-1 PDZ3-SH3-GuK tandem solved in this study reveals that the PDZ domain directly interacts with the SH3-GuK module, forming a structural supramodule with distinct target binding properties with respect to the isolated domains. Structure-based sequence analysis suggests that the PDZ-SH3-GuK tandems of other members of the MAGUK family also form supramodules.	[Pan, Lifeng; Chen, Jia; Yu, Jiang; Yu, Haoyue; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China; [Chen, Jia] Hong Kong Univ Sci & Technol, Nano Sci & Technol Program, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Yu, Jiang/C-6980-2012	Zhang, Mingjie/0000-0001-9404-0190; Chen, Jia/0000-0003-0080-0748	Research Grants Council of Hong Kong [663808, 664009, 660709, 663610, HKUST6/CRF/10, SEG_HKUST06, AoE/B-15/01-II, AoE/M-04/04]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Grants 663808, 664009, 660709, 663610, HKUST6/CRF/10, SEG_HKUST06, AoE/B-15/01-II, and AoE/M-04/04 from the Research Grants Council of Hong Kong (to M. Z.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brenman JE, 1998, J NEUROSCI, V18, P8805; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; de Mendoza A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-93; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lye MF, 2010, J BIOL CHEM, V285, P13907, DOI 10.1074/jbc.M109.093674; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; te Velthuis A. J., 2007, GUT, V7, P129; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107	24	45	47	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40069	40074		10.1074/jbc.C111.293084	http://dx.doi.org/10.1074/jbc.C111.293084			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965684	hybrid, Green Published			2022-12-27	WOS:000296925700039
J	Thevenot, E; Moreau, AW; Rousseau, V; Combeau, G; Domenichini, F; Jacquet, C; Goupille, O; Amar, M; Kreis, P; Fossier, P; Barnier, JV				Thevenot, Emmanuel; Moreau, Alexandre William; Rousseau, Veronique; Combeau, Gaelle; Domenichini, Florence; Jacquet, Claire; Goupille, Olivier; Amar, Muriel; Kreis, Patricia; Fossier, Philippe; Barnier, Jean-Vianney			p21-activated Kinase 3 (PAK3) Protein Regulates Synaptic Transmission through Its Interaction with the Nck2/Grb4 Protein Adaptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSPECIFIC MENTAL-RETARDATION; EXCITATION-INHIBITION BALANCE; SPINE MORPHOGENESIS; BIOLOGICAL-PROPERTIES; CORTICAL NETWORKS; REVERSE SIGNALS; NCK-BETA; ACTIVATION; PLASTICITY; NEURONS	Mutations in the p21-activated kinase 3 gene (pak3) are responsible for nonsyndromic forms of mental retardation. Expression of mutated PAK3 proteins in hippocampal neurons induces abnormal dendritic spine morphology and long term potentiation anomalies, whereas pak3 gene invalidation leads to cognitive impairments. How PAK3 regulates synaptic plasticity is still largely unknown. To better understand how PAK3 affects neuronal synaptic plasticity, we focused on its interaction with the Nck adaptors that play a crucial role in PAK signaling. We report here that PAK3 interacts preferentially with Nck2/Grb4 in brain extracts and in transfected cells. This interaction is independent of PAK3 kinase activity. Selective uncoupling of the Nck2 interactions in acute cortical slices using an interfering peptide leads to a rapid increase in evoked transmission to pyramidal neurons. The P12A mutation in the PAK3 protein strongly decreases the interaction with Nck2 but only slightly with Nck1. In transfected hippocampal cultures, expression of the P12A-mutated protein has no effect on spine morphogenesis or synaptic density. The PAK3-P12A mutant does not affect synaptic transmission, whereas the expression of the wild-type PAK3 protein decreases the amplitude of spontaneous miniature excitatory currents. Altogether, these data show that PAK3 down-regulates synaptic transmission through its interaction with Nck2.	[Barnier, Jean-Vianney] Univ Paris 11, Ctr Univ Orsay, Ctr Neurosci Paris Sud, UMR 8195, F-91405 Orsay, France; [Thevenot, Emmanuel; Moreau, Alexandre William; Rousseau, Veronique; Combeau, Gaelle; Domenichini, Florence; Jacquet, Claire; Goupille, Olivier; Amar, Muriel; Kreis, Patricia; Fossier, Philippe; Barnier, Jean-Vianney] CNRS, Inst Neurobiol Alfred Fessard, Neurobiol Cellulaire & Mol Lab, F-91190 Gif Sur Yvette, France; [Rousseau, Veronique; Combeau, Gaelle; Domenichini, Florence; Jacquet, Claire; Amar, Muriel; Fossier, Philippe; Barnier, Jean-Vianney] CNRS, UMR 8195, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Barnier, JV (corresponding author), Univ Paris 11, Ctr Univ Orsay, Ctr Neurosci Paris Sud, UMR 8195, Bat 444, F-91405 Orsay, France.	jean-vianney.barnier@u-psud.fr	Kreis, Patricia/GYJ-3521-2022; Goupille, Olivier/AAO-2716-2020	Kreis, Patricia/0000-0002-1702-4805	Agence Nationale de la Recherche [ANR-MNP-2009]; Fondation Jerome Lejeune; Association pour la Recherche sur le Cancer	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Jerome Lejeune; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported in part by Agence Nationale de la Recherche Grant ANR-MNP-2009, the Fondation Jerome Lejeune, and by a fellowship from Association pour la Recherche sur le Cancer (to E. T.).	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bienvenu T, 2000, AM J MED GENET, V93, P294, DOI 10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Boda B, 2002, NEUROSCIENCE, V114, P13, DOI 10.1016/S0306-4522(02)00218-X; Boda B, 2004, J NEUROSCI, V24, P10816, DOI 10.1523/JNEUROSCI.2931-04.2004; Boda B, 2006, MOL NEUROBIOL, V34, P67, DOI 10.1385/MN:34:1:67; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Braverman LE, 1999, J BIOL CHEM, V274, P5542, DOI 10.1074/jbc.274.9.5542; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Fawcett JP, 2007, P NATL ACAD SCI USA, V104, P20973, DOI 10.1073/pnas.0710316105; Fryer BH, 2006, J BIOL CHEM, V281, P11487, DOI 10.1074/jbc.M600279200; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Guan S, 2007, MOL CELL BIOL, V27, P6001, DOI 10.1128/MCB.01807-06; Guan SX, 2009, J INVEST DERMATOL, V129, P1909, DOI 10.1038/jid.2008.457; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; Kiosses WB, 2002, CIRC RES, V90, P697, DOI 10.1161/01.RES.0000014227.76102.5D; Konig S, 2001, CR ACAD SCI III-VIE, V324, P673, DOI 10.1016/S0764-4469(01)01356-7; Kreis P, 2008, J NEUROCHEM, V106, P1184, DOI 10.1111/j.1471-4159.2008.05474.x; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Le Roux N, 2008, EUR J NEUROSCI, V27, P3244, DOI 10.1111/j.1460-9568.2008.06288.x; Le Roux N, 2006, EUR J NEUROSCI, V24, P3507, DOI 10.1111/j.1460-9568.2006.05203.x; Lee HW, 2010, J NEUROSCI, V30, P5508, DOI 10.1523/JNEUROSCI.4283-09.2010; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Moreau AW, 2010, CEREB CORTEX, V20, P456, DOI 10.1093/cercor/bhp114; Orr AW, 2007, J CELL BIOL, V176, P719, DOI 10.1083/jcb.200609008; Pilpel Y, 2005, J NEUROCHEM, V95, P1401, DOI 10.1111/j.1471-4159.2005.03467.x; Puto LA, 2003, J BIOL CHEM, V278, P9388, DOI 10.1074/jbc.M208414200; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Round JE, 2011, MOL CELL NEUROSCI, V47, P265, DOI 10.1016/j.mcn.2011.04.009; Rousseau V, 2003, J BIOL CHEM, V278, P3912, DOI 10.1074/jbc.M207251200; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Tao J, 2011, MOL ENDOCRINOL, V25, P1565, DOI 10.1210/me.2011-0062; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	55	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40044	40059		10.1074/jbc.M111.262246	http://dx.doi.org/10.1074/jbc.M111.262246			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949127	Green Published, hybrid			2022-12-27	WOS:000296925700037
J	Pawlak, KJ; Prasad, M; Thomas, JL; Whittal, RM; Bose, HS				Pawlak, Kevin J.; Prasad, Manoj; Thomas, James L.; Whittal, Randy M.; Bose, Himangshu S.			Inner Mitochondrial Translocase Tim50 Interacts with 3 beta-Hydroxysteroid Dehydrogenase Type 2 to Regulate Adrenal and Gonadal Steroidogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE-SPACE DOMAIN; CHAIN CLEAVAGE SYSTEM; PROTEIN IMPORT; PREPROTEIN TRANSLOCASE; GEL-ELECTROPHORESIS; MOLECULAR-BIOLOGY; TIM23 COMPLEX; MEMBRANES; COMPONENT; TOM22	In the adrenals, testes, and ovaries, 3 beta-hydroxysteroid dehydrogenase type 2 (3 beta HSD2) catalyzes the conversion of pregnenolone to progesterone and dehydroepiandrostenedione to androstenedione. Alterations in this pathway can have deleterious effects, including sexual development impairment, spontaneous abortion, and breast cancer. 3 beta HSD2, synthesized in the cytosol, is imported into the inner mitochondrial membrane (IMM) by translocases. Steroidogenesis requires that 3 beta HSD2 acts as both a dehydrogenase and isomerase. To achieve this dual functionality, 3 beta HSD2 must undergo a conformational change; however, what triggers that change remains unknown. We propose that 3 beta HSD2 associates with IMM or outer mitochondrial membrane translocases facing the intermembrane space (IMS) and that this interaction promotes the conformational change needed for full activity. Fractionation assays demonstrate that 3 beta HSD2 associated with the IMM but did not integrate into the membrane. Through mass spectrometry and Western blotting of mitochondrial complexes and density gradient ultracentrifugation, we show that that 3 beta HSD2 formed a transient association with the translocases Tim50 and Tom22 and with Tim23. This association occurred primarily through the interaction of Tim50 with the N terminus of 3 beta HSD2 and contributed to enzymatic activity. Tim50 knockdown inhibited catalysis of dehydroepiandrostenedione to androstenedione and pregnenolone to progesterone. Although Tim50 knock-down decreased 3 beta HSD2 expression, restoration of expression via proteasome and protease inhibition did not rescue activity. In addition, protein fingerprinting and CD spectroscopy reveal the flexibility of 3 beta HSD2, a necessary characteristic for forming multiple associations. In summary, Tim50 regulates 3 beta HSD2 expression and activity, representing a new role for translocases in steroidogenesis.	[Bose, Himangshu S.] Mercer Univ Sch Med, Dept Biochem, Div Biomed Sci, Savannah, GA 31404 USA; [Bose, Himangshu S.] Mem Univ Med Ctr, Savannah, GA 31404 USA; [Thomas, James L.] Mercer Univ Sch Med, Dept Biochem, Div Basic Med Sci, Macon, GA 31207 USA; [Whittal, Randy M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	Mercer University; Mercer University; University of Alberta	Bose, HS (corresponding author), Mercer Univ Sch Med, Dept Biochem, Div Biomed Sci, Hoskins Res Bldg,4700 Waters Ave, Savannah, GA 31404 USA.	bose_hs@mercer.edu	Prasad, Manoj/I-9623-2014; Pawlak, Kevin/HDO-6979-2022	Whittal, Randy/0000-0003-1174-8172	National Institutes of Health [HD057876]; Anderson Cancer Institute; Mercer University School of Medicine; Canada Foundation for Innovation; Alberta Science and Research Investment Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anderson Cancer Institute; Mercer University School of Medicine; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Science and Research Investment Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD057876 (to H. S. B.).; Supported by the Anderson Cancer Institute and the Mercer University School of Medicine. To whom correspondence should be addressed: Dept. of Biochemistry, Division of Biomedical Sciences, Mercer University School of Medicine and Memorial University Medical Center, Hoskins Research Bldg., 4700 Waters Ave., Savannah, GA 31404. Tel.: 912-350-1710; Fax: 912-350-1765; E-mail: bose_hs@mercer.edu and bosehi1@memorialhealth.com.; We are thankful to Drs. Toshio Endo for Tim50 and Walter Miller for the P450c17 antibody. Funding for equipment in the Mass Spectrometry Facility at the University of Alberta was supported by the Canada Foundation for Innovation and Alberta Science and Research Investment Program.	Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; BERTHOLD J, 1995, CELL, V81, P1085, DOI 10.1016/S0092-8674(05)80013-3; BLACK SM, 1993, ENDOCRINOLOGY, V132, P539, DOI 10.1210/en.132.2.539; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bose HS, 1998, BIOCHEMISTRY-US, V37, P9768, DOI 10.1021/bi980588a; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; Bose M, 2008, ELECTROPHORESIS, V29, P753, DOI 10.1002/elps.200700782; Bose M, 2007, J MOL ENDOCRINOL, V39, P67, DOI 10.1677/JME-07-0051; Briere N, 1997, J HISTOCHEM CYTOCHEM, V45, P1409; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Court DA, 1996, MOL CELL BIOL, V16, P4035; de la Cruz L, 2010, PROTEIN SCI, V19, P2045, DOI 10.1002/pro.482; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Gevorkyan-Airapetov L, 2009, J BIOL CHEM, V284, P4865, DOI 10.1074/jbc.M807041200; Guo Y, 2004, J BIOL CHEM, V279, P24813, DOI 10.1074/jbc.M402049200; HARIKRISHNA JA, 1993, DNA CELL BIOL, V12, P371, DOI 10.1089/dna.1993.12.371; Herrmann JM, 2000, CURR OPIN MICROBIOL, V3, P210, DOI 10.1016/S1369-5274(00)00077-1; HORST M, 1995, EMBO J, V14, P2293, DOI 10.1002/j.1460-2075.1995.tb07223.x; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Komarov AG, 2005, BIOPHYS J, V89, P3950, DOI 10.1529/biophysj.105.070037; Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199; Labrie F, 2001, FRONT NEUROENDOCRIN, V22, P185, DOI 10.1006/frne.2001.0216; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629; NAKAJIN S, 1981, J BIOL CHEM, V256, P3871; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; PFANNER N, 1992, CELL, V68, P999, DOI 10.1016/0092-8674(92)90069-O; Praporski S, 2009, J BIOL CHEM, V284, P33224, DOI 10.1074/jbc.M109.006064; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Schwartz MP, 1999, P NATL ACAD SCI USA, V96, P13086, DOI 10.1073/pnas.96.23.13086; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Sugiyama S, 2007, GENETICS, V176, P927, DOI 10.1534/genetics.107.072074; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Thomas JL, 2010, J STEROID BIOCHEM, V120, P192, DOI 10.1016/j.jsbmb.2010.04.015; Thomas JL, 2009, MOL CELL ENDOCRINOL, V301, P174, DOI 10.1016/j.mce.2008.09.029; Thomas JL, 2003, J BIOL CHEM, V278, P35483, DOI 10.1074/jbc.M304752200; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; TINKER DA, 1988, J BIOL CHEM, V263, P5024; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Welzel M, 2008, J CLIN ENDOCR METAB, V93, P1418, DOI 10.1210/jc.2007-1874; Woody RW, 1996, CIRCULAR DICHROISM C, P109; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	52	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39130	39140		10.1074/jbc.M111.290031	http://dx.doi.org/10.1074/jbc.M111.290031			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930695	Green Published, hybrid			2022-12-27	WOS:000296759800032
J	Seth, S; Qiu, Q; Danisch, S; Maier, MK; Braun, A; Ravens, I; Czeloth, N; Hyde, R; Dittrich-Breiholz, O; Forster, R; Bernhardt, G				Seth, Sebastian; Qiu, Quan; Danisch, Simon; Maier, Michael K.; Braun, Asolina; Ravens, Inga; Czeloth, Niklas; Hyde, Rebecca; Dittrich-Breiholz, Oliver; Foerster, Reinhold; Bernhardt, Guenter			Intranodal Interaction with Dendritic Cells Dynamically Regulates Surface Expression of the Co-stimulatory Receptor CD226 Protein on Murine T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFT RECRUITMENT; POLIOVIRUS RECEPTOR; ADHESION MOLECULE; DNAM-1 CD226; CCR7-DEFICIENT MICE; NEGATIVE SELECTION; CENTRAL TOLERANCE; LYMPHOID ORGANS; NECTIN-2 CD112; STEADY-STATE	Dendritic cells (DCs) are the most potent antigen-presenting cells of the immune system. Depending on their maturation status, they prime T cells to induce adaptive immunity or tolerance. DCs express CD155, an immunoglobulin-like receptor binding CD226 present on T and natural killer (NK) cells. CD226 represents an important co-stimulator during T cell priming but also serves as an activating receptor on cytotoxic T and NK cells. Here, we report that cells of the T and NK cell lineage of CD155(-/-) mice express markedly elevated protein levels of CD226 compared with wild type (WT). On heterozygous CD155(+/-) T cells, CD226 up-regulation is half-maximal, implying an inverse gene-dosis effect. Moreover, CD226 up-regulation is independent of antigen-driven activation because it occurs already in thymocytes and native peripheral T cells. In vivo, neutralizing anti-CD155 antibody elicits up-regulation of CD226 on T cells demonstrating, that the observed modulation can be triggered by interrupting CD155-CD226 contacts. Adoptive transfers of WT or CD155(-/-) T cells into CD155(-/-) or WT recipients, respectively, revealed that CD226 modulation is accomplished in trans. Analysis of bone marrow chimeras showed that regulators in trans are of hematopoietic origin. We demonstrate that DCs are capable of manipulating CD226 levels on T cells in vivo but not in vitro, suggesting that the process of T cells actively scanning antigen-presenting DCs inside secondary lymphoid organs is required for CD226 modulation. Hence, a CD226 level divergent from WT may be exploited as a sensor to detect abnormal DC/T-cell cross-talk as illustrated for T cells in mice lacking CCR7.	[Seth, Sebastian; Qiu, Quan; Danisch, Simon; Maier, Michael K.; Braun, Asolina; Ravens, Inga; Czeloth, Niklas; Hyde, Rebecca; Foerster, Reinhold; Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Dittrich-Breiholz, Oliver] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School	Bernhardt, G (corresponding author), Carl Neuberg Str 1, D-30625 Hannover, Germany.	bernhardt.guenter@mh-hannover.de	Bernhardt, Günter/F-6946-2012; Förster, Reinhold/D-6770-2011	Bernhardt, Günter/0000-0002-0510-2853; Forster, Reinhold/0000-0001-6190-7923; Braun, Asolina/0000-0002-2646-5362	Deutsche Forschungsgemeinschaft [BE1886/2-1, BE1886/2-2]; Hannover Biomedical Research School; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hannover Biomedical Research School; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported by Deutsche Forschungsgemeinschaft Grants BE1886/2-1 and BE1886/2-2 (to G. B.).; Scholarship holder of Hannover Biomedical Research School program "Infection Biology."; Scholarship holder of the Boehringer Ingelheim Fonds.	Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Carlsten M, 2009, J IMMUNOL, V183, P4921, DOI 10.4049/jimmunol.0901226; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; Cella M, 2010, EUR J IMMUNOL, V40, P949, DOI 10.1002/eji.200940234; Chan CJ, 2010, J IMMUNOL, V184, P902, DOI 10.4049/jimmunol.0903225; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Davalos-Misslitz ACM, 2007, BLOOD, V110, P4351, DOI 10.1182/blood-2007-01-070284; Davalos-Misslitz ACM, 2007, EUR J IMMUNOL, V37, P613, DOI 10.1002/eji.200636656; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; Enloe BM, 2011, J NEURO-ONCOL, V102, P225, DOI 10.1007/s11060-010-0323-5; Erickson BM, 2006, HEPATOLOGY, V43, P325, DOI 10.1002/hep.21021; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Merrill MK, 2004, NEURO-ONCOLOGY, V6, P208, DOI 10.1215/S1152851703000577; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Morimoto K, 2008, ONCOGENE, V27, P264, DOI 10.1038/sj.onc.1210645; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Nakai R, 2010, CANCER SCI, V101, P1326, DOI 10.1111/j.1349-7006.2010.01530.x; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Ogita H, 2008, J MICROSC-OXFORD, V231, P455, DOI 10.1111/j.1365-2818.2008.02058.x; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Qiu Q, 2010, J IMMUNOL, V184, P1681, DOI 10.4049/jimmunol.0900062; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Ravens I, 2003, BIOCHEM BIOPH RES CO, V312, P1364, DOI 10.1016/j.bbrc.2003.11.067; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Seth S, 2009, J LEUKOCYTE BIOL, V86, P91, DOI [10.1189/JLB.1208745, 10.1189/jlb.1208745]; Seth S, 2011, P NATL ACAD SCI USA, V108, pE32, DOI 10.1073/pnas.1017969108; Seth S, 2009, EUR J IMMUNOL, V39, P3160, DOI 10.1002/eji.200939470; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Shirakawa J, 2005, INT IMMUNOL, V17, P217, DOI 10.1093/intimm/dxh199; Shirakawa J, 2006, INT IMMUNOL, V18, P951, DOI 10.1093/intimm/dxl031; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Textor S, 2008, INT J CANCER, V123, P2343, DOI 10.1002/ijc.23733; Toutirais O, 2009, EUR J IMMUNOL, V39, P1361, DOI 10.1002/eji.200838409; Worbs T, 2009, CURR TOP MICROBIOL, V334, P71, DOI 10.1007/978-3-540-93864-4_4; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001	56	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39153	39163		10.1074/jbc.M111.264697	http://dx.doi.org/10.1074/jbc.M111.264697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937446	hybrid, Green Published			2022-12-27	WOS:000296759800034
J	Lin, KY; Zhang, XJ; Feng, DD; Zhang, H; Zeng, CW; Han, BW; Zhou, AD; Qu, LH; Xu, L; Chen, YQ				Lin, Kang-Yu; Zhang, Xing-Ju; Feng, Dan-Dan; Zhang, Hua; Zeng, Cheng-Wu; Han, Bo-Wei; Zhou, Ai-Dong; Qu, Liang-Hu; Xu, Ling; Chen, Yue-Qin			miR-125b, a Target of CDX2, Regulates Cell Differentiation through Repression of the Core Binding Factor in Hematopoietic Malignancies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; HOMEOBOX GENE CDX2; ACUTE LYMPHOBLASTIC-LEUKEMIA; CBF-BETA; MICRORNAS; EXPRESSION; CANCER; TRANSCRIPTION; PROLIFERATION	MicroRNA-125b (miR-125b), a small noncoding RNA molecule, has been found to be deregulated and functions as an oncogene in many cancers including hematopoietic malignancies. However, the mechanisms accounting for miR-125b dysregulation remain to be elucidated. The present study aims to identify the factors that might contribute to up-regulation of miR-125b in human hematopoietic malignancies and its downstream targets for lineage-specific differentiation. We at first reported that CDX2, a homeobox transcription factor, binds to promoter regions of the miR-125b gene and activates transcriptional regulation of miR-125b in malignant myeloid cells. We further revealed that increasing levels of CDX2 in malignant myeloid cells activate miR-125b expression, which in turn inhibits core binding factor beta (CBF beta) translation, thereby counteracting myeloid cell differentiation, at least for granulocytic lineage, and promoting leukemogenesis. Interestingly, we found that this novel pathway including CDX2, miR-125b, and CBF beta was mediated by undergoing all-trans-retinoic acid induction. Once differentiation ensues with all-trans-retinoic acid treatment, CDX2 activity decreases, leading to a reduction in miR-125b transcription and up-regulation of CBF beta in myeloid cells and in patients. The study provides a new mechanism that contributes to hematopoietic malignancies, which could involve deregulation of miR-125b and its up-and downstream factors. As altered expression of miRNAs has been reported in a wide range of malignancies, delineating the underlying molecular mechanisms of aberrant miRNA expression and characterizing the upstream and downstream factors will help to understand important steps in the pathogenesis of these afflictions.	[Xu, Ling] Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Kang-Yu; Zhang, Xing-Ju; Feng, Dan-Dan; Zhang, Hua; Zeng, Cheng-Wu; Han, Bo-Wei; Zhou, Ai-Dong; Qu, Liang-Hu; Chen, Yue-Qin] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xu, L (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China.	luoxul64@yahoo.com; lsscyq@mail.sysu.edu.cn	Zhang, Hua/AAA-2164-2022; Zhang, Hua/AAF-3999-2020; Xie, Huangming/B-2260-2012; Zeng, Chengwu/AAA-8920-2019; Lin, Kangyu/I-8050-2016	Zhang, Hua/0000-0001-9731-2737; Lin, Kangyu/0000-0003-0140-2557; Zhang, Xingju/0000-0003-0717-2510; Qu, Liang-Hu/0000-0003-3657-2863; Zhou, Aidong/0000-0001-8389-9522; Zeng, Chengwu/0000-0002-1333-3918	National Science and Technology Department [2011CBA01105, 2011CB811301, 2009ZX09103-641]; National Natural Science Foundation of China [30672254, 30872784]; Fundamental Research Funds for the Central Universities	National Science and Technology Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Science and Technology Department 973 Program Grants 2011CBA01105, 2011CB811301, and 2009ZX09103-641, National Natural Science Foundation of China Grants 30672254 and 30872784, and the Fundamental Research Funds for the Central Universities.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Hart SM, 2002, HAEMATOLOGICA, V87, P1307; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Kundu M, 2002, BLOOD, V100, P2449, DOI 10.1182/blood-2002-04-1064; Kuo YH, 2006, CANCER CELL, V9, P57, DOI 10.1016/j.ccr.2005.12.014; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Link KA, 2010, J CELL PHYSIOL, V222, P50, DOI 10.1002/jcp.21950; Lo Coco F, 2002, CANCER RES, V62, P5618; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Rawat VPS, 2008, BLOOD, V111, P309, DOI 10.1182/blood-2007-04-085407; Riedt T, 2009, BLOOD, V113, P4049, DOI 10.1182/blood-2008-12-196634; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Roudaia L, 2009, BLOOD, V113, P3070, DOI 10.1182/blood-2008-03-147207; Roussel MJS, 2001, ONCOGENE, V20, P7287, DOI 10.1038/sj.onc.1204863; Scholl C, 2007, J CLIN INVEST, V117, P1037, DOI 10.1172/JCI30182; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Smirnov DA, 2008, AM J HUM GENET, V83, P243, DOI 10.1016/j.ajhg.2008.07.003; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Talebian L, 2007, BLOOD, V109, P11, DOI 10.1182/blood-2006-05-021188; Tallman MS, 2002, BLOOD, V99, P759, DOI 10.1182/blood.V99.3.759; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Thoene S, 2009, LEUKEMIA, V23, P649, DOI 10.1038/leu.2008.355; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	39	58	60	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38253	38263		10.1074/jbc.M111.269670	http://dx.doi.org/10.1074/jbc.M111.269670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21903586	hybrid, Green Published			2022-12-27	WOS:000296594200039
J	Schoeberl, UE; Mochizuki, K				Schoeberl, Ursula E.; Mochizuki, Kazufumi			Keeping the Soma Free of Transposons: Programmed DNA Elimination in Ciliates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DICER-LIKE PROTEIN; TETRAHYMENA-THERMOPHILA; GENOME REARRANGEMENTS; SMALL RNAS; MACRONUCLEAR DEVELOPMENT; CHROMODOMAIN PROTEIN; MEIOTIC PROPHASE; DELETION ELEMENT; SEQUENCE; METHYLATION	Many transposon-related sequences are removed from the somatic macronucleus of ciliates during sexual reproduction. In the ciliate Tetrahymena, an RNAi-related mechanism produces small noncoding RNAs that induce heterochromatin formation, which is followed by DNA elimination. Because RNAi-related mechanisms repress transposon activities in a variety of eukaryotes, the DNA elimination mechanism of ciliates might have evolved from these types of transposon-silencing mechanisms. Nuclear dimorphism allows ciliates to identify any DNA that has invaded the germ-line micronucleus using small RNAs and a whole genome comparison of the micronucleus and the somatic macronucleus.	[Schoeberl, Ursula E.; Mochizuki, Kazufumi] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Mochizuki, K (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	kazufumi.mochizuki@imba.oeaw.ac.at	Mochizuki, Kazufumi/AAW-4382-2020; Mochizuki, Kazufumi/A-5686-2016	Mochizuki, Kazufumi/0000-0001-7987-9852; Mochizuki, Kazufumi/0000-0001-7987-9852	European Research Council (ERC) under the European Community [204986]; Doktoratskolleg RNA Biology and the Special Research Program (SFB) RNA Regulation of the Transcriptome of the Austrian Science Fund (FWF); Austrian Academy of Sciences	European Research Council (ERC) under the European Community(European Research Council (ERC)); Doktoratskolleg RNA Biology and the Special Research Program (SFB) RNA Regulation of the Transcriptome of the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Academy of Sciences	This work was supported by European Research Council (ERC) Starting Grant 204986 under the European Community's Seventh Framework Programme, by the Doktoratskolleg RNA Biology and the Special Research Program (SFB) RNA Regulation of the Transcriptome of the Austrian Science Fund (FWF), and by the Austrian Academy of Sciences (to K. M.). This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; AUSTERBERRY CF, 1989, NUCLEIC ACIDS RES, V17, P7263, DOI 10.1093/nar/17.18.7263; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Bednenko J, 2009, MOL CELL BIOL, V29, P5020, DOI 10.1128/MCB.00076-09; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Cenik ES, 2011, CURR BIOL, V21, pR446, DOI 10.1016/j.cub.2011.05.020; Chalker DL, 1999, MOL CELL BIOL, V19, P5631; Chalker DL, 1996, MOL CELL BIOL, V16, P3658; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Chalker DL, 2008, BBA-MOL CELL RES, V1783, P2130, DOI 10.1016/j.bbamcr.2008.07.012; Cheng CY, 2010, MOL BIOL CELL, V21, P1753, DOI 10.1091/mbc.E09-12-1079; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Coyne RS, 1999, MOL CELL, V4, P865, DOI 10.1016/S1097-2765(00)80396-2; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Fillingham JS, 2004, EUKARYOT CELL, V3, P157, DOI 10.1128/EC.3.1.157-169.2004; Fillingham JS, 2001, NUCLEIC ACIDS RES, V29, P488, DOI 10.1093/nar/29.2.488; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; GODISKA R, 1990, CELL, V61, P1237, DOI 10.1016/0092-8674(90)90688-B; GODISKA R, 1993, GENE DEV, V7, P2357, DOI 10.1101/gad.7.12a.2357; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; HUNTER DJ, 1989, GENE DEV, V3, P2101, DOI 10.1101/gad.3.12b.2101; Iwamoto M, 2009, CURR BIOL, V19, P843, DOI 10.1016/j.cub.2009.03.055; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jacobs ME, 2003, EUKARYOT CELL, V2, P103, DOI 10.1128/EC.2.1.103-114.2003; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; JAHN CL, 1993, GENE, V133, P71, DOI 10.1016/0378-1119(93)90226-S; Kapusta A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002049; KATOH M, 1993, NUCLEIC ACIDS RES, V21, P2409, DOI 10.1093/nar/21.10.2409; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Le Mouel A, 2003, EUKARYOT CELL, V2, P1076, DOI 10.1128/EC.2.5.1076-1090.2003; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Liu YF, 2005, EUKARYOT CELL, V4, P421, DOI 10.1128/EC.4.2.421-431.2005; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; MADIREDDI MT, 1994, DEV BIOL, V165, P418, DOI 10.1006/dbio.1994.1264; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Malone CD, 2008, EUKARYOT CELL, V7, P1487, DOI 10.1128/EC.00193-08; Martienssen RA, 2008, COLD SH Q B, V73, P265, DOI 10.1101/sqb.2008.73.062; MARTINDALE DW, 1985, J PROTOZOOL, V32, P644, DOI 10.1111/j.1550-7408.1985.tb03094.x; Meyer E, 1997, MOL CELL BIOL, V17, P3589, DOI 10.1128/MCB.17.7.3589; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2004, EUKARYOT CELL, V3, P1233, DOI 10.1128/EC.3.5.1233-1240.2004; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mochizuki K, 2010, WIRES RNA, V1, P376, DOI 10.1002/wrna.34; Nikiforov MA, 2000, MOL CELL BIOL, V20, P4128, DOI 10.1128/MCB.20.11.4128-4134.2000; Noto T, 2010, CELL, V140, P692, DOI 10.1016/j.cell.2010.02.010; Nowacki M, 2005, CURR BIOL, V15, P1616, DOI 10.1016/j.cub.2005.07.033; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Patil NS, 1997, J EUKARYOT MICROBIOL, V44, P518, DOI 10.1111/j.1550-7408.1997.tb05733.x; Patil NS, 2000, NUCLEIC ACIDS RES, V28, P1465, DOI 10.1093/nar/28.6.1465; Rexer CH, 2007, EUKARYOT CELL, V6, P1320, DOI 10.1128/EC.00157-07; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saveliev SV, 1996, EMBO J, V15, P2858, DOI 10.1002/j.1460-2075.1996.tb00647.x; Smothers JF, 1997, DEVELOPMENT, V124, P4537; STARGELL LA, 1993, GENE DEV, V7, P2641, DOI 10.1101/gad.7.12b.2641; SUGAI T, 1974, J PROTOZOOL, V21, P542, DOI 10.1111/j.1550-7408.1974.tb03695.x; Sweet MT, 1996, J CELL BIOL, V135, P1219, DOI 10.1083/jcb.135.5.1219; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wuitschick JD, 2002, NUCLEIC ACIDS RES, V30, P2524, DOI 10.1093/nar/30.11.2524; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; YAO MC, 1984, CELL, V36, P433, DOI 10.1016/0092-8674(84)90236-8; Yao MC, 2007, J CELL SCI, V120, P1978, DOI 10.1242/jcs.006502; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	68	27	29	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37045	37052		10.1074/jbc.R111.276964	http://dx.doi.org/10.1074/jbc.R111.276964			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21914793	Green Published, hybrid			2022-12-27	WOS:000296542400003
J	Nakane, S; Wakamatsu, T; Masui, R; Kuramitsu, S; Fukui, K				Nakane, Shuhei; Wakamatsu, Taisuke; Masui, Ryoji; Kuramitsu, Seiki; Fukui, Kenji			In Vivo, in Vitro, and X-ray Crystallographic Analyses Suggest the Involvement of an Uncharacterized Triose-phosphate Isomerase (TIM) Barrel Protein in Protection against Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMUS-THERMOPHILUS HB8; SINGLE-STRANDED-DNA; OLD YELLOW ENZYME; CRYSTAL-STRUCTURE; ENDONUCLEASE-IV; DEINOCOCCUS-RADIODURANS; HELICOBACTER-PYLORI; EXCISION-REPAIR; DAMAGE; EXONUCLEASE	Accumulating genome sequences have revealed the existence of a large number of conserved hypothetical proteins. Characterization of these proteins is considered essential in the elucidation of intracellular biological pathways. Our previous transcriptomic analysis suggested that, in Thermus thermophilus HB8, loss of an oxidized DNA-repairing activity leads to the up-regulation of a function-unknown gene, tthb071, which is conserved in a wide range of bacteria. Interestingly, the tthb071 gene product, TTHB071, showed a significant primary structure similarity to apurinic/apyrimidinic (AP) endonucleases, which are required for the repair of oxidized DNA. In the present study, we observed that disruption of tthb071 increases the H2O2 sensitivity in T. thermophilus HB8, suggesting the involvement of tthb071 in a protection mechanism against oxidative stress. However, purified TTHB071 exhibited no AP endonuclease or DNA-binding activities, indicating that TTHB071 plays no major role in repairing oxidative DNA damage. Then we determined the three-dimensional structure of TTHB071 complexed with zinc ions by x-ray crystallography. In addition to the overall structural similarity, the zinc-binding fashion was almost identical to that of the phosphatase active site of an AP endonuclease, implying that TTHB071 possesses a phosphatase activity. Based on the structural information around the zinc-binding site, we investigated the binding of TTHB071 to 14 different compounds. As a result, TTHB071 favorably bound FMN and pyridoxal phosphate in a zinc ion-mediated manner. Our results suggest that TTHB071 protects the cell from oxidative stress, through controlling the metabolism of FMN, pyridoxal phosphate, or an analogous compound.	[Masui, Ryoji; Kuramitsu, Seiki; Fukui, Kenji] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Nakane, Shuhei; Masui, Ryoji; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Wakamatsu, Taisuke; Kuramitsu, Seiki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	RIKEN; Osaka University; Osaka University	Fukui, K (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	k.fukui@spring8.or.jp	Wakamatsu, Taisuke/AAD-8007-2022	Fukui, Kenji/0000-0003-2463-7578	Japan Society for the Promotion of Science [22-37]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Recipient of a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists (Grant 22-37).	Adalbjornsson BV, 2010, CHEMBIOCHEM, V11, P197, DOI 10.1002/cbic.200900570; Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Agari Y, 2010, FEMS MICROBIOL LETT, V313, P127, DOI 10.1111/j.1574-6968.2010.02133.x; Agari Y, 2010, J MOL BIOL, V395, P270, DOI 10.1016/j.jmb.2009.10.057; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Asano R, 2011, ACTA CRYSTALLOGR D, V67, P149, DOI 10.1107/S0907444910052479; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BONNY C, 1991, BIOCHIM BIOPHYS ACTA, V1089, P213, DOI 10.1016/0167-4781(91)90010-J; Cortial S, 2010, FEBS LETT, V584, P3916, DOI 10.1016/j.febslet.2010.08.019; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DISCHE Z, 1951, J BIOL CHEM, V192, P583; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fukui K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019053; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; Iino H, 2008, ACTA CRYSTALLOGR F, V64, P487, DOI 10.1107/S1744309108013572; Ivanov I, 2007, P NATL ACAD SCI USA, V104, P1465, DOI 10.1073/pnas.0603468104; Iwasaki W, 2007, J MOL BIOL, V371, P123, DOI 10.1016/j.jmb.2007.05.007; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Leulliot N, 2009, J BIOL CHEM, V284, P11992, DOI 10.1074/jbc.M809342200; Liao RZ, 2010, J PHYS CHEM B, V114, P2533, DOI 10.1021/jp910992f; Luria SE, 1943, GENETICS, V28, P491; Mega R, 2010, BIOCHEM BIOPH RES CO, V399, P336, DOI 10.1016/j.bbrc.2010.07.065; Monds RD, 2010, J BACTERIOL, V192, P3011, DOI 10.1128/JB.01571-09; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; Morita R, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/179594; Nakane S, 2009, NUCLEIC ACIDS RES, V37, P2037, DOI 10.1093/nar/gkp064; Odat O, 2007, J BIOL CHEM, V282, P36010, DOI 10.1074/jbc.M704058200; Ooga T, 2009, J BIOL CHEM, V284, P15549, DOI 10.1074/jbc.M900582200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paspaleva K, 2007, STRUCTURE, V15, P1316, DOI 10.1016/j.str.2007.05.010; PINARD R, 1993, FASEB J, V7, P173, DOI 10.1096/fasebj.7.1.7678560; Romier C, 1998, PROTEINS, V32, P414, DOI 10.1002/(SICI)1097-0134(19980901)32:4<414::AID-PROT2>3.3.CO;2-5; Sakamoto K, 2008, GENE, V423, P153, DOI 10.1016/j.gene.2008.07.012; Shimada A, 2010, NUCLEIC ACIDS RES, V38, P5692, DOI 10.1093/nar/gkq350; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Tazoe M, 2005, BIOSCI BIOTECH BIOCH, V69, P2277, DOI 10.1271/bbb.69.2277; Tian B, 2007, BBA-GEN SUBJECTS, V1770, P902, DOI 10.1016/j.bbagen.2007.01.016; Tirrell IM, 2006, BIOCHEM J, V394, P665, DOI 10.1042/BJ20051172; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; Wakamatsu T, 2010, J BIOL CHEM, V285, P9762, DOI 10.1074/jbc.M109.096487; Wang G, 2005, MOL MICROBIOL, V58, P166, DOI 10.1111/j.1365-2958.2005.04833.x; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712	57	1	1	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41636	41646		10.1074/jbc.M111.293886	http://dx.doi.org/10.1074/jbc.M111.293886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984829	Green Published, hybrid			2022-12-27	WOS:000298057500048
J	Wang, ZX; Oh, E; Clapp, DW; Chernoff, J; Thurmond, DC				Wang, Zhanxiang; Oh, Eunjin; Clapp, D. Wade; Chernoff, Jonathan; Thurmond, Debbie C.			Inhibition or Ablation of p21-activated Kinase (PAK1) Disrupts Glucose Homeostatic Mechanisms in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUT4 TRANSLOCATION; INSULIN-SECRETION; MUSCLE-CELLS; SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASE; CYTOSKELETAL DYNAMICS; SIGNALING PATHWAY; REGULATED KINASE; ACTIN; ACTIVATION	The p21-activated kinase PAK1 is implicated in tumorigenesis, and efforts to inhibit PAK1 signaling as a means to induce tumor cell apoptosis are underway. However, PAK1 has also been implicated as a positive effector of mechanisms in clonal pancreatic beta cells and skeletal myotubes that would be crucial to maintaining glucose homeostasis in vivo. Of relevance, human islets of Type 2 diabetic donors contained similar to 80% less PAK1 protein compared with non-diabetics, implicating PAK1 in islet signaling/scaffolding functions. Mimicking this, islets from PAK1(-/-) knock-out mice exhibited profound defects in the second/sustained-phase of insulin secretion. Reiteration of this specific defect by human islets treated with the PAK1 signaling inhibitor IPA3 revealed PAK1 signaling to be of primary functional importance. Analyses of human and mouse islet beta cell signaling revealed PAK1 activation to be 1) dependent upon Cdc42 abundance, 2) crucial for signaling downstream to activate ERK1/2, but 3) dispensable for cofilin phosphorylation. Importantly, the PAK1(-/-) knock-out mice were found to exhibit whole body glucose intolerance in vivo. Exacerbating this, the PAK1(-/-) knock-out mice also exhibited peripheral insulin resistance. Insulin resistance was coupled to ablation of insulin-stimulated GLUT4 translocation in skeletal muscle from PAK1(-/-) knock-out mice, and in sharp contrast to islet beta cells, skeletal muscle PAK1 loss was underscored by defective cofilin phosphorylation but normal ERK1/2 activation. Taken together, these data provide the first human islet and mammalian in vivo data unveiling the key and crucial roles for differential PAK1 signaling in the multi-tissue regulation of whole body glucose homeostasis.	[Wang, Zhanxiang; Oh, Eunjin; Clapp, D. Wade; Thurmond, Debbie C.] Herman B Wells Ctr Pediat Res, Dept Pediat, Basic Diabet Grp, Indianapolis, IN 46202 USA; [Chernoff, Jonathan] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Thurmond, DC (corresponding author), Herman B Wells Ctr Pediat Res, Dept Pediat, Basic Diabet Grp, 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836	National Institutes of Health [DK067912, DK076614, CTSI-KL2 RR025760, CA058836]; Showalter Trust of Indiana University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA058836] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076614, R01DK067912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Trust of Indiana University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported, in whole or in part, by Grants DK067912 and DK076614 (to D. C. T.), CTSI-KL2 RR025760 (to Z. W.), and CA058836 (to J. C.) from the National Institutes of Health and from the Showalter Trust of Indiana University School of Medicine (to E. O.).	Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; Alejandro E. U., 2011, FASEB J IN PRESS; Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Arias-Romero Luis E, 2010, Small GTPases, V1, P124, DOI 10.4161/sgtp.1.2.14109; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Ke YB, 2008, PROG BIOPHYS MOL BIO, V98, P238, DOI 10.1016/j.pbiomolbio.2009.01.007; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Khayat ZA, 2000, J CELL SCI, V113, P279; Kowluru A, 2010, DIABETES, V59, P967, DOI 10.2337/db09-1334; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Ong CC, 2011, ONCOTARGET, V2, P491; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Stanley FM, 2007, ENDOCRINOLOGY, V148, P5874, DOI 10.1210/en.2007-0127; Stockton R, 2007, MOL BIOL CELL, V18, P2346, DOI 10.1091/mbc.E06-07-0584; Sun J, 2009, ONCOGENE, V28, P3132, DOI 10.1038/onc.2009.167; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Trumper J, 2005, DIABETOLOGIA, V48, P1534, DOI 10.1007/s00125-005-1820-5; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Ueda S, 2010, FASEB J, V24, P2254, DOI 10.1096/fj.09-137380; Usui I, 2003, J BIOL CHEM, V278, P13765, DOI 10.1074/jbc.M208904200; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Yu JS, 1998, BIOCHEM J, V334, P121, DOI 10.1042/bj3340121; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhou M, 1998, AM J PHYSIOL-ENDOC M, V275, pE187, DOI 10.1152/ajpendo.1998.275.2.E187	50	93	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41359	41367		10.1074/jbc.M111.291500	http://dx.doi.org/10.1074/jbc.M111.291500			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969371	Green Published, hybrid			2022-12-27	WOS:000298057500023
J	Amable, L; Grankvist, N; Largen, JW; Ortsater, H; Sjoholm, A; Honkanen, RE				Amable, Lauren; Grankvist, Nina; Largen, Jason W.; Ortsater, Henrik; Sjoholm, Ake; Honkanen, Richard E.			Disruption of Serine/Threonine Protein Phosphatase 5 (PP5: PPP5c) in Mice Reveals a Novel Role for PP5 in the Regulation of Ultraviolet Light-induced Phosphorylation of SerinefThreonine Protein Kinase Chk1 (CHEK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; CELL-CYCLE ARREST; CHECKPOINT ACTIVATION; 14-3-3 BINDING; GROWTH ARREST; ATR; PROTEIN-PHOSPHATASE-5; CDC25A; EXPRESSION; DEGRADATION	PPS is a ubiquitously expressed Ser/Thr protein phosphatase. High levels of PP5 have been observed in human cancers, and constitutive PP5 overexpression aids tumor progression in mouse models of tumor development. However, PP5 is highly conserved among species, and the roles of PP5 in normal tissues are not clear. Here, to help evaluate the biological actions of PP5, a CrelloxP-conditional mouse line was generated. In marked contrast to the early embryonic lethality associated with the genetic disruption of other PPP family phosphatases (e.g. PP2A and PP4), intercrosses with mouse lines that ubiquitously express Cre recombinase starting early in development (e.g. MeuCre40 and ACTB-Cre) produced viable and fertile PP5-deficient mice. Phenotypic differences caused by the total disruption of PP5 were minor, suggesting that small molecule inhibitors of PP5 will not have widespread systemic toxicity. Examination of roles for PP5 in fibroblasts generated from PP5, deficient embryos (PP5' mouse embryonic fibroblasts) confirmed some known roles and identified new actions for PP5. PP5(-/-) mouse embryonic fibroblasts demonstrated increased sensitivity to UV light, hydroxyurea, and camptothecin, which are known activators of ATR (ataxia-telangiectasia and Rad3-related) kinase. Further study revealed a previously unrecognized role for PP5 downstream of ATR activation in a UV light-induced response. The genetic disruption of PP5 is associated with enhanced and prolonged phosphorylation of a single senile (Ser-345) on Chk1, increased phosphorylation of the p53 tumor suppressor protein (p53) at serine 18, and increased p53 protein levels. A comparable role for PP5 in the regulation of Chk1 phosphorylation was also observed in human cells.	[Amable, Lauren; Largen, Jason W.; Honkanen, Richard E.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Grankvist, Nina; Ortsater, Henrik; Sjoholm, Ake; Honkanen, Richard E.] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, SE-11883 Stockholm, Sweden	University of South Alabama; Karolinska Institutet; Sodersjukhuset Hospital	Honkanen, RE (corresponding author), Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA.	richard.honkanen@ki.se		Grankvist, Nina/0000-0002-3111-4575	National Institutes of Health [CA60750, T32 HL076125]; Olle Engkvist Byggmastare Foundation; Diabetes Research and Wellness Foundation; Berth von Kantzow's Foundation; Golje's Memorial Foundation; Eva and Oscar Ahren's Foundation; Karolinska Institutet; Swedish Society for Medical Research; United States National Center for Research Resources [C06 RR11174]; NATIONAL CANCER INSTITUTE [R29CA060750, R01CA060750] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR011174] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Olle Engkvist Byggmastare Foundation; Diabetes Research and Wellness Foundation; Berth von Kantzow's Foundation; Golje's Memorial Foundation; Eva and Oscar Ahren's Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Society for Medical Research; United States National Center for Research Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA60750 (to R. E. H.) and T32 HL076125 (to J. W. L.). This work was also supported by the Olle Engkvist Byggmastare Foundation, the Diabetes Research and Wellness Foundation, Berth von Kantzow's Foundation, Golje's Memorial Foundation, the Eva and Oscar Ahren's Foundation, and the Karolinska Institutet (to A. S.) and the Swedish Society for Medical Research (to H. O.). Some of the studies for this investigation were conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR11174 from the United States National Center for Research Resources.	Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Amable L, 2009, THESIS U S ALABAMA; Ben Mkaddem S, 2009, J BIOL CHEM, V284, P12541, DOI 10.1074/jbc.M808376200; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Cheng AY, 2000, J BIOL CHEM, V275, P1846, DOI 10.1074/jbc.275.3.1846; Fukuda H, 2007, J CELL BIOCHEM, V101, P321, DOI 10.1002/jcb.21178; Ghobrial IM, 2005, BLOOD, V105, P3722, DOI 10.1182/blood-2004-10-3999; Golden T, 2004, CANCER LETT, V215, P95, DOI 10.1016/j.canlet.2004.03.027; Golden TA, 2003, METHOD ENZYMOL, V366, P372; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Kang N, BIOCH BIOPHYS RES CO, V404, P476; Kutuzov MA, 2005, J BIOL CHEM, V280, P25388, DOI 10.1074/jbc.M413202200; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu QH, 2000, GENE DEV, V14, P1448; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Lubert EJ, 2001, J BIOL CHEM, V276, P38582, DOI 10.1074/jbc.M106906200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Post S, 2001, P NATL ACAD SCI USA, V98, P13102, DOI 10.1073/pnas.231364598; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Shao J, 2002, BIOCHEMISTRY-US, V41, P6770, DOI 10.1021/bi025737a; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Shirato H, 2000, INT J ONCOL, V17, P909; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Smits VAJ, 2010, FRONT BIOSCI-LANDMRK, V15, P840, DOI 10.2741/3649; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Swingle Mark, 2007, V365, P23; Swingle MR, 2009, J PHARMACOL EXP THER, V331, P45, DOI 10.1124/jpet.109.155630; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200; Zhang J, 2005, MOL CELL BIOL, V25, P9910, DOI 10.1128/MCB.25.22.9910-9919.2005; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou GF, 2004, J BIOL CHEM, V279, P46595, DOI 10.1074/jbc.M408320200; Zuo Z, 1999, BIOCHEMISTRY-US, V38, P8849, DOI 10.1021/bi990842e; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	49	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40413	40422		10.1074/jbc.M111.244053	http://dx.doi.org/10.1074/jbc.M111.244053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21921034	hybrid, Green Published			2022-12-27	WOS:000297315400001
J	Hussmann, GP; Yasuda, RP; Xiao, YX; Wolfe, BB; Kellar, KJ				Hussmann, Gregory P.; Yasuda, Robert P.; Xiao, Yingxian; Wolfe, Barry B.; Kellar, Kenneth J.			Endogenously Expressed Muscarinic Receptors in HEK293 Cells Augment Up-regulation of Stably Expressed alpha 4 beta 2 Nicotinic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE BINDING-SITES; RAT-BRAIN; CHOLINERGIC-RECEPTORS; ALZHEIMERS-DISEASE; PHARMACOLOGICAL-PROPERTIES; DIFFERENTIAL REGULATION; FUNCTIONAL-ACTIVITY; CEREBRAL-CORTEX; LIGAND-BINDING; LONG-TERM	Nicotine-induced up-regulation of neuronal nicotinic receptors (nAChRs) has been known and studied for more than 25 years. Other nAChR ligands can also up-regulate nAChRs, but it is not known if these ligands induce up-regulation by mechanisms similar to that of nicotine. In this study, we compared up-regulation by three different nicotinic agonists and a competitive antagonist of several different nAChR subtypes expressed in HEK293 cells. Nicotine markedly increased alpha 4 beta 2 nAChR binding site density and beta 2 subunit protein. Carbachol, a known nAChR and muscarinic receptor agonist, up-regulated both alpha 4 beta 2 nAChR binding sites and subunit protein 2-fold more than did nicotine. This increased up-regulation was shown pharmacologically to involve endogenously expressed muscarinic receptors, and stimulation of these muscarinic receptors also correlated with a 2-fold increase in alpha 4 and beta 2 mRNA. Muscarinic receptor activation in these cells appears to affect CMV promoter activity only minimally (similar to 1.2 fold), suggesting that the increase in alpha 4 and beta 2 nAChR mRNA may not be dependent on enhanced transcription. Instead, other mechanisms may contribute to the increase in mRNA and a consequent increase in receptor subunits and binding site density. These studies demonstrate the possibility of augmentingn ChR expression in a cell model through mechanisms and targets other than the nAChR receptor itself.	[Hussmann, Gregory P.; Yasuda, Robert P.; Xiao, Yingxian; Wolfe, Barry B.; Kellar, Kenneth J.] Georgetown Univ, Sch Med, Dept Physiol & Pharmacol, Washington, DC 20057 USA	Georgetown University	Kellar, KJ (corresponding author), Georgetown Univ, Sch Med, Dept Physiol & Pharmacol, 3900 Reservoir Rd NW, Washington, DC 20057 USA.	kellark@georgetown.edu			National Institutes of Health [DA012976, T32DA007291]; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012976, R01DA012976, T32DA007291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA012976 and T32DA007291.	Ancellin N, 1999, CELL SIGNAL, V11, P743, DOI 10.1016/S0898-6568(99)00035-2; Avila AM, 2003, MOL PHARMACOL, V64, P974, DOI 10.1124/mol.64.4.974; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Brandish PE, 2003, ANAL BIOCHEM, V313, P311, DOI 10.1016/S0003-2697(02)00630-9; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Davila-Garcia MI, 2003, J NEUROCHEM, V85, P1237, DOI 10.1046/j.1471-4159.2003.01774.x; Del Signore A, 2004, J NEUROPATH EXP NEUR, V63, P138, DOI 10.1093/jnen/63.2.138; Eaton JB, 2003, MOL PHARMACOL, V64, P1283, DOI 10.1124/mol.64.6.1283; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Flores CM, 1997, J NEUROCHEM, V69, P2216; FLORES CM, 1992, MOL PHARMACOL, V41, P31; FLYNN DD, 1986, J NEUROCHEM, V47, P1948, DOI 10.1111/j.1471-4159.1986.tb13113.x; Gahring LC, 2008, J BIOL CHEM, V283, P693, DOI 10.1074/jbc.M707330200; Gahring LC, 2010, J BIOL CHEM, V285, P19793, DOI 10.1074/jbc.M110.108803; GIL DW, 1985, J PHARMACOL EXP THER, V232, P608; Gopalakrishnan M, 1996, J PHARMACOL EXP THER, V276, P289; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Griffiths R, 1997, BRIT J ANAESTH, V79, P389, DOI 10.1093/bja/79.3.389; Hakak Y, 2003, FEBS LETT, V550, P11, DOI 10.1016/S0014-5793(03)00762-2; HANCOCK K, 1983, ANAL BIOCHEM, V133, P157, DOI 10.1016/0003-2697(83)90237-3; Ke L, 1998, J PHARMACOL EXP THER, V286, P825; KELLAR KJ, 1987, BRAIN RES, V436, P62, DOI 10.1016/0006-8993(87)91556-3; Kishi M, 2006, MOL PHARMACOL, V70, P2037, DOI 10.1124/mol.106.029298; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; LEK LH, 1995, J BIOCHEM BIOPH METH, V30, P9, DOI 10.1016/0165-022X(94)00059-M; Lomazzo E, 2010, J NEUROCHEM, V115, P625, DOI 10.1111/j.1471-4159.2010.06967.x; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; MALTHESORENSSEN D, 1972, BIOCHEM J, V127, P229, DOI 10.1042/bj1270229; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; Mao D, 2006, MOL PHARMACOL, V70, P1693, DOI 10.1124/mol.106.027458; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; MARKS MJ, 1993, J PHARMACOL EXP THER, V264, P542; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Meyer EL, 2001, MOL PHARMACOL, V60, P568; MINDEL JS, 1976, INVEST OPHTH VISUAL, V15, P808; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nguyen HN, 2004, J NEUROCHEM, V90, P40, DOI 10.1111/j.1471-4159.2004.02482.x; Nguyen HN, 2003, J PHARMACOL EXP THER, V307, P1090, DOI 10.1124/jpet.103.056408; NORDBERG A, 1986, NEUROSCI LETT, V72, P115, DOI 10.1016/0304-3940(86)90629-4; Peng X, 1997, MOL PHARMACOL, V51, P776, DOI 10.1124/mol.51.5.776; PENG X, 1994, MOL PHARMACOL, V46, P523; Perry DC, 2007, J PHARMACOL EXP THER, V322, P306, DOI 10.1124/jpet.107.121228; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Perry E, 2000, EUR J PHARMACOL, V393, P215, DOI 10.1016/S0014-2999(00)00064-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROWELL PP, 1990, J NEUROCHEM, V55, P2105, DOI 10.1111/j.1471-4159.1990.tb05802.x; Rumenapp U, 2001, J BIOL CHEM, V276, P2474, DOI 10.1074/jbc.M004957200; Sallette J, 2004, J BIOL CHEM, V279, P18767, DOI 10.1074/jbc.M308260200; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; SCHWARTZ RD, 1983, SCIENCE, V220, P214, DOI 10.1126/science.6828889; SCHWARTZ RD, 1985, J NEUROCHEM, V45, P427, DOI 10.1111/j.1471-4159.1985.tb04005.x; SHIMOHAMA S, 1986, J NEUROCHEM, V46, P288, DOI 10.1111/j.1471-4159.1986.tb12960.x; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Turner JR, 2011, NICOTINE TOB RES, V13, P48, DOI 10.1093/ntr/ntq206; Wecker L, 2010, NEUROSCIENCE, V171, P12, DOI 10.1016/j.neuroscience.2010.09.005; Whiteaker P, 1998, MOL PHARMACOL, V53, P950; WHITEHOUSE PJ, 1986, BRAIN RES, V371, P146, DOI 10.1016/0006-8993(86)90819-X; Xiao YX, 2009, ACTA PHARMACOL SIN, V30, P842, DOI 10.1038/aps.2009.69; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322; Xu W, 1999, J NEUROSCI, V19, P9298; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zoli M, 2002, J NEUROSCI, V22, P8785	71	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39726	39737		10.1074/jbc.M111.289546	http://dx.doi.org/10.1074/jbc.M111.289546			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21940627	Green Published, hybrid			2022-12-27	WOS:000296925700006
J	Karim, AF; Chandra, P; Chopra, A; Siddiqui, Z; Bhaskar, A; Singh, A; Kumar, D				Karim, Ahmad Faisal; Chandra, Pallavi; Chopra, Aanchal; Siddiqui, Zaved; Bhaskar, Ashima; Singh, Amit; Kumar, Dhiraj			Express Path Analysis Identifies a Tyrosine Kinase Src-centric Network Regulating Divergent Host Responses to Mycobacterium tuberculosis Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-EDGED-SWORD; GENE-EXPRESSION; INTRACELLULAR MYCOBACTERIA; SIGNAL-TRANSDUCTION; HUMAN MACROPHAGES; CLUSTER-ANALYSIS; FAMILY KINASES; AUTOPHAGY; SURVIVAL; TRANSCRIPTION	Global gene expression profiling has emerged as a major tool in understanding complex response patterns of biological systems to perturbations. However, a lack of unbiased analytical approaches has restricted the utility of complex microarray data to gain novel system level insights. Here we report a strategy, express path analysis (EPA), that helps to establish various pathways differentially recruited to achieve specific cellular responses under contrasting environmental conditions in an unbiased manner. The analysis superimposes differentially regulated genes between contrasting environments onto the network of functional protein associations followed by a series of iterative enrichments and network analysis. To test the utility of the approach, we infected THP1 macrophage cells with a virulent Mycobacterium tuberculosis strain (H37Rv) or the attenuated non-virulent strain H37Ra as contrasting perturbations and generated the temporal global expression profiles. EPA of the results provided details of response-specific and time-dependent host molecular network perturbations. Further analysis identified tyrosine kinase Src as the major regulatory hub discriminating the responses between wildtype and attenuated Mtb infection. We were then able to verify this novel role of Src experimentally and show that Src executes its role through regulating two vital antimicrobial processes of the host cells (i.e. autophagy and acidification of phagolysosome). These results bear significant potential for developing novel anti-tuberculosis therapy. We propose that EPA could prove extremely useful in understanding complex cellular responses for a variety of perturbations, including pathogenic infections.	[Karim, Ahmad Faisal; Chandra, Pallavi; Chopra, Aanchal; Siddiqui, Zaved; Bhaskar, Ashima; Singh, Amit; Kumar, Dhiraj] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	dhiraj@icgeb.res.in	Ismail, Hanafi/A-3564-2009; ismail, hanafi/AAH-9159-2020	Singh, Amit/0000-0001-6761-1664; BHASKAR, ASHIMA/0000-0002-7367-874X	IYBA [DB01/DK/10/363]; Centre of Excellence from the Department of Biotechnology, Government of India; Indian Council of Medical Research; Wellcome-DBT Alliance [WTA01/10/355]; NIH [P30AI027767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	IYBA; Centre of Excellence from the Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Wellcome-DBT Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an IYBA Grant (DB01/DK/10/363) and a Centre of Excellence grant from the Department of Biotechnology, Government of India, and an Indian Council of Medical Research Grant (to D. K.). This work was also supported in part by a Wellcome-DBT Alliance Grant WTA01/10/355 and an NIH developmental supplement grant P30AI027767 entitled "Creative and Novel Ideas in HIV Research" (to A. S.).	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Bar-Yam Y, 2004, P NATL ACAD SCI USA, V101, P4341, DOI 10.1073/pnas.0400673101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Behr M, 2010, CELL, V140, P615, DOI 10.1016/j.cell.2010.02.030; Brosch R, 1999, INFECT IMMUN, V67, P5768, DOI 10.1128/IAI.67.11.5768-5774.1999; Chang JT, 2009, MOL CELL, V34, P104, DOI 10.1016/j.molcel.2009.02.030; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Coombes BK, 2001, INFECT IMMUN, V69, P1420, DOI 10.1128/IAI.69.3.1420-1427.2001; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dunn R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-39; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; George MD, 2003, VIROLOGY, V312, P84, DOI 10.1016/S0042-6822(03)00207-1; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2009, VET IMMUNOL IMMUNOP, V128, P37, DOI 10.1016/j.vetimm.2008.10.293; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; Keller C, 2004, TUBERCULOSIS, V84, P144, DOI 10.1016/j.tube.2003.12.003; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Marr MT, 2006, GENE DEV, V20, P1458, DOI 10.1101/gad.1418806; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McGarvey JA, 2004, CLIN EXP IMMUNOL, V136, P490, DOI 10.1111/j.1365-2249.2004.02490.x; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Porcelli SA, 2008, NAT IMMUNOL, V9, P1101, DOI 10.1038/ni1008-1101; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Silver RF, 2009, AM J RESP CELL MOL, V40, P491, DOI 10.1165/rcmb.2008-0219OC; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Volpe E, 2006, IMMUNOLOGY, V118, P449, DOI 10.1111/j.1365-2567.2006.02378.x; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Xu D, 2003, NUCLEIC ACIDS RES, V31, P5582, DOI 10.1093/nar/gkg783; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	55	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40307	40319		10.1074/jbc.M111.266239	http://dx.doi.org/10.1074/jbc.M111.266239			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953458	hybrid, Green Published			2022-12-27	WOS:000296925700062
J	Lee, JE; Jeong, PY; Joo, HJ; Kim, H; Lee, T; Koo, HS; Paik, YK				Lee, Jeong-Eui; Jeong, Pan-Young; Joo, Hyoe-Jin; Kim, Heekyeong; Lee, Taehoon; Koo, Hyeon-Sook; Paik, Young-Ki			STR-33, a Novel G Protein-coupled Receptor That Regulates Locomotion and Egg Laying in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVOUS-SYSTEM; DEG/ENAC CHANNEL; SEROTONIN; NEURONS; TOUCH; GENETICS; MUTANTS; CIRCUIT; CALCIUM; PATHWAY	Despite their predicted functional importance, most G protein-coupled receptors (GPCRs) in Caenorhabditis elegans have remained largely uncharacterized. Here, we focused on one GPCR, STR-33, encoded by the str-33 gene, which was discovered through a ligand-based screening procedure. To characterize STR-33 function, we performed UV-trimethylpsolaren mutagenesis and isolated an str-33-null mutant. The resulting mutant showed hypersinusoidal movement and a hyperactive egg-laying phenotype. Two types of egg laying-related mutations have been characterized: egg laying-deficient (Egl-d) and hyperactive egg laying (Egl-c). The defect responsible for the egg laying-deficient Egl-d phenotype is related to G alpha(q) signaling, whereas that responsible for the opposite, hyperactive egg-laying Egl-c phenotype is related to G alpha(o) signaling. We found that the hyperactive egg-laying defect of the str-33(ykp001) mutant is dependent on the G protein GOA-1/G alpha(o). Endogenous acetylcholine suppressed egg laying in C. elegans via a G alpha(o)-signaling pathway by inhibiting serotonin biosynthesis or release from the hermaphrodite-specific neuron. Consistent with this, in vivo expression of the serotonin biosynthetic enzyme, TPH-1, was up-regulated in the str-33(ykp001) mutant. Taken together, these results suggest that the GPCR, STR-33, may be one of the neurotransmitter receptors that regulates locomotion and egg laying in C. elegans.	[Lee, Jeong-Eui; Jeong, Pan-Young; Joo, Hyoe-Jin; Kim, Heekyeong; Lee, Taehoon; Koo, Hyeon-Sook; Paik, Young-Ki] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Lee, Jeong-Eui; Jeong, Pan-Young; Joo, Hyoe-Jin; Kim, Heekyeong; Lee, Taehoon; Koo, Hyeon-Sook; Paik, Young-Ki] Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea; [Paik, Young-Ki] Yonsei Univ, Dept Integrated Omi Biomed Sci, World Class Univ Program, Grad Sch, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University	Paik, YK (corresponding author), Yonsei Univ, Dept Biochem, 134 Shinchon Dong, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr		LEE, TAE HOON/0000-0001-6396-9378	National Research Foundation of Korea [2011-0028112]; World Class University Program [R31-2008-000-10086-0]; Korean government (Ministry of Education, Science and Technology); National Project for Personalized Genomic Medicine Grant [A111218-11-CP01]	National Research Foundation of Korea(National Research Foundation of Korea); World Class University Program; Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); National Project for Personalized Genomic Medicine Grant	This work was supported by National Research Foundation of Korea Grant 2011-0028112 (to Y.-K. P.) and World Class University Program Grant R31-2008-000-10086-0 funded by the Korean government (Ministry of Education, Science and Technology) and National Project for Personalized Genomic Medicine Grant A111218-11-CP01 (to Y.-K. P.).	Bany IA, 2003, J NEUROSCI, V23, P8060; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Dittman JS, 2008, J NEUROSCI, V28, P7104, DOI 10.1523/JNEUROSCI.0378-08.2008; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Govorunova EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010368; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Jose AM, 2007, GENETICS, V175, P93, DOI 10.1534/genetics.106.065516; Jospin M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000265; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Lee J, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.022665; Liu YS, 2007, J NEUROSCI, V27, P1411, DOI 10.1523/JNEUROSCI.4320-06.2007; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Moresco JJ, 2004, J NEUROSCI, V24, P8522, DOI 10.1523/JNEUROSCI.1915-04.2004; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; OLIVEIRA L, 1993, J COMPUT AID MOL DES, V7, P649, DOI 10.1007/BF00125323; RAND JB, 1984, GENETICS, V106, P227; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Robertson H. M, 2006, WORMBOOK C ELEGANS R, DOI [doi/10.1895/wormbook.1.66.1, DOI 10.1895/WORMB00K.1.66.1]; Robertson HM, 2001, CHEM SENSES, V26, P151, DOI 10.1093/chemse/26.2.151; Royal DC, 2005, J BIOL CHEM, V280, P41976, DOI 10.1074/jbc.M510732200; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schuske K, 2004, TRENDS NEUROSCI, V27, P407, DOI 10.1016/j.tins.2004.05.005; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shyn SI, 2003, CURR BIOL, V13, P1910, DOI 10.1016/j.cub.2003.10.025; Steger KA, 2004, GENETICS, V167, P633, DOI 10.1534/genetics.103.020230; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tanis JE, 2008, GENETICS, V178, P157, DOI 10.1534/genetics.107.079780; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; TRENT C, 1983, GENETICS, V104, P619; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Zhang M, 2008, CURR BIOL, V18, P1445, DOI 10.1016/j.cub.2008.08.047	37	3	5	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39860	39870		10.1074/jbc.M111.241000	http://dx.doi.org/10.1074/jbc.M111.241000			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937442	Green Published, hybrid			2022-12-27	WOS:000296925700020
J	Rezvanpour, A; Santamaria-Kisiel, L; Shaw, GS				Rezvanpour, Atoosa; Santamaria-Kisiel, Liliana; Shaw, Gary S.			The S100A10-Annexin A2 Complex Provides a Novel Asymmetric Platform for Membrane Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S100 TARGET SPECIFICITY; N-TERMINAL DOMAIN; ANNEXIN-II; GLUTAMATE-DECARBOXYLASE; STRUCTURAL BASIS; EARLY ENDOSOMES; BINDING-SITE; PROTEIN; DYSFERLIN; PEPTIDE	Membrane repair is mediated by multiprotein complexes, such as that formed between the dimeric EF-hand protein S100A10, the calcium- and phospholipid-binding protein annexin A2, the enlargeosome protein AHNAK, and members of the transmembrane ferlin family. Although interactions between these proteins have been shown, little is known about their structural arrangement and mechanisms of formation. In this work, we used a non-covalent complex between S100A10 and the N terminus of annexin A2 (residues 1-15) and a designed hybrid protein (A10A2), where S100A10 is linked in tandem to the N-terminal region of annexin A2, to explore the binding region, stoichiometry, and affinity with a synthetic peptide from the C terminus of AHNAK. Using multiple biophysical methods, we identified a novel asymmetric arrangement between a single AHNAK peptide and the A10A2 dimer. The AHNAK peptide was shown to require the annexin A2 N terminus, indicating that the AHNAK binding site comprises regions on both S100A10 and annexin proteins. NMR spectroscopy was used to show that the AHNAK binding surface comprised residues from helix IV in S100A10 and the C-terminal portion from the annexin A2 peptide. This novel surface maps to the exposed side of helices IV and IV' of the S100 dimeric structure, a region not identified in any previous S100 target protein structures. The results provide the first structural details of the ternary S100A10 protein complex required for membrane repair.	[Rezvanpour, Atoosa; Santamaria-Kisiel, Liliana; Shaw, Gary S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Shaw, GS (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625	Canadian Institutes of Health Research [95320]; Canada Research Chairs Program; Ontario Graduate Student Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Ontario Graduate Student Scholarship	This work was supported by grant FRN #95320 from the Canadian Institutes of Health Research (to G. S. S.) and the Canada Research Chairs Program (to G. S. S.) and an Ontario Graduate Student Scholarship (to A. R.).	Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; Beaton AR, 2002, P NATL ACAD SCI USA, V99, P13154, DOI 10.1073/pnas.192432299; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Bhattacharya S, 2003, BIOCHEMISTRY-US, V42, P14416, DOI 10.1021/bi035089a; Borthwick LA, 2008, CELL CALCIUM, V44, P147, DOI 10.1016/j.ceca.2007.11.001; Cacciottolo M, 2011, J BIOL CHEM, V286, P5404, DOI 10.1074/jbc.M110.173559; Charpentier TH, 2010, J MOL BIOL, V396, P1227, DOI 10.1016/j.jmb.2009.12.057; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013854; De Seranno S, 2006, J BIOL CHEM, V281, P35030, DOI 10.1074/jbc.M606545200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diakonova M, 1997, J CELL SCI, V110, P1199; Doherty KR, 2003, TRENDS MOL MED, V9, P327, DOI 10.1016/S1471-4914(03)00136-9; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Illien F, 2010, BBA-BIOMEMBRANES, V1798, P1790, DOI 10.1016/j.bbamem.2010.05.001; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jost M, 1997, J CELL SCI, V110, P221; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Kouno M, 2004, J INVEST DERMATOL, V123, P700, DOI 10.1111/j.0022-202X.2004.23412.x; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; MacLeod TJ, 2003, J BIOL CHEM, V278, P25577, DOI 10.1074/jbc.M301017200; McClintock KA, 2003, J BIOL CHEM, V278, P6251, DOI 10.1074/jbc.M210622200; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Morigasaki S, 2000, BIOCHEM BIOPH RES CO, V273, P261, DOI 10.1006/bbrc.2000.2945; Nebgen DR, 1999, J DENT RES, V78, P1484, DOI 10.1177/00220345990780090201; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Rety S, 2000, STRUCTURE, V8, P175, DOI 10.1016/S0969-2126(00)00093-9; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rezvanpour A, 2009, GEN PHYSIOL BIOPHYS, V28, pF39; Rezvanpour A, 2009, PROTEIN SCI, V18, P2528, DOI 10.1002/pro.267; Rintala-Dempsey AC, 2006, BIOCHEMISTRY-US, V45, P14695, DOI 10.1021/bi061754e; Rosengarth A, 2003, J MOL BIOL, V326, P1317, DOI 10.1016/S0022-2836(03)00027-5; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Smith SP, 1998, BIOCHEM CELL BIOL, V76, P324, DOI 10.1139/bcb-76-2-3-324; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; Umbrecht-Jenck E, 2010, TRAFFIC, V11, P958, DOI 10.1111/j.1600-0854.2010.01065.x; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Wright NT, 2009, J MOL BIOL, V386, P1265, DOI 10.1016/j.jmb.2009.01.022; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zibouche M, 2008, J BIOL CHEM, V283, P22121, DOI 10.1074/jbc.M801000200	58	46	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40174	40183		10.1074/jbc.M111.244038	http://dx.doi.org/10.1074/jbc.M111.244038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949189	Green Published, hybrid			2022-12-27	WOS:000296925700050
J	Farkas, T; Daugaard, M; Jaattela, M				Farkas, Thomas; Daugaard, Mads; Jaattela, Marja			Identification of Small Molecule Inhibitors of Phosphatidylinositol 3-Kinase and Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-DEATH; MAMMALIAN DEVELOPMENT; TARGETING AUTOPHAGY; CANCER; MACROAUTOPHAGY; APOPTOSIS; 3-PHOSPHATE; SELECTIVITY; NECROSIS	Macroautophagy (hereafter autophagy) is a lysosomal catabolic pathway that controls cellular homeostasis and survival. It has recently emerged as an attractive target for the treatment of a variety of degenerative diseases and cancer. The targeting of autophagy has, however, been hampered by the lack of specific small molecule inhibitors. Thus, we screened two small molecule kinase inhibitor libraries for inhibitors of rapamycin-induced autophagic flux. The three most potent inhibitors identified conferred profound inhibition of autophagic flux by inhibiting the formation of autophagosomes. Notably, the autophagy inhibitory effects of all three compounds were independent of their established kinase targets, i.e. ataxia telangiectasia mutated for KU55933, protein kinase C for Go6976, and Janus kinase 3 for Jak3 inhibitor VI. Instead, we identified phosphatidylinositol 3-kinase (PtdIns3K) as a direct target of KU55933 and Go6976. Importantly, and in contrast to the currently available inhibitors of autophagosome formation (e.g. 3-methyladenine), none of the three compounds inhibited the cell survival promoting class I phosphoinositide 3-kinase-Akt signaling at the concentrations required for effective autophagy inhibition. Accordingly, they proved to be valuable tools for investigations of autophagy-associated cell death and survival. Employing KU55399, we demonstrated that autophagy protects amino acid-starved cells against both apoptosis and necroptosis. Taken together, our data introduce new possibilities for the experimental study of autophagy and can form a basis for the development of clinically relevant autophagy inhibitors.	Danish Canc Soc, Apoptosis Dept, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, Inst Canc Biol, DK-2100 Copenhagen, Denmark	Danish Cancer Society; Danish Cancer Society	Jaattela, M (corresponding author), Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	mj@cancer.dk	Jäättelä, Marja/AAT-7932-2021; Daugaard, Mads/Y-6483-2018	Jäättelä, Marja/0000-0001-5950-7111; Farkas, Thomas/0000-0003-1903-6081; Daugaard, Mads/0000-0001-8383-055X	Danish National Research Foundation,; Danish Cancer Society; European Commission; Lundbeck Foundation; Meyer Foundation; Novo Nordisk Foundation	Danish National Research Foundation,(Danmarks Grundforskningsfond); Danish Cancer Society(Danish Cancer Society); European Commission(European CommissionEuropean Commission Joint Research Centre); Lundbeck Foundation(Lundbeckfonden); Meyer Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by grants from the Danish National Research Foundation, the Danish Cancer Society, the European Commission FP7 (APO-SYS), the Lundbeck Foundation, the Meyer Foundation, and the Novo Nordisk Foundation (to M. J.).	Adams C, 2003, BIOORG MED CHEM LETT, V13, P3105, DOI 10.1016/S0960-894X(03)00657-7; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Corcelle EA, 2009, FEBS J, V276, P6084, DOI 10.1111/j.1742-4658.2009.07332.x; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dietrich N, 2004, CELL DEATH DIFFER, V11, P301, DOI 10.1038/sj.cdd.4401353; Farkas T, 2009, AUTOPHAGY, V5, P1018, DOI 10.4161/auto.5.7.9443; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knight ZA, 2007, NAT PROTOC, V2, P2459, DOI 10.1038/nprot.2007.361; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Sarkaria JN, 1999, CANCER RES, V59, P4375; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Szyniarowski P, 2011, AUTOPHAGY, V7, P892, DOI 10.4161/auto.7.8.15770; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	46	74	78	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38904	38912		10.1074/jbc.M111.269134	http://dx.doi.org/10.1074/jbc.M111.269134			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930714	Green Published, hybrid			2022-12-27	WOS:000296759800009
J	Fenner, D; Odili, S; Hong, HK; Kobayashi, Y; Kohsaka, A; Siepka, SM; Vitaterna, MH; Chen, P; Zelent, B; Grimsby, J; Takahashi, JS; Matschinsky, FM; Bass, J				Fenner, Deborah; Odili, Stella; Hong, Hee-Kyung; Kobayashi, Yumiko; Kohsaka, Akira; Siepka, Sandra M.; Vitaterna, Martha H.; Chen, Pan; Zelent, Bogumil; Grimsby, Joseph; Takahashi, Joseph S.; Matschinsky, Franz M.; Bass, Joseph			Generation of N-Ethyl-N-nitrosourea (ENU) Diabetes Models in Mice Demonstrates Genotype-specific Action of Glucokinase Activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL GLUCOKINASE; HIGH-FAT DIET; REGULATORY PROTEIN; GLUCOSE-HOMEOSTASIS; SUSCEPTIBILITY LOCI; ANIMAL-MODEL; ALPHA-GENE; RISK LOCI; YOUNG	We performed genome-wide mutagenesis in C57BL/6J mice using N-ethyl-N-nitrosourea to identify mutations causing high blood glucose early in life and to produce new animal models of diabetes. Of a total of 13 new lines confirmed by heritability testing, we identified two semi-dominant pedigrees with novel missense mutations (Gck(K140E) and Gck(P417R)) in the gene encoding glucokinase (Gck), the mammalian glucose sensor that is mutated in human maturity onset diabetes of the young type 2 and the target of emerging anti-hyperglycemic agents that function as glucokinase activators (GKAs). Diabetes phenotype corresponded with genotype (mild-to-severe: Gck(+/+) < Gck(P417R/+), Gck(K140E/+) < Gck(P417R/P417R), Gck(P417R/K140E), and Gck(K140E/K140E)) and with the level of expression of GCK in liver. Each mutant was produced as the recombinant enzyme in Escherichia coli, and analysis of k(cat) and tryptophan fluorescence (I-320/360) during thermal shift unfolding revealed a correlation between thermostability and the severity of hyperglycemia in the whole animal. Disruption of the glucokinase regulatory protein-binding site (GCK(K140E)), but not the ATP binding cassette (GCK(P417R)), prevented inhibition of enzyme activity by glucokinase regulatory protein and corresponded with reduced responsiveness to the GKA drug. Surprisingly, extracts from liver of diabetic GCK mutants inhibited activity of the recombinant enzyme, a property that was also observed in liver extracts from mice with streptozotocin-induced diabetes. These results indicate a relationship between genotype, phenotype, and GKA efficacy. The integration of forward genetic screening and bio-chemical profiling opens a pathway for preclinical development of mechanism-based diabetes therapies.	[Fenner, Deborah; Kobayashi, Yumiko; Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Fenner, Deborah; Hong, Hee-Kyung; Kobayashi, Yumiko; Kohsaka, Akira; Siepka, Sandra M.; Vitaterna, Martha H.; Takahashi, Joseph S.; Bass, Joseph] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Hong, Hee-Kyung; Siepka, Sandra M.; Vitaterna, Martha H.; Bass, Joseph] Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA; [Odili, Stella; Chen, Pan; Zelent, Bogumil; Matschinsky, Franz M.] Univ Penn, Sch Med, Dept Biochem & Biophys, Childrens Hosp Penn, Philadelphia, PA 19104 USA; [Odili, Stella; Chen, Pan; Zelent, Bogumil; Matschinsky, Franz M.] Univ Penn, Sch Med, Ctr Diabet, Philadelphia, PA 19104 USA; [Grimsby, Joseph] Hoffmann La Roche, Dept Metab Dis, Nutley, NJ 07110 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kohsaka, Akira] Wakayama Med Univ, Dept Med, Wakayama 6408265, Japan; [Kohsaka, Akira] Wakayama Med Univ, Dept Physiol 2, Wakayama 6408265, Japan	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Roche Holding; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wakayama Medical University; Wakayama Medical University	Bass, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 303 E Super St, Chicago, IL 60611 USA.	j-bass@northwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Fenner, Deborah/0000-0002-3193-2084	National Institutes of Health, NIMH [U01 MH61915]; National Institutes of Health, NIDDK [R01 DK022122]; University of Chicago Diabetes Research and Training Center [DK-20595]; Chicago Biomedical Consortium [C-007]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090625, P60DK020595, R01DK022122, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH061915] Funding Source: NIH RePORTER	National Institutes of Health, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Chicago Diabetes Research and Training Center(University of Chicago); Chicago Biomedical Consortium; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 MH61915 from NIMH (to J. S. T.) and R01 DK022122 from NIDDK (to F. M. M.). This work was also supported by the University of Chicago Diabetes Research and Training Center Grant DK-20595 (to J. B.) and the Chicago Biomedical Consortium with support from The Searle Funds at the Chicago Community Trust Grant C-007 (to J. B.).	Augustin M, 2005, MAMM GENOME, V16, P405, DOI 10.1007/s00335-004-3028-2; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; BEDOYA FJ, 1986, J BIOL CHEM, V261, P760; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boles MK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000759; Burke CV, 1999, BIOCHEM J, V342, P345, DOI 10.1042/0264-6021:3420345; Concepcion D, 2004, GENETICS, V168, P953, DOI 10.1534/genetics.104.029843; de la Iglesia N, 1999, FEBS LETT, V456, P332, DOI 10.1016/S0014-5793(99)00971-0; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Gloyn AL, 2003, HUM MUTAT, V22, P353, DOI 10.1002/humu.10277; Gloyn AL, 2004, FRONT DIABETES, V16, P92; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; Gorman T, 2008, DIABETES OBES METAB, V10, P885, DOI 10.1111/j.1463-1326.2007.00819.x; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; Marotta DE, 2005, ARCH BIOCHEM BIOPHYS, V436, P23, DOI 10.1016/j.abb.2005.01.018; Michaud EJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-164; Nakamura A, 2009, ENDOCRINOLOGY, V150, P1147, DOI 10.1210/en.2008-1183; NISHI S, 1992, DIABETOLOGIA, V35, P743; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pino MF, 2007, J BIOL CHEM, V282, P13906, DOI 10.1074/jbc.M610094200; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rozen S, 2000, Methods Mol Biol, V132, P365; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Sakuraba Y, 2005, BIOCHEM BIOPH RES CO, V336, P609, DOI 10.1016/j.bbrc.2005.08.134; Salpeter SJ, 2010, DEVELOPMENT, V137, P3205, DOI 10.1242/dev.054304; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Takahasi KR, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-52; Terauchi Y, 1995, J BIOL CHEM, V270, P30253, DOI 10.1074/jbc.270.51.30253; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Vanhaesebroeck B, 2004, CELL, V118, P274, DOI 10.1016/j.cell.2004.07.018; VeigadaCunha M, 1996, J BIOL CHEM, V271, P6292, DOI 10.1074/jbc.271.11.6292; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Vitaterna MH, 2006, TRENDS NEUROSCI, V29, P233, DOI 10.1016/j.tins.2006.02.006; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zelent B, 2011, BIOCHEM J, V440, P203, DOI 10.1042/BJ20110440; Zhang YL, 2004, ACTA PHARMACOL SIN, V25, P1659	53	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39560	39572		10.1074/jbc.M111.269100	http://dx.doi.org/10.1074/jbc.M111.269100			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21921030	Green Published, hybrid			2022-12-27	WOS:000296759800073
J	Kouki, A; Haataja, S; Loimaranta, V; Pulliainen, AT; Nilsson, UJ; Finne, J				Kouki, Annika; Haataja, Sauli; Loimaranta, Vuokko; Pulliainen, Arto T.; Nilsson, Ulf J.; Finne, Jukka			Identification of a Novel Streptococcal Adhesin P (SadP) Protein Recognizing Galactosyl-alpha 1-4-galactose-containing Glycoconjugates CONVERGENT EVOLUTION OF BACTERIAL PATHOGENS TO BINDING OF THE SAME HOST RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SUIS SEROTYPE-2; GLYCOLIPID BINDING; ENDOTHELIAL-CELLS; STRUCTURAL BASIS; H2O2 RESISTANCE; SURFACE PROTEIN; GORDONII DL1; SIALIC-ACID; E. COLI	Bacterial adhesion is often a prerequisite for infection, and host cell surface carbohydrates play a major role as adhesion receptors. Streptococci are a leading cause of infectious diseases. However, only few carbohydrate-specific streptococcal adhesins are known. Streptococcus suis is an important pig pathogen and a zoonotic agent causing meningitis in pigs and humans. In this study, we have identified an adhesin that mediates the binding of S. suis to galactosyl-alpha 1-4-galactose (Gal alpha 1-4Gal)-containing host receptors. A functionally unknown S. suis cell wall protein (SSU0253), designated here as SadP (streptococcal adhesin P), was identified using a Gal alpha 1-4Gal-containing affinity matrix and LC-ESI mass spectrometry. Although the function of the protein was not previously known, it was recently identified as an immunogenic cell wall protein in a proteomic study. Insertional inactivation of the sadP gene abolished S. suis Gal alpha 1-4Gal-dependent binding. The adhesin gene sadP was cloned and expressed in Escherichia coli. Characterization of its binding specificity showed that SadP recognizes Gal alpha 1-4Gal-oligosaccharides and binds its natural glycolipid receptor, GbO(3) (CD77). The N terminus of SadP was shown to contain a Gal alpha 1-Gal-binding site and not to have apparent sequence similarity to other bacterial adhesins, including the E. coli P fimbrial adhesins, or to E. coli verotoxin or Pseudomonas aeruginosa lectin I also recognizing the same Gal alpha 1-4Gal disaccharide. The SadP and E. coli P adhesins represent a unique example of convergent evolution toward binding to the same host receptor structure.	[Kouki, Annika; Haataja, Sauli; Loimaranta, Vuokko; Pulliainen, Arto T.] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland; [Finne, Jukka] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FI-00014 Helsinki, Finland; [Pulliainen, Arto T.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Nilsson, Ulf J.] Lund Univ, SE-22100 Lund, Sweden	University of Turku; University of Helsinki; University of Basel; Lund University	Haataja, S (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FI-20520 Turku, Finland.	sauli.haataja@utu.fi	Nilsson, Ulf J./L-3219-2014; Haataja, Sauli/AAR-5103-2020; Pulliainen, Arto/AAX-2052-2021; Finne, Jukka/B-6881-2008	Nilsson, Ulf J./0000-0001-5815-9522; Loimaranta, Vuokko/0000-0002-6873-2270; Finne, Jukka/0000-0002-8076-3344; Pulliainen, Arto Tapio/0000-0002-9361-8963	Finnish Academy [114100]; Turku University Foundation; Duodecim Society of Turunmaa; Finnish Graduate School of Glycosciences	Finnish Academy(Academy of Finland); Turku University Foundation; Duodecim Society of Turunmaa; Finnish Graduate School of Glycosciences	This study was supported by Finnish Academy Grant 114100, the Turku University Foundation, the Duodecim Society of Turunmaa and the Finnish Graduate School of Glycosciences.	Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Berthelot-Herault F, 2005, CAN J VET RES, V69, P236; Berthelot-Herault F, 2001, CAN J VET RES, V65, P196; Blanchard B, 2008, J MOL BIOL, V383, P837, DOI 10.1016/j.jmb.2008.08.028; BOYD B, 1993, J EXP MED, V177, P1745, DOI 10.1084/jem.177.6.1745; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Chen B, 2010, FEMS MICROBIOL LETT, V307, P12, DOI 10.1111/j.1574-6968.2010.01944.x; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; Devenica D., 2010, MED ONCOL IN PRESS; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Duensing TD, 1999, INFECT IMMUN, V67, P4463, DOI 10.1128/IAI.67.9.4463-4468.1999; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; FRANCOISGERARD C, 1979, BIOCHEM J, V177, P679, DOI 10.1042/bj1770679; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; Gu HW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-201; HAATAJA S, 1993, J BIOL CHEM, V268, P4311; HAATAJA S, 1994, J BIOL CHEM, V269, P27466; Hansen HC, 1997, J AM CHEM SOC, V119, P6974, DOI 10.1021/ja970859p; HIGGINS R, 2005, DIS SWINE, P769; Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005; Joosten JAF, 2004, J MED CHEM, V47, P6499, DOI 10.1021/jm049476+; KARLSSON KA, 1986, CHEM PHYS LIPIDS, V42, P153, DOI 10.1016/0009-3084(86)90050-2; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; KRIVAN HC, 1988, P NATL ACAD SCI USA, V85, P6157, DOI 10.1073/pnas.85.16.6157; KURL DN, 1989, INFECT IMMUN, V57, P384, DOI 10.1128/IAI.57.2.384-389.1989; Li W, 2010, INT J MED MICROBIOL, V300, P482, DOI 10.1016/j.ijmm.2010.04.018; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Lingwood CA, 2010, FEBS LETT, V584, P1879, DOI 10.1016/j.febslet.2009.11.089; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; LIUKKONEN J, 1992, J BIOL CHEM, V267, P21105; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Mandanici F, 2010, J PROTEOMICS, V73, P2365, DOI 10.1016/j.jprot.2010.07.009; Moschioni M, 2010, INFECT IMMUN, V78, P5033, DOI 10.1128/IAI.00601-10; Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1; Ohlsson J, 2005, ORG BIOMOL CHEM, V3, P886, DOI 10.1039/b416878j; Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pulliainen AT, 2008, J BACTERIOL, V190, P3225, DOI 10.1128/JB.01843-07; Pulliainen AT, 2005, MOL MICROBIOL, V57, P1086, DOI 10.1111/j.1365-2958.2005.04756.x; Pulliainen AT, 2003, J BIOL CHEM, V278, P7996, DOI 10.1074/jbc.M210174200; SCHMIDT KH, 1993, ZBL BAKT-INT J MED M, V279, P472, DOI 10.1016/S0934-8840(11)80419-6; Schweppe CH, 2008, GLYCOCONJUGATE J, V25, P291, DOI 10.1007/s10719-007-9091-7; Sharon N, 2000, GLYCOCONJUGATE J, V17, P659, DOI 10.1023/A:1011091029973; Sikora S, 2005, TRENDS MICROBIOL, V13, P522, DOI 10.1016/j.tim.2005.08.010; Smith HE, 1999, INFECT IMMUN, V67, P1750; STROMBERG N, 1990, EMBO J, V9, P2001, DOI 10.1002/j.1460-2075.1990.tb08328.x; STROMBERG N, 1991, P NATL ACAD SCI USA, V88, P9340, DOI 10.1073/pnas.88.20.9340; Suzuki N, 2001, J BIOL CHEM, V276, P23221, DOI 10.1074/jbc.M101379200; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2009, VET MICROBIOL, V138, P132, DOI 10.1016/j.vetmic.2009.02.013; Tan C, 2008, FEMS MICROBIOL LETT, V278, P108, DOI 10.1111/j.1574-6968.2007.00980.x; TIKKANEN K, 1995, J BIOL CHEM, V270, P28874, DOI 10.1074/jbc.270.48.28874; TYRRELL GJ, 1992, P NATL ACAD SCI USA, V89, P524, DOI 10.1073/pnas.89.2.524; Uchiyama S, 2009, J EXP MED, V206, P1845, DOI 10.1084/jem.20090386; Urano-Tashiro Y, 2008, INFECT IMMUN, V76, P4686, DOI 10.1128/IAI.00238-08; Vanier G, 2008, VET MICROBIOL, V127, P417, DOI 10.1016/j.vetmic.2007.08.032; Wilson TL, 2007, VET MICROBIOL, V122, P135, DOI 10.1016/j.vetmic.2006.12.025; WINTERS BD, 1993, INFECT IMMUN, V61, P3259, DOI 10.1128/IAI.61.8.3259-3264.1993; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x; Ye CY, 2009, J INFECT DIS, V199, P97, DOI 10.1086/594370; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007	68	33	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38854	38864		10.1074/jbc.M111.260992	http://dx.doi.org/10.1074/jbc.M111.260992			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21908601	Green Published, hybrid			2022-12-27	WOS:000296759800004
J	Lee, KH; Hsu, EC; Guh, JH; Yang, HC; Wang, DS; Kulp, SK; Shapiro, CL; Chen, CS				Lee, Kuen-Haur; Hsu, En-Chi; Guh, Jih-Hwa; Yang, Hsiao-Ching; Wang, Dasheng; Kulp, Samuel K.; Shapiro, Charles L.; Chen, Ching-Shih			Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple-negative Breast Cancer by a Novel Adenosine Monophosphate-activated Protein Kinase (AMPK) Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADHERIN GENE-EXPRESSION; MESENCHYMAL TRANSITION; METFORMIN; GROWTH; STAT3; RISK; PHOSPHORYLATION; TRANSLATION; METASTASIS; MECHANISM	The antitumor activities of the novel adenosine monophosphate-activated protein kinase (AMPK) activator, OSU-53, were assessed in in vitro and in vivo models of triple-negative breast cancer. OSU-53 directly stimulated recombinant AMPK kinase activity (EC50, 0.3 mu M) and inhibited the viability and clonogenic growth of MDA-MB-231 and MDA-MB-468 cells with equal potency (IC50, 5 and 2 mu M, respectively) despite lack of LKB1 expression in MDA-MB-231 cells. Nonmalignant MCF-10A cells, however, were unaffected. Beyond AMPK-mediated effects on mammalian target of rapamycin signaling and lipogenesis, OSU-53 also targeted multiple AMPK downstream pathways. Among these, the protein phosphatase 2A-dependent dephosphorylation of Akt is noteworthy because it circumvents the feedback activation of Akt that results from mammalian target of rapamycin inhibition. OSU-53 also modulated energy homeostasis by suppressing fatty acid biosynthesis and shifting the metabolism to oxidation by up-regulating the expression of key regulators of mitochondrial biogenesis, such as a peroxisome proliferator-activated receptor gamma coactivator 1 alpha and the transcription factor nuclear respiratory factor 1. Moreover, OSU-53 suppressed LPS-induced IL-6 production, thereby blocking subsequent Stat3 activation, and inhibited hypoxia-induced epithelial-mesenchymal transition in association with the silencing of hypoxia-inducible factor 1a and the E-cadherin repressor Snail. In MDA-MB-231 tumor-bearing mice, daily oral administration of OSU-53 (50 and 100 mg/kg) suppressed tumor growth by 47-49% and modulated relevant intratumoral biomarkers of drug activity. However, OSU-53 also induced protective autophagy that attenuated its antiproliferative potency. Accordingly, cotreatment with the autophagy inhibitor chloroquine increased the in vivo tumor-suppressive activity of OSU-53. OSU-53 is a potent, orally bioavailable AMPK activator that acts through a broad spectrum of antitumor activities.	[Lee, Kuen-Haur; Hsu, En-Chi; Wang, Dasheng; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA; [Shapiro, Charles L.] Ohio State Univ, Coll Med, Div Med Oncol, Columbus, OH 43210 USA; [Guh, Jih-Hwa] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 10051, Taiwan; [Yang, Hsiao-Ching] Fu Jen Catholic Univ, Dept Chem, New Taipei City 24205, Taiwan	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Taiwan University; Fu Jen Catholic University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem, 336 Pk Hall,500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu	Yang, Hsiao-Ching/AGI-3553-2022; Hsu, En-Chi/AAH-4589-2021	Yang, Hsiao-Ching/0000-0002-7970-1357; Hsu, En-Chi/0000-0002-5671-6169; GUH, JIH-HWA/0000-0002-6738-6054	National Institutes of Health (USPHS) from NCI [R01CA112250, R21CA158807]; NATIONAL CANCER INSTITUTE [R01CA112250, R21CA158807] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Institutes of Health (USPHS) from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA112250 and R21CA158807 (USPHS) from NCI (to C. S. C.).	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3271, DOI 10.1200/JCO.2009.22.1630; Guh JH, 2010, J MED CHEM, V53, P2552, DOI 10.1021/jm901773d; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Hadad SM, 2008, CRIT REV ONCOL HEMAT, V67, P1, DOI 10.1016/j.critrevonc.2008.01.007; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Kuznetsov JN, 2011, MOL CANCER THER, V10, P437, DOI 10.1158/1535-7163.MCT-10-0777; Leclerc Gilles M, 2010, J Mol Signal, V5, P15, DOI 10.1186/1750-2187-5-15; Lihn AS, 2008, MOL CELL ENDOCRINOL, V292, P36, DOI 10.1016/j.mce.2008.06.004; Ma YW, 2010, BBA-BIOENERGETICS, V1797, P29, DOI 10.1016/j.bbabio.2009.07.008; Mbalaviele G, 1996, CANCER RES, V56, P4063; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Memmott RM, 2009, J CLIN ONCOL, V27, pE226, DOI 10.1200/JCO.2009.25.3963; Nerstedt A, 2010, DIABETOLOGIA, V53, P2406, DOI 10.1007/s00125-010-1856-z; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Thomson DM, 2009, ACTA PHYSIOL, V196, P147, DOI 10.1111/j.1748-1716.2009.01973.x; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Vilar E, 2011, MOL CANCER THER, V10, P395, DOI 10.1158/1535-7163.MCT-10-0905; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu L, 2010, NEUROSCIENCE, V169, P23, DOI 10.1016/j.neuroscience.2010.04.063; Zadra G, 2010, CLIN CANCER RES, V16, P3322, DOI 10.1158/1078-0432.CCR-09-1955; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang L, 2007, AM J PHYSIOL-HEART C, V293, pH457, DOI 10.1152/ajpheart.00002.2007; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhou WB, 2003, CANCER RES, V63, P7330	62	87	93	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39247	39258		10.1074/jbc.M111.264598	http://dx.doi.org/10.1074/jbc.M111.264598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21917926	Green Published, hybrid			2022-12-27	WOS:000296759800043
J	Yoo, BH; Wang, YF; Erdogan, M; Sasazuki, T; Shirasawa, S; Corcos, L; Sabapathy, K; Rosen, KV				Yoo, Byong Hoon; Wang, Yanfei; Erdogan, Mete; Sasazuki, Takehiko; Shirasawa, Senji; Corcos, Laurent; Sabapathy, Kanaga; Rosen, Kirill V.			Oncogenic ras-induced Down-regulation of Pro-apoptotic Protease Caspase-2 Is Required for Malignant Transformation of Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; ANOIKIS RESISTANCE; PROMOTES APOPTOSIS; SERINE-PROTEASE; UP-REGULATION; IN-VIVO; GROWTH; DETACHMENT; DEATH; GENE	Resistance of carcinoma cells to anoikis, apoptosis that is normally induced by loss of cell-to-extracellular matrix adhesion, is thought to be essential for the ability of these cells to form primary tumors, invade adjacent tissues, and metastasize to distant organs. Current knowledge about the mechanisms by which cancer cells evade anoikis is far from complete. In an effort to understand these mechanisms, we found that ras, a major oncogene, down-regulates protease caspase-2 (which initiates certain steps of the cellular apoptotic program) in malignant human and rat intestinal epithelial cells. This down-regulation could be reversed by inhibition of a protein kinase Mek, a mediator of Ras signaling. We also found that enforced down-regulation of caspase-2 in nonmalignant intestinal epithelial cells by RNA interference protected them from anoikis. Furthermore, the reversal of the effect of Ras on caspase-2 achieved by the expression of exogenous caspase-2 in detached ras-transformed intestinal epithelial cells promoted well established apoptotic events, such as the release of the pro-apoptotic mitochondrial factors cytochrome c and HtrA2/Omi into the cytoplasm of these cells, significantly enhanced their anoikis susceptibility, and blocked their long term growth in the absence of adhesion to the extracellular matrix. Finally, the blockade of the effect of Ras on caspase-2 substantially suppressed growth of tumors formed by the ras-transformed cells in mice. We conclude that ras-induced down-regulation of caspase-2 represents a novel mechanism by which oncogenic Ras protects malignant intestinal epithelial cells from anoikis, promotes their anchorage-independent growth, and allows them to form tumors in vivo.	[Rosen, Kirill V.] Dalhousie Univ, Atlantic Res Ctr, CRC, Dept Pediat, Halifax, NS B3H 4H7, Canada; [Yoo, Byong Hoon; Wang, Yanfei; Erdogan, Mete; Rosen, Kirill V.] Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada; [Sasazuki, Takehiko] Int Med Ctr Japan, Dept Pathol, Res Inst, Tokyo 1638655, Japan; [Shirasawa, Senji] Fukuoka Univ, Dept Cell Biol, Sch Med, Fukuoka 8140180, Japan; [Corcos, Laurent] INSERM, Fac Med, F-29200 Brest, France; [Sabapathy, Kanaga] Natl Canc Ctr, Mol Carcinogenesis Lab, Singapore 169610, Singapore	Dalhousie University; Dalhousie University; National Center for Global Health & Medicine - Japan; Fukuoka University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; National Cancer Centre Singapore (NCCS)	Rosen, KV (corresponding author), Dalhousie Univ, Atlantic Res Ctr, CRC, Dept Pediat, Room C-302,5849 Univ Ave, Halifax, NS B3H 4H7, Canada.	kirill.rosen@dal.ca	Corcos, Laurent/K-1859-2015; Corcos, Laurent/M-8915-2017; Corcos, Laurent/AAJ-2692-2020	Corcos, Laurent/0000-0001-8019-2505; Corcos, Laurent/0000-0001-8019-2505; Rosen, Kirill/0000-0002-4317-9907	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from Canadian Institutes of Health Research.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Colussi PA, 1998, J BIOL CHEM, V273, P24535, DOI 10.1074/jbc.273.38.24535; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FILMUS J, 1994, ONCOGENE, V9, P3627; Frankel A, 2001, CANCER RES, V61, P4837; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Li HB, 2009, J BIOL CHEM, V284, P2012, DOI 10.1074/jbc.M805612200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Liu ZP, 2006, J BIOL CHEM, V281, P14738, DOI 10.1074/jbc.M508664200; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; LJUBIMOV AV, 1992, INT J CANCER, V50, P562, DOI 10.1002/ijc.2910500412; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Logette E, 2003, ONCOGENE, V22, P935, DOI 10.1038/sj.onc.1206172; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Meredith JE, 1997, TRENDS CELL BIOL, V7, P146, DOI 10.1016/S0962-8924(97)01002-7; Olson M., 2001, Current Molecular Medicine (Hilversum), V1, P91, DOI 10.2174/1566524013364239; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Rosen K, 2002, J BIOL CHEM, V277, P46123, DOI 10.1074/jbc.M207883200; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; Rytomaa M, 2000, ONCOGENE, V19, P4461, DOI 10.1038/sj.onc.1203805; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scotlandi K, 2002, CANCER GENE THER, V9, P296, DOI 10.1038/sj.cgt.7700442; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Yoo NJ, 2004, APMIS, V112, P330; Zohrabian VM, 2007, ONCOL REP, V18, P321; Zouq NK, 2009, J CELL SCI, V122, P357, DOI 10.1242/jcs.030478	66	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38894	38903		10.1074/jbc.M111.290692	http://dx.doi.org/10.1074/jbc.M111.290692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21903589	hybrid, Green Published			2022-12-27	WOS:000296759800008
J	Busillo, JM; Azzam, KM; Cidlowski, JA				Busillo, John M.; Azzam, Kathleen M.; Cidlowski, John A.			Glucocorticoids Sensitize the Innate Immune System through Regulation of the NLRP3 Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALP3 INFLAMMASOME; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; OXIDATIVE STRESS; CUTTING EDGE; RECEPTOR; ACTIVATION; ATP; RELEASE; GENE	Glucocorticoids have long been recognized as powerful anti-inflammatory compounds that are one of the most widely prescribed classes of drugs in the world. However, their role in the regulation of innate immunity is not well understood. We sought to examine the effects of glucocorticoids on the NOD-like receptors (NLRs), a central component of the inflammasome and innate immunity. Surprisingly, we show that glucocorticoids induce both NLRP3 messenger RNA and protein, which is a critical component of the inflammasome. The glucocorticoid-dependent induction of NLRP3 sensitizes the cells to extracellular ATP and significantly enhances the ATP-mediated release of proinflammatory molecules, including mature IL-1 beta, TNF-alpha, and IL-6. This effect was specific for glucocorticoids and dependent on the glucocorticoid receptor. These studies demonstrate a novel role for glucocorticoids in sensitizing the initial inflammatory response by the innate immune system.	[Busillo, John M.; Cidlowski, John A.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Azzam, Kathleen M.] NIEHS, Lab Resp Biol, Dept Hlth & Human Serv, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), 111 TW Alexander Dr,Rm F349, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	National Institutes of Health of the NIEHS [1ZIAES090057-15]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090057] Funding Source: NIH RePORTER	National Institutes of Health of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by a National Institutes of Health grant 1ZIAES090057-15 (intramural research program of the NIEHS).	Anderson JP, 2008, GENES IMMUN, V9, P721, DOI 10.1038/gene.2008.66; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Bodin P, 1998, INFLAMM RES, V47, P351, DOI 10.1007/s000110050341; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Chanson P, 2010, NEUROENDOCRINOLOGY, V92, P96, DOI 10.1159/000314272; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Ding Y, 2010, J PHARMACOL EXP THER, V335, P693, DOI 10.1124/jpet.110.171975; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P19, DOI 10.1016/j.bbi.2009.07.008; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; JOELS M, 1989, SCIENCE, V245, P1502, DOI 10.1126/science.2781292; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; KNUDSEN PJ, 1987, J IMMUNOL, V139, P4129; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; McIntosh LJ, 1996, EXP NEUROL, V141, P201, DOI 10.1006/exnr.1996.0154; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Oakley RH, 2011, J BIOL CHEM, V286, P3177, DOI 10.1074/jbc.R110.179325; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Perretti M, 2000, MICROCIRCULATION, V7, P147, DOI 10.1038/sj.mn.7300108; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Smith LK, 2010, PROG BRAIN RES, V182, P1, DOI 10.1016/S0079-6123(10)82001-1; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Smyth GP, 2004, J SURG RES, V116, P253, DOI 10.1016/S0022-4804(03)00300-7; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; WURTMAN RJ, 1966, J BIOL CHEM, V241, P2301; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	61	162	167	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38703	38713		10.1074/jbc.M111.275370	http://dx.doi.org/10.1074/jbc.M111.275370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21940629	hybrid, Green Published			2022-12-27	WOS:000296594200082
J	Du, ZM; Liu, JJ; Albracht, CD; Hsu, A; Chen, W; Marieni, MD; Colelli, KM; Williams, JE; Reitter, JN; Mills, KV; Wang, CY				Du, Zhenming; Liu, Jiajing; Albracht, Clayton D.; Hsu, Alice; Chen, Wen; Marieni, Michelle D.; Colelli, Kathryn M.; Williams, Jennie E.; Reitter, Julie N.; Mills, Kenneth V.; Wang, Chunyu			Structural and Mutational Studies of a Hyperthermophilic Intein from DNA Polymerase II of Pyrococcus abyssi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; CRYSTAL-STRUCTURE; HOMING ENDONUCLEASE; BACKBONE DYNAMICS; PROTEIN-STRUCTURE; VMA1-DERIVED ENDONUCLEASE; CHEMICAL-SHIFT; PEPTIDE-BOND; NMR	Protein splicing is a precise self-catalyzed process in which an intein excises itself from a precursor with the concomitant ligation of the flanking polypeptides (exteins). Protein splicing proceeds through a four-step reaction but the catalytic mechanism is not fully understood at the atomic level. We report the solution NMR structures of the hyperthermophilic Pyrococcus abyssi PolII intein, which has a noncanonical C-terminal glutamine instead of an asparagine. The NMR structures were determined to a backbone root mean square deviation of 0.46 angstrom and a heavy atom root mean square deviation of 0.93 angstrom. The Pab PolII intein has a common HINT (hedgehog intein) fold but contains an extra beta-hairpin that is unique in the structures of thermophilic inteins. The NMR structures also show that the Pab PolII intein has a long and disordered loop in place of an endonuclease domain. The N-terminal Cys-1 amide is hydrogen bonded to the Thr-90 hydroxyl in the conserved block-B TXXH motif and the Cys-1 thiol forms a hydrogen bond with the block F Ser-166. Mutating Thr-90 to Ala dramatically slows N-terminal cleavage, supporting its pivotal role in promoting the N-S acyl shift. Mutagenesis also showed that Thr-90 and His-93 are synergistic in catalyzing the N-S acyl shift. The block F Ser-166 plays an important role in coordinating the steps of protein splicing. NMR spin relaxation indicates that the Pab PolII intein is significantly more rigid than mesophilic inteins, which may contribute to the higher optimal temperature for protein splicing.	[Marieni, Michelle D.; Colelli, Kathryn M.; Williams, Jennie E.; Reitter, Julie N.; Mills, Kenneth V.] Coll Holy Cross, Dept Chem, Worcester, MA 01610 USA; [Du, Zhenming; Liu, Jiajing; Albracht, Clayton D.; Hsu, Alice; Chen, Wen; Wang, Chunyu] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	College of the Holy Cross; Rensselaer Polytechnic Institute	Mills, KV (corresponding author), Coll Holy Cross, Dept Chem, Worcester, MA 01610 USA.	kmills@holycross.edu; wangc5@rpi.edu	Wang, Chunyu/AAH-5952-2019; Chen, Wen/P-3663-2014	Wang, Chunyu/0000-0001-5165-7959	National Institutes of Health [GM081408]; National Science Foundation [0950245]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081408 (to C. W.) and National Science Foundation Grant 0950245 (to K. V. M.).	Amitai G, 2004, J BIOL CHEM, V279, P3121, DOI 10.1074/jbc.M311343200; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101; Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Du ZM, 2011, J AM CHEM SOC, V133, P10275, DOI 10.1021/ja203209f; Du ZM, 2010, J MOL BIOL, V400, P755, DOI 10.1016/j.jmb.2010.05.044; Du ZM, 2009, J AM CHEM SOC, V131, P11581, DOI 10.1021/ja904318w; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; ERAUSO G, 1993, ARCH MICROBIOL, V160, P338; Evans TC, 1999, J BIOL CHEM, V274, P18359, DOI 10.1074/jbc.274.26.18359; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Frutos S, 2010, NAT CHEM BIOL, V6, P527, DOI [10.1038/NCHEMBIO.371, 10.1038/nchembio.371]; Goodman JL, 2000, J MOL BIOL, V295, P963, DOI 10.1006/jmbi.1999.3419; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu DL, 2000, J BIOL CHEM, V275, P2705, DOI 10.1074/jbc.275.4.2705; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; Johnson MA, 2007, PROTEIN SCI, V16, P1316, DOI 10.1110/ps.072816707; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Kwon Y, 2006, ANGEW CHEM INT EDIT, V45, P1726, DOI 10.1002/anie.200503475; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu J., 2011, BIOMOL NMR ASSIGN; Matsumura H, 2006, PROTEINS, V63, P711, DOI 10.1002/prot.20858; Mills KV, 2004, J BIOL CHEM, V279, P20685, DOI 10.1074/jbc.M400887200; Mizutani R, 2004, J SYNCHROTRON RADIAT, V11, P109, DOI 10.1107/S0909049503023495; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813; Moure CM, 2002, NAT STRUCT BIOL, V9, P764, DOI 10.1038/nsb840; Oeemig JS, 2009, FEBS LETT, V583, P1451, DOI 10.1016/j.febslet.2009.03.058; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Paulus H, 1998, CHEM SOC REV, V27, P375, DOI 10.1039/a827375z; Paulus H, 2007, DRUG FUTURE, V32, P973, DOI 10.1358/dof.2007.032.11.1140690; Pereira B, 2011, J MOL BIOL, V406, P430, DOI 10.1016/j.jmb.2010.12.024; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Pietrokovski S, 1998, CURR BIOL, V8, pR634, DOI 10.1016/S0960-9822(07)00409-5; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Seyedsayamdost MR, 2006, J AM CHEM SOC, V128, P1562, DOI 10.1021/ja055927j; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sun P, 2005, J MOL BIOL, V353, P1093, DOI 10.1016/j.jmb.2005.09.039; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Van Roey P, 2007, J MOL BIOL, V367, P162, DOI 10.1016/j.jmb.2006.12.050; Werner E, 2002, NUCLEIC ACIDS RES, V30, P3962, DOI 10.1093/nar/gkf523; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wood DW, 2000, BIOTECHNOL PROGR, V16, P1055, DOI 10.1021/bp0000858; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	62	21	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38638	38648		10.1074/jbc.M111.290569	http://dx.doi.org/10.1074/jbc.M111.290569			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914805	hybrid, Green Published			2022-12-27	WOS:000296594200076
J	Rapley, J; Oshiro, N; Ortiz-Vega, S; Avruch, J				Rapley, Joseph; Oshiro, Noriko; Ortiz-Vega, Sara; Avruch, Joseph			The Mechanism of Insulin-stimulated 4E-BP Protein Binding to Mammalian Target of Rapamycin (mTOR) Complex 1 and Its Contribution to mTOR Complex 1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH AKT SUBSTRATE; AMINO-ACID SUFFICIENCY; P70 S6 KINASE; 40 KDA PRAS40; CELL-GROWTH; DISTINCT ROLES; RAG GTPASES; TOS MOTIF; IN-VITRO; RAPTOR	Insulin activation of mTOR complex 1 is accompanied by enhanced binding of substrates. We examined the mechanism and contribution of this enhancement to insulin activation of mTORC1 signaling in 293E and HeLa cells. In 293E, insulin increased the amount of mTORC1 retrieved by the transiently expressed nonphosphorylatable 4E-BP[5A] to an extent that varied inversely with the amount of PRAS40 bound to mTORC1. RNAi depletion of PRAS40 enhanced 4E-BP[5A] binding to similar to 70% the extent of maximal insulin, and PRAS40 RNAi and insulin together did not increase 4E-BP[5A] binding beyond insulin alone, suggesting that removal of PRAS40 from mTORC1 is the predominant mechanism of an insulin-induced increase in substrate access. As regards the role of increased substrate access in mTORC1 signaling, RNAi depletion of PRAS40, although increasing 4E-BP[5A] binding, did not stimulate phosphorylation of endogenous mTORC1 substrates S6K1(Thr(389)) or 4E-BP (Thr(37)/Thr(46)), the latter already similar to 70% of maximal in amino acid replete, serum-deprived 293E cells. In HeLa cells, insulin and PRAS40 RNAi also both enhanced the binding of 4E-BP[5A] to raptor but only insulin stimulated S6K1 and 4E-BP phosphorylation. Furthermore, Rheb overexpression in 293E activated mTORC1 signaling completely without causing PRAS40 release. In the presence of Rheb and insulin, PRAS40 release is abolished by Akt inhibition without diminishing mTORC1 signaling. In conclusion, dissociation of PRAS40 from mTORC1 and enhanced mTORC1 substrate binding results from Akt and mTORC1 activation and makes little or no contribution to mTORC1 signaling, which rather is determined by Rheb activation of mTOR catalytic activity, through mechanisms that remain to be fully elucidated.	[Avruch, Joseph] Massachusetts Gen Hosp, Diabet Res Lab, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Med Serv, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Avruch, J (corresponding author), Massachusetts Gen Hosp, Diabet Res Lab, Dept Mol Biol, Simches Res Bldg 6408,185 Cambridge St, Boston, MA 02114 USA.	avruch@molbio.mgh.harvard.edu			National Institutes of Health [DK17776, CA73818]; NATIONAL CANCER INSTITUTE [R01CA073818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017776, R37DK017776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK17776 and CA73818.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; Fonseca BD, 2008, BIOCHEM J, V411, P141, DOI 10.1042/BJ20071001; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hong-Brown LQ, 2010, J CELL BIOCHEM, V109, P1172, DOI 10.1002/jcb.22496; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	42	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38043	38053		10.1074/jbc.M111.245449	http://dx.doi.org/10.1074/jbc.M111.245449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914810	Green Published, hybrid			2022-12-27	WOS:000296594200016
J	Clarke, BR; Richards, MR; Greenfield, LK; Hou, DJ; Lowary, TL; Whitfield, C				Clarke, Bradley R.; Richards, Michele R.; Greenfield, Laura K.; Hou, Dianjie; Lowary, Todd L.; Whitfield, Chris			In Vitro Reconstruction of the Chain Termination Reaction in Biosynthesis of the Escherichia coli O9a O-Polysaccharide THE CHAIN-LENGTH REGULATOR, WbdD, CATALYZES THE ADDITION OF METHYL PHOSPHATE TO THE NON-REDUCING TERMINUS OF THE GROWING GLYCAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; SERUM RESISTANCE; LIPOPOLYSACCHARIDE; ANTIGEN; EXPRESSION; MUTANTS; SYSTEM; EXPORT; GENE; PROTEINS	The Escherichia coli O9a O-polysaccharide (O-PS) represents a model system for glycan biosynthesis and export by the ATP-binding cassette (ABC) transporter-dependent pathway. The polymannose O9a O-PS is synthesized using an undecaprenol-diphosphate-linked acceptor by mannosyltransferases located at the cytoplasmic membrane. An ABC-transporter subsequently exports the polymer to the periplasm where it is assembled onto lipopolysaccharide prior to translocation to the cell surface. The chain length of the O9a O-PS is regulated by the dual kinase/methyltransferase activity of the WbdD enzyme and modification of the polymer is crucial for binding and export by the ABC-transporter. Previous biochemical data provided evidence for phosphorylation/methylation at the non-reducing end of the O9a O-PS but the structure of the terminus has not been determined. Here, we describe the exploitation of a synthetic O9a O-PS repeating unit carrying a fluorescent tag as an acceptor for in vitro phosphorylation and methylation by a purified soluble form of WbdD. Phosphorylation of the acceptor was evident by both a mobility shift in thin layer chromatography and radiolabeling of the acceptor using [gamma-P-33]ATP. Methylation of the acceptor was dependent on phosphorylation and was demonstrated by radiolabeling using S-[methyl-H-3]adenosylmethionine as a substrate, in the presence of ATP. NMR spectroscopic and mass spectrometric methods were used to determine the precise structure of the terminal modification, leading to the conclusion that WbdD catalyzes the addition of a novel methyl phosphate group to the 3-position of the non-reducing terminal mannose of the O9a O-PS repeating unit.	[Clarke, Bradley R.; Greenfield, Laura K.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Richards, Michele R.; Hou, Dianjie; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Richards, Michele R.; Hou, Dianjie; Lowary, Todd L.] Univ Alberta, Alberta Innovates Ctr Carbohydrate Sci, Edmonton, AB T6G 2G2, Canada	University of Guelph; University of Alberta; Alberta Innovates; University of Alberta	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Lowary, Todd L/F-9608-2019; Richards, Mickey/E-8140-2011; Hou, Dianjie/G-4214-2013	Lowary, Todd L/0000-0002-8331-8211; Richards, Mickey/0000-0002-1973-5678; Hou, Dianjie/0000-0002-6555-5993	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; Alberta Innovates Centre for Carbohydrate Science	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Centre for Carbohydrate Science	This work was supported by the Canadian Institutes of Health Research (to C.W.), the Natural Sciences and Engineering Research Council (to T.L.L), and by the Alberta Innovates Centre for Carbohydrate Science (to T.L.L.).	BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Burns SM, 1998, INFECT IMMUN, V66, P4244; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GOLDMAN RC, 1980, EUR J BIOCHEM, V107, P145, DOI 10.1111/j.1432-1033.1980.tb04635.x; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HASEGAWA T, 1985, CHEM PHARM BULL, V33, P333; Hou DJ, 2008, CARBOHYD RES, V343, P1778, DOI 10.1016/j.carres.2008.02.025; JANN K, 1982, EUR J BIOCHEM, V127, P157, DOI 10.1111/j.1432-1033.1982.tb06850.x; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; Kahlig H, 2005, J BIOL CHEM, V280, P20292, DOI 10.1074/jbc.M501724200; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; McNally DJ, 2007, J BIOL CHEM, V282, P28566, DOI 10.1074/jbc.M704413200; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Miller J. H., 1972, EXPT MOL GENETICS, P432; Najdenski H, 2003, FEMS IMMUNOL MED MIC, V38, P97, DOI 10.1016/S0928-8244(03)00183-4; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NEUHARD J, 1976, J BACTERIOL, V126, P999, DOI 10.1128/JB.126.2.999-1001.1976; PREHM P, 1976, EUR J BIOCHEM, V67, P53, DOI 10.1111/j.1432-1033.1976.tb10631.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rasband WS, 2011, IMAGEJ; ROBERTS IS, 1988, J BACTERIOL, V170, P1305, DOI 10.1128/jb.170.3.1305-1310.1988; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Steiner K, 2008, J BIOL CHEM, V283, P21120, DOI 10.1074/jbc.M801833200; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; WHITFIELD C, 1989, J GEN MICROBIOL, V135, P2589	39	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41391	41401		10.1074/jbc.M111.295857	http://dx.doi.org/10.1074/jbc.M111.295857			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990359	hybrid, Green Published			2022-12-27	WOS:000298057500026
J	Desai, PR; Thakur, A; Ganguli, D; Paul, S; Morschhauser, J; Bachhawat, AK				Desai, Prashant Ramesh; Thakur, Anil; Ganguli, Dwaipayan; Paul, Sanjoy; Morschhaeuser, Joachim; Bachhawat, Anand K.			Glutathione Utilization by Candida albicans Requires a Functional Glutathione Degradation (DUG) Pathway and OPT7, an Unusual Member of the Oligopeptide Transporter Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN 9; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; SUBSTRATE RECOGNITION; YEAST PATHOGENS; GROWTH; GENE; THIOREDOXIN; INFECTION; VIRULENCE	Candida albicans lacks the ability to survive within its mammalian host in the absence of endogenous glutathione biosynthesis. To examine the ability of this yeast to utilize exogenous glutathione, we exploited the organic sulfur auxotrophy of C. albicans met15 Delta strains. We observed that glutathione is utilized efficiently by the alternative pathway of glutathione degradation (DUG pathway). The major oligopeptide transporters OPT1-OPT5 of C. albicans that were most similar to the known yeast glutathione transporters were not found to contribute to glutathione transport to any significant extent. A genomic library approach to identify the glutathione transporter of C. albicans yielded OPT7 as the primary glutathione transporter. Biochemical studies on OPT7 using radiolabeled GSH uptake revealed a K-m of 205 mu M indicating that it was a high affinity glutathione transporter. OPT7 is unusual in several aspects. It is the most remote member to known yeast glutathione transporters, lacks the two highly conserved cysteines in the family that are known to be crucial in trafficking, and also has the ability to take up tripeptides. The transporter was regulated by sulfur sources in the medium. OPT7 orthologues were prevalent among many pathogenic yeasts and fungi and formed a distinct cluster quite remote from the Saccharomyces cerevisiae HGT1 glutathione transporter duster. In vivo experiments using a systemic model of candidiasis failed to detect expression of OPT7 in vivo, and strains disrupted either in the degradation (dug3 Delta) or transport (opt7 Delta) of glutathione failed to show a defect in virulence.	[Bachhawat, Anand K.] Indian Inst Sci Educ & Res Mohali, Sas Nagar 140306, Punjab, India; [Desai, Prashant Ramesh; Thakur, Anil; Ganguli, Dwaipayan; Paul, Sanjoy; Bachhawat, Anand K.] CSIR, Inst Microbial Technol, Chandigarh 160036, India; [Morschhaeuser, Joachim] Univ Wurzburg, Inst Mol Infekt Biol, D-97080 Wurzburg, Germany	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Wurzburg	Bachhawat, AK (corresponding author), Indian Inst Sci Educ & Res, Sas Nagar 140306, Punjab, India.	anand@iisermohali.ac.in	Morschhäuser, Joachim/AFS-2547-2022; Morschhäuser, Joachim/E-2918-2013	Morschhäuser, Joachim/0000-0003-4227-8687; Morschhäuser, Joachim/0000-0003-4227-8687	Council of Scientific and Industrial Research, Government of India; Deutsche Forschungsgemeinschaft [MO 846/4]; Department of Science and Technology; Department of Biotechnology	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology	Recipients of a Research Fellowship from the Council of Scientific and Industrial Research, Government of India.; Supported by Deutsche Forschungsgemeinschaft Grant MO 846/4.; Supported by grant-in-aid projects from the Department of Science and Technology, the Department of Biotechnology, and the Council of Scientific and Industrial Research, Government of India. To whom correspondence should be addressed: Indian Institute of Science Education & Research, Knowledge City, S.A.S. Nagar, Punjab-140306, India.Tel.: 91-172-2240119; Fax: 91-172-2790188; E-mail: anand@iisermohali.ac.in.	Baudouin-Cornu P, 2006, BIOCHIMIE, V88, P1673, DOI 10.1016/j.biochi.2006.03.001; Biswas K, 2003, GENE, V323, P43, DOI 10.1016/j.gene.2003.09.005; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; Chauhan N, 2006, NAT REV MICROBIOL, V4, P435, DOI 10.1038/nrmicro1426; Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; HAZEN KC, 1995, CLIN MICROBIOL REV, V8, P462, DOI 10.1128/CMR.8.4.462; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; Kaur J, 2009, J BIOL CHEM, V284, P23872, DOI 10.1074/jbc.M109.029728; Kaur J, 2009, FEMS YEAST RES, V9, P849, DOI 10.1111/j.1567-1364.2009.00529.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lubkowitz MA, 1997, MICROBIOL-UK, V143, P387, DOI 10.1099/00221287-143-2-387; Michan C, 2009, FEMS YEAST RES, V9, P1078, DOI 10.1111/j.1567-1364.2009.00558.x; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Reuss O, 2006, MOL MICROBIOL, V60, P795, DOI 10.1111/j.1365-2958.2006.05136.x; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Rodaki A, 2006, EUKARYOT CELL, V5, P1371, DOI 10.1128/EC.00115-06; Sambrook J., 2002, MOL CLONING LAB MANU; Sharma KG, 2000, CURR GENET, V38, P71, DOI 10.1007/s002940000137; Staib P, 1999, MOL MICROBIOL, V32, P533, DOI 10.1046/j.1365-2958.1999.01367.x; Staib P, 2000, P NATL ACAD SCI USA, V97, P6102, DOI 10.1073/pnas.110031497; Thakur A, 2008, FEMS YEAST RES, V8, P916, DOI 10.1111/j.1567-1364.2008.00423.x; Thakur A, 2010, BIOCHEM J, V429, P593, DOI 10.1042/BJ20100240; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Viaene J, 2000, YEAST, V16, P1205, DOI 10.1002/1097-0061(20000930)16:13&lt;1205::AID-YEA615&gt;3.0.CO;2-C; Yadav AK, 2011, MICROBIOL-SGM, V157, P484, DOI 10.1099/mic.0.045054-0	34	16	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41183	41194		10.1074/jbc.M111.272377	http://dx.doi.org/10.1074/jbc.M111.272377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994941	Green Published, hybrid			2022-12-27	WOS:000298057500007
J	Muhlenhoff, U; Richter, N; Pines, O; Pierik, AJ; Lill, R				Muehlenhoff, Ulrich; Richter, Nadine; Pines, Ophry; Pierik, Antonio J.; Lill, Roland			Specialized Function of Yeast Isa1 and Isa2 Proteins in the Maturation of Mitochondrial [4Fe-4S] Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; ASSEMBLY PROTEIN; OXIDATIVE STRESS; BINDING ACTIVITY; ISCA; BIOGENESIS; SUFA; BIOSYNTHESIS; MECHANISMS	Most eukaryotes contain iron-sulfur cluster (ISC) assembly proteins related to Saccharomyces cerevisiae Isa1 and Isa2. We show here that Isa1 but not Isa2 can be functionally replaced by the bacterial relatives IscA, SufA, and ErpA. The specific function of these "A-type" ISC proteins within the framework of mitochondrial and bacterial Fe/S protein biogenesis is still unresolved. In a comprehensive in vivo analysis, we show that S. cerevisiae Isa1 and Isa2 form a complex that is required for maturation of mitochondrial [4Fe-4S] proteins, including aconitase and homoaconitase. In contrast, Isa1-Isa2 were dispensable for the generation of mitochondrial [2Fe-2S] proteins and cytosolic [4Fe-4S] proteins. Targeting of bacterial [2Fe-2S] and [4Fe-4S] ferredoxins to yeast mitochondria further supported this specificity. Isa1 and Isa2 proteins are shown to bind iron in vivo, yet the Isa1-Isa2-bound iron was not needed as a donor for de novo assembly of the [2Fe-2S] cluster on the general Fe/S scaffold proteins Isu1-Isu2. Upon depletion of the ISC assembly factor Iba57, which specifically interacts with Isa1 and Isa2, or in the absence of the major mitochondrial [4Fe-4S] protein aconitase, iron accumulated on the Isa proteins. These results suggest that the iron bound to the Isa proteins is required for the de novo synthesis of [4Fe-4S] clusters in mitochondria and for their insertion into apoproteins in a reaction mediated by Iba57. Taken together, these findings define Isa1, Isa2, and Iba57 as a specialized, late-acting ISC assembly subsystem that is specifically dedicated to the maturation of mitochondrial [4Fe-4S] proteins.	[Muehlenhoff, Ulrich; Richter, Nadine; Pierik, Antonio J.; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, D-35032 Marburg, Germany; [Pines, Ophry] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel	Philipps University Marburg; Hebrew University of Jerusalem	Lill, R (corresponding author), Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany.	Lill@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010; pines, ophry/C-4086-2011	Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518; pines, ophry/0000-0001-7126-2575	Deutsche Forschungsgemeinschaft [SFB 593, GRK 1216]; von Behring-Rontgen Stiftung; LOEWE program of state Hessen; Max-Planck Gesellschaft; German-Israeli Foundation; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); von Behring-Rontgen Stiftung; LOEWE program of state Hessen; Max-Planck Gesellschaft(Max Planck Society); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 593, Gottfried-Wilhelm Leibniz program, and GRK 1216), von Behring-Rontgen Stiftung, the LOEWE program of state Hessen, Max-Planck Gesellschaft, the German-Israeli Foundation, and Fonds der Chemischen Industrie.	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Ding HG, 2007, J BIOL CHEM, V282, P7997, DOI 10.1074/jbc.M609665200; FLINT DH, 1988, J BIOL CHEM, V263, P3558; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Harlow E., 1988, ANTIBODIES LAB MANUA; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson DC, 2006, J BACTERIOL, V188, P7551, DOI 10.1128/JB.00596-06; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Link TA, 1996, EUR J BIOCHEM, V237, P71, DOI 10.1111/j.1432-1033.1996.0071n.x; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; Long SJ, 2011, MOL MICROBIOL, V81, P1403, DOI 10.1111/j.1365-2958.2011.07769.x; Lu JX, 2008, BIOCHEM J, V409, P535, DOI 10.1042/BJ20071166; Lu JX, 2010, BIOCHEM J, V428, P125, DOI 10.1042/BJ20100122; Molik S, 2007, METHOD CELL BIOL, V80, P261, DOI 10.1016/S0091-679X(06)80013-0; Morimoto K, 2006, J MOL BIOL, V360, P117, DOI 10.1016/j.jmb.2006.04.067; Muhlenhoff U, 2007, EUKARYOT CELL, V6, P495, DOI 10.1128/EC.00191-06; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Ollagnier-de Choudens S, 2003, J BIOL CHEM, V278, P17993, DOI 10.1074/jbc.M300285200; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Pelzer W, 2000, FEBS LETT, V476, P134, DOI 10.1016/S0014-5793(00)01711-7; Py B, 2011, CURR OPIN MICROBIOL, V14, P218, DOI 10.1016/j.mib.2011.01.004; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Sambrook J., 2001, MOL CLONING LAB MANU; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Sheftel AD, 2009, ANN MED, V41, P82, DOI 10.1080/07853890802322229; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; SULO P, 1993, J BIOL CHEM, V268, P17634; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; Wang W, 2010, BIOCHEM J, V432, P429, DOI 10.1042/BJ20101507; Wu G, 2002, J BIOL INORG CHEM, V7, P526, DOI 10.1007/s00775-001-0330-2; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; ZHENG LM, 1994, J BIOL CHEM, V269, P18723	65	119	120	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41205	41216		10.1074/jbc.M111.296152	http://dx.doi.org/10.1074/jbc.M111.296152			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987576	Green Published, hybrid			2022-12-27	WOS:000298057500009
J	Brown, RV; Danford, FL; Gokhale, V; Hurley, LH; Brooks, TA				Brown, Robert V.; Danford, Forest L.; Gokhale, Vijay; Hurley, Laurence H.; Brooks, Tracy A.			Demonstration that Drug-targeted Down-regulation of MYC in Non-Hodgkins Lymphoma Is Directly Mediated through the Promoter G-quadruplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN C-MYC; NUCLEASE HYPERSENSITIVE ELEMENT; ACID-BINDING-PROTEIN; TETRAPLEX FORMATION; Z-DNA; EXPRESSION; ONCOGENE; GENE; REGION; IDENTIFICATION	Most transcription of the MITC proto-oncogene initiates in the near upstream promoter, within which lies the nuclease hypersensitive element (NHE) III1 region containing the CT-element. This dynamic stretch of DNA can form at least three different topologies: single-stranded DNA, double-stranded DNA, or higher order secondary structures that silence transcription. In the current report, we identify the ellipticine analog GQC-05 (NSC338258) as a high affinity, potent, and selective stabilizer of the MYC G-quadruplex (G4). In cells, GQC-05 induced cytotoxicity with corresponding decreased MYC mRNA and altered protein binding to the NHE III1 region, in agreement with a G4 stabilizing compound. We further describe a unique feature of the Burkitt's lymphoma cell line CA46 that allowed us to clearly demonstrate the mechanism and location of action of GQC-05 within this region of DNA and through the G4. Most importantly, these data present, as far as we are aware, the most direct evidence of intracellular G4-mediated control of a particular promoter.	[Brown, Robert V.; Danford, Forest L.; Gokhale, Vijay; Hurley, Laurence H.; Brooks, Tracy A.] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA; [Gokhale, Vijay; Hurley, Laurence H.; Brooks, Tracy A.] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Gokhale, Vijay; Hurley, Laurence H.; Brooks, Tracy A.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; Arizona Center Cancer Care; University of Arizona	Brooks, TA (corresponding author), 1657 E Helen St,Room 421, Tucson, AZ 85721 USA.	brooks@pharmacy.arizona.edu			National Institutes of Health [GM085585]; Leukemia & Lymphoma Society [6225-8]; National Foundation for Cancer Research [VONHOFF0601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM085585. This work was also supported by grants from the Leukemia & Lymphoma Society (6225-8) and the National Foundation for Cancer Research (VONHOFF0601).	Alarcon-Vargas D, 2004, J BIOL CHEM, V279, P5008, DOI 10.1074/jbc.M312054200; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; BAZAR L, 1995, J BIOL CHEM, V270, P8241, DOI 10.1074/jbc.270.14.8241; Borgognone M, 2010, BIOCHEM J, V428, P491, DOI 10.1042/BJ20100038; Brooks Tracy A, 2010, Genes Cancer, V1, P641; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Chaires J. B., 2003, CURR PROTOC NUCL ACI, P831; Cheng M, 1999, J BIOL CHEM, V274, P6553, DOI 10.1074/jbc.274.10.6553; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dang Chi V, 2010, Genes Cancer, V1, P526; Dang CV, 1995, C MYC FUNCTION NEOPL; De Cian A, 2007, METHODS, V42, P183, DOI 10.1016/j.ymeth.2006.10.004; Dexheimer TS, 2009, MOL CANCER THER, V8, P1363, DOI 10.1158/1535-7163.MCT-08-1093; FAHRLANDER PD, 1985, P NATL ACAD SCI USA, V82, P3746, DOI 10.1073/pnas.82.11.3746; Fernando H, 2008, BIOCHEMISTRY-US, V47, P9365, DOI 10.1021/bi800983u; Fernando H, 2009, NUCLEIC ACIDS RES, V37, P6716, DOI 10.1093/nar/gkp740; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Izbicka E, 1999, CANCER RES, V59, P639; Kang HJ, 2009, BIOCHEMISTRY-US, V48, P7392, DOI 10.1021/bi9006836; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; Mathur V, 2004, BIOCHEM BIOPH RES CO, V320, P1220, DOI 10.1016/j.bbrc.2004.06.074; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Nasi S, 2001, FEBS LETT, V490, P153, DOI 10.1016/S0014-5793(01)02118-4; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Qin Y, 2010, BIOCHEMISTRY-US, V49, P4208, DOI 10.1021/bi100330w; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; SHOWE LC, 1985, MOL CELL BIOL, V5, P501, DOI 10.1128/MCB.5.3.501; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; TOFFOLI G, 1989, LEUKEMIA RES, V13, P279, DOI 10.1016/0145-2126(89)90064-7; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; WITTIG B, 1992, EMBO J, V11, P4653, DOI 10.1002/j.1460-2075.1992.tb05567.x; WITTIG B, 1991, P NATL ACAD SCI USA, V88, P2259, DOI 10.1073/pnas.88.6.2259; Wolfl S, 1997, BBA-GENE STRUCT EXPR, V1352, P213, DOI 10.1016/S0167-4781(97)00015-8; Zimonjic DB, 2001, LEUKEMIA, V15, P1582, DOI 10.1038/sj.leu.2402281	56	129	131	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41018	41027		10.1074/jbc.M111.274720	http://dx.doi.org/10.1074/jbc.M111.274720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956115	Green Published, hybrid			2022-12-27	WOS:000297315400061
J	Browning, S; Baker, CA; Smith, E; Mahal, SP; Herva, ME; Demczyk, CA; Li, JL; Weissmann, C				Browning, Shawn; Baker, Christopher A.; Smith, Emery; Mahal, Sukhvir P.; Herva, Maria E.; Demczyk, Cheryl A.; Li, Jiali; Weissmann, Charles			Abrogation of Complex Glycosylation by Swainsonine Results in Strain- and Cell-specific Inhibition of Prion Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE NEUROBLASTOMA-CELLS; PROTEIN ACCUMULATION; DISEASE; INFECTION; PRPSC; CULTURES; RELEASE; AUTOPHAGOSOMES; GLYCOPROTEINS; CONFORMATION	Neuroblastoma-derived N2a-PK1 cells, fibroblastic LD9 cells, and CNS-derived CAD5 cells can be infected efficiently and pertly by various prion strains, as measured by the standard scrapie cell assay. Swainsonine, an inhibitor of Golgi alpha-mannosidase II that causes abnormal N-glycosylation, strongly inhibits infection of PK1 cells by RML, 79A and 22F, less so by 139A, and not at all by 221, prions, and it does not diminish propagation of any of these strains in LD9 or CADS cells. Misglycosylated PrPC formed in the presence of swainsonine is a good substrate for conversion to PrPSc, and misglycosylated PrPSc is fully able to trigger infection and seed the protein misfolding cyclic amplification reaction. Distinct subdones of PK1 cells mediate swainsonine inhibition to very different degrees, implicating misglycosylation of one or more host proteins in the inhibitory process. The use of swainsonine and other glycosylation inhibitors described herein enhances the ability of the cell panel assay to differentiate between prion strains. Moreover, as shown elsewhere, the susceptibility of prions to inhibition by swainsonine in PK1 cells is a mutable trait.	[Browning, Shawn; Baker, Christopher A.; Smith, Emery; Mahal, Sukhvir P.; Herva, Maria E.; Demczyk, Cheryl A.; Li, Jiali; Weissmann, Charles] Scripps Florida, Dept Infectol, Jupiter, FL 33458 USA	State University System of Florida; University of Florida	Weissmann, C (corresponding author), Scripps Florida, Dept Infectol, 130 Scripps Way, Jupiter, FL 33458 USA.	charlesw@scripps.edu	li, Jiali/HGF-2395-2022	li, Jiali/0000-0001-6202-7741	National Institutes of Health [1RO1NSO59543, 1RO1NS067214]; Alafi Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alafi Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1NSO59543 and 1RO1NS067214. This work was also supported by The Alafi Family Foundation (to C. W.).	Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BRUCE ME, 1992, E H S NEURO, P497; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Caughey B, 2003, J VIROL, V77, P5499, DOI 10.1128/JVI.77.9.5499-5502.2003; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Crispin M, 2007, FEBS LETT, V581, P1963, DOI 10.1016/j.febslet.2007.04.020; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; Demaimay R, 1998, J NEUROCHEM, V71, P2534; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Groschup MH, 2007, PRIONS IN HUMANS AND ANIMALS, P166; Heiseke A, 2010, CURR ISSUES MOL BIOL, V12, P87; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kocisko DA, 2005, NEUROSCI LETT, V388, P106, DOI 10.1016/j.neulet.2005.06.053; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Lehmann Sylvain, 2004, V299, P227; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Mahal S. P, 2008, METHODS MOL BIOL PRI; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mahal SP, 2010, P NATL ACAD SCI USA, V107, P22653, DOI 10.1073/pnas.1013014108; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Mays CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018047; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Perrier V, 2004, J NEUROCHEM, V89, P454, DOI 10.1111/j.1471-4159.2004.02356.x; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Rudd PM, 2001, BIOCHEMISTRY-US, V40, P3759, DOI 10.1021/bi002625f; Saa Paula, 2004, V299, P53; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; TULSIANI DRP, 1983, J BIOL CHEM, V258, P7578; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Weissmann C, 2009, FOLIA NEUROPATHOL, V47, P104; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	63	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40962	40973		10.1074/jbc.M111.283978	http://dx.doi.org/10.1074/jbc.M111.283978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21930694	Green Published, hybrid			2022-12-27	WOS:000297315400056
J	Bosch, DE; Wittchen, ES; Qiu, CN; Burridge, K; Siderovski, DP				Bosch, Dustin E.; Wittchen, Erika S.; Qiu, Connie; Burridge, Keith; Siderovski, David P.			Unique Structural and Nucleotide Exchange Features of the Rho1 GTPase of Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RAS-SUPERFAMILY; ONCOGENIC MUTANT; FAMILY; CDC42; COMPLEX; PHAGOCYTOSIS; CYTOSKELETON; ACTIVATION; PROTEINS	The single-celled human parasite Entamoeba histolytica possesses a dynamic actin cytoskeleton vital for its intestinal and systemic pathogenicity. The E. histolytica genome encodes several Rho family GTPases known to regulate cytoskeletal dynamics. EhRho1, the first family member identified, was reported to be insensitive to the Rho GTPase-specific Clostridium botulinum C3 exoenzyme, raising the possibility that it may be a misclassified Ras family member. Here, we report the crystal structures of EhRho1 in both active and inactive states. EhRho1 is activated by a conserved switch mechanism, but diverges from mammalian Rho GTPases in lacking a signature Rho insert helix. EhRho1 engages a homolog of mDia, EhFormin1, suggesting a role in mediating serum-stimulated actin reorganization and microtubule formation during mitosis. EhRho1, but not a constitutively active mutant, interacts with a newly identified EhRhoGDI in a prenylation-dependent manner. Furthermore, constitutively active EhRho1 induces actin stress fiber formation in mammalian fibroblasts, thereby identifying it as a functional Rho family GTPase. EhRho1 exhibits a fast rate of nucleotide exchange relative to mammalian Rho GTPases due to a distinctive switch one isoleucine residue reminiscent of the constitutively active F28L mutation in human Cdc42, which for the latter protein, is sufficient for cellular transformation. Nonconserved, nucleotide-interacting residues within EhRho1, revealed by the crystal structure models, were observed to contribute a moderating influence on fast spontaneous nucleotide exchange. Collectively, these observations indicate that EhRho1 is a bona fide member of the Rho GTPase family, albeit with unique structural and functional aspects compared with mammalian Rho GTPases.	[Bosch, Dustin E.; Qiu, Connie; Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Burridge, Keith; Siderovski, David P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wittchen, Erika S.; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Siderovski, DP (corresponding author), 4073 Genet Med Bldg,120 Mason Farm Rd,CB 7365, Chapel Hill, NC 27599 USA.	dsiderov@med.unc.edu	Siderovski, David Peter/AAA-9603-2019; , PEP-MX Core/AGV-4051-2022	Siderovski, David Peter/0000-0002-0688-8210; Bosch, Dustin/0000-0002-7430-2939	National Institutes of Health [R01GM082892, R01GM029860, T32GM008719, T32GM007040]; NIDDK [F30DK091978]; American Heart Association [10SDG3430042]; American Society of Pharmacology and Experimental Therapeutics (ASPET); Carolina Summer Fellows program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860, T32GM008719, R01GM082892, T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); American Society of Pharmacology and Experimental Therapeutics (ASPET); Carolina Summer Fellows program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM082892 (to D. P. S.) and R01GM029860 (to K. B.).; Supported by National Institutes of Health institutional training grants T32GM008719 and T32GM007040 and an independent F30 NRSA Grant F30DK091978 from the NIDDK.; Supported by American Heart Association Scientist Development Grant 10SDG3430042.; Supported by the Carolina Summer Fellows program funded in part by the American Society of Pharmacology and Experimental Therapeutics (ASPET).	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2004, BIOCHEMISTRY-US, V43, P9968, DOI 10.1021/bi0490901; Adams PD, 2006, BIOCHEMISTRY-US, V45, P2577, DOI 10.1021/bi051686g; Aguilar-Rojas A, 2005, EXP PARASITOL, V109, P150, DOI 10.1016/j.exppara.2004.12.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1997, Epidemiol Bull, V18, P13; Arias-Romero LE, 2007, CELL MOTIL CYTOSKEL, V64, P390, DOI 10.1002/cm.20191; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Ghosh SK, 1997, INFECT IMMUN, V65, P4243, DOI 10.1128/IAI.65.10.4243-4249.1997; Gilchrist CA, 2010, MBIO, V1, DOI 10.1128/mBio.00057-10; Godbold GD, 2002, EXP PARASITOL, V101, P107, DOI 10.1016/S0014-4894(02)00101-7; Guillen N, 1996, TRENDS MICROBIOL, V4, P191, DOI 10.1016/0966-842X(96)10033-0; Guillen N, 1998, J CELL SCI, V111, P1729; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman GR, 2000, CELL, V102, P403, DOI 10.1016/S0092-8674(00)00045-3; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Kimple AJ, 2010, METHODS MOL BIOL, V627, P91, DOI 10.1007/978-1-60761-670-2_5; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Labruyere E, 2003, J CELL SCI, V116, P61, DOI 10.1242/jcs.00190; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; LOHIA A, 1993, MOL BIOCHEM PARASIT, V58, P177, DOI 10.1016/0166-6851(93)90104-6; Lohia A, 1996, GENE, V173, P205, DOI 10.1016/0378-1119(96)00232-6; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Majumder S, 2008, INFECT IMMUN, V76, P2368, DOI 10.1128/IAI.01449-07; Markiewicz JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001002; Maugis B, 2010, J CELL SCI, V123, P3884, DOI 10.1242/jcs.065672; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meza I, 2006, ARCH MED RES, V37, P234, DOI 10.1016/j.arcmed.2005.09.008; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Raines KW, 2007, CARDIOVASC RES, V75, P229, DOI 10.1016/j.cardiores.2007.04.013; Ravdin J. I., 2000, AMOEBIASIS; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Voigt H, 1999, CELL MICROBIOL, V1, P195, DOI 10.1046/j.1462-5822.1999.00021.x; Walker SJ, 2000, J BIOL CHEM, V275, P15665, DOI 10.1074/jbc.M000076200; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Willard MD, 2007, EMBO J, V26, P2029, DOI 10.1038/sj.emboj.7601659	55	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39236	39246		10.1074/jbc.M111.253898	http://dx.doi.org/10.1074/jbc.M111.253898			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930699	Green Published, hybrid			2022-12-27	WOS:000296759800042
J	Liang, K; Du, W; Zhu, WZ; Liu, S; Cui, YQ; Sun, HC; Luo, B; Xue, YH; Yang, L; Chen, LY; Li, F				Liang, Kuo; Du, Wen; Zhu, Wenzhen; Liu, Shuang; Cui, Yeqing; Sun, Haichen; Luo, Bin; Xue, Yanhong; Yang, Lu; Chen, Liangyi; Li, Fei			Contribution of Different Mechanisms to Pancreatic Beta-cell Hyper-secretion in Non-obese Diabetic (NOD) Mice during Pre-diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CA2+-ATPASE; INSULIN-SECRETION; CA2+ HOMEOSTASIS; CALCIUM; GLUCOSE; MOUSE; ISLETS; RELEASE; EXPRESSION; DYNAMICS	The development of insulin-dependent diabetes mellitus (IDDM) results from the selective destruction of pancreatic beta-cells. Both humans and spontaneous models of IDDM, such as NOD mice, have an extended pre-diabetic stage. Dynamic changes in beta-cell mass and function during pre-diabetes, such as insulin hyper-secretion, remain largely unknown. In this paper, we evaluated pre-diabetic female NOD mice at different ages (6, 10, and 14 weeks old) to illustrate alterations in beta-cell mass and function as disease progressed. We found an increase in beta-cell mass in 6-week-old NOD mice that may account for improved glucose tolerance in these mice. As NOD mice aged, beta-cell mass progressively reduced with increasing insulitis. In parallel, secretory ability of individual beta-cells was enhanced due to an increase in the size of slowly releasable pool (SRP) of vesicles. Moreover, expression of both SERCA2 and SERCA3 genes were progressively down-regulated, which facilitated depolarization-evoked secretion by prolonging Ca2+ elevation upon glucose stimulation. In summary, we propose that different mechanisms contribute to the insulin hyper-secretion at different ages of pre-diabetic NOD mice, which may provide some new ideas concerning the progression and management of type I diabetes.	[Zhu, Wenzhen; Yang, Lu; Chen, Liangyi] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Zhu, Wenzhen; Yang, Lu; Chen, Liangyi] Natl Ctr Nanosci & Technol, Beijing 100871, Peoples R China; [Liang, Kuo; Liu, Shuang; Cui, Yeqing; Sun, Haichen; Luo, Bin; Li, Fei] Capital Med Univ, XuanWu Hosp, Dept Gen Surg, Beijing 100053, Peoples R China; [Du, Wen; Xue, Yanhong] Chinese Acad Sci, Inst Biophys, Natl Key Lab Biomacromol, Beijing 100101, Peoples R China	Peking University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Capital Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, LY (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	lychen@pku.edu.cn; feili36@ccmu.edu.cn	Chen, Liangyi/F-1352-2010	Chen, Liangyi/0000-0003-1270-7321	National Science Foundation of China [30871225]; Beijing Municipal Health Bureau [QN2008-029]; Beijing Science and Technology Program Project [D070501350706]; Beijing Municipal Science and Technology Commission [7082042]; Department of Education of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Health Bureau; Beijing Science and Technology Program Project; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Department of Education of China	This work was supported by grants from the National Science Foundation of China (No. 30871225), a Youth Research Grant from Beijing Municipal Health Bureau (QN2008-029), the Beijing Science and Technology Program Project (D070501350706), and a grant from Beijing Municipal Science and Technology Commission (7082042) and a '985' fund from the Department of Education of China to Peking Univesity.	Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Amrani A, 1996, J ENDOCRINOL, V148, P139, DOI 10.1677/joe.0.1480139; Arredouani A, 2002, DIABETES, V51, P3245, DOI 10.2337/diabetes.51.11.3245; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; Beauvois MC, 2006, AM J PHYSIOL-CELL PH, V290, pC1503, DOI 10.1152/ajpcell.00400.2005; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Borge PD, 2002, DIABETES, V51, pS427, DOI 10.2337/diabetes.51.2007.S427; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chen LY, 2003, DIABETES, V52, P1723, DOI 10.2337/diabetes.52.7.1723; Cho JH, 2010, ENDOCRINOLOGY, V151, P1541, DOI 10.1210/en.2009-0362; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Dula SB, 2010, CELL CALCIUM, V48, P133, DOI 10.1016/j.ceca.2010.07.007; Duman JG, 2006, TRAFFIC, V7, P859, DOI 10.1111/j.1600-0854.2006.00432.x; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; Gaisano HY, 2002, ENDOCRINOLOGY, V143, P4218, DOI 10.1210/en.2002-220237; He ZX, 2008, TRAFFIC, V9, P910, DOI 10.1111/j.1600-0854.2008.00730.x; Homo-Delarche F, 1997, DIABETES METAB, V23, P473; HomoDelarche F, 1997, DIABETES METAB, V23, P181; Hughes E, 2006, ENDOCRINOLOGY, V147, P1396, DOI 10.1210/en.2005-1023; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; KANO Y, 1986, DIABETES, V35, P486, DOI 10.2337/diabetes.35.4.486; Kruglikov I, 2004, PFLUG ARCH EUR J PHY, V448, P395, DOI 10.1007/s00424-004-1263-8; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Lemmens R, 2001, J BIOL CHEM, V276, P9971, DOI 10.1074/jbc.M009463200; Levy J, 1998, METABOLISM, V47, P185, DOI 10.1016/S0026-0495(98)90218-9; Lu JZ, 2008, BIOCHEM BIOPH RES CO, V371, P315, DOI 10.1016/j.bbrc.2008.04.077; Orban T, 2001, METABOLISM, V50, P1369, DOI 10.1053/meta.2001.27191; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Rabinovitch A, 2007, CELL BIOCHEM BIOPHYS, V48, P159, DOI 10.1007/s12013-007-0029-2; Racz G, 2009, ACTA BIOCHIM POL, V56, P487; Randriamboavonjy V, 2008, CIRCULATION, V117, P52, DOI 10.1161/CIRCULATIONAHA.107.719807; REDDY S, 1992, DIABETES RES CLIN PR, V17, P17, DOI 10.1016/0168-8227(92)90039-T; ROE MW, 1994, J BIOL CHEM, V269, P18279; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; Searls YM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-8; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; STRANDELL E, 1990, J CLIN INVEST, V85, P1944, DOI 10.1172/JCI114657; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; TERUYA M, 1993, DIABETES, V42, P1310, DOI 10.2337/diabetes.42.9.1310; Vandecaetsbeek I, 2009, BIOFACTORS, V35, P484, DOI 10.1002/biof.63; Varadi A, 1999, DIABETOLOGIA, V42, P1240, DOI 10.1007/s001250051298; Varadi A, 1996, BIOCHEM J, V319, P521, DOI 10.1042/bj3190521; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Willcox A, 2010, DIABETOLOGIA, V53, P2020, DOI 10.1007/s00125-010-1817-6; Xie L, 2006, TRAFFIC, V7, P429, DOI 10.1111/j.1600-0854.2006.00401.x; Zaitsev S, 1997, BIOCHEM BIOPH RES CO, V239, P129, DOI 10.1006/bbrc.1997.7441	47	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39537	39545		10.1074/jbc.M111.295931	http://dx.doi.org/10.1074/jbc.M111.295931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21914804	Green Published, hybrid			2022-12-27	WOS:000296759800071
J	Lyons, PJ; Fricker, LD				Lyons, Peter J.; Fricker, Lloyd D.			Carboxypeptidase O Is a Glycosylphosphatidylinositol-anchored Intestinal Peptidase with Acidic Amino Acid Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURKINJE-CELL DEGENERATION; METALLOCARBOXYPEPTIDASE GENE FAMILY; CYTOSOLIC CARBOXYPEPTIDASES; PANCREATIC CARBOXYPEPTIDASE; 3-DIMENSIONAL STRUCTURE; EMBRYONIC-DEVELOPMENT; CRYSTAL-STRUCTURE; CANAVAN-DISEASE; MOUSE; ENZYME	The first metallocarboxypeptidase (CP) was identified in pancreatic extracts more than 80 years ago and named carboxypeptidase A (CPA; now known as CPA1). Since that time, seven additional mammalian members of the CPA subfamily have been described, all of which are initially produced as proenzymes, are activated by endoproteases, and remove either C-terminal hydrophobic or basic amino acids from peptides. Here we describe the enzymatic and structural properties of carboxypeptidase O (CPO), a previously uncharacterized and unique member of the CPA subfamily. Whereas all other members of the CPA subfamily contain an N-terminal prodomain necessary for folding, bioinformatics and expression of both human and zebrafish CPO orthologs revealed that CPO does not require a prodomain. CPO was purified by affinity chromatography, and the purified enzyme was able to cleave proteins and synthetic peptides with greatest activity toward acidic C-terminal amino acids unlike other CPA-like enzymes. CPO displayed a neutral pH optimum and was inhibited by common metallo carboxypeptidase inhibitors as well as citrate. CPO was modified by attachment of a glycosylphosphatidylinositol membrane anchor to the C terminus of the protein. Immunocytochemistry of Madin-Darby canine kidney cells stably expressing CPO showed localization to vesicular membranes in subconfluent cells and to the plasma membrane in differentiated cells. CPO is highly expressed in intestinal epithelial cells in both zebrafish and human. These results suggest that CPO cleaves acidic amino acids from dietary proteins and peptides, thus complementing the actions of well known digestive carboxypeptidases CPA and CPB.	[Lyons, Peter J.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu		Lyons, Peter/0000-0001-5214-5445	National Institutes of Health [DA-004494, EY-194332]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA-004494 (to L. D. F.) and EY-194332 (to P. J. L.).	ADIBI SA, 1973, J CLIN INVEST, V52, P1586, DOI 10.1172/JCI107335; Alonso-del-Rivero M, 2009, FEBS J, V276, P4875, DOI 10.1111/j.1742-4658.2009.07187.x; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; BECK IT, 1973, AM J CLIN NUTR, V26, P311, DOI 10.1093/ajcn/26.3.311; Benjamin MA, 2000, GUT, V47, P112, DOI 10.1136/gut.47.1.112; Bitto E, 2007, P NATL ACAD SCI USA, V104, P456, DOI 10.1073/pnas.0607817104; Bown DP, 2004, EUR J BIOCHEM, V271, P2000, DOI 10.1111/j.1432-1033.2004.04113.x; COLL M, 1991, EMBO J, V10, P1; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; DEDDISH PA, 1990, J BIOL CHEM, V265, P15083; Drozdowski L, 2009, WORLD J GASTROENTERO, V15, P385, DOI 10.3748/wjg.15.385; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; ERDOS EG, 1962, BIOCHEM PHARMACOL, V11, P585, DOI 10.1016/0006-2952(62)90119-3; FACER P, 1985, GASTROENTEROLOGY, V89, P1366, DOI 10.1016/0016-5085(85)90657-2; Fernandez D., 2011, ENZYME RES, V2011; Fernandez D, 2010, BIOCHIMIE, V92, P1484, DOI 10.1016/j.biochi.2010.05.002; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; FOLK JE, 1956, J AM CHEM SOC, V78, P3541, DOI 10.1021/ja01595a077; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; GARDELL SJ, 1988, J BIOL CHEM, V263, P17828; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; GUASCH A, 1992, J MOL BIOL, V224, P141, DOI 10.1016/0022-2836(92)90581-4; Hsieh JM, 2010, P NATL ACAD SCI USA, V107, P17962, DOI 10.1073/pnas.1006687107; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kalinina EV, 2003, J BIOL CHEM, V278, P9244, DOI 10.1074/jbc.M209379200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Lei YH, 1999, DNA CELL BIOL, V18, P175, DOI 10.1089/104454999315565; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Nagell CF, 2004, SCAND J GASTROENTERO, V39, P353, DOI 10.1080/00365520410004424; Namboodiri AMA, 2006, MOL CELL ENDOCRINOL, V252, P216, DOI 10.1016/j.mce.2006.03.016; Phillips MA, 1996, BIOCHEMISTRY-US, V35, P6771, DOI 10.1021/bi960113o; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rosenberg I. M., 2005, PROTEIN ANAL PURIFIC, P308; Schneider E, 2006, CLIN CHIM ACTA, V374, P25, DOI 10.1016/j.cca.2006.05.044; Song LX, 1997, J BIOL CHEM, V272, P10543; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; Stoll B, 1999, AM J PHYSIOL-ENDOC M, V277, pE168, DOI 10.1152/ajpendo.1999.277.1.E168; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thomas AG, 2006, ADV EXP MED BIOL, V576, P327; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Waldschmidt-Leitz E, 1929, BER DTSCH CHEM GES, V62, P2217, DOI 10.1002/cber.19290620857; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	53	21	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39023	39032		10.1074/jbc.M111.265819	http://dx.doi.org/10.1074/jbc.M111.265819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21921028	hybrid, Green Published			2022-12-27	WOS:000296759800021
J	Tang, HZ; Yao, YX; Zhang, DK; Meng, XZ; Wang, LJ; Yu, H; Ma, LY; Xu, P				Tang, Hongzhi; Yao, Yuxiang; Zhang, Dake; Meng, Xiangzhou; Wang, Lijuan; Yu, Hao; Ma, Lanying; Xu, Ping			A Novel NADH-dependent and FAD-containing Hydroxylase Is Crucial for Nicotine Degradation by Pseudomonas putida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASTE; GENE; BIODEGRADATION; PURIFICATION; PROTEINS	Nicotine, the main alkaloid produced by Nicotiana tabacum and other Solanaceae, is very toxic and may be a leading toxicant causing preventable disease and death, with the rise in global tobacco consumption. Several different microbial pathways of nicotine metabolism have been reported: Arthrobacter uses the pyridine pathway, and Pseudomonas, like mammals, uses the pyrrolidine pathway. We identified and characterized a novel 6-hydroxy-3-succinoyl-pyridine (HSP) hydroxylase (HspB) using enzyme purification, peptide sequencing, and sequencing of the Pseudomonas putida S16 genome. The HSP hydroxylase has no known orthologs and converts HSP to 2,5-dihydroxy-pyridine and succinic semialdehyde, using NADH. O-18(2) labeling experiments provided direct evidence for the incorporation of oxygen from O-2 into 2,5-dihydroxy-pyridine. The hspB gene deletion showed that this enzyme is essential for nicotine degradation, and site-directed mutagenesis identified an FAD-binding domain. This study demonstrates the importance of the newly discovered enzyme HspB, which is crucial for nicotine degradation by the Pseudomonas strain.	[Tang, Hongzhi; Yao, Yuxiang; Meng, Xiangzhou; Wang, Lijuan; Yu, Hao; Ma, Lanying; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Tang, Hongzhi; Yao, Yuxiang; Meng, Xiangzhou; Wang, Lijuan; Yu, Hao; Ma, Lanying; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Zhang, Dake] Chinese Acad Sci, Beijing Inst Genom, Beijing 100029, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Xu, P (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China.	pingxu@sjtu.edu.cn	Meng, Xiangzhou/M-1583-2019; Zhang, Dake/H-3210-2019	Meng, Xiangzhou/0000-0003-2827-7661; Zhang, Dake/0000-0001-9508-8209	Chinese National Natural Science Foundation [30900042, 30821005]; Ministry of Science and Technology of China [2009CB118906]; Shanghai Municipal Education Commission [10CG10]; Key Basic Research Program of Shanghai [09JC1407700]; Shanghai Education Development Foundation	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Key Basic Research Program of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Education Development Foundation	This work was supported in part by Chinese National Natural Science Foundation Grants 30900042 and 30821005 and from Ministry of Science and Technology of China National Basic Research Program Grant 2009CB118906. This work was also supported by Key Basic Research Program of Shanghai Grant 09JC1407700 and Grant 10CG10 from the Chen Guang Project from the Shanghai Municipal Education Commission and the Shanghai Education Development Foundation.	Brandsch R, 2006, APPL MICROBIOL BIOT, V69, P493, DOI 10.1007/s00253-005-0226-0; Civilini M, 1997, WASTE MANAGE RES, V15, P349, DOI 10.1177/0734242X9701500403; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Diaz E, 2004, INT MICROBIOL, V7, P173; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Eberhardt Hans-Jochen, 1995, Beitraege zur Tabakforschung International, V16, P119; Eppink MHM, 1997, J BACTERIOL, V179, P6680, DOI 10.1128/jb.179.21.6680-6687.1997; GRIFFITH IP, 1972, BIOCHEM J, V126, P553, DOI 10.1042/bj1260553; Hecht SS, 2000, P NATL ACAD SCI USA, V97, P12493, DOI 10.1073/pnas.220207697; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Hunter GR, 2000, MOL BIOCHEM PARASIT, V105, P203, DOI 10.1016/S0166-6851(99)00176-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li HJ, 2010, APPL MICROBIOL BIOT, V86, P11, DOI 10.1007/s00253-009-2427-4; Meng XJ, 2010, RES MICROBIOL, V161, P626, DOI 10.1016/j.resmic.2010.05.017; Nakano H, 1999, EUR J BIOCHEM, V260, P120, DOI 10.1046/j.1432-1327.1999.00124.x; Novotny TE, 1999, TOB CONTROL, V8, P75, DOI 10.1136/tc.8.1.75; Sambrook J., 2001, MOL CLONING LAB MANU; Tang HZ, 2008, APPL ENVIRON MICROB, V74, P1567, DOI 10.1128/AEM.02529-07; Tang HZ, 2009, APPL ENVIRON MICROB, V75, P772, DOI 10.1128/AEM.02300-08; Tao F, 2006, APPL ENVIRON MICROB, V72, P4604, DOI 10.1128/AEM.00081-06; Wang SN, 2007, MICROBIOL-SGM, V153, P1556, DOI 10.1099/mic.0.2006/005223-0; Wang SN, 2005, ENVIRON SCI TECHNOL, V39, P6877, DOI 10.1021/es0500759; Wang SN, 2004, BIOTECHNOL LETT, V26, P1493, DOI 10.1023/B:BILE.0000044450.16235.65; Wei Q, 2010, BIODEGRADATION, V21, P575, DOI 10.1007/s10532-009-9325-4; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	26	52	60	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39179	39187		10.1074/jbc.M111.283929	http://dx.doi.org/10.1074/jbc.M111.283929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949128	hybrid, Green Published			2022-12-27	WOS:000296759800037
J	Pierson, HE; Uhlemann, EME; Dmitriev, OY				Pierson, Hannah E.; Uhlemann, Eva-Maria E.; Dmitriev, Oleg Y.			Interaction with Monomeric Subunit c Drives Insertion of ATP Synthase Subunit a into the Membrane and Primes a-c Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; ESCHERICHIA-COLI; CROSS-LINKING; F-0 SECTOR; TRANSMEMBRANE HELICES; FOF1-ATP SYNTHASE; ALPHA-SUBUNIT; ROTOR RING; NMR SYSTEM; PROTEIN	Subunit a is the main part of the membrane stator of the ATP synthase molecular turbine. Subunit c is the building block of the membrane rotor. We have generated two molecular fusions of a and c subunits with different orientations of the helical hairpin of subunit c. The a/c fusion protein with correct orientation of transmembrane helices was inserted into the membrane, and co-incorporated into the F-0 complex of ATP synthase with wild type subunit c. The fused c subunit was incorporated into the c-ring tethering the ATP synthase rotor to the stator. The a/c fusion with incorrect orientation of the c-helices required wild type subunit c for insertion into the membrane. In this case, the fused c subunit remained on the periphery of the c-ring and did not interfere with rotor movement. Wild type subunit a inserted into the membrane equally well with wild type subunit c and c-ring assembly mutants that remained monomeric in the membrane. These results show that interaction with monomeric subunit c triggers insertion of subunit a into the membrane, and initiates formation of the a-c complex, the ion-translocating module of the ATP synthase. Correct assembly of the ATP synthase incorporating topologically correct fusion of subunits a and c validates using this model protein for high resolution structural studies of the ATP synthase proton channel.	[Pierson, Hannah E.; Uhlemann, Eva-Maria E.; Dmitriev, Oleg Y.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Dmitriev, OY (corresponding author), 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	Oleg.Dmitriev@usask.ca	Dmitriev, Oleg/AAB-7830-2019		Saskatchewan Health Research Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)	Saskatchewan Health Research Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Saskatchewan Health Research Foundation New Investigator grant and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (to O. Y. D.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; Akiyama Y, 2002, P NATL ACAD SCI USA, V99, P8066, DOI 10.1073/pnas.122616899; Arechaga I, 2003, FEBS LETT, V547, P97, DOI 10.1016/S0014-5793(03)00677-X; Arechaga I, 2002, FEBS LETT, V515, P189, DOI 10.1016/S0014-5793(02)02447-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Dmitriev OY, 2008, BBA-BIOENERGETICS, V1777, P227, DOI 10.1016/j.bbabio.2007.11.011; Dmitriev OY, 2004, J BIOMOL NMR, V29, P439, DOI 10.1023/B:JNMR.0000032519.14221.20; Dmitriev OY, 2004, FEBS LETT, V556, P35, DOI 10.1016/S0014-5793(03)01360-7; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; EKMAN P, 1993, ANAL BIOCHEM, V214, P138, DOI 10.1006/abio.1993.1468; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Fillingame RH, 2002, BBA-BIOMEMBRANES, V1565, P232, DOI 10.1016/S0005-2736(02)00572-2; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; GAY NJ, 1984, J BACTERIOL, V158, P820, DOI 10.1128/JB.158.3.820-825.1984; Girvin ME, 1998, BIOCHEMISTRY-US, V37, P8817, DOI 10.1021/bi980511m; HARTZOG PE, 1994, J BIOL CHEM, V269, P32313; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; IWAMOTO A, 1991, J BIOL CHEM, V266, P16350; JANS DA, 1983, BIOCHEM J, V211, P717, DOI 10.1042/bj2110717; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jones PC, 1998, J BIOL CHEM, V273, P29701, DOI 10.1074/jbc.273.45.29701; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; KANAZAWA H, 1984, J BACTERIOL, V158, P300, DOI 10.1128/JB.158.1.300-306.1984; KLIONSKY DJ, 1983, J BIOL CHEM, V258, P136; Kol S, 2009, J MOL BIOL, V390, P893, DOI 10.1016/j.jmb.2009.05.074; Krebstakies T, 2005, J BIOL CHEM, V280, P33338, DOI 10.1074/jbc.M506251200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; Ono S, 2004, J BIOL CHEM, V279, P33409, DOI 10.1074/jbc.M404993200; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; ROTTENBERG H, 1993, BIOCHIM BIOPHYS ACTA, V1183, P161, DOI 10.1016/0005-2728(93)90014-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNEIDER E, 1986, METHOD ENZYMOL, V126, P569; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Stalz WD, 2003, J BIOL CHEM, V278, P27068, DOI 10.1074/jbc.M302027200; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Vik SB, 2000, BBA-BIOENERGETICS, V1458, P457, DOI 10.1016/S0005-2728(00)00094-3; Vik SB, 2005, J BIOENERG BIOMEMBR, V37, P445, DOI 10.1007/s10863-005-9488-6; VIK SB, 1994, J BIOL CHEM, V269, P30364; VONMEYENBURG K, 1985, EMBO J, V4, P2357, DOI 10.1002/j.1460-2075.1985.tb03939.x; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	56	11	11	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38583	38591		10.1074/jbc.M111.294868	http://dx.doi.org/10.1074/jbc.M111.294868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900248	Green Published, hybrid			2022-12-27	WOS:000296594200071
J	Thakur, AK; Srivastava, AK; Srinivas, V; Chary, KVR; Rao, CM				Thakur, Abhay Kumar; Srivastava, Atul Kumar; Srinivas, Volety; Chary, Kandala Venkata Ramana; Rao, Chintalagiri Mohan			Copper Alters Aggregation Behavior of Prion Protein and Induces Novel Interactions between Its N- and C-terminal Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTHALPY-ENTROPY COMPENSATION; BINDING-SITES; STRUCTURAL-CHARACTERIZATION; CONFORMATIONAL-CHANGES; AMYLOIDOGENIC REGION; PEPTIDE-FRAGMENTS; OCTAREPEAT DOMAIN; HEAT-CAPACITY; ALPHA-HELIX; PRPC	Copper is reported to promote and prevent aggregation of prion protein. Conformational and functional consequences of Cu2+-binding to prion protein (PrP) are not well understood largely because most of the Cu2+-binding studies have been performed on fragments and truncated variants of the prion protein. In this context, we set out to investigate the conformational consequences of Cu2+-binding to full-length prion protein (PrP) by isothermal calorimetry, NMR, and small angle x-ray scattering. In this study, we report altered aggregation behavior of full-length PrP upon binding to Cu2+. At physiological temperature, Cu2+ did not promote aggregation suggesting that Cu2+ may not play a role in the aggregation of PrP at physiological temperature (37 degrees C). However, Cu2+-bound PrP aggregated at lower temperatures. This temperature-dependent process is reversible. Our results show two novel intraprotein interactions upon Cu2+-binding. The N-terminal region (residues 90-120 that contain the site His-96/His-111) becomes proximal to helix-1 (residues 144-147) and its nearby loop region (residues 139-143), which may be important in preventing amyloid fibril formation in the presence of Cu2+. In addition, we observed another novel interaction between the N-terminal region comprising the octapeptide repeats (residues 60-91) and helix-2 (residues 174-185) of PrP. Small angle x-ray scattering studies of full-length PrP show significant compactness upon Cu2+-binding. Our results demonstrate novel long range inter-domain interactions of the N- and C-terminal regions of PrP upon Cu2+ binding, which might have physiological significance.	[Thakur, Abhay Kumar; Srinivas, Volety; Rao, Chintalagiri Mohan] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Srivastava, Atul Kumar; Chary, Kandala Venkata Ramana] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Tata Institute of Fundamental Research (TIFR)	Rao, CM (corresponding author), CSIR, Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	mohan@ccmb.res.in	Thakur, Abhay/K-4167-2012	Srivastava, Atul/0000-0003-2314-8457	Council of Scientific and Industrial Research, New Delhi, India; Department of Science and Technology, Government of India; Department of Science and Technology; Department of Biotechnology; Tata Institute of Fundamental Research, Mumbai, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Tata Institute of Fundamental Research, Mumbai, India	Recipient of a senior research fellowship from Council of Scientific and Industrial Research, New Delhi, India.; Recipient of a J. C. Bose National Fellowship from the Department of Science and Technology, Government of India.; We thank T. Ramakrishna, T. K. Chowdary, Z. Kamal, and B. Raman for insightful discussion and critical reading of the manuscript. A. K. S. and K. V. R. C. acknowledge the facilities provided by the National Facility for High Field NMR, supported by Department of Science and Technology, Department of Biotechnology, Council of Scientific and Industrial Research, New Delhi, India, and Tata Institute of Fundamental Research, Mumbai, India.	Aronoff-Spencer E, 2000, BIOCHEMISTRY-US, V39, P13760, DOI 10.1021/bi001472t; Badrick AC, 2009, J INORG BIOCHEM, V103, P1169, DOI 10.1016/j.jinorgbio.2009.06.005; BALDWIN MA, 1994, PHILOS T ROY SOC B, V343, P435, DOI 10.1098/rstb.1994.0041; Banci L, 2002, ADV PROTEIN CHEM, V60, P397; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 2002, MOL BIOTECHNOL, V22, P165, DOI 10.1385/MB:22:2:165; Brown DR, 2004, J INORG BIOCHEM, V98, P133, DOI 10.1016/j.jinorgbio.2003.09.006; Cereghetti GM, 2001, BIOPHYS J, V81, P516, DOI 10.1016/S0006-3495(01)75718-9; Cereghetti GM, 2003, BIOPHYS J, V84, P1985, DOI 10.1016/S0006-3495(03)75007-3; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chattopadhyay M, 2005, J AM CHEM SOC, V127, P12647, DOI 10.1021/ja053254z; Colombo MC, 2008, PROTEINS, V70, P1084, DOI 10.1002/prot.21604; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; Di Natale G, 2005, INORG CHEM, V44, P7214, DOI 10.1021/ic050754k; Di Natale G, 2009, INORG CHEM, V48, P4239, DOI 10.1021/ic802190v; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Giese A, 2004, BIOCHEM BIOPH RES CO, V320, P1240, DOI 10.1016/j.bbrc.2004.06.075; Guinier A., 1955, SMALL ANGLE SCATTERI, P5; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hasnain SS, 2001, J MOL BIOL, V311, P467, DOI 10.1006/jmbi.2001.4795; Hodak M, 2009, P NATL ACAD SCI USA, V106, P11576, DOI 10.1073/pnas.0903807106; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; Hortells P, 2010, ZOONOSES PUBLIC HLTH, V57, P358, DOI 10.1111/j.1863-2378.2009.01230.x; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200; Kachel N, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-16; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Leclerc E, 2006, ARCH VIROL, V151, P2103, DOI 10.1007/s00705-006-0804-1; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li RL, 2000, J MOL BIOL, V301, P567, DOI 10.1006/jmbi.2000.3986; LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002; Miura T, 1996, FEBS LETT, V396, P248, DOI 10.1016/0014-5793(96)01104-0; Monnet C, 2004, FEBS LETT, V576, P114, DOI 10.1016/j.febslet.2004.08.076; Morrissey MP, 1999, P NATL ACAD SCI USA, V96, P11293, DOI 10.1073/pnas.96.20.11293; Nadal RC, 2009, BIOCHEMISTRY-US, V48, P8929, DOI 10.1021/bi9011397; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Norstrom EM, 2006, J VIROL, V80, P8521, DOI 10.1128/JVI.00366-06; Orem NR, 2006, J NEUROCHEM, V96, P1409, DOI 10.1111/j.1471-4159.2006.03650.x; Osz K, 2007, CHEM-EUR J, V13, P7129, DOI 10.1002/chem.200601568; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Redecke L, 2007, J STRUCT BIOL, V157, P308, DOI 10.1016/j.jsb.2006.06.013; Ricchelli F, 2006, BIOCHEMISTRY-US, V45, P6724, DOI 10.1021/bi0601454; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarzinger S, 2006, J BIOMOL STRUCT DYN, V23, P581, DOI 10.1080/07391102.2006.10507083; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Stevens DJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000390; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; Thakur AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002688; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Tsiroulnikov K, 2006, BBA-PROTEINS PROTEOM, V1764, P1218, DOI 10.1016/j.bbapap.2006.04.013; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watanabe Y, 2010, BIOCHEM BIOPH RES CO, V394, P522, DOI 10.1016/j.bbrc.2010.03.003; Watzlawik J, 2006, J BIOL CHEM, V281, P30242, DOI 10.1074/jbc.M605141200; Yu SL, 2008, FEBS J, V275, P5564, DOI 10.1111/j.1742-4658.2008.06680.x; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 2003, J MOL BIOL, V334, P477, DOI 10.1016/j.jmb.2003.09.048; Ziegler J, 2006, FEBS LETT, V580, P2033, DOI 10.1016/j.febslet.2006.03.002	73	54	54	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38533	38545		10.1074/jbc.M111.265645	http://dx.doi.org/10.1074/jbc.M111.265645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900252	hybrid, Green Published			2022-12-27	WOS:000296594200067
J	Corcoran, K; Jabbour, M; Bhagwandin, C; Deymier, MJ; Theisen, DL; Lybarger, L				Corcoran, Kathleen; Jabbour, Maurice; Bhagwandin, Candida; Deymier, Martin J.; Theisen, Debra L.; Lybarger, Lonnie			Ubiquitin-mediated Regulation of CD86 Protein Expression by the Ubiquitin Ligase Membrane-associated RING-CH-1 (MARCH1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; DENDRITIC CELL SUBSETS; DOWN-REGULATION; INVARIANT CHAIN; PLASMA-MEMBRANE; HERPESVIRUS K3; VIRAL PROTEIN; MOLECULES; SURFACE	The activation of naive T cells requires antigen presentation by dendritic cells (DCs), and the process of antigen presentation is regulated over the course of DC maturation. One key aspect of this regulation is the cell surface up-regulation upon DC maturation of peptide center dot MHC-II complexes and the costimulatory molecule CD86. It is now clear that these critical induction events involve changes in ubiquitin-dependent trafficking of MHC-II and CD86 by the E3 ligase membrane-associated RING-CH-1 (MARCH1). Although ubiquitin-dependent trafficking of MHC-II has been well characterized, much less is known regarding the post-transcriptional regulation of CD86 expression. Here, we examined the physical and functional interaction between CD86 and MARCH1. We observed that CD86 is rapidly endocytosed in the presence of MARCH1 followed by lysosome-dependent degradation. Furthermore, we found that the association between CD86 and MARCH1 was conferred primarily by the transmembrane domains of the respective proteins. In contrast to MHC-II, which has a single, conserved ubiquitin acceptor site in the cytosolic domain, we found that multiple lysine residues in the cytosolic tail of CD86 could support ubiquitination consistent with the relative lack of sequence conservation across species within the CD86 cytosolic domain. These findings suggest that MARCH1 recruits multiple substrates via transmembrane domain-mediated interactions to permit substrate ubiquitination in the face of diverse cytosolic domain sequences.	[Corcoran, Kathleen; Bhagwandin, Candida; Lybarger, Lonnie] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Jabbour, Maurice; Lybarger, Lonnie] Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA; [Deymier, Martin J.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Lybarger, Lonnie] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Lybarger, L (corresponding author), Univ Arizona, Dept Cellular & Mol Med, 1501 N Campbell Ave,LSN 444, Tucson, AZ 85724 USA.	lybarger@email.arizona.edu			National Institutes of Health [AI060723, AI080756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060723, R56AI080756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI060723 and AI080756.	BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Berger AC, 2009, J CELL SCI, V122, P1, DOI 10.1242/jcs.035089; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Corcoran K, 2009, J BIOL CHEM, V284, P17475, DOI 10.1074/jbc.M808258200; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Engering A, 2001, INT IMMUNOL, V13, P127, DOI 10.1093/intimm/13.2.127; Girvin AR, 2000, J IMMUNOL, V164, P136, DOI 10.4049/jimmunol.164.1.136; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hoer S, 2007, FEBS LETT, V581, P45, DOI 10.1016/j.febslet.2006.11.075; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nathan JA, 2009, EXP CELL RES, V315, P1593, DOI 10.1016/j.yexcr.2008.10.026; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Salek-Ardakani S, 2009, J IMMUNOL, V182, P2909, DOI 10.4049/jimmunol.0803545; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Unternaehrer JJ, 2007, P NATL ACAD SCI USA, V104, P234, DOI 10.1073/pnas.0609665104; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2008, SEMIN CANCER BIOL, V18, P441, DOI 10.1016/j.semcancer.2008.09.002; Wang XL, 2006, J BIOL CHEM, V281, P8636, DOI 10.1074/jbc.M513920200; Wang XL, 2004, J VIROL, V78, P8673, DOI 10.1128/JVI.78.16.8673-8686.2004; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429; zum Bueschenfelde COM, 2004, J IMMUNOL, V173, P6119, DOI 10.4049/jimmunol.173.10.6119	66	49	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37168	37180		10.1074/jbc.M110.204040	http://dx.doi.org/10.1074/jbc.M110.204040			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896490	Green Published, hybrid			2022-12-27	WOS:000296542400017
J	Pourebrahim, R; Houtmeyers, R; Ghogomu, S; Janssens, S; Thelie, A; Tran, HT; Langenberg, T; Vleminckx, K; Bellefroid, E; Cassiman, JJ; Tejpar, S				Pourebrahim, Rasoul; Houtmeyers, Rob; Ghogomu, Stephen; Janssens, Sylvie; Thelie, Aurore; Hong Thi Tran; Langenberg, Tobias; Vleminckx, Kris; Bellefroid, Eric; Cassiman, Jean-Jacques; Tejpar, Sabine			Transcription Factor Zic2 Inhibits Wnt/beta-Catenin Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; BETA-CATENIN; POLY(ADP-RIBOSE) POLYMERASE-1; XENOPUS-LAEVIS; WNT; GENE; ACTIVATION; EXPRESSION; MUTATIONS; HINDBRAIN	The Zic transcription factors play critical roles during embryonic development. Mutations in the ZIC2 gene are associated with human holoprosencephaly, but the etiology is still unclear. Here, we report a novel function for ZIC2 as a regulator of beta-catenin.TCF4-mediated transcription. We show that ZIC2 can bind directly to the DNA-binding high mobility group box of TCF4 via its zinc finger domain and inhibit the transcriptional activity of the beta-catenin.TCF4 complex. However, the binding of TCF4 to DNA was not affected by ZIC2. Zic2 RNA injection completely inhibited beta-catenin-induced axis duplication in Xenopus embryos and strongly blocked the ability of beta-catenin to induce expression of known Wnt targets in animal caps. Moreover, Zic2 knockdown in transgenic Xenopus Wnt reporter embryos led to ectopic Wnt signaling activity mainly at the midbrain-hindbrain boundary. Together, our results demonstrate a previously unknown role for ZIC2 as a transcriptional regulator of the beta-catenin.TCF4 complex.	[Pourebrahim, Rasoul; Houtmeyers, Rob; Cassiman, Jean-Jacques; Tejpar, Sabine] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Tejpar, Sabine] Katholieke Univ Leuven, Dept Gastroenterol, B-3000 Louvain, Belgium; [Ghogomu, Stephen; Thelie, Aurore; Bellefroid, Eric] Univ Libre Bruxelles, Lab Embryol Mol, B-6041 Gosselies, Belgium; [Langenberg, Tobias] VRC, B-3000 Louvain, Belgium; [Janssens, Sylvie; Hong Thi Tran; Vleminckx, Kris] Univ Ghent, Dept Mol Biomed Res, VIB, B-9052 Ghent, Belgium; [Janssens, Sylvie; Hong Thi Tran; Vleminckx, Kris] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	KU Leuven; KU Leuven; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Tejpar, S (corresponding author), Katholieke Univ Leuven, Dept Human Genet, O&N1, B-3000 Louvain, Belgium.	sabine.tejpar@med.kuleuven.be	Tran, Hong/C-6831-2015; Vleminckx, Kris/J-5699-2013; Ghogomu, Stephen/AAF-6825-2020	THELIE, Aurore/0000-0002-2951-2523; Houtmeyers, Rob/0000-0002-1126-6010; Pourebrahim, Rasoul/0000-0003-1175-2032	Belgian Federation	Belgian Federation	Supported by research grants from the Belgian Federation against Cancer. S. T. is senior clinical investigator for the Fund for Scientific Research-Flanders (FWO). To whom correspondence should be addressed: Katholieke Universiteit Leuven, O&N1, 3000 Leuven, Belgium. Tel.: 32-16-345-860; Fax: 32-16-345-997; E-mail: sabine.tejpar@med.kuleuven.be.	Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Aruga J, 1998, J NEUROSCI, V18, P284; Aruga J, 2011, NEUROCHEM RES, V36, P1286, DOI 10.1007/s11064-011-0422-5; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Brannon M, 1999, DEVELOPMENT, V126, P3159; Brown L, 2005, HUM MOL GENET, V14, P411, DOI 10.1093/hmg/ddi037; Brown L, 2009, GENE EXPR PATTERNS, V9, P43, DOI 10.1016/j.gep.2008.08.002; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Buckles GR, 2004, MECH DEVELOP, V121, P437, DOI 10.1016/j.mod.2004.03.026; CUI YZ, 1995, DEVELOPMENT, V121, P2177; Elms P, 2003, DEV BIOL, V264, P391, DOI 10.1016/j.ydbio.2003.09.005; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Heeg-Truesdell E, 2006, DEV BIOL, V298, P71, DOI 10.1016/j.ydbio.2006.06.015; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Houston DW, 2005, DEVELOPMENT, V132, P4845, DOI 10.1242/dev.02066; Idogawa M, 2005, GASTROENTEROLOGY, V128, P1919, DOI 10.1053/j.gastro.2005.03.007; Idogawa M, 2007, CANCER RES, V67, P911, DOI 10.1158/0008-5472.CAN-06-2360; Inoue T, 2007, DEV BIOL, V306, P669, DOI 10.1016/j.ydbio.2007.04.003; Ishiguro A, 2007, J BIOL CHEM, V282, P9983, DOI 10.1074/jbc.M610821200; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kong XB, 2009, IN VITRO CELL DEV-AN, V45, P185, DOI 10.1007/s11626-008-9157-2; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; MCGREW LL, 1992, DEVELOPMENT, V115, P463; Merzdorf CS, 2006, INT J DEV BIOL, V50, P611, DOI 10.1387/ijdb.052110cm; Mizugishi K, 2004, BIOCHEM BIOPH RES CO, V320, P233, DOI 10.1016/j.bbrc.2004.05.158; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Salero E, 2001, J BIOL CHEM, V276, P1881, DOI 10.1074/jbc.M007008200; Sen A, 2010, DEV BIOL, V343, P167, DOI 10.1016/j.ydbio.2010.04.003; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Tran HT, 2010, P NATL ACAD SCI USA, V107, P16160, DOI 10.1073/pnas.1007725107; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Warr N, 2008, HUM MOL GENET, V17, P2986, DOI 10.1093/hmg/ddn197; WOLDA SL, 1993, DEV BIOL, V155, P46, DOI 10.1006/dbio.1993.1005; Yang Y, 2000, J BIOL CHEM, V275, P38863, DOI 10.1074/jbc.M007906200	44	58	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37732	37740		10.1074/jbc.M111.242826	http://dx.doi.org/10.1074/jbc.M111.242826			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908606	hybrid, Green Published			2022-12-27	WOS:000296542400069
J	Ganguly, A; Yang, HL; Pedroza, M; Bhattacharya, R; Cabral, F				Ganguly, Anutosh; Yang, Hailing; Pedroza, Mesias; Bhattacharya, Rajat; Cabral, Fernando			Mitotic Centromere-associated Kinesin (MCAK) Mediates Paclitaxel Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-TUBULIN ISOTYPES; HAMSTER OVARY CELLS; MICROTUBULE DYNAMIC INSTABILITY; CONFERS RESISTANCE; DEPENDENT MUTANTS; SPINDLE FORMATION; MEIOTIC SPINDLE; ALPHA-TUBULIN; CENTROSOME; EXPRESSION	Paclitaxel has powerful anticancer activity, but some tumors are inherently resistant to the drug, whereas others are initially sensitive but acquire resistance during treatment. To deal with this problem, it will be necessary to understand the mechanisms of drug action and resistance. Recent studies indicate that paclitaxel blocks cell division by inhibiting the detachment of micro-tubules from centrosomes. Here, we demonstrate that mitotic centromere-associated kinesin (MCAK), a kinesin-related protein that destabilizes microtubules, plays an important role in microtubule detachment. Depletion of MCAK altered mitotic spindle morphology, increased the frequency of lagging chromosomes, and inhibited the proliferation of WT CHO cells, confirming that it is an essential protein for cell division. In contrast, MCAK depletion rescued the proliferation of mutant paclitaxel-dependent cell lines that are unable to divide because of defective spindle function resulting from altered alpha-tubulin or class III beta-tubulin overexpression. In concert with the correction of mitotic defects, loss of MCAK reversed an aberrantly high frequency of microtubule detachment in the mutant cells and increased their sensitivity to paclitaxel. The results indicate that MCAK affects cell sensitivity to mitotic inhibitors by modulating the frequency of microtubule detachment, and they demonstrate that changes in a microtubule-interacting protein can reverse the effects of mutant tubulin expression.	[Ganguly, Anutosh; Yang, Hailing; Pedroza, Mesias; Bhattacharya, Rajat; Cabral, Fernando] Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Cabral, F (corresponding author), Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	fernando.r.cabral@uth.tmc.edu		Ganguly, Anutosh/0000-0002-7228-7827; Bhattacharya, Rajat/0000-0001-5693-6754	National Institutes of Health [CA085935]; NATIONAL CANCER INSTITUTE [R01CA085935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA085935 (to F. C.).	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; ABRAHAM I, 1983, J CELL BIOL, V97, P1055, DOI 10.1083/jcb.97.4.1055; Barlow SB, 2002, J CELL SCI, V115, P3469; Blade K, 1999, J CELL SCI, V112, P2213; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; CABRAL F, 1991, PHARMACOL THERAPEUT, V52, P159, DOI 10.1016/0163-7258(91)90006-8; CABRAL F, 1980, CELL, V20, P29, DOI 10.1016/0092-8674(80)90231-7; Cabral F., 2000, DRUG RESIST UPDATE, V3, P1; Cabral Fernando, 2008, P337, DOI 10.1007/978-1-59745-336-3_14; CABRAL FR, 1983, J CELL BIOL, V97, P22, DOI 10.1083/jcb.97.1.22; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Gaglio T, 1997, J CELL BIOL, V138, P1055, DOI 10.1083/jcb.138.5.1055; Ganguly A, 2008, CELL CYCLE, V7, P3187, DOI 10.4161/cc.7.20.6814; Ganguly A, 2011, MOL CANCER THER, V10, P929, DOI 10.1158/1535-7163.MCT-10-1109; Ganguly A, 2010, MOL CANCER THER, V9, P2914, DOI 10.1158/1535-7163.MCT-10-0552; Gonzalez-Garay ML, 1999, J BIOL CHEM, V274, P23875, DOI 10.1074/jbc.274.34.23875; Hari M, 2003, CELL MOTIL CYTOSKEL, V56, P45, DOI 10.1002/cm.10132; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; Luduena RF, 1998, INT REV CYTOL, V178, P207; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Rizk RS, 2009, MOL BIOL CELL, V20, P1639, DOI 10.1091/mbc.E08-09-0985; Rusan NM, 2005, J CELL BIOL, V168, P21, DOI 10.1083/jcb.200409153; SAWADA T, 1989, J BIOL CHEM, V264, P3013; SCHIBLER MJ, 1986, J CELL BIOL, V102, P1522, DOI 10.1083/jcb.102.4.1522; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820	44	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36378	36384		10.1074/jbc.M111.296483	http://dx.doi.org/10.1074/jbc.M111.296483			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21903575	Green Published, hybrid			2022-12-27	WOS:000296538300023
J	Giang, KTN; Zhang, S; Wang, W; Wong, CTT; Ngan, TKN; Tam, JP				Giang Kien Truc Nguyen; Zhang, Sen; Wang, Wei; Wong, Clarence Tsun Ting; Ngan Thi Kim Nguyen; Tam, James P.			Discovery of a Linear Cyclotide from the Bracelet Subfamily and Its Disulfide Mapping by Top-down Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC CYSTINE KNOT; OLDENLANDIA-AFFINIS; KALATA B1; PROTEIN CHARACTERIZATION; CIRCULAR MINIPROTEINS; STRUCTURAL MOTIF; PLANT CYCLOTIDES; PEPTIDES; BIOSYNTHESIS; POLYPEPTIDES	Cyclotides are heat-stable macrocyclic peptides from plants that display a wide range of biological activities. They can be divided into two subfamilies: Mobius or bracelet, based on the presence or absence of a cis-proline residue in loop 5, respectively. Currently, over 150 cyclotides have been discovered, but only four linear variants of the Mobius subfamily have been hitherto isolated. In this study, we report the discovery of two novel cyclotides, hedyotide B1 and hedyotide B2, from the aerial parts of Hedyotis biflora. Hedyotide B1 has a cyclic cystine knot structure typical of cyclotides. Interestingly, hedyotide B2 possesses a linear backbone and is the first linear representative of the bracelet subfamily. Disulfide mapping of hedyotide B2 by a top-down MS/MS approach showed that it shares the same knotted disulfide arrangement as conventional cyclotides. Its unfolding pathway also showed that the penetrating disulfide bond Cys III-VI is the most stable disulfide linkage. Cloning of the gene encoding hedyotide B2 revealed a nonsense mutation that introduces a premature stop codon at the conserved Asn residue position, which is essential for an end-to-end backbone ligation. Biophysical characterization showed that hedyotide B2 was more susceptible to exopeptidase degradation as compared with hedyotide B1. Hedyotide B2 was also inactive against all four tested bacterial strains, whereas hedyotide B1 was bactericidal to Escherichia coli and Streptococcus salivarius at low micromolar concentration. Our results provide a deeper understanding of the structures, functions, and biosynthetic processing of cyclotides and uncyclotides in plants.	[Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	jptam@ntu.edu.sg	Tam, James P/A-2176-2011; Wong, Clarence Tsun Ting/AAH-6159-2020	Tam, James P/0000-0003-4433-198X; Wong, Clarence Tsun Ting/0000-0001-8950-0033; Zhang, Sen/0000-0003-1409-5795	Biomedical Research Council [BMRC09/1/22/19/612]; A*STAR; Ministry of Education in Singapore [ARC21/08]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); A*STAR(Agency for Science Technology & Research (A*STAR)); Ministry of Education in Singapore(Ministry of Education, Singapore)	This work was supported by Biomedical Research Council Grant BMRC09/1/22/19/612, A*STAR, and Grant ARC21/08 from the Academic Research Fund of the Ministry of Education in Singapore.	Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; DAGAR HS, 1991, ECON BOT, V45, P114, DOI 10.1007/BF02860056; Daly NL, 1999, J MOL BIOL, V285, P333, DOI 10.1006/jmbi.1998.2276; Datta P. C., 1969, QUARTERNARY J CRUDE, V9, P1356; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; GRAN L, 1973, LLOYDIA, V36, P207; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gupta MK, 1996, HYDROBIOLOGIA, V335, P33, DOI 10.1007/BF00013680; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Karehed J, 2008, MOL PHYLOGENET EVOL, V49, P843, DOI 10.1016/j.ympev.2008.09.025; Kelleher NL, 1999, J AM CHEM SOC, V121, P806, DOI 10.1021/ja973655h; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; Reid GE, 2002, J MASS SPECTROM, V37, P663, DOI 10.1002/jms.346; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Sze SK, 2009, ANAL CHEM, V81, P1079, DOI 10.1021/ac802175r; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trabi M, 2004, J NAT PROD, V67, P806, DOI 10.1021/np034068e; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wong CTT, 2011, BIOCHEMISTRY-US, V50, P7275, DOI 10.1021/bi2007004	41	53	53	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44833	44844		10.1074/jbc.M111.290296	http://dx.doi.org/10.1074/jbc.M111.290296			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21979955	Green Published, hybrid			2022-12-27	WOS:000298645500052
J	Bogema, DR; Scott, NE; Padula, MP; Tacchi, JL; Raymond, BBA; Jenkins, C; Cordwell, SJ; Minion, FC; Walker, MJ; Djordjevic, SP				Bogema, Daniel R.; Scott, Nichollas E.; Padula, Matthew P.; Tacchi, Jessica L.; Raymond, Benjamin B. A.; Jenkins, Cheryl; Cordwell, Stuart J.; Minion, F. Chris; Walker, Mark J.; Djordjevic, Steven P.			Sequence TTKF down arrow QE Defines the Site of Proteolytic Cleavage in Mhp683 Protein, a Novel Glycosaminoglycan and Cilium Adhesin of Mycoplasma hyopneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVED PREDICTION; ORAL IMMUNIZATION; SIGNAL PEPTIDES; BINDING PROTEIN; COILED COILS; IDENTIFICATION; SWINE; ADHERENCE; HEPARIN; ANTIGEN	Mycoplasma hyopneumoniae colonizes the ciliated respiratory epithelium of swine, disrupting mucociliary function and inducing chronic inflammation. P97 and P102 family members are major surface proteins of M. hyopneumoniae and play key roles in colonizing cilia via interactions with glycosaminoglycans and mucin. The p102 paralog, mhp683, and homologs in strains from different geographic origins encode a 135-kDa preprotein (P135) that is cleaved into three fragments identified here as P45(683), P48(683), and P50(683). A peptide sequence (TTKF down arrow QE) was identified surrounding both cleavage sites in Mhp683. N-terminal sequences of P48(683) and P50(683), determined by Edman degradation and mass spectrometry, confirmed cleavage after the phenylalanine residue. A similar proteolytic cleavage site was identified by mass spectrometry in another paralog of the P97/P102 family. Trypsin digestion and surface biotinylation studies showed that P45(683), P48(683), and P50(683) reside on the M. hyopneumoniae cell surface. Binding assays of recombinant proteins F1(683)-F5(683), spanning Mhp683, showed saturable and dose-dependent binding to biotinylated heparin that was inhibited by unlabeled heparin, fucoidan, and mucin. F1(683)-F5(683) also bound porcine epithelial cilia, and antisera to F2(683) and F5(683) significantly inhibited cilium binding by M. hyopneumoniae cells. These data suggest that P45(683), P48(683), and P50(683) each display cilium- and proteoglycan-binding sites. Mhp683 is the first characterized glycosaminoglycan-binding member of the P102 family.	[Bogema, Daniel R.; Jenkins, Cheryl; Djordjevic, Steven P.] Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Camden, NSW 2567, Australia; [Bogema, Daniel R.; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Scott, Nichollas E.; Cordwell, Stuart J.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Padula, Matthew P.; Tacchi, Jessica L.; Raymond, Benjamin B. A.; Djordjevic, Steven P.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Minion, F. Chris] Iowa State Univ, Ames, IA 50011 USA; [Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Walker, Mark J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia	NSW Department of Primary Industries; University of Wollongong; University of Sydney; University of Technology Sydney; Iowa State University; University of Queensland; University of Queensland	Djordjevic, SP (corresponding author), POB 123, Broadway, NSW 2007, Australia.	steven.djordjevic@uts.edu.au	Bogema, Daniel/ABE-8287-2020; Djordjevic, Steven/A-2024-2013; Bogema, Daniel/AAE-2935-2020; Bogema, Daniel/B-4629-2011; Raymond, Benjamin/X-5739-2019; Minion, Chris/A-2955-2015; djordjevic, steven/GNP-4000-2022; Walker, Mark J./F-6940-2011; Jenkins, Cheryl/N-1937-2015; Padula, Matthew P/R-6150-2016	Bogema, Daniel/0000-0001-7013-7326; Djordjevic, Steven/0000-0001-9301-5372; Bogema, Daniel/0000-0001-7013-7326; Bogema, Daniel/0000-0001-7013-7326; Raymond, Benjamin/0000-0003-3610-9289; Minion, Chris/0000-0003-4876-8396; djordjevic, steven/0000-0001-9301-5372; Jenkins, Cheryl/0000-0002-5966-072X; Padula, Matthew P/0000-0002-8283-0643; Walker, Mark/0000-0001-7423-2769; Scott, Nichollas/0000-0003-2556-8316; Cordwell, Stuart/0000-0002-0995-0171	ARC [LP776711]; McGarvie Smith Trust; Australian postgraduate award (Industry)	ARC(Australian Research Council); McGarvie Smith Trust; Australian postgraduate award (Industry)(Australian Government)	This work was supported by ARC-Linkage Grant LP776711 and a grant from the McGarvie Smith Trust (to S. P. D.).; Recipient of an Australian postgraduate award (Industry).	Adams C, 2005, INFECT IMMUN, V73, P7784, DOI 10.1128/IAI.73.11.7784-7787.2005; Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baron MJ, 2007, J BIOL CHEM, V282, P10526, DOI 10.1074/jbc.M608279200; Belloy L, 2003, MICROBIOL-SGM, V149, P185, DOI 10.1099/mic.0.25864-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boesen T, 2001, PROTEIN SCI, V10, P2577, DOI 10.1110/ps.ps.31901; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Burnett TA, 2006, MOL MICROBIOL, V60, P669, DOI 10.1111/j.1365-2958.2006.05139.x; Chin J, 1996, J BIOTECHNOL, V44, P13, DOI 10.1016/0168-1656(95)00099-2; Clark L. K., 1993, Swine Health and Production, V1, P10; Cordwell SJ, 2008, PROTEOMICS, V8, P122, DOI 10.1002/pmic.200700561; Courtney HS, 1999, MOL MICROBIOL, V32, P89, DOI 10.1046/j.1365-2958.1999.01328.x; Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153; de Castro LA, 2006, VET MICROBIOL, V116, P258, DOI 10.1016/j.vetmic.2006.04.022; DEBEY MC, 1994, INFECT IMMUN, V62, P5312, DOI 10.1128/IAI.62.12.5312-5318.1994; Deutscher AT, 2010, MOL MICROBIOL, V78, P444, DOI 10.1111/j.1365-2958.2010.07345.x; Djordjevic SP, 1997, AUST VET J, V75, P504, DOI 10.1111/j.1751-0813.1997.tb14383.x; Djordjevic SP, 2004, INFECT IMMUN, V72, P2791, DOI 10.1128/IAI.72.5.2791-2802.2004; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; ERLINGER R, 1995, CELL TISSUE RES, V281, P473, DOI 10.1007/BF00417864; Fagan PK, 1997, INFECT IMMUN, V65, P2502, DOI 10.1128/IAI.65.6.2502-2507.1997; Fagan PK, 1996, INFECT IMMUN, V64, P1060, DOI 10.1128/IAI.64.3.1060-1064.1996; Fagan PK, 2001, MICROB PATHOGENESIS, V30, P101, DOI 10.1006/mpat.2000.0412; FISCHETTI VA, 1985, J EXP MED, V161, P1384, DOI 10.1084/jem.161.6.1384; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gonciarz-Swiatek M, 2006, MOL IMMUNOL, V43, P1993, DOI 10.1016/j.molimm.2005.11.012; Haesebrouck F, 2004, VET MICROBIOL, V100, P255, DOI 10.1016/j.vetmic.2004.03.002; Hellstrom JL, 2006, BBA-PROTEINS PROTEOM, V1764, P1735, DOI 10.1016/j.bbapap.2006.08.018; Hsu T, 1998, INFECT IMMUN, V66, P4762, DOI 10.1128/IAI.66.10.4762-4766.1998; Hsu T, 1997, J BACTERIOL, V179, P1317, DOI 10.1128/jb.179.4.1317-1323.1997; Jenkins C, 2006, INFECT IMMUN, V74, P481, DOI 10.1128/IAI.74.1.481-487.2006; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; KELLY C, 1989, FEBS LETT, V258, P127, DOI 10.1016/0014-5793(89)81632-1; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Matic JN, 2009, INFECT IMMUN, V77, P1817, DOI 10.1128/IAI.01301-08; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; MEBUS CA, 1977, AM J VET RES, V38, P1249; Menozzi FD, 2002, MOL MICROBIOL, V43, P1379, DOI 10.1046/j.1365-2958.2002.02841.x; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; Minion FC, 2000, INFECT IMMUN, V68, P3056, DOI 10.1128/IAI.68.5.3056-3060.2000; Moelleken K, 2008, MOL MICROBIOL, V67, P403, DOI 10.1111/j.1365-2958.2007.06050.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nunomura K, 2005, MOL CELL PROTEOMICS, V4, P1968, DOI 10.1074/mcp.M500216-MCP200; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Proft T, 1996, GENE, V171, P79, DOI 10.1016/0378-1119(96)00014-5; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; REALINI C, 1994, FEBS LETT, V348, P109, DOI 10.1016/0014-5793(94)00569-9; REALINI C, 1995, J BIOL CHEM, V270, P29664; Scarman AL, 1997, MICROBIOL-SGM, V143, P663, DOI 10.1099/00221287-143-2-663; Scott NE, 2010, PROTEOMICS, V10, P277, DOI 10.1002/pmic.200900440; Scott NE, 2009, J PROTEOME RES, V8, P4654, DOI 10.1021/pr900544x; Seymour LM, 2011, J BIOL CHEM, V286, P10097, DOI 10.1074/jbc.M110.208140; Seymour LM, 2010, J BIOL CHEM, V285, P33971, DOI 10.1074/jbc.M110.104463; SOBEL M, 1992, J BIOL CHEM, V267, P8857; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Szczepanek SM, 2010, INFECT IMMUN, V78, P3475, DOI 10.1128/IAI.00154-10; TAJIMA M, 1982, INFECT IMMUN, V37, P1162, DOI 10.1128/IAI.37.3.1162-1169.1982; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Wilton J, 2009, MOL MICROBIOL, V71, P566, DOI 10.1111/j.1365-2958.2008.06546.x; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; WRIGHT HT, 1991, PROTEIN ENG, V4, P283, DOI 10.1093/protein/4.3.283; Zhang KR, 2006, J PROTEOME RES, V5, P3355, DOI 10.1021/pr060336t; ZHANG QJ, 1994, INFECT IMMUN, V62, P1616, DOI 10.1128/IAI.62.5.1616-1622.1994; ZHANG QJ, 1995, INFECT IMMUN, V63, P1013, DOI 10.1128/IAI.63.3.1013-1019.1995; ZIELINSKI GC, 1990, AM J VET RES, V51, P339; Zimmermann L, 2010, J BACTERIOL, V192, P3773, DOI 10.1128/JB.00253-10	71	42	44	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41217	41229		10.1074/jbc.M111.226084	http://dx.doi.org/10.1074/jbc.M111.226084			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969369	Green Published, hybrid			2022-12-27	WOS:000298057500010
J	Liu, T; Wan, L; Wu, Y; Chen, JJ; Huang, J				Liu, Ting; Wan, Li; Wu, Yue; Chen, Junjie; Huang, Jun			hSWS1.SWSAP1 Is an Evolutionarily Conserved Complex Required for Efficient Homologous Recombination Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; SACCHAROMYCES-CEREVISIAE; GENOMIC STABILITY; MAMMALIAN-CELLS; PROTEINS; GENES; RAD51; PROMOTE; SCREEN	The Shu complex in yeast plays an important role in the homologous recombination pathway, which is critical for the maintenance of genomic integrity. The identification of human SWS1 (hSWS1) as the homolog of budding yeast Shu2 implicated that the Shu complex is evolutionarily conserved. However, the human counterparts of other components in this complex have not yet been identified and characterized. Here we describe the characterization of a novel human component of this complex, SWSAP1 (hSWS1-associated protein 1)/C19orf39. We show that hSWS1 and SWSAP1 form a stable complex in vivo and in vitro. hSWS1 and SWSAP1 are mutually interdependent for their stability. We further demonstrate that the purified hSWS1.SWSAP1 complex possesses single-stranded DNA-binding activity and DNA-stimulated ATPase activity. Moreover, SWSAP1 interacts with RAD51 and RAD51 paralogs, and depletion of SWSAP1 causes defects in homologous recombination repair. Thus, our results suggest that the human Shu complex (hSWS1.SWSAP1) has an evolutionarily conserved function in homologous recombination.	[Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Liu, Ting; Wan, Li; Wu, Yue; Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Zhejiang University	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org; jhuang@zju.edu.cn	Wan, Li/AFR-0017-2022		National Natural Science Foundation of China [31071243]; Natural Science Foundation of Zhejiang Province [R2110569]; China's Fundamental Research Funds for the Central Universities; Department of Defense [W81XWH-05-1-0470]; Anderson Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [R01CA089239] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); China's Fundamental Research Funds for the Central Universities; Department of Defense(United States Department of Defense); Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Natural Science Foundation of China (Grant 31071243), the Natural Science Foundation of Zhejiang Province (Grant R2110569), and the China's Fundamental Research Funds for the Central Universities (to J. H.).; A recipient of an Era of Hope Scholar award from the Department of Defense (Grant W81XWH-05-1-0470) and a member of the M.D. Anderson Cancer Center (Grant CA016672). To whom correspondence may be addressed. E-mail: jchen8@mdanderson.org.	Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Bernstein KA, 2011, MOL BIOL CELL, V22, P1599, DOI 10.1091/mbc.E10-08-0691; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Komori K, 2000, J BIOL CHEM, V275, P33791, DOI 10.1074/jbc.M004556200; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Lukas J, 2004, CELL, V118, P666, DOI 10.1016/j.cell.2004.09.006; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Martin V, 2006, EMBO J, V25, P2564, DOI 10.1038/sj.emboj.7601141; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Sandler SJ, 1996, NUCLEIC ACIDS RES, V24, P2125, DOI 10.1093/nar/24.11.2125; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Shor E, 2005, GENETICS, V169, P1275, DOI 10.1534/genetics.104.036764; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127	23	51	59	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41758	41766		10.1074/jbc.M111.271080	http://dx.doi.org/10.1074/jbc.M111.271080			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965664	hybrid, Green Published			2022-12-27	WOS:000298057500059
J	Wu, W; Sun, XH				Wu, Wei; Sun, Xiao-Hong			A Mechanism Underlying NOTCH-Induced and Ubiquitin-mediated JAK3 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; CYTOKINE SIGNAL-TRANSDUCTION; T-CELL DEVELOPMENT; LYMPHOID DEVELOPMENT; JANUS KINASES; SUPPRESSOR-OF-CYTOKINE-SIGNALING-1 SOCS-1; ACTIVATION LOOP; GAMMA-CHAIN; B-CELLS; FATE	Although NOTCH signaling is well known to regulate lymphopoiesis, Janus kinase 3 (JAK3) also plays a critical role in promoting lymphocyte development. We have previously found that NOTCH signaling leads to the degradation of JAK3 in B lineage cells, suggesting that NOTCH signaling exerts its biological effect on lymphopoiesis through modulating JAK3 levels. Here, we delineate the biochemical mechanisms involved in NOTCH-induced JAK3 ubiquitination and degradation. NOTCH signaling is known to transcriptionally activate the genes encoding ASB2 (ankyrin-repeat SOCS box containing protein 2) and SKP2 (S-phase kinase-associated protein 2). We show that not only NOTCH but also ASB2 and SKP2 can promote the ubiquitination and degradation of JAK3. Both ASB2 and SKP2 can interact with JAK3 through different domains; the FERM and pseudo-kinase domains each had high affinities for ASB2, whereas the kinase domain primarily associated with SKP2. ASB2 and SKP2 previously have been shown to associate with each other to bridge the formation of a non-canonical Cullin1 and Cullin5-containing dimeric E3 ligase complex. Interestingly, the R980W mutant of JAK3 exhibited diminished interaction with SKP2 and resistance to NOTCH or ASB2-induced degradation. Furthermore, dominant-negative mutants of either Cullin1 or Cullin5, which lack the C terminus responsible for recruiting the E2 enzymes, were able to prevent JAK3 degradation induced by both ASB2/SKP2 and NOTCH signaling. Together, these results suggest that JAK3 ubiquitination involves the non-canonical dimeric E3 ligase complex, and the R980W mutant will serve as an excellent tool for investigating the biological significance of NOTCH-mediated JAK3 turnover.	[Wu, Wei; Sun, Xiao-Hong] Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA; [Wu, Wei; Sun, Xiao-Hong] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Sun, XH (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	sunx@omrf.org			National Institutes of Health [AI56129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI56129 (to X.-H. S.).	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bergamin E, 2006, STRUCTURE, V14, P1285, DOI 10.1016/j.str.2006.06.011; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Callahan R, 2001, J MAMMARY GLAND BIOL, V6, P23, DOI 10.1023/A:1009512414430; Candotti F, 1997, BLOOD, V90, P3996, DOI 10.1182/blood.V90.10.3996; Chatti K, 2004, BIOCHEMISTRY-US, V43, P4272, DOI 10.1021/bi036109b; Cornejo MG, 2009, BLOOD, V113, P2746, DOI 10.1182/blood-2008-06-164368; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Giordanetto F, 2003, PROTEIN ENG, V16, P115, DOI 10.1093/proeng/gzg015; Gurniak CB, 1996, BLOOD, V87, P3151, DOI 10.1182/blood.V87.8.3151.bloodjournal8783151; He YW, 1997, J IMMUNOL, V158, P2592; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Milne CD, 2006, SEMIN IMMUNOL, V18, P20, DOI 10.1016/j.smim.2005.10.003; Moore TA, 1996, J IMMUNOL, V157, P2366; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Nie L, 2008, MOL CELL BIOL, V28, P2078, DOI 10.1128/MCB.00844-07; Nie L, 2011, CELL RES, V21, P754, DOI 10.1038/cr.2010.165; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; O'Shea JJ, 2004, ANN RHEUM DIS, V63, P67, DOI 10.1136/ard.2004.028290; O'Shea JJ, 2004, MOL IMMUNOL, V41, P727, DOI 10.1016/j.molimm.2004.04.014; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Simpson P, 1998, SEMIN CELL DEV BIOL, V9, P581, DOI 10.1006/scdb.1998.0265; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thomis DC, 1997, CURR OPIN IMMUNOL, V9, P541, DOI 10.1016/S0952-7915(97)80108-2; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vainchenker W, 2008, SEMIN CELL DEV BIOL, V19, P385, DOI 10.1016/j.semcdb.2008.07.002; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Waiboci LW, 2007, J IMMUNOL, V178, P5058, DOI 10.4049/jimmunol.178.8.5058; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yan Q, 2004, J BIOL CHEM, V279, P43019, DOI 10.1074/jbc.M408018200	58	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41153	41162		10.1074/jbc.M111.273755	http://dx.doi.org/10.1074/jbc.M111.273755			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969365	Green Published, hybrid			2022-12-27	WOS:000298057500004
J	Ponts, N; Saraf, A; Chung, DWD; Harris, A; Prudhomme, J; Washburn, MP; Florens, L; Le Roch, KG				Ponts, Nadia; Saraf, Anita; Chung, Duk-Won D.; Harris, Alona; Prudhomme, Jacques; Washburn, Michael P.; Florens, Laurence; Le Roch, Karine G.			Unraveling the Ubiquitome of the Human Malaria Parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM; UBIQUITINATED PROTEINS; FOOD VACUOLE; IDENTIFICATION; GENE; PLASMEPSINS; REVEALS; COMPLEX; PURIFICATION; QUANTITATION	Malaria is one of the deadliest infectious diseases worldwide. The most severe form is caused by the eukaryotic protozoan parasite Plasmodium falciparum. Recent studies have highlighted the importance of post-translational regulations for the parasite's progression throughout its life cycle, protein ubiquitylation being certainly one of the most abundant. The specificity of its components and the wide range of biological processes in which it is involved make the ubiquitylation pathway a promising source of suitable targets for anti-malarial drug development. Here, we combined immunofluorescent microscopy, biochemical assays, in silico prediction, and mass spectrometry analysis using the multidimensional protein identification technology, or MudPIT, to describe the P. falciparum ubiquitome. We found that ubiquitin conjugates are detected at every morphological stage of the parasite erythrocytic cycle. Furthermore, we detected that more than half of the parasite's proteome represents possible targets for ubiquitylation, especially proteins found to be present at the most replicative stage of the asexual cycle, the trophozoite stage. A large proportion of ubiquitin conjugates were also detected at the schizont stage, consistent with a cell activity slowdown to prepare for merozoite differentiation and invasion. Finally, for the first time in the human malaria parasite, our results strongly indicate the presence of heterologous mixed conjugations, SUMO/UB. This discovery suggests that sumoylated proteins may be regulated by ubiquitylation in P. falciparum. Altogether, our results present the first stepping stone toward a better understanding of ubiquitylation and its role(s) in the biology of the human malaria parasite.	[Ponts, Nadia; Chung, Duk-Won D.; Harris, Alona; Prudhomme, Jacques; Le Roch, Karine G.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Saraf, Anita; Washburn, Michael P.; Florens, Laurence] Stowers Inst Med Res, Kansas City, MO 64110 USA	University of California System; University of California Riverside; Stowers Institute for Medical Research	Le Roch, KG (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, 900 Univ Ave, Riverside, CA 92521 USA.	karine.leroch@ucr.edu		Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650	University of California, Riverside; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085077] Funding Source: NIH RePORTER	University of California, Riverside(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by University of California, Riverside, start-up funds (to K. L. R.).	Banerjee R, 2003, MOL BIOCHEM PARASIT, V129, P157, DOI 10.1016/S0166-6851(03)00119-1; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Berkers CR, 2010, BIOCHEM SOC T, V38, P14, DOI 10.1042/BST0380014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Daulny A, 2009, DNA REPAIR, V8, P444, DOI 10.1016/j.dnarep.2009.01.017; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FIELD SJ, 1993, CELL MOTIL CYTOSKEL, V25, P43, DOI 10.1002/cm.970250106; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Golebiowski F, 2010, NAT PROTOC, V5, P873, DOI 10.1038/nprot.2010.40; Goodman SR, 2007, EXP BIOL MED, V232, P1391, DOI 10.3181/0706-MR-156; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Manzano C, 2008, PLANT MOL BIOL, V68, P145, DOI 10.1007/s11103-008-9358-9; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; McFadden G. I, 2011, PROTOPLASMA IN PRESS; Pavelka N, 2008, MOL CELL PROTEOMICS, V7, P631, DOI 10.1074/mcp.M700240-MCP200; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Ponder EL, 2007, EUKARYOT CELL, V6, P1943, DOI 10.1128/EC.00282-07; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Prudhomme J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002335; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Reynolds Jennifer M, 2007, BMC Clin Pharmacol, V7, P13, DOI 10.1186/1472-6904-7-13; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Spallek T, 2009, CELL MICROBIOL, V11, P1425, DOI 10.1111/j.1462-5822.2009.01346.x; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Svejstrup JQ, 2007, TRENDS BIOCHEM SCI, V32, P165, DOI 10.1016/j.tibs.2007.02.005; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tan FW, 2008, PROTEOMICS, V8, P2885, DOI 10.1002/pmic.200700887; Tomlinson E, 2007, PROTEOMICS, V7, P1016, DOI 10.1002/pmic.200601008; Tonkin CJ, 2008, P NATL ACAD SCI USA, V105, P4781, DOI 10.1073/pnas.0707827105; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trelle MB, 2009, J PROTEOME RES, V8, P3439, DOI 10.1021/pr9000898; Tung J, 2009, NATURE, V460, P388, DOI 10.1038/nature08149; Venable JD, 2004, NAT METHODS, V1, P39, DOI 10.1038/NMETH705; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Xiang Y, 2007, PLOS BIOL, V5, P2831, DOI 10.1371/journal.pbio.0050323; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	60	52	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40320	40330		10.1074/jbc.M111.238790	http://dx.doi.org/10.1074/jbc.M111.238790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21930698	hybrid, Green Published			2022-12-27	WOS:000296925700063
J	Chruszcz, M; Maleki, SJ; Majorek, KA; Demas, M; Bublin, M; Solberg, R; Hurlburt, BK; Ruan, SB; Mattisohn, CP; Breiteneder, H; Minor, W				Chruszcz, Maksymilian; Maleki, Soheila J.; Majorek, Karolina A.; Demas, Matthew; Bublin, Merima; Solberg, Robert; Hurlburt, Barry K.; Ruan, Sanbao; Mattisohn, Christopher P.; Breiteneder, Heimo; Minor, Wladek			Structural and Immunologic Characterization of Ara h 1, a Major Peanut Allergen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGE-BINDING EPITOPES; X-RAY-DIFFRACTION; MACROMOLECULAR STRUCTURES; STRUCTURE VALIDATION; MOLECULAR-WEIGHT; NATURAL-HISTORY; PSI-BLAST; IN-VITRO; PROTEIN; SCATTERING	Allergic reactions to peanuts and tree nuts are major causes of anaphylaxis in the United States. We compare different properties of natural and recombinant versions of Ara h 1, a major peanut allergen, through structural, immunologic, and bioinformatics analyses. Small angle x-ray scattering studies show that natural Ara h 1 forms higher molecular weight aggregates in solution. In contrast, the full-length recombinant protein is partially unfolded and exists as a monomer. The crystal structure of the Ara h 1 core (residues 170-586) shows that the central part of the allergen has a bicupin fold, which is in agreement with our bioinformatics analysis. In its crystalline state, the core region of Ara h 1 forms trimeric assemblies, while in solution the protein exists as higher molecular weight assemblies. This finding reveals that the residues forming the core region of the protein are sufficient for formation of Ara h 1 trimers and higher order oligomers. Natural and recombinant variants of proteins tested in in vitro gastric and duodenal digestion assays show that the natural protein is the most stable form, followed by the recombinant Ara h 1 core fragment and the full-length recombinant protein. Additionally, IgE binding studies reveal that the natural and recombinant allergens have different patterns of interaction with IgE antibodies. The molecular basis of cross-reactivity between vicilin allergens is also elucidated.	[Chruszcz, Maksymilian; Majorek, Karolina A.; Demas, Matthew; Solberg, Robert; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Maleki, Soheila J.; Hurlburt, Barry K.; Ruan, Sanbao; Mattisohn, Christopher P.] ARS, So Reg Res Ctr, USDA, New Orleans, LA 70124 USA; [Bublin, Merima; Breiteneder, Heimo] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, A-1090 Vienna, Austria	University of Virginia; United States Department of Agriculture (USDA); Medical University of Vienna	Chruszcz, M (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	maks@iwonka.med.virginia.edu; wladek@iwonka.med.virginia.edu	Chruszcz, Maksymilian/E-6407-2011; Minor, Wladek/F-3096-2014	Chruszcz, Maksymilian/0000-0001-7521-5485; Minor, Wladek/0000-0001-7075-7090; Bublin, Merima/0000-0002-7191-9431	Austrian Research Promotion Agency (FFG) [820127]; US Dept. of Agriculture-Agricultural Research Service; New York Structural Genomics Consortium [GM094662]; U.S. Dept. of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357];  [GM53163]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053163, U54GM094662] Funding Source: NIH RePORTER	Austrian Research Promotion Agency (FFG); US Dept. of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); New York Structural Genomics Consortium; U.S. Dept. of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant GM53163, the Austrian Research Promotion Agency (FFG) BRIDGE Grant 820127, and the US Dept. of Agriculture-Agricultural Research Service.; We thank Steve Almo and Alexander Wlodawer for valuable comments on the manuscript and Michal Sabat for help with SAXS experiments. Some of the methodology used in this publication was developed for the New York Structural Genomics Consortium supported by Grant GM094662. The structural results shown in this report are derived from work performed at Argonne National Laboratory, at the Structural Biology Center of the Advanced Photon Source. Argonne is operated by University of Chicago Argonne, LLC, for the U.S. Dept. of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barre A, 2005, BIOCHIMIE, V87, P499, DOI 10.1016/j.biochi.2005.02.011; Barre A, 2008, MOL IMMUNOL, V45, P1231, DOI 10.1016/j.molimm.2007.09.014; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Burks AW, 1997, EUR J BIOCHEM, V245, P334, DOI 10.1111/j.1432-1033.1997.t01-1-00334.x; BURKS AW, 1995, J CLIN INVEST, V96, P1715, DOI 10.1172/JCI118216; Cabanos C, 2010, ACTA CRYSTALLOGR F, V66, P1071, DOI 10.1107/S1744309110029040; Chung SY, 2007, J AGR FOOD CHEM, V55, P9054, DOI 10.1021/jf071213b; Cong YJ, 2008, FOOD AGR IMMUNOL, V19, P175, DOI 10.1080/09540100802172599; Cymborowski M., 2010, Journal of Structural and Functional Genomics, V11, P211, DOI 10.1007/s10969-010-9092-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Leon Maria P., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000208; DeLano W.L, PYMOL MOL GRAPHICS S; Dooper MMBW, 2009, J INVEST ALLERG CLIN, V19, P283; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fleischer DM, 2007, CURR ALLERGY ASTHM R, V7, P175, DOI 10.1007/s11882-007-0018-y; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Keet CA, 2007, IMMUNOL ALLERGY CLIN, V27, P193, DOI 10.1016/j.iac.2007.03.005; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koppelman SJ, 1999, J BIOL CHEM, V274, P4770, DOI 10.1074/jbc.274.8.4770; Koppelman SJ, 2010, MOL NUTR FOOD RES, V54, P1711, DOI 10.1002/mnfr.201000011; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Li JX, 2010, PROTEIN SCI, V19, P174, DOI 10.1002/pro.295; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maleki SJ, 2000, J IMMUNOL, V164, P5844, DOI 10.4049/jimmunol.164.11.5844; Mills ENC, 2002, BIOCHEM SOC T, V30, P925, DOI 10.1042/BST0300925; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mondoulet L, 2005, J AGR FOOD CHEM, V53, P4547, DOI 10.1021/jf050091p; Moreno FJ, 2005, FEBS J, V272, P341, DOI 10.1111/j.1742-4658.2004.04472.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neugut AI, 2001, ARCH INTERN MED, V161, P15, DOI 10.1001/archinte.161.1.15; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Schmitt DA, 2010, J AGR FOOD CHEM, V58, P1138, DOI 10.1021/jf902694j; Shin DS, 1998, J BIOL CHEM, V273, P13753, DOI 10.1074/jbc.273.22.13753; Shinmoto Hiroshi, 2010, Human Antibodies, V19, P101, DOI 10.3233/HAB-2010-0233; Sicherer SH, 2007, J ALLERGY CLIN IMMUN, V120, P491, DOI 10.1016/j.jaci.2007.07.015; Skolnick HS, 2001, J ALLERGY CLIN IMMUN, V107, P367, DOI 10.1067/mai.2001.112129; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Teuber SS, 2004, CURR OPIN ALLERGY CL, V4, P201, DOI 10.1097/01.all.0000129451.19469.e2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Boxtel EL, 2008, J AGR FOOD CHEM, V56, P2223, DOI 10.1021/jf072907n; van Boxtel EL, 2007, J AGR FOOD CHEM, V55, P8772, DOI 10.1021/jf071585k; Van Boxtel EL, 2006, J AGR FOOD CHEM, V54, P7180, DOI 10.1021/jf061433+; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wensing M, 2003, J ALLERGY CLIN IMMUN, V111, P420, DOI 10.1067/mai.2003.61; Willison LN, 2008, CLIN EXP ALLERGY, V38, P1229, DOI 10.1111/j.1365-2222.2008.02998.x; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zimmerman M, 2005, ACTA CRYSTALLOGR A, V61, pC178, DOI 10.1107/S0108767305092391	67	73	83	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39318	39327		10.1074/jbc.M111.270132	http://dx.doi.org/10.1074/jbc.M111.270132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21917921	hybrid, Green Published			2022-12-27	WOS:000296759800050
J	Karena, E; Frillingos, S				Karena, Ekaterini; Frillingos, Stathis			The Role of Transmembrane Segment TM3 in the Xanthine Permease XanQ of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING ANALYSIS; TRANSPORTER SIGNATURE MOTIF; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE RECOGNITION; PURINE TRANSPORTERS; NAT/NCS2 FAMILY; BACTERIAL; SPECIFICITY; MECHANISM; PLASMIDS	The xanthine permease XanQ of Escherichia coli is used as a study prototype for function-structure analysis of the ubiquitous nucleobase-ascorbate transporter (NAT/NCS2) family. Our previous mutagenesis study of polar residues of XanQ has shown that Asn-93 at the middle of putative TM3 is a determinant of substrate affinity and specificity. To study the role of TM3 in detail we employed Cys-scanning mutagenesis. Using a functional mutant devoid of Cys residues (C-less), each amino acid residue in sequence 79-107 (YGIVGSGLL-SIQSVNFSFVTVMIALGSSM) including TM3 (underlined) and flanking sequences was replaced individually with Cys. Of 29 single-Cys mutants, 20 accumulate xanthine to 40-110% of the steady state observed with C-less, six (S88C, F94C, A102C, G104C, S106C) accumulate to low levels (10-30%) and three (G83C, G85C, N93C) are inactive. Extensive mutagenesis reveals that Gly-83 and, to a lesser extent, Gly-85, are crucial for expression in the membrane. Replacements of Asn-93 disrupt affinity (Thr) or permit recognition of 8-methylxanthine which is not a wild-type ligand (Ala, Ser, Asp) and utilization of uric acid which is not a wild-type substrate (Ala, Ser). Replacements of Phe-94 impair affinity for 2-thio and 6-thioxanthine (Tyr) or 3-methylxanthine (Ile). Single-Cys mutants S84C, L86C, L87C, and S95C are highly sensitive to inactivation by N-ethylmaleimide. Our data reveal that key residues of TM3 cluster in two conserved sequence motifs, 83GSGLL87 and 93NFS95, and highlight the importance of Asn-93 and Phe-94 in substrate recognition and specificity; these findings are supported by structural modeling on the recently described x-ray structure of the uracil- transporting homolog UraA.	[Karena, Ekaterini; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021		European Union; European Social Fund (ESF); National Sources; Hellenic Ministry of Education, Lifelong Learning and Religious Affairs	European Union(European Commission); European Social Fund (ESF)(European Social Fund (ESF)); National Sources; Hellenic Ministry of Education, Lifelong Learning and Religious Affairs	This report is part of a research project co-funded by the European Union, European Social Fund (ESF) and National Sources, in the framework of program "Hraklitos II" through the Operational Program "Education and Lifelong Learning" of the Hellenic Ministry of Education, Lifelong Learning and Religious Affairs, in the context of the National Strategic Reference Framework (NSRF).	Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Goudela S, 2005, MOL MEMBR BIOL, V22, P263, DOI 10.1080/09687860500093016; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jiang XX, 2011, BIOCHEMISTRY-US, V50, P1634, DOI 10.1021/bi101988s; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Mermelekas G, 2010, J BIOL CHEM, V285, P35011, DOI 10.1074/jbc.M110.170415; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Tavoulari S, 2008, J MOL BIOL, V376, P681, DOI 10.1016/j.jmb.2007.12.015; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961	23	19	19	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39595	39605		10.1074/jbc.M111.299164	http://dx.doi.org/10.1074/jbc.M111.299164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21917919	hybrid, Green Published			2022-12-27	WOS:000296759800076
J	Schrader, EK; Harstad, KG; Holmgren, RA; Matouschek, A				Schrader, Erin K.; Harstad, Kristine G.; Holmgren, Robert A.; Matouschek, Andreas			A Three-part Signal Governs Differential Processing of Gli1 and Gli3 Proteins by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GLYCINE-RICH REGION; SCF-BETA-TRCP; CUBITUS-INTERRUPTUS; TRANSCRIPTION FACTOR; DEGRADATION SIGNAL; UBIQUITIN LIGASE; VERTEBRATE LIMB; P50 SUBUNIT; KINASE-A	The Gli proteins are the transcriptional effectors of the mammalian Hedgehog signaling pathway. In an unusual mechanism, the proteasome partially degrades or processes Gli3 in the absence of Hedgehog pathway stimulation to create a Gli3 fragment that opposes the activity of the full-length protein. In contrast, Gli1 is not processed but degraded completely, despite considerable homology with Gli3. We found that these differences in processing can be described by defining a processing signal that is composed of three parts: the zinc finger domain, an adjacent linker sequence, and a degron. Gli3 processing is inhibited when any one component of the processing signal is disrupted. We show that the zinc fingers are required for processing only as a folded structure and that the location but not the identity of the processing degron is critical. Within the linker sequence, regions of low sequence complexity play a crucial role, but other sequence features are also important. Gli1 is not processed because two components of the processing signal, the linker sequence and the degron, are ineffective. These findings provide new insights into the molecular elements that regulate Gli protein processing by the proteasome.	Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Matouschek, A (corresponding author), 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	matouschek@northwestern.edu	Matouschek, Andreas/L-9379-2013	Matouschek, Andreas/0000-0001-6016-2341	National Institutes of Health [R01GM63004, U54 CA143869, P50CA090386]; Oncogenesis and Developmental Biology NIH [T32 CA080621]; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; NATIONAL CANCER INSTITUTE [T32CA080621, U54CA143869, P50CA090386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oncogenesis and Developmental Biology NIH; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM63004 and U54 CA143869 (to A. M.), by NIH Grant P50CA090386 (to R. H.), by Oncogenesis and Developmental Biology NIH training grant T32 CA080621 (to E. K. S.). This work was also supported by the Robert H. Lurie Comprehensive Cancer Center at Northwestern University (to R. A. H. and A. M.).	AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Brown K, 1997, MOL CELL BIOL, V17, P3021, DOI 10.1128/MCB.17.6.3021; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kaesler S, 2000, BIOL CHEM, V381, P545, DOI 10.1515/BC.2000.070; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Kraut DA, 2011, ACS CHEM BIOL, V6, P1087, DOI 10.1021/cb2002285; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Orian A, 1999, MOL CELL BIOL, V19, P3664; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Park HL, 2000, DEVELOPMENT, V127, P1593; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Sadowski M, 2010, MOL CELL BIOL, V30, P2316, DOI 10.1128/MCB.01094-09; Sears C, 1998, J BIOL CHEM, V273, P1409, DOI 10.1074/jbc.273.3.1409; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Wang CB, 2007, DEV DYNAM, V236, P769, DOI 10.1002/dvdy.21082; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wang YF, 2008, MOL CELL BIOL, V28, P5555, DOI 10.1128/MCB.00524-08; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wulczyn FG, 1998, NUCLEIC ACIDS RES, V26, P1724, DOI 10.1093/nar/26.7.1724; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106	52	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39051	39058		10.1074/jbc.M111.274993	http://dx.doi.org/10.1074/jbc.M111.274993			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21921029	Green Published, hybrid			2022-12-27	WOS:000296759800024
J	Nunez, N; Clifton, MMK; Funnell, APW; Artuz, C; Hallal, S; Quinlan, KGR; Font, J; Vandevenne, M; Setiyaputra, S; Pearson, RCM; Mackay, JP; Crossley, M				Nunez, Noelia; Clifton, Molly M. K.; Funnell, Alister P. W.; Artuz, Crisbel; Hallal, Samantha; Quinlan, Kate G. R.; Font, Josep; Vandevenne, Marylene; Setiyaputra, Surya; Pearson, Richard C. M.; Mackay, Joel P.; Crossley, Merlin			The Multi-zinc Finger Protein ZNF217 Contacts DNA through a Two-finger Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-8; BOX-BINDING-PROTEIN; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REPRESSOR; RECOGNITION MOTIFS; COREPRESSOR CTBP; GAGA FACTOR; COMPLEX; SEQUENCE; PEPTIDE	Classical C2H2 zinc finger proteins are among the most abundant transcription factors found in eukaryotes, and the mechanisms through which they recognize their target genes have been extensively investigated. In general, a tandem array of three fingers separated by characteristic TGERP links is required for sequence-specific DNA recognition. Nevertheless, a significant number of zinc finger proteins do not contain a hallmark three-finger array of this type, raising the question of whether and how they contact DNA. We have examined the multi-finger protein ZNF217, which contains eight classical zinc fingers. ZNF217 is implicated as an oncogene and in repressing the E-cadherin gene. We show that two of its zinc fingers, 6 and 7, can mediate contacts with DNA. We examine its putative recognition site in the E-cadherin promoter and demonstrate that this is a suboptimal site. NMR analysis and mutagenesis is used to define the DNA binding surface of ZNF217, and we examine the specificity of the DNA binding activity using fluorescence anisotropy titrations. Finally, sequence analysis reveals that a variety of multi-finger proteins also contain two-finger units, and our data support the idea that these may constitute a distinct subclass of DNA recognition motif.	[Funnell, Alister P. W.; Artuz, Crisbel; Pearson, Richard C. M.; Crossley, Merlin] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Nunez, Noelia; Clifton, Molly M. K.; Funnell, Alister P. W.; Hallal, Samantha; Quinlan, Kate G. R.; Font, Josep; Vandevenne, Marylene; Setiyaputra, Surya; Pearson, Richard C. M.; Mackay, Joel P.; Crossley, Merlin] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	Crossley, M (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	m.crossley@unsw.edu.au	Crossley, Merlin/D-7888-2011; Pearson, Richard/J-4411-2012; Sadurni, Josep Font/A-2499-2010; Mackay, Joel/D-6834-2011	Crossley, Merlin/0000-0003-2057-3642; Pearson, Richard/0000-0002-7918-9111; Sadurni, Josep Font/0000-0001-5284-1344; Hallal, Samantha/0000-0003-1884-7579; Mackay, Joel/0000-0001-7508-8033; Quinlan, Kate/0000-0002-5722-8183; Vandevenne, Marylene/0000-0002-4492-2635; Funnell, Alister/0000-0002-1062-5296	National Health and Medical Research Council; Australian Research Council; Prostate Cancer Foundation of Australia; Australian Postgraduate Awards	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Prostate Cancer Foundation of Australia; Australian Postgraduate Awards(Australian Government)	This work was supported by grants from the National Health and Medical Research Council, Australian Research Council, and the Prostate Cancer Foundation of Australia (to M. C. and J. P. M.).; Supported by Australian Postgraduate Awards.	AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Banck MS, 2009, EPIGENETICS-US, V4, P100, DOI 10.4161/epi.4.2.7953; Bessiere D, 2008, J BIOL CHEM, V283, P4352, DOI 10.1074/jbc.M707537200; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Crossley M, 1996, MOL CELL BIOL, V16, P1695; FAIRALL L, 1992, J MOL BIOL, V226, P349, DOI 10.1016/0022-2836(92)90952-G; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Huang GQ, 2005, HUM MOL GENET, V14, P3219, DOI 10.1093/hmg/ddi352; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Krizek BA, 1996, P NATL ACAD SCI USA, V93, P4063, DOI 10.1073/pnas.93.9.4063; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kwan AHY, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng124; Liew CK, 2005, P NATL ACAD SCI USA, V102, P583, DOI 10.1073/pnas.0407511102; Liew CK, 2000, STRUCTURE, V8, P1157, DOI 10.1016/S0969-2126(00)00527-X; Lo Surdo P, 2004, NAT STRUCT MOL BIOL, V11, P382, DOI 10.1038/nsmb745; Mackay JP, 2011, NAT STRUCT MOL BIOL, V18, P256, DOI 10.1038/nsmb.2005; Magner DB, 2008, TRENDS ENDOCRIN MET, V19, P153, DOI 10.1016/j.tem.2008.02.005; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matharu NK, 2010, J MOL BIOL, V400, P434, DOI 10.1016/j.jmb.2010.05.010; Matthews JM, 2000, EUR J BIOCHEM, V267, P1030, DOI 10.1046/j.1432-1327.2000.01095.x; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Nonet GH, 2001, CANCER RES, V61, P1250; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; OMICHINSKI JG, 1993, P NATL ACAD SCI USA, V90, P1676, DOI 10.1073/pnas.90.5.1676; Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Qin Z, 2009, MOL CELL BIOL, V29, P3633, DOI 10.1128/MCB.00362-09; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Sakai T, 2003, DNA RES, V10, P155, DOI 10.1093/dnares/10.4.155; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Thillainadesan G, 2008, MOL CELL BIOL, V28, P6066, DOI 10.1128/MCB.00246-08; Trainor CD, 2000, J BIOL CHEM, V275, P28157; Ueda J, 2006, J BIOL CHEM, V281, P20120, DOI 10.1074/jbc.M603087200; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291	64	17	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38190	38201		10.1074/jbc.M111.301234	http://dx.doi.org/10.1074/jbc.M111.301234			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908891	Green Published, hybrid			2022-12-27	WOS:000296594200033
J	Bahl, N; Du, RJ; Winarsih, I; Ho, B; Tucker-Kellogg, L; Tidor, B; Ding, JL				Bahl, Neha; Du, Ruijuan; Winarsih, Imelda; Ho, Bow; Tucker-Kellogg, Lisa; Tidor, Bruce; Ding, Jeak Ling			Delineation of Lipopolysaccharide (LPS)-binding Sites on Hemoglobin FROM IN SILICO PREDICTIONS TO BIOPHYSICAL CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-CONTAINING PROTEINS; BIOLOGICAL-ACTIVITY; BACTERIAL LIPOPOLYSACCHARIDES; LIPID-A; ENDOTOXINS; BINDING; LPS; RECOGNITION; ACTIVATION; MYOGLOBIN		[Du, Ruijuan; Winarsih, Imelda; Ding, Jeak Ling] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Singapore Massachusetts Inst Technol Alliance, Singapore 117576, Singapore; [Ho, Bow] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Tidor, Bruce] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Tidor, Bruce] MIT, Dept Elect Engn, Cambridge, MA 02139 USA; [Tidor, Bruce] MIT, Dept Comp Sci, Cambridge, MA 02139 USA	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsdjl@nus.edu.sg	Tucker-Kellogg, Lisa/G-3376-2012; Ding, Jeak/H-8057-2012; Tucker-Kellogg, Lisa/AAD-9265-2022	Tucker-Kellogg, Lisa/0000-0002-1301-7069; /0000-0002-3320-3969	Singapore-Massachusetts Institute of Technology Alliance; Ministry of Education [T208B3109]	Singapore-Massachusetts Institute of Technology Alliance; Ministry of Education	This work was supported by the Singapore-Massachusetts Institute of Technology Alliance and Tier 2 Grant T208B3109 from the Ministry of Education.	Alayash AI, 2001, ANTIOXID REDOX SIGN, V3, P313, DOI 10.1089/152308601300185250; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; BELANGER M, 1995, INFECT IMMUN, V63, P656; BONE RC, 1991, CHEST, V100, P802, DOI 10.1378/chest.100.3.802; Brandenburg K, 2003, J BIOL CHEM, V278, P47660, DOI 10.1074/jbc.M304743200; CORRIVEAU CC, 1993, INFECT AGENT DIS, V2, P35; Cunningham MD, 2000, J IMMUNOL, V164, P3255, DOI 10.4049/jimmunol.164.6.3255; DAVID SA, 1992, BIOCHIM BIOPHYS ACTA, V1165, P147, DOI 10.1016/0005-2760(92)90180-4; Ding JL, 2001, TRENDS BIOTECHNOL, V19, P277, DOI 10.1016/S0167-7799(01)01694-8; Du RJ, 2010, EMBO J, V29, P632, DOI 10.1038/emboj.2009.380; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2000, STRUCTURE, V8, P585; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Howe J, 2008, INNATE IMMUN-LONDON, V14, P39, DOI 10.1177/1753425907087257; Howe J, 2007, MED CHEM, V3, P13, DOI 10.2174/157340607779317625; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Joughin BA, 2005, PROTEIN SCI, V14, P131, DOI 10.1110/ps.04964705; Jurgens G, 2001, EUR J BIOCHEM, V268, P4233, DOI 10.1046/j.1432-1327.2001.02338.x; KACA W, 1995, BIOCHEMISTRY-US, V34, P11176, DOI 10.1021/bi00035a024; KACA W, 1994, J BIOL CHEM, V269, P25078; KACA W, 1994, J ENDOTOXIN RES, V1, P243; Lamping N, 1996, J IMMUNOL, V157, P4648; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Mak P, 2000, ANTON LEEUW INT J G, V77, P197, DOI 10.1023/A:1002081605784; Mancek M, 2002, BIOCHEM BIOPH RES CO, V292, P880, DOI 10.1006/bbrc.2002.6748; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; RIETSCHEL ET, 1971, EUR J BIOCHEM, V22, P218, DOI 10.1111/j.1432-1033.1971.tb01535.x; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; WATSON HC, 1961, NATURE, V190, P670, DOI 10.1038/190670a0	39	22	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37793	37803		10.1074/jbc.M111.245472	http://dx.doi.org/10.1074/jbc.M111.245472			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900232	Green Published, hybrid			2022-12-27	WOS:000296542400074
J	Laplante, P; Amireault, P; Subang, R; Dieude, M; Levine, JS; Rauch, J				Laplante, Patrick; Amireault, Pascal; Subang, Rebecca; Dieude, Melanie; Levine, Jerrold S.; Rauch, Joyce			Interaction of beta(2)-Glycoprotein I with Lipopolysaccharide Leads to Toll-like Receptor 4 (TLR4)-dependent Activation of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ADP-INDUCED AGGREGATION; ANTIPHOSPHOLIPID ANTIBODIES; ENDOTOXIN CONTAMINATION; MURINE MACROPHAGES; INNATE IMMUNITY; APOPTOTIC CELLS; HUMAN-PLATELETS; TISSUE FACTOR; FACTOR-ALPHA	beta(2)-Glycoprotein I (beta(2)GPI) is an abundant plasma protein that binds to the surface of cells and particles expressing negatively charged lipids, but its physiological role remains unknown. Antibodies to beta(2)GPI are found in patients with anti-phospholipid syndrome, a systemic autoimmune disease associated with vascular thrombosis and pregnancy morbidity. Although it has been suggested that anti-beta(2)GPI antibodies activate endothelial cells and monocytes by signaling through TLR4, it is unclear how anti-beta(2)GPI antibodies and/or beta(2)GPI interact with TLR4. A number of mammalian proteins (termed "endogenous Toll-like receptor (TLR) ligands") have been reported to bind to TLR4, but, in most cases, subsequent studies have shown that LPS interaction with these proteins is responsible for TLR activation. We hypothesized that, like other endogenous TLR ligands, beta(2)GPI interacts specifically with LPS and that this interaction is responsible for apparent TLR4 activation by beta(2)GPI. Here, we show that both LPS and TLR4 are required for beta(2)GPI to bind to and activate macrophages. Untreated beta(2)GPI stimulated TNF-alpha production in TLR4-sufficient (but not TLR4-deficient) macrophages. In contrast, neither polymyxin B-treated nor delipidated beta(2)GPI stimulated TNF-alpha production. Furthermore, beta(2)GPI bound to LPS in a specific and dose-dependent manner. Finally, untreated beta(2)GPI bound to the surface of TLR4-sufficient (but not TLR4-deficient) macrophages. Polymyxin B treatment of beta(2)GPI abolished macrophage binding. Our findings suggest a potential new biological activity for beta(2)GPI as a protein that interacts specifically with LPS and point to the need to evaluate newly discovered endogenous TLR ligands for potential interactions with LPS.	[Laplante, Patrick; Amireault, Pascal; Subang, Rebecca; Dieude, Melanie; Rauch, Joyce] McGill Univ, Dept Med, Div Rheumatol, Res Inst,Hlth Ctr, Montreal, PQ H3G 1A4, Canada; [Levine, Jerrold S.] Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL 60680 USA; [Levine, Jerrold S.] Jesse Brown Vet Affairs Med Ctr, Nephrol Sect, Dept Med, Chicago, IL 60612 USA	McGill University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Rauch, J (corresponding author), Montreal Gen Hosp, Rm A6 148,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	joyce.rauch@mcgill.ca	Amireault, Pascal/ABH-7300-2020; Amireault, Pascal/H-9356-2015	Amireault, Pascal/0000-0002-5562-7586; Dieude, Melanie/0000-0002-9300-4232	Canadian Institutes of Health Research (CIHR) [MOP-67101, MOP-97916]; Institute of Musculoskeletal Health and Arthritis (IMHA); Arthritis Society [MOP-42391]; CIHR/IMHA [MUS-67101]; Research Institute of the McGill University Health Centre; Canada Foundation for Innovation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis (IMHA); Arthritis Society; CIHR/IMHA(Canadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Centre; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This was supported in part by operating grants from the Canadian Institutes of Health Research (CIHR) and the Institute of Musculoskeletal Health and Arthritis (IMHA) and by Arthritis Society Grant MOP-42391 (to J. R.), CIHR Grants MOP-67101 and MOP-97916, CIHR/IMHA Fall 2008 Priority Announcement Grant MUS-67101, and a post-doctoral fellowship from the Research Institute of the McGill University Health Centre (to P. L.).; We are grateful to Evan Roter for contribution to experiments related to this study and to Dr. Simone Chevalier for providing access to the fluorescence microscope (funded by the Canada Foundation for Innovation and the Research Institute of the McGill University Health Centre).	Agar C, 2011, BLOOD, V117, P6939, DOI 10.1182/blood-2010-12-325951; Alard JE, 2010, J IMMUNOL, V185, P1550, DOI 10.4049/jimmunol.1000526; Antal-Szalmas P, 2000, EUR J CLIN INVEST, V30, P167; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; DELPAPA N, 1995, CLIN EXP RHEUMATOL, V13, P179; Di Simone N, 2007, ANN NY ACAD SCI, V1108, P505, DOI 10.1196/annals.1422.054; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; GOLDSMITH GH, 1994, BRIT J HAEMATOL, V87, P548, DOI 10.1111/j.1365-2141.1994.tb08311.x; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Lambrianides A, 2010, J IMMUNOL, V184, P6622, DOI 10.4049/jimmunol.0902765; Levine JS, 2006, J IMMUNOL, V177, P6504, DOI 10.4049/jimmunol.177.9.6504; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Lin IC, 2010, FOOD CHEM TOXICOL, V48, P2642, DOI 10.1016/j.fct.2010.06.034; Lutters BCH, 2003, J BIOL CHEM, V278, P33831, DOI 10.1074/jbc.M212655200; Maiti SN, 2008, J BIOL CHEM, V283, P3761, DOI 10.1074/jbc.M704990200; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mulla MJ, 2009, AM J REPROD IMMUNOL, V62, P96, DOI 10.1111/j.1600-0897.2009.00717.x; NIMPF J, 1987, ATHEROSCLEROSIS, V63, P109, DOI 10.1016/0021-9150(87)90110-9; NIMPF J, 1985, THROMB HAEMOSTASIS, V54, P397; NIMPF J, 1986, BIOCHIM BIOPHYS ACTA, V884, P142, DOI 10.1016/0304-4165(86)90237-0; Pierangeli SS, 2007, ANN RHEUM DIS, V66, P1327, DOI 10.1136/ard.2006.065037; Price BE, 1996, J IMMUNOL, V157, P2201; Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349; Rauch J, 2010, LUPUS, V19, P347, DOI 10.1177/0961203310361492; Reed JH, 2009, ARTHRITIS RHEUM-US, V60, P860, DOI 10.1002/art.24361; Romay-Penabad Z, 2011, BLOOD, V117, P1408, DOI 10.1182/blood-2010-07-299099; Romay-Penabad Z, 2009, BLOOD, V114, P3074, DOI 10.1182/blood-2008-11-188698; Sarter K, 2009, BIOCHEM BIOPH RES CO, V379, P155, DOI 10.1016/j.bbrc.2008.12.024; Shi T, 2004, P NATL ACAD SCI USA, V101, P3939, DOI 10.1073/pnas.0400281101; SHI W, 1993, BLOOD, V81, P1255; Sorice M, 2007, ARTHRITIS RHEUM-US, V56, P2687, DOI 10.1002/art.22802; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Turner JJO, 2009, SCAND J IMMUNOL, V69, P329, DOI 10.1111/j.1365-3083.2008.02224.x; Willems GM, 1996, BIOCHEMISTRY-US, V35, P13833, DOI 10.1021/bi960657q; Yang JS, 2006, CLIN VACCINE IMMUNOL, V13, P309, DOI 10.1128/CVI.13.3.309-313.2006; Zhou H, 2011, CLIN EXP IMMUNOL, V163, P189, DOI 10.1111/j.1365-2249.2010.04291.x	39	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42494	42503		10.1074/jbc.M111.230383	http://dx.doi.org/10.1074/jbc.M111.230383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965665	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000298180900057
J	Hillringhaus, L; Yue, WW; Rose, NR; Ng, SS; Gileadi, C; Loenarz, C; Bello, SH; Bray, JE; Schofield, CJ; Oppermann, U				Hillringhaus, Lars; Yue, Wyatt W.; Rose, Nathan R.; Ng, Stanley S.; Gileadi, Carina; Loenarz, Christoph; Bello, Simon H.; Bray, James E.; Schofield, Christopher J.; Oppermann, Udo			Structural and Evolutionary Basis for the Dual Substrate Selectivity of Human KDM4 Histone Demethylase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; JMJD2 FAMILY; ANDROGEN RECEPTOR; JUMONJI-DOMAIN; JARID1C GENE; PHF8; METHYLATION; MUTATIONS; HYPOXIA; SPECIFICITY	N-epsilon-Methylations of histone lysine residues play critical roles in cell biology by "marking" chromatin for transcriptional activation or repression. Lysine demethylases reverse Art-methylation in a sequence- and rnethylation-selective manner. The determinants of sequence selectivity for histone demethylases have been unclear. The human JMJD2 (KDM4) H3K9 and H3K36 demethylases can be divided into members that act on both H3K9 and H3K36 and H3K9 alone. Kinetic, crystallographic, and mutagenetic studies in vitro and in cells on KDM4A-E reveal that selectivity is determined by multiple interactions within the catalytic domain but outside the active site. Structurally informed phylogenetic analyses reveal that KDM4A-C orthologues exist in all genome-sequenced vertebrates with earlier animals containing only a single KDM4 enzyme. KDM4D orthologues only exist in eutherians (placental mammals) where they are conserved, including proposed substrate sequence-determining residues. The results will be useful for the identification of inhibitors for specific histone demethylases.	[Hillringhaus, Lars; Rose, Nathan R.; Loenarz, Christoph; Bello, Simon H.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England; [Hillringhaus, Lars; Rose, Nathan R.; Loenarz, Christoph; Bello, Simon H.; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Chem Res Lab, Oxford OX1 3TA, England; [Yue, Wyatt W.; Ng, Stanley S.; Gileadi, Carina; Bray, James E.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Headington OX3 7DQ, England; [Oppermann, Udo] Botnar Res Ctr, Natl Inst Hlth Res Oxford Biomed Res Unit, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Oxford OX3 7LD, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, 12 Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk; udo.oppermann@sgc.ox.ac.uk	Rose, Nathan R/A-9270-2013	Rose, Nathan R/0000-0002-1871-1156; BRAY, JAMES/0000-0003-3554-4254; Loenarz, Christoph/0000-0002-8843-2531; Schofield, Christopher/0000-0002-0290-6565	Biotechnology and Biological Sciences Research Council; Wellcome Trust; Oxford National Institute for Health Research Oxford Biomedical Research Biomedical Research Unit	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford National Institute for Health Research Oxford Biomedical Research Biomedical Research Unit	This work was supported in part by the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, and by the Oxford National Institute for Health Research Oxford Biomedical Research Biomedical Research Unit.	Abidi FE, 2008, J MED GENET, V45, P787, DOI 10.1136/jmg.2008.058990; Adegbola A, 2008, AM J MED GENET A, V146A, P505, DOI 10.1002/ajmg.a.32142; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chen ZZ, 2007, P NATL ACAD SCI USA, V104, P10818, DOI 10.1073/pnas.0704525104; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Ishimura A, 2009, BIOCHEM BIOPH RES CO, V389, P366, DOI 10.1016/j.bbrc.2009.08.155; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Katoh M, 2004, INT J ONCOL, V24, P1623; Katoh Y, 2007, INT J MOL MED, V20, P269; King ONF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015535; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Koivisto AM, 2007, CLIN GENET, V72, P145, DOI 10.1111/j.1399-0004.2007.00836.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Leung IKH, 2010, CHEM BIOL, V17, P1316, DOI 10.1016/j.chembiol.2010.09.016; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Ponnaluri VKC, 2011, BIOCHEM BIOPH RES CO, V405, P588, DOI 10.1016/j.bbrc.2011.01.073; Ponnaluri VKC, 2009, BIOCHEM BIOPH RES CO, V390, P280, DOI 10.1016/j.bbrc.2009.09.107; Rose NR, 2008, J MED CHEM, V51, P7053, DOI 10.1021/jm800936s; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Strobl-Mazzulla PH, 2010, DEV CELL, V19, P460, DOI 10.1016/j.devcel.2010.08.009; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; Wang JL, 2010, BIOL REPROD, V82, P105, DOI 10.1095/biolreprod.109.078055; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Yu L, 2010, CELL RES, V20, P166, DOI 10.1038/cr.2010.8; Yue WW, 2010, FEBS LETT, V584, P825, DOI 10.1016/j.febslet.2009.12.055	68	112	115	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41616	41625		10.1074/jbc.M111.283689	http://dx.doi.org/10.1074/jbc.M111.283689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21914792	Green Published, hybrid			2022-12-27	WOS:000298057500046
J	Lee, KA; Hammerle, LP; Andrews, PS; Stokes, MP; Mustelin, T; Silva, JC; Black, RA; Doedens, JR				Lee, Kimberly A.; Hammerle, Lisa P.; Andrews, Paul S.; Stokes, Matthew P.; Mustelin, Tomas; Silva, Jeffrey C.; Black, Roy A.; Doedens, John R.			Ubiquitin Ligase Substrate Identification through Quantitative Proteomics at Both the Protein and Peptide Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CULTURE; AMINO-ACIDS; HUMAN HRD1; SYNOVIOLIN; EXPRESSION; SILAC	Protein ubiquitination is a key regulatory process essential to life at a cellular level; significant efforts have been made to identify ubiquitinated proteins through proteomics studies, but the level of success has not reached that of heavily studied post-translational modifications, such as phosphorylation. HRD1 an E3 ubiquitin ligase, has been implicated in rheumatoid arthritis, but no disease-relevant substrates have been identified. To identify these substrates, we have taken both peptide and protein level approaches to enrich for ubiquitinated proteins in the presence and absence of HRD1. At the protein level, a two-step strategy was taken using cells expressing His(6)-tagged ubiquitin, enriching proteins first based on their ubiquitination and second based on the His tag with protein identification by LC-MS/MS. Application of this method resulted in identification and quantification of more than 400 ubiquitinated proteins, a fraction of which were found to be sensitive to HRD1 and were therefore deemed candidate substrates. In a second approach, ubiquitinated peptides were enriched after tryptic digestion by peptide immunoprecipitation using an antibody specific for the diglycine-labeled internal lysine residue indicative of protein ubiquitination, with peptides and ubiquitination sites identified by LC-MS/MS. Peptide immunoprecipitation resulted in identification of over 1800 ubiquitinated peptides on over 900 proteins in each study, with several proteins emerging as sensitive to HRD1 levels. Notably, significant overlap exists between the HRD1 substrates identified by the protein-based and the peptide-based strategies, with clear cross-validation apparent both qualitatively and quantitatively, demonstrating the effectiveness of both strategies and furthering our understanding of HRD1 biology.	[Lee, Kimberly A.] Amgen Inc, Dept Mol Sci, Seattle, WA 98119 USA; [Hammerle, Lisa P.; Mustelin, Tomas; Black, Roy A.; Doedens, John R.] Amgen Inc, Dept Inflammat, Seattle, WA 98119 USA; [Andrews, Paul S.] Amgen Inc, Dept Lead Discovery, Cambridge, MA 02142 USA; [Stokes, Matthew P.; Silva, Jeffrey C.] Cell Signaling Technol Inc, Danvers, MA 01923 USA	Amgen; Amgen; Amgen	Doedens, JR (corresponding author), 119 NW 50th St, Seattle, WA 98107 USA.	jdoedens@yahoo.com		Mustelin, Tomas/0000-0001-5912-8840				Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ehinger M, 2001, IMMUNOLOGY, V103, P291, DOI 10.1046/j.1365-2567.2001.01257.x; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lossner C, 2011, ANAL BIOCHEM, V412, P123, DOI 10.1016/j.ab.2011.01.011; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Mayor T, 2005, MOL CELL PROTEOMICS, V4, P741, DOI 10.1074/mcp.M400220-MCP200; Naor D, 2007, ANN NY ACAD SCI, V1110, P233, DOI 10.1196/annals.1423.025; Notley CA, 2010, ARTHRITIS RHEUM-US, V62, P171, DOI 10.1002/art.25058; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pirila L, 2001, J RHEUMATOL, V28, P478; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Toh ML, 2006, ARTHRITIS RHEUM-US, V54, P2109, DOI 10.1002/art.21926; Toh ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013416; Vasilescu J, 2005, J PROTEOME RES, V4, P2192, DOI 10.1021/pr050265i; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654	28	67	71	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41530	41538		10.1074/jbc.M111.248856	http://dx.doi.org/10.1074/jbc.M111.248856			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987572	Green Published, hybrid			2022-12-27	WOS:000298057500039
J	Brown, CR; Mao, CH; Falkovskaia, E; Law, JK; Boeger, H				Brown, Christopher R.; Mao, Changhui; Falkovskaia, Elena; Law, Jason K.; Boeger, Hinrich			In Vivo Role for the Chromatin-remodeling Enzyme SWI/SNF in the Removal of Promoter Nucleosomes by Disassembly Rather Than Sliding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PHO5 PROMOTER; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; POSITIONED NUCLEOSOMES; OCTAMER TRANSFER; HISTONE OCTAMER; HO PROMOTER; SWI-SNF; COMPLEX	Analysis of in vivo chromatin remodeling at the PHO5 promoter of yeast led to the conclusion that remodeling removes nucleosomes from the promoter by disassembly rather than sliding away from the promoter. The catalytic activities required for nucleosome disassembly remain unknown. Transcriptional activation of the yeast PHO8 gene was found to depend on the chromatin-remodeling complex SWI/SNF, whereas activation of PHO5 was not. Here, we show that PHO8 gene circles formed in vivo lose nucleosomes upon PHO8 induction, indicative of nucleosome removal by disassembly. Our quantitative analysis of expression noise and chromatin-remodeling data indicates that the dynamics of continual nucleosome removal and reformation at the activated promoters of PHO5 and PHO8 are closely similar. In contrast to PHO5, however, activator-stimulated transcription of PHO8 appears to be limited mostly to the acceleration of promoter nucleosome disassembly with little or no acceleration of promoter transitions following nucleosome disassembly, accounting for the markedly lower expression level of PHO8.	[Brown, Christopher R.; Mao, Changhui; Falkovskaia, Elena; Law, Jason K.; Boeger, Hinrich] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Boeger, H (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 1156 High St, Santa Cruz, CA 95064 USA.	hboeger@ucsc.edu		Brown, Christopher/0000-0001-6076-4035	National Institutes of Health [F32GM087867, GM078111]; Pew Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078111, F32GM087867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Research Service Award Grant F32GM087867 from the National Institutes of Health.; Supported by National Institutes of Health Grant GM078111 and the Pew Scholars Program. To whom correspondence should be addressed: Dept. of Molecular, Cell, and Developmental Biology, University of California, 1156 High St., Santa Cruz, CA 95064. Tel.: 831-459-4487; Fax: 831-459-3139; E-mail: hboeger@ucsc.edu.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; ALMER A, 1986, EMBO J, V5, P2681, DOI 10.1002/j.1460-2075.1986.tb04551.x; Ansari A, 1999, P NATL ACAD SCI USA, V96, P343, DOI 10.1073/pnas.96.2.343; BARBARIC S, 1992, NUCLEIC ACIDS RES, V20, P1031, DOI 10.1093/nar/20.5.1031; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Cote J, 1998, P NATL ACAD SCI USA, V95, P4947, DOI 10.1073/pnas.95.9.4947; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Ehrensberger AH, 2011, P NATL ACAD SCI USA, V108, P10115, DOI 10.1073/pnas.1101449108; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; FASCHER KD, 1993, J MOL BIOL, V231, P658, DOI 10.1006/jmbi.1993.1317; Fazzio TG, 2003, MOL CELL, V12, P1333, DOI 10.1016/S1097-2765(03)00436-2; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; Ge LM, 1997, BIOTECHNIQUES, V22, P28, DOI 10.2144/97221bm03; Gkikopoulos T, 2009, MOL CELL BIOL, V29, P4057, DOI 10.1128/MCB.00400-09; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Griesenbeck J, 2003, MOL CELL BIOL, V23, P9275, DOI 10.1128/MCB.23.24.9275-9282.2003; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Lorch Y, 2011, NAT STRUCT MOL BIOL, V18, P881, DOI 10.1038/nsmb.2072; Mao CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017521; Mao CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.83; Munsterkotter M, 2000, J BIOL CHEM, V275, P22678, DOI 10.1074/jbc.M001409200; Neef DW, 2003, MOL CELL BIOL, V23, P3788, DOI 10.1128/MCB.23.11.3788-3797.2003; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025	59	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40556	40565		10.1074/jbc.M111.289918	http://dx.doi.org/10.1074/jbc.M111.289918			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21979950	Green Published, hybrid			2022-12-27	WOS:000297315400015
J	Dossena, S; Gandini, R; Tamma, G; Vezzoli, V; Nofziger, C; Tamplenizza, M; Salvioni, E; Bernardinelli, E; Meyer, G; Valenti, G; Wolf-Watz, M; Furst, J; Paulmichl, M				Dossena, Silvia; Gandini, Rosaria; Tamma, Grazia; Vezzoli, Valeria; Nofziger, Charity; Tamplenizza, Margherita; Salvioni, Elisabetta; Bernardinelli, Emanuele; Meyer, Giuliano; Valenti, Giovanna; Wolf-Watz, Magnus; Fuerst, Johannes; Paulmichl, Markus			The Molecular and Functional Interaction between ICln and HSPC038 Proteins Modulates the Regulation of Cell Volume	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS OPERONS; MEMBRANE TRANSPOSITION; CHLORIDE CHANNELS; ANION CHANNEL; I-CLN; TRANSLOCATION; ACTIVATION; CYTOSOL; PICLN; CONDUCTANCE	Identifying functional partners for protein/protein interactions can be a difficult challenge. We proposed the use of the operon structure of the Caenorhabditis elegans genome as a "new gene-finding tool" (Eichmuller, S., Vezzoli, V., Bazzini, C., Ritter, M., Furst, J., Jakab, M., Ravasio, A., Chwatal, S., Dossena, S., Botta, G., Meyer, G., Maier, B., Valenti, G., Lang, F., and Paulmichl, M. (2004) J. Biol. Chem. 279, 7136 7146) that could be functionally translated to the human system. Here we show the validity of this approach by studying the predicted functional interaction between ICln and HSPC038. In C. elegans, the gene encoding for the ICln homolog (icln-1) is embedded in an operon with two other genes, Nx (the human homolog of Nx is HSPC038) and Ny. ICln is a highly conserved, ubiquitously expressed multifunctional protein that plays a critical role in the regulatory volume decrease after cell swelling. Following hypotonic stress, ICln translocates from the cytosol to the plasma membrane, where it has been proposed to participate in the activation of the swelling-induced chloride current (IClswell). Here we show that the interaction between human ICln and HSPC038 plays a role in volume regulation after cell swelling and that HSPC038 acts as an escort, directing ICln to the cell membrane after cell swelling and facilitating the activation of IClswell. Assessment of the NMR structure of HSPC038 showed the presence of a zinc finger motif. Moreover, NMR and additional biochemical techniques enabled us to identify the putative ICln/HSPC038 interacting sites, thereby explaining the functional interaction of both proteins on a molecular level.	[Dossena, Silvia; Nofziger, Charity; Tamplenizza, Margherita; Salvioni, Elisabetta; Bernardinelli, Emanuele; Paulmichl, Markus] Paracelsus Med Univ, Inst Pharmacol & Toxicol, A-5020 Salzburg, Austria; [Gandini, Rosaria; Fuerst, Johannes] Innsbruck Med Univ, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Gandini, Rosaria] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Tamma, Grazia; Valenti, Giovanna] Univ Bari, Dept Gen & Environm Physiol, I-70125 Bari, Italy; [Vezzoli, Valeria; Tamplenizza, Margherita; Salvioni, Elisabetta; Meyer, Giuliano] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy; [Wolf-Watz, Magnus] Umea Univ, Dept Chem, Chem Biol Ctr, SE-90187 Umea, Sweden	Paracelsus Private Medical University; Medical University of Innsbruck; Karolinska Institutet; Universita degli Studi di Bari Aldo Moro; University of Milan; Umea University	Dossena, S (corresponding author), Paracelsus Med Univ, Inst Pharmacol & Toxicol, A-5020 Salzburg, Austria.	silvia.dossena@pmu.ac.at	Salvioni, Elisabetta/ABD-9775-2020; Dossena, Silvia/G-1437-2018; Tamma, Grazia/F-8823-2016; Meyer, Giuliano/G-8062-2011	Tamma, Grazia/0000-0002-8890-0278; Salvioni, Elisabetta/0000-0002-8448-7551; Vezzoli, Valeria/0000-0001-6396-7284; BERNARDINELLI, EMANUELE/0000-0002-6119-3067; VALENTI, GIOVANNA/0000-0003-0233-0778; Gandini, Rosaria/0000-0003-4171-0693	Fonds zur Forderung der Wissenschaftlichen Forschung [P18608, P17119, M11108-B11]; Swedish Research Council [621-2010-5247]	Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by Fonds zur Forderung der Wissenschaftlichen Forschung Grants P18608 (to M.P.) and P17119 (to J.F.).; Supported by the Lise Meitner stipend of Fonds zur Forderung der Wissenschaftlichen Forschung Grant M11108-B11.; Supported by Swedish Research Council Grant 621-2010-5247.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; CHEN BPC, 1994, GENE, V139, P73, DOI 10.1016/0378-1119(94)90525-8; Chen LX, 1999, AM J PHYSIOL-CELL PH, V276, pC182, DOI 10.1152/ajpcell.1999.276.1.C182; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eichmuller S, 2004, J BIOL CHEM, V279, P7136, DOI 10.1074/jbc.M307347200; Furst J, 2006, ACTA PHYSIOL, V187, P43, DOI 10.1111/j.1748-1716.2006.01549.x; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Furst J, 2002, J BIOL CHEM, V277, P4435, DOI 10.1074/jbc.M107372200; Furst J, 2000, PFLUG ARCH EUR J PHY, V440, P100; Gandini R, 2008, CELL PHYSIOL BIOCHEM, V22, P579, DOI 10.1159/000185542; Garavaglia M, 2004, CELL PHYSIOL BIOCHEM, V14, P231, DOI 10.1159/000080332; Garavaglia ML, 2002, PFLUG ARCH EUR J PHY, V443, P748, DOI 10.1007/s00424-001-0772-y; Gschwentner M, 1996, J ALLERGY CLIN IMMUN, V98, pS98, DOI 10.1016/S0091-6749(96)80135-7; Gschwentner M, 1999, EXP PHYSIOL, V84, P1023; GSCHWENTNER M, 1995, MOL MED, V1, P407, DOI 10.1007/BF03401578; GSCHWENTNER M, 1995, PFLUG ARCH EUR J PHY, V430, P464, DOI 10.1007/BF00373882; Helgstrand M, 2000, J BIOMOL NMR, V18, P329, DOI 10.1023/A:1026729404698; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; HOFFMANN EK, 1989, PHYSIOL REV, V69, P315, DOI 10.1152/physrev.1989.69.2.315; Hubert MD, 2000, BBA-BIOMEMBRANES, V1466, P105, DOI 10.1016/S0005-2736(00)00177-2; Jakab M, 2006, CONTRIB NEPHROL, V152, P161, DOI 10.1159/000096322; Jakab M, 2002, CELL PHYSIOL BIOCHEM, V12, P235, DOI 10.1159/000067895; Jakab M, 2006, CELL PHYSIOL BIOCHEM, V18, P21, DOI 10.1159/000095131; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krapivinsky G, 1998, J BIOL CHEM, V273, P10811, DOI 10.1074/jbc.273.18.10811; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; Larkin D, 2004, J BIOL CHEM, V279, P27286, DOI 10.1074/jbc.M402159200; Li CH, 1998, J GEN PHYSIOL, V112, P727, DOI 10.1085/jgp.112.6.727; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Meyer G, 2004, FEBS LETT, V559, P45, DOI 10.1016/S0014-5793(04)00020-1; MORGAN RA, 1992, NUCLEIC ACIDS RES, V20, P1293, DOI 10.1093/nar/20.6.1293; Musch MW, 1997, J EXP ZOOL, V277, P460, DOI 10.1002/(SICI)1097-010X(19970415)277:6<460::AID-JEZ6>3.0.CO;2-M; Musch MW, 1998, PFLUG ARCH EUR J PHY, V436, P415, DOI 10.1007/s004240050651; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Paulmichl M., 1992, NATURE, V356, P238; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Ritter M, 2003, J BIOL CHEM, V278, P50163, DOI 10.1074/jbc.M300374200; Schedlbauer A, 2003, J BIOMOL NMR, V27, P399, DOI 10.1023/A:1025809828637; Strange K, 1998, J GEN PHYSIOL, V111, P617, DOI 10.1085/jgp.111.5.617; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Wienk H, 2009, BIOCHEMISTRY-US, V48, P4431, DOI 10.1021/bi9001997; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200	46	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40659	40670		10.1074/jbc.M111.260430	http://dx.doi.org/10.1074/jbc.M111.260430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21917931	hybrid, Green Published			2022-12-27	WOS:000297315400027
J	Bodon, G; Chassefeyre, R; Pernet-Gallay, K; Martinelli, N; Effantin, G; Hulsik, DL; Belly, A; Goldberg, Y; Chatellard-Causse, C; Blot, B; Schoehn, G; Weissenhorn, W; Sadoul, R				Bodon, Gilles; Chassefeyre, Romain; Pernet-Gallay, Karin; Martinelli, Nicolas; Effantin, Gregory; Hulsik, David Lutje; Belly, Agnes; Goldberg, Yves; Chatellard-Causse, Christine; Blot, Beatrice; Schoehn, Guy; Weissenhorn, Winfried; Sadoul, Remy			Charged Multivesicular Body Protein 2B (CHMP2B) of the Endosomal Sorting Complex Required for Transport-III (ESCRT-III) Polymerizes into Helical Structures Deforming the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL DEMENTIA; FILAMENTS; ATPASE; VPS4; AUTOINHIBITION; CYTOKINESIS; MACHINERY; DYNAMICS; CARGO; ALIX	The endosomal sorting complexes required for transport (ESCRT-0-III) allow membrane budding and fission away from the cytosol. This machinery is used during multivesicular endosome biogenesis, cytokinesis, and budding of some enveloped viruses. Membrane fission is catalyzed by ESCRT-III complexes made of polymers of charged multivesicular body proteins (CHMPs) and by the AAA-type ATPase VPS4. How and which of the ESCRT-III subunits sustain membrane fission from the cytoplasmic surface remain uncertain. In vitro, CHMP2 and CHMP3 recombinant proteins polymerize into tubular helical structures, which were hypothesized to drive vesicle fission. However, this model awaits the demonstration that such structures exist and can deform membranes in cellulo. Here, we show that depletion of VPS4 induces specific accumulation of endogenous CHMP2B at the plasma membrane. Unlike other CHMPs, overexpressed full-length CHMP2B polymerizes into long, rigid tubes that protrude out of the cell. CHMP4s relocalize at the base of the tubes, the formation of which depends on VPS4. Cryo-EM of the CHMP2B membrane tubes demonstrates that CHMP2B polymerizes into a tightly packed helical lattice, in close association with the inner leaflet of the membrane tube. This association is tight enough to deform the lipid bilayer in cases where the tubular CHMP2B helix varies in diameter or is closed by domes. Thus, our observation that CHMP2B polymerization scaffolds membranes in vivo represents a first step toward demonstrating its structural role during outward membrane deformation.	[Bodon, Gilles; Chassefeyre, Romain; Pernet-Gallay, Karin; Belly, Agnes; Goldberg, Yves; Chatellard-Causse, Christine; Blot, Beatrice; Sadoul, Remy] Univ Grenoble 1, Grenoble Inst Neurosci, F-38042 Grenoble, France; [Bodon, Gilles; Chassefeyre, Romain; Belly, Agnes; Goldberg, Yves; Chatellard-Causse, Christine; Blot, Beatrice; Sadoul, Remy] INSERM, Equipe 2, U836, F-38042 Grenoble, France; [Martinelli, Nicolas; Effantin, Gregory; Hulsik, David Lutje; Schoehn, Guy; Weissenhorn, Winfried] Univ Grenoble 1, EMBL, CNRS, UVHCI,UMI 3265, F-38042 Grenoble, France; [Schoehn, Guy] CEA, Inst Biol Struct Jean Pierre Ebel, UMR 5075, F-38027 Grenoble, France; [Schoehn, Guy] CNRS, Inst Biol Struct Jean Pierre Ebel, UMR 5075, F-38027 Grenoble, France; [Schoehn, Guy] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, UMR 5075, F-38027 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Sadoul, R (corresponding author), Univ Grenoble 1, Grenoble Inst Neurosci, Chemin Fortune Ferrini,BP 170, F-38042 Grenoble, France.	remy.sadoul@ujf-grenoble.fr		Schoehn, Guy/0000-0002-1459-3201; SADOUL, Remy/0000-0002-4763-0320; Goldberg, Yves/0000-0001-7446-8595; PERNET GALLAY, Karin/0000-0003-3468-3316	INSERM; CNRS; Universite Joseph Fourier; Fondation France Alzheimer; ANR [08-Blanc-0271]; Region Rhone-Alpes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier; Fondation France Alzheimer; ANR(French National Research Agency (ANR)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by INSERM, CNRS, Universite Joseph Fourier, Fondation France Alzheimer, and ANR(Grant 08-Blanc-0271, to W. W., R. S., and G. S.).; Supported by the Region Rhone-Alpes (Cluster 10 Infectiologie).	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Belly A, 2010, J CELL SCI, V123, P2943, DOI 10.1242/jcs.068817; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley J. H., 2010, NAT REV MOL CELL BIO; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lenz M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038101; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Mahul-Mellier AL, 2009, BIOCHEM SOC T, V37, P200, DOI 10.1042/BST0370200; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Peel S, 2011, TRENDS BIOCHEM SCI, V36, P199, DOI 10.1016/j.tibs.2010.09.004; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	49	76	76	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40276	40286		10.1074/jbc.M111.283671	http://dx.doi.org/10.1074/jbc.M111.283671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21926173	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000296925700059
J	Minobe, E; Asmara, H; Saud, ZA; Kameyama, M				Minobe, Etsuko; Asmara, Hadhimulya; Saud, Zahangir A.; Kameyama, Masaki			Calpastatin Domain L Is a Partial Agonist of the Calmodulin-binding Site for Channel Activation in Cav1.2 Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL TAIL; PIG VENTRICULAR MYOCYTES; CALCIUM-CHANNELS; CA2+-DEPENDENT INACTIVATION; CA(V)1.2 CHANNEL; RUN-DOWN; FACILITATION; CALPAIN; HEART; ALPHA(1C)	Cav1.2 Ca2+ channel activity diminishes in inside-out patches (run-down). Previously, we have found that with ATP, calpastatin domain L (CSL) and calmodulin (CaM) recover channel activity from the run-down in guinea pig cardiac myocytes. Because the potency of the CSL repriming effect was smaller than that of CaM, we hypothesized that CSL might act as a partial agonist of CaM in the channel-repriming effect. To examine this hypothesis, we investigated the effect of the competitions between CSL and CaM on channel activity and on binding in the channel. We found that CSL suppressed the channel-activating effect of CaM in a reversible and concentration-dependent manner. The channel-inactivating effect of CaM seen at high concentrations of CaM, however, did not seem to be affected by CSL. In the GST pull-down assay, CSL suppressed binding of CaM to GST fusion peptides derived from C-terminal regions in a competitive manner. The inhibition of CaM binding by CSL was observed with the IQ peptide but not the PreIQ peptide, which is the CaM-binding domain in the C terminus. The results are consistent with the hypothesis that CSL competes with CaM as a partial agonist for the site in the IQ domain in the C-terminal region of the Cav1.2	[Minobe, Etsuko; Asmara, Hadhimulya; Saud, Zahangir A.; Kameyama, Masaki] Kagoshima Univ, Dept Physiol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan	Kagoshima University	Kameyama, M (corresponding author), 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	kame@m.kufm.kagoshima-u.ac.jp	Saud, Zahangir Alam/ADC-1753-2022	Saud, Zahangir Alam/0000-0003-0019-053X	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Kodama Memorial Foundation for Medical Research	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kodama Memorial Foundation for Medical Research	This work was supported by a grant-in-aid for young scientists from the Ministry of Education, Culture, Sports, Science, and Technology (to E. M.), a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (to M. K.), and a grant from the Kodama Memorial Foundation for Medical Research (to E. M.).	Asmara H, 2010, J PHARMACOL SCI, V112, P397, DOI 10.1254/jphs.09342FP; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; De Tullio R, 2000, FEBS LETT, V475, P17, DOI 10.1016/S0014-5793(00)01613-6; Ding S, 1999, J BIOCHEM, V125, P750, DOI 10.1093/oxfordjournals.jbchem.a022346; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Enns D., 2002, Molecular and Cellular Biochemistry, V241, P29, DOI 10.1023/A:1020861120368; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Evans TIA, 2011, BIOPHYS CHEM, V159, P172, DOI 10.1016/j.bpc.2011.06.007; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Guo F, 2010, BIOCHEM BIOPH RES CO, V391, P1170, DOI 10.1016/j.bbrc.2009.11.171; Han DY, 2010, J PHARMACOL SCI, V112, P310, DOI 10.1254/jphs.09282FP; Hao LY, 2000, BIOCHEM BIOPH RES CO, V279, P756, DOI 10.1006/bbrc.2000.4040; Hao LY, 1999, J PHYSIOL-LONDON, V514, P687, DOI 10.1111/j.1469-7793.1999.687ad.x; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hofer GF, 1997, BIOPHYS J, V73, P1857, DOI 10.1016/S0006-3495(97)78216-X; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Kepplinger KJF, 2000, J PHYSIOL-LONDON, V529, P119, DOI 10.1111/j.1469-7793.2000.00119.x; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; LANE RD, 1985, J MOL CELL CARDIOL, V17, P863, DOI 10.1016/S0022-2828(85)80100-0; LEE WJ, 1992, J BIOL CHEM, V267, P8437; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; Minobe E, 2006, BIOCHEM BIOPH RES CO, V348, P288, DOI 10.1016/j.bbrc.2006.07.052; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; OROURKE B, 1992, SCIENCE, V257, P245, DOI 10.1126/science.1321495; OTSUKA Y, 1987, J BIOL CHEM, V262, P5839; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Saud ZA, 2007, BIOCHEM BIOPH RES CO, V364, P372, DOI 10.1016/j.bbrc.2007.10.017; SEYDL K, 1995, PFLUG ARCH EUR J PHY, V429, P503, DOI 10.1007/BF00704155; TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200; Xu JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1717, DOI 10.1152/ajpcell.00105.2004; Yazawa K, 1997, PFLUG ARCH EUR J PHY, V433, P557, DOI 10.1007/s004240050314; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	45	23	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39013	39022		10.1074/jbc.M111.242248	http://dx.doi.org/10.1074/jbc.M111.242248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937422	Green Published, hybrid			2022-12-27	WOS:000296759800020
J	Collard, F; Vertommen, D; Constantinescu, S; Buts, L; Van Schaftingen, E				Collard, Francois; Vertommen, Didier; Constantinescu, Stefan; Buts, Lieven; Van Schaftingen, Emile			Molecular Identification of beta-Citrylglutamate Hydrolase as Glutamate Carboxypeptidase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITRYL-L-GLUTAMATE; ALPHA-ASPARTYLGLUTAMIC ACID; L-ASPARTIC ACID; N-ACETYLASPARTYLGLUTAMATE; MEMBRANE ANTIGEN; RAT; BRAIN; DIPEPTIDASE; SYNTHASE; RECEPTOR	beta-Citrylglutamate (BCG), a compound present in adult testis and in the CNS during the pre- and perinatal periods is synthesized by an intracellular enzyme encoded by the RIMKLB gene and hydrolyzed by an as yet unidentified ectoenzyme. To identify beta-citrylglutamate hydrolase, this enzyme was partially purified from mouse testis and characterized. Interestingly, in the presence of Ca2+, the purified enzyme specifically hydrolyzed beta-citrylglutamate and did not act on N-acetyl-aspartylglutamate (NAAG). However, both compounds were hydrolyzed in the presence of Mn2+. This behavior and the fact that the enzyme was glycosylated and membrane-bound suggested that beta-citrylglutamate hydrolase belonged to the same family of protein as glutamate carboxypeptidase 2 (GCP2), the enzyme that catalyzes the hydrolysis of N-acetyl-aspartylglutamate. The mouse tissue distribution of beta-citrylglutamate hydrolase was strikingly similar to that of the glutamate carboxypeptidase 3 (GCP3) mRNA, but not that of the GCP2 mRNA. Furthermore, similarly to beta-citrylglutamate hydrolase purified from testis, recombinant GCP3 specifically hydrolyzed beta-citrylglutamate in the presence of Ca2+, and acted on both N-acetyl-aspartylglutamate and beta-citrylglutamate in the presence of Mn2+, whereas recombinant GCP2 only hydrolyzed N-acetyl-aspartylglutamate and this, in a metal-independent manner. A comparison of the structures of the catalytic sites of GCP2 and GCP3, as well as mutagenesis experiments revealed that a single amino acid substitution (Asn-519 in GCP2, Ser-509 in GCP3) is largely responsible for GCP3 being able to hydrolyze beta-citrylglutamate. Based on the crystal structure of GCP3 and kinetic analysis, we propose that GCP3 forms a labile catalytic Zn-Ca cluster that is critical for its beta-citrylglutamate hydrolase activity.	[Collard, Francois; Vertommen, Didier; Constantinescu, Stefan; Van Schaftingen, Emile] Duve Inst, B-1200 Brussels, Belgium; [Collard, Francois; Vertommen, Didier; Constantinescu, Stefan; Van Schaftingen, Emile] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Buts, Lieven] Vrije Univ Brussel, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Buts, Lieven] VIB, B-1050 Brussels, Belgium	Universite Catholique Louvain; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Van Schaftingen, E (corresponding author), Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Constantinescu, Stefan N/E-5277-2012; Van+Schaftingen, Emile/AAF-5532-2020	Constantinescu, Stefan N./0000-0002-8599-2699; Van Schaftingen, Emile/0000-0002-6199-7647; Vertommen, Didier/0000-0001-7648-8282	Interuniversity Attraction Poles Program-Belgian Science Policy [P6/05, P6/28]; DIANE Center of Excellence program of the Region Wallonne; Fonds de la Recherche Scientifique Medicale; ASCO industries	Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office); DIANE Center of Excellence program of the Region Wallonne; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); ASCO industries	This work was supported by grants from the Interuniversity Attraction Poles Program-Belgian Science Policy (Networks P6/05 and P6/28), by the DIANE Center of Excellence program of the Region Wallonne, by the Fonds de la Recherche Scientifique Medicale, and by a grant from ASCO industries (to E. V. S.).	ASAKURA M, 1995, BBA-PROTEIN STRUCT M, V1250, P35, DOI 10.1016/0167-4838(95)00077-8; Barinka C, 2004, PROTEIN SCI, V13, P1627, DOI 10.1110/ps.04622104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter RE, 1996, P NATL ACAD SCI USA, V93, P749, DOI 10.1073/pnas.93.2.749; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Collard F, 2010, J BIOL CHEM, V285, P29826, DOI 10.1074/jbc.M110.152629; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Fricker AC, 2009, NEUROPHARMACOLOGY, V56, P1060, DOI 10.1016/j.neuropharm.2009.03.002; Halsted CH, 1998, J BIOL CHEM, V273, P20417, DOI 10.1074/jbc.273.32.20417; Hamada-Kanazawa M, 2010, BIOL PHARM BULL, V33, P729, DOI 10.1248/bpb.33.729; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Hlouchova K, 2007, J NEUROCHEM, V101, P682, DOI 10.1111/j.1471-4159.2006.04341.x; Hlouchova K, 2009, FEBS J, V276, P4448, DOI 10.1111/j.1742-4658.2009.07152.x; Hourvitz A, 2006, J ENDOCRINOL, V188, P531, DOI 10.1677/joe.1.06231; Maliekal P, 2007, J BIOL CHEM, V282, P31844, DOI 10.1074/jbc.M706818200; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Michalke B, 2010, ANAL CHIM ACTA, V682, P23, DOI 10.1016/j.aca.2010.09.054; MIYAKE M, 1982, BIOCHIM BIOPHYS ACTA, V719, P495, DOI 10.1016/0304-4165(82)90238-0; MIYAKE M, 1978, BIOCHIM BIOPHYS ACTA, V544, P656, DOI 10.1016/0304-4165(78)90340-9; MIYAKE M, 1983, BIOCHIM BIOPHYS ACTA, V760, P206, DOI 10.1016/0304-4165(83)90165-4; MIYAKE M, 1981, J NEUROCHEM, V36, P804, DOI 10.1111/j.1471-4159.1981.tb01665.x; MIYAKE M, 1981, J NEUROCHEM, V37, P1064, DOI 10.1111/j.1471-4159.1981.tb04500.x; Narahara M, 2000, BIOL PHARM BULL, V23, P1287; Narahara M, 2010, BIOL PHARM BULL, V33, P1938, DOI 10.1248/bpb.33.1938; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; NEALE JH, 2011, J NEUROCHEM IN PRESS; Pangalos MN, 1999, J BIOL CHEM, V274, P8470, DOI 10.1074/jbc.274.13.8470; Pinto JT, 1996, CLIN CANCER RES, V2, P1445; ROBINSON MB, 1987, J BIOL CHEM, V262, P14498; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	35	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38220	38230		10.1074/jbc.M111.287318	http://dx.doi.org/10.1074/jbc.M111.287318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908619	hybrid, Green Published			2022-12-27	WOS:000296594200036
J	Rietdorf, K; Funnell, TM; Ruas, M; Heinemann, J; Parrington, J; Galione, A				Rietdorf, Katja; Funnell, Tim M.; Ruas, Margarida; Heinemann, Jennifer; Parrington, John; Galione, Antony			Two-pore Channels Form Homo- and Heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; ION CHANNELS; MOLECULAR DETERMINANTS; ACIDIC ORGANELLES; COMPLEX-FORMATION; CALCIUM-CHANNEL; CA2+ CHANNEL; NAADP; TRAFFICKING; AUTOPHAGY	Two-pore channels (TPCs) have been recently identified as NAADP-regulated Ca2+ release channels, which are localized on the endolysosomal system. TPCs have a 12-transmembrane domain (TMD) structure and are evolutionary intermediates between the 24-TMD alpha-subunits of Na+ or Ca2+ channels and the transient receptor potential channel superfamily, which have six TMDs in a single subunit and form tetramers with 24 TMDs as active channels. Based on this relationship, it is predicted that TPCs dimerize to form functional channels, but the dimerization of human TPCs has so far not been studied. Using co-immunoprecipitation studies and a mass spectroscopic analysis of the immunocomplex, we show the presence of homo-and heteromeric complexes for human TPC1 and TPC2. Despite their largely distinct localization, we identified a discrete number of endosomes that coexpressed TPC1 and TPC2. Homo-and heteromerization were confirmed by a FRET study, showing that both proteins interacted in a rotational (N- to C-terminal/head-to-tail) symmetry. This is the first report describing the presence of homomultimeric TPC1 channels and the first study showing that TPCs are capable of forming heteromers.	[Rietdorf, Katja; Funnell, Tim M.; Ruas, Margarida; Heinemann, Jennifer; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Galione, A (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	antony.galione@pharm.ox.ac.uk		Ruas, Margarida/0000-0002-4872-7618; Galione, Antony/0000-0002-4132-7646	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by a Wellcome Trust project programme grant (to A. G. and J. P.).	Abel M, 2005, N-S ARCH PHARMACOL, V371, P295, DOI 10.1007/s00210-005-1021-2; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Chung JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1153; Clapham DE, 2005, PHARMACOL REV, V57, P451, DOI 10.1124/pr.57.4.7; Curcio-Morelli C, 2010, J CELL PHYSIOL, V222, P328, DOI 10.1002/jcp.21956; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Galione A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004036; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; Karacsonyi C, 2007, TRAFFIC, V8, P1404, DOI 10.1111/j.1600-0854.2007.00619.x; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Lepage PK, 2007, BIOCHEM SOC T, V35, P81, DOI 10.1042/BST0350081; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; Murata K, 2001, BIOCHEM BIOPH RES CO, V282, P284, DOI 10.1006/bbrc.2001.4529; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Nucifora FC, 1996, MOL BIOL CELL, V7, P949, DOI 10.1091/mbc.7.6.949; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Schilling William P, 2004, Novartis Found Symp, V258, P18; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang MC, 2004, J BIOL CHEM, V279, P7159, DOI 10.1074/jbc.M308057200; Xu L, 2008, J BIOL CHEM, V283, P6321, DOI 10.1074/jbc.M707353200; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004; Zeevi DA, 2010, J CELL SCI, V123, P3112, DOI 10.1242/jcs.067330; Zeevi DA, 2009, J PATHOL, V219, P153, DOI 10.1002/path.2587; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	54	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37058	37062		10.1074/jbc.C111.289835	http://dx.doi.org/10.1074/jbc.C111.289835			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903581	hybrid, Green Published			2022-12-27	WOS:000296542400005
J	Ward, RJ; Pediani, JD; Milligan, G				Ward, Richard J.; Pediani, John D.; Milligan, Graeme			Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; TIME-RESOLVED FRET; ALLOSTERIC MODULATION; REVEALS OLIGOMERS; PHARMACOLOGY; HETEROMERS; INTERNALIZATION; ANTAGONIST; AGONIST; BINDING	Agonist-induced internalization was observed for both inducible and constitutively expressed forms of the cannabinoid CB1 receptor. These were also internalized by the peptide orexin A, which has no direct affinity for the cannabinoid CB1 receptor, but only when the orexin OX1 receptor was co-expressed along with the cannabinoid CB1 receptor. This effect of orexin A was concentration-dependent and blocked by OX1 receptor antagonists. Moreover, the ability of orexin A to internalize the CB1 receptor was also blocked by CB1 receptor antagonists. Remarkably, orexin A was substantially more potent in producing internalization of the CB1 receptor than in causing internalization of the bulk OX1 receptor population, and this was true in cells in which the CB1 receptor was maintained at a constant level, whereas levels of OX1 could be varied and vice versa. Both co-immunoprecipitation and cell surface, homogenous time-resolved fluorescence resonance energy transfer based on covalent labeling of N-terminal "SNAP" and "CLIP" tags present in the extracellular N-terminal domain of the receptors confirmed the capacity of these two receptors to heteromultimerize. These studies confirm the capacity of the CB1 and OX1 receptors to interact directly and demonstrate that this complex has unique regulatory characteristics. The higher potency of the agonist orexin A to regulate the CB1-OX1 heteromer compared with the OX1-OX1 homomer present in the same cells and the effects of CB1 receptor antagonists on the function of orexin A suggest an interplay between these two systems that may modulate appetite, feeding, and wakefulness.	[Ward, Richard J.; Pediani, John D.; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Mol Pharmacol Grp, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Pediani, John/F-2708-2019; Milligan, Graeme/F-9426-2011	Pediani, John/0000-0001-6615-537X; Milligan, Graeme/0000-0002-6946-3519	Medical Research Council [G0900050]; MRC [G0900050] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0900050.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/NCHEMBIO.396, 10.1038/nchembio.396]; Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; Birdsall NJM, 2010, TRENDS PHARMACOL SCI, V31, P499, DOI 10.1016/j.tips.2010.08.003; Borroto-Escuela DO, 2011, J MOL BIOL, V406, P687, DOI 10.1016/j.jmb.2011.01.022; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Casado V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005; Christopoulou FD, 2011, J CLIN PHARM THER, V36, P10, DOI 10.1111/j.1365-2710.2010.01164.x; Coleman PJ, 2011, CURR TOP MED CHEM, V11, P696; Comps-Agrar L, 2011, EMBO J, V30, P2336, DOI 10.1038/emboj.2011.143; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; Ecke D, 2008, BIOCHEM J, V409, P107, DOI 10.1042/BJ20070671; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Ferre S, 2010, PROG MOL BIOL TRANSL, V91, P41, DOI 10.1016/S1877-1173(10)91002-8; Filizola M, 2010, LIFE SCI, V86, P590, DOI 10.1016/j.lfs.2009.05.004; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gomes I, 2011, MOL PHARMACOL, V79, P1044, DOI 10.1124/mol.110.070847; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Hojo M, 2008, J PHARMACOL SCI, V108, P308, DOI 10.1254/jphs.08244FP; Hudson BD, 2010, BRIT J PHARMACOL, V160, P627, DOI 10.1111/j.1476-5381.2010.00681.x; Hudson BD, 2010, MOL PHARMACOL, V77, P1, DOI 10.1124/mol.109.060251; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Laburthe M., 2011, BR J PHARM IN PRESS; Langmead CJ, 2004, BRIT J PHARMACOL, V141, P340, DOI 10.1038/sj.bjp.0705610; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Marcellino D, 2008, NEUROPHARMACOLOGY, V54, P815, DOI 10.1016/j.neuropharm.2007.12.011; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Milan-Lobo L, 2011, J PHARMACOL EXP THER, V337, P868, DOI 10.1124/jpet.111.179093; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Milligan G, 2007, ERNST SCHERING FOUND, V2, P145, DOI 10.1007/2789_2006_007; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Milligan G, 2006, DRUG DISCOV TODAY, V11, P541, DOI 10.1016/j.drudis.2006.04.007; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Panetta R, 2008, DRUG DISCOV TODAY, V13, P1059, DOI 10.1016/j.drudis.2008.09.002; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Przybyla JA, 2010, J PHARMACOL EXP THER, V332, P710, DOI 10.1124/jpet.109.162701; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Rovira X, 2009, BRIT J PHARMACOL, V156, P28, DOI 10.1111/j.1476-5381.2008.00031.x; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Scammell TE, 2011, ANNU REV PHARMACOL, V51, P243, DOI 10.1146/annurev-pharmtox-010510-100528; Schroder H, 2009, NEUROPHARMACOLOGY, V56, P768, DOI 10.1016/j.neuropharm.2008.12.010; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Soriano A, 2009, J MED CHEM, V52, P5590, DOI 10.1021/jm900298c; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; Voisin T, 2011, CANCER RES, V71, P3341, DOI 10.1158/0008-5472.CAN-10-3473; Ward RJ, 2011, BRIT J PHARMACOL, V162, P1439, DOI 10.1111/j.1476-5381.2010.01156.x; Wu YK, 2011, CURR TOP MED CHEM, V11, P1421, DOI 10.2174/156802611795860997; Xu TR, 2011, BIOCHEM J, V439, P171, DOI 10.1042/BJ20110230; Yu XH, 2010, PAIN, V151, P337, DOI 10.1016/j.pain.2010.07.019	67	65	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37414	37428		10.1074/jbc.M111.287649	http://dx.doi.org/10.1074/jbc.M111.287649			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908614	Green Published, hybrid			2022-12-27	WOS:000296542400042
J	Hands, S; Sajjad, MU; Newton, MJ; Wyttenbach, A				Hands, Sarah; Sajjad, Mohammad U.; Newton, Michael J.; Wyttenbach, Andreas			In Vitro and in Vivo Aggregation of a Fragment of Huntingtin Protein Directly Causes Free Radical Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; CYTOCHROME-C RELEASE; MUTANT HUNTINGTIN; OXIDATIVE DAMAGE; HYDROGEN-PEROXIDE; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL DYSFUNCTION; TRANSGENIC MOUSE; CELL-DEATH; HEAT-SHOCK	Neurodegenerative diseases are characterized by intra- and/or extracellular protein aggregation and oxidative stress. Intense attention has been paid to whether protein aggregation itself contributes to abnormal production of free radicals and ensuing cellular oxidative damage. Although this question has been investigated in the context of extracellular protein aggregation, it remains unclear whether protein aggregation inside cells alters the redox homeostasis. To address this, we have used in vitro and in vivo (cellular) models of Huntington disease, one of nine polyglutamine (poly(Q)) disorders, and examined the causal relationship among intracellular protein aggregation, reactive oxygen species (ROS) production, and toxicity. Live imaging of cells expressing a fragment of huntingtin (httExon1) with a poly(Q) expansion shows increased ROS production preceding cell death. ROS production is poly(Q) length-dependent and not due to the httExon 1 flanking sequence. Aggregation inhibition by the MW7 intrabody and Pgl-135 treatment abolishes ROS production, showing that increased ROS is caused by poly(Q) aggregation itself. To examine this hypothesis further, we determined whether aggregation of poly(Q) peptides in vitro generated free radicals. Monitoring poly(Q) protein aggregation using atomic force microscopy and hydrogen peroxide (H2O2) production over time in parallel we show that oligomerization of httEx1Q53 results in early generation of H2O2. Inhibition of poly(Q) oligomerization by the single chain antibody MW7 abrogates H2O2 formation. These results demonstrate that intracellular protein aggregation directly causes free radical production, and targeting potentially toxic poly(Q) oligomers may constitute a therapeutic target to counteract oxidative stress in poly(Q) diseases.	[Hands, Sarah; Sajjad, Mohammad U.; Newton, Michael J.; Wyttenbach, Andreas] Univ Southampton, Southampton Neurosci Grp, Sch Biol Sci, Southampton SO17 1BJ, Hants, England	University of Southampton	Wyttenbach, A (corresponding author), Univ Southampton, Southampton Neurosci Grp, Sch Biol Sci, Southampton SO17 1BJ, Hants, England.	aw3@soton.ac.uk			Medical Research Council; Gerald Kerkut Trust; Bestway Foundation; University of Southampton; Medical Research Council [G120/881] Funding Source: researchfish; MRC [G120/881] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gerald Kerkut Trust; Bestway Foundation; University of Southampton; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (to S. H. and A. W.).; Supported by the Gerald Kerkut Trust, Bestway Foundation, and the University of Southampton.	Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Allsop D, 2008, BIOCHEM SOC T, V36, P1293, DOI 10.1042/BST0361293; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bertoni A, 2011, J BIOL CHEM, V286, P4727, DOI 10.1074/jbc.M110.156521; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 1999, BRAIN PATHOL, V9, P147; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Firdaus WJJ, 2006, FEBS J, V273, P5428, DOI 10.1111/j.1742-4658.2006.05537.x; Firdaus WJJ, 2006, FEBS J, V273, P3076, DOI 10.1111/j.1742-4658.2006.05318.x; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; Halliwell B., 2007, FREE RADICALS BIOL M; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Hands SL, 2010, BIOCHEM SOC T, V38, P552, DOI 10.1042/BST0380552; Hockly E, 2006, NEUROBIOL DIS, V21, P228, DOI 10.1016/j.nbd.2005.07.007; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Kirkland RA, 2001, J NEUROSCI, V21, P1949, DOI 10.1523/JNEUROSCI.21-06-01949.2001; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Martinez A, 2010, BRAIN PATHOL, V20, P281, DOI 10.1111/j.1750-3639.2009.00326.x; Nadal RC, 2008, BIOCHEMISTRY-US, V47, P11653, DOI 10.1021/bi8011093; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perez-Severiano F, 2004, NEUROCHEM RES, V29, P729, DOI 10.1023/B:NERE.0000018843.83770.4b; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Puranam KL, 2006, BIOCHEM BIOPH RES CO, V341, P607, DOI 10.1016/j.bbrc.2006.01.007; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Turnbull S, 2003, BIOCHEMISTRY-US, V42, P7675, DOI 10.1021/bi030036e; van Roon-Mom WMC, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-84; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wyttenbach A, 2006, J NEUROCHEM, V96, P1213, DOI 10.1111/j.1471-4159.2005.03676.x; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137	48	80	81	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44512	44520		10.1074/jbc.M111.307587	http://dx.doi.org/10.1074/jbc.M111.307587			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21984825	hybrid, Green Published			2022-12-27	WOS:000298645500023
J	Jensen, MB; Bhatia, VK; Jao, CC; Rasmussen, JE; Pedersen, SL; Jensen, KJ; Langen, R; Stamou, D				Jensen, Martin Borch; Bhatia, Vikram Kjoller; Jao, Christine C.; Rasmussen, Jakob Ewald; Pedersen, Soren L.; Jensen, Knud J.; Langen, Ralf; Stamou, Dimitrios			Membrane Curvature Sensing by Amphipathic Helices A SINGLE LIPOSOME STUDY USING alpha-SYNUCLEIN AND ANNEXIN B12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN BINDING; EPSIN-RELATED PROTEINS; LIPID-MEMBRANES; BAR DOMAINS; SIZE DISTRIBUTIONS; STRUCTURAL-CHANGES; ANCHORED PROTEINS; CURVED MEMBRANES; EXTENDED HELIX; ANNEXIN B12	Preferential binding of proteins on curved membranes (membrane curvature sensing) is increasingly emerging as a general mechanism whereby cells may effect protein localization and trafficking. Here we use a novel single liposome fluorescence microscopy assay to examine a common sensing motif, the amphipathic helix (AH), and provide quantitative measures describing and distinguishing membrane binding and sensing behavior. By studying two AH-containing proteins, alpha-synuclein and annexin B12, as well as a range of AH peptide mutants, we reveal that both the hydrophobic and hydrophilic faces of the helix greatly influence binding and sensing. Although increased hydrophobic and electrostatic interactions with the membrane both lead to greater densities of bound protein, the former yields membrane curvature-sensitive binding, whereas the latter is not curvature-dependent. However, the relative contributions of both components determine the sensing of AHs. In contrast, charge density in the lipid membrane seems important primarily in attracting AHs to the membrane but does not significantly influence sensing. These observations were made possible by the ability of our assay to distinguish within our samples liposomes with and without bound protein as well as the density of bound protein. Our findings suggest that the description of membrane curvature-sensing requires consideration of several factors such as short and long range electrostatic interactions, hydrogen bonding, and the volume and structure of inserted hydrophobic residues.	[Jensen, Martin Borch; Bhatia, Vikram Kjoller; Stamou, Dimitrios] Univ Copenhagen, Bionanotechnol & Nanomed Lab, Dept Neurosci & Pharmacol, DK-2100 Copenhagen, Denmark; [Jensen, Martin Borch; Bhatia, Vikram Kjoller; Stamou, Dimitrios] Univ Copenhagen, Nanosci Ctr, DK-2100 Copenhagen, Denmark; [Bhatia, Vikram Kjoller; Stamou, Dimitrios] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, DK-2100 Copenhagen, Denmark; [Jao, Christine C.; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Rasmussen, Jakob Ewald; Pedersen, Soren L.; Jensen, Knud J.] Univ Copenhagen, IGM Bioorgan Chem, Fac Life Sci, DK-1871 Frederiksberg C, Denmark	University of Copenhagen; University of Copenhagen; Lundbeckfonden; University of Copenhagen; University of Southern California; University of Copenhagen	Stamou, D (corresponding author), Univ Copenhagen, Bionanotechnol & Nanomed Lab, Dept Neurosci & Pharmacol, Univ Sparken 5, DK-2100 Copenhagen, Denmark.	stamou@nano.ku.dk	Stamou, Dimitrios/D-5042-2016; Jensen, Knud J/D-1145-2016	Stamou, Dimitrios/0000-0001-8456-8995; Jensen, Knud J/0000-0003-3525-5452; Pedersen, Soren Ljungberg/0000-0002-6130-955X	National Institutes of Health [GM063915]; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Danish Councils for Independent and Strategic Research; University of Copenhagen; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation Center for Biomembranes in Nanomedicine; Danish Councils for Independent and Strategic Research; University of Copenhagen; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM063915. This work was also supported by the Lundbeck Foundation Center for Biomembranes in Nanomedicine, the Danish Councils for Independent and Strategic Research, and the University of Copenhagen program of excellence "BioScaRT."	Ambroggio E, 2010, EMBO J, V29, P292, DOI 10.1038/emboj.2009.341; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; Bendix PM, 2009, P NATL ACAD SCI USA, V106, P12341, DOI 10.1073/pnas.0903052106; BENFENATI F, 1989, CELL BIOL INT REP, V13, P1007, DOI 10.1016/0309-1651(89)90016-7; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bhatia VK, 2010, SEMIN CELL DEV BIOL, V21, P381, DOI 10.1016/j.semcdb.2009.12.004; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Capraro BR, 2010, J AM CHEM SOC, V132, P1200, DOI 10.1021/ja907936c; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DEMATTEIS MA, 1993, NATURE, V364, P818, DOI 10.1038/364818a0; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Donnelly SR, 1997, CELL MOL LIFE SCI, V53, P533, DOI 10.1007/s000180050068; Drin G, 2005, NATURE, V437, P1247, DOI 10.1038/4371247a; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fischer T, 2007, J BIOL CHEM, V282, P9996, DOI 10.1074/jbc.M611180200; Furuya T, 2003, BIOPHYS J, V84, P1950, DOI 10.1016/S0006-3495(03)75003-6; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Hegde BG, 2006, BIOCHEMISTRY-US, V45, P934, DOI 10.1021/bi052143+; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Isas JM, 2003, J BIOL CHEM, V278, P30227, DOI 10.1074/jbc.M301228200; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Klocek G, 2009, BIOCHEMISTRY-US, V48, P2586, DOI 10.1021/bi802127h; Kunding AH, 2008, BIOPHYS J, V95, P1176, DOI 10.1529/biophysj.108.128819; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langen R, 1998, J BIOL CHEM, V273, P22453, DOI 10.1074/jbc.273.35.22453; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lohr C, 2009, METHOD ENZYMOL, V465, P143, DOI 10.1016/S0076-6879(09)65008-4; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Mailliard WS, 1997, BIOCHEMISTRY-US, V36, P9045, DOI 10.1021/bi970749v; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Moseley JB, 2010, CELL, V142, P189, DOI 10.1016/j.cell.2010.07.004; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Spillantini MG, 1999, PARKINSONISM RELAT D, V5, P157, DOI 10.1016/S1353-8020(99)00031-0; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5	64	93	94	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42603	42614		10.1074/jbc.M111.271130	http://dx.doi.org/10.1074/jbc.M111.271130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21953452	hybrid, Green Published			2022-12-27	WOS:000298180900068
J	Wang, W; Okeyo, GO; Tao, BL; Hong, JS; Kirk, KL				Wang, Wei; Okeyo, George O.; Tao, Binli; Hong, Jeong S.; Kirk, Kevin L.			Thermally Unstable Gating of the Most Common Cystic Fibrosis Mutant Channel (Delta F508) "RESCUE" BY SUPPRESSOR MUTATIONS IN NUCLEOTIDE BINDING DOMAIN 1 AND BY CONSTITUTIVE MUTATIONS IN THE CYTOSOLIC LOOPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAINS; CFTR CHLORIDE CHANNEL; PHARMACOLOGICAL CHAPERONES; PROCESSING MUTANTS; ABC TRANSPORTER; PLASMA-MEMBRANE; MOLECULAR-BASIS; P-GLYCOPROTEIN; ATP BINDING	Most cystic fibrosis (CF) cases are caused by the Delta F508 mutation in the CF transmembrane conductance regulator (CFTR), which disrupts both the processing and gating of this chloride channel. The cell surface expression of Delta F508-CFTR can be "rescued" by culturing cells at 26-28 degrees C and treating cells with small molecule correctors or intragenic suppressor mutations. Here, we determined whether these various rescue protocols induce a Delta F508-CFTR conformation that is thermally stable in excised membrane patches. We also tested the impact of constitutive cytosolic loop mutations that increase ATP-independent channel activity (K978C and K190C/K978C) on Delta F508-CFTR function. Low temperature-rescued Delta F508-CFTR channels irreversibly inactivated with a time constant of 5-6 min when excised patches were warmed from 22 degrees C to 36.5 degrees C. A panel of CFTR correctors and potentiators that increased Delta F508-CFTR maturation or channel activity failed to prevent this inactivation. Conversely, three suppressor mutations in the first nucleotide binding domain rescued Delta F508-CFTR maturation and stabilized channel activity at 36.5 degrees C. The constitutive loop mutations increased ATP-independent activity of low temperature-rescued Delta F508-CFTR but did not enhance protein maturation. Importantly, the ATP-independent activities of these Delta F508-CFTR constructs were stable at 36.5 degrees C, whereas their ATP-dependent activities were not. Single channel recordings of this thermally stable ATP-independent activity revealed dynamic gating and unitary currents of normal amplitudes. We conclude that: (i) Delta F508-CFTR gating is highly unstable at physiologic temperature; (ii) most rescue protocols do not prevent this thermal instability; and (iii) ATP-independent gating and the pore are spared from Delta F508-induced thermal instability, a finding that may inform alternative treatment strategies.	[Wang, Wei; Okeyo, George O.; Tao, Binli; Kirk, Kevin L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Hong, Jeong S.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Wang, Wei; Okeyo, George O.; Tao, Binli; Hong, Jeong S.; Kirk, Kevin L.] Univ Alabama, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, W (corresponding author), Univ Alabama, Dept Physiol & Biophys, 740 MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	weiwang@uab.edu			National Institutes of Health [R01 DK056796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK056796.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2009, BIOCHEMISTRY-US, V48, P9882, DOI 10.1021/bi9004842; Loo TW, 2006, BIOCHEM J, V395, P537, DOI 10.1042/BJ20060013; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mathews CJ, 1998, J MEMBRANE BIOL, V163, P55, DOI 10.1007/s002329900370; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roxo-Rosa M, 2006, P NATL ACAD SCI USA, V103, P17891, DOI 10.1073/pnas.0608312103; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; SMITH JJ, 1994, J CLIN INVEST, V93, P1307, DOI 10.1172/JCI117087; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	60	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41937	41948		10.1074/jbc.M111.296061	http://dx.doi.org/10.1074/jbc.M111.296061			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965669	hybrid, Green Published			2022-12-27	WOS:000298180900005
J	Esposito, V; Musi, V; de Chiara, C; Veggi, D; Serruto, D; Scarselli, M; Kelly, G; Pizza, M; Pastore, A				Esposito, Veronica; Musi, Valeria; de Chiara, Cesira; Veggi, Daniele; Serruto, Davide; Scarselli, Maria; Kelly, Geoff; Pizza, Mariagrazia; Pastore, Annalisa			Structure of the C-terminal Domain of Neisseria Heparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine against Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-H-BINDING; MONOCLONAL-ANTIBODY; PROTECTIVE ANTIGEN; PROTEIN; ASSIGNMENT; GNA1870; SYSTEM	Neisseria heparin binding antigen (NHBA), also known as GNA2132 (genome-derived Neisseria antigen 2132), is a surface-exposed lipoprotein from Neisseria meningitidis that was originally identified by reverse vaccinology. It is one the three main antigens of a multicomponent vaccine against serogroup B meningitis (4CMenB), which has just completed phase III clinical trials in infants. In contrast to the other two main vaccine components, little is known about the origin of the immunogenicity of this antigen, and about its ability to induce a strong cross-bactericidal response in animals and humans. To characterize NHBA in terms of its structural/immunogenic properties, we have analyzed its sequence and identified a C-terminal region that is highly conserved in all strains. We demonstrate experimentally that this region is independently folded, and solved its three-dimensional structure by nuclear magnetic resonance. Notably, we need detergents to observe a single species in solution. The NHBA domain fold consists of an 8-strand beta-barrel that closely resembles the C-terminal domains of N. meningitidis factor H-binding protein and transferrin-binding protein B. This common fold together with more subtle structural similarities suggest a common ancestor for these important antigens and a role of the beta-barrel fold in inducing immunogenicity against N. meningitidis. Our data represent the first step toward understanding the relationship between structural, functional, and immunological properties of this important vaccine component.	[Esposito, Veronica; Musi, Valeria; de Chiara, Cesira; Kelly, Geoff; Pastore, Annalisa] MRC Natl Inst Med Res, London NW7 1AA, England; [Veggi, Daniele; Serruto, Davide; Scarselli, Maria; Pizza, Mariagrazia] Novartis Vaccines & Diagnost, I-53100 Siena, Italy	MRC National Institute for Medical Research; Novartis	Pastore, A (corresponding author), MRC Natl Inst Med Res, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk		de Chiara, Cesira/0000-0002-9766-2515	Medical Research Council [U117584256]; Novartis; MRC [MC_U117584256, MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117584256] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novartis(Novartis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council Grant U117584256.; Supported by a fellowship from Novartis.	Bai XL, 2011, EXPERT OPIN BIOL TH, V11, P969, DOI 10.1517/14712598.2011.585965; Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Cantini F, 2009, J BIOL CHEM, V284, P9022, DOI 10.1074/jbc.C800214200; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Cendron L, 2011, ACTA CRYSTALLOGR F, V67, P531, DOI 10.1107/S1744309111006154; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desvaux M, 2004, CURR ISSUES MOL BIOL, V6, P111; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Esposito V, 2010, BIOMOL NMR ASSIGN, V4, P107, DOI 10.1007/s12104-010-9220-2; FINNE J, 1987, J IMMUNOL, V138, P4402; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P46, DOI 10.1016/S0167-4838(00)00147-3; Folmer RHA, 1997, J BIOMOL NMR, V9, P245, DOI 10.1023/A:1018670623695; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Jacobsson S, 2009, VACCINE, V27, P5755, DOI 10.1016/j.vaccine.2009.07.056; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; Lewis S, 2009, EXPERT REV VACCINES, V8, P729, DOI [10.1586/erv.09.30, 10.1586/ERV.09.30]; Linge JP, 2004, J MAGN RESON, V167, P334, DOI 10.1016/j.jmr.2004.01.010; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Litt DJ, 2004, J INFECT DIS, V190, P1488, DOI 10.1086/424464; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Mascioni A, 2009, J BIOL CHEM, V284, P8729, DOI 10.1074/jbc.M808831200; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Pace D, 2009, EXPERT REV VACCINES, V8, P529, DOI [10.1586/erv.09.18, 10.1586/ERV.09.18]; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Snape MD, 2011, LANCET, V377, P1809, DOI 10.1016/S0140-6736(11)60762-9; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Thomas D, 2005, ACTA CRYSTALLOGR D, V61, P112, DOI 10.1107/S0907444904027684; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Vandeputte-Rutten L, 2003, J BIOL CHEM, V278, P24825, DOI 10.1074/jbc.M302803200; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	51	30	34	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41767	41775		10.1074/jbc.M111.289314	http://dx.doi.org/10.1074/jbc.M111.289314			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965688	Green Published, hybrid			2022-12-27	WOS:000298057500060
J	Winkler, DD; Muthurajan, UM; Hieb, AR; Luger, K				Winkler, Duane D.; Muthurajan, Uma M.; Hieb, Aaron R.; Luger, Karolin			Histone Chaperone FACT Coordinates Nucleosome Interaction through Multiple Synergistic Binding Events	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; RECOMBINANT HISTONES; TRANSCRIPT ELONGATION; DNA INTERACTIONS; CORE PARTICLE; CHROMATIN; COMPLEX; PROTEIN	In eukaryotic cells, DNA maintenance requires ordered disassembly and re-assembly of chromatin templates. These processes are highly regulated and require extrinsic factors such as chromatin remodelers and histone chaperones. The histone chaperone FACT (facilitates chromatin transcription) is a large heterodimeric complex with roles in transcription, replication, and repair. FACT promotes and subsequently restricts access to DNA as a result of dynamic nucleosome reorganization. However, until now, there lacked a truly quantitative assessment of the critical contacts mediating FACT function. Here, we demonstrate that FACT binds histones, DNA, and intact nucleosomes at nanomolar concentrations. We also determine roles for the histone tails in free histone and nudeosome binding by FACT. Furthermore, we propose that the conserved acidic C-terminal domain of the FACT subunit Spt16 actively displaces nucleosomal DNA to provide access to the histone octamer. Experiments with tri-nudeosome arrays indicate a possible mode for FACT binding within chromatin. Together, the data reveal that specific FACT subunits synchronize interactions with various target sites on individual nucleosomes to generate a high affinity binding event and promote reorganization.	[Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Howard Hughes Medical Institute; Colorado State University	Luger, K (corresponding author), Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA.	Karolin.Luger@colostate.edu		Winkler, Duane D./0000-0003-1045-0323; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	National Institutes of Health [1P01GM088409]; National Institutes of Health NRSA, NIGMS [F32GM096531]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096531, P01GM088409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NRSA, NIGMS; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P01GM088409 (to K. L.).; Supported by National Institutes of Health NRSA Award F32GM096531 from NIGMS.; Supported by the Howard Hughes Medical Institute.	Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Evans DRH, 1998, GENETICS, V150, P1393; Formosa T., 2011, BIOCHIM BIO IN PRESS; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Hammermann M, 2000, BIOPHYS J, V79, P584, DOI 10.1016/S0006-3495(00)76318-1; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hsieh FK, 2010, EMBO REP, V11, P705, DOI 10.1038/embor.2010.113; Huang JY, 2006, NUCLEIC ACIDS RES, V34, P2398, DOI 10.1093/nar/gkl241; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kelley DE, 1999, CHROMOSOMA, V108, P10, DOI 10.1007/s004120050347; Korolev N, 2007, PROG BIOPHYS MOL BIO, V95, P23, DOI 10.1016/j.pbiomolbio.2006.11.003; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LASKEY RA, 1980, NATURE, V286, P763, DOI 10.1038/286763a0; Li Q., 2011, BIOCHIM BIO IN PRESS; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Loyola A, 2004, METHOD ENZYMOL, V377, P474; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; McCullough L, 2011, GENETICS, V188, P835, DOI 10.1534/genetics.111.128769; Moyle-Heyrman G, 2011, J MOL BIOL, V412, P634, DOI 10.1016/j.jmb.2011.07.032; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; OOHARA I, 1987, J MOL BIOL, V196, P399, DOI 10.1016/0022-2836(87)90700-5; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Schlesinger MB, 2000, GENETICS, V155, P1593; Shibahara K, 2000, P NATL ACAD SCI USA, V97, P7766, DOI 10.1073/pnas.97.14.7766; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Tsunaka Y, 2009, J BIOL CHEM, V284, P24610, DOI 10.1074/jbc.M109.001958; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; WILHELM FX, 1978, NUCLEIC ACIDS RES, V5, P505, DOI 10.1093/nar/5.2.505; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024	55	110	112	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41883	41892		10.1074/jbc.M111.301465	http://dx.doi.org/10.1074/jbc.M111.301465			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969370	hybrid, Green Published			2022-12-27	WOS:000298057500070
J	Payne, CM; Bomble, Y; Taylor, CB; McCabe, C; Himmel, ME; Crowley, MF; Beckham, GT				Payne, Christina M.; Bomble, Yannicki; Taylor, Courtney B.; McCabe, Clare; Himmel, Michael E.; Crowley, Michael F.; Beckham, Gregg T.			Multiple Functions of Aromatic-Carbohydrate Interactions in a Processive Cellulase Examined with Molecular Simulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; CRYSTALLINE CHITIN HYDROLYSIS; FAMILY 18 CHITINASES; SERRATIA-MARCESCENS; CONFORMATIONAL-ANALYSIS; BIOMASS RECALCITRANCE; STEREOCHEMICAL COURSE; HUMICOLA-INSOLENS; BINDING MODULES; MODEL SYSTEM	Proteins employ aromatic residues for carbohydrate binding in a wide range of biological functions. Glycoside hydrolases, which are ubiquitous in nature, typically exhibit tunnels, clefts, or pockets lined with aromatic residues for processing carbohydrates. Mutation of these aromatic residues often results in significant activity differences on insoluble and soluble substrates. However, the thermodynamic basis and molecular level role of these aromatic residues remain unknown. Here, we calculate the relative ligand binding free energy by mutating tryptophans in the Trichoderma reesei family 6 cellulase (Ce16A) to alanine. Removal of aromatic residues near the catalytic site has little impact on the ligand binding free energy, suggesting that aromatic residues immediately upstream of the active site are not directly involved in binding, but play a role in the glucopyranose ring distortion necessary for catalysis. Removal of aromatic residues at the entrance and exit of the Ce16A tunnel, however, dramatically impacts the binding affinity, suggesting that these residues play a role in chain acquisition and product stabilization, respectively. The roles suggested from differences in binding affinity are confirmed by molecular dynamics and normal mode analysis. Surprisingly, our results illustrate that aromatic-carbohydrate interactions vary dramatically depending on the position in the enzyme tunnel. As aromatic-carbohydrate interactions are present in all carbohydrate-active enzymes, these results have implications for understanding protein structure-function relationships in carbohydrate metabolism and recognition, carbon turnover in nature, and protein engineering strategies for biomass utilization. Generally, these results suggest that nature employs aromatic-carbohydrate interactions with a wide range of binding affinities for diverse functions.	[Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Payne, Christina M.; Bomble, Yannicki; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Taylor, Courtney B.; McCabe, Clare] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [McCabe, Clare] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Vanderbilt University; Vanderbilt University; Colorado School of Mines	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	Gregg.Beckham@nrel.gov	Payne, Christina/ABE-8330-2020; McCabe, Clare/I-8017-2012; Payne, Christina M/C-7338-2011; crowley, michael F/A-4852-2013	Payne, Christina/0000-0001-5264-0964; McCabe, Clare/0000-0002-8552-9135; Payne, Christina M/0000-0001-5264-0964; crowley, michael F/0000-0001-5163-9398; Bomble, Yannick/0000-0001-7624-8000	Department of Energy Office; National Institute for Computational Sciences Athena cluster under the National Science Foundation [MCB090159]; Department of Energy Office of Energy Efficiency and Renewable Energy [DE-AC36-08GO28308]	Department of Energy Office; National Institute for Computational Sciences Athena cluster under the National Science Foundation; Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This work was supported by the Department of Energy Office of the Biomass Program.; Computer time was provided by the Texas Advanced Computing Center Ranger cluster and the National Institute for Computational Sciences Athena cluster under the National Science Foundation Teragrid Grant MCB090159 and the National Renewable Energy Laboratory Computational Sciences Center supported by the Department of Energy Office of Energy Efficiency and Renewable Energy under Contract DE-AC36 - 08GO28308. We thank Michelle Kuttel fbr helpful discussions regarding ring parameters, Deanne Sammond Seonah Kim, and Stephen Chmely fir help with figure preparation, and Alex MacKerell for providing updated force field parameters. We also thank Peter Ciesielski, Steve Decker, Mike Resch and Deanne Sammond for helpful discussions and a critical reading of the manuscript. Fig. I was made with PyMOL (78). The glucose ring conformation and hydrogen bonding analyses were performed using VMD (54, 79, 80).	Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2011, J PHYS CHEM B, V115, P4516, DOI 10.1021/jp200912q; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Biarnes X, 2007, J AM CHEM SOC, V129, P10686, DOI 10.1021/ja068411o; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; CLAEYSSENS M, 1990, FEBS LETT, V263, P89, DOI 10.1016/0014-5793(90)80712-R; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 1996, CURR OPIN STRUC BIOL, V6, P679, DOI 10.1016/S0959-440X(96)80036-4; Cross Simon, 2009, J Mol Graph Model, V28, P131, DOI 10.1016/j.jmgm.2009.04.010; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DOWD MK, 1992, CARBOHYD RES, V233, P15, DOI 10.1016/S0008-6215(00)90917-0; Fernandez MD, 2005, J AM CHEM SOC, V127, P7379, DOI 10.1021/ja051020+; Frenkel D., 2000, UNDERSTANDING MOL SI; Gabius HJ, 2004, CHEMBIOCHEM, V5, P740, DOI 10.1002/cbic.200300753; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hill AD, 2007, J CHEM INF MODEL, V47, P1031, DOI 10.1021/ci600492e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jeoh T, 2007, BIOTECHNOL BIOENG, V98, P112, DOI 10.1002/bit.21408; Jitonnom J, 2011, BIOCHEMISTRY-US, V50, P4697, DOI 10.1021/bi101362g; Katouno F, 2004, J BIOCHEM, V136, P163, DOI 10.1093/jb/mvh105; Kiehna SE, 2007, CHEM COMMUN, P4026, DOI 10.1039/b711431a; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; KNOWLES JKC, 1988, J CHEM SOC CHEM COMM, P1401, DOI 10.1039/c39880001401; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Kuttel M, 2006, J MOL GRAPH MODEL, V25, P380, DOI 10.1016/j.jmgm.2006.02.007; Laughrey ZR, 2008, J AM CHEM SOC, V130, P14625, DOI 10.1021/ja803960x; Laurent N, 2008, CHEM COMMUN, P4400, DOI 10.1039/b806983m; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mertz B, 2007, BIOPOLYMERS, V87, P249, DOI 10.1002/bip.20831; Norberg AL, 2010, THERMOCHIM ACTA, V511, P189, DOI 10.1016/j.tca.2010.08.013; Norberg AL, 2010, FEBS LETT, V584, P4581, DOI 10.1016/j.febslet.2010.10.017; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Ramirez-Gualito K, 2009, J AM CHEM SOC, V131, P18129, DOI 10.1021/ja903950t; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Screen J, 2007, ANGEW CHEM INT EDIT, V46, P3644, DOI 10.1002/anie.200605116; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Smith EA, 2003, J AM CHEM SOC, V125, P6140, DOI 10.1021/ja034165u; Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l; STRAATSMA TP, 1991, J CHEM PHYS, V95, P1175, DOI 10.1063/1.461148; Terraneo G, 2007, J AM CHEM SOC, V129, P2890, DOI 10.1021/ja066633g; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Vandenbussche S, 2008, CHEM-EUR J, V14, P7570, DOI 10.1002/chem.200800247; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Vuong TV, 2009, APPL ENVIRON MICROB, V75, P6655, DOI 10.1128/AEM.01260-09; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Williams SJ, 2001, TRENDS BIOTECHNOL, V19, P356, DOI 10.1016/S0167-7799(01)01699-7; YUI T, 1994, BIOPOLYMERS, V34, P203, DOI 10.1002/bip.360340206; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhong LH, 2009, CARBOHYD RES, V344, P1984, DOI 10.1016/j.carres.2009.07.005; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	80	88	90	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41028	41035		10.1074/jbc.M111.297713	http://dx.doi.org/10.1074/jbc.M111.297713			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965672	hybrid, Green Published			2022-12-27	WOS:000297315400062
J	Zhang, RP; Shao, JZ; Xiang, LX				Zhang, Rui-peng; Shao, Jian-zhong; Xiang, Li-xin			GADD45A Protein Plays an Essential Role in Active DNA Demethylation during Terminal Osteogenic Differentiation of Adipose-derived Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE DEAMINASE AID; PRIMORDIAL GERM-CELLS; ZYGOTIC PATERNAL GENOME; CPG ISLAND SHORES; EMBRYONIC STEM; STRESS-PROTEIN; MAMMALIAN DNA; GROWTH ARREST; PROMOTER DNA; METHYLATION	Methylation and demethylation of DNA are the complementary processes of epigenetic regulation. These two types of regulation influence a diverse array of cellular activities, including the maintenance of pluripotency and self-renewal in embryonic stem cells. It was generally believed that DNA demethylation occurs passively over several cycles of DNA replication and that active DNA demethylation is rare. Recently, evidence for active DNA demethylation has been obtained in several cancer, neuronal, and embryonic stem cell lines. Studies in embryonic stem cell models, however, suggested that active DNA demethylation might be restricted to the early development of progenitor cells. Whether active demethylation is involved in terminal differentiation of adult stem cells is poorly understood. We provide evidence that active DNA demethylation does occur during terminal specification of stem cells in an adipose-derived mesenchymal stern cell-derived osteogenic differentiation model. The medium CpG regions in promoters of the Dlx5, Runx2, Bglap, and Osterix osteogenic lineage-specific genes were demethylated during the increase in gene expression associated with osteogenic differentiation. The growth arrest and DNA damage-inducible protein GADD45A was up-regulated in these processes. Knockdown of GADD45A led to hypermethylation of Dlx5, Runx2, Bglap, and Osterix promoters, followed by suppression of the expression of these genes and interruption of osteogenic differentiation. These results reveal that GADD45A plays an essential role in gene-specific active DNA demethylation during adult stem cell differentiation. They enhance the current knowledge of osteogenic specification and may also lead to a better understanding of the common mechanisms underlying epigenetic regulation in adult stern cell differentiation.	[Zhang, Rui-peng; Shao, Jian-zhong; Xiang, Li-xin] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Rui-peng; Shao, Jian-zhong; Xiang, Li-xin] Key Lab Cell & Gene Engn, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Shao, JZ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	shaojz@zju.edu.cn; xianglx@zju.edu.cn			National Basic Research Program of China [973 2012CB114404]; Science and Technology Foundation of Ministry of Health of the People's Republic of China [WKJ2007-2-037]	National Basic Research Program of China(National Basic Research Program of China); Science and Technology Foundation of Ministry of Health of the People's Republic of China	This work was supported by National Basic Research Program of China Grant 973 2012CB114404 and Science and Technology Foundation of Ministry of Health of the People's Republic of China Grant WKJ2007-2-037.	Abdalla H, 2009, J REPROD DEVELOP, V55, P356, DOI 10.1262/jrd.20234; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Carrier F, 1999, MOL CELL BIOL, V19, P1673; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Fitzpatrick DR, 2003, CLIN IMMUNOL, V109, P37, DOI 10.1016/S1521-6616(03)00205-5; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Hollander MC, 2005, CELL CYCLE, V4, P704, DOI 10.4161/cc.4.5.1675; IMRE R, 1983, ACTA HISTOCHEM, V73, P17, DOI 10.1016/S0065-1281(83)80067-1; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jiricny J, 2008, CELL, V135, P1167, DOI 10.1016/j.cell.2008.12.008; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kress C, 2001, FEBS LETT, V494, P135, DOI 10.1016/S0014-5793(01)02328-6; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Latham T, 2008, CELL TISSUE RES, V331, P31, DOI 10.1007/s00441-007-0537-9; Lee J, 2002, DEVELOPMENT, V129, P1807; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanchez R, 2010, J BIOL CHEM, V285, P22196, DOI 10.1074/jbc.M109.069344; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Sorensen A. L., 2010, CELL, V21, P2066; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yeo S, 2007, BIOCHEM BIOPH RES CO, V359, P536, DOI 10.1016/j.bbrc.2007.05.120; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhou GS, 2009, CYTOTECHNOLOGY, V60, P11, DOI 10.1007/s10616-009-9203-2; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	62	85	94	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41083	41094		10.1074/jbc.M111.258715	http://dx.doi.org/10.1074/jbc.M111.258715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21917922	hybrid, Green Published			2022-12-27	WOS:000297315400067
J	Li, Q; Spencer, NY; Pantazis, NJ; Engelhardt, JF				Li, Qiang; Spencer, Netanya Y.; Pantazis, Nicholas J.; Engelhardt, John F.			Alsin and SOD1(G93A) Proteins Regulate Endosomal Reactive Oxygen Species Production by Glial Cells and Proinflammatory Pathways Responsible for Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEOTIDE EXCHANGE FACTOR; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; NADPH OXIDASE; CEREBROSPINAL-FLUID; MOTOR-NEURONS; ACTIVATION; GENE; ALS2/ALSIN	Recent studies have implicated enhanced Nox2-mediated reactive oxygen species (ROS) by microglia in the pathogenesis of motor neuron death observed in familial amyotrophic lateral sclerosis (ALS). In this context, ALS mutant forms of SOD1 enhance Rac1 activation, leading to increased Nox2-dependent microglial ROS production and neuron cell death in mice. It remains unclear if other genetic mutations that cause ALS also function through similar Nox-dependent pathways to enhance ROS-mediate motor neuron death. In the present study, we sought to understand whether alsin, which is mutated in an inherited juvenile form of ALS, functionally converges on Rac1-dependent pathways acted upon by SOD1(G93A) to regulate Nox-dependent ROS production. Our studies demonstrate that glial cell expression of SOD1(G93A) or wild type alsin induces ROS production, Rac1 activation, secretion of TNF alpha, and activation of NF kappa B, leading to decreased motor neuron survival in co-culture. Interestingly, coexpression of alsin, or shRNA against Nox2, with SOD1(G93A) in glial cells attenuated these proinflammatory indicators and protected motor neurons in co-culture, although shRNAs against Nox1 and Nox4 had little effect. SOD1(G93A) expression dramatically enhanced TNF alpha-mediated endosomal ROS in glial cells in a Rac1-dependent manner and alsin overexpression inhibited SOD1(G93A)-induced endosomal ROS and Rac1 activation. SOD1(G93A) expression enhanced recruitment of alsin to the endomembrane compartment in glial cells, suggesting that these two proteins act to modulate Nox2-dependent endosomal ROS and proinflammatory signals that modulate NF kappa B. These studies suggest that glial proinflammatory signals regulated by endosomal ROS are influenced by two gene products known to cause ALS.	[Li, Qiang; Spencer, Netanya Y.; Pantazis, Nicholas J.; Engelhardt, John F.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Engelhardt, JF (corresponding author), Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Rm 1-111 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu	Spencer, Netanya/AAS-7999-2020	Spencer, Netanya/0000-0003-1010-5458; Engelhardt, John/0000-0003-2389-9277	National Institutes of Health [DK51315, DK054759]; Department of Defense [W81XWH-08-1-0645]; Roy J. Carver Chair in Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK083429, R01DK051315, P30DK054759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Roy J. Carver Chair in Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51315 and DK054759, Department of Defense Grant W81XWH-08-1-0645, and a grant from the Roy J. Carver Chair in Molecular Medicine (to J. F. E.).	Carter BJ, 2009, ANTIOXID REDOX SIGN, V11, P1569, DOI 10.1089/ARS.2008.2414; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chandran J, 2007, MOL NEUROBIOL, V36, P224, DOI 10.1007/s12035-007-0034-x; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; DURHAM HD, 1993, NEUROTOXICOLOGY, V14, P387; Fiala M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-76; Ford LS, 2004, AMYOTROPH LATERAL SC, V5, P118, DOI 10.1080/14660820410019125; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goodall Emily F., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010854; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hadano S, 2007, NEUROCHEM INT, V51, P74, DOI 10.1016/j.neuint.2007.04.010; Hadano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009805; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jacquier A, 2006, ANN NEUROL, V60, P105, DOI 10.1002/ana.20886; Kanekura K, 2004, J BIOL CHEM, V279, P19247, DOI 10.1074/jbc.M313236200; KRIEGER C, 1992, CAN J NEUROL SCI, V19, P357, DOI 10.1017/S0317167100041998; Kunita R, 2007, J BIOL CHEM, V282, P16599, DOI 10.1074/jbc.M610682200; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee S, 2009, FREE RADICAL BIO MED, V47, P145, DOI 10.1016/j.freeradbiomed.2009.04.013; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2008, BIOCHEM J, V411, P531, DOI 10.1042/BJ20071534; Li Q, 2009, ANTIOXID REDOX SIGN, V11, P1249, DOI 10.1089/ARS.2008.2407; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; Matusica D, 2008, J NEUROSCI RES, V86, P553, DOI 10.1002/jnr.21507; Meng D, 2008, CARDIOVASC RES, V80, P299, DOI 10.1093/cvr/cvn173; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; Moreau C, 2005, NEUROLOGY, V65, P1958, DOI 10.1212/01.wnl.0000188907.97339.76; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Ono S, 2001, J NEUROL SCI, V187, P27, DOI 10.1016/S0022-510X(01)00514-7; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Otomo A, 2008, BIOCHEM BIOPH RES CO, V370, P87, DOI 10.1016/j.bbrc.2008.01.177; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Peterson JR, 2009, HYPERTENSION, V54, P1106, DOI 10.1161/HYPERTENSIONAHA.109.140087; Poloni M, 2000, NEUROSCI LETT, V287, P211, DOI 10.1016/S0304-3940(00)01177-0; Rey FE, 2002, CIRCULATION, V106, P2497, DOI 10.1161/01.CIR.0000038108.71560.70; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sekizawa T, 1998, J NEUROL SCI, V154, P194, DOI 10.1016/S0022-510X(97)00228-1; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Tolosa L, 2011, MOL CELL NEUROSCI, V46, P176, DOI 10.1016/j.mcn.2010.09.001; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	52	61	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40151	40162		10.1074/jbc.M111.279711	http://dx.doi.org/10.1074/jbc.M111.279711			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937428	Green Published, hybrid			2022-12-27	WOS:000296925700048
J	Ryuda, M; Tsuzuki, S; Matsumoto, H; Oda, Y; Tanimura, T; Hayakawa, Y				Ryuda, Masasuke; Tsuzuki, Seiji; Matsumoto, Hitoshi; Oda, Yasunori; Tanimura, Teiichi; Hayakawa, Yoichi			Identification of a Novel Gene, Anorexia, Regulating Feeding Activity via Insulin Signaling in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDATE TASTE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; PEPTIDE; FAMILY; EXPRESSION; PROTEIN; BEHAVIOR; NEURONS; TARGET	Feeding activities of animals, including insects, are influenced by various signals from the external environment, internal energy status, and physiological conditions. Full understanding of how such signals are integrated to regulate feeding activities has, however, been hampered by a lack of knowledge about the genes involved. Here, we identified an anorexic Drosophila melanogaster mutant (GS1189) in which the expression of a newly identified gene, Anorexia (Anox), is mutated. In Drosophila larvae, Anox encodes an acyl-CoA binding protein with an ankyrin repeat domain that is expressed in the cephalic chemosensory organs and various neurons in the central nervous system (CNS). Loss of its expression or disturbance of neural transmission in Anox-expressing cells decreased feeding activity. Conversely, overexpression of Anox in the CNS increased food intake. We further found that Anox regulates expression of the insulin receptor gene (dInR); overexpression and knockdown of Anox in the CNS, respectively, elevated and repressed dInR expression, which altered larval feeding activity in parallel with Anox expression levels. Anox mutant adults also showed significant repression of sugar-induced nerve responses and feeding potencies. Although Anox expression levels did not depend on the fasting and feeding states cycle, stressors such as high temperature and desiccation significantly repressed its expression levels. These results strongly suggest that Anox is essential for gustatory sensation and food intake of Drosophila through regulation of the insulin signaling activity that is directly regulated by internal nutrition status. Therefore, the mutant strain lacking Anox expression cannot enhance feeding potencies even under starvation.	[Ryuda, Masasuke; Tsuzuki, Seiji; Matsumoto, Hitoshi; Oda, Yasunori; Hayakawa, Yoichi] Saga Univ, Dept Appl Biol Sci, Saga 8408502, Japan; [Tanimura, Teiichi] Kyushu Univ, Grad Sch Sci, Dept Biol, Hakozaki 8128581, Japan	Saga University; Kyushu University	Hayakawa, Y (corresponding author), Honjo 1, Saga 8408502, Japan.	hayakayo@cc.saga-u.ac.jp			Grants-in-Aid for Scientific Research [21370003] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; Breitling Rainer, 2004, BMC Pediatr, V4, P5, DOI 10.1186/1471-2431-4-5; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Matsumoto Y, 2003, J BIOL CHEM, V278, P38579, DOI 10.1074/jbc.M305986200; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Ninomiya Y, 2008, FEBS J, V275, P894, DOI 10.1111/j.1742-4658.2008.06252.x; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; Oda Y, 2010, P NATL ACAD SCI USA, V107, P15862, DOI 10.1073/pnas.1003785107; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Ryuda M, 2008, J INSECT PHYSIOL, V54, P1440, DOI 10.1016/j.jinsphys.2008.08.006; Ryuda M, 2008, ZOOL SCI, V25, P746, DOI 10.2108/zsj.25.746; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; Toba G, 1999, GENETICS, V151, P725; Voie A. M., 1998, CELL BIOL LAB HDB, V275, P3; Voie A. M., 1998, CELL BIOL LAB HDB, V3, P3; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Zhang AH, 2004, J BIOL CHEM, V279, P33799, DOI 10.1074/jbc.M403997200	36	26	26	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38417	38426		10.1074/jbc.M111.267344	http://dx.doi.org/10.1074/jbc.M111.267344			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917925	Green Published, hybrid			2022-12-27	WOS:000296594200056
J	Steinberg, D				Steinberg, Daniel			Chance and Serendipity in Science: Two Examples from My Own Career	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HEREDOPATHIA ATACTICA POLYNEURITIFORMIS; OXIDATIVE MODIFICATION HYPOTHESIS; HERITABLE HYPERLIPIDEMIC RABBIT; ENHANCED MACROPHAGE DEGRADATION; MOUSE PERITONEAL-MACROPHAGES; RECEPTOR-DEFICIENT MICE; PHYTANIC-ACID; ENDOTHELIAL-CELLS; CHOLESTEROL BIOSYNTHESIS	The usual scientific paper follows a rather narrowly (but not ever rigidly) defined pattern. Both the author and the journal like to see a linear logical presentation of a "story." Seldom does the paper give the reader the "backstory." Where did the idea come from in the first place? How many false leads led down blind alleys? What happened by chance and what by logical planning? Was there an element of serendipity involved? Perhaps as we enter the paperless era and do not have to count words quite so religiously, it may be possible to encourage a more freewheeling scientific paper, but for now, we have to rely on the historians of science and/or those who "tell all" about their own research. "Reflections" seems an appropriate space for the latter. I have chosen two scenarios from my own career in which happy accidents played important roles but, unhappily, received little recognition in my published papers.	Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Steinberg, D (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.	dsteinberg@ucsd.edu						AVIGAN J, 1966, BIOCHEM BIOPH RES CO, V24, P838, DOI 10.1016/0006-291X(66)90324-X; AVIGAN J, 1960, BIOCHEM BIOPH RES CO, V2, P63, DOI 10.1016/0006-291X(60)90266-7; AVIGAN J, 1960, J BIOL CHEM, V235, P3123; Baldwin EJ, 2010, J NEUROL NEUROSUR PS, V81, P954, DOI 10.1136/jnnp.2008.161059; Bird DA, 1999, P NATL ACAD SCI USA, V96, P6347, DOI 10.1073/pnas.96.11.6347; BLOHM TR, 1959, ARCH BIOCHEM BIOPHYS, V85, P245, DOI 10.1016/0003-9861(59)90467-9; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; CAREW TE, 1978, BIOCHIM BIOPHYS ACTA, V529, P171, DOI 10.1016/0005-2760(78)90115-7; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chisolm GM, 2000, FREE RADICAL BIO MED, V28, P1815, DOI 10.1016/S0891-5849(00)00344-0; ELDJARN L, 1966, LANCET, V1, P691; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; HENRIKSEN T, 1982, ANN NY ACAD SCI, V401, P102, DOI 10.1111/j.1749-6632.1982.tb25711.x; HENRIKSEN T, 1979, SCAND J CLIN LAB INV, V39, P361, DOI 10.3109/00365517909106120; HENRIKSEN T, 1983, ARTERIOSCLEROSIS, V3, P149, DOI 10.1161/01.ATV.3.2.149; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; HESSLER JR, 1979, ATHEROSCLEROSIS, V32, P213, DOI 10.1016/0021-9150(79)90166-7; KESANIEMI YA, 1983, J CLIN INVEST, V71, P950, DOI 10.1172/JCI110849; KITA T, 1987, P NATL ACAD SCI USA, V84, P5928, DOI 10.1073/pnas.84.16.5928; KLENK E, 1965, H-S Z PHYSIOL CHEM, V343, P39; KLENK E, 1963, H-S Z PHYSIOL CHEM, V333, P133, DOI 10.1515/bchm2.1963.333.1.133; KODAMA T, 1988, P NATL ACAD SCI USA, V85, P9238, DOI 10.1073/pnas.85.23.9238; MIZE CE, 1966, BIOCHEM BIOPH RES CO, V25, P359, DOI 10.1016/0006-291X(66)90786-8; MOREL DW, 1984, ARTERIOSCLEROSIS, V4, P357, DOI 10.1161/01.ATV.4.4.357; MOREL DW, 1983, J LIPID RES, V24, P1070; NANDI DL, 1964, ARCH BIOCHEM BIOPHYS, V105, P7, DOI 10.1016/0003-9861(64)90230-9; Nicholson AC, 2000, ANN NY ACAD SCI, V902, P128; PALINSKI W, 1995, ARTERIOSCL THROM VAS, V15, P1569, DOI 10.1161/01.ATV.15.10.1569; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; PARTHASARATHY S, 1986, J CLIN INVEST, V77, P641, DOI 10.1172/JCI112349; Refsum S., 1946, ACTA PSYCHIAT SCAND, V38, P1; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; SAMBRANO GR, 1994, P NATL ACAD SCI USA, V91, P3265, DOI 10.1073/pnas.91.8.3265; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; STEINBER.D, 1965, BIOCHEM BIOPH RES CO, V19, P783, DOI 10.1016/0006-291X(65)90328-1; STEINBER.D, 1965, BIOCHEM BIOPH RES CO, V19, P412, DOI 10.1016/0006-291X(65)90138-5; STEINBERG D, 1970, ARCH INTERN MED, V125, P75, DOI 10.1001/archinte.125.1.75; STEINBERG D, 1967, SCIENCE, V156, P1740, DOI 10.1126/science.156.3783.1740; STEINBERG D, 1962, ADV PHARMACOL, V1, P59, DOI 10.1016/S1054-3589(08)60508-6; STEINBERG D, 1992, CIRCULATION, V85, P2338, DOI 10.1161/01.CIR.85.6.2337; STEINBERG D, 1995, ADV EXP MED BIOL, V369, P39; STEINBERG D, 1995, LANCET, V346, P36, DOI 10.1016/S0140-6736(95)92657-7; STEINBERG D, 1967, J CLIN INVEST, V46, P313, DOI 10.1172/JCI105533; STEINBERG D, 1958, P SOC EXP BIOL MED, V97, P784, DOI 10.3181/00379727-97-23880; STEINBERG D, 1956, ANN NY ACAD SCI, V64, P579, DOI 10.1111/j.1749-6632.1956.tb36832.x; Steinberg D., 1996, P 12 INT S DRUGS AFF, P1; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; STOFFEL W, 1965, BIOCHEM BIOPH RES CO, V19, P33, DOI 10.1016/0006-291X(65)90114-2; Tsimikas S, 2001, ARTERIOSCL THROM VAS, V21, P95, DOI 10.1161/01.ATV.21.1.95; Wanders RJA, 2003, BBA-MOL CELL BIOL L, V1631, P119, DOI 10.1016/S1388-1981(03)00003-9; Witztum JL, 2001, TRENDS CARDIOVAS MED, V11, P93, DOI 10.1016/S1050-1738(01)00111-6; WITZTUM JL, 1983, P NATL ACAD SCI-BIOL, V80, P2757, DOI 10.1073/pnas.80.9.2757; WITZTUM JL, 1984, P NATL ACAD SCI-BIOL, V81, P3204, DOI 10.1073/pnas.81.10.3204; YAMAMOTO A, 1986, AM J CARDIOL, V57, pH29, DOI 10.1016/0002-9149(86)90434-0	62	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37895	37904		10.1074/jbc.X111.302950	http://dx.doi.org/10.1074/jbc.X111.302950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908608	Green Published, hybrid			2022-12-27	WOS:000296594200003
J	Choudhary, S; Rosenblatt, KP; Fang, L; Tian, B; Wu, ZH; Brasier, AR				Choudhary, Sanjeev; Rosenblatt, Kevin P.; Fang, Ling; Tian, Bing; Wu, Zhao-Hui; Brasier, Allan R.			High Throughput Short Interfering RNA (siRNA) Screening of the Human Kinome Identifies Novel Kinases Controlling the Canonical Nuclear Factor-kappa B (NF-kappa B) Activation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; GENE-EXPRESSION; SER(276) PHOSPHORYLATION; IKK-BETA; ZETA-PKC; ALPHA; UBIQUITINATION; ATM; TRANSCRIPTION; NEMO	Nuclear factor-kappa B (NF-kappa B) is an inducible cytoplasmic transcription factor that plays a role as a master regulator of airway mucosal inflammation. The prototypical ("canonical") NF-kappa B pathway controls cytoplasmic to nuclear translocation in response to stimulation by the mononuclear cytokine, TNF. Despite intensive investigation, the spectrum of kinases involved in the canonical NF-kappa B pathway has not yet been systematically determined. Here we have applied a high throughput siRNA-mediated loss-of-function screening assay to identify novel kinases important in TNF-induced NF-kappa B signaling. Type II A549 epithelial cells stably expressing an IL-8/luciferase reporter gene optimized for high throughput siRNA format (Z' score of 0.65) and siRNAs for 636 human kinases were reverse-transfected and screened in the assay. 36 candidate genes were identified that inhibited TNF signaling with a Z score deviation of <-1.3 in replicate plates. From this group, 11 kinases were selected for independent validation, of which eight were successfully silenced. Six kinases were validated, including ATM, CDK2, -5, and -7, CALM3, MAPAKP5, and MAP3K/MEKK3. The surprising function of ATM in TNF signaling was confirmed where reduced NF-kappa B/RelA translocation and Ser-276 phosphorylation were seen in ATM(-/-) mouse embryo fibroblasts. These data indicate that ATM is a key regulatory kinase that may control global NF-kappa B activation in the TNF-induced canonical pathway.	[Choudhary, Sanjeev; Brasier, Allan R.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Choudhary, Sanjeev; Tian, Bing; Brasier, Allan R.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Fang, Ling] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Wu, Zhao-Hui] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN USA; [Rosenblatt, Kevin P.] Univ Texas Hlth Sci Ctr, Ctr Clin Prote, Houston, TX 77030 USA; [Rosenblatt, Kevin P.] Univ Texas Hlth Sci Ctr, Ctr Clin & Translat Sci, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Rosenblatt, Kevin P.] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Choudhary, S (corresponding author), Univ Texas Med Branch, Sealy Ctr Mol Med, MRB 8-138,301 Univ Blvd, Galveston, TX 77555 USA.	sachoudh@utmb.edu		Choudhary, Sanjeev/0000-0001-8290-7420; Brasier, Allan/0000-0002-5012-4090	National Institutes of Health (NIH) [AI062885]; NHLBI, NIH, Proteomics Center [HHSN268201000037C]; University of Texas Medical Branch Clinical and Translational Science [1U54RR02614]; NIDDK (NIH) [DK079053]; NHLBI (NIH) Proteomics Initiative [N01-HV-00245]; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Welch Foundation [L-AU-0002]; American Diabetes Association [1-08-CR-65]; University of Texas Health Science Center [U54CTSA]; NATIONAL CANCER INSTITUTE [R01CA149251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079053] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, NIH, Proteomics Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Texas Medical Branch Clinical and Translational Science; NIDDK (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI (NIH) Proteomics Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); John S. Dunn Gulf Coast Consortium for Chemical Genomics; Welch Foundation(The Welch Foundation); American Diabetes Association(American Diabetes Association); University of Texas Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants AI062885 (to A. R. B.), NHLBI, NIH, Proteomics Center Grant HHSN268201000037C (to A. R. B.), University of Texas Medical Branch Clinical and Translational Science Award Grant 1U54RR02614 (to A. R. B.), NIDDK (NIH) Grant DK079053 (to S. C.), and NHLBI (NIH) Proteomics Initiative Grant N01-HV-00245 (to K. P. R.). This work was also supported by a Discovery Project pilot grant from the John S. Dunn Gulf Coast Consortium for Chemical Genomics (to A. R. B. and S. C.), a Welch Foundation Endowment in Chemistry and Related Science Fellowship award (Grant L-AU-0002; to K. P. R.), American Diabetes Association Grant 1-08-CR-65 (to K. P. R.), and University of Texas Health Science Center Clinical and Translational Science Award U54CTSA.	Brasier AR, 2008, CELL CYCLE, V7, P2661, DOI 10.4161/cc.7.17.6594; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fan YH, 2009, J BIOL CHEM, V284, P29290, DOI 10.1074/jbc.M109.018994; Folmer F, 2006, BIOCHEM PHARMACOL, V71, P1206, DOI 10.1016/j.bcp.2005.12.032; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Harper JW, 1998, GENE DEV, V12, P285, DOI 10.1101/gad.12.3.285; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; Jhou RS, 2009, CELL PROLIFERAT, V42, P141, DOI 10.1111/j.1365-2184.2009.00584.x; Kai M, 2009, FEBS LETT, V583, P3265, DOI 10.1016/j.febslet.2009.09.017; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rieber N, 2009, BIOINFORMATICS, V25, P678, DOI 10.1093/bioinformatics/btp014; Rosato RR, 2010, J BIOL CHEM, V285, P10064, DOI 10.1074/jbc.M109.095208; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Sun WJ, 2010, J BIOL CHEM, V285, P7911, DOI 10.1074/jbc.M109.051219; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tian B., 2005, NUCL FACTOR KAPPAB N, P1; Vanden Bush T.J., 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019468; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	46	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37187	37195		10.1074/jbc.M111.224923	http://dx.doi.org/10.1074/jbc.M111.224923			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900239	Green Published, hybrid			2022-12-27	WOS:000296542400019
J	Salcedo-Sora, JE; Ochong, E; Beveridge, S; Johnson, D; Nzila, A; Biagini, GA; Stocks, PA; O'Neill, PM; Krishna, S; Bray, PG; Ward, SA				Salcedo-Sora, J. Enrique; Ochong, Edwin; Beveridge, Susan; Johnson, David; Nzila, Alexis; Biagini, Giancarlo A.; Stocks, Paul A.; O'Neill, Paul M.; Krishna, Sanjeev; Bray, Patrick G.; Ward, Stephen A.			The Molecular Basis of Folate Salvage in Plasmodium falciparum CHARACTERIZATION OF TWO FOLATE TRANSPORTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MALARIA PARASITE; MENSCHEN PL FALCIPARUM; PARA-AMINOBENZOIC ACID; DIE IMMUNITAT BEI; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; EXOGENOUS FOLATE; TRANSPORTER; SULFADOXINE; RESISTANCE	Tetrahydrofolates are essential cofactors for DNA synthesis and methionine metabolism. Malaria parasites are capable both of synthesizing tetrahydrofolates and precursors de novo and of salvaging them from the environment. The biosynthetic route has been studied in some detail over decades, whereas the molecular mechanisms that underpin the salvage pathway lag behind. Here we identify two functional folate transporters (named PfFT1 and PfFT2) and delineate unexpected substrate preferences of the folate salvage pathway in Plasmodium falciparum. Both proteins are localized in the plasma membrane and internal membranes of the parasite intra-erythrocytic stages. Transport substrates include folic acid, folinic acid, the folate precursor p-amino benzoic acid (pABA), and the human folate catabolite pABAG(n). Intriguingly, the major circulating plasma folate, 5-methyltetrahydrofolate, was a poor substrate for transport via PfFT2 and was not transported by PfFT1. Transport of all folates studied was inhibited by probenecid and methotrexate. Growth rescue in Escherichia coli and antifolate antagonism experiments in P. falciparum indicate that functional salvage of 5-methyltetrahydrofolate is detectable but trivial. In fact pABA was the only effective salvage substrate at normal physiological levels. Because pABA is neither synthesized nor required by the human host, pABA metabolism may offer opportunities for chemotherapeutic intervention.	[O'Neill, Paul M.; Bray, Patrick G.; Ward, Stephen A.] Univ Liverpool, Liverpool Sch Trop Med, Mol & Biochem Parasitol Grp, Liverpool L3 5QA, Merseyside, England; [O'Neill, Paul M.] Univ Liverpool, Robert Robinson Labs, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Krishna, Sanjeev] St Georges Univ London, London SW17 0RE, England; [Nzila, Alexis] Wellcome Trust Collaborat Res Programme, Kenya Med Res Inst, Kilifi 801808, Kenya	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; St Georges University London; Kenya Medical Research Institute	Ward, SA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Mol & Biochem Parasitol Grp, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	saward@liverpool.ac.uk	Ward, Steve/G-6003-2015; Biagini, Giancarlo A/F-3449-2011	Ward, Steve/0000-0003-2331-3192; Biagini, Giancarlo A/0000-0001-6356-6595; Krishna, Sanjeev/0000-0003-0066-0634	Medical Research Council [G0400173]; Bill and Melinda Gates Foundation; Wellcome Trust; MRC [G0400173] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0400173 (to P. G. B.), the Bill and Melinda Gates Foundation, and the Wellcome Trust (open access publishing grant).	ARFMAN N, 1992, J BACTERIOL, V174, P7370, DOI 10.1128/jb.174.22.7370-7378.1992; ASAWAMAHASAKDA W, 1993, PARASITOLOGY, V107, P1, DOI 10.1017/S0031182000079348; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; BRAY RS, 1953, BRIT MED J, V1, P1200, DOI 10.1136/bmj.1.4821.1200; BROCKELMAN CR, 1982, B WORLD HEALTH ORGAN, V60, P423; Carter EL, 2007, J BACTERIOL, V189, P3329, DOI 10.1128/JB.01940-06; Dridi L, 2010, BIOCHEM PHARMACOL, V79, P30, DOI 10.1016/j.bcp.2009.07.019; Eudes A, 2010, J BIOL CHEM, V285, P2867, DOI 10.1074/jbc.M109.063651; FERONE R, 1973, J PROTOZOOL, V20, P459, DOI 10.1111/j.1550-7408.1973.tb00926.x; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Hannisdal R, 2009, CLIN CHEM, V55, P1147, DOI 10.1373/clinchem.2008.114389; HAWKING F, 1954, BMJ-BRIT MED J, V1, P425, DOI 10.1136/bmj.1.4859.425; Hondorp ER, 2009, J BACTERIOL, V191, P3407, DOI 10.1128/JB.01722-08; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hussein MJ, 1998, J BACTERIOL, V180, P6260; Hyde JE, 2005, ACTA TROP, V94, P191, DOI 10.1016/j.actatropica.2005.04.002; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Kicska GA, 2003, J INFECT DIS, V188, P1776, DOI 10.1086/379373; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; KRETSCHM.W, 1966, Z TROPENMED PARASIT, V17, P369; KRETSCHMAR W, 1966, Z TROPENMED PARASIT, V17, P301; KRETSCHMAR W, 1966, Z TROPENMED PARASIT, V17, P375; KRUNGKRAI J, 1989, MOL BIOCHEM PARASIT, V32, P25, DOI 10.1016/0166-6851(89)90126-6; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lin YM, 2004, AM J CLIN NUTR, V80, P680; LO RS, 1991, P ROY SOC B-BIOL SCI, V246, P161, DOI 10.1098/rspb.1991.0139; MAEGRAITH BG, 1952, BRIT MED J, V2, P1382, DOI 10.1136/bmj.2.4799.1382; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Maughan SC, 2010, P NATL ACAD SCI USA, V107, P2331, DOI 10.1073/pnas.0913689107; MCCONKEY GA, 1994, P NATL ACAD SCI USA, V91, P4244, DOI 10.1073/pnas.91.10.4244; McDowell Margaret A, 2008, NCHS Data Brief, P1; MILHOUS WK, 1985, ANTIMICROB AGENTS CH, V27, P525, DOI 10.1128/AAC.27.4.525; Nduati E, 2008, PARASITOL RES, V102, P1227, DOI 10.1007/s00436-008-0897-4; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Nzila A, 2003, ANTIMICROB AGENTS CH, V47, P2108, DOI 10.1128/AAC.47.7.2108-2112.2003; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Richard D, 2004, J BIOL CHEM, V279, P54494, DOI 10.1074/jbc.M409264200; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAPIRA A, 1986, AM J TROP MED HYG, V35, P239, DOI 10.4269/ajtmh.1986.35.239; Sowunmi A, 2004, TROP MED INT HEALTH, V9, P606, DOI 10.1111/j.1365-3156.2004.01233.x; Subramanian VS, 2001, AM J PHYSIOL-GASTR L, V281, pG1477, DOI 10.1152/ajpgi.2001.281.6.G1477; Suh JR, 2001, ANNU REV NUTR, V21, P255, DOI 10.1146/annurev.nutr.21.1.255; TANARIYA P, 1983, J PARASITOL, V69, P353, DOI 10.2307/3281233; TANARIYA P, 1983, EXP PARASITOL, V55, P364, DOI 10.1016/0014-4894(83)90033-4; TANARIYA P, 1987, AM J TROP MED HYG, V37, P42, DOI 10.4269/ajtmh.1987.37.42; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Virkki LV, 2001, AM J PHYSIOL-REG I, V281, pR1994, DOI 10.1152/ajpregu.2001.281.6.R1994; Wang P, 2004, MOL BIOCHEM PARASIT, V135, P77, DOI 10.1016/j.molbiopara.2004.01.008; Wang P, 1999, MOL MICROBIOL, V32, P1254, DOI 10.1046/j.1365-2958.1999.01437.x; Wang P, 1997, PARASITOLOGY, V115, P223, DOI 10.1017/S0031182097001431; Wang P, 2007, MOL BIOCHEM PARASIT, V154, P40, DOI 10.1016/j.molbiopara.2007.04.002; Waterkeyn JG, 1999, INT J PARASITOL, V29, P945, DOI 10.1016/S0020-7519(99)00047-8; WATKINS WM, 1985, MOL BIOCHEM PARASIT, V14, P55, DOI 10.1016/0166-6851(85)90105-7; WONG SC, 1995, J BIOL CHEM, V270, P17468, DOI 10.1074/jbc.270.29.17468; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099	69	32	32	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44659	44668		10.1074/jbc.M111.286054	http://dx.doi.org/10.1074/jbc.M111.286054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21998306	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000298645500036
J	Bar-Lev, DD; Degani-Katzav, N; Perelman, A; Paas, Y				Bar-Lev, Dekel D.; Degani-Katzav, Nurit; Perelman, Alexander; Paas, Yoav			Molecular Dissection of Cl- -selective Cys-loop Receptor Points to Components That Are Dispensable or Essential for Channel Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; X-RAY-STRUCTURE; CELL-SURFACE EXPRESSION; AGONIST BINDING-SITES; ALPHA-BUNGAROTOXIN; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; CAENORHABDITIS-ELEGANS; GABA(A) RECEPTORS	Cys-loop receptors are pentameric ligand-gated ion channels (pLGICs) that bind neurotransmitters to open an intrinsic transmembrane ion channel pore. The recent crystal structure of a prokaryotic pLGIC from the cyanobacterium Gloeobacter violaceus (GLIC) revealed that it naturally lacks an N-terminal extracellular alpha helix and an intracellular domain that are typical of eukaryotic pLGICs. GLIC does not respond to neurotransmitters acting at eukaryotic pLGICs but is activated by protons. To determine whether the structural differences account for functional differences, we used a eukaryotic chimeric acetylcholine-glutamate pLGIC that was modified to carry deletions corresponding to the sequences missing in the prokaryotic homolog GLIC. Deletions made in the N-terminal extracellular alpha helix did not prevent the expression of receptor subunits and the appearance of receptor assemblies on the cell surface but abolished the capability of the receptor to bind alpha -bungarotoxin (a competitive antagonist) and to respond to the neurotransmitter. Other truncated chimeric receptors that lacked the intracellular domain did bind ligands; displayed robust acetylcholine-elicited responses; and shared with the full-length chimeric receptor similar anionic selectivity, effective open pore diameter, and unitary conductance. We suggest that the integrity of the N-terminal alpha helix is crucial for ligand accommodation because it stabilizes the intersubunit interfaces adjacent to the neurotransmitter-binding pocket(s). We also conclude that the intracellular domain of the chimeric acetylcholine-glutamate receptor does not modulate the ion channel conductance and is not involved in positioning of the pore-lining helices in the conformation necessary for coordinating a Cl- ion within the intracellular vestibule of the ion channel pore.	[Bar-Lev, Dekel D.; Degani-Katzav, Nurit; Paas, Yoav] Bar Ilan Univ, Lab Ion Channels, IL-52900 Ramat Gan, Israel; [Perelman, Alexander] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Sci Equipment Unit, IL-52900 Ramat Gan, Israel; [Bar-Lev, Dekel D.; Degani-Katzav, Nurit; Paas, Yoav] Bar Ilan Univ, Inst Nanotechnol & Adv Mat, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University; Bar Ilan University	Paas, Y (corresponding author), Bar Ilan Univ, Lab Ion Channels, IL-52900 Ramat Gan, Israel.	yoav.paas@biu.ac.il			Wolfson Family Foundation; Israel Science Foundation [812/07, 1645/07]	Wolfson Family Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by the Wolfson Family Foundation and Israel Science Foundation Grants 812/07 and 1645/07.	Adelsberger H, 1997, NEUROSCI LETT, V230, P183, DOI 10.1016/S0304-3940(97)00512-0; ANAND R, 1993, FEBS LETT, V327, P241, DOI 10.1016/0014-5793(93)80177-V; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; CHANG CC, 1966, BRIT J PHARM CHEMOTH, V28, P172, DOI 10.1111/j.1476-5381.1966.tb01883.x; Changeux JP, 2009, CR BIOL, V332, P421, DOI 10.1016/j.crvi.2009.02.005; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Chiara DC, 2009, BIOCHEMISTRY-US, V48, P10066, DOI 10.1021/bi901271w; Chiara DC, 2009, MOL PHARMACOL, V75, P1084, DOI 10.1124/mol.108.054353; COHEN BN, 1992, J GEN PHYSIOL, V99, P545, DOI 10.1085/jgp.99.4.545; COHEN BN, 1992, J GEN PHYSIOL, V100, P373, DOI 10.1085/jgp.100.3.373; Colquhoun D, 2004, TRENDS NEUROSCI, V27, P337, DOI 10.1016/j.tins.2004.04.010; Connolly CN, 2008, MOL MEMBR BIOL, V25, P293, DOI 10.1080/09687680801898503; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2011, NATURE, V474, P526, DOI 10.1038/nature10015; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; GU Y, 1991, NEURON, V6, P879, DOI 10.1016/0896-6273(91)90228-R; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Halevi S, 2003, J BIOL CHEM, V278, P34411, DOI 10.1074/jbc.M300170200; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P976, DOI 10.1021/bi051978h; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Keller SH, 1996, J BIOL CHEM, V271, P22871, DOI 10.1074/jbc.271.37.22871; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Kneussel M, 2007, BIOL CELL, V99, P297, DOI 10.1042/BC20060120; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; LESTER HA, 1970, NATURE, V227, P727, DOI 10.1038/227727a0; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; MacInnes D.A., 1961, PRINCIPLES ELECTROCH; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Moroni M, 2011, J BIOL CHEM, V286, P13414, DOI 10.1074/jbc.M110.204610; Nashmi R, 2003, J NEUROSCI, V23, P11554; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Pittel I, 2010, J BIOL CHEM, V285, P26519, DOI 10.1074/jbc.M110.102327; Pitzer K.S, 1991, ION INTERACTION APPR, Vsecond; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Samson AO, 2002, NEURON, V35, P319, DOI 10.1016/S0896-6273(02)00773-0; SINE SM, 1991, J BIOL CHEM, V266, P19369; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sine SM, 2010, J MOL NEUROSCI, V40, P70, DOI 10.1007/s12031-009-9260-1; SMITH MM, 1987, J BIOL CHEM, V262, P4367; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; SUKHNO IV, 2005, CHEM INT, V27; Sunesen M, 2006, J BIOL CHEM, V281, P14875, DOI 10.1074/jbc.M511657200; Taylor P, 2007, BIOCHEM PHARMACOL, V74, P1164, DOI 10.1016/j.bcp.2007.07.038; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326; Williams BM, 1998, NAT NEUROSCI, V1, P557, DOI 10.1038/2792; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; YU XM, 1994, J NEUROSCI, V14, P785; YU XM, 1994, NEURON, V13, P247, DOI 10.1016/0896-6273(94)90473-1; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	97	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43830	43841		10.1074/jbc.M111.282715	http://dx.doi.org/10.1074/jbc.M111.282715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21987577	Green Published, hybrid			2022-12-27	WOS:000298402300025
J	Cao, ZB; Tavender, TJ; Roszak, AW; Cogdell, RJ; Bulleid, NJ				Cao, Zhenbo; Tavender, Timothy J.; Roszak, Aleksander W.; Cogdell, Richard J.; Bulleid, Neil J.			Crystal Structure of Reduced and of Oxidized Peroxiredoxin IV Enzyme Reveals a Stable Oxidized Decamer and a Non-disulfide-bonded Intermediate in the Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; 2-CYS PEROXIREDOXINS; DIFFRACTION DATA; PATHWAY; STATE; PEROXIDASE; REFINEMENT; MECHANISMS; REDUCTION	Peroxiredoxin IV (PrxIV) is an endoplasmic reticulum-localized enzyme that metabolizes the hydrogen peroxide produced by endoplasmic reticulum oxidase 1 (Ero1). It has been shown to play a role in de novo disulfide formation, oxidizing members of the protein disulfide isomerase family of enzymes, and is a member of the typical 2-Cys peroxiredoxin family. We have determined the crystal structure of both reduced and disulfide-bonded, as well as a resolving cysteine mutant of human PrxIV. We show that PrxIV has a similar structure to other typical 2-Cys peroxiredoxins and undergoes a conformational change from a fully folded to a locally unfolded form following the formation of a disulfide between the peroxidatic and resolving cysteine residues. Unlike other mammalian typical 2-Cys peroxiredoxins, we show that human PrxIV forms a stable decameric structure even in its disulfide-bonded state. In addition, the structure of a resolving cysteine mutant reveals an intermediate in the reaction cycle that adopts the locally unfolded conformation. Interestingly the peroxidatic cysteine in the crystal structure is sulfenylated rather than sulfinylated or sulfonylated. In addition, the peroxidatic cysteine in the resolving cysteine mutant is resistant to hyper-oxidation following incubation with high concentrations of hydrogen peroxide. These results high-light some unique properties of PrxIV and suggest that the equilibrium between the fully folded and locally unfolded forms favors the locally unfolded conformation upon sulfenylation of the peroxidatic cysteine residue.	[Cao, Zhenbo; Tavender, Timothy J.; Cogdell, Richard J.; Bulleid, Neil J.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Roszak, Aleksander W.] Univ Glasgow, WestCHEM, Sch Chem, Coll Sci & Engn, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Bulleid, NJ (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.	neil.bulleid@glasgow.ac.uk		Bulleid, Neil/0000-0002-9839-5279	Wellcome Trust [88053]; Scottish University Life Science Alliance	Wellcome Trust(Wellcome TrustEuropean Commission); Scottish University Life Science Alliance	The work was supported by grants from the Wellcome Trust (Grant 88053) and the Scottish University Life Science Alliance (to N. J. B.).	Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; *COMP COLL PROJ 4, 1994, ACTA CRYSTALLOGR D, V50, P760; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hall A, 2010, J MOL BIOL, V402, P194, DOI 10.1016/j.jmb.2010.07.022; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Ikeda Y, 2010, PROTEIN EXPRES PURIF, V72, P1, DOI 10.1016/j.pep.2010.02.001; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MACER DRJ, 1988, J CELL SCI, V91, P61; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	37	61	62	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42257	42266		10.1074/jbc.M111.298810	http://dx.doi.org/10.1074/jbc.M111.298810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994946	hybrid, Green Published			2022-12-27	WOS:000298180900035
J	Agarwal, S; Agarwal, S; Pancholi, P; Pancholi, V				Agarwal, Shivani; Agarwal, Shivangi; Pancholi, Preeti; Pancholi, Vijay			Role of Serine/Threonine Phosphatase (SP-STP) in Streptococcus pyogenes Physiology and Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; FATTY-ACID BIOSYNTHESIS; GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; EUKARYOTIC-TYPE; REGULATORY NETWORKS; SIGNAL-TRANSDUCTION; GENE-REGULATION; PROTEIN-KINASE; CELL-SHAPE	Reversible phosphorylation is the key mechanism regulating several cellular events in prokaryotes and eukaryotes. In prokaryotes, signal transduction is perceived to occur primarily via the two-component signaling system involving histidine kinases and cognate response regulators. Although an alternative regulatory pathway controlled by the eukaryote-type serine/threonine kinase (Streptococcus pyogenes serine/threonine kinase; SP-STK) has been shown to modulate bacterial growth, division, adherence, invasion, and virulence in group A Streptococcus (GAS; S. pyogenes), the precise role of the co-transcribing serine/threonine phosphatase (SP-STP) has remained enigmatic. In this context, this is the first report describing the construction and characterization of non-polar SP-STP mutants in two different strains of Type M1 GAS. The STP knock-out mutants displayed increased bacterial chain lengths in conjunction with thickened cell walls, significantly reduced capsule and hemolysin production, and restoration of the phenotypes postcomplementation. The present study also reveals important contribution of cognately regulated-reversible phosphorylation by SP-STK/SP-STP on two major response regulators of two-component systems, WalRK and CovRS. We also demonstrate a distinct role of SP-STP in terms of expression of surface proteins and SpeB in a strain-specific manner. Further, the attenuation of virulence in the absence of SIP and its restoration only in the complemented strains that were generated by the use of a low copy plasmid and not by a high copy one emphasize not only the essential role of STP in virulence but also highlight the tightly regulated SP-STP/SP-STK-mediated cognate functions. SP-STP thus is an important regulator of GAS virulence and plays a critical role in GAS pathogenesis.	[Agarwal, Shivani; Agarwal, Shivangi; Pancholi, Preeti; Pancholi, Vijay] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Pancholi, V (corresponding author), 420 W 12th Ave,TMRF 288A, Columbus, OH 43210 USA.	Vijay.Pancholi@osumc.edu	Pancholi, Vijay/E-3810-2011	Agarwal, Shivangi/0000-0002-2406-7678	National Institutes of Health [AI-64912, AI-76889]; Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076889, R21AI064912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University(Ohio State University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-64912 and AI-76889 (to V. P.). This work was also supported by Ohio State University departmental funds (to P. P.).	Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Balemans W, 2010, NATURE, V463, pE3, DOI 10.1038/nature08667; Banu LD, 2010, INFECT IMMUN, V78, P2209, DOI 10.1128/IAI.01167-09; Barendt SM, 2009, J BACTERIOL, V191, P3024, DOI 10.1128/JB.01505-08; Barnett TC, 2007, J BACTERIOL, V189, P1866, DOI 10.1128/JB.01658-06; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Bugrysheva J, 2011, INFECT IMMUN, V79, P4201, DOI 10.1128/IAI.05360-11; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Choi KH, 2000, J BACTERIOL, V182, P365, DOI 10.1128/JB.182.2.365-370.2000; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fozo EA, 2004, APPL ENVIRON MICROB, V70, P929, DOI 10.1128/AEM.70.2.929-936.2004; Fozo EM, 2007, INFECT IMMUN, V75, P1537, DOI 10.1128/IAI.01938-06; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Jin H, 2011, MBIO, V2, DOI 10.1128/mBio.00068-11; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; McIver KS, 2009, CONTRIB MICROBIOL, V16, P103, DOI 10.1159/000219375; Musser JM, 2009, J CLIN INVEST, V119, P2455, DOI 10.1172/JCI38095; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pancholi V, 2010, J BIOL CHEM, V285, P30861, DOI 10.1074/jbc.M110.153825; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; Ravins M, 2000, J INFECT DIS, V182, P1702, DOI 10.1086/317635; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sun Y, 2010, INFECT IMMUN, V78, P4667, DOI 10.1128/IAI.00546-10; Treuner-Lange A, 2001, MOL MICROBIOL, V40, P126, DOI 10.1046/j.1365-2958.2001.02362.x; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Wehenkel A, 2007, J MOL BIOL, V374, P890, DOI 10.1016/j.jmb.2007.09.076; Winkler ME, 2008, J BACTERIOL, V190, P2645, DOI 10.1128/JB.01682-07; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	48	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41368	41380		10.1074/jbc.M111.286690	http://dx.doi.org/10.1074/jbc.M111.286690			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21917918	Green Published, hybrid			2022-12-27	WOS:000298057500024
J	Bhalla, K; Hwang, BJ; Choi, JH; Dewi, R; Ou, LH; Mclenithan, J; Twaddel, W; Pozharski, E; Stock, J; Girnum, GD				Bhalla, Kavita; Hwang, Bor Jang; Choi, Jang Hyun; Dewi, Ruby; Ou, Lihui; Mclenithan, John; Twaddel, William; Pozharski, Edwin; Stock, Jeffry; Girnum, Geoffrey D.			N-Acetylfarnesylcysteine Is a Novel Class of Peroxisome Proliferator-activated Receptor gamma Ligand with Partial and Full Agonist Activity in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; ADIPOSE-TISSUE MACROPHAGES; TYPE-2 DIABETES-MELLITUS; PPAR-GAMMA; INSULIN-RESISTANCE; ADIPOCYTE DIFFERENTIATION; FATTY-ACIDS; METABOLIC DISEASE; GENE-EXPRESSION; BINDING DOMAIN	The thiazolidedione (TZD) class of drugs is clinically approved for the treatment of type 2 diabetes. The therapeutic actions of TZDs are mediated via activation of peroxisome proliferator-activated receptor gamma (PPAR gamma). Despite their widespread use, concern exists regarding the safety of currently used TZDs. This has prompted the development of selective PPAR gamma modulators (SPPARMs), compounds that promote glucose homeostasis but with reduced side effects due to partial PPAR gamma agonism. However, this also results in partial agonism with respect to PPAR gamma target genes promoting glucose homeostasis. Using a gene expression-based screening approach we identified N-acetylfarnesylcysteine (AFC) as both a full and partial agonist depending on the PPAR gamma target gene (differential SPPARM). AFC activated PPAR gamma as effectively as rosiglitazone with regard to Adrp, Angpt14, and AdipoQ, but was a partial agonist of aP2, a PPAR gamma target gene associated with increased adiposity. Induction of adipogenesis by AFC was also attenuated compared with rosiglitazone. Reporter, ligand binding assays, and dynamic modeling demonstrate that AFC binds and activates PPAR gamma in a unique manner compared with other PPAR gamma ligands. Importantly, treatment of mice with AFC improved glucose tolerance similar to rosiglitazone, but AFC did not promote weight gain to the same extent. Finally, AFC had effects on adipose tissue remodeling similar to those of rosiglitazone and had enhanced antiinflammatory effects. In conclusion, we describe a new approach for the identification of differential SPPARMs and have identified AFC as a novel class of PPAR gamma ligand with both full and partial agonist activity in vitro and in vivo.	[Bhalla, Kavita; Dewi, Ruby; Ou, Lihui; Girnum, Geoffrey D.] Harvard Univ, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Boston, MA 02215 USA; [Hwang, Bor Jang; Girnum, Geoffrey D.] Harvard Univ, Sch Med, Dept Biochem & Mol Biol, Boston, MA 02215 USA; [Choi, Jang Hyun] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Mclenithan, John] Univ Maryland, Sch Med, Dept Endocrinol, Baltimore, MD 21201 USA; [Twaddel, William] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Pozharski, Edwin] Univ Maryland, Sch Med, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Stock, Jeffry] Princeton Univ, Dept Mol Biol, Princeton, NJ 08554 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Princeton University	Girnum, GD (corresponding author), Univ Maryland Greenebaum Canc Ctr, Dept Biochem & Mol Biol, 655 W Baltimore St,BRB Rm 10-039, Baltimore, MD 21201 USA.	ggirnun@som.umaryland.edu	Pozharski, Edwin/AAM-7692-2020	Pozharski, Edwin/0000-0001-7012-5376	National Institutes of Health [K01DK064685]; Maryland Cigarette Restitution Fund; University of Maryland Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064685, P30DK072488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund; University of Maryland Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported, in whole or in part, by National Institutes of Health Grant K01DK064685. This work was also supported by Maryland Cigarette Restitution Fund and a pilot grant from the University of Maryland Nutrition Obesity Research Center (to G.D.G).	Acton JJ, 2005, BIOORG MED CHEM LETT, V15, P357, DOI 10.1016/j.bmcl.2004.10.068; Anghel SI, 2007, CELL RES, V17, P486, DOI 10.1038/cr.2007.48; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Balint B. L., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P33; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Camp HS, 1997, J BIOL CHEM, V272, P10811; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Einstein M, 2008, MOL PHARMACOL, V73, P62, DOI 10.1124/mol.107.041202; Elbrecht A, 1999, J BIOL CHEM, V274, P7913, DOI 10.1074/jbc.274.12.7913; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Gordon JS, 2008, J INVEST DERMATOL, V128, P643, DOI 10.1038/sj.jid.5701061; Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kolak M, 2007, J CLIN ENDOCR METAB, V92, P720, DOI 10.1210/jc.2006-1465; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Marathe C, 2009, J LIPID RES, V50, P214, DOI 10.1194/jlr.M800189-JLR200; Mizuno CS, 2008, CURR MED CHEM, V15, P61; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V286, P735, DOI 10.1006/bbrc.2001.5460; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Phillips SA, 2005, OBES RES, V13, P1321, DOI 10.1038/oby.2005.160; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Rangwala Shamina M, 2002, Sci STKE, V2002, ppe9, DOI 10.1126/stke.2002.121.pe9; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Schwartz AV, 2008, PPAR RES, V2008, DOI 10.1155/2008/297893; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Shearer BG, 2007, BBA-MOL CELL BIOL L, V1771, P1082, DOI 10.1016/j.bbalip.2007.05.005; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Targett-Adams P, 2005, BBA-GENE STRUCT EXPR, V1728, P95, DOI 10.1016/j.bbaexp.2005.01.017; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; VOLKER C, 1991, J BIOL CHEM, V266, P21515; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Walkey CJ, 2008, J BIOL CHEM, V283, P24290, DOI 10.1074/jbc.C800139200; Watkins PB, 1998, NEW ENGL J MED, V338, P916, DOI 10.1056/NEJM199803263381314; Wellen KE, 2004, ENDOCRINOLOGY, V145, P2214, DOI 10.1210/en.2003-1580; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000	75	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41626	41635		10.1074/jbc.M111.257915	http://dx.doi.org/10.1074/jbc.M111.257915			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21979952	Green Published, hybrid			2022-12-27	WOS:000298057500047
J	Bedekovics, T; Li, HQ; Gajdos, GB; Isaya, G				Bedekovics, Tibor; Li, Hongqiao; Gajdos, Gabriella B.; Isaya, Grazia			Leucine Biosynthesis Regulates Cytoplasmic Iron-Sulfur Enzyme Biogenesis in an Atm1p-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER ATM1P; CYTOSOLIC FE/S PROTEINS; SACCHAROMYCES-CEREVISIAE; YEAST FRATAXIN; CLUSTER BIOGENESIS; IN-VITRO; EXPRESSION; MATURATION; MITOCHONDRIA; ACONITASE	Fe-S clusters (ISCs) are versatile cofactors utilized by many mitochondrial, cytoplasmic, and nuclear enzymes. Whereas mitochondria can independently initiate and complete ISC synthesis, other cellular compartments are believed to assemble ISCs from putative precursors exported from the mitochondria via an ATP binding cassette (ABC) transporter conserved from yeast (Atm1p) to humans (ABCB7). However, the regulatory interactions between mitochondrial and extramitochondrial ISC synthesis are largely unknown. In yeast, we found that mitochondrial ISC synthesis is regulated by the leucine biosynthetic pathway, which among other proteins involves an abundant cytoplasmic [4Fe-4S] enzyme, Leu1p. Enzymatic blocks in the pathway (i.e. leu1 Delta or leu2 Delta gene deletion mutations) induced post-transcriptional up-regulation of core components of mitochondrial ISC biosynthesis (i.e. the sulfur donor Nfs1p, the iron donor Yfh1p, and the ISC scaffold Isu1p). In leu2 Delta cells, transcriptional mechanisms also led to dramatic up-regulation of Leu1p with concomitant down-regulation of mitochondrial aconitase (Aco1p), a [4Fe-4S] enzyme in the tricarboxylic acid cycle. Accordingly, the leu2 Delta deletion mutation exacerbated Aco1p inactivation in cells with mutations in Yfh1p. These data indicate that defects in leucine biosynthesis promote the biogenesis of enzymatically active Leu1p at the expense of Aco1p activity. Surprisingly, this effect is independent of Atm1p; previous reports linking the loss of Leu1p activity to Atm1p depletion were confounded by the fact that LEU2 was used as a selectable marker to create Atm1p-depleted cells, whereas a leu2 Delta allele was present in Atm1p-repleted controls. Thus, still largely unknown transcriptional and post-transcriptional mechanisms control ISC distribution between mitochondria and other cellular compartments.	[Bedekovics, Tibor; Li, Hongqiao; Isaya, Grazia] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Bedekovics, Tibor; Li, Hongqiao; Isaya, Grazia] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Gajdos, Gabriella B.] Mayo Clin, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), Mayo Clin, Dept Pediat & Adolescent Med, 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health [AG15709]; Friedreich Ataxia Research Alliance and Muscular Dystrophy Association; Mayo Clinic Department of Pediatric and Adolescent Medicine; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich Ataxia Research Alliance and Muscular Dystrophy Association; Mayo Clinic Department of Pediatric and Adolescent Medicine; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15709 (to G. I.). This work was also supported by grants from the Friedreich Ataxia Research Alliance and Muscular Dystrophy Association (to G. I.) and the Mayo Clinic Department of Pediatric and Adolescent Medicine (to T. B. and H. L).	Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Boer VM, 2005, FEMS YEAST RES, V5, P885, DOI 10.1016/j.femsyr.2005.04.003; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chloupkova M, 2004, FEBS LETT, V569, P65, DOI 10.1016/j.febslet.2004.05.051; DAUM G, 1982, J BIOL CHEM, V257, P3028; Desmyter L, 2004, EXP GERONTOL, V39, P707, DOI 10.1016/j.exger.2004.01.008; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Fansler B., 1969, METHODS ENZYMOL, V13, P26; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hellauer K, 1996, MOL CELL BIOL, V16, P6096; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KOHLHAW GB, 1988, METHOD ENZYMOL, V166, P429; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Prohl C, 2000, METHOD ENZYMOL, V324, P365; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; SIKORSKI RS, 1989, GENETICS, V122, P19; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; SZE JY, 1992, SCIENCE, V258, P1143, DOI 10.1126/science.1439822; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798	51	17	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40878	40888		10.1074/jbc.M111.270082	http://dx.doi.org/10.1074/jbc.M111.270082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21926174	hybrid, Green Published			2022-12-27	WOS:000297315400048
J	Buurman, ET; Andrews, B; Gao, N; Hu, J; Keating, TA; Lahiri, S; Otterbein, LR; Patten, AD; Stokes, SS; Shapiro, AB				Buurman, Ed T.; Andrews, Beth; Gao, Ning; Hu, Jun; Keating, Thomas A.; Lahiri, Sushmita; Otterbein, Ludovic R.; Patten, Arthur D.; Stokes, Suzanne S.; Shapiro, Adam B.			In Vitro Validation of Acetyltransferase Activity of GlmU as an Antibacterial Target in Haemophilus influenzae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE; GENE; CHALLENGES; INHIBITORS; PROTEIN; SITE	GlmU is a bifunctional enzyme that is essential for bacterial growth, converting D-glucosamine 1-phosphate into UDP-GlicNAc via acetylation and subsequent uridyl transfer. A biochemical screen of AstraZeneca's compound library using GlmU of Escherichia coli identified novel sulfonamide inhibitors of the acetyltransferase reaction. Steady-state kinetics, ligand-observe NMR, isothermal titration calorimetry, and x-ray crystallography showed that the inhibitors were competitive with acetyl-CoA substrate. Iterative chemistry efforts improved biochemical potency against Gram-negative isozymes 300-fold and afforded antimicrobial activity against a strain of Haemophilus influenzae lacking its major efflux pump. Inhibition of precursor incorporation into bacterial macromolecules was consistent with the antimicrobial activity being caused by disruption of peptidoglycan and fatty acid biosyntheses. Isolation and characterization of two different resistant mutant strains identified the GlmU acetyltransferase domain as the molecular target. These data, along with x-ray co-crystal structures, confirmed the binding mode of the inhibitors and explained their relative lack of potency against Gram-positive GlmU isozymes. This is the first example of antimicrobial compounds mediating their growth inhibitory effects specifically via Glut U.	[Buurman, Ed T.; Andrews, Beth; Gao, Ning; Hu, Jun; Keating, Thomas A.; Lahiri, Sushmita; Patten, Arthur D.; Stokes, Suzanne S.; Shapiro, Adam B.] AstraZeneca R&D Boston, Infect Innovat Med Unit, Waltham, MA 02451 USA; [Otterbein, Ludovic R.] AstraZeneca, Discovery Enabling Capabil & Sci, Macclesfield SK10 4TG, Cheshire, England	AstraZeneca; AstraZeneca	Buurman, ET (corresponding author), AstraZeneca R&D Boston, Infect Innovat Med Unit, 35 Gatehouse Dr, Waltham, MA 02451 USA.	Ed.Buurman@astrazeneca.com	Fan, Jianqing/B-2115-2008	Shapiro, Adam/0000-0002-2662-6146; Gao, Ning/0000-0003-1605-4137				ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; Bazan JA, 2010, DRUG TODAY, V46, P743, DOI 10.1358/dot.2010.46.10.1519172; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Buurman ET, 2006, ANTIMICROB AGENTS CH, V50, P385, DOI 10.1128/AAC.50.1.385-387.2006; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE, V29; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Gehring AM, 1996, BIOCHEMISTRY-US, V35, P579, DOI 10.1021/bi952275a; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; Hogberg LD, 2010, TRENDS PHARMACOL SCI, V31, P509, DOI 10.1016/j.tips.2010.08.002; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; Mochalkin I, 2008, PROTEIN SCI, V17, P577, DOI 10.1110/ps.073271408; Olsen LR, 2007, PROTEIN SCI, V16, P1230, DOI 10.1110/ps.072779707; Pereira MP, 2009, ANTIMICROB AGENTS CH, V53, P2306, DOI 10.1128/AAC.01572-08; Pioli D., 1999, WIPO Pat., Patent No. [W0/1999/005297, 1999005297]; Saeed-Kothe A, 2004, APPL ENVIRON MICROB, V70, P4136, DOI 10.1128/AEM.70.7.4136-4143.2004; Sanchez L, 1997, J BACTERIOL, V179, P6855, DOI 10.1128/jb.179.21.6855-6857.1997; Scott K. S., 1995, J AM CHEM SOC, V117, P4199; Segel I. H., 1993, ENZYME KINETICS BEHA; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; WALKER JE, 1984, BIOCHEM J, V224, P799, DOI 10.1042/bj2240799	24	34	35	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40734	40742		10.1074/jbc.M111.274068	http://dx.doi.org/10.1074/jbc.M111.274068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21984832	Green Published, hybrid			2022-12-27	WOS:000297315400034
J	Fan, YB; Guo, YH; Hamblin, M; Chang, L; Zhang, JF; Chen, YE				Fan, Yanbo; Guo, Yanhong; Hamblin, Milton; Chang, Lin; Zhang, Jifeng; Chen, Y. Eugene			Inhibition of Gluconeogenic Genes by Calcium-regulated Heat-stable Protein 1 via Repression of Peroxisome Proliferator-activated Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK PROTEIN; FREE FATTY-ACIDS; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; TRANSCRIPTIONAL COACTIVATOR; PHYSIOLOGICAL SUBSTRATE; HEPATIC GLUCONEOGENESIS; PPAR; IDENTIFICATION; PHOSPHORYLATION	Gluconeogenesis contributes to insulin resistance in type 1 and type 2 diabetes, but its regulation and the underlying molecular mechanisms remain unclear. Recently, calcium-regulated heat-stable protein 1 (CARHSP1) was identified as a biomarker for diabetic complications. In this study, we investigated the role of CARHSP1 in hepatic gluconeogenesis. We assessed the regulation of hepatic CARHSP1 expression under conditions of fasting and refeeding. Adenovirus-mediated CARHSP1 overexpression and siRNA-mediated knockdown experiments were performed to characterize the role of CARHSP1 in the regulation of gluconeogenic gene expression. Here, we document for the first time that CARHSP1 is regulated by nutrient status in the liver and functions at the transcriptional level to negatively regulate gluconeogenic genes, including the glucose-6-phosphatase catalytic subunit (G6Pc) and phosphoenolpyruvate carboxykinase 1 (PEPCK1). In addition, we found that CARHSP1 can physically interact with peroxisome proliferator-activated receptor-alpha (PPAR alpha) and inhibit its transcriptional activity. Both pharmacological and genetic ablations of PPAR alpha attenuate the inhibitory effect of CARHSP1 on gluconeogenic gene expression in hepatocytes. Our data suggest that CARHSP1 inhibits hepatic gluconeogenic gene expression via repression of PPARa and that CARHSP1 may be a molecular target for the treatment of diabetes.	[Fan, Yanbo; Guo, Yanhong; Hamblin, Milton; Chang, Lin; Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Med Ctr, Cardiovasc Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chen, YE (corresponding author), Univ Michigan, Med Ctr, Cardiovasc Ctr, Dept Internal Med, MSRB 3 7200,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	echenum@umich.edu	Fan, Yanbo/C-6360-2013; Fan, Yanbo/AAD-4710-2020; Guo, Yanhong/D-9764-2012; GUO, Yanhong/B-5325-2012	Fan, Yanbo/0000-0002-3845-7562; Fan, Yanbo/0000-0002-3845-7562; 	National Institutes of Health [HL068878, HL105114, HL089544]; American Heart Association [10POST3270008, 09SDG2230270, 0835237N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089544, R01HL068878, R01HL105114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068878, HL105114, and HL089544 (to Y. E. C.). This work was also supported by American Heart Association Grants 10POST3270008 (Y. F.), 09SDG2230270 (L. C.), and 0835237N (J. Z.).	Aoyama H, 2006, INT J MOL MED, V18, P433; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Auld GC, 2005, BIOCHEM J, V389, P775, DOI 10.1042/BJ20050733; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Boden G, 2001, AM J PHYSIOL-ENDOC M, V280, pE23, DOI 10.1152/ajpendo.2001.280.1.E23; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen XH, 1999, J CLIN INVEST, V103, P365, DOI 10.1172/JCI5479; Dietrich CG, 2007, AM J PHYSIOL-GASTR L, V293, pG585, DOI 10.1152/ajpgi.00175.2007; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Freeman WM, 2010, PHARMACOGENOMICS J, V10, P385, DOI 10.1038/tpj.2009.60; Groblewski GE, 1998, J BIOL CHEM, V273, P22738, DOI 10.1074/jbc.273.35.22738; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hall Robert K., 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P119; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hou H, 2011, J BIOL CHEM, V286, P9623, DOI 10.1074/jbc.M110.177436; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Im SS, 2011, J BIOL CHEM, V286, P1157, DOI 10.1074/jbc.M110.157875; Jay MA, 2007, CURR DIABETES REV, V3, P33, DOI 10.2174/157339907779802067; Kaestner KH, 2008, CELL METAB, V8, P449, DOI 10.1016/j.cmet.2008.11.003; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; Lee SH, 2009, BIOCHEM BIOPH RES CO, V385, P413, DOI 10.1016/j.bbrc.2009.05.096; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Nakaminami K, 2006, P NATL ACAD SCI USA, V103, P10122, DOI 10.1073/pnas.0603168103; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Perriello G, 1997, DIABETES, V46, P1010, DOI 10.2337/diabetes.46.6.1010; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Schafer C, 2003, AM J PHYSIOL-GASTR L, V285, pG726, DOI 10.1152/ajpgi.00111.2003; SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zeeb M, 2003, PROTEIN SCI, V12, P112, DOI 10.1110/ps.0219703	47	13	13	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40584	40594		10.1074/jbc.M111.232918	http://dx.doi.org/10.1074/jbc.M111.232918			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21990353	hybrid, Green Published			2022-12-27	WOS:000297315400018
J	Lachance, V; Cartier, A; Genier, S; Munger, S; Germain, P; Labrecque, P; Parent, JL				Lachance, Veronik; Cartier, Andreane; Genier, Samuel; Munger, Sandra; Germain, Pascale; Labrecque, Pascale; Parent, Jean-Luc			Regulation of beta(2)-Adrenergic Receptor Maturation and Anterograde Trafficking by an Interaction with Rab Geranylgeranyltransferase MODULATION OF Rab GERANYLGERANYLATION BY THE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROSTACYCLIN RECEPTOR; TRANS-GOLGI NETWORK; GTP-BINDING; GTPASES; ASSOCIATION; PROTEINS; COMPLEX; DISSOCIATION; TRANSFERASE; INTERNALIZATION	Previous reports by us and others demonstrated that G protein-coupled receptors interact functionally with Rab GTPases. Here, we show that the beta(2)-adrenergic receptor (beta(2)AR) interacts with the Rab geranylgeranyltransferase alpha-subunit (RGGTA). Confocal microscopy showed that beta(2)AR co-localizes with RGGTA in intracellular compartments and at the plasma membrane. Site-directed mutagenesis revealed that RGGTA binds to the (LL340)-L-339 motif in the beta(2)AR C terminus known to be involved in the transport of the receptor from the endoplasmic reticulum to the cell surface. Modulation of the cellular levels of RGGTA protein by overexpression or siRNA-mediated knockdown of the endogenous protein demonstrated that RGGTA has a positive role in the maturation and anterograde trafficking of the beta(2)AR, which requires the interaction of RGGTA with the beta(2)AR (LL340)-L-339 motif. Furthermore, the beta(2)AR modulates the geranylgeranylation of Rab6a, Rab8a, and Rab Ha, but not of other Rab proteins tested in this study. Regulation of Rab geranylgeranylation by the beta(2)AR was dependent on the RGGTA-interacting (LL340)-L-339 motif. Interestingly, a RGGTA-Y107F mutant was unable to regulate Rab geranylgeranylation but still promoted beta(2)AR maturation, suggesting that RGGTA may have functions independent of Rab geranylgeranylation. We demonstrate for the first time an interaction between a transmembrane receptor and RGGTA which regulates the maturation and anterograde transport of the receptor, as well as geranylgeranylation of Rab GTPases.	[Parent, Jean-Luc] Univ Sherbrooke, Serv Rhumatol, Fac Med, Inst Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, Serv Rhumatol, Fac Med & Sci Sante, Ctr Rech Clin Etienne Le Bel,Dept Med, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke	Parent, JL (corresponding author), Univ Sherbrooke, Serv Rhumatol, Fac Med, Inst Pharmacol, 3001,12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	jean-luc.parent@usherbrooke.ca			Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institutes of Health Research (to J.-L. P).; Recipient of a Chercheur boursier-Senior salary award from the Fonds de la Recherche en Sante du Quebec and holder of the Andre-Lussier Research Chair during this work. To whom correspondence should be addressed: Service de Rhumatologie, Faculte de Medecine, 3001, 12<SUP>e</SUP> Avenue Nord, Sherbrooke, QC, Canada J1H 5N4. Tel.: 1-819-564-5264; Fax: 1-819-564-5265; E-mail: jean-luc.parent@usherbrooke.ca.	Anant JS, 1998, BIOCHEMISTRY-US, V37, P12559, DOI 10.1021/bi980881a; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Baron RA, 2008, BIOCHEM J, V415, P67, DOI 10.1042/BJ20080662; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Costanzi S, 2009, CURR PHARM DESIGN, V15, P3994, DOI 10.2174/138161209789824795; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Esseltine JL, 2011, MOL PHARMACOL, V79, P175, DOI 10.1124/mol.110.068379; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Gabilondo AM, 1997, P NATL ACAD SCI USA, V94, P12285, DOI 10.1073/pnas.94.23.12285; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Goalstone ML, 2001, J BIOL CHEM, V276, P12805, DOI 10.1074/jbc.M009443200; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Gromov P, 1998, ELECTROPHORESIS, V19, P1803, DOI 10.1002/elps.1150191043; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Kametaka S, 2010, J CELL SCI, V123, P460, DOI 10.1242/jcs.055103; Khandelwal P, 2008, P NATL ACAD SCI USA, V105, P15773, DOI 10.1073/pnas.0805636105; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; O'Keeffe MB, 2008, BBA-MOL CELL RES, V1783, P1914, DOI 10.1016/j.bbamcr.2008.04.010; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Reid HM, 2010, J BIOL CHEM, V285, P18709, DOI 10.1074/jbc.M110.106476; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Seachrist JL, 2002, J BIOL CHEM, V277, P679, DOI 10.1074/jbc.M109022200; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Smythe E, 2002, MOL CELL, V9, P205, DOI 10.1016/S1097-2765(02)00462-8; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; Theriault C, 2004, BIOCHEMISTRY-US, V43, P5600, DOI 10.1021/bi036268v; Thoma NH, 2001, J BIOL CHEM, V276, P48637, DOI 10.1074/jbc.M108241200; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Wikstrom K, 2008, CELL SIGNAL, V20, P2332, DOI 10.1016/j.cellsig.2008.09.003; Young J, 2005, MOL BIOL CELL, V16, P162, DOI 10.1091/mbc.E04-03-0260; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460	53	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40802	40813		10.1074/jbc.M111.267815	http://dx.doi.org/10.1074/jbc.M111.267815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21990357	hybrid, Green Published			2022-12-27	WOS:000297315400041
J	Borjesson, SI; Englund, UH; Asif, MH; Willander, M; Elinder, F				Borjesson, Sara I.; Englund, Ulrika H.; Asif, Muhammad H.; Willander, Magnus; Elinder, Fredrik			Intracellular K+ Concentration Decrease Is Not Obligatory for Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION CHANNELS VDAC; CELL-DEATH; NEURONAL APOPTOSIS; CASPASE ACTIVATION; VOLUME DECREASE; ION CHANNELS; FLUXES; CONFORMATIONS; CYTOSKELETON	K+ efflux is observed as an early event in the apoptotic process in various cell types. Loss of intracellular K+ and subsequent reduction in ionic strength are suggested to release the inhibition of proapoptotic caspases. In this work, a new K+-specific microelectrode was used to study possible alterations in intracellular K+ in Xenopus laevis oocytes during chemically induced apoptosis. The accuracy of the microelectrode to detect changes in intracellular K+ was verified with parallel electrophysiological measurements. In concordance with previous studies on other cell types, apoptotic stimuli reduced the intracellular K+ concentration in Xenopus oocytes and increased caspase-3 activity. The reduction in intracellular K+ was prevented by dense expression of voltage-gated K (Kv) channels. Despite this, the caspase-3 activity was increased similarly in Kv channel-expressing oocytes as in oocytes not expressing Kv channels. Thus, in Xenopus oocytes caspase-3 activity is not dependent on the intracellular concentration of K+	[Borjesson, Sara I.; Englund, Ulrika H.; Elinder, Fredrik] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, SE-58185 Linkoping, Sweden; [Asif, Muhammad H.; Willander, Magnus] Linkoping Univ, Dept Sci & Technol, SE-58185 Linkoping, Sweden	Linkoping University; Linkoping University	Elinder, F (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Campus Norrkoping, SE-58185 Linkoping, Sweden.	fredrik.elinder@liu.se	Liin, Sara/I-2941-2012	Elinder, Fredrik/0000-0001-9125-5583; Liin, Sara/0000-0001-8493-0114	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Brain Foundation; County Council of Ostergotland, King Gustaf V and Queen Victoria's Freemasons Foundation; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Brain Foundation; County Council of Ostergotland, King Gustaf V and Queen Victoria's Freemasons Foundation; Swedish Society for Medical Research	This work was supported by the Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Brain Foundation, the County Council of Ostergotland, King Gustaf V and Queen Victoria's Freemasons Foundation, and the Swedish Society for Medical Research.	Akanda N, 2008, CELL CYCLE, V7, P3225, DOI 10.4161/cc.7.20.6831; Ali S. M. U., 2010, NANOTECHNOLOGY IEEE, V10, P913; Arrebola F, 2005, APOPTOSIS, V10, P1317, DOI 10.1007/s10495-005-2718-x; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; BARBIERO G, 1995, EXP CELL RES, V217, P410, DOI 10.1006/excr.1995.1104; Borjesson SI, 2008, CELL BIOCHEM BIOPHYS, V52, P149, DOI 10.1007/s12013-008-9032-5; Borjesson SI, 2010, BIOPHYS J, V98, P396, DOI 10.1016/j.bpj.2009.10.026; Bortner CD, 2008, J BIOL CHEM, V283, P7219, DOI 10.1074/jbc.M707809200; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Colina C, 2002, BIOCHEM J, V362, P247, DOI 10.1042/0264-6021:3620247; Dallas ML, 2011, FASEB J, V25, P1519, DOI 10.1096/fj.10-173450; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; HEGINBOTHAM L, 1993, BIOPHYS J, V65, P2089, DOI 10.1016/S0006-3495(93)81244-X; Hernandez-Enriquez B, 2010, NEUROSCIENCE, V167, P298, DOI 10.1016/j.neuroscience.2010.01.046; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Izyumov DS, 2004, BBA-BIOENERGETICS, V1658, P141, DOI 10.1016/j.bbabio.2004.05.007; Johnson CE, 2010, CELL DEATH DIFFER, V17, P170, DOI 10.1038/cdd.2009.120; Krumschnabel G, 2007, APOPTOSIS, V12, P1755, DOI 10.1007/s10495-007-0103-7; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; O'Reilly N, 2002, BRAIN RES, V943, P245, DOI 10.1016/S0006-8993(02)02655-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Small DL, 2002, NEUROSCI LETT, V334, P95, DOI 10.1016/S0304-3940(02)01107-2; Thompson GJ, 2001, BIOCHEM J, V357, P137, DOI 10.1042/0264-6021:3570137; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vanagas L, 2007, BBA-BIOMEMBRANES, V1768, P1641, DOI 10.1016/j.bbamem.2007.03.012; Wang L, 1999, J BIOL CHEM, V274, P3678, DOI 10.1074/jbc.274.6.3678; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yurinskaya VE, 2011, J PHYSIOL-LONDON, V589, P2197, DOI 10.1113/jphysiol.2011.207571	33	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39823	39828		10.1074/jbc.M111.262725	http://dx.doi.org/10.1074/jbc.M111.262725			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949184	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000296925700016
J	Huang, SB; Yang, ZNJ; Yu, CR; Sinicrope, FA				Huang, Shengbing; Yang, Zhineng J.; Yu, Chunrong; Sinicrope, Frank A.			Inhibition of mTOR Kinase by AZD8055 Can Antagonize Chemotherapy-induced Cell Death through Autophagy Induction and Down-regulation of p62/Sequestosome 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER CELLS; MAMMALIAN TARGET; COLORECTAL-CANCER; APOPTOSIS; PHOSPHORYLATION; ACTIVATION; GROWTH; TUMORIGENESIS; DEGRADATION; CASPASE-8	AZD8055 is an ATP-competitive inhibitor of mammalian target of rapamycin (mTOR) that forms two multiprotein complexes, mTORC1 and mTORC2, and negatively regulates autophagy. We demonstrate that AZD8055 stimulates and potentiates chemotherapy-mediated autophagy, as shown by LC3I-II conversion and down-regulation of the ubiquitin-binding protein p62/sequestosome 1. AZD8055-induced autophagy was pro-survival as shown by its ability to attenuate cell death and DNA damage (p-H2AX), and to enhance clonogenic survival by cytotoxic chemotherapy. Autophagy inhibition by siRNA against Beclin 1 or LC3B, or by chloroquine, partially reversed the cytoprotective effect of AZD8055 that was independent of cell cycle inhibition. The pro-survival role of autophagy was confirmed using ectopic expression of Beclin 1 that conferred cytoprotection. To determine whether autophagy-mediated down-regulation of p62/sequestosome 1 contributes to its pro-survival role, we generated p62 knockdown cells using shRNA that showed protection from chemotherapy-induced cell death and DNA damage. We also overexpressed wild-type (wt) p62 that promoted chemotherapy-induced cell death, whereas mutated p62 at functional domains (PB1, UBA) failed to do so. The ability of ectopic wt p62 to promote cell death was blocked by AZD8055. AZD8055 was shown to inhibit phosphorylation of the autophagy-initiating kinase ULK1 at Ser(757) and inhibited known targets of mTORC1 (p-mTOR Ser(2448), p70S6K, p-S6, p4EBP1) and mTORC2 (p-mTOR Ser(2481), p-AKT Ser(473)). Knockdown of mTOR, but not Raptor or Rictor, reduced p-ULK1 at Ser(757) and enhanced chemotherapy-induced autophagy that resulted in a similar cytoprotective effect as shown for AZD8055. In conclusion, AZD8055 inhibits mTOR kinase and ULK1 phosphorylation to induce autophagy whose pro-survival effect is due, in part, to down-regulation of p62.	[Sinicrope, Frank A.] Mayo Clin, Rochester, MN 55905 USA; Mayo Canc Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Sinicrope, FA (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	sinicrope.frank@mayo.edu			NCI, National Institutes of Health [1 K05 CA142885-01]; Mayo Cancer Center [CA15083]; NATIONAL CANCER INSTITUTE [P30CA015083, K05CA142885] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant 1 K05 CA142885-01 (Senior Scientist Award, to F. A. S.), and the Mayo Cancer Center core Grant CA15083.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huang SB, 2010, MOL CANCER THER, V9, P742, DOI 10.1158/1535-7163.MCT-09-1004; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Long XM, 2007, J BIOL CHEM, V282, P18542, DOI 10.1074/jbc.M610736200; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Ronellenfitsch MW, 2009, BRAIN, V132, P1509, DOI 10.1093/brain/awp093; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sudarsanam S, 2010, CURR OPIN DRUG DISC, V13, P31; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wilkes Gail, 2003, Clin J Oncol Nurs, V7, P353	41	56	58	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40002	40012		10.1074/jbc.M111.297432	http://dx.doi.org/10.1074/jbc.M111.297432			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949121	hybrid, Green Published			2022-12-27	WOS:000296925700033
J	Ruangsri, S; Lin, A; Mulpuri, Y; Lee, K; Spigelman, I; Nishimura, I				Ruangsri, Supanigar; Lin, Audrey; Mulpuri, Yatendra; Lee, Kyung; Spigelman, Igor; Nishimura, Ichiro			Relationship of Axonal Voltage-gated Sodium Channel 1.8 (NaV1.8) mRNA Accumulation to Sciatic Nerve Injury-induced Painful Neuropathy in Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED SELECTIVE KNOCKDOWN; PERIPHERAL NEUROPATHY; EXPRESSION; NA(V)1.8; NEURONS; TRANSPORT; SNS/PN3; PROTEIN; MODEL; IMMUNOREACTIVITY	Painful peripheral neuropathy is a significant clinical problem; however, its pathological mechanism and effective treatments remain elusive. Increased peripheral expression of tetro-dotoxin-resistant voltage-gated sodium channel 1.8 (NaV1.8) has been shown to associate with chronic pain symptoms in humans and experimental animals. Sciatic nerve entrapment (SNE) injury was used to develop neuropathic pain symptoms in rats, resulting in increased NaV1.8 mRNA in the injured nerve but not in dorsal root ganglia (DRG). To study the role of NaV1.8 mRNA in the pathogenesis of SNE-induced painful neuropathy, NaV1.8 shRNA vector was delivered by subcutaneous injection of cationized gelatin/plasmid DNA polyplex into the rat hindpaw and its subsequent retrograde transport via sciatic nerve to DRG. This in vivo NaV1.8 shRNA treatment reversibly and repeatedly attenuated the SNE-induced pain symptoms, an effect that became apparent following a distinct lag period of 3-4 days and lasted for 4-6 days before returning to pretreatment levels. Surprisingly, apparent knockdown of NaV1.8 mRNA occurred only in the injured nerve, not in the DRG, during the pain alleviation period. Levels of heteronuclear NaV1.8 RNA were unaffected by SNE or shRNA treatments, suggesting that transcription of the Scn10a gene encoding NaV1.8 was unchanged. Based on these data, we postulate that increased axonal mRNA transport results in accumulation of functional NaV1.8 protein in the injured nerve and the development of painful neuropathy symptoms. Thus, targeted delivery of agents that interfere with axonal NaV1.8 mRNA may represent effective neuropathic pain treatments.	[Ruangsri, Supanigar; Lin, Audrey; Lee, Kyung; Nishimura, Ichiro] Univ Calif Los Angeles, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90095 USA; [Ruangsri, Supanigar; Mulpuri, Yatendra; Spigelman, Igor; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90095 USA; [Spigelman, Igor] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Ruangsri, Supanigar] Khon Kaen Univ, Fac Dent, Khon Kaen 40002, Thailand	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Khon Kaen University	Nishimura, I (corresponding author), UCLA Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Box 951668,CHS B3-087, Los Angeles, CA 90095 USA.	inishimura@dentistry.ucla.edu	Mulpuri, Yatendra/V-5481-2019	Mulpuri, Yatendra/0000-0003-1764-119X	National Institutes of Health Grants [NS049137, DA023163]; Royal Thai Government, Thailand; UCLA School; NCRR [C06 RR014529]; UCLA School of Dentistry; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS049137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023163] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Thai Government, Thailand; UCLA School; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UCLA School of Dentistry; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS049137 and DA023163. This work was also supported by a Royal Thai Government scholarship from Thailand, a UCLA School of Dentistry seed grant, and Research Facilities Improvement Program Grant C06 RR014529 from NCRR, National Institutes of Health.; We thank Prof. Yasuhiko Tabata (Institute for Frontier Medical Science, Kyoto University, Japan) for providing cationized gelatin nanoparticles, Dr. Emmanuelle Faure-Kuma (Vector Core, UCLA) for lentivirus production, Dr. Mathew Schibler (California NanoSystems Institute and Brain Research Institute microscopy core facility, UCLA) for confocal laser scanning micrography, Mari-ane Cilluffo (Brain Research Institute microscopy core facility) for immunohistochemistry consultation, and (Daniela Markovic of Department of Biomathematics), and David Geffen (School of Medicine at UCLA) for statistical consultation. We also thank Prof. David Wong (Associate Dean of Research, UCLA School of Dentistry) for generous funding support for statistical consultations.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Bailey AL, 2006, NEUROSCIENCE, V138, P675, DOI 10.1016/j.neuroscience.2005.11.051; Baron R, 2009, PAIN, V146, P34, DOI 10.1016/j.pain.2009.06.001; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Black JA, 2008, ANN NEUROL, V64, P644, DOI 10.1002/ana.21527; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coward K, 2000, PAIN, V85, P41, DOI 10.1016/S0304-3959(99)00251-1; Delaney A, 2009, NEUROTHERAPEUTICS, V6, P630, DOI 10.1016/j.nurt.2009.07.005; Dib-Hajj SD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-37; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Dong XW, 2007, NEUROSCIENCE, V146, P812, DOI 10.1016/j.neuroscience.2007.01.054; England JD, 1996, NEUROLOGY, V47, P272, DOI 10.1212/WNL.47.1.272; Frieboes LR, 2010, J ORTHOP RES, V28, P753, DOI 10.1002/jor.21047; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P430; Gilron I, 2006, CAN MED ASSOC J, V175, P265, DOI 10.1503/cmaj.060146; Gold MS, 2003, J NEUROSCI, V23, P158; Gupta R, 2006, EXP NEUROL, V200, P418, DOI 10.1016/j.expneurol.2006.02.134; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Hoffman EM, 2010, J HISTOCHEM CYTOCHEM, V58, P329, DOI 10.1369/jhc.2009.954008; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KAJANDER KC, 1992, J NEUROPHYSIOL, V68, P734, DOI 10.1152/jn.1992.68.3.734; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kretschmer T, 2002, J NEUROSURG, V97, P1424, DOI 10.3171/jns.2002.97.6.1424; Kretschmer T, 2002, ACTA NEUROCHIR, V144, P803, DOI 10.1007/s00701-002-0970-1; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lai J, 2004, ANNU REV PHARMACOL, V44, P371, DOI 10.1146/annurev.pharmtox.44.101802.121627; Liu JM, 2006, J NEUROSCI, V26, P5204, DOI 10.1523/JNEUROSCI.4917-05.2006; Loser P, 1998, J VIROL, V72, P180; Matsuka Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-66; MATZNER O, 1994, J NEUROPHYSIOL, V72, P349, DOI 10.1152/jn.1994.72.1.349; Mikami M, 2005, ANESTHESIOLOGY, V103, P828, DOI 10.1097/00000542-200510000-00022; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Murashov AK, 2007, FASEB J, V21, P656, DOI 10.1096/fj.06-6155com; Novakovic SD, 1998, J NEUROSCI, V18, P2174; Pitcher GM, 1999, PAIN, V83, P37, DOI 10.1016/S0304-3959(99)00085-8; Pitcher GM, 2008, EXP NEUROL, V214, P219, DOI 10.1016/j.expneurol.2008.08.003; Puigdellivol-Sanchez A, 2002, J NEUROSCI METH, V115, P115, DOI 10.1016/S0165-0270(01)00532-5; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Shembalkar PK, 2001, EUR J PAIN, V5, P319, DOI 10.1053/eujp.2001.0251; Siqueira SRDT, 2009, NEUROSCIENCE, V164, P573, DOI 10.1016/j.neuroscience.2009.08.037; Taylor Rod S, 2006, Pain Pract, V6, P22, DOI 10.1111/j.1533-2500.2006.00054.x; Thakor D, 2007, MOL THER, V15, P2124, DOI 10.1038/sj.mt.6300256; Thakor DK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-14; Tomishima MJ, 2001, TRAFFIC, V2, P429, DOI 10.1034/j.1600-0854.2001.020701.x; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; WAXMAN SG, 1999, PAIN S, V6, P133; Yiangou Y, 2000, FEBS LETT, V467, P249, DOI 10.1016/S0014-5793(00)01166-2; Zhang XF, 2004, BRAIN RES, V1009, P147, DOI 10.1016/j.brainres.2004.02.057; Zhao J, 2010, J NEUROSCI, V30, P10860, DOI 10.1523/JNEUROSCI.1980-10.2010	60	28	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39836	39847		10.1074/jbc.M111.261701	http://dx.doi.org/10.1074/jbc.M111.261701			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965668	Green Published, hybrid			2022-12-27	WOS:000296925700018
J	Karkusiewicz, I; Turowski, TW; Graczyk, D; Towpik, J; Dhungel, N; Hopper, AK; Boguta, M				Karkusiewicz, Iwona; Turowski, Tomasz W.; Graczyk, Damian; Towpik, Joanna; Dhungel, Nripesh; Hopper, Anita K.; Boguta, Magdalena			Maf1 Protein, Repressor of RNA Polymerase III, Indirectly Affects tRNA Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; NEGATIVE REGULATOR; DIVERSE SIGNALS; GLOBAL ANALYSIS; RIBOSOMAL-RNA; TRANSCRIPTION; GENE; LOCALIZATION; SUBUNIT	Maf1 is negative regulator of RNA polymerase III in yeast. We observed high levels of both primary transcript and end-matured, intron-containing pre-tRNAs in the maf1 Delta strain. This pre-tRNA accumulation could be overcome by transcription inhibition, arguing against a direct role of Maf1 in tRNA maturation and suggesting saturation of processing machinery by the increased amounts of primary transcripts. Saturation of the tRNA exportin, Los1, is one reason why end-matured introncontaining pre-tRNAs accumulate in maf1 Delta cells. However, it is likely possible that other components of the processing pathway are also limiting when tRNA transcription is increased. According to our model, Maf1-mediated transcription control and nuclear export by Los1 are two major stages of tRNA biosynthesis that are regulated by environmental conditions in a coordinated manner.	[Karkusiewicz, Iwona; Graczyk, Damian; Towpik, Joanna; Boguta, Magdalena] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Turowski, Tomasz W.; Boguta, Magdalena] Warsaw Univ Technol, Fac Chem, PL-00664 Warsaw, Poland; [Dhungel, Nripesh; Hopper, Anita K.] Ohio State Univ, Dept Mol Genet, Ctr RNA Biol, Columbus, OH 43210 USA	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Warsaw University of Technology; University System of Ohio; Ohio State University	Boguta, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A, PL-02106 Warsaw, Poland.	magda@ibb.waw.pl	Turowski, Tomasz/H-1870-2011; Graczyk, Damian/J-6494-2016	Graczyk, Damian/0000-0002-6006-647X; Turowski, Tomasz/0000-0002-7052-8682; Boguta, Magdalena/0000-0002-1545-0691	National Institutes of Health [27930]; Ministry of Science and Higher Education (Poland) [MNSIW N301 298837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 27930 (to A. K. H.). This work was also supported by Ministry of Science and Higher Education (Poland) Grant MNSIW N301 298837.	Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Boguta M, 1997, GENE, V185, P291, DOI 10.1016/S0378-1119(96)00669-5; Boguta M, 2009, CELL CYCLE, V8, P4023, DOI 10.4161/cc.8.24.10534; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; Conesa C, 2005, MOL CELL BIOL, V25, P8631, DOI 10.1128/MCB.25.19.8631-8642.2005; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Deprez E, 1999, MOL CELL BIOL, V19, P8042; Gajda A, 2010, J BIOL CHEM, V285, P35719, DOI 10.1074/jbc.M110.125286; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Graczyk D, 2011, P NATL ACAD SCI USA, V108, P4926, DOI 10.1073/pnas.1010010108; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hopper AK, 2006, CRIT REV BIOCHEM MOL, V41, P3, DOI 10.1080/10409230500405237; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; HURT DJ, 1987, MOL CELL BIOL, V7, P1208, DOI 10.1128/MCB.7.3.1208; Hurto RL, 2007, GENETICS, V176, P841, DOI 10.1534/genetics.106.069732; Huynh LN, 2010, CELL CYCLE, V9, P3112, DOI 10.4161/cc.9.15.12525; Ishiguro A, 2002, MOL CELL BIOL, V22, P3264, DOI 10.1128/MCB.22.10.3264-3275.2002; JIMENEZ A, 1973, ANTIMICROB AGENTS CH, V3, P729, DOI 10.1128/AAC.3.6.729; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Kufel J, 2003, RNA, V9, P202, DOI 10.1261/rna.2145103; Kwapisz M, 2002, CURR GENET, V42, P147, DOI 10.1007/s00294-002-0342-7; LEFEBVRE O, 1994, J BIOL CHEM, V269, P23374; Lipowsky G, 1999, RNA, V5, P539, DOI 10.1017/S1355838299982134; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Murthi A, 2010, MOL BIOL CELL, V21, P639, DOI 10.1091/mbc.E09-07-0551; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Qiu HF, 2000, MOL CELL BIOL, V20, P2505, DOI 10.1128/MCB.20.7.2505-2516.2000; Quan XX, 2007, BBA-MOL CELL RES, V1773, P1052, DOI 10.1016/j.bbamcr.2007.04.014; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shaheen HH, 2005, P NATL ACAD SCI USA, V102, P11290, DOI 10.1073/pnas.0503836102; SHEN WC, 1993, J BIOL CHEM, V268, P19436; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Towpik J, 2008, J BIOL CHEM, V283, P17168, DOI 10.1074/jbc.M709157200; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Wei YH, 2009, EMBO J, V28, P2220, DOI 10.1038/emboj.2009.179; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757; Yoshihisa T, 2007, GENES CELLS, V12, P285, DOI 10.1111/j.1365-2443.2007.01056.x	52	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39478	39488		10.1074/jbc.M111.253310	http://dx.doi.org/10.1074/jbc.M111.253310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940626	Green Published, hybrid			2022-12-27	WOS:000296759800065
J	Chacko, BK; Scott, DW; Chandler, RT; Patel, RP				Chacko, Balu K.; Scott, David W.; Chandler, Robert T.; Patel, Rakesh P.			Endothelial Surface N-Glycans Mediate Monocyte Adhesion and Are Targets for Anti-inflammatory Effects of Peroxisome Proliferator-activated Receptor gamma Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; CELL; GLYCOSYLATION; GLYCOCALYX; EXPRESSION; SELECTIN; FLOW; INFLAMMATION; BINDING; ISOFLAVONES	Endothelial-monocyte interactions are regulated by adhesion molecules and key in the development of vascular inflammatory disease. Peroxisome proliferator-activated receptor (PPAR) gamma activation in endothelial cells is recognized to mediate anti-inflammatory effects that inhibit monocyte rolling and adhesion. Herein, evidence is provided for a novel mechanism for the anti-inflammatory effects of PPAR gamma ligand action that involves inhibition of proinflammatory cytokine-dependent up-regulation of endothelial N-glycans. TNF alpha treatment of human umbilical vein endothelial cells increased surface expression of high mannose/hybrid N-glycans. A role for these sugars in mediating THP-1 or primary human monocyte rolling and adhesion was indicated by competition studies in which addition of alpha-methylmannose, but not alpha-methylglucose, inhibited monocyte rolling and adhesion during flow, but not under static conditions. This result supports the notion that adhesion molecules provide scaffolds for sugar epitopes to mediate adhesion with cognate receptors. A panel of structurally distinct PPAR gamma agonists all decreased TNF alpha-dependent expression of endothelial high mannose/hybrid N-glycans. Using rosiglitazone as a model PPAR gamma agonist, which decreased TNF alpha-induced high mannose N-glycan expression, we demonstrate a role for these carbohydrate residues in THP-1 rolling and adhesion that is independent of endothelial surface adhesion molecule expression (ICAM-1 and E-selectin). Data from N-glycan processing gene arrays identified alpha-mannosidases (MAN1A2 and MAN1C1) as targets for down-regulation by TNF alpha, which was reversed by rosiglitazone, a result consistent with altered high mannose/hybrid N-glycan epitopes. Taken together we propose a novel anti-inflammatory mechanism of endothelial PPAR gamma activation that involves targeting protein post-translational modification of adhesion molecules, specifically N-glycosylation.	[Chacko, Balu K.; Scott, David W.; Chandler, Robert T.; Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Patel, RP (corresponding author), 901 19th St S,BMR-2,Rm 532, Birmingham, AL 35294 USA.	rakeshp@uab.edu		Patel, Rakesh/0000-0002-1526-4303	American Heart Association; Howard Hughes Medical Institute through Med into Grad Initiative; Purdue-UAB Botanicals center	American Heart Association(American Heart Association); Howard Hughes Medical Institute through Med into Grad Initiative; Purdue-UAB Botanicals center	This work was supported in part by a American Heart Association Postdoctoral fellowship (to B. K. C.), a American Heart Association Predoctoral fellowship (to D. S.), a grant from the Howard Hughes Medical Institute through the Med into Grad Initiative (to D. W. S.), and a pilot grant from the Purdue-UAB Botanicals center (to R. P. P.).	Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; Chacko BK, 2007, J NUTR, V137, P351, DOI 10.1093/jn/137.2.351; Chacko BK, 2005, AM J PHYSIOL-HEART C, V289, pH908, DOI 10.1152/ajpheart.00781.2004; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Chappell D, 2009, BASIC RES CARDIOL, V104, P78, DOI 10.1007/s00395-008-0749-5; Cummings RD, 1999, BRAZ J MED BIOL RES, V32, P519, DOI 10.1590/S0100-879X1999000500004; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Garcia-Vallejo JJ, 2006, J CELL PHYSIOL, V206, P203, DOI 10.1002/jcp.20458; Gouverneur M, 2006, J INTERN MED, V259, P393, DOI 10.1111/j.1365-2796.2006.01625.x; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Ketsawatsomkron P, 2010, J BIOL CHEM, V285, P9311, DOI 10.1074/jbc.R109.025031; Kevil CG, 2003, AM J PHYSIOL-CELL PH, V285, pC112, DOI 10.1152/ajpcell.00334.2002; Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; Liu Y, 2004, CIRCULATION, V110, P1128, DOI 10.1161/01.CIR.0000139850.08365.EC; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Methe H, 2007, AM J PHYSIOL-HEART C, V292, pH2167, DOI 10.1152/ajpheart.00403.2006; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Mundhekar AN, 2006, AM J PHYSIOL-CELL PH, V291, pC130, DOI 10.1152/ajpcell.00261.2005; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; PAHLSSON P, 1995, EUR J IMMUNOL, V25, P2452, DOI 10.1002/eji.1830250907; Peng YL, 2010, MOL CELL BIOCHEM, V340, P143, DOI 10.1007/s11010-010-0411-z; Pinho S. S., 2011, CELL MOL LIFE SCI, V1218, P1379; Plutzky J, 2003, J AM COLL CARDIOL, V42, P1764, DOI 10.1016/j.jacc.2003.08.017; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Rachmilewitz J., 2010, SELF NONSELF, V1, P250, DOI DOI 10.4161/SELF.1.3.12330; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; RENKONEN R, 1991, EUR J IMMUNOL, V21, P777, DOI 10.1002/eji.1830210334; Rivera-Marrero CA, 2001, MICROB PATHOGENESIS, V30, P9, DOI 10.1006/mpat.2000.0407; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; SELLAK H, 1994, BLOOD, V83, P2669; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; Srikrishna G, 2001, J IMMUNOL, V166, P624, DOI 10.4049/jimmunol.166.1.624; SRIRAMARAO P, 1993, J CELL BIOCHEM, V51, P360, DOI 10.1002/jcb.240510316; Sumagin R, 2010, J IMMUNOL, V184, P5242, DOI 10.4049/jimmunol.0903319; Thornton BP, 1996, J IMMUNOL, V156, P1235; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vaisar Tomas, 2007, Curr Atheroscler Rep, V9, P417, DOI 10.1007/s11883-007-0054-z; Varki A, 1997, J CLIN INVEST, V100, pS31; Varki AP, 2008, GLYCOBIOLOGY, V18, P747, DOI 10.1093/glycob/cwn065; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Willhauck-Fleckenstein M, 2010, ANGIOGENESIS, V13, P25, DOI 10.1007/s10456-010-9162-4; Yang XJ, 2004, BIOCHEM CELL BIOL, V82, P559, DOI 10.1139/O04-058	50	52	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38738	38747		10.1074/jbc.M111.247981	http://dx.doi.org/10.1074/jbc.M111.247981			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911496	Green Published, hybrid			2022-12-27	WOS:000296594200085
J	Stoltzman, CA; Kaadige, MR; Peterson, CW; Ayer, DE				Stoltzman, Carrie A.; Kaadige, Mohan R.; Peterson, Christopher W.; Ayer, Donald E.			MondoA Senses Non-glucose Sugars REGULATION OF THIOREDOXIN-INTERACTING PROTEIN (TXNIP) AND THE HEXOSE TRANSPORT CURB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE RESPONSE ELEMENT; D-ALLOSE; AEROBIC GLYCOLYSIS; CHREBP; MUTANT; PHOSPHORYLATION; METABOLISM; MLX; TRANSCRIPTION; TUNICAMYCIN	Glucose is required for cell growth and proliferation. The MondoA.Mlx transcription factor is glucose-responsive and accumulates in the nucleus by sensing glucose 6-phosphate. One direct and glucose-induced target of MondoA.Mlx complexes is thioredoxin-interacting protein (TXNIP). TXNIP is a potent negative regulator of glucose uptake, and hence its regulation by MondoA.Mlx triggers a feedback loop that restricts glucose uptake. This feedback loop is similar to the "hexose transport curb" first described almost 30 years ago. We show here that MondoA responds to the non-glucose hexoses, allose, 3-O-methylglucose, and glucosamine by accumulating in the nucleus and activating TXNIP transcription. The metabolic inhibitor 3-bromopyruvate blocks the transcriptional response to allose and 3-O-methylglucose, indicating that their metabolism, or a parallel pathway, is required to stimulate MondoA activity. Our dissection of the hexosamine biosynthetic pathway suggests that in addition to sensing glucose 6-phosphate, MondoA can also sense glucosamine 6-phosphate. Analysis of glucose uptake in wild-type, MondoA-null, or TXNIP-null murine embryonic fibroblasts indicates a role for the MondoA-TXNIP regulatory circuit in the hexose transport curb, although other redundant pathways also contribute.	Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Ayer, DE (corresponding author), 4365 Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	don.ayer@hci.utah.edu		Ayer, Donald/0000-0002-5595-3269	National Institutes of Health [GM55668, GM60387]; Huntsman Cancer Foundation; Cancer Center [2P30 CA42014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055668, R01GM060387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntsman Cancer Foundation; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55668 and GM60387 (to D. E. A.). This work was also supported by the Huntsman Cancer Foundation. DNA sequencing and oligonucleotide synthesis were supported by the Cancer Center Support Grant 2P30 CA42014.	Ai J., 2005, ANAL CHEM, V77, P8086; Billin AN, 2006, CURR TOP MICROBIOL, V302, P255; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Cortes S, 2003, PLANT PHYSIOL, V131, P824, DOI 10.1104/pp.010538; Elgort Marc G, 2010, Genes Cancer, V1, P893, DOI 10.1177/1947601910389604; GATLEY SJ, 1984, BIOCHEM BIOPH RES CO, V119, P1008, DOI 10.1016/0006-291X(84)90874-X; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Kaadige MR, 2010, TRANSCR-AUSTIN, V1, P36, DOI 10.4161/trns.1.1.12142; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; KALCKAR HM, 1979, P NATL ACAD SCI USA, V76, P6453, DOI 10.1073/pnas.76.12.6453; KALCKAR HM, 1984, P NATL ACAD SCI-BIOL, V81, P1126, DOI 10.1073/pnas.81.4.1126; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2006, BIOCHEMISTRY-US, V45, P11047, DOI 10.1021/bi0603625; Muoio DM, 2007, CELL METAB, V5, P412, DOI 10.1016/j.cmet.2007.05.011; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; POUYSSEGUR J, 1980, NATURE, V287, P445, DOI 10.1038/287445a0; POUYSSEGUR J, 1980, P NATL ACAD SCI-BIOL, V77, P2698, DOI 10.1073/pnas.77.5.2698; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; ULLREY DB, 1986, P NATL ACAD SCI USA, V83, P5858, DOI 10.1073/pnas.83.16.5858; ULLREY DB, 1982, P NATL ACAD SCI-BIOL, V79, P3777, DOI 10.1073/pnas.79.12.3777; ULLREY DB, 1989, P NATL ACAD SCI USA, V86, P4350, DOI 10.1073/pnas.86.12.4350; ULLREY DB, 1987, P NATL ACAD SCI USA, V84, P3678, DOI 10.1073/pnas.84.11.3678; ULLREY DB, 1991, P NATL ACAD SCI USA, V88, P1504, DOI 10.1073/pnas.88.4.1504; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Yamaguchi F, 2008, INT J ONCOL, V32, P377	34	45	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38027	38034		10.1074/jbc.M111.275503	http://dx.doi.org/10.1074/jbc.M111.275503			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908621	Green Published, hybrid			2022-12-27	WOS:000296594200014
J	Jin, X; Stamnaes, J; Klock, C; DiRaimondo, TR; Sollid, LM; Khosla, C				Jin, Xi; Stamnaes, Jorunn; Klock, Cornelius; DiRaimondo, Thomas R.; Sollid, Ludvig M.; Khosla, Chaitan			Activation of Extracellular Transglutaminase 2 by Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; STRUCTURAL BASIS; MECHANISM; PLASMA; DISULFIDES; CANCER; ENZYME; CELLS; IDENTIFICATION; LOCALIZATION	The mechanism of activation of transglutaminase 2 (TG2) in the extracellular matrix remains a fundamental mystery in our understanding of the biology of this multifunctional mammalian enzyme. Earlier investigations have highlighted the role of a disulfide bond formed by vicinal Cys residues in maintaining calcium-bound TG2 in an inactive state. Here, we have shown that the redox potential of this disulfide bond is approximately -190 mV, a high value for a disulfide bond in proteins. Consistent with this observation, TG2 activity in a freshly wounded fibroblast culture depends upon the redox potential of the environment. We sought to identify a physiological mechanism for the activation of oxidized TG2. With a k(cat)/K-m of 1.6 mu M-1 min(-1), human thioredoxin (Trx) was a highly specific activator of oxidized human TG2. Trx-mediated activation of TG2 was blocked by PX-12, a small molecule Trx inhibitor that is undergoing clinical trials as a cancer chemotherapeutic agent. In a mixed culture containing fibroblasts and monocytic cells, interferon-gamma stimulated Trx release from monocytes, which in turn activated TG2 around the fibroblasts. Recombinant human Trx could also activate extracellular TG2 in cryosections of human and mouse small intestinal biopsies. In addition to explaining how TG2 can be activated by dietary gluten in the small intestinal mucosa of celiac sprue patients, our findings reveal a new strategy for inhibiting the undesirable consequences of TG2 activity in this widespread, lifelong disease.	[Jin, Xi; Klock, Cornelius; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Jin, Xi; Klock, Cornelius; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Stamnaes, Jorunn; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, N-0027 Oslo, Norway; [Stamnaes, Jorunn; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, N-0027 Oslo, Norway; Oslo Univ Hosp, Rikshosp, N-0027 Oslo, Norway	Stanford University; Stanford University; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Khosla, C (corresponding author), Stanford Univ, Dept Chem & Chem Engn, Stanford, CA 94305 USA.	khosla@stanford.edu	Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X; Stamnaes, Jorunn/0000-0002-0257-2112; Khosla, Chaitan/0000-0001-6529-495X	National Institutes of Health [R01 DK63158]; Research Council of Norway; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK63158 (to C. K.). This work was also supported by the Research Council of Norway (to L. M. S.).	Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Azimi I, 2010, J BIOL CHEM, V285, P40072, DOI 10.1074/jbc.M110.185371; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Baker AF, 2006, J LAB CLIN MED, V147, P83, DOI 10.1016/j.lab.2005.09.001; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Chaiswing L, 2010, ANTIOXID REDOX SIGN, V13, P449, DOI 10.1089/ars.2009.3020; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; HOLMGREN A, 1978, BIOCHEMISTRY-US, V17, P4071, DOI 10.1021/bi00612a031; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Kim SH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-64; Kirkpatrick DL, 1998, BIOCHEM PHARMACOL, V55, P987, DOI 10.1016/S0006-2952(97)00597-2; Klock C, 2011, BIOORG MED CHEM LETT, V21, P2692, DOI 10.1016/j.bmcl.2010.12.037; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Miyazaki K, 1998, BIOTHERAPY, V11, P277, DOI 10.1023/A:1008032703468; Nakamura H, 1998, FREE RADICAL BIO MED, V24, P1176, DOI 10.1016/S0891-5849(97)00429-2; Nakamura H, 1996, INT IMMUNOL, V8, P603, DOI 10.1093/intimm/8.4.603; Nakamura H, 2006, SEMIN CANCER BIOL, V16, P444, DOI 10.1016/j.semcancer.2006.09.001; Pekkari K, 2004, ANTIOXID REDOX SIGN, V6, P53, DOI 10.1089/152308604771978345; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sido B, 2005, EUR J IMMUNOL, V35, P408, DOI 10.1002/eji.200424500; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414	36	84	85	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37866	37873		10.1074/jbc.M111.287490	http://dx.doi.org/10.1074/jbc.M111.287490			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908620	Green Published, hybrid			2022-12-27	WOS:000296542400081
J	Zhang, J; Ye, F; Lan, LF; Jiang, HL; Luo, C; Yang, CG				Zhang, Jie; Ye, Fei; Lan, Lefu; Jiang, Hualiang; Luo, Cheng; Yang, Cai-Guang			Structural Switching of Staphylococcus aureus Clp Protease A KEY TO UNDERSTANDING PROTEASE DYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CLPP; STRESS TOLERANCE; N-TERMINUS; MODEL; SPECIFICITY; ACTIVATION; CHAPERONES; PROTEINS; INSIGHTS; SUBUNITS	ATP-dependent Clp protease (ClpP) is an attractive new target for the development of anti-infective agents. The ClpP protease consists of two heptameric rings that enclose a large chamber containing 14 proteolytic active sites. Recent studies indicate that ClpP likely undergoes conformational switching between an extended and degraded active state required for substrate proteolysis and a compacted and catalytically inactive state allowing product release. Here, we present the wild-type ClpP structures in two distinct states from Staphylococcus aureus. One structure is very similar to those solved ClpP structures in the extended states. The other is strikingly different from both the extended and the compacted state as observed in ClpP from other species; the handle domain of this structure kinks to take on a compressed conformation. Structural analysis and molecular dynamic simulations show that the handle domain predominantly controls the way in which degradation products exit the chamber through dynamic conformational switching from the extended state to the compressed state. Given the highly conserved sequences among ClpP from different species, this compressed conformation is unexpected and novel, which is potentially valuable for understanding the enzymatic dynamics and the acting mechanisms of ClpP.	[Zhang, Jie; Ye, Fei; Lan, Lefu; Jiang, Hualiang; Luo, Cheng; Yang, Cai-Guang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Luo, C (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	cluo@mail.shcnc.ac.cn; yangcg@mail.shcnc.ac.cn			National Natural Science Foundation of China [20972173, 20972174, 90913010, 91029704, 21021063, 21172234]; Chinese Academy of Sciences [XDA01040305]; Science and Technology Commission of Shanghai Municipality [09PJ1411600, 10410703900]; Key Project of Chinese National Programs for Fundamental Research and Development [2009CB918502]; National Science and Technology Major Project [2009ZX09301-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Key Project of Chinese National Programs for Fundamental Research and Development; National Science and Technology Major Project	This work was supported by National Natural Science Foundation of China Grants 20972173, 20972174, 90913010, 91029704, 21021063, and 21172234, by the Hundred Talent Program of the Chinese Academy of Sciences (to C.-G. Y. and L. L.), and by Science and Technology Commission of Shanghai Municipality Grants 09PJ1411600 and 10410703900, Key Project of Chinese National Programs for Fundamental Research and Development Grant 2009CB918502, National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant 2009ZX09301-001), and Special Grant of the Chinese Academy of Sciences Grant XDA01040305.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bewley MC, 2009, J STRUCT BIOL, V165, P118, DOI 10.1016/j.jsb.2008.10.005; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Butler SM, 2006, MOL MICROBIOL, V60, P553, DOI 10.1111/j.1365-2958.2006.05128.x; Chandu D, 2004, RES MICROBIOL, V155, P710, DOI 10.1016/j.resmic.2004.06.003; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; Corydon TJ, 1998, BIOCHEM J, V331, P309, DOI 10.1042/bj3310309; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Effantin G, 2010, J BIOL CHEM, V285, P14834, DOI 10.1074/jbc.M109.090498; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fletcher R., 1980, PRACTICAL METHODS OP, V1, P1; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11031, DOI 10.1021/bi8010169; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; Kim DY, 2008, J MOL BIOL, V379, P760, DOI 10.1016/j.jmb.2008.04.036; Kimber MS, 2010, STRUCTURE, V18, P798, DOI 10.1016/j.str.2010.04.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Maurizi MR, 1998, BIOCHEMISTRY-US, V37, P7778, DOI 10.1021/bi973093e; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; WOO KM, 1989, J BIOL CHEM, V264, P2088; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076	54	44	45	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37590	37601		10.1074/jbc.M111.277848	http://dx.doi.org/10.1074/jbc.M111.277848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900233	Green Published, hybrid			2022-12-27	WOS:000296542400057
J	Srinivasan, M; Janardhanam, S				Srinivasan, Mythily; Janardhanam, Srihari			Novel p65 Binding Glucocorticoid-induced Leucine Zipper Peptide Suppresses Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELL-ACTIVATION; TRANSACTIVATION DOMAIN; PROTEIN-STRUCTURE; INDUCED GENE; II HELIX; GILZ; TRANSCRIPTION; COACTIVATORS; RECOGNITION	Multiple sclerosis (MS) is a neurological disease characterized by inflammatory demyelination in the brain and spinal cord. The immune-mediated inflammation involves well orchestrated intermolecular interactions that exhibit rapid binding kinetics. The binding interfaces of transient interactions frequently include proline residues that favor an extended conformation for molecular recognition. Linear interface peptides are excellent lead inhibitors of specific protein-protein interactions because only small segments of the interface contribute to the binding. Glucocorticoid-induced leucine zipper (GILZ), a recently identified molecule exhibits potent anti-inflammatory properties. Mechanistically, a prolinerich segment in the carboxyl terminus of GILZ physically binds the p65 subunit of nuclear factor-kappa B and inhibits the transactivation of inflammatory cytokines. Integrating knowledge derived from the mechanism of action of GILZ with in silico structure prediction identified an immunomodulatory peptide, the GILZ-P. Treatment with GILZ-P exhibited therapeutic efficacy in experimental autoimmune encephalomyelitis, a model for human MS.	[Srinivasan, Mythily; Janardhanam, Srihari] Indiana Univ Purdue Univ, Sch Dent, Dept Oral Pathol Med & Radiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Srinivasan, M (corresponding author), 1121 W Michigan St, Indianapolis, IN 46202 USA.	mysriniv@iupui.edu	Janardhanam, Srihari/H-7429-2013					Asamitsu K, 2003, J BIOL CHEM, V278, P26879, DOI 10.1074/jbc.M211831200; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Beaulieu E, 2011, NAT REV RHEUMATOL, V7, P340, DOI 10.1038/nrrheum.2011.59; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bhattacharyya R, 2003, J MOL BIOL, V331, P925, DOI 10.1016/S0022-2836(03)00759-9; Bochicchio B, 2002, CHIRALITY, V14, P782, DOI 10.1002/chir.10153; Calzado MA, 2007, CURR MED CHEM, V14, P367, DOI 10.2174/092986707779941113; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cannarile L, 2001, CELL DEATH DIFFER, V8, P201, DOI 10.1038/sj.cdd.4400798; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; Chandra BR, 2004, PROTEIN ENG DES SEL, V17, P175, DOI 10.1093/protein/gzh024; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Delfino DV, 2006, INT IMMUNOPHARMACOL, V6, P1126, DOI 10.1016/j.intimp.2006.02.001; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Dudhgaonkar SP, 2009, J IMMUNOL, V183, P7505, DOI 10.4049/jimmunol.0902056; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Gros E, 2006, BBA-BIOMEMBRANES, V1758, P384, DOI 10.1016/j.bbamem.2006.02.006; Heinrich L, 2010, J IMMUNOL METHODS, V352, P13, DOI 10.1016/j.jim.2009.10.002; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Martino G. A., 1999, BASIC IMMUNOLOGY IMM, V1, P185; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; O'Shea JM, 2008, BIOCHEM SOC T, V36, P603, DOI 10.1042/BST0360603; Pande V, 2005, CURR MED CHEM, V12, P357, DOI 10.2174/0929867053363180; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saladin PM, 2009, IDRUGS, V12, P779; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; Seidel G, 1997, J BIOL CHEM, V272, P30918, DOI 10.1074/jbc.272.49.30918; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Srinivasan M, 2005, J BIOL CHEM, V280, P10149, DOI 10.1074/jbc.M409521200; Srinivasan M, 2001, J IMMUNOL, V167, P578, DOI 10.4049/jimmunol.167.1.578; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Tanaka K, 2001, JPN J CANCER RES, V92, P959, DOI 10.1111/j.1349-7006.2001.tb01187.x; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Vanderlugt CL, 1998, IMMUNOL REV, V164, P63, DOI 10.1111/j.1600-065X.1998.tb01208.x; Weber MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016009; Zimecki M, 2008, ADV EXP MED BIOL, V606, P241, DOI 10.1007/978-0-387-74087-4_9	46	49	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44799	44810		10.1074/jbc.M111.279257	http://dx.doi.org/10.1074/jbc.M111.279257			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21965677	Green Published, hybrid			2022-12-27	WOS:000298645500049
J	De Stefano, S; Pusch, M; Zifarelli, G				De Stefano, Silvia; Pusch, Michael; Zifarelli, Giovanni			Extracellular Determinants of Anion Discrimination of the Cl-/H+ Antiporter Protein CLC-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE-CHANNELS; CYSTEINE ACCESSIBILITY; NITRATE ACCUMULATION; PROKARYOTIC HOMOLOG; SELECTIVITY FILTER; MOLECULAR-BASIS; ION PERMEATION; BINDING-SITE; PORE; TRANSPORTER	Mammalian CLC proteins comprise both Cl- channels and Cl-/H+ antiporters that carry out fundamental physiological tasks by transporting Cl- across plasma membrane and intracellular compartments. TheNO(3)(-) over Cl- preference of a plant CLC transporter has been pinpointed to a conserved serine residue located at S-cen and it is generally assumed that the other two binding sites of CLCs, S-ext and S-in, do not substantially contribute to anion selectivity. Here we show for the Cl-/H+ antiporter CLC-5 that the conserved and extracellularly exposed Lys(210) residue is critical to determine the anion specificity for transport activity. In particular, mutations that neutralize or invert the charge at this position reverse the NO3- over Cl- preference of WT CLC-5 at a concentration of 100 mM, but do not modify the coupling stoichiometry with H+. The importance of the electrical charge is shown by chemical modification of K210C with positively charged cysteine-reactive compounds that reintroduce the WT preference for Cl-. At saturating extracellular anion concentrations, neutralization of Lys(210) is of little impact on the anion preference, suggesting an important role of Lys(210) on the association rate of extracellular anions to S-ext.	[De Stefano, Silvia; Pusch, Michael; Zifarelli, Giovanni] CNR, Ist Biofis, I-16149 Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Zifarelli, G (corresponding author), CNR, Ist Biofis, Via De Marini 6, I-16149 Genoa, Italy.	zifarelli@ge.ibf.cnr.it		Pusch, Michael/0000-0002-8644-8847	Telethon Italy [GGP08064]; Italian Institute of Technology (Progetto SEED); Compagnia San Paolo	Telethon Italy(Fondazione Telethon); Italian Institute of Technology (Progetto SEED); Compagnia San Paolo(Compagnia di San Paolo)	This work was supported by Telethon Italy Grant GGP08064, the Italian Institute of Technology (Progetto SEED), and the Compagnia San Paolo.	Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2003, J GEN PHYSIOL, V122, P277, DOI 10.1085/jgp.200308834; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; Engh AM, 2005, J GEN PHYSIOL, V125, P601, DOI 10.1085/jgp.200509258; Estevez R, 2003, NEURON, V38, P47, DOI 10.1016/S0896-6273(03)00168-5; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gradogna A, 2010, J GEN PHYSIOL, V136, P311, DOI 10.1085/jgp.201010455; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jossier M, 2010, PLANT J, V64, P563, DOI 10.1111/j.1365-313X.2010.04352.x; Lin CW, 2000, J GEN PHYSIOL, V116, P535, DOI 10.1085/jgp.116.4.535; Lin CW, 2003, J GEN PHYSIOL, V122, P147, DOI 10.1085/jgp.200308845; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1997, J GEN PHYSIOL, V110, P165, DOI 10.1085/jgp.110.2.165; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Rosental N, 2010, J BIOL CHEM, V285, P21241, DOI 10.1074/jbc.M109.087163; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Traverso S, 2003, J GEN PHYSIOL, V122, P295, DOI 10.1085/jgp.200308784; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Wege S, 2010, PLANT J, V63, P861, DOI 10.1111/j.1365-313X.2010.04288.x; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2007, REV PHYSIOL BIOCH P, V158, P23, DOI 10.1007/112_2006_0605; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	44	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44134	44144		10.1074/jbc.M111.272815	http://dx.doi.org/10.1074/jbc.M111.272815			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21921031	Green Published, hybrid			2022-12-27	WOS:000298402300054
J	Iliev, DB; Sobhkhez, M; Fremmerlid, K; Jorgensen, JB				Iliev, Dimitar B.; Sobhkhez, Mehrdad; Fremmerlid, Kjersti; Jorgensen, Jorunn B.			MyD88 Interacts with Interferon Regulatory Factor (IRF) 3 and IRF7 in Atlantic Salmon (Salmo salar) TRANSGENIC SsMyD88 MODULATES THE IRF-INDUCED TYPE I INTERFERON RESPONSE AND ACCUMULATES IN AGGRESOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSES; GENE INDUCTION-PROGRAM; I INTERFERON; RAINBOW-TROUT; CPG OLIGODEOXYNUCLEOTIDES; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; SIGNALING PATHWAY; DENDRITIC CELLS	MyD88 is an intracellular adaptor protein that transmits signals downstream of immune receptors such as the IL-1 receptor and the majority of the known mammalian toll-like receptors. Homologs of MyD88 have been identified in many vertebrate species; however, the adaptor has been studied mostly in mammals, and little is known about its function in lower vertebrates. The results presented in the current paper demonstrate, for the first time, that the teleost MyD88, through its Toll/Interleukin-1 receptor domain, interacts with SsIRF3 and two SsIRF7 paralogs: transcription factors that are critically involved in the virus-induced IFN responses. The data further highlight the potential of transgenic SsMyD88 to modulate the IRF-induced type I IFN response as the adaptor synergized with SsIRF3 to activate IRF-E/ IFN-stimulated response element-containing reporter gene constructs and endogenous myxovirus resistance homolog expression. Microscopy analyses demonstrated that, similar to mammalian MyD88, both endogenous and transgenic SsMyD88 accumulated in intracellular aggregates. However, unlike the endogenous SsMyD88 clusters, which co-localized with endocytosed CpGs and probably represented myddosomes, overexpressed SsMyD88 accumulated in aggresomes. Although these structures accumulated ubiquitinated proteins, they did not associate with the autophagosome markers p62 and light chain 3-like protein, indicating that they are most likely classical aggresomes rather than aggresome-like induced structures, aggregates of ubiquitinated proteins induced by toll-like receptor/ MyD88 signaling in antigen-presenting cells. The significance of the accumulation of transgenic MyD88 in aggresomes is currently unknown; nevertheless it is tempting to speculate that it might represent a defense mechanism against the potentially harmful effects of excessive MyD88 signaling.	[Iliev, Dimitar B.; Sobhkhez, Mehrdad; Fremmerlid, Kjersti; Jorgensen, Jorunn B.] Univ Tromso, Fac Biosci Fisheries & Econ, N-9037 Tromso, Norway	UiT The Arctic University of Tromso	Jorgensen, JB (corresponding author), Univ Tromso, Fac Biosci Fisheries & Econ, N-9037 Tromso, Norway.			jorgensen, jorunn/0000-0002-8163-6777	Research Council of Norway [183196/S40 InNoVacc, 183217/S40 Platform]	Research Council of Norway(Research Council of Norway)	This work was supported by Aquaculture Program of the Research Council of Norway Grants 183196/S40 InNoVacc and 183217/S40 Platform for Viral Aquamedicine.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bergan V, 2006, FEBS J, V273, P3893, DOI 10.1111/j.1742-4658.2006.05382.x; Bergan V, 2010, MOL IMMUNOL, V47, P2005, DOI 10.1016/j.molimm.2010.04.015; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Collet B, 2001, EUR J BIOCHEM, V268, P1577, DOI 10.1046/j.1432-1033.2001.02021.x; Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Fan S, 2008, J IMMUNOL, V180, P5373, DOI 10.4049/jimmunol.180.8.5373; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Holland JW, 2008, MOL IMMUNOL, V46, P269, DOI 10.1016/j.molimm.2008.08.265; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Honda K, 2006, IUBMB LIFE, V58, P290, DOI 10.1080/15216540600702206; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; Iliev DB, 2010, DEV COMP IMMUNOL, V34, P29, DOI 10.1016/j.dci.2009.07.009; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Jaunin F, 1998, EXP CELL RES, V243, P67, DOI 10.1006/excr.1998.4131; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Johansen A, 2004, FISH SHELLFISH IMMUN, V16, P173, DOI 10.1016/S1050-4648(03)00060-3; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jorgensen JB, 2001, DEV COMP IMMUNOL, V25, P313, DOI 10.1016/S0145-305X(00)00068-9; Jorgensen JB, 2001, FISH SHELLFISH IMMUN, V11, P673, DOI 10.1006/fsim.2001.0344; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; LANNAN CN, 1984, IN VITRO CELL DEV B, V20, P671, DOI 10.1007/BF02618871; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu YH, 2010, J IMMUNOL, V185, P3391, DOI 10.4049/jimmunol.0903147; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nagpal K, 2011, J BIOL CHEM, V286, P11875, DOI 10.1074/jbc.M110.199653; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; Oganesyan G, 2008, J BIOL CHEM, V283, P802, DOI 10.1074/jbc.M704755200; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pettersen EF, 2008, FISH SHELLFISH IMMUN, V25, P809, DOI 10.1016/j.fsi.2008.08.014; Purcell MK, 2006, COMP BIOCHEM PHYS D, V1, P77, DOI 10.1016/j.cbd.2005.07.003; Rebl A, 2011, DEV COMP IMMUNOL, V35, P81, DOI 10.1016/j.dci.2010.08.012; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Siednienko J, 2011, J IMMUNOL, V186, P2514, DOI 10.4049/jimmunol.1003093; Skjaeveland I, 2009, DEV COMP IMMUNOL, V33, P1011, DOI 10.1016/j.dci.2009.04.007; Skjesol A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-17; Strandskog G, 2008, VACCINE, V26, P4704, DOI 10.1016/j.vaccine.2008.06.054; Strandskog G, 2007, DEV COMP IMMUNOL, V31, P39, DOI 10.1016/j.dci.2006.05.004; Sun BJ, 2011, J VIROL, V85, P9188, DOI 10.1128/JVI.00319-11; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; van der Sar AM, 2006, INFECT IMMUN, V74, P2436, DOI 10.1128/IAI.74.4.2436-2441.2006; Wergeland HI, 2001, DIS AQUAT ORGAN, V44, P183, DOI 10.3354/dao044183; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022	67	43	46	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42715	42724		10.1074/jbc.M111.293969	http://dx.doi.org/10.1074/jbc.M111.293969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21990356	Green Published, hybrid			2022-12-27	WOS:000298180900078
J	Reiss, K; Kirchner, E; Gijzen, M; Zocher, G; Loffelhardt, B; Nurnberger, T; Stehle, T; Brunner, F				Reiss, Kerstin; Kirchner, Eva; Gijzen, Mark; Zocher, Georg; Loeffelhardt, Birgit; Nuernberger, Thorsten; Stehle, Thilo; Brunner, Frederic			Structural and Phylogenetic Analyses of the GP42 Transglutaminase from Phytophthora sojae Reveal an Evolutionary Relationship between Oomycetes and Marine Vibrio Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING ENZYMES; OLIGOPEPTIDE ELICITOR; CRYSTAL-STRUCTURE; PLANT DEFENSE; BINDING; ACTIVATION; PROTEINS; PATHOGEN; HARVEYI; PEP-13	Transglutaminases (TGases) are ubiquitous enzymes that catalyze selective cross-linking between protein-bound glutamine and lysine residues; the resulting isopeptide bond confers high resistance to proteolysis. Phytophthora sojae, a pathogen of soybean, secretes a Ca2+-dependent TGase (GP42) that is activating defense responses in both host and non-host plants. A GP42 fragment of 13 amino acids, termed Pep-13, was shown to be absolutely indispensable for both TGase and elicitor activity. GP42 does not share significant primary sequence similarity with known TGases from mammals or bacteria. This suggests that GP42 has evolved novel structural and catalytic features to support enzymatic activity. We have solved the crystal structure of the catalytically inactive point mutant GP42 (C290S) at 2.95 angstrom resolution and identified residues involved in catalysis by mutational analysis. The protein comprises three domains that assemble into an elongated structure. Although GP42 has no structural homolog, its core region displays significant similarity to the catalytic core of the Mac-1 cysteine protease from Group A Streptococcus, a member of the papain-like superfamily of cysteine proteases. Proteins that are taxonomically related to GP42 are only present in plant pathogenic oomycetes belonging to the order of the Peronosporales (e. g. Phytophthora, Hyaloperonospora, and Pythium spp.) and in marine Vibrio bacteria. This suggests that a lateral gene transfer event may have occurred between bacteria and oomycetes. Our results offer a basis to design and use highly specific inhibitors of the GP42-like TGase family that may impair the growth of important oomycete and bacterial pathogens.	[Loeffelhardt, Birgit; Brunner, Frederic] Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; [Reiss, Kerstin; Kirchner, Eva; Zocher, Georg; Stehle, Thilo] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany; Agri Food Canada, London, ON N5V 4T3, Canada; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Vanderbilt University	Brunner, F (corresponding author), Univ Tubingen, Zentrum Mol Biol Pflanzen, Morgenstelle 5, D-72076 Tubingen, Germany.	frederic.brunner@zmbp.uni-tuebingen.de	Gijzen, Mark/C-6284-2011	Gijzen, Mark/0000-0002-3715-6389	German Research Foundation (DFG) [Br 3875/2-1, SFB766]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation (DFG) Grants Br 3875/2-1 (to F. B.) and SFB766 (to T. S.)	Agniswamy J, 2006, STRUCTURE, V14, P225, DOI 10.1016/j.str.2005.10.012; Ahvazi B, 2004, J STRUCT BIOL, V147, P200, DOI 10.1016/j.jsb.2004.03.009; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Cheng S, 2010, VACCINE, V28, P2716, DOI 10.1016/j.vaccine.2010.01.023; Chica RA, 2004, PROTEIN SCI, V13, P979, DOI 10.1110/ps.03433304; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAHLBROCK K, 1995, P NATL ACAD SCI USA, V92, P4150, DOI 10.1073/pnas.92.10.4150; Halim VA, 2004, PHYSIOL MOL PLANT P, V64, P311, DOI 10.1016/j.pmpp.2004.10.003; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Liu PC, 1997, CURR MICROBIOL, V35, P32, DOI 10.1007/s002849900207; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LORAND L, 1972, ANAL BIOCHEM, V50, P623, DOI 10.1016/0003-2697(72)90074-7; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murthy SNP, 2002, P NATL ACAD SCI USA, V99, P2738, DOI 10.1073/pnas.052715799; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; NURNBERGER T, 1994, CELL, V78, P449, DOI 10.1016/0092-8674(94)90423-5; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Pfister P, 1998, MOL MICROBIOL, V30, P233, DOI 10.1046/j.1365-2958.1998.01073.x; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Serafini-Fracassini D, 2008, ANN BOT-LONDON, V102, P145, DOI 10.1093/aob/mcn075; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5	35	14	14	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42585	42593		10.1074/jbc.M111.290544	http://dx.doi.org/10.1074/jbc.M111.290544			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994936	hybrid, Green Published			2022-12-27	WOS:000298180900066
J	Hickok, JR; Sahni, S; Mikhed, Y; Bonini, MG; Thomas, DD				Hickok, Jason R.; Sahni, Sumit; Mikhed, Yuliya; Bonini, Marcelo G.; Thomas, Douglas D.			Nitric Oxide Suppresses Tumor Cell Migration through N-Myc Downstream-regulated Gene-1 (NDRG1) Expression ROLE OF CHELATABLE IRON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE BREAST-CANCER; METASTASIS SUPPRESSOR; INDUCIBLE FACTOR-1-ALPHA; POOR-PROGNOSIS; DIFFERENTIATION; TARGET; GROWTH; DRG-1; CHELATORS; PROTEINS	N-Myc downstream-regulated gene 1 (NDRG1) is a ubiquitous cellular protein that is up-regulated under a multitude of stress and growth-regulatory conditions. Although the exact cellular functions of this protein have not been elucidated, mutations in this gene or aberrant expression of this protein have been linked to both tumor suppressive and oncogenic phenotypes. Previous reports have demonstrated that NDRG1 is strongly up-regulated by chemical iron chelators and hypoxia, yet its regulation by the free radical nitric oxide ((NO)-N-center dot) has never been demonstrated. Herein, we examine the chemical biology that confers NDRG1 responsiveness at the mRNA and protein levels to (NO)-N-center dot. We demonstrate that the interaction of (NO)-N-center dot with the chelatable iron pool (CIP) and the appearance of dinitrosyliron complexes (DNIC) are key determinants. Using HCC 1806 triple negative breast cancer cells, we find that NDRG1 is up-regulated by physiological (NO)-N-center dot concentrations in a dose- and time-dependant manner. Tumor cell migration was suppressed by NDRG1 expression and we excluded the involvement of HIF-1 alpha, sGC, N-Myc, and c-Myc as upstream regulatory targets of (NO)-N-center dot. Augmenting the chelatable iron pool abolished (NO)-N-center dot-mediated NDRG1 expression and the associated phenotypic effects. These data, in summary, reveal a link between (NO)-N-center dot, chelatable iron, and regulation of NDRG1 expression and signaling in tumor cells.	[Thomas, Douglas D.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA; [Bonini, Marcelo G.] Univ Illinois, Dept Med & Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Thomas, DD (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, 833 S Wood St,MC 781, Chicago, IL 60612 USA.	ddthomas@uic.edu		Sahni, Sumit/0000-0002-2900-8845; Thomas, Douglas/0000-0003-1252-0786	National Institutes of Health from the National Cancer Institute [K22CA113315]; American Cancer Society; University of Illinois at Chicago, Cancer Center; NATIONAL CANCER INSTITUTE [K22CA113315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094175] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); University of Illinois at Chicago, Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant K22CA113315 from the National Cancer Institute, grants from the American Cancer Society, and the University of Illinois at Chicago, Cancer Center.	Akiba J, 2008, ONCOL REP, V20, P1329, DOI 10.3892/or_00000148; Ando T, 2006, DIS ESOPHAGUS, V19, P454, DOI 10.1111/j.1442-2050.2006.00618.x; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; BOUTON C, 2003, SCI STKE, pPE17; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Chowdhury R, 2011, J MOL BIOL, V410, P268, DOI 10.1016/j.jmb.2011.04.075; Chua MS, 2007, MODERN PATHOL, V20, P76, DOI 10.1038/modpathol.3800711; Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Doi K, 1996, CANCER-AM CANCER SOC, V77, P1598, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1598::AID-CNCR3>3.0.CO;2-A; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Griffith M., 2007, DATABASE MRNA EXPRES; Guang RJ, 2000, CANCER RES, V60, P749; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Hickok JR, 2010, CURR PHARM DESIGN, V16, P381, DOI 10.2174/138161210790232149; Hwang J, 2011, J BIOL CHEM, V286, P12450, DOI 10.1074/jbc.M110.170803; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Li J, 2003, MOL CELL BIOCHEM, V250, P91, DOI 10.1023/A:1024918328162; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Masuda K, 2003, INT J CANCER, V105, P803, DOI 10.1002/ijc.11152; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; Nishio S, 2008, CANCER LETT, V264, P36, DOI 10.1016/j.canlet.2008.01.020; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Petrat F, 2001, BIOCHEM J, V356, P61, DOI 10.1042/0264-6021:3560061; Pieper GM, 2003, P NATL ACAD SCI USA, V100, P3125, DOI 10.1073/pnas.0636938100; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rutherford MN, 2001, LEUKEMIA, V15, P362, DOI 10.1038/sj.leu.2402059; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Salnikow K, 2003, CANCER RES, V63, P3524; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Schwab M, 2004, CANCER LETT, V204, P179, DOI 10.1016/S0304-3835(03)00454-3; Shah MA, 2005, CLIN CANCER RES, V11, P3296, DOI 10.1158/1078-0432.CCR-04-2417; Shaw E, 2002, PROTEINS, V47, P163, DOI 10.1002/prot.10083; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902; Sun BQ, 2009, J NEURO-ONCOL, V94, P213, DOI 10.1007/s11060-009-9859-7; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Thomas DD, 2003, ANTIOXID REDOX SIGN, V5, P307, DOI 10.1089/152308603322110887; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; vanBelzen N, 1997, LAB INVEST, V77, P85; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wistuba II, 1998, CLIN CANCER RES, V4, P2931; Xu X, 2008, MOL PHARMACOL, V73, P833, DOI 10.1124/mol.107.041335; Yan XR, 2008, CANCER LETT, V262, P133, DOI 10.1016/j.canlet.2007.12.010; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	59	59	60	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41413	41424		10.1074/jbc.M111.287052	http://dx.doi.org/10.1074/jbc.M111.287052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21976667	hybrid, Green Published			2022-12-27	WOS:000298057500028
J	Pickens, LB; Sawaya, MR; Rasool, H; Pashkov, I; Yeates, TO; Tang, Y				Pickens, Lauren B.; Sawaya, Michael R.; Rasool, Huma; Pashkov, Inna; Yeates, Todd O.; Tang, Yi			Structural and Biochemical Characterization of the Salicylyl-acyltranferase SsfX3 from a Tetracycline Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; COLI THIOESTERASE-I; GENE-CLUSTER; CATALYTIC TRIAD; ACTIVE-SITE; PROTEASE-I; ANTITUMOR-ACTIVITY; FAMILY; IDENTIFICATION; ENZYME	SsfX3 is a GDSL, family acyltransferase that transfers salicylate to the C-4 hydroxyl of a tetracycline intermediate in the penultimate step during biosynthesis of the anticancer natural product ST2575. The C-4 salicylate takes the place of the more common C-4 dimethylamine functionality, making SsfX3 the first acyltransferase identified to act on a tetracycline substrate. The crystal structure of SsfX3 was determined at 2.5 angstrom, revealing two distinct domains as follows: an N-terminal beta-sandwich domain that resembles a carbohydrate-binding module, and a C-terminal catalytic domain that contains the atypical alpha/beta-hydrolase fold found in the GDSL, hydrolase family of enzymes. The active site lies at one end of a large open binding pocket, which is spatially defined by structural elements from both the N- and C-terminal domains. Mutational analysis in the putative substrate binding pocket identified residues from both domains that are important for binding the acyl donor and acceptor. Furthermore, removal of the N-terminal carbohydrate-binding module-like domain rendered the stand-alone alp-hydrolase domain inactive. The additional noncatalytic module is therefore proposed to be required to define the binding pocket and provide sufficient interactions with the spatially extended tetracyclic substrate. SsfX3 was also demonstrated to accept a variety of non-native acyl groups. This relaxed substrate specificity toward the acyl donor allowed the chemoenzymatic biosynthesis of C-4-modified analogs of the immediate precursor to the bioactive SF2575; these were used to assay the structure activity relationships at the C-4 position.	[Pickens, Lauren B.; Rasool, Huma; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Pashkov, Inna; Yeates, Todd O.; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Yeates, Todd O.; Tang, Yi] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Tang, Y (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	yitang@ucla.edu		Yeates, Todd/0000-0001-5709-9839	National Institutes of Health from NCRR [RR-15301]; United States Department of Energy [W-31-109-ENG-38]; National Science Foundation [0545860, 1033070]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; Directorate For Engineering [1033070] Funding Source: National Science Foundation	National Institutes of Health from NCRR; United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank Dr. Duilio Cascio, the staff of the Advanced Light Source beamline 8.2.1, and the staff of the Advanced Photon Source, Northeastern Collaborative Access Team (NECAT) beamline 24-ID-C for assistance with data collection, The NECAT beamline is supported by National Institutes of Health Award RR-15301 from NCRR. Use of the Advanced Photon Source is supported by the United States Department of Energy, (Vice of Basic Energy Sciences under Contract W-31-109-ENG-38.; This work was supported by National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) Grants 0545860 and 1033070 (to V. T.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Asler IL, 2010, CHEMBIOCHEM, V11, P2158, DOI 10.1002/cbic.201000398; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bricogne G, 2009, BUSTER VERSION 2 8 0; Chang RC, 1996, BIOCHEM BIOPH RES CO, V221, P477, DOI 10.1006/bbrc.1996.0620; CHO HS, 1993, J BIOL CHEM, V268, P9238; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Ghatge MS, 2009, APPL ENVIRON MICROB, V75, P3469, DOI 10.1128/AEM.02590-08; HATSU M, 1992, J ANTIBIOT, V45, P320, DOI 10.7164/antibiotics.45.320; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HORIGUCHI T, 1994, J ANTIBIOT, V47, P545, DOI 10.7164/antibiotics.47.545; Huang YT, 2001, J MOL BIOL, V307, P1075, DOI 10.1006/jmbi.2001.4539; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARASAWA K, 1991, J BIOCHEM, V109, P288; Karasawa K, 1999, J BIOCHEM-TOKYO, V126, P445, DOI 10.1093/oxfordjournals.jbchem.a022470; Kaysser L, 2010, CHEMBIOCHEM, V11, P191, DOI 10.1002/cbic.200900637; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; Kruger RG, 2005, CHEM BIOL, V12, P131, DOI 10.1016/j.chembiol.2004.12.005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Li TL, 2004, CHEM BIOL, V11, P107, DOI 10.1016/j.chembiol.2004.01.001; Lo YC, 2000, ACTA CRYSTALLOGR D, V56, P756, DOI 10.1107/S0907444900004339; Lo YC, 2003, J MOL BIOL, V330, P539, DOI 10.1016/S0022-2836(03)00637-5; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Menendez N, 2004, CHEM BIOL, V11, P21, DOI 10.1016/j.chembiol.2003.12.011; Menendez N, 2007, MICROBIOL-SGM, V153, P3061, DOI 10.1099/mic.0.2007/007922-0; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Montanier C, 2009, PLOS BIOL, V7, P687, DOI 10.1371/journal.pbio.1000071; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Moss SJ, 2002, J AM CHEM SOC, V124, P6544, DOI 10.1021/ja020214b; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Olano C, 2010, NAT PROD REP, V27, P571, DOI 10.1039/b911956f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACAUD M, 1971, EUR J BIOCHEM, V23, P435, DOI 10.1111/j.1432-1033.1971.tb01638.x; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pickens LB, 2009, J AM CHEM SOC, V131, P17677, DOI 10.1021/ja907852c; ROBERTSON DL, 1994, J BIOL CHEM, V269, P2146; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Tyukhtenko SI, 2002, FEBS LETT, V528, P203, DOI 10.1016/S0014-5793(02)03308-2; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; WEI YY, 1995, NAT STRUCT BIOL, V2, P218, DOI 10.1038/nsb0395-218; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xie XK, 2006, CHEM BIOL, V13, P1161, DOI 10.1016/j.chembiol.2006.09.008; Xie XK, 2009, J AM CHEM SOC, V131, P8388, DOI 10.1021/ja903203g	60	10	10	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41539	41551		10.1074/jbc.M111.299859	http://dx.doi.org/10.1074/jbc.M111.299859			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965680	Green Published, hybrid			2022-12-27	WOS:000298057500040
J	Zhang, Y; Liu, LL; Wu, XR; An, XX; Stubbe, J; Huang, MX				Zhang, Yan; Liu, Lili; Wu, Xiaorong; An, Xiuxiang; Stubbe, JoAnne; Huang, Mingxia			Investigation of in Vivo Diferric Tyrosyl Radical Formation in Saccharomyces cerevisiae Rnr2 Protein REQUIREMENT OF Rnr4 AND CONTRIBUTION OF Grx3/4 AND Dre2 PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; YEAST RIBONUCLEOTIDE REDUCTASE; COUPLED ELECTRON-TRANSFER; ESCHERICHIA-COLI; SMALL-SUBUNIT; 2FE-2S CLUSTER; MONOTHIOL GLUTAREDOXINS; ALLOSTERIC REGULATION; SUPEROXIDE-DISMUTASE; KINETIC-ANALYSIS	The beta(2) subunit of class La ribonucleotide reductase (RNR) contains a diferric tyrosyl radical cofactor (Fe-2(III)-Tyr) that is essential for nucleotide reduction. The beta(2) subunit of Saccharomyces cerevisiae is a heterodimer of Rnr2 (beta) and Rnr4 (beta'). Although only beta is capable of iron binding and Tyr formation, cells lacking beta' are either dead or exhibit extremely low Tyr levels and RNR activity depending on genetic backgrounds. Here, we present evidence supporting the model that beta' is required for iron loading and Tyr' formation in beta in vivo via a pathway that is likely dependent on the cytosolic monothiol glutaredoxins Grx3/Grx4 and the Fe-S duster protein Dre2. rnr4 mutants are defective in iron loading into nascent beta and are hypersensitive to iron depletion and the Tyr'-reducing agent hydroxyurea. transient induction of beta' in a GaIRNR4 strain leads to a concomitant increase in iron loading and Tyr' levels in beta. Tyr' can also be rapidly generated using endogenous iron when permeabilized Delta rnr4 spheroplasts are supplemented with recombinant beta' and is inhibited by adding an iron chelator prior to, but not after, beta' supplementation. The growth defects of rnr4 mutants are enhanced by deficiencies in grx3/grx4 and dre2. Moreover, depletion of Dre2 in Gal-DRE2 cells leads to a decrease in both Tyr' levels and beta beta' activity. This result, in combination with previous findings that a low level of Gnc3/4 impairs RNR function, strongly suggests that Grx3/4 and Dre2 serve in the assembly of the deferric Tyr' cofactor in RNR.	[Zhang, Yan; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA; [Liu, Lili; Wu, Xiaorong; An, Xiuxiang; Huang, Mingxia] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Colorado System; University of Colorado Anschutz Medical Campus	Stubbe, J (corresponding author), MIT, Dept Chem, 77 Mass Ave, Cambridge, MA 02139 USA.	stubbe@mit.edu; mingxia.huang@ucdenver.edu	Zhang, Yan/K-1638-2015	Zhang, Yan/0000-0003-2031-0631	National Institutes of Health [GM81393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM81393 (to J. S. and M. H.).	ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; Alves R, 2004, PROTEINS, V56, P354, DOI 10.1002/prot.20110; An XX, 2006, GENETICS, V173, P63, DOI 10.1534/genetics.105.055236; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Banci L, 2011, CHEM BIOL, V18, P794, DOI 10.1016/j.chembiol.2011.03.015; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; FLICK JS, 1990, MOL CELL BIOL, V10, P4757, DOI 10.1128/MCB.10.9.4757; Ge H, 2001, P NATL ACAD SCI USA, V98, P10067, DOI 10.1073/pnas.181336498; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; HARDER J, 1990, FREE RADICAL RES COM, V10, P281, DOI 10.3109/10715769009149896; Hartman JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r49; Hristova D, 2008, BIOCHEMISTRY-US, V47, P3989, DOI 10.1021/bi702408k; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Kashlan OB, 2003, BIOCHEMISTRY-US, V42, P1696, DOI 10.1021/bi020634d; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Licht S., 1999, COMPREHENSIVE NATURA, P163; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Nguyen HHT, 1999, P NATL ACAD SCI USA, V96, P12339, DOI 10.1073/pnas.96.22.12339; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Ortigosa AD, 2006, BIOCHEMISTRY-US, V45, P12282, DOI 10.1021/bi0610404; Perlstein DL, 2005, BIOCHEMISTRY-US, V44, P15366, DOI 10.1021/bi051616+; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Ravi N., 1995, METHOD ENZYMOL, V258, P278; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Saito Y, 2011, BIOCHEM BIOPH RES CO, V408, P329, DOI 10.1016/j.bbrc.2011.04.033; Sommerhalter M, 2004, BIOCHEMISTRY-US, V43, P7736, DOI 10.1021/bi049510m; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; STEEPER JR, 1970, ANAL BIOCHEM, V34, P123, DOI 10.1016/0003-2697(70)90092-8; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Stubbe J, 2011, CURR OPIN CHEM BIOL, V15, P284, DOI 10.1016/j.cbpa.2010.12.001; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; THELANDER L, 1983, BIOCHEM BIOPH RES CO, V110, P859, DOI 10.1016/0006-291X(83)91040-9; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Voegtli WC, 2001, P NATL ACAD SCI USA, V98, P10073, DOI 10.1073/pnas.181336398; Wang J, 2009, BIOCHEMISTRY-US, V48, P11612, DOI 10.1021/bi901588z; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454; Wu G, 2002, BIOCHEMISTRY-US, V41, P5024, DOI 10.1021/bi016073s; Wu SP, 2002, BIOCHEMISTRY-US, V41, P8876, DOI 10.1021/bi0256781; Yu Y, 2006, CLIN CANCER RES, V12, P6876, DOI 10.1158/1078-0432.CCR-06-1954; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	63	42	44	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41499	41509		10.1074/jbc.M111.294074	http://dx.doi.org/10.1074/jbc.M111.294074			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21931161	Green Published, hybrid			2022-12-27	WOS:000298057500036
J	Deshmukh, L; Meller, N; Alder, N; Byzova, T; Vinogradova, O				Deshmukh, Lalit; Meller, Nahum; Alder, Nathan; Byzova, Tatiana; Vinogradova, Olga			Tyrosine Phosphorylation as a Conformational Switch A CASE STUDY OF INTEGRIN beta(3) CYTOPLASMIC TAIL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR-SPECTROSCOPY; STRUCTURAL BASIS; ALPHA-IIB-BETA-3; TRANSMEMBRANE; ACTIVATION; COMPLEX; SYSTEM; ALPHA(IIB)BETA(3); MECHANISM; DYNAMICS	Reversible protein phosphorylation is vital for many fundamental cellular processes. The actual impact of adding and removing phosphate group(s) is 3-fold: changes in the local/global geometry, alterations in the electrostatic potential and, as the result of both, modified protein-target interactions. Here we present a comprehensive structural investigation of the effects of phosphorylation on the conformational as well as functional states of a crucial cell surface receptor, alpha(IIb)beta(3) integrin. We have analyzed phosphorylated (Tyr(747) and Tyr(759)) beta(3) integrin cytoplasmic tail (CT) primarily by NMR, and our data demonstrate that under both aqueous and membrane-mimetic conditions, phosphorylation causes substantial conformational rearrangements. These changes originate from novel ionic interactions and revised phospholipid binding. Under aqueous conditions, the critical Tyr(747) phosphorylation prevents beta 3CT from binding to its heterodimer partner alpha IIbCT, thus likely maintaining an activated state of the receptor. This conclusion was tested in vivo and confirmed by integrin-dependent endothelial cells adhesion assay. Under membrane-mimetic conditions, phosphorylation results in a modified membrane embedding characterized by significant changes in the secondary structure pattern and the overall fold of beta 3CT. Collectively these data provide unique molecular insights into multiple regulatory roles of phosphorylation.	[Deshmukh, Lalit; Vinogradova, Olga] Univ Connecticut, Dept Pharmaceut Sci, Sch Pharm, Storrs, CT 06269 USA; [Alder, Nathan] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Meller, Nahum; Byzova, Tatiana] Cleveland Clin Fdn, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Deshmukh, Lalit] NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA	University of Connecticut; University of Connecticut; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Vinogradova, O (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Sch Pharm, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	olga.vinogradova@uconn.edu	Vinogradova, Olga/ABE-8367-2020; Deshmukh, Lalit/C-5073-2015	Vinogradova, Olga/0000-0001-5101-7361; Byzova, Tatiana/0000-0002-2615-875X	American Heart Association; National Institutes of Health (NIH); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098777] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by American Heart Association and National Institutes of Health (NIH) Grants (to O. V.) and NIH grants (to T. B.).	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshmukh L, 2007, J BIOL CHEM, V282, P32349, DOI 10.1074/jbc.M704666200; Deshmukh L, 2010, J BIOL CHEM, V285, P34875, DOI 10.1074/jbc.M110.159087; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; FISCHER EH, 1955, J BIOL CHEM, V216, P121; Guuntert P, 2004, METHOD MOL BIOL, V278, P353; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li RH, 2002, BIOCHEMISTRY-US, V41, P15618, DOI 10.1021/bi026822l; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips DR, 2001, CURR OPIN CELL BIOL, V13, P546, DOI 10.1016/S0955-0674(00)00250-7; Qin J, 2001, METHOD ENZYMOL, V339, P377, DOI 10.1016/S0076-6879(01)39323-0; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106	32	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40943	40953		10.1074/jbc.M111.231951	http://dx.doi.org/10.1074/jbc.M111.231951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956114	hybrid, Green Published			2022-12-27	WOS:000297315400054
J	Lee, SJ; Cho, KS; Kim, HN; Kim, HJ; Koh, JY				Lee, Sook-Jeong; Cho, Kyung-Sook; Kim, Ha Na; Kim, Hyun-Jae; Koh, Jae-Young			Role of Zinc Metallothionein-3 (ZnMt3) in Epidermal Growth Factor (EGF)-induced c-Abl Protein Activation and Actin Polymerization in Cultured Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CORTICAL-NEURONS; METAL-THIOLATE CLUSTERS; CENTRAL-NERVOUS-SYSTEM; DISEASE BRAIN EXTRACT; INHIBITORY FACTOR; TYROSINE KINASE; ALZHEIMERS-DISEASE; F-ACTIN; BINDING PROTEINS; FAMILY KINASES	Recent evidence indicates that zinc plays a major role in neurochemistry. Of the many zinc-binding proteins, metallothionein-3 (Mt3) is regarded as one of the major regulators of cellular zinc in the brain. However, biological functions of Mt3 are not yet well characterized. Recently, we found that lysosomal dysfunction in metallothionein-3 (Mt3)-null astrocytes involves down-regulation of c-Abl. In this study, we investigated the role of Mt3 in c-Abl activation and actin polymerization in cultured astrocytes following treatment with epidermal growth factor (EGF). Compared with wildtype (WT) astrocytes, Mt3-null cells exhibited a substantial reduction in the activation of c-Abl upon treatment with EGF. Consistent with previous studies, activation of c-Abl by EGF induced dissociation of c-Abl from F-actin. Mt3 added to astrocytic cell lysates bound F-actin, augmented F-actin polymerization, and promoted the dissociation of c-Abl from F-actin, suggesting a possible role for Mt3 in this process. Conversely, Mt3-deficient astrocytes showed significantly reduced dissociation of c-Abl from F-actin following EGF treatment. Experiments using various peptide fragments of Mt3 showed that a fragment containing the N-terminal TCPCP motif (peptide 1) is sufficient for this effect. Removal of zinc from Mt3 or pep 1 with tetrakis(2-pyridylmethyl)ethylenediamine abrogated the effect of Mt3 on the association of c-Abl and F-actin, indicating that zinc binding is necessary for this action. These results suggest that ZnMt3 in cultured astrocytes may be a normal component of c-Abl activation in EGF receptor signaling. Hence, modulation of Mt3 levels or distribution may prove to be a useful strategy for controlling cytoskeletal mobilization following EGT stimulation in brain cells.	[Lee, Sook-Jeong; Cho, Kyung-Sook; Kim, Ha Na; Kim, Hyun-Jae; Koh, Jae-Young] Univ Ulsan, Coll Med, Neural Injury Res Lab, Seoul 138736, South Korea; [Koh, Jae-Young] Univ Ulsan, Coll Med, Dept Neurol, Seoul 138736, South Korea; [Lee, Sook-Jeong; Cho, Kyung-Sook; Kim, Ha Na; Kim, Hyun-Jae; Koh, Jae-Young] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 138736, South Korea	University of Ulsan; University of Ulsan; University of Ulsan	Koh, JY (corresponding author), 388-1 Poongnap Dong, Seoul 138736, South Korea.	jkko@amc.seoul.kr	Koh, Jae-Young/C-9014-2011	Koh, Jae-Young/0000-0002-4318-495X	National Research Foundation of Korea [2005-0093836, 2006-0052326, 2009-0081487]; Korean Government; Korean Health Technology RD Project [A092042]; Ministry of Health and Welfare	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); Korean Health Technology RD Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants 2005-0093836, 2006-0052326, and 2009-0081487 from the National Research Foundation of Korea funded by the Korean Government and Grant A092042 from the Korean Health Technology R&D Project funded by the Ministry of Health and Welfare.	Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; Bell SG, 2009, CHEMBIOCHEM, V10, P55, DOI 10.1002/cbic.200800511; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; Cao HM, 2004, EXP CELL RES, V294, P159, DOI 10.1016/j.yexcr.2003.11.010; Carrasco J, 2000, EXP NEUROL, V163, P46, DOI 10.1006/exnr.1999.7335; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Ding ZC, 2008, J INORG BIOCHEM, V102, P1965, DOI 10.1016/j.jinorgbio.2008.07.007; Ding ZC, 2010, FEBS J, V277, P2912, DOI 10.1111/j.1742-4658.2010.07716.x; DITSCH A, 1994, EUR J BIOCHEM, V224, P223, DOI 10.1111/j.1432-1033.1994.tb20015.x; El Ghazi I, 2006, EXP BIOL MED, V231, P1500; El Ghazi I., 2010, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2011/20863421234102; Faller P, 2010, FEBS J, V277, P2921, DOI 10.1111/j.1742-4658.2010.07717.x; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; HARTWIG JH, 1989, J CELL BIOL, V108, P467, DOI 10.1083/jcb.108.2.467; Hasler DW, 1998, BIOCHEMISTRY-US, V37, P14966, DOI 10.1021/bi9813734; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Jing Z, 2009, J ALZHEIMERS DIS, V17, P409, DOI 10.3233/JAD-2009-1062; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lahti DW, 2005, PROTEIN SCI, V14, P1151, DOI 10.1110/ps.041113005; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; MCCABE MJ, 1993, LAB INVEST, V69, P101; Mendoza-Naranjo A, 2007, J CELL SCI, V120, P279, DOI 10.1242/jcs.03323; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Ni FY, 2007, PROTEINS, V68, P255, DOI 10.1002/prot.21404; OTVOS JD, 1980, P NATL ACAD SCI-BIOL, V77, P7094, DOI 10.1073/pnas.77.12.7094; Palumaa P, 2002, BIOCHEMISTRY-US, V41, P6158, DOI 10.1021/bi025664v; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P1, DOI 10.1016/j.proghi.2008.10.002; Penkowa M, 1999, GLIA, V25, P343; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; REDDY EP, 1983, P NATL ACAD SCI-BIOL, V80, P3623, DOI 10.1073/pnas.80.12.3623; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SCHLIWA M, 1982, PHILOS T ROY SOC B, V299, P199, DOI 10.1098/rstb.1982.0126; SEWELL AK, 1995, BIOCHEMISTRY-US, V34, P4740, DOI 10.1021/bi00014a031; SHERIDAN RE, 1995, TOXICON, V33, P539, DOI 10.1016/0041-0101(94)00185-B; Shumaker DK, 1998, CELL CALCIUM, V23, P151, DOI 10.1016/S0143-4160(98)90114-2; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Smith JM, 2002, FRONT BIOSCI, V7, pD31; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; UCHIDA Y, 1995, J BIOL CHEM, V270, P3365, DOI 10.1074/jbc.270.7.3365; UCHIDA Y, 1989, BRAIN RES, V481, P190, DOI 10.1016/0006-8993(89)90503-9; UCHIDA Y, 1988, BIOCHEM BIOPH RES CO, V150, P1263, DOI 10.1016/0006-291X(88)90765-6; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; West AK, 2008, NEUROTOXICOLOGY, V29, P489, DOI 10.1016/j.neuro.2007.12.006; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2002, J CELL BIOL, V156, P879, DOI 10.1083/jcb.200110014; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Yu WH, 2001, BRAIN RES, V894, P37, DOI 10.1016/S0006-8993(00)03196-6; Zangger K, 1999, PROTEIN SCI, V8, P2630, DOI 10.1110/ps.8.12.2630; Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0	57	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40847	40856		10.1074/jbc.M111.245993	http://dx.doi.org/10.1074/jbc.M111.245993			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21900236	Green Published, hybrid			2022-12-27	WOS:000297315400045
J	Wang, WM; Wu, SY; Lee, AY; Chiang, CM				Wang, Wei-Ming; Wu, Shwu-Yuan; Lee, A-Young; Chiang, Cheng-Ming			Binding Site Specificity and Factor Redundancy in Activator Protein-1-driven Human Papillomavirus Chromatin-dependent Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; TYPE-18 PROMOTER; EPITHELIAL-CELLS; C-FOS; AP-1; JUN; EXPRESSION; FAMILY; AP1; TUMORIGENESIS	Activator protein-1 (AP-1) regulates diverse gene responses triggered by environmental cues and virus-induced cellular stress. Although many signaling events leading to AP-1 activation have been described, the fundamental features underlying binding site selection and factor recruitment of dimeric AP-1 complexes to their target genes remain mostly uncharacterized. Using recombinant full-length human AP-1 dimers formed between c-Jun and Fos family members (c-Fos, FosB, Fra-1, Fra-2) for DNA binding and transcriptional analysis, we found that each of these AP-1 complex exhibits differential activity for distinct non-consensus AP-1 sites present in human papillomavirus (HPV), and each AP-1 complex is capable of activating transcription from in vitro-reconstituted HPV chromatin in a p300- and acetyl-CoA-dependent manner. Transcription from HPV chromatin requires AP-1-dependent and contact-driven recruitment of p300. Acetylation of dimeric AP-1 complexes by p300 enhances AP-1 binding to DNA. Using a human C-33A cervical cancer-derived cell line harboring the episomal HPV type 11 genome, we illustrate binding site selectivity recognized by c-Jun, JunB, JunD, and various Fos family members in a combinatorial and unique pattern, highlighting the diversity and importance of non-canonical binding site recognition by various AP-1 family proteins.	[Wang, Wei-Ming; Wu, Shwu-Yuan; Lee, A-Young; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Lee, A-Young; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Wang, Wei-Ming; Chiang, Cheng-Ming] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Wang, Wei-Ming] Triserv Gen Hosp, Dept Dermatol, Natl Def Med Ctr, Taipei 114, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; National Defense Medical Center; Tri-Service General Hospital	Chiang, CM (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Bldg ND2-210H,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	cheng-ming.chiang@utsouthwestern.edu			National Institutes of Health [CA103867, CA124760]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA103867 and CA124760. This work is Report CSCN 064 from University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center.	ABATE C, 1991, MOL CELL BIOL, V11, P3624, DOI 10.1128/MCB.11.7.3624; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Antinore MJ, 1996, EMBO J, V15, P1950, DOI 10.1002/j.1460-2075.1996.tb00546.x; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; BAUKNECHT T, 1992, EMBO J, V11, P4607, DOI 10.1002/j.1460-2075.1992.tb05563.x; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bouallaga I, 2003, MOL CELL BIOL, V23, P2329, DOI 10.1128/MCB.23.7.2329-2340.2003; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; CHAN WK, 1990, NUCLEIC ACIDS RES, V18, P763, DOI 10.1093/nar/18.4.763; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; CHONG T, 1991, J VIROL, V65, P5933, DOI 10.1128/JVI.65.11.5933-5943.1991; CRIPE T P, 1990, New Biologist, V2, P450; de Wilde J, 2008, CELL ONCOL, V30, P77; DOLLARD SC, 1992, GENE DEV, V6, P1131, DOI 10.1101/gad.6.7.1131; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; GIUS D, 1989, J VIROL, V63, P555, DOI 10.1128/JVI.63.2.555-563.1989; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HERBER B, 1994, ONCOGENE, V9, P1295; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hou SY, 2002, J BIOL CHEM, V277, P45619, DOI 10.1074/jbc.M206829200; Hou SY, 2000, MOL CELL BIOL, V20, P113, DOI 10.1128/MCB.20.1.113-125.2000; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kyo S, 1997, J GEN VIROL, V78, P401, DOI 10.1099/0022-1317-78-2-401; Lee AY, 2009, J BIOL CHEM, V284, P2778, DOI 10.1074/jbc.M805835200; Lee JS, 1996, MOL CELL BIOL, V16, P4312; Lee W, 1987, Cell, V49, P741; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; MACK DH, 1991, P NATL ACAD SCI USA, V88, P9102, DOI 10.1073/pnas.88.20.9102; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; OConnor MJ, 1996, J VIROL, V70, P6529, DOI 10.1128/JVI.70.10.6529-6539.1996; OFFORD EA, 1990, J VIROL, V64, P4792, DOI 10.1128/JVI.64.10.4792-4798.1990; Rosl F, 1997, J VIROL, V71, P362; Sahu G, 2010, J BIOL CHEM, V285, P1321, DOI 10.1074/jbc.M109.081182; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; THIERRY F, 1992, J VIROL, V66, P3740, DOI 10.1128/JVI.66.6.3740-3748.1992; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Vries RGJ, 2001, EMBO J, V20, P6095, DOI 10.1093/emboj/20.21.6095; Wang WM, 2008, PROTEIN EXPRES PURIF, V59, P144, DOI 10.1016/j.pep.2008.01.016; Welter JF, 1995, ONCOGENE, V11, P2681; WISDOM R, 1993, MOL CELL BIOL, V13, P7429, DOI 10.1128/MCB.13.12.7429; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; Wu SY, 1996, BIOTECHNIQUES, V21, P718; Zhao W, 1997, J VIROL, V71, P8832, DOI 10.1128/JVI.71.11.8832-8840.1997; Zhou X, 2011, MOL CELL, V42, P826, DOI 10.1016/j.molcel.2011.05.025	56	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40974	40986		10.1074/jbc.M111.290874	http://dx.doi.org/10.1074/jbc.M111.290874			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21937452	hybrid, Green Published			2022-12-27	WOS:000297315400057
J	Jung, MS; Park, JH; Ryu, YS; Choi, SH; Yoon, SH; Kwen, MY; Oh, JY; Song, WJ; Chung, SH				Jung, Min-Su; Park, Jung-Hwa; Ryu, Young Shin; Choi, Sun-Hee; Yoon, Song-Hee; Kwen, Mi-Yang; Oh, Ji Youn; Song, Woo-Joo; Chung, Sul-Hee			Regulation of RCAN1 Protein Activity by Dyrk1A Protein-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; CALCINEURIN PHOSPHATASE-ACTIVITY; DOWN-SYNDROME; ALZHEIMERS-DISEASE; FUNCTIONAL-LINK; HUMAN HOMOLOG; TAU-PROTEIN; STRIATED-MUSCLES; OXIDATIVE STRESS; T-CELLS	Two genes on chromosome 21, namely dual specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) and regulator of calcineurin 1 (RCAN1), have been implicated in some of the phenotypic characteristics of Downsyndrome, including the early onset of Alzheimer disease. Although a link between Dyrk1A and RCAN1 and the nuclear factor of activated T cells (NFAT) pathway has been reported, it remains unclear whether Dyrk1A directly interacts with RCAN1. In the present study, Dyrk1A is shown to directly interact with and phosphorylate RCAN1 at Ser(112) and Thr(192) residues. Dyrk1A-mediated phosphorylation of RCAN1 at Ser(112) primes the protein for the GSK3 beta-mediated phosphorylation of Ser(108). Phosphorylation of RCAN1 at Thr(192) by Dyrk1A enhances the ability of RCAN1 to inhibit the phosphatase activity of calcineurin (Caln), leading to reduced NFAT transcriptional activity and enhanced Tau phosphorylation. These effects are mediated by the enhanced binding of RCAN1 to Caln and its extended half-life caused by Dyrk1A-mediated phosphorylation. Furthermore, an increased expression of phospho-Thr(192)-RCAN1 was observed in the brains of transgenic mice overexpressing the Dyrk1A protein. These results suggest a direct link between Dyrk1A and RCAN1 in the Caln-NFAT signaling and Tau hyperphosphorylation pathways, supporting the notion that the synergistic interaction between the chromosome 21 genes RCAN1 and Dyrk1A is associated with a variety of pathological features associated with DS.	[Jung, Min-Su; Park, Jung-Hwa; Ryu, Young Shin; Choi, Sun-Hee; Yoon, Song-Hee; Kwen, Mi-Yang; Oh, Ji Youn; Song, Woo-Joo; Chung, Sul-Hee] Inje Univ, Grad Program Neurosci, Inst Brain Sci & Technol, Res Grp 1, Pusan 614735, South Korea	Inje University	Song, WJ (corresponding author), Inje Univ, Grad Program Neurosci, Inst Brain Sci & Technol, Res Grp 1, 633-146 Gaegeum,2 Dong, Pusan 614735, South Korea.	wjsong@inje.ac.kr; sulchung@inje.ac.kr			Korea Healthcare Technology RD Project; Ministry of Health, Welfare, and Family Affairs, Republic of Korea [A092004, A080227]; National Research Foundation of Korea; Ministry of Education, Science, and Technology [2009-0073210, 2009-0067388, 2011-0014085, 2011-0023401]	Korea Healthcare Technology RD Project; Ministry of Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Korea Healthcare Technology R&D Project and Ministry of Health, Welfare, and Family Affairs, Republic of Korea, Grants A092004 and A080227. This work was also supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (Grants 2009-0073210, 2009-0067388, 2011-0014085, and 2011-0023401).	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abdul Hafiz Mohmmad, 2010, Mol Cell Pharmacol, V2, P7; Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Aubareda A, 2006, CELL SIGNAL, V18, P1430, DOI 10.1016/j.cellsig.2005.11.006; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Cook CN, 2005, J ALZHEIMERS DIS, V8, P63; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; de la Luna S, 2006, TRENDS MOL MED, V12, P451, DOI 10.1016/j.molmed.2006.08.001; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Garver TD, 1999, MOL PHARMACOL, V55, P632; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Lee J, 2008, J BIOL CHEM, V283, P3392, DOI 10.1074/jbc.M706707200; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; Martinez-Martineza S, 2009, P NATL ACAD SCI USA, V106, P6117, DOI 10.1073/pnas.0812544106; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Mulero MC, 2009, J BIOL CHEM, V284, P9394, DOI 10.1074/jbc.M805889200; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Pfister SC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-24; Poppek D, 2006, BIOCHEM J, V400, P511, DOI 10.1042/BJ20060463; Porta S, 2007, HUM MOL GENET, V16, P1039, DOI 10.1093/hmg/ddm049; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Ryu YS, 2010, J NEUROCHEM, V115, P574, DOI 10.1111/j.1471-4159.2010.06769.x; Sagoo JK, 1996, BIOCHEM J, V320, P879, DOI 10.1042/bj3200879; Shindoh N, 1996, BIOCHEM BIOPH RES CO, V225, P92, DOI 10.1006/bbrc.1996.1135; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Wegiel J, 2011, J NEUROPATH EXP NEUR, V70, P36, DOI 10.1097/NEN.0b013e318202bfa1; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zeitelhofer M, 2007, NAT PROTOC, V2, P1692, DOI 10.1038/nprot.2007.226	55	60	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40401	40412		10.1074/jbc.M111.253971	http://dx.doi.org/10.1074/jbc.M111.253971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965663	Green Published, hybrid			2022-12-27	WOS:000296925700071
J	Lommel, M; Schott, A; Jank, T; Hofmann, V; Strahl, S				Lommel, Mark; Schott, Andrea; Jank, Thomas; Hofmann, Verena; Strahl, Sabine			A Conserved Acidic Motif Is Crucial for Enzymatic Activity of Protein O-Mannosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOLICHYL PHOSPHATE-MANNOSE; SACCHAROMYCES-CEREVISIAE; GENE FAMILY; GLYCOSYLATION; YEAST; MANNOSYLATION; POMT1; GLYCOSYLTRANSFERASES; MEMBERS; PMT1P	Protein O-mannosylation is an essential modification in fungi and mammals. It is initiated at the endoplasmic reticulum by a conserved family of dolichyl phosphate mannose-dependent protein O-mannosyltransferases (PMTs). PMTs are integral membrane proteins with two hydrophilic loops (loops 1 and 5) facing the endoplasmic reticulum lumen. Formation of dimeric PMT complexes is crucial for mannosyltransferase activity, but the direct cause is not known to date. In bakers' yeast, O-mannosylation is catalyzed largely by heterodimeric Pmt1p-Pmt2p and homodimeric Pmt4p complexes. To further characterize Pmt1p-Pmt2p complexes, we developed a photoaffinity probe based on the artificial mannosyl acceptor substrate Tyr-Ala-Thr-Ala-Val. The photoreactive probe was preferentially crosslinked to Pmt1p, and deletion of the loop 1 (but not loop 5) region abolished this interaction. Analysis of Pmt1p loop 1 mutants revealed that especially Glu-78 is crucial for binding of the photoreactive probe. Glu-78 belongs to an Asp-Glu motif that is highly conserved among PMTs. We further demonstrate that single amino acid substitutions in this motif completely abolish activity of Pmt4p complexes. In contrast, both acidic residues need to be exchanged to eliminate activity of Pmt1p-Pmt2p complexes. On the basis of our data, we propose that the loop 1 regions of dimeric complexes form part of the catalytic site.	[Lommel, Mark; Schott, Andrea; Jank, Thomas; Hofmann, Verena; Strahl, Sabine] Heidelberg Univ, Ctr Organismal Studies Heidelberg, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Strahl, S (corresponding author), Heidelberg Univ, Ctr Organismal Studies Heidelberg, Neuenheimer Feld 360, D-69120 Heidelberg, Germany.	sabine.strahl@cos.uni-heidelberg.de	Jank, Thomas/R-9627-2017; Lommel, Mark/E-3836-2014	Lommel, Mark/0000-0001-6954-3714	Deutsche Forschungsgemeinschaft [SFB638]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB638.	Arroyo J, 2011, MOL MICROBIOL, V79, P1529, DOI 10.1111/j.1365-2958.2011.07537.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Endo T, 2005, Acta Myol, V24, P64; Gentzsch M, 1995, FEBS LETT, V377, P128, DOI 10.1016/0014-5793(95)01324-5; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Goder V, 2011, J CELL SCI, V124, P144, DOI 10.1242/jcs.072181; Hendershot LL, 2002, ANAL BIOCHEM, V307, P273, DOI 10.1016/S0003-2697(02)00059-3; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; IMMERVOLL T, 1995, YEAST, V11, P1345, DOI 10.1002/yea.320111403; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; Kang JY, 2005, J BIOL CHEM, V280, P9489, DOI 10.1074/jbc.M413867200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lommel M, 2010, METHOD ENZYMOL, V479, P323, DOI 10.1016/S0076-6879(10)79018-2; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; LUSSIER M, 1995, J BIOL CHEM, V270, P2770, DOI 10.1074/jbc.270.6.2770; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Mahne M, 2006, FEMS MICROBIOL LETT, V259, P226, DOI 10.1111/j.1574-6968.2006.00269.x; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; Oriol R, 2002, MOL BIOL EVOL, V19, P1451, DOI 10.1093/oxfordjournals.molbev.a004208; Sambrook J., 2001, MOL CLONING LAB MANU; SHARMA C B, 1991, Glycobiology, V1, P367, DOI 10.1093/glycob/1.4.367; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; STRAHLBOLSINGER S, 1993, P NATL ACAD SCI USA, V90, P8164, DOI 10.1073/pnas.90.17.8164; STRAHLBOLSINGER S, 1991, EUR J BIOCHEM, V196, P185, DOI 10.1111/j.1432-1033.1991.tb15802.x; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086	39	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39768	39775		10.1074/jbc.M111.281196	http://dx.doi.org/10.1074/jbc.M111.281196			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21956107	Green Published, hybrid			2022-12-27	WOS:000296925700010
J	Bonocora, RP; Decker, PK; Glass, S; Knipling, L; Hinton, DM				Bonocora, Richard P.; Decker, Phillip K.; Glass, Stephanie; Knipling, Leslie; Hinton, Deborah M.			Bacteriophage T4 MotA Activator and the beta-Flap Tip of RNA Polymerase Target the Same Set of sigma(70) Carboxyl-terminal Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR; PROTEIN-PROTEIN; PROMOTER RECOGNITION; ABORTIVE INITIATION; ANGSTROM RESOLUTION; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; OPEN-COMPLEX; REGION 4	Sigma factors, the specificity subunits of RNA polymerase, are involved in interactions with promoter DNA, the core subunits of RNA polymerase, and transcription factors. The bacteriophage T4-encoded activator, MotA, is one such factor, which engages the C terminus of the Escherichia coli housekeeping sigma factor, sigma(70). MotA functions in concert with a phage-encoded co-activator, AsiA, as a molecular switch. This process, termed sigma appropriation, inhibits host transcription while activating transcription from a class of phage promoters. Previous work has demonstrated that MotA contacts the C terminus of sigma(70), H5, a region that is normally bound within RNA polymerase by its interaction with the beta-flap tip. To identify the specific sigma(70) residues responsible for interacting with MotA and the beta-flap tip, we generated single substitutions throughout the C terminus of sigma(70). We find that MotA targets H5 residues that are normally engaged by the beta-flap. In two-hybrid assays, the interaction of sigma(70) with either the beta-flap tip or MotA is impaired by alanine substitutions at residues Leu-607, Arg-608, Phe-610, Leu-611, and Asp-613. Transcription assays identify Phe-610 and Leu-611 as the key residues for MotA/AsiA-dependent transcription. Phe-610 is a crucial residue in the H5/beta-flap tip interaction using promoter clearance assays with RNA polymerase alone. Our results show how the actions of small transcriptional factors on a defined local region of RNA polymerase can fundamentally change the specificity of polymerase.	[Bonocora, Richard P.; Decker, Phillip K.; Glass, Stephanie; Knipling, Leslie; Hinton, Deborah M.] NIDDK, Gene Express & Regulat Sect, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hinton, DM (corresponding author), NIDDK, Gene Express & Regulat Sect, Lab Cell & Mol Biol, NIH, Bldg 8,Rm 2A-13, Bethesda, MD 20892 USA.	dhinton@helix.nih.gov	Hinton, Deborah/AAQ-2596-2021	Knipling, Leslie/0000-0002-2636-6460	NIDDK, National Institutes of Health	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of the NIDDK, National Institutes of Health.	Arthur TM, 2000, J BIOL CHEM, V275, P23113, DOI 10.1074/jbc.M002040200; Baxter K, 2006, J MOL BIOL, V363, P931, DOI 10.1016/j.jmb.2006.08.074; Bonocora RP, 2008, MOL MICROBIOL, V69, P331, DOI 10.1111/j.1365-2958.2008.06276.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; Burns HD, 1996, BIOCHEM J, V317, P305, DOI 10.1042/bj3170305; CARPOUSIS AJ, 1982, J MOL BIOL, V157, P619, DOI 10.1016/0022-2836(82)90502-2; Chen Q, 2010, MOL MICROBIOL, V77, P1326, DOI 10.1111/j.1365-2958.2010.07293.x; Decker KB, 2009, MOL MICROBIOL, V73, P137, DOI 10.1111/j.1365-2958.2009.06759.x; Dove SL, 2000, P NATL ACAD SCI USA, V97, P13215, DOI 10.1073/pnas.97.24.13215; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Geszvain K, 2004, J MOL BIOL, V343, P569, DOI 10.1016/j.jmb.2004.08.063; Gregory BD, 2004, P NATL ACAD SCI USA, V101, P4554, DOI 10.1073/pnas.0400923101; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hinton DM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-289; HINTON DM, 1991, J BIOL CHEM, V266, P18034; Hinton DM, 1996, METHOD ENZYMOL, V274, P43; Hinton DM, 2000, J MOL BIOL, V304, P731, DOI 10.1006/jmbi.2000.4113; Hook-Barnard I, 2006, J BACTERIOL, V188, P8352, DOI 10.1128/JB.00853-06; HOOKBARNARD IG, 2007, GENE REGULATION SYST; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; Hu JC, 2000, METHODS, V20, P80, DOI 10.1006/meth.1999.0908; KEILTY S, 1987, J BIOL CHEM, V262, P6389; Klocko AD, 2009, MOL MICROBIOL, V73, P152, DOI 10.1111/j.1365-2958.2009.06758.x; KUMAR A, 1994, J MOL BIOL, V235, P405, DOI 10.1006/jmbi.1994.1001; KUMAR A, 1993, J MOL BIOL, V232, P406, DOI 10.1006/jmbi.1993.1400; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Lambert LJ, 2004, EMBO J, V23, P2952, DOI 10.1038/sj.emboj.7600312; MARCHAMEGADZIE R, 1995, MOL MICROBIOL, V15, P649, DOI 10.1111/j.1365-2958.1995.tb02374.x; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Miller J. H, 1972, EXPT MOL GENETICS; Minakhin L, 2001, J MOL BIOL, V306, P631, DOI 10.1006/jmbi.2001.4445; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Nickels BE, 2005, P NATL ACAD SCI USA, V102, P4488, DOI 10.1073/pnas.0409850102; Nickels BE, 2002, J MOL BIOL, V324, P17, DOI 10.1016/S0022-2836(02)01043-4; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Pal D, 2003, J MOL BIOL, V325, P827, DOI 10.1016/S0022-2836(02)01307-4; Pande S, 2002, J BACTERIOL, V184, P3957, DOI 10.1128/JB.184.14.3957-3964.2002; Patikoglou GA, 2007, J MOL BIOL, V372, P649, DOI 10.1016/j.jmb.2007.06.081; Rhodius VA, 2000, J MOL BIOL, V299, P311, DOI 10.1006/jmbi.2000.3737; SCHERZINGER E, 1977, NUCLEIC ACIDS RES, V4, P4151, DOI 10.1093/nar/4.12.4151; Stevens A., 1976, RNA POLYMERASE, P617; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vo NV, 2003, BIOCHEMISTRY-US, V42, P3798, DOI 10.1021/bi026962v; Yuan AH, 2009, MOL MICROBIOL, V74, P1018, DOI 10.1111/j.1365-2958.2009.06916.x; Yuan AH, 2009, P NATL ACAD SCI USA, V106, P6597, DOI 10.1073/pnas.0812832106	47	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39290	39296		10.1074/jbc.M111.278762	http://dx.doi.org/10.1074/jbc.M111.278762			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21911499	Green Published, hybrid			2022-12-27	WOS:000296759800047
J	Rajesh, S; Bago, R; Odintsova, E; Muratov, G; Baldwin, G; Sridhar, P; Rajesh, S; Overduin, M; Berditchevski, F				Rajesh, Sundaresan; Bago, Ruzica; Odintsova, Elena; Muratov, Gayrat; Baldwin, Gouri; Sridhar, Pooja; Rajesh, Sandya; Overduin, Michael; Berditchevski, Fedor			Binding to Syntenin-1 Protein Defines a New Mode of Ubiquitin-based Interactions Regulated by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MELANOMA CELLS; PDZ PROTEIN; MDA-9/SYNTENIN; SYNDECAN; DOMAINS; RECOGNITION; ADHESION; TETRASPANINS; TRAFFICKING; DEGRADATION	Syntenin-1 is a PDZ domain-containing adaptor that controls trafficking of transmembrane proteins including those associated with tetraspanin-enriched microdomains. We describe the interaction of syntenin-1 with ubiquitin through a novel binding site spanning the C terminus of ubiquitin, centered on Arg72, Leu73, and Arg74. A conserved LYPSL sequence in the N terminus, as well as the C-terminal region of syntenin-1, are essential for binding to ubiquitin. We present evidence for the regulation of this interaction through syntenin-1 dimerization. We have also established that syntenin-1 is phosphorylated downstream of Ulk1, a serine/threonine kinase that plays a critical role in autophagy and regulates endocytic trafficking. Importantly, Ulk1-dependent phosphorylation of Ser6 in the LYPSL prevents the interaction of syntenin-1 with ubiquitin. These results define an unprecedented ubiquitin-dependent pathway involving syntenin-1 that is regulated by Ulk1.	[Rajesh, Sundaresan; Bago, Ruzica; Odintsova, Elena; Muratov, Gayrat; Baldwin, Gouri; Sridhar, Pooja; Rajesh, Sandya; Overduin, Michael; Berditchevski, Fedor] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Overduin, M (corresponding author), Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England.	m.overduin@bham.ac.uk; f.berditchevski@bham.ac.uk		Odintsova, Elena/0000-0002-4098-5559; Overduin, Michael/0000-0002-3114-6585	Breast Cancer Campaign; Cancer Research UK; Medical Research Council; Biotechnology and Biological Sciences Research Council; Wellcome Trust; MRC [G0601073] Funding Source: UKRI; Medical Research Council [G0601073] Funding Source: researchfish	Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Breast Cancer Campaign (to F. B.), Cancer Research UK (to F. B. and M.O.), and the Medical Research Council and the Biotechnology and Biological Sciences Research Council (to M.O.).; We thank Dr. D. Powner for generating a FLAG-tagged syntenin-1 construct, Prof. J. Baz Jackson for isothermal calorimetry access, and Drs. T. Cierpicki and Z. Derewenda (University of Virginia) for their GST-syntenin-1 expression plasmid. NMR data were collected at the Wellcome Trust-funded Henry Wellcome Building for Nuclear Magnetic Resonance.	Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; Carvallo L, 2010, J BIOL CHEM, V285, P29546, DOI 10.1074/jbc.M110.155812; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; de Juan-Sanz J., 2011, TRAFFIC         0912, DOI [10.1111/j.1600-0854.2011.01278.x, DOI 10.1111/J.1600-0854.2011.01278.X]; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Drag M, 2008, BIOCHEM J, V415, P367, DOI 10.1042/BJ20080779; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Hwangbo C, 2011, J BIOL CHEM, V286, P33601, DOI 10.1074/jbc.M110.206789; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Ko JW, 2006, J NEUROSCI, V26, P963, DOI 10.1523/JNEUROSCI.4475-05.2006; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Okumura F, 2011, MOL CELL BIOCHEM, V352, P163, DOI 10.1007/s11010-011-0750-4; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Sakamoto T, 1999, BIOCHEMISTRY-US, V38, P11634, DOI 10.1021/bi990310y; Tomoda T, 2004, GENE DEV, V18, P541, DOI 10.1101/gad.1151204; Urena JM, 1999, J CELL SCI, V112, P773; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zhou X, 2007, P NATL ACAD SCI USA, V104, P5842, DOI 10.1073/pnas.0701402104; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	40	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39606	39614		10.1074/jbc.M111.262402	http://dx.doi.org/10.1074/jbc.M111.262402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949238	hybrid, Green Published			2022-12-27	WOS:000296759800077
J	Warfel, NA; Niederst, M; Newton, AC				Warfel, Noel A.; Niederst, Matt; Newton, Alexandra C.			Disruption of the Interface between the Pleckstrin Homology (PH) and Kinase Domains of Akt Protein Is Sufficient for Hydrophobic Motif Site Phosphorylation in the Absence of mTORC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; GROWTH-FACTORS; IN-VIVO; ACTIVATION; PATHWAY; INHIBITION; MECHANISM; COMPLEX; RICTOR; DEGRADATION	The pro-survival kinase Akt requires phosphorylation at two conserved residues, the activation loop site (Thr-308) and the hydrophobic motif site (Ser-473), for maximal activation. Previous reports indicate that mTORC2 is necessary for phosphorylation of the hydrophobic motif and that this site is not phosphorylated in cells lacking components of the mTORC2 complex, such as Sin1. Here we show that Akt can be phosphorylated at the hydrophobic motif site (Ser-473) in the absence of mTORC2. First, increasing the levels of PIP3 in Sin1(-/-) MEFs by (i) expression of a constitutively active PI3K or (ii) relief of a negative feedback loop on PI3K by prolonged inhibition of mTORC1 or S6K is sufficient to rescue hydrophobic motif phosphorylation of Akt. The resulting accumulation of PIP3 at the plasma membrane results in Ser-473 phosphorylation. Second, constructs of Akt in which the PH domain is constitutively dis-engaged from the kinase domain are phosphorylated at the hydrophobic motif site in Sin1(-/-) MEFs; both myristoylated-Akt and Akt lacking the PH domain are phosphorylated at Ser-473. Thus, disruption of the interface between the PH and kinase domains of Akt bypasses the requirement for mTORC2. In summary, these data support a model in which Akt can be phosphorylated at Ser-473 and activated in the absence of mTORC2 by mechanisms that depend on removal of the PH domain from the kinase domain.	[Warfel, Noel A.; Niederst, Matt; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Warfel, Noel A.; Niederst, Matt] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), 9500 Gilman Dr,MC 0721, La Jolla, CA 92093 USA.	anewton@ucsd.edu		Warfel, Noel/0000-0001-6410-9011	National Institutes of Health [GM43154, NIH GM067946]; DoD BCRP [BC093021]; UCSD through National Institute of General Medical Sciences [T32 GM007752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, T32GM007752, R01GM067946, R37GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD BCRP(United States Department of Defense); UCSD through National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM43154 and NIH GM067946 (to A. C. N.) and DoD BCRP award BC093021 (to N. A. W.). This work was also supported by the UCSD Graduate Training Program in Cellular and Molecular Pharmacology through an institutional training grant from the National Institute of General Medical Sciences T32 GM007752 (to N. A. W. and M. N.).	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kim JH, 2006, CARCINOGENESIS, V27, P475, DOI 10.1093/carcin/bgi272; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Liu JY, 2011, J BIOL CHEM, V286, P6510, DOI 10.1074/jbc.M110.183087; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Rodik-Outmezguine V. S., 2011, CANCER DISCOV, V1, P248; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	43	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39122	39129		10.1074/jbc.M111.278747	http://dx.doi.org/10.1074/jbc.M111.278747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21908613	Green Published, hybrid			2022-12-27	WOS:000296759800031
J	Yamaguchi, Y; Du, XY; Zhao, L; Morser, J; Leung, LLK				Yamaguchi, Yasuto; Du, Xiao-Yan; Zhao, Lei; Morser, John; Leung, Lawrence L. K.			Proteolytic Cleavage of Chemerin Protein Is Necessary for Activation to the Active Form, Chem157S, Which Functions as a Signaling Molecule in Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; RECEPTOR; INFLAMMATION; EXPRESSION; PROTEASES; ADIPOKINE; CHEMR23; LIGAND; ADIPOGENESIS; CASCADES	Chemerin is a chemoattractant involved in innate and adaptive immunity as well as an adipokine implicated in adipocyte differentiation. Chemerin circulates as an inactive precursor in blood whose bioactivity is closely regulated through proteolytic processing at its C terminus. We developed methodology for production of different recombinant chemerin isoforms (chem163S, chem157S, and chem155A) which allowed us to obtain large quantities of these proteins with purity of >95%. Chem158K was generated from chem163S by plasmin cleavage. Characterization by mass spectrometry and Edman degradation demonstrated that both the N and C termini were correct for weach isoform. Ca2+ mobilization assays showed that the EC50 values for chem163S and chem158K were 54.2 +/- 19.9 nM and 65.2 +/- 13.2 nM, respectively, whereas chem157S had a similar to 50-fold higher potency with an EC50 of 1.2 +/- 0.7 nM. Chem155A had no agonist activity and weak antagonist activity, causing a 50% reduction of chem157S activity at a molar ratio of 100:1. Similar results were obtained in a chemotaxis assay. Because chem158K is the dominant form in cerebrospinal fluid from patients with glioblastoma (GBM), we examined the significance of chemerin in GBM biology. In silico analysis showed chemerin mRNA was significantly increased in tissue from grade III and IV gliomas. Furthermore, U-87 MG cells, a human GBM line, express the chemerin receptors, chemokine-like receptor 1 and chemokine receptor-like 2, and chem157S triggered Ca2+ flux. This study emphasized the necessity of appropriate C-terminal proteolytic processing to generate the likely physiologic form of active chemerin, chem157S, and suggested a possible role in malignant GBM.	[Yamaguchi, Yasuto; Du, Xiao-Yan; Zhao, Lei; Morser, John] Stanford Univ, Div Hematol, Dept Med, Sch Med, Stanford, CA 94305 USA; [Leung, Lawrence L. K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Morser, J (corresponding author), 269 Campus Dr,CCSR 1155,MC5156, Stanford, CA 94305 USA.	jmorser@stanford.edu; lawrence.leung@stanford.edu			National Institutes of Health [HL057530, AI085268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL057530 and AI085268.	Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Benton T, 2002, CYTOTECHNOLOGY, V38, P43, DOI 10.1023/A:1021141712344; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Cash JL, 2010, J IMMUNOL, V184, P5315, DOI 10.4049/jimmunol.0903378; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Fernandez-Ranvier GG, 2008, ARCH SURG-CHICAGO, V143, P841, DOI 10.1001/archsurg.143.9.841; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Guillabert A, 2008, J LEUKOCYTE BIOL, V84, P1530, DOI 10.1189/jlb.0508322; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Miao ZH, 2007, J IMMUNOL, V178, P7395, DOI 10.4049/jimmunol.178.11.7395; Mohr S, 2004, BIOCHIMIE, V86, P13, DOI 10.1016/j.biochi.2003.11.008; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Shimamura K, 2009, PEPTIDES, V30, P1529, DOI 10.1016/j.peptides.2009.05.030; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Williams S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-17; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Xiang D, 2010, PROTEIN EXPRES PURIF, V69, P153, DOI 10.1016/j.pep.2009.07.013; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zhao L, 2011, J BIOL CHEM, V286, P39520, DOI 10.1074/jbc.M111.258954	31	51	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39510	39519		10.1074/jbc.M111.258921	http://dx.doi.org/10.1074/jbc.M111.258921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949124	Green Published, hybrid			2022-12-27	WOS:000296759800068
J	Chauhan, AK; Moore, TL				Chauhan, Anil K.; Moore, Terry L.			T Cell Activation by Terminal Complex of Complement and Immune Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MEMBRANE ATTACK COMPLEX; PROTEIN-KINASE PATHWAY; IMMUNOLOGICAL SYNAPSE; ACTIN CYTOSKELETON; LIPID RAFTS; REGULATORY PROTEINS; ADHESION MOLECULES; ACQUIRED-IMMUNITY; ENDOTHELIAL-CELLS	T cell hyperactivation and complement consumption are prominent features of the immunopathology of systemic lupus erythematosus. Although complement activation is secondary to autoantibodies that form immune complexes (ICs), the trigger for alterations in human peripheral blood T cells is poorly understood. To study the impact (on T cells) of several types of preformed ICs and terminal complement complex, also referred to as C5b-9, we incubated these immune reactants with peripheral blood naive CD4(+) T cells as well as Jurkat cells and analyzed their effects on cellular behavior. We first assembled the C5b-9 in situ on the membrane and observed its assembly primarily on a single site where it promoted aggregation of membrane rafts and recruitment of the CD3 signaling complex. However, C5b-9 alone did not initiate proliferation or commencement of downstream signaling events associated with T cell activation. When T cells were treated with ICs together with nonlytic C5b-9, changes associated with T cell activation by possible antigen engagement then occurred. T cell antigen receptor signaling proteins, including zeta-chain, ZAP-70, Syk, Src, and Lck, were phosphorylated and organized in a synapse-like structure. The cytoskeleton formed F-actin spindles and a distal pole complex, resulting in a bipolar distribution of phosphorylated ezrin-radixin-moesin and F-actin. Furthermore, ICs and nonlytic C5b-9 induced T cell proliferation and IFN-gamma production. These results raise the possibility that ICs and the nonlytic C5b-9 modulate T cell-mediated responses in systemic lupus erythematosus and other related chronic inflammatory disorders.	[Chauhan, Anil K.; Moore, Terry L.] St Louis Univ, Sch Med, Div Adult & Pediat Rheumatol, St Louis, MO 63104 USA	Saint Louis University	Chauhan, AK (corresponding author), St Louis Univ, Sch Med, Div Adult & Pediat Rheumatol, 1402 S Grand Blvd, St Louis, MO 63104 USA.	chauhana@slu.edu			Campbell-Avery Charitable Trust; Dorr Family Charitable Trust; Lupus/Juvenile Research Group of St. Louis, MO	Campbell-Avery Charitable Trust; Dorr Family Charitable Trust; Lupus/Juvenile Research Group of St. Louis, MO	This work was supported by The Campbell-Avery Charitable Trust, The Dorr Family Charitable Trust, and Lupus/Juvenile Research Group of St. Louis, MO.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; ACCARDOPALUMBO A, 1993, J IMMUNOL METHODS, V163, P169, DOI 10.1016/0022-1759(93)90119-R; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bangs SC, 2006, TRENDS IMMUNOL, V27, P518, DOI 10.1016/j.it.2006.09.006; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Bossi F, 2004, J IMMUNOL, V173, P6921, DOI 10.4049/jimmunol.173.11.6921; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Casarsa C, 2003, EUR J IMMUNOL, V33, P1260, DOI 10.1002/eji.200323574; Chauhan AK, 2006, CLIN EXP IMMUNOL, V145, P398, DOI 10.1111/j.1365-2249.2006.03135.x; Chiu YY, 1998, J INVEST ALLERG CLIN, V8, P239; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; CYBULSKY AV, 1989, AM J PHYSIOL, V257, pF826, DOI 10.1152/ajprenal.1989.257.5.F826; Czermak BJ, 1999, AM J PATHOL, V154, P1513, DOI 10.1016/S0002-9440(10)65405-3; Dashiell SM, 2000, GLIA, V30, P187, DOI 10.1002/(SICI)1098-1136(200004)30:2<187::AID-GLIA8>3.0.CO;2-7; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Deng GM, 2008, J IMMUNOL, V181, P4019, DOI 10.4049/jimmunol.181.6.4019; Dykstra M, 2001, J LEUKOCYTE BIOL, V70, P699; EICHMANN K, 1995, IMMUNOL LETT, V44, P87, DOI 10.1016/0165-2478(94)00197-Y; Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B; ESSER AF, 1979, P NATL ACAD SCI USA, V76, P1410, DOI 10.1073/pnas.76.3.1410; Fang YF, 1998, J IMMUNOL, V160, P5273; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; Fosbrink M, 2006, J BIOL CHEM, V281, P19009, DOI 10.1074/jbc.M602055200; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GREEN H, 1960, ANN NY ACAD SCI, V87, P352, DOI 10.1111/j.1749-6632.1960.tb23205.x; HAMMER CH, 1975, P NATL ACAD SCI USA, V72, P5076, DOI 10.1073/pnas.72.12.5076; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; He HT, 2008, EMBO REP, V9, P525, DOI 10.1038/embor.2008.78; HEYNINGEN SV, 1974, SCIENCE, V183, P656, DOI DOI 10.1126/SCIENCE.183.4125.656; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Krishnan S, 2004, J IMMUNOL, V172, P7821, DOI 10.4049/jimmunol.172.12.7821; Leitinger B, 2002, J CELL SCI, V115, P963; Low JM, 2009, PROTEOM CLIN APPL, V3, P829, DOI 10.1002/prca.200800073; MANNIK M, 1987, J RHEUMATOL, V14, P35; MARMONT AM, 1980, LANCET, V1, P1088; MaStellos D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P125, DOI 10.2174/1568010053622993; Mellbye OJ, 1996, CLIN RHEUMATOL, V15, P441, DOI 10.1007/BF02229640; MERRILL JE, 1980, CLIN EXP IMMUNOL, V42, P345; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Mitchell JS, 2002, J IMMUNOL, V168, P2737, DOI 10.4049/jimmunol.168.6.2737; MORGAN BP, 1988, CLIN EXP IMMUNOL, V73, P473; MORGAN BP, 1987, J IMMUNOL, V138, P246; MORGAN BP, 1989, BIOCHEM J, V264, P1; Moskovich O, 2007, J BIOL CHEM, V282, P29977, DOI 10.1074/jbc.M703742200; NICULESCU F, 1994, J BIOL CHEM, V269, P4417; NICULESCU F, 1993, J IMMUNOL, V150, P214; Niculescu F, 1997, J IMMUNOL, V158, P4405; Niculescu F, 2001, IMMUNOL RES, V24, P191, DOI 10.1385/IR:24:2:191; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Palmer E, 2009, NAT REV IMMUNOL, V9, P206, DOI 10.1038/nri2469; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; PODACK ER, 1979, P NATL ACAD SCI USA, V76, P897, DOI 10.1073/pnas.76.2.897; Rus H, 1997, IMMUNOPHARMACOLOGY, V38, P177, DOI 10.1016/S0162-3109(97)00063-5; SANTANA V, 1975, IMMUNOLOGY, V28, P1173; SHIN ML, 1996, BIOMEMBRANE, P119; STOUT RD, 1975, J EXP MED, V142, P611, DOI 10.1084/jem.142.3.611; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; WENER MH, 1987, MEDICINE, V66, P85, DOI 10.1097/00005792-198703000-00001; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZWIRNER J, 1989, IMMUNOLOGY, V66, P270	82	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38627	38637		10.1074/jbc.M111.266809	http://dx.doi.org/10.1074/jbc.M111.266809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900254	Green Published, hybrid			2022-12-27	WOS:000296594200075
J	Fassler, M; Li, XL; Kaether, C				Fassler, Matthias; Li, Xiaolin; Kaether, Christoph			Polar Transmembrane-based Amino Acids in Presenilin 1 Are Involved in Endoplasmic Reticulum Localization, Pen2 Protein Binding, and gamma-Secretase Complex Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; PLASMA-MEMBRANE; TRAFFICKING; DOMAIN; NICASTRIN; ENDOPROTEOLYSIS; ASSOCIATION; RETENTION; TRANSPORT	gamma-Secretase is composed of the four membrane proteins presenilin, nicastrin, Pen2, and Aph1. These four proteins assemble in a coordinated and regulated manner into a high molecular weight complex. The subunits constitute a total of 19 transmembrane domains (TMD), with many carrying important amino acids involved in catalytic activity, interaction with other subunits, or in ER retention/retrieval of unassembled subunits. We here focus on TMD4 of presenilin 1 (PS1) and show that a number of polar amino acids are critical for gamma-secretase assembly and function. An asparagine, a threonine, and an aspartate form a polar interface important for endoplasmic reticulum retention/retrieval. A single asparagine in TMD4 of PS1 is involved in a protein-protein interaction by binding to another asparagine in Pen2. Intriguingly, a charged aspartate in TMD4 is critical for gamma-secretase activity, most likely by stabilizing the newly formed complex.	[Fassler, Matthias; Li, Xiaolin; Kaether, Christoph] Fritz Lipmann Inst, Leibniz Inst Altersforsch, D-07745 Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Kaether, C (corresponding author), Fritz Lipmann Inst, Leibniz Inst Altersforsch, Beutenbergstr 11, D-07745 Jena, Germany.	ckaether@fli-leibniz.de	LI, Xiaolin/GXH-0388-2022	LI, Xiaolin/0000-0003-1524-051X	Deutsche Forschungsgemeinschaft [KA 1751/4-1]; Hans-and-Ilse-Breuer Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans-and-Ilse-Breuer Stiftung	This work was supported by Grant KA 1751/4-1 from the Deutsche Forschungsgemeinschaft (to C. K.) and the Hans-and-Ilse-Breuer Stiftung (to M. F.).	Capell A, 1997, J NEUROCHEM, V69, P2432; Chiang P. M., 2010, NEUROBIOL AGING; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Fassler M, 2010, TRAFFIC, V11, P250, DOI 10.1111/j.1600-0854.2009.01014.x; Gong P, 2010, J BIOL CHEM, V285, P38042, DOI 10.1074/jbc.M110.132613; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kaether C, 2006, NEURODEGENER DIS, V3, P275, DOI 10.1159/000095267; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P16298, DOI 10.1074/jbc.M109.000067; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schwappach B, 2008, MOL MEMBR BIOL, V25, P270, DOI 10.1080/09687680801960998; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Wacker I, 1997, J CELL SCI, V110, P1453; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Watanabe N, 2010, J BIOL CHEM, V285, P19738, DOI 10.1074/jbc.M110.101287; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	38	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38390	38396		10.1074/jbc.M111.252429	http://dx.doi.org/10.1074/jbc.M111.252429			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914807	Green Published, hybrid			2022-12-27	WOS:000296594200053
J	Kapeli, K; Hurlin, PJ				Kapeli, Katannya; Hurlin, Peter J.			Differential Regulation of N-Myc and c-Myc Synthesis, Degradation, and Transcriptional Activity by the Ras/Mitogen-activated Protein Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GENE-REGULATION; MESSENGER-RNAS; CODING REGIONS; E-BOX; PHOSPHORYLATION; RAS; CELLS; TRANSFORMATION; TRANSLATION	Myc transcription factors are important regulators of proliferation and can promote oncogenesis when deregulated. Deregulated Myc expression in cancers can result from MYC gene amplification and translocation but also from alterations in mitogenic signaling pathways that affect Myc levels through both transcriptional and post-transcription mechanisms. For example, mutations in Ras family GTPase proteins that cause their constitutive activation can increase cellular levels of c-Myc by interfering with its rapid proteasomal degradation. Although enhanced protein stability is generally thought to be applicable to other Myc family members, here we show that c-Myc and its paralog N-Myc respond to oncogenic H-Ras (H-Ras(G12V)) in very different ways. H-Ras(G12V) promotes accumulation of both c-Myc and N-Myc, but although c-Myc accumulation is achieved by enhanced protein stability, N-Myc accumulation is associated with an accelerated rate of translation that overcomes a surprising H-Ras(G12V)-mediated destabilization of N-Myc. We show that H-Ras(G12V)-mediated degradation of N-Myc functions independently of key phosphorylation sites in the highly conserved Myc homology box I region that controls c-Myc protein stability by oncogenic Ras. Finally, we found that N-Myc and c-Myc transcriptional activity is associated with their proteasomal degradation but that N-Myc may be uniquely dependent on Ras-stimulated proteolysis for target gene expression. Taken together, these studies provide mechanistic insight into how oncogenic Ras augments N-Myc levels in cells and suggest that enhanced N-Myc translation and degradation-coupled transactivation may contribute to oncogenesis.	[Hurlin, Peter J.] Shriners Hosp Children, Res Ctr, Portland, OR 97239 USA; [Kapeli, Katannya; Hurlin, Peter J.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University	Hurlin, PJ (corresponding author), Shriners Hosp Children, Res Ctr, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	pjh@shcc.org			N. L. Tartar Trust; Shriners Hospitals for Children	N. L. Tartar Trust; Shriners Hospitals for Children	This work was supported by an N. L. Tartar Trust award (to K. K.) and a Shriners Hospitals for Children grant (to P. J. H.).	AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dhall G, 2009, J CHILD NEUROL, V24, P1418, DOI 10.1177/0883073809341668; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Forman JJ, 2010, CELL CYCLE, V9, P1533, DOI 10.4161/cc.9.8.11202; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gomez-Roman N, 2006, BIOCHEM SOC SYMP, V73, P141, DOI 10.1042/bss0730141; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hurlin Peter J., 2005, Birth Defects Research, V75, P340, DOI 10.1002/bdrc.20059; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Jang JH, 2001, CANCER RES, V61, P3541; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Karreth FA, 2009, CURR OPIN GENET DEV, V19, P4, DOI 10.1016/j.gde.2008.12.006; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; Katoh M, 2008, INT J ONCOL, V33, P233, DOI 10.3892/ijo_00000001; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Keppler BR, 2011, BBA-GENE REGUL MECH, V1809, P109, DOI 10.1016/j.bbagrm.2010.08.005; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lonard DM, 2009, PROG MOL BIOL TRANSL, V87, P117, DOI 10.1016/S1877-1173(09)87004-X; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; MILTENBERGER RJ, 1995, MOL CELL BIOL, V15, P2527; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Origanti S, 2007, CANCER RES, V67, P4834, DOI 10.1158/0008-5472.CAN-06-4627; Ota S, 2007, DEVELOPMENT, V134, P1583, DOI 10.1242/dev.000703; Ota S, 2009, HUM MOL GENET, V18, P2609, DOI 10.1093/hmg/ddp195; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; SAWAI S, 1991, NEW BIOL, V3, P861; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seo HR, 2008, J BIOL CHEM, V283, P15601, DOI 10.1074/jbc.M800987200; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Spence J, 2006, MOL CANCER RES, V4, P47, DOI 10.1158/1541-7786.MCR-04-0187; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; Tanaka T, 2005, CANCER LETT, V228, P267, DOI 10.1016/j.canlet.2004.12.051; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Tsuneoka M, 1998, J BIOCHEM-TOKYO, V124, P1013, DOI 10.1093/oxfordjournals.jbchem.a022193; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; Wang XM, 2007, METHOD ENZYMOL, V431, P113, DOI 10.1016/S0076-6879(07)31007-0; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yaari S, 2005, CLIN CANCER RES, V11, P4321, DOI 10.1158/1078-0432.CCR-04-2071; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; YANCOPOULOS GD, 1985, P NATL ACAD SCI USA, V82, P5455, DOI 10.1073/pnas.82.16.5455; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191	65	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38498	38508		10.1074/jbc.M111.276675	http://dx.doi.org/10.1074/jbc.M111.276675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908617	Green Published, hybrid			2022-12-27	WOS:000296594200064
J	Lorente, E; Garcia, R; Lopez, D				Lorente, Elena; Garcia, Ruth; Lopez, Daniel			Allele-dependent Processing Pathways Generate the Endogenous Human Leukocyte Antigen (HLA) Class I Peptide Repertoire in Transporters Associated with Antigen Processing (TAP)-deficient Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD8(+) T-LYMPHOCYTES; EPSTEIN-BARR-VIRUS; TRIPEPTIDYL-PEPTIDASE; PROTEASOME INHIBITORS; ENDOPLASMIC-RETICULUM; VIRAL-ANTIGEN; MONOCLONAL-ANTIBODY; CONVERTING-ENZYME; MOLECULES; PROTEIN	The transporters associated with antigen processing (TAP) allow the supply of peptides derived from the cytosol to translocate to the endoplasmic reticulum, where they complex with nascent human leukocyte antigen (HLA) class I molecules. However, infected and tumor cells with TAP molecules blocked or individuals with nonfunctional TAP complexes are able to present HLA class I ligands generated by TAP-independent processing pathways. These peptides are detected by the CD8(+) lymphocyte cellular response. Here, the generation of the overall peptide repertoire associated with four different HLA class I molecules in TAP-deficient cells was studied. Using different protease inhibitors, four different proteolytic specificities were identified. These data demonstrate the different allele-dependent complex processing pathways involved in the generation of the HLA class I peptide repertoire in TAP-deficient cells.	[Lopez, Daniel] Inst Salud Carlos III, Unidad Procesamiento Antigen, Ctr Nacl Microbiol, Majadahonda 28220, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Lopez, D (corresponding author), Inst Salud Carlos III, Unidad Procesamiento Antigen, Ctr Nacl Microbiol, Majadahonda 28220, Madrid, Spain.	dlopez@isciii.es	Lorente, Elena/B-1219-2019; López, Daniel/I-2632-2014	Lorente, Elena/0000-0002-2246-6851; López, Daniel/0000-0003-0268-5878	Fundacion para la Investigacion y Prevencion del SIDA en Espana Foundation	Fundacion para la Investigacion y Prevencion del SIDA en Espana Foundation	This work was supported by Fundacion para la Investigacion y Prevencion del SIDA en Espana Foundation grants.	ANDERSON KS, 1993, J IMMUNOL, V151, P3407; Bangert I, 2011, BIOL CHEM, V392, P61, DOI 10.1515/BC.2011.007; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; CHESNUT RW, 1982, J IMMUNOL, V129, P2382; Contin C, 2003, J BIOL CHEM, V278, P32801, DOI 10.1074/jbc.M209993200; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fromm SV, 2002, CELL IMMUNOL, V215, P207; Gil-Torregrosa BC, 2000, TRAFFIC, V1, P641, DOI 10.1034/j.1600-0854.2000.010808.x; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; HANADA M, 1992, J ANTIBIOT, V45, P1746, DOI 10.7164/antibiotics.45.1746; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Johnstone C, 2008, J GEN VIROL, V89, P2194, DOI 10.1099/vir.0.2008/002485-0; Johnstone C, 2007, TRAFFIC, V8, P1486, DOI 10.1111/j.1600-0854.2007.00635.x; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; KOZLOWSKI S, 1993, J IMMUNOL, V151, P4033; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Lautscham G, 2003, MICROBES INFECT, V5, P291, DOI 10.1016/S1286-4579(03)00031-5; Lautscham G, 2001, J EXP MED, V194, P1053, DOI 10.1084/jem.194.8.1053; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lopez D, 2001, J IMMUNOL, V167, P4238, DOI 10.4049/jimmunol.167.8.4238; Lopez D, 2011, J BIOL CHEM, V286, P16910, DOI 10.1074/jbc.M111.234658; Lopez D, 2010, J IMMUNOL, V184, P5193, DOI 10.4049/jimmunol.1000050; Luckey CJ, 2001, J IMMUNOL, V167, P1212, DOI 10.4049/jimmunol.167.3.1212; MCDONALD JK, 1968, J BIOL CHEM, V243, P2028; Neumeister C, 2001, J GEN VIROL, V82, P441, DOI 10.1099/0022-1317-82-2-441; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; OMURA S, 1991, J ANTIBIOT, V44, P113, DOI 10.7164/antibiotics.44.113; PARHAM P, 1978, NATURE, V276, P397, DOI 10.1038/276397a0; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Rose C, 1996, NATURE, V380, P403, DOI 10.1038/380403a0; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; SCHIRMBECK R, 1995, EUR J IMMUNOL, V25, P1063, DOI 10.1002/eji.1830250431; Schwarz K, 2000, J IMMUNOL, V164, P6147, DOI 10.4049/jimmunol.164.12.6147; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; THORNBERRY NA, 1994, METHOD ENZYMOL, V244, P615; Tiwari N, 2007, J IMMUNOL, V178, P7932, DOI 10.4049/jimmunol.178.12.7932; Umezawa H, 1976, Methods Enzymol, V45, P678; van den Hoorn T, 2011, CURR OPIN IMMUNOL, V23, P88, DOI 10.1016/j.coi.2010.11.002; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Weinzierl AO, 2008, EUR J IMMUNOL, V38, P1503, DOI 10.1002/eji.200838136; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; York IA, 2006, J IMMUNOL, V177, P1434, DOI 10.4049/jimmunol.177.3.1434; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175	58	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38054	38059		10.1074/jbc.M111.281808	http://dx.doi.org/10.1074/jbc.M111.281808			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914809	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000296594200017
J	Sandtner, W; Egwolf, B; Khalili-Araghi, F; Sanchez-Rodriguez, JE; Roux, B; Bezanilla, F; Holmgren, M				Sandtner, Walter; Egwolf, Bernhard; Khalili-Araghi, Fatemeh; Sanchez-Rodriguez, Jorge E.; Roux, Benoit; Bezanilla, Francisco; Holmgren, Miguel			Ouabain Binding Site in a Functioning Na+/K+ ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; NA,K-ATPASE ALPHA-SUBUNIT; SODIUM-POTASSIUM PUMP; CARDIAC GLYCOSIDE BINDING; BETA-SUBUNIT; DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; EXTRACELLULAR DOMAIN; STRUCTURAL INSIGHTS; NA+,K+-ATPASE PUMP	The Na+/K+ ATPase is an almost ubiquitous integral membrane protein within the animal kingdom. It is also the selective target for cardiotonic derivatives, widely prescribed inhibitors for patients with heart failure. Functional studies revealed that ouabain-sensitive residues distributed widely throughout the primary sequence of the protein. Recently, structural work has brought some consensus to the functional observations. Here, we use a spectroscopic approach to estimate distances between a fluorescent ouabain and a lanthanide binding tag (LBT), which was introduced at five different positions in the Na+/K+ ATPase sequence. These five normally functional LBT-Na+/K+ ATPase constructs were expressed in the cell membrane of Xenopus laevis oocytes, operating under physiological internal and external ion conditions. The spectroscopic data suggest two mutually exclusive distances between the LBT and the fluorescent ouabain. From the estimated distances and using homology models of the LBT-Na+/K+ ATPase constructs, approximate ouabain positions could be determined. Our results suggest that ouabain binds at two sites along the ion permeation pathway of the Na+/K+ ATPase. The external site (low apparent affinity) occupies the same region as previous structural findings. The high apparent affinity site is, however, slightly deeper toward the intracellular end of the protein. Interestingly, in both cases the lactone ring faces outward. We propose a sequential ouabain binding mechanism that is consistent with all functional and structural studies.	Med Univ Vienna, Dept Pharmacol, A-1090 Vienna, Austria; [Egwolf, Bernhard] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Khalili-Araghi, Fatemeh; Sanchez-Rodriguez, Jorge E.; Roux, Benoit; Bezanilla, Francisco] Univ Chicago, Gordon Ctr Integrat Sci, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Holmgren, Miguel] NINDS, Mol Neurophysiol Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	Medical University of Vienna; Max Planck Society; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roux, B (corresponding author), 929 E 57 St, Chicago, IL 60637 USA.	roux@uchicago.edu; fbezanilla@uchicago.edu; holmgren@ninds.nih.gov		Khalili-Araghi, Fatemeh/0000-0002-0756-5560; Sanchez-Rodriguez, Jorge E./0000-0001-8747-7239	National Institutes of Health [R01-GM062342, R01-GM030376, U54-GM087519]; NINDS, National Institutes of Health; Consejo Nacional de Ciencia y TecnologIa (Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062342, R01GM030376, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003019, ZIANS002993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Consejo Nacional de Ciencia y TecnologIa (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM062342, R01-GM030376, and U54-GM087519. This work was also supported by the Intramural Research Program NINDS, National Institutes of Health.; Recipient of a postdoctoral fellowship from Consejo Nacional de Ciencia y TecnologIa (Mexico).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; ANTOLOVIC R, 1995, FEBS LETT, V368, P169, DOI 10.1016/0014-5793(95)00637-O; Brinkmann K, 1997, EUR J BIOCHEM, V249, P301, DOI 10.1111/j.1432-1033.1997.t01-2-00301.x; CANESSA CM, 1993, J BIOL CHEM, V268, P17722; CANESSA CM, 1992, EMBO J, V11, P1681, DOI 10.1002/j.1460-2075.1992.tb05218.x; Colina C, 2007, NAT STRUCT MOL BIOL, V14, P427, DOI 10.1038/nsmb1237; Croyle ML, 1997, EUR J BIOCHEM, V248, P488, DOI 10.1111/j.1432-1033.1997.00488.x; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; De Pont JJHHM, 2009, PFLUG ARCH EUR J PHY, V457, P623, DOI 10.1007/s00424-008-0467-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; HILGEMANN DW, 1994, SCIENCE, V263, P1429, DOI 10.1126/science.8128223; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; JAISSER F, 1992, J BIOL CHEM, V267, P16895; JEFFREY PD, 1995, J MOL BIOL, V248, P344, DOI 10.1016/S0022-2836(95)80055-7; KAWAMURA M, 1984, BIOCHIM BIOPHYS ACTA, V774, P188, DOI 10.1016/0005-2736(84)90290-6; KIRLEY TL, 1989, J BIOL CHEM, V264, P7185; LINGREL JB, 1991, SOC GEN PHY, V46, P1; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martinez-Francois JR, 2010, J GEN PHYSIOL, V135, P149, DOI 10.1085/jgp.200910324; Middleton DA, 2000, P NATL ACAD SCI USA, V97, P13602, DOI 10.1073/pnas.250471997; MILLER RP, 1990, BIOCHEMISTRY-US, V29, P1524, DOI 10.1021/bi00458a025; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nitz M, 2004, ANGEW CHEM INT EDIT, V43, P3682, DOI 10.1002/anie.200460028; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; PRICE EM, 1989, J BIOL CHEM, V264, P21902; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Qiu LY, 2005, J BIOL CHEM, V280, P32349, DOI 10.1074/jbc.M505168200; Reyes N, 2006, NATURE, V443, P470, DOI 10.1038/nature05129; Sandtner W, 2007, BIOPHYS J, V93, pL45, DOI 10.1529/biophysj.107.119073; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; STURMER W, 1992, FEBS LETT, V300, P1, DOI 10.1016/0014-5793(92)80151-6; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	46	42	45	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38177	38183		10.1074/jbc.M111.267682	http://dx.doi.org/10.1074/jbc.M111.267682			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911500	Green Published, hybrid			2022-12-27	WOS:000296594200031
J	Syson, K; Stevenson, CEM; Rejzek, M; Fairhurst, SA; Nair, A; Bruton, CJ; Field, RA; Chater, KF; Lawson, DM; Bornemann, S				Syson, Karl; Stevenson, Clare E. M.; Rejzek, Martin; Fairhurst, Shirley A.; Nair, Alap; Bruton, Celia J.; Field, Robert A.; Chater, Keith F.; Lawson, David M.; Bornemann, Stephen			Structure of Streptomyces Maltosyltransferase GlgE, a Homologue of a Genetically Validated Anti-tuberculosis Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE FAMILY; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; TREHALOSE METABOLISM; MALTOGENIC AMYLASE; COELICOLOR A3(2); GLYCOGEN; GLUCAN; SPECIFICITY; SOFTWARE	GlgE is a recently identified (1 -> 4)-alpha-D-glucan:phosphate alpha-D-maltosyltransferase involved in alpha-glucan biosynthesis in bacteria and is a genetically validated anti-tuberculosis drug target. It is a member of the GH13_3 CAZy subfamily for which no structures were previously known. We have solved the structure of GlgE isoform I from Streptomyces coelicolor and shown that this enzyme has the same catalytic and very similar kinetic properties to GlgE from Mycobacterium tuberculosis. The S. coelicolor enzyme forms a homodimer with each subunit comprising five domains, including a core catalytic alpha-amylase-type domain A with a (beta/alpha)(8) fold. This domain is elaborated with domain B and two inserts that are specifically configured to define a well conserved donor pocket capable of binding maltose. Domain A, together with domain N from the neighboring subunit, forms a hydrophobic patch that is close to the maltose-binding site and capable of binding cyclodextrins. Cyclodextrins competitively inhibit the binding of maltooligosaccharides to the S. coelicolor enzyme, showing that the hydrophobic patch overlaps with the acceptor binding site. This patch is incompletely conserved in the M. tuberculosis enzyme such that cyclodextrins do not inhibit this enzyme, despite acceptor length specificity being conserved. The crystal structure reveals two further domains, C and S, the latter being a helix bundle not previously reported in GH13 members. The structure provides a framework for understanding how GlgE functions and will help guide the development of inhibitors with therapeutic potential.	[Syson, Karl; Stevenson, Clare E. M.; Rejzek, Martin; Fairhurst, Shirley A.; Nair, Alap; Field, Robert A.; Lawson, David M.; Bornemann, Stephen] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Bruton, Celia J.; Chater, Keith F.] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bornemann, S (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stephen.bornemann@jic.ac.uk	Bornemann, Stephen/K-2938-2012	Bornemann, Stephen/0000-0001-5930-9473; Field, Rob/0000-0001-8574-0275	United Kingdom Biotechnology and Biological Sciences Research Council [BB/I012850/1]; Metabolism Institute; BBSRC [BBS/E/J/000C0647, BBS/E/J/000C0618, BB/I012850/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0647, BBS/E/J/000C0618, BB/I012850/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Metabolism Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Grant BB/I012850/1 and the Metabolism Institute Strategic Programme Grant to the John Innes Centre.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Damager I, 2004, CARBOHYD RES, V339, P1727, DOI 10.1016/j.carres.2004.05.019; Damager I, 2010, CHEM REV, V110, P2049, DOI 10.1021/cr900227t; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL, 2002, PYMOL USERS MANUAL; DEWAARD P, 1989, J MAGN RESON, V81, P173, DOI 10.1016/0022-2364(89)90276-X; Dinadayala P, 2004, J BIOL CHEM, V279, P12369, DOI 10.1074/jbc.M308908200; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; GENGHOF DS, 1978, CARBOHYD RES, V61, P291, DOI 10.1016/S0008-6215(00)84489-4; Goedl C, 2008, CARBOHYD RES, V343, P2032, DOI 10.1016/j.carres.2008.01.029; Henrissat B, 2008, CURR OPIN STRUC BIOL, V18, P527, DOI 10.1016/j.sbi.2008.09.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; Janecek S, 1997, J MOL EVOL, V45, P322, DOI 10.1007/PL00006236; JUNNEMANN J, 1993, CARBOHYD RES, V249, P91, DOI 10.1016/0008-6215(93)84062-B; Kalscheuer R, 2010, DRUG NEWS PERSPECT, V23, P619, DOI 10.1358/dnp.2010.23.10.1534855; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Machius M, 1996, J MOL BIOL, V260, P409, DOI 10.1006/jmbi.1996.0410; MacRae IJ, 2007, ACTA CRYSTALLOGR D, V63, P993, DOI 10.1107/S0907444907036128; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PLASKITT KA, 1995, PHILOS T R SOC B, V347, P105, DOI 10.1098/rstb.1995.0016; Preiss J., 2009, ENCY MICROBIOLOGY, P145; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Roujeinikova A, 2002, J MOL BIOL, V321, P149, DOI 10.1016/S0022-2836(02)00570-3; Roujeinikova A, 2001, J MOL BIOL, V312, P119, DOI 10.1006/jmbi.2001.4944; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; SOGAARD M, 1993, CARBOHYD POLYM, V21, P137, DOI 10.1016/0144-8617(93)90008-R; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Yeo M, 2005, MICROBIOL-SGM, V151, P855, DOI 10.1099/mic.0.27428-0	53	41	48	6	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38298	38310		10.1074/jbc.M111.279315	http://dx.doi.org/10.1074/jbc.M111.279315			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914799	hybrid, Green Published			2022-12-27	WOS:000296594200043
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			Bacterial Chimeras and Reversible Phosphorylation: The Work of Walther Stoeckenius	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Reprint							CATALYZING OXIDATIVE PHOSPHORYLATION; ADENOSINE TRIPHOSPHATASE; PARTIAL RESOLUTION; PURPLE MEMBRANE							Kresge, Nicole/0000-0003-1551-6627				OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; PENEFSKY HS, 1960, J BIOL CHEM, V235, P3330; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; STOECKENIUS W, 1979, BIOCHIM BIOPHYS ACTA, V505, P215, DOI 10.1016/0304-4173(79)90006-5	5	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31							e7	10.1074/jbc.O111.000246	http://dx.doi.org/10.1074/jbc.O111.000246			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21919246	hybrid, Green Published			2022-12-27	WOS:000293268700001
J	Swant, J; Goodwin, JS; North, A; Ali, AA; Gamble-George, J; Chirwa, S; Khoshbouei, H				Swant, Jarod; Goodwin, J. Shawn; North, Ashley; Ali, Ahmad Abdul; Gamble-George, Joyonna; Chirwa, Sanika; Khoshbouei, Habibeh			alpha-Synuclein Stimulates a Dopamine Transporter-dependent Chloride Current and Modulates the Activity of the Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; PARKINSONS-DISEASE; MICE LACKING; AMPHETAMINE; COCAINE; RECEPTOR; KINETICS; NEURONS; CHANNEL; BINDING	Dysregulation of dopamine (DA) homeostasis is implicated in neurodegenerative diseases, drug addiction, and neuropsychiatric disorders. The neuronal plasma membrane dopamine transporter (DAT) is essential for the maintenance of DA homeostasis in the brain. alpha-Synuclein is a 140-amino acid protein that forms a stable complex with DAT and is linked to the pathogenesis of neurodegenerative disease. To elucidate the potential functional consequences of DAT/alpha-synuclein interaction, we explored alpha-synuclein modulation of DAT activity in midbrain dopaminergic neurons obtained from TH::RFP mice, immortalized DA neurons, and a heterologous system expressing DAT. We used dual pipette whole cell patch clamp recording to measure the DAT-mediated current before and after dialysis of recombinant alpha-synuclein into immortalized DA neurons. Our data suggest that intracellular alpha-synuclein induces a Na+ independent but Cl--sensitive inward current in DAT-expressing cells. This current is blocked by DAT blocker GBR12935 and is absent when heat-inactivated alpha-synuclein is dialyzed into these cells. The functional consequence of this interaction on DAT activity was further examined with real-time monitoring of transport function using a fluorescent substrate of DAT, 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP(+)). Overexpression of alpha-synucleinin DAT-positive immortalized DA neurons and CHO cells expressing DAT decreased the magnitude and rate of DAT-mediated substrate uptake without a decrease in the initial binding of the substrate at the plasma membrane. Taken together our findings are consistent with the interpretation that DAT/alpha-synuclein interaction at the cell surface results in a DAT-dependent, Na+-insensitive, Cl-sensitive inward current with a decrease in substrate uptake, suggesting that DAT/alpha-synuclein interaction can modulate dopamine transmission and thus neuronal function.	[Swant, Jarod; Goodwin, J. Shawn; North, Ashley; Gamble-George, Joyonna; Chirwa, Sanika; Khoshbouei, Habibeh] Meharry Med Coll, Dept Biomed Sci, Nashville, TN 37208 USA; [Ali, Ahmad Abdul] James Madison Univ, Harrisonburg, VA 22807 USA	Meharry Medical College; James Madison University	Khoshbouei, H (corresponding author), Meharry Med Coll, Dept Biomed Sci, Nashville, TN 37208 USA.	hkhoshbouei@mmc.edu	Gamble-George, Joyonna C/Q-2075-2017; Gamble-George, Joyonna Carrie/GQA-7423-2022; Gamble-George, Joyonna/AAM-7598-2021	Gamble-George, Joyonna C/0000-0002-5492-9216; Gamble-George, Joyonna/0000-0002-5492-9216; Khoshbouei, Habibeh/0000-0002-1533-8771	National Institutes of Health [DA026947, DA021471, NS071122, U01NS041071, U54RR026140, S10RR0254970]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025497, U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041071, R01NS071122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA021471, R01DA026947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA026947, DA021471, and NS071122.; Microscopy experiments were performed using the Meharry Medical College Morphology Core, which is supported in part by National Institutes of Health Grants U01NS041071, U54RR026140, and S10RR0254970. We thank Drs. Lee Limbird and Louis DeFelice for helpful suggestions and critical review of this manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Adams FS, 1996, NEUROCHEM RES, V21, P619, DOI 10.1007/BF02527762; Amara S G, 1993, Curr Opin Neurobiol, V3, P337, DOI 10.1016/0959-4388(93)90126-J; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Blakely RD, 2007, MOL PHARMACOL, V71, P1206, DOI 10.1124/mol.107.035493; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Carneiro AM, 2002, J NEUROSCI, V22, P7045; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Clarkson ED, 1999, P SOC EXP BIOL MED, V222, P157, DOI 10.1046/j.1525-1373.1999.d01-126.x; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Felix K, 2005, J BIOCHEM MOL TOXIC, V19, P67, DOI 10.1002/jbt.20062; Feng LR, 2010, EUR J NEUROSCI, V32, P10, DOI 10.1111/j.1460-9568.2010.07266.x; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gnegy ME, 2004, MOL PHARMACOL, V66, P137, DOI 10.1124/mol.66.1.137; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Gwinn-Hardy K, 2000, ACTA NEUROPATHOL, V99, P663, DOI 10.1007/s004010051177; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Ingram SL, 2000, J NEUROSCI, V20, P550, DOI 10.1523/JNEUROSCI.20-02-00550.2000; IVERSEN L, 1992, NATURE, V358, P109, DOI 10.1038/358109a0; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Lute BJ, 2008, BIOCHEM BIOPH RES CO, V372, P656, DOI 10.1016/j.bbrc.2008.05.091; Mash DC, 2003, J NEUROSCI, V23, P2564; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; MAZZANTI M, 1987, BIOPHYS J, V52, P95, DOI 10.1016/S0006-3495(87)83192-2; MAZZANTI M, 1987, BIOPHYS J, V51, P115, DOI 10.1016/S0006-3495(87)83316-7; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Oz M, 2010, J NEUROCHEM, V112, P1454, DOI 10.1111/j.1471-4159.2009.06557.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prasad KN, 1998, MOL GENET METAB, V65, P1, DOI 10.1006/mgme.1998.2726; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; REYNOLDS GP, 1983, NATURE, V305, P527, DOI 10.1038/305527a0; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Schwartz JW, 2006, HANDB EXP PHARM, V175, P23; Schwartz JW, 2005, J BIOL CHEM, V280, P19177, DOI 10.1074/jbc.M412923200; Schwartz JW, 2003, J BIOL CHEM, V278, P9768, DOI 10.1074/jbc.M209824200; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sonders MS, 1997, J NEUROSCI, V17, P960; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wersinger C, 2003, FASEB J, V17, P2151, DOI 10.1096/fj.03-0152fje; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p; Zapata A, 2007, J BIOL CHEM, V282, P35842, DOI 10.1074/jbc.M611758200; Zarranz J, 2004, REV NEUROLOGIA, V39, P576, DOI 10.33588/rn.3906.2004278; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang DQ, 2004, NEUROREPORT, V15, P1761, DOI 10.1097/01.wnr.0000135699.75775.41; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	72	49	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43933	43943		10.1074/jbc.M111.241232	http://dx.doi.org/10.1074/jbc.M111.241232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21990355	hybrid, Green Published			2022-12-27	WOS:000298402300034
J	Kim, WY; Lee, SY; Jung, YJ; Chae, HB; Nawkar, GM; Shin, MR; Kim, SY; Park, JH; Kang, CH; Chi, YH; Ahn, IP; Yun, DJ; Lee, KO; Kim, YM; Kim, MG; Lee, SY				Kim, Woe Yeon; Lee, Sun Yong; Jung, Young Jun; Chae, Ho Byoung; Nawkar, Ganesh M.; Shin, Mi Rim; Kim, Sun Young; Park, Jin Ho; Kang, Chang Ho; Chi, Yong Hun; Ahn, Il Pyung; Yun, Dae Jin; Lee, Kyun Oh; Kim, Young-Myeong; Kim, Min Gab; Lee, Sang Yeol			Inhibitor of Apoptosis (IAP)-like Protein Lacks a Baculovirus IAP Repeat (BIR) Domain and Attenuates Cell Death in Plant and Animal Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; UBIQUITIN LIGASE; HYPERSENSITIVE RESPONSE; PSEUDOMONAS-SYRINGAE; ANTIAPOPTOTIC GENES; CYSTEINE PROTEASES; EMERGING ROLE; NAIP GENES; ARABIDOPSIS; DROSOPHILA	A novel Arabidopsis thaliana inhibitor of apoptosis was identified by sequence homology to other known inhibitor of apoptosis (IAP) proteins. Arabidopsis IAP-like protein (AtILP) contained a C-terminal RING finger domain but lacked a baculovirus IAP repeat (BIR) domain, which is essential for antiapoptotic activity in other IAP family members. The expression of AtILP in HeLa cells conferred resistance against tumor necrosis factor (TNF)-alpha/ActD-induced apoptosis through the inactivation of caspase activity. In contrast to the C-terminal RING domain of AtILP, which did not inhibit the activity of caspase-3, the N-terminal region, despite displaying no homology to known BIR domains, potently inhibited the activity of caspase-3 in vitro and blocked TNF-alpha/ActD-induced apoptosis. The antiapoptotic activity of the AtILP N-terminal domain observed in plants was reproduced in an animal system. Transgenic Arabidopsis lines overexpressing AtILP exhibited anti-apoptotic activity when challenged with the fungal toxin fumonisin B1, an agent that induces apoptosis-like cell death in plants. In AtIPL transgenic plants, suppression of cell death was accompanied by inhibition of caspase activation and DNA fragmentation. Overexpression of AtILP also attenuated effector protein-induced cell death and increased the growth of an avirulent bacterial pathogen. The current results demonstrated the existence of a novel plant IAP-like protein that prevents caspase activation in Arabidopsis and showed that a plant anti-apoptosis gene functions similarly in plant and animal systems.	[Ahn, Il Pyung; Kim, Min Gab] RDA, Natl Acad Agr Sci, Suwon 441856, South Korea; [Kim, Woe Yeon; Lee, Sun Yong; Jung, Young Jun; Chae, Ho Byoung; Nawkar, Ganesh M.; Shin, Mi Rim; Kim, Sun Young; Park, Jin Ho; Kang, Chang Ho; Chi, Yong Hun; Yun, Dae Jin; Lee, Kyun Oh; Lee, Sang Yeol] Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Jinju 660701, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Coll Med, Dept Mol & Cellular Biochem, Chunchon, South Korea; [Kim, Min Gab] Gyeongsang Natl Univ, Coll Pharm, Jinju 660751, South Korea	Rural Development Administration (RDA); Gyeongsang National University; Kangwon National University; Gyeongsang National University	Kim, MG (corresponding author), RDA, Natl Acad Agr Sci, Suwon 441856, South Korea.	mgk1284@gnu.ac.kr; sylee@gnu.ac.kr	Kim, Sun/GSN-4867-2022; Nawkar, Ganesh Mahadeo/AAT-3117-2020	Nawkar, Ganesh Mahadeo/0000-0002-1693-097X; Kang, Chang Ho/0000-0003-4342-5247; Yun, Dae-Jin/0000-0002-3638-6043	RDA [PJ008109]; Cooperative Research Program for Agriculture Science and Technology Development Project [PJ007850]; MOEST [R32-10148]; BK21 Program, Korea	RDA(Rural Development Administration (RDA), Republic of Korea); Cooperative Research Program for Agriculture Science and Technology Development Project; MOEST; BK21 Program, Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the RDA for the Next-Generation BioGreen Program (SSAC; Grant PJ008109), by Cooperative Research Program for Agriculture Science and Technology Development Project PJ007850, and by MOEST for the WCU Program R32-10148.; Supported by the BK21 Program, Korea.	Ali S, 2010, BIOCHEM BIOPH RES CO, V391, P1512, DOI 10.1016/j.bbrc.2009.12.107; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Basnayake BMVS, 2011, PLANT CELL REP, V30, P37, DOI 10.1007/s00299-010-0941-6; Beers EP, 2001, CURR OPIN PLANT BIOL, V4, P561, DOI 10.1016/S1369-5266(00)00216-8; Behjati R, 2011, CANCER SCI, V102, P267, DOI 10.1111/j.1349-7006.2010.01750.x; Benard G, 2010, EMBO J, V29, P1458, DOI 10.1038/emboj.2010.39; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Boyce M, 2004, CELL DEATH DIFFER, V11, P29, DOI 10.1038/sj.cdd.4401339; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Burguillos MA, 2011, NEUROBIOL DIS, V41, P177, DOI 10.1016/j.nbd.2010.09.005; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; De Jong AJ, 2000, PLANTA, V211, P656, DOI 10.1007/s004250000341; del Pozo O, 1998, CURR BIOL, V8, P1129, DOI 10.1016/S0960-9822(98)70469-5; Dickman MB, 2001, P NATL ACAD SCI USA, V98, P6957, DOI 10.1073/pnas.091108998; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Eichmann R, 2004, MOL PLANT MICROBE IN, V17, P484, DOI 10.1094/MPMI.2004.17.5.484; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Harvey HA, 1998, ONCOLOGY-NY, V12, P32; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; He X, 2003, PLANT MOL BIOL, V52, P729, DOI 10.1023/A:1025008117046; Hengartner MO, 1998, NATURE, V391, P441, DOI 10.1038/35036; Herman MD, 2009, ACTA CRYSTALLOGR F, V65, P1091, DOI 10.1107/S1744309109038597; Higashi K, 2005, APOPTOSIS, V10, P471, DOI 10.1007/s10495-005-1876-1; Hornle M, 2011, ONCOGENE, V30, P575, DOI 10.1038/onc.2010.434; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jones G, 2000, J BIOL CHEM, V275, P22157, DOI 10.1074/jbc.M000369200; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kimchi A, 2007, CYTOKINE GROWTH F R, V18, P435, DOI 10.1016/j.cytogfr.2007.06.004; Korthout HAAJ, 2000, FEBS LETT, V475, P139, DOI 10.1016/S0014-5793(00)01643-4; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lacomme C, 1999, P NATL ACAD SCI USA, V96, P7956, DOI 10.1073/pnas.96.14.7956; Lam E, 2000, PLANT MOL BIOL, V44, P417, DOI 10.1023/A:1026509012695; Leong WF, 2005, MICROBES INFECT, V7, P248, DOI 10.1016/j.micinf.2004.11.004; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Lincoln JE, 2002, P NATL ACAD SCI USA, V99, P15217, DOI 10.1073/pnas.232579799; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; MacNeill AL, 2009, VIROLOGY, V384, P151, DOI 10.1016/j.virol.2008.10.041; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Morel JB, 1997, CELL DEATH DIFFER, V4, P671, DOI 10.1038/sj.cdd.4400309; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Ni T, 2005, IUBMB LIFE, V57, P779, DOI 10.1080/15216540500389013; Pereira WF, 2008, AN ACAD BRAS CIENC, V80, P129, DOI 10.1590/S0001-37652008000100008; Rohmer L, 2003, MOL MICROBIOL, V47, P1545, DOI 10.1046/j.1365-2958.2003.03402.x; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Stone JM, 2000, PLANT CELL, V12, P1811, DOI 10.1105/tpc.12.10.1811; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Sung JH, 2007, NEUROSCIENCE, V149, P804, DOI 10.1016/j.neuroscience.2007.07.030; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, BRIT MED BULL, V53, P478; Tripathy MK, 2010, APOPTOSIS, V15, P1453, DOI 10.1007/s10495-010-0527-3; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Vucic D, 2005, BIOCHEM J, V385, P11, DOI 10.1042/BJ20041108; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Watihayati MS, 2007, PEDIATR INT, V49, P11, DOI 10.1111/j.1442-200X.2007.02302.x; Wei YB, 2008, ACTA BIOCH BIOPH SIN, V40, P278, DOI 10.1111/j.1745-7270.2008.00407.x; Williams B, 2008, MOL PLANT PATHOL, V9, P531, DOI [10.1111/j.1364-3703.2008.00473.x, 10.1111/J.1364-3703.2008.00473.X]; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636; Xu M, 2002, BBA-GENE STRUCT EXPR, V1574, P35, DOI 10.1016/S0167-4781(01)00343-8; Xu P, 2004, P NATL ACAD SCI USA, V101, P15805, DOI 10.1073/pnas.0407094101; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Yu D, 2010, ENDOCR J, V57, P825, DOI 10.1507/endocrj.K10E-085; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	84	15	16	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42670	42678		10.1074/jbc.M111.262204	http://dx.doi.org/10.1074/jbc.M111.262204			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21926169	Green Published, hybrid			2022-12-27	WOS:000298180900074
J	Rosental, N; Gameiro, A; Grewer, C; Kanner, BI				Rosental, Noa; Gameiro, Armanda; Grewer, Christof; Kanner, Baruch I.			A Conserved Aspartate Residue Located at the Extracellular End of the Binding Pocket Controls Cation Interactions in Brain Glutamate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; RAT-BRAIN; SUBSTRATE INTERACTIONS; INDIVIDUAL SUBUNITS; ANION CONDUCTANCE; MEMBRANE-VESICLES; CHLORIDE CHANNEL; MAMMALIAN-CELLS; REENTRANT LOOP; EAAC1	In the brain, transporters of the major excitatory neurotransmitter glutamate remove their substrate from the synaptic cleft to allow optimal glutamatergic neurotransmission. Their transport cycle consists of two sequential translocation steps, namely cotransport of glutamic acid with three Na+ ions, followed by countertransport of K+ Recent studies, based on several crystal structures of the archeal homologue Glt(ph), indicate that glutamate translocation occurs by an elevator-like mechanism. The resolution of these structures was not sufficiently high to unambiguously identify the sites of Na+ binding, but functional and computational studies suggest some candidate sites. In the Gltph structure, a conserved aspartate residue (Asp-390) is located adjacent to a conserved tyrosine residue, previously shown to be a molecular determinant of ion selectivity in the brain glutamate transporter GET-1. In this study, we characterize mutants of Asp-440 of the neuronal transporter EAAC1, which is the counterpart of Asp-390 of Glt(ph). Except for substitution by glutamate, this residue is functionally irreplaceable. Using biochemical and electrophysiological approaches, we conclude that although D440E is intrinsically capable of net flux, this mutant behaves as an exchanger under physiological conditions, due to increased and decreased apparent affinities for Na+ and K+ respectively. Our present and previous data are compatible with the idea that the conserved tyrosine and aspartate residues, located at the external end of the binding pocket, may serve as a transient or stable cation binding site in the glutamate transporters.	[Rosental, Noa; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Gameiro, Armanda; Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA	Hebrew University of Jerusalem; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Kanner, BI (corresponding author), POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il	Albers, Thomas/A-9082-2012		National Institutes of Health [NS16708, 2R01NS049335-06A1]; Binational Science Foundation [2007051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708, R01NS049335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS16708 and 2R01NS049335-06A1 (to B. I. K. and C. G.) and Binational Science Foundation Grant 2007051 (to C. G. and B. I. K.).	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Holmseth S, 2005, NEUROSCIENCE, V136, P649, DOI 10.1016/j.neuroscience.2005.07.022; Huang S, 2009, J BIOL CHEM, V284, P4510, DOI 10.1074/jbc.M808495200; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Lowry O. H., 1951, BIOL CHEM, V193, P265; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; NELSON PJ, 1983, BIOCHEMISTRY-US, V22, P5459, DOI 10.1021/bi00292a030; Otis TS, 2000, J NEUROSCI, V20, P2749; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Rosental N, 2010, J BIOL CHEM, V285, P21241, DOI 10.1074/jbc.M109.087163; Ryan RM, 2010, J NEUROCHEM, V114, P565, DOI 10.1111/j.1471-4159.2010.06796.x; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Tao Z, 2008, BIOCHEMISTRY-US, V47, P12923, DOI 10.1021/bi8017174; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	60	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41381	41390		10.1074/jbc.M111.291021	http://dx.doi.org/10.1074/jbc.M111.291021			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984827	Green Published, hybrid			2022-12-27	WOS:000298057500025
J	Kumadaki, S; Karasawa, T; Matsuzaka, T; Ema, M; Nakagawa, Y; Nakakuki, M; Saito, R; Yahagi, N; Iwasaki, H; Sone, H; Takekoshi, K; Yatoh, S; Kobayashi, K; Takahashi, A; Suzuki, H; Takahashi, S; Yamada, N; Shimano, H				Kumadaki, Shin; Karasawa, Tadayoshi; Matsuzaka, Takashi; Ema, Masatsugu; Nakagawa, Yoshimi; Nakakuki, Masanori; Saito, Ryo; Yahagi, Naoya; Iwasaki, Hitoshi; Sone, Hirohito; Takekoshi, Kazuhiro; Yatoh, Shigeru; Kobayashi, Kazuto; Takahashi, Akimitsu; Suzuki, Hiroaki; Takahashi, Satoru; Yamada, Nobuhiro; Shimano, Hitoshi			Inhibition of Ubiquitin Ligase F-box and WD Repeat Domain-containing 7 alpha (Fbw7 alpha) Causes Hepatosteatosis through Kruppel-like Factor 5 (KLF5)/Peroxisome Proliferator-activated Receptor gamma 2 (PPAR gamma 2) Pathway but Not SREBP-1c Protein in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL REGULATORY ELEMENT; PHOSPHORYLATION-DEPENDENT DEGRADATION; LEUCINE ZIPPER PROTEIN; LEPTIN-DEFICIENT MICE; TRANSCRIPTION FACTOR; BINDING-PROTEIN; INSULIN-RESISTANCE; PPAR-GAMMA; C-MYC; HEPATIC STEATOSIS	F-box and WD repeat domain-containing 7 alpha (Ebw7 alpha) is the substrate recognition component of a ubiquitin ligase that controls the degradation of factors involved in cellular growth, including c-Myc, cyclin E, and c-Jun. In addition, Fbw7 alpha degrades the nuclear form of sterol regulatory element-binding protein (SREBP)-1a, a global regulator of lipid synthesis, particularly during mitosis in cultured cells. This study investigated the in vivo role of Ebw7 alpha in hepatic lipid metabolism. siRNA knockdown of Ebw7 alpha in mice caused marked hepatosteatosis with the accumulation of triglycerides. However, inhibition of Ebw7 alpha did not change the level of nuclear SREBP-1 protein or the expression of genes involved in fatty acid synthesis and oxidation. In vivo experiments on the gain and loss of Fbw7 alpha function indicated that Fbw7 alpha regulated the expression of peroxisome proliferator-activated receptor (PPAR) gamma 2 and its target genes involved in fatty acid uptake and triglyceride synthesis. These genes included fatty acid transporter Cd36, diacylglycerol acyltransferase 1 (Dgatl), and fat-specific protein 27 (Cidec). The regulation of PPAR gamma 2 by Fbw7 alpha was mediated, at least in part, by the direct degradation of the Krtippel-like factor 5 (KI.F5) protein, upstream of PPAR gamma 2 expression. Hepatic Fbw7 alpha contributes to normal fatty acid and triglyceride metabolism, functions that represent novel aspects of this cell growth regulator.	[Kumadaki, Shin; Karasawa, Tadayoshi; Matsuzaka, Takashi; Nakagawa, Yoshimi; Nakakuki, Masanori; Saito, Ryo; Yahagi, Naoya; Iwasaki, Hitoshi; Sone, Hirohito; Takekoshi, Kazuhiro; Yatoh, Shigeru; Kobayashi, Kazuto; Takahashi, Akimitsu; Suzuki, Hiroaki; Yamada, Nobuhiro; Shimano, Hitoshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Internal Med Endocrinol & Metab, Tsukuba, Ibaraki 3058575, Japan; [Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba; University of Tsukuba	Shimano, H (corresponding author), 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hshimano@md.tsukuba.ac.jp	Shimano, Hitoshi/V-1761-2019; Shimano, Hitoshi/AAI-5648-2020; Yahagi, Naoya/D-2360-2014; Sone, Hirohito/ABC-9346-2021	Shimano, Hitoshi/0000-0002-5562-5572; Yahagi, Naoya/0000-0002-1823-1865; Sone, Hirohito/0000-0003-1263-2817; Ema, Masatsugu/0000-0003-0645-6183; Karasawa, Tadayoshi/0000-0002-6738-2360	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21591123] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bengoechea-Alonso MT, 2005, P NATL ACAD SCI USA, V102, P11681, DOI 10.1073/pnas.0501494102; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carmona MC, 2005, INT J OBESITY, V29, P864, DOI 10.1038/sj.ijo.0802943; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Inoue N, 2005, MOL CELL BIOL, V25, P8938, DOI 10.1128/MCB.25.20.8938-8947.2005; Kato T, 2006, CELL METAB, V4, P143, DOI 10.1016/j.cmet.2006.06.009; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Matsumoto A, 2006, BIOCHEM BIOPH RES CO, V350, P114, DOI 10.1016/j.bbrc.2006.09.003; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Matsuzaka T, 2002, J LIPID RES, V43, P911; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Nakakuki M, 2007, FEBS J, V274, P4440, DOI 10.1111/j.1742-4658.2007.05973.x; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; Riu E, 2003, FASEB J, V17, P1715, DOI 10.1096/fj.02-1163fje; Riu E, 1996, P NATL ACAD SCI USA, V93, P2198, DOI 10.1073/pnas.93.5.2198; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 2002, VITAM HORM, V65, P167, DOI 10.1016/S0083-6729(02)65064-2; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	53	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40835	40846		10.1074/jbc.M111.235283	http://dx.doi.org/10.1074/jbc.M111.235283			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21911492	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000297315400044
J	Oliveira, MT; Kaguni, LS				Oliveira, Marcos T.; Kaguni, Laurie S.			Reduced Stimulation of Recombinant DNA Polymerase gamma and Mitochondrial DNA (mtDNA) Helicase by Variants of Mitochondrial Single-stranded DNA-binding Protein (mtSSB) Correlates with Defects in mtDNA Replication in Animal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; FUNCTIONAL INTERACTIONS; DROSOPHILA EMBRYOS; TWINKLE; MUTATIONS; REGION; DOMAIN; PROCESSIVITY; MUTANTS	The mitochondrial single-stranded DNA-binding protein (mtSSB) is believed to coordinate the functions of DNA polymerase gamma (pot gamma) and the mitochondrial DNA (mtDNA) helicase at the mtDNA replication fork. We generated five variants of the human mtSSB bearing mutations in amino acid residues specific to metazoans that map on the protein surface, removed from the single-stranded DNA (ssDNA) binding groove. Although the mtSSB variants bound ssDNA with only slightly different affinities, they exhibited distinct capacities to stimulate the DNA polymerase activity of human pot gamma and the DNA unwinding activity of human mtDNA helicase in vitro. Interestingly, we observed that the variants with defects in stimulating pot gamma had unaltered capacities to stimulate the mtDNA helicase; at the same time, variants showing reduced stimulation of the mtDNA helicase activity promoted DNA synthesis by pot gamma similarly to the wild-type mtSSB. The overexpression of the equivalent variants of Drosophila inelanogaster mtSSB in S2 cells in culture caused mtDNA depletion under conditions of mitochondrial homeostasis. Furthermore, we observed more severe reduction of mtDNA copy number upon expression of these proteins during recovery from treatment with ethidium bromide, when mtDNA replication is stimulated in vivo. Our findings suggest that mtSSB uses distinct structural elements to interact functionally with its intDNA replisome partners and to promote proper mtDNA replication in animal cells.	[Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA; Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Ctr Mitochondrial Sci & Med, 319 Biochem Bldg, E Lansing, MI 48824 USA.	lskaguni@msu.edu	Oliveira, Marcos/B-3249-2014; Oliveira, Marcos Túlio/AAN-2804-2020	Oliveira, Marcos/0000-0003-4779-5755; 	National Institutes of Health [GM45295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45295.	Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bortot B, 2009, DIGEST LIVER DIS, V41, P494, DOI 10.1016/j.dld.2008.11.013; BUJALOWSKI W, 1991, J BIOL CHEM, V266, P1616; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109; Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618; Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779; Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Langston LD, 2009, CELL CYCLE, V8, P2686, DOI 10.4161/cc.8.17.9390; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Li K, 1997, J BIOL CHEM, V272, P8686, DOI 10.1074/jbc.272.13.8686; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026; Oliveira MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015379; Oliveira MT, 2009, METHODS MOL BIOL, V554, P37, DOI 10.1007/978-1-59745-521-3_3; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092; Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; THOMMES P, 1995, J BIOL CHEM, V270, P21137, DOI 10.1074/jbc.270.36.21137; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; WILLIAMS AJ, 1993, J BIOL CHEM, V268, P24855; Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d	43	37	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40649	40658		10.1074/jbc.M111.289983	http://dx.doi.org/10.1074/jbc.M111.289983			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21953457	Green Published, hybrid			2022-12-27	WOS:000297315400026
J	Bolger, TA; Wente, SR				Bolger, Timothy A.; Wente, Susan R.			Gle1 Is a Multifunctional DEAD-box Protein Regulator That Modulates Ded1 in Translation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; NUCLEAR-PORE COMPLEX; EUKARYOTIC TRANSLATION; SACCHAROMYCES-CEREVISIAE; INOSITOL HEXAKISPHOSPHATE; CYTOPLASMIC FIBRILS; CONSERVED MECHANISM; ATPASE ACTIVITY; START CODON; DBP5 CYCLE	DEAD-box protein (Dbp) family members are essential for gene expression; however, their precise roles and regulation are not fully defined. During messenger (m) RNA export, Gle1 bound to inositol hexakisphosphate (IP6) acts via Dbp5 to facilitate remodeling of mRNA-protein complexes. In contrast, here we define a novel Gle1 role in translation initiation through regulation of a different DEAD-box protein, the initiation factor Ded1. We find that Gle1 physically and genetically interacts with Ded1. Surprisingly, whereas Gle1 stimulates Dbp5, it inhibits Ded1 ATPase activity in vitro, and IP6 does not affect this inhibition. Functionally, a gle1-4 mutant specifically suppresses initiation defects in a ded1-120 mutant, and ded1 and gle1 mutants have complementary perturbations in AUG start site recognition. Consistent with this role in initiation, Gle1 inhibits translation in vitro in competent extracts. These results indicate that Gle1 has a direct role in initiation and negatively regulates Ded1. Together, the differential regulation of two distinct DEAD-box proteins by a common factor (Gle1) establishes a new paradigm for controlling gene expression and coupling translation with mRNA export.	[Bolger, Timothy A.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 465 21st Ave S, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu			National Institutes of Health [R37-GM51219, F32-GM082065]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082065, R37GM051219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-GM51219 (to S. R. W.) and F32-GM082065 (to T. A. B.).	Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Balagopal V, 2011, RNA, V17, P835, DOI 10.1261/rna.2677311; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Berthelot K, 2004, MOL MICROBIOL, V51, P987, DOI 10.1046/j.1365-2958.2003.03898.x; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; Del Priore V, 1997, J CELL SCI, V110, P2987; DONAHUE TF, 1988, MOL CELL BIOL, V8, P2955, DOI 10.1128/MCB.8.7.2955; Dossani ZY, 2009, P NATL ACAD SCI USA, V106, P16251, DOI 10.1073/pnas.0902251106; Granneman S, 2006, NUCLEIC ACIDS RES, V34, P3189, DOI 10.1093/nar/gkl419; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Hodge CA, 2011, GENE DEV, V25, P1052, DOI 10.1101/gad.2041611; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Linder P, 2003, BIOL CELL, V95, P157, DOI 10.1016/S0248-4900(03)00032-7; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Marsden S, 2006, J MOL BIOL, V361, P327, DOI 10.1016/j.jmb.2006.06.016; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Mitchell SF, 2008, J BIOL CHEM, V283, P27345, DOI 10.1074/jbc.R800031200; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Stewart M, 2010, TRENDS BIOCHEM SCI, V35, P609, DOI 10.1016/j.tibs.2010.07.001; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Tarn WY, 2009, RNA BIOL, V6, P17, DOI 10.4161/rna.6.1.7440; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Watanabe R, 2010, J BIOL CHEM, V285, P21922, DOI 10.1074/jbc.M110.132027; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wolf A, 2010, J CELL BIOL, V188, P463, DOI 10.1083/jcb.200908135; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	52	32	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39750	39759		10.1074/jbc.M111.299321	http://dx.doi.org/10.1074/jbc.M111.299321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949122	hybrid, Green Published			2022-12-27	WOS:000296925700008
J	Lee, WS; Kang, C; Drayna, D; Kornfeld, S				Lee, Wang-Sik; Kang, Changsoo; Drayna, Dennis; Kornfeld, Stuart			Analysis of Mannose 6-Phosphate Uncovering Enzyme Mutations Associated with Persistent Stuttering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-N-ACETYLGLUCOSAMINIDASE	GlcNAc-1-phosphodiester-N-acetylglucosaminidase ("uncovering enzyme" (UCE); EC 3.1.4.45) is a Golgi enzyme that mediates the second step in the synthesis of the mannose 6-phosphate lysosomal targeting signal on acid hydrolases. Recently, three mutations (two missense and one deletion/frameshift) in the NAGPA gene that encodes UCE have been identified in individuals with persistent stuttering. We now demonstrate that each mutation leads to lower cellular UCE activity. The p.R328C mutation impairs folding in the endoplasmic reticulum, resulting in degradation of a significant portion by the proteasomal system. The p.H84Q mutation also impairs folding and, in addition, decreases the specific activity of the enzyme that folds sufficiently to traffic to the Golgi. The p.F513SfsX113 frameshift mutation adds 113 amino acids to the C terminus of the cytoplasmic tail of the protein, including a VWLL sequence that causes rapid degradation via the proteasomal system. These biochemical findings extend the genetic data implicating mutations	[Lee, Wang-Sik; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Kang, Changsoo; Drayna, Dennis] NIDCD, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	skornfel@wustl.edu			National Institutes of Health (NIH), NIDCD [Grant Z01-00046-11]; NIH [CA08759]; NATIONAL CANCER INSTITUTE [R37CA008759, R01CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011332, ZIADC000046] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIDCD, Grant Z01-00046-11 (to D. D.) and by NIH Grant CA08759 (to S. K.).	Bloodstein O, 2007, HDB STUTTERING, Vsixth; Cathey SS, 2010, J MED GENET, V47, P38, DOI 10.1136/jmg.2009.067736; Do H, 2002, J BIOL CHEM, V277, P29737, DOI 10.1074/jbc.M202369200; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; Kang CS, 2011, ANNU REV GENOM HUM G, V12, P145, DOI 10.1146/annurev-genom-090810-183119; Kang C, 2010, NEW ENGL J MED, V362, P677, DOI 10.1056/NEJMoa0902630; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kornfeld R, 1999, J BIOL CHEM, V274, P32778, DOI 10.1074/jbc.274.46.32778; KORNFELD S, 2000, METABOLIC MOL BASES, P3469; MULLIS KG, 1992, ANAL BIOCHEM, V205, P200, DOI 10.1016/0003-2697(92)90424-6; Park B, 2010, J EXP MED, V207, P2033, DOI 10.1084/jem.20091793; Rohrer J, 2001, MOL BIOL CELL, V12, P1623, DOI 10.1091/mbc.12.6.1623; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5	13	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39786	39793		10.1074/jbc.M111.295899	http://dx.doi.org/10.1074/jbc.M111.295899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21956109	hybrid, Green Published			2022-12-27	WOS:000296925700012
J	Leskov, KS; Araki, S; Lavik, JP; Gomez, JA; Gama, V; Gonos, ES; Trougakos, IP; Matsuyama, S; Boothman, DA				Leskov, Konstantin S.; Araki, Shinako; Lavik, John-Paul; Gomez, Jose A.; Gama, Vivian; Gonos, Efstathios S.; Trougakos, Ioannis P.; Matsuyama, Shigemi; Boothman, David A.			CRM1 Protein-mediated Regulation of Nuclear Clusterin (nCLU), an Ionizing Radiation-stimulated, Bax-dependent Pro-death Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; INDUCED APOPTOSIS; EPITHELIAL-CELLS; IN-VITRO; EXPRESSION; CHAPERONE; EXPORT; LOCALIZATION; ACTIVATION; INDUCTION	Expression of the clusterin (CLU) gene results in the synthesis of a conventional secretory isoform set (pre- and mature secretory clusterin proteins, psCLU/sCLU), as well as another set of intracellular isoforms, appearing in the cytoplasm (pre-nuclear CLU, pnCLU) and in the nucleus as an similar to 55-kDa mature nuclear clusterin (nCLU) form. These two isoform sets have opposing cell functions: pro-survival and pro-death, respectively. Although much is known about the regulation and function of sCLU as a pro-survival factor, the regulation and function of endogenous nCLU in cell death are relatively unexplored. Here, we show that depletion of endogenous nCLU protein using siRNA specific to its truncated mRNA increased clonogenic survival of ionizing radiation (IR)-exposed cells. nCLU-mediated apoptosis was Bax-dependent, and lethality correlated with accumulation of mature nCLU protein. nCLU accumulation was regulated by CRM1 because binding between CRM1 and nCLU proteins was significantly diminished by leptomycin B (LMB), and nuclear levels of nCLU protein were significantly enhanced by LMB and IR co-treatment. Moreover, LMB treatment significantly enhanced IR-induced nCLU-mediated cell death responses. Importantly, bax(-/-) and bax(-/-)/bak(-/-) double knock-out cells were resistant to nCLU-mediated cell death, whereas bak(-/-) or wild-type bax(+/+)/bak(+/+) cells were hypersensitive. The regulation of nCLU by CRM1 nuclear export/import may explain recent clinical results showing that highly malignant tumors have lost the ability to accumulate nCLU levels, thereby avoiding growth inhibition and cell death.	[Leskov, Konstantin S.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44109 USA; [Lavik, John-Paul; Gomez, Jose A.; Gama, Vivian; Matsuyama, Shigemi] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44109 USA; [Matsuyama, Shigemi] Case Western Reserve Univ, Dept Hematol Oncol, Cleveland, OH 44109 USA; [Gonos, Efstathios S.] Natl Hellen Res Fdn, Lab Mol & Cellular Aging, Inst Biol Res & Biotechnol, Athens 11635, Greece; [Trougakos, Ioannis P.] Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens 15784, Greece; [Araki, Shinako; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Lab Mol Cell Stress Responses, Program Cell Stress & Canc Nanomed,Simmons Compre, Dallas, TX 75390 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Hellenic Research Foundation; National & Kapodistrian University of Athens; University of Texas System; University of Texas Southwestern Medical Center Dallas	Leskov, KS (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44109 USA.	ksl9@case.edu; david.boothman@UTSouthwestern.edu	Trougakos, Ioannis/R-6149-2018; Boothman, David/Q-7776-2019; Leskov, Konstantin S/J-2339-2017	Trougakos, Ioannis/0000-0002-6179-2772; Leskov, Konstantin S/0000-0001-6201-5660; Gama, Vivian/0000-0002-1201-1394	Department of Energy [DE-FG02-09ER64789]; NATIONAL CANCER INSTITUTE [R01CA078530, P30CA142543, R01CA139217] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Energy Grant DE-FG02-09ER64789 (to D. A. B.). This is paper CSCN070 from the University of Texas Southwestern program in cell stress and cancer nanomedicine.	BOOTHMAN DA, 1989, CANCER RES, V49, P605; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Caccamo AE, 2003, ANN NY ACAD SCI, V1010, P514, DOI 10.1196/annals.1299.095; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Debure L, 2003, J CELL SCI, V116, P3109, DOI 10.1242/jcs.00619; Feng ZH, 2004, J BIOL CHEM, V279, P28574, DOI 10.1074/jbc.M404137200; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; He HZ, 2004, WORLD J GASTROENTERO, V10, P1387; July LV, 2004, MOL CANCER THER, V3, P223; Kim N., 2011, J CELL PHYSL    0512, DOI [10.1022/jcp.22836, DOI 10.1022/JCP.22836]; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lee DH, 2011, BIOCHEM BIOPH RES CO, V408, P541, DOI 10.1016/j.bbrc.2011.04.054; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Markopoulou S, 2009, FEBS J, V276, P4208, DOI 10.1111/j.1742-4658.2009.07093.x; O'Sullivan J, 2003, CELL DEATH DIFFER, V10, P914, DOI 10.1038/sj.cdd.4401254; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Porter LA, 2003, BLOOD, V101, P1928, DOI 10.1182/blood-2002-04-1103; Pucci S, 2004, ONCOGENE, V23, P2298, DOI 10.1038/sj.onc.1207404; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Redondo M, 2000, AM J PATHOL, V157, P393, DOI 10.1016/S0002-9440(10)64552-X; Sutton D, 2006, INT J NANOMED, V1, P155, DOI 10.2147/nano.2006.1.2.155; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yang CR, 1999, NUCLEIC ACIDS RES, V27, P2165, DOI 10.1093/nar/27.10.2165; Yang CR, 2000, P NATL ACAD SCI USA, V97, P5907, DOI 10.1073/pnas.97.11.5907; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	33	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40083	40090		10.1074/jbc.M111.252957	http://dx.doi.org/10.1074/jbc.M111.252957			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953454	hybrid, Green Published			2022-12-27	WOS:000296925700041
J	Levi, B; Wan, DC; Glotzbach, JP; Hyun, J; Januszyk, M; Montoro, D; Sorkin, M; James, AW; Nelson, ER; Li, SL; Quarto, N; Lee, M; Gurtner, GC; Longaker, MT				Levi, Benjamin; Wan, Derrick C.; Glotzbach, Jason P.; Hyun, Jeong; Januszyk, Michael; Montoro, Daniel; Sorkin, Michael; James, Aaron W.; Nelson, Emily R.; Li, Shuli; Quarto, Natalina; Lee, Min; Gurtner, Geoffrey C.; Longaker, Michael T.			CD105 Protein Depletion Enhances Human Adipose-derived Stromal Cell Osteogenesis through Reduction of Transforming Growth Factor beta 1 (TGF-beta 1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE CALVARIAL DEFECTS; STEM-CELLS; ENDOTHELIAL-CELLS; TEMPORAL-CHANGES; IN-VITRO; BONE; ENDOGLIN; TISSUE; DIFFERENTIATION; MODULATION	Clinically available sources of bone for repair and reconstruction are limited by the accessibility of autologous grafts, infectious risks of cadaveric materials, and durability of synthetic substitutes. Cell-based approaches for skeletal regeneration can potentially fill this need, and adipose tissue represents a promising source for development of such therapies. Here, we enriched for an osteogenic subpopulation of cells derived from human subcutaneous adipose tissue utilizing microfluidic-based single cell transcriptional analysis and fluorescence-activated cell sorting (FACS). Statistical analysis of single cell transcriptional profiles demonstrated that low expression of endoglin (CD105) correlated with a subgroup of adipose-derived cells with increased osteogenic gene expression. FACS-sorted CD105(low) cells demonstrated significantly enhanced in vitro osteogenic differentiation and in vivo bone regeneration when compared with either CD105(high) or unsorted cells. Evaluation of the endoglin pathway suggested that enhanced osteogenesis among CD105(low) adipose-derived cells is likely due to identification of a subpopulation with lower TGF-beta 1/Smad2 signaling. These findings thus highlight a potential avenue to promote osteogenesis in adipose-derived mesenchymal cells for skeletal regeneration.	[Levi, Benjamin; Wan, Derrick C.; Glotzbach, Jason P.; Hyun, Jeong; Januszyk, Michael; Montoro, Daniel; Sorkin, Michael; James, Aaron W.; Nelson, Emily R.; Li, Shuli; Quarto, Natalina; Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Sch Med, Dept Surg,Plast & Reconstruct Surg Div, Stanford, CA 94305 USA; [Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Lee, Min] Univ Calif Los Angeles, Sch Dent, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA 90095 USA	Stanford University; Stanford University; University of California System; University of California Los Angeles	Gurtner, GC (corresponding author), Stanford Univ, Hagey Lab Pediat Regenerat Med, Sch Med, Dept Surg,Plast & Reconstruct Surg Div, 257 Campus Dr, Stanford, CA 94305 USA.	ggurtner@stanford.edu; longaker@stanford.edu	Glotzbach, Jason P./O-4394-2019	Glotzbach, Jason P./0000-0002-8002-9422; Montoro, Daniel/0000-0002-6222-2149; Wan, Derrick/0000-0003-4666-1683	National Institutes of Health, NIDCR [1 R21 DE019274-01, 1 RC2 DE020771-01]; NIDDK [2 RO1 DK074095-07]; National Endowment for Plastic Surgery; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health through the NIAMS [1F32AR057302-02]; National Institutes of Health National Research Service [F32DK088448-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020771, R21DE019274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074095] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Endowment for Plastic Surgery; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1 R21 DE019274-01 and 1 RC2 DE020771-01 from the NIDCR (to M. T. L.) and 2 RO1 DK074095-07 from the NIDDK (to G. C. G). This work was also supported by grants from the National Endowment for Plastic Surgery, the Oak Foundation, and the Hagey Laboratory for Pediatric Regenerative Medicine (to M. T. L.).; Supported by the National Institutes of Health Grant 1F32AR057302-02 through the NIAMS.; Supported by the National Institutes of Health National Research Service Award Grant F32DK088448-01.	[Anonymous], HCUP FACTS FIGURES S; Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Devlin B, 2003, GENET EPIDEMIOL, V25, P36, DOI 10.1002/gepi.10237; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eadie W. T., 1971, STAT METHODS EXPT PH, P313; Gimble JM, 2004, ENDOCRINE, V23, P183, DOI 10.1385/ENDO:23:2-3:183; Glotzbach JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021211; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Gupta DM, 2008, J CRANIOFAC SURG, V19, P192, DOI 10.1097/scs.0b013e31815c93b7; Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088; Holmes AM, 2011, J CELL COMMUN SIGNAL, V5, P173, DOI 10.1007/s12079-011-0140-4; James AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007120; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jiang T, 2010, BIOMATERIALS, V31, P3564, DOI 10.1016/j.biomaterials.2010.01.050; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kumar P, 1996, J PATHOL, V178, P363, DOI 10.1002/(SICI)1096-9896(199604)178:4<363::AID-PATH491>3.0.CO;2-8; Lee M, 2007, BIOMATERIALS, V28, P1862, DOI 10.1016/j.biomaterials.2006.12.006; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; Levi B, 2011, STEM CELLS, V29, P1241, DOI 10.1002/stem.670; Levi B, 2010, PLAST RECONSTR SURG, V126, P822, DOI 10.1097/PRS.0b013e3181e5f892; Levi B, 2010, PLAST RECONSTR SURG, V126, P412, DOI 10.1097/PRS.0b013e3181df64dc; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Li S, 2007, AM J PHYSIOL-CELL PH, V293, pC1834, DOI 10.1152/ajpcell.00135.2007; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nassiri F, 2011, ANTICANCER RES, V31, P2283; ONG LDY, 1968, HEALTH PHYS, V14, P376; Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120; Peterson LE, 2008, INT J APPROX REASON, V47, P17, DOI 10.1016/j.ijar.2007.03.006; Pohl David, 2011, Acta Medica (Hradec Kralove), V54, P59; Rada T, 2011, J TISSUE ENG REGEN M, V5, P655, DOI 10.1002/term.364; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Wallace SA, 1999, PERCEPT MOTOR SKILL, V88, P759, DOI 10.2466/PMS.88.3.759-764; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Xu Y, 2009, TISSUE ENG PT A, V15, P3697, DOI [10.1089/ten.tea.2009.0213, 10.1089/ten.TEA.2009.0213]; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Yu G, 2010, CYTOTHERAPY, V12, P538, DOI 10.3109/14653241003649528; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zhang LY, 2011, BLOOD, V118, P88, DOI 10.1182/blood-2010-12-325019; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	55	119	123	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39497	39509		10.1074/jbc.M111.256529	http://dx.doi.org/10.1074/jbc.M111.256529			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949130	Green Published, hybrid			2022-12-27	WOS:000296759800067
J	Snyder, M; Huang, XY; Zhang, JJ				Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian			Signal Transducers and Activators of Transcription 3 (STAT3) Directly Regulates Cytokine-induced Fascin Expression and Is Required for Breast Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; TUMOR-METASTASIS; CARCINOMA-CELLS; BETA-CATENIN; ONCOSTATIN-M; INTERLEUKIN-6; GENE; MICE; PROGRESSION	The cytokines oncostatin M (OSM) and IL-6 promote breast cancer cell migration and metastasis. Both cytokines activate STAT3, a member of the STAT (signal transducers and activators of transcription) family of transcription factors. Through transcriptional regulation of its target genes, STAT3 controls a wide range of cellular processes, including cellular proliferation, oncogenesis, and cancer metastasis. Fascin is an actin-bundling protein involved in cell migration. Elevated levels of fascin expression are found in many metastatic cancers, and inhibition of fascin function by small chemical compounds leads to a block of tumor metastasis. In this work, we demonstrate that fascin is a direct STAT3 target gene in response to OSM and IL-6 in both mouse and human breast cancer cells. We show that NF kappa B also binds to the fascin promoter in response to cytokine treatment and this binding is STAT3-dependent. Both STAT3 and NF kappa B are required for the cytokine-induced expression of fascin in cancer cells. Furthermore, we demonstrate that STAT3, in directly controlling fascin expression, is both necessary and sufficient for breast cancer cell migration.	[Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	Cornell University	Zhang, JJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA.	jjz2002@med.cornell.edu			National Institutes of Health [CA136837]; NATIONAL CANCER INSTITUTE [R01CA136837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136837 ( to X.-Y.H.).	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Aparicio OM, 2005, CURR PROTOC MOL BIOL; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Grothey A, 2000, ONCOGENE, V19, P4864, DOI 10.1038/sj.onc.1203838; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Hashimoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005130; Heinrich PC, 1998, Z ERNAHRUNGSWISS, V37, P43; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Jorcyk CL, 2006, CYTOKINE, V33, P323, DOI 10.1016/j.cyto.2006.03.004; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Liu QL, 2010, J NEURO-ONCOL, V100, P165, DOI 10.1007/s11060-010-0158-0; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Said NABM, 2011, CELLS TISSUES ORGANS, V193, P85, DOI 10.1159/000320360; Santos CI, 2011, BBA-REV CANCER, V1816, P38, DOI 10.1016/j.bbcan.2011.03.003; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Snyder M, 2011, FEBS LETT, V585, P148, DOI 10.1016/j.febslet.2010.11.030; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sun W, 2006, FEBS LETT, V580, P5880, DOI 10.1016/j.febslet.2006.09.054; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	41	74	77	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38886	38893		10.1074/jbc.M111.286245	http://dx.doi.org/10.1074/jbc.M111.286245			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937440	Green Published, hybrid			2022-12-27	WOS:000296759800007
J	Cvetkov, TL; Huynh, KW; Cohen, MR; Moiseenkova-Bell, VY				Cvetkov, Teresa L.; Huynh, Kevin W.; Cohen, Matthew R.; Moiseenkova-Bell, Vera Y.			Molecular Architecture and Subunit Organization of TRPA1 Ion Channel Revealed by Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; AUTOMATIC PARTICLE PICKUP; ANKYRIN REPEAT DOMAIN; YEAST SACCHAROMYCES-CEREVISIAE; RECEPTOR POTENTIAL CHANNELS; PROTEIN SECONDARY STRUCTURE; MEMBRANE-PROTEIN; CRYSTAL-STRUCTURE; CATION CHANNEL; I-TASSER	Transient receptor potential ankyrin 1 (TRPA1) is a non-selective ion channel, which is expressed in nociceptor sensory neurons and transduces chemical, inflammatory, and neuropathic pain signals. Numerous non-reactive compounds and electrophilic compounds, such as endogenous inflammatory mediators and exogenous pungent chemicals, can activate TRPA1. Here we report a 16-angstrom resolution structure of purified, functional, amphipol-stabilized TRPA1 analyzed by single-particle EM. Molecular models of the N and C termini of the channel were generated using the I-TASSER protein structure prediction server and docked into the EM density to provide insight into the TRPA1 subunit organization. This structural analysis suggests a location for critical N-terminal cysteine residues involved in electrophilic activation at the interface between neighboring subunits. Our results indicate that covalent modifications within this pocket may alter interactions between subunits and promote conformational changes that lead to channel activation.	[Cvetkov, Teresa L.; Huynh, Kevin W.; Cohen, Matthew R.; Moiseenkova-Bell, Vera Y.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Moiseenkova-Bell, VY (corresponding author), 10900 Euclid Ave,Wood Bldg,W151D, Cleveland, OH 44106 USA.	vxm102@case.edu			American Lung Association [RG-166985-N]	American Lung Association	This work was supported by American Lung Association Biomedical Research Grant RG-166985-N (to V. Y. M.-B.).	Anand U, 2008, NEUROSCI LETT, V438, P221, DOI 10.1016/j.neulet.2008.04.007; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Banke TG, 2011, BRAIN RES, V1381, P21, DOI 10.1016/j.brainres.2011.01.021; Baraldi PG, 2010, J MED CHEM, V53, P5085, DOI 10.1021/jm100062h; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Bobkov YV, 2011, BBA-BIOMEMBRANES, V1808, P1120, DOI 10.1016/j.bbamem.2010.12.024; Caterina MJ, 2007, NATURE, V445, P491, DOI 10.1038/nature05565; Catoire LJ, 2010, EUR BIOPHYS J BIOPHY, V39, P623, DOI 10.1007/s00249-009-0513-2; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; Chiu PL, 2007, STRUCTURE, V15, P1053, DOI 10.1016/j.str.2007.06.020; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Cvetkov TL, 2007, PROTEIN EXPRES PURIF, V56, P189, DOI 10.1016/j.pep.2007.07.012; De Petrocellis L, 2008, J PHARMACOL EXP THER, V325, P1007, DOI 10.1124/jpet.107.134809; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Figler RA, 2000, ARCH BIOCHEM BIOPHYS, V376, P34, DOI 10.1006/abbi.2000.1712; Flotenmeyer M, 2007, J MICROSC-OXFORD, V227, P229, DOI 10.1111/j.1365-2818.2007.01805.x; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Gohon Y, 2003, CURR OPIN COLLOID IN, V8, P15, DOI 10.1016/S1359-0294(03)00013-X; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lee SP, 2008, BRIT J PHARMACOL, V153, P1739, DOI 10.1038/bjp.2008.85; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Li MH, 2011, ADV EXP MED BIOL, V704, P1, DOI 10.1007/978-94-007-0265-3_1; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Moiseenkova VY, 2003, BIOCHEM BIOPH RES CO, V310, P196, DOI 10.1016/j.bbrc.2003.09.011; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Moiseenkova-Bell VY, 2009, J GEN PHYSIOL, V133, P239, DOI 10.1085/jgp.200810123; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; NILIUS B, 2005, SCI STKE, pRE8; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2001, J STRUCT BIOL, V136, P227, DOI 10.1006/jsbi.2002.4442; Orlova EV, 2003, J MOL BIOL, V326, P1005, DOI 10.1016/S0022-2836(02)00708-8; Petri ET, 2010, P NATL ACAD SCI USA, V107, P9176, DOI 10.1073/pnas.0912295107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schumann F, 2009, J BIOL CHEM, V284, P24372, DOI 10.1074/jbc.M109.025635; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Sokolova O, 2004, FEBS LETT, V564, P251, DOI 10.1016/S0014-5793(04)00254-6; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Tribet C, 2009, LANGMUIR, V25, P12623, DOI 10.1021/la9018772; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wilkens S, 2000, J BIOENERG BIOMEMBR, V32, P333, DOI 10.1023/A:1005567717821; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zoonens M, 2005, P NATL ACAD SCI USA, V102, P8893, DOI 10.1073/pnas.0503750102	83	92	94	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38168	38176		10.1074/jbc.M111.288993	http://dx.doi.org/10.1074/jbc.M111.288993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908607	Green Published, hybrid			2022-12-27	WOS:000296594200030
J	Mei, XH; Atkinson, D				Mei, Xiaohu; Atkinson, David			Crystal Structure of C-terminal Truncated Apolipoprotein A-I Reveals the Assembly of High Density Lipoprotein (HDL) by Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-FREE STRUCTURE; SECONDARY STRUCTURE; HELIX STABILIZATION; AMPHIPATHIC HELIX; APOA-I; STABILITY; PROTEIN; LECITHIN; BINDING; MILANO	Apolipoprotein A-I (apoA-I) plays important structural and functional roles in plasma high density lipoprotein (HDL) that is responsible for reverse cholesterol transport. However, a molecular understanding of HDL assembly and function remains enigmatic. The 2.2-angstrom crystal structure of Delta(185-243) apoA-I reported here shows that it forms a half-circle dimer. The backbone of the dimer consists of two elongated antiparallel proline-kinked helices (five AB tandem repeats). The N-terminal domain of each molecule forms a four-helix bundle with the helical C-terminal region of the symmetry-related partner. The central region forms a flexible domain with two antiparallel helices connecting the bundles at each end. The two-domain dimer structure based on helical repeats suggests the role of apoA-I in the formation of discoidal HDL particles. Furthermore, the structure suggests the possible interaction with lecithin-cholesterol acyltransferase and may shed light on the molecular details of the effect of the Milano, Paris, and Fin mutations.	[Mei, Xiaohu; Atkinson, David] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University	Atkinson, D (corresponding author), 700 Albany St,W302, Boston, MA 02118 USA.	atkinson@bu.edu	Mei, Xiaohu/B-7513-2012	Mei, Xiaohu/0000-0002-4868-2288; Atkinson, David/0000-0002-4796-7396	National Institutes of Health [P01-HL026335]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL026335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL026335.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDREWS AL, 1976, EUR J BIOCHEM, V64, P549, DOI 10.1111/j.1432-1033.1976.tb10335.x; Bashtovyy D, 2011, J LIPID RES, V52, P435, DOI 10.1194/jlr.R012658; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Bielicki JK, 2002, BIOCHEMISTRY-US, V41, P2089, DOI 10.1021/bi011716p; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Catte A, 2008, BIOPHYS J, V94, P2306, DOI 10.1529/biophysj.107.115857; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Chroni A, 2004, BIOCHEMISTRY-US, V43, P10442, DOI 10.1021/bi049782p; Davidson WS, 2005, CURR OPIN LIPIDOL, V16, P295, DOI 10.1097/01.mol.0000169349.38321.ad; Davidson WS, 2003, J BIOL CHEM, V278, P27199, DOI 10.1074/jbc.M302764200; Fang YL, 2003, BIOCHEMISTRY-US, V42, P13260, DOI 10.1021/bi0354031; Fang YL, 2003, BIOCHEMISTRY-US, V42, P6881, DOI 10.1021/bi034152t; FIELDING CJ, 1995, J LIPID RES, V36, P211; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FRANCESCHINI G, 1982, J BIOL CHEM, V257, P9926; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gorshkova IN, 2006, BIOCHEMISTRY-US, V45, P1242, DOI 10.1021/bi051669r; Gorshkova IN, 2002, BIOCHEMISTRY-US, V41, P10529, DOI 10.1021/bi025807d; Gorshkova IN, 2000, BIOCHEMISTRY-US, V39, P15910, DOI 10.1021/bi0014406; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Jones MK, 2009, BIOCHEMISTRY-US, V48, P11196, DOI 10.1021/bi901242k; Jones MK, 2009, BIOPHYS J, V96, P354, DOI 10.1016/j.bpj.2008.09.041; Klon AE, 2002, BIOCHEMISTRY-US, V41, P10895, DOI 10.1021/bi020315m; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Marcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/00041433-200304000-00006; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; McManus DC, 2001, J BIOL CHEM, V276, P21292, DOI 10.1074/jbc.M100463200; Nallamsetty S, 2007, NAT PROTOC, V2, P383, DOI 10.1038/nprot.2007.50; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; Okon M, 2002, FEBS LETT, V517, P139, DOI 10.1016/S0014-5793(02)02600-5; Okon M, 2001, FEBS LETT, V487, P390, DOI 10.1016/S0014-5793(00)02375-9; Olson CA, 2001, PROTEINS, V44, P123, DOI 10.1002/prot.1079; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perez-Mendez O, 2000, ATHEROSCLEROSIS, V148, P317, DOI 10.1016/S0021-9150(99)00279-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Roosbeek S, 2001, J LIPID RES, V42, P31; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SEGREST JP, 1992, J LIPID RES, V33, P141; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Sirtori CR, 2001, CIRCULATION, V103, P1949; Sorci-Thomas MG, 1998, J BIOL CHEM, V273, P11776, DOI 10.1074/jbc.273.19.11776; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; SorciThomas MG, 1997, J BIOL CHEM, V272, P7278, DOI 10.1074/jbc.272.11.7278	56	153	155	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38570	38582		10.1074/jbc.M111.260422	http://dx.doi.org/10.1074/jbc.M111.260422			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914797	hybrid, Green Published			2022-12-27	WOS:000296594200070
J	Wada, S; Kato, Y; Okutsu, M; Miyaki, S; Suzuki, K; Yan, Z; Schiaffino, S; Asahara, H; Ushida, T; Akimoto, T				Wada, Shogo; Kato, Yoshio; Okutsu, Mitsuharu; Miyaki, Shigeru; Suzuki, Katsuhiko; Yan, Zhen; Schiaffino, Stefano; Asahara, Hiroshi; Ushida, Takashi; Akimoto, Takayuki			Translational Suppression of Atrophic Regulators by MicroRNA-23a Integrates Resistance to Skeletal Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET MESSENGER-RNAS; CARDIAC-HYPERTROPHY; GENE-REGULATION; IN-VIVO; EXPRESSION; PROTEIN; TRANSCRIPTION; MICE; DIFFERENTIATION; ACTIVATION	Muscle atrophy is caused by accelerated protein degradation and occurs in many pathological states. Two muscle-specific ubiquitin ligases, MAFbx/atrogin-1 and muscle RING-finger 1 (MuRF1), are prominently induced during muscle atrophy and mediate atrophy-associated protein degradation. Blocking the expression of these two ubiquitin ligases provides protection against muscle atrophy. Here we report that miR-23a suppresses the translation of both MAFbx/atrogin-1 and MuRF1 in a 3'-UTR-dependent manner. Ectopic expression of miR-23a is sufficient to protect muscles from atrophy in vitro and in vivo. Furthermore, miR-23a transgenic mice showed resistance against glucocorticoid-induced skeletal muscle atrophy. These data suggest that suppression of multiple regulators by a single miRNA can have significant consequences in adult tissues.	[Wada, Shogo; Ushida, Takashi; Akimoto, Takayuki] Univ Tokyo, Div Regenerat Med Engn, Ctr Dis Biol & Integrat Med, Grad Sch Med,Bunkyo Ku, Tokyo 1130033, Japan; [Okutsu, Mitsuharu; Suzuki, Katsuhiko; Akimoto, Takayuki] Waseda Univ, Inst Biomed Engn Consolidated Res Inst Adv Sci &, Shinjuku Ku, Tokyo 1620041, Japan; [Kato, Yoshio] Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Okutsu, Mitsuharu; Yan, Zhen] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Miyaki, Shigeru; Asahara, Hiroshi] Natl Res Inst Child Hlth & Dev, Dept Regenerat Biol & Med, Setagaya Ku, Tokyo 1578535, Japan; [Suzuki, Katsuhiko] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan; [Schiaffino, Stefano; Akimoto, Takayuki] Venetian Inst Mol Med, I-35129 Padua, Italy	University of Tokyo; Waseda University; National Institute of Advanced Industrial Science & Technology (AIST); University of Virginia; National Center for Child Health & Development - Japan; Waseda University; Veneto Institute Molecular Medicine	Akimoto, T (corresponding author), Univ Tokyo, Div Regenerat Med Engn, Ctr Dis Biol & Integrat Med, Grad Sch Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	akimoto@m.u-tokyo.ac.jp	Miyaki, Shigeru/E-4293-2013; Akimoto, Takayuki/H-6704-2012; Kato, Yoshio/M-1093-2018; Suzuki, Katsuhiko/AAI-2197-2019	Miyaki, Shigeru/0000-0002-1602-5777; Akimoto, Takayuki/0000-0002-8874-7779; Kato, Yoshio/0000-0001-8584-367X; Suzuki, Katsuhiko/0000-0002-6572-5809; Yan, Zhen/0000-0002-4826-9813; Schiaffino, Stefano/0000-0002-5607-6421	Ministry of Education, Culture, Sports, Science, and Technology, Japan [18680047, 21680049]; Takeda Science Foundation; Suzuken Memorial Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [10J05580] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Young Investigators (A) 18680047 and 21680049 (to T. A.) and in part by the "Establishment of Consolidated Research Institute for Advanced Science and Medical Care," Encouraging Development Strategic Research Centers Program, the Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science, and Technology, Japan, and the Takeda Science Foundation (2009) and Suzuken Memorial Foundation (2009).; Supported by Japan Society for the Promotion of Science.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC790, DOI 10.1152/ajpcell.00425.2003; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kalsotra A, 2010, GENE DEV, V24, P653, DOI 10.1101/gad.1894310; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952	40	140	149	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38456	38465		10.1074/jbc.M111.271270	http://dx.doi.org/10.1074/jbc.M111.271270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21926429	Green Published, hybrid			2022-12-27	WOS:000296594200060
J	Balasubramanian, R; Kenney, GE; Rosenzweig, AC				Balasubramanian, Ramakrishnan; Kenney, Grace E.; Rosenzweig, Amy C.			Dual Pathways for Copper Uptake by Methanotrophic Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLOSINUS-TRICHOSPORIUM OB3B; SUBSTITUTED BOROSILICATE GLASS; CONTAINING N2O REDUCTASE; MEMBRANE RECEPTOR FPVA; OUTER-MEMBRANE; METHANE MONOOXYGENASE; PSEUDOMONAS-AERUGINOSA; THERMODYNAMIC PROPERTIES; MASS-SPECTROMETRY; METHANOBACTIN	Methanobactin (Mb), a 1217-Da copper chelator produced by the methanotroph Methylosinus trichosporium OB3b, is hypothesized to mediate copper acquisition from the environment, particularly from insoluble copper mineral sources. Although indirect evidence suggests that Mb provides copper for the regulation and activity of methane monooxygenase enzymes, experimental data for direct uptake of copper loaded Mb (Cu-Mb) are lacking. Uptake of intact Cu-Mb by M. trichosporium OB3b was demonstrated by isotopic and fluorescent labeling experiments. Confocal microscopy data indicate that Cu-Mb is localized in the cytoplasm. Both Cu-Mb and unchelated Cu are taken up by M. trichosporium OB3b, but by different mechanisms. Uptake of unchelated Cu is inhibited by spermine, suggesting a porin-dependent passive transport process. By contrast, uptake of Cu-Mb is inhibited by the uncoupling agents carbonyl cyanide m-chlorophenylhydrazone and methylamine, but not by spermine, consistent with an active transport process. Cu-Mb from M. trichosporium OB3b can also be internalized by other strains of methanotroph, but not by Escherichia coli, suggesting that Cu-Mb uptake is specific to methanotrophic bacteria. These findings are consistent with a key role for Cu-Mb in copper acquisition by methanotrophs and have important implications for further investigation of the copper uptake machinery.	[Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	amyr@northwestern.edu	Balasubramanian, Ramakrishnan/C-7620-2011	Kenney, Grace/0000-0002-9579-3351	National Science Foundation [MCB0842366]; National Institutes of Health through the NCI [CCSG P30 CA060553]; National Institutes of Health [GM08061]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Science Foundation Grant MCB0842366. Imaging work was performed at the Northwestern University Cell Imaging Facility supported by National Institutes of Health Grant CCSG P30 CA060553 through the NCI, awarded to the Robert H. Lurie Comprehensive Cancer Center.; Supported in part by National Institutes of Health Training Grant GM08061.	Balasubramanian R, 2008, CURR OPIN CHEM BIOL, V12, P245, DOI 10.1016/j.cbpa.2008.01.043; Balasubramanian R, 2010, APPL ENVIRON MICROB, V76, P7356, DOI 10.1128/AEM.00935-10; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Behling LA, 2008, J AM CHEM SOC, V130, P12604, DOI 10.1021/ja804747d; Braun M, 1999, MOL MICROBIOL, V33, P1037, DOI 10.1046/j.1365-2958.1999.01546.x; Choi DW, 2010, J INORG BIOCHEM, V104, P1240, DOI 10.1016/j.jinorgbio.2010.08.002; Choi DW, 2006, J INORG BIOCHEM, V100, P2150, DOI 10.1016/j.jinorgbio.2006.08.017; Choi DW, 2006, BIOCHEMISTRY-US, V45, P1442, DOI 10.1021/bi051815t; Clement E, 2004, BIOCHEMISTRY-US, V43, P7954, DOI 10.1021/bi049768c; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; DEMANGE P, 1990, BIOCHEMISTRY-US, V29, P11041, DOI 10.1021/bi00502a005; DiSpirito AA, 1998, J BACTERIOL, V180, P3606, DOI 10.1128/JB.180.14.3606-3613.1998; Drechsel H, 1998, J PEPT SCI, V4, P147, DOI 10.1002/(SICI)1099-1387(199805)4:3<147::AID-PSC136>3.0.CO;2-C; El Ghazouani A, 2011, INORG CHEM, V50, P1378, DOI 10.1021/ic101965j; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hakemian AS, 2005, J AM CHEM SOC, V127, P17142, DOI 10.1021/ja0558140; Iyer R, 1997, J BIOL CHEM, V272, P18595, DOI 10.1074/jbc.272.30.18595; Jelinkova A, 2010, PLANT J, V61, P883, DOI 10.1111/j.1365-313X.2009.04102.x; Journo D, 2008, METHOD ENZYMOL, V451, P79, DOI 10.1016/S0076-6879(08)03207-2; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Kim HJ, 2005, BIOCHEMISTRY-US, V44, P5140, DOI 10.1021/bi047367r; Knapp CW, 2007, P NATL ACAD SCI USA, V104, P12040, DOI 10.1073/pnas.0702879104; Krentz BD, 2010, BIOCHEMISTRY-US, V49, P10117, DOI 10.1021/bi1014375; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; Kulczycki E, 2007, GEOBIOLOGY, V5, P251, DOI 10.1111/j.1472-4669.2007.00102.x; Kulczycki E, 2011, GEOMICROBIOL J, V28, P1, DOI 10.1080/01490451003614971; Larsen RA, 1999, MOL MICROBIOL, V31, P1809, DOI 10.1046/j.1365-2958.1999.01317.x; LEE HS, 1989, J BACTERIOL, V171, P2096, DOI 10.1128/jb.171.4.2096-2100.1989; LEE HS, 1991, J BACTERIOL, V173, P5406, DOI 10.1128/jb.173.17.5406-5413.1991; Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0; Martinho M, 2007, J AM CHEM SOC, V129, P15783, DOI 10.1021/ja077682b; Minato Y, 2008, BIOL PHARM BULL, V31, P516, DOI 10.1248/bpb.31.516; Mokhele H., 1987, J BACTERIOL, V169, P5721; Muchova K, 2010, RES MICROBIOL, V161, P783, DOI 10.1016/j.resmic.2010.07.006; Murrell JC, 2000, TRENDS MICROBIOL, V8, P221, DOI 10.1016/S0966-842X(00)01739-X; Navarrete JU, 2011, APPL GEOCHEM, V26, pS319, DOI 10.1016/j.apgeochem.2011.04.002; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Paixao Laura, 2009, J Biol Eng, V3, P18, DOI 10.1186/1754-1611-3-18; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Schalk IJ, 2004, MOL MICROBIOL, V54, P14, DOI 10.1111/j.1365-2958.2004.04241.x; Schalk IJ, 2001, MOL MICROBIOL, V39, P351, DOI 10.1046/j.1365-2958.2001.02207.x; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; Stein LY, 2010, J BACTERIOL, V192, P6497, DOI 10.1128/JB.01144-10; Summer KH, 2011, J TRACE ELEM MED BIO, V25, P36, DOI 10.1016/j.jtemb.2010.12.002; Tellez CM, 1998, APPL ENVIRON MICROB, V64, P1115; Turovskiy Y, 2009, PROBIOTICS ANTIMICRO, V1, P67, DOI 10.1007/s12602-008-9003-6; Yoneyama H, 1996, MICROBIOL-UK, V142, P2137, DOI 10.1099/13500872-142-8-2137; Yoon S, 2010, ENV MICROBIOL REP, V2, P295, DOI 10.1111/j.1758-2229.2009.00125.x; Zumft WG, 2005, J MOL MICROB BIOTECH, V10, P154, DOI 10.1159/000091562	54	63	67	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37313	37319		10.1074/jbc.M111.284984	http://dx.doi.org/10.1074/jbc.M111.284984			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900235	Green Published, hybrid			2022-12-27	WOS:000296542400031
J	He, KY; Chan, CB; Liu, X; Jia, YH; Luo, HBR; France, SA; Liu, Y; Wilson, WD; Ye, KQ				He, Kunyan; Chan, Chi-Bun; Liu, Xia; Jia, Yonghui; Luo, Hongbo R.; France, Stefan A.; Liu, Yang; Wilson, W. David; Ye, Keqiang			Identification of a Molecular Activator for Insulin Receptor with Potent Anti-diabetic Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; 1,4-NAPHTHOQUINONE DERIVATIVES; SERUM-ALBUMIN; PLUMBAGIN; NAPHTHOQUINONES; DISCOVERY; AGENTS; CELLS; MICE; VIVO	Insulin exerts its actions through the insulin receptor (IR) and plays an essential role in diabetes. The inconvenient daily injection and undesirable side-effects associated with insulin injection demand novel drugs for the diseases. To search for bioactive insulin mimetics, we developed an in vitro screening assay using phospho-IR ELISA. After screening the small molecule chemical libraries, we have obtained a compound (5,8-diacetyloxy-2,3-dichloro-1,4-naphthoquinone) that provokes IR activation by directly binding to the receptor kinase domain to trigger its kinase activity at micromolar concentrations. This compound selectively activates IR but not other receptors and sensitizes insulin's action. Moreover, it elevates glucose uptake in adipocytes and has oral hypoglycemic effect in wild-type C57BL/6J mice and db/db and ob/ob mice without demonstrable toxicity. Hence, this promising compound mimics the biological functions of insulin and is useful for further drug development for diabetes treatment.	[He, Kunyan; Chan, Chi-Bun; Liu, Xia; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Jia, Yonghui; Luo, Hongbo R.] Harvard Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02115 USA; [Jia, Yonghui; Luo, Hongbo R.] Childrens Hosp, Boston, MA 02115 USA; [France, Stefan A.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Liu, Yang; Wilson, W. David] Georgia State Univ, Dept Chem, Atlanta, GA 30033 USA	Emory University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia State University	Chan, CB (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	cbchan@emory.edu; kye@emory.edu		France, Stefan/0000-0001-5998-6167	National Institutes of Health, NCI [CA127119]; NATIONAL CANCER INSTITUTE [R01CA127119] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA127119 from NCI (to K. Y.).	BABICH H, 1993, TOXICOL LETT, V69, P69, DOI 10.1016/0378-4274(93)90147-P; Babula P, 2007, Ceska Slov Farm, V56, P114; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Campbell RK, 2009, J AM PHARM ASSOC, V49, pS3, DOI 10.1331/JAPhA.2009.09077; Fonseca VA, 2008, J AM DIET ASSOC, V108, pS29, DOI 10.1016/j.jada.2008.01.047; FUJII N, 1992, ANTIMICROB AGENTS CH, V36, P2589, DOI 10.1128/AAC.36.12.2589; Hsu YL, 2006, J PHARMACOL EXP THER, V318, P484, DOI 10.1124/jpet.105.098863; Jayabharathi J, 2011, SPECTROCHIM ACTA A, V79, P502, DOI 10.1016/j.saa.2011.03.020; Kim BH, 2006, ARCH PHARM RES, V29, P123, DOI 10.1007/BF02974272; KRISHNASWAMY M, 1980, INDIAN J EXP BIOL, V18, P876; Lin B, 2007, J PHARMACOL EXP THER, V323, P579, DOI 10.1124/jpet.107.126102; Liu K, 2000, J MED CHEM, V43, P3487, DOI 10.1021/jm000285q; Maiti TK, 2008, J PHOTOCH PHOTOBIO A, V194, P297, DOI 10.1016/j.jphotochem.2007.08.028; Manchem VP, 2001, DIABETES, V50, P824, DOI 10.2337/diabetes.50.4.824; Pender C, 2002, J BIOL CHEM, V277, P43565, DOI 10.1074/jbc.M202426200; Prasad V. Satya, 1996, Indian Journal of Experimental Biology, V34, P857; Singh U. V., 1997, Indian Journal of Physiology and Pharmacology, V41, P171; SMITH MT, 1985, J TOXICOL ENV HEALTH, V16, P665, DOI 10.1080/15287398509530776; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Wilkie N, 2001, J NEUROCHEM, V78, P1135, DOI 10.1046/j.1471-4159.2001.00504.x; YAMASHITA N, 1991, CLIN IMMUNOL IMMUNOP, V59, P335, DOI 10.1016/0090-1229(91)90029-A; Zaccaro MC, 2005, CHEM BIOL, V12, P1015, DOI 10.1016/j.chembiol.2005.06.015; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974	23	28	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37379	37388		10.1074/jbc.M111.247387	http://dx.doi.org/10.1074/jbc.M111.247387			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908618	Green Published, hybrid			2022-12-27	WOS:000296542400038
J	Vohwinkel, CU; Lecuona, E; Sun, HY; Sommer, N; Vadasz, I; Chandel, NS; Sznajder, JI				Vohwinkel, Christine U.; Lecuona, Emilia; Sun, Haying; Sommer, Natascha; Vadasz, Istvan; Chandel, Navdeep S.; Sznajder, Jacob I.			Elevated CO2 Levels Cause Mitochondrial Dysfunction and Impair Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ACUTE EXACERBATION; CARBON-DIOXIDE; HYPERCAPNIA; METABOLISM; ACID; FIBROBLASTS; RESPIRATION; NA,K-ATPASE; MUTATIONS	Elevated CO2 concentrations (hypercapnia) occur in patients with severe lung diseases. Here, we provide evidence that high CO2 levels decrease O-2 consumption and ATP production and impair cell proliferation independently of acidosis and hypoxia in fibroblasts (N12) and alveolar epithelial cells (A549). Cells exposed to elevated CO2 died in galactose medium as well as when glucose-6-phosphate isomerase was knocked down, suggesting mitochondrial dysfunction. High CO2 levels led to increased levels of microRNA-183 (miR-183), which in turn decreased expression of IDH2 (isocitrate dehydrogenase 2). The high CO2-induced decrease in cell proliferation was rescued by alpha-ketoglutarate and overexpression of IDH2, whereas proliferation decreased in normocapnic cells transfected with siRNA for IDH2. Also, overexpression of miR-183 decreased IDH2 (mRNA and protein) as well as cell proliferation under normocapnic conditions, whereas inhibition of miR-183 rescued the normal proliferation phenotype in cells exposed to elevated levels of CO2. Accordingly, we provide evidence that high CO2 induces miR-183, which down-regulates IDH2, thus impairing mitochondrial function and cell proliferation. These results are of relevance to patients with hypercapnia such as those with chronic obstructive pulmonary disease, asthma, cystic fibrosis, bronchopulmonary dysplasia, and muscular dystrophies.	[Vohwinkel, Christine U.; Lecuona, Emilia; Sun, Haying; Chandel, Navdeep S.; Sznajder, Jacob I.] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Vohwinkel, Christine U.] Northwestern Univ, Div Pediat Crit Care Med, Childrens Mem Hosp, Feinberg Sch Med, Chicago, IL 60614 USA; [Sommer, Natascha; Vadasz, Istvan] Univ Giessen, Lung Ctr, Dept Internal Med, D-35390 Giessen, Germany	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Justus Liebig University Giessen	Sznajder, JI (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, 240 E Huron,McGaw M300, Chicago, IL 60611 USA.	j-sznajder@northwestern.edu	Sommer, Natascha/AAD-5406-2020; Vadasz, Istvan/AAO-8288-2021	Vadasz, Istvan/0000-0003-1370-9783; Sommer, Natascha/0000-0002-8915-7762; Vohwinkel, Christine/0000-0001-8959-157X	National Institutes of Health [HL-85534]; Deutsche Forschungsgemeinschaft [IRTG 1062]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-85534. This work was also supported by Deutsche Forschungsgemeinschaft Grant IRTG 1062.	Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belkin RA, 2006, AM J RESP CRIT CARE, V173, P659, DOI 10.1164/rccm.200410-1369OC; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Darzynkiewicz Z, 2001, CURR PROTOC CYTOM, V7, P771; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; deZengotita VM, 2002, BIOTECHNOL BIOENG, V78, P741, DOI 10.1002/bit.10255; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fritz KI, 2005, PEDIATR RES, V57, P299, DOI 10.1203/01.PDR.0000148718.47137.9B; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; GonzalezMeler MA, 1996, PLANT PHYSIOL, V112, P1349, DOI 10.1104/pp.112.3.1349; Goyal MMZA, 2005, BIOTECHNOL PROGR, V21, P70, DOI 10.1021/bp049815s; GULY MF, 1979, UKR BIOKHIM ZH+, V51, P160; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Kessler R, 1999, AM J RESP CRIT CARE, V159, P158, DOI 10.1164/ajrccm.159.1.9803117; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lang JD, 2000, AM J PHYSIOL-LUNG C, V279, pL994, DOI 10.1152/ajplung.2000.279.5.L994; Lowery AJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-502; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Matzi V, 2007, EUR J CARDIO-THORAC, V32, P776, DOI 10.1016/j.ejcts.2007.07.016; Monnet X, 2007, CURR OPIN CRIT CARE, V13, P6, DOI 10.1097/MCC.0b013e328013c865; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; PARDO A, 1991, CONNECT TISSUE RES, V26, P259, DOI 10.3109/03008209109152443; PARDO A, 1992, CHEST, V102, P1085, DOI 10.1378/chest.102.4.1085; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Ridge KM, 2002, MOL BIOL CELL, V13, P1381, DOI 10.1091/mbc.01-07-0323; Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134; SHEVCHENKO MI, 1979, UKR BIOKHIM ZH+, V51, P53; Sin DD, 2005, CAN J PHYSIOL PHARM, V83, P8, DOI 10.1139/Y04-116; Sin DD, 2005, AM J MED, V118, P145, DOI 10.1016/j.amjmed.2004.10.014; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Varughese M, 2002, PEDIATR PULM, V33, P56, DOI 10.1002/ppul.10032; Vitacca M, 2005, CHEST, V128, P1209, DOI 10.1378/chest.128.3.1209; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Zhou YH, 2005, P NATL ACAD SCI USA, V102, P3875, DOI 10.1073/pnas.0500423102	48	119	126	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37067	37076		10.1074/jbc.M111.290056	http://dx.doi.org/10.1074/jbc.M111.290056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903582	Green Published, hybrid			2022-12-27	WOS:000296542400007
J	Wakayama, Y; Miura, K; Sabe, H; Mochizuki, N				Wakayama, Yuki; Miura, Koichi; Sabe, Hisataka; Mochizuki, Naoki			EphrinA1-EphA2 Signal Induces Compaction and Polarization of Madin-Darby Canine Kidney Cells by Inactivating Ezrin through Negative Regulation of RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR TYROSINE KINASE; ERM PROTEINS; EZRIN/RADIXIN/MOESIN PROTEINS; DOWNSTREAM EFFECTOR; RAC1 ACTIVATION; EPH RECEPTORS; MORPHOGENESIS; ADHESION; PHOSPHORYLATION	The epithelial cells exhibit either a columnar or a flat shape dependent on extracellular stimuli or the cell-cell adhesion. Membrane-anchored ephrinA stimulates EphA receptor tyrosine kinases as a ligand in a cell-cell contact-dependent manner. The mechanism through which ephrinA1/EphA2 signal regulates the cell morphology remains elusive. We demonstrate here that ephrinA1/EphA2 signal induces compaction and enhanced polarization (columnar change) of Madin-Darby canine kidney epithelial cells by regulating Ezrin, a linker that connects plasma membrane and actin cytoskeleton. Activation of EphA2 resulted in RhoA inactivation through p190RhoGAP-A and subsequent dephosphorylation of Ezrin on Thr-567 phosphorylated by Rho kinase. Consistently, the cells expressing an active mutant of Ezrin in which Thr-567 was replaced with Asp did not change their shape in response to ephrinA1. Furthermore, depletion of Ezrin led to compaction and enhanced polarization without ephrinA1 stimulation, suggesting the role for active Ezrin in keeping the flat cell shape. Ezrin localized to apical domain irrespective of ephrinA1 stimulation, whereas phosphorylated Ezrin on the apical domain was reduced by ephrinA1 stimulation. Collectively, ephrinA1/EphA2 signal negatively regulates Ezrin and promotes the alteration of cell shape, from flat to columnar shape.	[Wakayama, Yuki; Miura, Koichi; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, Suita, Osaka 5658565, Japan; [Sabe, Hisataka] Hokkaido Univ, Grad Sch Med, Dept Mol Biol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	National Cerebral & Cardiovascular Center - Japan; Hokkaido University	Miura, K (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	miurako@ri.ncvc.go.jp; nmochizu@ri.ncvc.go.jp	Sabe, Hisataka/A-4066-2012; Sabe, Hisataka/GPF-4385-2022		Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour, and Welfare of Japan; Takeda Science Foundation; Mitsubishi Foundation; AstraZeneca	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; AstraZeneca(AstraZeneca)	This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture of Japan (to N. M.); the Ministry of Health, Labour, and Welfare of Japan (to N. M.); Takeda Science Foundation (to N. M.); the Mitsubishi Foundation (to N. M.); and an AstraZeneca Research Grant (to N. M.).	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Dard N, 2004, DEV BIOL, V271, P87, DOI 10.1016/j.ydbio.2004.03.024; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kondo T, 1997, J CELL BIOL, V139, P749, DOI 10.1083/jcb.139.3.749; Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Miura K, 2009, MOL BIOL CELL, V20, P1949, DOI 10.1091/mbc.E08-06-0549; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; PANDEY A, 1994, J BIOL CHEM, V269, P30154; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stein E, 1997, TRENDS CARDIOVAS MED, V7, P329, DOI 10.1016/S1050-1738(97)00095-9; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Yonemura S, 2002, J CELL SCI, V115, P2569; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	42	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44243	44253		10.1074/jbc.M111.267047	http://dx.doi.org/10.1074/jbc.M111.267047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21979959	hybrid, Green Published			2022-12-27	WOS:000298402300064
J	Plum, M; Michel, Y; Wallach, K; Raiber, T; Blank, S; Bantleon, FI; Diethers, A; Greunke, K; Braren, I; Hackl, T; Meyer, B; Spillner, E				Plum, Melanie; Michel, Yvonne; Wallach, Katharina; Raiber, Tim; Blank, Simon; Bantleon, Frank I.; Diethers, Andrea; Greunke, Kerstin; Braren, Ingke; Hackl, Thomas; Meyer, Bernd; Spillner, Edzard			Close-up of the Immunogenic alpha 1,3-Galactose Epitope as Defined by a Monoclonal Chimeric Immunoglobulin E and Human Serum Using Saturation Transfer Difference (STD) NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE CARBOHYDRATE DETERMINANTS; HYMENOPTERA-VENOM ALLERGY; CRYSTAL-STRUCTURE; IGE ANTIBODIES; FAB FRAGMENT; XENOREACTIVE ANTIBODIES; BINDING-SPECIFICITY; CLINICAL-RELEVANCE; MARASMIUS-OREADES; CROSS-REACTIVITY	Anaphylaxis mediated by carbohydrate structures is a controversially discussed phenomenon. Nevertheless, IgE with specificity for the xenotransplantation antigen alpha 1,3-Gal (alpha-Gal) are associated with a delayed type of anaphylaxis, providing evidence for the clinical relevance of carbohydrate epitopes in allergy. The aim of this study was to dissect immunoreactivity, interaction, and fine epitope of alpha-Gal-specific antibodies to obtain insights into the recognition of carbohydrate epitopes by IgE antibodies and their consequences on a molecular and cellular level. The antigen binding moiety of an alpha-Gal-specific murine IgM antibody was employed to construct chimeric IgE and IgG antibodies. Reactivity and specificity of the resulting antibodies were assessed by means of ELISA and receptor binding studies. Using defined carbohydrates, interaction of the IgE and human serum was assessed by mediator release assays, surface plasmon resonance (SPR), and saturation transfer difference NMR analyses. The alpha-Gal-specific chimeric IgE and IgG antibodies were proven functional regarding interaction with antigen and Fc receptors. SPR measurements demonstrated affinities in the micromolar range. In contrast to a reference antibody, anti-Gal IgE did not induce mediator release, potentially reflecting the delayed type of anaphylaxis. The alpha 1,3-Gal epitope fine structures of both the recombinant IgE and affinity-purified serum were defined by saturation transfer difference NMR, revealing similar contributions of carbohydrate residues and participation of both galactose residues in interaction. The antibodies generated here constitute the principle underlying alpha 1,3-Gal-mediated anaphylaxis. The complementary data of affinity and fine specificity may help to elucidate the recognition of carbohydrates by the adaptive immune response and the molecular requirements of carbohydrate-based anaphylaxis.	[Spillner, Edzard] Univ Hamburg, Inst Biochem & Mol Biol, Dept Chem, D-20146 Hamburg, Germany; [Wallach, Katharina; Hackl, Thomas; Meyer, Bernd] Univ Hamburg, Inst Organ Chem, D-20146 Hamburg, Germany; [Braren, Ingke] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Expt Therapy Res, D-20246 Hamburg, Germany	University of Hamburg; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Spillner, E (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Dept Chem, Martin Luther King Pl 6, D-20146 Hamburg, Germany.	spillner@chemie.uni-hamburg.de	Hackl, Thomas/B-6447-2009; Meyer, Bernd/A-8828-2008; Blank, Simon/M-7708-2013	Hackl, Thomas/0000-0002-9875-9415; spillner, edzard/0000-0003-0999-5254				AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Agostino M, 2010, GLYCOBIOLOGY, V20, P724, DOI 10.1093/glycob/cwq022; Agostino M, 2009, MOL IMMUNOL, V47, P233, DOI 10.1016/j.molimm.2009.09.031; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bencurova M, 2004, GLYCOBIOLOGY, V14, P457, DOI 10.1093/glycob/cwh058; Braren I, 2007, CLIN CHEM, V53, P837, DOI 10.1373/clinchem.2006.078360; Braren I, 2011, ANAL BIOCHEM, V412, P134, DOI 10.1016/j.ab.2010.12.013; Chiang TR, 2000, TRANSPLANTATION, V69, P2593, DOI 10.1097/00007890-200006270-00020; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Clement MJ, 2006, J BIOL CHEM, V281, P2317, DOI 10.1074/jbc.M510172200; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; Diswall M, 2011, XENOTRANSPLANTATION, V18, P28, DOI 10.1111/j.1399-3089.2011.00623.x; Enriquez-Navas PM, 2011, CHEM-EUR J, V17, P1547, DOI 10.1002/chem.201002519; Fotisch K, 1999, INT ARCH ALLERGY IMM, V120, P30, DOI 10.1159/000024217; Fromberg J, 2006, ALLERGY, V61, P1234, DOI 10.1111/j.1398-9995.2006.01222.x; Gehlhar K, 2005, INT ARCH ALLERGY IMM, V136, P311, DOI 10.1159/000083976; Gehlhar K, 2006, INT ARCH ALLERGY IMM, V140, P285, DOI 10.1159/000093706; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Grahn EM, 2009, J MOL BIOL, V390, P457, DOI 10.1016/j.jmb.2009.04.074; Greunke K, 2006, J BIOTECHNOL, V124, P446, DOI 10.1016/j.jbiotec.2005.12.032; Gronlund H, 2009, J ALLERGY CLIN IMMUN, V123, P1189, DOI 10.1016/j.jaci.2009.03.011; Hantusch B, 2004, J ALLERGY CLIN IMMUN, V114, P1294, DOI 10.1016/j.jaci.2004.06.048; Herfurth L, 2005, J MED CHEM, V48, P6879, DOI 10.1021/jm0502687; Houliston RS, 2009, BIOCHEMISTRY-US, V48, P220, DOI 10.1021/bi802100u; ISHIZAKA K, 1966, J IMMUNOL, V97, P840; Jappe U, 2006, ALLERGY, V61, P1220, DOI 10.1111/j.1398-9995.2006.01232.x; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Kooistra O, 2002, EUR J BIOCHEM, V269, P573, DOI 10.1046/j.0014-2956.2001.02684.x; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Maaheimo H, 2000, BIOCHEMISTRY-US, V39, P12778, DOI 10.1021/bi000780o; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Malandain H, 2005, Eur Ann Allergy Clin Immunol, V37, P122; Mari A, 2008, ALLERGY, V63, P891, DOI 10.1111/j.1398-9995.2008.01703.x; Martin-Santamaria S, 2011, ORG BIOMOL CHEM, V9, P5445, DOI 10.1039/c0ob01235a; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; McKenzie IFC, 1999, TRANSPLANTATION, V67, P864, DOI 10.1097/00007890-199903270-00013; Mertens M, 2010, CLIN EXP ALLERGY, V40, P1333, DOI 10.1111/j.1365-2222.2010.03535.x; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Mikeska R, 2005, ACTA CRYSTALLOGR F, V61, P17, DOI 10.1107/S1744309104031501; Milland J, 2007, IMMUNOL CELL BIOL, V85, P623, DOI 10.1038/sj.icb.7100111; MILLER MC, 2011, GLYCOBIOLOG IN PRESS; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Niedziela T, 2005, INFECT IMMUN, V73, P7381, DOI 10.1128/IAI.73.11.7381-7389.2005; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Oberli MA, 2010, J AM CHEM SOC, V132, P10239, DOI 10.1021/ja104027w; Padavattan S, 2007, J MOL BIOL, V368, P742, DOI 10.1016/j.jmb.2007.02.036; Padavattan S, 2009, J IMMUNOL, V182, P2141, DOI 10.4049/jimmunol.0803018; Steinberger P, 1996, J BIOL CHEM, V271, P10967, DOI 10.1074/jbc.271.18.10967; Tempel W, 2002, J BIOL CHEM, V277, P6615, DOI 10.1074/jbc.M109919200; van Roon AMM, 2004, STRUCTURE, V12, P1227, DOI 10.1016/j.str.2004.05.008; Villeneuve S, 2000, P NATL ACAD SCI USA, V97, P8433, DOI 10.1073/pnas.060022997; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Wicklein D, 2004, BIOL CHEM, V385, P397, DOI 10.1515/BC.2004.044; Yu PB, 1996, J IMMUNOL, V157, P5163; Zakhour M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000504	60	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43103	43111		10.1074/jbc.M111.291823	http://dx.doi.org/10.1074/jbc.M111.291823			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21990360	Green Published, hybrid			2022-12-27	WOS:000298351300031
J	Rao, JN; Warren, GZL; Estolt-Povedano, S; Zammit, VA; Ulmer, TS				Rao, Jampani N.; Warren, Gemma Z. L.; Estolt-Povedano, Sara; Zammit, Victor A.; Ulmer, Tobias S.			An Environment-dependent Structural Switch Underlies the Regulation of Carnitine Palmitoyltransferase 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; MALONYL-COA SENSITIVITY; RAT-LIVER MITOCHONDRIA; FATTY-ACID OXIDATION; NMR CHEMICAL-SHIFTS; CONTACT SITES; INTRAMOLECULAR INTERACTIONS; MOLECULAR-STRUCTURE; DIPOLAR COUPLINGS; CPT I	The enzyme carnitine palmitoyltransferase 1 (CPT1), which is anchored in the outer mitochondrial membrane (OMM), controls the rate-limiting step in fatty acid beta-oxidation in mammalian tissues. It is inhibited by malonyl-CoA, the first intermediate of fatty acid synthesis, and it responds to OMM curvature and lipid characteristics, which reflect long term nutrient/hormone availability. Here, we show that the N-terminal regulatory domain (N) of CPT1A can adopt two complex amphiphilic structural states, termed N alpha and N beta, that interchange in a switch-like manner in response to offered binding surface curvature. Structure-based site-directed mutageneses of native CPT1A suggest N alpha to be inhibitory and N beta to be noninhibitory, with the relative N alpha/N beta ratio setting the prevalent malonyl-CoA sensitivity of the enzyme. Based on the amphiphilic nature of N and molecular modeling, we propose malonyl-CoA sensitivity to be coupled to the properties of the OMM by N alpha-OMM associations that alter the N alpha/N beta ratio. For enzymes residing at the membrane-water interface, this constitutes an integrative regulatory mechanism of exceptional sophistication.	[Rao, Jampani N.; Ulmer, Tobias S.] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA; [Rao, Jampani N.; Ulmer, Tobias S.] Univ So Calif, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA; [Warren, Gemma Z. L.; Estolt-Povedano, Sara; Zammit, Victor A.] Univ Warwick, Warwick Med Sch, Metab & Vasc Hlth Div, Coventry CV4 7AL, W Midlands, England	University of Southern California; University of Southern California; University of Warwick	Ulmer, TS (corresponding author), 1501 San Pablo St,ZNI 111, Los Angeles, CA 90033 USA.	tulmer@usc.edu			National Institutes of Health [HL089726]; John Douglas French Alzheimer's Foundation; British Heart Foundation; University of Southern California Liver Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Douglas French Alzheimer's Foundation; British Heart Foundation(British Heart Foundation); University of Southern California Liver Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL089726 (to T. S. U.). This work was also supported by The John Douglas French Alzheimer's Foundation.; Supported by the British Heart Foundation.; Supported by the University of Southern California Liver Center.	Akkaoui M, 2009, BIOCHEM J, V420, P429, DOI 10.1042/BJ20081932; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BIRD MI, 1985, BIOCHEM J, V230, P161, DOI 10.1042/bj2300161; BOCKER J, 1994, J PHYS CHEM-US, V98, P712; Brdiczka D, 1998, BIOFACTORS, V8, P235, DOI 10.1002/biof.5520080311; Cai YY, 2004, EMBO J, V23, P2047, DOI 10.1038/sj.emboj.7600221; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Decatur SM, 2000, BIOPOLYMERS, V54, P180, DOI 10.1002/1097-0282(200009)54:3<180::AID-BIP40>3.3.CO;2-0; Distler AM, 2007, BBA-PROTEINS PROTEOM, V1774, P628, DOI 10.1016/j.bbapap.2007.03.012; Faye A, 2005, BIOCHEM J, V387, P67, DOI 10.1042/BJ20041533; Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711; Fraser F, 2001, J BIOL CHEM, V276, P20182, DOI 10.1074/jbc.M101078200; Gobin S, 2003, J BIOL CHEM, V278, P50428, DOI 10.1074/jbc.M310130200; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Gunasekaran K, 1997, PROTEIN ENG, V10, P1131, DOI 10.1093/protein/10.10.1131; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; IMAE T, 1986, J PHYS CHEM-US, V90, P5216, DOI 10.1021/j100412a065; Jackson VN, 2000, J BIOL CHEM, V275, P38410, DOI 10.1074/jbc.M007722200; Jackson VN, 1999, BIOCHEM J, V341, P483, DOI 10.1042/0264-6021:3410483; Jackson VN, 2000, J BIOL CHEM, V275, P19560, DOI 10.1074/jbc.M002177200; Jackson VN, 2001, BIOCHEMISTRY-US, V40, P14629, DOI 10.1021/bi011632g; Jaroniec CP, 2004, J BIOMOL NMR, V30, P181, DOI 10.1023/B:JNMR.0000048946.71249.2f; JENEI ZA, 2011, FASEB J IN PRESS; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim HJ, 2009, PROG NUCL MAG RES SP, V55, P335, DOI 10.1016/j.pnmrs.2009.07.002; KOLODZIEJ MP, 1990, BIOCHEM J, V272, P421, DOI 10.1042/bj2720421; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Lopez-Vinas E, 2007, J BIOL CHEM, V282, P18212, DOI 10.1074/jbc.M700885200; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; Mera P, 2009, BIOCHEM PHARMACOL, V77, P1084, DOI 10.1016/j.bcp.2008.11.020; Morillas M, 2004, BIOCHEM J, V379, P777, DOI 10.1042/BJ20031373; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; ONTKO JA, 1980, BIOCHEM J, V192, P959, DOI 10.1042/bj1920959; Pan Y, 2002, J BIOL CHEM, V277, P47184, DOI 10.1074/jbc.M208055200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Phoenix DA, 2002, CURR PROTEIN PEPT SC, V3, P201, DOI 10.2174/1389203024605368; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; Rufer AC, 2007, FEBS LETT, V581, P3247, DOI 10.1016/j.febslet.2007.05.080; SAGGERSON ED, 1982, BIOCHEM J, V202, P397, DOI 10.1042/bj2020397; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2007, PROTEINS, V69, P734, DOI 10.1002/prot.21754; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi JY, 1999, J BIOL CHEM, V274, P9421, DOI 10.1074/jbc.274.14.9421; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Woldegiorgis G, 2005, MONATSH CHEM, V136, P1325, DOI 10.1007/s00706-005-0334-7; Zammit VA, 1998, LIPIDS, V33, P371, DOI 10.1007/s11745-998-0217-7; Zammit VA, 1997, ADV ENZYME REGUL, V37, P295, DOI 10.1016/S0065-2571(96)00015-5; ZAMMIT VA, 1983, BIOCHEM J, V214, P1027, DOI 10.1042/bj2141027; Zammit VA, 2001, BIOCHEM SOC T, V29, P287, DOI 10.1042/BST0290287; Zammit VA, 2009, ADV DRUG DELIVER REV, V61, P1353, DOI 10.1016/j.addr.2009.04.024	63	17	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42545	42554		10.1074/jbc.M111.306951	http://dx.doi.org/10.1074/jbc.M111.306951			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21990363	Green Published, hybrid			2022-12-27	WOS:000298180900062
J	Towne, JE; Renshaw, BR; Douangpanya, J; Lipsky, BP; Shen, M; Gabel, CA; Sims, JE				Towne, Jennifer E.; Renshaw, Blair R.; Douangpanya, Jason; Lipsky, Brian P.; Shen, Min; Gabel, Christopher A.; Sims, John E.			Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36 alpha, IL-36 beta, and IL-36 gamma) or Antagonist (IL-36Ra) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERALIZED PUSTULAR PSORIASIS; NF-KAPPA-B; FAMILY; MEMBERS; RECEPTOR; ACTIVATION; IDENTIFICATION; PROTEINS; SUBUNIT; CLONING	IL-36 alpha, IL-36 beta, and IL-36 gamma (formerly IL-1F6, IL-1F8, and IL-1F9) are IL-1 family members that signal through the IL-1 receptor family members IL-1Rrp2 (IL-1RL2) and IL-1RAcP. IL-36Ra (formerly IL-1F5) has been reported to antagonize IL-36 gamma. However, our previous attempts to demonstrate IL-36Ra antagonism were unsuccessful. Here, we demonstrate that IL-36Ra antagonist activity is dependent upon removal of its N-terminal methionine. IL-36Ra starting at Val-2 is fully active and capable of inhibiting not only IL-36 gamma but also IL-36 alpha and IL-36 beta. Val-2 of IL-36Ra lies 9 amino acids N-terminal to an A-X-Asp motif conserved in all IL-1 family members. In further experiments, we show that truncation of IL-36 alpha, IL-36 beta, and IL-36 gamma to this same point increased their specific activity by similar to 10(3)-10(4)-fold (from EC50 1 mu g/ml to EC50 1 ng/ml). Inhibition of truncated IL-36 beta activity required similar to 10(2)-10(3)-fold excess IL-36Ra, similar to the ratio required for IL-1Ra to inhibit IL-1 beta. Chimeric receptor experiments demonstrated that the extracellular (but not cytoplasmic) domain of IL-1Rrp2 or IL-1R1 is required for inhibition by their respective natural antagonists. IL-36Ra bound to IL-1Rrp2, and pretreatment of IL-1Rrp2-expressing cells with IL-36Ra prevented IL-36 beta-mediated co-immunoprecipitation of IL-1Rrp2 with IL-1RAcP. Taken together, these results suggest that the mechanism of IL-36Ra antagonism is analogous to that of IL-1Ra, such that IL-36Ra binds to IL-1Rrp2 and prevents IL-1RAcP recruitment and the formation of a functional signaling complex. In addition, truncation of IL-36 alpha, IL-36 beta, and IL-36 gamma dramatically enhances their activity, suggesting that post-translational processing is required for full activity.	[Shen, Min] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA; [Towne, Jennifer E.; Renshaw, Blair R.; Douangpanya, Jason; Lipsky, Brian P.; Gabel, Christopher A.; Sims, John E.] Amgen Inc, Dept Inflammat Res, Seattle, WA 98119 USA	Amgen; Amgen	Towne, JE (corresponding author), Amgen Inc, Dept Prot Sci, 1201 Amgen Court W, Seattle, WA 98119 USA.	townej@amgen.com		Sims, John/0000-0002-5667-9185				Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Born TL, 2000, J BIOL CHEM, V275, P29946, DOI 10.1074/jbc.M004077200; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Dunn E, 2001, TRENDS IMMUNOL, V22, P533, DOI 10.1016/S1471-4906(01)02034-8; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martin U, 2009, J IMMUNOL, V183, P4021, DOI 10.4049/jimmunol.0803301; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200	20	238	278	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42594	42602		10.1074/jbc.M111.267922	http://dx.doi.org/10.1074/jbc.M111.267922			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965679	Green Published, hybrid			2022-12-27	WOS:000298180900067
J	Yamamoto, T; Iino, H; Kim, K; Kuramitsu, S; Fukui, K				Yamamoto, Tatsuya; Iino, Hitoshi; Kim, Kwang; Kuramitsu, Seiki; Fukui, Kenji			Evidence for ATP-dependent Structural Rearrangement of Nuclease Catalytic Site in DNA Mismatch Repair Endonuclease MutL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; C-TERMINAL DOMAIN; MASS-SPECTROMETRY; HYDROGEN/DEUTERIUM EXCHANGE; CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; SWISS-MODEL; ALPHA; PROTEINS; BINDING	DNA mismatch repair (MMR) greatly contributes to genome integrity via the correction of mismatched bases that are mainly generated by replication errors. Postreplicative MMR excises a relatively long tract of error-containing single-stranded DNA. MutL is a widely conserved nicking endonuclease that directs the excision reaction to the error-containing strand of the duplex by specifically nicking the daughter strand. Because MutL apparently exhibits nonspecific nicking endonuclease activity in vitro, the regulatory mechanism of MutL has been argued. Recent studies suggest ATP-dependent conformational and functional changes of MutL, indicating that the regulatory mechanism involves the ATP binding and hydrolysis cycle. In this study, we investigated the effect of ATP binding on the structure of MutL. First, a cross-linking experiment confirmed that the N-terminal ATPase domain physically interacts with the C-terminal endonuclease domain. Next, hydrogen/deuterium exchange mass spectrometry clarified that the binding of ATP to the N-terminal domain induces local structural changes at the catalytic sites of MutL C-terminal domain. Finally, on the basis of the results of the hydrogen/deuterium exchange experiment, we successfully identified novel regions essential for the endonuclease activity of MutL. The results clearly show that ATP modulates the nicking endonuclease activity of MutL via structural rearrangements of the catalytic site. In addition, several Lynch syndrome-related mutations in human MutL homolog are located in the position corresponding to the newly identified catalytic region. Our data contribute toward understanding the relationship between mutations in MutL homolog and human disease.	[Yamamoto, Tatsuya; Iino, Hitoshi; Kuramitsu, Seiki; Fukui, Kenji] Harima Inst, RIKEN SPring Ctr 8, Sayo Cho, Hyogo 6795148, Japan; [Kim, Kwang; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	RIKEN; Osaka University	Fukui, K (corresponding author), Harima Inst, RIKEN SPring Ctr 8, 1-1-1 Kouto, Sayo Cho, Hyogo 6795148, Japan.	k.fukui@spring8.or.jp		Yamamoto, Tatsuya/0000-0001-8356-8248; Fukui, Kenji/0000-0003-2463-7578				Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Duppatla V, 2009, BIOCHEM J, V423, P265, DOI 10.1042/BJ20090626; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Friedberg E. C., 1995, DNA REPAIR MUTAGENES, P1; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Fukui K, 2007, NUCLEIC ACIDS RES, V35, P850, DOI 10.1093/nar/gkl735; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Iino H, 2011, BIOSCIENCE REP, V31, P309, DOI 10.1042/BSR20100116; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kondo E, 2001, NUCLEIC ACIDS RES, V29, P1695, DOI 10.1093/nar/29.8.1695; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Mendillo ML, 2010, J BIOL CHEM, V285, P13170, DOI 10.1074/jbc.M110.108894; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Morita R, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/179594; Mueller J, 2009, CANCER RES, V69, P7053, DOI 10.1158/0008-5472.CAN-09-0358; Namadurai S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013726; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; VAJDA T, 1976, ACTA BIOCHIM BIOPHYS, V11, P287; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yamamoto T, 2004, J BIOCHEM, V135, P663, DOI 10.1093/jb/mvh080; Yamamoto T, 2006, FEBS LETT, V580, P3638, DOI 10.1016/j.febslet.2006.05.049; Yamamoto T, 2010, J BIOL CHEM, V285, P5646, DOI 10.1074/jbc.M109.081836; Yang W, 2007, DNA REPAIR, V6, P135, DOI 10.1016/j.dnarep.2006.10.021	43	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42337	42348		10.1074/jbc.M111.277335	http://dx.doi.org/10.1074/jbc.M111.277335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21953455	hybrid, Green Published			2022-12-27	WOS:000298180900043
J	Lucas, N; Cho, W				Lucas, Nathan; Cho, Wonhwa			Phosphatidylserine Binding Is Essential for Plasma Membrane Recruitment and Signaling Function of 3-Phosphoinositide-dependent Kinase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PROTEIN-KINASE; C-ALPHA; DIFFERENTIAL ROLES; 3T3-L1 ADIPOCYTES; PH DOMAIN; ACTIVATION; PDK1; TRANSLOCATION; LOCALIZATION	3-Phosphoinositide-dependent kinase-1 (PDK1) is a ubiquitously expressed serine/threonine kinase that functions downstream of phosphoinositide 3-kinase. Although binding of 3'-phosphoinositides, phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,4-bisphosphate, to the pleckstrin homology (PH) domain of PDK1 is known to be essential for its interaction with and activation of downstream kinases, the mechanism by which PDK1 is recruited to the plasma membrane remains controversial. Our surface plasmon resonance analysis of the PDK1 PH domain and selected mutants shows that the PH domain specifically binds phosphatidylserine using a site that is separate from the canonical phosphoinositide-binding site. Further cell studies show that this specific phosphatidylserine binding is important for the plasma membrane localization and signaling function of PDK1.	[Lucas, Nathan; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cho, W (corresponding author), Univ Illinois, Dept Chem, M-C 111,845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu			National Institutes of Health [GM68849]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68849.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bayascas JR, 2008, CELL CYCLE, V7, P2978, DOI 10.4161/cc.7.19.6810; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CHO W, 2006, SCI STKE, pPE7, DOI DOI 10.1126/STKE.3212006PE7; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Garza LA, 2000, J BIOL CHEM, V275, P2560, DOI 10.1074/jbc.275.4.2560; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Whiteman EL, 2003, ENDOCRINOLOGY, V144, P3811, DOI 10.1210/en.2003-0480; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	39	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41265	41272		10.1074/jbc.M111.300806	http://dx.doi.org/10.1074/jbc.M111.300806			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971045	hybrid, Green Published			2022-12-27	WOS:000298057500014
J	Qi, DF; Huang, SP; Miao, RD; She, ZG; Quinn, T; Chang, YZ; Liu, JG; Fan, DP; Chen, YE; Fu, MG				Qi, Dongfei; Huang, Shengping; Miao, Ruidong; She, Zhi-Gang; Quinn, Tim; Chang, Yingzi; Liu, Jianguo; Fan, Daping; Chen, Y. Eugene; Fu, Mingui			Monocyte Chemotactic Protein-induced Protein 1 (MCPIP1) Suppresses Stress Granule Formation and Determines Apoptosis under Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; BODIES; TRANSLATION; SITES; CELLS; IDENTIFICATION; ACTIVATION; EXPRESSION; MODULATORS; REVEALS	It is unclear how stress granule (SG) formation and cellular apoptosis are coordinately regulated. MCPIP1 (monocyte chemotactic protein-induced protein 1), also known as Zc3h12a, is a critical regulator of the inflammatory response and immune homeostasis. However, the role of MCPIP1 in stress response remains unknown. Here, we report that overexpression of MCPIP1 inhibited the assembly of SGs in response to various stresses. Conversely, MCPIP1-deficient splenocytes developed more SGs even without stress. On the other hand, overexpression of MCPIP1 sensitized RAW 264.7 cells to apoptosis under stress, whereas MCPIP1-deficient cells were resistant to stress-induced apoptosis. Mutagenesis study showed that the ability of MCPIP1 to repress SG formation is dependent on its deubiquitinating activity. Consistently, MCPIP1 negatively regulated stress-induced phosphorylation of eIF2 alpha and thus released stress-induced inhibition of protein translation. However, MCPIP1 also inhibited 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced SG formation, which was reported to be independent of eIF2 alpha phosphorylation. Taken together, these results suggest that MCPIP1 coordinates SG formation and apoptosis during cellular stress and may play a critical role in immune homeostasis and resolution of macrophage inflammation.	[Qi, Dongfei; Huang, Shengping; Miao, Ruidong; Quinn, Tim; Fu, Mingui] Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA; [Qi, Dongfei; Huang, Shengping; Miao, Ruidong; Quinn, Tim; Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [She, Zhi-Gang] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92037 USA; [Chang, Yingzi] AT Still Univ Hlth Sci, Dept Pharmacol, Kirksville, MO 63501 USA; [Liu, Jianguo] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA; [Fan, Daping] Univ S Carolina, Dept Cell Biol & Anat, Columbia, SC 29209 USA; [Chen, Y. Eugene] Univ Michigan, Med Ctr, Ctr Cardiovasc, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Sanford Burnham Prebys Medical Discovery Institute; A.T. Still University of Health Sciences; Saint Louis University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Michigan System; University of Michigan	Fu, MG (corresponding author), Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA.	fum@umkc.edu	Qi, Dongfei/L-9548-2015; Qi, Dongfei/M-1050-2015	Qi, Dongfei/0000-0001-9104-978X; Qi, Dongfei/0000-0001-9104-978X	National Institutes of Health [HL-098794, CA-137126, AR-055353, HL-106325, RR-016434, HL-092421, HL-068878, HL-89544]; American Heart Association; NATIONAL CANCER INSTITUTE [K22CA137126] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092421, R01HL089544, R01HL068878, R21HL106325, R21HL098794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-098794 (to M. F.), CA-137126 and AR-055353 (to L.), HL-106325 and RR-016434 (to D. F.), and HL-092421, HL-068878, and HL-89544 (to Y. E. C.). This work was also supported by an American Heart Association beginning grant-in-aid award (to M. F.).	Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cande C, 2004, J CELL SCI, V117, P4461, DOI 10.1242/jcs.01356; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rossi JJ, 2005, NAT CELL BIOL, V7, P643, DOI 10.1038/ncb0705-643; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Serman A, 2007, NUCLEIC ACIDS RES, V35, P4715, DOI 10.1093/nar/gkm491; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tsai NP, 2010, CELL SIGNAL, V22, P668, DOI 10.1016/j.cellsig.2009.12.001; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	33	40	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41692	41700		10.1074/jbc.M111.276006	http://dx.doi.org/10.1074/jbc.M111.276006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971051	Green Published, hybrid			2022-12-27	WOS:000298057500053
J	von Stockum, S; Basso, E; Petronilli, V; Sabatelli, P; Forte, MA; Bernardi, P				von Stockum, Sophia; Basso, Emy; Petronilli, Valeria; Sabatelli, Patrizia; Forte, Michael A.; Bernardi, Paolo			Properties of Ca2+ Transport in Mitochondria of Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; HEART-MITOCHONDRIA; CYCLOSPORINE-A; RUTHENIUM RED; ESSENTIAL COMPONENT; INNER MEMBRANE; STEADY-STATE; CELL-DEATH; CALCIUM; LIVER	We have studied the pathways for Ca2+ transport in mitochondria of the fruit fly Drosophila rnelanogaster. We demonstrate the presence of ruthenium red (RR)-sensitive Ca2+ uptake, of RR-insensitive Ca2+ release, and of Na+-stimulated Ca2+ release in energized mitochondria, which match well characterized Ca2+ transport pathways of mammalian mitochondria. Following larger matrix Ca2+ loading Drosophila mitochondria underwent spontaneous RR-insensitive Ca2+ release, an event that in mammals is due to opening of the permeability transition pore (PTP). Like the PIP of mammals, Drosophila Ca2+-induced Ca2+ release could be triggered by uncoupler, diamide, and N-ethylmaleimide, indicating the existence of regulatory voltage- and redox-sensitive sites and was inhibited by tetracaine. Unlike PTP-mediated Ca2+ release in mammals, however, it was (i) insensitive to cyclosporin A, ubiquinone 0, and ADP; (ii) inhibited by P-i, as is the PTP of yeast mitochondria; and (iii) not accompanied by matrix swelling and cytochrome c release even in KCl-based medium. We conclude that Drosophila mitochondria possess a selective Ca2+ release channel with features intermediate between the PTP of yeast and mammals.	[von Stockum, Sophia; Basso, Emy; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [von Stockum, Sophia; Basso, Emy; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, CNR, Inst Neurosci, I-35121 Padua, Italy; [Sabatelli, Patrizia] Ist Ortoped Rizzoli, Inst Mol Genet, I-40126 Bologna, Italy; [Forte, Michael A.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Istituto Ortopedico Rizzoli; Oregon Health & Science University	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@bio.unipd.it	Basso, Emy/F-7687-2015; Sabatelli, Patrizia/C-7479-2019; Petronilli, Valeria/C-3558-2015; Bernardi, Paolo/C-3656-2008	Basso, Emy/0000-0003-2962-7213; Sabatelli, Patrizia/0000-0003-2345-5094; Petronilli, Valeria/0000-0003-4026-6404; Bernardi, Paolo/0000-0001-9187-3736	National Institutes of Health [GM069883]; Fondazione Cariparo; University of Padova Progetti di Eccellenza Models of Mitochondrial Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Cariparo(Fondazione Cariparo); University of Padova Progetti di Eccellenza Models of Mitochondrial Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069883. This work was also supported in part by grants from the Fondazione Cariparo and the University of Padova Progetti di Eccellenza Models of Mitochondrial Diseases.	ALTSCHULD RA, 1992, AM J PHYSIOL, V262, pH1699, DOI 10.1152/ajpheart.1992.262.6.H1699; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Azzolin L, 2010, BBA-BIOENERGETICS, V1797, P1775, DOI 10.1016/j.bbabio.2010.07.002; Azzolin L, 2010, FEBS LETT, V584, P2504, DOI 10.1016/j.febslet.2010.04.023; AZZONE GF, 1977, FEBS LETT, V78, P21, DOI 10.1016/0014-5793(77)80264-0; Barsukova A, 2011, EUR J NEUROSCI, V33, P831, DOI 10.1111/j.1460-9568.2010.07576.x; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Broekemeier KM, 1998, BIOCHEMISTRY-US, V37, P13059, DOI 10.1021/bi980820c; BROEKEMEIER KM, 1985, J BIOL CHEM, V260, P105; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; CARAFOLI E, 1972, BIOCHEM BIOPH RES CO, V49, P1498, DOI 10.1016/0006-291X(72)90509-8; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; Cesura AM, 2003, J BIOL CHEM, V278, P49812, DOI 10.1074/jbc.M304748200; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; CROMPTON M, 1977, EUR J BIOCHEM, V79, P549, DOI 10.1111/j.1432-1033.1977.tb11839.x; CROMPTON M, 1976, EUR J BIOCHEM, V69, P453, DOI 10.1111/j.1432-1033.1976.tb10930.x; CROMPTON M, 1988, BIOCHEM J, V255, P357; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; DAWSON AP, 1979, NATURE, V277, P484, DOI 10.1038/277484a0; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Di Lisa F, 2011, BBA-MOL CELL RES, V1813, P1316, DOI 10.1016/j.bbamcr.2011.01.031; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Friel DD, 2000, CELL CALCIUM, V28, P307, DOI 10.1054/ceca.2000.0172; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; GUERIN B, 1994, J BIOL CHEM, V269, P25406; Gunter TE, 2001, IUBMB LIFE, V52, P197, DOI 10.1080/15216540152846000; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; JACOBS EE, 1960, J BIOL CHEM, V235, P531; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jung DW, 1997, J BIOL CHEM, V272, P21104, DOI 10.1074/jbc.272.34.21104; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Krieser RJ, 2009, APOPTOSIS, V14, P961, DOI 10.1007/s10495-009-0362-6; Manon S, 1998, J BIOENERG BIOMEMBR, V30, P419, DOI 10.1023/A:1020533928491; McQuibban AG, 2010, HUM MOL GENET, V19, P987, DOI 10.1093/hmg/ddp563; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; NICHOLLS DG, 1978, BIOCHEM J, V176, P463, DOI 10.1042/bj1760463; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; PFEIFFER DR, 1979, J BIOL CHEM, V254, P1485; Prieto S, 1996, ARCH BIOCHEM BIOPHYS, V334, P43, DOI 10.1006/abbi.1996.0427; PRIETO S, 1992, EUR J BIOCHEM, V208, P487, DOI 10.1111/j.1432-1033.1992.tb17212.x; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Rizzuto R, 2003, NAT GENET, V34, P135, DOI 10.1038/ng0603-135; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Roucou X, 1997, BBA-BIOMEMBRANES, V1324, P120, DOI 10.1016/S0005-2736(96)00215-5; SCARPA A, 1970, EUR J BIOCHEM, V12, P328, DOI 10.1111/j.1432-1033.1970.tb00854.x; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; STUCKI JW, 1974, EUR J BIOCHEM, V48, P365, DOI 10.1111/j.1432-1033.1974.tb03778.x; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Taupin P, 2008, EUR J HISTOCHEM, V52, P135; Uribe-Carvajal S, 2011, MITOCHONDRION, V11, P382, DOI 10.1016/j.mito.2011.02.004; VASINGTON FD, 1972, BIOCHIM BIOPHYS ACTA, V256, P43, DOI 10.1016/0005-2728(72)90161-2; WINGROVE DE, 1984, J BIOL CHEM, V259, P9390; Yamada A, 2009, BBA-BIOENERGETICS, V1787, P1486, DOI 10.1016/j.bbabio.2009.07.001; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353	80	46	46	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41163	41170		10.1074/jbc.M111.268375	http://dx.doi.org/10.1074/jbc.M111.268375			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984833	hybrid, Green Published			2022-12-27	WOS:000298057500005
J	Wang, XB; Hu, GQ; Betts, C; Harmon, EY; Keller, RS; Van De Water, L; Zhou, JL				Wang, Xiaobo; Hu, Guoqing; Betts, Courtney; Harmon, Erin Yund; Keller, Rebecca S.; Van De Water, Livingston; Zhou, Jiliang			Transforming Growth Factor-beta 1-induced Transcript 1 Protein, a Novel Marker for Smooth Muscle Contractile Phenotype, Is Regulated by Serum Response Factor/Myocardin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION PROTEIN; LIM PROTEIN; CELL-LINES; TGF-BETA; HIC-5; DIFFERENTIATION; EXPRESSION; GENE; CONTRIBUTES; COACTIVATOR	Serum response factor (SRF) plays a central role in regulating expression of smooth muscle-specific genes partly by associating with the potent tissue-specific cofactor myocardin. Previous studies have shown that transforming growth factor-beta 1-induced transcript 1 (TGFB1I1, also known as Hic-5) is a TGF-beta-responsive gene and is involved in the cellular response to vascular injury, but the regulation of TGFB1I1 expression remains elusive. In this report, we demonstrated that TGFB1I1 is a novel marker for the smooth muscle contractile phenotype and is regulated by SRF/myocardin. We found that TGFB1I1 is specifically expressed in smooth muscle cells (SMCs) and in smooth muscle-rich tissues. Furthermore, TGFB1I1 expression is significantly down-regulated in a variety of models for smooth muscle phenotypic modulation. The TGFB1I1 promoter contains an evolutionarily conserved CArG element, and this element is indispensible for myocardin-induced transactivation of TGFB1I1 promoter. By oligonucleotide pulldown and chromatin immunoprecipitation assays, we found that SRI binds to this CArG element in vitro and in vivo. Ectopic expression of myocardin is sufficient to induce endogenous TGFB1I1 expression in multiple cell lines whereas knocking-down myocardin or SRF significantly attenuated TGFB1I1 expression in SMCs. Furthermore, our data demonstrated that SRF is essential for TGF-beta-mediated induction of TGFB1I1. Finally, silencing of TGFB1I1 expression significantly promotes SMC proliferation. Collectively, this study provides the first evidence that TGFB1I1 is not only an SRF/myocardin-regulated smooth muscle marker but also critical for maintaining smooth muscle contractile phenotype by inhibiting smooth muscle proliferation.	[Wang, Xiaobo; Hu, Guoqing; Harmon, Erin Yund; Keller, Rebecca S.; Zhou, Jiliang] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Betts, Courtney; Van De Water, Livingston] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Zhou, JL (corresponding author), 47 New Scotland Ave,Mail Code 8, Albany, NY 12208 USA.	zhouj1@mail.amc.edu	Wang, Xiaobo/J-4312-2014; Wang, Xiaobo/S-2476-2019	Wang, Xiaobo/0000-0001-6044-914X; Van De Water, Livingston/0000-0002-3825-9224	National Institutes of Health [GM56442]; NIGMS, National Institutes of Health; Albany Medical College and Scientist Development; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Albany Medical College and Scientist Development; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56442 and by American Recovery and Reinvestment Act funds from the NIGMS, National Institutes of Health (to L. V. D. W.). This work was also supported by a start-up fund from Albany Medical College and Scientist Development Grant from the American Heart Association (to J. Z.).	Aghajanova L, 2009, ENDOCRINOLOGY, V150, P3863, DOI 10.1210/en.2009-0008; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Brunskill EW, 2001, DEV BIOL, V235, P507, DOI 10.1006/dbio.2001.0313; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; Ghogomu SM, 2006, J BIOL CHEM, V281, P1755, DOI 10.1074/jbc.M505869200; Heitzer MD, 2006, MOL ENDOCRINOL, V20, P56, DOI 10.1210/me.2005-0065; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683; Kim-Kaneyama JR, 2008, BIOCHEM BIOPH RES CO, V376, P682, DOI 10.1016/j.bbrc.2008.09.051; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; KUROO M, 1991, J BIOL CHEM, V266, P3768; Li X, 2011, ONCOGENE, V30, P167, DOI 10.1038/onc.2010.400; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; ROTHMAN A, 1992, CIRCULATION, V86, P1977, DOI 10.1161/01.CIR.86.6.1977; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Thomas SM, 1999, J CELL SCI, V112, P181; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Yuminamochi T, 2003, J HISTOCHEM CYTOCHEM, V51, P513, DOI 10.1177/002215540305100413; Yund EE, 2009, J MOL CELL CARDIOL, V47, P520, DOI 10.1016/j.yjmcc.2009.06.006; Zheng JP, 2010, EXP MOL PATHOL, V88, P52, DOI 10.1016/j.yexmp.2009.10.006; Zhou JL, 2010, J BIOL CHEM, V285, P23175, DOI 10.1074/jbc.M110.109868	49	41	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41589	41599		10.1074/jbc.M111.250878	http://dx.doi.org/10.1074/jbc.M111.250878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984848	hybrid, Green Published			2022-12-27	WOS:000298057500044
J	Cho, S; Park, JS; Kang, YK				Cho, Sunwha; Park, Jung Sun; Kang, Yong-Kook			Dual Functions of Histone-Lysine N-Methyltransferase Setdb1 Protein at Promyelocytic Leukemia-Nuclear Body (PML-NB) MAINTAINING PML-NB STRUCTURE AND REGULATING THE EXPRESSION OF ITS ASSOCIATED GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; BODIES; CHROMATIN; H3; HETEROCHROMATIN; METHYLATION; DNA; TRANSCRIPTION; DOMAIN; INTERACTS	Setdb1/Eset is a histone H3 lysine 9 (H3K9)-specific methyltransferase that associates with various transcription factors to regulate gene expression via chromatin remodeling. Here, we report that Setdb1 associates with promyelocytic leukemia (Pm1) protein from the early stage of mouse development and is a constitutive member of promyelocytic leukemia (PML)-nuclear bodies (PML-NBs) that have been linked to many cellular processes such as apoptosis, DNA damage responses, and transcriptional regulation. Arsenic treatment, which induces Pm1 degradation, caused Setdb1 signals to disappear. Setdb1 knockdown resulted in dismantlement of PML-NBs. Immunoprecipitation results demonstrated physical interactions between Setdb1 and Pm1. Chromatin immunoprecipitation revealed that, within the frame of PML-NBs, Setdb1 binds the promoter of Id2 and suppresses its expression through installing H3K9 methylation. Our findings suggest that Setdb1 performs dual, but inseparable, functions at PML-NBs to maintain the structural integrity of PML-NBs and to control PML-NB-associated genes transcriptionally.	[Cho, Sunwha; Park, Jung Sun; Kang, Yong-Kook] Korea Res Inst Biosci & Biotechnol, Dev & Differentiat Res Ctr, Taejon 305806, South Korea; [Cho, Sunwha; Kang, Yong-Kook] Univ Sci & Technol, Dept Funct Genom, Taejon 305806, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kang, YK (corresponding author), 111 Gwahangno, Taejon 305806, South Korea.	ykkang@kribb.re.kr			National Research Foundation of Korea [2011-0027808, 2011-0030769]; Next-generation BioGreen21 Grant [PJ008002]; KRIBB initiative	National Research Foundation of Korea(National Research Foundation of Korea); Next-generation BioGreen21 Grant; KRIBB initiative	This work was supported by National Research Foundation of Korea Grants 2011-0027808 and 2011-0030769, Next-generation BioGreen21 Grant PJ008002, and KRIBB initiative program.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Cairo S, 2005, ONCOGENE, V24, P2195, DOI 10.1038/sj.onc.1208338; Chen GQ, 1997, BLOOD, V89, P3345; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Ebrahimian M, 2010, CELLS TISSUES ORGANS, V192, P374, DOI 10.1159/000319466; Eskiw CH, 2004, J BIOL CHEM, V279, P9577, DOI 10.1074/jbc.M312580200; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Everett RD, 1999, J CELL SCI, V112, P3443; Everett RD, 1999, J CELL SCI, V112, P4581; GODDARD AD, 1995, MAMM GENOME, V6, P732, DOI 10.1007/BF00354296; Gratze P, 2008, CIRCULATION, V117, P2645, DOI 10.1161/CIRCULATIONAHA.107.760116; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jeong YS, 2007, DEV DYNAM, V236, P1509, DOI 10.1002/dvdy.21150; Jeong YS, 2010, GENES CELLS, V15, P181, DOI 10.1111/j.1365-2443.2009.01375.x; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Kang YK, 1999, J BIOL CHEM, V274, P36585, DOI 10.1074/jbc.274.51.36585; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kurowska-Stolarska M, 2009, ARTHRITIS RHEUM-US, V60, P3663, DOI 10.1002/art.25001; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Shiels C, 2001, J CELL SCI, V114, P3705; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Yeap LS, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-12; Yeo S, 2005, MOL CELLS, V20, P423; Yoon J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002234; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	51	41	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41115	41124		10.1074/jbc.M111.248534	http://dx.doi.org/10.1074/jbc.M111.248534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21921037	hybrid, Green Published			2022-12-27	WOS:000297315400070
J	Shapira, S; Kazanov, D; Weisblatt, S; Starr, A; Arber, N; Kraus, S				Shapira, Shiran; Kazanov, Dina; Weisblatt, Samuel; Starr, Alex; Arber, Nadir; Kraus, Sarah			The CD24 Protein Inducible Expression System Is an Ideal Tool to Explore the Potential of CD24 as an Oncogene and a Target for Immunotherapy in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLED GENE-EXPRESSION; CELL-PROLIFERATION; B-CELLS; TETRACYCLINE; CANCER; APOPTOSIS; INTERNALIZATION; CARCINOGENESIS; PRECURSORS; ADHESION	CD24 is a cell surface, heavily glycosylated glycosylphosphatidylinositol-anchored mucin-like protein that is overexpressed in various human malignancies. To accurately analyze CD24 function and dissect its biological role in a defined genetic background, it is critical to tightly regulate its expression and be able to turn it on/off in a restricted environment and at a specific time, rho tetracycline-induced expression system is most promising as it exhibits such regulation, lack of pleiotropic effects, and high and rapid induction levels. To evaluate the oncogenic and immunotherapeutic potential of CD24 by applying the Tet-On system, the human CD24 gene was cloned downstream to two tetracycline operator sequences, resulting in pCDNA4/TO-CD24, which was then transfected into tetracycline (Tet) repressor-expressing cells (293T-REx), allowing tight on/off regulation, thereby resulting in a very low background or leaky CD24 expression. Selected clones were chosen for further studies and characterized in vitro and in vivo, and several treatment modalities were examined. In addition, the role of CD24 in promoting cell proliferation and tumor growth was studied. The tetracycline-dependent system was successfully implemented. Tetracycline treatment induced CD24 expression in a dose- and time-dependent fashion, which was abrogated following treatment with anti-CD24 monoclonal antibodies (mAbs). CD24-induced expression led to an increased proliferation rate that was inhibited by mAb treatment. In vivo, significantly larger tumors were developed in tetracycline-fed mice. The CD24 Tet-On system is a good model to unravel the role and underlying CD24 pathogenesis in vivo. This valuable tool allows the successful study of novel treatment options, whose effectiveness depends on the CD24 expression level. This set of experiments supports CD24 oncogenic properties.	[Shapira, Shiran; Kazanov, Dina; Weisblatt, Samuel; Arber, Nadir; Kraus, Sarah] Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, IL-64239 Tel Aviv, Israel; [Starr, Alex] Tel Aviv Sourasky Med Ctr, Lung & Allergy Inst, IL-64239 Tel Aviv, Israel; [Starr, Alex] Tel Aviv Univ, Dept Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Shapira, Shiran; Weisblatt, Samuel; Arber, Nadir; Kraus, Sarah] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Arber, N (corresponding author), Tel Aviv Med Ctr & Sch Med, Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, 3-3rd Fl,Arison Med Tower,6 Weizmann St, IL-64239 Tel Aviv, Israel.	nadir@tasmc.health.gov.il		Arber, Nadir/0000-0001-5283-6991; Starr, Alexander/0000-0002-9329-3740	Deutsches Krebsforschungszentrum (DFKZ); Israel Ministry of Science and Technology (MOST)	Deutsches Krebsforschungszentrum (DFKZ); Israel Ministry of Science and Technology (MOST)	This work was supported in part by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DFKZ) and the Israel Ministry of Science and Technology (MOST).	Aiba A, 2007, NEUROSCI RES, V58, P113, DOI 10.1016/j.neures.2007.01.009; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Chappel MS, 1996, J EXP MED, V184, P1639, DOI 10.1084/jem.184.5.1639; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Kim HJ, 2007, CANCER LETT, V258, P98, DOI 10.1016/j.canlet.2007.08.025; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Li O, 2004, J EXP MED, V200, P1083, DOI 10.1084/jem.20040779; Lim SC, 2005, PATHOL RES PRACT, V201, P479, DOI 10.1016/j.prp.2005.05.004; Matzke AJM, 2003, PLANT MOL BIOL REP, V21, P9, DOI 10.1007/BF02773392; Mazor Y, 2007, J IMMUNOL METHODS, V321, P41, DOI 10.1016/j.jim.2007.01.008; MUCCI D, 1995, INFECT IMMUN, V63, P2912, DOI 10.1128/IAI.63.8.2912-2918.1995; Nieoullon V, 2005, MOL CELL NEUROSCI, V28, P462, DOI 10.1016/j.mcn.2004.10.007; Nieoullon V, 2007, CELL TISSUE RES, V329, P457, DOI 10.1007/s00441-007-0395-5; Nizard P, 2001, PROTEIN ENG, V14, P439, DOI 10.1093/protein/14.6.439; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Petry IB, 2010, CLIN CANCER RES, V16, P451, DOI 10.1158/1078-0432.CCR-09-1617; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Sagiv E, 2006, BIOMED PHARMACOTHER, V60, P280, DOI 10.1016/j.biopha.2006.06.006; Sagiv E, 2008, CANCER RES, V68, P2803, DOI 10.1158/0008-5472.CAN-07-6463; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Sagiv Eyal, 2008, Expert Rev Gastroenterol Hepatol, V2, P125, DOI 10.1586/17474124.2.1.125; Shapira S, 2011, GASTROENTEROLOGY, V140, P935, DOI 10.1053/j.gastro.2010.12.004; Stebbins MJ, 2001, P NATL ACAD SCI USA, V98, P10775, DOI 10.1073/pnas.121186498; Suzuki T, 2001, J IMMUNOL, V166, P5567, DOI 10.4049/jimmunol.166.9.5567; Taguchi T, 2003, J IMMUNOL, V170, P252, DOI 10.4049/jimmunol.170.1.252; Wang WF, 2010, CANCER SCI, V101, P112, DOI 10.1111/j.1349-7006.2009.01370.x; WEINMANN P, 1994, PLANT J, V5, P559, DOI 10.1046/j.1365-313X.1994.5040559.x; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Yin DX, 1996, ANAL BIOCHEM, V235, P195, DOI 10.1006/abio.1996.0112	30	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40548	40555		10.1074/jbc.M111.286534	http://dx.doi.org/10.1074/jbc.M111.286534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21976680	Green Published, hybrid			2022-12-27	WOS:000297315400014
J	Muscolini, M; Montagni, E; Palermo, V; Di Agostino, S; Gu, W; Abdelmoula-Souissi, S; Mazzoni, C; Blandino, G; Tuosto, L				Muscolini, Michela; Montagni, Elisa; Palermo, Vanessa; Di Agostino, Silvia; Gu, Wei; Abdelmoula-Souissi, Salma; Mazzoni, Cristina; Blandino, Giovanni; Tuosto, Loretta			The Cancer-associated K351N Mutation Affects the Ubiquitination and the Translocation to Mitochondria of p53 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BAX-DEPENDENT APOPTOSIS; TETRAMERIZATION DOMAIN; NUCLEAR EXPORT; MDM2; DEGRADATION; ACTIVATION; DEATH; LOCALIZATION; DISRUPTION; PROMOTES	Stress-induced monoubiquitination of p53 is a crucial event for the nuclear-cytoplasm-mitochondria trafficking and transcription-independent pro-apoptotic functions of p53. Although an intact ubiquitination pathway and a functional nuclear export sequence are required for p53 nuclear export, the role of specific residues within this region in regulating both processes remains largely unknown. Here we characterize the mechanisms accounting for the nuclear accumulation of a new point mutation (Lys-351 to Asn) in the nuclear export sequence of p53 identified in a cisplatin-resistant ovarian carcinoma cell line (A2780 CIS). We found that K351N substitution abrogates the monoubiquitination of p53 induced by both Mdm2 and MSL2 E3-ligases. As a consequence, cells expressing p53 K351N mutant showed defects in cisplatin-induced translocation of p53 to mitochondria, Bax oligomerization, and mitochondrial membrane depolarization. These data identify K351N as a critical mutation of p53 that contributes	[Muscolini, Michela; Montagni, Elisa; Palermo, Vanessa; Mazzoni, Cristina; Tuosto, Loretta] Univ Roma La Sapienza, Dept Biol & Biotechnol, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Di Agostino, Silvia; Blandino, Giovanni] Ist Regina Elena IFO, Translat Oncogen Unit, I-00144 Rome, Italy; [Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10027 USA; [Abdelmoula-Souissi, Salma] Univ Sfax, Ctr Biotechnol Sfax, Sfax 3018, Tunisia	Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Columbia University; Columbia University; Centre de Biotechnologie de Sfax; Universite de Sfax	Tuosto, L (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol, Ist Pasteur Fdn Cenci Bolognetti, Via Sardi 70, I-00185 Rome, Italy.	loretta.tuosto@uniroma1.it	Di Agostino, Silvia/S-8566-2019; Blandino, Giovanni/B-1137-2013; Mazzoni, Cristina/U-2658-2018; Di Agostino, Silvia/H-1121-2018; Tuosto, Loretta/F-7017-2011; Muscolini, Michela/AAB-3904-2019	Blandino, Giovanni/0000-0002-6970-2241; Mazzoni, Cristina/0000-0002-1504-6189; Di Agostino, Silvia/0000-0003-3730-1125; Tuosto, Loretta/0000-0001-9056-4077; Muscolini, Michela/0000-0003-4090-4779	Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome; Minister of University and Research; Istituto Pasteur-Fondazione Cenci Bolognetti; NATIONAL CANCER INSTITUTE [P01CA097403, P01CA080058, R01CA131439] Funding Source: NIH RePORTER	Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Minister of University and Research; Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grants from the Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome and the Minister of University and Research.; Supported by a fellowship from the Istituto Pasteur-Fondazione Cenci Bolognetti.	Abdelmoula-Souissi S, 2011, APOPTOSIS, V16, P746, DOI 10.1007/s10495-011-0607-z; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Amor IYH, 2008, FEMS YEAST RES, V8, P1254, DOI 10.1111/j.1567-1364.2008.00445.x; BEHRENS BC, 1987, CANCER RES, V47, P414; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brachmann CB, 1998, YEAST, V14, P115; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Coutinho I, 2011, EXP CELL RES, V317, P1147, DOI 10.1016/j.yexcr.2011.02.007; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldstein I, 2009, CELL CYCLE, V8, P3259; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Kruse JP, 2009, J BIOL CHEM, V284, P3250, DOI 10.1074/jbc.M805658200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Lwin TZ, 2007, J MOL BIOL, V373, P1334, DOI 10.1016/j.jmb.2007.07.080; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Muscolini M, 2008, MOL CANCER THER, V7, P1410, DOI 10.1158/1535-7163.MCT-08-0299; Muscolini M, 2009, CELL CYCLE, V8, P3396, DOI 10.4161/cc.8.20.9910; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Palacios G, 2008, CELL CYCLE, V7, P2584, DOI 10.4161/cc.7.16.6070; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Pietsch EC, 2007, CANCER BIOL THER, V6, P1576, DOI 10.4161/cbt.6.10.4719; Raffo AJ, 2000, ONCOGENE, V19, P6216, DOI 10.1038/sj.onc.1203995; Schlereth K, 2010, MOL CELL, V38, P356, DOI 10.1016/j.molcel.2010.02.037; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Soussi T, 2005, 25 YEARS OF P53 RESEARCH, P255, DOI 10.1007/1-4020-2922-5_12; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waster PK, 2009, J INVEST DERMATOL, V129, P1769, DOI 10.1038/jid.2008.421; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980	50	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39693	39702		10.1074/jbc.M111.279539	http://dx.doi.org/10.1074/jbc.M111.279539			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953469	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000296925700003
J	Wang, JR; Markova, D; Anderson, DG; Zheng, ZM; Shapiro, IM; Risbud, MV				Wang, Jianru; Markova, Dessislava; Anderson, D. Greg; Zheng, Zhaomin; Shapiro, Irving M.; Risbud, Makarand V.			TNF-alpha and IL-1 beta Promote a Disintegrin-like and Metalloprotease with Thrombospondin Type I Motif-5-mediated Aggrecan Degradation through Syndecan-4 in Intervertebral Disc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NUCLEUS PULPOSUS TISSUE; CYTOKINE EXPRESSION; GENE-EXPRESSION; HEPARAN-SULFATE; NITRIC-OXIDE; DEGENERATION; ACTIVATION; MATRIX; OSTEOARTHRITIS	Elevated levels of TNF-alpha, IL-1 beta and a resultant increase in ADAMTS (a disintegrin-like and metalloprotease with thrombospondin type I motifs) expression is seen during disc degeneration. However, if these pro-inflammatory cytokines control ADAMTS activity is not definitively known. The goal of the investigation was to study if TNF-alpha and IL-1 beta regulate syndecan-4 (SDC4) expression, and if SDC4 was responsible for promoting aggrecan degradation through controlling ADAMTS activity in nucleus pulposus cells of the intervertebral disc. Cytokine treatment increased SDC4 expression and promoter activity. Use of inhibitor, SM7368 and co-transfections with I kappa B alpha, RelA/p50 showed that NF-kappa B regulated both basal and cytokine-dependent SDC4 transcription. SDC4 promoter har-boring RelA binding site mutation was unresponsive to the cytokines. Moreover, cytokines failed to increase SDC4 promoter activity in RelA-null cells. Cytokines increased ADAMTS-4/5 expression and aggrecan degradation and promoted SDC4 interaction with ADAMTS-5. Treatment with heparinase-III and p-nitrophenyl-beta-D-xylopyranoside (PNPX), an inhibitor of heparan sulfate synthesis and transfection with SDC4-shRNA partially blocked cytokine mediated aggrecan degradation. Analysis of human tissues showed increased aggrecan degradation with a concomitant increase in SDC4 and ADAMTS-5 protein expression with severity of disc disease. Likewise, SDC4, TNF-alpha, IL-1 beta, ADAMTS-4, and ADAMTS-5 mRNA expression increased in degenerate tissues. We conclude that in nucleus pulposus, TNF-alpha and IL-1 beta regulate SDC4 expression, which plays a key role in pathogenesis of degenerative disc disease by promoting aggrecan degradation by ADAMTS-5.	[Wang, Jianru; Markova, Dessislava; Anderson, D. Greg; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Wang, Jianru; Markova, Dessislava; Anderson, D. Greg; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Wang, Jianru; Zheng, Zhaomin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Guangzhou 510080, Guangdong, Peoples R China	Jefferson University; Jefferson University; Sun Yat Sen University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1015 Walnut St,Suite 501 Curtis Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			National Institutes of Health [R01-AR050087, R01-AR055655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by Grants R01-AR050087 and R01-AR055655 from the National Institutes of Health.	Asplund A, 2009, J LEUKOCYTE BIOL, V86, P381, DOI 10.1189/jlb.0908536; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Barbir A, 2011, SPINE, V36, P607, DOI 10.1097/BRS.0b013e3181d9b58b; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Haschtmann D, 2008, EUR SPINE J, V17, P289, DOI 10.1007/s00586-007-0509-5; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lee JM, 2011, J ORTHOP RES, V29, P265, DOI 10.1002/jor.21210; Lee S, 2009, CLIN BIOCHEM, V42, P1504, DOI 10.1016/j.clinbiochem.2009.06.017; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; Ng L, 2003, J STRUCT BIOL, V143, P242, DOI 10.1016/j.jsb.2003.08.006; Omlor GW, 2006, J ORTHOP RES, V24, P385, DOI 10.1002/jor.20055; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Smith MF, 2006, GLYCOBIOLOGY, V16, P221, DOI 10.1093/glycob/cwj061; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Ulrich JA, 2007, SPINE, V32, P2812, DOI 10.1097/BRS.0b013e31815b9850; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Yamashita M, 2008, SPINE, V33, P1836, DOI 10.1097/BRS.0b013e31817bab2a	29	194	215	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39738	39749		10.1074/jbc.M111.264549	http://dx.doi.org/10.1074/jbc.M111.264549			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949132	Green Published, hybrid			2022-12-27	WOS:000296925700007
J	Hall, BM; Owens, KM; Singh, KK				Hall, Brandon M.; Owens, Kjerstin M.; Singh, Keshav K.			Distinct Functions of Evolutionary Conserved MSF1 and Late Embryogenesis Abundant (LEA)-like Domains in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; GENE DELETION; DNA DAMAGE; PRELI-LIKE; CARDIOLIPIN; PROTEINS; LEA; PHOSPHOLIPIDS; VECTORS	PRELID1, the only late embryogenesis abundant (LEA) domain-containing protein in humans, exerts cytoprotective effects through its LEA domain within the mitochondria. Although PRELID1 homologs in vertebrates contain the LEA domain, homologs in lower eukaryotes are thought to lack this domain. In this study, we identify a novel LEA-like domain in a yeast PRELID1 homolog, Ups2p, which contains sequence conservation with the LEA domain of human PRELID1. PRELID1 homologs, including Ups2p, are known to contain the PRELI/MSF1 domain. Our study reveals that the MSF1 domain of Ups2p maintains proper mitochondrial electron transport chain function, respiratory competency, and mitochondrial phosphatidylethanolamine metabolism. The Ups2p MSF1 domain mediates cardiolipin depletion in the absence of Ups1p. However, the Ups2p LEA-like domain is responsible for cardiolipin depletion resulting from UPS2 overexpression. The regulation of phosphatidylethanolamine levels by the MSF1 domain is antagonized by the Ups2p LEA-like domain. We demonstrate that the yeast LEA-like domain protects cells from oxidative stress and can be functionally replaced by the human LEA domain. Together our studies suggest distinct roles of MSF1 and LEA-like domains in mitochondrial function and resistance to oxidative stress.	[Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Ctr Aging, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Hall, Brandon M.; Owens, Kjerstin M.; Singh, Keshav K.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Roswell Park Cancer Institute; University of Alabama System; University of Alabama Birmingham	Singh, KK (corresponding author), Univ Alabama Birmingham, Dept Genet, Ctr Aging, Ctr Free Rad Biol, KAUL 620,720 S 20th St, Birmingham, AL 35294 USA.	kksingh@uab.edu		Owens, Kjerstin/0000-0001-5210-319X	National Institutes of Health [R01 CA116430, 121904, 113655]; NATIONAL CANCER INSTITUTE [R01CA113655, R01CA116430, R01CA121904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA116430, 121904, and 113655 (to K. K. S.).	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Anantharaman V, 2002, GENOME BIOL, V3; Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Brachmann CB, 1998, YEAST, V14, P115; Carhan A, 2004, INVERTEBR NEUROSCI, V5, P65, DOI 10.1007/s10158-003-0028-y; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Dee CT, 2005, DEV GENES EVOL, V215, P248, DOI 10.1007/s00427-005-0470-4; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Fox EJ, 2004, BIOCHEM J, V378, P817, DOI 10.1042/BJ20031504; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Guzman-Rojas L, 2000, INT IMMUNOL, V12, P607, DOI 10.1093/intimm/12.5.607; Hand SC, 2007, J EXP ZOOL PART A, V307A, P62, DOI 10.1002/jez.a.343; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; HUGHES DW, 1991, PLANT CELL, V3, P605, DOI 10.1105/tpc.3.6.605; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Kim IS, 2007, J MICROBIOL, V45, P326; Leister D., 2007, METHODS MOL BIOL MIT, V372, P87; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McKeller MR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.19; Menze MA, 2009, J BIOL CHEM, V284, P10714, DOI 10.1074/jbc.C900001200; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NAKAI M, 1993, BIOCHIM BIOPHYS ACTA, V1174, P282, DOI 10.1016/0167-4781(93)90198-M; Niu S, 1996, GENE, V175, P187, DOI 10.1016/0378-1119(96)00146-1; O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002; OHTSUKA T, 1993, J BIOL CHEM, V268, P22914; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; Osman C., 2008, CHARACTERIZATION GEN; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Powers WJ, 2007, NEUROBIOL DIS, V27, P99, DOI 10.1016/j.nbd.2007.04.008; Reeve S, 2007, GENESIS, V45, P66, DOI 10.1002/dvg.20265; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; SIKORSKI RS, 1989, GENETICS, V122, P19; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Tahvanainen J, 2009, BLOOD, V113, P1268, DOI 10.1182/blood-2008-07-166553; Tamura Y, 2010, EMBO J, V29, P2875, DOI 10.1038/emboj.2010.149; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029; TREGER JM, 1990, MOL CELL BIOL, V10, P3174, DOI 10.1128/MCB.10.6.3174; Tsubouchi A, 2009, DEVELOPMENT, V136, P3757, DOI 10.1242/dev.042135; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	56	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39141	39152		10.1074/jbc.M111.259853	http://dx.doi.org/10.1074/jbc.M111.259853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930701	Green Published, hybrid			2022-12-27	WOS:000296759800033
J	Hanada, Y; Sekimizu, K; Kaito, C				Hanada, Yuichi; Sekimizu, Kazuhisa; Kaito, Chikara			Silkworm Apolipophorin Protein Inhibits Staphylococcus aureus Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-B; BOMBYX-MORI; SIGNAL-TRANSDUCTION; 2-COMPONENT SYSTEM; PRECURSOR PROTEIN; BINDING; BACTERIAL; EXPRESSION; LIPOPHORIN; REGULATOR	Silkworm hemolymph inhibits hemolysin production by Staphylococcus aureus. We purified a factor in the silkworm hemolymph responsible for this inhibitory activity. The final fraction with the greatest specific activity contained 220- and 74-kDa proteins. Determination of the N-terminal amino acid sequence revealed that the 220- and 74-kDa proteins were apolipophorin I and apolipophorin II, respectively, indicating that the factor was apolipophorin (ApoLp). The purified ApoLp fraction showed decreased expression of S. aureus hla encoding alpha-hemolysin, hlb encoding beta-hemolysin, saeRS, and RNAIII, which activate the expression of these hemolysin genes. Injection of an anti-ApoLp antibody into the hemolymph increased the sensitivity of silkworms to the lethal effect of S. aureus. Hog gastric mucin, a mammalian homologue of ApoLp, decreased the expression of S. aureus hla and hlb. These findings suggest that ApoLp in the silkworm hemolymph inhibits S. aureus virulence and contributes to defense against S. aureus infection and that its activity is conserved in mammalian mucin.	[Hanada, Yuichi; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/G-1248-2017; Kaito, Chikara/W-1815-2019	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	National Institute of Biomedical Innovation (NIBIO); Genome Pharmaceutical Institute	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Genome Pharmaceutical Institute	This work was supported by grants-in-aid for scientific research and in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) and the Genome Pharmaceutical Institute.	Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; Avarre JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-3; Babin PJ, 1999, J MOL EVOL, V49, P150, DOI 10.1007/PL00006528; Cheung AL, 2001, INFECT IMMUN, V69, P2448, DOI 10.1128/IAI.69.4.2448-2455.2001; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; CHINO H, 1969, BIOCHIM BIOPHYS ACTA, V176, P1; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Hossain MS, 2006, J BIOCHEM, V140, P439, DOI 10.1093/jb/mvj171; Ishii K, 2008, J BIOL CHEM, V283, P2185, DOI 10.1074/jbc.M705480200; Ishii K, 2010, J BIOL CHEM, V285, P28635, DOI 10.1074/jbc.M110.138446; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2007, DRUG DISCOV THER, V1, P89; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Kutty RK, 1996, J BIOL CHEM, V271, P20641, DOI 10.1074/jbc.271.34.20641; Liang XD, 2006, INFECT IMMUN, V74, P4655, DOI 10.1128/IAI.00322-06; Mainiero M, 2010, J BACTERIOL, V192, P613, DOI 10.1128/JB.01242-09; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; Matsumoto Y, 2010, STRUCTURE, V18, P537, DOI 10.1016/j.str.2010.02.007; Matsuo M, 2003, FEMS MICROBIOL LETT, V222, P107, DOI 10.1016/S0378-1097(03)00260-X; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; Niere M, 2001, BIOCHEMISTRY-US, V40, P11502, DOI 10.1021/bi010117f; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; OKADA M, 1983, BIOCHEM J, V211, P727, DOI 10.1042/bj2110727; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; Pratt CC, 2004, BIOL CHEM, V385, P1113, DOI 10.1515/BC.2004.145; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Sakashita K, 2009, J FAC AGR KYUSHU U, V54, P401; Smolenaars MMW, 2005, J LIPID RES, V46, P412, DOI 10.1194/jlr.M400374-JLR200; Steinhuber A, 2003, J BACTERIOL, V185, P6278, DOI 10.1128/JB.185.21.6278-6286.2003; Sundermeyer K, 1996, INSECT BIOCHEM MOLEC, V26, P735, DOI 10.1016/S0965-1748(96)00060-4; Tsuchida K, 1998, INSECT BIOCHEM MOLEC, V28, P927, DOI 10.1016/S0965-1748(98)00036-8; WEERS PMM, 1993, J BIOL CHEM, V268, P4300; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Ziebandt AK, 2001, PROTEOMICS, V1, P480, DOI 10.1002/1615-9861(200104)1:4<480::AID-PROT480>3.0.CO;2-O	45	34	38	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39360	39369		10.1074/jbc.M111.278416	http://dx.doi.org/10.1074/jbc.M111.278416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937431	Green Published, hybrid			2022-12-27	WOS:000296759800054
J	Yen, JH; Kocieda, VP; Jing, HE; Ganea, D				Yen, Jui-Hung; Kocieda, Virginia P.; Jing, Huie; Ganea, Doina			Prostaglandin E2 Induces Matrix Metalloproteinase 9 Expression in Dendritic Cells through Two Independent Signaling Pathways Leading to Activator Protein 1 (AP-1) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; IV COLLAGENASE GENE; FACTOR-KAPPA-B; MATRIX METALLOPROTEINASES; MMP-9 EXPRESSION; UP-REGULATION; TRANSCRIPTIONAL ACTIVITY; PROSTANOID RECEPTORS; REGULATED KINASES; LANGERHANS CELLS	Dendritic Cells (DCs) play an important role in the initiation of the immune response by migrating to regional lymph nodes and presenting antigen processed at the inflammatory site to antigen-specific naive T cells. Prostaglandin E2 (PGE2) has been reported to play an essential role in DC migration. We reported previously that PGE2 induces matrix metalloproteinase 9 (MMP-9) expression in DCs and that PGE2-induced MMP-9 is required for DC migration in vivo and in vitro. In this study, we investigated the signaling mechanisms involved in PGE2-induced MMP-9 expression in DCs. We show that PGE2-induced MMP-9 expression is mediated primarily through the EP2/EP4 -> cAMP -> protein kinase A (PKA)/PI3K -> ERK signaling pathway, leading to c-Fos expression, and through JNK-mediated activation of c-Jun in a PKA/PI3K/ERK-independent manner. EP2 and EP4 receptor agonists, as well as cAMP analogs, mimic the up-regulation of MMP-9 by PGE2. PKA, PI3K, and ERK inhibitors abolished PGE2- and cAMP-induced c-Fos and MMP-9 up-regulation, and ERK activation was required for the binding of activator protein 1 (AP-1) transcription factor to the MMP-9 promoter. Our results describe a new molecular mechanism for the effect of PGE2 on MMP-9 production in DCs that could lead to future therapeutic approaches using ERK inhibitors to regulate DC migration.	[Yen, Jui-Hung; Kocieda, Virginia P.; Ganea, Doina] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Jing, Huie] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yen, JH (corresponding author), Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA.	doina.ganea@temple.edu	Yen, Jui-Hung/AAV-3455-2020; Jing, Hui/GXM-4109-2022	Jing, Hui/0000-0002-8389-8252; Yen, Jui-Hung Jimmy/0000-0002-7325-9756				Chabot V, 2006, J LEUKOCYTE BIOL, V79, P767, DOI 10.1189/jlb.0804464; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Chernogubova E, 2004, ENDOCRINOLOGY, V145, P269, DOI 10.1210/en.2003-0857; CORCORAN ML, 1992, J BIOL CHEM, V267, P515; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Hollender P, 2002, IMMUNOBIOLOGY, V206, P441, DOI 10.1078/0171-2985-00193; Holvoet S, 2003, EXP CELL RES, V290, P108, DOI 10.1016/S0014-4827(03)00293-3; Ichiyasu H, 2004, AM J RESP CELL MOL, V30, P761, DOI 10.1165/rcmb.2003-0370OC; Itatsu K, 2009, AM J PATHOL, V174, P829, DOI 10.2353/ajpath.2009.080012; Jing H, 2004, J BIOL CHEM, V279, P55176, DOI 10.1074/jbc.M409816200; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kim HS, 2004, ANTICANCER RES, V24, P747; Kim JH, 2008, BIOCHEM BIOPH RES CO, V377, P195, DOI 10.1016/j.bbrc.2008.09.095; Lan HC, 2007, MOL CELL BIOL, V27, P2027, DOI 10.1128/MCB.02253-06; Lee KW, 2005, ANTIOXID REDOX SIGN, V7, P1612, DOI 10.1089/ars.2005.7.1612; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Li W, 2007, BIOL REPROD, V76, P654, DOI 10.1095/biolreprod.106.057034; Lin CC, 2008, TOXICOL APPL PHARM, V229, P386, DOI 10.1016/j.taap.2008.01.032; Luft T, 2002, BLOOD, V100, P1362, DOI 10.1182/blood-2001-12-0360; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park MK, 2009, BIOCHEM BIOPH RES CO, V379, P1043, DOI 10.1016/j.bbrc.2009.01.005; Pavlovic S, 2006, J BIOL CHEM, V281, P3321, DOI 10.1074/jbc.M506846200; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Reno F, 2005, PROSTAG OTH LIPID M, V75, P13, DOI 10.1016/j.prostaglandins.2004.08.001; Sanchez S, 2004, NEUROCHEM INT, V44, P231, DOI 10.1016/S0197-0186(03)00150-5; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; St-Pierre Y, 2004, EXPERT OPIN THER TAR, V8, P473, DOI 10.1517/14728222.8.5.473; Sturm EM, 2008, J IMMUNOL, V181, P7273, DOI 10.4049/jimmunol.181.10.7273; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; Vassiliou E, 2003, CELL IMMUNOL, V223, P120, DOI 10.1016/S0008-8749(03)00158-8; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Wang HH, 2009, GLIA, V57, P24, DOI 10.1002/glia.20732; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Xue J, 2010, BIOMED PHARMACOTHER, V64, P118, DOI 10.1016/j.biopha.2009.04.033; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Yue W., 2010, CLIN EXP PHARM PHYSL; Zhang BC, 2011, BBA-MOL CELL RES, V1813, P73, DOI 10.1016/j.bbamcr.2010.10.001; Zozulya AL, 2007, J IMMUNOL, V178, P520, DOI 10.4049/jimmunol.178.1.520	49	63	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38913	38923		10.1074/jbc.M111.252932	http://dx.doi.org/10.1074/jbc.M111.252932			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940623	Green Published, hybrid			2022-12-27	WOS:000296759800010
J	Kim, DK; Kim, JR; Koh, M; Kim, YD; Lee, JM; Chanda, D; Park, SB; Min, JJ; Lee, CH; Park, TS; Choi, HS				Kim, Don-Kyu; Kim, Jung Ran; Koh, Minseob; Kim, Yong Deuk; Lee, Ji-Min; Chanda, Dipanjan; Park, Seung Bum; Min, Jung-Joon; Lee, Chul-Ho; Park, Tae-Sik; Choi, Hueng-Sik			Estrogen-related Receptor gamma (ERR gamma) Is a Novel Transcriptional Regulator of Phosphatidic Acid Phosphatase, LIPIN1, and Inhibits Hepatic Insulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; SMALL-HETERODIMER-PARTNER; FATTY LIVER-DISEASE; GENE-EXPRESSION; OXIDATIVE-METABOLISM; ADIPOSE-TISSUE; ACTIVATION; RESISTANCE; ALPHA; MUTATION	LIPINs have been reported to perform important roles in the regulation of intracellular lipid levels. Their mutations induce lipodystrophy, myoglobinuria, and inflammatory disorders. Recently, the phosphatidic acid phosphatase function of LIPINs has been associated with the perturbation of hepatic insulin receptor signaling via the diacylglycerol-mediated stimulation of PKC epsilon activity. Here, we report that nuclear estrogen-related receptor (ERR) gamma is a novel transcriptional regulator of LIPIN1. Overexpression of ERR gamma significantly increased LIPIN1 expression in primary hepatocytes, whereas the abolition of ERR gamma gene expression attenuated the expression of LIPIN1. Deletion and mutation analyses of the LIPIN1 promoter showed that ERR gamma exerts its effect on the transcriptional regulation of LIPIN1 via ERRE1 of the LIPIN1 promoter, as confirmed by ChIP assay. We also determined that the gene transcription of LIPIN1 by ERR gamma is controlled by the competition between PGC-1 alpha and small heterodimer partner. Additionally, ERR gamma leads to the induction of hepatic LIPIN1 expression and diacylglycerol production in vivo. Finally, an inverse agonist of ERR gamma, GSK5182, restores the impaired insulin signaling induced by LIPIN1-mediated PKC epsilon activation. Our findings indicate that the selective control of ERR gamma transcriptional activity by its specific inverse agonist could provide a novel therapeutic approach to the amelioration of impaired hepatic insulin signaling induced by LIPIN1-mediated PKC epsilon activation.	[Kim, Don-Kyu; Kim, Yong Deuk; Lee, Ji-Min; Chanda, Dipanjan; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Kim, Don-Kyu; Kim, Yong Deuk; Lee, Ji-Min; Chanda, Dipanjan; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Kim, Jung Ran; Park, Tae-Sik] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Dept Med, Inchon 406840, South Korea; [Koh, Minseob; Park, Seung Bum] Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul 151747, South Korea; [Park, Seung Bum] Seoul Natl Univ, Dept Biophys & Chem Biol, Coll Nat Sci, Seoul 151747, South Korea; [Min, Jung-Joon] Chonnam Natl Univ, Sch Med, Dept Nucl Med, Kwangju 501746, South Korea; [Min, Jung-Joon] Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju 501746, South Korea; [Min, Jung-Joon] Gwangju Inst Sci & Technol, Bioimaging Res Ctr, Kwangju 500712, South Korea; [Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju 501746, South Korea	Chonnam National University; Chonnam National University; Gachon University; Seoul National University (SNU); Seoul National University (SNU); Chonnam National University; Chonnam National University; Gwangju Institute of Science & Technology (GIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Park, Seung Bum/N-1901-2014; Chanda, Dipanjan/AAU-3996-2021	Park, Seung Bum/0000-0003-1753-1433; Chanda, Dipanjan/0000-0003-0685-187X; Koh, Minseob/0000-0003-1935-4776	National Creative Research Initiatives from the Korean Ministry of Education, Science, and Technology [20110018305]; Korea Healthcare Technology RD Project; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A100588]; National Research Foundation of Korea; Ministry of Education, Science and Technology [20100019512]	National Creative Research Initiatives from the Korean Ministry of Education, Science, and Technology; Korea Healthcare Technology RD Project; Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Creative Research Initiatives Grant 20110018305 from the Korean Ministry of Education, Science, and Technology, a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea Grant A100588, and the Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 20100019512.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Herzog B, 2007, MOL ENDOCRINOL, V21, P2687, DOI 10.1210/me.2007-0213; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; Jeong BC, 2009, J BIOL CHEM, V284, P14211, DOI 10.1074/jbc.M808345200; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Mitra MS, 2011, J MOL CELL CARDIOL, V51, P120, DOI 10.1016/j.yjmcc.2011.04.009; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Pacheco YM, 1998, J CHROMATOGR B, V714, P127, DOI 10.1016/S0378-4347(98)00231-X; Park YY, 2004, MOL ENDOCRINOL, V18, P1082, DOI 10.1210/me.2003-0339; Pearen MA, 2008, ENDOCRINOLOGY, V149, P2853, DOI 10.1210/en.2007-1202; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Razzaque MA, 2004, GENE, V340, P275, DOI 10.1016/j.gene.2004.07.010; Reue K, 2000, J LIPID RES, V41, P1067; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanyal S, 2004, MOL ENDOCRINOL, V18, P312, DOI 10.1210/me.2003-0165; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	43	56	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38035	38042		10.1074/jbc.M111.250613	http://dx.doi.org/10.1074/jbc.M111.250613			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911493	Green Published, hybrid			2022-12-27	WOS:000296594200015
J	Kouvidi, K; Berdiaki, A; Nikitovic, D; Katonis, P; Afratis, N; Hascall, VC; Karamanos, NK; Tzanakakis, GN				Kouvidi, Katerina; Berdiaki, Aikaterini; Nikitovic, Dragana; Katonis, Pavlos; Afratis, Nikos; Hascall, Vincent C.; Karamanos, Nikos K.; Tzanakakis, George N.			Role of Receptor for Hyaluronic Acid-mediated Motility (RHAMM) in Low Molecular Weight Hyaluronan (LMWHA)-mediated Fibrosarcoma Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INDEPENDENT PROSTATE-CANCER; ACTIVATED PROTEIN-KINASE; BINDING-PROTEIN; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; TUMOR PROGRESSION; CARCINOMA-CELLS; FOCAL ADHESIONS; CD44	Hyaluronan (HA) modulates key cancer cell functions through interaction with its CD44 and receptor for hyaluronic acid-mediated motility (RHAMM) receptors. HA was recently found to regulate the migration of fibrosarcoma cells in a manner specifically dependent on its size. Here, we investigated the effect of HA/RHAMM signaling on the ability of HT1080 fibrosarcoma cells to adhere onto fibronectin. Low molecular weight HA (LMWHA) significantly increased (p <= 0.01) the adhesion capacity of HT1080 cells, which high molecular weight HA inhibited. The ability of HT1080 RHAMM-deficient cells, but not of CD44-deficient ones, to adhere was significantly decreased (p <= 0.001) as compared with control cells. Importantly, the effect of LMWHA on HT1080 cell adhesion was completely attenuated in RHAMM-deficient cells. In contrast, adhesion of RHAMM-deficient cells was not sensitive to high molecular weight HA treatment, which identifies RHAMM as a specific conduit of the LMWHA effect. Western blot and real time-PCR analyses indicated that LMWHA significantly increased RHAMM transcript (p <= 0.05) and protein isoform levels (53%, 95 kDa; 37%, 73 kDa) in fibrosarcoma cells. Moreover, Western blot analyses showed that LMWHA in a RHAMM-dependent manner enhanced basal and adhesion-dependent ERK1/2 and focal adhesion kinase (FAK) phosphorylation in HT1080 cells. Utilization of a specific ERK1/2 inhibitor completely inhibited (p <= 0.001) LMWHA-dependent adhesion, suggesting that ERK1/2 is a downstream effector of LMWHA/RHAMM signaling. Likewise, the utilization of the specific ERK1 inhibitor resulted in a strong down-regulation of FAK activation in HT1080 cells, which identifies ERK1/2 as a FAK upstream activator. In conclusion, our results suggest that RHAMM/HA interaction regulates fibrosarcoma cell adhesion via the activation of FAK and ERK1/2 signaling pathways.	[Kouvidi, Katerina; Berdiaki, Aikaterini; Nikitovic, Dragana; Tzanakakis, George N.] Univ Crete, Sch Med, Dept Histol Embryol, Iraklion 71003, Greece; [Katonis, Pavlos] Univ Crete, Sch Med, Dept Orthopaed, Iraklion 71003, Greece; [Afratis, Nikos; Karamanos, Nikos K.] Univ Patras, Dept Chem, Biochem Lab, GR-26110 Patras, Greece; [Hascall, Vincent C.] Cleveland Clin, Cleveland, OH 44195 USA	University of Crete; University of Crete; University of Patras; Cleveland Clinic Foundation	Tzanakakis, GN (corresponding author), Univ Crete, Sch Med, Dept Histol Embryol, Iraklion 71003, Greece.	tzanakak@med.uoc.gr	Tzanakakis, George N/F-6955-2010; Karamanos, Nikos/A-3616-2008; Nikitovic, Dragana/AAS-6215-2020; afratis, nikos/N-1893-2016; Afratis, Nikolaos/HCI-4508-2022; Tzanakakis, George/ABH-7725-2020	Tzanakakis, George N/0000-0001-5276-4764; Karamanos, Nikos/0000-0003-3618-0288; Nikitovic, Dragana/0000-0003-3882-7399; afratis, nikos/0000-0002-3962-2451; Afratis, Nikolaos/0000-0002-3962-2451; Tzanakakis, George/0000-0001-5276-4764				A-Ayoubi A, 2008, J CELL BIOCHEM, V105, P875, DOI 10.1002/jcb.21889; Ahrens T, 2001, J INVEST DERMATOL, V116, P93, DOI 10.1046/j.1523-1747.2001.00236.x; Akiyama Y, 2001, J NEURO-ONCOL, V53, P115, DOI 10.1023/A:1012297132047; Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Assmann V, 1999, J CELL SCI, V112, P3943; Assmann V, 2001, J PATHOL, V195, P191, DOI 10.1002/path.941; Assmann V, 1998, J CELL SCI, V111, P1685; Berdiaki A, 2009, BBA-GEN SUBJECTS, V1790, P1258, DOI 10.1016/j.bbagen.2009.06.013; Boraldi F, 2003, TISSUE CELL, V35, P37, DOI 10.1016/S0040-8166(02)00101-5; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Chalkiadaki G., 2011, CANC LETT IN PRESS; Cheung WF, 1999, BIOCHEM SOC T, V27, P135, DOI 10.1042/bst0270135; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; ENTWISTLE J, 1995, GENE, V163, P233, DOI 10.1016/0378-1119(95)00398-P; Fieber C, 1999, GENE, V226, P41, DOI 10.1016/S0378-1119(98)00566-6; Gao F, 2008, CLIN INVEST MED, V31, pE106, DOI 10.25011/cim.v31i3.3467; Gares S L, 2000, Dev Immunol, V7, P209, DOI 10.1155/2000/94616; Gares SL, 1998, J LEUKOCYTE BIOL, V64, P781, DOI 10.1002/jlb.64.6.781; Gares SL, 1999, SCAND J IMMUNOL, V50, P626; Geiger T, 2010, SEMIN CANCER BIOL, V20, P146, DOI 10.1016/j.semcancer.2010.05.004; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; Gust KM, 2009, NEOPLASIA, V11, P956, DOI 10.1593/neo.09694; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hall CL, 1996, ONCOGENE, V13, P2213; Hall CL, 2001, MATRIX BIOL, V20, P183, DOI 10.1016/S0945-053X(01)00133-0; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Herrera-Gayol A, 2001, INT J EXP PATHOL, V82, P193, DOI 10.1111/j.1365-2613.2001.iep196.x; Hofmann M, 1998, J CELL SCI, V111, P1673; Hus I, 2008, LEUKEMIA, V22, P1007, DOI 10.1038/leu.2008.29; Johnson TR, 2008, MOL CANCER RES, V6, P1639, DOI 10.1158/1541-7786.MCR-08-0052; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; KARAMANOS NK, 1995, ANAL BIOCHEM, V225, P220, DOI 10.1006/abio.1995.1147; Karousou EG, 2004, ELECTROPHORESIS, V25, P2919, DOI 10.1002/elps.200406034; KLEWES L, 1993, BIOCHEM J, V290, P791, DOI 10.1042/bj2900791; Laurich C, 2004, J SURG RES, V122, P70, DOI 10.1016/j.jss.2004.05.018; LESLEY J, 1998, FRONT BIOSCI, V3, P616; Lin SL, 2008, CARCINOGENESIS, V29, P282, DOI 10.1093/carcin/bgm259; Lin SL, 2007, CARCINOGENESIS, V28, P310, DOI 10.1093/carcin/bgl134; Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641; Malavaki CJ, 2008, ANAL BIOCHEM, V374, P213, DOI 10.1016/j.ab.2007.11.006; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Maxwell CA, 2005, CANCER RES, V65, P850; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Militsopoulou M, 2002, ELECTROPHORESIS, V23, P1104, DOI 10.1002/1522-2683(200204)23:7/8<1104::AID-ELPS1104>3.0.CO;2-1; Mohapatra S, 1996, J EXP MED, V183, P1663, DOI 10.1084/jem.183.4.1663; Nagy JI, 1996, CELL GROWTH DIFFER, V7, P745; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; PIEPKORN M, 1988, J CELL PHYSIOL, V135, P189, DOI 10.1002/jcp.1041350206; Price RD, 2007, J PLAST RECONSTR AES, V60, P1110, DOI 10.1016/j.bjps.2007.03.005; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rein DT, 2003, J CANCER RES CLIN, V129, P161, DOI 10.1007/s00432-003-0415-0; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Tolg C, 2003, ONCOGENE, V22, P6873, DOI 10.1038/sj.onc.1206811; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; TURLEY EA, 1992, CANCER METAST REV, V11, P21, DOI 10.1007/BF00047600; TURLEY EA, 1987, BIOCHEMISTRY-US, V26, P2997, DOI 10.1021/bi00385a007; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Wang C, 1998, CLIN CANCER RES, V4, P567; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zlobec I, 2008, GUT, V57, P1413, DOI 10.1136/gut.2007.141192	79	95	98	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38509	38520		10.1074/jbc.M111.275875	http://dx.doi.org/10.1074/jbc.M111.275875			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914806	Green Published, hybrid			2022-12-27	WOS:000296594200065
J	Yukiura, H; Hama, K; Nakanaga, K; Tanaka, M; Asaoka, Y; Okudaira, S; Arima, N; Inoue, A; Hashimoto, T; Arai, H; Kawahara, A; Nishina, H; Aoki, J				Yukiura, Hiroshi; Hama, Kotaro; Nakanaga, Keita; Tanaka, Masayuki; Asaoka, Yoichi; Okudaira, Shinichi; Arima, Naoaki; Inoue, Asuka; Hashimoto, Takafumi; Arai, Hiroyuki; Kawahara, Atsuo; Nishina, Hiroshi; Aoki, Junken			Autotaxin Regulates Vascular Development via Multiple Lysophosphatidic Acid (LPA) Receptors in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTILITY-STIMULATING PROTEIN; LYSOPHOSPHOLIPASE-D; IDENTIFICATION; ENZYME; BLOOD; MORPHOGENESIS; ANGIOGENESIS; P2Y5/LPA(6); REVEALS; EMBRYOS	Autotaxin (ATX) is a multifunctional ecto-type phosphodiesterase that converts lysophospholipids, such as lysophosphatidylcholine, to lysophosphatidic acid (LPA) by its lysophospholipase D activity. LPA is a lipid mediator with diverse biological functions, most of which are mediated by G protein-coupled receptors specific to LPA (LPA(1-6)). Recent studies on ATX knock-out mice revealed that ATX has an essential role in embryonic blood vessel formation. However, the underlying molecular mechanisms remain to be solved. A data base search revealed that ATX and LPA receptors are conserved in wide range of vertebrates from fishes to mammals. Here we analyzed zebrafish ATX (zATX) and LPA receptors both biochemically and functionally. zATX, like mammalian ATX, showed lysophospholipase D activity to produce LPA. In addition, all zebrafish LPA receptors except for LPA(5)a and LPA(5)b were found to respond to LPA. Knockdown of zATX in zebrafish embryos by injecting morpholino antisense oligonucleotides (MOs) specific to zATX caused abnormal blood vessel formation, which has not been observed in other morphant embryos or mutants with vascular defects reported previously. In ATX morphant embryos, the segmental arteries sprouted normally from the dorsal aorta but stalled in midcourse, resulting in aberrant vascular connection around the horizontal myoseptum. Similar vascular defects were not observed in embryos in which each single LPA receptor was attenuated by using MOs. Interestingly, similar vascular defects were observed when both LPA(1) and LPA(4) functions were attenuated by using MOs and/or a selective LPA receptor antagonist, Ki16425. These results demonstrate that the ATX-LPA-LPAR axis is a critical regulator of embryonic vascular development that is conserved in vertebrates.	[Yukiura, Hiroshi; Hama, Kotaro; Nakanaga, Keita; Tanaka, Masayuki; Okudaira, Shinichi; Arima, Naoaki; Inoue, Asuka; Hashimoto, Takafumi; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Tanaka, Masayuki; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Asaoka, Yoichi; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Kawahara, Atsuo] Riken Quantitat Biol Ctr, Lab Cardiovasc Mol Dynam, Suita, Osaka 5650874, Japan; [Aoki, Junken] Tohoku Univ, Grad Sch Med, Ctr Metab Dis, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University; University of Tokyo; Tokyo Medical & Dental University (TMDU); RIKEN; Tohoku University	Aoki, J (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	jaoki@m.tohoku.ac.jp		Aoki, Junken/0000-0001-9435-1896	National Institute of Biomedical Innovation [09-11]; Ministry of Education [MPB3]; CREST (Japan Science and Technology Corporation), Science, Sports, and Culture of Japan [22116004, 21770131]; Grants-in-Aid for Scientific Research [23227004, 23790071] Funding Source: KAKEN	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education; CREST (Japan Science and Technology Corporation), Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by grants from the National Institute of Biomedical Innovation (Grant Number: 09-11), the National Project on Protein Structural and Functional Analyses, from the Ministry of Education (Grant Number: MPB3), CREST (Japan Science and Technology Corporation), Science, Sports, and Culture of Japan (to J. A. (KAKENHI #22116004) and K. H. (#21770131)).	Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Baldessari D, 2008, PHARMACOL THERAPEUT, V118, P206, DOI 10.1016/j.pharmthera.2008.02.010; Clair T, 2003, CANCER RES, V63, P5446; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; Ferry G, 2007, FEBS LETT, V581, P3572, DOI 10.1016/j.febslet.2007.06.064; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura T, 2011, CARDIOVASC RES, V92, P149, DOI 10.1093/cvr/cvr154; Kishimoto T, 2003, CLIN CHIM ACTA, V333, P59, DOI 10.1016/S0009-8981(03)00165-7; Koike S, 2009, J BIOL CHEM, V284, P33561, DOI 10.1074/jbc.M109.012716; Lee SJ, 2008, FASEB J, V22, P3706, DOI 10.1096/fj.08-106088; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; MURATA J, 1994, J BIOL CHEM, V269, P30479; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Tsuda S, 2006, J BIOL CHEM, V281, P26081, DOI 10.1074/jbc.M602925200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505	39	71	72	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43972	43983		10.1074/jbc.M111.301093	http://dx.doi.org/10.1074/jbc.M111.301093			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21971049	hybrid, Green Published			2022-12-27	WOS:000298402300038
J	Ghisla, S; Pollegioni, L; Molla, G				Ghisla, Sandro; Pollegioni, Loredano; Molla, Gianluca			Revisitation of the beta Cl-Elimination Reaction of D-Amino Acid Oxidase NEW INTERPRETATION OF THE REACTION THAT SPARKED FLAVOPROTEIN DEHYDROGENATION MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE ALPHA-HYDROGEN; ACYL-COA DEHYDROGENASE; LACTATE OXIDASE; CATALYTIC MECHANISM; CARBONYL-COMPOUNDS; HYDRIDE TRANSFER; ENZYME; REDUCTION; OXIDATION; KINETICS	D-Amino acid oxidase (DAAO) from pig has been reported to catalyze the beta-elimination of Cl- from beta Cl-D-alanine via abstraction of the substrate alpha-H as W ("carbanion mechanism") (Walsh, C. T., Schonbrunn, A., and Abeles, R. H. (1971) J. Biol. Chem. 246, 6855-6866). In view of the fundamental mechanistic importance of this reaction and of the recent reinterpretation of the DAAO dehydrogenation step as occurring via a hydride mechanism, we reinvestigated the elimination reaction using yeast DAAO. That enzyme catalyzes the same reactions as the pig enzyme but with a much higher efficiency and a substantially different kinetic behavior. The reaction is initiated by a very rapid and fully reversible dehydrogenation step. This leads to an equilibrium (k(on) approximate to k(reverse)) between the complexes of oxidized enzyme-beta Cl-D-alanine and reduced enzyme-beta Cl-iminopyruvate. In the presence of O-2 the latter complex can partition between an oxidative half-reaction and elimination of Cl-, which proceeds at a rate of approximate to 50 s(-1). This step forms a complex between oxidized enzyme and enamine that is characterized by a charge transfer absorption (which describes its rates of formation and decay). A minimal scheme that lists relevant steps of the reductive and oxidative half-reactions and elimination pathways along with the estimate of the corresponding rate constants is presented. beta-Elimination of Cl- is proposed to originate at the locus of the enzyme-beta Cl-iminopyruvate complex. A chemical mechanism that can account for elimination is discussed in detail.	[Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Vita, I-21100 Varese, Italy; Politecn Milan, Ctr Interuniv Ric Biotecnol Prot Prot Factory, I-20131 Milan, Italy; Univ Insubria, I-20131 Milan, Italy	University of Insubria; Polytechnic University of Milan; University of Insubria	Pollegioni, L (corresponding author), Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, I-21100 Varese, Italy.	loredano.pollegioni@uninsubria.it	Molla, Gianluca/G-3326-2013	Molla, Gianluca/0000-0003-3688-3397; POLLEGIONI, LOREDANO/0000-0003-1733-7243	Fonda di Ateneo per la Ricerca	Fonda di Ateneo per la Ricerca	This work was supported by grants from Fonda di Ateneo per la Ricerca (to L. P. and G. M.).	BLANKENHORN G, 1972, Z NATURFORSCH PT B, VB 27, P1038; Bright H.B., 1975, ENZYMES, V12B, P421; CHEUNG YF, 1976, BIOCHEMISTRY-US, V15, P2432, DOI 10.1021/bi00656a029; Curti B., 1991, CHEM BIOCH FLAVOENZY, V3, P69; DANG TY, 1976, BIOCHEM BIOPH RES CO, V72, P960, DOI 10.1016/S0006-291X(76)80225-2; Engst S, 1999, BIOCHEMISTRY-US, V38, P257, DOI 10.1021/bi9815041; Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019; Fitzpatrick PF, 2004, BIOORG CHEM, V32, P125, DOI 10.1016/j.bioorg.2003.02.001; GHISLA S, 1980, J BIOL CHEM, V255, P5688; Ghisla S., 2005, FLAV FLAV P 15 INT S; Ghisla S., 1982, FLAVINS FLAVOPROTEIN, P133; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Gradinaru R, 2007, BIOCHEMISTRY-US, V46, P2497, DOI 10.1021/bi0614582; GROB CA, 1967, ANGEW CHEM INT EDIT, V6, P1, DOI 10.1002/anie.196700011; Harris CM, 2001, EUR J BIOCHEM, V268, P5504, DOI 10.1046/j.1432-1033.2001.02462.x; HERSH LB, 1975, J BIOL CHEM, V250, P8728; MASSEY V, 1974, ANN NY ACAD SCI, V227, P446, DOI 10.1111/j.1749-6632.1974.tb14407.x; Massey V., 1975, FLAVINS FLAVOPROTEIN, P199; Mattevi A, 1996, P NATL ACAD SCI USA, V93, P7496, DOI 10.1073/pnas.93.15.7496; Mattevi A, 1997, CURR OPIN STRUC BIOL, V7, P804, DOI 10.1016/S0959-440X(97)80150-9; MIYAKE Y, 1973, J BIOCHEM-TOKYO, V73, P1; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Pollegioni L, 1997, J BIOL CHEM, V272, P4924, DOI 10.1074/jbc.272.8.4924; Pollegioni L, 1993, BIOL CHEM, V268, P13850; Porter D, 1976, FLAVINS FLAVOPROTEIN, P225; PORTER DJT, 1972, BIOCHEM BIOPH RES CO, V49, P257, DOI 10.1016/0006-291X(72)90038-1; Rosini E, 2009, FEBS J, V276, P4921, DOI 10.1111/j.1742-4658.2009.07191.x; Schowen KB, 2000, BBA-BIOENERGETICS, V1458, P43, DOI 10.1016/S0005-2728(00)00059-1; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; URBAN P, 1984, EUR J BIOCHEM, V144, P345, DOI 10.1111/j.1432-1033.1984.tb08470.x; VOET JG, 1972, Z NATURFORSCH PT B, VB 27, P1054, DOI 10.1515/znb-1972-0915; WALSH C, 1973, J BIOL CHEM, V248, P7049; WALSH CT, 1973, J BIOL CHEM, V248, P1946; WALSH CT, 1971, J BIOL CHEM, V246, P6855; WILLIAMS RF, 1977, J AM CHEM SOC, V99, P921, DOI 10.1021/ja00445a040; Yorita K, 1997, P NATL ACAD SCI USA, V94, P9590, DOI 10.1073/pnas.94.18.9590	39	4	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40987	40998		10.1074/jbc.M111.266536	http://dx.doi.org/10.1074/jbc.M111.266536			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21949129	Green Published, hybrid			2022-12-27	WOS:000297315400058
J	Lu, JH; Ellsworth, JL; Hamacher, N; Oak, SW; Sun, PD				Lu, Jinghua; Ellsworth, Jeff L.; Hamacher, Nels; Oak, Si Won; Sun, Peter D.			Crystal Structure of Fc gamma Receptor I and Its Implication in High Affinity gamma-Immunoglobulin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IGG; MOLECULAR-BASIS; COMPLEX; RECOGNITION; FRAGMENT; DOMAINS; RIII; IIB	Fc gamma receptors (Fc gamma Rs) play critical roles in humoral and cellular immune responses through interactions with the Fc region of immunoglobulin G (IgG). Among them, Fc gamma RI is the only high affinity receptor for IgG and thus is a potential target for immunotherapy. Here we report the first crystal structure of an Fc gamma RI with all three extracellular Ig-like domains (designated as D1, D2, and D3). The structure shows that, first, Fc gamma RI has an acute D1-D2 hinge angle similar to that of Fc epsilon RI but much smaller than those observed in the low affinity Fc gamma receptors. Second, the D3 domain of Fc gamma RI is positioned away from the putative IgG binding site on the receptor and is thus unlikely to make direct contacts with Fc. Third, the replacement of Fc gamma RIII FG-loop ((171)LVGSKNV(177)) with that of Fc gamma RI ((171)MGKHRY(176)) resulted in a 15-fold increase in IgG, binding affinity, whereas a valine insertion in the Fc gamma RI FG-loop ((171)MVGKHRY(177)) abolished the affinity enhancement. Thus, the Fc gamma RI FG-loop with its conserved one-residue deletion is critical to the high affinity IgG binding. The structural results support Fc gamma RI binding to IgG in a similar mode as its low affinity counterparts. Taken together, our study suggests a molecular mechanism for the high affinity IgG recognition by Fc gamma RI and provides a structural basis for understanding its physiological function and its therapeutic implication in treating autoimmune diseases.	[Lu, Jinghua; Oak, Si Won; Sun, Peter D.] NIAID, Struct Immunol Sect, Lab Immunogenet, NIH, Rockville, MD USA; [Hamacher, Nels] ZymoGenetics, Dept BioProc Dev, Seattle, WA 98102 USA; [Ellsworth, Jeff L.] ZymoGenetics, Dept Immunol, Seattle, WA 98102 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Zymogenet Inc.; Zymogenet Inc.	Sun, PD (corresponding author), 12441 Parklawn Dr, Rockville, MD 20852 USA.	psun@niaid.nih.gov	lu, jinghua/G-5872-2012	Oak, Allen/0000-0003-2837-6846	National Institutes of Health (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000853] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health intramural research funding (NIAID).	Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; DeLano W.L, PYMOL MOL GRAPHICS S; Ellsworth JL, 2008, J IMMUNOL, V180, P580, DOI 10.4049/jimmunol.180.1.580; Ellsworth JL, 2009, J IMMUNOL, V182, P7272, DOI 10.4049/jimmunol.0803497; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feige MJ, 2009, J MOL BIOL, V391, P599, DOI 10.1016/j.jmb.2009.06.048; FRIDMAN WH, 1991, FASEB J, V5, P2684, DOI 10.1096/fasebj.5.12.1916092; Galon J, 1997, EUR J IMMUNOL, V27, P1928, DOI 10.1002/eji.1830270816; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; HULETT MD, 1993, EUR J IMMUNOL, V23, P640, DOI 10.1002/eji.1830230310; Hulett MD, 1998, MOL IMMUNOL, V35, P989, DOI 10.1016/S0161-5890(98)00069-8; HULETT MD, 1991, J IMMUNOL, V147, P1863; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kleinau S, 2000, J EXP MED, V191, P1611, DOI 10.1084/jem.191.9.1611; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powell MS, 1999, IMMUNOL LETT, V68, P17, DOI 10.1016/S0165-2478(99)00025-5; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Ravetch JV, 2002, J CLIN INVEST, V110, P1759, DOI 10.1172/JCI200217349; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 2001, J MOL BIOL, V309, P737, DOI 10.1006/jmbi.2001.4670; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251, DOI 10.1146/annurev.iy.06.040188.001343; van de Velde NC, 2006, SPRINGER SEMIN IMMUN, V28, P329, DOI 10.1007/s00281-006-0056-x; van de Winkel JGJ, 2010, IMMUNOL LETT, V128, P4, DOI 10.1016/j.imlet.2009.09.005; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187; Zhang YH, 2000, IMMUNITY, V13, P387, DOI 10.1016/S1074-7613(00)00038-8	45	59	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40608	40613		10.1074/jbc.M111.257550	http://dx.doi.org/10.1074/jbc.M111.257550			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965667	Green Published, hybrid			2022-12-27	WOS:000297315400021
J	Verissimo, AF; Yang, HH; Wu, XM; Sanders, C; Daldal, F				Verissimo, Andreia F.; Yang, Honghui; Wu, Xiaomin; Sanders, Carsten; Daldal, Fevzi			Ccml Subunit of CcmFHI Heme Ligation Complex Functions as an Apocytochrome c Chaperone during c-Type Cytochrome Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; RHODOBACTER-CAPSULATUS; RHODOPSEUDOMONAS-CAPSULATA; ESCHERICHIA-COLI; IN-VITRO; PARACOCCUS-DENITRIFICANS; 3-DIMENSIONAL STRUCTURE; CIRCULAR-DICHROISM; NITROGEN-FIXATION; CYCHJKL GENES	Cytochrome c maturation (Ccm) is a sophisticated post-translational process. It occurs after translocation of apocytochromes c to the p side of energy transducing membranes and forms stereo-specific thioether bonds between the vinyl groups of heme b (protoporphyrin IX-Fe) and the thiol groups of cysteines at their conserved heme binding sites. In many organisms this process involves up to 10 (CcmABCDEFGHI and CcdA) membrane proteins. One of these proteins is CcmI, which has an N-terminal membrane-embedded domain with two transmembrane helices and a large C-terminal periplasmic domain with protein-protein interaction motifs. Together with CcmF and CcmH, CcmI forms a multisubunit heme ligation complex. How the CcmFHI complex recognizes its apocytochrome c substrates remained unknown. In this study, using Rhodobacter capsulatus apocytochrome c(2) as a Ccm substrate, we demonstrate for the first time that CcmI binds apocytochrome c(2), but not holocytochrome c(2). Mainly the C-terminal portions of both CcmI and apocytochrome c(2) mediate this binding. Other physical interactions via the conserved structural elements in apocytochrome c(2), like the heme ligating cysteines or heme iron axial ligands, are less crucial. Furthermore, we show that the N-terminal domain of CcmI can also weakly bind apocytochrome c(2), but this interaction requires a free thiol group at apocytochrome c(2) heme binding site. We conclude that the CcmI subunit of the CcmFHI complex functions as an apocytochrome c chaperone during the Ccm process used by proteobacteria, archaea, mitochondria of plants and red algae.	[Verissimo, Andreia F.; Yang, Honghui; Wu, Xiaomin; Sanders, Carsten; Daldal, Fevzi] Univ Penn Philadelphia, Dept Biol, Philadelphia, PA 19014 USA	University of Pennsylvania	Daldal, F (corresponding author), Univ Penn Philadelphia, Dept Biol, Philadelphia, PA 19014 USA.	fdaldal@sas.upenn.edu			National Institutes of Health [GM38239]; Department of Energy [91ER20052]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38239 (to F. D.). This work was also supported by Department of Energy Grant 91ER20052 (to F. D.).	Akiyama S, 2000, NAT STRUCT BIOL, V7, P514; Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; AMBLER RP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P42, DOI 10.1016/S0005-2728(05)80266-X; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; BENNING C, 1992, J BACTERIOL, V174, P2352, DOI 10.1128/JB.174.7.2352-2360.1992; BENNING MM, 1991, J MOL BIOL, V220, P673, DOI 10.1016/0022-2836(91)90109-J; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; BHAGWAT AS, 1986, J BACTERIOL, V166, P751, DOI 10.1128/jb.166.3.751-755.1986; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Cinege G, 2004, MOL GENET GENOMICS, V271, P171, DOI 10.1007/s00438-003-0968-2; Colon W, 1996, BIOCHEMISTRY-US, V35, P5538, DOI 10.1021/bi960052u; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; Daltrop O, 2003, J BIOL CHEM, V278, P4404, DOI 10.1074/jbc.M211124200; DAMASCHUN G, 1991, BIOCHIM BIOPHYS ACTA, V1078, P289, DOI 10.1016/0167-4838(91)90571-G; DAVIDSON E, 1987, J MOL BIOL, V195, P13, DOI 10.1016/0022-2836(87)90323-8; DELGADO MJ, 1995, J BACTERIOL, V177, P4927, DOI 10.1128/jb.177.17.4927-4934.1995; Deshmukh M, 2002, MOL MICROBIOL, V46, P1069, DOI 10.1046/j.1365-2958.2002.03212.x; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; DUMONT ME, 1994, BIOCHEMISTRY-US, V33, P7368, DOI 10.1021/bi00189a043; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; FISHER WR, 1973, J BIOL CHEM, V248, P3188; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P3120, DOI 10.1021/bi00176a047; Greenfield Norma J, 2004, Methods Mol Biol, V261, P55; HAMADA D, 1993, BIOCHEMISTRY-US, V32, P10351, DOI 10.1021/bi00090a010; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; HOLDEN HM, 1987, J MOL BIOL, V195, P229, DOI 10.1016/0022-2836(87)90341-X; Inoue H, 2011, FEBS J, V278, P2341, DOI 10.1111/j.1742-4658.2011.08155.x; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Keilin D., 1966, HIST CELL RESP CYTOC; KERESZT A, 1995, MOL GEN GENET, V247, P39, DOI 10.1007/BF00425819; Khan MKA, 2009, J BIOL INORG CHEM, V14, P751, DOI 10.1007/s00775-009-0488-6; Koch HG, 1998, J BACTERIOL, V180, P969, DOI 10.1128/JB.180.4.969-978.1998; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lang SE, 1996, J BACTERIOL, V178, P5279, DOI 10.1128/jb.178.17.5279-5290.1996; Lee JH, 2007, BBA-BIOMEMBRANES, V1768, P2164, DOI 10.1016/j.bbamem.2007.04.022; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Monika EM, 1997, J MOL BIOL, V271, P679, DOI 10.1006/jmbi.1997.1227; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; PAGE MD, 1995, MOL MICROBIOL, V15, P307, DOI 10.1111/j.1365-2958.1995.tb02245.x; PIELAK GJ, 1995, BIOCHEMISTRY-US, V34, P3268, DOI 10.1021/bi00010a017; Richard-Fogal CL, 2009, EMBO J, V28, P2349, DOI 10.1038/emboj.2009.189; RITZ D, 1993, MOL MICROBIOL, V9, P729, DOI 10.1111/j.1365-2958.1993.tb01733.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sanders C, 2005, J BACTERIOL, V187, P4245, DOI 10.1128/JB.187.12.4245-4256.2005; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Sauder JM, 1996, BIOCHEMISTRY-US, V35, P16852, DOI 10.1021/bi961976k; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; STELLWAGEN E, 1972, J BIOL CHEM, V247, P8074; Tomlinson EJ, 2000, P NATL ACAD SCI USA, V97, P5156, DOI 10.1073/pnas.090089397; Travaglini-Allocatelli C, 2004, TRENDS BIOCHEM SCI, V29, P535, DOI 10.1016/j.tibs.2004.08.004; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; ZANNONI D, 1993, ARCH MICROBIOL, V160, P413, DOI 10.1007/BF00245301	61	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40452	40463		10.1074/jbc.M111.277764	http://dx.doi.org/10.1074/jbc.M111.277764			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956106	hybrid, Green Published			2022-12-27	WOS:000297315400005
J	Manna, P; Jain, SK				Manna, Prasenjit; Jain, Sushil K.			Hydrogen Sulfide and L-Cysteine Increase Phosphatidylinositol 3,4,5-Trisphosphate (PIP3) and Glucose Utilization by Inhibiting Phosphatase and Tensin Homolog (PTEN) Protein and Activating Phosphoinositide 3-Kinase (PI3K)/Serine/Threonine Protein Kinase (AKT)/Protein Kinase C zeta/lambda (PKC zeta/lambda) in 3T3l1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; ATHEROSCLEROTIC LESIONS; MOLECULAR-MECHANISMS; MYOCARDIAL-ISCHEMIA; AKT PHOSPHORYLATION; POSITIVE REGULATION	This work examined the novel hypothesis that reduced levels of H2S or L-cysteine (LC) play a role in the impaired glucose metabolism seen in diabetes. 3T3L1 adipocytes were treated with high glucose (HG, 25 mM) in the presence or absence of LC or H2S. Both LC and H2S treatments caused an increase in phosphatidylinositol-3,4,5 trisphosphate (PIP3), AKT phosphorylation, and glucose utilization in HG-treated cells. The effect of LC on PIP3 and glucose utilization was prevented by propargylglycine, an inhibitor of cystathionine gamma-lyase that catalyzes H2S formation from LC. This demonstrates that H2S mediates the effect of LC on increased PIP3 and glucose utilization. H2S and LC caused phosphatidylinositol 3-kinase activation and PTEN inhibition. Treatment with LC, H2S, or PIP3 increased the phosphorylation of IRS1, AKT, and PKC zeta/lambda as well as GLUT4 activation and glucose utilization in HG-treated cells. This provides evidence that PIP3 is involved in the increased glucose utilization observed in cells supplemented with LC or H2S. Comparative signal silencing studies with siAKT2 or siPKC zeta revealed that PKC zeta phosphorylation is more effective for the GLUT4 activation and glucose utilization in LC-, H2S-,or PIP3-treated cells exposed to HG. This is the first report to demonstrate that H2S or LC can increase cellular levels of PIP3, a positive regulator of glucose metabolism. The PIP3 increase is mediated by PI3K activation and inhibition of PTEN but not of SHIP2. This study provides evidence for a molecular mechanism by which H2S or LC can up-regulate the insulin-signaling pathways essential for maintenance of glucose metabolism.	[Manna, Prasenjit; Jain, Sushil K.] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jain, SK (corresponding author), Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, 1501 Kings Hwy, Shreveport, LA 71130 USA.	sjain@lsuhsc.edu		Jain, Sushil/0000-0002-9574-0436; Manna, Prasenjit/0000-0003-1952-6531	NIDDK; Office of Dietary Supplements of the National Institutes of Health [R01 DK072433]; Malcolm Feist Endowed Chair in Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072433] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Dietary Supplements of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malcolm Feist Endowed Chair in Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by grants from NIDDK and the Office of Dietary Supplements of the National Institutes of Health Grant R01 DK072433. This work was also supported by the Malcolm Feist Endowed Chair in Diabetes.	Abe K, 1996, J NEUROSCI, V16, P1066; An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Bandyopadhyay G, 2000, ENDOCRINOLOGY, V141, P4120, DOI 10.1210/en.141.11.4120; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Bandyopadhyay G, 2000, J BIOL CHEM, V275, P40817, DOI 10.1074/jbc.M007920200; Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Bianca RDD, 2009, P NATL ACAD SCI USA, V106, P4513, DOI 10.1073/pnas.0807974105; Blouet C, 2007, J NUTR BIOCHEM, V18, P519, DOI 10.1016/j.jnutbio.2006.10.002; Blouet C, 2007, FREE RADICAL BIO MED, V42, P1089, DOI 10.1016/j.freeradbiomed.2007.01.006; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; CANDILOROS H, 1995, DIABETES CARE, V18, P549, DOI 10.2337/diacare.18.4.549; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Darmaun D, 2008, PEDIATR DIABETES, V9, P577, DOI 10.1111/j.1399-5448.2008.00436.x; Droge W, 2005, PHILOS T R SOC B, V360, P2355, DOI 10.1098/rstb.2005.1770; Egashira K, 2003, HYPERTENSION, V41, P834, DOI 10.1161/01.HYP.0000051642.65283.36; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Farese RV, 2002, AM J PHYSIOL-ENDOC M, V283, pE1, DOI 10.1152/ajpendo.00045.2002; Garg SK, 2011, ANTIOXID REDOX SIGN, V15, P39, DOI 10.1089/ars.2010.3496; Guha M, 2000, J BIOL CHEM, V275, P17728, DOI 10.1074/jbc.275.23.17728; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hinchliffe KA, 2001, CURR BIOL, V11, pR371, DOI 10.1016/S0960-9822(01)00197-X; Hsu CC, 2004, J NUTR, V134, P3245, DOI 10.1093/jn/134.12.3245; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Iyer SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005017; Jain SK, 2006, FREE RADICAL BIO MED, V41, P92, DOI 10.1016/j.freeradbiomed.2006.03.008; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Jain SK, 2009, FREE RADICAL BIO MED, V46, P1633, DOI 10.1016/j.freeradbiomed.2009.03.014; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanoh Y, 2000, J BIOL CHEM, V275, P16690, DOI 10.1074/jbc.M000287200; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Madkor HR, 2011, BRIT J NUTR, V105, P1210, DOI 10.1017/S0007114510004927; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Ono H, 2001, MOL ENDOCRINOL, V15, P1411, DOI 10.1210/me.15.8.1411; Pendaries C, 2003, FEBS LETT, V546, P25, DOI 10.1016/S0014-5793(03)00437-X; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Song DZ, 2005, EUR J PHARMACOL, V508, P205, DOI 10.1016/j.ejphar.2004.12.018; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; van den Brandhof WE, 2001, ATHEROSCLEROSIS, V157, P403, DOI 10.1016/S0021-9150(00)00724-3; Vinciguerra Manlio, 2006, Archives of Physiology and Biochemistry, V112, P89, DOI 10.1080/13813450600711359; Wan XP, 2011, J BIOL CHEM, V286, P2843, DOI 10.1074/jbc.M110.125526; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; Zhu YZ, 2007, J APPL PHYSIOL, V102, P261, DOI 10.1152/japplphysiol.00096.2006	66	82	87	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39848	39859		10.1074/jbc.M111.270884	http://dx.doi.org/10.1074/jbc.M111.270884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953448	Green Published, hybrid			2022-12-27	WOS:000296925700019
J	Dahlhoff, M; Blutke, A; Wanke, R; Wolf, E; Schneider, MR				Dahlhoff, Maik; Blutke, Andreas; Wanke, Ruediger; Wolf, Eckhard; Schneider, Marlon R.			In Vivo Evidence for Epidermal Growth Factor Receptor (EGFR)-mediated Release of Prolactin from the Pituitary Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MAMMARY-GLAND; ERBB SIGNALING NETWORK; FACTOR-ALPHA; LOBULOALVEOLAR DEVELOPMENT; KNOCKOUT MICE; ACTIVATION; AMPHIREGULIN; EXPRESSION; EGF; PROLIFERATION	Members of the epidermal growth factor receptor (EGFR/ERBB) system are essential local regulators of mammary gland development and function. Emerging evidence suggests that EGFR signaling may also influence mammary gland activity indirectly by promoting the release of prolactin from the pituitary gland in a MAPK and estrogen receptor-alpha (ER alpha)-dependent manner. Here, we report that overexpression of the EGFR ligand betacellulin (BTC) causes a lactating-like phenotype in the mammary gland of virgin female mice including the major hallmarks of lactogenesis. BTC transgenic (BTC-tg) females showed reduced levels of prolactin in the pituitary gland and increased levels of the hormone in the circulation. Furthermore, treatment of BTC-tg females with bromocriptine, an inhibitor of prolactin secretion, blocked the development of the lactation-like phenotype, suggesting that it is caused by central release of prolactin rather than by local actions of BTC in the mammary gland. Introduction of the antimorphic Egfr allele Wa5 also blocked the appearance of the mammary gland alterations, revealing that the phenotype is EGFR-dependent. We detected an increase in MAPK activity, but unchanged phosphorylation of ER alpha in the pituitary gland of BTC-tg females as compared with control mice. These results provide the first functional evidence in vivo for a role of the EGFR system in regulating mammary gland activity by modulating prolactin release from the pituitary gland.	[Dahlhoff, Maik; Wolf, Eckhard; Schneider, Marlon R.] Ludwig Maximilians Univ Munchen, Gene Ctr, Inst Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Blutke, Andreas; Wanke, Ruediger] Ludwig Maximilians Univ Munchen, Inst Vet Pathol, D-80533 Munich, Germany	University of Munich; University of Munich	Schneider, MR (corresponding author), Ludwig Maximilians Univ Munchen, Gene Ctr, Inst Mol Anim Breeding & Biotechnol, Feodor Lynen Str 25, D-81377 Munich, Germany.	schnder@lmb.uni-muenchen.de	Dahlhoff, Maik/AGH-1182-2022	Wolf, Eckhard/0000-0002-0430-9510; Schneider, Marlon/0000-0002-9570-3491; Dahlhoff, Maik/0000-0001-9189-7631; Wanke, Rudiger/0000-0002-0153-224X				Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Ben-Jonathan N, 2009, ENDOCRINOLOGY, V150, P795, DOI 10.1210/en.2008-0756; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Dahlhoff M, 2010, GASTROENTEROLOGY, V138, P1585, DOI 10.1053/j.gastro.2009.12.045; FAN XM, 1995, ENDOCRINOLOGY, V136, P2284, DOI 10.1210/en.136.5.2284; FINLEY EL, 1994, J ENDOCRINOL, V141, P547, DOI 10.1677/joe.0.1410547; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Kenney NJ, 1996, CELL GROWTH DIFFER, V7, P1769; Lee D, 2004, MAMM GENOME, V15, P525, DOI 10.1007/s00335-004-2384-2; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; MCANDREW J, 1995, ENDOCRINOLOGY, V136, P4479, DOI 10.1210/en.136.10.4479; MURDOCH GH, 1982, NATURE, V300, P192, DOI 10.1038/300192a0; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; RUI H, 1994, J BIOL CHEM, V269, P5364; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Schneider MR, 2005, ENDOCRINOLOGY, V146, P5237, DOI 10.1210/en.2005-0418; SCHONBRUNN A, 1980, J CELL BIOL, V85, P786, DOI 10.1083/jcb.85.3.786; Schroeder JA, 1998, CELL GROWTH DIFFER, V9, P451; Stern DF, 2003, EXP CELL RES, V284, P89, DOI 10.1016/S0014-4827(02)00103-9; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Troyer KL, 2001, J MAMMARY GLAND BIOL, V6, P7, DOI 10.1023/A:1009560330359; VONDERHAAR BK, 1987, J CELL PHYSIOL, V132, P581, DOI 10.1002/jcp.1041320324; Watters JJ, 2000, MOL ENDOCRINOL, V14, P1872, DOI 10.1210/me.14.11.1872; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	32	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39297	39306		10.1074/jbc.M111.243493	http://dx.doi.org/10.1074/jbc.M111.243493			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21914800	Green Published, hybrid			2022-12-27	WOS:000296759800048
J	Dickinson, RJ; Delavaine, L; Cejudo-Marin, R; Stewart, G; Staples, CJ; Didmon, MP; Trinidad, AG; Alonso, A; Pulido, R; Keyse, SM				Dickinson, Robin J.; Delavaine, Laurent; Cejudo-Marin, Rocio; Stewart, Graeme; Staples, Christopher J.; Didmon, Mark P.; Garcia Trinidad, Antonio; Alonso, Andres; Pulido, Rafael; Keyse, Stephen M.			Phosphorylation of the Kinase Interaction Motif in Mitogen-activated Protein (MAP) Kinase Phosphatase-4 Mediates Cross-talk between Protein Kinase A and MAP Kinase Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASES; TYROSINE-PHOSPHATASE; CATALYTIC ACTIVATION; DIFFERENTIAL REGULATION; INSULIN-RESISTANCE; PTP-SL; CAMP; ERK2; INACTIVATION; ASSOCIATION	MAP kinase phosphatase 4 (DUSP9/MKP-4) plays an essential role during placental development and is one of a subfamily of three closely related cytoplasmic dual-specificity MAPK phosphatases, which includes the ERK-specific enzymes DUSP6/MKP-3 and DUSP7/MKP-X. However, unlike DUSP6/MKP-3, DUSP9/MKP-4 also inactivates the p38 alpha MAP kinase both in vitro and in vivo. Here we demonstrate that inactivation of both ERK1/2 and p38 alpha by DUSP9/MKP-4 is mediated by a conserved arginine-rich kinase interaction motif located within the amino-terminal non-catalytic domain of the protein. Furthermore, DUSP9/MKP-4 is unique among these cytoplasmic MKPs in containing a conserved PKA consensus phosphorylation site 55RRXSer-58 immediately adjacent to the kinase interaction motif. DUSP9/MKP-4 is phosphorylated on Ser-58 by PKA in vitro, and phosphorylation abrogates the binding of DUSP9/MKP-4 to both ERK2 and p38 alpha MAP kinases. In addition, although mutation of Ser-58 to either alanine or glutamic acid does not affect the intrinsic catalytic activity of DUSP9/MKP-4, phospho-mimetic (Ser-58 to Glu) substitution inhibits both the interaction of DUSP9/MKP-4 with ERK2 and p38 alpha in vivo and its ability to dephosphorylate and inactivate these MAP kinases. Finally, the use of a phospho-specific antibody demonstrates that endogenous DUSP9/MKP-4 is phosphorylated on Ser-58 in response to the PKA agonist forskolin and is also modified in placental tissue. We conclude that DUSP9/MKP-4 is a bona fide target of PKA signaling and that attenuation of DUSP9/MKP-4 function can mediate cross-talk between the PKA pathway and MAPK signaling through both ERK1/2 and p38 alpha in vivo.	[Dickinson, Robin J.; Delavaine, Laurent; Stewart, Graeme; Staples, Christopher J.; Didmon, Mark P.; Keyse, Stephen M.] Univ Dundee, CR UK Stress Response Lab, Med Res Inst, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Cejudo-Marin, Rocio; Pulido, Rafael] Ctr Invest Principe Felipe, Valencia 46013, Spain; [Garcia Trinidad, Antonio; Alonso, Andres] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain	University of Dundee; Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Keyse, SM (corresponding author), Univ Dundee, CR UK Stress Response Lab, Biomed Res Inst, Ninewells Hosp & Med Sch, Level 5, Dundee DD1 9SY, Scotland.	s.m.keyse@dundee.ac.uk	Alonso, Andrés/L-7523-2014; Keyse, Stephen M./B-9575-2009; Cejudo, Rocio/I-2794-2015	Alonso, Andrés/0000-0001-8674-9378; Keyse, Stephen M./0000-0002-5150-8221; Pulido, Rafael/0000-0001-9100-248X; Cejudo Marin, Rocio/0000-0001-5389-7200; Staples, Christopher/0000-0002-0482-9954	Ministerio de Ciencia e Innovacion [SAF2009-10226]; Generalitat Valenciana [AP-040/10, ACOMP/2010/222]; Instituto de Salud Carlos III (Spain); EU Research Training Network [MRTN-CT-2006-035830]; Cancer Research UK CR-UK [C8227/A12053]; Fondo Europeo de Desarrollo Regional ISCIII-RETICS [RD06/0020/0049]; Cancer Research UK (CR-UK Stress Response Laboratory) [C8227/A12053]; Medical Research Council; Ministerio de Ciencia e Innovacion (Spain) [JC2007-00077]; Cancer Research UK [12053] Funding Source: researchfish	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); EU Research Training Network; Cancer Research UK CR-UK(Cancer Research UK); Fondo Europeo de Desarrollo Regional ISCIII-RETICS; Cancer Research UK (CR-UK Stress Response Laboratory)(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cancer Research UK(Cancer Research UK)	This work was supported in part by Ministerio de Ciencia e Innovacion Grant SAF2009-10226, Generalitat Valenciana Grants AP-040/10 and ACOMP/2010/222, Instituto de Salud Carlos III (Spain and Fondo Europeo de Desarrollo Regional ISCIII-RETICS RD06/0020/0049), and EU Research Training Network MRTN-CT-2006-035830 (to R. C.-M.). This work was also supported by Cancer Research UK CR-UK Stress Response Laboratory Programme Grant C8227/A12053 (to S. M. K.).; Supported by a Cancer Research UK programme grant (CR-UK Stress Response Laboratory C8227/A12053, to S. M. K.) and a Medical Research Council Ph.D studentship (to C. J. S.).; Supported in part by Ministerio de Ciencia e Innovacion Grant SAF2009-10226. Generalitat Valenciana Grants AP-040/10 and ACOMP/2010/222, Instituto de Salud Carlos III (Spain and Fondo Europeo de Desarrollo Regional ISCIII-RETICS RD06/0020/0049), and EU Research Training Network MRTN-CT-2006-035830. R. C.-M. was also supported in part by Ministerio de Ciencia e Innovacion (Spain) Programa Jose Castillejo Grant JC2007-00077.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Christie GR, 2005, MOL CELL BIOL, V25, P8323, DOI 10.1128/MCB.25.18.8323-8333.2005; Dickinson RJ, 2002, BIOCHEM J, V364, P145, DOI 10.1042/bj3640145; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Dowd S, 1998, J CELL SCI, V111, P3389; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Escamilla-Hernandez R, 2008, MOL ENDOCRINOL, V22, P1842, DOI 10.1210/me.2008-0103; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; James P, 1996, GENETICS, V144, P1425; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; Nika K, 2004, BIOCHEM J, V378, P335, DOI 10.1042/BJ20031244; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Perander M, 2008, BIOCHEM J, V411, P613, DOI 10.1042/BJ20071369; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Staples CJ, 2010, J BIOL CHEM, V285, P25928, DOI 10.1074/jbc.M110.117911; Tarrega C, 2005, J BIOL CHEM, V280, P37885, DOI 10.1074/jbc.M504366200; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200	31	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38018	38026		10.1074/jbc.M111.255844	http://dx.doi.org/10.1074/jbc.M111.255844			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908610	hybrid, Green Published			2022-12-27	WOS:000296594200013
J	Geng, H; Harvey, CT; Pittsenbarger, J; Liu, Q; Beer, TM; Xue, CH; Qian, DZ				Geng, Hao; Harvey, Chris T.; Pittsenbarger, Janet; Liu, Qiong; Beer, Tomasz M.; Xue, Changhui; Qian, David Z.			HDAC4 Protein Regulates HIF1 alpha Protein Lysine Acetylation and Cancer Cell Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; INDUCIBLE FACTOR-I; TUMOR-GROWTH; HIF-1-ALPHA; ANGIOGENESIS; DEGRADATION; STABILITY; VHL; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; FACTOR-1-ALPHA	Hypoxia-inducible factor 1 alpha (HIF1 alpha) is an essential part of the HIF-1 transcriptional complex that regulates angiogenesis, cellular metabolism, and cancer development. In von Hippel-Lindau (VHL)-null kidney cancer cell lines, we reported previously that HIF1 alpha proteins can be acetylated and inhibited by histone deacetylase (HDAC) inhibitors or specific siRNA against HDAC4. To investigate the mechanism and biological consequence of the inhibition, we have generated stableHDAC4 knockdown via shRNA in VHL-positive normal and cancer cell lines. We report that HDAC4 regulates HIF1 alpha protein acetylation and stability. Specifically, the HIF1 alpha protein acetylation can be increased by HDAC4 shRNA and decreased by HDAC4 overexpression. HDAC4 shRNA inhibits HIF1 alpha protein stability. In contrast, HDAC1 or HDAC3 shRNA has no such inhibitory effect. Mutations of the first five lysine residues (lysine 10, 11, 12, 19, and 21) to arginine within the HIF1 alpha N terminus reduce protein acetylation but render the mutant HIF1 alpha protein resistant to HDAC4 and HDACi-mediated inhibition. Functionally, in VHL-positive cancer cell lines, stable inhibition of HDAC4 decreases both the HIF-1 transcriptional activity and a subset of HIF-1 hypoxia target gene expression. On the cellular level, HDAC4 inhibition reduces the hypoxia-related increase of glycolysis and resistance to docetaxel chemotherapy. Taken together, the novel biological relationship between HDAC4 and HIF1 alpha presented here suggests a potential role for the deacetylase enzyme in regulating HIF-1 cancer cell response to hypoxia and presents a more specific molecular target of inhibition.	[Geng, Hao; Harvey, Chris T.; Pittsenbarger, Janet; Liu, Qiong; Beer, Tomasz M.; Xue, Changhui; Qian, David Z.] OHSU, Knight Canc Inst, Portland, OR 97239 USA	Oregon Health & Science University	Qian, DZ (corresponding author), OHSU, Knight Canc Inst, 3303 SW Bond Ave,CH14R, Portland, OR 97239 USA.	qianzh@ohsu.edu	Qian, David Z/AAL-3441-2021; Liu, Qiong/G-8666-2014	Liu, Qiong/0000-0003-4114-5540	National Institutes of Health NCI [R01CA149253 01]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA149253] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in whole or in part, by National Institutes of Health NCI Grant R01CA149253 01 (to D. Z. Q.). This work was also supported by a New Investigator Award from the Department of Defense Prostate Cancer Research Program (to D. Z. Q.).	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Geng H, 2010, CANCER RES, V70, P3239, DOI 10.1158/0008-5472.CAN-09-3186; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Kim SH, 2007, ONCOL REP, V17, P647; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Qian DZ, 2004, CANCER RES, V64, P6626, DOI 10.1158/0008-5472.CAN-04-0540; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang AH, 1999, MOL CELL BIOL, V19, P7816; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Yuan Zhigang, 2009, V523, P279, DOI 10.1007/978-1-59745-190-1_19; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	35	140	148	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38095	38102		10.1074/jbc.M111.257055	http://dx.doi.org/10.1074/jbc.M111.257055			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917920	hybrid, Green Published			2022-12-27	WOS:000296594200022
J	Germain, C; Meier, A; Jensen, T; Knapnougel, P; Poupon, G; Lazzari, A; Neisig, A; Hakansson, K; Dong, T; Wagtmann, N; Galsgaard, ED; Spee, P; Braud, VM				Germain, Claire; Meier, Anders; Jensen, Teis; Knapnougel, Perrine; Poupon, Gwenola; Lazzari, Anne; Neisig, Anne; Hakansson, Katarina; Dong, Tao; Wagtmann, Nicolai; Galsgaard, Elizabeth D.; Spee, Pieter; Braud, Veronique M.			Induction of Lectin-like Transcript 1 (LLT1) Protein Cell Surface Expression by Pathogens and Interferon-gamma Contributes to Modulate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NKR-P1A; T-CELLS; NK CELLS; DENDRITIC CELLS; UP-REGULATION; CUTTING EDGE; ACTIVATION; CD161; LIGAND; MOUSE	CD161 is a C-type lectin-like receptor expressed on human natural killer (NK) cells and subsets of T cells. CD161 has been described as an inhibitory receptor that regulates NK cell-mediated cytotoxicity and IFN-gamma production. Its role on T cells has remained unclear. Studies have shown that triggering of CD161 enhances NK T cell proliferation and T cell-IFN-gamma production while inhibiting TNF-alpha production by CD8(+) T cells. Lectin-like transcript 1 (LLT1), the ligand of CD161, was found to be expressed on Toll-like receptor (TLR)-activated plasmacytoid and monocyte-derived dendritic cells (DC) and on activated B cells. Using newly developed anti-LLT1 mAbs, we show that LLT1 is not expressed on the surface of circulating B and T lymphocytes, NK cells, monocytes, and dendritic cells but that LLT1 is up-regulated upon activation. Not only TLR-stimulated dendritic cells and B cells but also T cell receptor-activated T cells and activated NK cells up-regulate LLT1. Interestingly, IFN-gamma increases LLT1 expression level on antigen-presenting cells. LLT1 is also induced on B cells upon viral infection such as Epstein-Barr virus or HIV infection and in inflamed tonsils. Finally, expression of LLT1 on B cells inhibits NK cell function but costimulates T cell proliferation or IFN-gamma production, and coengagement of CD161 with CD3 increases IL-17 secretion. Altogether, our results point toward a role for LLT1/CD161 in modulating immune responses to pathogens.	[Germain, Claire; Knapnougel, Perrine; Poupon, Gwenola; Lazzari, Anne; Braud, Veronique M.] CNRS UNSA UMR6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Meier, Anders; Jensen, Teis; Neisig, Anne; Hakansson, Katarina; Wagtmann, Nicolai; Galsgaard, Elizabeth D.; Spee, Pieter] Novo Nordisk AS, Biopharmaceut Res Unit, DK-2760 Malov, Denmark; [Dong, Tao] John Radcliffe Hosp, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9DU, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Novo Nordisk; University of Oxford	Braud, VM (corresponding author), CNRS UNSA UMR6097, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	braud@ipmc.cnrs.fr	POUPON, Gwénola/M-4632-2016; braud, veronique M/I-4597-2013	POUPON, Gwénola/0000-0001-5772-2539; braud, veronique M/0000-0001-8213-3947; Dong, Tao/0000-0003-3545-3758	Novo Nordisk S/A; Agence Nationale de Recherches sur le Syndrome de l'Immunodeficience Acquise (SIDA); Ensemble contre le SIDA; Centre National de la Recherche Scientifique; Medical Research Council [G0600520, G1001046] Funding Source: researchfish; MRC [G1001046, G0600520] Funding Source: UKRI	Novo Nordisk S/A; Agence Nationale de Recherches sur le Syndrome de l'Immunodeficience Acquise (SIDA)(French National Research Agency (ANR)); Ensemble contre le SIDA; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Novo Nordisk S/A, Agence Nationale de Recherches sur le Syndrome de l'Immunodeficience Acquise (SIDA), Ensemble contre le SIDA, and the Centre National de la Recherche Scientifique. A. M., T. J., A. N., K. H., N. W., E. D. G., and P. S. are employees of Novo Nordisk, which has developed products related to this work.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Aust JG, 2009, J IMMUNOL, V183, P106, DOI 10.4049/jimmunol.0804281; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Beuneu H, 2009, BLOOD, V114, P3227, DOI 10.1182/blood-2009-06-228759; Bihl F, 2010, J IMMUNOL, V185, P2174, DOI 10.4049/jimmunol.1001486; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Carlyle JR, 1999, J IMMUNOL, V162, P5917; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Exley M, 1998, J EXP MED, V188, P867, DOI 10.1084/jem.188.5.867; Germain C, 2010, J BIOL CHEM, V285, P36207, DOI 10.1074/jbc.M110.179622; GIORDA R, 1991, J IMMUNOL, V147, P1701; GIORDA R, 1990, SCIENCE, V249, P1298, DOI 10.1126/science.2399464; GIORDA R, 1992, J IMMUNOL, V149, P1957; Holmes S, 2005, P NATL ACAD SCI USA, V102, P5519, DOI 10.1073/pnas.0501437102; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kalinski P, 2010, METHODS MOL BIOL, V595, P117, DOI 10.1007/978-1-60761-421-0_7; Kamishikiryo J, 2011, J BIOL CHEM, V286, P23823, DOI 10.1074/jbc.M110.214254; Kveberg L, 2009, EUR J IMMUNOL, V39, P541, DOI 10.1002/eji.200838891; LANIER LL, 1994, J IMMUNOL, V153, P2417; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Plougastel B, 2001, IMMUNOGENETICS, V53, P592, DOI 10.1007/s002510100367; Poggi A, 1998, EUR J IMMUNOL, V28, P1611, DOI 10.1002/(SICI)1521-4141(199805)28:05<1611::AID-IMMU1611>3.0.CO;2-6; Poggi A, 1997, IMMUNOL LETT, V57, P121, DOI 10.1016/S0165-2478(97)00050-3; Poggi A, 1999, J IMMUNOL, V162, P4349; Pozo D, 2006, J IMMUNOL, V176, P2397, DOI 10.4049/jimmunol.176.4.2397; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211	41	85	85	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37964	37975		10.1074/jbc.M111.285312	http://dx.doi.org/10.1074/jbc.M111.285312			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21930700	Green Published, hybrid			2022-12-27	WOS:000296594200009
J	Liu, YN; Tian, XL; Leitner, WW; Aldridge, ME; Zheng, JY; Yu, ZY; Restifo, NP; Weiss, R; Scheiblhofer, S; Xie, C; Sun, R; Cheng, GH; Zeng, G				Liu, Yanan; Tian, Xiaoli; Leitner, Wolfgang W.; Aldridge, Michael E.; Zheng, Junying; Yu, Zhiya; Restifo, Nicholas P.; Weiss, Richard; Scheiblhofer, Sandra; Xie, Chong; Sun, Ren; Cheng, Genhong; Zeng, Gang			Polymeric Structure and Host Toll-like Receptor 4 Dictate Immunogenicity of NY-ESO-1 Antigen in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-SYSTEM; SURFACE CALRETICULIN; TUMOR-ANTIGEN; GENE; IDENTIFICATION; IMMUNOTHERAPY; PROGRESSION; EXPRESSION; TOLERANCE; DANGER	In search of intrinsic factors that contribute to the distinctively strong immunogenicity of a non-mutated cancer/testis antigen, we found that NY-ESO-1 forms polymeric structures through disulfide bonds. NY-ESO-1 binding to immature dendritic cells was dependent on its polymeric structure and involved Toll-like receptor-4 (TLR4) on the surface of immature dendritic cells in mouse and human. Gene gun-delivered plasmid encoding the wild-type NY-ESO-1 readily induced T cell-dependent antibody (Ab) responses in wild-type C57BL/10 mice but not TLR4-knock-out C57BL/10ScNJ mice. Disrupting polymeric structures of NY-ESO-1 by cysteine-to-serine (Cys-to-Ser) substitutions lead to diminished immunogenicity and altered TLR4-dependence in the induced Ab response. To demonstrate its adjuvant effect, NY-ESO-1 was fused with a major mugwort pollen allergen Art v 1 and a tumor-associated antigen, carbonic anhydrase 9. Plasmid DNA vaccines encoding the fusion genes generated robust immune responses against otherwise non-immunogenic targets in mice. Polymeric structure and TLR4 may play important roles in rendering NY-ESO-1 immunogenic and thus serve as a potent molecular adjuvant. NY-ESO-1 thus represents the first example of a cancer/testis antigen that is a also damage-associated molecular pattern.	[Liu, Yanan; Tian, Xiaoli; Aldridge, Michael E.; Zheng, Junying; Xie, Chong; Zeng, Gang] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Leitner, Wolfgang W.] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA; [Yu, Zhiya; Restifo, Nicholas P.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Weiss, Richard; Scheiblhofer, Sandra] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Salzburg University	Zeng, G (corresponding author), 66 128 Ctr Hlth Sci, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	gzeng@mednet.ucla.edu	Weiss, Richard/N-7279-2013; Restifo, Nicholas P/A-5713-2008; Leitner, Wolfgang W/F-5741-2011; Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas Phillip/Z-1614-2019	Weiss, Richard/0000-0003-3185-7253; Leitner, Wolfgang W/0000-0003-3125-5922; Restifo, Nicholas P./0000-0003-4229-4580; Scheiblhofer, Sandra/0000-0003-2867-9054	UCLA; American Cancer Society [RSG-08-070-01-LIB]; NATIONAL CANCER INSTITUTE [R21CA137651, ZIABC010763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056154, R01AI078389] Funding Source: NIH RePORTER	UCLA(University of California System); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the UCLA Gene Medicine Program (to G. Z.) and Research Scholar Award RSG-08-070-01-LIB from the American Cancer Society (to G. Z.).	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bauer R, 2003, ALLERGY, V58, P1003, DOI 10.1034/j.1398-9995.2003.00170.x; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chen DQ, 2005, J BIOL CHEM, V280, P22425, DOI 10.1074/jbc.M413380200; Gnjatic S, 2006, ADV CANCER RES, V95, P1, DOI 10.1016/S0065-230X(06)95001-5; Hartl A, 2004, METHODS, V32, P328, DOI 10.1016/j.ymeth.2003.08.014; Hernandez JM, 2003, CLIN CANCER RES, V9, P1906; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813; Lethe B, 1998, INT J CANCER, V76, P903, DOI 10.1002/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Riker AI, 2000, INT J CANCER, V86, P818, DOI 10.1002/(SICI)1097-0215(20000615)86:6<818::AID-IJC10>3.3.CO;2-N; Rosenberg SA, 2001, NATURE, V411, P380, DOI 10.1038/35077246; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Zeng G, 2000, J IMMUNOL, V165, P1153, DOI 10.4049/jimmunol.165.2.1153; Zeng G, 2005, INT J CANCER, V114, P268, DOI 10.1002/ijc.20716; Zeng G, 2006, J IMMUNOL, V177, P3582, DOI 10.4049/jimmunol.177.6.3582	22	7	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37077	37084		10.1074/jbc.M111.280123	http://dx.doi.org/10.1074/jbc.M111.280123			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900253	Green Published, hybrid			2022-12-27	WOS:000296542400008
J	Yang, YC; Lin, S; Chang, PC; Lin, HC; Kuo, CC				Yang, Ya-Chin; Lin, Shin; Chang, Po-Chun; Lin, Hsiao-Chun; Kuo, Chung-Chin			Functional Extension of Amino Acid Triads from the Fourth Transmembrane Segment (S4) into Its External Linker in Shaker K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; VOLTAGE SENSOR; POTASSIUM CHANNEL; SODIUM-CHANNELS; ELECTROSTATIC INTERACTIONS; CLOSED STATES; STRUCTURAL MODELS; CHARGE MOVEMENT; ACTIVATION; DOMAIN	The highly conserved fourth transmembrane segment (S4) is the primary voltage sensor of the voltage-dependent channel and would move outward upon membrane depolarization. S4 comprises repetitive amino acid triads, each containing one basic (presumably charged and voltage-sensing) followed by two hydrophobic residues. We showed that the triad organization is functionally extended into the S3-4 linker right external to S4 in Shaker K+ channels. The arginine (and lysine) substitutes for the third and the sixth residues (Ala-359 and Met-356, respectively) external to the outmost basic residue (Arg-362) in S4 dramatically and additively stabilize S4 in the resting conformation. Also, Leu-361 and Leu-358 play a very similar role in stabilization of S4 in the resting position, presumably by their hydrophobic side chains. Moreover, the double mutation A359R/E283A leads to a partially extruded position of S4 and consequently prominent closed-state inactivation, suggesting that Glu-283 in S2 may coordinate with the arginines in the extruded S4 upon depolarization. We conclude that the triad organization extends into the S3-4 linker for about six amino acids in terms of their microenvironment. These approximately six residues should retain the same helical structure as S4, and their microenvironment serves as part of the "gating canal" accommodating the extruding S4. Upon depolarization, S4 most likely moves initially as a sliding helix and follows the path that is set by the approximately six residues in the S3-4 linker in the resting state, whereas further S4 translocation could be more like, for example, a paddle, without orderly coordination from the contiguous surroundings.	[Lin, Shin; Chang, Po-Chun; Lin, Hsiao-Chun; Kuo, Chung-Chin] Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei 100, Taiwan; [Yang, Ya-Chin] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan 333, Taiwan; [Yang, Ya-Chin] Chang Gung Univ, Dept Biomed Sci, Tao Yuan 333, Taiwan; [Kuo, Chung-Chin] Natl Taiwan Univ Hosp, Dept Neurol, Taipei 100, Taiwan	National Taiwan University; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Kuo, CC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Physiol, 1 Jen Ai Rd,1st Sect, Taipei 100, Taiwan.	chungchinkuo@ntu.edu.tw		Kuo, Chung-Chin/0000-0001-8208-6829	National Science Council, Taiwan [NSC99-2321-B-002-008, NSC99-2311-B-182-001-MY3]; National Health Research Institutes, Taiwan [NHRI-EX100-10006NI]; Chang Gung Hospital, Taiwan [CMRPD170453]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Chang Gung Hospital, Taiwan	This work was supported by National Science Council, Taiwan, Grants NSC99-2321-B-002-008 (to C.-C. K.) and NSC99-2311-B-182-001-MY3 (to Y.-C. Y.). This work was also supported by National Health Research Institutes, Taiwan, Grant NHRI-EX100-10006NI (to C.-C. K.) and Chang Gung Hospital, Taiwan, Medical Research Project CMRPD170453 (to Y.-C. Y.).	Armstrong CM, 2006, P NATL ACAD SCI USA, V103, P17991, DOI 10.1073/pnas.0607603103; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; El-Din TMG, 2010, CHANNELS, V4, P93, DOI 10.4161/chan.4.2.10672; Elinder F, 2001, J GEN PHYSIOL, V118, P1, DOI 10.1085/jgp.118.1.1; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Sands ZA, 2007, STRUCTURE, V15, P235, DOI 10.1016/j.str.2007.01.004; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Upadhyay SK, 2009, J PHYSIOL-LONDON, V587, P3851, DOI 10.1113/jphysiol.2009.174730; Wu D, 2010, J GEN PHYSIOL, V135, P595, DOI 10.1085/jgp.201010408; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yang YC, 2007, J PHYSIOL-LONDON, V582, P1059, DOI 10.1113/jphysiol.2007.131490; Yang YC, 2009, J GEN PHYSIOL, V134, P95, DOI 10.1085/jgp.200810158; Yang YC, 2003, J NEUROSCI, V23, P4922; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104	55	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37503	37514		10.1074/jbc.M111.237792	http://dx.doi.org/10.1074/jbc.M111.237792			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900243	hybrid, Green Published			2022-12-27	WOS:000296542400049
J	Mohamed, JS; Hajira, A; Li, ZL; Paulin, D; Boriek, AM				Mohamed, Junaith S.; Hajira, Ameena; Li, Zhenlin; Paulin, Denise; Boriek, Aladin M.			Desmin Regulates Airway Smooth Muscle Hypertrophy through Early Growth-responsive Protein-1 and MicroRNA-26a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CARDIAC-HYPERTROPHY; KINASE 3-BETA; EGR-1 EXPRESSION; MOUSE MODEL; GENE; PHOSPHORYLATION; TRANSCRIPTION; CELLS; DIFFERENTIATION	Bronchial biopsies of asthmatic patients show a negative correlation between desmin expression in airway smooth muscle cell (ASMC) and airway hyperresponsiveness. We previously showed that desmin is an intracellular load-bearing protein, which influences airway compliance, lung recoil, and airway contractile responsiveness (Shardonofsky, F. R., Capetanaki, Y., and Boriek, A. M. (2006) Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L890-L896). These results suggest that desmin may play an important role in ASMC homeostasis. Here, we report that ASMCs of desmin null mice (ASMCs(Des-/-)) show hypertrophy and up-regulation microRNA-26a (miR-26a). Knockdown of miR-26a in ASMCs(Des-/-) inhibits hypertrophy, whereas enforced expression of miR-26a in ASMCs(Des-/-) induces hypertrophy. We identify that Egr1 (early growth responsive protein-1) activates miR-26a promoter via enhanced phosphorylation of Erk1/2 in ASMCs(Des-/-). We show glycogen synthase kinase-3 beta (GSK-3 beta) as a target gene of miR-26a. Moreover, induction of ASMCs(Des-/-) hypertrophy by the Erk-1/2/Egr-1/miR-26a/GSK-3 beta pathway is consistent in human recombinant ASMCs, which stably suppresses 90% endogenous desmin expression. Overall, our data demonstrate a novel role for desmin as an anti-hypertrophic protein necessary for ASMC homeostasis and identifies desmin as a novel regulator of microRNA.	[Mohamed, Junaith S.; Hajira, Ameena; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Sect Pulm Crit Care & Sleep Med, Houston, TX 77030 USA; [Li, Zhenlin; Paulin, Denise] Univ Paris 06, UR4, F-75005 Paris, France	Baylor College of Medicine; UDICE-French Research Universities; Sorbonne Universite	Boriek, AM (corresponding author), Baylor Coll Med, Dept Med, Sect Pulm Crit Care & Sleep Med, Houston, TX 77030 USA.	boriek@bcm.edu	Li, Zhenlin/E-3937-2016; Mohamed, Junaith/AAC-4050-2020	LI, Zhenlin/0000-0002-3706-4505	National Science Foundation; Keck Foundation	National Science Foundation(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation)	This work was supported by the National Science Foundation and the Keck Foundation.	Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bentley JK, 2009, AM J PHYSIOL-LUNG C, V296, pL176, DOI 10.1152/ajplung.90376.2008; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calogero A, 2001, CLIN CANCER RES, V7, P2788; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Costa ML, 2004, BRAZ J MED BIOL RES, V37, P1819, DOI 10.1590/S0100-879X2004001200007; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Deng H, 2008, J BIOL CHEM, V283, P10198, DOI 10.1074/jbc.M800624200; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Halayko AJ, 1996, AM J PHYSIOL-LUNG C, V270, pL1040, DOI 10.1152/ajplung.1996.270.6.L1040; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hays SR, 2005, THORAX, V60, P226, DOI 10.1136/thx.2004.028340; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; KAPANCI Y, 1992, J HISTOCHEM CYTOCHEM, V40, P1955, DOI 10.1177/40.12.1333502; Kramer EL, 2009, AM J RESP CELL MOL, V41, P415, DOI 10.1165/rcmb.2008-0470OC; LEVIN WJ, 1994, CHEST, V106, pS372, DOI 10.1378/chest.106.6.372S; Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70; Liu LX, 2000, BLOOD, V96, P1772, DOI 10.1182/blood.V96.5.1772.h8001772_1772_1781; Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667; MOHAMED JS, 2011, FASEB J IN PRESS; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Ogawa H, 2011, CLIN EXP ALLERGY, V41, P104, DOI 10.1111/j.1365-2222.2010.03564.x; PARK S, 1986, J BIOL CHEM, V261, P5734; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; RAUSCHER FJ, 1993, ADV EXP MED BIOL, V348, P23; Regamey N, 2008, AM J RESP CRIT CARE, V177, P837, DOI 10.1164/rccm.200707-977OC; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shardonofsky FR, 2006, AM J PHYSIOL-LUNG C, V290, pL890, DOI 10.1152/ajplung.00397.2005; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Slats AM, 2008, J ALLERGY CLIN IMMUN, V121, P1196, DOI 10.1016/j.jaci.2008.02.017; Terzano C, 2003, Eur Rev Med Pharmacol Sci, V7, P9; Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002; Williams AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005889; Yamada M, 2005, J HISTOCHEM CYTOCHEM, V53, P735, DOI 10.1369/jhc.4A6483.2005; Yang Y, 2000, J CLIN INVEST, V106, P1321, DOI 10.1172/JCI8893	49	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43394	43404		10.1074/jbc.M111.235127	http://dx.doi.org/10.1074/jbc.M111.235127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21903578	hybrid, Green Published			2022-12-27	WOS:000298351300059
J	Boersma, YL; Chao, G; Steiner, D; Wittrup, KD; Pluckthun, A				Boersma, Ykelien L.; Chao, Ginger; Steiner, Daniel; Wittrup, K. Dane; Plueckthun, Andreas			Bispecific Designed Ankyrin Repeat Proteins (DARPins) Targeting Epidermal Growth Factor Receptor Inhibit A431 Cell Proliferation and Receptor Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; YEAST SURFACE DISPLAY; MONOCLONAL-ANTIBODIES; IN-VITRO; AUTOPHOSPHORYLATION SITES; ERBB RECEPTORS; EXTRACELLULAR DOMAIN; THERAPEUTIC TARGETS; PERSISTENT ACTIVITY; STRUCTURAL BASIS	The EGF receptor (EGFR) has been implicated in the development and progression of many tumors. Although monoclonal antibodies directed against EGFR have been approved for the treatment of cancer in combination with chemotherapy, there are limitations in their clinical efficacy, necessitating the search for robust targeting molecules that can be equipped with new effector functions or show a new mechanism of action. Designed ankyrin repeat proteins (DARPins) may provide the targeting component for such novel reagents. Previously, four DARPins were selected against EGFR with (sub)nanomolar affinity. As any targeting module should preferably be able to inhibit EGFR-mediated signaling, their effect on A431 cells overexpressing EGFR was examined: three of them were shown to inhibit proliferation by inducing G(1) arrest, as seen for the Food and Drug Administration-approved antibody cetuximab To understand this inhibitory mechanism, we mapped the epitopes of the DARPins using yeast surface display. The epitopes for the biologically active DARPins overlapped with the EGF-binding site, whereas the fourth DARPin bound to a different domain, explaining the lack of a biological effect. To optimize the biological activity of the DARPins, we combined two DARPins binding to different epitopes with a flexible linker or with a leucine zipper, leading to a homodimer. The latter DARPin was able to reduce surface EGFR by inhibiting receptor recycling, leading to a dramatic decrease in cell viability. These results indicate that multispecific EGFR-specific DARPins are superior to cetuximab and may form the basis of new opportunities in tumor targeting and tumor therapy.	[Boersma, Ykelien L.; Steiner, Daniel; Plueckthun, Andreas] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Chao, Ginger; Wittrup, K. Dane] MIT, Dept Chem Engn & Bioengn, Cambridge, MA 02139 USA	University of Zurich; Massachusetts Institute of Technology (MIT)	Pluckthun, A (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	plueckthun@bioc.uzh.ch	Plückthun, Andreas/C-2746-2009	Plückthun, Andreas/0000-0003-4191-5306	National Institutes of Health [CA96504]; Dutch Organization for Scientific Research (NWO) [680-50-0704, OCS-02128-08-2007]; NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA96504 (to G. C. and K. D. W.). This work was also supported by Dutch Organization for Scientific Research (NWO) Rubicon Postdoctoral Grant 680-50-0704 (to V L B.) and Oncosuisse Grant OCS-02128-08-2007 (to A. P.).	Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Boersma Y. L., 2011, CURR OPIN BIOTECH, DOI [10.1016/j.copbio.2011.06.004, DOI 10.1016/TCOPBIO.2011.06.004]; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Clayton AHA, 2007, BIOCHEMISTRY-US, V46, P4589, DOI 10.1021/bi700002b; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Dassonville O, 2007, CRIT REV ONCOL HEMAT, V62, P53, DOI 10.1016/j.critrevonc.2006.12.008; DECKER SJ, 1993, J BIOL CHEM, V268, P9176; FAN Z, 1993, CANCER RES, V53, P4322; FAN Z, 1994, J BIOL CHEM, V269, P27595; FAN Z, 1993, J BIOL CHEM, V268, P21073; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Friedlander E, 2008, IMMUNOL LETT, V116, P126, DOI 10.1016/j.imlet.2007.12.001; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Garrett TPJ, 2009, P NATL ACAD SCI USA, V106, P5082, DOI 10.1073/pnas.0811559106; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GILL GN, 1984, J BIOL CHEM, V259, P7755; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hildebrandt Bert, 2007, V176, P135; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hong KW, 2010, J BIOTECHNOL, V145, P84, DOI 10.1016/j.jbiotec.2009.09.023; Huang SM, 2000, CLIN CANCER RES, V6, P2166; Huber T, 2007, J STRUCT BIOL, V159, P206, DOI 10.1016/j.jsb.2007.01.013; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Janmaat ML, 2003, CLIN CANCER RES, V9, P2316; Jaramillo ML, 2006, EXP CELL RES, V312, P2778, DOI 10.1016/j.yexcr.2006.05.008; Kamat V, 2008, CANCER BIOL THER, V7, P726, DOI 10.4161/cbt.7.5.6097; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; Kawe M, 2006, J BIOL CHEM, V281, P40252, DOI 10.1074/jbc.M602506200; Kim YS, 2006, PROTEINS, V62, P1026, DOI 10.1002/prot.20618; Li S, 2008, STRUCTURE, V16, P216, DOI 10.1016/j.str.2007.11.009; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002; Maegawa M, 2009, CANCER SCI, V100, P552, DOI 10.1111/j.1349-7006.2008.01071.x; Martin-Killias P, 2011, CLIN CANCER RES, V17, P100, DOI 10.1158/1078-0432.CCR-10-1303; Meira DD, 2009, EUR J CANCER, V45, P1265, DOI 10.1016/j.ejca.2008.12.012; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Mendelsohn J, 2002, J CLIN ONCOL, V20, p1S, DOI 10.1200/JCO.2002.07.121; Miqueli AD, 2007, HYBRIDOMA, V26, P423, DOI 10.1089/hyb.2007.0516; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; PARKER PJ, 1984, J BIOL CHEM, V259, P9906; Patel D, 2009, INT J ONCOL, V34, P25, DOI 10.3892/ijo_00000125; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Raben D, 2005, CLIN CANCER RES, V11, P795; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Roovers RC, 2011, INT J CANCER, V129, P2013, DOI 10.1002/ijc.26145; Sato J D, 1983, Mol Biol Med, V1, P511; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Schmitz KR, 2009, EXP CELL RES, V315, P659, DOI 10.1016/j.yexcr.2008.10.008; Sergina NV, 2007, TRENDS MOL MED, V13, P527, DOI 10.1016/j.molmed.2007.10.002; Spangler JB, 2010, P NATL ACAD SCI USA, V107, P13252, DOI 10.1073/pnas.0913476107; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Winkler J, 2009, MOL CANCER THER, V8, P2674, DOI 10.1158/1535-7163.MCT-09-0402; XU FG, 1993, INT J CANCER, V53, P401, DOI 10.1002/ijc.2910530310; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zahnd C, 2006, J BIOL CHEM, V281, P35167, DOI 10.1074/jbc.M602547200; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	68	71	80	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41273	41285		10.1074/jbc.M111.293266	http://dx.doi.org/10.1074/jbc.M111.293266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21979953	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000298057500015
J	Smith, SE; Granell, S; Salcedo-Sicilia, L; Baldini, G; Egea, G; Teckman, JH; Baldini, G				Smith, Steven E.; Granell, Susana; Salcedo-Sicilia, Laia; Baldini, Giovanna; Egea, Gustavo; Teckman, Jeff H.; Baldini, Giulia			Activating Transcription Factor 6 Limits Intracellular Accumulation of Mutant alpha(1)-Antitrypsin Z and Mitochondrial Damage in Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ALPHA-1-ANTITRYPSIN Z; INCLUSION-BODIES; LIVER-DISEASE; MANNOSIDASE I; ER STRESS; DEGRADATION; AUTOPHAGY; DEFICIENCY	alpha(1)-Antitrypsin is a serine protease inhibitor secreted by hepatocytes. A variant of alpha(1)-antitrypsin with an E342K (Z) mutation (ATZ) has propensity to form polymers, is retained in the endoplasmic reticulum (ER), is degraded by both ER-associated degradation and autophagy, and causes hepatocyte loss. Constant features in hepatocytes of PiZZ individuals and in PiZ transgenic mice expressing ATZ are the formation of membrane-limited globular inclusions containing ATZ and mitochondrial damage. Expression of ATZ in the liver does not induce the unfolded protein response (UPR), a protective mechanism aimed to maintain ER homeostasis in the face of an increased load of proteins. Here we found that in hepatoma cells the ER E3 ligase HRD1 functioned to degrade most of the ATZ before globular inclusions are formed. Activation of the activating transcription factor 6 (ATF6) branch of the UPR by expression of spliced ATF6(1-373) decreased intracellular accumulation of ATZ and the formation of globular inclusions by a pathway that required HRD1 and the proteasome. Expression of ATF6(1- 373) in ATZ-expressing hepatoma cells did not induce autophagy and increased the level of the proapoptotic factor CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP) but did not lead to apoptotic DNA fragmentation. Expression of ATF6(1-373) did not cause inhibition of protein synthesis and prevented mitochondrial damage induced by ATZ expression. It was concluded that activation of the ATE6 pathway of the UPR limits ATZ-dependent cell toxicity by selectively promoting ER-associated degradation of ATZ and is thereby a potential target to prevent hepatocyte loss in addition to autophagy-enhancing drugs.	[Smith, Steven E.; Granell, Susana; Baldini, Giulia] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Salcedo-Sicilia, Laia; Egea, Gustavo] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Fac Med, Inst Invest Biomediquens August Pi I Sunyer IDIBA, E-08036 Barcelona, Spain; [Baldini, Giovanna] Univ Trieste, Dipartimento Univ Clin Sci Med Chirurg & Salute, I-34138 Trieste, Italy; [Teckman, Jeff H.] St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63104 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Trieste; Saint Louis University	Baldini, G (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham, Little Rock, AR 72205 USA.	gbaldini@uams.edu	Egea, Gustavo/I-2394-2014; granell, susana/H-2734-2012	Egea, Gustavo/0000-0001-5242-150X; Teckman, Jeffrey/0000-0002-4870-2621	National Institutes of Health from the National Center for Research Resources [UL1RR029884]; Alpha-1 Foundation; Secretaria de Estado de Universidades Del Ministerio de Educacion y Ciencia, Spain; Ministerio de Innovacion y Ciencia, Spain [BEU2009-07186]; Arkansas Tobacco Settlement; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Alpha-1 Foundation; Secretaria de Estado de Universidades Del Ministerio de Educacion y Ciencia, Spain(Spanish Government); Ministerio de Innovacion y Ciencia, Spain; Arkansas Tobacco Settlement; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant UL1RR029884 from the National Center for Research Resources (to the University of Arkansas for Medical Sciences Translational Research Institute). This work was also supported by a grant from the Alpha-1 Foundation, the Arkansas Tobacco Settlement (to Giulia Baldini), a postdoctoral grant from the Secretaria de Estado de Universidades Del Ministerio de Educacion y Ciencia, Spain (to S. G.), and Grant BEU2009-07186 from the Ministerio de Innovacion y Ciencia, Spain (to G. E.).	An JK, 2005, HEPATOLOGY, V41, P160, DOI 10.1002/hep.20508; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Bobrovnikova-Marjon E, 2007, DEV CELL, V13, P322, DOI 10.1016/j.devcel.2007.08.006; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Egawa N, 2011, J BIOL CHEM, V286, P7947, DOI 10.1074/jbc.M110.156430; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Granell S, 2008, MOL BIOL CELL, V19, P572, DOI 10.1091/mbc.E07-06-0587; Granell S, 2008, AUTOPHAGY, V4, P375, DOI 10.4161/auto.5605; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kaushal S, 2010, EXP BIOL MED, V235, P700, DOI 10.1258/ebm.2010.009297; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; LE A, 1990, J BIOL CHEM, V265, P14001; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Teckman JH, 2007, SEMIN LIVER DIS, V27, P274, DOI 10.1055/s-2007-985072; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2004, AM J PHYSIOL-GASTR L, V286, pG851, DOI 10.1152/ajpgi.00175.2003; Teckman JH, 1996, J BIOL CHEM, V271, P13215, DOI 10.1074/jbc.271.22.13215; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V278, pG39, DOI 10.1152/ajpgi.2000.278.1.G39; Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200; Termine DJ, 2009, J CELL SCI, V122, P976, DOI 10.1242/jcs.037291; Wang Y, 2000, J BIOL CHEM, V275, P27013; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ying Z, 2011, J BIOL CHEM, V286, P20835, DOI 10.1074/jbc.M110.200808; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	44	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41563	41577		10.1074/jbc.M111.280073	http://dx.doi.org/10.1074/jbc.M111.280073			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21976666	Green Published, hybrid			2022-12-27	WOS:000298057500042
J	Zhang, J; Petit, CM; King, DS; Lee, AL				Zhang, Jun; Petit, Chad M.; King, David S.; Lee, Andrew L.			Phosphorylation of a PDZ Domain Extension Modulates Binding Affinity and Interdomain Interactions in Postsynaptic Density-95 (PSD-95) Protein, a Membrane-associated Guanylate Kinase (MAGUK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; SCAFFOLDING PROTEINS; SYNAPTIC PLASTICITY; COMPLEX; RECEPTOR; IDENTIFICATION; AUTOINHIBITION; DYNAMICS; LIGAND; SITES	Postsynaptic density-95 is a multidomain scaffolding protein that recruits glutamate receptors to postsynaptic sites and facilitates signal processing and connection to the cytoskeleton. It is the leading member of the membrane-associated guanylate kinase family of proteins, which are defined by the PSD-95/Discs large/ZO-1 (PDZ)-Src homology 3 (SH3)-guanylate kinase domain sequence. We used NMR to show that phosphorylation of conserved tyrosine 397, which occurs in vivo and is located in an atypical helical extension (alpha 3), initiates a rapid equilibrium of docked and undocked conformations. Undocking reduced ligand binding affinity allosterically and weakened the interaction of PDZ3 with SH3 even though these domains are separated by a similar to 25-residue linker. Additional phosphorylation at two linker sites further disrupted the interaction, implicating alpha 3 and the linker in tuning interdomain communication. These experiments revealed a novel mode of regulation by a detachable PDZ element and offer a first glimpse at the dynamic interaction of PDZ and SH3-guanylate kinase domains in membrane-associated guanylate kinases.	[Lee, Andrew L.] Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Zhang, Jun; Petit, Chad M.; Lee, Andrew L.] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA; [King, David S.] Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA; [King, David S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lee, AL (corresponding author), Univ N Carolina, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Beard Hall,CB 7568, Chapel Hill, NC 27599 USA.	drewlee@unc.edu	Zhang, Jun/R-1502-2016; Lee, Andrew/GVU-2817-2022	Zhang, Jun/0000-0002-5842-7424; 	National Science Foundation [MCB-0344354]; University of North Carolina; Eshelman School of Pharmacy	National Science Foundation(National Science Foundation (NSF)); University of North Carolina; Eshelman School of Pharmacy	This work was supported by National Science Foundation Grant MCB-0344354 (to A. L L.) and bridge funding provided by the University of North Carolina and the Eshelman School of Pharmacy.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; An YF, 2005, APPL MICROBIOL BIOT, V68, P774, DOI 10.1007/s00253-005-1948-8; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P15400, DOI 10.1021/bi9814991; Brenman JE, 1998, J NEUROSCI, V18, P8805; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardoni F, 2009, NEUROSCIENCE, V158, P324, DOI 10.1016/j.neuroscience.2008.07.068; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kalia LV, 2003, NEUROPHARMACOLOGY, V45, P720, DOI 10.1016/S0028-3908(03)00313-7; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Korkin D, 2006, PLOS COMPUT BIOL, V2, P1365, DOI 10.1371/journal.pcbi.0020153; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Lin DH, 2002, J BIOMOL NMR, V23, P317, DOI 10.1023/A:1020225206644; Liu W, 2011, CELL, V145, P1088, DOI 10.1016/j.cell.2011.05.015; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Massari S, 2005, J BIOL CHEM, V280, P7388, DOI 10.1074/jbc.M412668200; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pan LF, 2009, P NATL ACAD SCI USA, V106, P5575, DOI 10.1073/pnas.0901819106; Parker LL, 2003, J BIOL CHEM, V278, P21576, DOI 10.1074/jbc.M210973200; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Popovic Matija, 2011, J Mol Recognit, V24, P245, DOI 10.1002/jmr.1042; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Sapienza PJ, 2010, CURR OPIN PHARMACOL, V10, P723, DOI 10.1016/j.coph.2010.09.006; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; Stein ELA, 2010, J NEUROCHEM, V113, P42, DOI 10.1111/j.1471-4159.2009.06529.x; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Tyler RC, 2010, BIOCHEMISTRY-US, V49, P951, DOI 10.1021/bi9017335; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b	60	53	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41776	41785		10.1074/jbc.M111.272583	http://dx.doi.org/10.1074/jbc.M111.272583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965656	hybrid, Green Published			2022-12-27	WOS:000298057500061
J	Freitas, MO; Francisco, T; Rodrigues, TA; Alencastre, IS; Pinto, MP; Grou, CP; Carvalho, AF; Fransen, M; Sa-Miranda, C; Azevedo, JE				Freitas, Marta O.; Francisco, Tania; Rodrigues, Tony A.; Alencastre, Ines S.; Pinto, Manuel P.; Grou, Claudia P.; Carvalho, Andreia F.; Fransen, Marc; Sa-Miranda, Clara; Azevedo, Jorge E.			PEX5 Protein Binds Monomeric Catalase Blocking Its Tetrarnerization and Releases It upon Binding the N-terminal Domain of PEX14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL TARGETING SIGNAL; RAT-LIVER PEROXISOMES; IMPORT RECEPTOR PEX5P; SACCHAROMYCES-CEREVISIAE; PTS1 RECEPTOR; MEMBRANE-PROTEIN; CYCLING RECEPTOR; QUATERNARY STRUCTURE; CONSERVED CYSTEINE; YEAST PEX14P	Newly synthesized peroxisomal matrix proteins are targeted to the organelle by PEX5. PEX5 has a dual role in this process. First, it acts as a soluble receptor recognizing these proteins in the cytosol. Subsequently, at the peroxisomal docking/translocation machinery, PEX5 promotes their translocation across the organelle membrane. Despite significant advances made in recent years, several aspects of this pathway remain unclear. Two important ones regard the formation and disruption of the PEX5-cargo protein interaction in the cytosol and at the docking/translocation machinery, respectively. Here, we provide data on the interaction of PEX5 with catalase, a homotetrameric enzyme in its native state. We found that PEX5 interacts with monomeric catalase yielding a stable protein complex; no such complex was detected with tetrameric catalase. Binding of PEX5 to monomeric catalase potently inhibits its tetramerization, a property that depends on domains present in both the N- and C-terminal halves of PEX5. Interestingly, the PEX5-catalase interaction is disrupted by the N-terminal domain of PEX14, a component of the docking/translocation machinery. One or two of the seven PEX14-binding diaromatic motifs present in the N-terminal half of PEX5 are probably involved in this phenomenon. These results suggest the following: 1) catalase domain(s) involved in the interaction with PEX5 are no longer accessible upon tetramerization of the enzyme; 2) the catalase-binding interface in PEX5 is not restricted to its C-terminal peroxisomal targeting sequence type 1-binding domain and also involves PEX5 N-terminal domain(s); and 3) PEX14 participates in the cargo protein release step.	[Freitas, Marta O.; Francisco, Tania; Rodrigues, Tony A.; Alencastre, Ines S.; Pinto, Manuel P.; Grou, Claudia P.; Carvalho, Andreia F.; Sa-Miranda, Clara; Azevedo, Jorge E.] Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; [Freitas, Marta O.; Francisco, Tania; Rodrigues, Tony A.; Alencastre, Ines S.; Azevedo, Jorge E.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4009003 Oporto, Portugal; [Fransen, Marc] Katholieke Univ Leuven, Dept Mol Celbiol, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	sá Miranda, Maria Clara/K-3920-2013; Grou, Claudia P/K-5472-2013; Francisco, Tânia FAG/K-5545-2013; Francisco, Tânia/AAK-9920-2020; Freitas, Marta/J-8699-2013; Carvalho, Andreia/J-9013-2015; Fransen, Marc/ADL-0723-2022; Azevedo, Jorge E/A-4113-2008; Fransen, Marc/C-6262-2008; Pinto, Manuel/K-6425-2013; Rodrigues, Tony A. Q./K-1141-2014	sá Miranda, Maria Clara/0000-0003-0123-5525; Grou, Claudia P/0000-0001-5197-2270; Francisco, Tânia FAG/0000-0003-3571-5164; Francisco, Tânia/0000-0003-3571-5164; Freitas, Marta/0000-0001-5779-2289; Carvalho, Andreia/0000-0001-8781-5680; Azevedo, Jorge E/0000-0001-7714-5302; Fransen, Marc/0000-0001-9284-1197; Pinto, Manuel/0000-0001-9778-2093; Rodrigues, Tony A. Q./0000-0003-2311-8258; Alencastre, Ines/0000-0002-5591-5596	Fundacao para a Ciencia e Tecnologia, Portugal; Fundo Europeu de Desenvolvimento Regional through COMPETE; Programa Operacional Factores de Cornpetitividade, Portugal [PEst-C/SAU/LA0002/2011, PTDC/BIA-BCM/64771/2006]; European Union [LSHGCT-2004-512018]; Fundacao para a Ciencia e Tecnologia; Programa Operacional Potencial Human do OREN; Fund Social Europeu; Programa Ciencia; Programa Operacional Potencial Humane do QREN; Tipologia [4.2]; Promocao do Emprego Cientifico; Fundo Social Europeu; Ministerio da Ciencia, Tecnologia e Ensino Superior	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundo Europeu de Desenvolvimento Regional through COMPETE; Programa Operacional Factores de Cornpetitividade, Portugal; European Union(European Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Human do OREN; Fund Social Europeu; Programa Ciencia(Spanish Government); Programa Operacional Potencial Humane do QREN; Tipologia; Promocao do Emprego Cientifico; Fundo Social Europeu; Ministerio da Ciencia, Tecnologia e Ensino Superior	This work was supported in part by Fundacao para a Ciencia e Tecnologia, Portugal, and Fundo Europeu de Desenvolvimento Regional through COMPETE, Programa Operacional Factores de Cornpetitividade in the context of QREN, Portugal, Grants PEst-C/SAU/LA0002/2011 and PTDC/BIA-BCM/64771/2006, and by the European Union VI Framework Program Grant LSHGCT-2004-512018, Peroxisomes in Health and Disease.; Supported by Fundacao para a Ciencia e Tecnologia, Programa Operacional Potencial Human do OREN, and Fund Social Europeu.; Supported by Programa Ciencia, funded by Programa Operacional Potencial Humane do QREN, Tipologia 4.2, Promocao do Emprego Cientifico, by Fundo Social Europeu and by national funds from Ministerio da Ciencia, Tecnologia e Ensino Superior.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Azevedo JE, 2006, BBA-MOL CELL RES, V1763, P1574, DOI 10.1016/j.bbamcr.2006.09.002; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; BRUL S, 1988, BIOCHEM BIOPH RES CO, V152, P1083, DOI 10.1016/S0006-291X(88)80395-4; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Faber KN, 2002, BBA-MOL CELL RES, V1591, P157, DOI 10.1016/S0167-4889(02)00274-4; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Ghosh D, 2010, J AM CHEM SOC, V132, P3973, DOI 10.1021/ja9109049; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Gould SJ, 2002, NAT REV MOL CELL BIO, V3, P382, DOI 10.1038/nrm807; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 1999, ANAL BIOCHEM, V274, P270, DOI 10.1006/abio.1999.4281; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Islinger M, 2009, TRAFFIC, V10, P1711, DOI 10.1111/j.1600-0854.2009.00966.x; Koepke JI, 2007, TRAFFIC, V8, P1590, DOI 10.1111/j.1600-0854.2007.00633.x; KRAGLER F, 1993, J CELL BIOL, V120, P665, DOI 10.1083/jcb.120.3.665; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; LAZAROW PB, 1982, ANN NY ACAD SCI, V386, P285, DOI 10.1111/j.1749-6632.1982.tb21423.x; LAZAROW PB, 1973, J CELL BIOL, V59, P491, DOI 10.1083/jcb.59.2.491; LAZAROW PB, 1973, J CELL BIOL, V59, P507, DOI 10.1083/jcb.59.2.507; Lee MS, 1997, PLANT CELL, V9, P185, DOI 10.1105/tpc.9.2.185; LEIGHTON F, 1969, J CELL BIOL, V41, P521, DOI 10.1083/jcb.41.2.521; LEIGHTON F, 1975, J CELL BIOL, V67, P281, DOI 10.1083/jcb.67.2.281; Leiper JM, 1996, J CELL BIOL, V135, P939, DOI 10.1083/jcb.135.4.939; Leon S, 2006, BBA-MOL CELL RES, V1763, P1552, DOI 10.1016/j.bbamcr.2006.08.037; Luo B, 2008, J MOL BIOL, V380, P31, DOI 10.1016/j.jmb.2008.04.064; Ma C, 2009, MOL BIOL CELL, V20, P3680, DOI 10.1091/mbc.E09-01-0037; Ma C, 2009, IUBMB LIFE, V61, P713, DOI 10.1002/iub.196; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Mate MJ, 1999, J MOL BIOL, V286, P135, DOI 10.1006/jmbi.1998.2453; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; MIDDELKOOP E, 1991, FEBS LETT, V279, P79, DOI 10.1016/0014-5793(91)80255-2; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; Mullen RT, 1997, PLANT J, V12, P313, DOI 10.1046/j.1365-313X.1997.12020313.x; MURTHY MRN, 1981, J MOL BIOL, V152, P465, DOI 10.1016/0022-2836(81)90254-0; Niederhoff K, 2005, J BIOL CHEM, V280, P35571, DOI 10.1074/jbc.M502460200; Nilsen T, 2004, J BIOL CHEM, V279, P4794, DOI 10.1074/jbc.M309653200; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; Oshima Y, 2008, PLANT CELL PHYSIOL, V49, P671, DOI 10.1093/pcp/pcn038; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Palosaari P. M, 1990, BIOL CHEM, V265, P2446; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Ple S, 2010, J BACTERIOL, V192, P3801, DOI 10.1128/JB.00117-10; POOLE B, 1969, J CELL BIOL, V41, P536, DOI 10.1083/jcb.41.2.536; Purdue PE, 1996, ANN NY ACAD SCI, V804, P775, DOI 10.1111/j.1749-6632.1996.tb18699.x; Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Sacksteder KA, 2000, ANNU REV GENET, V34, P623, DOI 10.1146/annurev.genet.34.1.623; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; SCANDALIOS JG, 1965, P NATL ACAD SCI USA, V53, P1035, DOI 10.1073/pnas.53.5.1035; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schluter A, 2006, MOL BIOL EVOL, V23, P838, DOI 10.1093/molbev/msj103; Shiozawa K, 2009, J BIOL CHEM, V284, P25334, DOI 10.1074/jbc.M109.002311; Stanley WA, 2006, BBA-MOL CELL RES, V1763, P1592, DOI 10.1016/j.bbamcr.2006.10.015; Stewart MQ, 2001, J CELL SCI, V114, P2863; SULLIVAN DT, 1985, J BIOL CHEM, V260, P4345; Tanaka N, 2008, STRUCTURE, V16, P388, DOI 10.1016/j.str.2007.12.022; Trelease RN, 1996, EUR J CELL BIOL, V71, P248; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Will GK, 1999, MOL CELL BIOL, V19, P2265; Williams C, 2005, FEBS LETT, V579, P3416, DOI 10.1016/j.febslet.2005.05.011; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Williams C, 2006, BBA-MOL CELL RES, V1763, P1585, DOI 10.1016/j.bbamcr.2006.09.007; Wolf J, 2010, FEBS J, V277, P3268, DOI 10.1111/j.1742-4658.2010.07739.x; Zamocky M, 1999, PROG BIOPHYS MOL BIO, V72, P19, DOI 10.1016/S0079-6107(98)00058-3	88	64	64	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40509	40519		10.1074/jbc.M111.287201	http://dx.doi.org/10.1074/jbc.M111.287201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21976670	hybrid, Green Published			2022-12-27	WOS:000297315400010
J	Harmon, EB; Harmon, ML; Larsen, TD; Yang, J; Glasford, JW; Perryman, MB				Harmon, Erin B.; Harmon, Michelle L.; Larsen, Tricia D.; Yang, Jie; Glasford, Joseph W.; Perryman, M. Benjamin			Myotonic Dystrophy Protein Kinase Is Critical for Nuclear Envelope Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; LAMIN-A/C; TRIPLET REPEAT; IN-VITRO; TRANSCRIPTIONAL REPRESSOR; STRUCTURAL ORGANIZATION; CTG REPEAT; MUSCLE; RNA; DIFFERENTIATION	Myotonic dystrophy 1 (DM1) is a multisystemic disease caused by a triplet nucleotide repeat expansion in the 3' untranslated region of the gene coding for myotonic dystrophy protein kinase (DMPK). DMPK is a nuclear envelope (NE) protein that promotes myogenic gene expression in skeletal myoblasts. Muscular dystrophy research has revealed the NE to be a key determinant of nuclear structure, gene regulation, and muscle function. To investigate the role of DMPK in NE stability, we analyzed DMPK expression in epithelial and myoblast cells. We found that DMPK localizes to the NE and coimmunoprecipitates with Lamin-A/C. Overexpression of DMPK in HeLa cells or C2C12 myoblasts disrupts Lamin-A/C and Lamin-B1 localization and causes nuclear fragmentation. Depletion of DMPK also disrupts NE lamina, showing that DMPK is required for NE stability. Our data demonstrate for the first time that DMPK is a critical component of the NE. These novel findings suggest that reduced DMPK may contribute to NE instability, a common mechanism of skeletal muscle wasting in muscular dystrophies.	[Harmon, Erin B.; Harmon, Michelle L.; Larsen, Tricia D.; Yang, Jie; Glasford, Joseph W.] Sanford Res USD, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Perryman, M. Benjamin] Sanford Hlth, Sioux Falls, SD 57104 USA	Sanford Health; Sanford Health	Harmon, EB (corresponding author), Sanford Res USD, Cardiovasc Hlth Res Ctr, 2301 E 60th St N, Sioux Falls, SD 57104 USA.	erin.harmon@sanfordhealth.org			National Institutes of Health [HL064136, P20-RR-017662]; South Dakota 2010 Initiative Research Center; Sanford Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Dakota 2010 Initiative Research Center; Sanford Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL064136 (to M. B. P.) and P20-RR-017662 (to E. B. H.). This work was also supported by the South Dakota 2010 Initiative Research Center Program and by Sanford Health.	Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Bush EW, 2000, BIOCHEMISTRY-US, V39, P8480, DOI 10.1021/bi992142f; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Furling D, 2001, NEUROMUSCULAR DISORD, V11, P728, DOI 10.1016/S0960-8966(01)00226-7; Furling D, 2003, AM J PATHOL, V162, P1001, DOI 10.1016/S0002-9440(10)63894-1; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Harmon EB, 2008, DEV DYNAM, V237, P2353, DOI 10.1002/dvdy.21653; Harper PS, 2001, MYOTONIC DYSTROPHY; Helmke SM, 2006, J MOL RECOGNIT, V19, P215, DOI 10.1002/jmr.769; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Holaska JM, 2008, CIRC RES, V103, P16, DOI 10.1161/CIRCRESAHA.108.172197; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Kaliman P, 2005, J BIOL CHEM, V280, P8016, DOI 10.1074/jbc.M412845200; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; LEHNER CF, 1986, J BIOL CHEM, V261, P3293; LIN F, 1993, J BIOL CHEM, V268, P16321; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.E04-02-0154; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Morrone A, 1997, J CLIN INVEST, V99, P1691, DOI 10.1172/JCI119332; Muchir A, 2004, PHYSIOLOGY, V19, P309, DOI 10.1152/physiol.00022.2004; Muralikrishna B, 2001, J CELL SCI, V114, P4001; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; OZAKI T, 1994, ONCOGENE, V9, P2649; Roux KJ, 2007, BBA-MOL BASIS DIS, V1772, P118, DOI 10.1016/j.bbadis.2006.06.001; Sasagawa N, 2003, J BIOCHEM, V134, P537, DOI 10.1093/jb/mvg171; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; Wansink DG, 2003, CYTOGENET GENOME RES, V100, P230, DOI 10.1159/000072859; Yadava RS, 2008, NAT GENET, V40, P61, DOI 10.1038/ng.2007.28; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238	48	17	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40296	40306		10.1074/jbc.M111.241455	http://dx.doi.org/10.1074/jbc.M111.241455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949239	Green Published, hybrid			2022-12-27	WOS:000296925700061
J	Mierke, CT				Mierke, Claudia Tanja			Cancer Cells Regulate Biomechanical Properties of Human Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; TRANSENDOTHELIAL MIGRATION; BARRIER FUNCTION; TUMOR-CELLS; CADHERIN; METASTASIS; PROLIFERATION; EXPRESSION; MECHANISM; MUSCLE	Metastasis is a key event of malignant tumor progression. The capability to metastasize depends on the ability of the cancer cell to migrate into connective tissue, adhere, and possibly transmigrate through the endothelium. Previously we reported that the endothelium does not generally act as barrier for cancer cells to migrate in three-dimensional extracellular matrices (3D-ECMs). Instead, the endothelium acts as an enhancer or a promoter for the invasiveness of certain cancer cells. How invasive cancer cells diminish the endothelial barrier function still remains elusive. Therefore, this study investigates whether invasive cancer cells can decrease the endothelial barrier function through alterations of endothelial biomechanical properties. To address this, MDA-MB-231 breast cancer cells were used that invade deeper and more numerous into 3D-ECMs when co-cultured with microvascular endothelial cells. Using magnetic tweezer measurements, MDA-MB-231 cells were found to alter the mechanical properties of endothelial cells by reducing endothelial cell stiffness. Using spontaneous bead diffusion, actin cytoskeletal remodeling dynamics were shown to be increased in endothelial cells co-cultured with MDA-MB-231 cells compared with mono-cultured endothelial cells. In addition, knockdown of the alpha 5 integrin subunit in highly transmigrating alpha 5 beta 1(high) cells derived from breast, bladder, and kidney cancer cells abolished the endothelial invasion-enhancing effect comparable with the inhibition of myosin light chain kinase. These results indicate that the endothelial invasion-enhancing effect is alpha 5 beta 1 integrin-dependent. Moreover, inhibition of Rac-1, Rho kinase, MEK kinase, and PI3K reduced the endothelial invasion-enhancing effect, indicating that signaling via small GTPases may play a role in the endothelial facilitated increased invasiveness of cancer cells. In conclusion, decreased stiffness and increased cytoskeletal remodeling dynamics of endothelial cells may account for the breakdown of endothelial barrier function, suggesting that biomechanical alterations are sufficient to facilitate the transmigration and invasion of invasive cancer cells into 3D-ECMs.	Univ Leipzig, Fac Phys & Earth Sci, Inst Expt Phys 1, Soft Matter Phys Div, D-04103 Leipzig, Germany	Leipzig University	Mierke, CT (corresponding author), Univ Leipzig, Fac Phys & Earth Sci, Inst Expt Phys 1, Soft Matter Phys Div, Linnestr 5, D-04103 Leipzig, Germany.	claudia.mierke@t-online.de	Mierke, Claudia Tanja/L-5293-2018	Mierke, Claudia Tanja/0000-0002-6622-335X	Deutsche Krebshilfe [109432]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe (109432).	Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; DAMSKY CH, 1985, J CELL BIOL, V100, P1528, DOI 10.1083/jcb.100.5.1528; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fredberg JJ, 1996, J APPL PHYSIOL, V81, P2703, DOI 10.1152/jappl.1996.81.6.2703; Fritsch A, 2010, NAT PHYS, V6, P730, DOI 10.1038/nphys1800; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; HILDEBRANDT J, 1969, B MATH BIOPHYS, V31, P651, DOI 10.1007/BF02477779; Kasza KE, 2009, BIOPHYS J, V96, P4326, DOI 10.1016/j.bpj.2009.02.035; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kollmannsberger P, 2011, SOFT MATTER, V7, P3127, DOI 10.1039/c0sm00833h; Kollmannsberger P, 2009, SOFT MATTER, V5, P1771, DOI 10.1039/b820228a; Metzner C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194105; Mierke C. T., 2011, CELL BIOCH IN PRESS; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Mierke CT, 2000, J EXP MED, V192, P801, DOI 10.1084/jem.192.6.801; Mierke CT, 2008, J BIOPHYS, V2008; Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002; NEFF NT, 1982, J CELL BIOL, V95, P654, DOI 10.1083/jcb.95.2.654; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Rabodzey A, 2008, BIOPHYS J, V95, P1428, DOI 10.1529/biophysj.107.119156; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Raupach C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011918; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Van Sluis GL, 2009, BLOOD, V114, P1968, DOI 10.1182/blood-2009-04-217679; VERIN AD, 1995, AM J PHYSIOL-LUNG C, V269, pL99, DOI 10.1152/ajplung.1995.269.1.L99; Voura EB, 2001, CLIN EXP METASTAS, V18, P527, DOI 10.1023/A:1011884807746; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	38	80	85	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40025	40037		10.1074/jbc.M111.256172	http://dx.doi.org/10.1074/jbc.M111.256172			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21940631	Green Published, hybrid			2022-12-27	WOS:000296925700035
J	Ma, Y; Munch, D; Schneider, T; Sahl, HG; Bouhss, A; Ghoshdastider, U; Wang, JF; Dotsch, V; Wang, XN; Bernhard, F				Ma, Yi; Muench, Daniela; Schneider, Tanja; Sahl, Hans-Georg; Bouhss, Ahmed; Ghoshdastider, Umesh; Wang, Jufang; Doetsch, Volker; Wang, Xiaoning; Bernhard, Frank			Preparative Scale Cell-free Production and Quality Optimization of MraY Homologues in Different Expression Modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST MEMBRANE STEP; ACETYLMURAMOYL-PENTAPEPTIDE-TRANSFERASE; ESCHERICHIA-COLI; PEPTIDOGLYCAN BIOSYNTHESIS; WALL BIOSYNTHESIS; FREE SYSTEMS; PROTEINS; TRANSLOCASE; PHOSPHATE; RECONSTITUTION	MraY translocase catalyzes the first committed membrane-bound step of bacterial peptidoglycan synthesis leading to the formation of lipid I. The essential membrane protein therefore has a high potential as target for drug screening approaches to develop antibiotics against Gram-positive as well as Gram-negative bacteria. However, the production of large integral membrane proteins in conventional cellular expression systems is still very challenging. Cell-free expression technologies have been optimized in recent times for the production of membrane proteins in the presence of detergents (D-CF), lipids (L-CF), or as precipitates (P-CF). We report the development of preparative scale production protocols for the MraY homologues of Escherichia coli and Bacillus subtilis in all three cell-free expression modes followed by their subsequent quality evaluation. Although both proteins can be cell-free produced at comparable high levels, their requirements for optimal expression conditions differ markedly. B. subtilus MraY was stably folded in all three expression modes and showed highest translocase activities after P-CF production followed by defined treatment with detergents. In contrast, the E. coli MraY appears to be unstable after post- or cotranslational solubilization in detergent micelles. Expression kinetics and reducing conditions were identified as optimization parameters for the quality improvement of E. coli MraY. Most remarkably, in contrast to B. subtilis MraY the E. coli MraY has to be stabilized by lipids and only the production in the L-CF mode in the presence of preformed liposomes resulted in stable and translocase active protein samples.	[Ma, Yi; Wang, Jufang; Wang, Xiaoning] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Ma, Yi; Ghoshdastider, Umesh; Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Muench, Daniela; Schneider, Tanja; Sahl, Hans-Georg] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53105 Bonn, Germany; [Bouhss, Ahmed] Univ Paris 11, Inst Biochem & Mol & Cellular Biophys, UMR 8619, Orsay, France	South China University of Technology; Goethe University Frankfurt; University of Bonn; UDICE-French Research Universities; Universite Paris Saclay	Bernhard, F (corresponding author), Max von Laue Str 9, D-60438 Frankfurt, Germany.	fbern@bpc.uni-frankfurt.de	Schneider, Tanja/L-8049-2013; Ghoshdastider, Umesh/O-5327-2015	Dotsch, Volker/0000-0001-5720-212X; Schneider, Tanja/0000-0001-7269-4716; Bernhard, Frank/0000-0002-4860-1783; Rausch, Daniela/0000-0003-3211-5745; Ghoshdastider, Umesh/0000-0003-4471-9394	European Drug Initiative on Channels and Transporters [HEALTH-F4-2007-201924]; European Initiative on Structural Biology of Membrane Proteins (SBMP) [PITN-GA-2008-211800]; National Natural Science Foundation of China [20736008, 20876060];  [Sonderforschungsbereich 807]	European Drug Initiative on Channels and Transporters; European Initiative on Structural Biology of Membrane Proteins (SBMP); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported by European Drug Initiative on Channels and Transporters Grant HEALTH-F4-2007-201924, European Initiative on Structural Biology of Membrane Proteins (SBMP) Grant PITN-GA-2008-211800, the Sonderforschungsbereich 807, and Key Program of the National Natural Science Foundation of China Grants 20736008 and 20876060.	Abdine A, 2010, J MAGN RESON, V204, P155, DOI 10.1016/j.jmr.2010.02.003; Al-Dabbagh B, 2008, BIOCHEMISTRY-US, V47, P8919, DOI 10.1021/bi8006274; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Brandish PE, 1996, ANTIMICROB AGENTS CH, V40, P1640, DOI 10.1128/AAC.40.7.1640; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; ELBEIN AD, 1979, ANNU REV PLANT PHYS, V30, P239, DOI 10.1146/annurev.pp.30.060179.001323; GEIS A, 1978, BIOCHIM BIOPHYS ACTA, V527, P414, DOI 10.1016/0005-2744(78)90355-8; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Henrichfreise B, 2009, MOL MICROBIOL, V73, P913, DOI 10.1111/j.1365-2958.2009.06815.x; Hyland SA, 2003, ANAL BIOCHEM, V317, P156, DOI 10.1016/S0003-2697(03)00088-5; IKEDA M, 1991, J BACTERIOL, V173, P1021, DOI 10.1128/jb.173.3.1021-1026.1991; Junge F, 2011, NEW BIOTECHNOL, V28, P262, DOI 10.1016/j.nbt.2010.07.002; Junge F, 2010, J STRUCT BIOL, V172, P94, DOI 10.1016/j.jsb.2010.05.004; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Kalmbach R, 2007, J MOL BIOL, V371, P639, DOI 10.1016/j.jmb.2007.05.087; Keller T, 2008, BIOCHEMISTRY-US, V47, P4552, DOI 10.1021/bi800060w; Lecercle D, 2010, BIOORGAN MED CHEM, V18, P4560, DOI 10.1016/j.bmc.2010.04.023; Mravljak J, 2011, EUR J MED CHEM, V46, P1582, DOI 10.1016/j.ejmech.2011.02.006; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Nozawa A, 2007, PLANT CELL PHYSIOL, V48, P1815, DOI 10.1093/pcp/pcm150; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P359, DOI 10.2174/138920109788488815; PLESS DD, 1973, J BIOL CHEM, V248, P1568; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reckel S, 2010, METHODS MOL BIOL, V607, P187, DOI 10.1007/978-1-60327-331-2_16; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; Rubinchik E, 2011, ANTIMICROB AGENTS CH, V55, P2743, DOI 10.1128/AAC.00170-11; Schneider B, 2010, METHODS MOL BIOL, V601, P165, DOI 10.1007/978-1-60761-344-2_11; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Schneider T, 2010, INT J MED MICROBIOL, V300, P161, DOI 10.1016/j.ijmm.2009.10.005; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Stachyra T, 2004, ANTIMICROB AGENTS CH, V48, P897, DOI 10.1128/AAC.48.3.897-902.2004; UMBREIT JN, 1972, P NATL ACAD SCI USA, V69, P1972, DOI 10.1073/pnas.69.7.1972; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; Zawadzke LE, 2003, ANAL BIOCHEM, V314, P243, DOI 10.1016/S0003-2697(02)00622-X	40	51	51	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38844	38853		10.1074/jbc.M111.301085	http://dx.doi.org/10.1074/jbc.M111.301085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937437	Green Published, hybrid			2022-12-27	WOS:000296759800003
J	Vadon-Le Goff, S; Kronenberg, D; Bourhis, JM; Bijakowski, C; Raynal, N; Ruggiero, F; Farndale, RW; Stocker, W; Hulmes, DJS; Moali, C				Vadon-Le Goff, Sandrine; Kronenberg, Daniel; Bourhis, Jean-Marie; Bijakowski, Cecile; Raynal, Nicolas; Ruggiero, Florence; Farndale, Richard W.; Stoecker, Walter; Hulmes, David J. S.; Moali, Catherine			Procollagen C-proteinase Enhancer Stimulates Procollagen Processing by Binding to the C-propeptide Region Only	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; SUBSTRATE EXCLUSION; COLLAGEN-BINDING; CUB DOMAINS; FIBROSIS; CLEAVAGE; BMP-1; ACTIVATION; MECHANISMS; EXPRESSION	Bone morphogenetic protein-1(BMP-1) and the tolloid-like metalloproteinases control several aspects of embryonic development and tissue repair. Unlike other proteinases whose activities are regulated mainly by endogenous inhibitors, regulation of BMP-1/tolloid-like proteinases relies mostly on proteins that stimulate activity. Among these, procollagen C-proteinase enhancers (PCPEs) markedly increase BMP-1/tolloid-like proteinase activity on fibrillar procollagens, in a substrate-specific manner. Here, we performed a detailed quantitative study of the binding of PCPE-1 and of its minimal active fragment (CUB1-CUB2) to three regions of the procollagen III molecule: the triple helix, the C-telopeptide, and the C-propeptide. Contrary to results described elsewhere, we found the PCPE-1-binding sites to be located exclusively in the C-propeptide region. In addition, binding and enhancing activities were found to be independent of the glycosylation state of the C-propeptide. These data exclude previously proposed mechanisms for the action of PCPEs and also suggest new mechanisms to explain how these proteins can stimulate BMP-1/tolloid-like proteinases by up to 20-fold.	[Vadon-Le Goff, Sandrine; Kronenberg, Daniel; Bourhis, Jean-Marie; Bijakowski, Cecile; Hulmes, David J. S.; Moali, Catherine] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, FRE3310, F-69367 Lyon 7, France; [Kronenberg, Daniel; Stoecker, Walter] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Cell & Matrix Biol, D-55128 Mainz, Germany; [Raynal, Nicolas; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ruggiero, Florence] Univ Lyon 1, Inst Genom Fonct Lyon, ENS Lyon, UMR CNRS 5242, F-69364 Lyon 7, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Johannes Gutenberg University of Mainz; University of Cambridge; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Hulmes, DJS (corresponding author), Univ Lyon 1, CNRS, Inst Biol & Chim Prot, FRE3310, 7 Passage du Vercors, F-69367 Lyon 7, France.	d.hulmes@ibcp.fr	le goff, sandrine/AAE-1990-2019; Kronenberg, Daniel/ABA-9255-2020; Stöcker, Walter/AAB-9704-2019	Kronenberg, Daniel/0000-0001-6807-7328; Stöcker, Walter/0000-0002-1515-6994; MOALI, Catherine/0000-0003-2479-4290; vadon-le goff, sandrine/0000-0002-4582-2273; RUGGIERO, Florence/0000-0003-2915-5359; Hulmes, David/0000-0002-0651-1317	Region Rhone-Alpes; European Commission [NMP2-CT-2003-504017]; Agence Nationale de la Recherche; Fondation Coloplast; CNRS; Universite Claude Bernard Lyon 1; Wellcome Trust; Medical Research Council; Deutscher Akademischer Austauschdienst (DAAD); MRC [G0400701] Funding Source: UKRI; Medical Research Council [G0400701] Funding Source: researchfish	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Coloplast; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Region Rhone-Alpes, European Commission Contract NMP2-CT-2003-504017, the Agence Nationale de la Recherche, the Fondation Coloplast, CNRS, and the Universite Claude Bernard Lyon 1. Synthesis of the collagen toolkits was supported by the Wellcome Trust and the Medical Research Council.; Supported by the Deutscher Akademischer Austauschdienst (DAAD). Present address: Inst. for Experimental Musculoskeletal Medicine, University of Munster, 48149 Munster, Germany.	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Bailey S, 2008, BIOORG MED CHEM LETT, V18, P6562, DOI 10.1016/j.bmcl.2008.10.036; Bekhouche M, 2010, J BIOL CHEM, V285, P15950, DOI 10.1074/jbc.M109.086447; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Bernocco S, 2001, J BIOL CHEM, V276, P48930, DOI 10.1074/jbc.M108611200; Berry R, 2010, FEBS LETT, V584, P657, DOI 10.1016/j.febslet.2009.12.050; Berry R, 2009, P NATL ACAD SCI USA, V106, P8561, DOI 10.1073/pnas.0812178106; Blanc G, 2007, J BIOL CHEM, V282, P16924, DOI 10.1074/jbc.M701610200; Burchardt ER, 1998, MATRIX BIOL, V17, P673, DOI 10.1016/S0945-053X(98)90118-4; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Clark TG, 1999, DEVELOPMENT, V126, P2631; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Ge GX, 2007, P NATL ACAD SCI USA, V104, P10010, DOI 10.1073/pnas.0704179104; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Hulmes D. J. S., 2008, P15, DOI 10.1007/978-0-387-73906-9_2; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kessler-Icekson G, 2006, INT J BIOCHEM CELL B, V38, P358, DOI 10.1016/j.biocel.2005.10.007; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Kronenberg D, 2009, J BIOL CHEM, V284, P33437, DOI 10.1074/jbc.M109.046128; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Moali C, 2009, EUR J DERMATOL, V19, P552, DOI 10.1684/ejd.2009.0770; Moschcovich L, 2001, EUR J BIOCHEM, V268, P2991, DOI 10.1046/j.1432-1327.2001.02189.x; Ogata I, 1997, HEPATOLOGY, V26, P611, DOI 10.1002/hep.510260312; Petropoulou V, 2005, J BIOL CHEM, V280, P22616, DOI 10.1074/jbc.M413468200; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Steiglitz BM, 2006, MOL CELL BIOL, V26, P238, DOI 10.1128/MCB.26.1.238-249.2006; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; SUZUKI A, 1995, DEV GROWTH DIFFER, V37, P581; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Turtle ED, 2004, EXPERT OPIN THER PAT, V14, P1185, DOI 10.1517/13543776.14.8.1185; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	44	36	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38932	38938		10.1074/jbc.M111.274944	http://dx.doi.org/10.1074/jbc.M111.274944			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940633	Green Published, hybrid			2022-12-27	WOS:000296759800012
J	Bartolommei, G; Tadini-Buoninsegni, F; Moncelli, MR; Gemma, S; Camodeca, C; Butini, S; Campiani, G; Lewis, D; Inesi, G				Bartolommei, Gianluca; Tadini-Buoninsegni, Francesco; Moncelli, Maria Rosa; Gemma, Sandra; Camodeca, Caterina; Butini, Stefania; Campiani, Giuseppe; Lewis, David; Inesi, Giuseppe			The Ca2+-ATPase (SERCA1) Is Inhibited by 4-Aminoquinoline Derivatives through Interference with Catalytic Activation by Ca2+, Whereas the ATPase E-2 State Remains Functional	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENT ANTIMALARIAL AGENTS; SARCOPLASMIC-RETICULUM; PLASMODIUM-FALCIPARUM; CALCIUM-PUMP; INNOVATIVE PHARMACOPHORE; CLOTRIMAZOLE SCAFFOLD; CYCLOPIAZONIC ACID; PROSTATE-CANCER; IN-VITRO; BINDING	Several clotrimazole (CLT) and 4-aminoquinoline derivatives were synthesized and found to exhibit in vitro antiplasmodial activity with IC50 ranging from nM to mu M values. We report here that some of these compounds produce inhibition of rabbit sarcoplasmic reticulum Ca2+-ATPase (SERCA1) with IC50 values in the mu M range. The highest affinity for the Ca2+-ATPase was observed with NF1442 (N-((3-chlorophenyl)(4-((4-(7-chloroquinolin-4-yl) piperazin-1-yl)methyl)phenyl)methyl)-7-chloro-4-aminoquinoline) and NF1058 (N-((3-chlorophenyl)(4-(pyrrolidin-1-ylmethyl)phenyl)methyl)-7-chloro-4-aminoquinoline), yielding IC50 values of 1.3 and 8.0 mu M as demonstrated by measurements of steady state ATPase activity as well as single cycle charge transfer. Characterization of sequential reactions comprising the ATPase catalytic and transport cycle then demonstrated that NF1058, and similarly CLT, interferes with the mechanism of Ca2+ binding and Ca2+-dependent enzyme activation (E-2 to E-1.Ca-2 transition) required for formation of phosphorylated intermediate by ATP utilization. On the other hand, Ca2+ independent phosphoenzyme formation by utilization of P-i (i.e. reverse of the hydrolytic reaction in the absence of Ca2+) was not inhibited by NF1058 or CLT. Comparative experiments showed that the high affinity inhibitor thapsigargin interferes not only with Ca2+ binding and phosphoenzyme formation with ATPbut also with phosphoenzyme formation by utilization of P-i even though this reaction does not require Ca2+. It is concluded that NF1058 and CLT inhibit SERCA by stabilization of an E-2 state that, as opposed to that obtained with thapsigargin, retains the functional ability to form E-2-P by reacting with P-i.	[Bartolommei, Gianluca; Tadini-Buoninsegni, Francesco; Moncelli, Maria Rosa] Univ Florence, Dept Chem Ugo Schiff, I-50019 Sesto Fiorentino, Florence, Italy; [Gemma, Sandra; Camodeca, Caterina; Butini, Stefania; Campiani, Giuseppe] Univ Siena, European Res Ctr Drug Discovery & Dev, I-53100 Siena, Italy; [Gemma, Sandra; Camodeca, Caterina; Butini, Stefania; Campiani, Giuseppe] Univ Siena, Dept Pharmaceut & Appl Chem, I-53100 Siena, Italy; [Lewis, David; Inesi, Giuseppe] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA	University of Florence; University of Siena; University of Siena; California Pacific Medical Center; California Pacific Medical Center Research Institute	Tadini-Buoninsegni, F (corresponding author), Univ Florence, Dept Chem Ugo Schiff, Via Lastruccia 3, I-50019 Sesto Fiorentino, Florence, Italy.	francesco.tadini@unifi.it	butini, stefania/D-9954-2015; Tadini-Buoninsegni, Francesco/CAJ-5745-2022; Gemma, Sandra/D-3568-2009	butini, stefania/0000-0002-8471-0880; Gemma, Sandra/0000-0002-8313-2417; Camodeca, Caterina/0000-0002-8676-7311; TADINI-BUONINSEGNI, Francesco/0000-0001-5594-2554; Campiani, Giuseppe/0000-0001-5295-9529	National Institutes of Health [RO301-69830]; Ministero dell'Istruzione, dell'Universita e della Ricerca; Ente Cassa di Risparmio di Firenze; Monte dei Paschi di Siena; NatSynDrugs	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Monte dei Paschi di Siena; NatSynDrugs	This work was supported, in whole or in part, by National Institutes of Health Grant RO301-69830 (NHBLI). This work was also supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN2008), the Ente Cassa di Risparmio di Firenze, Monte dei Paschi di Siena and NatSynDrugs.	ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; Andrews S, 2010, J MED CHEM, V53, P916, DOI 10.1021/jm900972u; Arnou B, 2011, BIOCHEM SOC T, V39, P823, DOI 10.1042/BST0390823; Avellanal M, 1998, J CARDIOVASC PHARM, V32, P845, DOI 10.1097/00005344-199811000-00022; Bartolommei G, 2006, J BIOL CHEM, V281, P9547, DOI 10.1074/jbc.M510550200; Bartolommei G, 2008, BIOPHYS J, V95, P1813, DOI 10.1529/biophysj.108.133546; Berman MC, 2003, BIOCHEMISTRY-US, V42, P3556, DOI 10.1021/bi026071n; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; Campiani G, 2008, Italy patent, Patent No. [WO2008/101891, 2008101891]; de Meis L, 1974, Biochemistry, V13, P2057, DOI 10.1021/bi00707a009; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V290, P178, DOI 10.1016/0005-2736(72)90062-4; Gemma S, 2009, J MED CHEM, V52, P502, DOI 10.1021/jm801352s; Gemma Sandra, 2007, Bioorg Med Chem Lett, V17, P3535, DOI 10.1016/j.bmcl.2007.04.077; Gemma S, 2008, J MED CHEM, V51, P1278, DOI 10.1021/jm701247k; Gemma S, 2007, J MED CHEM, V50, P595, DOI 10.1021/jm061429p; INESI G, 1988, METHOD ENZYMOL, V157, P154; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; INESI G, 1980, J BIOL CHEM, V255, P3025; Kaplan J.H., 2004, HDB ATPASES BIOCH CE, P63; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; Michelangeli F, 2011, BIOCHEM SOC T, V39, P789, DOI 10.1042/BST0390789; MOORE GA, 1987, FEBS LETT, V224, P331, DOI 10.1016/0014-5793(87)80479-9; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Pintschovius J, 1999, BIOPHYS J, V76, P814, DOI 10.1016/S0006-3495(99)77245-0; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Saliba KJ, 1998, T ROY SOC TROP MED H, V92, P666, DOI 10.1016/S0035-9203(98)90805-7; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Sohoel H, 2006, BIOORGAN MED CHEM, V14, P2810, DOI 10.1016/j.bmc.2005.12.001; Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104; Tadini-Buoninsegni F, 2008, ARCH BIOCHEM BIOPHYS, V476, P75, DOI 10.1016/j.abb.2008.02.031; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Tiffert T, 2000, P NATL ACAD SCI USA, V97, P331, DOI 10.1073/pnas.97.1.331; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Witzke A, 2010, BIOCHEMISTRY-US, V49, P4524, DOI 10.1021/bi1004014; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361	46	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38383	38389		10.1074/jbc.M111.287276	http://dx.doi.org/10.1074/jbc.M111.287276			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914795	Green Published, hybrid			2022-12-27	WOS:000296594200052
J	Few, AP; Nanou, E; Scheuer, T; Catterall, WA				Few, Alexandra P.; Nanou, Evanthia; Scheuer, Todd; Catterall, William A.			Molecular Determinants of Ca(v)2.1 Channel Regulation by Calcium-binding Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERM SYNAPTIC PLASTICITY; VISININ-LIKE PROTEIN-2; CA2+ CHANNELS; CA2+-BINDING PROTEINS; P/Q; CALMODULIN; FACILITATION; INACTIVATION; DEPRESSION; MODULATION	Presynaptic Ca(v)2.1 channels, which conduct P/Q-type Ca2+ currents, initiate synaptic transmission at most synapses in the central nervous system. Regulation of Ca(v)2.1 channels by CaM contributes significantly to short term facilitation and rapid depression of synaptic transmission. Short term synaptic plasticity is diverse in form and function at different synapses, yet CaMis ubiquitously expressed. Differential regulation of Ca(v)2.1 channels by CaM-like Ca2+ sensor (CaS) proteins differentially affects short term synaptic facilitation and rapid synaptic depression in transfected sympathetic neuron synapses. Here, we define the molecular determinants for differential regulation of Ca(v)2.1 channels by the CaS protein calcium-binding protein- 1 (CaBP1) by analysis of chimeras in which the unique structural domains of CaBP1 are inserted into CaM. Our results show that the N-terminal domain, including its myristoylation site, and the second EF-hand, which is inactive in Ca2+ binding, are the key molecular determinants of differential regulation of Ca(v)2.1 channels by CaBP1. These findings give insight into the molecular code by which CaS proteins differentially regulate Ca(v)2.1 channel function and provide diversity of form and function of short term synaptic plasticity.	[Few, Alexandra P.; Nanou, Evanthia; Scheuer, Todd; Catterall, William A.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu			National Institutes of Health [R01 NS22625, F31 MH078345]; Swedish Research Council [524-2010-913]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH078345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS22625 (to W. A. C.) and Predoctoral Fellowship F31 MH078345 (to A. P. F.). This work was also supported by Swedish Research Council Postdoctoral Fellowship 524-2010-913 (to E. N.).	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Haeseleer F, 2002, ADV EXP MED BIOL, V514, P303; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu JH, 2007, CURR OPIN NEUROBIOL, V17, P352, DOI 10.1016/j.conb.2007.04.005; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	24	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41917	41923		10.1074/jbc.M111.292417	http://dx.doi.org/10.1074/jbc.M111.292417			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965686	hybrid, Green Published			2022-12-27	WOS:000298180900003
J	Finlay-Schultz, J; Canastar, A; Short, M; El Gazzar, M; Coughlan, C; Leonard, S				Finlay-Schultz, Jessica; Canastar, Andrew; Short, Margaret; El Gazzar, Mohamed; Coughlan, Christina; Leonard, Sherry			Transcriptional Repression of the alpha 7 Nicotinic Acetylcholine Receptor Subunit Gene (CHRNA7) by Activating Protein-2 alpha (AP-2 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FACTOR AP-2; DNA-BINDING; FUNCTIONAL-CHARACTERIZATION; LINKAGE ANALYSIS; CARCINOMA-CELLS; FRONTAL-CORTEX; RETINOIC ACID; FACTOR EGR-1; SCHIZOPHRENIA	The CHRNA7 gene, which encodes the alpha 7 nicotinic acetylcholine receptor (alpha 7*nAChR), has been implicated as a candidate gene in schizophrenia. Expression of the alpha 7*nAChR mRNA and protein are reduced in multiple regions of post-mortem brain from patients diagnosed with schizophrenia. Transcriptional regulation may therefore be an important mechanism for the regulation of this gene. A 230-bp proximal promoter fragment, necessary for transcription in cultured neuroblastoma cells, was used to study a putative AP-2 alpha binding site. Mutation of the site indicates that AP-2 alpha plays a negative role in regulating CHRNA7 transcription. This was confirmed through knockdown and overexpression of AP-2 alpha. Electrophoretic mobility shift assays (EMSAs) identified positive DNA-protein interaction at this same site, and supershift assays indicate that the complex includes AP-2 alpha. The interaction was confirmed in cells using chromatin immunoprecipitation (ChIP). DNA methylation was discovered as an anomalous mechanism for CHRNA7 regulation in one cell line. These studies suggest a role for AP-2 alpha regulation of CHRNA7 mRNA expression in multiple tissues during development.	[Finlay-Schultz, Jessica; Canastar, Andrew; El Gazzar, Mohamed; Leonard, Sherry] Univ Colorado Denver, Dept Psychiat, Aurora, CO 80045 USA; [Finlay-Schultz, Jessica] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Leonard, Sherry] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Coughlan, Christina] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Short, Margaret; Leonard, Sherry] Denver Vet Affairs Med Ctr, Denver, CO 80220 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Leonard, S (corresponding author), Univ Colorado Denver, Dept Psychiat, Mail Stop 8344,POB 6511,Anschutz Med Campus, Aurora, CO 80045 USA.	Sherry.Leonard@ucdenver.edu		Finlay-Schultz, Jessica/0000-0002-7855-9870	National Institutes of Health [DA009457, MH081177]; Veterans Affairs Medical Research Service Merit Review; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Medical Research Service Merit Review; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA009457 and MH081177 and a Veterans Affairs Medical Research Service Merit Review (to S. L.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Baskin F, 1997, NEUROSCIENCE, V76, P821; Bazinet RP, 2005, PSYCHOPHARMACOLOGY, V182, P180, DOI 10.1007/s00213-005-0059-7; BIEDLER JL, 1978, CANCER RES, V38, P3751; BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; Carrasco-Serrano C, 1998, J BIOL CHEM, V273, P20021, DOI 10.1074/jbc.273.32.20021; Carrasco-Serrano C, 2000, J NEUROCHEM, V74, P932, DOI 10.1046/j.1471-4159.2000.0740932.x; Cheng C, 2002, INT J BIOCHEM CELL B, V34, P78, DOI 10.1016/S1357-2725(01)00098-X; Citrome L, 2009, J CLIN PSYCHIAT, V70, P932, DOI 10.4088/JCP.09ac05289; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Court J, 1999, J NEUROCHEM, V73, P1590, DOI 10.1046/j.1471-4159.1999.0731590.x; Criado M, 1997, J NEUROSCI, V17, P6554; DAVIES AF, 1995, HUM MOL GENET, V4, P121; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Fornasari D, 1997, MOL PHARMACOL, V51, P250, DOI 10.1124/mol.51.2.250; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Fu XW, 2009, AM J RESP CELL MOL, V41, P93, DOI 10.1165/rcmb.2008-0352OC; Garcia MA, 2000, J MOL BIOL, V301, P807, DOI 10.1006/jmbi.2000.4019; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; GERZANICH V, 1994, MOL PHARMACOL, V45, P212; GETMAN DK, 1995, J BIOL CHEM, V270, P23511, DOI 10.1074/jbc.270.40.23511; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HERMANN R, 1991, FEBS LETT, V281, P191, DOI 10.1016/0014-5793(91)80391-F; Houy E, 2004, MOL PSYCHIATR, V9, P320, DOI 10.1038/sj.mp.4001443; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.0.CO;2-W; Kawanishi Y, 2000, J HUM GENET, V45, P24, DOI 10.1007/s100380050005; Kumari V, 2005, NEUROSCI BIOBEHAV R, V29, P1021, DOI 10.1016/j.neubiorev.2005.02.006; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Leonard S, 2001, Nicotine Tob Res, V3, P203; Leonard S, 2001, PHARMACOL BIOCHEM BE, V70, P561, DOI 10.1016/S0091-3057(01)00677-3; Leonard Sherry, 2007, J Dual Diagn, V3, P43, DOI 10.1300/J374v03n03_05; Liu CM, 2001, AM J MED GENET, V105, P658, DOI 10.1002/ajmg.1547; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; Marutle A, 2001, J CHEM NEUROANAT, V22, P115, DOI 10.1016/S0891-0618(01)00117-X; Mexal S, 2010, J MOL NEUROSCI, V40, P185, DOI 10.1007/s12031-009-9233-4; Mitchell DL, 2010, EXP CELL RES, V316, P194, DOI 10.1016/j.yexcr.2009.08.008; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Mohibullah N, 1999, NUCLEIC ACIDS RES, V27, P2760, DOI 10.1093/nar/27.13.2760; MOSER M, 1995, DEVELOPMENT, V121, P2779; Nagavarapu U, 2001, J BIOL CHEM, V276, P16749, DOI 10.1074/jbc.M009712200; Olavesen MG, 1997, GENOMICS, V46, P303, DOI 10.1006/geno.1997.5032; OuladAbdelghani M, 1996, EXP CELL RES, V225, P338, DOI 10.1006/excr.1996.0184; Pfisterer P, 2002, J BIOL CHEM, V277, P6637, DOI 10.1074/jbc.M108578200; Rao Jagadeesh S, 2009, Curr Mol Pharmacol, V2, P207; Rao JS, 2005, NEUROPSYCHOPHARMACOL, V30, P2006, DOI 10.1038/sj.npp.1300740; Reynolds PR, 2005, J BIOL CHEM, V280, P32548, DOI 10.1074/jbc.M502231200; Schulte JH, 2008, CANCER LETT, V271, P56, DOI 10.1016/j.canlet.2008.05.039; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Sharma G, 2008, CURR MED CHEM, V15, P2921, DOI 10.2174/092986708786848703; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Stober G, 2000, AM J HUM GENET, V67, P1201, DOI 10.1086/321183; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Sun XJ, 2009, CANCER RES, V69, P6445, DOI 10.1158/0008-5472.CAN-09-1001; Terzano S, 2000, J BIOL CHEM, V275, P41495, DOI 10.1074/jbc.M006197200; Tregellas JR, 2011, BIOL PSYCHIAT, V69, P7, DOI 10.1016/j.biopsych.2010.07.004; Tsuang DW, 2001, AM J MED GENET, V105, P662, DOI 10.1002/ajmg.1550.abs; Wankhade S, 2000, J BIOL CHEM, V275, P29701, DOI 10.1074/jbc.M000931200; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xu JZ, 2001, AM J MED GENET, V105, P669, DOI 10.1002/ajmg.1549; YANG XD, 1995, J BIOL CHEM, V270, P8514, DOI 10.1074/jbc.270.15.8514; Zhao F, 2001, J BIOL CHEM, V276, P40755, DOI 10.1074/jbc.M106284200; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-0051OC; Zink M, 2010, CURR OPIN PSYCHIATR, V23, P103, DOI 10.1097/YCO.0b013e3283366427	75	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42123	42132		10.1074/jbc.M111.276014	http://dx.doi.org/10.1074/jbc.M111.276014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21979958	hybrid, Green Published			2022-12-27	WOS:000298180900023
J	Tajima, H; Imada, K; Sakuma, M; Hattori, F; Nara, T; Kamo, N; Homma, M; Kawagishi, I				Tajima, Hirotaka; Imada, Katsumi; Sakuma, Mayuko; Hattori, Fumiyuki; Nara, Toshifumi; Kamo, Naoki; Homma, Michio; Kawagishi, Ikuro			Ligand Specificity Determined by Differentially Arranged Common Ligand-binding Residues in Bacterial Amino Acid Chemoreceptors Tsr and Tar	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI TSR; ASPARTATE RECEPTOR; SULFHYDRYL MODIFICATION; 3-DIMENSIONAL STRUCTURE; SIGNAL-TRANSDUCTION; SERINE RECEPTOR; CHEMOTAXIS; DOMAIN; SITE; MUTANTS	Escherichia coli has closely related amino acid chemoreceptors with distinct ligand specificity, Tar for L-aspartate and Tsr for L-serine. Crystallography of the ligand-binding domain of Tar identified the residues interacting with aspartate, most of which are conserved in Tsr. However, swapping of the nonconserved residues between Tsr and Tar did not change ligand specificity. Analyses with chimeric receptors led us to hypothesize that distinct three-dimensional arrangements of the conserved ligand-binding residues are responsible for ligand specificity. To test this hypothesis, the structures of the apo- and serine-binding forms of the ligand-binding domain of Tsr were determined at 1.95 and 2.5 angstrom resolutions, respectively. Some of the Tsr residues are arranged differently from the corresponding aspartate-binding residues of Tar to form a high affinity serine-binding pocket. The ligand-binding pocket of Tsr was surrounded by negatively charged residues, which presumably exclude negatively charged aspartate molecules. We propose that all these Tsr- and Tar-specific features contribute to specific recognition of serine and aspartate with the arrangement of the side chain of residue 68 (Asn in Tsr and Ser in Tar) being the most critical.	[Imada, Katsumi] Osaka Univ, Dept Macromol Sci, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Tajima, Hirotaka; Sakuma, Mayuko; Hattori, Fumiyuki; Homma, Michio] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tajima, Hirotaka; Kawagishi, Ikuro] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 1848584, Japan; [Tajima, Hirotaka; Kawagishi, Ikuro] Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo 1848584, Japan; [Imada, Katsumi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Nara, Toshifumi; Kamo, Naoki] Matsuyama Univ, Coll Pharmaceut Sci, Matsuyama, Ehime 7908578, Japan	Osaka University; Nagoya University; Hosei University; Hosei University; Osaka University	Imada, K (corresponding author), Osaka Univ, Dept Macromol Sci, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan.	kimada@chem.sci.osaka-u.ac.jp; ikurok@hosei.ac.jp		Imada, Katsumi/0000-0003-1342-8885	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research and the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. I. and I. K.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; BOWIE JU, 1995, ACTA CRYSTALLOGR D, V51, P145, DOI 10.1107/S0907444994010498; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chi YI, 1997, FEBS LETT, V414, P327, DOI 10.1016/S0014-5793(97)01027-2; CLARKE S, 1979, J BIOL CHEM, V254, P9695; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; GARDINA P, 1992, J BACTERIOL, V174, P1528, DOI 10.1128/jb.174.5.1528-1536.1992; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; GOMI S, 1993, J BIOCHEM-TOKYO, V113, P208, DOI 10.1093/oxfordjournals.jbchem.a124027; GOMI S, 1994, OLFACTION TASTE, V9, P210; HEDBLOM ML, 1983, J BACTERIOL, V155, P1463, DOI 10.1128/JB.155.3.1463-1466.1983; HEDBLOM ML, 1980, J BACTERIOL, V144, P1048, DOI 10.1128/JB.144.3.1048-1060.1980; IWAMA T, 1995, J BACTERIOL, V177, P2218, DOI 10.1128/jb.177.8.2218-2221.1995; Iwama T, 1997, J BIOL CHEM, V272, P13810, DOI 10.1074/jbc.272.21.13810; JEFFERY CJ, 1993, PROTEIN SCI, V2, P559; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEE L, 1990, J BACTERIOL, V172, P377, DOI 10.1128/JB.172.1.377-382.1990; LEE L, 1988, J BACTERIOL, V170, P4769, DOI 10.1128/jb.170.10.4769-4774.1988; LEE L, 1990, THESIS NAGOYA U JAPA; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; LYNCH BA, 1992, FEBS LETT, V307, P3, DOI 10.1016/0014-5793(92)80891-J; MACAB RM, 1987, ESCHERICHIA COLI SAL, P732; MELTON T, 1978, J BACTERIOL, V133, P708, DOI 10.1128/JB.133.2.708-716.1978; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; MILLIGAN DL, 1988, J BIOL CHEM, V263, P6268; MILLIGAN DL, 1993, J BIOL CHEM, V268, P19991; MOWBRAY SL, 1990, J BIOL CHEM, V265, P15638; SCOTT WG, 1993, J MOL BIOL, V232, P555, DOI 10.1006/jmbi.1993.1411; STOCK JB, 1996, ESCHERICHIA COLI SAL, V2, P1103; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; TATSUNO I, 1994, MOL MICROBIOL, V14, P755, DOI 10.1111/j.1365-2958.1994.tb01312.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; WOLFE AJ, 1987, J BACTERIOL, V169, P1878, DOI 10.1128/jb.169.5.1878-1885.1987; WOLFF C, 1988, J BACTERIOL, V170, P4509, DOI 10.1128/jb.170.10.4509-4515.1988; YEH JI, 1993, J BIOL CHEM, V268, P9787; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507	41	43	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42200	42210		10.1074/jbc.M111.221887	http://dx.doi.org/10.1074/jbc.M111.221887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21979954	hybrid, Green Published			2022-12-27	WOS:000298180900030
J	Diana, D; Basile, A; De Rosa, L; Di Stasi, R; Auriemma, S; Arra, C; Pedone, C; Turco, MC; Fattorusso, R; D'Andrea, LD				Diana, Donatella; Basile, Anna; De Rosa, Lucia; Di Stasi, Rossella; Auriemma, Sara; Arra, Claudio; Pedone, Carlo; Turco, Maria Caterina; Fattorusso, Roberto; D'Andrea, Luca Domenico			beta-Hairpin Peptide That Targets Vascular Endothelial Growth Factor (VEGF) Receptors DESIGN, NMR CHARACTERIZATION, AND BIOLOGICAL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; STRUCTURAL DETERMINANTS; CRYSTAL-STRUCTURE; IN-VIVO; ANGIOGENESIS; STABILITY; FLT-1; DOMAIN; MODEL; STABILIZATION	VEGF receptors have been the target of intense research aimed to develop molecules able to inhibit or stimulate angiogenesis. Based on the x-ray structure of the complex placental growth factor-VEGF receptor 1,2, we designed a VEGF receptor-binding peptide reproducing the placental growth factor beta-hairpin region Gln(87)-Val(100) that is involved in receptor recognition. A conformational analysis showed that the designed peptide adopts the expected fold in pure water. Moreover, a combination of NMR interaction analysis and cell binding studies were used to demonstrate that the peptide targets VEGF receptors. The VEGF receptor 1(D2)-interacting residues were characterized at the molecular level, and they correspond to the residues recognizing the placental growth factor sequence Gln(87)-Val(100). Finally, the peptide biological activity was characterized in vitro and in vivo, and it showed a VEGF-like behavior. Indeed, the peptide activated VEGF-dependent intracellular pathways, induced endothelial cell proliferation and rescue from apoptosis, and promoted angiogenesis in vivo. This compound is one of the few peptides known with proangiogenic activity, which makes it a candidate for the development of a novel peptide-based drug for medical applications in therapeutic angiogenesis.	[D'Andrea, Luca Domenico] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Basile, Anna; Turco, Maria Caterina] Univ Salerno, Dipartimento Sci Farmaceut & Biomed, I-84084 Salerno, Italy; [Auriemma, Sara; Pedone, Carlo] Univ Naples Federico II, Dipartimento Sci Biol, I-80134 Naples, Italy; [Arra, Claudio] Ist Nazl Tumori Fdn G Pascale, I-80131 Naples, Italy; [Fattorusso, Roberto] Univ Naples 2, Dipartimento Sci Ambientali, I-81100 Caserta, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Salerno; University of Naples Federico II; IRCCS Fondazione Pascale; Universita della Campania Vanvitelli	D'Andrea, LD (corresponding author), CNR, Ist Biostrutture & Bioimmagini, Via Mezzocannone 16, I-80134 Naples, Italy.	ldandrea@unina.it	TURCO, Maria Caterina/AAC-5282-2022	TURCO, Maria Caterina/0000-0002-7835-359X; Basile, Anna/0000-0002-4523-8202; Fattorusso, Roberto/0000-0002-3539-5343; Arra, Claudio/0000-0003-3162-2091; D'ANDREA, LUCA DOMENICO/0000-0002-2589-216X	Diagnostica e Farmaceutica Molecolari scarl; Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN2008-200875WHMR, FIRB2008-RBRN07BMCT]; Programma Operativo Nazionale (PON) Ricerca e Competitivita [PON01_02388]	Diagnostica e Farmaceutica Molecolari scarl; Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Programma Operativo Nazionale (PON) Ricerca e Competitivita	This work was supported by Diagnostica e Farmaceutica Molecolari scarl and the Ministero dell'Istruzione, dell'Universita e della Ricerca (Grant PRIN2008-200875WHMR, Grant FIRB2008-RBRN07BMCT, Programma Operativo Nazionale (PON) Ricerca e Competitivita 2007-2013, and Grant PON01_02388).	Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Blanco F, 1998, CURR OPIN STRUC BIOL, V8, P107, DOI 10.1016/S0959-440X(98)80017-1; BLANCO FJ, 1994, BIOCHEMISTRY-US, V33, P6004, DOI 10.1021/bi00185a041; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; D'Andrea LD, 2005, P NATL ACAD SCI USA, V102, P14215, DOI 10.1073/pnas.0505047102; D'Andrea LD, 2009, CURR PHARM DESIGN, V15, P2414, DOI 10.2174/138161209788682235; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; Di Stasi R, 2010, BIOPOLYMERS, V94, P800, DOI 10.1002/bip.21448; Diana D, 2008, CHEM-EUR J, V14, P4164, DOI 10.1002/chem.200800180; Diana D, 2010, CHEM-EUR J, V16, P5400, DOI 10.1002/chem.200903428; Dudar GK, 2008, AM J PHYSIOL-GASTR L, V295, pG374, DOI 10.1152/ajpgi.90325.2008; Eidenschink L, 2009, PROTEINS, V75, P308, DOI 10.1002/prot.22240; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Gautier B, 2010, J MED CHEM, V53, P4428, DOI 10.1021/jm1002167; Goddard T. D., 2001, SPARKY VERSION 3; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Garcia-Aranda MI, 2011, BIOORGAN MED CHEM, V19, P1978, DOI 10.1016/j.bmc.2011.01.056; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; Maynard AJ, 1998, J AM CHEM SOC, V120, P1996, DOI 10.1021/ja9726769; Mirassou Y, 2009, CHEMBIOCHEM, V10, P902, DOI 10.1002/cbic.200800834; MORRIS KF, 1992, J AM CHEM SOC, V114, P3139, DOI 10.1021/ja00034a071; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PARK JE, 1994, J BIOL CHEM, V269, P25646; Pastor MT, 2005, CHEMBIOCHEM, V6, P1753, DOI 10.1002/cbic.200500178; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Russell SJ, 2003, J AM CHEM SOC, V125, P388, DOI 10.1021/ja028075l; Santiveri CM, 2010, BIOPOLYMERS, V94, P779, DOI 10.1002/bip.21436; Santulli G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-41; Soro S, 2008, BLOOD, V111, P3479, DOI 10.1182/blood-2007-03-077537; Starovasnik MA, 1999, J MOL BIOL, V293, P531, DOI 10.1006/jmbi.1999.3134; Vicari D, 2011, J BIOL CHEM, V286, P13612, DOI 10.1074/jbc.M110.216812; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107; Yao SG, 2000, J BIOMOL NMR, V16, P109, DOI 10.1023/A:1008382624724; Yilmaz A, 2003, BIOCHEM BIOPH RES CO, V306, P730, DOI 10.1016/S0006-291X(03)01064-7; Ziche M, 1997, LAB INVEST, V76, P517; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	52	32	33	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41680	41691		10.1074/jbc.M111.257402	http://dx.doi.org/10.1074/jbc.M111.257402			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21969375	Green Published, hybrid			2022-12-27	WOS:000298057500052
J	Inanobe, A; Nakagawa, A; Kurachi, Y				Inanobe, Atsushi; Nakagawa, Atsushi; Kurachi, Yoshihisa			Interactions of Cations with the Cytoplasmic Pores of Inward Rectifier K+ Channels in the Closed State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; ACTIVATION GATE; CONFORMATIONAL-CHANGES; STRUCTURAL BASIS; RECTIFICATION; MECHANISM; RESIDUES; KIR2.1; PIP2	Ion channels gate at membrane-embedded domains by changing their conformation along the ion conduction pathway. Inward rectifier K+ (Kir) channels possess a unique extramembrane cytoplasmic domain that extends this pathway. However, the relevance and contribution of this domain to ion permeation remain unclear. By qualitative x-ray crystallographic analysis, we found that the pore in the cytoplasmic domain of Kir3.2 binds cations in a valency-dependent manner and does not allow the displacement of Mg2+ by monovalent cations or spermine Electrophysiological analyses revealed that the cytoplasmic pore of Kir3.2 selectively binds positively charged molecules and has a higher affinity for Mg2+ when it has a low probability of being open. The selective blocking of chemical modification of the side chain of pore-facing residues by Mg2+ indicates that the mode of binding of Mg2+ is likely to be similar to that observed in the crystal structure. These results indicate that the Kir3.2 crystal structure has a closed conformation with a negative electrostatic field potential at the cytoplasmic pore, the potential of which may be controlled by conformational changes in the cytoplasmic domain to regulate ion diffusion along the pore.	[Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Dept Pharmacol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Inanobe, Atsushi; Kurachi, Yoshihisa] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan; [Nakagawa, Atsushi] Osaka Univ, Lab Supramol Crystallog, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Inanobe, A (corresponding author), Osaka Univ, Dept Pharmacol, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	inanobe@pharma2.med.osaka-u.ac.jp; ykurachi@pharma2.med.osaka-u.ac.jp	Nakagawa, Atsushi/D-4329-2009; Nakagawa, Atsushi/M-5731-2019	Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861	Ministry of Education, Culture, Sports, Science and Technology of Japan [22136002];  [23590301]; Grants-in-Aid for Scientific Research [22136002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by Grant-in-Aid for Scientific Research (C) 23590301.; Supported by Grant-in-Aid for Scientific Research on Innovative Areas 22136002 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bruening-Wright A, 2002, J NEUROSCI, V22, P6499; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Contreras JE, 2008, P NATL ACAD SCI USA, V105, P3310, DOI 10.1073/pnas.0709809105; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Guo Y, 2002, J BIOL CHEM, V277, P48289, DOI 10.1074/jbc.M207987200; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; Hansen SG, 2011, NATURE; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A., 1999, J PHYSL, V521, P19; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Inanobe A, 2011, BIOCHEM BIOPH RES CO, V407, P366, DOI 10.1016/j.bbrc.2011.03.025; Inanobe A, 2010, J BIOL CHEM, V285, P38517, DOI 10.1074/jbc.M110.161703; ITO H, 1991, J GEN PHYSIOL, V98, P517, DOI 10.1085/jgp.98.3.517; Jaroslawski S, 2007, J MOL BIOL, V374, P500, DOI 10.1016/j.jmb.2007.09.043; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Nemec J, 1999, BIOPHYS J, V76, P246, DOI 10.1016/S0006-3495(99)77193-6; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Xie LH, 2004, J PHYSIOL-LONDON, V561, P159, DOI 10.1113/jphysiol.2004.072330; Xu YP, 2009, NAT STRUCT MOL BIOL, V16, P1252, DOI 10.1038/nsmb.1717; Yamashita T, 1996, J PHYSIOL-LONDON, V493, P143, DOI 10.1113/jphysiol.1996.sp021370; Yan DH, 2005, J PHYSIOL-LONDON, V563, P725, DOI 10.1113/jphysiol.2004.079186; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Zeidner G, 2001, J BIOL CHEM, V276, P35564, DOI 10.1074/jbc.M105189200; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	53	11	11	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41801	41811		10.1074/jbc.M111.278531	http://dx.doi.org/10.1074/jbc.M111.278531			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21982822	Green Published, hybrid			2022-12-27	WOS:000298057500063
J	Lee, M; Kang, Y; Suk, K; Schwab, C; Yu, S; McGeer, PL				Lee, Moonhee; Kang, Yunhee; Suk, Kyoungho; Schwab, Claudia; Yu, Sheng; McGeer, Patrick L.			Acidic Fibroblast Growth Factor (FGF) Potentiates Glial-mediated Neurotoxicity by Activating FGFR2 IIIb Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; CELLS; ASTROCYTES; MECHANISMS; RECEPTORS; NEURONS; FAMILY	Previous studies indicate that astrocytes are the brain cells that express acidic fibroblast growth factor (aFGF) and that the expression is increased upon activation. However, there has been no study investigating the significance of this phenomenon. Here we report that aFGF treatment of IFN gamma-stimulated human astrocytes, and LPS/IFN gamma-stimulated human microglia, enhances their secretion of inflammatory cytokines and other materials toxic to human neuroblastoma SH-SY5Y cells. The mechanism of aFGF enhancement involves stimulation of the receptor FGFR2 IIIb. We show by RT-PCR that this receptor, but not other FGF receptors, is robustly expressed by astrocytes and microglia. We establish by Western blotting, and immunohistochemistry on postmortem human brain tissue that the FGFR2 IIIb protein is expressed by both of these glial cell types. We blocked the inflammatory stimulant action of aFGF by transfecting microglia and astrocytes with a small inhibitory RNA (siRNA) to FGFR2 IIIb as well as by removal of aFGF using an anti-aFGF antibody. Treatment with bFGF in combination with the stimulants was without effect, but together with aFGF, it partially counteracted the action of aFGF, indicating that it may be a weak antagonist of FGFR2 IIIb. The inflammatory effect was also attenuated by treatment with inhibitors of protein kinase C, Src tyrosine kinase, and MEK-1/2 indicating the involvement of these intracellular pathways. Our data suggest that inhibition of expression or release of aFGF could have therapeutic potential by inhibiting inflammation in neurodegenerative diseases such as Alzheimer disease where many neuroinflammatory molecules are prominently expressed.	[Lee, Moonhee; Schwab, Claudia; Yu, Sheng; McGeer, Patrick L.] Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada; [Kang, Yunhee] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Brain Sci & Engn Inst, Dept Pharmacol, Taegu 700422, South Korea	University of British Columbia; University of British Columbia; Kyungpook National University	McGeer, PL (corresponding author), 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	mcgeerpl@interchange.ubc.ca			Pacific Alzheimer Research Foundation	Pacific Alzheimer Research Foundation	This work was supported by the Pacific Alzheimer Research Foundation.	BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; CASPER D, 1994, J NEUROCHEM, V62, P2166; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Galzie Z, 1997, BIOCHEM CELL BIOL, V75, P669, DOI 10.1139/bcb-75-6-669; Hashioka S, 2009, NEUROBIOL AGING, V30, P1924, DOI 10.1016/j.neurobiolaging.2008.02.019; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; Kim HJ, 2006, ACTA OTO-LARYNGOL, V126, P600, DOI 10.1080/00016480500452533; KIMURA H, 1994, TOHOKU J EXP MED, V174, P279, DOI 10.1620/tjem.174.279; Klegeris A, 2000, J LEUKOCYTE BIOL, V67, P127, DOI 10.1002/jlb.67.1.127; Lee M, 2011, GLIA, V59, P152, DOI 10.1002/glia.21087; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; MATTSON MP, 1993, J NEUROSCI, V13, P4575; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Ridyard MS, 2003, J BIOL CHEM, V278, P13803, DOI 10.1074/jbc.M210245200; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; ZHAO XM, 1994, J CLIN INVEST, V94, P992, DOI 10.1172/JCI117466	21	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41230	41245		10.1074/jbc.M111.270470	http://dx.doi.org/10.1074/jbc.M111.270470			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990352	Green Published, hybrid			2022-12-27	WOS:000298057500011
J	Maki, K; Inoue, T; Onaka, A; Hashizunne, H; Sonnete, N; Kobayashi, Y; Murakami, S; Shigaki, C; Takahashi, TS; Masukata, H; Nakagawa, T				Maki, Kentaro; Inoue, Takahiro; Onaka, Atsushi; Hashizunne, Hiroko; Sonnete, Naoko; Kobayashi, Yuko; Murakami, Shigefunni; Shigaki, Chikako; Takahashi, Tatsuro S.; Masukata, Hisao; Nakagawa, Takuro			Abundance of Prereplicative Complexes (Pre-RCs) Facilitates Recombinational Repair under Replication Stress in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; MEIER-GORLIN SYNDROME; DOUBLE-STRAND BREAKS; ORIGIN RECOGNITION COMPLEX; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; S-PHASE; RAD51-MEDIATED RECOMBINATION	Mcm2-7 complexes are loaded onto chromatin with the aid of Cdt1 and Cdc18/Cdc6 and form prereplicative complexes (pre-RCs) at multiple sites on each chromosome. Pre-RCs are essential for DNA replication and surviving replication stress. However, the mechanism by which pre-RCs contribute to surviving replication stress is largely unknown. Here, we isolated the fission yeast mcm6-S1 mutant that was hypersensitive to methyl methanesulfonate (MMS) and camptothecin (CPT), both of which cause forks to collapse. The mcm6-S1 mutation impaired the interaction with Cdt1 and decreased the binding of minichromosome maintenance (MCM) proteins to replication origins. Overexpression of Cdt1 restored MCM binding and suppressed the sensitivity to MMS and CPT, suggesting that the Cdt1-Mcm6 interaction is important for the assembly of pre-RCs and the repair of collapsed forks. MMS-induced Chk1 phosphorylation and Rad22/Rad52 focus formation occurred normally, whereas cells containing Rhp54/Rad54 foci, which are involved in DNA strand exchange and dissociation of the joint molecules, were increased. Remarkably. G, phase extension through deletion of an S phase cyclin, Cig2, as well as Cdt1 overexpression restored pre-RC assembly and suppressed Rhp54 accumulation. A cdc18 mutation also caused hypersensitivity to MMS and CPT and accumulation of Rhp54 foci. These data suggest that an abundance of pre-RCs facilitates a late step in the recombinational repair of collapsed forks in the following S phase.	[Maki, Kentaro; Inoue, Takahiro; Onaka, Atsushi; Hashizunne, Hiroko; Sonnete, Naoko; Kobayashi, Yuko; Murakami, Shigefunni; Shigaki, Chikako; Takahashi, Tatsuro S.; Masukata, Hisao; Nakagawa, Takuro] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Maki, Kentaro; Murakami, Shigefunni; Masukata, Hisao] Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 5600043, Japan	Osaka University; Osaka University	Nakagawa, T (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	takuro4@bio.sci.osaka-u.ac.jp	Takahashi, Tatsuro/F-4669-2016; Takahashi, Tatsuro/AAD-9936-2020; Nakagawa, Takuro/A-1367-2017	Takahashi, Tatsuro/0000-0002-1947-7680; Takahashi, Tatsuro/0000-0002-1947-7680; Nakagawa, Takuro/0000-0003-3455-8224; Onaka, Atsushi/0000-0001-7765-5812	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for scientific research on innovative areas from the Ministry of Education, Culture, Sports, Science and Technology (to T. N.) and a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (to T. N.).	Alfa C, 1993, EXPT FISSION YEAST L; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chen SY, 2011, GENE DEV, V25, P363, DOI 10.1101/gad.2011511; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Coulon S, 2006, MOL BIOL CELL, V17, P2081, DOI 10.1091/mbc.E05-11-1006; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Doksani Y, 2009, CELL, V137, P247, DOI 10.1016/j.cell.2009.02.016; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; Groth P, 2010, J MOL BIOL, V402, P70, DOI 10.1016/j.jmb.2010.07.010; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jallepalli PV, 1998, P NATL ACAD SCI USA, V95, P8159, DOI 10.1073/pnas.95.14.8159; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Kurokawa Y, 2008, PLOS BIOL, V6, P836, DOI 10.1371/journal.pbio.0060088; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Murayama Y, 2008, NATURE, V451, P1018, DOI 10.1038/nature06609; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nitani N, 2008, P NATL ACAD SCI USA, V105, P12973, DOI 10.1073/pnas.0805307105; Nitani N, 2006, GENETICS, V174, P155, DOI 10.1534/genetics.106.060053; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Okuno Y, 1999, MOL CELL BIOL, V19, P6699; Orr SJ, 2010, ONCOGENE, V29, P3803, DOI 10.1038/onc.2010.138; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rhind N, 2000, J CELL SCI, V113, P3889; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; SLATER ML, 1973, J BACTERIOL, V113, P263, DOI 10.1128/JB.113.1.263-270.1973; Takahashi T, 2003, EMBO J, V22, P964, DOI 10.1093/emboj/cdg079; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wei Z, 2010, J BIOL CHEM, V285, P12469, DOI 10.1074/jbc.C109.094599; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; Zafar F., 2011, FUNDAMENTAL ASPECTS, P65; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	78	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41701	41710		10.1074/jbc.M111.285619	http://dx.doi.org/10.1074/jbc.M111.285619			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971174	Green Published, hybrid			2022-12-27	WOS:000298057500054
J	Kapeller, K; Milman, N; Yaffe, N; Shlomai, J				Kapeller, Kit; Milman, Neta; Yaffe, Nurit; Shlomai, Joseph			Interactions of a Replication Initiator with Histone H1-like Proteins Remodel the Condensed Mitochondrial Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNIVERSAL MINICIRCLE SEQUENCE; KINETOPLAST DNA-REPLICATION; ZINC-FINGER PROTEIN; BINDING-PROTEIN; CELL-GROWTH; ORIGIN; CHROMATIN; ORGANIZATION; TOPOISOMERASE; NUCLEOSOMES	Kinetoplast DNA (kDNA), the mitochondrial genome of trypanosomatids, consists of several thousand topologically interlocked DNA circles. Mitochondrial histone H1-like proteins were implicated in the condensation of kDNA into a nucleoid structure in the mitochondrial matrix. However, the mechanism that remodels kDNA, promoting its accessibility to the replication machinery, has not yet been described. Analyses, using yeast two hybrid system, co-immunoprecipitation, and protein-protein cross-linking, revealed specific protein-protein interactions between the kDNA replication initiator protein universal minicircle sequence-binding protein (UMSBP) and two mitochondrial histone H1-like proteins. Fluorescence and electron microscopy, as well as biochemical analyses, demonstrated that these protein-protein interactions result in the decondensation of kDNA. UMSBP-mediated decondensation rendered the kDNA network accessible to topological decatenation by topoisomerase II, yielding free kDNA minicircle monomers. Hence, UMSBP has the potential capacity to function in vivo in the activation of the prereplication release of minicircles from the network, a key step in kDNA replication, which precedes and enables its replication initiation. These observations demonstrate the prereplication remodeling of a condensed mitochondrial DNA, which is mediated via specific interactions of histone-like proteins with a replication initiator, rather than through their posttranslational covalent modifications.	[Kapeller, Kit; Milman, Neta; Yaffe, Nurit; Shlomai, Joseph] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, Kuvin Ctr Study Infect & Trop Dis,Inst Med Res Is, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Shlomai, J (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, Kuvin Ctr Study Infect & Trop Dis,Inst Med Res Is, IL-91120 Jerusalem, Israel.	josephs@ekmd.huji.ac.il			United States-Israel Binational Science Foundation, Jerusalem, Israel [2005023]; Israel Science Foundation [54/06, 1127]	United States-Israel Binational Science Foundation, Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This work was supported by United States-Israel Binational Science Foundation, Jerusalem, Israel Grant 2005023 and by Israel Science Foundation Grants 54/06 and 1127.	ABELIOVICH H, 1993, MOL CELL BIOL, V13, P7766, DOI 10.1128/MCB.13.12.7766; Abu-Elneel K, 1999, J BIOL CHEM, V274, P13419, DOI 10.1074/jbc.274.19.13419; Avliyakulov NK, 2004, EUKARYOT CELL, V3, P518, DOI 10.1128/EC.3.2.518-526.2004; AVRAHAMI D, 1995, P NATL ACAD SCI USA, V92, P10511, DOI 10.1073/pnas.92.23.10511; Bogenhagen DF, 2010, EXP GERONTOL, V45, P473, DOI 10.1016/j.exger.2009.12.002; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brewer LR, 2003, BIOPHYS J, V85, P2519, DOI 10.1016/S0006-3495(03)74674-8; Bullerwell CE, 2005, CURR OPIN MICROBIOL, V8, P362, DOI 10.1016/j.mib.2005.06.009; ENGLUND PT, 1979, J BIOL CHEM, V254, P4895; HAJDUK SL, 1984, CELL, V36, P483, DOI 10.1016/0092-8674(84)90241-1; Hines JC, 2011, EUKARYOT CELL, V10, P445, DOI 10.1128/EC.00308-10; Hines JC, 2010, MOL CELL BIOL, V30, P1319, DOI 10.1128/MCB.01231-09; Hines JC, 1998, MOL BIOCHEM PARASIT, V94, P41, DOI 10.1016/S0166-6851(98)00048-6; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; KAS E, 1989, J MOL BIOL, V210, P587, DOI 10.1016/0022-2836(89)90134-4; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lukes J, 2001, MOL BIOCHEM PARASIT, V117, P179, DOI 10.1016/S0166-6851(01)00348-6; MELENDY T, 1988, CELL, V55, P1083, DOI 10.1016/0092-8674(88)90252-8; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Milman N, 2007, P NATL ACAD SCI USA, V104, P19250, DOI 10.1073/pnas.0706858104; Onn I, 2004, EUKARYOT CELL, V3, P277, DOI 10.1128/EC.3.2.277-287.2004; Onn I, 2006, J BIOL CHEM, V281, P37468, DOI 10.1074/jbc.M606374200; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; RAMSPERGER U, 1995, EMBO J, V14, P3215, DOI 10.1002/j.1460-2075.1995.tb07324.x; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; Sasaki N, 2003, MOL BIOL CELL, V14, P4758, DOI 10.1091/mbc.E03-02-0099; Sasaki T, 2007, CURR OPIN CELL BIOL, V19, P337, DOI 10.1016/j.ceb.2007.04.007; SAUCIER JM, 1981, BIOCHEM BIOPH RES CO, V101, P988, DOI 10.1016/0006-291X(81)91846-5; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sela D, 2008, J BIOL CHEM, V283, P32034, DOI 10.1074/jbc.M804417200; Sela D, 2009, NUCLEIC ACIDS RES, V37, P279, DOI 10.1093/nar/gkn927; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002; Studitsky VM, 2004, TRENDS BIOCHEM SCI, V29, P127, DOI 10.1016/j.tibs.2004.01.003; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Swindle CS, 1998, J VIROL, V72, P1994, DOI 10.1128/JVI.72.3.1994-2001.1998; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; TZFATI Y, 1992, P NATL ACAD SCI USA, V89, P6891, DOI 10.1073/pnas.89.15.6891; TZFATI Y, 1995, J BIOL CHEM, V270, P21339, DOI 10.1074/jbc.270.36.21339; Wang ZF, 2001, EMBO J, V20, P4674, DOI 10.1093/emboj/20.17.4674; Xu CW, 1996, MOL CELL BIOL, V16, P564; XU CX, 1993, P NATL ACAD SCI USA, V90, P1786, DOI 10.1073/pnas.90.5.1786	47	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40566	40574		10.1074/jbc.M111.270322	http://dx.doi.org/10.1074/jbc.M111.270322			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21984849	hybrid, Green Published			2022-12-27	WOS:000297315400016
J	Na, GN; Salt, DE				Na, GunNam; Salt, David E.			Differential Regulation of Serine Acetyltransferase Is Involved in Nickel Hyperaccumulation in Thlaspi goesingense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE BIOSYNTHESIS; ESCHERICHIA-COLI; MOLECULAR-CLONING; SUBCELLULAR-LOCALIZATION; SULFUR ASSIMILATION; KINETIC-PROPERTIES; HIGHER-PLANTS; SYNTHASE; GENE; EXPRESSION	When growing in its native habitat, Thlaspi goesingense can hyperaccumulate 1.2% of its shoot dry weight as nickel We reported previously that both constitutively elevated activity of serine acetyltransferase (SAT) and concentration of glutathione (GSH) are involved in the ability of T. goesingense to tolerate nickel. A feature of SAT is its feedback inhibition by L-cysteine. To understand the role of this regulation of SAT by Cys on GSH-mediated nickel tolerance in T. goesingense, we characterized the enzymatic properties of SATs from T. goesingense. We demonstrate that all three isoforms of SAT in T. goesingense are insensitive to inhibition by Cys. Further, two amino acids (proline and alanine) in the C-terminal region of the cytosolic SAT (SAT-c) from T. goesingense are responsible for converting the enzyme from a Cys-sensitive to a Cys-insensitive form. Furthermore, the Cys-insensitive isoform of SAT-c confers elevated resistance to nickel when expressed in Escherichia colt and Arabidopsis thaliana, supporting a role for altered regulation of SAT by Cys in nickel tolerance in T. goesingense.	[Na, GunNam; Salt, David E.] Purdue Univ, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Salt, DE (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Cruickshank Bldg,St Machar Dr, Aberdeen AB24 3UU, Scotland.	david.salt@abdn.ac.uk			National Science Foundation [IOS-0419695]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS-0419695 (to D. E. S).	BROOKS RR, 1977, J GEOCHEM EXPLOR, V7, P49, DOI 10.1016/0375-6742(77)90074-7; BROOKS SPJ, 1992, BIOTECHNIQUES, V13, P906; Chronis D, 2004, PLANTA, V218, P417, DOI 10.1007/s00425-003-1123-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DENK D, 1987, J GEN MICROBIOL, V133, P515; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Freeman JL, 2005, APPL ENVIRON MICROB, V71, P8627, DOI 10.1128/AEM.71.12.8627-8633.2005; Freeman JL, 2005, PLANT PHYSIOL, V137, P1082, DOI 10.1104/pp.104.055293; Freeman JL, 2004, PLANT CELL, V16, P2176, DOI 10.1105/tpc.104.023036; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Howarth JR, 1997, BBA-GENE STRUCT EXPR, V1350, P123, DOI 10.1016/S0167-4781(96)00213-8; Inoue K, 1999, EUR J BIOCHEM, V266, P220, DOI 10.1046/j.1432-1327.1999.00847.x; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kawashima CG, 2005, PLANT PHYSIOL, V137, P220, DOI 10.1104/pp.104.045377; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Kramer U, 2000, PLANT PHYSIOL, V122, P1343, DOI 10.1104/pp.122.4.1343; Kramer U, 1997, PLANT PHYSIOL, V115, P1641, DOI 10.1104/pp.115.4.1641; Kredich N. M, 1971, BIOL CHEM, V246, P3474; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2009.01928.x, 10.1111/j.1365-3040.2008.01928.x]; Liszewska F, 2001, ACTA BIOCHIM POL, V48, P647; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; Nakamori S, 1998, APPL ENVIRON MICROB, V64, P1607; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Noji M, 2002, AMINO ACIDS, V22, P231, DOI 10.1007/s007260200011; Peer WA, 2003, NEW PHYTOL, V159, P421, DOI 10.1046/j.1469-8137.2003.00822.x; Peer WA, 2006, NEW PHYTOL, V172, P248, DOI 10.1111/j.1469-8137.2006.01820.x; Rausch T, 2007, PLANT BIOLOGY, V9, P565, DOI 10.1055/s-2007-965580; REEVES RD, 1983, J GEOCHEM EXPLOR, V18, P275, DOI 10.1016/0375-6742(83)90073-0; RUFFET ML, 1994, PLANT PHYSIOL, V104, P597, DOI 10.1104/pp.104.2.597; RUFFET ML, 1995, EUR J BIOCHEM, V227, P500, DOI 10.1111/j.1432-1033.1995.tb20416.x; Saby S, 1999, APPL ENVIRON MICROB, V65, P5600; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; SAITO K, 1994, PLANT PHYSIOL, V106, P887, DOI 10.1104/pp.106.3.887; Saito K, 1997, GENE, V189, P57, DOI 10.1016/S0378-1119(96)00833-5; Tsakraklides G, 2002, PLANT J, V32, P879, DOI 10.1046/j.1365-313X.2002.01477.x; Urano Y, 2000, GENE, V257, P269, DOI 10.1016/S0378-1119(00)00399-1; Wirtz M, 2006, J PLANT PHYSIOL, V163, P273, DOI 10.1016/j.jplph.2005.11.013; Wirtz M, 2005, PHOTOSYNTH RES, V86, P345, DOI 10.1007/s11120-005-8810-9; Zubieta C, 2008, J BIOL CHEM, V283, P7561, DOI 10.1074/jbc.M709283200	42	12	12	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40423	40432		10.1074/jbc.M111.247411	http://dx.doi.org/10.1074/jbc.M111.247411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21930704	Green Published, hybrid			2022-12-27	WOS:000297315400002
J	Nakano, TA; Steirer, LM; Moe, GR				Nakano, Taizo A.; Steirer, Lindsay M.; Moe, Gregory R.			The Expression Profile of De-N-acetyl Polysialic Acid (NeuPSA) in Normal and Diseased Human Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MENINGITIDIS GROUP-B; MONOCLONAL-ANTIBODIES; NERVOUS-SYSTEM; BRAIN; STX; PST; POLYSIALYLTRANSFERASES; LOCALIZATION; EPITOPES	Although sialic acids have a key role in many aspects of human biology, the expression of polysialic acid (PSA) in human tissues is thought to be relatively rare. We identified a derivative of PSA called neuraminic acid-containing PSA or NeuPSA that was highly expressed in primary human melanoma tumors and in several cancer cell lines. Moreover, anti-NeuPSA antibodies could induce apoptosis of cancer cells. However, little was known about NeuPSA expression in normal or diseased tissues. In this study we investigated the complete expression profile of NeuPSA in human tissues and a few primary tumors using the anti-NeuPSA monoclonal antibody, SEAM 3. Almost every human tissue tested spanning a representative sample of all organ types was positive for SEAM 3 binding. Specificity of SEAM 3 binding was established by inhibition with NeuPSA but not closely related meningococcal C polysaccharide and loss of SEAM 3 binding when specimens were treated with periodate at high pH, which specifically destroys NeuPSA. Only subsets of cells in each specimen stained positive, and the relative staining between tissues was variable. The distribution and amount of NeuPSA antigen in tissues was correlated with known levels of polysialyltransferase PST or STX expression. The majority of anti-NeuPSA binding occurred intracellularly in the cytoplasm of cells. Tumors generally exhibited considerably increased staining compared with corresponding normal tissues. Identifying the diverse tissue distribution and intracellular location of NeuPSA provides a foundation for investigating the functional role of NeuPSA in human health and disease.	[Nakano, Taizo A.; Steirer, Lindsay M.; Moe, Gregory R.] Childrens Hosp Oakland Res Inst, Ctr Canc, Oakland, CA 94609 USA; [Moe, Gregory R.] Childrens Hosp Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Moe, GR (corresponding author), 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gmoe@chori.org			National Institutes of Health (NIAID) [AI064314]; National Institutes of Health NHLBI [5T32DK078514-09]; Swim Across America; Jennifer Leigh Wells Family; NATIONAL CANCER INSTITUTE [T32CA082086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064314, R56AI064314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK078514] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swim Across America; Jennifer Leigh Wells Family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064314 (NIAID; to G. R. M.).; Supported in part by National Institutes of Health NHLBI T-32 Training Grant 5T32DK078514-09 and funds provided by Swim Across America and the Jennifer Leigh Wells Family.	ANDREWS RG, 1989, J EXP MED, V169, P1721, DOI 10.1084/jem.169.5.1721; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; BAUMHUETER S, 1994, BLOOD, V84, P2554; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; Flitter BA, 2010, VACCINE, V28, P5967, DOI 10.1016/j.vaccine.2010.06.119; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; GIELEN W, 1967, H-S Z PHYSIOL CHEM, V348, P329, DOI 10.1515/bchm2.1967.348.1.329; Granoff DM, 1998, J IMMUNOL, V160, P5028; Iovannisci DM, 2010, J EUKARYOT MICROBIOL, V57, P405, DOI 10.1111/j.1550-7408.2010.00496.x; Kini U, 2005, DIAGN CYTOPATHOL, V33, P145, DOI 10.1002/dc.20271; KITAJIMA K, 1988, J BIOL CHEM, V263, P18269; LACKIE PM, 1994, DIFFERENTIATION, V57, P119, DOI 10.1046/j.1432-0436.1994.5720119.x; MANZI AE, 1994, J BIOL CHEM, V269, P23617; Moe GR, 2006, MOL IMMUNOL, V43, P1424, DOI 10.1016/j.molimm.2005.07.033; Moe GR, 2005, INFECT IMMUN, V73, P2123, DOI 10.1128/IAI.73.4.2123-2128.2005; Moe GR, 2009, J IMMUNOL, V182, P6610, DOI 10.4049/jimmunol.0803677; Nadanaka S, 2001, J BIOL CHEM, V276, P33657, DOI 10.1074/jbc.M011100200; Nakayama J, 1998, PATHOL INT, V48, P665, DOI 10.1111/j.1440-1827.1998.tb03967.x; PAERELS GB, 1965, BIOCHEM J, V96, P787, DOI 10.1042/bj0960787; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SEID R, 2003, Patent No. 6638513; Sonnenburg JL, 2002, J BIOL CHEM, V277, P17502, DOI 10.1074/jbc.M110867200; Steirer L. M., 2011, PLOS ONE IN PRESS; TROY FA, 1979, J BIOL CHEM, V254, P7377; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZUBER C, 1992, J BIOL CHEM, V267, P9965	30	6	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40343	40353		10.1074/jbc.M111.296046	http://dx.doi.org/10.1074/jbc.M111.296046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949236	Green Published, hybrid			2022-12-27	WOS:000296925700065
J	Xu, Z; Prigent, S; Deslys, JP; Rezaei, H				Xu, Zhou; Prigent, Stephanie; Deslys, Jean-Philippe; Rezaei, Human			Dual Conformation of H2H3 Domain of Prion Protein in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE PRION; SACCHAROMYCES-CEREVISIAE; PODOSPORA-ANSERINA; APLYSIA CPEB; YEAST; PROPAGATION; BRAIN; OLIGOMERIZATION; IDENTIFICATION; ORGANIZATION	The concept of prion is applied to protein modules that share the ability to switch between at least two conformational states and transmit one of these through intermolecular interaction and change of conformation. Although much progress has been achieved through the understanding of prions from organisms such as Saccharomyces cerevisiae, Podospora anserina, or Aplysia californica, the criteria that qualify a protein module as a prion are still unclear. In addition, the functionality of known prion domains fails to provide clues to understand the first identified prion, the mammalian infectious prion protein, PrP. To address these issues, we generated mammalian cellular models of expression of the C-terminal two helices of PrP, H2 and H3, which have been hypothesized, among other models, to hold the replication and conversion properties of the infectious PrP. We found that the H2H3 domain is an independent folding unit that undergoes glycosylations and glycosylphosphatidylinositol anchoring similar to full-length PrP. Surprisingly, in some conditions the normally folded H2H3 was able to systematically go through a conversion process and generate insoluble proteinase K-resistant aggregates. This structural switch involves the assembly of amyloid structures that bind thioflavin S and oligomers that are reactive to A11 antibody, which specifically detects protein oligomers from neurological disorders. Overall, we show that H2H3 is a conformational switch in a cellular context and is thus suggested to be a candidate for the conversion domain of PrP.	[Prigent, Stephanie; Rezaei, Human] Inst Natl Rech Agron Virol & Immunol Mol, Equipe Biol Physicochim Prions, F-78350 Jouy En Josas, France; [Xu, Zhou; Deslys, Jean-Philippe] CEA, Inst Emerging Dis & Innovat Therapies, SEPIA, F-92260 Fontenay Aux Roses, France	INRAE; CEA; UDICE-French Research Universities; Universite Paris Saclay	Rezaei, H (corresponding author), Inst Natl Rech Agron Virol & Immunol Mol, Equipe Biol Physicochim Prions, F-78350 Jouy En Josas, France.	human.rezaei@jouy.inra.fr	Xu, Zhou/F-8513-2011	Xu, Zhou/0000-0001-9468-1406				Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Cancellotti E, 2007, BBA-MOL BASIS DIS, V1772, P673, DOI 10.1016/j.bbadis.2006.10.013; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; CHRISTOFINIS GJ, 1968, J PATHOL BACTERIOL, V95, P377, DOI 10.1002/path.1700950204; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Derkatch IL, 1996, GENETICS, V144, P1375; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; HAMMOND DN, 1990, BRAIN RES, V512, P190, DOI 10.1016/0006-8993(90)90626-M; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Kascsak R, 2010, J BIOL CHEM, V285, pLE5, DOI 10.1074/jbc.L109.088831; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kimura Y, 2003, CELL STRUCT FUNCT, V28, P187; Krammer C, 2009, P NATL ACAD SCI USA, V106, P462, DOI 10.1073/pnas.0811571106; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Speare JO, 2010, EMBO J, V29, P782, DOI 10.1038/emboj.2009.392; Su HW, 2007, J BIOL CHEM, V282, P9883, DOI 10.1074/jbc.M606754200; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Xu Z., 2011, FASEB J IN PRESS	42	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40060	40068		10.1074/jbc.M111.275255	http://dx.doi.org/10.1074/jbc.M111.275255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21911495	Green Published, hybrid			2022-12-27	WOS:000296925700038
J	Hassinen, A; Pujol, FM; Kokkonen, N; Pieters, C; Kihlstrom, M; Korhonen, K; Kellokumpu, S				Hassinen, Antti; Pujol, Francois M.; Kokkonen, Nina; Pieters, Caroline; Kihlstrom, Minna; Korhonen, Kati; Kellokumpu, Sakari			Functional Organization of Golgi N- and O-Glycosylation Pathways Involves pH-dependent Complex Formation That Is Impaired in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; FLUORESCENT PROTEIN; LIVING CELLS; GLYCOSYLTRANSFERASES; GLYCANS; LOCALIZATION; GALACTOSYLTRANSFERASE; ACETYLGLUCOSAMINE; IDENTIFICATION; RECOGNITION	Glycosylation is one of the most common modifications of proteins and lipids and also a major source of biological diversity in eukaryotes. It is critical for many basic cellular functions and recognition events that range from protein folding to cell signaling, immunological defense, and the development of multicellular organisms. Glycosylation takes place mainly in the endoplasmic reticulum and Golgi apparatus and involves dozens of functionally distinct glycosidases and glycosyltransferases. How the functions of these enzymes, which act sequentially and often competitively, are coordinated to faithfully synthesize a vast array of different glycan structures is currently unclear. Here, we investigate the supramolecular organization of the Golgi N- and O-glycosylation pathways in live cells using a FRET flow cytometric quantification approach. We show that the enzymes form enzymatically active homo- and/or heteromeric complexes within each pathway. However, no complexes composed of enzymes that operate in different pathways, were detected, which suggests that the pathways are physically distinct. In addition, we show that complex formation is mediated almost exclusively by the catalytic domains of the interacting enzymes. Our data also suggest that the heteromeric complexes are functionally more important than enzyme homomers. Heteromeric complex formation was found to be dependent on Golgi acidity, markedly impaired in acidification-defective cancer cells, and required for the efficient synthesis of cell surface glycans. Collectively, the results emphasize that the Golgi glycosylation pathways are functionally organized into complexes that are important for glycan synthesis.	[Kellokumpu, Sakari] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; Univ Oulu, Finnish Glycosci Grad Sch, FIN-90014 Oulu, Finland	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Kellokumpu, S (corresponding author), Univ Oulu, Dept Biochem, Rm MN212-1,POB 3000, FIN-90014 Oulu, Finland.	sakari.kellokumpu@oulu.fi		Kihlstrom, Minna/0000-0002-3180-4875; Kokkonen, Nina/0000-0003-0913-4892; Hassinen, Antti/0000-0001-9491-2868	Academy of Finland; Finnish Glycoscience Graduate School	Academy of Finland(Academy of Finland); Finnish Glycoscience Graduate School	This work was supported by The Academy of Finland (to S. K.) and the Finnish Glycoscience Graduate School (to A. H.).	Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; BERGER EG, 1978, EUR J BIOCHEM, V90, P213, DOI 10.1111/j.1432-1033.1978.tb12593.x; BERGER EG, 1981, J HISTOCHEM CYTOCHEM, V29, P364, DOI 10.1177/29.3.6787115; Bieberich E, 2002, BIOCHEMISTRY-US, V41, P11479, DOI 10.1021/bi0259958; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Campbell BJ, 2001, GLYCOBIOLOGY, V11, P385, DOI 10.1093/glycob/11.5.385; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Fahrenkrug J, 2009, BIOCHEMISTRY-US, V48, P5142, DOI 10.1021/bi900249n; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GERBER AC, 1979, EUR J BIOCHEM, V93, P453, DOI 10.1111/j.1432-1033.1979.tb12843.x; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Holappa K, 2001, J HISTOCHEM CYTOCHEM, V49, P259, DOI 10.1177/002215540104900213; Huang HH, 2010, J CELL BIOL, V190, P893, DOI 10.1083/jcb.201004102; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; KELLOKUMPU S, 1988, SCIENCE, V242, P1308, DOI 10.1126/science.2461589; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Legaigneur P, 2001, J BIOL CHEM, V276, P21608, DOI 10.1074/jbc.M100860200; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Rivinoja A, 2009, J CELL PHYSIOL, V220, P144, DOI 10.1002/jcp.21744; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Thyrock A, 2010, BIOCHEM BIOPH RES CO, V396, P679, DOI 10.1016/j.bbrc.2010.04.161; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Varki A., 2008, ESSENTIALS GLYCOBIOL; YAMASHITA K, 1987, CANCER RES, V47, P3451; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]	42	88	90	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38329	38340		10.1074/jbc.M111.277681	http://dx.doi.org/10.1074/jbc.M111.277681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911486	hybrid, Green Published			2022-12-27	WOS:000296594200046
J	Mitsui, K; Koshimura, Y; Yoshikawa, Y; Matsushita, M; Kanazawa, H				Mitsui, Keiji; Koshimura, Yuri; Yoshikawa, Yuriko; Matsushita, Masafumi; Kanazawa, Hiroshi			The Endosomal Na+/H+ Exchanger Contributes to Multivesicular Body Formation by Regulating the Recruitment of ESCRT-0 Vps27p to the Endosomal Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; FYVE DOMAIN; H+-ATPASE; YEAST; PH; COMPARTMENT; MACHINERY; MUTANTS; BIOGENESIS	Multivesicular bodies (MVBs) are late endosomal compartments containing luminal vesicles (MVB vesicles) that are formed by inward budding of the endosomal membrane. In budding yeast, MVBs are an important cellular mechanism for the transport of membrane proteins to the vacuolar lumen. This process requires a class E subset of vacuolar protein sorting (VPS) genes. VPS44 (allelic to NHX1) encodes an endosome-localized Na+/H+ exchanger. The function of the VPS44 exchanger in the context of vacuolar protein transport is largely unknown. Using a cell-free MVB formation assay system, we demonstrated that Nhx1p is required for the efficient formation of MVB vesicles in the late endosome. The recruitment of Vps27p, a class E Vps protein, to the endosomal membrane was dependent on Nhx1p activity and was enhanced by an acidic pH at the endosomal surface. Taken together, we propose that Nhx1p contributes to MVB formation by the recruitment of Vps27p to the endosomal membrane, possibly through Nhx1p antiporter activity.	[Mitsui, Keiji; Koshimura, Yuri; Yoshikawa, Yuriko; Matsushita, Masafumi; Kanazawa, Hiroshi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	Osaka University	Mitsui, K (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Machikaneyama Cho 1-1, Toyonaka, Osaka 5600043, Japan.	mitsui8@bio.sci.osaka-u.ac.jp; kanazawa@bio.sci.osaka-u.ac.jp			Japanese Ministry of Education, Science, Sports, Technology, and Culture	Japanese Ministry of Education, Science, Sports, Technology, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid from the Japanese Ministry of Education, Science, Sports, Technology, and Culture.	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; BIANCHINI L, 1994, J EXP BIOL, V196, P337; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brachmann CB, 1998, YEAST, V14, P115; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fukura N, 2010, J MEMBRANE BIOL, V234, P149, DOI 10.1007/s00232-010-9242-9; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; KANAZAWA H, 1979, P NATL ACAD SCI USA, V76, P1126, DOI 10.1073/pnas.76.3.1126; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mitsui K, 2010, BIOCHEM J, V432, P343, DOI 10.1042/BJ20100796; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nelson N, 2000, J EXP BIOL, V203, P89; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Ohgaki R, 2011, BIOCHEMISTRY-US, V50, P443, DOI 10.1021/bi101082e; Ohgaki R, 2010, MOL BIOL CELL, V21, P1293, DOI 10.1091/mbc.E09-09-0767; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; TSE CM, 1993, J BIOL CHEM, V268, P11917; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	51	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37625	37638		10.1074/jbc.M111.260612	http://dx.doi.org/10.1074/jbc.M111.260612			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896492	hybrid, Green Published			2022-12-27	WOS:000296542400060
J	Kresge, N; Hill, RL				Kresge, Nicole; Hill, Robert L.			Regulation of Cholesterol Metabolism: The Work of Robert D. Simoni (Reprinted)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Reprint														Kresge, Nicole/0000-0003-1551-6627				COMB DG, 1960, J BIOL CHEM, V235, P2529; KUNDIG W, 1971, J BIOL CHEM, V246, P1393; OLENDER EH, 1992, J BIOL CHEM, V267, P4223	3	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					E9	E10		10.1074/jbc.O111.000249	http://dx.doi.org/10.1074/jbc.O111.000249			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21961162	Green Published, hybrid			2022-12-27	WOS:000293837000001
J	Cong, L; Pakala, SB; Ohshiro, K; Li, DQ; Kumar, R				Cong, Lin; Pakala, Suresh B.; Ohshiro, Kazufumi; Li, Da-Qiang; Kumar, Rakesh			SUMOylation and SUMO-interacting Motif (SIM) of Metastasis Tumor Antigen 1 (MTA1) Synergistically Regulate Its Transcriptional Repressor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; TRANSACTIVATION FUNCTIONS; E3 LIGASE; PROTEIN; CANCER; PROLIFERATION; RECOGNITION; ASSOCIATION; CONJUGATION; STABILITY	Metastasis tumor antigen 1 (MTA1), a component of the Mi-2 center dot nucleosome remodeling and deacetylase complex, plays a crucial role in gene transcription, but the mechanism involved remains largely unknown. Here, we report that MTA1 is a substrate for small ubiquitin-related modifier 2/3 (SUMO2/3) in vivo. Protein inhibitor of activated STAT (PIAS) proteins enhance SUMOylation of MTA1 and may participate in para-log-selective SUMOylation, whereas sentrin/SUMO-specific protease 1 (SENP1) and 2 may act as deSUMOylation enzymes for MTA1. Moreover, MTA1 contains a functional SUMO-interacting motif (SIM) at its C terminus, and SIM is required for the efficient SUMOylation of MTA1. SUMO conjugation on Lys-509, which is located within the SUMO consensus site, together with SIM synergistically regulates the co-repressor activity of MTA1 on PS2 transcription, probably by recruiting HDAC2 onto the PS2 promoter. Interestingly, MTA1 may upregulate the expression of SUMO2 via interaction with RNA polymerase II and SP1 at the SUMO2 promoter. These findings not only provide novel mechanistic insights into the regulation of the transcriptional repressor function of MTA1 by SUMOylation and SIM but also uncover a potential function of MTA1 in modulating the SUMOylation pathway.	[Cong, Lin; Pakala, Suresh B.; Ohshiro, Kazufumi; Li, Da-Qiang; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Kumar, Rakesh] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India	George Washington University; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Kumar, R (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803; Pakala, Suresh Babu/0000-0002-5679-4837	National Institutes of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 (to R. K.).	Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Buache E, 2011, ONCOGENE, V30, P3261, DOI 10.1038/onc.2011.41; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Han Y, 2010, J BIOL CHEM, V285, P12906, DOI 10.1074/jbc.M109.071431; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mishra SK, 2003, J BIOL CHEM, V278, P19209, DOI 10.1074/jbc.M301968200; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Ohshiro K, 2010, EMBO REP, V11, P691, DOI 10.1038/embor.2010.99; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saether T, 2011, ONCOGENE, V30, P212, DOI 10.1038/onc.2010.397; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Talukder AH, 2003, J BIOL CHEM, V278, P11676, DOI 10.1074/jbc.M209570200; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.3.CO;2-H; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	37	25	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43793	43808		10.1074/jbc.M111.267237	http://dx.doi.org/10.1074/jbc.M111.267237			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21965678	Green Published, hybrid			2022-12-27	WOS:000298402300022
J	David, Y; Ternette, N; Edelmann, MJ; Ziv, T; Gayer, B; Sertchook, R; Dadon, Y; Kessler, BM; Navon, A				David, Yael; Ternette, Nicola; Edelmann, Mariola J.; Ziv, Tamar; Gayer, Batya; Sertchook, Rotem; Dadon, Yakir; Kessler, Benedikt M.; Navon, Ami			E3 Ligases Determine Ubiquitination Site and Conjugate Type by Enforcing Specificity on E2 Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN CHAIN; NUCLEAR EXPORT; RING DOMAIN; STRUCTURAL BASIS; PROTEIN LIGASE; MEDIATED DEGRADATION; P53-BINDING PROTEIN; P53 STABILITY; TARGET P53; C-TERMINUS	Ubiquitin-conjugating enzymes (E2s) have a dominant role in determining which of the seven lysine residues of ubiquitin is used for polyubiquitination. Here we show that tethering of a substrate to an E2 enzyme in the absence of an E3 ubiquitin ligase is sufficient to promote its ubiquitination, whereas the type of the ubiquitin conjugates and the identity of the target lysine on the substrate are promiscuous. In contrast, when an E3 enzyme is introduced, a clear decision between mono-and polyubiquitination is made, and the conjugation type as well as the identity of the target lysine residue on the substrate becomes highly specific. These features of the E3 can be further regulated by auxiliary factors as exemplified by MDMX (Murine Double Minute X). In fact, we show that this interactor reconfigures MDM2-dependent ubiquitination of p53. Based on several model systems, we propose that although interaction with an E2 is sufficient to promote substrate ubiquitination the E3 molds the reaction into a specific, physiologically relevant protein modification.	[David, Yael; Gayer, Batya; Dadon, Yakir; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Ternette, Nicola; Edelmann, Mariola J.; Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Sertchook, Rotem] Weizmann Inst Sci, Fac Biochem, IL-76100 Rehovot, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Smoler Prote Ctr, IL-31096 Haifa, Israel	Weizmann Institute of Science; University of Oxford; Weizmann Institute of Science; Technion Israel Institute of Technology	Navon, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	ami.navon@weizmann.ac.il	Kessler, Benedikt/AAY-8614-2021	Kessler, Benedikt/0000-0002-8160-2446; Ziv, Tamar/0000-0003-4299-7454; Ternette, Nicola/0000-0002-9283-0743; Edelmann, Mariola/0000-0003-0459-7716	Israel Science Foundation (ISF); Minerva Foundation (Germany); German-Israeli Foundation for Scientific Research and Development (GIF); MRC [G0501068] Funding Source: UKRI; Medical Research Council [G0501068] Funding Source: researchfish	Israel Science Foundation (ISF)(Israel Science Foundation); Minerva Foundation (Germany); German-Israeli Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Israel Science Foundation (ISF), the Minerva Foundation (Germany), the German-Israeli Foundation for Scientific Research and Development (GIF), and a special donation from Rolando Uziel.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; BUSCH H, 1981, MOL CELL BIOCHEM, V40, P173; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Chan WM, 2006, MOL CANCER RES, V4, P15, DOI 10.1158/1541-7786.MCR-05-0097; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; HAAS A, 1990, J BIOL CHEM, V265, P21664; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERSHKO A, 1981, J BIOL CHEM, V256, P1525; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; KINTER M, 2000, PROTEIN SEQUENCING I, P147, DOI DOI 10.1002/0471721980; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Lewis MJ, 2006, J BIOMOL NMR, V34, P89, DOI 10.1007/s10858-005-5583-6; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009	63	47	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44104	44115		10.1074/jbc.M111.234559	http://dx.doi.org/10.1074/jbc.M111.234559			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21965653	hybrid, Green Published			2022-12-27	WOS:000298402300051
J	Boncela, J; Przygodzka, P; Papiewska-Pajak, I; Wyroba, E; Cierniewski, CS				Boncela, Joanna; Przygodzka, Patrycja; Papiewska-Pajak, Izabela; Wyroba, Elzbieta; Cierniewski, Czeslaw S.			Association of Plasminogen Activator Inhibitor Type 2 (PAI-2) with Proteasome within Endothelial Cells Activated with Inflammatory Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ALPHA-INDUCED APOPTOSIS; PCR-RFLP DETECTION; CROSS-LINKING; SERPIN; PROTECTION; DISEASE; TISSUE; POLYMORPHISM; IL-1-BETA	Quiescent endothelial cells contain low concentrations of plasminogen activator inhibitor type 2 (PAI-2). However, its synthesis can be rapidly stimulated by a variety of inflammatory mediators. In this study, we provide evidence that PAI-2 interacts with proteasome and affects its activity in endothelial cells. To ensure that the PAI-2.proteasome complex is formed in vivo, both proteins were coimmunoprecipitated from endothelial cells and identified with specific antibodies. The specificity of this interaction was evidenced after (a) transfection of HeLa cells with pCMV-PAI-2 and coimmunoprecipitation of both proteins with anti-PAI-2 antibodies and (b) silencing of the PAI-2 gene using specific small interfering RNA (siRNA). Subsequently, cellular distribution of the PAI-2.proteasome complexes was established by immunogold staining and electron microscopy analyses. As judged by confocal microscopy, both proteins appeared in a diffuse cytosolic pattern, but they also could be found in a dense perinuclear and nuclear location. PAI-2 was not polyubiquitinated, suggesting that it bound to proteasome not as the substrate but rather as its inhibitor. Consistently, increased PAI-2 expression (a) abrogated degradation of degron analyzed after cotransfection of HeLa cells with pCMV-PAI-2 and pd2EGFP-N1, (b) prevented degradation of p53, as evidenced both by confocal microscopy and Western immunoblotting, and (c) inhibited proteasome cleavage of specific fluorogenic substrate. This suggests that PAI-2, in endothelial cells induced with inflammatory stimuli, can inhibit proteasome and thus tilt the balance favoring proapoptotic signaling.	[Papiewska-Pajak, Izabela; Cierniewski, Czeslaw S.] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Boncela, Joanna; Przygodzka, Patrycja; Cierniewski, Czeslaw S.] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Wyroba, Elzbieta] Polish Acad Sci, Nencki Inst Expt Biol, PL-02093 Warsaw, Poland	Medical University Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	czeslaw.cierniewski@umed.lodz.pl	Wyroba, Elzbieta/R-7525-2016; Boncela, Joanna/AAU-4481-2020; Wyroba, Elzbieta/P-4434-2019	Boncela, Joanna/0000-0001-8419-7012; Papiewska-Pajak, Izabela/0000-0001-6116-3418; Przygodzka, Patrycja/0000-0001-7529-8815	Polish Ministry of Science and Higher Education [N 301 3386 33, N301 4392 38]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Polish Ministry of Science and Higher Education Projects N 301 3386 33 (to J. B.) and N301 4392 38 (to C. S. C.).	Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; Arcangeletti C, 1997, J STRUCT BIOL, V119, P35, DOI 10.1006/jsbi.1997.3871; BELIN D, 1989, EMBO J, V8, P3287, DOI 10.1002/j.1460-2075.1989.tb08489.x; Boncela J, 2011, J BIOL CHEM, V286, P6820, DOI 10.1074/jbc.M110.173781; Buyru N, 2003, CLIN APPL THROMB-HEM, V9, P333, DOI 10.1177/107602960300900409; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dickinson JL, 1998, CELL DEATH DIFFER, V5, P163, DOI 10.1038/sj.cdd.4400324; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Duval Helene, 2003, Angiogenesis, V6, P171, DOI 10.1023/B:AGEN.0000021390.09275.bc; Fan J, 2004, ACTA BIOCH BIOPH SIN, V36, P42, DOI 10.1093/abbs/36.1.42; Fish RJ, 2006, EXP CELL RES, V312, P350, DOI 10.1016/j.yexcr.2005.11.003; Foy CA, 1997, THROMB HAEMOSTASIS, V77, P955; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; GENTON C, 1987, J CELL BIOL, V104, P705, DOI 10.1083/jcb.104.3.705; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Heda GD, 2008, J AM PODIAT MED ASSN, V98, P345, DOI 10.7547/0980345; Jensen PH, 1996, J BIOL CHEM, V271, P26892, DOI 10.1074/jbc.271.43.26892; JENSEN PH, 1994, J BIOL CHEM, V269, P15394; Kardesler L, 2008, CLIN BIOCHEM, V41, P863, DOI 10.1016/j.clinbiochem.2008.04.013; Kasyapa CS, 2006, BLOOD, V107, P3693, DOI 10.1182/blood-2005-04-1505; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; Lijnen HR, 2007, J THROMB HAEMOST, V5, P2259, DOI 10.1111/j.1538-7836.2007.02735.x; Lobov S, 2004, J MOL BIOL, V344, P1359, DOI 10.1016/j.jmb.2004.10.010; Lobov S, 2008, THROMB HAEMOSTASIS, V100, P319, DOI 10.1160/TH08-02-0119; Macaluso M, 2006, CELL DEATH DIFFER, V13, P1515, DOI 10.1038/sj.cdd.4401835; Manders P, 2004, CANCER RES, V64, P659, DOI 10.1158/0008-5472.CAN-03-1820; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; Ohkuchi A, 2001, AM J REPROD IMMUNOL, V46, P252, DOI 10.1034/j.1600-0897.2001.d01-10.x; Palafox-Sanchez CA, 2009, CLIN APPL THROMB-HEM, V15, P233, DOI 10.1177/1076029607308868; Ritchie H, 2000, EXP CELL RES, V260, P20, DOI 10.1006/excr.2000.4957; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Vazquez-Del Mercado M, 2007, SCAND J RHEUMATOL, V36, P206, DOI 10.1080/03009740601089648; Wojcik C, 2002, J CELL MOL MED, V6, P25, DOI 10.1111/j.1582-4934.2002.tb00309.x; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Yu H, 2002, BLOOD, V99, P2810, DOI 10.1182/blood.V99.8.2810; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhang YQ, 2003, ACTA BIOCH BIOPH SIN, V35, P661	39	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43164	43171		10.1074/jbc.M111.245647	http://dx.doi.org/10.1074/jbc.M111.245647			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21976669	hybrid, Green Published			2022-12-27	WOS:000298351300037
J	Haudenschild, DR; Hong, E; Yik, JHN; Chromy, B; Morgelin, M; Snow, KD; Acharya, C; Takada, Y; Di Cesare, PE				Haudenschild, Dominik R.; Hong, Eunmee; Yik, Jasper H. N.; Chromy, Brett; Morgelin, Matthias; Snow, Kaylene D.; Acharya, Chitrangada; Takada, Yoshikazu; Di Cesare, Paul E.			Enhanced Activity of Transforming Growth Factor beta 1 (TGF-beta 1) Bound to Cartilage Oligomeric Matrix Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; EXTRACELLULAR-MATRIX; COILED-COIL; COLLAGEN-IX; COMP; CELLS; DOMAIN; ALPHA-V-BETA-3; THROMBOSPONDIN-1; DIFFERENTIATION	Cartilage oligomeric matrix protein (COMP) is an important non-collagenous cartilage protein that is essential for the structural integrity of the cartilage extracellular matrix. The repeated modular structure of COMP allows it to "bridge" and assemble multiple cartilage extracellular matrix components such as collagens, matrilins, and proteoglycans. With its modular structure, COMP also has the potential to act as a scaffold for growth factors, thereby affecting how and when the growth factors are presented to cell-surface receptors. However, it is not known whether COMP binds growth factors. We studied the binding interaction between COMP and TGF-beta 1 in vitro and determined the effect of COMP on TGF-beta 1-induced signal transduction in reporter cell lines and primary cells. Our results demonstrate that mature COMP protein binds to multiple TGF-beta 1 molecules and that the peak binding occurs at slightly acidic pH. These interactions were confirmed by dual polarization interferometry and visualized by rotary shadow electron microscopy. There is cation-independent binding of TGF-beta 1 to the C-terminal domain of COMP. In the presence of manganese, an additional TGF-beta-binding site is present in the TSP3 repeats of COMP. Finally, we show that COMP-bound TGF-beta 1 causes increased TGF-beta 1-dependent transcription. We conclude that TGF-beta 1 binds to COMP and that TGF-beta 1 bound to COMP has enhanced bioactivity.	[Haudenschild, Dominik R.; Hong, Eunmee; Yik, Jasper H. N.; Snow, Kaylene D.; Acharya, Chitrangada; Di Cesare, Paul E.] Univ Calif Davis Med Ctr, Lawrence J Ellison Musculoskeletal Res Ctr, Dept Orthopaed Surg, Sacramento, CA 95817 USA; [Takada, Yoshikazu] Univ Calif Davis Med Ctr, Dept Dermatol, Sacramento, CA 95817 USA; [Chromy, Brett] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, S-22100 Lund, Sweden	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Lund University	Haudenschild, DR (corresponding author), Univ Calif Davis Med Ctr, 4635 2nd Ave,Suite 2000, Sacramento, CA 95618 USA.	dominik.haudenschild@ucdmc.ucdavis.edu	Haudenschild, Dominik/B-2381-2008	Haudenschild, Dominik/0000-0001-9947-9864; takada, yoshikazu/0000-0001-5481-9589	Swedish Research Council [7480]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by departmental startup funds (to D. R. H.) and Swedish Research Council Project 7480 (to M. M.).	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Bengtson SH, 2009, J INNATE IMMUN, V1, P18, DOI 10.1159/000145543; Blumbach K, 2008, MATRIX BIOL, V27, P306, DOI 10.1016/j.matbio.2007.11.007; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; DERYNCK R, 2007, COLD SPRING HARBOR M, V50; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; DiCesare PE, 1996, J ORTHOPAED RES, V14, P946, DOI 10.1002/jor.1100140615; DICESARE PE, 1994, EUR J BIOCHEM, V223, P927, DOI 10.1111/j.1432-1033.1994.tb19070.x; Efimov VP, 1996, PROTEINS, V24, P259, DOI 10.1002/(SICI)1097-0134(199602)24:2<259::AID-PROT13>3.0.CO;2-M; FRANZEN A, 1987, DIFFERENTIATION, V36, P199, DOI 10.1111/j.1432-0436.1987.tb00194.x; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; JOYCE ME, 1990, J CELL BIOL, V110, P2195, DOI 10.1083/jcb.110.6.2195; KAWAMURA M, 1988, DEV BIOL, V130, P435, DOI 10.1016/0012-1606(88)90339-9; Koelling S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1922; Li H, 2011, OSTEOARTHR CARTILAGE, V19, P1246, DOI 10.1016/j.joca.2011.07.011; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Motaung SCKM, 2011, J TISSUE ENG REGEN M, V5, pE87, DOI 10.1002/term.358; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; OHSHIMA H, 1992, SPINE, V17, P1079, DOI 10.1097/00007632-199209000-00012; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Ozbek S, 2002, EMBO J, V21, P5960, DOI 10.1093/emboj/cdf628; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Posey KL, 2008, AM J PATHOL, V172, P1664, DOI 10.2353/ajpath.2008.071094; Recklies AD, 1998, ARTHRITIS RHEUM, V41, P997, DOI 10.1002/1529-0131(199806)41:6<997::AID-ART6>3.0.CO;2-G; Rock MJ, 2010, MOL CELL BIOCHEM, V338, P215, DOI 10.1007/s11010-009-0355-3; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saini S, 2004, TISSUE ENG, V10, P825, DOI 10.1089/1076327041348545; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SIMKIN PA, 1992, J RHEUMATOL, V19, P1017; SOKOLOFF L, 1978, JOINTS SYNOVIAL FLUI, P274; Tan KM, 2009, FASEB J, V23, P2490, DOI 10.1096/fj.08-128090; Wang L, 2010, CIRC RES, V106, P514, DOI 10.1161/CIRCRESAHA.109.202762; Zaia J, 1997, J BIOL CHEM, V272, P14120, DOI 10.1074/jbc.272.22.14120; Zaucke F, 2001, BIOCHEM J, V358, P17, DOI 10.1042/0264-6021:3580017	45	48	52	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43250	43258		10.1074/jbc.M111.234716	http://dx.doi.org/10.1074/jbc.M111.234716			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21940632	hybrid, Green Published			2022-12-27	WOS:000298351300045
J	Mayberry, LK; Allen, ML; Nitka, KR; Campbell, L; Murphy, PA; Browning, KS				Mayberry, Laura K.; Allen, M. Leah; Nitka, Kelley R.; Campbell, Lara; Murphy, Patricia A.; Browning, Karen S.			Plant Cap-binding Complexes Eukaryotic Initiation Factors eIF4F and eIFISO4F MOLECULAR SPECIFICITY OF SUBUNIT BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS INITIATION; TRANSLATION INITIATION; WHEAT-GERM; ARABIDOPSIS-THALIANA; ISOZYME FORM; ELONGATION-FACTORS; MESSENGER-RNA; FACTOR 4B; PURIFICATION; EXPRESSION	The initiation of translation in eukaryotes requires a suite of eIFs that include the cap-binding complex, eIF4F. eIF4F is comprised of the subunits eIF4G and eIF4E and often the helicase, eIF4A. The eIF4G subunit serves as an assembly point for other initiation factors, whereas eIF4E binds to the 7-methyl guanosine cap of mRNA. Plants have an isozyme form of eIF4F (eIFiso4F) with comparable subunits, eIFiso4E and eIFiso4G. Plant eIF4A is very loosely associated with the plant cap-binding complexes. The specificity of interaction of the individual subunits of the two complexes was previously unknown. To address this issue, mixed complexes (eIF4E-eIFiso4G or eIFiso4E-eIF4G) were expressed and purified from Escherichia coli for biochemical analysis. The activity of the mixed complexes in in vitro translation assays correlated with the large subunit of the respective correct complex. These results suggest that the eIF4G or eIFiso4G subunits influence translational efficiency more than the cap-binding subunits. The translation assays also showed varying responses of the mRNA templates to eIF4F or eIFiso4F, suggesting that some level of mRNA discrimination is possible. The dissociation constants for the correct complexes have K-D values in the subnanomolar range, whereas the mixed complexes were found to have K-D values in the similar to 10 nM range. Displacement assays showed that the correct binding partner readily displaces the incorrect binding partner in a manner consistent with the difference in K-D values. These results show molecular specificity for the formation of plant eIF4F and eIFiso4F complexes and suggest a role in mRNA discrimination during initiation of translation.	[Browning, Karen S.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Browning, KS (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn A5300, Austin, TX 78712 USA.	kbrowning@mail.utexas.edu			National Science Foundation [MCB1052530, MCB0745146]; Direct For Biological Sciences [1052530] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB1052530 and MCB0745146 (to K. S. B.).	ALLEN ML, 1992, J BIOL CHEM, V267, P23232; Bellsolell L, 2006, STRUCTURE, V14, P913, DOI 10.1016/j.str.2006.03.012; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; BROWNING KS, 1990, J BIOL CHEM, V265, P17967; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Clarkson BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009114; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Freire MA, 2000, PLANT MOL BIOL, V44, P129, DOI 10.1023/A:1006494628892; Freire MA, 2005, GENE, V345, P271, DOI 10.1016/j.gene.2004.11.030; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAUER SJ, 1985, BIOCHEMISTRY-US, V24, P2928, DOI 10.1021/bi00333a017; LAX S, 1985, P NATL ACAD SCI USA, V82, P330, DOI 10.1073/pnas.82.2.330; LAX SR, 1986, METHOD ENZYMOL, V118, P109; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Lellis AD, 2010, PLANT MOL BIOL, V74, P249, DOI 10.1007/s11103-010-9670-z; Livingstone M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/021001; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; Mayberry LK, 2009, PLANT PHYSIOL, V150, P1844, DOI 10.1104/pp.109.138438; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Metz AM, 1999, BIOCHEM BIOPH RES CO, V266, P314, DOI 10.1006/bbrc.1999.1814; METZ AM, 1992, NUCLEIC ACIDS RES, V20, P4096, DOI 10.1093/nar/20.15.4096; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Park EH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-68; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serino Giovanna, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4683; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; VANHEERDEN A, 1994, J BIOL CHEM, V269, P17454	40	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42566	42574		10.1074/jbc.M111.280099	http://dx.doi.org/10.1074/jbc.M111.280099			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965660	Green Published, hybrid			2022-12-27	WOS:000298180900064
J	Epis, MR; Barker, A; Giles, KM; Beveridge, DJ; Leedman, PJ				Epis, Michael R.; Barker, Andrew; Giles, Keith M.; Beveridge, Dianne J.; Leedman, Peter J.			The RNA-binding Protein HuR Opposes the Repression of ERBB-2 Gene Expression by MicroRNA miR-331-3p in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELAV-LIKE PROTEIN; MESSENGER-RNA; CYCLOOXYGENASE-2 EXPRESSION; POLY(C)-BINDING PROTEIN; 3'-UNTRANSLATED REGION; COX-2 EXPRESSION; OVEREXPRESSION; PROLIFERATION; CARCINOMA; TRASTUZUMAB	ERBB-2 overexpression is associated with the development and progression of cancer and mediates its resistance to therapy. It has been suggested that post-transcriptional mechanisms control the overexpression of ERBB-2 in prostate cancer (PCa). We recently demonstrated that the 3'-untranslated region (3'-UTR) of ERBB-2 mRNA contains two specific target sites for binding of the microRNA miR-331-3p and that miR-331-3p represses ERBB-2 expression and signaling in PCa cells. Here we investigate a U-rich element situated in close proximity to the distal miR-331-3p target site in the ERBB-2 3'-UTR. Specific binding of HuR to this U-rich element promotes ERBB-2 expression in PCa cells. We show that HuR antagonizes the repressive action of miR-331-3p on its distal ERBB-2 3'-UTR target site. These results support a model in which the interplay between RNA-binding proteins and microRNAs controls the post-transcriptional regulation of gene expression and suggest that both HuR and miR-3:31-3p participate in the overexpression of ERBB-2 observed in some PCas.	[Epis, Michael R.; Barker, Andrew; Giles, Keith M.; Beveridge, Dianne J.; Leedman, Peter J.] Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia; [Epis, Michael R.; Barker, Andrew; Giles, Keith M.; Beveridge, Dianne J.; Leedman, Peter J.] Univ Western Australia, Med Res Ctr, Royal Perth Hosp, Perth, WA 6000, Australia; [Leedman, Peter J.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6008, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Leedman, PJ (corresponding author), Western Australian Inst Med Res, Lab Canc Med, Level 6,MRF Bldg,Rear 50 Murray St, Perth, WA 6000, Australia.	peterl@waimr.uwa.edu.au	Leedman, Peter J/O-4044-2014; Jackson, Benjamin L/C-4297-2012; Barker, Andrew/A-4289-2013		National Health and Medical Research Council of Australia; Prostate Cancer Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Prostate Cancer Foundation of Australia	This work was supported by the National Health and Medical Research Council of Australia and the Prostate Cancer Foundation of Australia.	Abdelmohsen K, 2010, CELL CYCLE, V9, P1354, DOI 10.4161/cc.9.7.11164; Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Australian Institute of Heakh and Welfare, 2010, CANC AUSTR OV CANC S, V60; Barbisan F, 2009, EUR UROL, V56, P105, DOI 10.1016/j.eururo.2008.04.043; Barnabas N, 2011, PROSTATE, V71, P857, DOI 10.1002/pros.21302; Barreau C, 2006, BIOCHIMIE, V88, P515, DOI 10.1016/j.biochi.2005.10.011; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bubendorf L, 1999, CANCER RES, V59, P803; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cho NP, 2007, J ORAL PATHOL MED, V36, P297, DOI 10.1111/j.1600-0714.2007.00526.x; Cho NH, 2006, CANCER LETT, V232, P170, DOI 10.1016/j.canlet.2005.02.026; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; De Silanes IL, 2004, GENE EXPRESSION, V12, P49, DOI 10.3727/000000004783992215; Denkert C, 2004, CANCER RES, V64, P189, DOI 10.1158/0008-5472.CAN-03-1987; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Epis MR, 2009, J BIOL CHEM, V284, P24696, DOI 10.1074/jbc.M109.030098; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gandellini P, 2010, DISCOV MED, V9, P212; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hostetter C, 2008, CANCER BIOL THER, V7, P1498, DOI 10.4161/cbt.7.9.6490; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kang MJ, 2008, GASTROENTEROLOGY, V135, P2030, DOI 10.1053/j.gastro.2008.08.009; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; Legrier ME, 2007, BRIT J CANCER, V96, P269, DOI 10.1038/sj.bjc.6603553; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mehta A, 2006, GENE DEV, V20, P939, DOI 10.1101/gad.1388706; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Niesporek S, 2008, INT J ONCOL, V32, P341; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Scott GK, 2008, MOL CANCER RES, V6, P1250, DOI 10.1158/1541-7786.MCR-07-2110; Neto AS, 2010, J UROLOGY, V184, P842, DOI 10.1016/j.juro.2010.04.077; Shaw G, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-3; Small EJ, 2001, SEMIN ONCOL, V28, P71, DOI 10.1053/sonc.2001.26908; Sridhar SS, 2010, AM J CLIN ONCOL-CANC, V33, P609, DOI 10.1097/COC.0b013e3181beac33; Stavridi F, 2010, CANCER TREAT REV, V36, P122, DOI 10.1016/j.ctrv.2009.06.001; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Thomson AM, 1999, BIOTECHNIQUES, V27, P1032, DOI 10.2144/99275rr03; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Xu F, 2010, J CELL BIOCHEM, V111, P727, DOI 10.1002/jcb.22762; Xu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015519; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Yap TA, 2011, NAT REV CLIN ONCOL, V8, P597, DOI 10.1038/nrclinonc.2011.117; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Ziada A, 2004, PROSTATE, V60, P332, DOI 10.1002/pros.20065	69	78	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41442	41454		10.1074/jbc.M111.301481	http://dx.doi.org/10.1074/jbc.M111.301481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971048	Green Published, hybrid			2022-12-27	WOS:000298057500031
J	Lin, PC; Chan, PM; Hall, C; Manser, E				Lin, Pao-Chun; Chan, Perry M.; Hall, Christine; Manser, Ed			Collapsin Response Mediator Proteins (CRMPs) Are a New Class of Microtubule-associated Protein (MAP) That Selectively Interacts with Assembled Microtubules via a Taxol-sensitive Binding Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GROWTH-CONE COLLAPSE; ALZHEIMERS-DISEASE; GSK3-BETA PHOSPHORYLATION; NEURONAL POLARIZATION; SIGNALING PATHWAYS; NERVOUS-SYSTEM; CELL-MIGRATION; RHO-KINASE; TUBULIN	Collapsin response mediator proteins are ubiquitously expressed from multiple genes (CRMPs 1-5) and play important roles in dividing cells and during semaphorin 3A (Sema3A)signaling. Nonetheless, their mode of action remains opaque. Here we carried out in vivo and in vitro assays that demonstrate that CRMPs are a new class of microtubule-associated protein (MAP). In experiments with CRMP1 or CRMP2 and their derivatives, only the C-terminal region (residues 490-572) mediated microtubule binding. The in vivo microtubule association of CRMPs was abolished by taxol or epothilone B, which is highly unusual. CRMP2-depleted cells exhibited destabilized anaphase astral microtubules and altered spindle position. In a cell-based assay, all CRMPs stabilized interphase microtubules against nocodazole-mediated depolymerization, with CRMP1 being the most potent. Remarkably, a 82-residue C-terminal region of CRMP1 or CRMP2, unrelated to other microtubule binding motifs, is sufficient to stabilize microtubules. In cells, we demonstrate that glycogen synthase kinase-3 beta (GSK3 beta) inhibition potentiates this activity. Thus, CRMPs are a new class of MAP that binds through a unique motif, but in common with others such as Tau, is antagonized by GSK3 beta. This regulation is consistent with such kinases being critical for the Sema3A (collapsin) pathway. These findings have implications for cancer and neurodegeneration.	[Chan, Perry M.; Manser, Ed] Small G Prot Signaling & Kinases sGSK NRP Grp, Singapore 138673, Singapore; [Lin, Pao-Chun; Manser, Ed] Inst Med Biol, Singapore 138648, Singapore; [Hall, Christine] UCL, Inst Neurol, London WC1N 1PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of London; University College London	Manser, E (corresponding author), Small G Prot Signaling & Kinases sGSK NRP Grp, Room 4-16B,61 Biopolis Dr, Singapore 138673, Singapore.	ed.manser@imb.a-star.edu.sg	Hall, Christine/C-8390-2009; Manser, Edward/ABD-2301-2020		GSK-IMCB	GSK-IMCB	This work was partially supported by the GSK-IMCB fund.	Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CROSS D, 1991, BIOCHEMISTRY-US, V30, P4362, DOI 10.1021/bi00231a036; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Erskine L, 2011, NEURON, V70, P951, DOI 10.1016/j.neuron.2011.02.052; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Goold RG, 1999, J CELL SCI, V112, P3373; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nishiyama M, 2011, NAT CELL BIOL, V13, P676, DOI 10.1038/ncb2255; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Pasterkarnp RJ, 2006, PHILOS T R SOC B, V361, P1499, DOI 10.1098/rstb.2006.1892; Piaton G, 2011, BRAIN, V134, P1156, DOI 10.1093/brain/awr022; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; Quach TT, 2008, FASEB J, V22, P401, DOI 10.1096/fj.07-9012com; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Soutar MPM, 2009, CURR ALZHEIMER RES, V6, P269, DOI 10.2174/156720509788486572; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Spriggs MK, 1999, CURR OPIN IMMUNOL, V11, P387, DOI 10.1016/S0952-7915(99)80065-X; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Syed YA, 2011, J NEUROSCI, V31, P3719, DOI 10.1523/JNEUROSCI.4930-10.2011; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Tone SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014345; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Uchida Y, 2009, J BIOL CHEM, V284, P27393, DOI 10.1074/jbc.M109.000240; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650; Wagner U, 1996, J CELL SCI, V109, P1537; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang LH, 1997, J NEUROCHEM, V69, P2261; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Yamada T, 1997, P NATL ACAD SCI USA, V94, P14713, DOI 10.1073/pnas.94.26.14713; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	76	74	79	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41466	41478		10.1074/jbc.M111.283580	http://dx.doi.org/10.1074/jbc.M111.283580			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21953449	Green Published, hybrid			2022-12-27	WOS:000298057500033
J	Chen, JJ; Tsu, CA; Gavin, JM; Milhollen, MA; Bruzzese, FJ; Mallender, WD; Sintchak, MD; Bump, NJ; Yang, XF; Ma, JY; Loke, HK; Xu, Q; Li, P; Bence, NF; Brownell, JE; Dick, LR				Chen, Jesse J.; Tsu, Christopher A.; Gavin, James M.; Milhollen, Michael A.; Bruzzese, Frank J.; Mallender, William D.; Sintchak, Michael D.; Bump, Nancy J.; Yang, Xiaofeng; Ma, Jingya; Loke, Huay-Keng; Xu, Qing; Li, Ping; Bence, Neil F.; Brownell, James E.; Dick, Lawrence R.			Mechanistic Studies of Substrate-assisted Inhibition of Ubiquitin-activating Enzyme by Adenosine Sulfamate Analogues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEDD8-ACTIVATING ENZYME; PROTEIN-ACTIVATION; PROTEASOME SYSTEM; CELL LYMPHOMA; SUMO E1; CANCER; INSIGHTS; NEDD8; CONJUGATION; DISEASES	Ubiquitin-activating enzyme (UAE or E1) activates ubiquitin via an adenylate intermediate and catalyzes its transfer to a ubiquitin-conjugating enzyme (E2). MLN4924 is an adenosine sulfamate analogue that was identified as a selective, mechanism-based inhibitor of NEDD8-activating enzyme (NAE), another E1 enzyme, by forming a NEDD8-MLN4924 adduct that tightly binds at the active site of NAE, a novel mechanism termed substrate-assisted inhibition (Brownell, J. E., Sintchak, M. D., Gavin, J. M., Liao, H., Bruzzese, F. J., Bump, N. J., Soucy, T. A., Milhollen, M. A., Yang, X., Burkhardt, A. L., Ma, J., Loke, H. K, Lingaraj, T., Wu, D., Hamman, K. B., Spelman, J. J., Cullis, C. A., Langston, S. P., Vyskocil, S., Sells, T. B., Mallender, W. D., Visiers, I., Li, P., Claiborne, C. F., Rolfe, M., Bolen, J. B., and Dick, L. R. (2010) Mol. Cell 37, 102-111). In the present study, substrate-assisted inhibition of human UAL (Ube1) by another adenosine sulfamate analogue, 5'-O-sulfamoyl-N-6-[(1S)-2,3-dihydro-1H-inden-1-yl] -adenosine (Compound I), a nonselective E1 inhibitor, was characterized. Compound I inhibited UAE-dependent ATP-PP1 exchange activity, caused loss of UAE thioester, and inhibited E1-E2 transthiolation in a dose-dependent manner. Mechanistic studies on Compound I and its purified ubiquitin adduct demonstrate that the proposed substrate-assisted inhibition via covalent adduct formation is entirely consistent with the three-step ubiquitin activation process and that the adduct is formed via nucleophilic attack of UAL thioester by the sulfamate group of Compound I after completion of step 2. Kinetic and affinity analysis of Compound I, MLN4924, and their purified ubiquitin adducts suggest that both the rate of adduct formation and the affinity between the adduct and E1 contribute to the overall potency. Because all Lis are thought to use a similar mechanism to activate their cognate ubiquitin-like proteins, the substrate-assisted inhibition by adenosine sulfamate analogues represents a promising strategy to develop potent and selective E1 inhibitors that can modulate diverse biological pathways.	[Chen, Jesse J.; Tsu, Christopher A.; Gavin, James M.; Milhollen, Michael A.; Bruzzese, Frank J.; Mallender, William D.; Sintchak, Michael D.; Bump, Nancy J.; Yang, Xiaofeng; Ma, Jingya; Loke, Huay-Keng; Xu, Qing; Li, Ping; Bence, Neil F.; Brownell, James E.; Dick, Lawrence R.] Millennium Pharmaceut Inc, Discovery, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Chen, JJ (corresponding author), 40 Landsdowne St, Cambridge, MA 02139 USA.	jesse.chen@mpi.com	Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405				Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bruzzese FJ, 2009, ANAL BIOCHEM, V394, P24, DOI 10.1016/j.ab.2009.07.011; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; Valero E, 2000, BIOCHEM J, V350, P237, DOI 10.1042/0264-6021:3500237; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456	32	66	70	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40867	40877		10.1074/jbc.M111.279984	http://dx.doi.org/10.1074/jbc.M111.279984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969368	Green Published, hybrid			2022-12-27	WOS:000297315400047
J	Beecher, N; Roseman, AM; Jowitt, TA; Berry, R; Troilo, H; Kammerer, RA; Shuttleworth, CA; Kielty, CM; Baldock, C				Beecher, Nicola; Roseman, Alan M.; Jowitt, Thomas A.; Berry, Richard; Troilo, Helen; Kammerer, Richard A.; Shuttleworth, C. Adrian; Kielty, Cay M.; Baldock, Clair			Collagen VI, Conformation of A-domain Arrays and Microfibril Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; CONGENITAL MUSCULAR-DYSTROPHY; ALPHA-3(VI) CHAIN; TERMINAL REGION; C5 DOMAIN; BINDING; PROTEIN; MACROMOLECULES; VISUALIZATION; ORGANIZATION	Collagen VI is a ubiquitous extracellular matrix protein that assembles into beaded microfibrils that form networks linking cells to the matrix. Collagen VI microfibrils are typically formed from a heterotrimer of the alpha 1, alpha 2, and alpha 3 chains. The alpha 3 chain is distinct as it contains an extended N terminus with up to 10 consecutive von Willebrand factor type A-domains (VWA). Here, we use solution small angle x-ray scattering (SAXS) and single particle analysis EM to determine the nanostructure of nine of these contiguous A-domains. Both techniques reveal a tight C-shape conformation for the A-domains. Furthermore, using biophysical approaches, we demonstrate that the N-terminal region undergoes a conformational change and a proportion forms dimers in the presence of Zn2+. This is the first indication that divalent cations interact with collagen VI A-domains. A three-dimensional reconstruction of tissue-purified collagen VI microfibrils was generated using EM and single particle image analysis. The reconstruction showed the intricate architecture of the collagen VI globular regions, in particular the highly structurally conserved C-terminal region and variations in the appearance of the N-terminal region. The N-terminal domains project out from the globular beaded region like angled radial spokes. These could potentially provide interactive surfaces for other cell matrix molecules.	[Baldock, Clair] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Baldock, C (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England.	clair.baldock@manchester.ac.uk	Roseman, Alan/AAE-6689-2019	Roseman, Alan/0000-0002-4783-2619; Baldock, Clair/0000-0003-3497-1959; Troilo, Helen/0000-0003-0537-1786; Jowitt, Thomas/0000-0002-4045-0933; berry, richard/0000-0001-7043-0469; Kammerer, Richard/0000-0003-4570-5197	Biotechnology and Biological Sciences Research Council [D008662, BBSSC200513125]; Wellcome Trust [WT081406MA]; Biotechnology and Biological Sciences Research Council [BB/D008662/1] Funding Source: researchfish; BBSRC [BB/D008662/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by Biotechnology and Biological Sciences Research Council Grant D008662 (to C. B., C. M. K., and C. A. S.); Supported by Biotechnology and Biological Sciences Research Council Studentship BBSSC200513125 (to C. B.).; We thank Elizabeth Lord for excellent technical assistance. We acknowledge Dr. David Knight, Marge Howard, and Emma Keevill in the Biomolecular analysis facility, Adam Huffman in the Bioinformatics facility and the staff in the EM facility, and in particular, Drs. David Holmes and Tobias Starborg (University of Manchester). We thank Professor Mon Li Chu (Thomas Jefferson University) for collagen VI DNA. We also thank Daresbury SRS for beam-time and Dr. J. G. Grossmann for assistance during data collection. The FEI Polara was supported by Wellcome Trust Grant WT081406MA.	ABEDINIA M, 1990, EXP EYE RES, V51, P419, DOI 10.1016/0014-4835(90)90154-M; Aigner T, 2002, BIOCHEM BIOPH RES CO, V290, P743, DOI 10.1006/bbrc.2001.6227; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Baldock C, 2003, J MOL BIOL, V330, P297, DOI 10.1016/S0022-2836(03)00585-0; Ball SG, 2001, J BIOL CHEM, V276, P7422, DOI 10.1074/jbc.M002816200; Berry R, 2009, P NATL ACAD SCI USA, V106, P8561, DOI 10.1073/pnas.0812178106; CHU ML, 1990, ANN NY ACAD SCI, V580, P55, DOI 10.1111/j.1749-6632.1990.tb17917.x; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; Dickeson SK, 1998, CELL MOL LIFE SCI, V54, P556, DOI 10.1007/s000180050184; Dziadek M, 2002, MATRIX BIOL, V21, P227, DOI 10.1016/S0945-053X(02)00009-4; ENGEL J, 1985, ANN NY ACAD SCI, V460, P25, DOI 10.1111/j.1749-6632.1985.tb51154.x; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; Fitzgerald J, 2001, J BIOL CHEM, V276, P187, DOI 10.1074/jbc.M008173200; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fresquet M, 2007, J BIOL CHEM, V282, P34634, DOI 10.1074/jbc.M705301200; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Grahn BH, 2001, J AM COLL NUTR, V20, P106, DOI 10.1080/07315724.2001.10719022; Hanssen E, 2003, J BIOL CHEM, V278, P24334, DOI 10.1074/jbc.M303455200; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; MAYER U, 1994, EUR J BIOCHEM, V225, P573, DOI 10.1111/j.1432-1033.1994.00573.x; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; STOKES DG, 1991, J BIOL CHEM, V266, P8626; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tooley LD, 2010, J BIOL CHEM, V285, P33567, DOI 10.1074/jbc.M110.152520; TRUEB B, 1986, EMBO J, V5, P2815, DOI 10.1002/j.1460-2075.1986.tb04573.x; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; ZANUSSI S, 1992, J BIOL CHEM, V267, P24082; ZIMMERMANN DR, 1986, FEBS LETT, V197, P55, DOI 10.1016/0014-5793(86)80297-6	43	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40266	40275		10.1074/jbc.M111.265595	http://dx.doi.org/10.1074/jbc.M111.265595			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21908605	Green Published, hybrid			2022-12-27	WOS:000296925700058
J	Lei, JT; Mazumdar, T; Martinez-Moczygemba, M				Lei, Jonathan T.; Mazumdar, Tuhina; Martinez-Moczygemba, Margarita			Three Lysine Residues in the Common beta Chain of the Interleukin-5 Receptor Are Required for Janus Kinase (JAK)-dependent Receptor Ubiquitination, Endocytosis, and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR TRAFFICKING; ERYTHROPOIETIN RECEPTOR; INDUCED INTERNALIZATION; JUXTAMEMBRANE DOMAIN; CYTOKINE RECEPTORS; ALPHA-CHAIN; IL-5; TRANSPORTER; DEGRADATION; REVEALS	Eosinophils are multifunctional leukocytes implicated in the pathogenesis of numerous inflammatory diseases including allergic asthma and hypereosinophilic syndrome. Eosinophil physiology is critically dependent on IL-5 and the IL-5 receptor (IL-5R), composed of a ligand binding alpha chain (IL-5R alpha), and a common beta chain, beta c. Previously, we demonstrated that the beta c cytoplasmic tail is ubiquitinated and degraded by proteasomes following IL-5 stimulation. However, a complete understanding of the role of beta c ubiquitination in IL-5R biology is currently lacking. By using a well established, stably transduced HEK293 cell model system, we show here that in the absence of ubiquitination, beta c subcellular localization, IL-5-induced endocytosis, turnover, and IL-5R signaling were significantly impaired. Whereas ubiquitinated IL-5Rs internalized into trafficking endosomes for their degradation, ubiquitination-deficient IL-5Rs accumulated on the cell surface and displayed blunted signaling even after IL-5 stimulation. Importantly, we identified a cluster of three membrane-proximal beta c lysine residues (Lys(457), Lys(461), and Lys(467)) whose presence was required for both JAK1/2 binding to beta c and receptor ubiquitination. These findings establish that JAK kinase binding to beta c requires the presence of three critical beta c lysine residues, and this binding event is essential for receptor ubiquitination, endocytosis, and signaling.	[Martinez-Moczygemba, Margarita] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, Coll Med, Houston, TX 77030 USA; [Lei, Jonathan T.; Mazumdar, Tuhina; Martinez-Moczygemba, Margarita] Texas A&M Hlth Sci Ctr, Clin Sci & Translat Res Inst, Coll Med, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Martinez-Moczygemba, M (corresponding author), 2121 W Holcombe Blvd,Suite 805, Houston, TX 77030 USA.	mmoczygemba@medicine.tamhsc.edu		Lei, Jonathan/0000-0002-0209-8051	National Institutes of Health from NIAID [AI063178]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063178] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI063178 from the NIAID (to M. M.-M.).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Asquith KL, 2008, J IMMUNOL, V180, P1199, DOI 10.4049/jimmunol.180.2.1199; Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Boyle K, 2009, CELL SIGNAL, V21, P394, DOI 10.1016/j.cellsig.2008.11.002; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; de Pablo Y, 2008, J NEUROCHEM, V104, P124, DOI 10.1111/j.1471-4159.2007.05027.x; dos Santos CMA, 2001, J BIOL CHEM, V276, P10839, DOI 10.1074/jbc.M003635200; Fernandez-Sanchez E, 2009, J BIOL CHEM, V284, P19482, DOI 10.1074/jbc.M109.005165; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Greiser JS, 2002, J BIOL CHEM, V277, P26959, DOI 10.1074/jbc.M204113200; Haan C, 2002, BIOCHEM J, V361, P105, DOI 10.1042/0264-6021:3610105; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; He K, 2005, ENDOCRINOLOGY, V146, P4755, DOI 10.1210/en.2005-0514; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Kouro T, 1996, INT IMMUNOL, V8, P237, DOI 10.1093/intimm/8.2.237; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lei JT, 2008, J LEUKOCYTE BIOL, V84, P499, DOI 10.1189/jlb.1207828; Liu LY, 2002, J IMMUNOL, V169, P6459, DOI 10.4049/jimmunol.169.11.6459; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Martinez-Moczygemba M, 2001, J CLIN INVEST, V108, P1797, DOI 10.1172/JCI200113877; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; Meenhuis A, 2009, BIOCHEM J, V417, P737, DOI 10.1042/BJ20081153; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; Ogata N, 1998, BLOOD, V91, P2264, DOI 10.1182/blood.V91.7.2264.2264_2264_2271; Okuda K, 1999, ANN NY ACAD SCI, V872, P305, DOI 10.1111/j.1749-6632.1999.tb08474.x; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Pelletier S, 2006, MOL CELL BIOL, V26, P8527, DOI 10.1128/MCB.01035-06; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; van Kerkhof P, 2001, J BIOL CHEM, V276, P3778, DOI 10.1074/jbc.M007326200; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Yan H, 1996, MOL CELL BIOL, V16, P2074	61	13	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40091	40103		10.1074/jbc.M111.273482	http://dx.doi.org/10.1074/jbc.M111.273482			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965659	hybrid, Green Published			2022-12-27	WOS:000296925700042
J	Schjoldager, KTBG; Vester-Christensen, MB; Goth, CK; Petersen, TN; Brunak, S; Bennett, EP; Levery, SB; Clausen, H				Schjoldager, Katrine Ter-Borch Gram; Vester-Christensen, Malene B.; Goth, Christoffer K.; Petersen, Thomas Nordahl; Brunak, Soren; Bennett, Eric P.; Levery, Steven B.; Clausen, Henrik			A Systematic Study of Site-specific GalNAc-type O-Glycosylation Modulating Proprotein Convertase Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC PEPTIDE; INHIBIN-ALPHA; GROWTH; FURIN; INTEGRIN; ACTIVATION; EXPRESSION; PREDICTION; SECRETION; CLEAVAGE	Site-specific GalNAc-type O-glycosylation is emerging as an important co-regulator of proprotein convertase (PC) processing of proteins. PC processing is crucial in regulating many fundamental biological pathways and O-glycans in or immediately adjacent to processing sites may affect recognition and function of PCs. Thus, we previously demonstrated that deficiency in site-specific O-glycosylation in a PC site of the fibroblast growth factor, FGF23, resulted in marked reduction in secretion of active unprocessed FGF23, which cause familial tumoral calcinosis and hyperostosis hyperphosphatemia. GalNAc-type O-glycosylation is found on serine and threonine amino acids and up to 20 distinct polypeptide GalNAc transferases catalyze the first addition of GalNAc to proteins making this step the most complex and differentially regulated steps in protein glycosylation. There is no reliable prediction model for O-glycosylation especially of isolated sites, but serine and to a lesser extent threonine residues are frequently found adjacent to PC processing sites. In the present study we used in vitro enzyme assays and ex vivo cell models to systematically address the boundaries of the region within site-specific O-glycosylation affect PC processing. The results demonstrate that O-glycans within at least +/- 3 residues of the RXXR furin cleavage site may affect PC processing suggesting that site-specific O-glycosylation is a major co-regulator of PC processing.	[Schjoldager, Katrine Ter-Borch Gram; Vester-Christensen, Malene B.; Goth, Christoffer K.; Bennett, Eric P.; Levery, Steven B.; Clausen, Henrik] Univ Copenhagen, Ctr Glyc, Dept Cellular & Mol Med, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Schjoldager, Katrine Ter-Borch Gram; Vester-Christensen, Malene B.; Goth, Christoffer K.; Bennett, Eric P.; Levery, Steven B.; Clausen, Henrik] Univ Copenhagen, Sch Dent, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Brunak, Soren] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Petersen, Thomas Nordahl] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal CBS, DK-2800 Lyngby, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Technical University of Denmark	Clausen, H (corresponding author), Univ Copenhagen, Ctr Glyc, Dept Cellular & Mol Med, Fac Hlth Sci, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	hclau@sund.ku.dk	clausen, henrik/AAD-8016-2021; Brunak, Soren/O-6621-2016	Goth, Christoffer/0000-0002-5766-1411; Petersen, Thomas Nordahl/0000-0002-2484-5716; Brunak, Soren/0000-0003-0316-5866; Clausen, Henrik/0000-0002-0915-5055; Bennett, Eric Paul/0000-0002-4976-0647	Kirsten og Freddy Johansen Fonden; A. P. Moller og Hustru Chastine McKinney Mollers Fond til Almene Formaal; Carlsberg Foundation; Novo Nordisk Foundation; Alfred Benzon Foundation; Danish Research Councils; University of Copenhagen	Kirsten og Freddy Johansen Fonden; A. P. Moller og Hustru Chastine McKinney Mollers Fond til Almene Formaal; Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Alfred Benzon Foundation; Danish Research Councils(Det Frie Forskningsrad (DFF)); University of Copenhagen	This work was supported by Kirsten og Freddy Johansen Fonden, A. P. Moller og Hustru Chastine McKinney Mollers Fond til Almene Formaal, the Carlsberg Foundation, Novo Nordisk Foundation, Alfred Benzon Foundation, Danish Research Councils, and a program of excellence from the University of Copenhagen.	Antenos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017348; Antenos M, 2008, J BIOL CHEM, V283, P33059, DOI 10.1074/jbc.M804190200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; BIRCH NP, 1991, FEBS LETT, V290, P191, DOI 10.1016/0014-5793(91)81257-9; Blais V, 2002, FEBS LETT, V524, P43, DOI 10.1016/S0014-5793(02)02998-8; CALVETE JJ, 1993, FEBS LETT, V328, P30, DOI 10.1016/0014-5793(93)80959-X; Clement M, 2004, J CELL SCI, V117, P5059, DOI 10.1242/jcs.01350; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Gordon VM, 1997, INFECT IMMUN, V65, P3370, DOI 10.1128/IAI.65.8.3370-3375.1997; Hassan H, 2000, CARBOHYDRATES CHEM B, P273, DOI DOI 10.1002/9783527618255.CH55; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Herbert E, 1980, Ann N Y Acad Sci, V343, P79, DOI 10.1111/j.1749-6632.1980.tb47244.x; Hsu YR, 1998, PROTEIN EXPRES PURIF, V12, P189, DOI 10.1006/prep.1997.0840; John H, 1999, BIOCHEMISTRY-US, V38, P10217, DOI 10.1021/bi990787+; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Lehmann M, 1996, BIOCHEM J, V317, P803, DOI 10.1042/bj3170803; MAINS RE, 1981, J BIOL CHEM, V256, P5683; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; MEUNIER H, 1988, P NATL ACAD SCI USA, V85, P247, DOI 10.1073/pnas.85.1.247; Meyts ERD, 2007, VIRCHOWS ARCH, V451, P805, DOI 10.1007/s00428-007-0478-4; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; SHAW SK, 1994, J BIOL CHEM, V269, P6016; Shifley ET, 2008, BBA-MOL CELL RES, V1783, P2384, DOI 10.1016/j.bbamcr.2008.07.009; SICILIANO RA, 1994, J BIOL CHEM, V269, P910; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Sun XW, 2011, J BIOL CHEM, V286, P29063, DOI 10.1074/jbc.M111.242479; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	50	72	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40122	40132		10.1074/jbc.M111.287912	http://dx.doi.org/10.1074/jbc.M111.287912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937429	Green Published, hybrid			2022-12-27	WOS:000296925700045
J	Araki, M; Shima, F; Yoshikawa, Y; Muraoka, S; Ijiri, Y; Nagahara, Y; Shirono, T; Kataoka, T; Tamura, A				Araki, Mitsugu; Shima, Fumi; Yoshikawa, Yoko; Muraoka, Shin; Ijiri, Yuichi; Nagahara, Yuka; Shirono, Tomoya; Kataoka, Tohru; Tamura, Atsuo			Solution Structure of the State 1 Conformer of GTP-bound H-Ras Protein and Distinct Dynamic Properties between the State 1 and State 2 Conformers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN ENTROPY; NMR-SPECTROSCOPY; CONFORMATIONAL DYNAMICS; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; BACKBONE DYNAMICS; BINDING PROTEINS; CHEMICAL-SHIFT; GAMMA-S; ACTIVATION	Ras small GTPases undergo dynamic equilibrium of two interconverting conformations, state 1 and state 2, in the GTP-bound forms, where state 2 is recognized by effectors, whereas physiological functions of state 1 have been unknown. Limited information, such as static crystal structures and P-31 NMR spectra, was available for the study of the conformational dynamics. Here we determine the solution structure and dynamics of state 1 by multidimensional heteronuclear NMR analysis of an H-RasT35S mutant in complex with guanosine 5'-(beta, gamma-imido)triphosphate (GppNHp). The state 1 structure shows that the switch I loop fluctuates extensively compared with that in state 2 or H-Ras-GDP. Also, backbone H-1, N-15 signals for state 2 are identified, and their dynamics are studied by utilizing a complex with c-Raf-1. Furthermore, the signals for almost all the residues of H-Ras.GppNHp are identified by measurement at low temperature, and the signals for multiple residues are found split into two peaks corresponding to the signals for state 1 and state 2. Intriguingly, these residues are located not only in the switch regions and their neighbors but also in the rigidly structured regions, suggesting that global structural rearrangements occur during the state interconversion. The backbone dynamics of each state show that the switch loops in state 1 are dynamically mobile on the picosecond to nanosecond time scale, and these mobilities are significantly reduced in state 2. These results suggest that multiconformations existing in state 1 are mostly deselected upon the transition toward state 2 induced by the effector binding.	[Shima, Fumi; Yoshikawa, Yoko; Muraoka, Shin; Ijiri, Yuichi; Shirono, Tomoya; Kataoka, Tohru] Kobe Univ, Grad Sch Med, Div Mol Biol, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Araki, Mitsugu; Nagahara, Yuka; Tamura, Atsuo] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan	Kobe University; Kobe University	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Div Mol Biol, Dept Biochem & Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@people.kobe-u.ac.jp; tamuatsu@kobe-u.ac.jp	Araki, Mitsugu/C-7470-2016	Tamura, Atsuo/0000-0001-8238-8851	Ministry of Education, Science, Sports, and Culture of Japan [17014061, 18057014, A08]; National Institute of Biomedical Innovation [06-3]; Grants-in-Aid for Scientific Research [23390071] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research in Priority Areas 17014061 and 18057014 and Global COE Program A08 from the Ministry of Education, Science, Sports, and Culture of Japan and by Grant for the Program for Promotion of Fundamental Studies of Health Sciences 06-3 from the National Institute of Biomedical Innovation.	Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hu JS, 1997, BIOCHEMISTRY-US, V36, P5045, DOI 10.1021/bi963010e; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Kalbitzer HR, 2009, J AM CHEM SOC, V131, P16714, DOI 10.1021/ja904314q; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Kobayashi C, 2010, BIOPHYS J, V99, P3726, DOI 10.1016/j.bpj.2010.09.063; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Liao JL, 2008, BIOCHEM BIOPH RES CO, V369, P327, DOI 10.1016/j.bbrc.2008.01.169; Loh AP, 2001, BIOCHEMISTRY-US, V40, P4590, DOI 10.1021/bi002418f; Matsumoto K, 2011, J BIOL CHEM, V286, P15403, DOI 10.1074/jbc.M110.204933; O'Connor C, 2008, BIOCHEMISTRY-US, V47, P10244, DOI 10.1021/bi801076c; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Shima F, 2010, J BIOL CHEM, V285, P22696, DOI 10.1074/jbc.M110.125161; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Tamura A, 1997, J MOL BIOL, V273, P1048, DOI 10.1006/jmbi.1997.1368; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	40	72	75	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39644	39653		10.1074/jbc.M111.227074	http://dx.doi.org/10.1074/jbc.M111.227074			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930707	hybrid, Green Published			2022-12-27	WOS:000296759800081
J	Barthson, J; Germano, CM; Moore, F; Maida, A; Drucker, DJ; Marchetti, P; Gysemans, C; Mathieu, C; Nunez, G; Jurisicova, A; Eizirik, DL; Gurzov, EN				Barthson, Jenny; Germano, Carla M.; Moore, Fabrice; Maida, Adriano; Drucker, Daniel J.; Marchetti, Piero; Gysemans, Conny; Mathieu, Chantal; Nunez, Gabriel; Jurisicova, Andrea; Eizirik, Decio L.; Gurzov, Esteban N.			Cytokines Tumor Necrosis Factor-alpha and Interferon-gamma Induce Pancreatic beta-Cell Apoptosis through STAT1-mediated Bim Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SIGNAL TRANSDUCER; FAMILY-MEMBER; ER STRESS; DEATH; BCL-2; ISLETS; PUMA; GENE; BAX	Type 1 diabetes is characterized by local inflammation (insulitis) in the pancreatic islets causing beta-cell loss. The mitochondrial pathway of apoptosis is regulated by the balance and interaction between Bcl-2 members. Here we clarify the molecular mechanism of beta-cell death triggered by the pro-inflammatory cytokines tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma. The combination of TNF-alpha + IFN-gamma induced DP5, p53 up-regulated modulator of apoptosis (PUMA), and Bim expression in human islets and rodent beta-cells. DP5 and PUMA inactivation by RNA interference partially protected against TNF-alpha + IFN-gamma-induced beta-cell apoptosis. DP5 knock-out mice had increased beta-cell area, and isolated islets from these mice were resistant to cytokine exposure. Bim expression was transcriptionally regulated by STAT1, and its activation triggered cleavage of caspases. Silencing of Bim protected rodent and human beta-cells to a large extent against TNF-alpha + IFN-gamma, indicating a major role of this BH3-only activator protein in the mechanism of apoptosis. Our data support a highly regulated and context-dependent modulation of specific Bcl-2 members controlling the mitochondrial pathway of beta-cell apoptosis during insulitis.	[Barthson, Jenny; Germano, Carla M.; Moore, Fabrice; Gurzov, Esteban N.] Univ Libre Bruxelles, Expt Med Lab, B-1070 Brussels, Belgium; [Maida, Adriano; Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Jurisicova, Andrea] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; [Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Metab Unit, I-56126 Pisa, Italy; [Gysemans, Conny; Mathieu, Chantal] Katholieke Univ Leuven, Dept Expt Med Endocrinol, Fac Med, B-3000 Louvain, Belgium; [Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	Universite Libre de Bruxelles; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Pisa; KU Leuven; University of Michigan System; University of Michigan	Eizirik, DL (corresponding author), Univ Libre Bruxelles, Expt Med Lab, Route Lennik,808 CP-618, B-1070 Brussels, Belgium.	deizirik@ulb.ac.be; egurzov@ulb.ac.be	Marchetti, Piero/J-7439-2013; Drucker, Daniel J/A-4092-2010; germano, carla/N-1736-2015; Jurisicova, Andrea/E-4580-2013; GERMANO, CARLA MARIA RAMOS/S-5312-2019; Nuñez, Gabriel/A-7160-2014; mathieu, chantal/ABD-5505-2021	Marchetti, Piero/0000-0003-4907-0635; GERMANO, CARLA MARIA RAMOS/0000-0001-5030-7164; mathieu, chantal/0000-0002-4055-5233; gysemans, conny/0000-0003-3559-6089; Gurzov, Esteban/0000-0003-4642-0273	Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC); Fonds National de la Recherche Scientifique (FNRS) (Belgium); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State [IUAP P6/40]; Juvenile Diabetes Research Foundation International (JDRFI) [17-2009-106]; European Union; European Molecular Biology Organization (EMBO)	Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC); Fonds National de la Recherche Scientifique (FNRS) (Belgium)(Fonds de la Recherche Scientifique - FNRS); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State; Juvenile Diabetes Research Foundation International (JDRFI)(Juvenile Diabetes Research Foundation); European Union(European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported by grants from the Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC), the Fonds National de la Recherche Scientifique (FNRS) (Belgium), the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State (IUAP P6/40), the Juvenile Diabetes Research Foundation International (JDRFI Grant 17-2009-106), and the European Union (Project Naimit, in the Framework Programme 7 of the European Community).; Supported by an European Molecular Biology Organization (EMBO) long-term fellowship. .	Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Callewaert HI, 2007, DIABETES, V56, P2169, DOI 10.2337/db07-0052; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Eizirik DL, 2008, BIOCHEM SOC T, V36, P321, DOI 10.1042/BST0360321; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Fox SA, 2005, BIOCHEM BIOPH RES CO, V337, P983, DOI 10.1016/j.bbrc.2005.09.147; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gowda A, 2008, BLOOD, V111, P4723, DOI 10.1182/blood-2007-07-099531; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Gysemans CA, 2005, DIABETES, V54, P2396, DOI 10.2337/diabetes.54.8.2396; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Imaizumi K, 2004, J NEUROSCI, V24, P3721, DOI 10.1523/JNEUROSCI.5101-03.2004; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim S, 2007, DIABETES, V56, P2561, DOI 10.2337/db06-1372; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Maida A, 2008, ENDOCRINOLOGY, V149, P5670, DOI 10.1210/en.2008-0336; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; O'Sullivan BJ, 2006, J IMMUNOL, V176, P7278, DOI 10.4049/jimmunol.176.12.7278; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Thomas D, 2002, TRANSPLANTATION, V74, P1489, DOI 10.1097/00007890-200212150-00003; Thomas HE, 2010, CELL DEATH DIFFER, V17, P577, DOI 10.1038/cdd.2009.165; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	46	82	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39632	39643		10.1074/jbc.M111.253591	http://dx.doi.org/10.1074/jbc.M111.253591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937453	hybrid, Green Published			2022-12-27	WOS:000296759800080
J	Sznee, K; Dekker, JP; Dame, RT; van Roon, H; Wuite, GJL; Frese, RN				Sznee, Kinga; Dekker, Jan P.; Dame, Remus T.; van Roon, Henny; Wuite, Gijs J. L.; Frese, Raoul N.			Jumping Mode Atomic Force Microscopy on Grana Membranes from Spinach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II SUPERCOMPLEXES; LIGHT-HARVESTING ANTENNA; THYLAKOID MEMBRANES; PHOTOSYNTHETIC APPARATUS; MOLECULAR ARCHITECTURE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; ATP SYNTHASE; TAPPING-MODE; ORGANIZATION	The thylakoid membrane system is a complex membrane system that organizes and reorganizes itself to provide plants optimal chemical energy from sunlight under different and varying environmental conditions. Grana membranes are part of this system and contain the light-driven water-splitting enzyme Photosystem II (PSII) and light-harvesting antenna complexes. Here, we present a direct visualization of PSII complexes within grana membranes from spinach. By means of jumping mode atomic force microscopy in liquid, minimal forces were applied between the scanning tip and membrane or protein, allowing complexes to be imaged with high detail. We observed four different packing arrangements of PSII complexes, which occur primarily as dimers: co-linear crystalline rows, nanometric domains of straight or skewed rows, and disordered domains. Upon storing surface-adhered membranes at low temperature prior to imaging, large-scale reorganizations of supercomplexes between PSII and light-harvesting complex II could be induced. The highest resolution images show the existence of membrane domains without obvious topography extending beyond supercomplexes. These observations illustrate the possibility for diffusion of proteins and smaller molecules within these densely packed membranes.	[Sznee, Kinga; Dekker, Jan P.; Dame, Remus T.; van Roon, Henny; Wuite, Gijs J. L.; Frese, Raoul N.] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Frese, RN (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	r.n.frese@vu.nl	Dame, Remus T./E-1941-2014; Dame, Remus/AAT-2989-2020; Dame, Remus/A-8570-2008	Dame, Remus T./0000-0001-9863-1692; Dame, Remus/0000-0001-9863-1692; wuite, gijs/0000-0002-5706-043X; frese, raoul/0000-0001-8243-9954	Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by the Netherlands Organization for Scientific Research (NWO).r Supported by a Netherlands Organization for Scientific Research Vidi grant. To whom correspondence should be addressed. E-mail: r.n.frese@vu.nl.	Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Buzhynskyy N, 2007, EMBO REP, V8, P51, DOI 10.1038/sj.embor.7400858; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DUNAHAY TG, 1984, BIOCHIM BIOPHYS ACTA, V764, P179, DOI 10.1016/0005-2728(84)90027-6; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Frese RN, 2008, BIOPHYS J, V94, P640, DOI 10.1529/biophysj.107.116913; Goncalves RP, 2005, J STRUCT BIOL, V152, P221, DOI 10.1016/j.jsb.2005.10.002; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Kirchhoff H, 2002, BIOCHEMISTRY-US, V41, P4872, DOI 10.1021/bi011650y; Kirchhoff H, 2008, PLANT PHYSIOL, V146, P1571, DOI 10.1104/pp.107.115170; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kirchhoff H, 2007, BIOCHEMISTRY-US, V46, P11169, DOI 10.1021/bi700748y; Kouril R, 2012, BBA-BIOENERGETICS, V1817, P2, DOI 10.1016/j.bbabio.2011.05.024; Kouril R, 2011, BBA-BIOENERGETICS, V1807, P368, DOI 10.1016/j.bbabio.2010.11.007; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Magis GJ, 2010, BBA-BIOMEMBRANES, V1798, P637, DOI 10.1016/j.bbamem.2009.12.018; Moller C, 1999, BIOPHYS J, V77, P1150, DOI 10.1016/S0006-3495(99)76966-3; Moreno-Herrero F, 2000, SURF SCI, V453, P152, DOI 10.1016/S0039-6028(00)00341-1; Moreno-Herrero F, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031915; Moreno-Herrero F, 2002, APPL PHYS LETT, V81, P2620, DOI 10.1063/1.1509856; Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nield J, 2002, J BIOL CHEM, V277, P15006, DOI 10.1074/jbc.M110549200; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Scheuring S, 2006, J MOL BIOL, V358, P83, DOI 10.1016/j.jmb.2006.01.085; Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; SEMENOVA GA, 1995, CAN J BOT, V73, P1676, DOI 10.1139/b95-181; Staehelin LA, 2003, PHOTOSYNTH RES, V76, P185, DOI 10.1023/A:1024994525586; van Roon H, 2000, PHOTOSYNTH RES, V64, P155, DOI 10.1023/A:1006476213540; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	41	32	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39164	39171		10.1074/jbc.M111.284844	http://dx.doi.org/10.1074/jbc.M111.284844			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21911498	Green Published, hybrid			2022-12-27	WOS:000296759800035
J	Zanzoni, S; Assfalg, M; Giorgetti, A; D'Onofrio, M; Molinari, H				Zanzoni, Serena; Assfalg, Michael; Giorgetti, Alejandro; D'Onofrio, Mariapina; Molinari, Henriette			Structural Requirements for Cooperativity in Ileal Bile Acid-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; SITE SELECTIVITY; NMR; DETERMINANTS; CRYSTALLOGRAPHY; IDENTIFICATION; ACTIVATION; EVOLUTION; ALLOSTERY; DYNAMICS	Ileal bile acid-binding proteins (I-BABP), belonging to the family of intracellular lipid-binding proteins, control bile acid trafficking in enterocytes and participate in regulating the homeostasis of these cholesterol-derived metabolites. I-BABP orthologues share the same structural fold and are able to host up to two ligands in their large internal cavities. However variations in the primary sequences determine differences in binding properties such as the degree of binding cooperativity. To investigate the molecular requirements for cooperativity we adopted a gain-of-function approach, exploring the possibility to turn the noncooperative chicken I-BABP (cI-BABP) into a cooperative mutant protein. To this aim we first solved the solution structure of cI-BABP in complex with two molecules of the physiological ligand glycochenodeoxycholate. A comparative structural analysis with closely related members of the same protein family provided the basis to design a double mutant (H99Q/A101S cI-BABP) capable of establishing a cooperative binding mechanism. Molecular dynamics simulation studies of the wild type and mutant complexes and essential dynamics analysis of the trajectories supported the role of the identified amino acid residues as hot spot mediators of communication between binding sites. The emerging picture is consistent with a binding mechanism that can be described as an extended conformational selection model.	[Zanzoni, Serena; Assfalg, Michael; Giorgetti, Alejandro; D'Onofrio, Mariapina; Molinari, Henriette] Univ Verona, Dept Biotechnol, I-37134 Verona, Italy; [Giorgetti, Alejandro] FZ Julich, German Res Sch Simulat Sci, D-52428 Julich, Germany; [Giorgetti, Alejandro] Rhein Westfal TH Aachen, D-52428 Julich, Germany	University of Verona; RWTH Aachen University	Molinari, H (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie 15, I-37134 Verona, Italy.	henriette.molinari@univr.it	molinari, henriette/ABE-9775-2021; Molinari, Henriette/A-1695-2008	Molinari, Henriette/0000-0002-3678-130X; D'ONOFRIO, Mariapina/0000-0002-8699-0847; Giorgetti, Alejandro/0000-0001-8738-6150; Assfalg, Michael/0000-0001-9331-3169	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base, Futuro in Ricerca) [RBFR08R7OU]; European Community [RII3-026145]; University of Verona; Cariverona Foundation; Netherlands Organization for Scientific Research [213010]	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base, Futuro in Ricerca); European Community(European Commission); University of Verona; Cariverona Foundation(Fondazione Cariverona); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base, Futuro in Ricerca 2008, Grant RBFR08R7OU).; We thank Simona Tomaselli for help with structure calculations. We thank the European Community (EU-NMR Contract RII3-026145) for access to the HWB-NMR facility at Birmingham, United Kingdom; the Consorzio Interuniversitario di Risonanze Magnetiche di Metalloproteine Paramagnetiche (CIRMMP) for access to high field spectrometers; the e-NMR project (a European FP7 e-Infrastructure grant, Contract 213010), supported by the national GRID Initiatives of Italy, Germany, and the Dutch BiG Grid project (Netherlands Organization for Scientific Research) for the use of Web server facilities; and the University of Verona and the Cariverona Foundation for financial support for the acquisition of anNMR spectrometer and cryoprobe.	Argmann Carmen A, 2006, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29a03s75; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capaldi S, 2009, J MOL BIOL, V385, P99, DOI 10.1016/j.jmb.2008.10.007; Chau CD, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016701; Cogliati C, 2010, CHEM-EUR J, V16, P11300, DOI 10.1002/chem.201000498; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; DARDEN TA, 1993, ENVIRON HEALTH PERSP, V101, P410, DOI 10.2307/3431897; Daura X, 1999, PROTEINS, V36, P542, DOI 10.1002/(SICI)1097-0134(19990901)36:4<542::AID-PROT17>3.0.CO;2-M; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eliseo T, 2007, BIOCHEMISTRY-US, V46, P12557, DOI 10.1021/bi7013085; ELKIN RG, 1990, COMP BIOCHEM PHYS B, V96, P157, DOI 10.1016/0305-0491(90)90356-X; EUFRI D, 1989, J MOL GRAPHICS, V7, P165, DOI 10.1016/0263-7855(89)80021-9; Eufri D., 1989, J MOL GRAPHICS, V7, P158; Guariento M, 2008, PROTEINS, V70, P462, DOI 10.1002/prot.21518; Guariento M, 2010, BIOCHEM J, V425, P413, DOI 10.1042/BJ20091209; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HAGEY LR, 1994, J LIPID RES, V35, P2041; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Houten SM, 2006, CELL METAB, V4, P423, DOI 10.1016/j.cmet.2006.11.006; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ijare OB, 2005, LIPIDS, V40, P1031, DOI 10.1007/s11745-005-1466-1; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kouvatsos N, 2007, J MOL BIOL, V371, P1365, DOI 10.1016/j.jmb.2007.06.024; Kouvatsos N, 2006, CHEM COMMUN, P4623, DOI 10.1039/b610130e; Kramer W, 2001, J BIOL CHEM, V276, P7291, DOI 10.1074/jbc.M006877200; Kurz M, 2003, PROTEINS, V50, P312, DOI 10.1002/prot.10289; Lew JL, 2004, J BIOL CHEM, V279, P8856, DOI 10.1074/jbc.M306422200; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Nei M., 2000, MOL EVOLUTION PHYLOG; Nunez S, 2006, J PHYS CHEM A, V110, P463, DOI 10.1021/jp051277u; Pedo M, 2009, PROTEINS, V77, P718, DOI 10.1002/prot.22496; Ragona L, 2006, J BIOL CHEM, V281, P9697, DOI 10.1074/jbc.M513003200; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tochtrop GP, 2004, J AM CHEM SOC, V126, P11024, DOI 10.1021/ja047589c; Tochtrop GP, 2003, BIOCHEMISTRY-US, V42, P11561, DOI 10.1021/bi0346502; Tochtrop GP, 2002, P NATL ACAD SCI USA, V99, P1847, DOI 10.1073/pnas.012379199; Toke O, 2006, BIOCHEMISTRY-US, V45, P727, DOI 10.1021/bi051781p; Toke O, 2007, BIOCHEMISTRY-US, V46, P5427, DOI 10.1021/bi700030r; Tornaselli S, 2008, J MED CHEM, V51, P6782, DOI 10.1021/jm800820b; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	57	16	16	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39307	39317		10.1074/jbc.M111.261099	http://dx.doi.org/10.1074/jbc.M111.261099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21917914	Green Published, hybrid			2022-12-27	WOS:000296759800049
J	Zierler, S; Yao, GM; Zhang, Z; Kuo, WC; Porzgen, P; Penner, R; Horgen, FD; Fleig, A				Zierler, Susanna; Yao, Guangmin; Zhang, Zheng; Kuo, W. Cedric; Poerzgen, Peter; Penner, Reinhold; Horgen, F. David; Fleig, Andrea			Waixenicin A Inhibits Cell Proliferation through Magnesium-dependent Block of Transient Receptor Potential Melastatin 7 (TRPM7) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANOXIC NEURONAL DEATH; NORDIHYDROGUAIARETIC ACID; ION-CHANNEL; ATRIAL-FIBRILLATION; MG2+ HOMEOSTASIS; CALCIUM; CURRENTS; ENTRY; CRAC; LIPOXYGENASE	Transient receptor potential melastatin 7 (TRPM7) channels represent the major magnesium-uptake mechanism in mammalian cells and are key regulators of cell growth and proliferation. They are expressed abundantly in a variety of human carcinoma cells controlling survival, growth, and migration. These characteristics are the basis for recent interest in the channel as a target for cancer therapeutics. We screened a chemical library of marine organism-derived extracts and identified waixenicin A from the soft coral Sarcothelia edmondsoni as a strong inhibitor of overexpressed and native TRPM7. Waixenicin A activity was cytosolic and potentiated by intracellular free magnesium (Mg2+) concentration. Mutating a Mg2+ binding site on the TRPM7 kinase domain reduced the potency of the compound, whereas kinase deletion enhanced its efficacy independent of Mg2+. Waixenicin A failed to inhibit the closely homologous TRPM6 channel and did not significantly affect TRPM2, TRPM4, and Ca2+ release-activated Ca2+ current channels. Therefore, waixenicin A represents the first potent and relatively specific inhibitor of TRPM7 ion channels. Consistent with TRPM7 inhibition, the compound blocked cell proliferation in human Jurkat T-cells and rat basophilic leukemia cells. Based on the ability of the compound to inhibit cell proliferation through Mg2+-dependent block of TRPM7, waixenicin A, or structural analogs may have cancer-specific therapeutic potential, particularly because certain cancers accumulate cytosolic Mg2+.	[Zierler, Susanna; Zhang, Zheng; Penner, Reinhold; Fleig, Andrea] Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Honolulu, HI 96813 USA; [Zierler, Susanna; Zhang, Zheng; Penner, Reinhold; Fleig, Andrea] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; [Yao, Guangmin; Kuo, W. Cedric; Poerzgen, Peter; Horgen, F. David] Hawaii Pacific Univ, Dept Nat Sci, Lab Marine Biol Chem, Kaneohe, HI 96744 USA	The Queen's Medical Center; University of Hawaii System; University of Hawaii System	Fleig, A (corresponding author), Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Honolulu, HI 96813 USA.	afleig@hawaii.edu	Zierler, Susanna/E-2070-2012; Horgen, David/N-1393-2016	Zierler, Susanna/0000-0002-4684-0385; Horgen, David/0000-0001-9409-3030; Penner, Reinhold/0000-0002-5366-1537	National Institutes of Health [P01GM078195, P20 RR-016467]; University of Hawaii [5G12 RR003061-22]; American Society of Pharmacognosy; Austrian Science Fund [J2784]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR016467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM078195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Hawaii; American Society of Pharmacognosy; Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01GM078195 (to A. F.), P20 RR-016467 (to F. D. H.), and 5G12 RR003061-22 (University of Hawaii Imaging Core). This work was also supported by an American Society of Pharmacognosy Undergraduate Research Award (to W. C. K.) and Austrian Science Fund Grant J2784 (to S. Z.).	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Abed E, 2007, CELL PROLIFERAT, V40, P849, DOI 10.1111/j.1365-2184.2007.00476.x; Abed E, 2009, AM J PHYSIOL-CELL PH, V297, pC360, DOI 10.1152/ajpcell.00614.2008; Cao G, 2008, CURR OPIN NEPHROL HY, V17, P373, DOI 10.1097/MNH.0b013e328303e184; Castillo B, 2010, J BIOMOL SCREEN, V15, P498, DOI 10.1177/1087057110368294; Chen HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011161; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Chubanov V, 2005, PFLUG ARCH EUR J PHY, V451, P228, DOI 10.1007/s00424-005-1470-y; Coburn RF, 2009, J CELL PHYSIOL, V221, P544, DOI 10.1002/jcp.21899; COVAL SJ, 1984, TETRAHEDRON, V40, P3823, DOI 10.1016/S0040-4020(01)88813-X; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Du JY, 2010, CIRC RES, V106, P992, DOI 10.1161/CIRCRESAHA.109.206771; Gong YZ, 2008, EUR J PHARMACOL, V600, P18, DOI 10.1016/j.ejphar.2008.10.010; Guilbert A, 2009, AM J PHYSIOL-CELL PH, V297, pC493, DOI 10.1152/ajpcell.00624.2008; Hatton CJ, 1997, BRIT J PHARMACOL, V122, P923, DOI 10.1038/sj.bjp.0701452; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kerschbaum HH, 2003, BIOPHYS J, V84, P2293, DOI 10.1016/S0006-3495(03)75035-8; Kim BJ, 2008, CANCER SCI, V99, P2502, DOI 10.1111/j.1349-7006.2008.00982.x; KORN SJ, 1990, MOL PHARMACOL, V38, P524; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Kucherenko YV, 2010, J MEMBRANE BIOL, V237, P93, DOI 10.1007/s00232-010-9310-1; Lang G, 2006, J NAT PROD, V69, P621, DOI 10.1021/np0504917; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MK, 2009, AM J PHYSIOL-CELL PH, V297, pC1445, DOI 10.1152/ajpcell.00259.2009; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; MASTROCOLA T, 1991, BIOCHIM BIOPHYS ACTA, V1097, P275, DOI 10.1016/0925-4439(91)90081-J; Matsuda H, 2010, J PHYSIOL-LONDON, V588, P4673, DOI 10.1113/jphysiol.2010.194480; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nicotera P, 2003, CELL, V115, P768, DOI 10.1016/S0092-8674(03)01019-5; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Sahni J, 2008, CELL METAB, V8, P84, DOI 10.1016/j.cmet.2008.06.002; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Sontia B, 2008, HYPERTENSION, V51, P915, DOI 10.1161/HYPERTENSIONAHA.107.100339; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tani D, 2007, CELL CALCIUM, V41, P249, DOI 10.1016/j.ceca.2006.07.004; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wolf FI, 2008, MAGNESIUM RES, V21, P83; Wolf FI, 2009, CANCER TREAT REV, V35, P378, DOI 10.1016/j.ctrv.2009.01.003; Wykes RCE, 2007, J IMMUNOL, V179, P4045, DOI 10.4049/jimmunol.179.6.4045; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yue LX, 2011, CARDIOVASC RES, V89, P744, DOI 10.1093/cvr/cvq329; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	57	110	114	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39328	39335		10.1074/jbc.M111.264341	http://dx.doi.org/10.1074/jbc.M111.264341			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21926172	Green Published, hybrid			2022-12-27	WOS:000296759800051
J	Tang, GQ; Deshpande, AP; Patel, SS				Tang, Guo-Qing; Deshpande, Aishwarya P.; Patel, Smita S.			Transcription Factor-dependent DNA Bending Governs Promoter Recognition by the Mitochondrial RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SC-MTTFB; PROTEIN; INITIATION; BINDING; PURIFICATION; SPECIFICITY; COMPLEXES	Promoter recognition is the first and the most important step during gene expression. Our studies of the yeast (Saccharomyces cerevisiae) mitochondrial (mt) transcription machinery provide mechanistic understandings on the basic problem of how the mt RNA polymerase (RNAP) with the help of the initiation factor discriminates between promoter and non-promoter sequences. We have used fluorescence-based approaches to quantify DNA binding, bending, and opening steps by the core mtRNAP subunit (Rpo41) and the transcription factor (Mtf1). Our results show that promoter recognition is not achieved by tight and selective binding to the promoter sequence. Instead, promoter recognition is achieved by an induced-fit mechanism of transcription factor-dependent differential conformational changes in the promoter and non-promoter DNAs. While Rpo41 induces a slight bend upon binding both the DNAs, addition of the Mtf1 results in severe bending of the promoter and unbending of the non-promoter DNA. Only the sharply bent DNA results in the catalytically active open complex. Such an induced-fit mechanism serves three purposes: 1) assures catalysis at promoter sites, 2) prevents RNA synthesis at non-promoter sites, and 3) provides a conformational state at the non-promoter sites that would aid in facile translocation to scan for specific sites.	[Tang, Guo-Qing; Deshpande, Aishwarya P.; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu			National Institutes of Health [GM51966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051966, R37GM051966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by National Institutes of Health Grant GM51966 (to S. S. P.).	Albright RA, 1998, P NATL ACAD SCI USA, V95, P3431, DOI 10.1073/pnas.95.7.3431; Bandwar RP, 2002, J MOL BIOL, V324, P63, DOI 10.1016/S0022-2836(02)01034-3; Bartlett MS, 2005, CURR OPIN MICROBIOL, V8, P677, DOI 10.1016/j.mib.2005.10.016; BISWAS TK, 1986, J BIOL CHEM, V261, P3927; BISWAS TK, 1990, P NATL ACAD SCI USA, V87, P9338, DOI 10.1073/pnas.87.23.9338; BISWAS TK, 1990, J BIOL CHEM, V265, P19053; BISWAS TK, 1987, J BIOL CHEM, V262, P13690; BISWAS TK, 1985, P NATL ACAD SCI USA, V82, P1954, DOI 10.1073/pnas.82.7.1954; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; DIFFLEY JFX, 1992, J BIOL CHEM, V267, P3368; DIFFLEY JFX, 1991, P NATL ACAD SCI USA, V88, P7864, DOI 10.1073/pnas.88.17.7864; ERIE DA, 1994, SCIENCE, V266, P1562, DOI 10.1126/science.7985026; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; HEUMANN H, 1988, EMBO J, V7, P4379, DOI 10.1002/j.1460-2075.1988.tb03336.x; JANG SH, 1991, J BIOL CHEM, V266, P22671; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; Jiang HY, 2011, NUCLEIC ACIDS RES, V39, P5119, DOI 10.1093/nar/gkr103; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kim H, 2012, NUCLEIC ACIDS RES, V40, P371, DOI 10.1093/nar/gkr736; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LEVENS D, 1981, J BIOL CHEM, V256, P1474; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; MCALLISTER WT, 1993, CELL MOL BIOL RES, V39, P385; Nagaich AK, 1997, J BIOL CHEM, V272, P14842, DOI 10.1074/jbc.272.23.14842; Paratkar S, 2010, J BIOL CHEM, V285, P3949, DOI 10.1074/jbc.M109.050732; PerezMartin J, 1997, ANNU REV MICROBIOL, V51, P593, DOI 10.1146/annurev.micro.51.1.593; Post CB, 1995, BIOCHEMISTRY-US, V34, P15881, DOI 10.1021/bi00049a001; Record M. T., 1996, ESCHERICHIA COLI RNA; REZNIKOFF WS, 1985, ANNU REV GENET, V19, P355, DOI 10.1146/annurev.ge.19.120185.002035; Rippe K, 1997, J MOL BIOL, V270, P125, DOI 10.1006/jmbi.1997.1079; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; SCHINKEL AH, 1988, NUCLEIC ACIDS RES, V16, P9147, DOI 10.1093/nar/16.19.9147; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; SHADEL GS, 1995, MOL CELL BIOL, V15, P2101; Shutt TE, 2010, P NATL ACAD SCI USA, V107, P12133, DOI 10.1073/pnas.0910581107; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Soppa J, 1999, MOL MICROBIOL, V31, P1295, DOI 10.1046/j.1365-2958.1999.01273.x; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4947, DOI 10.1021/bi052292s; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Wang H, 2003, P NATL ACAD SCI USA, V100, P14822, DOI 10.1073/pnas.2433654100; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; XU BJ, 1992, NUCLEIC ACIDS RES, V20, P1053, DOI 10.1093/nar/20.5.1053; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	54	24	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38805	38813		10.1074/jbc.M111.261966	http://dx.doi.org/10.1074/jbc.M111.261966			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911502	Green Published, hybrid			2022-12-27	WOS:000296594200091
J	Hatton, O; Phillips, LK; Vaysberg, M; Hurwich, J; Krams, SM; Martinez, OM				Hatton, Olivia; Phillips, Lori K.; Vaysberg, Maria; Hurwich, Jordan; Krams, Sheri M.; Martinez, Olivia M.			Syk Activation of Phosphatidylinositol 3-Kinase/Akt Prevents HtrA2-dependent Loss of X-linked Inhibitor of Apoptosis Protein (XIAP) to Promote Survival of Epstein-Barr Virus plus (EBV plus ) B Cell Lymphomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SPLEEN TYROSINE KINASE; NON-HODGKIN-LYMPHOMA; SERINE-PROTEASE; SIGNAL-TRANSDUCTION; THERAPEUTIC TARGET; ANTIGEN RECEPTOR; SURFACE-IMMUNOGLOBULIN; AKT PHOSPHORYLATION; MEDIATED APOPTOSIS	B cell lymphoma survival requires tonic or ligand-independent signals through activation of Syk by the B cell receptor. The Epstein-Barr virus (EBV) protein latent membrane 2a (LMP2a), a mimic of the B cell receptor, provides constitutive survival signals for latently infected cells through Syk activation; however, the precise downstream mechanisms coordinating this survival response in EBV+ B cell lymphomas remain to be elucidated. Herein, we assess the mechanism of Syk survival signaling in EBV+ B cell lymphomas from post-transplant lymphoproliferative disorder (PTLD) to discover virally controlled therapeutic targets involved in lymphomagenesis and tumor progression. Using small molecule inhibition and siRNA strategies, we show that Syk inhibition reduces proliferation and induces apoptosis of PTLD-derived EBV+ B cell lines. Syk inhibition also reduces autocrine IL-10 production. Although Syk inhibition attenuates signaling through both the PI3K/Akt and Erk pathways, only PI3K/Akt inhibition causes apoptosis of PTLD-derived cell lines. Loss of the endogenous caspase inhibitor XIAP is observed after Syk or PI3K/Akt inhibition. The loss of XIAP and apoptosis that results from Syk or PI3K/Akt inhibition is reversed by inhibition of the mitochondrial protease HtrA2. Thus, Syk drives EBV+ B cell lymphoma survival through PI3K/Akt activation, which prevents the HtrA2-dependent loss of XIAP. Syk, Akt, and XIAP antagonists may present potential new therapeutic strategies for PTLD through targeting of EBV-driven survival signals.	[Hatton, Olivia; Phillips, Lori K.; Vaysberg, Maria; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Hatton, Olivia; Phillips, Lori K.; Vaysberg, Maria; Hurwich, Jordan; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Sch Med, Dept Surg, Div Transplantat, Stanford, CA 94305 USA	Stanford University; Stanford University	Martinez, OM (corresponding author), 1201 Welch Rd,MSLS P312, Stanford, CA 94305 USA.	omm@stanford.edu		, Olivia/0000-0002-2798-0251; Krams, Sheri/0000-0002-6049-5119	National Institutes of Health [AI41769]; Stanford Graduate Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041769, R21AI041769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI41769 (to O. M. M.).; Recipient of a Stanford Graduate Fellowship.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Beatty PR, 1997, J IMMUNOL, V158, P4045; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Buchner M, 2009, CANCER RES, V69, P5424, DOI 10.1158/0008-5472.CAN-08-4252; BURKHARDT AL, 1992, J VIROL, V66, P5161, DOI 10.1128/JVI.66.8.5161-5167.1992; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Gobessi S, 2009, LEUKEMIA, V23, P686, DOI 10.1038/leu.2008.346; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Green D R, 1998, Results Probl Cell Differ, V24, P45; Gururajan M, 2007, J IMMUNOL, V178, P111, DOI 10.4049/jimmunol.178.1.111; Gururajan M, 2006, J IMMUNOL, V176, P5715, DOI 10.4049/jimmunol.176.10.5715; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Klupsch K, 2006, CELL DEATH DIFFER, V13, P2157, DOI 10.1038/sj.cdd.4401955; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Lindsley CW, 2010, CURR TOP MED CHEM, V10, P458, DOI 10.2174/156802610790980602; LONGNECKER R, 1991, J VIROL, V65, P3681, DOI 10.1128/JVI.65.7.3681-3692.1991; Longnecker R, 1996, TRENDS MICROBIOL, V4, P38; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matskova L, 2001, J VIROL, V75, P10941, DOI 10.1128/JVI.75.22.10941-10949.2001; Meffre E, 2002, P NATL ACAD SCI USA, V99, P11334, DOI 10.1073/pnas.172369999; Merchant M, 2000, J VIROL, V74, P9115, DOI 10.1128/JVI.74.19.9115-9124.2000; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Morrison JA, 2005, J VIROL, V79, P2375, DOI 10.1128/JVI.79.4.2375-2382.2005; Nepomuceno RR, 2003, CANCER RES, V63, P4472; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Portis T, 2004, ONCOGENE, V23, P8619, DOI 10.1038/sj.onc.1207905; Portis T, 2002, FRONT BIOSCI-LANDMRK, V7, pD414, DOI 10.2741/portis; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Scholle F, 2000, J VIROL, V74, P10681, DOI 10.1128/JVI.74.22.10681-10689.2000; Shin H, 2003, BIOCHEM J, V373, P965, DOI 10.1042/BJ20030583; Snow AL, 2001, J IMMUNOL, V167, P5404, DOI 10.4049/jimmunol.167.9.5404; Snow AL, 2007, AM J TRANSPLANT, V7, P271, DOI 10.1111/j.1600-6143.2006.01650.x; Srinivasula SM, 2003, J BIOL CHEM, V278, P31469, DOI 10.1074/jbc.C300240200; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Uckun FM, 2010, BRIT J HAEMATOL, V149, P508, DOI 10.1111/j.1365-2141.2010.08106.x; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yang L, 2007, J BIOL CHEM, V282, P10981, DOI 10.1074/jbc.M700445200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young RM, 2009, BLOOD, V113, P2508, DOI 10.1182/blood-2008-05-158618	68	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37368	37378		10.1074/jbc.M111.255125	http://dx.doi.org/10.1074/jbc.M111.255125			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908615	Green Published, hybrid			2022-12-27	WOS:000296542400037
J	Wang, SA; Li, HY; Hsu, TI; Chen, SH; Wu, CJ; Chang, WC; Hung, JJ				Wang, Shao-An; Li, Hao-Yi; Hsu, Tsung-I; Chen, Shu-Hui; Wu, Chin-Jen; Chang, Wen-Chang; Hung, Jan-Jong			Heat Shock Protein 90 Stabilizes Nucleolin to Increase mRNA Stability in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; BINDING PROTEIN; HSP90; CELLS; RECEPTORS; EXPRESSION; CANCER; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION	Most studies on heat shock protein 90 (Hsp90) have focused on the involvement of Hsp90 in the interphase, whereas the role of this protein in the nucleus during mitosis remains largely unclear. In this study, we found that the level of the acetylated form of Hsp90 decreased dramatically during mitosis, which indicates more chaperone activity during mitosis. We thus probed proteins that interacted with Hsp90 by liquid chromatography/mass spectrometry (LC/MS) and found that nucleolin was one of those interacting proteins during mitosis. The nucleolin level decreased upon geldanamycin treatment, and Hsp90 maintained the cyclin-dependent kinase 1 (CDK1) activity to phosphorylate nucleolin at Thr-641/707. Mutation of Thr641/707 resulted in the destabilization of nucleolin in mitosis. We globally screened the level of mitotic mRNAs and found that 229 mRNAs decreased during mitosis in the presence of geldanamycin. Furthermore, a bioinformatics tool and an RNA immunoprecipitation assay found that 16 mRNAs, including cadherin and Bcl-xl, were stabilized through the recruitment of nucleolin to the 3' -untranslated regions (3'-UTRs) of those genes. Overall, strong correlations exist between the up-regulation of Hsp90, nucleolin, and the mRNAs related to tumorigenesis of the lung. Our findings thus indicate that nucleolin stabilized by Hsp90 contributes to the lung tumorigenesis by increasing the level of many tumor-related mRNAs during mitosis.	[Wang, Shao-An; Li, Hao-Yi; Hsu, Tsung-I; Chang, Wen-Chang; Hung, Jan-Jong] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan; [Chang, Wen-Chang; Hung, Jan-Jong] Natl Cheng Kung Univ, Ctr Infect Dis & Signal Transduct Res, Coll Sci, Tainan 701, Taiwan; [Chen, Shu-Hui; Wu, Chin-Jen] Natl Cheng Kung Univ, Coll Sci, Dept Chem, Tainan 701, Taiwan; [Hung, Jan-Jong] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan; [Hsu, Tsung-I; Chang, Wen-Chang; Hung, Jan-Jong] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan; [Chang, Wen-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 11031, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Hung, JJ (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan.	petehung@mail.ncku.edu.tw	Hsu, Tsung-I/AAK-9942-2020	Hsu, Tsung-I/0000-0002-7524-7740; Wang, Shao-an/0000-0002-5473-4195	National Cheng-Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers, together with National Science Council, Taiwan [NSC 99-2320-B-006-031-MY3, NSC 100-2321-B-006-011]	National Cheng-Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers, together with National Science Council, Taiwan	This work was supported by the National Cheng-Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers, together with National Science Council, Taiwan, Grants NSC 99-2320-B-006-031-MY3 and NSC 100-2321-B-006-011.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; ALCAIDE JRC, 2006, CLIN TRANSL ONCOL, V8, P148; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4; Blancafort P, 2003, NAT BIOTECHNOL, V21, P269, DOI 10.1038/nbt794; CAIZERGUESFERRER M, 1989, GENE DEV, V3, P324, DOI 10.1101/gad.3.3.324; Chen CY, 2000, GENE DEV, V14, P1236; Citri A, 2004, CELL CYCLE, V3, P51; Dranovsky A, 2001, NEUROBIOL AGING, V22, P517, DOI 10.1016/S0197-4580(00)00248-7; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; ERARD M, 1990, EUR J BIOCHEM, V191, P19, DOI 10.1111/j.1432-1033.1990.tb19088.x; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Garfinkel Mark D, 2004, Methods Mol Biol, V287, P151; GASC JM, 1990, EXP CELL RES, V186, P362, DOI 10.1016/0014-4827(90)90317-4; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GhisolfiNieto L, 1996, J MOL BIOL, V260, P34, DOI 10.1006/jmbi.1996.0380; Ginisty H, 1999, J CELL SCI, V112, P761; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Kang HT, 2003, J BIOL CHEM, V278, P51223, DOI 10.1074/jbc.M307332200; Katafiasz BJ, 2003, J BIOL CHEM, V278, P27513, DOI 10.1074/jbc.M304119200; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; KHARRAT A, 1991, BIOCHEMISTRY-US, V30, P10329, DOI 10.1021/bi00106a034; Kimmins S, 2000, CELL STRESS CHAPERON, V5, P76, DOI 10.1379/1466-1268(2000)005<0076:MOSRAE>2.0.CO;2; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Liang P, 1997, J CELL SCI, V110, P1431; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mazzucchelli R, 2004, ANAL QUANT CYTOL, V26, P127; Mi YC, 2003, J BIOL CHEM, V278, P8572, DOI 10.1074/jbc.M207637200; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Rothstein TL, 2000, CELL RES, V10, P245, DOI 10.1038/sj.cr.7290053; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Schulz S, 2006, J HISTOCHEM CYTOCHEM, V54, P1015, DOI 10.1369/jhc.6A6966.2006; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Steinman RA, 2007, LEUKEMIA, V21, P1158, DOI 10.1038/sj.leu.2404656; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; TUTEJA N, 1995, GENE, V160, P143, DOI 10.1016/0378-1119(95)00207-M; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wang SA, 2009, J MOL BIOL, V387, P1106, DOI 10.1016/j.jmb.2009.02.040; Willimott S, 2010, BIOCHEM SOC T, V38, P1571, DOI 10.1042/BST0381571; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhang YD, 2006, NUCLEIC ACIDS RES, V34, P485, DOI 10.1093/nar/gkj459; Zhou GS, 1997, J BIOL CHEM, V272, P31130, DOI 10.1074/jbc.272.49.31130	56	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43816	43829		10.1074/jbc.M111.310979	http://dx.doi.org/10.1074/jbc.M111.310979			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21998300	Green Published, hybrid			2022-12-27	WOS:000298402300024
J	de Souza, AR; Zago, M; Pollock, SJ; Sime, PJ; Phipps, RP; Baglole, CJ				de Souza, Angela Rico; Zago, Michela; Pollock, Stephen J.; Sime, Patricia J.; Phipps, Richard P.; Baglole, Carolyn J.			Genetic Ablation of the Aryl Hydrocarbon Receptor Causes Cigarette Smoke-induced Mitochondrial Dysfunction and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; HUMAN LUNG FIBROBLASTS; CELL-DEATH; QUANTITATIVE-DETERMINATION; DECREASED EXPRESSION; OXIDATIVE STRESS; HEME OXYGENASE-1; IN-VITRO; T-CELL; INDUCTION	Cigarette smoke is the primary risk factor for chronic obstructive pulmonary disease (COPD). Alterations in the balance between apoptosis and proliferation are involved in the etiology of COPD. Fibroblasts and epithelial cells are sensitive to the oxidative properties of cigarette smoke, and whose loss may precipitate the development of COPD. Fibroblasts express the aryl hydrocarbon receptor (AhR), a transcription factor that attenuates pulmonary inflammation and may also regulate apoptosis. We hypothesized the AhR would prevent apoptosis caused by cigarette smoke. Using genetically deleted in vitro AhR expression models and an established method of cigarette smoke exposure, we report that AhR expression regulates fibroblasts proliferation and prevents morphological features of apoptosis, including membrane blebbing and chromatin condensation caused by cigarette smoke extract (CSE). Absence of AhR expression results in cleavage of PARP, lamin, and caspase-3. Mitochondrial dysfunction, including cytochrome c release, was associated with loss of AhR expression, indicating activation of the intrinsic apoptotic cascade. Heightened sensitivity of AhR-deficient fibroblasts was not the result of alterations in GSH, Nrf2, or HO-1 expression. Instead, AhR(-/-) cells had significantly less MnSOD and CuZn-SOD expression, enzymes that protects against oxidative stress. The ability of the AhR to suppress apoptosis was not restricted to fibroblasts, as siRNA-mediated knockdown of the AhR in lung epithelial cells also increased sensitivity to smoke-induced apoptosis. Collectively, these results suggest that cigarette smoke induced loss of lung structural support (i.e. fibroblasts, epithelial cells) caused by aberrations in AhR expression may explain why some smokers develop lung diseases such as COPD.	[de Souza, Angela Rico; Zago, Michela] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H2X 2P2, Canada; [Zago, Michela; Baglole, Carolyn J.] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ H2X 2P2, Canada; [Pollock, Stephen J.; Sime, Patricia J.; Phipps, Richard P.] Univ Rochester, Dept Environm Med, Rochester, NY 14642 USA; [Sime, Patricia J.] Univ Rochester, Dept Med, Rochester, NY 14642 USA; [Phipps, Richard P.] Univ Rochester, Dept Ophthalmol, Rochester, NY 14642 USA; [Phipps, Richard P.] Univ Rochester, Lung Biol & Dis Program, Rochester, NY 14642 USA	McGill University; McGill University; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Baglole, CJ (corresponding author), 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	Carolyn.baglole@McGill.ca		Pollock, Stephen/0000-0002-2091-1675	National Institutes of Health [HL075432, HL088325, HL04492, ES01247]; American Thoracic Society; Department of Medicine at McGill University; Research Institute of the McGill University Health Centre; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075432, R01HL088325, K08HL004492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society; Department of Medicine at McGill University; Research Institute of the McGill University Health Centre; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL075432, HL088325, HL04492, and ES01247, an American Thoracic Society Research Grant, the Department of Medicine at McGill University, and the Research Institute of the McGill University Health Centre.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Aoshiba Kazutetsu, 2009, Proc Am Thorac Soc, V6, P596, DOI 10.1513/pats.200904-017RM; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Baglole CJ, 2008, AM J PHYSIOL-LUNG C, V295, pL624, DOI 10.1152/ajplung.90215.2008; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Calabrese F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-14; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Eltom SE, 1998, CARCINOGENESIS, V19, P1437, DOI 10.1093/carcin/19.8.1437; Emmert SW, 2010, BIOORG MED CHEM LETT, V20, P2675, DOI 10.1016/j.bmcl.2010.01.044; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Henry EC, 2006, ARCH BIOCHEM BIOPHYS, V450, P67, DOI 10.1016/j.abb.2006.02.008; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Huang YH, 1999, DNA CELL BIOL, V18, P643, DOI 10.1089/104454999315051; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Joseph A, 2008, FREE RADICAL BIO MED, V45, P1143, DOI 10.1016/j.freeradbiomed.2008.07.006; Karaflou M, 2008, MINI-REV MED CHEM, V8, P912, DOI 10.2174/138955708785132765; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; Kleeff J, 2000, INT J CANCER, V86, P399, DOI 10.1002/(SICI)1097-0215(20000501)86:3<399::AID-IJC15>3.0.CO;2-G; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lehmann GM, 2011, AM J PATHOL, V178, P1556, DOI 10.1016/j.ajpath.2010.12.025; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Loo DT, 1998, METHOD CELL BIOL, V57, P251; Marlowe JL, 2008, MOL BIOL CELL, V19, P3263, DOI 10.1091/mbc.E08-04-0359; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; Mulligan RM, 2009, AM J RHINOL ALLERGY, V23, pE1, DOI 10.2500/ajra.2009.23.3400; Nagata K, 2007, RESP MED, V101, P800, DOI 10.1016/j.rmed.2006.07.017; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Niittynen M, 2008, TOXICOLOGY, V250, P132, DOI 10.1016/j.tox.2008.06.014; Ohnishi K, 1998, LAB INVEST, V78, P1077; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Padilla J, 2002, CLIN IMMUNOL, V103, P22, DOI 10.1006/clim.2001.5181; Park Jeong-Woong, 2007, COPD, V4, P347, DOI 10.1080/15412550701603775; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Peraza MA, 2006, J APPL TOXICOL, V26, P356, DOI 10.1002/jat.1149; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Ridnour LA, 2004, ANTIOXID REDOX SIGN, V6, P501, DOI 10.1089/152308604773934260; Rogers RJ, 2001, J BIOL CHEM, V276, P20419, DOI 10.1074/jbc.M008915200; Ryu DY, 1999, J BIOCHEM MOL TOXIC, V13, P249, DOI 10.1002/(SICI)1099-0461(1999)13:5<249::AID-JBT4>3.0.CO;2-L; Sampsonas F, 2006, CURR MED CHEM, V13, P2857, DOI 10.2174/092986706778521922; Sarsour EH, 2005, J BIOL CHEM, V280, P18033, DOI 10.1074/jbc.M501939200; Scovassi AI, 2009, ANN NY ACAD SCI, V1171, P12, DOI 10.1111/j.1749-6632.2009.04707.x; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shapiro SD, 2004, AM J RESP CELL MOL, V31, P481, DOI 10.1165/rcmb.F285; Shimba S, 2002, J BIOCHEM, V132, P795, DOI 10.1093/oxfordjournals.jbchem.a003289; Sin Don D, 2009, Proc Am Thorac Soc, V6, P543, DOI 10.1513/pats.200904-019DS; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Stringer KA, 2007, AM J PHYSIOL-LUNG C, V292, pL1572, DOI 10.1152/ajplung.00325.2006; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Tanaka KI, 2011, J PHARMACOL EXP THER, V338, P810, DOI 10.1124/jpet.111.179051; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Weydert C, 2003, MOL CANCER THER, V2, P361; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Yokohori N, 2004, CHEST, V125, P626, DOI 10.1378/chest.125.2.626; Zavitz CCJ, 2008, CELL IMMUNOL, V253, P38, DOI 10.1016/j.cellimm.2008.04.012; Zhivotosky B., 2001, CURR PROTOC CELL BIO	74	66	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43214	43228		10.1074/jbc.M111.258764	http://dx.doi.org/10.1074/jbc.M111.258764			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21984831	hybrid, Green Published			2022-12-27	WOS:000298351300042
J	Hedrich, CM; Rauen, T; Tsokos, GC				Hedrich, Christian M.; Rauen, Thomas; Tsokos, George C.			cAMP-responsive Element Modulator (CREM)alpha Protein Signaling Mediates Epigenetic Remodeling of the Human Interleukin-2 Gene IMPLICATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSES IL-2 PRODUCTION; CD4(+) T-CELLS; DNA METHYLATION; EXPRESSION; LYMPHOCYTES; PROMOTER; BINDING; ALPHA; AUTOIMMUNITY; ACTIVATION	IL-2 is a key cytokine during proliferation and activation of T lymphocytes and functions as an auto-and paracrine growth factor. Regardless of activating effects on T lymphocytes, the absence of IL-2 has been linked to the development of autoimmune pathology in mice and humans. Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease and characterized by dysregulation of lymphocyte function, transcription factor and cytokine expression, and antigen presentation. Reduced IL-2 expression is a hallmark of SLETlymphocytes and results in decreased numbers of regulatory T lymphocytes which play an important role in preventing autoimmunity. Reduced IL-2 expression was linked to overproduction of the transcription regulatory factor cAMP-responsive element modulator (CREM)alpha in SLE T lymphocytes and subsequent CREM alpha binding to a CRE site within the IL2 promoter (-180 CRE). In this study, we demonstrate the involvement of CREM alpha-mediated IL2 silencing inTlymphocytes from SLE patients through a gene-wide histone deacetylase 1-directed deacetylation of histone H3K18 and DNA methyltransferase 3a-directed cytosine phosphate guanosine (CpG)-DNA hypermethylation. For the first time, we provide direct evidence that CREM alpha mediates silencing of the IL2 gene in SLE T cells though histone deacetylation and CpG-DNA methylation.	[Hedrich, Christian M.; Rauen, Thomas; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Rheumatol, Boston, MA 02115 USA; [Rauen, Thomas] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52074 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University	Hedrich, CM (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Rheumatol, Boston, MA 02115 USA.	chedrich@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	Hedrich, Christian/AAW-3958-2020; tsokos, george C/O-3360-2013; Hedrich, Christian/AAD-6855-2019	tsokos, george C/0000-0001-9589-2360; Hedrich, Christian/0000-0002-1295-6179	National Institutes of Health [R01 AI42269, R01 AI49954, R01 AI85567]; Deutsche Forschungsgemeinschaft [RA1927-1/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269, R01AI049954, R01AI085567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42269, R01 AI49954, and R01 AI85567 (to G. C. T.). This work was also supported by Deutsche Forschungsgemeinschaft Research Fellowship RA1927-1/1 (to T. R.).	Adachi S, 2005, NUCLEIC ACIDS RES, V33, P3200, DOI 10.1093/nar/gki637; ALCOCERVARELA J, 1982, J CLIN INVEST, V69, P1388, DOI 10.1172/JCI110579; Bailey J, 2005, J MOL ENDOCRINOL, V34, P1, DOI 10.1677/jme.1.01594; Balada E, 2008, IMMUNOLOGY, V124, P339, DOI 10.1111/j.1365-2567.2007.02771.x; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Crispin JC, 2010, CURR OPIN RHEUMATOL, V22, P499, DOI 10.1097/BOR.0b013e32833c62b0; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; DEFAUCAL P, 1984, ANN INST PASTEUR IMM, VD135, P161, DOI 10.1016/S0769-2625(84)81108-3; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hedrich CM, 2010, MOL IMMUNOL, V48, P73, DOI 10.1016/j.molimm.2010.09.009; Hedrich CM, 2010, IMMUNOL RES, V47, P185, DOI 10.1007/s12026-009-8150-5; HEDRICH CM, 2011, TRENDS MOL IN PRESS; Hewagama A, 2009, J AUTOIMMUN, V33, P3, DOI 10.1016/j.jaut.2009.03.007; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; ISHIDA H, 1987, J IMMUNOL, V139, P1070; Januchowski R, 2008, CLIN RHEUMATOL, V27, P21, DOI 10.1007/s10067-007-0644-8; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Kovacs B, 1996, CLIN EXP RHEUMATOL, V14, P695; Lei W, 2009, SCAND J RHEUMATOL, V38, P369, DOI 10.1080/03009740902758875; Lieberman LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/740619; LINKERISRAELI M, 1983, J IMMUNOL, V130, P2651; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Mosca M, 2006, CLIN EXP RHEUMATOL, V24, pS100; Nambiar MP, 2002, J CELL BIOCHEM, V85, P459, DOI 10.1002/jcb.10160; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Renaudineau Yves, 2011, Keio Journal of Medicine, V60, P10; Solomou EE, 2001, J IMMUNOL, V166, P5665, DOI 10.4049/jimmunol.166.9.5665; Strickland FM, 2008, AUTOIMMUNITY, V41, P278, DOI 10.1080/08916930802024616; Sullivan KE, 2007, CLIN IMMUNOL, V123, P74, DOI 10.1016/j.clim.2006.12.008; Sunahori K, 2011, J IMMUNOL, V186, P4508, DOI 10.4049/jimmunol.1000340; Sunahori K, 2009, J IMMUNOL, V182, P1500, DOI 10.4049/jimmunol.182.3.1500; Tenbrock K, 2003, J IMMUNOL, V170, P2971, DOI 10.4049/jimmunol.170.6.2971; Tenbrock K, 2006, J IMMUNOL, V177, P6159, DOI 10.4049/jimmunol.177.9.6159; Wang GS, 2009, LUPUS, V18, P1037, DOI 10.1177/0961203309106181; WIGFALL DR, 1988, CLIN IMMUNOL IMMUNOP, V47, P354, DOI 10.1016/S0090-1229(88)80012-6; Xu LT, 2004, NAT MED, V10, P411, DOI 10.1038/nm1005; Zhao M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3214; Zhao M, 2010, J AUTOIMMUN, V35, P58, DOI 10.1016/j.jaut.2010.02.002; ZHOU Y, 2011, LUPUS IN PRESS	42	64	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43429	43436		10.1074/jbc.M111.299339	http://dx.doi.org/10.1074/jbc.M111.299339			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21976679	hybrid, Green Published			2022-12-27	WOS:000298351300062
J	Capyk, JK; Casabon, I; Gruninger, R; Strynadka, NC; Eltis, LD				Capyk, Jenna K.; Casabon, Israeel; Gruninger, Robert; Strynadka, Natalie C.; Eltis, Lindsay D.			Activity of 3-Ketosteroid 9 alpha-Hydroxylase (KshAB) Indicates Cholesterol Side Chain and Ring Degradation Occur Simultaneously in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-RHODOCHROUS DSM43269; ERYTHROPOLIS SQ1; MONOOXYGENASE; MACROPHAGES; IDENTIFICATION; DEHYDROGENASE; PERSISTENCE; OXYGENASE; REQUIRES; ENZYMES	Mycobacterium tuberculosis (Mtb), a significant global pathogen, contains a cholesterol catabolic pathway. Although the precise role of cholesterol catabolism in Mtb remains unclear, the Rieske monooxygenase in this pathway, 3-ketosteroid 9 alpha-hydroxylase (KshAB), has been identified as a virulence factor. To investigate the physiological substrate of KshAB, a rhodococcal acyl-CoA synthetase was used to produce the coenzyme A thioesters of two cholesterol derivatives: 3-oxo-23,24-bisnorchol-4-en-22-oic acid (forming 4-BNC-CoA) and 3-oxo-23,24-bisnorchola-1,4-dien-22-oic acid (forming 1,4-BNC-CoA). The apparent specificity constant (k(cat)/K-m) of KshAB for the CoA thioester substrates was 20-30 times that for the corresponding 17-keto compounds previously proposed as physiological substrates. The apparent K-mO2 was 90 +/- 10 mu M in the presence of 1,4-BNC-CoA, consistent with the value for two other cholesterol catabolic oxygenases. The Delta(1) ketosteroid dehydrogenase KstD acted with KshAB to cleave steroid ring B with a specific activity eight times greater for a CoA thioester than the corresponding ketone. Finally, modeling 1,4-BNC-CoA into the KshA crystal structure suggested that the CoA moiety, binds in a pocket at the mouth of the active site channel and could contribute to substrate specificity. These results indicate that the physiological substrates of KshAB are CoA thioester intermediates of cholesterol side chain degradation and that side chain and ring degradation occur concurrently in Mtb. This finding has implications for steroid metabolites potentially released by the pathogen during infection and for the design of inhibitors for cholesterol-degrading enzymes. The methodologies and rhodococcal enzymes used to generate thioesters will facilitate the further study of cholesterol catabolism.	[Capyk, Jenna K.; Gruninger, Robert; Strynadka, Natalie C.; Eltis, Lindsay D.] Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z3, Canada; [Capyk, Jenna K.; Gruninger, Robert; Strynadka, Natalie C.; Eltis, Lindsay D.] Univ British Columbia, Dept Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Casabon, Israeel; Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@mai.ubc.ca	Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158	Canadian Institutes for Health Research; Natural Science and Engineering Research Council	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an operating grant from the Canadian Institutes for Health Research (to L. D. E.).; Recipient of a studentship from Natural Science and Engineering Research Council.	Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Birkenmaier A, 2007, J BACTERIOL, V189, P7165, DOI 10.1128/JB.00665-07; Brzostek A, 2005, MICROBIOL-SGM, V151, P2393, DOI 10.1099/mic.0.27953-0; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Cornish-Bowden A., 1994, ANAL ENZYME KINETIC; Dresen C, 2010, J BIOL CHEM, V285, P22264, DOI 10.1074/jbc.M109.099028; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Knol J, 2008, BIOCHEM J, V410, P339, DOI 10.1042/BJ20071130; Lack NA, 2010, J BIOL CHEM, V285, P434, DOI 10.1074/jbc.M109.058081; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Petrusma M, 2009, APPL ENVIRON MICROB, V75, P5300, DOI 10.1128/AEM.00066-09; Petrusma M, 2011, J BACTERIOL, V193, P3931, DOI 10.1128/JB.00274-11; PULLEYBLANK D, 1983, MOL BIOL REP, V9, P191, DOI 10.1007/BF00775367; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van der Geize R, 2008, APPL ENVIRON MICROB, V74, P7197, DOI 10.1128/AEM.00888-08; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Wilbrink MH, 2011, APPL ENVIRON MICROB, V77, P4455, DOI 10.1128/AEM.00380-11; WORLD HEALTH ORGANIZATION-WHO, 2010, GLOBAL OBSERVATORY E, V2; Yam KC, 2010, MICROBIOL MONOGR, V16, P133, DOI 10.1007/978-3-642-12937-7_6; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x	36	65	72	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40717	40724		10.1074/jbc.M111.289975	http://dx.doi.org/10.1074/jbc.M111.289975			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21987574	hybrid, Green Published			2022-12-27	WOS:000297315400032
J	Garnett, JP; Hickman, E; Burrows, R; Hegyi, P; Tiszlavicz, L; Cuthbert, AW; Fong, PY; Gray, MA				Garnett, James P.; Hickman, Emma; Burrows, Rachel; Hegyi, Peter; Tiszlavicz, Laszlo; Cuthbert, Alan W.; Fong, Peying; Gray, Michael A.			Novel Role for Pendrin in Orchestrating Bicarbonate Secretion in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-expressing Airway Serous Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACHEAL SUBMUCOSAL GLANDS; BRONCHIAL EPITHELIAL-CELLS; CILIARY BEAT FREQUENCY; SYNDROME GENE PDS; CL-/HCO3-EXCHANGE; MUCUS SECRETION; FUNCTIONAL-CHARACTERIZATION; SULFATE TRANSPORTER; CHLORIDE SECRETION; LIQUID SECRETION	In most HCO3--secreting epithelial tissues, SLC26 Cl-/HCO3- transporters work in concert with the cystic fibrosis transmembrane conductance regulator (CFTR) to regulate the magnitude and composition of the secreted fluid, a process that is vital for normal tissue function. By contrast, CFTR is regarded as the only exit pathway for HCO3- in the airways. Here we show that Cl-/HCO3- anion exchange makes a major contribution to transcellular HCO3- transport in airway serous cells. Real-time measurement of intracellular pH from polarized cultures of human Calu-3 cells demonstrated cAMP/PKA-activated Cl--dependent HCO3- transport across the luminal membrane via CFTR-dependent coupled Cl-/HCO3- anion exchange. The pharmacological and functional profile of the luminal anion exchanger was consistent with SLC26A4 (pendrin), which was shown to be expressed by quantitative RT-PCR, Western blot, and immunofluorescence. Pendrin-mediated anion exchange activity was confirmed by shRNA pendrin knockdown (KD), which markedly reduced cAMP-activated Cl-/HCO3- exchange. To establish the relative roles of CFTR and pendrin in net HCO3- secretion, transepithelial liquid secretion rate and liquid pH were measured in wild type, pendrin KD, and CFTR KD cells. cAMP/PKA increased the rate and pH of the secreted fluid. Inhibiting CFTR reduced the rate of liquid secretion but not the pH, whereas decreasing pendrin activity lowered pH with little effect on volume. These results establish that CFTR predominately controls the rate of liquid secretion, whereas pendrin regulates the composition of the secreted fluid and identifies a critical role for this anion exchanger in transcellular HCO3- secretion in airway serous cells.	[Gray, Michael A.] Newcastle Univ, Epithelial Res Grp, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Hickman, Emma; Burrows, Rachel] Novartis Horsham Res Ctr, Novartis Inst Biomed Res, Horsham RH12 5AB, W Sussex, England; [Hegyi, Peter] Univ Szeged, Dept Med, H-6701 Szeged, Hungary; [Tiszlavicz, Laszlo] Univ Szeged, Dept Pathol, H-6701 Szeged, Hungary; [Cuthbert, Alan W.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Fong, Peying] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66505 USA	Newcastle University - UK; Novartis; Szeged University; Szeged University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Kansas State University	Gray, MA (corresponding author), Newcastle Univ, Epithelial Res Grp, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	m.a.gray@ncl.ac.uk	Fong, Peying/AAU-3774-2021; Garnett, James/O-7093-2014	Garnett, James/0000-0002-4767-020X; Talbot, Rachel/0000-0001-9085-9318; GRAY, MICHAEL/0000-0002-6774-6283	Biotechnology and Biological Sciences Research Council [BBS/S/M/2006/13134]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council-Industrial Collaborative PhD. Studentship Award BBS/S/M/2006/13134 (to J. P. G.).	Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; Babu PBR, 2004, BIOCHEM BIOPH RES CO, V319, P1132, DOI 10.1016/j.bbrc.2004.05.101; Ballard ST, 1999, AM J PHYSIOL-LUNG C, V277, pL694, DOI 10.1152/ajplung.1999.277.4.L694; Ballard ST, 2004, J PHYSIOL-LONDON, V556, P1, DOI 10.1113/jphysiol.2003.052779; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; BHASKAR KR, 1991, AM J PHYSIOL, V261, pG827, DOI 10.1152/ajpgi.1991.261.5.G827; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chen WY, 2009, BIOL REPROD, V80, P115, DOI 10.1095/biolreprod.108.068528; Cho HJ, 2010, AM J PHYSIOL-LUNG C, V299, pL124, DOI 10.1152/ajplung.00049.2010; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; Clary-Meinesz C, 1998, EUR RESPIR J, V11, P330, DOI 10.1183/09031936.98.11020330; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Cobb BR, 2002, AM J PHYSIOL-LUNG C, V282, pL12, DOI 10.1152/ajplung.2002.282.1.L12; Derand R, 2004, BRIT J PHARMACOL, V141, P698, DOI 10.1038/sj.bjp.0705597; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Dossena S, 2006, CELL PHYSIOL BIOCHEM, V17, P245, DOI 10.1159/000094137; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; HOLMA P, 1989, SCI TOTAL ENVIRON, V84, P71, DOI 10.1016/0048-9697(89)90371-9; Illek B, 1997, AM J PHYSIOL-LUNG C, V272, pL752, DOI 10.1152/ajplung.1997.272.4.L752; Inglis SK, 2002, J PHYSIOL-LONDON, V538, P527, DOI 10.1113/jphysiol.2001.012806; Irokawa T, 2004, AM J PHYSIOL-LUNG C, V287, pL784, DOI 10.1152/ajplung.00124.2004; Ishiguro H, 2002, J PHYSIOL-LONDON, V539, P175, DOI 10.1113/jphysiol.2001.012490; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; Khansaheb M, 2011, AM J PHYSIOL-LUNG C, V300, pL370, DOI 10.1152/ajplung.00372.2010; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Krouse ME, 2004, AM J PHYSIOL-LUNG C, V287, pL1274, DOI 10.1152/ajplung.00036.2004; Lee MC, 1998, AM J PHYSIOL-LUNG C, V274, pL450, DOI 10.1152/ajplung.1998.274.3.L450; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Loffing J, 2000, AM J PHYSIOL-CELL PH, V279, pC1016, DOI 10.1152/ajpcell.2000.279.4.C1016; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MacVinish LJ, 2007, BRIT J PHARMACOL, V150, P1055, DOI 10.1038/sj.bjp.0707175; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Muchekehu RW, 2010, J PHYSIOL-LONDON, V588, P2329, DOI 10.1113/jphysiol.2010.187237; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Pedemonte N, 2007, J IMMUNOL, V178, P5144, DOI 10.4049/jimmunol.178.8.5144; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; Rakonczay Z, 2008, J CELL PHYSIOL, V214, P442, DOI 10.1002/jcp.21220; Royaux IE, 2000, ENDOCRINOLOGY, V141, P839, DOI 10.1210/en.141.2.839; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Satoh H, 1998, J BIOL CHEM, V273, P12307, DOI 10.1074/jbc.273.20.12307; Schmid A, 2010, J BIOL CHEM, V285, P29998, DOI 10.1074/jbc.M110.113621; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; Shcheynikov N, 2006, J GEN PHYSIOL, V127, P511, DOI 10.1085/jgp.200509392; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; SIMCHOWITZ L, 1985, J CLIN INVEST, V76, P1079, DOI 10.1172/JCI112061; Simpson JE, 2005, AM J PHYSIOL-GASTR L, V288, pG1241, DOI 10.1152/ajpgi.00493.2004; Singh AK, 2010, AM J PHYSIOL-CELL PH, V298, pC1057, DOI 10.1152/ajpcell.00454.2009; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Sohma Y, 2000, J MEMBRANE BIOL, V176, P77, DOI 10.1007/s002320001077; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; Stewart AK, 2007, AM J PHYSIOL-CELL PH, V292, pC909, DOI 10.1152/ajpcell.00265.2006; Stewart AK, 2009, AM J PHYSIOL-GASTR L, V296, pG1307, DOI 10.1152/ajpgi.90697.2008; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; Wall SM, 2008, CURR OPIN NEPHROL HY, V17, P18, DOI 10.1097/MNH.0b013e3282f29086; Wheat VJ, 2000, AM J PHYSIOL-CELL PH, V279, pC62, DOI 10.1152/ajpcell.2000.279.1.C62; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015	70	73	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41069	41082		10.1074/jbc.M111.266734	http://dx.doi.org/10.1074/jbc.M111.266734			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21914796	Green Published, hybrid			2022-12-27	WOS:000297315400066
J	Hernandez-Ortega, A; Lucas, F; Ferreira, P; Medina, M; Guallar, V; Martinez, AT				Hernandez-Ortega, Aitor; Lucas, Fatima; Ferreira, Patricia; Medina, Milagros; Guallar, Victor; Martinez, Angel T.			Modulating O-2 Reactivity in a Fungal Flavoenzyme INVOLVEMENT OF ARYL-ALCOHOL OXIDASE PHE-501 CONTIGUOUS TO CATALYTIC HISTIDINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; LIGNINOLYTIC FUNGI; OXYGEN REACTIVITY; HYDROGEN-PEROXIDE; GLUCOSE-OXIDASE; OXIDATION; PROTEIN; DEGRADATION; ACTIVATION	Aryl-alcohol oxidase (AAO) is a tlavoenzyme responsible for activation of O-2 to H2O2 in fungal degradation of lignin. The AAO crystal structure shows a buried active site connected to the solvent by a hydrophobic funnel-shaped channel, with Phe-501 and two other aromatic residues forming a narrow bottleneck that prevents the direct access of alcohol substrates. However, ligand diffusion simulations show O-2 access to the active site following this channel. Site-directed mutagenesis of Phe-501 yielded a F501A variant with strongly reduced O-2 reactivity. However, a variant with increased reactivity, as shown by kinetic constants and steady-state oxidation degree, was obtained by substitution of Phe-501 with tryptophan. The high oxygen catalytic efficiency of F501W, similar to 2-fold that of native AAO and similar to 120-fold that of F501A, seems related to a higher O-2 availability because the turnover number was slightly decreased with respect to the native enzyme. Free diffusion simulations of O-2 inside the active-site cavity of AAO (and several in sitico Phe-501 variants) yielded >60% O-2 population at 3-4 angstrom from flavin C4a in F501W compared with 44% in AAO and only 14% in F501A. Paradoxically, the O-2 reactivity of AAO decreased when the access channel was enlarged and increased when it was constricted by introducing a tryptophan residue. This is because the side chain of Phe-501, contiguous to the catalytic histidine (His-502 in AAO), helps to position O-2 at an adequate distance from flavin C4a (and His-502 N epsilon). Phe-501 substitution with a bulkier tryptophan residue resulted in an increase in the O-2 reactivity of this flavoenzyme.	[Lucas, Fatima; Guallar, Victor] Barcelona Supercomp Ctr, ICREA, Joint BSC Inst Res Biomed IRB, Res Programme Computat Biol, E-08034 Barcelona, Spain; [Hernandez-Ortega, Aitor; Martinez, Angel T.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Ferreira, Patricia; Medina, Milagros] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain; [Ferreira, Patricia; Medina, Milagros] Univ Zaragoza, Dept Biochem & Mol & Cellular Biol, E-50009 Zaragoza, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Zaragoza; University of Zaragoza	Guallar, V (corresponding author), Barcelona Supercomp Ctr, ICREA, Joint BSC Inst Res Biomed IRB, Res Programme Computat Biol, Jordi Girona 29, E-08034 Barcelona, Spain.	victor.guallar@bsc.es; atmartinez@cib.csic.es	Medina, Milagros/F-8310-2012; Lucas, Maria Fatima/C-4522-2008; Martínez, Angel T/G-7284-2017; Guallar, Victor/B-1579-2013; Neila, Patricia Ferreira/Y-4803-2019	Medina, Milagros/0000-0001-8743-0182; Lucas, Maria Fatima/0000-0001-8672-9940; Martínez, Angel T/0000-0002-1584-2863; Guallar, Victor/0000-0002-4580-1114; Ferreira Neila, Patricia/0000-0003-4076-6118	Spanish Projects [BIO2008-01533, BIO2010-1493]; PEROXICATS [KBBE-2010-4-265397]; PELE [ERC-2009-Adg 25027]; ICREA Funding Source: Custom	Spanish Projects(Spanish Government); PEROXICATS; PELE; ICREA(ICREA)	This work was supported in part by Spanish Projects BIO2008-01533 and BIO2010-1493 (to A. T. M. and M. M., respectively) and by the PEROXICATS (KBBE-2010-4-265397) and PELE (ERC-2009-Adg 25027) European Projects (to A. T. M. and V. G., respectively).	[Anonymous], 2011, JAG VERS 7 8; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Borrelli KW, 2010, J COMPUT CHEM, V31, P1224, DOI 10.1002/jcc.21409; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; BOURBONNAIS R, 1988, BIOCHEM J, V255, P445, DOI 10.1042/bj2550445; Chen L, 2008, BIOCHEMISTRY-US, V47, P5368, DOI 10.1021/bi800228w; Coulombe R, 2001, J BIOL CHEM, V276, P30435, DOI 10.1074/jbc.M104103200; DEJONG E, 1992, FEBS LETT, V305, P220, DOI 10.1016/0014-5793(92)80672-4; Fernandez IS, 2009, ACTA CRYSTALLOGR D, V65, P1196, DOI 10.1107/S0907444909035860; Ferreira P, 2005, BIOCHEM J, V389, P731, DOI 10.1042/BJ20041903; Ferreira P, 2006, FEBS J, V273, P4878, DOI 10.1111/j.1742-4658.2006.05488.x; Ferreira P, 2010, BIOCHEM J, V425, P585, DOI 10.1042/BJ20091499; Ferreira P, 2009, J BIOL CHEM, V284, P24840, DOI 10.1074/jbc.M109.011593; Finnegan S, 2010, BIOCHEMISTRY-US, V49, P2952, DOI 10.1021/bi902048c; Fraaije MW, 1997, J BIOL CHEM, V272, P18111, DOI 10.1074/jbc.272.29.18111; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gadda G, 2008, BIOCHEMISTRY-US, V47, P13745, DOI 10.1021/bi801994c; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Guallar V, 2009, J BIOL CHEM, V284, P3106, DOI 10.1074/jbc.M806183200; GUILLEN F, 1990, APPL MICROBIOL BIOT, V32, P465, DOI 10.1007/BF00903784; GUILLEN F, 1994, APPL ENVIRON MICROB, V60, P2811; GUTIERREZ A, 1994, APPL ENVIRON MICROB, V60, P1783; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Hernandez-Ortega A, 2008, FLAVINS FLAVOPROTEIN, P303; Hernandez-Ortega A, 2011, BIOCHEM J, V436, P341, DOI 10.1042/BJ20102090; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Macheroux P, 1999, METH MOL B, V131, P1; Martinez AT, 2011, ENVIRON MICROBIOL, V13, P96, DOI 10.1111/j.1462-2920.2010.02312.x; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; MARTINEZ AT, 1994, FEMS MICROBIOL REV, V13, P265, DOI 10.1016/0168-6445(94)90084-1; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; MUHEIM A, 1990, ENZYME MICROB TECH, V12, P204, DOI 10.1016/0141-0229(90)90039-S; Munteanu FD, 2008, J ELECTROANAL CHEM, V618, P83, DOI 10.1016/j.jelechem.2008.02.023; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Piubelli L, 2008, J BIOL CHEM, V283, P24738, DOI 10.1074/jbc.M802321200; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Romero E, 2010, P OESIB SANT COMP 14, P86; Romero E, 2009, BBA-PROTEINS PROTEOM, V1794, P689, DOI 10.1016/j.bbapap.2008.11.013; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Ruiz-Duenas FJ, 2006, PROTEIN EXPRES PURIF, V45, P191, DOI 10.1016/j.pep.2005.06.003; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Saam J, 2010, J BIOL CHEM, V285, P24439, DOI 10.1074/jbc.M110.131193; Schrodinger LLC, 2011, MAESTR VERS 9 2; Varela E, 2000, BBA-PROTEIN STRUCT M, V1481, P202, DOI 10.1016/S0167-4838(00)00127-8; Varela E, 1999, BIOCHEM J, V341, P113, DOI 10.1042/0264-6021:3410113; Xin Y, 2009, BIOCHEMISTRY-US, V48, P9599, DOI 10.1021/bi901295a	56	41	41	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41105	41114		10.1074/jbc.M111.282467	http://dx.doi.org/10.1074/jbc.M111.282467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21940622	hybrid, Green Published			2022-12-27	WOS:000297315400069
J	Jin, Y; Wang, C; Liu, XQ; Mu, WB; Chen, ZJ; Yu, DS; Wang, AX; Dai, Y; Zhou, XF				Jin, Yi; Wang, Cheng; Liu, Xiqiang; Mu, Wenbo; Chen, Zujian; Yu, Dongsheng; Wang, Anxun; Dai, Yang; Zhou, Xiaofeng			Molecular Characterization of the MicroRNA-138-Fos-like Antigen 1 (FOSL1) Regulatory Module in Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; MESSENGER-RNAS; CANCER-CELLS; LUNG-CANCER; MICRORNA; EXPRESSION; TONGUE; HEAD; ABUNDANCE; MIR-138	MicroRNA-138 is one of the most frequently down-regulated microRNAs in cancer. We recently identified 51 candidate targets of microRNA-138 (Jiang, L., Dai, Y., Liu, X., Wang, C., Wang, A., Chen, Z., Heidbreder, C. E., Kolokythas, A., and Zhou, X. (2011) Hum. Genet. 129, 189-197). Among these candidates, Fos-like antigen 1 (FOSL1) is a member of Fos gene family and is a known proto-oncogene. In this study, we first confirmed the microRNA-138-mediated down-regulation of FOSL1 in squamous cell carcinoma cell lines. We then demonstrated the effect of this microRNA-138-FOSL1 regulatory module on downstream genes (homolog of Snail 2 (Snai2) expression and the Snai2-mediated repression of E-cadherin expression), as well as its contributions to tumorigenesis. The microRNA-138-directed recruitment of FOSL1 mRNA to the RNAi-induced silencing complex was confirmed by a ribonucleoprotein-immunoprecipitation assay. Three canonical and three high affinity non-canonical microRNA-138 (miR-138) targeting sites were identified on the FOSL1 mRNA: one in the 5'-UTR, three overlapping sites in the coding sequences, and two overlapping sites in the 3'-UTR. The direct targeting of miR-138 to these sites was confirmed using luciferase reporter gene assays. In summary, we describe an important microRNA regulatory module, which may play an important role in cancer initiation and progression. Our results also provide evidence that microRNAs target both canonical and non-canonical targeting sites located in all areas of the mRNA molecule (e. g. 5'-UTR, coding sequences, and 3'-UTR).	[Zhou, Xiaofeng] Univ Illinois, Dept Periodont, Coll Dent, Chicago, IL 60612 USA; [Jin, Yi; Wang, Cheng; Liu, Xiqiang; Chen, Zujian; Yu, Dongsheng; Wang, Anxun; Zhou, Xiaofeng] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Mu, Wenbo; Dai, Yang] Univ Illinois, Dept Bioengn, Coll Engn, Chicago, IL 60612 USA; [Dai, Yang] Univ Illinois, Univ Illinois Chicago UIC Canc Ctr, Chicago, IL 60612 USA; [Wang, Cheng; Liu, Xiqiang; Yu, Dongsheng] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Guanghua Sch, Guangzhou 510055, Guangdong, Peoples R China; [Wang, Cheng; Liu, Xiqiang; Yu, Dongsheng] Sun Yat Sen Univ, Res Inst Stomatol, Guangzhou 510055, Guangdong, Peoples R China; [Wang, Anxun] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Affiliated Hosp 1, Guangzhou 510055, Guangdong, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhou, XF (corresponding author), Univ Illinois, Dept Periodont, Coll Dent, 801 S Paulina St,Room 530C, Chicago, IL 60612 USA.	xfzhou@uic.edu			National Institutes of Health Grant Public Health Service [CA135992, CA139596, DE014847]; UIC Center for Clinical and Translational Science (CCTS) [UL1RR029879]; National Institutes of Health [DE018381]; NATIONAL CANCER INSTITUTE [R03CA135992, R01CA139596] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K22DE014847] Funding Source: NIH RePORTER	National Institutes of Health Grant Public Health Service; UIC Center for Clinical and Translational Science (CCTS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant Public Health Service Grants CA135992, CA139596, and DE014847 (to X. Z.). This work was also supported by supplementary funding from the UIC Center for Clinical and Translational Science (CCTS) (Grant UL1RR029879).; Supported by National Institutes of Health T32 Training Grant DE018381.	Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Hogg RP, 2002, EUR J CANCER, V38, P1585, DOI 10.1016/S0959-8049(01)00422-1; Jiang L, 2011, HUM GENET, V129, P189, DOI 10.1007/s00439-010-0915-3; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jiang L, 2010, INT J CANCER, V127, P505, DOI 10.1002/ijc.25320; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Liao JM, 2011, J BIOL CHEM, V286, P33901, DOI 10.1074/jbc.M111.262030; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Moretti F, 2010, RNA, V16, P2493, DOI 10.1261/rna.2384610; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Piccinin S, 1998, BRIT J CANCER, V78, P1147, DOI 10.1038/bjc.1998.644; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Wang C, 2012, INT J CANCER, V130, P2249, DOI 10.1002/ijc.26226; Wang Q, 2011, EXP LUNG RES, V37, P427, DOI 10.3109/01902148.2011.584263; Wang X, 1999, INT J ONCOL, V14, P557; Wang YM, 2011, MOL CANCER RES, V9, P1100, DOI 10.1158/1541-7786.MCR-11-0007; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Zhao XH, 2010, LEUKEMIA RES, V34, P1078, DOI 10.1016/j.leukres.2009.10.002; Zhou XF, 2006, NEOPLASIA, V8, P925, DOI 10.1593/neo.06430	32	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40104	40109		10.1074/jbc.C111.296707	http://dx.doi.org/10.1074/jbc.C111.296707			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21969367	Green Published, hybrid			2022-12-27	WOS:000296925700043
J	Sun, JW; He, HF; Xiong, Y; Lu, S; Shen, JL; Cheng, AN; Chang, WC; Hou, MF; Lancaster, JM; Kim, M; Yang, SY				Sun, Jianwei; He, Huifang; Xiong, Yin; Lu, Shuang; Shen, Junling; Cheng, Anna; Chang, Wei-Chiao; Hou, Ming-Feng; Lancaster, Johnathan M.; Kim, Minjung; Yang, Shengyu			Fascin Protein Is Critical for Transforming Growth Factor beta Protein-induced Invasion and Filopodia Formation in Spindle-shaped Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE BREAST-CANCER; TGF-BETA; PROGNOSTIC-SIGNIFICANCE; METASTASIS; ACTIN; CARCINOMA; EXPRESSION; MIGRATION; MOTILITY; RECEPTOR	Fascin, an actin-bundling protein overexpressed in all carcinomas, has been associated with poor prognosis, shorter survival, and more metastatic diseases. It is believed that fascin facilitates tumor metastasis by promoting the formation of invasive membrane protrusions. However, the mechanisms by which fascin is overexpressed in tumors are not clear. TGF beta is a cytokine secreted by tumor and mesenchymal cells and promotes metastasis in many late stage tumors. The pro-metastasis mechanisms of TGF beta remain to be fully elucidated. Here we demonstrated that TGF beta induced fascin expression in spindleshaped tumor cells through the canonical Smad-dependent pathway. Fascin was critical for TGF beta-promoted filopodia formation, migration, and invasion in spindle tumor cells. More importantly, fascin expression significantly correlates with TGF beta 1 and TGF beta receptor I levels in a cohort of primary breast tumor samples. Our results indicate that elevated TGF beta level in the tumor microenvironment may be responsible for fascin overexpression in some of the metastatic tumors. Our data also suggest that fascin could play a central role in TGF beta-promoted tumor metastasis.	[Sun, Jianwei; He, Huifang; Lu, Shuang; Shen, Junling; Cheng, Anna; Kim, Minjung; Yang, Shengyu] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA; [Sun, Jianwei; He, Huifang; Lu, Shuang; Shen, Junling; Cheng, Anna; Yang, Shengyu] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Xiong, Yin; Lancaster, Johnathan M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Womens Oncol, Tampa, FL 33612 USA; [Kim, Minjung] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Shen, Junling] Qingdao Agr Univ, Qingdao 266109, Peoples R China; [Chang, Wei-Chiao; Hou, Ming-Feng] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Qingdao Agricultural University; Kaohsiung Medical University	Yang, SY (corresponding author), 12902 Magnolia Dr,SRB-2, Tampa, FL 33612 USA.	shengyu.yang@moffitt.org	Yang, Shengyu/I-9531-2012	Yang, Shengyu/0000-0002-7933-6118; Kim, Minjung/0000-0002-5682-6640; Chang, Wei-Chiao/0000-0002-8573-5924	American Cancer Society [IRG-93-032-16]; Donald A. Adams Comprehensive Melanoma Research Center; Miles for Moffitt Foundation Center; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Donald A. Adams Comprehensive Melanoma Research Center; Miles for Moffitt Foundation Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by an Institutional Research Grant from the American Cancer Society (IRG-93-032-16), a Career Development Award from the Donald A. Adams Comprehensive Melanoma Research Center, and a Milestone Award from Miles for Moffitt Foundation Center (to S. Y.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bakin AV, 2004, MOL BIOL CELL, V15, P4682, DOI 10.1091/mbc.E04-04-0353; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Goncharuk VN, 2002, J CUTAN PATHOL, V29, P430, DOI 10.1034/j.1600-0560.2002.290708.x; Grothey A, 2000, ONCOGENE, V19, P4864, DOI 10.1038/sj.onc.1203838; Hagedorn HG, 2001, INT J ONCOL, V18, P669; Hashimoto Y, 2005, CLIN CANCER RES, V11, P2597, DOI 10.1158/1078-0432.CCR-04-1378; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Hashimoto Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-241; Hashimoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005130; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Kang YB, 2006, J CELL BIOCHEM, V98, P1380, DOI 10.1002/jcb.20928; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Massague J, 2000, GENE DEV, V14, P627; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Moustakas A, 1999, J CELL SCI, V112, P1169; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pelosi G, 2003, LUNG CANCER-J IASLC, V42, P203, DOI 10.1016/S0169-5002(03)00294-0; Puppa G, 2007, BRIT J CANCER, V96, P1118, DOI 10.1038/sj.bjc.6603690; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romano LA, 2000, DEV BIOL, V223, P91, DOI 10.1006/dbio.2000.9750; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; STOLER AB, 1993, J CELL BIOL, V122, P1103, DOI 10.1083/jcb.122.5.1103; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yoder BJ, 2005, CLIN CANCER RES, V11, P186	42	46	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38865	38875		10.1074/jbc.M111.270413	http://dx.doi.org/10.1074/jbc.M111.270413			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21914811	hybrid, Green Published			2022-12-27	WOS:000296759800005
J	Antonaki, A; Demetriades, C; Polyzos, A; Banos, A; Vatsellas, G; Lavigne, MD; Apostolou, E; Mantouvalou, E; Papadopoulou, D; Mosialos, G; Thanos, D				Antonaki, Athina; Demetriades, Constantinos; Polyzos, Alexander; Banos, Aggelos; Vatsellas, Giannis; Lavigne, Matthieu D.; Apostolou, Effie; Mantouvalou, Eva; Papadopoulou, Deppie; Mosialos, George; Thanos, Dimitris			Genomic Analysis Reveals a Novel Nuclear Factor-kappa B (NF-kappa B)-binding Site in Alu-repetitive Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-BINDING; CHROMATIN; ACTIVATION; RECRUITMENT; OCCUPANCY; DYNAMICS; INSIGHTS; INNATE; IMPACT	The transcription factor NF-kappa B is a critical regulator of immune responses. To determine how NF-kappa B builds transcriptional control networks, we need to obtain a topographic map of the factor bound to the genome and correlate it with global gene expression. We used a ChIP cloning technique and identified novel NF-kappa B target genes in response to virus infection. We discovered that most of the NF-kappa B-bound genomic sites deviate from the consensus and are located away from conventional promoter regions. Remarkably, we identified a novel abundant NF-kappa B-binding site residing in specialized Alu-repetitive elements having the potential for long range transcription regulation, thus suggesting that in addition to its known role, NF-kappa B has a primate-specific function and a role in human evolution. By combining these data with global gene expression profiling of virus-infected cells, we found that most of the sites bound by NF-kappa B in the human genome do not correlate with changes in gene expression of the nearby genes and they do not appear to function in the context of synthetic promoters. These results demonstrate that repetitive elements interspersed in the human genome function as common target sites for transcription factors and may play an important role in expanding the repertoire of binding sites to engage new genes into regulatory networks.	[Demetriades, Constantinos; Mosialos, George] Aristotle Univ Thessaloniki, Dept Biol, Thessaloniki 54124, Greece; [Antonaki, Athina; Polyzos, Alexander; Banos, Aggelos; Vatsellas, Giannis; Lavigne, Matthieu D.; Apostolou, Effie; Mantouvalou, Eva; Papadopoulou, Deppie; Thanos, Dimitris] Acad Athens, Inst Mol Biol Genet & Biotechnol, Biomed Res Fdn, Athens 11527, Greece	Aristotle University of Thessaloniki; Academy of Athens	Mosialos, G (corresponding author), Aristotle Univ Thessaloniki, Dept Biol, Univ Campus, Thessaloniki 54124, Greece.	gmosialo@bio.auth.gr; thanos@bioacademy.gr	Apostolou, Effie/AAG-1559-2020; Demetriades, Constantinos/AAD-3600-2021; Thanos, Dimitris/AAE-5720-2019; Demetriades, Constantinos/E-7444-2015; cheng, yong/I-4270-2012	Demetriades, Constantinos/0000-0001-7813-7726; Demetriades, Constantinos/0000-0001-7813-7726; Lavigne, Matthieu/0000-0003-1543-8745	European Union [LSHC-CT-2005-018704]; Greek Secretariat for Research and Technology	European Union(European Commission); Greek Secretariat for Research and Technology(Greek Ministry of Development-GSRT)	This work was supported by the Sixth Research Framework Programme of the European Union (MRC-RTN TAF CHROMATIN and INCA, LSHC-CT-2005-018704) and by the Greek Secretariat for Research and Technology (Program PENED 2001, PENED 2003, co-financed by E.U.-European Social Fund (75%) and GSRT (25%)).	Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Beckett D, 2009, P NATL ACAD SCI USA, V106, P22035, DOI 10.1073/pnas.0912300107; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Jurka J, 2004, CURR OPIN GENET DEV, V14, P603, DOI 10.1016/j.gde.2004.08.008; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Koutroubas G, 2008, MOL CELL BIOL, V28, P926, DOI 10.1128/MCB.01344-07; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Linnell J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh042; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Pan YP, 2010, TRENDS GENET, V26, P75, DOI 10.1016/j.tig.2009.12.003; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Topalidou I, 2003, EMBO REP, V4, P872, DOI 10.1038/sj.embor.embor931; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; White RB, 2006, BIOCHEM BIOPH RES CO, V346, P479, DOI 10.1016/j.bbrc.2006.05.145; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002	48	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38768	38782		10.1074/jbc.M111.234161	http://dx.doi.org/10.1074/jbc.M111.234161			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21896491	Green Published, hybrid			2022-12-27	WOS:000296594200088
J	Brunotte, L; Kerber, R; Shang, WF; Hauer, F; Hass, M; Gabriel, M; Lelke, M; Busch, C; Stark, H; Svergun, DI; Betzel, C; Perbandt, M; Gunther, S				Brunotte, Linda; Kerber, Romy; Shang, Weifeng; Hauer, Florian; Hass, Meike; Gabriel, Martin; Lelke, Michaela; Busch, Carola; Stark, Holger; Svergun, Dmitri I.; Betzel, Christian; Perbandt, Markus; Guenther, Stephan			Structure of the Lassa Virus Nucleoprotein Revealed by X-ray Crystallography, Small-angle X-ray Scattering, and Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							Z-PROTEIN; BIOLOGICAL MACROMOLECULES; RNA-POLYMERASE; CAP-BINDING; REPLICATION; TRANSCRIPTION; PROGRAM; SYSTEM; DOMAIN; FEVER	The nucleoprotein (NP) of Lassa virus (LASV) strain AV was expressed in a recombinant baculovirus system. The crystal structure of full-length NP was solved at a resolution of 2.45 angstrom. The overall fold corresponds to that of NP of LASV strain Josiah (Qi, X., Lan, S., Wang, W., Schelde, L. M., Dong, H., Wallat, G. D., Ly, H., Liang, Y., and Dong, C. (2010) Nature 468, 779-783) with a root mean square deviation of 0.67 angstrom for all atoms (6.3% difference in primary sequence). As the packing in the crystal offers two different trimer architectures for the biological assembly, the quaternary structure of NP in solution was determined by small-angle x-ray scattering and EM. After classification and averaging of >6000 EM raw images, trimeric centrosymmetric structures were obtained, which correspond in size and shape to one trimer in the crystal structure formed around a crystallographic 3-fold rotation axis (symmetric trimer). The symmetric trimer is also a good model for the small-angle x-ray scattering data and could be well embedded into the ab initio model. The N-terminal domain of NP contains a deep nucleotide-binding cavity that has been proposed to bind cellular cap structures for priming viral mRNA synthesis. All residues implicated in m(7)GpppN binding were exchanged, and the transcription/replication phenotype of the NP mutant was tested using a LASV replicon system. None of the mutants showed a specific defect in mRNA expression; most were globally defective in RNA synthesis. In conclusion, we describe the full-length crystal structure and the quaternary structure in solution of LASV NP. The nucleotide-binding pocket of NP could not be assigned a specific role in viral mRNA synthesis.	[Betzel, Christian; Perbandt, Markus] Univ Hamburg, Lab Struct Biol Infect & Inflammat, DESY, Dept Chem, D-22603 Hamburg, Germany; [Brunotte, Linda; Kerber, Romy; Hass, Meike; Gabriel, Martin; Lelke, Michaela; Busch, Carola; Guenther, Stephan] Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany; [Shang, Weifeng; Svergun, Dmitri I.] DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; [Hauer, Florian; Stark, Holger] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Hauer, Florian; Stark, Holger] Univ Gottingen, Gottingen Ctr Mol Biol, D-37077 Gottingen, Germany; [Perbandt, Markus] Univ Med Ctr Hamburg Eppendorf, Dept Med Microbiol Virol & Hyg, D-20246 Hamburg, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Bernhard Nocht Institut fur Tropenmedizin; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Perbandt, M (corresponding author), Univ Hamburg, Lab Struct Biol Infect & Inflammat, DESY, Dept Chem, Bldg 22A,Notkestr 85, D-22603 Hamburg, Germany.	perbandt@chemie.uni-hamburg.de; guenther@bni.uni-hamburg.de	Perbandt, Markus/K-7603-2018; Betzel, Christian/G-8105-2018	Betzel, Christian/0000-0002-3879-5019; Gunther, Stephan/0000-0002-6562-0230; Svergun, Dmitri/0000-0003-0830-5696; Holger, Stark/0000-0002-6161-1118	Deutsche Forschungsgemeinschaft (DFG) [GU 883/1-1]; Bundesministerium fur Bildung und Forschung (BMBF) [05K10YEA]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant GU 883/1-1 and Bundesministerium fur Bildung und Forschung (BMBF) Sync-Life Contract 05K10YEA.	Brunotte L, 2011, J VIROL, V85, P324, DOI 10.1128/JVI.00721-10; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Casabona JC, 2009, J VIROL, V83, P7029, DOI 10.1128/JVI.00329-09; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Ferron F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002030; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Gunther S, 2000, EMERG INFECT DIS, V6, P466, DOI 10.3201/eid0605.000504; Gunther S, 2004, CRIT REV CL LAB SCI, V41, P339, DOI 10.1080/10408360490497456; Hass M, 2004, J VIROL, V78, P13793, DOI 10.1128/JVI.78.24.13793-13803.2004; Hass M, 2008, J VIROL, V82, P10207, DOI 10.1128/JVI.00220-08; Hass M, 2006, J VIROL, V80, P12414, DOI 10.1128/JVI.01374-06; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Jacamo R, 2003, J VIROL, V77, P10383, DOI 10.1128/JVI.77.19.10383-10393.2003; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Lee KJ, 2000, J VIROL, V74, P3470, DOI 10.1128/JVI.74.8.3470-3477.2000; Lelke M, 2010, J VIROL, V84, P1934, DOI 10.1128/JVI.01657-09; Macleod JML, 2011, J VIROL, V85, P2012, DOI 10.1128/JVI.01875-10; Lopez N, 2001, J VIROL, V75, P12241, DOI 10.1128/JVI.75.24.12241-12251.2001; Lukashevich IS, 1997, J GEN VIROL, V78, P547, DOI 10.1099/0022-1317-78-3-547; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shtanko O, 2011, J VIROL, V85, P3631, DOI 10.1128/JVI.01984-10; Shtanko O, 2010, J VIROL, V84, P5415, DOI 10.1128/JVI.02417-09; Strecker T, 2003, J VIROL, V77, P10700, DOI 10.1128/JVI.77.19.10700-10705.2003; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	50	42	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38748	38756		10.1074/jbc.M111.278838	http://dx.doi.org/10.1074/jbc.M111.278838			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917929	Green Published, hybrid			2022-12-27	WOS:000296594200086
J	Zhang, Q; Xiao, H; Chai, SC; Hoang, QQ; Lu, H				Zhang, Qi; Xiao, Hui; Chai, Sergio C.; Hoang, Quyen Q.; Lu, Hua			Hydrophilic Residues Are Crucial for Ribosomal Protein L11 (RPL11) Interaction with Zinc Finger Domain of MDM2 and p53 Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAMOND-BLACKFAN ANEMIA; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; NUCLEOLAR PROTEIN; HUMAN 5Q-SYNDROME; ONCOPROTEIN MDM2; MOUSE MODEL; DNA-DAMAGE; PATHWAY; DEGRADATION	Ribosomal protein L11 (RPL11) has been shown to activate p53 by binding to MDM2 and negating its p53 suppression activity in response to ribosomal stress. Although a mutation at Cys-305 within the zinc finger domain of MDM2 has been shown to drastically impair MDM2 interaction with RPL11 and thus escapes the inhibition by this ribosomal protein, it still remains elusive whether RPL11 inactivates MDM2 via direct action on this zinc finger domain and what is the chemical nature of this specific interaction. To define the roles of the MDM2 zinc finger in association with RPL11, we conducted hydrogen-deuterium exchange mass spectrometry, computational modeling, circular dichroism, and mutational analyses of the zinc finger domain of MDM2 and human RPL11. Our study reveals that RPL11 forms a stable complex with MDM2 in vitro through direct contact with its zinc finger. This binding is disrupted by single mutations of non-cysteine amino acids within the zinc finger domain of MDM2. Basic residues in RPL11 are crucial for the stable binding and RPL11 suppression of MDM2 activity toward p53. These results provide the first line of evidence for the specific interaction between RPL11 and the zinc finger of MDM2 via hydrophilic residues as well as a molecular foundation for better understanding RPL11 inhibition of MDM2 function.	[Zhang, Qi; Chai, Sergio C.; Hoang, Quyen Q.; Lu, Hua] Indiana Univ, Sch Med, Simon Canc Ctr, Dept Biochem & Mol Biol, Indianapolis, IN 46032 USA; [Xiao, Hui] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Yeshiva University; Albert Einstein College of Medicine	Lu, H (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	hualu@iupui.edu	Zhang, Qi/I-1049-2012	Chai, Sergio/0000-0002-8257-8599	National Institutes of Health from NCI [CA127724, CA095441, CA129828]; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA127724, R01CA129828] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019891, S10RR019352] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA127724, CA095441, and CA129828 from NCI (to H. L.).	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakraborty A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004152; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Devlin EE, 2010, BLOOD, V116, P2826, DOI 10.1182/blood-2010-03-275776; Ebert B, 2011, SEMIN HEMATOL, V48, P73, DOI 10.1053/j.seminhematol.2011.01.003; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Ge JP, 2010, MOL CELL BIOL, V30, P413, DOI 10.1128/MCB.01128-09; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Komrokji RS, 2010, HEMATOL ONCOL CLIN N, V24, P377, DOI 10.1016/j.hoc.2010.02.013; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Llanos S, 2010, CELL CYCLE, V9, P4005, DOI 10.4161/cc.9.19.13299; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Pellagatti A, 2010, BLOOD, V115, P2721, DOI 10.1182/blood-2009-12-259705; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Sieff CA, 2010, BRIT J HAEMATOL, V148, P611, DOI 10.1111/j.1365-2141.2009.07993.x; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yu GW, 2006, PROTEIN SCI, V15, P384, DOI 10.1110/ps.051927306; Yu WS, 2011, NUCLEIC ACIDS RES, V39, P2234, DOI 10.1093/nar/gkq1117; Zakharov SD, 1998, P NATL ACAD SCI USA, V95, P4282, DOI 10.1073/pnas.95.8.4282; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P6544, DOI 10.1093/nar/gkq536; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	62	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38264	38274		10.1074/jbc.M111.277012	http://dx.doi.org/10.1074/jbc.M111.277012			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21903592	Green Published, hybrid			2022-12-27	WOS:000296594200040
J	Harris, C; Herker, E; Farese, RV; Ott, M				Harris, Charles; Herker, Eva; Farese, Robert V., Jr.; Ott, Melanie			Hepatitis C Virus Core Protein Decreases Lipid Droplet Turnover A MECHANISM FOR CORE-INDUCED STEATOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; AMINO-ACID SUBSTITUTIONS; HEPATOCELLULAR-CARCINOMA; DIACYLGLYCEROL ACYLTRANSFERASE; TRIACYLGLYCEROL BIOSYNTHESIS; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; LIVER STEATOSIS; TRANSGENIC MICE; GENOTYPE	Steatosis is a frequent complication of hepatitis C virus infection. In mice, this condition is recapitulated by the expression of a single viral protein, the nucleocapsid core. Core localizes to the surface of lipid droplets (LDs) in infected liver cells through a process dependent on host diacylglycerol acyltransferase 1 (DGAT1), an enzyme that synthesizes triglycerides in the endoplasmic reticulum. Whether DGAT1 also plays a role in core-induced steatosis is uncertain. Here, we show that mouse embryonic fibroblasts isolated from DGAT1(-/-) mice are protected from core-induced steatosis, as are livers of DGAT1(-/-) mice expressing core, demonstrating that the steatosis is DGAT1-dependent. Surprisingly, core expression did not increase DGAT1 activity or triglyceride synthesis, thus excluding the possibility that core activates DGAT1 to cause steatosis. Instead, we find that DGAT1-dependent localization of core to LDs is a prerequisite for the steatogenic properties of the core. Using biochemical and immunofluorescence microscopy techniques, we show that the turnover of lipids in core-coated droplets is decreased, providing a physiological mechanism for core-induced steatosis. Our results support a bipartite model in which core first requires DGAT1 to gain access to LDs, and then LD-localized core interferes with triglyceride turnover, thus stabilizing lipid droplets and leading to steatosis.	[Herker, Eva; Ott, Melanie] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Harris, Charles; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Harris, Charles; Herker, Eva; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA; [Harris, Charles; Herker, Eva; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ott, M (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Herker, Eva/B-9699-2014; Herker, Eva/AAQ-1944-2021	Herker, Eva/0000-0001-9644-2484; Ott, Melanie/0000-0002-5697-1274	National Institutes of Health [R56 AI085056, R01-DK056084]; NIDDK [DK081680]; NCRR [CO6 RR-018928]; Hellman Family Foundation; University of California, San Francisco [P30 DK026743]; Liver Center; Human Frontiers Science Program; J. David Gladstone Institutes; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081680, P30DK026743, R01DK056084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Hellman Family Foundation; University of California, San Francisco(University of California System); Liver Center; Human Frontiers Science Program(Human Frontier Science Program); J. David Gladstone Institutes(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R56 AI085056 (to M. O.) and R01-DK056084 (to R. V. F.), Grant DK081680 (Mentored Clinical Scientist Research Career Development Award) from NIDDK (to C. H.), and Grant CO6 RR-018928 from NCRR (to Gladstone animal facilities). This work was also supported by the Hellman Family Foundation (to M. O.), Pilot/Feasibility Grant P30 DK026743 from the University of California, San Francisco, Liver Center (to C. H. and E. H.), fellowship from the Human Frontiers Science Program (to E. H.), and the J. David Gladstone Institutes.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Castera L, 2003, GUT, V52, P288, DOI 10.1136/gut.52.2.288; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jhaveri R, 2008, J INFECT DIS, V197, P283, DOI 10.1086/524846; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; McPherson S, 2008, J HEPATOL, V49, P1046, DOI 10.1016/j.jhep.2008.06.022; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Pazienza V, 2007, HEPATOLOGY, V45, P1164, DOI 10.1002/hep.21634; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Sanyal AJ, 2011, LIVER INT, V31, P23, DOI 10.1111/j.1478-3231.2010.02397.x; SELBY MJ, 1993, J GEN VIROL, V74, P1103, DOI 10.1099/0022-1317-74-6-1103; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sumida Y, 2011, J GASTROEN HEPATOL, V26, P836, DOI 10.1111/j.1440-1746.2010.06568.x; Tachi Y, 2010, LIVER INT, V30, P554, DOI 10.1111/j.1478-3231.2009.02164.x; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tsutsumi T, 2002, HEPATOLOGY, V35, P937, DOI 10.1053/jhep.2002.32470; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Yamaguchi A, 2005, DIGEST DIS SCI, V50, P1361, DOI 10.1007/s10620-005-2788-1; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zhang CB, 2009, AM J PHYSIOL-ENDOC M, V296, pE862, DOI 10.1152/ajpendo.90651.2008	51	63	67	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42615	42625		10.1074/jbc.M111.285148	http://dx.doi.org/10.1074/jbc.M111.285148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21984835	Green Published, hybrid			2022-12-27	WOS:000298180900069
J	Rosenberg, MF; O'Ryan, LP; Hughes, G; Zhao, ZF; Aleksandrov, LA; Riordan, JR; Ford, RC				Rosenberg, Mark F.; O'Ryan, Liam P.; Hughes, Guy; Zhao, Zhefeng; Aleksandrov, Luba A.; Riordan, John R.; Ford, Robert C.			The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) THREE-DIMENSIONAL STRUCTURE AND LOCALIZATION OF A CHANNEL GATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER P-GLYCOPROTEIN; NUCLEOTIDE-BINDING DOMAINS; MULTIDRUG ABC TRANSPORTER; MALTOSE TRANSPORTER; ELECTRON CRYSTALLOGRAPHY; DELTA-F508 MUTATION; ALTERNATING ACCESS; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; CL-CHANNELS	Cystic fibrosis affects about 1 in 2500 live births and involves loss of transmembrane chloride flux due to a lack of a membrane protein channel termed the cystic fibrosis transmembrane conductance regulator (CFTR). We have studied CFTR structure by electron crystallography. The data were compared with existing structures of other ATP-binding cassette transporters. The protein was crystallized in the outward facing state and resembled the well characterized Sav1866 transporter. We identified regions in the CFTR map, not accounted for by Sav1866, which were potential locations for the regulatory region as well as the channel gate. In this analysis, we were aided by the fact that the unit cell was composed of two molecules not related by crystallographic symmetry. We also identified regions in the fitted Sav1866 model that were missing from the map, hence regions that were either disordered in CFTR or differently organized compared with Sav1866. Apart from the N and C termini, this indicated that in CFTR, the cytoplasmic end of transmembrane helix 5/11 and its associated loop could be partly disordered (or alternatively located).	[Ford, Robert C.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Zhao, Zhefeng; Aleksandrov, Luba A.; Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of Manchester; University of North Carolina; University of North Carolina Chapel Hill	Ford, RC (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England.	robert.ford@manchester.ac.uk		Ford, Robert/0000-0002-0958-1505	National Institutes of Health [DK051619]; Cystic Fibrosis Foundation [FORD08XX0, RIORDA06XX0]; Wellcome Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK051619. This work was also supported by Cystic Fibrosis Foundation Grants FORD08XX0 and RIORDA06XX0. The Polara electron microscope was obtained with funding from the Wellcome Trust.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Cai ZW, 2003, J GEN PHYSIOL, V122, P605, DOI 10.1085/jgp.200308921; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; Da Paula AC, 2010, J BIOL CHEM, V285, P27033, DOI 10.1074/jbc.M110.120352; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Ford RC, 2008, TRENDS BIOCHEM SCI, V33, P38, DOI 10.1016/j.tibs.2007.10.002; Gabriel MP, 2003, BIOCHEMISTRY-US, V42, P7780, DOI 10.1021/bi0341049; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Heikal A, 2009, CRYOBIOLOGY, V58, P37, DOI 10.1016/j.cryobiol.2008.10.125; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Jiang QS, 1998, J CELL BIOL, V143, P645, DOI 10.1083/jcb.143.3.645; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010; Linsdell P, 1996, J PHYSIOL-LONDON, V496, P687, DOI 10.1113/jphysiol.1996.sp021719; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; McDevitt CA, 2008, FEBS LETT, V582, P2950, DOI 10.1016/j.febslet.2008.07.022; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Pagano MA, 2008, BIOCHEMISTRY-US, V47, P7925, DOI 10.1021/bi800316z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenberg MF, 2010, J STRUCT BIOL, V170, P540, DOI 10.1016/j.jsb.2010.01.011; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; SCARBOROUGH GA, 1994, ACTA CRYSTALLOGR D, V50, P643, DOI 10.1107/S0907444993014283; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sheppard DN, 2004, J GEN PHYSIOL, V124, P109, DOI 10.1085/JGP.200409135; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; Stenham DR, 2003, FASEB J, V17, P2287, DOI 10.1096/fj.03-0107fje; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Vankeerberghen A, 1998, FEBS LETT, V437, P1, DOI 10.1016/S0014-5793(98)01042-4; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang LA, 2011, BBA-BIOMEMBRANES, V1808, P399, DOI 10.1016/j.bbamem.2010.08.012; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004; Zhang ZR, 2000, J MEMBRANE BIOL, V175, P35, DOI 10.1007/s002320001053; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	61	57	58	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42647	42654		10.1074/jbc.M111.292268	http://dx.doi.org/10.1074/jbc.M111.292268			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21931164	Green Published, hybrid			2022-12-27	WOS:000298180900072
J	Gijsbers, R; Vets, S; De Rijck, J; Ocwieja, KE; Ronen, K; Malani, N; Bushman, FD; Debyser, Z				Gijsbers, Rik; Vets, Sofie; De Rijck, Jan; Ocwieja, Karen E.; Ronen, Keshet; Malani, Nirav; Bushman, Frederic D.; Debyser, Zeger			RETRACTED: Role of the PWWP Domain of Lens Epithelium-derived Growth Factor (LEDGF)/p75 Cofactor in Lentiviral Integration Targeting (Retracted article. See vol. 293, pg. 114, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							NUCLEAR-LOCALIZATION SIGNAL; HIV-1 INTEGRASE; CHROMATIN-BINDING; HUMAN GENOME; RETROVIRAL INTEGRATION; SITE SELECTION; T-CELLS; LEDGF/P75; DNA; IDENTIFICATION	LEDGF/p75 is a chromatin-interacting, cellular cofactor of HIV integrase that dictates lentiviral integration site preference. In this study we determined the role of the PWWP domain of LEDGF/p75 in tethering and targeting of the lentiviral pre-integration complex, employing potent knockdown cell lines allowing analysis in the absence of endogenous LEDGF/p75. Deletion of the PWWP domain resulted in a diffuse subnuclear distribution pattern, loss of interaction with condensed chromatin, and failure to rescue proviral integration, integration site distribution, and productive virus replication. Substitution of the PWWP domain of LEDGF/p75 with that of hepatoma-derived growth factor or HDGF-related protein-2 rescued viral replication and lentiviral integration site distribution in LEDGF/p75-depleted cells. Replacing all chromatin binding elements of LEDGF/p75 with full-length hepatoma-derived growth factor resulted in more integration in genes combined with a preference for CpG islands. In addition, we showed that any PWWP domain targets SMYD1-like sequences. Analysis of integration preferences of lentiviral vectors for epigenetic marks indicates that the PWWP domain is critical for interactions specifying the relationship of integration sites to regions enriched in specific histone post-translational modifications.	[Gijsbers, Rik; Vets, Sofie; De Rijck, Jan; Debyser, Zeger] Katholieke Univ Leuven, Div Mol Med, B-3000 Louvain, Belgium; [Ocwieja, Karen E.; Ronen, Keshet; Malani, Nirav; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	KU Leuven; University of Pennsylvania	Gijsbers, R (corresponding author), Kapucijnenvoer 33,VCTB 5, B-3000 Louvain, Belgium.	rik.gijsbers@med.kuleuven.be; zeger.debyser@med.kuleuven.be	De Rijck, Jan/A-2729-2013	Ocwieja, Karen/0000-0002-1738-1634; Bushman, Frederic/0000-0003-4740-4056	National Institutes of Health [A152845, A166290, 132 A1007324, T32 A1-07324-17]; KU Leuven Research Council [OT/09/047]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) Cell-CoVir SBO [60813]; Flanders Research Foundation (FWO) [G.0530.08]; European Commission THINC [HEALTH-F3-2008-201032]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Amfar; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052845, U19AI066290, T32AI007324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KU Leuven Research Council(KU Leuven); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) Cell-CoVir SBO(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Flanders Research Foundation (FWO)(FWO); European Commission THINC(European CommissionEuropean Commission Joint Research Centre); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Amfar; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants A152845 and A166290 (to F. D. B.), 132 A1007324 (to K. E. O.), and T32 A1-07324-17] (to K. R.). This work was also supported by KU Leuven Research Council Grant OT/09/047, Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) Cell-CoVir SBO Grant 60813, Flanders Research Foundation (FWO) Grant G.0530.08, European Commission THINC Grant HEALTH-F3-2008-201032 (to Z. D.), a predoctoral fellowship from Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) (to S. V.), and a Mathilde-Krim postdoctoral fellowship from Amfar (to J. D. R.).	Astiazaran P, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-27; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127; Brady T, 2009, AIDS, V23, P1461, DOI 10.1097/QAD.0b013e32832caf28; Brady TL, 2008, MOL CELL BIOL, V28, P1230, DOI 10.1128/MCB.01502-07; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brown-Bryan TA, 2008, MOL CANCER RES, V6, P1293, DOI 10.1158/1541-7786.MCR-08-0125; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Dal J., 2007, MOL CELL, V27, P289; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107; Garcia-Rivera JA, 2010, J VIROL, V84, P740, DOI 10.1128/JVI.01043-09; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36; Hacker CV, 2006, MOL THER, V14, P536, DOI 10.1016/j.ymthe.2006.06.006; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Lukasik SM, 2006, PROTEIN SCI, V15, P314, DOI 10.1110/ps.051751706; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; McNeely M, 2011, J MOL BIOL, V410, P811, DOI 10.1016/j.jmb.2011.03.073; Meehan AM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000522; Meekings KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000027; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nameki N, 2005, PROTEIN SCI, V14, P756, DOI 10.1110/ps.04975305; Narezkina A, 2004, J VIROL, V78, P11656, DOI 10.1128/JVI.78.21.11656-11663.2004; Olsen JC, 1998, GENE THER, V5, P1481, DOI 10.1038/sj.gt.3300768; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Silvers RM, 2010, HUM GENE THER, V21, P337, DOI 10.1089/hum.2009.134; Singh DP, 2006, J MOL BIOL, V355, P379, DOI 10.1016/j.jmb.2005.10.054; Slater LM, 2003, J MOL BIOL, V330, P571, DOI 10.1016/S0022-2836(03)00470-4; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tsutsui KM, 2011, NUCLEIC ACIDS RES, V39, P5067, DOI 10.1093/nar/gkr088; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wu X, 2002, CELL DEATH DIFFER, V9, P915, DOI 10.1038/sj.cdd.4401063; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Yang J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-101; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zielske SP, 2006, J VIROL, V80, P7275, DOI 10.1128/JVI.02470-05	84	39	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41812	41825		10.1074/jbc.M111.255711	http://dx.doi.org/10.1074/jbc.M111.255711			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987578	hybrid, Green Published			2022-12-27	WOS:000298057500064
J	Kim, BS; Hwang, J; Kim, MH; Choi, SH				Kim, Byoung Sik; Hwang, Jungwon; Kim, Myung Hee; Choi, Sang Ho			Cooperative Regulation of the Vibrio vulnificus nan Gene Cluster by NanR Protein, cAMP Receptor Protein, and N-Acetylmannosamine 6-Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC-ACID CATABOLISM; RNA-POLYMERASE; ESCHERICHIA-COLI; CYCLIC-AMP; PROMOTER; BINDING; TRANSCRIPTION; EXPRESSION; VIRULENCE; CHOLERAE	The nan cluster of Vibrio vulnificus, a food-borne pathogen, consists of two divergently transcribed operons, nanT(PSL)AR and nanEK nagA, required for transport and catabolism of N-acetylneuraminic acid (Neu5Ac). A mutation of nanR abolished the extensive lag phase observed for the bacteria growing on Neu5Ac and increased transcription of nanT(p) and nanE, suggesting that NanR is a transcriptional repressor of both nan operons. Intracellular accumulation of Neu5Ac was dependent on the carbon source, implying that the nan operons are also subject to catabolite repression. Hence, cAMP receptor protein (CRP) appeared to activate and repress transcription of nanT(PSL)AR and nanEK nagA, respectively. Direct bindings of NanR and CRP to the nanT(p)-nanE intergenic DNA were demonstrated by EMSA. Two adjacent NanR-binding sites centered at +44.5 and -10 and a CRP-binding site centered at -60.5 from the transcription start site of nanT(p) were identified by DNase I protection assays. Mutagenesis approaches, in vitro transcription, and isothermal titration calorimetry experiments demonstrated that N-acetylmannosamine 6-phosphate specifically binds to NanR and functions as the inducer of the nan operons. The combined results propose a model in which NanR, CRP, and N-acetylmannosamine 6-phosphate cooperate for precise adjustment of the expression level of the V. vulnificus nan cluster.	[Kim, Byoung Sik; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Natl Res Lab Mol Microbiol & Toxicol, Ctr Food Safety & Toxicol, Seoul 151921, South Korea; [Kim, Byoung Sik; Choi, Sang Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Hwang, Jungwon; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Natl Res Lab Mol Microbiol & Toxicol, Ctr Food Safety & Toxicol, Seoul 151921, South Korea.	choish@snu.ac.kr	Kim, Byoungsik/AAE-6239-2021	Kim, Byoung Sik/0000-0001-9820-6071; Choi, Sang Ho/0000-0003-3865-1039	National Research Laboratory through National Research Foundation [R0A-2007-000-20039-0]; Ministry of Education, Science, and Technology; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	National Research Laboratory through National Research Foundation; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by National Research Laboratory Grant R0A-2007-000-20039-0 through National Research Foundation funded by Ministry of Education, Science, and Technology (to S. H. C.) and by the Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea.	Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Barnard A, 2004, CURR OPIN MICROBIOL, V7, P102, DOI 10.1016/j.mib.2004.02.011; Bateman A, 1999, TRENDS BIOCHEM SCI, V24, P94, DOI 10.1016/S0968-0004(99)01357-2; Bergendahl V, 2003, PROTEIN EXPRES PURIF, V31, P155, DOI 10.1016/S1046-5928(03)00145-1; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Choi HK, 2002, J BIOL CHEM, V277, P47292, DOI 10.1074/jbc.M206893200; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Jeong HG, 2009, INFECT IMMUN, V77, P3209, DOI 10.1128/IAI.00109-09; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Johnston JW, 2007, MOL MICROBIOL, V66, P26, DOI 10.1111/j.1365-2958.2007.05890.x; Johnston JW, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-240; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kalivoda KA, 2003, J BACTERIOL, V185, P4806, DOI 10.1128/JB.185.16.4806-4815.2003; Kim Y, 2010, J BIOL CHEM, V285, P14020, DOI 10.1074/jbc.M109.100248; LANG H, 1994, INFECT IMMUN, V62, P4781; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lee HJ, 2008, J BIOL CHEM, V283, P30438, DOI 10.1074/jbc.M802219200; Lee I, 2007, INT J ELECTRON COMM, V11, P11, DOI 10.2753/JEC1086-4415110401; Lee JH, 2006, MOL MICROBIOL, V60, P513, DOI 10.1111/j.1365-2958.2006.05115.x; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; NEWLANDS JT, 1993, J BACTERIOL, V175, P661, DOI 10.1128/JB.175.3.661-668.1993; Oh MH, 2009, INFECT IMMUN, V77, P1208, DOI 10.1128/IAI.01006-08; Park JH, 2011, J BACTERIOL, V193, P2062, DOI 10.1128/JB.00110-11; Rhee JE, 2006, J BACTERIOL, V188, P6490, DOI 10.1128/JB.00533-06; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; Sambrook J., 2001, MOL CLONING LAB MANU; Santangelo TJ, 2011, NAT REV MICROBIOL, V9, P319, DOI 10.1038/nrmicro2560; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Toulme F, 2005, J MOL BIOL, V351, P39, DOI 10.1016/j.jmb.2005.05.052; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402	40	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40889	40899		10.1074/jbc.M111.300988	http://dx.doi.org/10.1074/jbc.M111.300988			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956110	Green Published, hybrid			2022-12-27	WOS:000297315400049
J	Zhang, W; Coldefy, AS; Hubbard, SR; Burden, SJ				Zhang, Wei; Coldefy, Anne-Sophie; Hubbard, Stevan R.; Burden, Steven J.			Agrin Binds to the N-terminal Region of Lrp4 Protein and Stimulates Association between Lrp4 and the First Immunoglobulin-like Domain in Muscle-specific Kinase (MuSK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; NERVE GROWTH-FACTOR; NEUROMUSCULAR-JUNCTION; LDL-RECEPTOR; CRYSTAL-STRUCTURE; COMPLEX; DOK-7; WNT; MEDIATE; TRKA	Neuromuscular synapse formation depends upon coordinated interactions between motor neurons and muscle fibers, leading to the formation of a highly specialized postsynaptic membrane and a highly differentiated nerve terminal. Synapse formation begins as motor axons approach muscles that are prepatterned in the prospective synaptic region in a manner that depends upon Lrp4, a member of the LDL receptor family, and muscle-specific kinase (MuSK), a receptor tyrosine kinase. Motor axons supply Agrin, which binds Lrp4 and stimulates further MuSK phosphorylation, stabilizing nascent synapses. How Agrin binds Lrp4 and stimulates MuSK kinase activity is poorly understood. Here, we demonstrate that Agrin binds to the N-terminal region of Lrp4, including a subset of the LDLa repeats and the first of four beta-propeller domains, which promotes association between Lrp4 and MuSK and stimulates MuSK kinase activity. In addition, we show that Agrin stimulates the formation of a functional complex between I.rp4 and MuSK on the surface of myotubes in the absence of the transmembrane and intracellular domains of Lrp4. Further, we demonstrate that the first Ig-like domain in MuSK, which shares homology with the NGF-binding region in Tropomyosin Receptor Kinase (TrKA), is required for MuSK to bind Lrp4. These findings suggest that Lrp4 is a cis-acting ligand for MUSK, whereas Agrin functions as an allosteric and paracrine regulator to promote association between Lrp4 and MuSK.	[Zhang, Wei; Coldefy, Anne-Sophie; Burden, Steven J.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA; [Hubbard, Stevan R.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Struct Biol Program, New York, NY 10016 USA	New York University; New York University	Burden, SJ (corresponding author), 540 1st Ave, New York, NY 10016 USA.	burden@saturn.med.nyu.edu		Hubbard, Stevan/0000-0002-2707-9383; Burden, Steven/0000-0002-3550-6891	National Institutes of Health [NS36193, NS53414]; Association Francaise contre les Myopathies; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036193, R01NS053414, R01NS036193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS36193 (to S. J. B.) and NS53414 (to S. R. H.) and a postdoctoral fellowship from the Association Francaise contre les Myopathies (to A. S. C.).	Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Burden SJ, 2011, CELL, V144, P826, DOI 10.1016/j.cell.2011.02.037; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Cheng HJ, 2000, METH MOL B, V124, P313; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Farrugia ME, 2010, CURR OPIN NEUROL, V23, P489, DOI 10.1097/WCO.0b013e32833cc968; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Ibanez C. F., 2010, COMMUN, V396, P24; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; Johnson EB, 2006, GENOMICS, V88, P600, DOI 10.1016/j.ygeno.2006.08.005; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li Y, 2010, AM J HUM GENET, V86, P696, DOI 10.1016/j.ajhg.2010.03.004; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Ohazama A, 2010, AM J MED GENET A, V152A, P2974, DOI 10.1002/ajmg.a.33372; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; Stiegler AL, 2006, J MOL BIOL, V364, P424, DOI 10.1016/j.jmb.2006.09.019; Stiegler AL, 2009, J MOL BIOL, V393, P1, DOI 10.1016/j.jmb.2009.07.091; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; WOODRUFF ML, 1987, J CELL BIOL, V104, P939, DOI 10.1083/jcb.104.4.939; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	42	96	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40624	40630		10.1074/jbc.M111.279307	http://dx.doi.org/10.1074/jbc.M111.279307			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969364	Green Published, hybrid			2022-12-27	WOS:000297315400023
J	Andrew, AJ; Kao, S; Strebel, K				Andrew, Amy J.; Kao, Sandra; Strebel, Klaus			C-terminal Hydrophobic Region in Human Bone Marrow Stromal Cell Antigen 2 (BST-2)/Tetherin Protein Functions as Second Transmembrane Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLATHRIN-MEDIATED ENDOCYTOSIS; ANCHORED MEMBRANE-PROTEINS; FORMING TOXIN AEROLYSIN; HIV-1 VPU; GLYCOSYL-PHOSPHATIDYLINOSITOL; PARTICLE RELEASE; MODIFICATION SITES; MOLECULAR-CLONING; PRION PROTEIN	BST-2/CD317/HM1.24/tetherin is a host factor that inhibits the release of HIV-1 and other enveloped viruses. Structurally, tetherin consists of an N-terminal transmembrane (TM) region, a central coiled coil motif, and a putative C-terminal glycosylphosphatidylinositol (GPI) anchor motif. A current working model proposes that BST-2 inhibits virus release by physically tethering viral particles to the cell surface via its TM motif and GPI anchor. Here we analyzed the functional importance of the C-terminal GPI anchor motif in BST-2. We replaced the GPI anchor motif in BST-2 with the TM regions of several surface markers and found that the TM motifs of CD40 and transferrin receptor, but not that of CD45, could functionally substitute for a GPI anchor in BST-2. Conversely, replacing the TM region of CD4 by the putative GPI anchor signal of human BST-2 resulted in proper membrane targeting and surface expression of the chimeric protein, indicating that the BST-2 GPI anchor signal can function as a bona fide TM region. In fact, attempts to demonstrate GPI anchor modification of human BST-2 by biochemical methods failed. Our results demonstrate that the putative C-terminal GPI anchor motif in human BST-2 fulfills the requirements of a bona fide TM motif, leading us to propose that human BST-2 may in fact contain a second TM segment rather than a GPI anchor.	[Andrew, Amy J.; Kao, Sandra; Strebel, Klaus] NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strebel, K (corresponding author), NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bldg 4,Rm 310,4 Ctr Dr,MSC 0460, Bethesda, MD 20892 USA.	kstrebel@nih.gov			National Institutes of Health from NIAID [AI000669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000669, ZIAAI000669] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI000669 from the Intramural Research Program of NIAID.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Andrew A.J., 2009, CELL, V6, P80; Andrew A, 2011, J INTERF CYTOK RES, V31, P137, DOI 10.1089/jir.2010.0108; Andrew A, 2010, MOL ASPECTS MED, V31, P407, DOI 10.1016/j.mam.2010.08.002; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Bour S, 1999, J BIOL CHEM, V274, P33800, DOI 10.1074/jbc.274.47.33800; BROWN D, 1992, J AM SOC NEPHROL, V3, P895; BUCKLEY JT, 1981, CAN J BIOCHEM CELL B, V59, P430, DOI 10.1139/o81-059; Cardoso de Almeida M.L., 1983, NATURE, V302, P349; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; DEALMEIDA MLC, 1983, NATURE, V302, P349, DOI 10.1038/302349a0; Doering T.L., 2001, CURR PROTOC MOL BIOL; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Fitzpatrick K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000701; Fukushima K, 2003, J BIOL CHEM, V278, P36296, DOI 10.1074/jbc.M304341200; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; GOTO T, 1994, BLOOD, V84, P1922; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; HOWARD SP, 1985, J BACTERIOL, V163, P336, DOI 10.1128/JB.163.1.336-340.1985; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; MEDOF ME, 1986, BIOCHEMISTRY-US, V25, P6740, DOI 10.1021/bi00370a003; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2010, BIOL CELL, V102, P335, DOI 10.1042/BC20090165; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; PLOUG M, 1991, J BIOL CHEM, V266, P1926; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; WILLEY RL, 1992, J VIROL, V66, P226, DOI 10.1128/JVI.66.1.226-234.1992; Wong SK, 2009, J VIROL, V83, P8771, DOI 10.1128/JVI.00112-09; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107; ZERIAL M, 1986, EMBO J, V5, P1543, DOI 10.1002/j.1460-2075.1986.tb04395.x	51	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39967	39981		10.1074/jbc.M111.287011	http://dx.doi.org/10.1074/jbc.M111.287011			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937450	Green Published, hybrid			2022-12-27	WOS:000296925700030
J	Bertuccio, C; Veron, D; Aggarwal, PK; Holzman, L; Tufro, A				Bertuccio, Claudia; Veron, Delma; Aggarwal, Pardeep K.; Holzman, Lawrence; Tufro, Alda			Vascular Endothelial Growth Factor Receptor 2 Direct Interaction with Nephrin Links VEGF-A Signals to Actin in Kidney Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL NEPHROTIC SYNDROME; SLIT DIAPHRAGM; GLOMERULAR PODOCYTES; CELL-LINES; NCK; MOUSE; PHOSPHORYLATION; CYTOSKELETON; ACTIVATION; PROTEIN	The transmembrane protein nephrin is an essential component of slit diaphragms, the specialized cell junctions that link podocyte foot processes. Podocytes are epithelial cells that surround the glomerular capillaries in the kidney and are necessary for the organ-filtering function. Nephrin signaling complex transduces extracellular cues to the podocyte cytoskeleton and regulates podocyte shape and function. Vascular endothelial growth factor A (VEGF-A) is a required growth factor produced and secreted by podocytes. Accumulating evidence suggests a cross-talk between VEGF-A and nephrin signaling pathways. We previously showed that in vivo nephrin associates with VEGF receptor-2 (VEGFR2), the signaling receptor for VEGF-A. In the present work, we characterized the interaction between nephrin and VEGFR2 in cultured cells and in vitro. We demonstrate that nephrin-VEGFR2 interaction is direct using mass spectrometry, immunoprecipitation, GST-binding assays, and blot overlay experiments. This interaction occurs through VEGFR2 and nephrin cytoplasmic domains. Nephrin-VEGFR2 interaction is modulated by tyrosine phosphorylation of both cytoplasmic domains. Furthermore, the nephrin-VEGFR2 complex involves Nck and actin. VEGF-A signaling via this complex results in decreased cell size. We provide evidence that this multiprotein interaction occurs in cultured podocytes. We propose that the nephrin-VEGFR2 complex acts as a key mediator to transduce local VEGF-A signals to the podocyte actin cytoskeleton, regulating the foot process structure and glomerular filter integrity.	[Bertuccio, Claudia; Veron, Delma; Aggarwal, Pardeep K.; Tufro, Alda] Yale Univ, Dept Pediat, Sch Med, New Haven, CT 06520 USA; [Holzman, Lawrence] Univ Penn, Div Nephrol, Sch Med, Philadelphia, PA 19104 USA	Yale University; University of Pennsylvania	Tufro, A (corresponding author), 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	alda.tufro@yale.edu		Holzman, Lawrence/0000-0002-8961-234X	National Institutes of Health [RO1-DK59333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK59333 (to A. T.).	Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Foster RR, 2005, AM J PHYSIOL-RENAL, V288, pF48, DOI 10.1152/ajprenal.00146.2004; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; Hovind P, 2000, KIDNEY INT, V57, pS56, DOI 10.1046/j.1523-1755.2000.07504.x; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kaukinen A, 2008, NEPHROL DIAL TRANSPL, V23, P1224, DOI 10.1093/ndt/gfm799; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Ku CH, 2008, DIABETES, V57, P2824, DOI 10.2337/db08-0647; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lehtonen S, 2002, AM J PHYSIOL-RENAL, V283, pF734, DOI 10.1152/ajprenal.00312.2001; Matsukawa M, 2009, GENES CELLS, V14, P1167, DOI 10.1111/j.1365-2443.2009.01343.x; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Mizuno K, 2002, J IMMUNOL, V169, P778, DOI 10.4049/jimmunol.169.2.778; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Putaala H, 2000, J AM SOC NEPHROL, V11, P991, DOI 10.1681/ASN.V116991; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; RODEWALD R, 1974, J CELL BIOL, V60, P423, DOI 10.1083/jcb.60.2.423; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; SIMON M, 1995, AM J PHYSIOL-RENAL, V268, pF240, DOI 10.1152/ajprenal.1995.268.2.F240; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Stoletov KV, 2001, J BIOL CHEM, V276, P22748, DOI 10.1074/jbc.M009720200; Stone K.L., 2004, CURR PROTOC PROTEIN; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Uchida K, 2008, KIDNEY INT, V73, P926, DOI [10.1038/ki.2008.19, 10.1038/KI.2008.19]; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Veron D, 2011, DIABETOLOGIA, V54, P1227, DOI 10.1007/s00125-010-2034-z; Veron D, 2010, AM J PATHOL, V177, P2225, DOI 10.2353/ajpath.2010.091146; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Wernerson A, 2003, NEPHROL DIAL TRANSPL, V18, P70, DOI 10.1093/ndt/18.1.70	53	55	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39933	39944		10.1074/jbc.M111.241620	http://dx.doi.org/10.1074/jbc.M111.241620			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937443	hybrid, Green Published			2022-12-27	WOS:000296925700027
J	Chen, XJ; Zhang, X; Jia, CX; Xu, JX; Gao, HX; Zhang, GH; Du, XN; Zhang, HL				Chen, Xingjuan; Zhang, Xuan; Jia, Caixia; Xu, Jiaxi; Gao, Haixia; Zhang, Guohong; Du, Xiaona; Zhang, Hailin			Membrane Depolarization Increases Membrane PtdIns(4,5)P-2 Levels through Mechanisms Involving PKC beta II and PI4 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED INHIBITION; PROTEIN-COUPLED RECEPTOR; SKELETAL-MUSCLE CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INOSITOL TRISPHOSPHATE; ACTIN POLYMERIZATION; C2 DOMAINS; CHANNELS; CALCIUM; PIP2	In a previous study, we showed that membrane depolarization induced elevation of membrane phosphatidylinositol 4,5-bis-phosphates (PtdIns(4,5) P-2, also known as PIP2) and subsequently increased the KCNQ2/Q3 currents expressed in Xenopus oocytes through increased PI4 kinase activity. In this study, the underlying mechanism for this depolarization-induced enhancement of PIP2 synthesis was further investigated. Our results indicate that activation of protein kinase C (PKC) isozyme beta II was responsible for the enhanced PIP2 synthesis. We found that phorbol-12-myristate, 13-acetate (PMA), an activator of PKC, mimicked the effects of the membrane depolarization by increasing KCNQ2/Q3 activity, elevating membrane PIP2 levels and increasing activity of PI4 kinase beta. Furthermore, membrane depolarization enhanced PKC activity. The effects of both depolarization and PMA were blocked by a PKC inhibitor or PI4 kinase beta RNA interference. Further results demonstrate that the depolarization selectively activated the PKC beta II isoform and enhanced its interaction with PI4 kinase beta. These results reveal that the depolarization-induced elevation of membrane PIP2 is through activation of PKC and the subsequent increased activity of PI4 kinase beta	[Chen, Xingjuan; Zhang, Xuan; Jia, Caixia; Xu, Jiaxi; Gao, Haixia; Zhang, Guohong; Du, Xiaona; Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Key Lab Neural & Vasc Biol, Key Lab Pharmacol & Toxicol New Drug,Minist Educ, Shijiazhuang 050017, Hebei, Peoples R China	Hebei Medical University	Zhang, HL (corresponding author), Hebei Med Univ, Dept Pharmacol, Key Lab Neural & Vasc Biol, Key Lab Pharmacol & Toxicol New Drug,Minist Educ, 361 E Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China.	zhanghl@hebmu.edu.cn	xu, jia/GSD-6347-2022; chen, xingjuan/V-4064-2019; Xu, Jiaxi/N-3532-2018	chen, xingjuan/0000-0002-7380-8399; 	National Natural Science Foundation of China [30730031]; National Basic Research Program [2007CB512100]; National Science Fund for Distinguished Young Scholars of China [30325038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Natural Science Foundation of China (30730031, to H. Z.) and the National Basic Research Program (2007CB512100).; Recipient of National Science Fund for Distinguished Young Scholars of China (30325038). To whom correspondence should be addressed: Department of Pharmacology, Hebei Medical University, No. 361 East Zhongshan Road, Shijiazhuang, Hebei, 050017, China. Tel.: 86-311-86265562; E-mail: zhanghl@hebmu.edu.cn or z.hailin@yahoo.com.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; APGAR JR, 1995, MOL BIOL CELL, V6, P97, DOI 10.1091/mbc.6.1.97; Araya R, 2003, J GEN PHYSIOL, V121, P3, DOI 10.1085/jgp.20028671; Audigier C, 1998, GASTROEN CLIN BIOL, V22, P471; Babwah AV, 2003, J BIOL CHEM, V278, P5419, DOI 10.1074/jbc.M211053200; Becker KP, 2004, J BIOL CHEM, V279, P28251, DOI 10.1074/jbc.M400770200; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; Cardenas C, 2004, J BIOL CHEM, V279, P39122, DOI 10.1074/jbc.M401044200; Cenni V, 2002, BIOCHEM J, V363, P537, DOI 10.1042/0264-6021:3630537; Corbalan-Garcia S, 2007, BIOCHEM SOC T, V35, P1046, DOI 10.1042/BST0351046; Di Paolo D, 2006, DIGEST LIVER DIS, V38, P749, DOI 10.1016/j.dld.2006.06.011; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Eltit JM, 2004, BIOPHYS J, V86, P3042, DOI 10.1016/S0006-3495(04)74353-2; Etkovitz N, 2007, BIOL REPROD, V77, P263, DOI 10.1095/biolreprod.106.056705; Evans JP, 2002, NAT CELL BIOL, V4, pS57, DOI 10.1038/ncb-nm-fertilityS57; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Gonzales ML, 2006, J CELL BIOCHEM, V97, P252, DOI 10.1002/jcb.20655; GOUELI BS, 1995, ANAL BIOCHEM, V225, P10, DOI 10.1006/abio.1995.1100; Guerrero-Valero M, 2007, J MOL BIOL, V371, P608, DOI 10.1016/j.jmb.2007.05.086; Hamplova B, 2010, PHYSIOL RES, V59, P25, DOI 10.33549/physiolres.931638; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Johnson J, 1997, MECH DEVELOP, V67, P215, DOI 10.1016/S0925-4773(97)00122-6; KLINE D, 1985, DEV BIOL, V111, P471, DOI 10.1016/0012-1606(85)90499-3; Krauss M, 2007, FEBS LETT, V581, P2105, DOI 10.1016/j.febslet.2007.01.089; Lee SH, 2010, CLIN LUNG CANCER, V11, P169, DOI 10.3816/CLC.2010.n.021; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Maasch C, 2000, FASEB J, V14, P1653, DOI 10.1096/fj.14.11.1653; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Powell JA, 2001, J CELL SCI, V114, P3673; Rajagopal S, 2008, BRAIN RES, V1210, P1, DOI 10.1016/j.brainres.2008.03.017; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Snow P, 1996, DEV BIOL, V180, P108, DOI 10.1006/dbio.1996.0288; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stith BJ, 1997, MOL BIOL CELL, V8, P755, DOI 10.1091/mbc.8.4.755; STUMPO DJ, 1994, J BIOL CHEM, V269, P21184; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tolias KF, 1999, CHEM PHYS LIPIDS, V98, P69, DOI 10.1016/S0009-3084(99)00019-5; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Zhang C, 2004, NEURON, V42, P225, DOI 10.1016/S0896-6273(04)00189-8; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang X, 2010, J BIOL CHEM, V285, P9402, DOI 10.1074/jbc.M109.068205; Zhao ZY, 2008, PFLUG ARCH EUR J PHY, V456, P413, DOI 10.1007/s00424-007-0391-3	50	12	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39760	39767		10.1074/jbc.M111.289090	http://dx.doi.org/10.1074/jbc.M111.289090			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953466	Green Published, hybrid			2022-12-27	WOS:000296925700009
J	Gleyzer, N; Scarpulla, RC				Gleyzer, Natalie; Scarpulla, Richard C.			PGC-1-related Coactivator (PRC), a Sensor of Metabolic Stress, Orchestrates a Redox-sensitive Program of Inflammatory Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RESPIRATORY FACTORS; MITOCHONDRIAL BIOGENESIS; ERR-ALPHA; INDUCIBLE COACTIVATOR; SIGNALING PATHWAYS; ENERGY-METABOLISM; RECEPTOR-ALPHA; DNA-BINDING; IN-VIVO; CANCER	PGC-1-related coactivator (PRC) is a growth-regulated transcriptional cofactor that activates many nuclear genes specifying mitochondrial respiratory function. Stable PRC silencing in U2OS cells results in a complex phenotype typical of mitochondrial dysfunction including abundant abnormal mitochondria, reduced respiratory subunit expression, diminished respiratory enzymes and ATP levels, and elevated lactate production. The PRC response to metabolic stress was investigated by subjecting cells to metabolic insults including treatment with the uncoupler carbonyl cyanide 3-chlorophenylhydrazone (CCCP), expression of a dominant negative allele of nuclear respiratory factor 1 (NRF-1), and glucose deprivation. These treatments led to constitutively elevated PRC protein levels, a departure from its normal transient expression upon the initiation of cell growth. A microarray screen identified 45 genes that require PRC for their induction by CCCP. A subset of these genes specific to inflammation and cell stress was also induced by dominant negative NRF-1 and by glucose deprivation, suggesting that diverse metabolic insults converge on the same PRC-dependent inflammatory program. The PRC-dependent inflammatory response was inhibited by N-acetylcysteine, suggesting that PRC may contribute to the inflammatory microenvironment linked to oxidant signaling. The induction of this PRC-dependent program may be an early event in adaptations linked to cancer and degenerative diseases.	[Gleyzer, Natalie; Scarpulla, Richard C.] NW Med Sch, Dept Cell & Mol Biol, Chicago, IL USA		Scarpulla, RC (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	rsc248@northwestern.edu			National Institutes of Health, NIGMS [GM 32525-29]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM032525, R01GM032525] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 32525-29 from NIGMS.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bi TQ, 2010, CANCER BIOL THER, V10, P119, DOI 10.4161/cbt.10.2.12581; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Keibel A, 2009, CURR PHARM DESIGN, V15, P1949, DOI 10.2174/138161209788453167; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee YJ, 2010, ARCH PHARM RES, V33, P1539, DOI 10.1007/s12272-010-1006-7; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lohman FP, 1997, EXP CELL RES, V231, P141, DOI 10.1006/excr.1996.3458; Mammucari C, 2010, MECH AGEING DEV, V131, P536, DOI 10.1016/j.mad.2010.07.003; Mantovani A, 2010, ANN MED, V42, P161, DOI 10.3109/07853890903405753; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Podar K, 2010, CELL CYCLE, V9, P1722, DOI 10.4161/cc.9.9.11358; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Savagner F, 2003, BIOCHEM BIOPH RES CO, V310, P779, DOI 10.1016/j.bbrc.2003.09.076; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shao D, 2010, MITOCHONDRION, V10, P516, DOI 10.1016/j.mito.2010.05.012; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Tesfaigzi Johannes, 1999, Cell Biochemistry and Biophysics, V30, P243, DOI 10.1007/BF02738069; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YAAR M, 1995, EXP CELL RES, V217, P217, DOI 10.1006/excr.1995.1081	48	37	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39715	39725		10.1074/jbc.M111.291575	http://dx.doi.org/10.1074/jbc.M111.291575			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937425	Green Published, hybrid			2022-12-27	WOS:000296925700005
J	Hislop, JN; Henry, AG; von Zastrow, M				Hislop, James N.; Henry, Anastasia G.; von Zastrow, Mark			Ubiquitination in the First Cytoplasmic Loop of mu-Opioid Receptors Reveals a Hierarchical Mechanism of Lysosomal Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; AGONIST-PROMOTED UBIQUITINATION; BETA(2)-ADRENERGIC RECEPTOR; ENDOCYTIC TRAFFICKING; ESCRT MACHINERY; RESENSITIZATION; INTERNALIZATION; DEGRADATION; DEPENDENCE; ENDOSOMES	mu-Type opioid receptors (MORs) are members of the large seven-transmembrane receptor family which transduce the effects of both endogenous neuropeptides and clinically important opioid drugs. Prolonged activation of MORs promotes their proteolytic degradation by endocytic trafficking to lysosomes. This down-regulation process is known to contribute to homeostatic regulation of cellular opioid responsiveness, but mechanisms that mediate and control MOR down-regulation have not been defined. We show here that lysosomal down-regulation of MORs is ESCRT (endosomal sorting complex required for transport)-dependent and involves ubiquitin-promoted transfer of internalized MORs from the limiting endosome membrane to lumen. We also show that MOR down-regulation measured by conventional radioligand binding assay is determined specifically by ubiquitination in the first cytoplasmic loop. Surprisingly, we were unable to find any role of ubiquitination in determining whether internalized receptors recycle or are delivered to lysosomes. Instead, this decision is dictated specifically by the MOR C-tail and occurs irrespectively of the presence or absence of receptor ubiquitination. Our results support a hierarchical organization of discrete ubiquitin-independent and -dependent sorting operations, which function non-redundantly in the conserved down-regulation pathway to mediate precise endocytic control. Furthermore, they show that this hierarchical mechanism discriminates the endocytic regulation of naturally occurring MOR isoforms. Moreover, they are the first to reveal, we believe, for any seven-transmembrane receptor, a functional role of ubiquitination in the first cytoplasmic loop.	[von Zastrow, Mark] Univ Calif San Francisco, Cell Biol Program, San Francisco, CA 94158 USA; [Hislop, James N.; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Hislop, James N.; von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Henry, Anastasia G.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), MC 2140,600 16th St, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu			National Institutes of Health [DA010711, DA012864]; United States National Science Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010711, R01DA010711, R37DA010711, R01DA012864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA010711 and DA012864 (to M. v. Z.).; Recipient of a predoctoral fellowship from the United States National Science Foundation.	Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Chen LY, 2002, TRAFFIC, V3, P110, DOI 10.1034/j.1600-0854.2002.030204.x; Cottrell GS, 2006, J BIOL CHEM, V281, P27773, DOI 10.1074/jbc.M603369200; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Henry AG, 2011, TRAFFIC, V12, P170, DOI 10.1111/j.1600-0854.2010.01145.x; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kieffer BL, 2009, NEUROPHARMACOLOGY, V56, P205, DOI 10.1016/j.neuropharm.2008.07.033; Koch T, 2001, J BIOL CHEM, V276, P31408, DOI 10.1074/jbc.M100305200; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Liang W, 2008, BIOCHEMISTRY-US, V47, P11750, DOI 10.1021/bi800219q; Mansour A, 1997, J NEUROCHEM, V68, P344, DOI 10.1046/j.1471-4159.1997.68010344.x; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; Pons V, 2008, PLOS BIOL, V6, P1942, DOI 10.1371/journal.pbio.0060214; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roxrud I, 2010, BIOL CELL, V102, P293, DOI 10.1042/BC20090161; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; Thompson D, 2007, J BIOL CHEM, V282, P29178, DOI 10.1074/jbc.M704014200; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Walwyn WM, 2010, DRUG ALCOHOL DEPEN, V108, P156, DOI 10.1016/j.drugalcdep.2010.01.001; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091	39	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40193	40204		10.1074/jbc.M111.288555	http://dx.doi.org/10.1074/jbc.M111.288555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953467	Green Published, hybrid			2022-12-27	WOS:000296925700052
J	Li, JH; Deng, M; Wei, Q; Liu, T; Tong, XM; Ye, X				Li, Junhui; Deng, Min; Wei, Qian; Liu, Ting; Tong, Xiaomei; Ye, Xin			Phosphorylation of MCM3 Protein by Cyclin E/Cyclin-dependent Kinase 2 (Cdk2) Regulates Its Function in Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION ORIGINS; XENOPUS EGG EXTRACTS; MINICHROMOSOME MAINTENANCE PROTEINS; S-PHASE; CHECKPOINT KINASES; BUDDING YEAST; COMPLEX; ATR; CHK1; IDENTIFICATION	MCM2-7 proteins form a stable heterohexamer with DNA helicase activity functioning in the DNA replication of eukaryotic cells. The MCM2-7 complex is loaded onto chromatin in a cell cycle-dependent manner. The phosphorylation of MCM2-7 proteins contributes to the formation of the MCM2-7 complex. However, the regulation of specific MCM phosphorylation still needs to be elucidated. In this study, we demonstrate that MCM3 is a substrate of cyclin E/Cdk2 and can be phosphorylated by cyclin E/Cdk2 at Thr-722. We find that the MCM3 T722A mutant binds chromatin much less efficiently when compared with wild type MCM3, suggesting that this phosphorylation site is involved in MCM3 loading onto chromatin. Interestingly, overexpression of MCM3, but not MCM3 T722A mutant, inhibits the S phase entry, whereas it does not affect the exit from mitosis. Knockdown of MCM3 does not affect S phase entry and progression, indicating that a small fraction of MCM3 is sufficient for normal S phase completion. These results suggest that excess accumulation of MCM3 protein onto chromatin may inhibit DNA replication. Other studies indicate that excess of MCM3 up-regulates the phosphorylation of CHK1 Ser-345 and CDK2 Thr-14. These data reveal that the phosphorylation of MCM3 contributes to its function in controlling the S phase checkpoint of cell cycle in addition to the regulation of formation of the MCM2-7 complex.	[Li, Junhui; Deng, Min; Wei, Qian; Liu, Ting; Tong, Xiaomei; Ye, Xin] Chinese Acad Sci, Ctr Mol Immunol, Chinese Acad Sci Key Lab Pathogen Microbiol & Imm, Inst Microbiol, Beijing 100101, Peoples R China; [Li, Junhui; Deng, Min; Wei, Qian; Liu, Ting] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Ctr Mol Immunol, Chinese Acad Sci Key Lab Pathogen Microbiol & Imm, Inst Microbiol, 1 Beichen W Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn			National Natural Science Foundation of China [30871238]; Ministry of Science and Technology of China [2009ZX10004-101, 2008ZX10002-009, 2011CB504705, 2012CB519003]; Chinese Academy of Sciences [KSCX2-EW-J-6];  [81021003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); 	This work was supported by National Natural Science Foundation of China Grant 30871238, The Ministry of Science and Technology of China Grants 2009ZX10004-101, 2008ZX10002-009, 2011CB504705, 2012CB519003, and Chinese Academy of Sciences Innovation Projects KSCX2-EW-J-6.; A principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (81021003). To whom correspondence should be addressed: Center for Molecular Immunology, Chinese Academy of Science Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 1 Beichen West Rd., Chaoyang District, Beijing 100101, China. Tel.: 86-10-64807508; Fax: 86-10-64807513; E-mail: yex@im.ac.cn.	Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Early A, 2004, PHILOS T R SOC B, V359, P31, DOI 10.1098/rstb.2003.1362; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Hendrickson M, 1996, P NATL ACAD SCI USA, V93, P12223, DOI 10.1073/pnas.93.22.12223; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Laezza C, 2006, FEBS LETT, V580, P6076, DOI 10.1016/j.febslet.2006.09.074; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shechter D, 2004, P NATL ACAD SCI USA, V101, P10845, DOI 10.1073/pnas.0404143101; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shi YL, 2007, J BIOL CHEM, V282, P9236, DOI 10.1074/jbc.M609256200; Snyder M, 2009, J BIOL CHEM, V284, P13466, DOI 10.1074/jbc.M809471200; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Sun JY, 2010, ACTA BIOCH BIOPH SIN, V42, P433, DOI 10.1093/abbs/gmq048; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Yim H, 2010, P NATL ACAD SCI USA, V107, P19742, DOI 10.1073/pnas.1013557107	38	34	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39776	39785		10.1074/jbc.M111.226464	http://dx.doi.org/10.1074/jbc.M111.226464			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965652	Green Published, hybrid			2022-12-27	WOS:000296925700011
J	Bindu, S; Pal, C; Dey, S; Goyal, M; Alam, A; Iqbal, MS; Dutta, S; Sarkar, S; Kumar, R; Maity, P; Bandyopadhyay, U				Bindu, Samik; Pal, Chinmay; Dey, Sumanta; Goyal, Manish; Alam, Athar; Iqbal, Mohd Shameel; Dutta, Shubham; Sarkar, Souvik; Kumar, Rahul; Maity, Pallab; Bandyopadhyay, Uday			Translocation of Heme Oxygenase-1 to Mitochondria Is a Novel Cytoprotective Mechanism against Non-steroidal Anti-inflammatory Drug-induced Mitochondrial Oxidative Stress, Apoptosis, and Gastric Mucosal Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; HYDROGEN-PEROXIDE; REACTIVE-OXYGEN; GENE-EXPRESSION; CELL-DEATH; IRON-METABOLISM; CARBON-MONOXIDE; HUMAN MONOCYTES; PROTECTIVE ROLE; HEPATOMA-CELLS	The mechanism of action of heme oxygenase-1 (HO-1) in mitochondrial oxidative stress (MOS)-mediated apoptotic tissue injury was investigated. MOS-mediated gastric mucosal apoptosis and injury were introduced in rat by indomethacin, a non-steroidal anti-inflammatory drug. Here, we report that HO-1 was not only induced but also translocated to mitochondria during gastric mucosal injury to favor repair mechanisms. Furthermore, mitochondrial translocation of HO-1 resulted in the prevention of MOS and mitochondrial pathology as evident from the restoration of the complex I-driven mitochondrial respiratory control ratio and transmembrane potential. Mitochondrial translocation of HO-1 also resulted in time-dependent inhibition of apoptosis. We searched for the plausible mechanisms responsible for HO-1 induction and mitochondrial localization. Free heme, the substrate for HO-1, was increased inside mitochondria during gastric injury, and mitochondrial entry of HO-1 decreased intramitochondrial free heme content, suggesting that a purpose of mitochondrial translocation of HO-1 is to detoxify accumulated heme. Heme may activate nuclear translocation of NF-E2-related factor 2 to induce HO-1 through reactive oxygen species generation. Electrophoretic mobility shift assay and chromatin immunoprecipitation studies indicated nuclear translocation of NF-E2-related factor 2 and its binding to HO-1 promoter to induce HO-1 expression during gastric injury. Inhibition of HO-1 by zinc protoporphyrin aggravated the mucosal injury and delayed healing. Zinc protoporphyrin further reduced the respiratory control ratio and transmembrane potential and enhanced MOS and apoptosis. In contrast, induction of HO-1 by cobalt protoporphyrin reduced MOS, corrected mitochondrial dysfunctions, and prevented apoptosis and gastric injury. Thus, induction and mitochondrial localization of HO-1 are a novel cytoprotective mechanism against MOS-mediated apoptotic tissue injury.	[Bindu, Samik; Pal, Chinmay; Dey, Sumanta; Goyal, Manish; Alam, Athar; Iqbal, Mohd Shameel; Dutta, Shubham; Sarkar, Souvik; Kumar, Rahul; Maity, Pallab; Bandyopadhyay, Uday] Indian Inst Chem Biol, Dept Infect Dis & Immunol, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, Dept Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Dutta, Shubham/ABA-2754-2020; Maity, Pallab/L-3896-2017; Goyal, Manish/O-2183-2015; Alam, Athar/B-3642-2010; Iqbal, Mohd Shameel/AAD-9641-2021	Dutta, Shubham/0000-0001-8484-0717; Maity, Pallab/0000-0001-9769-3533; Goyal, Manish/0000-0003-2383-5409; Iqbal, Mohd Shameel/0000-0002-0353-3561; Bindu, Samik/0000-0003-1416-2003	Council of Scientific and Industrial Research, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grants from the Council of Scientific and Industrial Research, New Delhi.	Aburaya M, 2006, J BIOL CHEM, V281, P33422, DOI 10.1074/jbc.M602074200; ADAMS SS, 1958, NATURE, V181, P773, DOI 10.1038/181773b0; Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; ALAM J, 1989, J BIOL CHEM, V264, P6371; Andreadi CK, 2006, MOL PHARMACOL, V69, P1033, DOI 10.1124/mol.105.018374; APPLEGATE LA, 1991, CANCER RES, V51, P974; Bailey SM, 2002, FREE RADICAL BIO MED, V32, P11, DOI 10.1016/S0891-5849(01)00769-9; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bandyopadhyay U, 2002, LIFE SCI, V71, P2845, DOI 10.1016/S0024-3205(02)02143-4; Bayir H, 2008, CRIT CARE, V12, DOI 10.1186/cc6779; Becker JC, 2003, BIOCHEM BIOPH RES CO, V312, P507, DOI 10.1016/j.bbrc.2003.10.146; Beckman JD, 2011, J BIOL CHEM, V286, P3194, DOI 10.1074/jbc.M110.148726; Belcher JD, 2010, ANTIOXID REDOX SIGN, V12, P233, DOI 10.1089/ars.2009.2822; Benallaoua M, 2007, ARTHRITIS RHEUM, V56, P2585, DOI 10.1002/art.22749; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; BRITTON RS, 1987, CHEM PHYS LIPIDS, V45, P207, DOI 10.1016/0009-3084(87)90066-1; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Campanella A, 2009, HUM MOL GENET, V18, P1, DOI 10.1093/hmg/ddn308; Chan KH, 2011, CLIN SCI, V120, P493, DOI 10.1042/CS20100508; Chattopadhyay I, 2006, FREE RADICAL BIO MED, V40, P1397, DOI 10.1016/j.freeradbiomed.2005.12.016; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Converso DP, 2006, FASEB J, V20, P1236, DOI 10.1096/fj.05-4204fje; Corsi B, 2002, J BIOL CHEM, V277, P22430, DOI 10.1074/jbc.M105372200; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; Farombi EO, 2008, FOOD CHEM TOXICOL, V46, P1279, DOI 10.1016/j.fct.2007.09.095; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Fornai M, 2011, PHARMACOL RES, V63, P59, DOI 10.1016/j.phrs.2010.10.013; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gomes AS, 2010, EUR J PHARMACOL, V642, P140, DOI 10.1016/j.ejphar.2010.05.023; GONZALEZFLECHA B, 1993, J CLIN INVEST, V91, P456, DOI 10.1172/JCI116223; GOPINATHAN V, 1994, FEBS LETT, V349, P197, DOI 10.1016/0014-5793(94)00666-0; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Guha M, 2007, J PINEAL RES, V43, P372, DOI 10.1111/j.1600-079X.2007.00488.x; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Guo JS, 2003, WORLD J GASTROENTERO, V9, P1767, DOI 10.3748/wjg.v9.i8.1767; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Han ZS, 2009, J PHARMACOL EXP THER, V329, P94, DOI 10.1124/jpet.108.145557; Hira S, 2007, IUBMB LIFE, V59, P542, DOI 10.1080/15216540701225941; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Inoue K, 2008, SHOCK, V29, P252, DOI 10.1097/shk.0b013e3180cab913; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Jacob M, 2001, ALIMENT PHARM THER, V15, P1837, DOI 10.1046/j.1365-2036.2001.01095.x; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim JY, 2009, CARDIOVASC RES, V82, P550, DOI 10.1093/cvr/cvp072; Kim NH, 2006, J BIOCHEM MOL BIOL, V39, P452; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Laine L, 1996, Gastrointest Endosc Clin N Am, V6, P489; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lang D, 2005, INT IMMUNOL, V17, P155, DOI 10.1093/intimm/dxh196; Lawson TE, 2011, WOUND REPAIR REGEN, V19, P241, DOI 10.1111/j.1524-475X.2010.00661.x; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li XL, 2008, J IMMUNOL, V180, P6933, DOI 10.4049/jimmunol.180.10.6933; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lithgow T, 2000, FEBS LETT, V476, P22, DOI 10.1016/S0014-5793(00)01663-X; Liu XM, 2005, J BIOL CHEM, V280, P872, DOI 10.1074/jbc.M410413200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAINES MD, 1981, BIOCHIM BIOPHYS ACTA, V673, P339, DOI 10.1016/0304-4165(81)90465-7; Maity P, 2003, MOL CELL BIOCHEM, V253, P329, DOI 10.1023/A:1026040723669; Maity P, 2008, J BIOL CHEM, V283, P14391, DOI 10.1074/jbc.M800414200; Maity P, 2009, J PINEAL RES, V46, P314, DOI 10.1111/j.1600-079X.2009.00663.x; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maricic N, 1999, BRIT J PHARMACOL, V128, P1659, DOI 10.1038/sj.bjp.0702966; Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103; Morse D, 2009, FREE RADICAL BIO MED, V47, P1, DOI 10.1016/j.freeradbiomed.2009.04.007; Musumba C, 2009, ALIMENT PHARM THER, V30, P517, DOI 10.1111/j.1365-2036.2009.04086.x; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pae Hyun-Ock, 2009, Immune Netw, V9, P12, DOI 10.4110/in.2009.9.1.12; Pal C, 2010, FREE RADICAL BIO MED, V49, P258, DOI 10.1016/j.freeradbiomed.2010.04.013; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Rousou AJ, 2004, AM J PHYSIOL-HEART C, V287, pH1967, DOI 10.1152/ajpheart.00338.2004; Rushworth SA, 2006, BIOCHEM BIOPH RES CO, V341, P1007, DOI 10.1016/j.bbrc.2006.01.065; SAHNI SK, 1991, EXP MOL PATHOL, V55, P55, DOI 10.1016/0014-4800(91)90018-S; Sammut IA, 1998, BRIT J PHARMACOL, V125, P1437, DOI 10.1038/sj.bjp.0702212; Santambrogio P, 2007, J HISTOCHEM CYTOCHEM, V55, P1129, DOI 10.1369/jhc.7A7273.2007; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shi ZH, 2010, ANTIOXID REDOX SIGN, V13, P783, DOI 10.1089/ars.2009.3018; Shibuya A, 2010, BIOCHEM BIOPH RES CO, V398, P581, DOI 10.1016/j.bbrc.2010.06.124; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Srivastava P, 1996, INT J BIOCHEM CELL B, V28, P1071, DOI 10.1016/1357-2725(96)00030-1; Sugiyama K, 1997, P NATL ACAD SCI USA, V94, P796, DOI 10.1073/pnas.94.3.796; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; SWIFT GL, 1992, DIGESTION, V53, P88, DOI 10.1159/000200975; Takagi T, 2009, J PHARMACOL EXP THER, V331, P255, DOI 10.1124/jpet.109.152702; Takahashi T, 2006, DRUG DEVELOP RES, V67, P130, DOI 10.1002/ddr.20073; Turkseven S, 2007, J CELL BIOCHEM, V100, P815, DOI 10.1002/jcb.21138; Ueda K, 2008, AM J PHYSIOL-GASTR L, V295, pG460, DOI 10.1152/ajpgi.00204.2007	99	75	78	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39387	39402		10.1074/jbc.M111.279893	http://dx.doi.org/10.1074/jbc.M111.279893			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21908612	Green Published, hybrid			2022-12-27	WOS:000296759800057
J	Mikami, Y; Shibuya, N; Kimura, Y; Nagahara, N; Yamada, M; Kimura, H				Mikami, Yoshinori; Shibuya, Norihiro; Kimura, Yuka; Nagahara, Noriyuki; Yamada, Masahiro; Kimura, Hideo			Hydrogen Sulfide Protects the Retina from Light-induced Degeneration by the Modulation of Ca2+ Influx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; BRAIN SERINE RACEMASE; HORIZONTAL CELLS; GAMMA-LYASE; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; PHOTORECEPTOR APOPTOSIS; CONE PHOTORECEPTORS; CALCIUM-CHANNELS; NITRIC-OXIDE; FEEDBACK	Hydrogen sulfide (H2S) has recently been recognized as a signaling molecule as well as a cytoprotectant. Cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CSE) are well-known as H2S-producing enzymes. We recently demonstrated that 3-mercaptopyruvate sulfurtransferase (3MST) along with cysteine aminotransferase (CAT) produces H2S in the brain and in vascular endothelium. However, the cellular distribution and regulation of these enzymes are not well understood. Here we show that 3MST and CAT are localized to retinal neurons and that the production of H2S is regulated by Ca2+; H2S, in turn, regulates Ca2+ influx into photoreceptor cells by activating vacuolar typeH(+)-ATPase (V-ATPase). We also show that H2S protects retinal neurons from light-induced degeneration. The excessive levels of light exposure deteriorated photoreceptor cells and increased the number of TUNEL- and 8-hydroxy-2'-deoxyguanosine (8-OHdG)-positive cells. Degeneration was greatly suppressed in the retina of mice administered with NaHS, a donor of H2S. The present study provides a new insight into the regulation of H2S production and the modulation of the retinal transmission by H2S. It also shows a cytoprotective effect of H2S on retinal neurons and provides a basis for the therapeutic target for retinal degeneration.	[Mikami, Yoshinori; Shibuya, Norihiro; Kimura, Yuka; Kimura, Hideo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Pharmacol, Kodaira, Tokyo 1878502, Japan; [Nagahara, Noriyuki] Nippon Med Sch, Dept Environm Med, Bunkyo Ku, Tokyo 1138602, Japan; [Yamada, Masahiro] RIKEN Brain Sci Inst, Lab Neuroinformat, Wako, Saitama 3510198, Japan	National Center for Neurology & Psychiatry - Japan; Nippon Medical School; RIKEN	Kimura, H (corresponding author), 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	kimura@ncnp.go.jp	Kimura, Hideo/AGK-0606-2022; Mikami, Yoshinori/G-6174-2011; Mikami, Yoshinori/W-3056-2019; Kimura, Hideo/J-6811-2016	Kimura, Hideo/0000-0002-6069-0475; Mikami, Yoshinori/0000-0002-4335-4170; Mikami, Yoshinori/0000-0002-4335-4170; Kimura, Yuka/0000-0001-9072-9329	National Institute of Neuroscience; KAKENHI [23659089, 23790316, 23700434, 22590258]; Ministry of Health Labor and Welfare; Grants-in-Aid for Scientific Research [23790316] Funding Source: KAKEN	National Institute of Neuroscience; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the National Institute of Neuroscience and by KAKENHI (23659089) from Grant-in-Aid for Challenging Exploratory Research (to H. K.), by KAKENHI (23790316) from Grant-in-Aid for Young Scientists (B) (to Y. M.), by KAKENHI (23700434) from Grant-in-Aid for Young Scientists (B) and Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare (to N. S.), and by KAKENHI (22590258) from Grant-in-Aid for Scientific Research (C) (to Y. K.).	Abe K, 1996, J NEUROSCI, V16, P1066; Babai N, 2009, J PHYSIOL-LONDON, V587, P2353, DOI 10.1113/jphysiol.2009.169656; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Baumgart F, 2007, FEBS J, V274, P4561, DOI 10.1111/j.1742-4658.2007.05986.x; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Boehning D, 2004, J BIOL CHEM, V279, P30927, DOI 10.1074/jbc.C400222200; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Cook SP, 2002, J BIOL CHEM, V277, P27782, DOI 10.1074/jbc.M111814200; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Donovan M, 2002, CELL DEATH DIFFER, V9, P1220, DOI 10.1038/sj.cdd.4401105; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; FENG Y, 1992, J BIOL CHEM, V267, P5817; Hayashida Y, 2002, J NEUROPHYSIOL, V87, P172, DOI 10.1152/jn.00778.2000; Hirasawa H, 2003, J GEN PHYSIOL, V122, P657, DOI 10.1085/jgp.200308863; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Ichinohe A, 2005, BIOCHEM BIOPH RES CO, V338, P1547, DOI 10.1016/j.bbrc.2005.10.118; INAGAKI N, 1985, BRAIN RES, V325, P336, DOI 10.1016/0006-8993(85)90335-X; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Jouhou H, 2007, J PHYSIOL-LONDON, V585, P401, DOI 10.1113/jphysiol.2007.142646; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Kawamura N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012086; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; MILLER JE, 1971, J BIOL CHEM, V246, P3234; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Noell W K, 1966, Invest Ophthalmol, V5, P450; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Pong WW, 2007, J COMP NEUROL, V505, P158, DOI 10.1002/cne.21468; Rutter GA, 2000, TRENDS BIOCHEM SCI, V25, P215, DOI 10.1016/S0968-0004(00)01585-1; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; TACHIBANA M, 1984, P NATL ACAD SCI-BIOL, V81, P7961, DOI 10.1073/pnas.81.24.7961; Tatsukawa T, 2005, VISUAL NEUROSCI, V22, P317, DOI 10.1017/S0952523805223076; Tsugane M, 2007, ANTIOXID REDOX SIGN, V9, P257, DOI 10.1089/ars.2007.9.257; UBUKA T, 1978, PHYSIOL CHEM PHYS M, V10, P483; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	49	106	117	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39379	39386		10.1074/jbc.M111.298208	http://dx.doi.org/10.1074/jbc.M111.298208			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937432	Green Published, hybrid			2022-12-27	WOS:000296759800056
J	Ohashi, T; Erickson, HP				Ohashi, Tomoo; Erickson, Harold P.			Fibronectin Aggregation and Assembly THE UNFOLDING OF THE SECOND FIBRONECTIN TYPE III DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; STREPTOCOCCUS-PYOGENES; PLASMA FIBRONECTIN; SELF-ASSOCIATION; TERMINAL 70-KDA; GELATIN-BINDING; MATRIX; DOMAIN; PROTEIN; SITES	The mechanism of fibronectin (FN) assembly and the self-association sites are still unclear and contradictory, although the N-terminal 70-kDa region ((I)1-9) is commonly accepted as one of the assembly sites. We previously found that (I)1-9 binds to superfibronectin, which is an artificial FN aggregate induced by anastellin. In the present study, we found that (I)1-9 bound to the aggregate formed by anastellin and a small FN fragment, (III)1-2. An engineered disulfide bond in (III)2, which stabilizes folding, inhibited aggregation, but a disulfide bond in (III)1 did not. A gelatin precipitation assay showed that (I)1-9 did not interact with anastellin, (III)1, (III)2, (III)1-2, or several (III)1-2 mutants including (III)1-2KADA. (In contrast to previous studies, we found that the (III)1-2KADA mutant was identical in conformation to wildtype (III)1-2.) Because (I)1-9 only bound to the aggregate and the unfolding of (III)2 played a role in aggregation, we generated a (III)2 domain that was destabilized by deletion of the G strand. This mutant bound (I)1-9 as shown by the gelatin precipitation assay and fluorescence resonance energy transfer analysis, and it inhibited FN matrix assembly when added to cell culture. Next, we introduced disulfide mutations into full-length FN. Three disulfide locks in (III)2, (III)3, and (III)11 were required to dramatically reduce anastellin-induced aggregation. When we tested the disulfide mutants in cell culture, only the disulfide bond in (III)2 reduced the FN matrix. These results suggest that the unfolding of (III)2 is one of the key factors for FN aggregation and assembly.	[Ohashi, Tomoo; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Ohashi, T (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3709, Durham, NC 27710 USA.	t.ohashi@cellbio.duke.edu			National Institutes of Health [CA047056]; NATIONAL CANCER INSTITUTE [R37CA047056, R01CA047056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA047056.	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; AN SSA, 1992, BIOCHEMISTRY-US, V31, P9927, DOI 10.1021/bi00156a010; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; Chen F, 1996, J BIOL CHEM, V271, P9084, DOI 10.1074/jbc.271.15.9084; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Hamill SJ, 1998, BIOCHEMISTRY-US, V37, P8071, DOI 10.1021/bi9801659; Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241; HSIEH P, 1980, J CELL BIOL, V87, P14, DOI 10.1083/jcb.87.1.14; HYNES RO, 1977, P NATL ACAD SCI USA, V74, P2855, DOI 10.1073/pnas.74.7.2855; Hynes RO, 1990, FIBRONECTINS; ICHIHARATANAKA K, 1992, FEBS LETT, V299, P155, DOI 10.1016/0014-5793(92)80236-A; ICHIHARATANAKA K, 1995, J CELL SCI, V108, P907; KAR L, 1993, J BIOL CHEM, V268, P8580; Karuri NW, 2009, J BIOL CHEM, V284, P3445, DOI 10.1074/jbc.M805025200; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; KESKIOJA J, 1977, BIOCHEM BIOPH RES CO, V74, P699, DOI 10.1016/0006-291X(77)90359-X; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; Maqueda A, 2007, MATRIX BIOL, V26, P642, DOI 10.1016/j.matbio.2007.06.001; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCCONNELL MR, 1978, J BIOL CHEM, V253, P7522; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Niimi T, 2001, J BIOMOL NMR, V21, P281, DOI 10.1023/A:1012947209393; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ohashi T, 2002, J CELL SCI, V115, P1221; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Ohashi T, 2009, BIOCHEMISTRY-US, V48, P4189, DOI 10.1021/bi900001g; Ohashi T, 2009, MATRIX BIOL, V28, P170, DOI 10.1016/j.matbio.2009.03.002; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; PETERSEN TE, 1983, P NATL ACAD SCI-BIOL, V80, P137, DOI 10.1073/pnas.80.1.137; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Santas AJ, 2002, J BIOL CHEM, V277, P13650, DOI 10.1074/jbc.M111361200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 2000, J CELL SCI, V113, P1491; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; SOTTILE J, 1993, BIOCHEMISTRY-US, V32, P1641, DOI 10.1021/bi00057a031; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Wu CY, 1998, J BIOL CHEM, V273, P528, DOI 10.1074/jbc.273.1.528; Xu JL, 2010, J BIOL CHEM, V285, P8563, DOI 10.1074/jbc.M109.062646; YAMADA KM, 1977, BIOCHEMISTRY-US, V16, P5552, DOI 10.1021/bi00644a025	57	26	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39188	39199		10.1074/jbc.M111.262337	http://dx.doi.org/10.1074/jbc.M111.262337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949131	Green Published, hybrid			2022-12-27	WOS:000296759800038
J	Sasaki, M; Kim, E; Igarashi, M; Ito, K; Hasebe, R; Fukushi, H; Sawa, H; Kimura, T				Sasaki, Michihito; Kim, Eunmi; Igarashi, Manabu; Ito, Kimihito; Hasebe, Rie; Fukushi, Hideto; Sawa, Hirofumi; Kimura, Takashi			Single Amino Acid Residue in the A2 Domain of Major Histocompatibility Complex Class I Is Involved in the Efficiency of Equine Herpesvirus-1 Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-D; EHV-1; RECEPTOR; TYPE-1; VIRUS; ACTIVATION; SOLVATION; MUTANT; GENES; CELLS	Equine herpesvirus-1 (EHV-1), an alpha-herpesvirus of the family Herpesviridae, causes respiratory disease, abortion, and encephalomyelitis in horses. EHV-1 utilizes equine MHC class I molecules as entry receptors. However, hamster MHC class I molecules on EHV-1-susceptible CHO-K1 cells play no role in EHV-1 entry. To identify the MHC class I molecule region that is responsible for EHV-1 entry, domain exchange and site-directed mutagenesis experiments were performed, in which parts of the extracellular region of hamster MHC class I (clone C5) were replaced with corresponding sequences from equine MHC class I (clone A68). Substitution of alanine for glutamine at position 173 (Q173A) within the alpha 2 domain of the MHC class I molecule enabled hamster MHC class I C5 to mediate EHV-1 entry into cells. Conversely, substitution of glutamine for alanine at position 173 (A173Q) in equine MHC class I A68 resulted in loss of EHV-1 receptor function. Equine MHC class I clone 3.4, which possesses threonine at position 173, was unable to act as an EHV-1 receptor. Substitution of alanine for threonine at position 173 (T173A) enabled MHC class I 3.4 to mediate EHV-1 entry into cells. These results suggest that the amino acid residue at position 173 of the MHC class I molecule is involved in the efficiency of EHV-1 entry.	[Kimura, Takashi] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Mol Pathobiol, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Igarashi, Manabu; Ito, Kimihito] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioinformat, Sapporo, Hokkaido 0010020, Japan; [Hasebe, Rie] Hokkaido Univ, Lab Vet Hyg, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan; [Fukushi, Hideto] Gifu Univ, United Grad Sch Vet Sci, Dept Appl Vet Sci, Gifu 5011193, Japan; [Fukushi, Hideto] Gifu Univ, Lab Vet Microbiol, Fac Appl Biol Sci, Gifu 5011193, Japan; [Sawa, Hirofumi] Hokkaido Univ, Global COE Program, Sapporo, Hokkaido 0600818, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Gifu University; Gifu University; Hokkaido University	Kimura, T (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Dept Mol Pathobiol, Kita Ku, West 10,North 20, Sapporo, Hokkaido 0010020, Japan.	kimura@czc.hokudai.ac.jp	Ito, Kimihito/E-9975-2012; Sawa, Hirofumi/F-6954-2012; Igarashi, Manabu/F-6871-2012; Sawa, Hirofumi/AAW-8816-2021; Kimura, Takashi/F-6880-2012; Sasaki, Michihito/AAY-1900-2021	Ito, Kimihito/0000-0003-4986-1795; Sawa, Hirofumi/0000-0003-2569-2755; Sasaki, Michihito/0000-0003-1607-2175; HASEBE, Rie/0000-0003-2009-0595	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Akiyama Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Akiyama Foundation	This work was supported by a grant-in-aid for scientific research (B) (to T. K.), by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases (to M. S., T. K., and H. S.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and by a grant from the Akiyama Foundation (to T. K.).	BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Csellner H, 2000, ARCH VIROL, V145, P2371, DOI 10.1007/s007050070027; DeLano W.L, PYMOL MOL GRAPHICS S; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Frampton AR, 2005, J VIROL, V79, P3169, DOI 10.1128/JVI.79.5.3169-3173.2005; Frampton AR, 2007, J VIROL, V81, P10879, DOI 10.1128/JVI.00504-07; Furukawa H, 2002, J IMMUNOL, V169, P126, DOI 10.4049/jimmunol.169.1.126; Hasebe R, 2009, VIROLOGY, V393, P198, DOI 10.1016/j.virol.2009.07.032; Ibrahim ESM, 2004, MICROBIOL IMMUNOL, V48, P831, DOI 10.1111/j.1348-0421.2004.tb03615.x; Janeway C. A., 2005, IMMUNOBIOLOGY, P169; Kohn C. W., 2006, Clinical Techniques in Equine Practice, V5, P60, DOI 10.1053/j.ctep.2006.01.011; Kurtz BM, 2010, J VIROL, V84, P9027, DOI 10.1128/JVI.00287-10; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Osterrieder N, 1999, VIRUS RES, V59, P165, DOI 10.1016/S0168-1702(98)00134-8; Patel JR, 2005, VET J, V170, P14, DOI 10.1016/j.tvjl.2004.04.018; Sasaki M, 2011, GENES CELLS, V16, P343, DOI 10.1111/j.1365-2443.2011.01491.x; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Stierstorfer B, 2002, J VET MED B, V49, P37, DOI 10.1046/j.1439-0450.2002.00537.x; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Studdert MJ, 2003, VET REC, V153, P417, DOI 10.1136/vr.153.14.417; Sugahara Y, 1997, ARCH VIROL, V142, P1849, DOI 10.1007/s007050050202; Tallmadge RL, 2010, IMMUNOGENETICS, V62, P159, DOI 10.1007/s00251-009-0420-9; Tallmadge RL, 2005, IMMUNOGENETICS, V57, P763, DOI 10.1007/s00251-005-0034-9; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Van de Walle GR, 2008, J VIROL, V82, P11859, DOI 10.1128/JVI.00868-08; Whalley JM, 2007, ARCH VIROL, V152, P717, DOI 10.1007/s00705-006-0885-x	27	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39370	39378		10.1074/jbc.M111.251751	http://dx.doi.org/10.1074/jbc.M111.251751			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949188	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000296759800055
J	Sharma, V; Ichikawa, M; He, P; Bravo, Y; Dahl, R; Ng, BG; Cosford, NDP; Freeze, HH				Sharma, Vandana; Ichikawa, Mie; He, Ping; Bravo, Yalda; Dahl, Russell; Ng, Bobby G.; Cosford, Nicholas D. P.; Freeze, Hudson H.			Phosphomannose Isomerase Inhibitors Improve N-Glycosylation in Selected Phosphomannomutase-deficient Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL DISORDERS; EMBRYONIC LETHALITY; MUTATIONS; IA; PMM2; DERIVATIVES	Congenital disorders of glycosylation (CDG) are rare genetic disorders due to impaired glycosylation. The patients with sub-types CDG-Ia and CDG-Ib have mutations in the genes encoding phosphomannomutase 2 (PMM2) and phosphomannose isomerase (MPI or PMI), respectively. PMM2(mannose 6-phosphate -> mannose 1-phosphate) and MPI (mannose 6-phosphate double left right arrow fructose 6-phosphate) deficiencies reduce the metabolic flux of mannose 6-phosphate (Man-6-P) into glycosylation, resulting in unoccupied N-glycosylation sites. Both PMM2 and MPI compete for the same substrate, Man-6-P. Daily mannose doses reverse most of the symptoms of MPI-deficient CDG-Ib patients. However, CDG-Ia patients do not benefit from mannose supplementation because >95% Man-6-P is catabolized by MPI. We hypothesized that inhibiting MPI enzymatic activity would provide more Man-6-P for glycosylation and possibly benefit CDG-Ia patients with residual PMM2 activity. Here we show that MLS0315771, a potent MPI inhibitor from the benzoisothiazolone series, diverts Man-6-P toward glycosylation in various cell lines including fibroblasts from CDG-Ia patients and improves N-glycosylation. Finally, we show that MLS0315771 increases mannose metabolic flux toward glycosylation in zebrafish embryos.	[Sharma, Vandana; Ichikawa, Mie; He, Ping; Ng, Bobby G.; Freeze, Hudson H.] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA; [Bravo, Yalda; Dahl, Russell; Cosford, Nicholas D. P.] Sanford Burnham Med Res Inst, Apoptosis & Cell Death Res Program, La Jolla, CA 92037 USA; [Bravo, Yalda; Dahl, Russell; Cosford, Nicholas D. P.] Sanford Burnham Med Res Inst, Conrad Prebys Ctr Chem Genom, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Freeze, HH (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org		Dahl, Russell/0000-0002-2939-1004; Cosford, Nic/0000-0001-7228-4709; Freeze, Hudson/0000-0001-6316-0501; Scott, David/0000-0002-8668-2449	National Institutes of Health [R01-DK55615, R21-HD062914]; Rocket Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocket Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK55615 and R21-HD062914 and The Rocket Fund (to H. H. F.).	Briones P, 2002, J INHERIT METAB DIS, V25, P635; Dahl R, 2011, J MED CHEM, V54, P3661, DOI 10.1021/jm101401a; DeRossi C, 2006, J BIOL CHEM, V281, P5916, DOI 10.1074/jbc.M511982200; Eklund EA, 2005, GLYCOBIOLOGY, V15, P1084, DOI 10.1093/glycob/cwj006; Freeze H. H., 2010, CURRENT PROTOCOLS MO, V4; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Freeze HH, 2010, SEMIN CELL DEV BIOL, V21, P655, DOI 10.1016/j.semcdb.2010.03.011; GRACY RW, 1968, J BIOL CHEM, V243, P3161; Grunewald S, 2009, BBA-MOL BASIS DIS, V1792, P827, DOI 10.1016/j.bbadis.2009.01.003; Haeuptle MA, 2011, J BIOL CHEM, V286, P6085, DOI 10.1074/jbc.M110.165795; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Vega AI, 2011, J INHERIT METAB DIS, V34, P929, DOI 10.1007/s10545-011-9328-2; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Kjaergaard S, 1998, EUR J HUM GENET, V6, P331, DOI 10.1038/sj.ejhg.5200194; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Panneerselvam K, 1996, J CLIN INVEST, V97, P1478, DOI 10.1172/JCI118570; Pirard M, 1999, FEBS LETT, V452, P319, DOI 10.1016/S0014-5793(99)00673-0; Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10; Price NPJ, 2004, ANAL CHEM, V76, P6566, DOI 10.1021/ac049198m; PROUDFOOT AEI, 1994, J PROTEIN CHEM, V13, P619, DOI 10.1007/BF01890460; Schollen E, 2000, EUR J HUM GENET, V8, P367, DOI 10.1038/sj.ejhg.5200470; Sharma V, 2011, J BIOL CHEM, V286, P10193, DOI 10.1074/jbc.M110.194241; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; Vuillaumier-Barrot S, 2000, J MED GENET, V37, P579, DOI 10.1136/jmg.37.8.579	29	28	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39431	39438		10.1074/jbc.M111.285502	http://dx.doi.org/10.1074/jbc.M111.285502			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949237	Green Published, hybrid			2022-12-27	WOS:000296759800060
J	Xu, LH; Huang, M; Fang, SG; Liu, DX				Xu, Ling Hui; Huang, Mei; Fang, Shou Guo; Liu, Ding Xiang			Coronavirus Infection Induces DNA Replication Stress Partly through Interaction of Its Nonstructural Protein 13 with the p125 Subunit of DNA Polymerase delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; ACUTE RESPIRATORY SYNDROME; TELANGIECTASIA MUTATED KINASE; S-PHASE CHECKPOINT; CELL-CYCLE ARREST; BRONCHITIS VIRUS; ATAXIA-TELANGIECTASIA; CULTURED-CELLS; VIRAL REPLICATION	Perturbation of cell cycle regulation is a characteristic feature of infection by many DNA and RNA viruses, including Coronavirus infectious bronchitis virus (IBV). IBV infection was shown to induce cell cycle arrest at both S and G(2)/M phases for the enhancement of viral replication and progeny production. However, the underlying mechanisms are not well explored. In this study we show that activation of cellular DNA damage response is one of the mechanisms exploited by Coronavirus to induce cell cycle arrest. An ATR-dependent cellular DNA damage response was shown to be activated by IBV infection. Suppression of the ATR kinase activity by chemical inhibitors and siRNA-mediated knockdown of ATR reduced the IBV-induced ATR signaling and inhibited the replication of IBV. Furthermore, yeast two-hybrid screens and subsequent biochemical and functional studies demonstrated that interaction between Coronavirus nsp13 and DNA polymerase delta induced DNA replication stress in IBV-infected cells. These findings indicate that the ATR signaling activated by IBV replication contributes to the IBV-induced S-phase arrest and is required for efficient IBV replication and progeny production.	[Xu, Ling Hui; Huang, Mei; Fang, Shou Guo; Liu, Ding Xiang] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liu, DX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	dxliu@ntu.edu.sg	Liu, Ding Xiang/A-2226-2011					ABOUSSEKHRA A, 1995, EXP CELL RES, V221, P326, DOI 10.1006/excr.1995.1382; ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Ariumi Y, 2008, J VIROL, V82, P9639, DOI 10.1128/JVI.00351-08; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Chaurushiya MS, 2009, DNA REPAIR, V8, P1166, DOI 10.1016/j.dnarep.2009.04.016; Choudhuri T, 2007, J VIROL, V81, P6718, DOI 10.1128/JVI.00053-07; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costanzo V, 2003, CELL CYCLE, V2, pA16, DOI 10.4161/cc.2.1.290; Digweed M, 2002, ONCOGENE, V21, P4873, DOI 10.1038/sj.onc.1205616; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Dove B, 2006, J VIROL, V80, P4147, DOI 10.1128/JVI.80.8.4147-4156.2006; Fang SG, 2005, BIOCHEM BIOPH RES CO, V336, P417, DOI 10.1016/j.bbrc.2005.08.105; Fang SG, 2008, VIROLOGY, V379, P175, DOI 10.1016/j.virol.2008.06.038; Fang SG, 2007, VIROLOGY, V358, P136, DOI 10.1016/j.virol.2006.08.020; Hagemeijer MC, 2010, J VIROL, V84, P2134, DOI 10.1128/JVI.01716-09; Halas A, 1997, CURR GENET, V31, P292, DOI 10.1007/s002940050208; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Kudoh A, 2009, J VIROL, V83, P6641, DOI 10.1128/JVI.00049-09; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; Larrea AA, 2010, P NATL ACAD SCI USA, V107, P17674, DOI 10.1073/pnas.1010178107; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li FQS, 2005, FEBS LETT, V579, P2387, DOI 10.1016/j.febslet.2005.03.039; Li FQ, 2007, VIROLOGY, V365, P435, DOI 10.1016/j.virol.2007.04.015; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Liu C, 2001, J VIROL, V75, P6402, DOI 10.1128/JVI.75.14.6402-6409.2001; Liu JS, 2006, J CELL BIOCHEM, V99, P1452, DOI 10.1002/jcb.21066; Longley MJ, 1997, J BIOL CHEM, V272, P10917; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Manthey KC, 2007, J CELL SCI, V120, P4221, DOI 10.1242/jcs.004580; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Nishida H, 2009, NUCLEIC ACIDS RES, V37, P5678, DOI 10.1093/nar/gkp593; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Overmeer RM, 2010, MOL CELL BIOL, V30, P4828, DOI 10.1128/MCB.00285-10; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Pohler JRG, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-17; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Rohaly G, 2010, J VIROL, V84, P10727, DOI 10.1128/JVI.00122-10; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schang Luis M, 2003, Prog Cell Cycle Res, V5, P103; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; Shen HY, 2009, J VIROL METHODS, V160, P48, DOI 10.1016/j.jviromet.2009.04.023; Shi YL, 2005, J BIOL CHEM, V280, P40195, DOI 10.1074/jbc.C500400200; Spardy N, 2009, CANCER RES, V69, P7022, DOI 10.1158/0008-5472.CAN-09-0925; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wang K, 2010, CANCER GENET CYTOGEN, V200, P40, DOI 10.1016/j.cancergencyto.2010.03.006; Wang XX, 2009, J VIROL, V83, P12462, DOI 10.1128/JVI.01546-09; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Won JJ, 2006, NAT CHEM BIOL, V2, P369, DOI 10.1038/nchembio800; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Xiao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001494; Xu LH, 2010, J VIROL, V84, P8571, DOI 10.1128/JVI.00392-10; Yamada Y, 2009, J VIROL, V83, P8744, DOI 10.1128/JVI.00613-09; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; ZENG XR, 1994, J BIOL CHEM, V269, P13748; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	89	61	63	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39546	39559		10.1074/jbc.M111.242206	http://dx.doi.org/10.1074/jbc.M111.242206			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21918226	hybrid, Green Published			2022-12-27	WOS:000296759800072
J	Zhang, GY; Xiang, BG; Ye, SJ; Chrzanowska-Wodnicka, M; Morris, AJ; Gartner, TK; Whiteheart, SW; White, GC; Smyth, SS; Li, ZY				Zhang, Guoying; Xiang, Binggang; Ye, Shaojing; Chrzanowska-Wodnicka, Magdalena; Morris, Andrew J.; Gartner, T. Kent; Whiteheart, Sidney W.; White, Gilbert C., II; Smyth, Susan S.; Li, Zhenyu			Distinct Roles for Rap1b Protein in Platelet Secretion and Integrin alpha(IIb)beta(3) Outside-in Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE RAP1B; MICE LACKING; CALDAG-GEFI; BETA-3-INTEGRIN-DEFICIENT MICE; THROMBUS FORMATION; THROMBOXANE A(2); RELEASE REACTION; GRANULE RELEASE; RHO-GTPASES; ACTIVATION	Rap1b is activated by platelet agonists and plays a critical role in integrin alpha(IIb)beta(3) inside-out signaling and platelet aggregation. Here we show that agonist-induced Rap1b activation plays an important role in stimulating secretion of platelet granules. We also show that alpha(IIb)beta(3) outside-in signaling can activate Rap1b, and integrin outside-in signaling-mediated Rap1b activation is important in facilitating platelet spreading on fibrinogen and clot retraction. Rap1b-deficient platelets had diminished ATP secretion and P-selectin expression induced by thrombin or collagen. Importantly, addition of low doses of ADP and/or fibrinogen restored aggregation of Rap1b-deficient platelets. Furthermore, we found that Rap1b was activated by platelet spreading on immobilized fibrinogen, a process that was not affected by P2Y(12) or TXA(2) receptor deficiency, but was inhibited by the selective Src inhibitor PP2, the PKC inhibitor Ro-31-8220, or the calcium chelator demethyl-1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid tetrakis. Clot retraction was abolished, and platelet spreading on fibrinogen was diminished in Rap1b-deficient platelets compared with wild-type controls. The defects in clot retraction and spreading on fibrinogen of Rap1b-deficient platelets were not rescued by addition of MnCl2, which elicits alpha(IIb)beta(3) outside-in signaling in the absence of inside-out signaling. Thus, our results reveal two different activation mechanisms of Rap1b as well as novel functions of Rap1b in platelet secretion and in integrin alpha(IIb)beta(3) outside-in signaling.	[Zhang, Guoying; Xiang, Binggang; Morris, Andrew J.; Smyth, Susan S.; Li, Zhenyu] Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, Lexington, KY 40536 USA; [Ye, Shaojing; Whiteheart, Sidney W.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Chrzanowska-Wodnicka, Magdalena] Med Coll Wisconsin, Blood Res Inst, Dept Vasc Signaling, Milwaukee, WI 53226 USA; [Gartner, T. Kent] Univ Memphis, Dept Biol, Memphis, TN 38152 USA; [White, Gilbert C., II] Med Coll Wisconsin, Dept Med, Lab Platelet, Milwaukee, WI 53226 USA; [Smyth, Susan S.] Lexington Vet Adm Med Ctr, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; University of Memphis; Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Li, ZY (corresponding author), Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, 741 S Limestone St,BBSRB Bldg,Rm 251, Lexington, KY 40536 USA.	zhenyuli08@uky.edu	Xiang, Binggang/N-6494-2013	Whiteheart, Sidney/0000-0001-5577-0473; Chrzanowska, Magdalena/0000-0003-4182-2126	National Institutes of Health Cardiovascular Disease from the National Center for Research Resources [P20RR021954]; American Heart Association [0855698G, 0950118G]; Centers of Biomedical Research Excellence in Obesity; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056652] Funding Source: NIH RePORTER	National Institutes of Health Cardiovascular Disease from the National Center for Research Resources; American Heart Association(American Heart Association); Centers of Biomedical Research Excellence in Obesity; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Cardiovascular Disease Grant P20RR021954 from the National Center for Research Resources. This work was also supported by American Heart Association Midwest affiliate Grand-in-Aid 0855698G (to Z. L.) and 0950118G (to M. C.-W.), and in part by the Centers of Biomedical Research Excellence in Obesity. This material is the result of work supported with the resources and use of the facilities at the Lexington VA Medical Center.	Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; Arai A, 2001, J BIOL CHEM, V276, P10453, DOI 10.1074/jbc.M004627200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Bernardi B, 2006, BLOOD, V107, P2728, DOI 10.1182/blood-2005-07-3023; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Boylan B, 2008, BLOOD, V112, P2780, DOI 10.1182/blood-2008-02-142125; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Campus F, 2005, J BIOL CHEM, V280, P24386, DOI 10.1074/jbc.M501174200; CHEN YP, 1994, J BIOL CHEM, V269, P18307; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Franke B, 2000, MOL CELL BIOL, V20, P779, DOI 10.1128/MCB.20.3.779-785.2000; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Graham GJ, 2009, BLOOD, V114, P1083, DOI 10.1182/blood-2009-03-210211; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Larson MK, 2003, BLOOD, V101, P1409, DOI 10.1182/blood-2002-05-1533; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Reddy KB, 2008, J CELL SCI, V121, P1641, DOI 10.1242/jcs.014076; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Smyth SS, 2001, BLOOD, V98, P1055, DOI 10.1182/blood.V98.4.1055; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Wang Z, 2009, J THROMB HAEMOST, V7, P693, DOI 10.1111/j.1538-7836.2009.03289.x; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200; Xiang B, 2010, J THROMB HAEMOST, V8, P2032, DOI 10.1111/j.1538-7836.2010.03969.x	55	52	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39466	39477		10.1074/jbc.M111.239608	http://dx.doi.org/10.1074/jbc.M111.239608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940635	Green Published, hybrid			2022-12-27	WOS:000296759800064
J	Cipolla, A; D'Amico, S; Barumandzadeh, R; Matagne, A; Feller, G				Cipolla, Alexandre; D'Amico, Salvino; Barumandzadeh, Roya; Matagne, Andre; Feller, Georges			Stepwise Adaptations to Low Temperature as Revealed by Multiple Mutants of Psychrophilic alpha-Amylase from Antarctic Bacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD ADAPTATION; ALTEROMONAS-HALOPLANCTIS; THERMODYNAMIC STABILITY; STRUCTURAL-ANALYSIS; CITRATE SYNTHASE; ENZYMES; PROTEIN; ENVIRONMENTS; INHIBITOR; INSIGHTS	The mutants Mut5 and Mut5CC from a psychrophilic alpha-amylase bear representative stabilizing interactions found in the heat-stable porcine pancreatic alpha-amylase but lacking in the cold-active enzyme from an Antarctic bacterium. From an evolutionary perspective, these mutants can be regarded as structural intermediates between the psychrophilic and the mesophilic enzymes. We found that these engineered interactions improve all the investigated parameters related to protein stability as follows: compactness; kinetically driven stability; thermodynamic stability; resistance toward chemical denaturation, and the kinetics of unfolding/refolding. Concomitantly to this improved stability, both mutants have lost the kinetic optimization to low temperature activity displayed by the parent psychrophilic enzyme. These results provide strong experimental support to the hypothesis assuming that the disappearance of stabilizing interactions in psychrophilic enzymes increases the amplitude of concerted motions required by catalysis and the dynamics of active site residues at low temperature, leading to a higher activity.	[Feller, Georges] Univ Liege, Inst Chem B6A, Ctr Prot Engn, Biochem Lab, B-4000 Liege, Belgium; [Barumandzadeh, Roya; Matagne, Andre] Univ Liege, Ctr Prot Engn, Labs Enzymol & Prot Folding, B-4000 Liege, Belgium	University of Liege; University of Liege	Feller, G (corresponding author), Univ Liege, Inst Chem B6A, Ctr Prot Engn, Biochem Lab, B-4000 Liege, Belgium.	gfeller@ulg.ac.be			Fonds de la Recherche Scientifique-Fonds; National de la Recherche Scientifique; Belgium Fonds de la Recherche Fondamentale et Collective [2.4535.08, 2.4530.09]; Belgian Program of Interuniversity Attraction Poles [P6/19]; Institut Polaire Francais	Fonds de la Recherche Scientifique-Fonds; National de la Recherche Scientifique; Belgium Fonds de la Recherche Fondamentale et Collective(Fonds de la Recherche Scientifique - FNRS); Belgian Program of Interuniversity Attraction Poles; Institut Polaire Francais	This work was supported by the Fonds de la Recherche Scientifique-Fonds, National de la Recherche Scientifique, Belgium Fonds de la Recherche Fondamentale et Collective Contracts 2.4535.08 (to G. F.) and 2.4530.09 (to A. M.) and the Belgian Program of Interuniversity Attraction Poles initiated by the Federal Office for Scientific, Technical and Cultural Affaires P6/19.; We thank H. Bichoff (Bayer AG, Germany) for the kind gift of acarbose. The support of the Institut Polaire Francais was also appreciated.	Aghajari N, 1998, STRUCTURE, V6, P1503, DOI 10.1016/S0969-2126(98)00149-X; Aghajari N, 1998, PROTEIN SCI, V7, P564, DOI 10.1002/pro.5560070304; Aghajari N, 2002, PROTEIN SCI, V11, P1435, DOI 10.1110/ps.0202602; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Bell GS, 2002, EUR J BIOCHEM, V269, P6250, DOI 10.1046/j.1432-1033.2002.03344.x; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; Collins T, 2006, ANAL BIOCHEM, V352, P299, DOI 10.1016/j.ab.2006.01.035; Coquelle N, 2007, J MOL BIOL, V374, P547, DOI 10.1016/j.jmb.2007.09.049; D'Amico S, 2000, GENE, V253, P95, DOI 10.1016/S0378-1119(00)00229-8; D'Amico S, 2006, J MOL BIOL, V358, P1296, DOI 10.1016/j.jmb.2006.03.004; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; D'Amico S, 2003, J MOL BIOL, V332, P981, DOI 10.1016/j.jmb.2003.07.014; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; D'Amico S, 2002, J BIOL CHEM, V277, P46110, DOI 10.1074/jbc.M207253200; D'Amico S, 2001, J BIOL CHEM, V276, P25791, DOI 10.1074/jbc.M102741200; D'Amico S, 2009, ANAL BIOCHEM, V385, P389, DOI 10.1016/j.ab.2008.11.016; Da Lage JL, 2004, CELL MOL LIFE SCI, V61, P97, DOI 10.1007/s00018-003-3334-y; Deming JW, 2002, CURR OPIN MICROBIOL, V5, P301, DOI 10.1016/S1369-5274(02)00329-6; Feller G, 1999, BIOCHEMISTRY-US, V38, P4613, DOI 10.1021/bi982650+; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; FELLER G, 1994, EUR J BIOCHEM, V222, P441, DOI 10.1111/j.1432-1033.1994.tb18883.x; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Gerday C, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, pXV; Gianese G, 2002, PROTEINS, V47, P236, DOI 10.1002/prot.10084; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Margesin R., 2008, PSYCHROPHILES BIODIV; MATOUSCHEK A, 1994, PROTEIN ENG, V7, P1089, DOI 10.1093/protein/7.9.1089; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229; Privalov Peter L., 1992, P83; QIAN MX, 1994, BIOCHEMISTRY-US, V33, P6284, DOI 10.1021/bi00186a031; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Roulling F., 2011, EXTREMOPHILES HDB, P891; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Smalas A O, 2000, Biotechnol Annu Rev, V6, P1, DOI 10.1016/S1387-2656(00)06018-X; Tehei M, 2004, EMBO REP, V5, P66, DOI 10.1038/sj.embor.7400049; Tronelli D, 2007, FEBS J, V274, P4595, DOI 10.1111/j.1742-4658.2007.05988.x; VUILLARD L, 1995, BIOCHEM J, V305, P337, DOI 10.1042/bj3050337	44	21	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38348	38355		10.1074/jbc.M111.274423	http://dx.doi.org/10.1074/jbc.M111.274423			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900238	Green Published, hybrid			2022-12-27	WOS:000296594200048
J	Devlin, CM; Lahm, T; Hubbard, WC; Van Demark, M; Wang, KC; Wu, X; Bielawska, A; Obeid, LM; Ivan, M; Petrache, I				Devlin, Cecilia M.; Lahm, Tim; Hubbard, Walter C.; Van Demark, Mary; Wang, Kevin C.; Wu, Xue; Bielawska, Alicja; Obeid, Lina M.; Ivan, Mircea; Petrache, Irina			Dihydroceramide-based Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR; HIF-ALPHA; PROLYL 4-HYDROXYLASES; CERAMIDE SYNTHASE; C-ELEGANS; DESATURASE; HYDROXYLATION; APOPTOSIS; STRESS; INVOLVEMENT	To understand the mechanisms of ceramide-based responses to hypoxia, we performed a mass spectrometry-based survey of ceramide species elicited by a wide range of hypoxic conditions (0.2-5% oxygen). We describe a rapid, time-dependent, marked up-regulation of dihydroceramides (DHCs) in mammalian cells and in the lungs of hypoxic rats. The increase affected all DHC species and was proportional with the depth and duration of hypoxia, ranging from 2-(1 h) to 10-fold (24 h), with complete return to normal after 1 h of reoxygenation at the expense of increased ceramides. We demonstrate that a DHC-based response to hypoxia occurs in a hypoxia-inducible factor-independent fashion and is catalyzed by theDHCdesaturase (DEGS) in the de novo ceramide pathway. Both the impact of hypoxia on DHC molecular species and its inhibitory effect on cell proliferation were reproduced by knockdown of DEGS1 or DEGS2 by siRNA during normoxia. Conversely, overexpression of DEGS1 or DEGS2 attenuated the DHC accumulation and increased cell proliferation during hypoxia. Based on the amplitude and kinetics of DHC accumulation, the enzymatic desaturation of DHCs fulfills the criteria of an oxygen sensor across physiological hypoxic conditions, regulating the balance between biologically active components of ceramide metabolism.	[Ivan, Mircea; Petrache, Irina] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA; [Wu, Xue; Ivan, Mircea] Indiana Univ, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Lahm, Tim; Petrache, Irina] RL Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Hubbard, Walter C.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21286 USA; [Bielawska, Alicja; Obeid, Lina M.] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Johns Hopkins University; Medical University of South Carolina	Ivan, M (corresponding author), Indiana Univ, Dept Med, 980 W Walnut St,Walther Hall C225, Indianapolis, IN 46202 USA.	mivan@iupui.edu; ipetrach@iupui.edu	Ivan, Mircea/A-8109-2012; Wu, Xue/AAJ-9340-2020; Lahm, Tim/AAF-7162-2020; Petrache, Irina/AAZ-9648-2020	Wu, Xue/0000-0002-0511-9436; obeid, lina/0000-0002-0734-0847; Ivan, Mircea/0000-0003-3424-6642	National Institutes of Health [RO1HL077328, 1 S10 RR16798]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016798] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL077328 (to I. P.) and 1 S10 RR16798 (to W. C. H. for funding the API4000 LC-MS/MS system).	Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bhuiyan MIH, 2010, BIOL PHARM BULL, V33, P11, DOI 10.1248/bpb.33.11; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cogolludo A, 2009, CARDIOVASC RES, V82, P296, DOI 10.1093/cvr/cvn349; Crowder CM, 2009, SCIENCE, V324, P343, DOI 10.1126/science.1173278; Cuzzocrea S, 2008, J PHARMACOL EXP THER, V327, P45, DOI 10.1124/jpet.108.139808; Dobrowsky RT, 2001, METHOD CELL BIOL, V66, P135; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; GAROFALO O, 1988, J NEUROCHEM, V51, P172, DOI 10.1111/j.1471-4159.1988.tb04851.x; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kang MS, 2010, CELL SIGNAL, V22, P610, DOI 10.1016/j.cellsig.2009.11.015; KENDLER A, 1992, J NEUROSCI RES, V31, P205, DOI 10.1002/jnr.490310202; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Liu J, 2000, AM J PHYSIOL-CELL PH, V278, pC144, DOI 10.1152/ajpcell.2000.278.1.C144; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Noureddine L, 2008, PROSTAG OTH LIPID M, V86, P49, DOI 10.1016/j.prostaglandins.2008.02.003; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Ryan HE, 2000, CANCER RES, V60, P4010; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; Stiban J, 2006, APOPTOSIS, V11, P773, DOI 10.1007/s10495-006-5882-8; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Ye JB, 2009, CURR MOL MED, V9, P411, DOI 10.2174/156652409788167096	40	50	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38069	38078		10.1074/jbc.M111.297994	http://dx.doi.org/10.1074/jbc.M111.297994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914808	hybrid, Green Published			2022-12-27	WOS:000296594200019
J	Fujita, K; Takashi, Y; Obuchi, E; Kitahara, K; Suganuma, T				Fujita, Kiyotaka; Takashi, Yukari; Obuchi, Eriko; Kitahara, Kanefumi; Suganuma, Toshihiko			Characterization of a Novel beta-L-Arabinofuranosidase in Bifidobacterium longum FUNCTIONAL ELUCIDATION OF A DUF1680 FAMILY MEMBER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL CHARACTERIZATION; PECTIC POLYSACCHARIDE; RHAMNOGALACTURONAN-II; IDENTIFICATION; PROTEIN; FAMILY; OLIGOSACCHARIDES; RETICULATUM; EXTENSIN	Pfam DUF1680( PF07944) is an uncharacterized protein family conserved in many species of bacteria, actinomycetes, fungi, and plants. In a previous article, we cloned and characterized the hypBA2 gene as a beta-L-arabinobiosidase in Bifidobacterium longum JCM 1217. In this study, we cloned a DUF1680 family member, the hypBA1 gene, which constitutes a gene cluster with hypBA2. HypBA1 is a novel beta-L-arabinofuranosidase that liberates L-arabinose from the L-arabinofuranose(Araf)-beta 1,2-Araf disaccharide. HypBA1 also transglycosylates 1-alkanols with retention of the anomeric configuration. Mutagenesis and azide rescue experiments indicated that Glu-366 is a critical residue for catalytic activity. This report provides the first characterization of a DUF1680 family member, which defines a new family of glycoside hydrolases, the GH family 127.	[Fujita, Kiyotaka; Takashi, Yukari; Obuchi, Eriko; Kitahara, Kanefumi; Suganuma, Toshihiko] Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan	Kagoshima University	Fujita, K (corresponding author), Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan.	kfujita@ms.kagoshima-u.ac.jp		Fujita, Kiyotaka/0000-0002-3780-3750	Japan Society for the Promotion of Science [22780094]; Grants-in-Aid for Scientific Research [22780094] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for Young Scientists (B) 22780094 from the Japan Society for the Promotion of Science.	BIAVATI B, 1982, INT J SYST BACTERIOL, V32, P358, DOI 10.1099/00207713-32-3-358; Brecker L, 2005, CARBOHYD RES, V340, P657, DOI 10.1016/j.carres.2005.01.006; Cao W, 2006, CARBOHYD POLYM, V66, P149, DOI 10.1016/j.carbpol.2006.02.034; Cardoso SM, 2002, CARBOHYD RES, V337, P917, DOI 10.1016/S0008-6215(02)00082-4; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fujita K, 2011, J BIOL CHEM, V286, P5143, DOI 10.1074/jbc.M110.190512; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fushinobu S, 2010, BIOSCI BIOTECH BIOCH, V74, P2374, DOI 10.1271/bbb.100494; Gray W.R., 1967, METHODS ENZYMOL, V11, P139, DOI [10.1016/S0076-6879(67)11014-8, DOI 10.1016/S0076-6879(67)11014-8]; HOLMES EW, 1979, ANAL BIOCHEM, V93, P167, DOI 10.1016/S0003-2697(79)80060-3; JOSELEAU JP, 1977, CARBOHYD RES, V58, P165, DOI 10.1016/S0008-6215(00)83412-6; Kawaguchi H, 2009, APPL ENVIRON MICROB, V75, P3419, DOI 10.1128/AEM.02912-08; KIELISZEWSKI MJ, 1994, PLANT J, V5, P849, DOI 10.1046/j.1365-313X.1994.5060849.x; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Konishi M, 2004, J NAT PROD, V67, P1309, DOI 10.1021/np040008c; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Miyake H, 2002, J BIOCHEM, V131, P587, DOI 10.1093/oxfordjournals.jbchem.a003138; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; Pastell H, 2009, J AGR FOOD CHEM, V57, P8598, DOI 10.1021/jf901397b; Perez S, 2003, BIOCHIMIE, V85, P109, DOI 10.1016/S0300-9084(03)00053-1; ROY D, 1990, J APPL BACTERIOL, V69, P739, DOI 10.1111/j.1365-2672.1990.tb01571.x; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; Souto ML, 2005, J NAT PROD, V68, P420, DOI 10.1021/np040164j; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Suzuki Y, 2004, J JPN SOC HORTIC SCI, V73, P574, DOI 10.2503/jjshs.73.574; WHITCOMBE AJ, 1995, CARBOHYD RES, V271, P15, DOI 10.1016/0008-6215(94)00002-W; York WS, 1996, CARBOHYD RES, V285, P99, DOI 10.1016/0008-6215(96)00029-8; Yoshimoto M, 2005, JARQ-JPN AGR RES Q, V39, P37, DOI 10.6090/jarq.39.37	32	6	7	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38079	38085		10.1074/jbc.M111.248690	http://dx.doi.org/10.1074/jbc.M111.248690			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914802	Green Published, hybrid			2022-12-27	WOS:000296594200020
J	Kumar, KK; Jacques, DA; Pishchany, G; Caradoc-Davies, T; Spirig, T; Malmirchegini, GR; Langley, DB; Dickson, CF; Mackay, JP; Clubb, RT; Skaar, EP; Guss, JM; Gell, DA				Kumar, Kaavya Krishna; Jacques, David A.; Pishchany, Gleb; Caradoc-Davies, Tom; Spirig, Thomas; Malmirchegini, G. Reza; Langley, David B.; Dickson, Claire F.; Mackay, Joel P.; Clubb, Robert T.; Skaar, Eric P.; Guss, J. Mitchell; Gell, David A.			Structural Basis for Hemoglobin Capture by Staphylococcus aureus Cell-surface Protein, IsdH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-IRON; ALPHA-HEMOGLOBIN; UPTAKE SYSTEM; RECEPTOR; BINDING; NEAT; IDENTIFICATION; ACQUISITION; DOMAIN; STREPTOCOCCUS	Pathogens must steal iron from their hosts to establish infection. In mammals, hemoglobin (Hb) represents the largest reservoir of iron, and pathogens express Hb-binding proteins to access this source. Here, we show how one of the commonest and most significant human pathogens, Staphylococcus aureus, captures Hb as the first step of an iron-scavenging pathway. The x-ray crystal structure of Hb bound to a domain from the Isd (iron-regulated surface determinant) protein, IsdH, is the first structure of a Hb capture complex to be determined. Surface mutations in Hb that reduce binding to the Hb-receptor limit the capacity of S. aureus to utilize Hb as an iron source, suggesting that Hb sequence is a factor in host susceptibility to infection. The demonstration that pathogens make highly specific recognition complexes with Hb raises the possibility of developing inhibitors of Hb binding as antibacterial agents.	[Kumar, Kaavya Krishna; Jacques, David A.; Langley, David B.; Mackay, Joel P.; Guss, J. Mitchell] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Pishchany, Gleb; Skaar, Eric P.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Caradoc-Davies, Tom] Australian Synchrotron, Clayton, Vic 3168, Australia; [Spirig, Thomas; Malmirchegini, G. Reza; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Dickson, Claire F.; Gell, David A.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia	University of Sydney; Vanderbilt University; University of California System; University of California Los Angeles; University of Tasmania; Menzies Institute for Medical Research	Gell, DA (corresponding author), Menzies Res Inst Tasmania, 17 Liverpool St, Hobart, Tas 7000, Australia.	david.gell@utas.edu.au	Guss, Jules Mitchell/N-1387-2019; Langley, David B/B-1861-2009; Pishchany, Gleb/E-2016-2015; Mackay, Joel/D-6834-2011	Guss, Jules Mitchell/0000-0003-4259-6079; Langley, David B/0000-0003-2752-0041; Gell, David/0000-0003-0382-1181; Spirig, Thomas/0000-0001-8936-238X; Jacques, David/0000-0002-6426-4510; Pishchany, Gleb/0000-0001-9303-010X; Mackay, Joel/0000-0001-7508-8033	University of Sydney; Australian Institute of Nuclear Science and Engineering; Australia Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER	University of Sydney(University of Sydney); Australian Institute of Nuclear Science and Engineering; Australia Research Council(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by a University of Sydney international scholarship.; Supported by an Australian Institute of Nuclear Science and Engineering postgraduate research award.; Supported by an Australia Research Council research fellowship.	Alontaga AY, 2009, BIOCHEMISTRY-US, V48, P96, DOI 10.1021/bi801860g; Andrade MA, 2002, GENOME BIOL, V3; Bahrami F, 2005, MICROB PATHOGENESIS, V39, P45, DOI 10.1016/j.micpath.2005.03.002; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Carlson PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006988; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Iorio E E, 1981, Methods Enzymol, V76, P57; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eaton W A, 1981, Methods Enzymol, V76, P175; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gonzalez-Lopez MA, 2009, BIOMETALS, V22, P889, DOI 10.1007/s10534-009-9240-5; Graves PE, 2008, BBA-PROTEINS PROTEOM, V1784, P1471, DOI 10.1016/j.bbapap.2008.04.012; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Hempel K, 2011, J PROTEOME RES, V10, P1657, DOI 10.1021/pr1009838; JACOBSEN MP, 1995, BBA-PROTEIN STRUCT M, V1246, P17, DOI 10.1016/0167-4838(94)00174-F; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kumar KK, 2010, BIOCHEM J, V432, P275, DOI 10.1042/BJ20100642; Legrand D, 2010, BIOMETALS, V23, P365, DOI 10.1007/s10534-010-9297-1; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meehan M, 2010, MICROBIOL-SGM, V156, P1824, DOI 10.1099/mic.0.036087-0; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Morrissey JA, 2002, INFECT IMMUN, V70, P2399, DOI 10.1128/IAI.70.5.2399-2407.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Nepluev I, 2009, INFECT IMMUN, V77, P3065, DOI 10.1128/IAI.00034-09; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Rohde KH, 2004, INFECT IMMUN, V72, P2494, DOI 10.1128/IAI.72.5.2494-2506.2004; SAWATZKI G, 1983, INFECT IMMUN, V39, P659, DOI 10.1128/IAI.39.2.659-665.1983; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Simpson W, 2000, J BACTERIOL, V182, P5737, DOI 10.1128/JB.182.20.5737-5748.2000; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Ster C, 2010, VET IMMUNOL IMMUNOP, V136, P311, DOI 10.1016/j.vetimm.2010.03.010; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villarreal DM, 2008, APPL ENVIRON MICROB, V74, P5854, DOI 10.1128/AEM.01291-08; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	68	50	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38439	38447		10.1074/jbc.M111.287300	http://dx.doi.org/10.1074/jbc.M111.287300			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917915	hybrid, Green Published			2022-12-27	WOS:000296594200058
J	Posch, G; Pabst, M; Brecker, L; Altmann, F; Messner, P; Schaffer, C				Posch, Gerald; Pabst, Martin; Brecker, Lothar; Altmann, Friedrich; Messner, Paul; Schaeffer, Christina			Characterization and Scope of S-layer Protein O-Glycosylation in Tannerella forsythia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LC-ESI-MS; CELL-WALL POLYMER; STRUCTURAL-CHARACTERIZATION; NONREDUCTIVE RELEASE; LINKED GLYCANS; OLIGOSACCHARIDES; GLYCOPROTEINS; SURFACE; SYSTEM; IDENTIFICATION	Cell surface glycosylation is an important element in defining the life of pathogenic bacteria. Tannerella forsythia is a Gram-negative, anaerobic periodontal pathogen inhabiting the subgingival plaque biofilms. It is completely covered by a two-dimensional crystalline surface layer (S-layer) composed of two glycoproteins. Although the S-layer has previously been shown to delay the bacterium's recognition by the innate immune system, we characterize here the S-layer protein O-glycosylation as a potential virulence factor. The T. forsythia S-layer glycan was elucidated by a combination of electrospray ionization-tandem mass spectrometry and nuclear magnetic resonance spectroscopy as an oligosaccharide with the structure 4-Me-beta-ManpNAcCONH(2)-(1 -> 3)-[Pse5Am7Gc-(2 -> 4)-]-beta-ManpNAcA-(1 -> 4)-[4-Me-alpha-Galp-(1 -> 2)-]-alpha-Fucp-(1 -> 4)-[-alpha-Xylp-(1 -> 3)-]-beta-GlcpA-(1 -> 3)-[-beta-Digp-(1 -> 2)-]-alpha-Galp, which is O-glycosidically linked to distinct serine and threonine residues within the three-amino acid motif (D)(S/T)(A/I/L/M/T/V) on either S-layer protein. This S-layer glycan obviously impacts the life style of T. forsythia because increased biofilm formation of an UDP-N-acetylmannosaminuronic acid dehydrogenase mutant can be correlated with the presence of truncated S-layer glycans. We found that several other proteins of T. forsythia are modified with that specific oligosaccharide. Proteomics identified two of them as being among previously classified antigenic outer membrane proteins that are up-regulated under biofilm conditions, in addition to two predicted antigenic lipoproteins. Theoretical analysis of the S-layer O-glycosylation of T. forsythia indicates the involvement of a 6.8-kb gene locus that is conserved among different bacteria from the Bacteroidetes phylum. Together, these findings reveal the presence of a protein O-glycosylation system in T. forsythia that is essential for creating a rich glycoproteome pinpointing a possible relevance for the virulence of this bacterium.	[Posch, Gerald; Messner, Paul; Schaeffer, Christina] Univ Nat Resources & Appl Life Sci Vienna, Dept NanoBiotechnol, Vienna Inst BioTechnol, A-1190 Vienna, Austria; [Pabst, Martin; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci Vienna, Dept Chem, Vienna Inst BioTechnol, A-1190 Vienna, Austria; [Brecker, Lothar] Univ Vienna, Inst Organ Chem, A-1090 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Vienna	Schaffer, C (corresponding author), Univ Nat Resources & Appl Life Sci Vienna, Dept NanoBiotechnol, Vienna Inst BioTechnol, Muthgasse 11, A-1190 Vienna, Austria.	christina.schaeffer@boku.ac.at	Pabst, Martin/GOH-1766-2022; Schäffer, Christina/V-3404-2018; Messner, Paul/Q-5345-2017	Pabst, Martin/0000-0001-9897-0723; Schäffer, Christina/0000-0003-1613-7258; Messner, Paul/0000-0002-3246-5801; Altmann, Friedrich/0000-0002-0112-7877	Austrian Science Fund [P20605-B20, P21954-B20, P20745-B11]; Austrian Science Fund (FWF) [P 20745, P 21954, P 20605] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund projects P20605-B20 and P21954-B20 (to C. S.) and P20745-B11 (to P. M.).	ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; Beck JD, 2000, PERIODONTOL 2000, V23, P110, DOI 10.1034/j.1600-0757.2000.2230111.x; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Calo D, 2010, APPL ENVIRON MICROB, V76, P5684, DOI 10.1128/AEM.00681-10; Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200; Chai WG, 1997, GLYCOBIOLOGY, V7, P861, DOI 10.1093/glycob/7.6.861; DiGiandomenico A, 2002, MOL MICROBIOL, V46, P519, DOI 10.1046/j.1365-2958.2002.03171.x; Fletcher CM, 2007, P NATL ACAD SCI USA, V104, P2413, DOI 10.1073/pnas.0608797104; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Hart C, 2003, ELECTROPHORESIS, V24, P588, DOI 10.1002/elps.200390069; Honma K, 2007, MICROB PATHOGENESIS, V42, P156, DOI 10.1016/j.micpath.2007.01.003; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; Huang YP, 2001, ANAL CHEM, V73, P6063, DOI 10.1021/ac015534c; Kiss E, 2001, MOL PLANT MICROBE IN, V14, P1395, DOI 10.1094/MPMI.2001.14.12.1395; Knirel YA, 2003, ADV CARBOHYD CHEM BI, V58, P371, DOI 10.1016/S0065-2318(03)58007-6; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SW, 2006, GENE, V371, P102, DOI 10.1016/j.gene.2005.11.027; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Messner P, 2008, CARBOHYD RES, V343, P1934, DOI 10.1016/j.carres.2007.12.025; Pabst M, 2008, ANAL CHEM, V80, P7534, DOI 10.1021/ac801024r; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Pabst M, 2010, CARBOHYD RES, V345, P1389, DOI 10.1016/j.carres.2010.02.017; Pabst M, 2009, ANAL BIOCHEM, V384, P263, DOI 10.1016/j.ab.2008.09.041; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Petersen BO, 2008, CARBOHYD RES, V343, P1346, DOI 10.1016/j.carres.2008.03.029; Pham TK, 2010, PROTEOMICS, V10, P3130, DOI 10.1002/pmic.200900448; Ristl Robin, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/127870; Roy S, 2010, J BACTERIOL, V192, P2285, DOI 10.1128/JB.00079-10; Sabet M, 2003, MICROBIOL-SGM, V149, P3617, DOI 10.1099/mic.0.26535-0; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Schaffer C, 2000, EUR J BIOCHEM, V267, P5482, DOI 10.1046/j.1432-1327.2000.01610.x; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Sekot G, 2011, J DENT RES, V90, P109, DOI 10.1177/0022034510384622; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Sharma A, 2010, PERIODONTOL 2000, V54, P106, DOI 10.1111/j.1600-0757.2009.00332.x; Sleytr UB, 2002, BIOPOLYMERS, P285; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Steindl C, 2005, CARBOHYD RES, V340, P2290, DOI 10.1016/j.carres.2005.07.005; Steiner K, 2007, J BACTERIOL, V189, P2590, DOI 10.1128/JB.01592-06; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Taylor AM, 2006, PROTEOMICS, V6, P2936, DOI 10.1002/pmic.200500331; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wang L, 2010, PLANTA MED, V76, P909, DOI 10.1055/s-0029-1240842; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wuhrer M, 2011, MASS SPECTROM REV, V30, P664, DOI 10.1002/mas.20337; Zarschler K, 2010, GLYCOBIOLOGY, V20, P787, DOI 10.1093/glycob/cwq035; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8	53	60	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38714	38724		10.1074/jbc.M111.284893	http://dx.doi.org/10.1074/jbc.M111.284893			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911490	hybrid, Green Published			2022-12-27	WOS:000296594200083
J	Wentworth, CC; Alam, A; Jones, RM; Nusrat, A; Neish, AS				Wentworth, Christy C.; Alam, Ashfaqul; Jones, Rheinallt M.; Nusrat, Asma; Neish, Andrew S.			Enteric Commensal Bacteria Induce Extracellular Signal-regulated Kinase Pathway Signaling via Formyl Peptide Receptor-dependent Redox Modulation of Dual Specific Phosphatase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE OXYGEN; IN-VIVO; VACCINIA VIRUS; CELL-GROWTH; DISEASE; GUT; ACTIVATION; RESPONSES; RESTITUTION; GENERATION	The normal microbial occupants of the mammalian intestine are crucial for maintaining gut homeostasis, yet the mechanisms by which intestinal cells perceive and respond to the microbiota are largely unknown. Intestinal epithelial contact with commensal bacteria and/or their products has been shown to activate noninflammatory signaling pathways, such as extracellular signal-related kinase (ERK), thus influencing homeostatic processes. We previously demonstrated that commensal bacteria stimulate ERK pathway activity via interaction with formyl peptide receptors (FPRs). In the current study, we expand on these findings and show that commensal bacteria initiate ERK signaling through rapid FPR-dependent reactive oxygen species (ROS) generation and subsequent modulation of MAP kinase phosphatase redox status. ROS generation induced by the commensal bacteria Lactobacillus rhamnosus GG and the FPR peptide ligand, N-formyl-Met-Leu-Phe, was abolished in the presence of selective inhibitors for G protein-coupled signaling and FPR ligand interaction. In addition, pretreatment of cells with inhibitors of ROS generation attenuated commensal bacteria-induced ERK signaling, indicating that ROS generation is required for ERK pathway activation. Bacterial colonization also led to oxidative inactivation of the redox-sensitive and ERK-specific phosphatase, DUSP3/VHR, and consequent stimulation of ERK pathway signaling. Together, these data demonstrate that commensal bacteria and their products activate ROS signaling in an FPR-dependent manner and define a mechanism by which cellular ROS influences the ERK pathway through a redox-sensitive regulatory circuit.	[Wentworth, Christy C.; Alam, Ashfaqul; Jones, Rheinallt M.; Nusrat, Asma; Neish, Andrew S.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol Unit, Atlanta, GA 30322 USA	Emory University	Neish, AS (corresponding author), Whitehead Bldg,Rm 105F,615 Michael St, Atlanta, GA 30322 USA.	aneish@emory.edu	Jones, Rheinallt/C-4611-2013	Jones, Rheinallt/0000-0002-0415-9487	National Institutes of Health [R01DK071604, DK089763, AI064462, K01DK081481]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064462, R56AI064462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089763, K01DK081481, R56DK089763, R01DK071604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK071604, DK089763, and AI064462.; Supported by Grant K01DK081481 from the NIH.	Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; BOKOCH GM, 1984, CELL, V39, P301, DOI 10.1016/0092-8674(84)90008-4; Cerignoli F, 2006, CELL CYCLE, V5, P2210, DOI 10.4161/cc.5.19.3267; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hart AL, 2003, J CLIN GASTROENTEROL, V36, P111, DOI 10.1097/00004836-200302000-00005; Hooper LV, 1998, BIOESSAYS, V20, P336, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;336::AID-BIES10&gt;3.0.CO;2-3; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Kumar A, 2009, J IMMUNOL, V182, P538, DOI 10.4049/jimmunol.182.1.538; Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lin PW, 2008, PEDIATR RES, V64, P511, DOI 10.1203/PDR.0b013e3181827c0f; Lin PW, 2009, FREE RADICAL BIO MED, V47, P1205, DOI 10.1016/j.freeradbiomed.2009.07.033; LIU K, 1995, J VIROL, V69, P7823, DOI 10.1128/JVI.69.12.7823-7834.1995; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Park J, 2007, GASTROENTEROL CLIN N, V36, P47, DOI 10.1016/j.gtc.2007.03.001; Pauly N, 2006, J EXP BOT, V57, P1769, DOI 10.1093/jxb/erj184; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Swanson PA, 2011, P NATL ACAD SCI USA, V108, P8803, DOI 10.1073/pnas.1010042108; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; TORRES M, 1993, J IMMUNOL, V150, P1563; Wentworth CC, 2010, AM J PATHOL, V177, P2782, DOI 10.2353/ajpath.2010.100529; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	39	79	81	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38448	38455		10.1074/jbc.M111.268938	http://dx.doi.org/10.1074/jbc.M111.268938			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21921027	Green Published, hybrid			2022-12-27	WOS:000296594200059
J	Komissarov, AA; Florova, G; Idell, S				Komissarov, Andrey A.; Florova, Galina; Idell, Steven			Effects of Extracellular DNA on Plasminogen Activation and Fibrinolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; CELL-FREE DNA; DEEP-VEIN THROMBOSIS; FREE PLASMA DNA; RESPIRATORY-DISTRESS-SYNDROME; ACUTE MYOCARDIAL-INFARCTION; FLOW FLUORESCENCE KINETICS; DETERMINING REGION 3; ALPHA-HELIX-F; PLEURAL EFFUSIONS	The increased levels of extracellular DNA found in a number of disorders involving dysregulation of the fibrinolytic system may affect interactions between fibrinolytic enzymes and inhibitors. Double-stranded (ds) DNA and oligonucleotides bind tissue-(tPA) and urokinase (uPA)-type plasminogen activators, plasmin, and plasminogen with submicromolar affinity. The binding of enzymes to DNA was detected by EMSA, steady-state, and stopped-flow fluorimetry. The interaction of dsDNA/oligonucleotides with tPA and uPA includes a fast bimolecular step, followed by two monomolecular steps, likely indicating slow conformational changes in the enzyme. DNA (0.1-5.0 mu g/ml), but not RNA, potentiates the activation of Glu- and Lys-plasminogen by tPA and uPA by 480-and 70-fold and 10.7- and 17-fold, respectively, via a template mechanism similar to that known for fibrin. However, unlike fibrin, dsDNA/oligonucleotides moderately affect the reaction between plasmin and alpha(2)-antiplasmin and accelerate the inactivation of tPA and two chain uPA by plasminogen activator inhibitor-1 (PAI-1), which is potentiated by vitronectin. dsDNA (0.1-1.0 mu g/ml) does not affect the rate of fibrinolysis by plasmin but increases by 4 -5-fold the rate of fibrinolysis by Glu-plasminogen/plasminogen activator. The presence of alpha(2)-antiplasmin abolishes the potentiation of fibrinolysis by dsDNA. At higher concentrations (1.0-20 mu g/ml), dsDNA competes for plasmin with fibrin and decreases the rate of fibrinolysis. dsDNA/oligonucleotides incorporated into a fibrin film also inhibit fibrinolysis. Thus, extracellular DNA at physiological concentrations may potentiate fibrinolysis by stimulating fibrin-independent plasminogen activation. Conversely, DNA could inhibit fibrinolysis by increasing the susceptibility of fibrinolytic enzymes to serpins.	[Komissarov, Andrey A.; Florova, Galina; Idell, Steven] Univ Texas Hlth Sci Ctr Tyler, Texas Lung Injury Inst, Tyler, TX 75708 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Komissarov, AA (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Texas Lung Injury Inst, 11937 US Highway 271, Tyler, TX 75708 USA.	andrey.komissarov@uthct.edu		Komissarov, Andrey/0000-0003-4346-8888	NHLBI [PO-1 076406, P50 HL107186-02]; Texas Lung Injury Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL107186] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Texas Lung Injury Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO-1 076406 and P50 HL107186-02 from NHLBI. This work was also supported by the Texas Lung Injury Institute.	Albers GW, 2008, CHEST, V133, p630S, DOI 10.1378/chest.08-0720; Aleman C, 2003, CLIN SCI, V105, P601, DOI 10.1042/CS20030115; Allport LE, 2008, J CLIN NEUROSCI, V15, P917, DOI 10.1016/j.jocn.2007.03.026; ANDRADEGORDON P, 1986, BIOCHEMISTRY-US, V25, P4033, DOI 10.1021/bi00362a007; ANONICK PK, 1991, BIOCHEM J, V275, P53, DOI 10.1042/bj2750053; Benlloch S, 2006, CLIN LUNG CANCER, V8, P140, DOI 10.3816/CLC.2006.n.043; Bouros D, 2007, PULM PHARMACOL THER, V20, P616, DOI 10.1016/j.pupt.2006.08.001; Chan MHM, 2003, CLIN CHEM, V49, P740, DOI 10.1373/49.5.740; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; CHRISTENSEN S, 1995, BIOCHEM J, V305, P97, DOI 10.1042/bj3050097; Christensen U, 1996, FEBS LETT, V387, P58, DOI 10.1016/0014-5793(96)00429-2; CHRISTENSEN U, 1978, BIOCHEM J, V175, P635, DOI 10.1042/bj1750635; CHRISTENSEN U, 1977, BIOCHEM J, V163, P389, DOI 10.1042/bj1630389; DAWSON S, 1992, ATHEROSCLEROSIS, V95, P105, DOI 10.1016/0021-9150(92)90014-8; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; Duboscq C, 1997, THROMB HAEMOSTASIS, V77, P1090; FEARS R, 1985, BIOCHEM J, V229, P555, DOI 10.1042/bj2290555; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; GALLIMORE MJ, 1980, THROMB RES, V18, P601, DOI 10.1016/0049-3848(80)90214-5; GANDO S, 1995, CRIT CARE MED, V23, P1835, DOI 10.1097/00003246-199511000-00009; Gebbink MFBG, 2009, FEBS LETT, V583, P2691, DOI 10.1016/j.febslet.2009.06.013; GRIMAUDO V, 1992, THROMB HAEMOSTASIS, V67, P397; Hack CE, 2001, SEMIN THROMB HEMOST, V27, P633, DOI 10.1055/s-2001-18867; Haj MA, 1998, INTENS CARE MED, V24, P258, DOI 10.1007/s001340050561; HARDAWAY RM, 1990, CRIT CARE MED, V18, P1413, DOI 10.1097/00003246-199012000-00021; HARDAWAY RM, 1994, ADV THER, V11, P43; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Held C, 1997, CIRCULATION, V95, P2380, DOI 10.1161/01.CIR.95.10.2380; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; Iba T, 2005, SHOCK, V23, P25, DOI 10.1097/01.shk.0000144422.32647.b6; IDELL S, 1991, AM REV RESPIR DIS, V144, P187, DOI 10.1164/ajrccm/144.1.187; Idell S, 2005, CLIN PULM MED, V12, P184; Iglesias D, 2005, EUR RESPIR J, V25, P104, DOI 10.1183/09031936.04.00010504; Ioannidou-Papayannaki E, 2000, ACTA CARDIOL, V55, P247, DOI 10.2143/AC.55.4.2005747; Johansson L, 2000, STROKE, V31, P26, DOI 10.1161/01.STR.31.1.26; Johnsen LB, 1998, BIOCHEMISTRY-US, V37, P12631, DOI 10.1021/bi9806697; Kim HS, 2006, CARDIOVASC INTER RAD, V29, P1003, DOI 10.1007/s00270-005-0341-4; Kolev K., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P341, DOI 10.2174/156801605774322337; Kolev K, 2003, BLOOD, V101, P4380, DOI 10.1182/blood-2002-10-3227; Komissarov AA, 2005, J BIOL CHEM, V280, P1482, DOI 10.1074/jbc.M408608200; Komissarov AA, 2002, J BIOL CHEM, V277, P43858, DOI 10.1074/jbc.M204110200; Komissarov AA, 1999, BIOCHEMISTRY-US, V38, P14631, DOI 10.1021/bi991347l; Komissarov AA, 1997, J BIOL CHEM, V272, P26864, DOI 10.1074/jbc.272.43.26864; Komissarov AA, 1996, J BIOL CHEM, V271, P12241, DOI 10.1074/jbc.271.21.12241; Komissarov AA, 2007, J BIOL CHEM, V282, P26306, DOI 10.1074/jbc.M702089200; Komissarov AA, 2009, AM J PHYSIOL-LUNG C, V297, pL568, DOI 10.1152/ajplung.00066.2009; KVASSMAN JO, 1995, FIBRINOLYSIS, V9, P215, DOI 10.1016/S0268-9499(08)80062-8; Kvassman JO, 1998, BIOCHEMISTRY-US, V37, P15491, DOI 10.1021/bi9814787; Lam NYL, 2006, RESUSCITATION, V68, P71, DOI 10.1016/j.resuscitation.2005.05.021; Liang JF, 2000, THROMB RES, V97, P349, DOI 10.1016/S0049-3848(99)00188-7; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 2001, ANN NY ACAD SCI, V945, P1; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Mavrommatis AC, 2001, INTENS CARE MED, V27, P1853, DOI 10.1007/s00134-001-1139-8; Merkle DL, 1996, BLOOD COAGUL FIBRIN, V7, P650, DOI 10.1097/00001721-199609000-00011; NIEUWENHUIZEN W, 1988, EUR J BIOCHEM, V174, P163, DOI 10.1111/j.1432-1033.1988.tb14077.x; Nordenhem A, 2005, THROMB RES, V116, P223, DOI 10.1016/j.thromres.2004.12.007; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; PAQUES EP, 1986, THROMB RES, V42, P797, DOI 10.1016/0049-3848(86)90116-7; Parikh S, 2008, J VASC INTERV RADIOL, V19, P521, DOI 10.1016/j.jvir.2007.11.023; PARISE P, 1993, BLOOD COAGUL FIBRIN, V4, P721, DOI 10.1097/00001721-199304050-00008; PEDERSEN OD, 1994, CORONARY ARTERY DIS, V5, P617, DOI 10.1097/00019501-199407000-00010; PHILIPJOET F, 1995, EUR RESPIR J, V8, P1352, DOI 10.1183/09031936.95.08081352; PREISSNER KT, 1990, J BIOL CHEM, V265, P18490; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Raaphorst J, 2001, THROMB HAEMOSTASIS, V86, P543, DOI 10.1055/s-0037-1616084; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Samson AL, 2009, BLOOD, V114, P1937, DOI 10.1182/blood-2009-02-203448; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Saukkonen K, 2007, INTENS CARE MED, V33, P1624, DOI 10.1007/s00134-007-0686-z; Sen P, 2011, J THROMB HAEMOST, V9, P531, DOI 10.1111/j.1538-7836.2010.04167.x; SHORE JD, 1995, J BIOL CHEM, V270, P5395, DOI 10.1074/jbc.270.10.5395; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Thelwell C, 2007, J THROMB HAEMOST, V5, P804, DOI 10.1111/j.1538-7836.2007.02422.x; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tomasini B R, 1991, Prog Hemost Thromb, V10, P269; TORBET J, 1986, BIOCHEMISTRY-US, V25, P5309, DOI 10.1021/bi00366a048; Uzuelli JA, 2009, CLIN CHIM ACTA, V409, P112, DOI 10.1016/j.cca.2009.09.011; VARGO JS, 1990, CHEST, V97, P63, DOI 10.1378/chest.97.1.63; Watanabe R, 2001, CLIN APPL THROMB-HEM, V7, P229, DOI 10.1177/107602960100700309; WEITZ JI, 1991, THROMB HAEMOSTASIS, V65, P541; Wijeratne S, 2004, ANN NY ACAD SCI, V1022, P232, DOI 10.1196/annals.1318.036; Wiman B, 1999, SCAND J CLIN LAB INV, V59, P23; WIMAN B, 1978, EUR J BIOCHEM, V84, P573, DOI 10.1111/j.1432-1033.1978.tb12200.x; WU JH, 1995, THROMB HAEMOSTASIS, V74, P711; Wu TL, 2002, CLIN CHIM ACTA, V321, P77, DOI 10.1016/S0009-8981(02)00091-8; ZAMARRON C, 1984, J BIOL CHEM, V259, P2080; Zeerleder S, 2005, CHEST, V128, P2864, DOI 10.1378/chest.128.4.2864; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943; Zhu ZW, 2006, CHEST, V129, P1577, DOI 10.1378/chest.129.6.1577	95	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41949	41962		10.1074/jbc.M111.301218	http://dx.doi.org/10.1074/jbc.M111.301218			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21976662	hybrid, Green Published			2022-12-27	WOS:000298180900006
J	Vaz, SH; Jorgensen, TN; Cristovao-Ferreira, S; Duflot, S; Ribeiro, JA; Gether, U; Sebastiao, AM				Vaz, Sandra H.; Jorgensen, Trine N.; Cristovao-Ferreira, Sofia; Duflot, Sylvie; Ribeiro, Joaquim A.; Gether, Ulrik; Sebastiao, Ana M.			Brain-derived Neurotrophic Factor (BDNF) Enhances GABA Transport by Modulating the Trafficking of GABA Transporter-1 (GAT-1) from the Plasma Membrane of Rat Cortical Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC-ACID; ADENOSINE A(2A) RECEPTORS; PROTEIN-KINASE-C; SYNAPTIC-TRANSMISSION; LENTIVIRAL VECTOR; SIGNAL-TRANSDUCTION; NEUROTRANSMITTER TRANSPORTERS; TYROSINE PHOSPHORYLATION; SELECTIVE INHIBITOR; SURFACE EXPRESSION	The gamma-aminobutyric acid (GABA) transporters (GATs) are located in the plasma membrane of neurons and astrocytes and are responsible for termination of GABAergic transmission. It has previously been shown that brain derived neurotrophic factor (BDNF) modulates GAT-1-mediated GABA transport in nerve terminals and neuronal cultures. We now report that BDNF enhances GAT-1-mediated GABA transport in cultured astrocytes, an effect mostly due to an increase in the V-max kinetic constant. This action involves the truncated form of the TrkB receptor (TrkB-t) coupled to a non-classic PLC-gamma/PKC-delta and ERK/MAPIK pathway and requires active adenosine A(2A) receptors. Transport through GAT-3 is not affected by BDNF. To elucidate if BDNF affects trafficking of GAT-1 in astrocytes, we generated and infected astrocytes with a functional mutant of the rat GAT-1 (rGAT-1) in which the hemagglutinin (HA) epitope was incorporated into the second extracellular loop. An increase in plasma membrane of HA-rGAT-1 as well as of rGAT-1 was observed when both HA-GAT-1-transduced astrocytes and rGAT-1-overexpressing astrocytes were treated with BDNF. The effect of BDNF results from inhibition of dynamin/dathrin-dependent constitutive internalization of GAT-1 rather than from facilitation of the monensin-sensitive recycling of GAT-1 molecules back to the plasma membrane. We therefore conclude that BDNF enhances the time span of GAT-1 molecules at the plasma membrane of astrocytes. BDNF may thus play an active role in the clearance of GABA from synaptic and extrasynaptic sites and in this way influence neuronal excitability.	[Vaz, Sandra H.; Cristovao-Ferreira, Sofia; Duflot, Sylvie; Ribeiro, Joaquim A.; Sebastiao, Ana M.] Univ Lisbon, Inst Farmacol & Neurociencias, Fac Med, P-1649028 Lisbon, Portugal; [Vaz, Sandra H.; Cristovao-Ferreira, Sofia; Duflot, Sylvie; Ribeiro, Joaquim A.; Sebastiao, Ana M.] Univ Lisbon, Unit Neurosci, Inst Mol Med, P-1649028 Lisbon, Portugal; [Jorgensen, Trine N.; Gether, Ulrik] Univ Copenhagen, Dept Pharmacol & Neurosci, Mol Neuropharmacol Grp, Panum Inst, DK-2200 Copenhagen, Denmark	Universidade de Lisboa; Universidade de Lisboa; University of Copenhagen	Sebastiao, AM (corresponding author), Univ Lisbon, Inst Farmacol & Neurociencias, Fac Med, Av Prof Egas Moniz,Edificio Egas Moniz,Piso 1B, P-1649028 Lisbon, Portugal.	anaseb@fm.ul.pt	Vaz, Sandra H./L-7393-2015	Vaz, Sandra H./0000-0003-4258-9397; Gether, Ulrik/0000-0002-0020-3807; Ribeiro, Joaquim/0000-0002-9330-3507; Sebastiao, Ana M/0000-0001-9030-6115; Cristovao Ferreira, Ana Sofia/0000-0003-0606-8017	Fundacao para a Ciencia ea Tecnologia [SFRH/BD/227989/2006, SFRH/BD/38099/2007]	Fundacao para a Ciencia ea Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao para a Ciencia ea Tecnologia Grants SFRH/BD/227989/2006 (to S. H. V.) and SFRH/BD/38099/2007 (to S. C. F.).	Assaife-Lopes N, 2010, J NEUROSCI, V30, P8468, DOI 10.1523/JNEUROSCI.5695-09.2010; AWAD JA, 1983, J BIOL CHEM, V258, P2960; Baxter GT, 1997, J NEUROSCI, V17, P2683; Beckman ML, 1999, J NEUROSCI, V19; Bergami M, 2008, J CELL BIOL, V183, P213, DOI 10.1083/jcb.200806137; Biber K, 1997, J NEUROSCI, V17, P4956; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; BORDEN LA, 1994, RECEPTOR CHANNEL, V2, P207; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cristovao-Ferreira S, 2009, J NEUROCHEM, V109, P336, DOI 10.1111/j.1471-4159.2009.05963.x; Deken SL, 2003, J NEUROSCI, V23, P1563; DING JB, 1995, J BIOL CHEM, V270, P11684, DOI 10.1074/jbc.270.19.11684; Diogenes MJ, 2007, HIPPOCAMPUS, V17, P577, DOI 10.1002/hipo.20294; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Fontinha BM, 2008, NEUROPHARMACOLOGY, V54, P924, DOI 10.1016/j.neuropharm.2008.01.011; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; JARVIS MF, 1989, J PHARMACOL EXP THER, V251, P888; Jiang M, 2009, J NEUROSCI, V29, P8063, DOI 10.1523/JNEUROSCI.6139-08.2009; Johansen JL, 2005, MOL BIOTECHNOL, V29, P47, DOI 10.1385/MB:29:1:47; Kirmse K, 2009, SYNAPSE, V63, P921, DOI 10.1002/syn.20675; Law RM, 2000, J BIOL CHEM, V275, P23986, DOI 10.1074/jbc.M910283199; Lee TS, 2006, ACTA NEUROPATHOL, V111, P351, DOI 10.1007/s00401-005-0017-9; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ohira K, 2007, EUR J NEUROSCI, V25, P406, DOI 10.1111/j.1460-9568.2007.05282.x; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Pousinha PA, 2006, NEUROSCI LETT, V404, P143, DOI 10.1016/j.neulet.2006.05.036; Pyne NJ, 2011, TRENDS PHARMACOL SCI, V32, P443, DOI 10.1016/j.tips.2011.04.002; Quick MW, 2004, J BIOL CHEM, V279, P15961, DOI 10.1074/jbc.M306924200; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Schousboe A, 2004, EUR J PHARMACOL, V500, P281, DOI 10.1016/j.ejphar.2004.07.032; Schousboe A, 2004, NEUROCHEM INT, V45, P521, DOI 10.1016/j.neuint.2003.11.001; Sebastiao A. M., 2010, BIOCHIM BIOPHYS ACTA, V1808, P1340; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Tanaka T, 1997, J NEUROSCI, V17, P2959; TAPLEY P, 1992, ONCOGENE, V7, P371; Tebano MT, 2008, J NEUROCHEM, V104, P279, DOI 10.1111/j.1471-4159.2007.05046.x; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Vaz SH, 2008, BRAIN RES, V1219, P19, DOI 10.1016/j.brainres.2008.04.008; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Wardle RA, 2003, J NEUROSCI, V23, P8722; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; WOOD JD, 1986, J NEUROCHEM, V46, P739, DOI 10.1111/j.1471-4159.1986.tb13034.x; Zocchi C, 1996, J PHARMACOL EXP THER, V276, P398; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	64	47	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40464	40476		10.1074/jbc.M111.232009	http://dx.doi.org/10.1074/jbc.M111.232009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969376	hybrid, Green Published			2022-12-27	WOS:000297315400006
J	Brock, M; Trenkmann, M; Gay, RE; Gay, S; Speich, R; Huber, LC				Brock, Matthias; Trenkmann, Michelle; Gay, Renate E.; Gay, Steffen; Speich, Rudolf; Huber, Lars C.			MicroRNA-18a Enhances the Interleukin-6-mediated Production of the Acute-phase Proteins Fibrinogen and Haptoglobin in Human Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; INFLAMMATION; ELEMENTS; DISEASE; TARGETS; BINDING; GENES; CELLS	The acute-phase response is an inflammatory process triggered mainly by the cytokine IL-6. Signaling of IL-6 is transduced by activation of STAT3 (signal transducer and activator of transcription 3), which rapidly induces the production of acute-phase proteins such as haptoglobin and fibrinogen. Another target of the IL-6/STAT3 signal transduction pathway is the microRNA cluster miR-17/92. Here, we investigated the interplay of miR-17/92 and STAT3 signaling and its impact on the acute-phase response in primary human hepatocytes and hepatoma (HepG2) cells. Employing a reporter gene system consisting of STAT3-sensitive promoter sequences, we show that the miR-17/92 cluster member miR-18a enhanced the transcriptional activity of STAT3. IL-6 stimulation experiments in miR-18a-overexpressing hepatocytes and HepG2 cells revealed an augmented acute-phase response indicated by increased expression and secretion of haptoglobin and fibrinogen. This effect was due, at least in part, to repression of PIAS3 (protein inhibitor of activated STAT, 3), a repressor of STAT3 activity, which we identified as a novel direct target of miR-18a. Finally, we demonstrate that the expression of miR-17/92 in primary hepatocytes and HepG2 cells is modulated by IL-6. Our data reveal, for the first time, a microRNA-mediated positive feedback loop of IL-6 signal transduction leading to an enhanced acute-phase response in human hepatocytes.	[Brock, Matthias] Univ Zurich Hosp, Ctr Expt Rheumatol, Working Grp Pulm Hypertens, CH-8091 Zurich, Switzerland; [Brock, Matthias; Trenkmann, Michelle; Gay, Renate E.; Gay, Steffen; Huber, Lars C.] Univ Zurich, Ctr Expt Rheumatol, CH-8091 Zurich, Switzerland; [Brock, Matthias; Trenkmann, Michelle; Gay, Renate E.; Gay, Steffen; Huber, Lars C.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Brock, M (corresponding author), Univ Zurich Hosp, Ctr Expt Rheumatol, Working Grp Pulm Hypertens, Gloriastr 23, CH-8091 Zurich, Switzerland.	matthias.brock@usz.ch		Brock, Matthias/0000-0001-6445-0631; Trenkmann, Michelle/0000-0002-3332-6344	Swiss National Foundation [SNF-32000-116842]; Schwyzer Foundation; Zurich Lung League Foundation; Masterswitch FP7 Program; Institute for Arthritis Research Epalinges Program	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Schwyzer Foundation; Zurich Lung League Foundation; Masterswitch FP7 Program; Institute for Arthritis Research Epalinges Program	This work was supported by Swiss National Foundation Grant SNF-32000-116842, the Schwyzer Foundation, the Zurich Lung League Foundation, and the Masterswitch FP7 and Institute for Arthritis Research Epalinges Programs.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hou T, 2007, J BIOL CHEM, V282, P37091, DOI 10.1074/jbc.M706458200; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; ZHANG ZX, 1995, J BIOL CHEM, V270, P24287, DOI 10.1074/jbc.270.41.24287	20	61	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40142	40150		10.1074/jbc.M111.251793	http://dx.doi.org/10.1074/jbc.M111.251793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953462	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000296925700047
J	Chen, CH; Sarbassov, DD				Chen, Chien-Hung; Sarbassov, Dos D.			The mTOR (Mammalian Target of Rapamycin) Kinase Maintains Integrity of mTOR Complex 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; MOTIF PHOSPHORYLATION; S6 KINASE-1; CELL-GROWTH; RICTOR; AKT; ACTIVATION; RAPTOR; SITE	In higher eukaryotes, growth factors promote anabolic processes and stimulate cell growth, proliferation, and survival by activation of the phosphoinositide 3-kinase (PI3K)/Akt pathway. Deregulation of PI3K/Akt signaling is linked to human diseases, including cancer and metabolic disorders. The PI3K-dependent signaling kinase complex mTORC2(mammalian target of rapamycin complex 2) has been defined as the regulatory Ser-473 kinase of Akt. The regulation of mTORC2 remains very poorly characterized. We have reconstituted mTORC2 by its assembly in vitro or by co-expression its four essential components (rictor, SIN1, mTOR, mLST8). We show that the functional mTOR kinase domain is required for the mTORC2 activity as the Ser-473 kinase of Akt. We also found that mTOR by phosphorylation of SIN1 prevents its lysosomal degradation. Thus, the kinase domain of mTOR is required for the functional activity of mTORC2, and it controls integrity of mTORC2 by maintaining the protein stability of SIN1.	[Chen, Chien-Hung; Sarbassov, Dos D.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Chien-Hung; Sarbassov, Dos D.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Sarbassov, DD (corresponding author), 1515 Holcombe Blvd, Houston, TX 77030 USA.	dsarbass@mdanderson.org	Sarbassov, Dos/AAS-4950-2020	Sarbassov, Dos/0000-0002-6848-1133	National Institutes of Health [CA133522]; NATIONAL CANCER INSTITUTE [R01CA133522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA133522 (to D. D. S.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	40	33	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40386	40394		10.1074/jbc.M111.282590	http://dx.doi.org/10.1074/jbc.M111.282590			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965657	Green Published, hybrid			2022-12-27	WOS:000296925700069
J	Nguyen, TT; Stevens, MV; Kohr, M; Steenbergen, C; Sack, MN; Murphy, E				Nguyen, Tiffany T.; Stevens, Mark V.; Kohr, Mark; Steenbergen, Charles; Sack, Michael N.; Murphy, Elizabeth			Cysteine 203 of Cyclophilin D Is Critical for Cyclophilin D Activation of the Mitochondrial Permeability Transition Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; CYTOCHROME-C RELEASE; S-NITROSYLATION; NITRIC-OXIDE; CELL-DEATH; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; CARDIOPROTECTION; INJURY; RAT	The mitochondrial permeability transition pore (mPTP) opening plays a critical role in mediating cell death during ischemia/reperfusion (I/R) injury. Our previous studies have shown that cysteine 203 of cyclophilin D(CypD), a critical mPTP mediator, undergoes protein S-nitrosylation (SNO). To investigate the role of cysteine 203 in mPTP activation, we mutated cysteine 203 of CypD to a serine residue (C203S) and determined its effect on mPTP opening. Treatment of WT mouse embryonic fibroblasts (MEFs) with H2O2 resulted in an 50% loss of the mitochondrial calcein fluorescence, suggesting substantial activation of the mPTP. Consistent with the reported role of CypD in mPTP activation, CypD null (CypD(-/-)) MEFs exhibited significantly less mPTP opening. Addition of a nitric oxide donor, GSNO, to WT but not CypD(-/-) MEFs prior to H2O2 attenuated mPTP opening. To test whether Cys-203 is required for this protection, we infected CypD(-/-) MEFs with a C203S-CypD vector. Surprisingly, C203S-CypD reconstituted MEFs were resistant to mPTP opening in the presence or absence of GSNO, suggesting a crucial role for Cys-203 in mPTP activation. To determine whether mutation of C203S-CypD would alter mPTP in vivo, we injected a recombinant adenovirus encoding C203S-CypD or WT CypD into CypD(-/-) mice via tail vein. Mitochondria isolated from livers of CypD(-/-) mice or mice expressing C203S-CypD were resistant to Ca2+ -induced swelling as compared with WT CypD-reconstituted mice. Our results indicate that the Cys-203 residue of CypD is necessary for redox stress-induced activation of mPTP.	[Nguyen, Tiffany T.; Kohr, Mark; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Stevens, Mark V.; Sack, Michael N.] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Kohr, Mark; Steenbergen, Charles] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21257 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University	Murphy, E (corresponding author), NHLBI, Syst Biol Ctr, NIH, Bldg 10-8N202,10 Ctr Dr, Bethesda, MD 20892 USA.	murphy1@nhlbi.nih.gov	Nguyen, Tiffany/HGD-2431-2022		National Institutes of Health [Z01HL006059, Z01HL002066, 1F32HL096142, 5R01HL039752]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01HL006059 and Z01HL002066 (to T. T. N. and E. M.), 1F32HL096142 (to M. K.) and 5R01HL039752 (to C. S.).	Atar S, 2006, AM J PHYSIOL-HEART C, V290, pH1960, DOI 10.1152/ajpheart.01137.2005; Baines CP, 2007, AM J PHYSIOL-HEART C, V293, pH903, DOI 10.1152/ajpheart.00575.2007; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; Brookes PS, 2000, J BIOL CHEM, V275, P20474, DOI 10.1074/jbc.M001077200; Burwell LS, 2008, ANTIOXID REDOX SIGN, V10, P579, DOI 10.1089/ars.2007.1845; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Chernyak BV, 1997, BIOSCIENCE REP, V17, P293, DOI 10.1023/A:1027384628678; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cruz TS, 2010, BIOCHEM PHARMACOL, V80, P1284, DOI 10.1016/j.bcp.2010.06.052; Devalaraja-Narashimha K, 2009, AM J PHYSIOL-RENAL, V297, pF749, DOI 10.1152/ajprenal.00239.2009; Feldkamp T, 2005, AM J PHYSIOL-RENAL, V288, pF1092, DOI 10.1152/ajprenal.00443.2004; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Kohr MJ, 2011, AM J PHYSIOL-HEART C, V300, pH1327, DOI 10.1152/ajpheart.00997.2010; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Kowaltowski AJ, 1996, FEBS LETT, V378, P150, DOI 10.1016/0014-5793(95)01449-7; Lin J, 2009, CIRCULATION, V120, P245, DOI 10.1161/CIRCULATIONAHA.109.868729; Linard D, 2009, ARCH BIOCHEM BIOPHYS, V491, P39, DOI 10.1016/j.abb.2009.09.002; Maejima Y, 2005, J MOL CELL CARDIOL, V38, P163, DOI 10.1016/j.yjmcc.2004.10.012; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Morin D, 2004, BIOCHEM PHARMACOL, V68, P2065, DOI 10.1016/j.bcp.2004.07.006; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Pagliaro P, 2011, ANTIOXID REDOX SIGN, V14, P833, DOI 10.1089/ars.2010.3245; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Salet C, 1997, J BIOL CHEM, V272, P21938, DOI 10.1074/jbc.272.35.21938; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2006, ANTIOXID REDOX SIGN, V8, P1693, DOI 10.1089/ars.2006.8.1693; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452	34	141	143	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40184	40192		10.1074/jbc.M111.243469	http://dx.doi.org/10.1074/jbc.M111.243469			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21930693	Green Published, hybrid			2022-12-27	WOS:000296925700051
J	Placzek, WJ; Sturlese, M; Wu, BN; Cellitti, JF; Wei, J; Pellecchia, M				Placzek, William J.; Sturlese, Mattia; Wu, Bainan; Cellitti, Jason F.; Wei, Jun; Pellecchia, Maurizio			Identification of a Novel Mcl-1 Protein Binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY PROTEINS; ALLOSTERIC REGULATION; STRUCTURAL BASIS; BH3 DOMAINS; CELL-DEATH; APOPTOSIS; CANCER; INHIBITOR; COMPLEX; P53	Recent characterization of Mcl-1 as the primary anti-apoptotic Bcl-2 family member expressed in solid tumors, coupled with its ability to enable therapeutic resistance, has provided the impetus for further study into how Mcl-1 is involved in apoptosis signaling. Here, we employ Sabutoclax, a potent and effective Mcl-1 antagonist, as a competing agent to screen a randomized 12-residue phage display library for peptides that bind strongly to the Bcl-2 homology 3 (BH3) binding groove of Mcl-1. Although the screen identified a number of alpha-helical peptides with canonical BH3 domain sequences, it also isolated a pair of unique peptide sequences. These sequences exhibit a reverse organization of conserved hydrophobic and acidic residues when compared with canonical BH3 sequences, and we therefore refer to them as reverse BH3 (rBH3) peptides. Furthermore, studies of the rBH3 peptides using NMR spectroscopy, fluorescence polarization displacement assays, and alanine scanning data all suggest that they bind to the BH3 binding groove of Mcl-1 selectively over Bcl-x(L). A search for proteins containing the rBH3 motif has identified a number of interesting Mcl-1 protein partners, some of which have previously been associated with apoptosis regulation involving Mcl-1. These findings provide insights into the development of more specific Mcl-1 antagonists and open the way to the identification of a previously unknown family of apoptosis-regulating and Mcl-1 interacting proteins.	[Placzek, William J.; Sturlese, Mattia; Wu, Bainan; Cellitti, Jason F.; Wei, Jun; Pellecchia, Maurizio] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Pellecchia, M (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mpellecchia@sanfordburnham.org	Sturlese, Mattia/P-9473-2019; Pellecchia, Maurizio/Y-7072-2018; wu, bainan/C-2071-2012; Placzek, William/AAG-1172-2020	Sturlese, Mattia/0000-0003-3944-0313; Placzek, William/0000-0003-4096-8617	National Institutes of Health [CA149668]; NCI [CA121949]; Department of Chemical Sciences, University of Padova, Italy; NATIONAL CANCER INSTITUTE [R01CA149668, T32CA121949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Chemical Sciences, University of Padova, Italy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA149668 (to M. P.) and NCI T32 Fellowship Grant CA121949 (to W. J. P.). This work was also supported by the Department of Chemical Sciences, University of Padova, Italy (to M. S.).	Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Eguchi T, 2009, MOL CANCER THER, V8, P1460, DOI 10.1158/1535-7163.MCT-08-1159; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Keller R.L.J., 2005, OPTIMIZING PROCESS N; Lee EF, 2009, J BIOL CHEM, V284, P31315, DOI 10.1074/jbc.M109.048009; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Liang H, 1997, J MOL BIOL, V274, P291, DOI 10.1006/jmbi.1997.1415; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Rega MF, 2007, BIOORG CHEM, V35, P344, DOI 10.1016/j.bioorg.2007.03.001; Sheikh MS, 2000, J CELL PHYSIOL, V182, P171, DOI 10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wei J, 2010, J MED CHEM, V53, P4166, DOI 10.1021/jm1001265; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	33	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39829	39835		10.1074/jbc.M111.305326	http://dx.doi.org/10.1074/jbc.M111.305326			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953453	Green Published, hybrid			2022-12-27	WOS:000296925700017
J	Reboul, R; Geserick, C; Pabst, M; Frey, B; Wittmann, D; Lutz-Meindl, U; Leonard, R; Tenhaken, R				Reboul, Rebecca; Geserick, Claudia; Pabst, Martin; Frey, Beat; Wittmann, Doris; Luetz-Meindl, Ursula; Leonard, Renaud; Tenhaken, Raimund			Down-regulation of UDP-glucuronic Acid Biosynthesis Leads to Swollen Plant Cell Walls and Severe Developmental Defects Associated with Changes in Pectic Polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE DEHYDROGENASE; MATRIX POLYSACCHARIDES; ARABIDOPSIS-THALIANA; GENE FAMILY; ENZYME; MYOINOSITOL; PATHWAYS; OLIGOSACCHARIDES; GLUCURONOKINASE; XYLOGLUCAN	UDP-glucose dehydrogenase (UGD) plays a key role in the nucleotide sugar biosynthetic pathway, as its product UDP-glucuronic acid is the common precursor for arabinose, xylose, galacturonic acid, and apiose residues found in the cell wall. In this study we characterize an Arabidopsis thaliana double mutant ugd2,3 that lacks two of the four UGD isoforms. This mutant was obtained from a cross of ugd2 and ugd3 single mutants, which do not show phenotypical differences compared with the WT. In contrast, ugd2,3 has a strong dwarfed phenotype and often develops seedlings with severe root defects suggesting that the UGD2 and UGD3 isoforms act in concert. Differences in its cell wall composition in comparison to the WT were determined using biochemical methods indicating a significant reduction in arabinose, xylose, apiose, and galacturonic acid residues. Xyloglucan is less substituted with xylose, and pectins have a reduced amount of arabinan side chains. In particular, the amount of the apiose containing side chains A and B of rhamnogalacturonan II is strongly reduced, resulting in a swollen cell wall. The alternative pathway to UDP-glucuronic acid with the key enzyme myo-inositol oxygenase is not up-regulated in ugd2,3. The pathway also does not complement the ugd2,3 mutation, likely because the supply of myo-inositol is limited. Taken together, the presented data underline the importance of UDP GlcA for plant primary cell wall formation.	[Reboul, Rebecca; Geserick, Claudia; Wittmann, Doris; Tenhaken, Raimund] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria; [Pabst, Martin; Leonard, Renaud] Univ Nat Resources & Appl Life Sci, Dept Chem, A-1190 Vienna, Austria; [Frey, Beat] Rhizosphere Proc Grp, Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Luetz-Meindl, Ursula] Salzburg Univ, Dept Cell Biol Cell Struct & Cytomorphogenesis, A-5020 Salzburg, Austria	Salzburg University; University of Natural Resources & Life Sciences, Vienna; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Salzburg University	Tenhaken, R (corresponding author), Salzburg Univ, Dept Cell Biol Plant Physiol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	raimund.tenhaken@sbg.ac.at	Tenhaken, Raimund/O-6556-2019; Pabst, Martin/GOH-1766-2022; Frey, Beat/AAE-1745-2022	Tenhaken, Raimund/0000-0002-6764-4826; Pabst, Martin/0000-0001-9897-0723; Frey, Beat/0000-0002-6391-3574	German Science Foundation (Deutsche Forschungsgemeinschaft; Bonn, Germany)	German Science Foundation (Deutsche Forschungsgemeinschaft; Bonn, Germany)(German Research Foundation (DFG))	The project is funded by a grant from the German Science Foundation (Deutsche Forschungsgemeinschaft; Bonn, Germany; to R. T.).	Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Burget EG, 1999, PLANT PHYSIOL, V121, P383, DOI 10.1104/pp.121.2.383; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Eder M, 2008, J MICROSC-OXFORD, V231, P201, DOI 10.1111/j.1365-2818.2008.02036.x; Endres S, 2011, PLANTA, V234, P157, DOI 10.1007/s00425-011-1394-z; Endres S, 2009, PLANT PHYSIOL, V149, P1042, DOI 10.1104/pp.108.130948; Frey B, 2000, PLANT CELL ENVIRON, V23, P675, DOI 10.1046/j.1365-3040.2000.00590.x; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; JAENICKE R, 1986, BIOCHEMISTRY-US, V25, P7283, DOI 10.1021/bi00371a006; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Karkonen A, 2006, PLANTA, V223, P858, DOI 10.1007/s00425-005-0207-7; Klinghammer M, 2007, J EXP BOT, V58, P3609, DOI 10.1093/jxb/erm209; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; KROPF DL, 1993, DEV BIOL, V160, P303, DOI 10.1006/dbio.1993.1309; LEIBOWITZ MD, 1977, ARCH BIOCHEM BIOPHYS, V179, P559, DOI 10.1016/0003-9861(77)90144-8; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; Loewus Frank A., 2006, V39, P21; Lutz-Meindl U, 2004, PROTOPLASMA, V223, P155, DOI 10.1007/s00709-003-0033-3; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Oertel A, 2004, J PHYCOL, V40, P711, DOI 10.1111/j.1529-8817.2004.03222.x; Oka T, 2006, FEBS J, V273, P2645, DOI 10.1111/j.1742-4658.2006.05281.x; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Pieslinger AM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.069369; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Reiter WD, 2008, CURR OPIN PLANT BIOL, V11, P236, DOI 10.1016/j.pbi.2008.03.009; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Scheible WR, 2004, CURR OPIN PLANT BIOL, V7, P285, DOI 10.1016/j.pbi.2004.03.006; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Seifert GJ, 2004, PLANT CELL, V16, P723, DOI 10.1105/tpc.019661; Seitz B, 2000, PLANT J, V21, P537, DOI 10.1046/j.1365-313x.2000.00696.x; Seveno M, 2009, PLANTA, V230, P947, DOI 10.1007/s00425-009-0996-1; Sharples SC, 2007, PLANT J, V52, P252, DOI 10.1111/j.1365-313X.2007.03225.x; Shevell DE, 2000, PLANT CELL, V12, P2047, DOI 10.1105/tpc.12.11.2047; Siddique S, 2009, NEW PHYTOL, V184, P457, DOI 10.1111/j.1469-8137.2009.02981.x; Stewart DC, 1998, PLANT PHYSIOL, V116, P349, DOI 10.1104/pp.116.1.349; Tenhaken R, 1996, PLANT PHYSIOL, V112, P1127, DOI 10.1104/pp.112.3.1127; Vitha S, 2000, HISTOCHEM J, V32, P457, DOI 10.1023/A:1004171431449; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zykwinska AW, 2005, PLANT PHYSIOL, V139, P397, DOI 10.1104/pp.105.065912	46	85	88	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39982	39992		10.1074/jbc.M111.255695	http://dx.doi.org/10.1074/jbc.M111.255695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949134	Green Published, hybrid			2022-12-27	WOS:000296925700031
J	Cornish, AJ; Gartner, K; Yang, H; Peters, JW; Hegg, EL				Cornish, Adam J.; Gaertner, Katrin; Yang, Hui; Peters, John W.; Hegg, Eric L.			Mechanism of Proton Transfer in [FeFe]-Hydrogenase from Clostridium pasteurianum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-ONLY HYDROGENASE; ACTIVE-SITE; IRON HYDROGENASE; H-CLUSTER; COORDINATION; INHIBITION; MATURATION; REDUCTION; TRANSPORT; OXYGEN	[FeFe]-Hydrogenases are complex metalloproteins that catalyze the reversible reduction of protons to molecular hydrogen utilizing a unique diiron subcluster bridged to a [4Fe4S] subcluster. Extensive studies have concentrated on the nature and catalytic activity of the active site, yet relatively little information is available concerning the mechanism of proton transport that is required for this activity. Previously, structural characterization of [FeFe]-hydrogenase from Clostridium pasteurianum indicated a potential proton transport pathway involving four residues (Cys-299, Glu-279, Ser-319, and Glu-282) that connect the active site to the enzyme surface. Here, we demonstrate that substitution of any of these residues resulted in a drastic reduction in hydrogenase activity relative to the native enzyme, supporting the importance of these residues in catalysis. Inhibition studies of native and amino acid-substituted enzymes revealed that Zn2+ specifically blocked proton transfer by binding to Glu-282, confirming the role of this residue in the identified pathway. In addition, all four of these residues are strictly conserved, suggesting that they may form a proton transport pathway that is common to all [FeFe]-hydrogenases.	[Cornish, Adam J.; Gaertner, Katrin; Yang, Hui; Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Peters, John W.] Montana State Univ, Astrobiol Biogeocatalysis Res Ctr, Bozeman, MT 59717 USA	Michigan State University; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Hegg, EL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	erichegg@msu.edu		Peters, John/0000-0001-9117-9568	Air Force Office of Scientific Research [FA9550-05-1-0365]; United States Department of Energy Great Lakes Bioenergy Research Center (Biological and Environmental Research Office of Science) [DE-FC02-07ER64494]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); United States Department of Energy Great Lakes Bioenergy Research Center (Biological and Environmental Research Office of Science)(United States Department of Energy (DOE))	This work was supported by Air Force Office of Scientific Research Grant FA9550-05-1-0365 and by the United States Department of Energy Great Lakes Bioenergy Research Center (Biological and Environmental Research Office of Science Grant DE-FC02-07ER64494).	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bethel RD, 2010, ANGEW CHEM INT EDIT, V49, P8567, DOI 10.1002/anie.201003747; Chang YH, 2007, J BIOL CHEM, V282, P34306, DOI 10.1074/jbc.M706336200; Cukierman S, 2006, BBA-BIOENERGETICS, V1757, P876, DOI 10.1016/j.bbabio.2005.12.001; Czech I, 2011, FEBS LETT, V585, P225, DOI 10.1016/j.febslet.2010.11.052; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; English CM, 2009, DALTON T, P9970, DOI 10.1039/b913426n; Faxen K, 2006, BBA-BIOENERGETICS, V1757, P388, DOI 10.1016/j.bbabio.2006.05.010; FERNANDEZ VM, 1989, EUR J BIOCHEM, V185, P449, DOI 10.1111/j.1432-1033.1989.tb15135.x; Florin L, 2001, J BIOL CHEM, V276, P6125, DOI 10.1074/jbc.M008470200; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Fujii M, 2009, GENES CELLS, V14, P457, DOI 10.1111/j.1365-2443.2009.01282.x; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Hong G, 2011, BBA-BIOENERGETICS, V1807, P510, DOI 10.1016/j.bbabio.2011.01.011; KAMACHI T, 1995, J MOL CATAL A-CHEM, V96, P329, DOI 10.1016/1381-1169(94)00057-3; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lautier T, 2011, FARADAY DISCUSS, V148, P385, DOI 10.1039/c004099c; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Marshall MJ, 2008, ENVIRON MICROBIOL, V10, P125, DOI 10.1111/j.1462-2920.2007.01438.x; Moulis JM, 1995, BIOCHEMISTRY-US, V34, P16781, DOI 10.1021/bi00051a028; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nicolet Y, 2000, TRENDS BIOCHEM SCI, V25, P138, DOI 10.1016/S0968-0004(99)01536-4; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Ozawa K, 2001, BIOSCI BIOTECH BIOCH, V65, P185, DOI 10.1271/bbb.65.185; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Peters JW, 1999, CURR OPIN STRUC BIOL, V9, P670, DOI 10.1016/S0959-440X(99)00028-7; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Takahashi E, 2006, J BIOL CHEM, V281, P4413, DOI 10.1074/jbc.M511359200; TAKAHASHI E, 1991, FEBS LETT, V283, P140, DOI 10.1016/0014-5793(91)80572-K; Vannucci AK, 2010, DALTON T, V39, P3050, DOI 10.1039/b921067a; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Whitehead SJ, 2009, BBA-BIOENERGETICS, V1787, P1276, DOI 10.1016/j.bbabio.2009.06.001; Wright JA, 2009, CHEM COMMUN, P5719, DOI 10.1039/b912499c; Xu JC, 2005, P NATL ACAD SCI USA, V102, P6795, DOI 10.1073/pnas.0408117102; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	46	84	84	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38341	38347		10.1074/jbc.M111.254664	http://dx.doi.org/10.1074/jbc.M111.254664			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900241	hybrid, Green Published			2022-12-27	WOS:000296594200047
J	Klippel, S; Wieczorek, M; Schumann, M; Krause, E; Marg, B; Seidel, T; Meyer, T; Knapp, EW; Freund, C				Klippel, Stefan; Wieczorek, Marek; Schuemann, Michael; Krause, Eberhard; Marg, Berenice; Seidel, Thorsten; Meyer, Tim; Knapp, Ernst-Walter; Freund, Christian			Multivalent Binding of Formin-binding Protein 21 (FBP21)-Tandem-WW Domains Fosters Protein Recognition in the Pre-spliceosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM WW DOMAINS; LIGAND RECOGNITION; BACKBONE DYNAMICS; REDOX POTENTIALS; NMR-SPECTROSCOPY; SH3 DOMAINS; GYF DOMAIN; RNA; IDENTIFICATION; SPECIFICITY	The high abundance of repetitive but nonidentical proline-rich sequences in spliceosomal proteins raises the question of how these known interaction motifs recruit their interacting protein domains. Whereas complex formation of these adaptors with individual motifs has been studied in great detail, little is known about the binding mode of domains arranged in tandem repeats and long proline-rich sequences including multiple motifs. Here we studied the interaction of the two adjacent WW domains of spliceosomal protein FBP21 with several ligands of different lengths and composition to elucidate the hallmarks of multivalent binding for this class of recognition domains. First, we show that many of the proteins that define the cellular proteome interacting with FBP21-WW1-WW2 contain multiple proline-rich motifs. Among these is the newly identified binding partner SF3B4. Fluorescence resonance energy transfer (FRET) analysis reveals the tandem-WW domains of FBP21 to interact with splicing factor 3B4 (SF3B4) in nuclear speckles where splicing takes place. Isothermal titration calorimetry and NMR shows that the tandem arrangement of WW domains and the multivalency of the proline-rich ligands both contribute to affinity enhancement. However, ligand exchange remains fast compared with the NMR time scale. Surprisingly, a N-terminal spin label attached to a bivalent ligand induces NMR line broadening of signals corresponding to both WW domains of the FBP21-WW1-WW2 protein. This suggests that distinct orientations of the ligand contribute to a delocalized and semispecific binding mode that should facilitate search processes within the spliceosome.	[Klippel, Stefan; Wieczorek, Marek; Freund, Christian] Leibniz Inst Mol Pharmacol, Prot Engn Grp, D-13125 Berlin, Germany; [Klippel, Stefan; Wieczorek, Marek; Freund, Christian] Free Univ Berlin, D-13125 Berlin, Germany; [Schuemann, Michael; Krause, Eberhard] Leibniz Inst Mol Pharmacol, Mass Spectrometry Unit, D-13125 Berlin, Germany; [Marg, Berenice; Seidel, Thorsten] Univ Bielefeld, Dept Dynam Cell Imaging, D-33615 Bielefeld, Germany; [Meyer, Tim; Knapp, Ernst-Walter] Free Univ Berlin, Inst Chem, Theoret Chem Grp, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Bielefeld; Free University of Berlin	Freund, C (corresponding author), Leibniz Inst Mol Pharmacol, Prot Engn Grp, Robert Rossle Str 10, D-13125 Berlin, Germany.	freund@fmp-berlin.de	Knapp, Ernst-Walter/E-4493-2010; Knapp, Ernst-Walter/AAH-6720-2021	Knapp, Ernst-Walter/0000-0002-2858-0460; Knapp, Ernst-Walter/0000-0002-2858-0460	Deutsche Forschungsgemeinschaft [FG806, SFB765]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants FG806 and SFB765.	Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Enkhmandakh B, 2006, P NATL ACAD SCI USA, V103, P11631, DOI 10.1073/pnas.0605209103; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Furumai R, 2010, CANCER SCI, V101, P2483, DOI 10.1111/j.1349-7006.2010.01686.x; FUSHMAN D, 1994, J BIOMOL NMR, V4, P61, DOI 10.1007/BF00178336; Gamiz-Hernandez AP, 2010, CHEMPHYSCHEM, V11, P1196, DOI 10.1002/cphc.200900889; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Huang XJ, 2009, J BIOL CHEM, V284, P25375, DOI 10.1074/jbc.M109.024828; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Ishiyama A, 2011, J ANTIBIOT, V64, P381, DOI 10.1038/ja.2011.6; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kofler M, 2004, J BIOL CHEM, V279, P28292, DOI 10.1074/jbc.M402008200; Kofler M, 2009, MOL CELL PROTEOMICS, V8, P2461, DOI 10.1074/mcp.M900191-MCP200; Kofler MM, 2006, FEBS J, V273, P245, DOI 10.1111/j.1742-4658.2005.05078.x; Lange S, 2010, J PROTEOME RES, V9, P4113, DOI 10.1021/pr1003054; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mayer BJ, 2001, J CELL SCI, V114, P1253; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Popovic DM, 2001, J AM CHEM SOC, V123, P6040, DOI 10.1021/ja003878z; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Schlundt A, 2009, MOL CELL PROTEOMICS, V8, P2474, DOI 10.1074/mcp.M800337-MCP200; Seidel T, 2005, FEBS LETT, V579, P4374, DOI 10.1016/j.febslet.2005.06.077; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Wiesner S, 2002, J MOL BIOL, V324, P807, DOI 10.1016/S0022-2836(02)01145-2; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	39	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38478	38487		10.1074/jbc.M111.265710	http://dx.doi.org/10.1074/jbc.M111.265710			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917930	Green Published, hybrid			2022-12-27	WOS:000296594200062
J	Hirano, T; Serve, O; Yagi-Utsumi, M; Takemoto, E; Hiromoto, T; Satoh, T; Mizushima, T; Kato, K				Hirano, Takashi; Serve, Olivier; Yagi-Utsumi, Maho; Takemoto, Emi; Hiromoto, Takeshi; Satoh, Tadashi; Mizushima, Tsunehiro; Kato, Koichi			Conformational Dynamics of Wild-type Lys-48-linked Diubiquitin in Solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; 26 S PROTEASOME; POLYUBIQUITIN CHAINS; LYS48-LINKED TETRAUBIQUITIN; INTERDOMAIN MOBILITY; CRYSTAL-STRUCTURE; BINDING DOMAINS; PROTEIN; NMR; MODEL	Proteasomal degradation is mediated through modification of target proteins by Lys-48-linked polyubiquitin (polyUb) chain, which interacts with several binding partners in this pathway through hydrophobic surfaces on individual Ub units. However, the previously reported crystal structures of Lys-48-linked diUb exhibit a closed conformation with sequestered hydrophobic surfaces. NMR studies on mutated Lys-48-linked diUb indicated a pH-dependent conformational equilibrium between closed and open states with the predominance of the former under neutral conditions (90% at pH 6.8). To address the question of how Ub-binding proteins can efficiently access the sequestered hydrophobic surfaces of Ub chains, we revisited the conformational dynamics of Lys-48-linked diUb in solution using wild-type diUb and cyclic forms of diUb in which the Ub units are connected through two Lys-48-mediated isopeptide bonds. Our newly determined crystal structure of wild-type diUb showed an open conformation, whereas NMR analyses of cyclic Lys-48-linked diUb in solution revealed that its structure resembled the closed conformation observed in previous crystal structures. Comparison of a chemical shift of wild-type diUb with that of monomeric Ub and cyclic diUb, which mimic the open and closed states, respectively, with regard to the exposure of hydrophobic surfaces to the solvent indicates that wild-type Lys-48-linked diUb in solution predominantly exhibits the open conformation (75% at pH 7.0), which becomes more populated upon lowering pH. The intrinsic properties of Lys-48-linked Ub chains to adopt the open conformation may be advantageous for interacting with Ub-binding proteins.	[Hirano, Takashi; Serve, Olivier; Yagi-Utsumi, Maho; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Hirano, Takashi; Serve, Olivier; Yagi-Utsumi, Maho; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Hirano, Takashi; Serve, Olivier; Yagi-Utsumi, Maho; Takemoto, Emi; Hiromoto, Takeshi; Satoh, Tadashi; Mizushima, Tsunehiro; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Nagoya City University	Kato, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	kkatonmr@ims.ac.jp	Satoh, Tadashi/M-5157-2017	Satoh, Tadashi/0000-0002-4493-4978; Serve, Olivier/0000-0002-0199-8453; Mizushima, Tsunehiro/0000-0002-6631-2889; Kato, Koichi/0000-0001-7187-9612; Yagi-Utsumi, Maho/0000-0001-8144-740X	Ministry of Education, Culture, Sports, Science, and Technology [20107004, 21370050]; Grants-in-Aid for Scientific Research [20107004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 20107004, Grant-in-aid for Scientific Research (B) 21370050, the Targeted Proteins Research Program, and the Nanotechnology Network Project from the Ministry of Education, Culture, Sports, Science, and Technology.	Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; COOK WJ, 1992, J BIOL CHEM, V267, P16467; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Goddard T.D., 1993, SPARKY VERSION 3 0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Phillips CL, 2001, ACTA CRYSTALLOGR D, V57, P341, DOI 10.1107/S090744490001800X; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; Ryabov YE, 2007, J AM CHEM SOC, V129, P3315, DOI 10.1021/ja067667r; Satoh T, 2010, BIOCHEM BIOPH RES CO, V400, P329, DOI 10.1016/j.bbrc.2010.08.057; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Trempe JF, 2010, ACTA CRYSTALLOGR F, V66, P994, DOI 10.1107/S1744309110027600; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Wang X, 2008, PROTEIN SCI, V17, P899, DOI 10.1110/ps.073395108; Yao TT, 2000, J BIOL CHEM, V275, P36862, DOI 10.1074/jbc.M006050200; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	38	45	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37496	37502		10.1074/jbc.M111.256354	http://dx.doi.org/10.1074/jbc.M111.256354			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900242	hybrid, Green Published			2022-12-27	WOS:000296542400048
J	Nam, EA; Zhao, RX; Cortez, D				Nam, Edward A.; Zhao, Runxiang; Cortez, David			Analysis of Mutations That Dissociate G(2) and Essential S Phase Functions of Human Ataxia Telangiectasia-mutated and Rad3-related (ATR) Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY EMBRYONIC LETHALITY; PIK-RELATED KINASES; DNA-DAMAGE; CATALYTIC SUBUNIT; SECKEL-SYNDROME; HEAT REPEATS; CANCER-CELLS; IN-VITRO; CHECKPOINT; PHOSPHORYLATION	ATR (ataxia telangiectasia-mutated and Rad3-related) contains 16 conserved candidate autophosphorylation sites that match its preferred S/TQ consensus. To determine whether any is functionally important, we mutated the 16 candidate residues to alanine in a single cDNA to create a 16A-ATR mutant. The 16A-ATR mutant maintains kinase and G(2) checkpoint activities. However, it fails to rescue the essential function of ATR in maintaining cell viability and fails to promote replication recovery from a transient exposure to replication stress. Further analysis identified T1566A/T1578A/T1589A (3A-ATR) as critical mutations causing this separation of function activity. Secondary structure predictions indicate that these residues occur in a region between ATRHEAT repeats 31R and 32R that aligns with regions of ATM and DNA-PK containing regulatory autophosphorylation sites. Although this region is important for ATR function, the 3A-ATR residues do not appear to be sites of autophosphorylation. Nevertheless, our analysis identifies an important regulatory region of ATR that is shared among the PI3K-related protein kinase family. Furthermore, our data indicate that the essential function of ATR for cell viability is linked to its function in promoting proper replication in the context of replication stress and is independent of G(2) checkpoint activity.	[Zhao, Runxiang; Cortez, David] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Nam, Edward A.] Vanderbilt Univ, Dept Canc Biol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 613 Light Hall, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu			National Institutes of Health [R01CA102729]; Vanderbilt-Ingram Cancer Center (National Institutes of Health through the NCI) [CA06485]; Vanderbilt Center in Molecular Toxicology (National Institutes of Health through the NIEHS) [P30ES000267]; NATIONAL CANCER INSTITUTE [R01CA102729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center (National Institutes of Health through the NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt Center in Molecular Toxicology (National Institutes of Health through the NIEHS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA102729 (to D. C.). This work was also supported by the Vanderbilt-Ingram Cancer Center (National Institutes of Health Grant CA06485 through the NCI) and the Vanderbilt Center in Molecular Toxicology (National Institutes of Health Grant P30ES000267 through the NIEHS).	Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Gohler T, 2011, J CELL BIOL, V192, P219, DOI 10.1083/jcb.201008076; Jardim MJ, 2009, MOL BIOL CELL, V20, P3801, DOI 10.1091/mbc.E09-04-0303; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lewis KA, 2005, CANCER RES, V65, P7091, DOI 10.1158/0008-5472.CAN-05-1019; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	59	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37320	37327		10.1074/jbc.M111.276113	http://dx.doi.org/10.1074/jbc.M111.276113			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908846	hybrid, Green Published			2022-12-27	WOS:000296542400032
J	Ogura, K; Yahiro, K; Tsutsuki, H; Nagasawa, S; Yamasaki, S; Moss, J; Noda, M				Ogura, Kohei; Yahiro, Kinnosuke; Tsutsuki, Hiroyasu; Nagasawa, Sayaka; Yamasaki, Shinji; Moss, Joel; Noda, Masatoshi			Characterization of Cholix Toxin-induced Apoptosis in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATING FACTOR; CYTOCHROME-C; VIBRIO-CHOLERAE; PROTEINS; ACTIVATION; MECHANISMS; CLEAVAGE; CASPASE; GENE; TRANSLATION	Cholix toxin (Cholix) is a novel ADP-ribosylating cytotoxin produced by Vibrio cholerae, which utilizes eukaryotic elongation factor 2 as a substrate and acts by a mechanism similar to that of diphtheria toxin and Pseudomonas exotoxin A. First it was found that Cholix-treated HeLa cells exhibited caspase-dependent apoptosis, whereas intestinal cells such as Caco-2, HCT116, and RKO did not. Here we investigated Cholix-induced cell death signaling pathways in HeLa cells. Cholix-induced cytochrome c release into cytosol was initiated by specific conformational changes of pro-apoptotic Bak associated with Bax. Silencing of bak/bax genes or bak gene alone using siRNA significantly suppressed cytochrome c release and caspase-7 activation, but not activation of caspases-3 and -9. Although pretreatment with a caspase-8 inhibitor (Z-IETD-FMK) reduced Cholix-induced cytochrome c release and activation of caspases-3, -7, and -9, cytotoxicity was not decreased. Pretreatment with Z-YVAD-FMK, which inhibits caspase-1, -4, and -5, suppressed not only cytochrome c release, activation of caspase-3, -7, -8, or -9, and PARP cleavage, but also cytotoxicity, indicating that caspase-1, -4, and -5 activation is initiated at an early stage of Cholix-induced apoptosis and promotes caspase-8 activation. These results show that the inflammatory caspases (caspase-1, -4, and -5) and caspase-8 are responsible for both mitochondrial signals and other caspase activation. In conclusion, we showed that Cholix-induced caspase activation plays an essential role in generation of apoptotic signals, which are mediated by both mitochondria-dependent and -independent pathways.	[Ogura, Kohei; Yahiro, Kinnosuke; Tsutsuki, Hiroyasu; Nagasawa, Sayaka; Noda, Masatoshi] Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chuo Ku, Chiba, Japan; [Nagasawa, Sayaka] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, Chiba, Japan; [Yamasaki, Shinji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5988531, Japan; [Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	Chiba University; Chiba University; Osaka Metropolitan University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yahiro, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chuo Ku, 1-8-1 Inohana, Chiba, Japan.	yahirok@faculty.chiba-u.jp		Yahiro, Kinnosuke/0000-0002-9813-0780	Japan Science and Technology Agency; National Institutes of Health, National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants-in-aid for Scientific Research for Young Scientists (B) of Japan and Improvement of Research Environment for Young Researchers from Japan Science and Technology Agency.; Supported by the Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute.	Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Bian ZM, 2009, INVEST OPHTH VIS SCI, V50, P6006, DOI 10.1167/iovs.09-3628; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Chen M, 2007, J BIOL CHEM, V282, P33888, DOI 10.1074/jbc.M702969200; Chen Y, 2007, INFECT IMMUN, V75, P2645, DOI 10.1128/IAI.01317-06; Chiu CC, 2009, J VET MED SCI, V71, P1, DOI 10.1292/jvms.71.1; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Du X, 2010, MOL CELL BIOL, V30, P3444, DOI 10.1128/MCB.00813-09; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; HUGHES JM, 1978, ANN INTERN MED, V88, P602, DOI 10.7326/0003-4819-88-5-602; Jenkins CE, 2004, J BIOL CHEM, V279, P37201, DOI 10.1074/jbc.M405594200; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; McDonnell MA, 2003, CELL DEATH DIFFER, V10, P1005, DOI 10.1038/sj.cdd.4401271; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; MORRIS JG, 1985, NEW ENGL J MED, V312, P343, DOI 10.1056/NEJM198502073120604; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; PETERSON JW, 1989, SCIENCE, V245, P857, DOI 10.1126/science.2549637; Petsaris O, 2010, J MED MICROBIOL, V59, P1260, DOI 10.1099/jmm.0.021014-0; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Purdy AE, 2010, ENV MICROBIOL REP, V2, P198, DOI 10.1111/j.1758-2229.2010.00139.x; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Roy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015753; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yahiro K, 2010, MICROB PATHOGENESIS, V49, P153, DOI 10.1016/j.micpath.2010.05.007; Yamamuro A, 2011, J PHARMACOL SCI, V115, P239, DOI 10.1254/jphs.10217SC; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao Y, 2010, J CELL PHYSIOL, V225, P316, DOI 10.1002/jcp.22276; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	41	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37207	37215		10.1074/jbc.M111.246504	http://dx.doi.org/10.1074/jbc.M111.246504			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903588	hybrid, Green Published			2022-12-27	WOS:000296542400021
J	Li, ZG; Xie, WB; Escano, CS; Asico, LD; Xie, QY; Jose, PA; Chen, SY				Li, Zuguo; Xie, Wei-Bing; Escano, Crisanto S.; Asico, Laureano D.; Xie, Qiyun; Jose, Pedro A.; Chen, Shi-You			Response Gene to Complement 32 Is Essential for Fibroblast Activation in Renal Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; UNILATERAL URETERAL OBSTRUCTION; SMOOTH-MUSCLE-DIFFERENTIATION; CHRONIC KIDNEY-DISEASE; TGF-BETA; MYOFIBROBLAST DIFFERENTIATION; DIABETIC-NEPHROPATHY; TUBULAR CELLS; SMAD3	Response gene to complement 32 (RGC-32) is a downstream target of transforming growth factor-beta (TGE-beta). TGE-beta is known to play a pathogenic role in renal fibrosis. In this study, we investigated RGC-32 function in renal fibrosis following unilateral ureteral obstruction (UUO) in mice, a model of progressive tubulointerstitial fibrosis. RGC-32 is normally expressed only in blood vessels of mouse kidney. However, UUO induces RGC-32 expression in renal interstitial cells at the early stage of kidney injury, suggesting that RGC-32 is involved in interstitial fibroblast activation. Indeed, expression of smooth muscle alpha-actin (alpha-SMA), an indicator of fibroblast activation, is limited to the interstitial cells at the early stage, and became apparent later in both interstitial and tubular cells. RGC-32 knockdown by shRNA significantly inhibits UUO-induced renal structural damage, alpha-SMA expression and collagen deposition, suggesting that RGC-32 is essential for the onset of renal interstitial fibrosis. In vitro studies indicate that RGC-32 mediates TGF-beta-induced fibroblast activation. Mechanistically, RGC-32 interacts with Smad3 and enhances Smad3 binding to the Smad binding element in alpha-SMA promoter as demonstrated by DNA affinity assay. In the chromatin setting, Smad3, but not Smad2, binds to alpha-SMA promoter in fibroblasts. RGC-32 appears to be essential for Smad3 interaction with the promoters of fibroblast activation-related genes in vivo. Functionally, RGC-32 is crucial for Smad3-mediated alpha-SMA promoter activity. Taken together, we identify RGC-32 as a novel fibrogenic factor contributing to the pathogenesis of renal fibrosis through fibroblast activation.	[Li, Zuguo; Xie, Wei-Bing; Xie, Qiyun; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Escano, Crisanto S.; Asico, Laureano D.; Jose, Pedro A.] Childrens Natl Med Ctr, Ctr Mol Physiol Res, Washington, DC 20010 USA; [Jose, Pedro A.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA	University System of Georgia; University of Georgia; Children's National Health System; Georgetown University	Chen, SY (corresponding author), 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Asico, Laureano/AAM-6321-2020		National Institutes of Health [HL093429, HL107526, DK39308, HL23081]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107526, R01HL093429, R37HL023081, R01HL023081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants HL093429 and HL107526 (to S. Y. C.) and DK39308 and HL23081 (to P. A. J.) from the National Institutes of Health.	Badea T, 2002, J BIOL CHEM, V277, P502, DOI 10.1074/jbc.M109354200; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chatziantoniou C, 2005, AM J PHYSIOL-RENAL, V289, pF227, DOI 10.1152/ajprenal.00453.2004; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Cochrane AL, 2005, J AM SOC NEPHROL, V16, P3623, DOI 10.1681/ASN.2004090771; Dai CS, 2004, J AM SOC NEPHROL, V15, P2637, DOI 10.1097/01.ASN.0000139479.09658.EE; DIAMOND JR, 1995, AM J KIDNEY DIS, V26, P133, DOI 10.1016/0272-6386(95)90166-3; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Guo BL, 2005, KIDNEY INT, V68, P972, DOI 10.1111/j.1523-1755.2005.00491.x; Guo X, 2011, AM J PHYSIOL-CELL PH, V300, pC1415, DOI 10.1152/ajpcell.00204.2010; Hao S, 2010, AM J PATHOL, V177, P1164, DOI 10.2353/ajpath.2010.091269; HEWITSON TD, 1995, AM J NEPHROL, V15, P111, DOI 10.1159/000168813; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Huang WY, 2009, J BIOL CHEM, V284, P9426, DOI 10.1074/jbc.M900039200; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874; Jernigan S. M., 2000, EXPT INSIGHTS MECH T; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Klahr S, 2003, J NEPHROL, V16, P179; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Owen WF, 2003, J AM SOC NEPHROL, V14, pS76, DOI 10.1097/01.ASN.0000070145.00225.EC; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schnaper HW, 2006, J AM SOC NEPHROL, V17, P1777, DOI 10.1681/ASN.2006030267; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Yang NS, 1998, NEPHROL DIAL TRANSPL, V13, P1967, DOI 10.1093/ndt/13.8.1967; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	44	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41323	41330		10.1074/jbc.M111.259184	http://dx.doi.org/10.1074/jbc.M111.259184			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21990365	Green Published, hybrid			2022-12-27	WOS:000298057500019
J	Liu, LJ; Sanosaka, M; Lei, S; Bestwick, ML; Frey, JH; Surovtseva, YV; Shadel, GS; Cooper, MP				Liu, Lijun; Sanosaka, Masato; Lei, Shi; Bestwick, Megan L.; Frey, Joseph H., Jr.; Surovtseva, Yulia V.; Shadel, Gerald S.; Cooper, Marcus P.			LRP130 Protein Remodels Mitochondria and Stimulates Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-A; RICH PENTATRICOPEPTIDE-REPEAT; C-OXIDASE DEFICIENCY; MESSENGER-RNA; GENE-EXPRESSION; COMPLEX-I; ATP TURNOVER; FACTORS B1; NUCLEAR; DNA	Impaired oxidative phosphorylation (OXPHOS) is implicated in several metabolic disorders. Even though mitochondrial DNA encodes several subunits critical for OXPHOS, the metabolic consequence of activating mitochondrial transcription remains unclear. We show here that LRP130, a protein involved in Leigh syndrome, increases hepatic beta-fatty acid oxidation. Using convergent genetic and biochemical approaches, we demonstrate LRP130 complexes with the mitochondrial RNA polymerase to activate mitochondrial transcription. Activation of mitochondrial transcription is associated with increased OXPHOS activity, increased supercomplexes, and denser cristae, independent of mitochondrial biogenesis. Consistent with increased oxidative phosphorylation, ATP levels are increased in both cells and mouse liver, whereas coupled respiration is increased in cells. We propose activation of mitochondrial transcription remodels mitochondria and enhances oxidative metabolism.	[Liu, Lijun; Sanosaka, Masato; Lei, Shi; Frey, Joseph H., Jr.; Cooper, Marcus P.] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA 01605 USA; [Bestwick, Megan L.; Surovtseva, Yulia V.; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Bestwick, Megan L.; Surovtseva, Yulia V.; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	University of Massachusetts System; University of Massachusetts Worcester; Yale University; Yale University	Cooper, MP (corresponding author), Univ Massachusetts, Sch Med, Div Cardiovasc Med, 381 Plantat St,Biotech 5,Ste 200, Worcester, MA 01605 USA.	marcus.cooper@umassmed.edu		Bestwick, Megan/0000-0003-3670-5507	National Institutes of Health [K08DK071017, R03DK081564, R01DK089185, R01HL059655]; James Hudson Brown-Alexander Brown Coxe Fellowship; NIDDK [DK32520]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089185, R03DK081564, K08DK071017, P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Hudson Brown-Alexander Brown Coxe Fellowship; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08DK071017, R03DK081564, and R01DK089185 (to M. P. C.) and R01HL059655 (to G. S. S.). This work was also supported by a James Hudson Brown-Alexander Brown Coxe Fellowship (to Y. V. S.).; Core resources were supported by National Institutes of Health Diabetes Endocrinology Research Center Grant DK32520 from NIDDK	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Ainscow EK, 1999, EUR J BIOCHEM, V266, P737, DOI 10.1046/j.1432-1327.1999.00856.x; ALLEN JF, 1993, J THEOR BIOL, V165, P609, DOI 10.1006/jtbi.1993.1210; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Cooper MP, 2008, J BIOL CHEM, V283, P31960, DOI 10.1074/jbc.M805431200; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cotney J, 2009, HUM MOL GENET, V18, P2670, DOI 10.1093/hmg/ddp208; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; Duborjal H, 2002, GENOME RES, V12, P1901, DOI 10.1101/gr.194102; Duggan AT, 2011, J EXP BIOL, V214, P1880, DOI 10.1242/jeb.053322; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; FISHER RP, 1985, J BIOL CHEM, V260, P1330; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garbian Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009985; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Giege P, 2005, PLANT CELL, V17, P1497, DOI 10.1105/tpc.104.030254; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; HAFNER RP, 1990, EUR J BIOCHEM, V188, P313, DOI 10.1111/j.1432-1033.1990.tb15405.x; HAYASHI J, 1990, BIOCHEM BIOPH RES CO, V167, P216, DOI 10.1016/0006-291X(90)91753-F; Hokari M, 2010, NEUROPATHOLOGY, V30, P401, DOI 10.1111/j.1440-1789.2009.01086.x; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Labialle S, 2004, NUCLEIC ACIDS RES, V32, P3864, DOI 10.1093/nar/gkh722; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; Liang HY, 2007, ANN NY ACAD SCI, V1100, P264, DOI 10.1196/annals.1395.028; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Martinez-Azorin F, 2008, J NEUROCHEM, V105, P165, DOI 10.1111/j.1471-4159.2007.05122.x; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Montoya J, 1997, MOL CELL BIOCHEM, V174, P227, DOI 10.1023/A:1006812625445; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORIN C, 1993, AM J HUM GENET, V53, P488; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Rimoin David, 2006, PRINCIPLES PRACTICE; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Shadel GS, 2008, AM J PATHOL, V172, P1445, DOI 10.2353/ajpath.2008.071163; Shutt TE, 2010, P NATL ACAD SCI USA, V107, P12133, DOI 10.1073/pnas.0910581107; Soboll S, 1998, EUR J BIOCHEM, V254, P194, DOI 10.1046/j.1432-1327.1998.2540194.x; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Sondheimer N, 2010, BIOCHEMISTRY-US, V49, P7467, DOI 10.1021/bi1008479; Spurway TD, 1997, BIOCHEM J, V323, P119, DOI 10.1042/bj3230119; Sterky FH, 2010, BIOCHEM BIOPH RES CO, V398, P759, DOI 10.1016/j.bbrc.2010.07.019; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; Tavares-Carreon F, 2008, J BIOL CHEM, V283, P1472, DOI 10.1074/jbc.M708437200; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Topisirovic I, 2009, EMBO J, V28, P1087, DOI 10.1038/emboj.2009.53; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Tsuchiya N, 2004, BIOCHEM BIOPH RES CO, V317, P736, DOI 10.1016/j.bbrc.2004.03.103; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Xu F., 2011, BIOCHEM IN PRESS; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469	82	37	37	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41253	41264		10.1074/jbc.M111.276121	http://dx.doi.org/10.1074/jbc.M111.276121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21971050	Green Published, hybrid			2022-12-27	WOS:000298057500013
J	Luthra, A; Zhu, GY; Desrosiers, DC; Eggers, CH; Mulay, V; Anand, A; McArthur, FA; Romano, FB; Caimano, MJ; Heuck, AP; Malkowski, MG; Radolf, JD				Luthra, Amit; Zhu, Guangyu; Desrosiers, Daniel C.; Eggers, Christian H.; Mulay, Vishwaroop; Anand, Arvind; McArthur, Fiona A.; Romano, Fabian B.; Caimano, Melissa J.; Heuck, Alejandro P.; Malkowski, Michael G.; Radolf, Justin D.			The Transition from Closed to Open Conformation of Treponema pallidum Outer Membrane-associated Lipoprotein TP0453 Involves Membrane Sensing and Integration by Two Amphipathic Helices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORRELIA-BURGDORFERI; MYCOBACTERIUM-TUBERCULOSIS; SYPHILIS SPIROCHETE; PHYSICAL-PROPERTIES; ESCHERICHIA-COLI; PROTEIN; SURFACE; REFINEMENT; LOCALIZATION; PHAGOCYTOSIS	The molecular architecture and composition of the outer membrane (OM) of Treponema pallidum (Tp), the noncultivable agent of venereal syphilis, differ considerably from those of typical Gram-negative bacteria. Several years ago we described TP0453, the only lipoprotein associated with the inner leaflet of the Tp OM. Whereas polypeptides of other treponemal lipoproteins are hydrophilic, non-lipidated TP0453 can integrate into membranes, a property attributed to its multiple amphipathic helices (AHs). Furthermore, membrane integration of the TP0453 polypeptide was found to increase membrane permeability, suggesting the molecule functions in a porin-like manner. To better understand the mechanism of membrane integration of TP0453 and its physiological role in Tp OM biogenesis, we solved its crystal structure and used mutagenesis to identify membrane insertion elements. The crystal structure of TP0453 consists of an alpha/beta/alpha-fold and includes five stably folded AHs. In high concentrations of detergent, TP0453 transitions from a closed to open conformation by lateral movement of two groups of AHs, exposing a large hydrophobic cavity. Triton X-114 phase partitioning, liposome floatation assay, and bis-1-anilino-8-naphthalenesulfonate binding revealed that two adjacent AHs are critical for membrane sensing/integration. Using terbium-dipicolinic acid complex-loaded large unilamellar vesicles, we found that TP0453 increased efflux of fluorophore only at acidic pH. Gel filtration and cross-linking experiments demonstrated that one AH critical for membrane sensing/insertion also forms a dimeric interface. Based on structural dynamics and comparison with Mycobacterium tuberculosis lipoproteins LprG and LppX, we propose that TP0453 functions as a carrier of lipids, glycolipids, and/or derivatives during OM biogenesis.	[Luthra, Amit; Mulay, Vishwaroop; Anand, Arvind; McArthur, Fiona A.; Caimano, Melissa J.; Radolf, Justin D.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Ctr Hlth, Dept Pediat, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Radolf, Justin D.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA; [Zhu, Guangyu; Malkowski, Michael G.] SUNY Buffalo, Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Zhu, Guangyu; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Desrosiers, Daniel C.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [Eggers, Christian H.] Quinnipiac Univ, Dept Biomed Sci, Hamden, CT 06518 USA; [Heuck, Alejandro P.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Romano, Fabian B.; Heuck, Alejandro P.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yale University; Quinnipiac University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Radolf, JD (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA.	JRadolf@up.uchc.edu	Malkowski, Michael G/G-4939-2011; Caimano, Melissa J./AAR-6578-2020; Caimano, Melissa J./AAQ-7573-2021; Zhu, Guangyu/F-6279-2011; Romano-Chernac, Fabian B./K-9396-2019	Malkowski, Michael G/0000-0003-1025-0014; Zhu, Guangyu/0000-0003-4228-135X; Malkowski, Michael/0000-0002-1203-7463	Public Health Service [AI-26756, RG-71111-N]; National Institutes of Health [GM074899, GM094611, GM094597]; National Institutes of Health National Research Service [T32 GM08515]; Notional Science Foundation under National Science Foundation [DMR-0225180]; National Center for Research Resources National Institutes of Health [RR-01646]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health; National Center for Research Resources; Biomedical Technology Program; NIGMS; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI026756, R37AI026756, R01AI026756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, U54GM074899, T32GM008515, U54GM094611] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notional Science Foundation under National Science Foundation; National Center for Research Resources National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service Grants AI-26756 (to J. D. R.) and RG-71111-N (to A. P. H.). This work was also supported, in whole or in part, by National Institutes of Health Grants GM074899, GM094611, and GM094597 (NIGMS Protein Structure Initiative to the High throughput screening laboratory at the Hauptman Woodward Institute).; Supported in part by National Institutes of Health National Research Service Award T32 GM08515.; This work was based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the Notional Science Foundation under National Science Foundation Award DMR-0225180 using the Macromolecular Diffraction at CHESS (Mac CHESS,) facility, which is supported by National Center for Research Resources National Institutes of Health Award RR-01646. Portions of this research were also carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the NIGMS. We acknowledge the excellent technical assistance of Morgan LeDoyt and thank Star Dunham-Ems and V.Kuruthihalli (University of Connecticut Health Center) for valuable discussions,	BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; Brunner J, 1996, TRENDS CELL BIOL, V6, P154, DOI 10.1016/0962-8924(96)40001-0; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Cameron CE, 2006, PATHOGENIC TREPONEMA : MOLECULAR AND CELLULAR BIOLOGY, P237; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; Cox DL, 2001, MICROBIOL-SGM, V147, P1161, DOI 10.1099/00221287-147-5-1161; COX DL, 1994, METHOD ENZYMOL, V236, P390; Dasanayake D, 2011, MOL MICROBIOL, V81, P734, DOI 10.1111/j.1365-2958.2011.07727.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Desrosiers DC, 2011, MOL MICROBIOL, V80, P1496, DOI 10.1111/j.1365-2958.2011.07662.x; Drage MG, 2010, NAT STRUCT MOL BIOL, V17, P1088, DOI 10.1038/nsmb.1869; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARRIS FJ, 1978, J AM CHEM SOC, V100, P4469, DOI 10.1021/ja00482a026; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hazlett KRO, 2005, J BACTERIOL, V187, P6499, DOI 10.1128/JB.187.18.6499-6508.2005; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOPE MJ, 1986, CHEM PHYS LIPIDS, V40, P89, DOI 10.1016/0009-3084(86)90065-4; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; JONES JD, 1995, INFECT IMMUN, V63, P2424, DOI 10.1128/IAI.63.7.2424-2434.1995; Koszelak-Rosenblum M, 2009, PROTEIN SCI, V18, P1828, DOI 10.1002/pro.193; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; LUKEHART SA, 1978, J IMMUNOL, V121, P2014; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore MW, 2007, INFECT IMMUN, V75, P2046, DOI 10.1128/IAI.01666-06; Moreira JN, 1996, J MATER SCI-MATER M, V7, P301, DOI 10.1007/BF00058571; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RADOLF JD, 1995, INFECT IMMUN, V63, P4244, DOI 10.1128/IAI.63.11.4244-4252.1995; RADOLF JD, 1995, MOL MICROBIOL, V16, P1067, DOI 10.1111/j.1365-2958.1995.tb02332.x; ROSEVEAR P, 1980, BIOCHEMISTRY-US, V19, P4108, DOI 10.1021/bi00558a032; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shevchenko DV, 1999, INFECT IMMUN, V67, P2266, DOI 10.1128/IAI.67.5.2266-2276.1999; Smoot AL, 2001, BIOCHEMISTRY-US, V40, P4484, DOI 10.1021/bi001822b; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; WALKER EM, 1989, J BACTERIOL, V171, P5005, DOI 10.1128/jb.171.9.5005-5011.1989; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635	56	22	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41656	41668		10.1074/jbc.M111.305284	http://dx.doi.org/10.1074/jbc.M111.305284			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965687	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000298057500050
J	Nina, PB; Morrisey, JM; Ganesan, SM; Ke, HJ; Pershing, AM; Mather, MW; Vaidya, AB				Nina, Praveen Balabaskaran; Morrisey, Joanne M.; Ganesan, Suresh M.; Ke, Hangjun; Pershing, April M.; Mather, Michael W.; Vaidya, Akhil B.			ATP Synthase Complex of Plasmodium falciparum DIMERIC ASSEMBLY IN MITOCHONDRIAL MEMBRANES AND RESISTANCE TO GENETIC DISRUPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; TETRAHYMENA-PYRIFORMIS; MAMMALIAN MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; ELECTRON-TRANSPORT; YEAST; CRISTAE; GENOME; SUPERCOMPLEXES; DEHYDROGENASE	The rotary nanomotor ATP synthase is a central player in the bioenergetics of most organisms. Yet the role of ATP synthase in malaria parasites has remained unclear, as blood stages of Plasmodium falciparum appear to derive ATP largely through glycolysis. Also, genes for essential subunits of the F-O sector of the complex could not be detected in the parasite genomes. Here, we have used molecular genetic and immunological tools to investigate the localization, complex formation, and functional significance of predicted ATP synthase subunits in P. falciparum. We generated transgenic P. falciparum lines expressing seven epitope-tagged canonical ATP synthase subunits, revealing localization of all but one of the subunits to the mitochondrion. Blue native gel electrophoresis of P. falciparum mitochondrial membranes suggested the molecular mass of the ATP synthase complex to be greater than 1 million daltons. This size is consistent with the complex being assembled as a dimer in a manner similar to the complexes observed in other eukaryotic organisms. This observation also suggests the presence of previously unknown subunits in addition to the canonical subunits in P. falciparum ATP synthase complex. Our attempts to disrupt genes encoding beta and gamma subunits were unsuccessful, suggesting an essential role played by the ATP synthase complex in blood stages of P. falciparum. These studies suggest that, despite some unconventional features and its minimal contribution to ATP synthesis, P. falciparum ATP synthase is localized to the parasite mitochondrion, assembled as a large dimeric complex, and is likely essential for parasite survival.	[Nina, Praveen Balabaskaran; Morrisey, Joanne M.; Ganesan, Suresh M.; Ke, Hangjun; Pershing, April M.; Mather, Michael W.; Vaidya, Akhil B.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19129 USA	Drexel University	Vaidya, AB (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, 2900 Queen Ln, Philadelphia, PA 19129 USA.	avaidya@drexelmed.edu		Mather, Michael/0000-0002-1062-0137; Balabaskaran Nina, Praveen/0000-0003-4096-0738	National Institutes of Health [AI28398]; Drexel University College of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028398, R22AI028398, R01AI053148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Drexel University College of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI28398 (to A. B. V.). This work was also supported by Drexel University College of Medicine.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; ALLEN RD, 1995, PROTOPLASMA, V189, P1, DOI 10.1007/BF01280286; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bornhovd C, 2006, J BIOL CHEM, V281, P13990, DOI 10.1074/jbc.M512334200; Boysen KE, 2011, J BIOL CHEM, V286, P32661, DOI 10.1074/jbc.M111.269399; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; BRYANT C, 1964, AM J TROP MED HYG, V13, P515, DOI 10.4269/ajtmh.1964.13.515; CONKLIN KA, 1972, COMP BIOCHEM PHYSIOL, V41, P45, DOI 10.1016/0305-0491(72)90006-5; de Koning-Ward TF, 2000, MOL BIOCHEM PARASIT, V106, P199, DOI 10.1016/S0166-6851(99)00189-9; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; DILISA F, 1995, J PHYSIOL-LONDON, V486, P1; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; KILPATRICK L, 1977, BIOCHIM BIOPHYS ACTA, V462, P515, DOI 10.1016/0005-2728(77)90098-6; KOBAYASHI S, 1965, J BIOCHEM, V58, P444, DOI 10.1093/oxfordjournals.jbchem.a128224; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; Krungkrai Jerapan, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P636; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Mangiullo R, 2008, BBA-BIOENERGETICS, V1777, P1326, DOI 10.1016/j.bbabio.2008.08.003; Mather MW, 2007, CURR DRUG TARGETS, V8, P49, DOI 10.2174/138945007779315632; Mather MW, 2010, MOL BIOCHEM PARASIT, V174, P150, DOI 10.1016/j.molbiopara.2010.07.006; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Mogi T, 2009, MITOCHONDRION, V9, P443, DOI 10.1016/j.mito.2009.08.004; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; NISHI A, 1962, BIOCHIM BIOPHYS ACTA, V65, P419, DOI 10.1016/0006-3002(62)90443-2; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 2004, FEBS LETT, V570, P93, DOI 10.1016/j.febslet.2004.06.032; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Sherman Irwin W., 1998, P135; St-Pierre J, 2000, P NATL ACAD SCI USA, V97, P8670, DOI 10.1073/pnas.140093597; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; SUPLICK K, 1990, MOL CELL BIOL, V10, P6381, DOI 10.1128/MCB.10.12.6381; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Traba J, 2008, MOL MICROBIOL, V69, P570, DOI 10.1111/j.1365-2958.2008.06300.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TURNER G, 1971, J GEN MICROBIOL, V65, P359, DOI 10.1099/00221287-65-3-359; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; VAIDYA AB, 1993, MOL BIOCHEM PARASIT, V58, P33, DOI 10.1016/0166-6851(93)90088-F; Vaidya Akhil B., 2004, Current Drug Targets - Infectious Disorders, V4, P11, DOI 10.2174/1568005043480907; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xing SL, 2011, CELL BIOL INT, V35, P81, DOI 10.1042/CBI20090441; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	68	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41312	41322		10.1074/jbc.M111.290973	http://dx.doi.org/10.1074/jbc.M111.290973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21984828	Green Published, hybrid			2022-12-27	WOS:000298057500018
J	Zhang, NG; Panigrahi, AK; Mao, QL; Pati, D				Zhang, Nenggang; Panigrahi, Anil K.; Mao, Qilong; Pati, Debananda			Interaction of Sororin Protein with Polo-like Kinase 1 Mediates Resolution of Chromosomal Arm Cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; ANAPHASE-PROMOTING COMPLEX; BOX DOMAIN; PHOSPHORYLATION DYNAMICS; CELL-DIVISION; PROPHASE; CLEAVAGE; BINDING; PLK1; WAPL	Unlike in budding yeast, sister chromatid cohesion in vertebrate cells is resolved in two steps: cohesin complexes are removed from sister chromatid arms during prophase via phosphorylation, whereas centromeric cohesins are removed at anaphase by Separase. Phosphorylation of cohesin subunit SA2 by polo-like kinase 1 (Plk1) is required for the removal of cohesins at prophase, but how Plk1 is recruited to phosphorylate SA2 during prophase is currently not known. Here we report that Sororin, a cohesin-interacting protein essential for sister chromatid cohesion, plays a novel role in the resolution of sister chromatid arms by direct interaction with Plk1. We identified an evolutionarily conserved motif ((STP)-P-159) on Sororin, which was phosphorylated by Cdk1/cyclin B and bound to the polo box domain of Plk1. Mutating Thr(159) into alanine prevented the interaction of Plk1 and Sororin and inhibited the resolution of chromosomal arm cohesion. We propose that Sororin is phosphorylated by Cdk1/cyclin B at prophase and acts as a docking protein to bring Plk1 into proximity with SA2, resulting in the phosphorylation of SA2 and the removal of cohesin complexes from chromosomal arms.	[Zhang, Nenggang; Panigrahi, Anil K.; Mao, Qilong; Pati, Debananda] Baylor Coll Med, Dept Pediat Hematol Oncol, Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Texas Children's Cancer Center	Zhang, NG (corresponding author), Baylor Coll Med, Dept Pediat Hematol Oncol, Texas Childrens Canc & Hematol Ctr, 1102 Bates Ave,Suite 1220, Houston, TX 77030 USA.	nzhang@bcm.edu; pati@bcm.edu			National Institutes of Health, NCI [1RO1 CA109478, 1RO1 CA109330]; Simmons Family Foundation; NATIONAL CANCER INSTITUTE [R01CA109478, R01CA109330] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Simmons Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1 CA109478 and 1RO1 CA109330 from the NCI (to D. P.). This work was also supported by a 2008 Virginia and L. E. Simmons Family Foundation collaborative research award (to D. P.).	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dreier MR, 2011, J CELL SCI, V124, P2976, DOI 10.1242/jcs.085431; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Freshney R. I., 2000, CULTURE ANIMAL CELLS, P456; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Li JJ, 2006, PHARMACOL THERAPEUT, V111, P974, DOI 10.1016/j.pharmthera.2006.02.006; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2004, CELL CYCLE, V3, P128; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Nguyen MH, 2010, CANCER RES, V70, P5337, DOI 10.1158/0008-5472.CAN-09-4372; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker MG, 2001, CURR CANCER DRUG TAR, V1, P73, DOI 10.2174/1568009013334241; Wu FM, 2011, J BIOL CHEM, V286, P3579, DOI 10.1074/jbc.M110.196758; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	45	38	38	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41826	41837		10.1074/jbc.M111.305888	http://dx.doi.org/10.1074/jbc.M111.305888			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987589	Green Published, hybrid			2022-12-27	WOS:000298057500065
J	Prinetti, A; Cao, T; Illuzzi, G; Prioni, S; Aureli, M; Gagliano, N; Tredici, G; Rodriguez-Menendez, V; Chigorno, V; Sonnino, S				Prinetti, Alessandro; Cao, Ting; Illuzzi, Giuditta; Prioni, Simona; Aureli, Massimo; Gagliano, Nicoletta; Tredici, Giovanni; Rodriguez-Menendez, Virginia; Chigorno, Vanna; Sonnino, Sandro			A Glycosphingolipid/Caveolin-1 Signaling Complex Inhibits Motility of Human Ovarian Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED MEMBRANE DOMAINS; RAT CEREBELLAR NEURONS; BLADDER-CANCER CELLS; GM3 GANGLIOSIDE; TYROSINE KINASE; PRION PROTEIN; ACTIVE SRC; CAVEOLIN-1; TUMOR; EXPRESSION	The genetic (stable overexpression of sialyltransferase I, GM3 synthase) or pharmacological (selective pressure by N-(4-hydroxyphenyl)retinamide)) manipulation of A2780 human ovarian cancer cells allowed us to obtain clones characterized by higher GM3 synthase activity compared with wild-type cells. Clones with high GM3 synthase expression had elevated ganglioside levels, reduced in vitro cell motility, and enhanced expression of the membrane adaptor protein caveolin-1 with respect to wild-type cells. In high GM3 synthase-expressing clones, both depletion of gangliosides by treatment with the glucosylceramide synthase inhibitor D-threo -1-phenyl-2-decanoylamino-3-morpholino-1-propanol and silencing of caveolin-1 by siRNA were able to strongly increase in vitro cell motility. The motility of wild-type, low GM3 synthase-expressing cells was reduced in the presence of a Src inhibitor, and treatment of these cells with exogenous gangliosides, able to reduce their in vitro motility, inactivated c-Src kinase. Conversely, ganglioside depletion by D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol treatment or caveolin-1 silencing in high GM3 synthase-expressing cells led to c-Src kinase activation. In high GM3 synthase-expressing cells, caveolin-1 was associated with sphingolipids, integrin receptor subunits, p130(CAS), and c-Src forming a Triton X-100-insoluble noncaveolar signaling complex. These data suggest a role for gangliosides in regulating tumor cell motility by affecting the function of a signaling complex organized by caveolin-1, responsible for Src inactivation downstream to integrin receptors, and imply that GM3 synthase is a key target for the regulation of cell motility in human ovarian carcinoma.	[Prinetti, Alessandro; Cao, Ting; Illuzzi, Giuditta; Prioni, Simona; Aureli, Massimo; Chigorno, Vanna; Sonnino, Sandro] Univ Milan, Dept Med Chem, I-20090 Segrate, Italy; [Prinetti, Alessandro; Cao, Ting; Illuzzi, Giuditta; Prioni, Simona; Aureli, Massimo; Chigorno, Vanna; Sonnino, Sandro] Univ Milan, Dept Biochem & Biotechnol, I-20090 Segrate, Italy; [Gagliano, Nicoletta] Univ Milan, Dept Human Morphol, I-20090 Segrate, Italy; [Gagliano, Nicoletta] Univ Milan, Dept Biomed Sci Citta Studi, I-20090 Segrate, Italy; [Tredici, Giovanni; Rodriguez-Menendez, Virginia] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, I-20052 Monza, Italy	University of Milan; University of Milan; University of Milan; University of Milan; University of Milano-Bicocca	Prinetti, A (corresponding author), Univ Milan, Dept Med Chem, I-20090 Segrate, Italy.	alessandro.prinetti@unimi.it	Prinetti, Alessandro/R-4206-2017; Sonnino, Sandro/R-4154-2017; Aureli, Massimo/G-3876-2014; Gagliano, Nicoletta/L-1485-2016	Prinetti, Alessandro/0000-0003-0252-2593; Sonnino, Sandro/0000-0001-8180-5908; Aureli, Massimo/0000-0003-1916-2440; Gagliano, Nicoletta/0000-0002-3393-3144				ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Banquet S, 2011, CELL SIGNAL, V23, P1136, DOI 10.1016/j.cellsig.2011.02.008; Benistant C, 2000, BIOCHEM BIOPH RES CO, V273, P425, DOI 10.1006/bbrc.2000.2948; Benistant C, 2001, CANCER RES, V61, P1415; Cantiani L, 2007, CANCER RES, V67, P7675, DOI 10.1158/0008-5472.CAN-06-4697; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Chigorno V, 2000, EUR J BIOCHEM, V267, P4187, DOI 10.1046/j.1432-1327.2000.01454.x; Cornish-Bowden A, 1998, CARBOHYD RES, V312, P167; Deng W, 2002, GLYCOBIOLOGY, V12, P145, DOI 10.1093/glycob/12.3.145; Dong LX, 2011, GLYCOCONJUGATE J, V28, P137, DOI 10.1007/s10719-011-9330-9; Dong Y, 2010, CANCER SCI, V101, P2039, DOI 10.1111/j.1349-7006.2010.01613.x; Egan C, 1999, ONCOGENE, V18, P1227, DOI 10.1038/sj.onc.1202233; Engelman JA, 1999, J BIOL CHEM, V274, P32333, DOI 10.1074/jbc.274.45.32333; FRA AM, 1995, FEBS LETT, V375, P11, DOI 10.1016/0014-5793(95)95228-O; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Hinrichs JWJ, 2004, J BIOL CHEM, V279, P5734, DOI 10.1074/jbc.M306857200; Hyuga S, 1999, INT J CANCER, V83, P685, DOI 10.1002/(SICI)1097-0215(19991126)83:5<685::AID-IJC20>3.0.CO;2-4; Illuzzi G, 2010, J BIOL CHEM, V285, P18594, DOI 10.1074/jbc.M109.072801; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kawakami Y, 2002, J BIOL CHEM, V277, P34349, DOI 10.1074/jbc.M200771200; Kawamura S, 2001, INT J CANCER, V94, P343, DOI 10.1002/ijc.1482; Kazui A, 2000, BIOCHEM BIOPH RES CO, V273, P159, DOI 10.1006/bbrc.2000.2903; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Liu Y, 2010, ONCOGENE, V29, P3297, DOI 10.1038/onc.2010.85; Loberto N, 2005, J NEUROCHEM, V95, P771, DOI 10.1111/j.1471-4159.2005.03397.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mitsuzuka K, 2005, J BIOL CHEM, V280, P35545, DOI 10.1074/jbc.M505630200; Miura Y, 2004, P NATL ACAD SCI USA, V101, P16204, DOI 10.1073/pnas.0407297101; Ono M, 2001, BIOCHEMISTRY-US, V40, P6414, DOI 10.1021/bi0101998; Park JH, 2011, J CELL PHYSIOL, V226, P267, DOI 10.1002/jcp.22338; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Prinetti A, 2003, J BIOL CHEM, V278, P5574, DOI 10.1074/jbc.M207269200; Prinetti A, 2008, BBA-GEN SUBJECTS, V1780, P585, DOI 10.1016/j.bbagen.2007.08.002; Prinetti A, 2010, GLYCOBIOLOGY, V20, P62, DOI 10.1093/glycob/cwp143; Rivaroli A, 2007, J NEUROCHEM, V103, P1954, DOI 10.1111/j.1471-4159.2007.04890.x; Satoh M, 2001, INT J ONCOL, V19, P723; Scott WN, 2000, ANAL BIOCHEM, V287, P343, DOI 10.1006/abio.2000.4866; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sonnino S, 2009, FEBS LETT, V583, P597, DOI 10.1016/j.febslet.2009.01.007; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trimmer C, 2010, CANCER RES, V70, P7489, DOI 10.1158/0008-5472.CAN-10-0900; Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N; Wang L, 2006, GLYCOCONJUGATE J, V23, P303, DOI 10.1007/s10719-006-5742-3; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Watanabe R, 2002, CANCER RES, V62, P3850; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; ZETTER BR, 1987, METHOD ENZYMOL, V147, P135	57	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40900	40910		10.1074/jbc.M111.286146	http://dx.doi.org/10.1074/jbc.M111.286146			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21949119	Green Published, hybrid			2022-12-27	WOS:000297315400050
J	Reich, A; Klatsky, P; Carson, S; Wessel, G				Reich, Adrian; Klatsky, Peter; Carson, Sandra; Wessel, Gary			The Transcriptome of a Human Polar Body Accurately Reflects Its Sibling Oocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; PREIMPLANTATION DEVELOPMENT; MESSENGER-RNA; PROFILES; PROGRAM; BODIES	Improved methods are needed to reliably and accurately evaluate oocyte quality prior to fertilization and transfer into the woman of human embryos created through in vitro fertilization (IVF). All oocytes that are retrieved and matured in culture are exposed to sperm with little in the way of evaluating the oocyte quality. Furthermore, embryos created through IVF are currently evaluated for developmental potential by morphology, a criterion lacking in quantitation and accuracy. With the recent successes in oocyte vitrification and storage, clear metrics are needed to determine oocyte quality prior to fertilizing. The first polar body (PB) is extruded from the oocyte before fertilization and can be biopsied without damaging the oocyte. Here, we tested the hypothesis that the PB transcriptome is representative of that of the oocyte. Polar body biopsy was performed on metaphase II (MII) oocytes followed by single-cell transcriptome analysis of the oocyte and its sibling PB. Over 12,700 unique mRNAs and miRNAs from the oocyte samples were compared with the 5,431 mRNAs recovered from the sibling PBs (5,256 shared mRNAs or 97%, including miRNAs). The results show that human PBs reflect the oocyte transcript profile and suggests that mRNA detection and quantification through high-throughput quantitative PCR could result in the first molecular diagnostic for gene expression in MII oocytes. This could allow for both oocyte ranking and embryo preferences in IVF applications.	[Reich, Adrian; Wessel, Gary] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Klatsky, Peter; Carson, Sandra] Brown Univ, Women & Infants Hosp, Alpert Sch Med, Div Reprod Endocrinol & Infertil, Providence, RI 02905 USA	Brown University; Brown University; Women & Infants Hospital Rhode Island	Wessel, G (corresponding author), 185 Meeting St,Box G, Providence, RI 02912 USA.	rhet@brown.edu			Brown University provost's office; Center for Reproduction and Infertility at Women & Infants Hospital of Rhode Island and Sigma-Aldrich; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103410] Funding Source: NIH RePORTER	Brown University provost's office; Center for Reproduction and Infertility at Women & Infants Hospital of Rhode Island and Sigma-Aldrich; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by seed funds from the Brown University provost's office as well as departmental funds from the Center for Reproduction and Infertility at Women & Infants Hospital of Rhode Island and Sigma-Aldrich.	Antosh M, 2011, AGING-US, V3, P576, DOI 10.18632/aging.100342; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Bermudez M, 2004, REPROD BIOMED ONLINE, V8, P325, DOI 10.1016/S1472-6483(10)60913-3; Biddle A, 2009, DEVELOPMENT, V136, P2695, DOI 10.1242/dev.036327; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Centers for Disease Control and Prevention American Society for Reproductive Medicine Society for Assisted Reproductive Technology, 2008, 2008 ASS REPR TECHN; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evsikov AV, 2009, MOL REPROD DEV, V76, P805, DOI 10.1002/mrd.21038; Gasca S, 2007, REPROD BIOMED ONLINE, V14, P175, DOI 10.1016/S1472-6483(10)60785-7; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones GM, 2008, HUM REPROD, V23, P1138, DOI 10.1093/humrep/den085; Klatsky PC, 2010, MOL HUM REPROD, V16, P938, DOI 10.1093/molehr/gaq077; Klatsky PC, 2010, MOL REPROD DEV, V77, P386, DOI 10.1002/mrd.21172; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Rienzi L, 2010, HUM REPROD, V25, P66, DOI 10.1093/humrep/dep346; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seli E, 2005, P NATL ACAD SCI USA, V102, P367, DOI 10.1073/pnas.0408378102; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Sun F, 2007, CELL RES, V17, P117, DOI 10.1038/cr.2007.1; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; VERLINSKY Y, 1990, HUM REPROD, V5, P826, DOI 10.1093/oxfordjournals.humrep.a137192	24	42	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40743	40749		10.1074/jbc.M111.289868	http://dx.doi.org/10.1074/jbc.M111.289868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21953461	hybrid, Green Published			2022-12-27	WOS:000297315400035
J	Wang, YQ; Li, ZQ; Xu, PF; Huang, L; Tong, JY; Huang, HZ; Meng, AM				Wang, Yeqi; Li, Zhiqiang; Xu, Pengfei; Huang, Lei; Tong, Jingyuan; Huang, Huizhe; Meng, Anming			Angiomotin-like2 Gene (amotl2) Is Required for Migration and Proliferation of Endothelial Cells during Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZEBRAFISH EMBRYO; GROWTH-FACTORS; PROTEIN; RECEPTORS; INDUCTION; POLARITY; KINASES; BIOLOGY; GTPASE; FAMILY	Angiogenesis involves sprouting, migration, and proliferation of endothelial cells. The angiomotin-like2 gene (amotl2) has been found in blood vessels in zebrafish embryos, but its function in angiogenesis and underlying mechanisms remain unknown. In this study, we demonstrate that knockdown of amotl2 in zebrafish Tg(fli1:EGFP)(y1) and Tg(fli1:nEGFP)(y7) transgenic embryos impairs the intersegmental vessel growth and suppresses proliferation of endothelial cells. Transplantation experiments indicate that function of amotl2 in intersegmental vessel growth is cell-autonomous. AMOTL2 knockdown in cultured human umbilical vein endothelial cells also inhibits cell proliferation and migration and disrupts cell polarity, ultimately interrupting the formation of vascular tube-like structures. Amot12 promotes MAPK/ERK activation via c-Src, which is dependent on phosphorylation of tyrosine residue at position 103 but independent of the C-terminal PDZ-binding domain. Taking together, our data indicate that Amotl2 plays a pivotal role in polarity, migration and proliferation of angiogenic endothelial cells.	[Wang, Yeqi; Li, Zhiqiang; Xu, Pengfei; Huang, Lei; Tong, Jingyuan; Huang, Huizhe; Meng, Anming] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Engn, Sch Life Sci, Beijing 100084, Peoples R China; [Meng, Anming] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Zoology, CAS	Meng, AM (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Engn, Sch Life Sci, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Meng, Anming/A-4785-2012; Wang, Yeqi/V-8445-2019	Wang, Yeqi/0000-0003-2881-4607; Huang, Lan/0000-0001-9594-4722; Li, Zhiqiang/0000-0002-2768-5332; Meng, Anming/0000-0001-7228-3431	Major Science Programs of China [2011CB943800, 2012CB945101]; National Natural Science Foundation of China [30921004/C061003]	Major Science Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Science Programs of China Grants 2011CB943800 and 2012CB945101 and by National Natural Science Foundation of China Grant 30921004/C061003.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Childs S, 2002, DEVELOPMENT, V129, P973; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Levchenko T, 2004, ONCOGENE, V23, P1469, DOI 10.1038/sj.onc.1207264; Levchenko T, 2003, J CELL SCI, V116, P3803, DOI 10.1242/jcs.00694; Murakami M, 2008, CURR OPIN HEMATOL, V15, P215, DOI 10.1097/MOH.0b013e3282f97d98; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; SINGER SJ, 1986, ANNU REV CELL BIOL, V2, P337, DOI 10.1146/annurev.cb.02.110186.002005; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhang Y, 2009, J CELL SCI, V122, P2197, DOI 10.1242/jcs.040659; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156	36	46	52	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41095	41104		10.1074/jbc.M111.296806	http://dx.doi.org/10.1074/jbc.M111.296806			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21937427	hybrid, Green Published			2022-12-27	WOS:000297315400068
J	Zhao, YG; Thornton, AM; Kinney, MC; Ma, CA; Spinner, JJ; Fuss, IJ; Shevach, EM; Jain, A				Zhao, Yongge; Thornton, Angela M.; Kinney, Matthew C.; Ma, Chi A.; Spinner, Jacob J.; Fuss, Ivan J.; Shevach, Ethan M.; Jain, Ashish			The Deubiquitinase CYLD Targets Smad7 Protein to Regulate Transforming Growth Factor beta (TGF-beta) Signaling and the Development of Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE TAK1; UBIQUITIN LIGASE; INDUCTION; RECEPTOR; ACTIVATION; ENZYME; BINDS; A20; JNK	CYLD is a lysine 63-deubiquitinating enzyme that inhibits NF-kappa B and JNK signaling. Here, we show that CYLD knock-out mice have markedly increased numbers of regulatory T cells (Tregs) in peripheral lymphoid organs but not in the thymus. In vitro stimulation of CYLD-deficient naive T cells with anti-CD3/28 in the presence of TGF-beta led to a marked increase in the number of Foxp3-expressing T cells when compared with stimulated naive control CD4(+) cells. Under endogenous conditions, CYLD formed a complex with Smad7 that facilitated CYLD deubiquitination of Smad7 at lysine 360 and 374 residues. Moreover, this site-specific ubiquitination of Smad7 was required for activation of TAK1 and p38 kinases. Finally, knockdown of Smad7 or inhibition of p38 activity in primary T cells impaired Treg differentiation. Together, our results show that CYLD regulates TGF-beta signaling function in T cells and the development of Tregs through deubiquitination of Smad7.	[Zhao, Yongge; Kinney, Matthew C.; Ma, Chi A.; Spinner, Jacob J.; Fuss, Ivan J.; Jain, Ashish] NIAID, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Thornton, Angela M.; Shevach, Ethan M.] NIAID, Lab Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jain, A (corresponding author), Clin Res Ctr, Rm 5-W-3950,9000 Rockville Pike, Bethesda, MD 20892 USA.	ajain@niaid.nih.gov			National Institutes of Health through the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000959] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health through the NIAID.	Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Glittenberg M, 2007, FLY, V1, P330, DOI 10.4161/fly.5399; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JENTSCH S, 1990, TRENDS BIOCHEM SCI, V15, P195, DOI 10.1016/0968-0004(90)90161-4; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee AJ, 2010, J BIOL CHEM, V285, P15696, DOI 10.1074/jbc.M109.095190; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Prud'homme GJ, 2000, J AUTOIMMUN, V14, P23, DOI 10.1006/jaut.1999.0339; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tanaka K, 1998, MOL CELLS, V8, P503; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	34	54	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40520	40530		10.1074/jbc.M111.292961	http://dx.doi.org/10.1074/jbc.M111.292961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21931165	Green Published, hybrid			2022-12-27	WOS:000297315400011
J	Neniskyte, U; Neher, JJ; Brown, GC				Neniskyte, Urte; Neher, Jonas J.; Brown, Guy C.			Neuronal Death Induced by Nanomolar Amyloid beta Is Mediated by Primary Phagocytosis of Neurons by Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NITRIC-OXIDE; PHOSPHOLIPID ASYMMETRY; APOPTOTIC LYMPHOCYTES; IN-VITRO; PHOSPHATIDYLSERINE; BRAIN; EXPRESSION; PEPTIDE; PROTEIN	Alzheimer disease is characterized by neuronal loss and brain plaques of extracellular amyloid beta (A beta), but the means by which A beta may induce neuronal loss is not entirely clear. Although high concentrations of A beta (mu M) can induce direct toxicity to neurons, we find that low concentration (nM) induce neuronal loss through a microglia-mediated mechanism. In mixed neuronal-glial cultures from rat cerebellum, 250 nM A beta 1-42 (added as monomers, oligomers or fibers) induced about 30% loss of neurons between 2 and 3 days. This neuronal loss occurred without any increase in neuronal apoptosis or necrosis, and no neuronal loss occurred with A beta 42-1. A beta greatly increased the phagocytic capacity of microglia and induced phosphatidylserine exposure (an "eat-me" signal) on neuronal processes. Blocking exposed phosphatidylserine by adding annexin V or an antibody to phosphatidylserine or inhibiting microglial phagocytosis by adding either cytochalasin D (to block actin polymerization) or cyclo( RGDfV) (to block vitronectin receptors) significantly prevented neuronal loss. Loss of neuronal synapses occurred in parallel with loss of cell bodies and was also prevented by blocking phagocytosis. Inhibition of phagocytosis prevented neuronal loss with no increase in neuronal death, even after 7 days, suggesting that microglial phagocytosis was the primary cause of neuronal death induced by nanomolar A beta	[Neniskyte, Urte; Neher, Jonas J.; Brown, Guy C.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Neniskyte, U (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	us230@cam.ac.uk	Brown, Guy C./HHC-1102-2022; Neher, Jonas/AAQ-4927-2021; Neniskyte, Urte/AAI-2217-2021	Neher, Jonas/0000-0003-1346-8924; Neniskyte, Urte/0000-0001-7645-703X; Brown, Guy/0000-0002-3610-1730	Wellcome Trust [RG50995]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant RG50995.	Abdul HM, 2005, BBA-MOL BASIS DIS, V1741, P140, DOI 10.1016/j.bbadis.2004.12.002; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; BIANCA VD, 1999, J BIOL CHEM, V274, P15493; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Calissano P, 2009, Commun Integr Biol, V2, P163; Cappai R, 2008, NEUROCHEM RES, V33, P526, DOI 10.1007/s11064-007-9469-8; Ciccotosto GD, 2011, NEUROBIOL AGING, V32, P235, DOI 10.1016/j.neurobiolaging.2009.02.018; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; De Simone R, 2003, J NEUROPATH EXP NEUR, V62, P208, DOI 10.1093/jnen/62.2.208; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Gleiss B, 2002, FEBS LETT, V519, P153, DOI 10.1016/S0014-5793(02)02743-6; Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721; Hellstrom-Lindahl E, 2009, NEUROCHEM INT, V55, P243, DOI 10.1016/j.neuint.2009.03.007; Jana M, 2008, J IMMUNOL, V181, P7254, DOI 10.4049/jimmunol.181.10.7254; Jekabsone A, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-24; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kinsner A, 2005, J NEUROCHEM, V95, P1132, DOI 10.1111/j.1471-4159.2005.03422.x; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lange MLB, 2008, NEUROBIOL DIS, V29, P456, DOI 10.1016/j.nbd.2007.11.004; Lange MLB, 2010, NEUROBIOL DIS, V38, P104, DOI 10.1016/j.nbd.2010.01.004; Lee G, 2002, PEPTIDES, V23, P1249, DOI 10.1016/S0196-9781(02)00060-8; Liao MQ, 2007, FEBS LETT, V581, P1161, DOI 10.1016/j.febslet.2007.02.026; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; McArthur S, 2010, J IMMUNOL, V185, P6317, DOI 10.4049/jimmunol.1001095; Morgan K, 2011, NEUROPATH APPL NEURO, V37, P353, DOI 10.1111/j.1365-2990.2011.01181.x; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; OYLER GA, 1991, P NATL ACAD SCI USA, V88, P5247, DOI 10.1073/pnas.88.12.5247; Perry G, 1998, SCIENCE, V282, P1268; Raina A K, 2000, Prog Cell Cycle Res, V4, P235; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; SHENG JG, 1995, NEUROPATH APPL NEURO, V21, P290, DOI 10.1111/j.1365-2990.1995.tb01063.x; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Steinerman JR, 2008, ARCH NEUROL-CHICAGO, V65, P906, DOI 10.1001/archneur.65.7.906; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Styren SD, 1998, J COMP NEUROL, V396, P511; Tyurina YY, 2007, J BIOL CHEM, V282, P8498, DOI 10.1074/jbc.M606950200; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; VandenEijnde SM, 1997, CELL DEATH DIFFER, V4, P311, DOI 10.1038/sj.cdd.4400241; Weldon DT, 1998, J NEUROSCI, V18, P2161; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Witting A, 2000, J NEUROCHEM, V75, P1060, DOI 10.1046/j.1471-4159.2000.0751060.x; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Xie Z, 2002, J NEUROSCI, V22, P3484	56	139	144	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39904	39913		10.1074/jbc.M111.267583	http://dx.doi.org/10.1074/jbc.M111.267583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21903584	Green Published, hybrid			2022-12-27	WOS:000296925700024
J	Champ, S; Puvirajesinghe, TM; Perrody, E; Menouni, R; Genevaux, P; Ansaldi, M				Champ, Stephanie; Puvirajesinghe, Tania M.; Perrody, Elsa; Menouni, Rachid; Genevaux, Pierre; Ansaldi, Mireille			Chaperone-assisted Excisive Recombination, a Solitary Role for DnaJ (Hsp40) Chaperone in Lysogeny Escape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; HEAT-SHOCK PROTEINS; RESPONSE REGULATOR INHIBITOR; ESCHERICHIA-COLI; BACTERIOPHAGE-LAMBDA; J-DOMAIN; IN-VIVO; REPLICATION PROTEINS; MOLECULAR CHAPERONE; NUCLEOTIDE-SEQUENCE	Temperate bacteriophage lytic development is intrinsically related to the stress response in particular at the DNA replication and virion maturation steps. Alternatively, temperate phages become lysogenic and integrate their genome into the host chromosome. Under stressful conditions, the prophage resumes a lytic development program, and the phage DNA is excised before being replicated. The KplE1 defective prophage of Escherichia coli K12 constitutes a model system because it is fully competent for integrative as well as excisive recombination and presents an atypical recombination module, which is conserved in various phage genomes. In this work, we identified the host-encoded stress-responsive molecular chaperone DnaJ (Hsp40) as an active participant in KplE1 prophage excision. We first show that the recombination directionality factor TorI of KplE1 specifically interacts with DnaJ. In addition, we found that DnaJ dramatically enhances both TorI binding to its DNA target and excisive recombination in vitro. Remarkably, such stimulatory effect by DnaJ was performed independently of its DnaK chaperone partner and did not require a functional DnaJ J-domain. Taken together, our results underline a novel and unsuspected functional interaction between the generic host stress-regulated chaperone and temperate bacteriophage lysogenic development.	[Champ, Stephanie; Puvirajesinghe, Tania M.; Menouni, Rachid; Ansaldi, Mireille] Aix Marseille Univ, Lab Chim Bacterienne, Inst Microbiol Mediterranee, CNRS UPR9043, F-13402 Marseille 20, France; [Perrody, Elsa; Genevaux, Pierre] Univ Toulouse 3, Lab Microbiol & Genet Mol, CNRS UMR 5100, F-31062 Toulouse 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Ansaldi, M (corresponding author), Aix Marseille Univ, Lab Chim Bacterienne, Inst Microbiol Mediterranee, CNRS UPR9043, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	ansaldi@ifr88.cnrs-mrs.fr	Genevaux, Pierre/A-4851-2015; Puvirajesinghe, Tania/AAD-9137-2020	ANSALDI, Mireille/0000-0002-2878-0702; Puvirajesinghe, Tania/0000-0002-8304-9824; GENEVAUX, Pierre/0000-0001-7539-3126	CNRS; French Research Ministry (Ministere de l'Education Nationale de la Recherche et de la Technologie); National Research Agency [ANR-08-BLAN-0122-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Research Ministry (Ministere de l'Education Nationale de la Recherche et de la Technologie)(Ministry of Research, France); National Research Agency(French National Research Agency (ANR))	This work was supported by CNRS, the French Research Ministry (Ministere de l'Education Nationale de la Recherche et de la Technologie), and National Research Agency Grant ANR-08-BLAN-0122-01 (to M. A. and P. G.).	Abbani M, 2005, J MOL BIOL, V347, P11, DOI 10.1016/j.jmb.2005.01.019; ABREMSKI K, 1982, J BIOL CHEM, V257, P9658; Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; Ansaldi M, 2004, P NATL ACAD SCI USA, V101, P9423, DOI 10.1073/pnas.0401927101; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Campbell A. M., 1996, ESCHERICHIA COLI SAL, P2041; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; ElAntak L, 2005, J BIOL CHEM, V280, P36802, DOI 10.1074/jbc.M507409200; FRIEDMAN DI, 1984, MICROBIOL REV, V48, P299, DOI 10.1128/MMBR.48.4.299-325.1984; GAITANARIS GA, 1994, MOL MICROBIOL, V14, P861, DOI 10.1111/j.1365-2958.1994.tb01322.x; Genevaux P, 2003, J VIROL, V77, P10706, DOI 10.1128/JVI.77.19.10706-10713.2003; Genevaux P, 2002, GENETICS, V162, P1045; Genevaux P, 2001, J BACTERIOL, V183, P5747, DOI 10.1128/JB.183.19.5747-5750.2001; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Georgopoulos C, 2006, GENETICS, V174, P1699, DOI 10.1534/genetics.104.68262; GEORGOPOULOS CP, 1977, MOL GEN GENET, V151, P35, DOI 10.1007/BF00446910; GOTTESMAN S, 1980, J MOL BIOL, V138, P503, DOI 10.1016/S0022-2836(80)80015-5; Gur E, 2005, FEBS LETT, V579, P1935, DOI 10.1016/j.febslet.2005.01.084; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Huang W, 2007, CHINESE J STRUC CHEM, V26, P594; KAWASAKI Y, 1990, MOL GEN GENET, V220, P277; KAWASAKI Y, 1992, J BIOL CHEM, V267, P11520; LEBOWITZ JH, 1985, P NATL ACAD SCI USA, V82, P3988, DOI 10.1073/pnas.82.12.3988; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; LIBEREK K, 1990, J BIOL CHEM, V265, P3022; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Maynard ND, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001017; Mumm JP, 2006, EMBO J, V25, P4586, DOI 10.1038/sj.emboj.7601325; Nakamura A, 2007, P NATL ACAD SCI USA, V104, P18484, DOI 10.1073/pnas.0705623104; Nash H, 1996, ESCHERICHIA COLI SAL, P2363; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; Panis G, 2007, J BIOL CHEM, V282, P21798, DOI 10.1074/jbc.M701827200; Panis G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001149; Panis G, 2010, VIROLOGY, V404, P41, DOI 10.1016/j.virol.2010.04.027; Perales-Calvo J, 2010, J BIOL CHEM, V285, P34231, DOI 10.1074/jbc.M110.144642; Rokney A, 2008, MOL MICROBIOL, V68, P29, DOI 10.1111/j.1365-2958.2008.06119.x; Sakr S, 2010, J BIOL CHEM, V285, P23504, DOI 10.1074/jbc.M110.133058; Sam MD, 2002, J MOL BIOL, V324, P791, DOI 10.1016/S0022-2836(02)01150-6; SELL SM, 1990, J BACTERIOL, V172, P4827, DOI 10.1128/jb.172.9.4827-4835.1990; Shi YY, 2005, BIOCHEMISTRY-US, V44, P1683, DOI 10.1021/bi0480943; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Sullivan CS, 2001, VIROLOGY, V287, P1, DOI 10.1006/viro.2001.1038; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; WALL D, 1994, J BIOL CHEM, V269, P5446; WICKNER SH, 1979, COLD SPRING HARB SYM, V43, P303, DOI 10.1101/SQB.1979.043.01.037; Xiao A, 2010, ARCH VIROL, V155, P1021, DOI 10.1007/s00705-010-0691-3; Zylicz M, 1998, P NATL ACAD SCI USA, V95, P15259, DOI 10.1073/pnas.95.26.15259; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; ZYLICZ M, 1993, PHILOS T ROY SOC B, V339, P271, DOI 10.1098/rstb.1993.0025	57	9	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38876	38885		10.1074/jbc.M111.281865	http://dx.doi.org/10.1074/jbc.M111.281865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21908845	Green Published, hybrid			2022-12-27	WOS:000296759800006
J	Zhao, L; Yamaguchi, Y; Sharif, S; Du, XY; Song, JJ; Lee, DM; Recht, LD; Robinson, WH; Morser, J; Leung, LLK				Zhao, Lei; Yamaguchi, Yasuto; Sharif, Shadi; Du, Xiao-Yan; Song, Jason J.; Lee, David M.; Recht, Lawrence D.; Robinson, William H.; Morser, John; Leung, Lawrence L. K.			Chemerin158K Protein Is the Dominant Chemerin Isoform in Synovial and Cerebrospinal Fluids but Not in Plasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULATING LEVELS; DIABETES-MELLITUS; DENDRITIC CELLS; FATTY LIVER; INFLAMMATION; ACTIVATION; EXPRESSION; PROTEASES; LIGANDS; DISEASE	Chemerin is a chemoattractant involved in immunity that may also function as an adipokine. Chemerin circulates as an inactive precursor (chem163S), and its activation requires proteolytic cleavages at its C terminus, involving proteases involved in coagulation, fibrinolysis, and inflammation. However, the key proteolytic steps in prochemerin activation in vivo remain to be established. Previously, we have shown that C-terminal cleavage of chem163S by plasmin to chem158K, followed by a carboxypeptidase cleavage, leads to the most active isoform, chem157S. To identify and quantify the in vivo chemerin isoforms in biological specimens, we developed specific ELISAs for chem163S, chem158K, and chem157S, using antibodies raised against peptides from the C terminus of the different chemerin isoforms. We found that the mean plasma concentrations of chem163S, chem158K, and chem157S were 40 +/- 7.9, 8.1 +/- 2.9, and 0.7 +/- 0.8 ng/ml, respectively. The total level of cleaved and non-cleaved chemerins in cerebrospinal fluids was similar to 10% of plasma levels whereas it was elevated similar to 2-fold in synovial fluids from patients with arthritis. On the other hand, the fraction of cleaved chemerins was much higher in synovial fluid and cerebrospinal fluid samples than in plasma (similar to 75%, 50%, and 18% respectively). Chem158K was the dominant chemerin isoform, and it was not generated by ex vivo processing, indicating that cleavage of prochemerin at position Lys-158, whether by plasmin or another serine protease, represents a major step in prochemerin activation in vivo. Our study provides the first direct evidence that chemerin undergoes extensive proteolytic processing in vivo, underlining the importance of measuring individual isoforms.	[Zhao, Lei; Yamaguchi, Yasuto; Sharif, Shadi; Du, Xiao-Yan; Morser, John; Leung, Lawrence L. K.] Stanford Univ, Sch Med, Div Hematol, Dept Med, Stanford, CA 94305 USA; [Song, Jason J.; Robinson, William H.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA; [Recht, Lawrence D.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Lee, David M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Lee, David M.] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Robinson, William H.; Leung, Lawrence L. K.] Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Harvard University; Brigham & Women's Hospital; Novartis; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Morser, J (corresponding author), 269 Campus Dr,CCSR 1155,MC5156, Stanford, CA 94305 USA.	jmorser@stanford.edu; lawrence.leung@stanford.edu		Robinson, William/0000-0003-4385-704X	National Institutes of Health [HL057530, AI085268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL057530 and AI085268.	Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Dogru T, 2010, SCAND J GASTROENTERO, V45, P1000, DOI 10.3109/00365521003749826; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Guillabert A, 2008, J LEUKOCYTE BIOL, V84, P1530, DOI 10.1189/jlb.0508322; Hu WC, 2011, DIABETES RES CLIN PR, V91, P159, DOI 10.1016/j.diabres.2010.11.016; Kukla M, 2010, J VIRAL HEPATITIS, V17, P661, DOI 10.1111/j.1365-2893.2009.01224.x; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Pfau D, 2010, HORM RES PAEDIAT, V74, P56, DOI 10.1159/000282114; Pfau D, 2010, DIABETES CARE, V33, P171, DOI 10.2337/dc09-1351; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Sharif SA, 2009, ARTHRITIS RHEUM-US, V60, P2902, DOI 10.1002/art.24814; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Weigert J, 2010, INFLAMM BOWEL DIS, V16, P630, DOI 10.1002/ibd.21091; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamaguchi Y, 2011, J BIOL CHEM, V286, P39510, DOI 10.1074/jbc.M111.258921; Yamamoto T, 2010, NEPHROL DIAL TRANSPL, V25, P4017, DOI 10.1093/ndt/gfq329; Yang ML, 2010, J INVEST MED, V58, P883, DOI 10.231/JIM.0b013e3181ec5db2; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011	26	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39520	39527		10.1074/jbc.M111.258954	http://dx.doi.org/10.1074/jbc.M111.258954			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930706	hybrid, Green Published			2022-12-27	WOS:000296759800069
J	Earley, KW; Poethig, RS				Earley, Keith W.; Poethig, R. Scott			Binding of the Cyclophilin 40 Ortholog SQUINT to Hsp90 Protein Is Required for SQUINT Function in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL CIS/TRANS ISOMERASES; PLANT DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; IMMUNOPHILIN CHAPERONES; CATALYTIC MECHANISM; THALIANA; DOMAIN; SITE; COMPLEXES; ARGONAUTE1	SQN (SQUINT) is the Arabidopsis ortholog of the immunophilin CyP40 (cyclophilin 40) and promotes microRNA activity by promoting the activity of AGO1. In animals and Saccharomyces cerevisiae, CyP40 promotes protein activity in association with the protein chaperone Hsp90. To determine whether CyP40 also acts in association with Hsp90 in plants, we examined the interaction between SQN and Hsp90 in vitro and tested the importance of this interaction for the function of SQN in planta. We found that SQN interacts with cytoplasmic Hsp90 proteins but not with Hsp90 proteins localized to chloroplasts, mitochondria, or the endoplasmic reticulum. The interaction between SQN and Hsp90 in vitro requires the MEEVD domain of Hsp90, as well as several conserved amino acids within the tetratricopeptide repeat domain of SQN. Amino acid substitutions that disrupt the interaction between SQN and Hsp90 in vitro also impair the activity of SQN in planta. Our results indicate that the interaction between CyP40 and Hsp90 is conserved in plants and that this interaction is essential for the function of CyP40.	[Earley, Keith W.; Poethig, R. Scott] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Poethig, RS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	spoethig@sas.upenn.edu	Poethig, R. Scott/J-7009-2015	Poethig, R. Scott/0000-0001-6592-5862	National Institutes of Health [R01GM051893]; NIGMS [F32GM084591]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084591, R01GM051893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM051893 (to R. S. P.) and National Research Service Award Postdoctoral Fellowship F32GM084591 from NIGMS (to K. W. E.).	Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Berardini TZ, 2001, SCIENCE, V291, P2405, DOI 10.1126/science.1057144; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; Cao DS, 2003, PLANT J, V33, P107, DOI 10.1046/j.1365-313X.2003.016011.x; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Dorfman T, 1996, J VIROL, V70, P5751, DOI 10.1128/JVI.70.9.5751-5757.1996; Duina AA, 1996, YEAST, V12, P943, DOI 10.1002/(SICI)1097-0061(199608)12:10<943::AID-YEA997>3.0.CO;2-3; Duina AA, 1998, J BIOL CHEM, V273, P10819, DOI 10.1074/jbc.273.18.10819; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Earley K, 2010, SILENCE, V1, P15, DOI [10.1186/1758-907X-1-15, DOI 10.1186/1758-907X-1-15]; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Geisler M, 2004, MOL BIOL CELL, V15, P3393, DOI 10.1091/mbc.E03-11-0831; Geisler M, 2007, TRENDS PLANT SCI, V12, P465, DOI 10.1016/j.tplants.2007.08.015; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Ishiguro S, 2002, EMBO J, V21, P898, DOI 10.1093/emboj/21.5.898; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Mayr C, 2000, J BIOL CHEM, V275, P34140, DOI 10.1074/jbc.M005251200; Meiri D, 2009, PLANT J, V59, P387, DOI 10.1111/j.1365-313X.2009.03878.x; Moparthi SB, 2009, PROTEIN SCI, V18, P475, DOI 10.1002/pro.28; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pirkl F, 2001, J MOL BIOL, V308, P795, DOI 10.1006/jmbi.2001.4595; Prassinos C, 2008, PLANT MOL BIOL, V67, P323, DOI 10.1007/s11103-008-9322-8; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; Ratajczak T, 2009, INT J BIOCHEM CELL B, V41, P1652, DOI 10.1016/j.biocel.2009.03.006; Romano P, 2005, NEW PHYTOL, V166, P753, DOI 10.1111/j.1469-8137.2005.01373.x; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Smith MR, 2009, P NATL ACAD SCI USA, V106, P5424, DOI 10.1073/pnas.0812729106; Smyczynski C, 2006, J BIOL CHEM, V281, P25475, DOI 10.1074/jbc.M601815200; Taylor P, 2001, STRUCTURE, V9, P431, DOI 10.1016/S0969-2126(01)00603-7; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vittorioso P, 1998, MOL CELL BIOL, V18, P3034, DOI 10.1128/MCB.18.5.3034; Ward BK, 2002, J BIOL CHEM, V277, P40799, DOI 10.1074/jbc.M207097200; Wu GS, 2010, PLANT CELL, V22, P3295, DOI 10.1105/tpc.110.078360; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yurchenko V, 2002, J BIOL CHEM, V277, P22959, DOI 10.1074/jbc.M201593200; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	56	48	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38184	38189		10.1074/jbc.M111.290130	http://dx.doi.org/10.1074/jbc.M111.290130			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21908611	hybrid, Green Published			2022-12-27	WOS:000296594200032
J	Schichl, YM; Resch, U; Lemberger, CE; Stichlberger, D; de Martin, R				Schichl, Yvonne M.; Resch, Ulrike; Lemberger, Christof E.; Stichlberger, Dominik; de Martin, Rainer			Novel Phosphorylation-dependent Ubiquitination of Tristetraprolin by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase Kinase 1 (MEKK1) and Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA TURNOVER; ENDOTHELIAL-CELLS; GENE-EXPRESSION; TNF-ALPHA; INDUCIBLE EXPRESSION; NEGATIVE REGULATION; RICH ELEMENT; PLASMID DNA; IN-VITRO	Acute versus chronic inflammation is controlled by the accurate activation and regulation of interdependent signaling cascades. TNF-receptor 1 engagement concomitantly activates NF-kappa B and JNK signaling. The correctly timed activation of these pathways is the key to account for the balance between NF-kappa B-mediated cell survival and cell death, the latter fostered by prolonged JNK activation. Tristetraprolin (TTP), initially described as an mRNA destabilizing protein, acts as negative feedback regulator of the inflammatory response: it destabilizes cytokine-mRNAs but also acts as an NF-kappa B inhibitor by interfering with the p65/RelA nuclear import pathway. Our biochemical studies provide evidence that TTP contributes to the NF-kappa B/JNK balance. We find that the MAP 3-kinase MEKK1 acts as a novel TTP kinase that, together with the TNF receptor-associated factor 2 (TRAF2), constitutes not only a main determinate of the NF-kappa B-JNK cross-talk but also facilitates "TTP hypermodification": MEKK1 triggers TTP phosphorylation as prerequisite for its Lys-63-linked, TRAF2-mediated ubiquitination. Consequently, TTP no longer affects NF-kappa B activity but promotes the activation of JNK. Based on our data, we suggest a model where upon TNF alpha induction, TTP transits a hypo-to hypermodified state, thereby contributing to the molecular regulation of NF-kappa B versus JNK signaling cascades.	[Schichl, Yvonne M.; Resch, Ulrike; Lemberger, Christof E.; Stichlberger, Dominik; de Martin, Rainer] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	Medical University of Vienna	Schichl, YM (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Lazarettgasse 19, A-1090 Vienna, Austria.	Yvonne.Schichl@meduniwien.ac.at		Resch, Ulrike/0000-0002-8380-9555	Austrian Science Foundation [T511-B20, P19217-B13]; European Commission [LSHB-CT-2006-037377]; Austrian Science Fund (FWF) [T 511] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by Austrian Science Foundation Project T511-B20 (to Y. M. S.) and Project P19217-B13 (to R. d. M.) and European Commission XENOME Project LSHB-CT-2006-037377 (to R. d. M.).	Arlt A, 2008, BBA-MOL CELL RES, V1783, P941, DOI 10.1016/j.bbamcr.2007.12.010; Baker A, 1997, GENE THER, V4, P773, DOI 10.1038/sj.gt.3300471; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Berenjian S, 2006, VIRUS RES, V115, P16, DOI 10.1016/j.virusres.2005.07.001; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Boutaud O, 2003, ADV EXP MED BIOL, V525, P157; Cao HP, 2008, PROTEIN J, V27, P163, DOI 10.1007/s10930-007-9119-7; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Heximer SP, 1998, DNA CELL BIOL, V17, P249, DOI 10.1089/dna.1998.17.249; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Johnson BA, 2002, ONCOGENE, V21, P4237, DOI 10.1038/sj.onc.1205526; KANEDA N, 1992, GENE, V118, P289, DOI 10.1016/0378-1119(92)90202-Z; KANOH J, 1995, MOL BIOL CELL, V6, P1185, DOI 10.1091/mbc.6.9.1185; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Liang J, 2009, J BIOL CHEM, V284, P29383, DOI 10.1074/jbc.M109.024745; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; MA QF, 1994, ONCOGENE, V9, P3329; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Mayer H, 2004, ARTERIOSCL THROM VAS, V24, P1192, DOI 10.1161/01.ATV.0000131263.06296.77; Mongan M, 2008, TOXICOL SCI, V104, P405, DOI 10.1093/toxsci/kfn089; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ogawa K, 2003, J BIOL CHEM, V278, P30373, DOI 10.1074/jbc.M304856200; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; Rao N, 2005, MOL CELL BIOL, V25, P6521, DOI 10.1128/MCB.25.15.6521-6532.2005; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Schichl YM, 2009, J BIOL CHEM, V284, P29571, DOI 10.1074/jbc.M109.031237; Schlesinger TK, 2002, J BIOL CHEM, V277, P10283, DOI 10.1074/jbc.M106885200; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Tiedje C, 2010, BIOCHEM SOC T, V38, P1632, DOI 10.1042/BST0381632; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhang WJ, 1997, ARTERIOSCL THROM VAS, V17, P465, DOI 10.1161/01.ATV.17.3.465; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	66	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38466	38477		10.1074/jbc.M111.254888	http://dx.doi.org/10.1074/jbc.M111.254888			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21921033	Green Published, hybrid			2022-12-27	WOS:000296594200061
J	Takatsu, H; Baba, K; Shima, T; Umino, H; Kato, U; Umeda, M; Nakayama, K; Shin, HW				Takatsu, Hiroyuki; Baba, Keiko; Shima, Takahiro; Umino, Hiroyuki; Kato, Utako; Umeda, Masato; Nakayama, Kazuhisa; Shin, Hye-Won			ATP9B, a P4-ATPase (a Putative Aminophospholipid Translocase), Localizes to the trans-Golgi Network in a CDC50 Protein-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PLASMA-MEMBRANE; ADP-RIBOSYLATION FACTORS; P-TYPE ATPASES; PHOSPHOLIPID TRANSLOCATION; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; BETA-SUBUNIT; EXPRESSION; ASYMMETRY; PHOSPHATIDYLSERINE	Type IV P-type ATPases (P4-ATPases) are putative phospholipid flippases that translocate phospholipids from the exoplasmic (lumenal) to the cytoplasmic leaflet of lipid bilayers and are believed to function in complex with CDC50 proteins. In Saccharomyces cerevisiae, five P4-ATPases are localized to specific cellular compartments and are required for vesicle-mediated protein transport from these compartments, suggesting a role for phospholipid translocation in vesicular transport. The human genome encodes 14 P4-ATPases and three CDC50 proteins. However, the subcellular localization of human P4-ATPases and their interactions with CDC50 proteins are poorly understood. Here, we show that class 5 (ATP10A, ATP10B, and ATP10D) and class 6 (ATP11A, ATP11B, and ATP11C) P4-ATPases require CDC50 proteins, primarily CDC50A, for their exit from the endoplasmic reticulum (ER) and final subcellular localization. In contrast, class 2 P4-ATPases (ATP9A and ATP9B) are able to exit the ER in the absence of exogenous CDC50 expression: ATP9B, but not ATP11B, was able to exit the ER despite depletion of CDC50 proteins by RNAi. Although ATP9A and ATP9B show a high overall sequence similarity, ATP9A localizes to endosomes and the trans-Golgi network (TGN), whereas ATP9B localizes exclusively to the TGN. A chimeric ATP9 protein in which the N-terminal cytoplasmic region of ATP9A was replaced with the corresponding region of ATP9B was localized exclusively to the Golgi. These results indicate that ATP9B is able to exit the ER and localize to the TGN independently of CDC50 proteins and that this protein contains a Golgi localization signal in its N-terminal cytoplasmic region.	[Takatsu, Hiroyuki; Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan; [Baba, Keiko; Shima, Takahiro; Umino, Hiroyuki; Nakayama, Kazuhisa; Shin, Hye-Won] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Kato, Utako; Umeda, Masato] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158530, Japan	Kyoto University; Kyoto University; Kyoto University	Shin, HW (corresponding author), Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan.	shin@cp.kyoto-u.ac.jp	Nakayama, Kazuhisa/ABF-2924-2020; Shin, Hye-Won/P-5398-2018	Shin, Hye-Won/0000-0002-9138-9554; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science and Technology of Japan; Special Coordination Fund for Promoting Science and Technology; Targeted Proteins Research Program; Takeda Science Foundation; Inamori Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Fund for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Special Coordination Fund for Promoting Science and Technology; the Targeted Proteins Research Program; the Takeda Science Foundation; and the Inamori Foundation.	Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Kain R, 1998, J BIOL CHEM, V273, P981, DOI 10.1074/jbc.273.2.981; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Katoh Y, 2004, ONCOL REP, V12, P939; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Osada N, 2007, GENE, V392, P151, DOI 10.1016/j.gene.2006.11.021; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Prezant TR, 1996, MICROBIOL-SGM, V142, P3407, DOI 10.1099/13500872-142-12-3407; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; Ruaud AF, 2009, TRAFFIC, V10, P88, DOI 10.1111/j.1600-0854.2008.00844.x; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SCHRIER SL, 1992, BLOOD, V79, P782; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Williamson P, 2002, BBA-MOL CELL BIOL L, V1585, P53, DOI 10.1016/S1388-1981(02)00324-4; Xu P, 2007, ACTA BIOCH BIOPH SIN, V39, P739, DOI 10.1111/j.1745-7270.2007.00342.x; Yamamoto H, 2010, MOL BIOL CELL, V21, P2746, DOI 10.1091/mbc.E10-01-0074; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	41	83	96	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38159	38167		10.1074/jbc.M111.281006	http://dx.doi.org/10.1074/jbc.M111.281006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914794	hybrid, Green Published			2022-12-27	WOS:000296594200029
J	Vogl, K; Bryant, DA				Vogl, Kajetan; Bryant, Donald A.			Elucidation of the Biosynthetic Pathway for Okenone in Thiodictyon sp CAD16 Leads to the Discovery of Two Novel Carotene Ketolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURPLE SULFUR BACTERIA; STRAIN PCC 7002; RUBRIVIVAX-GELATINOSUS; ESCHERICHIA-COLI; HAEMATOCOCCUS-PLUVIALIS; RHODOBACTER-CAPSULATUS; PHOTOTROPHIC BACTERIA; CHLOROBIUM-TEPIDUM; LYCOPENE CYCLASE; BETA-CAROTENE	Okenone is a unique ketocarotenoid found in many purple sulfur bacteria; it is important because of its unique light absorption and photoprotection properties. Okenane, a compound formed by diagenetic reduction of okenone, is an important biomarker in geochemical analyses of sedimentary rocks. Despite its ecological and biogeochemical importance, the biochemical pathway for okenone synthesis has not yet been fully described. The genome sequence of an okenone-producing organism, Thiodictyon sp. strain CAD16, revealed four genes whose predicted proteins had strong sequence similarity to enzymes known to produce psi-end group modifications of carotenoids in proteobacteria. These four genes encoded homologs of a 1,2-carotenoid hydratase (CrtC), an O-methyltransferase (CrtF), and two paralogs of carotenoid 3,4-desaturases (CrtD). Expression studies in lycopene-or neurosporene-producing strains of Escherichia coli confirmed the functions of crtC and crtF, but the crtD paralogs encoded enzymes with previously undescribed functions. One enzyme, CruS, was only distantly related to CrtD desaturases, was bifunctional, and performed a 3,4-desaturation and introduced a C-2 keto group into neurosporene derivatives in the presence of dioxygen. The enzyme encoded by the other crtD paralog also represents a new enzyme in carotenogenesis and was named cruO. CruO encodes the C-4/4' ketolase uniquely required for okenone biosynthesis. The identification of CruO and the demonstration of its biochemical activity complete the elucidation of the biosynthetic pathway for okenone and other related ketocarotenoids.	[Vogl, Kajetan; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, S-235 Frear Bldg, University Pk, PA 16802 USA.	dab14@psu.edu			United States Department of Energy [DE-FG02-94ER20137]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported by United States Department of Energy Grant DE-FG02-94ER20137 (to D. A. B.).	AASEN AJ, 1967, ACTA CHEM SCAND, V21, P970, DOI 10.3891/acta.chem.scand.21-0970; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDREWES AG, 1972, ACTA CHEM SCAND, V26, P2194, DOI 10.3891/acta.chem.scand.26-2194; Badenhop F, 2003, FEMS MICROBIOL LETT, V222, P237, DOI 10.1016/S0378-1097(03)00302-1; BLANKENSHIP RE, 1994, ANTON LEEUW INT J G, V65, P311, DOI 10.1007/BF00872216; BRITTON G, 1985, METHOD ENZYMOL, V111, P113, DOI 10.1016/S0076-6879(85)11007-4; Britton G., 1995, SPECTROSCOPY-US, V1B, P13; Brocks JJ, 2005, NATURE, V437, P866, DOI 10.1038/nature04068; Brocks JJ, 2008, GEOCHIM COSMOCHIM AC, V72, P1396, DOI 10.1016/j.gca.2007.12.006; Brocks JJ, 2009, NAT REV MICROBIOL, V7, P601, DOI 10.1038/nrmicro2167; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Caumette P, 2004, INT J SYST EVOL MICR, V54, P1031, DOI 10.1099/ijs.0.02964-0; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FernandezGonzalez B, 1997, J BIOL CHEM, V272, P9728; Fraser PD, 1997, J BIOL CHEM, V272, P6128, DOI 10.1074/jbc.272.10.6128; Frigaard NU, 2004, METH MOL B, V274, P325; Frigaard NU, 2004, J BACTERIOL, V186, P5210, DOI 10.1128/JB.186.16.5210-5220.2004; Garcia Costas AM, 2011, ENV MICROBI IN PRESS; Gerjets T, 2009, BBA-MOL CELL BIOL L, V1791, P125, DOI 10.1016/j.bbalip.2008.12.006; Graham JE, 2009, J BACTERIOL, V191, P3292, DOI 10.1128/JB.00050-09; Graham JE, 2008, J BACTERIOL, V190, P7966, DOI 10.1128/JB.00985-08; Hoff A. J., 1997, PHYS REP, V287, P2; Imhoff J, 2004, ANOXYGENIC PHOTOSYNT, P1; IMHOFF JF, 1980, ZBL BAKT MIK HYG I C, V1, P61; Imhoff JF, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P874, DOI 10.1007/0-387-30746-x_32; KAJIWARA S, 1995, PLANT MOL BIOL, V29, P343, DOI 10.1007/BF00043657; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee PC, 2010, APPL ENVIRON MICROB, V76, P7328, DOI 10.1128/AEM.01606-10; Liaaen-Jensen S., 1963, ACTA CHEM SCAND, V17, P303; LOTAN T, 1995, FEBS LETT, V364, P125, DOI 10.1016/0014-5793(95)00368-J; Madigan Michael T., 2009, V28, P1; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; Maresca JA, 2008, PHOTOSYNTH RES, V97, P121, DOI 10.1007/s11120-008-9312-3; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Maresca JA, 2009, ENV MICROBIOL REP, V1, P524, DOI 10.1111/j.1758-2229.2009.00075.x; MCEWAN AG, 1994, ANTON LEEUW INT J G, V66, P151, DOI 10.1007/BF00871637; MISAWA N, 1995, J BACTERIOL, V177, P6575, DOI 10.1128/jb.177.22.6575-6584.1995; Mukoyama D, 2006, FEMS MICROBIOL LETT, V265, P69, DOI 10.1111/j.1574-6968.2006.00471.x; Peduzzi S, 2003, FEMS MICROBIOL ECOL, V45, P29, DOI 10.1016/S0168-6496(03)00107-7; Pinta V, 2003, ARCH MICROBIOL, V179, P354, DOI 10.1007/s00203-003-0538-3; Polli D, 2006, BIOPHYS J, V90, P2486, DOI 10.1529/biophysj.105.069286; SCHMIDT K, 1963, ARCH MIKROBIOL, V46, P117, DOI 10.1007/BF00408204; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; SHNEOUR EA, 1962, BIOCHIM BIOPHYS ACTA, V65, P510, DOI 10.1016/0006-3002(62)90455-9; STACKEBRANDT E, 1988, INT J SYST BACTERIOL, V38, P321, DOI 10.1099/00207713-38-3-321; Steiger S, 2003, ARCH BIOCHEM BIOPHYS, V414, P51, DOI 10.1016/S0003-9861(03)00099-7; Steiger S, 2002, J BIOTECHNOL, V97, P51, DOI 10.1016/S0168-1656(02)00055-X; Steiger S, 2000, BIOCHEM J, V349, P635, DOI 10.1042/0264-6021:3490635; Sun ZT, 2009, MICROBIOL-SGM, V155, P2775, DOI 10.1099/mic.0.027623-0; Takaichi S, 2001, PHOTOSYNTH RES, V67, P207, DOI 10.1023/A:1010666406176; Takaichi Shinichi, 2009, V28, P97; Vogl K., 2011, GEOBIOLOGY IN PRESS; Willows Robert D., 2009, V28, P57; Yeliseev AA, 1997, FEBS LETT, V403, P10, DOI 10.1016/S0014-5793(97)00006-9; Yu QJ, 2010, J BIOL CHEM, V285, P12109, DOI 10.1074/jbc.M109.091843; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; Zhu YH, 2010, ARCH BIOCHEM BIOPHYS, V504, P86, DOI 10.1016/j.abb.2010.07.007	59	12	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38521	38532		10.1074/jbc.M111.280131	http://dx.doi.org/10.1074/jbc.M111.280131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21921032	hybrid, Green Published			2022-12-27	WOS:000296594200066
J	Wang, Q; Lynch, JW				Wang, Qian; Lynch, Joseph W.			Activation and Desensitization Induce Distinct Conformational Changes at the Extracellular-Transmembrane Domain Interface of the Glycine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; LIGAND-BINDING DOMAIN; CYS-LOOP RECEPTORS; RAPID DESENSITIZATION; GLUTAMATE-RECEPTOR; GABA(A) RECEPTORS; AGONIST BINDING; BETA-2 SUBUNIT; ACH RECEPTORS; A RECEPTOR	Most ligand-gated channels exhibit desensitization, which is the progressive fading of ionic current in the prolonged presence of agonist. This process involves conformational changes that close the channel despite continued agonist binding. Despite the physiological and pathological importance of desensitization, little is known about the conformational changes that underlie this process in any Cys-loop ion channel receptor. Here we employed voltage clamp fluorometry to identify conformational changes that occur with a similar time course as the current desensitization rate in both slow-and fast-desensitizing alpha 1 glycine receptor chloride channels. Voltage clamp fluorometry provides a direct indication of conformational changes that occur in the immediate vicinity of residues labeled with environmentally sensitive fluorophores. We compared the rates of current desensitization and fluorescence changes at nine labeled extracellular sites in both wild type slow-desensitizing and mutated (A248L) fast-desensitizing glycine receptors. As labels attached to three sites at the interface between the ligand binding domain and transmembrane domain reported fluorescence responses that changed in parallel with the current desensitization rate, we concluded that they experienced local conformational changes associated with desensitization. These labeled sites included A52C in loop 2, Q219C in the pre-M1 domain, and M227C in the M1 domain. Activation and desensitization were accompanied by physically distinct conformational changes at each labeled site. Because activation is mediated by a specific reorganization of molecular interactions at the extracellular-transmembrane domain interface, we propose that desensitization is mediated by a distinct set of conformational changes that prevents this reorganization from occurring, thereby favoring channel closure.	[Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009		Australian Research Council; National Health and Medical Research Council of Australia; University of Queensland	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland)	This work was supported by the Australian Research Council and the National Health and Medical Research Council of Australia.; Supported by a University of Queensland Ph.D. Confirmation Scholarship.	Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Bohler S, 2001, BIOCHEMISTRY-US, V40, P2066, DOI 10.1021/bi0020022; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; Breitinger HG, 2004, CHEM BIOL, V11, P1339, DOI 10.1016/j.chembiol.2004.07.008; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; Engblom AC, 2002, J BIOL CHEM, V277, P17438, DOI 10.1074/jbc.M111215200; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Goldschen-Ohm MP, 2010, MOL PHARMACOL, V77, P35, DOI 10.1124/mol.109.058289; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; McCormack TJ, 2010, J PHYSIOL-LONDON, V588, P4415, DOI 10.1113/jphysiol.2010.195495; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Pless SA, 2009, J NEUROCHEM, V108, P1585, DOI 10.1111/j.1471-4159.2009.05930.x; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Wang J, 2007, J BIOL CHEM, V282, P26210, DOI 10.1074/jbc.M702314200; Wang QA, 2010, J BIOL CHEM, V285, P40373, DOI 10.1074/jbc.M110.161513; Weiland S, 1996, FEBS LETT, V398, P91, DOI 10.1016/S0014-5793(96)01215-X; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Yakel JL, 2010, J PHYSIOL-LONDON, V588, P597, DOI 10.1113/jphysiol.2009.182691; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p	44	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38814	38824		10.1074/jbc.M111.273631	http://dx.doi.org/10.1074/jbc.M111.273631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917927	hybrid, Green Published			2022-12-27	WOS:000296594200092
J	Mukundan, B; Ansari, A				Mukundan, Banupriya; Ansari, Athar			Novel Role for Mediator Complex Subunit Srb5/Med18 in Termination of Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEX; HEAD MODULE; YEAST; COACTIVATOR; RECRUITMENT; ACTIVATION; ELONGATION; BINDING	Mediator complex functions at the recruitment as well as the post-recruitment steps of transcription. Here we provide evidence for a novel role of Mediator in termination of transcription. Mediator subunit Srb5/Med18 cross-links to the 5' and 3' ends of INO1 and CHA1. In srb5(-) cells, recruitment of TATA-binding protein (TBP) and transcription factor IIB (TFIIB) onto the promoter of these genes remained unaffected, but cross-linking of the cleavage-polyadenylation factors Rna15 and Pta1 toward the 3' end of genes was compromised. In these cells, RNA polymerase II accumulated near the 3' end of genes and beyond. Transcription run-on analysis confirmed a transcription readthrough phenotype in the absence of Srb5/Med18. These results strongly suggest that Mediator subunit Srb5/Med18 is required for proper termination of transcription of a subset of genes in budding yeast.	[Mukundan, Banupriya; Ansari, Athar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Ansari, A (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	bb2749@wayne.edu	Ansari, Athar/AEK-0223-2022	Ansari, Athar/0000-0003-2806-421X	National Science Foundation (NSF) [MCB1020911]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by Grant MCB1020911 from the National Science Foundation (NSF) (to A. A.).	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Ansari SA, 2009, P NATL ACAD SCI USA, V106, P16734, DOI 10.1073/pnas.0905103106; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Conaway R. C., 2011, SEMIN CELL IN PRESS; Dettmann A, 2010, MOL GENET GENOMICS, V283, P211, DOI 10.1007/s00438-009-0508-9; El Kaderi B, 2009, J BIOL CHEM, V284, P25015, DOI 10.1074/jbc.M109.007948; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; Malik S, 2007, P NATL ACAD SCI USA, V104, P6182, DOI 10.1073/pnas.0608717104; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Medler S, 2011, J BIOL CHEM, V286, P33709, DOI 10.1074/jbc.M110.193870; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; PETERSEN JGL, 1988, GENETICS, V119, P527; Proshkina G M, 2009, Bioorg Khim, V35, P572; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603	44	41	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37053	37057		10.1074/jbc.C111.295915	http://dx.doi.org/10.1074/jbc.C111.295915			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21921038	hybrid, Green Published			2022-12-27	WOS:000296542400004
J	Huang, QJ; Lan, FH; Zheng, ZY; Xie, FL; Han, JY; Dong, LH; Xie, YC; Zheng, F				Huang, Qiaojia; Lan, Fenghua; Zheng, Zhiyong; Xie, Feilai; Han, Junyong; Dong, Lihong; Xie, Yanchuan; Zheng, Feng			Akt2 Kinase Suppresses Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH)-mediated Apoptosis in Ovarian Cancer Cells via Phosphorylating GAPDH at Threonine 237 and Decreasing Its Nuclear Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; PROTEIN; BREAST; ACTIVATION; TARGET; DEATH; PROLIFERATION; MIGRATION; SURVIVAL; AKT/PKB	Protein kinase B (Akt) plays important roles in regulation of cell growth and survival, but while many aspects of its mechanism of action are known, there are potentially additional regulatory events that remain to be discovered. Here we detected a 36-kDa protein that was co-immunoprecipitated with protein kinase B beta (Akt2) in OVCAR-3 ovarian cancer cells. The protein was identified to be glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by MALDI-TOF/TOF MS, and the interaction of Akt2 and GAPDH was verified by reverse immunoprecipitation. Our further study showed that Akt2 may suppress GAPDH-mediated apoptosis in ovarian cancer cells. Overexpression of GAPDH increased ovarian cancer cell apoptosis induced by H2O2, which was inhibited by Akt2 overexpression and restored by the PI3K/Akt inhibitor wortmannin or Akt2 siRNA. Akt2 phosphorylated Thr-237 of GAPDH and decreased its nuclear translocation, an essential step for GAPDH-mediated apoptosis. The interaction between Akt2 and GAPDH may be important in ovarian cancer as immunohistochemical analysis of 10 normal and 30 cancerous ovarian tissues revealed that decreased nuclear expression of GAPDH correlated with activation (phosphorylation) of Akt2. In conclusion, our study suggests that activated Akt2 may increase ovarian cancer cell survival via inhibition of GAPDH-induced apoptosis. This effect of Akt2 is partly mediated by its phosphorylation of GAPDH at Thr-237, which results in the inhibition of GAPDH nuclear translocation.	[Huang, Qiaojia; Lan, Fenghua; Han, Junyong; Dong, Lihong; Xie, Yanchuan] Dongfang Hosp, Fuzhou Gen Hosp, Dept Expt Med, Fuzhou 350025, Fujian Province, Peoples R China; [Zheng, Feng] Dongfang Hosp, Fuzhou Gen Hosp, Dept Nephrol, Fuzhou 350025, Fujian Province, Peoples R China; [Zheng, Zhiyong; Xie, Feilai] Dongfang Hosp, Fuzhou Gen Hosp, Dept Pathol, Fuzhou 350025, Fujian Province, Peoples R China		Huang, QJ (corresponding author), Dongfang Hosp, Fuzhou Gen Hosp, Dept Expt Med, 156 N Xi Er Huan Rd, Fuzhou 350025, Fujian Province, Peoples R China.	huangqj100@126.com			Medical Scientific Research Foundation of Nanjing Command [08MA100]; Natural Science Foundation of Fujian Province [2009J01181]; Fuzhou General Hospital Special Foundation [2004037]	Medical Scientific Research Foundation of Nanjing Command; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Fuzhou General Hospital Special Foundation	This work was supported by the Medical Scientific Research Foundation of Nanjing Command Grant 08MA100, Natural Science Foundation of Fujian Province Grant 2009J01181, and Fuzhou General Hospital Special Foundation Grant 2004037.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Arboleda MJ, 2003, CANCER RES, V63, P196; Baba T, 2010, FEBS LETT, V584, P2796, DOI 10.1016/j.febslet.2010.05.015; Chau NM, 2004, BREAST CANCER RES, V6, P55, DOI 10.1186/bcr739; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Dastoor Z, 2001, J CELL SCI, V114, P1643; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Du ZX, 2007, ENDOCRINOLOGY, V148, P4352, DOI 10.1210/en.2006-1511; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Harada N, 2007, J BIOL CHEM, V282, P22651, DOI 10.1074/jbc.M610724200; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Huang QJ, 2008, J CANCER RES CLIN, V134, P1219, DOI 10.1007/s00432-008-0398-y; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; Kallergi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2149; Kwon HJ, 2010, EXP MOL MED, V42, P254, DOI 10.3858/emm.2010.42.4.025; Li XY, 2006, TOXICOL MECH METHOD, V16, P1, DOI 10.1080/15376520500191797; Mackey AM, 2008, CELL DEATH DIFFER, V15, P1291, DOI 10.1038/cdd.2008.43; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Noske A, 2007, CANCER LETT, V246, P190, DOI 10.1016/j.canlet.2006.02.018; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Pecorari L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-58; Qin SF, 2003, BIOCHEMISTRY-US, V42, P2995, DOI 10.1021/bi0205911; Sadidi M, 2009, BIOCHIMIE, V91, P577, DOI 10.1016/j.biochi.2009.01.010; Sahin O, 2007, P NATL ACAD SCI USA, V104, P6579, DOI 10.1073/pnas.0606827104; Schmitz HD, 2001, EUR J CELL BIOL, V80, P419, DOI 10.1078/0171-9335-00174; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Villafuerte BC, 2004, J BIOL CHEM, V279, P36650, DOI 10.1074/jbc.M404349200; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	40	68	74	4	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42211	42220		10.1074/jbc.M111.296905	http://dx.doi.org/10.1074/jbc.M111.296905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21979951	Green Published, hybrid			2022-12-27	WOS:000298180900031
J	Paschall, CO; Thompson, JA; Marzahn, MR; Chiraniya, A; Hayner, JN; O'Donnell, M; Robbins, AH; McKenna, R; Bloom, LB				Paschall, Christopher O.; Thompson, Jennifer A.; Marzahn, Melissa R.; Chiraniya, Ankita; Hayner, Jaclyn N.; O'Donnell, Mike; Robbins, Arthur H.; McKenna, Robert; Bloom, Linda B.			The Escherichia coli Clamp Loader Can Actively Pry Open the beta-Sliding Clamp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; CELL NUCLEAR ANTIGEN; REPLICATION-FACTOR-C; ONE HOLOENZYME PARTICLE; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; DELTA-SUBUNIT; GAMMA-COMPLEX; MACHINE	Clamp loaders load ring-shaped sliding clamps onto DNA. Once loaded onto DNA, sliding clamps bind to DNA polymerases to increase the processivity of DNA synthesis. To load clamps onto DNA, an open clamp loader-clamp complex must form. An unresolved question is whether clamp loaders capture clamps that have transiently opened or whether clamp loaders bind closed clamps and actively open clamps. A simple fluorescence-based clamp opening assay was developed to address this question and to determine how ATP binding contributes to clamp opening. A direct comparison of real time binding and opening reactions revealed that the Escherichia coli alpha complex binds beta first and then opens the clamp. Mutation of conserved "arginine fingers" in the alpha complex that interact with bound ATP decreased clamp opening activity showing that arginine fingers make an important contribution to the ATP-induced conformational changes that allow the clamp loader to pry open the clamp.	[Paschall, Christopher O.; Thompson, Jennifer A.; Marzahn, Melissa R.; Chiraniya, Ankita; Hayner, Jaclyn N.; Robbins, Arthur H.; McKenna, Robert; Bloom, Linda B.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [O'Donnell, Mike] Howard Hughes Med Inst, New York, NY 10021 USA; [O'Donnell, Mike] Rockefeller Univ, New York, NY 10021 USA	State University System of Florida; University of Florida; Howard Hughes Medical Institute; Rockefeller University	Bloom, LB (corresponding author), Univ Florida, Dept Biochem & Mol Biol, 1600 SW Archer Rd,JHMHC R3-234, Gainesville, FL 32610 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014	O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM055596, GM082849, GM038839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082849, R37GM038839, R01GM055596, R01GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM055596 and GM082849 (to L.B.B.) and GM038839 (to M.O.D.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alley SC, 2000, BIOCHEMISTRY-US, V39, P3076, DOI 10.1021/bi992377r; Alley SC, 1999, BIOCHEMISTRY-US, V38, P7696, DOI 10.1021/bi9827971; Anderson SG, 2009, BIOCHEMISTRY-US, V48, P8516, DOI 10.1021/bi900912a; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; DONG ZM, 1993, J BIOL CHEM, V268, P11758; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; Leu FP, 2001, J BIOL CHEM, V276, P47185, DOI 10.1074/jbc.M106780200; MAKI S, 1988, J BIOL CHEM, V263, P6547; Millar D, 2004, BIOCHEMISTRY-US, V43, P12723, DOI 10.1021/bi048349c; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; O'Donnell M, 2006, CURR OPIN STRUC BIOL, V16, P35, DOI 10.1016/j.sbi.2005.12.004; Oakley AJ, 2003, ACTA CRYSTALLOGR D, V59, P1192, DOI 10.1107/S0907444903009958; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Snyder AK, 2004, J BIOL CHEM, V279, P4386, DOI 10.1074/jbc.M310430200; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; Thompson JA, 2009, J BIOL CHEM, V284, P32147, DOI 10.1074/jbc.M109.045997; Trakselis MA, 2001, P NATL ACAD SCI USA, V98, P8368, DOI 10.1073/pnas.111006698; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	41	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42704	42714		10.1074/jbc.M111.268169	http://dx.doi.org/10.1074/jbc.M111.268169			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21971175	Green Published, hybrid			2022-12-27	WOS:000298180900077
J	Weitz-Schmidt, G; Schurpf, T; Springer, TA				Weitz-Schmidt, Gabriele; Schuerpf, Thomas; Springer, Timothy A.			The C-Terminal alpha I Domain Linker as a Critical Structural Element in the Conformational Activation of alpha I Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; ADHESION MOLECULE-1 ICAM-1; BETA-PROPELLER DOMAIN; ALLOSTERIC SITE; CELL-ADHESION; SUBUNIT; ANTIBODIES; BINDING; LFA-1; ALPHA-L-BETA-2	The activation of alpha/beta heterodimeric integrins is the result of highly coordinated rearrangements within both subunits. The molecular interactions between the two subunits, however, remain to be characterized. In this study, we use the integrin alpha(L)beta(2) to investigate the functional role of the C-linker polypeptide that connects the C-terminal end of the inserted (I) domain with the beta-propeller domain on the alpha subunit and is located at the interface with the beta I domain of the alpha chain. We demonstrate that shortening of the C-linker by eight or more amino acids results in constitutively active alpha(L)beta(2) in which the alpha I domain is no longer responsive to the regulation by the beta I domain. Despite this intersubunit uncoupling, both I domains remain individually sensitive to intrasubunit conformational changes induced by allosteric modulators. Interestingly, the length and not the sequence of the C-linker appears to be critical for its functionality in alpha/beta intersubunit communication. Using two monoclonal antibodies (R7.1 and CBRLFA-1/1) we further demonstrate that shortening of the C-linker results in the gradual loss of combinational epitopes that require both the alpha I and beta-propeller domains for full reactivity. Taken together, our findings highlight the role of the C-linker as a spring-like element that allows relaxation of the alpha I domain in the resting state and controlled tension of the alpha I domain during activation, exerted by the beta chain.	[Weitz-Schmidt, Gabriele] Univ Basel, PharmaCtr, CH-4056 Basel, Switzerland; [Weitz-Schmidt, Gabriele; Schuerpf, Thomas; Springer, Timothy A.] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Weitz-Schmidt, Gabriele; Schuerpf, Thomas; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Basel; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Weitz-Schmidt, G (corresponding author), Univ Basel, PharmaCtr, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	gabriele.weitz-schmidt@unibas.ch; springer@idi.harvard.edu	Schürpf, Thomas/E-7380-2012	Schurpf, Thomas/0000-0003-3023-1136	National Institutes of Health [CA31798]; NATIONAL CANCER INSTITUTE [R01CA031798, R37CA031798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA31798.	ARGENBRIGHT LW, 1991, J LEUKOCYTE BIOL, V49, P253, DOI 10.1002/jlb.49.3.253; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; FOTOUHI N, 1999, Patent No. 0021920; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Huang CC, 2000, J BIOL CHEM, V275, P21514, DOI 10.1074/jbc.M002286200; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; Huang CC, 1997, P NATL ACAD SCI USA, V94, P3162, DOI 10.1073/pnas.94.7.3162; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Kelly TA, 1999, J IMMUNOL, V163, P5173; Lu CF, 2004, J IMMUNOL, V173, P3972, DOI 10.4049/jimmunol.173.6.3972; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; Lu CF, 1998, J BIOL CHEM, V273, P15138, DOI 10.1074/jbc.273.24.15138; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Lupher ML, 2001, J IMMUNOL, V167, P1431, DOI 10.4049/jimmunol.167.3.1431; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Smagghe BJ, 2010, J BIOL CHEM, V285, P32954, DOI 10.1074/jbc.M110.145177; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; Weetall M, 2001, ANAL BIOCHEM, V293, P277, DOI 10.1006/abio.2001.5140; Weitz-Schmidt G, 2004, J BIOL CHEM, V279, P46764, DOI 10.1074/jbc.M407951200; Welzenbach K, 2002, J BIOL CHEM, V277, P10590, DOI 10.1074/jbc.M110521200; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Yalamanchili P, 2000, J BIOL CHEM, V275, P21877, DOI 10.1074/jbc.M908868199; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101	36	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42115	42122		10.1074/jbc.M111.282830	http://dx.doi.org/10.1074/jbc.M111.282830			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21965670	Green Published, hybrid			2022-12-27	WOS:000298180900022
J	Chantret, I; Kodali, VP; Lahmouich, C; Harvey, DJ; Moore, SEH				Chantret, Isabelle; Kodali, Vidya P.; Lahmouich, Chaimaa; Harvey, David J.; Moore, Stuart E. H.			Endoplasmic Reticulum-associated Degradation (ERAD) and Free Oligosaccharide Generation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-N-GLYCANASE; MISFOLDED GLYCOPROTEINS; LINKED GLYCANS; NEGATIVE-IONS; HUMAN OS-9; YEAST; PROTEIN; MANNOSIDASE; GLYCOSYLATION; PATHWAY	In Saccharomyces cerevisiae, proteins with misfolded lumenal, membrane, and cytoplasmic domains are cleared from the endoplasmic reticulum (ER) by ER-associated degradation (ERAD)-L, -M, and -C, respectively. ERAD-L is N-glycan-dependent and is characterized by ER mannosidase (Mns1p) and ER mannosidase-like protein (Mnl1p), which generate Man(7)GlcNAc(2) (d1) N-glycans with non-reducing alpha 1,6-mannosyl residues. Glycoproteins bearing this motif bind Yos9p and are dislocated into the cytoplasm and then deglycosylated by peptide N-glycanase (Png1p) to yield free oligosaccharides (fOS). Here, we examined yeast fOS metabolism as a function of cell growth in order to obtain quantitative and mechanistic insights into ERAD. We demonstrate that both Png1p-dependent generation of Man(7-10)GlcNAc(2) fOS and vacuolar a-mannosidase (Ams1p)-dependent fOS demannosylation to yield Man(1)GlcNAc(2) are strikingly up-regulated during post-diauxic growth which occurs when the culture medium is depleted of glucose. Gene deletions in the ams1 Delta background revealed that, as anticipated, Mns1p and Mnl1p are required for efficient generation of the Man(7)GlcNAc(2) (d1) fOS, but for the first time, we demonstrate that small amounts of this fOS are generated in an Mnl1p-independent, Mns1p-dependent pathway and that a Man,GlcNAc., fOS that is known to bind Yos9p is generated in an Mnl1p-dependent, Mns1p-independent manner. This latter observation adds mechanistic insight into a recently described Mnl1p-dependent, Mns1p-independent ERAD pathway. Finally, we show that 50% of fOS generation is independent of ERAD-L, and because our data indicate that ERAD-M and ERAD-C contribute little to fOS levels, other important processes underlie fOS generation in S. cerevisiae.	[Moore, Stuart E. H.] Univ Paris 07, INSERM, U773, Fac Med Xavier Bichat,CRB3, F-75018 Paris, France; [Chantret, Isabelle; Kodali, Vidya P.; Lahmouich, Chaimaa; Moore, Stuart E. H.] Univ Paris 07, Paris, France; [Harvey, David J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Oxford	Moore, SEH (corresponding author), Univ Paris 07, INSERM, U773, Fac Med Xavier Bichat,CRB3, 16 Rue Henri Huchard, F-75018 Paris, France.	stuart.moore@inserm.fr	Kodali, Dr. Vidya Prabhakar/ABE-7646-2021; Moore, Stuart/AAF-3920-2021; Harvey, David/A-5579-2013; CHANTRET, Isabelle/AAF-7134-2021	Moore, Stuart/0000-0002-1020-2242; CHANTRET, Isabelle/0000-0002-0896-1274; Harvey, David/0000-0003-0544-771X	Mizutani Foundation; GIS-Institut des Maladies Rares/INSERM; French CDG Research Network, EUROGLY-CANET [LSHM-CT-2005-512131]; La Fondation pour la Recherche Medicale; INSERM	Mizutani Foundation; GIS-Institut des Maladies Rares/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); French CDG Research Network, EUROGLY-CANET; La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Mizutani Foundation, the GIS-Institut des Maladies Rares/INSERM-funded French CDG Research Network, EUROGLY-CANET (LSHM-CT-2005-512131), La Fondation pour la Recherche Medicale, and institutional funding from INSERM.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Davidson GS, 2011, MOL BIOL CELL, V22, P988, DOI 10.1091/mbc.E10-06-0499; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P622, DOI 10.1016/j.jasms.2005.01.004; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P631, DOI 10.1016/j.jasms.2005.01.005; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Herscovics A, 2002, GLYCOBIOLOGY, V12, p14G; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Kawaguchi S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015532; KENNEDY LD, 1983, ANAL BIOCHEM, V128, P465, DOI 10.1016/0003-2697(83)90402-5; Kostova Z, 2009, J CELL SCI, V122, P1374, DOI 10.1242/jcs.044255; Mikami K, 2010, GLYCOBIOLOGY, V20, P310, DOI 10.1093/glycob/cwp175; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Moore SEH, 1999, TRENDS CELL BIOL, V9, P441, DOI 10.1016/S0962-8924(99)01648-7; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; NAKANISHISHINDO Y, 1993, J BIOL CHEM, V268, P26338; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; OPHEIM DJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P121, DOI 10.1016/0005-2744(78)90110-9; Peric D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011675; Petracek ME, 2002, METHOD ENZYMOL, V350, P445, DOI 10.1016/S0076-6879(02)50978-2; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Reiss G, 1996, GLYCOBIOLOGY, V6, P493, DOI 10.1093/glycob/6.5.493; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 1998, J BIOL CHEM, V273, P21526, DOI 10.1074/jbc.273.34.21526; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723	47	22	23	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41786	41800		10.1074/jbc.M111.251371	http://dx.doi.org/10.1074/jbc.M111.251371			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21979948	Green Published, hybrid			2022-12-27	WOS:000298057500062
J	King, JG; Vernick, KD; Hillyer, JF				King, Jonas G.; Vernick, Kenneth D.; Hillyer, Julian F.			Members of the Salivary Gland Surface Protein (SGS) Family Are Major Immunogenic Components of Mosquito Saliva	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT FEMALE MOSQUITO; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; MONOCLONAL-ANTIBODIES; MEMBRANE-PROTEINS; MALARIA PARASITES; GENE-EXPRESSION; HUMAN IGE; INSIGHT; IDENTIFICATION	Mosquitoes transmit Plasmodium and certain arboviruses during blood feeding, when they are injected along with saliva. Mosquito saliva interferes with the host's hemostasis and inflammation response and influences the transmission success of some pathogens. One family of mosquito salivary gland proteins, named SGS, is composed of large bacterial-type proteins that in Aedes aegypti were implicated as receptors for Plasmodium on the basal salivary gland surface. Here, we characterize the biology of two SGSs in the malaria mosquito, Anopheles gambiae, and demonstrate their involvement in blood feeding. Western blots and RT-PCR showed that Sgs4 and Sgs5 are produced exclusively in female salivary glands, that expression increases with age and after blood feeding, and that protein levels fluctuate in a circadian manner. Immunohistochemistry showed that SGSs are present in the acinar cells of the distal lateral lobes and in the salivary ducts of the proximal lobes. PAGE, Western blots, bite blots, and immunization via mosquito bites showed that SGSs are highly immunogenic and form major components of mosquito saliva. Last, Western and bioinformatic analyses suggest that SGSs are secreted via a non-classical pathway that involves cleavage into a 300-kDa soluble fragment and a smaller membrane-bound fragment. Combined, these data strongly suggest that SGSs play an important role in blood feeding. Together with their role in malaria transmission, we propose that SGSs could be used as markers of human exposure to mosquito bites and in the development of disease control strategies.	[King, Jonas G.; Hillyer, Julian F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [King, Jonas G.; Hillyer, Julian F.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37235 USA; [Vernick, Kenneth D.] Inst Pasteur, Dept Parasitol & Mycol, F-75015 Paris, France	Vanderbilt University; Vanderbilt University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hillyer, JF (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B 35-1634, Nashville, TN 37235 USA.	julian.hillyer@vanderbilt.edu		Hillyer, Julian/0000-0002-3178-0201; King, Jonas/0000-0003-2270-4212	Vanderbilt University	Vanderbilt University	This work was supported by a Vanderbilt University Discovery Grant (to J. F. H.).	Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arca B, 2007, INSECT BIOCHEM MOLEC, V37, P107, DOI 10.1016/j.ibmb.2006.10.007; Barreau C, 1999, INSECT BIOCHEM MOLEC, V29, P515, DOI 10.1016/S0965-1748(99)00025-9; BILLINGSLEY PF, 1991, T ROY SOC TROP MED H, V85, P450, DOI 10.1016/0035-9203(91)90215-K; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; BOORMAN J, 1987, MED VET ENTOMOL, V1, P211, DOI 10.1111/j.1365-2915.1987.tb00346.x; Bowen MF, 1996, CIBA F SYMP, V200, P197; Brennan JDG, 2000, P NATL ACAD SCI USA, V97, P13859, DOI 10.1073/pnas.250472597; BRUMMERKORVENKONTIO H, 1994, J ALLERGY CLIN IMMUN, V93, P551, DOI 10.1016/S0091-6749(94)70066-4; Calvo E, 2010, J MED ENTOMOL, V47, P376, DOI 10.1603/ME09226; Castellanos-Serra L, 2006, NAT PROTOC, V1, P1544, DOI 10.1038/nprot.2006.233; Chen YL, 1998, INT ARCH ALLERGY IMM, V116, P269, DOI 10.1159/000023955; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; Dowling AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015693; Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Harlow E., 1988, ANTIBODIES LAB MANUA; Hillyer JF, 2010, DEV COMP IMMUNOL, V34, P141, DOI 10.1016/j.dci.2009.08.014; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; Jariyapan N, 2010, PARASITOL RES, V107, P509, DOI 10.1007/s00436-010-1883-1; Jeon SH, 2001, INT ARCH ALLERGY IMM, V126, P206, DOI 10.1159/000049515; Juhn J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-1; Kebaier C, 2010, INFECT IMMUN, V78, P545, DOI 10.1128/IAI.00807-09; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Klasson L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-33; Korochkina S, 2006, CELL MICROBIOL, V8, P163, DOI 10.1111/j.1462-5822.2005.00611.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malafronte Rdos S., 2003, INSECT BIOCHEM MOLEC, V33, P63; Mans B. J., 2011, TOXINS HEMOSTASIS, P21; Minet AD, 1999, J CELL SCI, V112, P2019; Moreira CK, 2001, J MED ENTOMOL, V38, P763, DOI 10.1603/0022-2585-38.5.763; Morris RV, 2001, J IMMUNOL, V167, P5226, DOI 10.4049/jimmunol.167.9.5226; Okulate MA, 2007, INSECT MOL BIOL, V16, P711, DOI 10.1111/j.1365-2583.2007.00765.x; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Owhashi M, 2001, PARASITOL RES, V87, P376, DOI 10.1007/s004360000355; Peng ZK, 1998, J ALLERGY CLIN IMMUN, V101, P498, DOI 10.1016/S0091-6749(98)70357-4; PENNEYS NS, 1989, ARCH DERMATOL, V125, P219, DOI 10.1001/archderm.125.2.219; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; RACIOPPI JV, 1987, INSECT BIOCHEM, V17, P503, DOI 10.1016/0020-1790(87)90010-2; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reddy V, 2008, J MOL NEUROSCI, V36, P241, DOI 10.1007/s12031-008-9079-1; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Sasse J., 2009, CURR PROTOC MOL BIOL; Saunders D. S., 2002, INSECT CLOCKS, P9; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Siriyasatien Padet, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P64; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Vaughan JA, 1999, INFECT IMMUN, V67, P4285, DOI 10.1128/IAI.67.8.4285-4289.1999; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x; *WHO, 1996, WEEKLY EPIDEMIOLOGIC, V71, P17; Youderian P, 2007, GENETICS, V177, P557, DOI 10.1534/genetics.107.076182	60	29	29	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40824	40834		10.1074/jbc.M111.280552	http://dx.doi.org/10.1074/jbc.M111.280552			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965675	Green Published, hybrid			2022-12-27	WOS:000297315400043
J	Mak, AB; Blakely, KM; Williams, RA; Penttila, PA; Shukalyuk, AI; Osman, KT; Kasimer, D; Ketela, T; Moffat, J				Mak, Anthony B.; Blakely, Kim M.; Williams, Rashida A.; Penttilae, Pier-Andree; Shukalyuk, Andrey I.; Osman, Khan T.; Kasimer, Dahlia; Ketela, Troy; Moffat, Jason			CD133 Protein N-Glycosylation Processing Contributes to Cell Surface Recognition of the Primitive Cell Marker AC133 Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEMATOPOIETIC STEM; SHORT INTERFERING RNAS; EPITHELIAL-CELLS; COLON-CANCER; EXPRESSION; IDENTIFICATION; ANTIGEN; GLYCOPROTEINS; GENES; LINES	The AC133 epitope expressed on the CD 133 glycoprotein has been widely used as a cell surface marker of numerous stem cell and cancer stem cell types. It has been recently proposed that posttranslational modification and regulation of CD133 may govern cell surface AC133 recognition. Therefore, we performed a large scale pooled RNA interference (RNAi) screen to identify genes involved in cell surface AC133 expression. Gene hits could be validated at a rate of 70.5% in a secondary assay using an orthogonal RNAi system, demonstrating that our primary RNAi screen served as a powerful genetic screening approach. Within the list of hits from the primary screen, genes involved in N-glycan biosynthesis were significantly enriched as determined by Ingenuity Canonical Pathway analyses. Indeed, inhibiting biosynthesis of the N-glycan precursor using the small molecule tunicamycin or inhibiting its transfer to CD 133 by generating N-glycan-deficient CD133 mutants resulted in undetectable cell surface AC133. Among the screen hits involved in N-glycosylation were genes involved in complex N-glycan processing, including the poorly characterized MGAT4C, which we demonstrate to be a positive regulator of cell surface AC133 expression. Our study identifies a set of genes involved in CD133 N-glycosylation as a direct contributing factor to cell surface AC133 recognition and provides biochemical evidence for the function and structure of CD133 N-glycans.	[Mak, Anthony B.; Blakely, Kim M.; Williams, Rashida A.; Moffat, Jason] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Mak, Anthony B.; Blakely, Kim M.; Williams, Rashida A.; Moffat, Jason] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Mak, Anthony B.; Blakely, Kim M.; Williams, Rashida A.; Osman, Khan T.; Kasimer, Dahlia; Ketela, Troy; Moffat, Jason] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Penttilae, Pier-Andree] Sickkids Univ Hlth Network Flow Cytometry Facil, Toronto, ON M5G 1L7, Canada; [Shukalyuk, Andrey I.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5T 1P7, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University Health Network Toronto; University of Toronto	Moffat, J (corresponding author), 802-160 Coll St, Toronto, ON M5S 3E1, Canada.	j.moffat@utoronto.ca	Moffat, Jason/AAC-1110-2020	Moffat, Jason/0000-0002-5663-8586; Penttila, Pier Andree/0000-0002-5861-4430	Stem Cell Network; Canadian Institutes of Health Research; Ontario Institute for Cancer Research	Stem Cell Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research	This work was supported by the Stem Cell Network, the Canadian Institutes of Health Research, and the Ontario Institute for Cancer Research (to J. M.).	Bhatia M, 2001, LEUKEMIA, V15, P1685, DOI 10.1038/sj.leu.2402255; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Ferrandina G, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-221; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Hashimoto K, 2006, GLYCOBIOLOGY, V16, p63R, DOI 10.1093/glycob/cwj010; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Hemmoranta H, 2007, EXP HEMATOL, V35, P1279, DOI 10.1016/j.exphem.2007.05.006; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Ketela T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-213; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mak AB, 2010, MOL CELL PROTEOMICS, V9, P811, DOI 10.1074/mcp.M000002-MCP201; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Olempska M, 2007, HEPATOB PANCREAT DIS, V6, P92; Platet N, 2007, CANCER LETT, V258, P286, DOI 10.1016/j.canlet.2007.09.012; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sasaki A, 2010, ONCOL REP, V24, P537, DOI 10.3892/or_00000890; Sgambato A, 2010, J CELL PHYSIOL, V224, P234, DOI 10.1002/jcp.22124; Shimada M, 2010, J GASTROENTEROL, V45, P896, DOI 10.1007/s00535-010-0235-3; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Thomas M, 2005, BLOOD, V106, P3559, DOI 10.1182/blood-2005-03-1283; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Wang XL, 2011, BIOCHEM J, V435, P285, DOI 10.1042/BJ20101864; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zhou FB, 2010, J BIOCHEM, V148, P273, DOI 10.1093/jb/mvq062	43	59	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41046	41056		10.1074/jbc.M111.261545	http://dx.doi.org/10.1074/jbc.M111.261545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21937449	hybrid, Green Published			2022-12-27	WOS:000297315400064
J	Grigorian, A; Araujo, L; Naidu, NN; Place, DJ; Choudhury, B; Demetriou, M				Grigorian, Ani; Araujo, Lindsey; Naidu, Nandita N.; Place, Dylan J.; Choudhury, Biswa; Demetriou, Michael			N-Acetylglucosamine Inhibits T-helper 1 (Th1)/T-helper 17 (Th17) Cell Responses and Treats Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACEBO-CONTROLLED TRIAL; INTERLEUKIN-7 RECEPTOR; SURFACE ORGANIZATION; MULTIPLE-SCLEROSIS; ORAL FINGOLIMOD; GLUCOSAMINE; ACTIVATION; CYTOKINE; GLYCOSYLATION; TOXICITY	Current treatments and emerging oral therapies for multiple sclerosis (MS) are limited by effectiveness, cost, and/or toxicity. Genetic and environmental factors that alter the branching of Asn (N)-linked glycans result in T cell hyperactivity, promote spontaneous inflammatory demyelination and neurodegeneration in mice, and converge to regulate the risk of MS. The sugar N-acetylglucosamine (GlcNAc) enhances N-glycan branching and inhibits T cell activity and adoptive transfer experimental autoimmune encephalomyelitis (EAE). Here, we report that oral GlcNAc inhibits T-helper 1 (Th1) and T-helper 17 (Th17) responses and attenuates the clinical severity of myelin oligodendrocyte glycoprotein (MOG)-induced EAE when administered after disease onset. Oral GlcNAc increased expression of branched N-glycans in T cells in vivo as shown by high pH anion exchange chromatography, MALDI-TOF mass spectroscopy and FACS analysis with the plant lectin L-phytohemagglutinin. Initiating oral GlcNAc treatment on the second day of clinical disease inhibited MOG-induced EAE as well as secretion of interferon-gamma, tumor necrosis factor-alpha, interleukin-17, and interleukin-22. In the more severe 2D2 T cell receptor transgenic EAE model, oral GlcNAc initiated after disease onset also inhibits clinical disease, except for those with rapid lethal progression. These data suggest that oral GlcNAc may provide an inexpensive and nontoxic oral therapeutic agent for MS that directly targets an underlying molecular mechanism causal of disease.	[Demetriou, Michael] Univ Calif Irvine, Dept Neurol, Multiple Sclerosis Res Ctr, Inst Immunol, Irvine, CA 92697 USA; [Araujo, Lindsey; Demetriou, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Naidu, Nandita N.; Choudhury, Biswa] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Diego	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, Multiple Sclerosis Res Ctr, Inst Immunol, 250 Sprague Hall, Irvine, CA 92697 USA.	mdemetri@uci.edu		Badin, Dylan/0000-0002-5038-2823; Demetriou, Michael/0000-0002-2224-7798	National Institutes of Health through the NIAID [R01AI053331, R01AI082266, F32AI081456]; Collaborative Multiple Sclerosis Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053331, R01AI082266, F32AI081456] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Collaborative Multiple Sclerosis Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI053331 and R01AI082266 (to M. D.) and F32AI081456 (to A. G.) through the NIAID. This work was also supported by a Collaborative Multiple Sclerosis Research Center award (to M. D.).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Broschat KO, 2002, J BIOL CHEM, V277, P14764, DOI 10.1074/jbc.M201056200; Brynedal B, 2010, J NEUROIMMUNOL, V220, P120, DOI 10.1016/j.jneuroim.2010.01.003; Chen HL, 2009, J BIOL CHEM, V284, P32454, DOI 10.1074/jbc.M109.023630; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian A, 2010, METHOD ENZYMOL, V480, P245, DOI 10.1016/S0076-6879(10)80012-6; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee KY, 2004, FOOD CHEM TOXICOL, V42, P687, DOI 10.1016/j.fct.2003.12.005; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; LEVIN RM, 1961, J LAB CLIN MED, V58, P927; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Ma LL, 2002, J BIOL CHEM, V277, P39343, DOI 10.1074/jbc.M204924200; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Salvatore S, 2000, ALIMENT PHARM THER, V14, P1567, DOI 10.1046/j.1365-2036.2000.00883.x; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; SHOJI A, 1999, CHITIN CHITOSAN RES, V5, P34; Takahashi M, 2009, FOOD CHEM TOXICOL, V47, P462, DOI 10.1016/j.fct.2008.12.002; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wolosker H, 1998, FASEB J, V12, P91, DOI 10.1096/fasebj.12.1.91; Ye ZY, 2004, GLYCOBIOLOGY, V14, P547, DOI 10.1093/glycob/cwh069; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202; Zhang J, 2003, J CELL BIOCHEM, V88, P932, DOI 10.1002/jcb.10444; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	44	74	81	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40133	40141		10.1074/jbc.M111.277814	http://dx.doi.org/10.1074/jbc.M111.277814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965673	Green Published, hybrid			2022-12-27	WOS:000296925700046
J	Insaidoo, FK; Borbulevych, OY; Hossain, M; Santhanagopolan, SM; Baxter, TK; Baker, BM				Insaidoo, Francis K.; Borbulevych, Oleg Y.; Hossain, Moushumi; Santhanagopolan, Sujatha M.; Baxter, Tiffany K.; Baker, Brian M.			Loss of T Cell Antigen Recognition Arising from Changes in Peptide and Major Histocompatibility Complex Protein Flexibility IMPLICATIONS FOR VACCINE DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-REACTIVE CTL; MOLECULAR-DYNAMICS; HLA-B27 SUBTYPES; HUMAN-MELANOMA; BINDING; IMMUNOGENICITY; THERMODYNAMICS; TEMPERATURE; SIMULATION; RECEPTORS	Modification of the primary anchor positions of antigenic peptides to improve binding to major histocompatibility complex (MHC) proteins is a commonly used strategy for engineering peptide-based vaccine candidates. However, such peptide modifications do not always improve antigenicity, complicating efforts to design effective vaccines for cancer and infectious disease. Here we investigated the MART-1(27-35) tumor antigen, for which anchor modification (replacement of the position two alanine with leucine) dramatically reduces or ablates antigenicity with a wide range of T cell clones despite significantly improving peptide binding to MHC. We found that anchor modification in the MART-1(27-35) antigen enhances the flexibility of both the peptide and the HLA-A*0201 molecule. Although the resulting entropic effects contribute to the improved binding of the peptide to MHC, they also negatively impact T cell receptor binding to the peptide.MHC complex. These results help explain how the "anchor-fixing" strategy fails to improve antigenicity in this case, and more generally, may be relevant for understanding the high specificity characteristic of the T cell repertoire. In addition to impacting vaccine design, modulation of peptide and MHC flexibility through changes to antigenic peptides may present an evolutionary strategy for the escape of pathogens from immune destruction.	Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Baker, BM (corresponding author), 251 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	brian-baker@nd.edu	Baker, Brian/B-4584-2009	Baker, Brian/0000-0002-0864-0964	National Institutes of Health from NIGMS [GM067079]; National Science Foundation [MCB0448298]; American Cancer Society [RSG-05-202-01-GMC]; Walther Cancer Research Foundation; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067079] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); Walther Cancer Research Foundation; United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM067079 from the NIGMS (to B. M. B.). This work was also supported by Grant MCB0448298 from the National Science Foundation and Grant RSG-05-202-01-GMC from the American Cancer Society.; Supported by a fellowship from the Walther Cancer Research Foundation.; We thank Cynthia Piepenbrink for outstanding technical assistance and Daniel R. Scott for critical comments on the manuscript. Results shown in this study are derived from work performed at the Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. The Argonne National Laboratory is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; Baxter TK, 2004, J BIOL CHEM, V279, P29175, DOI 10.1074/jbc.M403372200; Binz AK, 2003, BIOCHEMISTRY-US, V42, P4954, DOI 10.1021/bi034077m; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; BRUCCOLERI RE, 1990, BIOPOLYMERS, V29, P1847, DOI 10.1002/bip.360291415; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Czisch M, 1998, J MAGN RESON, V134, P158, DOI 10.1006/jmre.1998.1483; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Derre L, 2007, J IMMUNOL, V179, P7635, DOI 10.4049/jimmunol.179.11.7635; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Fabian H, 2011, FEBS J, V278, P1713, DOI 10.1111/j.1742-4658.2011.08097.x; Fabian H, 2010, ARTHRITIS RHEUM-US, V62, P978, DOI 10.1002/art.27316; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Goddard T. D., 2007, SPARKY 3 113; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kelly AE, 2002, J AM CHEM SOC, V124, P12013, DOI 10.1021/ja026121b; Khan AR, 2000, J IMMUNOL, V164, P6398, DOI 10.4049/jimmunol.164.12.6398; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Petrone PM, 2004, J MOL BIOL, V338, P419, DOI 10.1016/j.jmb.2004.02.039; Phan GQ, 2003, J IMMUNOTHER, V26, P349, DOI 10.1097/00002371-200307000-00007; Piepenbrink KH, 2009, METHOD ENZYMOL, V466, P359, DOI 10.1016/S0076-6879(09)66015-8; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Skipper JCA, 1999, INT J CANCER, V82, P669, DOI 10.1002/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-#; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valmori D, 1998, J IMMUNOL, V160, P1750; Vranken WF, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-20; Yu ZY, 2004, J CLIN INVEST, V114, P551, DOI 10.1172/JCI200421695; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743	41	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40163	40173		10.1074/jbc.M111.283564	http://dx.doi.org/10.1074/jbc.M111.283564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937447	Green Published, hybrid			2022-12-27	WOS:000296925700049
J	Ferrer, T; Cordero-Morales, JF; Arias, M; Ficker, E; Medovoy, D; Perozo, E; Tristani-Firouzi, M				Ferrer, Tania; Cordero-Morales, Julio F.; Arias, Marcelo; Ficker, Eckhard; Medovoy, David; Perozo, Eduardo; Tristani-Firouzi, Martin			Molecular Coupling in the Human ether-a-go-go-related gene-1 (hERG1) K+ Channel Inactivation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNEL; HUMAN INWARD RECTIFIER; C-TYPE INACTIVATION; CARDIAC-ARRHYTHMIA; SELECTIVITY FILTER; ALPHA-HELIX; ACTIVATION; MECHANISM; DYNAMICS; LINKER	Emerging evidence suggests that K+ channel inactivation involves coupling between residues in adjacent regions of the channel. Human ether-a-go-go-related gene-1 (hERG1) K+ channels undergo a fast inactivation gating process that is crucial for maintaining electrical stability in the heart. The molecular mechanisms that drive inactivation in hERG1 channels are unknown. Using alanine scanning mutagenesis, we show that a pore helix residue (Thr-618) that points toward the S5 segment is critical for normal inactivation gating. Amino acid substitutions at position 618 modulate the free energy of inactivation gating, causing enhanced or reduced inactivation. Mutation of an S5 residue that is predicted to be adjacent to Thr-618 (W568L) abolishes inactivation and alters ion selectivity. The introduction of the Thr-618-equivalent residue in Kv1.5 enhances inactivation. Molecular dynamic simulations of the Kv1.2 tetramer reveal van der Waals coupling between hERG1 618- and 568-equivalent residues and a significant increase in interaction energies when threonine is introduced at the 618-equivalent position. We propose that coupling between the S5 segment and pore helix may participate in the inactivation process in hERG1 channels.	[Tristani-Firouzi, Martin] Univ Utah, Sch Med, PCMC, Div Pediat Cardiol, Salt Lake City, UT 84113 USA; [Ferrer, Tania; Arias, Marcelo; Tristani-Firouzi, Martin] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Cordero-Morales, Julio F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Ficker, Eckhard] Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA; [Medovoy, David; Perozo, Eduardo] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; Case Western Reserve University; MetroHealth System; University of Chicago	Tristani-Firouzi, M (corresponding author), Univ Utah, Sch Med, PCMC, Div Pediat Cardiol, Suite 1500,100 N Mario Capecchi Way, Salt Lake City, UT 84113 USA.	mfirouzi@cvrti.utah.edu		Cordero Morales, Julio/0000-0002-6505-5403	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009412] Funding Source: NIH RePORTER; NIBIB NIH HHS [T32 EB009412] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Clarke CE, 2006, J PHYSIOL-LONDON, V573, P291, DOI 10.1113/jphysiol.2006.108332; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P319, DOI 10.1038/nsmb1070; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gajewski C, 2011, P NATL ACAD SCI USA, V108, P3240, DOI 10.1073/pnas.1017097108; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang M, 2005, J PHYSIOL-LONDON, V569, P75, DOI 10.1113/jphysiol.2005.093682; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Liu J, 2002, J GEN PHYSIOL, V120, P723, DOI 10.1085/jgp.20028687; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Panyi G, 2006, J GEN PHYSIOL, V128, P547, DOI 10.1085/jgp.200609644; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piper DR, 2008, CELL PHYSIOL BIOCHEM, V21, P37, DOI 10.1159/000113745; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; Rasmusson RL, 1998, CIRC RES, V82, P739, DOI 10.1161/01.RES.82.7.739; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Stefani E, 1998, METHOD ENZYMOL, V293, P300; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Torres AM, 2003, J BIOL CHEM, V278, P42136, DOI 10.1074/jbc.M212824200; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Wang HZ, 2002, CANCER RES, V62, P4843; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	41	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39091	39099		10.1074/jbc.M111.292060	http://dx.doi.org/10.1074/jbc.M111.292060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21908602	Green Published, hybrid			2022-12-27	WOS:000296759800028
J	Giorgi, L; Bontems, F; Fromant, M; Aubard, C; Blanquet, S; Plateau, P				Giorgi, Laurent; Bontems, Francois; Fromant, Michel; Aubard, Caroline; Blanquet, Sylvain; Plateau, Pierre			RNA-binding Site of Escherichia coli Peptidyl-tRNA Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC-HYDROLYSIS; CRYSTAL-STRUCTURE; PROTEIN; AMINOACYLATION; RIBOSOME; 5'-PHOSPHATE; GROWTH; YAEJ; NMR	In a cell, peptidyl-tRNA molecules that have prematurely dissociated from ribosomes need to be recycled. This work is achieved by an enzyme called peptidyl-tRNA hydrolase. To characterize the RNA-binding site of Escherichia coli peptidyl-tRNA hydrolase, minimalist substrates inspired from tRNA(His) have been designed and produced. Two minisubstrates consist of an N-blocked histidylated RNA minihelix or a small RNA duplex mimicking the acceptor and T psi C stem regions of tRNA(His). Catalytic efficiency of the hydrolase toward these two substrates is reduced by factors of 2 and 6, respectively, if compared with N-acetyl-histidyl-tRNA(His). In contrast, with an N-blocked histidylated microhelix or a tetraloop missing the T psi C arm, efficiency of the hydrolase is reduced 20-fold. NMR mapping of complex formation between the hydrolase and the small RNA duplex indicates amino acid residues sensitive to RNA binding in the following: (i) the enzyme active site region; (ii) the helix-loop covering the active site; (iii) the region including Leu-95 and the bordering residues 111-117, supposed to form the boundary between the tRNA core and the peptidyl-CCA moiety-binding sites; (iv) the region including Lys-105 and Arg-133, two residues that are considered able to clamp the 5'-phosphate of tRNA, and (v) the positively charged C-terminal helix (residues 180-193). Functional value of these interactions is assessed taking into account the catalytic properties of various engineered protein variants, including one in which the C-terminal helix was simply subtracted. A strong role of Lys-182 in helix binding to the substrate is indicated.	[Giorgi, Laurent; Fromant, Michel; Aubard, Caroline; Blanquet, Sylvain; Plateau, Pierre] Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France; [Bontems, Francois] CNRS UPR2301, Ctr Rech Gif, Inst Chim Subst Nat, F-91190 Gif Sur Yvette, France; [Bontems, Francois] Ecole Polytech, Antenne Inst Chim Subst Nat, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut Polytechnique de Paris	Plateau, P (corresponding author), Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France.	pierre.plateau@polytechnique.edu		launay, caroline/0000-0002-6587-6631				ATHERLY AG, 1972, NATURE-NEW BIOL, V240, P245, DOI 10.1038/newbio240245a0; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; CUZIN F, 1967, P NATL ACAD SCI USA, V58, P2079, DOI 10.1073/pnas.58.5.2079; DARDEL F, 1994, COMPUT APPL BIOSCI, V10, P273; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; DUTKA S, 1993, NUCLEIC ACIDS RES, V21, P4025, DOI 10.1093/nar/21.17.4025; Ferri-Fioni ML, 2006, J BIOL CHEM, V281, P27575, DOI 10.1074/jbc.M605860200; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; FRANCKLYN C, 1992, SCIENCE, V255, P1121, DOI 10.1126/science.1546312; FRANCKLYN C, 1990, P NATL ACAD SCI USA, V87, P8655, DOI 10.1073/pnas.87.21.8655; Fromant M, 2003, NUCLEIC ACIDS RES, V31, P3227, DOI 10.1093/nar/gkg428; Fromant M, 2000, BIOCHEMISTRY-US, V39, P4062, DOI 10.1021/bi9923297; Fromant M, 1999, BIOCHEMISTRY-US, V38, P4982, DOI 10.1021/bi982657r; Giorgi L, 2011, J MOL BIOL, V412, P619, DOI 10.1016/j.jmb.2011.06.025; Goodall JJ, 2004, BIOCHEMISTRY-US, V43, P4583, DOI 10.1021/bi0302200; Guillon L, 2005, BIOCHEMISTRY-US, V44, P15594, DOI 10.1021/bi051514j; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Jenkins BD, 2001, EMBO J, V20, P872, DOI 10.1093/emboj/20.4.872; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; KOSSEL H, 1968, J MOL BIOL, V35, P539, DOI 10.1016/S0022-2836(68)80013-0; Menez J, 2002, MOL MICROBIOL, V45, P123, DOI 10.1046/j.1365-2958.2002.02992.x; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; MUSIERFORSYTH K, 1993, FASEB J, V7, P282, DOI 10.1096/fasebj.7.2.7680012; Ostheimer GJ, 2005, J MOL BIOL, V345, P51, DOI 10.1016/j.jmb.2004.10.032; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; Pulavarti SVSRK, 2008, J MOL BIOL, V378, P165, DOI 10.1016/j.jmb.2008.02.027; Rosas-Sandoval G, 2002, P NATL ACAD SCI USA, V99, P16707, DOI 10.1073/pnas.222659199; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmitt E, 1997, EMBO J, V16, P4760, DOI 10.1093/emboj/16.15.4760; Schmitt E, 1997, PROTEINS, V28, P135, DOI 10.1002/(SICI)1097-0134(199705)28:1<135::AID-PROT14>3.3.CO;2-0; SCHULMAN LH, 1975, J BIOL CHEM, V250, P542; Selvaraj M, 2007, J MOL BIOL, V372, P186, DOI 10.1016/j.jmb.2007.06.053; SHI JP, 1992, BIOCHEMISTRY-US, V31, P4931, DOI 10.1021/bi00136a002; Snoussi K, 2001, J MOL BIOL, V309, P139, DOI 10.1006/jmbi.2001.4618; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	37	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39585	39594		10.1074/jbc.M111.281840	http://dx.doi.org/10.1074/jbc.M111.281840			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930710	Green Published, hybrid			2022-12-27	WOS:000296759800075
J	Jang, HD; Shin, JH; Park, DR; Hong, JH; Yoon, K; Ko, R; Ko, CY; Kim, HS; Jeong, D; Kim, N; Lee, SY				Jang, Hyun Duk; Shin, Ji Hye; Park, Doo Ri; Hong, Jin Hee; Yoon, Kwiyeom; Ko, Ryeojin; Ko, Chang-Yong; Kim, Han-Sung; Jeong, Daewon; Kim, Nacksung; Lee, Soo Young			Inactivation of Glycogen Synthase Kinase-3 beta Is Required for Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; BONE HOMEOSTASIS; RANKL; GSK3; EXPRESSION; NFATC1; KINASE; MICE; PHOSPHORYLATION; CALCINEURIN	Glycogen synthase kinase-3 beta (GSK-3 beta is a serine/threonine kinase originally identified as a regulator of glycogen deposition. Although the role of GSK-3 beta in osteoblasts is well characterized as a negative regulator of beta-catenin, its effect on osteoclast formation remains largely unidentified. Here, we show that the GSK-3 beta inactivation upon receptor activator of NF-kappa B ligand (RANKL) stimulation is crucial for osteoclast differentiation. Regulation of GSK-3 beta activity in bone marrow macrophages by retroviral expression of the constitutively active GSK-3 beta (GSK3 beta-S9A) mutant inhibits RANKL-induced osteoclastogenesis, whereas expression of the catalytically inactive GSK-3 beta (GSK3 beta-K85R) or small interfering RNA (siRNA)-mediated GSK-3 beta silencing enhances osteoclast formation. Pharmacological inhibition of GSK-3 beta further confirmed the negative role of GSK-3 beta in osteoclast formation. We also show that overexpression of the GSK3 beta-S9A mutant in bone marrow macrophages inhibits RANKL-mediated NFATc1 induction and Ca2+ oscillations. Remarkably, transgenic mice expressing the GSK3 beta-S9A mutant show an osteopetrotic phenotype due to impaired osteoclast differentiation. Further, osteoclast precursor cells from the transgenic mice show defects in expression and nuclear localization of NFATc1. These findings demonstrate a novel role for GSK-3 beta in the regulation of bone remodeling through modulation of NFATc1 in RANKL signaling.	[Lee, Soo Young] Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Bioinspired Sci, Ctr Cell Signaling & Drug Discovery Res,Dept Life, Seoul 120750, South Korea; [Hong, Jin Hee] Korea Univ, Ctr Cell Dynam, Seoul 136701, South Korea; [Hong, Jin Hee] Korea Univ, Dept Phys, Seoul 136701, South Korea; [Ko, Chang-Yong; Kim, Han-Sung] Yonsei Univ, Dept Biomed Engn, Coll Hlth Sci, Inst Med Engn, Wonju 220701, South Korea; [Jeong, Daewon] Yeungnam Univ, Coll Med, Dept Microbiol, Taegu 705717, South Korea; [Jeong, Daewon] Yeungnam Univ, Coll Med, Aging Associated Dis Res Ctr, Taegu 705717, South Korea; [Kim, Nacksung] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Kwangju 501746, South Korea	Ewha Womans University; Korea University; Korea University; Yonsei University; Yeungnam University; Yeungnam University; Chonnam National University	Lee, SY (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Bioinspired Sci, Ctr Cell Signaling & Drug Discovery Res,Dept Life, Seoul 120750, South Korea.	leesy@ewha.ac.kr			National Research Foundation of Korea (NRF); Korea Government (Ministry of Education, Science, and Technology) [R0A-2008-000-20001-0, R31-2008-000-10010-0, 2011-0006244, 2010-0020577]; Ewha Womans University; Brain Korea 21 Project	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Government (Ministry of Education, Science, and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ewha Womans University; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korea Government (Ministry of Education, Science, and Technology; Grants R0A-2008-000-20001-0; R31-2008-000-10010-0; 2011-0006244; and 2010-0020577).; Supported by Research Professor Grant 2010 of Ewha Womans University.; Supported by the second stage of the Brain Korea 21 Project.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hikata T, 2009, BLOOD, V113, P2202, DOI 10.1182/blood-2008-06-162594; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim JH, 2010, CELL SIGNAL, V22, P1341, DOI 10.1016/j.cellsig.2010.05.001; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; REDDY SV, 1995, J BONE MINER RES, V10, P601; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Suda T, 1997, METHOD ENZYMOL, V282, P223; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Yoon K, 2008, CELL DEATH DIFFER, V15, P730, DOI 10.1038/sj.cdd.4402304	39	66	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39043	39050		10.1074/jbc.M111.256768	http://dx.doi.org/10.1074/jbc.M111.256768			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21949120	hybrid, Green Published			2022-12-27	WOS:000296759800023
J	Sugimoto, N; Yugawa, T; Iizuka, M; Kiyono, T; Fujita, M				Sugimoto, Nozomi; Yugawa, Takashi; Iizuka, Masayoshi; Kiyono, Tohru; Fujita, Masatoshi			Chromatin Remodeler Sucrose Nonfermenting 2 Homolog (SNF2H) Is Recruited onto DNA Replication Origins through Interaction with Cdc10 Protein-dependent Transcript 1 (Cdt1) and Promotes Pre-replication Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MCM HETEROHEXAMERIC COMPLEXES; DROSOPHILA FOLLICLE CELLS; HBO1 HISTONE ACETYLASE; LICENSING FACTOR CDT1; ACETYLTRANSFERASE HBO1; CHROMOSOME INSTABILITY; WILLIAMS-SYNDROME; MAMMALIAN-CELLS; DORMANT ORIGINS; GENE-EXPRESSION	From late mitosis to the G(1) phase of the cell cycle, ORC, CDC6, and Cdt1 form the machinery necessary to load MCM2-7 complexes onto DNA. Here, we show that SNF2H, a member of the ATP-dependent chromatin-remodeling complex, is recruited onto DNA replication origins in human cells in a Cdt1-dependent manner and positively regulates MCM loading. SNF2H physically interacted with Cdt1. ChIP assays indicated that SNF2H associates with replication origins specifically during the G(1) phase. Binding of SNF2H at origins was decreased by Cdt1 silencing and, conversely, enhanced by Cdt1 overexpression. Furthermore, SNF2H silencing prevented MCM loading at origins and moderately inhibited S phase progression. Although neither SNF2H overexpression nor SNF2H silencing appeared to impact rereplication induced by Cdt1 overexpression, Cdt1-induced checkpoint activation was inhibited by SNF2H silencing. Collectively, these data suggest that SNF2H may promote MCM loading at DNA replication origins via interaction with Cdt1 in human cells. Because efficient loading of excess MCM complexes is thought to be required for cells to tolerate replication stress, Cdt1- and SNF2H-mediated promotion of MCM loading may be biologically relevant for the regulation of DNA replication.	[Sugimoto, Nozomi; Fujita, Masatoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Cellular Biochem, Higashi Ku, Fukuoka 8218582, Japan; [Yugawa, Takashi; Kiyono, Tohru] Natl Canc Ctr, Div Virol, Chuou Ku, Tokyo 1040045, Japan; [Iizuka, Masayoshi] Teikyo Univ Sch Med, Dept Biochem, Itabashi Ku, Tokyo 1738605, Japan	Kyushu University; National Cancer Center - Japan	Fujita, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Cellular Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8218582, Japan.	mfujita@phar.kyushu-u.ac.jp	Kiyono, Tohru/H-5834-2011	Sugimoto, Nozomi/0000-0002-4313-5728; Fujita, Masatoshi/0000-0001-6617-2452	Ministry of Education, Culture, Sports, Science and Technology of Japan; Promotion and Mutual Aid Corporation for Private Schools of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23590375, 09J07233, 22590276] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. F. and M. I.) and a grant from the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan (to M. I.).; Supported by a Japan Society for the Promotion of Science research fellowship.	Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Alexiadis V, 1998, EMBO J, V17, P3428, DOI 10.1093/emboj/17.12.3428; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; Danis E, 2004, NAT CELL BIOL, V6, P721, DOI 10.1038/ncb1149; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Fujita M, 1998, J BIOL CHEM, V273, P17095, DOI 10.1074/jbc.273.27.17095; Fujita M, 1997, J BIOL CHEM, V272, P10928; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gerhardt J, 2006, MOL CELL BIOL, V26, P7731, DOI 10.1128/MCB.01392-06; Ghosh M, 2006, MOL CELL BIOL, V26, P5270, DOI 10.1128/MCB.02137-05; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Han JH, 2010, GENE DEV, V24, P1485, DOI 10.1101/gad.1887310; Hartl T, 2007, CHROMOSOMA, V116, P197, DOI 10.1007/s00412-006-0092-2; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Iizuka M, 2008, MOL CELL BIOL, V28, P140, DOI 10.1128/MCB.00662-07; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Kemp MG, 2005, NUCLEIC ACIDS RES, V33, P325, DOI 10.1093/nar/gki177; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Lazzaro MA, 2001, J NEUROCHEM, V77, P1145, DOI 10.1046/j.1471-4159.2001.00324.x; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee J, 2010, MOL CELL, V40, P345, DOI 10.1016/j.molcel.2010.10.033; Lucas I, 2007, EMBO REP, V8, P770, DOI 10.1038/sj.embor.7401026; MacCallum DE, 2002, MOL BIOL CELL, V13, P25, DOI 10.1091/mbc.01-09-0441; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Orr SJ, 2010, ONCOGENE, V29, P3803, DOI 10.1038/onc.2010.138; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Rampakakis E, 2009, NUCLEIC ACIDS RES, V37, P5714, DOI 10.1093/nar/gkp617; Schaarschmidt D, 2002, NUCLEIC ACIDS RES, V30, P4176, DOI 10.1093/nar/gkf532; Shima N, 2007, CELL CYCLE, V6, P1135, DOI 10.4161/cc.6.10.4250; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Sugimoto N, 2008, MOL BIOL CELL, V19, P1007, DOI 10.1091/mbc.E07-09-0859; Sugimoto N, 2009, J CELL SCI, V122, P1184, DOI 10.1242/jcs.041889; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zhou J, 2005, CELL CYCLE, V4, P889, DOI 10.4161/cc.4.7.1823; Zhou J, 2005, EMBO J, V24, P1406, DOI 10.1038/sj.emboj.7600609	74	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39200	39210		10.1074/jbc.M111.256123	http://dx.doi.org/10.1074/jbc.M111.256123			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937426	Green Published, hybrid			2022-12-27	WOS:000296759800039
J	Tang, YS; Khan, RA; Zhang, YH; Xiao, SH; Wang, M; Hansen, DK; Jayaram, HN; Antony, AC				Tang, Ying-Sheng; Khan, Rehana A.; Zhang, Yonghua; Xiao, Suhong; Wang, Mu; Hansen, Deborah K.; Jayaram, Hiremagalur N.; Antony, Asok C.			Incrimination of Heterogeneous Nuclear Ribonucleoprotein E1 (hnRNP-E1) as a Candidate Sensor of Physiological Folate Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; POLY(C) BINDING-PROTEIN; 3' UNTRANSLATED REGION; NEURAL-TUBE DEFECTS; KH-DOMAIN PROTEINS; UP-REGULATION; 3'-UNTRANSLATED REGION; IN-VITRO; RADIAL GROWTH; TRANS-FACTOR	The mechanism underlying the sensing of varying degrees of physiological folate deficiency, prior to adaptive optimization of cellular folate uptake through the translational up-regulation of folate receptors (FR) is unclear. Because homocysteine, which accumulates intracellularly during folate deficiency, stimulated interactions between heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) and an 18-base FR-alpha mRNA cis-element that led to increased FR biosynthesis and net up-regulation of FR at cell surfaces, hnRNP-E1 was a plausible candidate sensor of folate deficiency. Accordingly, using purified components, we evaluated the physiological basis whereby L-homocysteine triggered these RNA-protein interactions to stimulate FR biosynthesis. L-Homocysteine induced a concentration-dependent increase in RNA-protein binding affinity throughout the range of physiological folate deficiency, which correlated with a proportionate increase in translation of FR in vitro and in cultured human cells. Targeted reduction of newly synthesized hnRNP-E1 proteins by siRNA to hnRNP-E1 mRNA reduced both constitutive and L-homocysteine-induced rates of FR biosynthesis. Furthermore, L-homocysteine covalently bound hnRNP-E1 via multiple protein-cysteine-S-S-homocysteine mixed disulfide bonds within K-homology domains known to interact with mRNA. These data suggest that a concentration-dependent, sequential disruption of critical cysteine-S-S-cysteine bonds by covalently bound L-homocysteine progressively unmasks an underlying RNA-binding pocket in hnRNP-E1 to optimize interaction with FR-alpha mRNA cis-element preparatory to FR up-regulation. Collectively, such data incriminate hnRNP-E1 as a physiologically relevant, sensitive, cellular sensor of folate deficiency. Because diverse mammalian and viral mRNAs also interact with this RNA-binding domain with functional consequences to their protein expression, homocysteinylated hnRNP-E1 also appears well positioned to orchestrate a novel, nutrition-sensitive (homocysteine-responsive), posttranscriptional RNA operon in folate-deficient cells.	[Tang, Ying-Sheng; Khan, Rehana A.; Zhang, Yonghua; Xiao, Suhong; Antony, Asok C.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Wang, Mu; Jayaram, Hiremagalur N.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hansen, Deborah K.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Jayaram, Hiremagalur N.; Antony, Asok C.] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Food & Drug Administration (FDA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Antony, AC (corresponding author), 980 W Walnut St,RIII C321B, Indianapolis, IN 46202 USA.	aantony@iupui.edu			National Institutes of Health [CA120843, HD39295]; Veterans Affairs Merit Review Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039295] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA120843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120843 and HD39295 (to A. C. A.). This work was also supported by a Veterans Affairs Merit Review Award (to A. C. A. and H. N. J.).	Antony A. C., 2009, HEMATOLOGY BASIC PRI, P491; Antony AC, 2004, J CLIN INVEST, V113, P285, DOI 10.1172/JCI200411548; Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441; ANTONY AC, 1987, J CLIN INVEST, V80, P1618, DOI 10.1172/JCI113249; ANTONY AC, 1981, J BIOL CHEM, V256, P9684; Antony AC, 2000, TERATOLOGY, V62, P42, DOI 10.1002/1096-9926(200007)62:1&lt;42::AID-TERA9&gt;3.0.CO;2-U; Antony AC, 2007, AM J CLIN NUTR, V85, p598S, DOI 10.1093/ajcn/85.2.598S; Barbato JC, 2007, ARTERIOSCL THROM VAS, V27, P49, DOI 10.1161/01.ATV.0000251536.49581.8a; Barber RC, 1998, AM J MED GENET, V76, P310, DOI 10.1002/(SICI)1096-8628(19980401)76:4<310::AID-AJMG6>3.0.CO;2-T; Beaudin AE, 2009, BIRTH DEFECTS RES A, V85, P274, DOI 10.1002/bdra.20553; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Bolton JA, 1999, GENE, V230, P215, DOI 10.1016/S0378-1119(99)00081-5; Budy B, 2006, ARCH BIOCHEM BIOPHYS, V446, P119, DOI 10.1016/j.abb.2005.12.014; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chkheidze AN, 1999, MOL CELL BIOL, V19, P4572; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Czyzyk-Krzeska MF, 1999, BLOOD, V93, P2111, DOI 10.1182/blood.V93.6.2111.406k24_2111_2120; CzyzykKrzeska MF, 1996, J BIOL CHEM, V271, P3293, DOI 10.1074/jbc.271.6.3293; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; Dobbyn HC, 2008, ONCOGENE, V27, P1167, DOI 10.1038/sj.onc.1210723; Ferguson SA, 2005, BIRTH DEFECTS RES A, V73, P249, DOI 10.1002/bdra.20111; Fujimura K, 2009, BBA-MOL CELL RES, V1793, P878, DOI 10.1016/j.bbamcr.2009.02.002; Garcia ML, 2003, J CELL BIOL, V163, P1011, DOI 10.1083/jcb.200308159; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Hajjar KA, 1998, J BIOL CHEM, V273, P9987, DOI 10.1074/jbc.273.16.9987; Hansen DK, 2003, BIRTH DEFECTS RES A, V67, P475, DOI 10.1002/bdra.10072; Heil SG, 1999, EUR J HUM GENET, V7, P393, DOI 10.1038/sj.ejhg.5200305; HENDERSON GI, 1995, J LAB CLIN MED, V126, P184; Holcik M, 2001, NAT REV MOL CELL BIO, V2, P550, DOI 10.1038/35080103; Jacobsen DW, 2005, CLIN CHEM LAB MED, V43, P1076, DOI 10.1515/CCLM.2005.188; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Majors AK, 2002, ARTERIOSCL THROM VAS, V22, P1354, DOI 10.1161/01.ATV.0000023899.93940.7C; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; Motulsky H., 2004, FITTING MODELS BIOL, P296; MUMA NA, 1991, J NEUROCYTOL, V20, P844, DOI 10.1007/BF01191735; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; Rao MV, 2003, J CELL BIOL, V163, P1021, DOI 10.1083/jcb.200308076; RONDON IJ, 1991, J BIOL CHEM, V266, P16594; Saitsu H, 2003, DEV DYNAM, V226, P112, DOI 10.1002/dvdy.10203; SCHLAEPFER WW, 1990, J NEUROSCI RES, V25, P39, DOI 10.1002/jnr.490250106; Schlotz W, 2010, J CHILD PSYCHOL PSYC, V51, P594, DOI 10.1111/j.1469-7610.2009.02182.x; Sengupta S, 2001, J BIOL CHEM, V276, P46896, DOI 10.1074/jbc.M108451200; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Stover PJ., 2010, FOLATE HLTH DIS, P49; SUN XL, 1995, J CLIN INVEST, V96, P1535, DOI 10.1172/JCI118192; Sun XL, 1996, J BIOL CHEM, V271, P25539; Thyagarajan A, 2004, J BIOL CHEM, V279, P49680, DOI 10.1074/jbc.M408915200; Thyagarajan A, 2008, BRAIN RES, V1189, P33, DOI 10.1016/j.brainres.2007.11.012; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; WANG XM, 1995, MOL CELL BIOL, V15, P1769; Woolaway K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-28; Xiao SH, 2005, BIRTH DEFECTS RES A, V73, P6, DOI 10.1002/bdra.20105; Xiao XL, 2001, J BIOL CHEM, V276, P41510, DOI 10.1074/jbc.M106824200; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Yu J, 2001, MOL CELL BIOL, V21, P5879, DOI 10.1128/MCB.21.17.5879-5888.2001; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969	76	22	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39100	39115		10.1074/jbc.M111.230938	http://dx.doi.org/10.1074/jbc.M111.230938			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930702	Green Published, hybrid			2022-12-27	WOS:000296759800029
J	Ehira, S; Ohmori, M				Ehira, Shigeki; Ohmori, Masayuki			NrrA, a Nitrogen-regulated Response Regulator Protein, Controls Glycogen Catabolism in the Nitrogen-fixing Cyanobacterium Anabaena sp Strain PCC 7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGMA-FACTOR; HETEROCYST DIFFERENTIATION; PCC-7120; GENE; EXPRESSION; HETR; INDUCTION; FIXATION; PCC-6803	Anabaena sp. strain PCC 7120 is a filamentous cyanobacterium in which certain vegetative cells differentiate into heterocysts that are specialized cells for nitrogen fixation. Heterocysts are unable to carry out photosynthesis and depend on vegetative cells for carbohydrate to generate ATP and reductants required for nitrogen fixation. Thus, carbohydrate metabolism is very important for nitrogen fixation in the filamentous cyanobacteria; however, its regulatory mechanism remains unknown. In the present study, a nitrogen-regulated response regulator NrrA, which is a transcriptional regulator involved in heterocyst differentiation, was shown to control glycogen catabolism. The transcript levels of genes involved in glycogen catabolism, such as glgP1 and xfp-gap1-pyk1-talB operon, were decreased by the nrrA disruption. Moreover, glycogen accumulation and depression of nitrogenase activities were observed in this disruptant. NrrA bound specifically to the promoter region of glgP1, encoding a glycogen phosphorylase, and to the promoter region of sigE, encoding a group 2 sigma factor of RNA polymerase. SigE activated expression of the xfp operon, encoding enzymes of glycolysis and the pentose phosphate pathway. It is concluded that NrrA controls not only heterocyst differentiation but also glycogen catabolism in Anabaena sp. strain PCC 7120.	[Ehira, Shigeki; Ohmori, Masayuki] Chuo Univ, Dept Biol Sci, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan	Chuo University	Ohmori, M (corresponding author), Chuo Univ, Dept Biol Sci, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	ohmori@bio.chuo-u.ac.jp	Ehira, Shigeki/D-6081-2013	Ehira, Shigeki/0000-0002-4121-7367	Japan Science and Technology Agency; Japan Society for the Promotion of Science [23603005]; Japan Science Society	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society	This work was supported by the Adaptable and Seamless Technology Transfer Program from the Japan Science and Technology Agency (to S. E.), Grant-in-aid for Scientific Research (B) 23603005 from the Japan Society for the Promotion of Science (to S. E.), and the Sasakawa Scientific Research Grant from the Japan Science Society (to S. E.).	Aldea MR, 2007, J BACTERIOL, V189, P8392, DOI 10.1128/JB.00821-07; Azuma M, 2011, PLANT CELL PHYSIOL, V52, P404, DOI 10.1093/pcp/pcq204; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; Cumino AC, 2007, PLANT PHYSIOL, V143, P1385, DOI 10.1104/pp.106.091736; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Ehira S, 2006, J BACTERIOL, V188, P8520, DOI 10.1128/JB.01314-06; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; ERNST A, 1990, J BACTERIOL, V172, P748, DOI 10.1128/jb.172.2.748-755.1990; FAY P, 1976, APPL ENVIRON MICROB, V31, P376, DOI 10.1128/AEM.31.3.376-379.1976; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; FORCHHAMMER K, 1995, J BACTERIOL, V177, P2033, DOI 10.1128/jb.177.8.2033-2040.1995; Herrero A, 2004, FEMS MICROBIOL REV, V28, P469, DOI 10.1016/j.femsre.2004.04.003; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; Lopez-Igual R, 2010, J BACTERIOL, V192, P5526, DOI 10.1128/JB.00776-10; Marcozzi C, 2009, ARCH MICROBIOL, V191, P255, DOI 10.1007/s00203-008-0450-y; Mella-Herrera RA, 2011, J BACTERIOL, V193, P1823, DOI 10.1128/JB.01472-10; Muro-Pastor AM, 2006, FEMS MICROBIOL LETT, V256, P171, DOI 10.1111/j.1574-6968.2006.00136.x; Muro-Pastor AM, 2001, J BACTERIOL, V183, P1090, DOI 10.1128/JB.183.3.1090-1095.2001; Olmedo-Verd E, 2006, J BACTERIOL, V188, P6694, DOI 10.1128/JB.00509-06; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; Osanai T, 2009, P NATL ACAD SCI USA, V106, P6860, DOI 10.1073/pnas.0810040106; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Suzuki E, 2010, APPL ENVIRON MICROB, V76, P3153, DOI 10.1128/AEM.00397-08; Valladares A, 2007, J BACTERIOL, V189, P4425, DOI 10.1128/JB.00220-07; Vargas WA, 2011, PLANTA, V233, P153, DOI 10.1007/s00425-010-1288-5; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; Yoshimura H, 2007, DNA RES, V14, P13, DOI 10.1093/dnares/dsm003	31	22	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38109	38114		10.1074/jbc.M111.289124	http://dx.doi.org/10.1074/jbc.M111.289124			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21926170	Green Published, hybrid			2022-12-27	WOS:000296594200024
J	Liu, S; Yan, SJ; Lee, YF; Liu, NC; Ting, HJ; Li, GH; Wu, Q; Chen, LM; Chang, CS				Liu, Su; Yan, Shian-Jang; Lee, Yi-Fen; Liu, Ning-Chun; Ting, Huei-Ju; Li, Gonghui; Wu, Qiao; Chen, Lu-Min; Chang, Chawnshang			Testicular Nuclear Receptor 4 (TR4) Regulates UV Light-induced Responses via Cockayne Syndrome B Protein-mediated Transcription-coupled DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ORPHAN RECEPTOR-4; CELLULAR REPAIR; GENE-EXPRESSION; MICE; INDUCTION; 8-HYDROXYADENINE; DEGENERATION; DEFICIENT; MUTATIONS	UV irradiation is one of the major external insults to cells and can cause skin aging and cancer. In response to UV light-induced DNA damage, the nucleotide excision repair (NER) pathways are activated to remove DNA lesions. We report here that testicular nuclear receptor 4 (TR4), a member of the nuclear receptor family, modulates DNA repair specifically through the transcription-coupled (TC) NER pathway but not the global genomic NER pathway. The level of Cockayne syndrome B protein (CSB), a member of the TC-NER pathway, is 10-fold reduced in TR4-deficient mouse tissues, and TR4 directly regulates CSB at the transcriptional level. Moreover, restored CSB expression rescues UV hypersensitivity of TR4-deficient cells. Together, these results indicate that TR4 modulates UV sensitivity by promoting the TC-NER DNA repair pathway through transcriptional regulation of CSB. These results may lead to the development of new treatments for UV light-sensitive syndromes, skin cancer, and aging.	[Liu, Su; Yan, Shian-Jang; Lee, Yi-Fen; Liu, Ning-Chun; Ting, Huei-Ju; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA; [Liu, Su; Yan, Shian-Jang; Lee, Yi-Fen; Liu, Ning-Chun; Ting, Huei-Ju; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA; [Wu, Qiao] Xiamen Univ, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China; [Chen, Lu-Min] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	University of Rochester; University of Rochester; Xiamen University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, CS (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA.	chang@urmc.rochester.edu	Wu, Q/G-4646-2010	Chang, Chawnshang/0000-0001-8510-3516; Ting, Huei-Ju/0000-0003-3709-5755	National Institutes of Health [DK073414, CA127548]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; NATIONAL CANCER INSTITUTE [R01CA127548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan Department of Health Clinical Trial and Research Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK073414 and CA127548. This work was also supported by the George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial and Research Center of Excellence Grant DOH99-TD-B-111-004 (to the China Medical University, Taiwan).	Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Balajee AS, 2000, ONCOGENE, V19, P477, DOI 10.1038/sj.onc.1203372; Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005; Christmann M, 2006, NUCLEIC ACIDS RES, V34, P6530, DOI 10.1093/nar/gkl895; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101; Corona R, 1996, Ann Ist Super Sanita, V32, P37; Filippi S, 2008, EMBO J, V27, P2545, DOI 10.1038/emboj.2008.180; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Gorgels TGMF, 2007, MOL CELL BIOL, V27, P1433, DOI 10.1128/MCB.01037-06; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Kim E, 2005, BIOCHEM BIOPH RES CO, V328, P85, DOI 10.1016/j.bbrc.2004.12.146; Kim E, 2007, BIOCHEM BIOPH RES CO, V361, P323, DOI 10.1016/j.bbrc.2007.06.168; Kim E, 2011, DIABETES, V60, P1493, DOI 10.2337/db10-0393; Laposa RR, 2007, P NATL ACAD SCI USA, V104, P1389, DOI 10.1073/pnas.0610619104; Lee YF, 2011, AM J PHYSIOL-ENDOC M, V301, pE91, DOI 10.1152/ajpendo.00701.2010; Li G, 2008, ENDOCRINOLOGY, V149, P3490, DOI 10.1210/en.2008-0121; Licht CL, 2003, AM J HUM GENET, V73, P1217, DOI 10.1086/380399; Liu NC, 2007, DIABETES, V56, P2901, DOI 10.2337/db07-0359; Liu NC, 2009, ENDOCRINE, V36, P211, DOI 10.1007/s12020-009-9220-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallery DL, 1998, AM J HUM GENET, V62, P77, DOI 10.1086/301686; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Plosky B, 2002, DNA REPAIR, V1, P683, DOI 10.1016/S1568-7864(02)00075-7; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Spivak G, 2006, METHOD ENZYMOL, V408, P223, DOI 10.1016/S0076-6879(06)08014-1; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Tanabe O, 2007, GENE DEV, V21, P2832, DOI 10.1101/gad.1593307; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai NP, 2009, BBA-GENE REGUL MECH, V1789, P734, DOI 10.1016/j.bbagrm.2009.09.010; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; Tuo JS, 2002, J BIOL CHEM, V277, P30832, DOI 10.1074/jbc.M204814200; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Xie S, 2009, P NATL ACAD SCI USA, V106, P13353, DOI 10.1073/pnas.0905724106; Yang Y, 2003, J BIOL CHEM, V278, P7709, DOI 10.1074/jbc.M207116200; Young WJ, 1997, J BIOL CHEM, V272, P3109, DOI 10.1074/jbc.272.5.3109; Zhang YQ, 2007, MOL ENDOCRINOL, V21, P908, DOI 10.1210/me.2006-0219; Zhou XE, 2011, J BIOL CHEM, V286, P2877, DOI 10.1074/jbc.M110.168740	44	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38103	38108		10.1074/jbc.M111.259523	http://dx.doi.org/10.1074/jbc.M111.259523			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21918225	hybrid, Green Published			2022-12-27	WOS:000296594200023
J	Suttisansanee, U; Lau, K; Lagishetty, S; Rao, KN; Swaminathan, S; Sauder, JM; Burley, SK; Honek, JF				Suttisansanee, Uthaiwan; Lau, Kelvin; Lagishetty, Satyanarayana; Rao, Krishnamurthy N.; Swaminathan, Subramanyam; Sauder, J. Michael; Burley, Stephen K.; Honek, John F.			Structural Variation in Bacterial Glyoxalase I Enzymes INVESTIGATION OF THE METALLOENZYME GLYOXALASE I FROM CLOSTRIDIUM ACETOBUTYLICUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE PLASMODIUM-FALCIPARUM; ACTIVE-SITE STRUCTURE; ESCHERICHIA-COLI; IMMUNOCHEMICAL CHARACTERIZATION; CRYSTALLOGRAPHIC ANALYSIS; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; GENE DUPLICATION; METAL-BINDING; PROTEIN	The glyoxalase system catalyzes the conversion of toxic, metabolically produced alpha-ketoaldehydes, such as methylglyoxal, into their corresponding nontoxic 2-hydroxycarboxylic acids, leading to detoxification of these cellular metabolites. Previous studies on the first enzyme in the glyoxalase system, glyoxalase I (GlxI), from yeast, protozoa, animals, humans, plants, and Gram-negative bacteria, have suggested two metal activation classes, Zn2+ and non-Zn2+ activation. Here, we report a biochemical and structural investigation of the GlxI from Clostridium acetobutylicum, which is the first GlxI enzyme from Gram-positive bacteria that has been fully characterized as to its three-dimensional structure and its detailed metal specificity. It is a Ni2+/Co2+-activated enzyme, in which the active site geometry forms an octahedral coordination with one metal atom, two water molecules, and four metal-binding ligands, although its inactive Zn2+-bound form possesses a trigonal bipyramidal geometry with only one water molecule liganded to the metal center. This enzyme also possesses a unique dimeric molecular structure. Unlike other small homodimeric GlxI where two active sites are located at the dimeric interface, the C. acetobutylicum dimeric GlxI enzyme also forms two active sites but each within single subunits. Interestingly, even though this enzyme possesses a different dimeric structure from previously studied GlxI, its metal activation characteristics are consistent with properties of other GlxI. These findings indicate that metal activation profiles in this class of enzyme hold true across diverse quaternary structure arrangements.	[Sauder, J. Michael; Burley, Stephen K.] Eli Lilly & Co, San Diego, CA 92121 USA; [Suttisansanee, Uthaiwan; Lau, Kelvin; Honek, John F.] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Lagishetty, Satyanarayana; Rao, Krishnamurthy N.; Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Eli Lilly; University of Waterloo; United States Department of Energy (DOE); Brookhaven National Laboratory	Burley, SK (corresponding author), Eli Lilly & Co, San Diego, CA 92121 USA.	sburley@sgxpharma.com; jhonek@uwaterloo.ca	Suttisansanee, Uthaiwan/GRR-1655-2022; Lau, Kelvin/M-2639-2019	Lau, Kelvin/0000-0002-9040-7597; Sauder, J Michael/0000-0002-0254-4955; Honek, John/0000-0002-4035-4538; Lagishetty, Satya/0000-0002-5329-1257; Suttisansanee, Uthaiwan/0000-0001-5887-6329; Burley, Stephen K./0000-0002-2487-9713	National Institutes of Health from NIGMS [GM074945]; Department of Energy [DEAC02-98CH10886]; Brookhaven National Laboratory; Natural Sciences and Engineering Research Council of Canada; University of Waterloo (Ontario, Canada); Government of Thailand; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074945] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); Brookhaven National Laboratory(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Waterloo (Ontario, Canada); Government of Thailand; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074945 (U54 Award) from NIGMS (to the New York-Structural Genomix Research Consortium under Department of Energy Prime Contract DEAC02-98CH10886 with Brookhaven National Laboratory; principal investigator, S. K. B.). This work was also supported by the Natural Sciences and Engineering Research Council of Canada, University of Waterloo (Ontario, Canada), and the Government of Thailand.	Akoachere M, 2005, BIOL CHEM, V386, P41, DOI 10.1515/BC.2005.006; Ariza A, 2006, MOL MICROBIOL, V59, P1239, DOI 10.1111/j.1365-2958.2006.05022.x; ARONSSON AC, 1978, BIOCHEM BIOPH RES CO, V81, P1235, DOI 10.1016/0006-291X(78)91268-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergdoll M, 1998, PROTEIN SCI, V7, P1661, DOI 10.1002/pro.5560070801; Bobik TA, 2004, APPL MICROBIOL BIOT, V63, P682, DOI 10.1007/s00253-003-1474-5; Bobik TA, 2003, ANAL BIOANAL CHEM, V375, P344, DOI 10.1007/s00216-002-1696-x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROPHY PM, 1990, INT J PARASITOL, V20, P259, DOI 10.1016/0020-7519(90)90109-Z; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cameron AD, 1997, EMBO J, V16, P3386, DOI 10.1093/emboj/16.12.3386; Cameron AD, 1999, BIOCHEMISTRY-US, V38, P13480, DOI 10.1021/bi990696c; Chen ZY, 2004, PHYTOPATHOLOGY, V94, P938, DOI 10.1094/PHYTO.2004.94.9.938; CLIFFE EE, 1961, BIOCHEM J, V79, P475, DOI 10.1042/bj0790475; Clugston SL, 1997, GENE, V186, P103, DOI 10.1016/S0378-1119(96)00691-9; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; Clugston SL, 2004, BIOCHEM J, V377, P309, DOI 10.1042/BJ20030271; Clugston SL, 1998, J MOL EVOL, V47, P230, DOI 10.1007/PL00006380; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Danshiftsoodol N, 2006, J MOL BIOL, V360, P398, DOI 10.1016/j.jmb.2006.05.017; Davidson G, 2000, INORG CHEM, V39, P2962, DOI 10.1021/ic0001208; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deswal R, 1998, PHYTOCHEMISTRY, V49, P2245, DOI 10.1016/S0031-9422(98)00334-3; DESWAL R, 1991, FEBS LETT, V282, P277, DOI 10.1016/0014-5793(91)80494-N; Feierberg I, 1999, FEBS LETT, V453, P90, DOI 10.1016/S0014-5793(99)00703-6; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; FRENCH FA, 1958, CANCER RES, V18, P172; Frickel EM, 2001, J BIOL CHEM, V276, P1845, DOI 10.1074/jbc.M005760200; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Greig N, 2006, BIOCHEM J, V400, P217, DOI 10.1042/BJ20060882; He MM, 2000, BIOCHEMISTRY-US, V39, P8719, DOI 10.1021/bi000856g; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; Inoue Y, 1995, Adv Microb Physiol, V37, P177, DOI 10.1016/S0065-2911(08)60146-0; Iozef R, 2003, FEBS LETT, V554, P284, DOI 10.1016/S0014-5793(03)01146-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kino K, 2007, BIOCHEM BIOPH RES CO, V352, P351, DOI 10.1016/j.bbrc.2006.11.016; LESLIE AGW, 1987, ACTA CRYSTALLOGR A, V43, P134, DOI 10.1107/S0108767387099720; Liyanage H, 2001, APPL ENVIRON MICROB, V67, P2004, DOI 10.1128/AEM.67.5.2004-2010.2001; MARMSTAL E, 1979, BIOCHEM J, V183, P23, DOI 10.1042/bj1830023; Martin TW, 2002, STRUCTURE, V10, P933, DOI 10.1016/S0969-2126(02)00778-5; Martins AM, 2001, EUR J BIOCHEM, V268, P3930, DOI 10.1046/j.1432-1327.2001.02304.x; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; McCarthy AA, 2001, STRUCTURE, V9, P637, DOI 10.1016/S0969-2126(01)00622-0; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; O'Young J, 2007, ARCH BIOCHEM BIOPHYS, V459, P20, DOI 10.1016/j.abb.2006.11.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; PAPOULIS A, 1995, BIOCHEMISTRY-US, V34, P648, DOI 10.1021/bi00002a032; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pfister T, 2000, J VIROL, V74, P334, DOI 10.1128/JVI.74.1.334-343.2000; RICHARD JP, 1991, BIOCHEMISTRY-US, V30, P4581, DOI 10.1021/bi00232a031; Richter U, 2001, J AM CHEM SOC, V123, P6973, DOI 10.1021/ja0105966; Ridderstrom M, 1996, BIOCHEM J, V314, P463; Saint-Jean AP, 1998, BIOCHEMISTRY-US, V37, P10345, DOI 10.1021/bi980868q; Sambrook J., 2001, MOL CLONING LAB MANU; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SELLIN S, 1983, J BIOL CHEM, V258, P2091; Sukdeo N, 2004, BIOCHEM J, V384, P111, DOI 10.1042/BJ20041006; Sukdeo N, 2007, BBA-PROTEINS PROTEOM, V1774, P756, DOI 10.1016/j.bbapap.2007.04.005; Takatsume Y, 2004, ARCH MICROBIOL, V181, P371, DOI 10.1007/s00203-004-0666-4; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Vander Jagt DL, 2003, CHEM-BIOL INTERACT, V143, P341, DOI 10.1016/S0009-2797(02)00212-0; VANDERJAGT DL, 1975, J MED CHEM, V18, P1155, DOI 10.1021/jm00245a025; Vickers TJ, 2004, P NATL ACAD SCI USA, V101, P13186, DOI 10.1073/pnas.0402918101; VINCE R, 1971, J MED CHEM, V14, P402, DOI 10.1021/jm00287a006	66	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38367	38374		10.1074/jbc.M111.251603	http://dx.doi.org/10.1074/jbc.M111.251603			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914803	Green Published, hybrid			2022-12-27	WOS:000296594200050
J	Lee, KK; Pessi, A; Gui, L; Santoprete, A; Talekar, A; Moscona, A; Porotto, M				Lee, Kelly K.; Pessi, Antonello; Gui, Long; Santoprete, Alessia; Talekar, Aparna; Moscona, Anne; Porotto, Matteo			Capturing a Fusion Intermediate of Influenza Hemagglutinin with a Cholesterol-conjugated Peptide, a New Antiviral Strategy for Influenza Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROXIMAL REGION; RECEPTOR-BINDING; CONFORMATIONAL CHANGE; ENTRY INHIBITORS; MEDIATED FUSION; VIRAL FUSION; A VIRUSES; PARAMYXOVIRUS; MECHANISM; POTENCY	We previously described fusion-inhibitory peptides that are targeted to the cell membrane by cholesterol conjugation and potently inhibit enveloped viruses that fuse at the cell surface, including HIV, parainfluenza, and henipaviruses. However, for viruses that fuse inside of intracellular compartments, fusion-inhibitory peptides have exhibited very low antiviral activity. We propose that for these viruses, too, membrane targeting via cholesterol conjugation may yield potent compounds. Here we compare the activity of fusion-inhibitory peptides derived from the influenza hemagglutinin (HA) and show that although the unconjugated peptides are inactive, the cholesterol-conjugated compounds are effective inhibitors of infectivity and membrane fusion. We hypothesize that the cholesterol moiety, by localizing the peptides to the target cell membrane, allows the peptides to follow the virus to the intracellular site of fusion. The cholesterol-conjugated peptides trap HA in a transient intermediate state after fusion is triggered but before completion of the refolding steps that drive the merging of the viral and cellular membranes. These results provide proof of concept for an antiviral strategy that is applicable to intracellularly fusing viruses, including known and emerging viral pathogens.	[Talekar, Aparna; Moscona, Anne; Porotto, Matteo] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA; [Talekar, Aparna; Moscona, Anne; Porotto, Matteo] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Lee, Kelly K.; Gui, Long] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Lee, Kelly K.; Gui, Long] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA; [Pessi, Antonello] PeptiPharma, I-00040 Rome, Italy	Cornell University; Cornell University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lee, KK (corresponding author), H-172J,Hlth Sci Bldg, Seattle, WA 98195 USA.	kklee@u.washington.edu; map2028@med.cornell.edu		POROTTO, Matteo/0000-0003-3866-9220; Gui, Long/0000-0002-2629-0689	NIAD, National Institutes of Health Northeast Center of Excellence for Biodefense and Emerging Infectious Disease [U54AI057158]; National Institutes of Health [R01AI076335, R01AI31971, R21AI090354, R21EBO11707, R00GM080352]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI031971, R01AI076335, R21AI090354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB011707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM080352, R00GM080352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076385] Funding Source: NIH RePORTER	NIAD, National Institutes of Health Northeast Center of Excellence for Biodefense and Emerging Infectious Disease; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NIAD, National Institutes of Health Northeast Center of Excellence for Biodefense and Emerging Infectious Disease Research Grant U54AI057158 (to M. P.), Principal Investigator of Center of Excellence Grant W. I. Lipkin (to A. M.), National Institutes of Health Grants R01AI076335, R01AI31971, and R21AI090354 (to A. M.); R21EBO11707 (to M. P.); and R00GM080352 (to K. K. L.).	Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Chernomordik LV, 1999, MOL MEMBR BIOL, V16, P33; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DANIELS RS, 1983, J GEN VIROL, V64, P1657, DOI 10.1099/0022-1317-64-8-1657; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Harrison C, 2009, NAT REV DRUG DISCOV, V8, P276, DOI 10.1038/nrd2856; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Lamb RA, 2006, VIROLOGY, V344, P30, DOI 10.1016/j.virol.2005.09.007; Lambert DM, 1996, P NATL ACAD SCI USA, V93, P2186, DOI 10.1073/pnas.93.5.2186; Lee KK, 2010, EMBO J, V29, P1299, DOI 10.1038/emboj.2010.13; Leikina E, 2002, EMBO J, V21, P5701, DOI 10.1093/emboj/cdf559; Miller EH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207084; Mirsaliotis A, 2008, J VIROL, V82, P4965, DOI 10.1128/JVI.02458-07; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P1171, DOI 10.1093/nar/24.6.1171; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Noah E, 2008, BIOCHEMISTRY-US, V47, P6782, DOI 10.1021/bi7023139; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Park HE, 2003, NAT STRUCT BIOL, V10, P1048, DOI 10.1038/nsb1012; Porotto M, 2007, J VIROL, V81, P10567, DOI 10.1128/JVI.01181-07; Porotto M, 2006, J VIROL, V80, P9837, DOI 10.1128/JVI.00736-06; Porotto M, 2004, J VIROL, V78, P13911, DOI 10.1128/JVI.78.24.13911-13919.2004; Porotto M, 2007, J VIROL, V81, P3216, DOI 10.1128/JVI.02617-06; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Porotto M, 2010, J VIROL, V84, P6760, DOI 10.1128/JVI.00135-10; Porotto M, 2009, J VIROL, V83, P6947, DOI 10.1128/JVI.00416-09; Porotto M, 2009, J VIROL, V83, P5148, DOI 10.1128/JVI.00164-09; Rojek JM, 2008, CELL MICROBIOL, V10, P828, DOI 10.1111/j.1462-5822.2007.01113.x; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Schmidt AG, 2010, J VIROL, V84, P12549, DOI 10.1128/JVI.01440-10; Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Veiga AS, 2007, FEBS J, V274, P5096, DOI 10.1111/j.1742-4658.2007.06029.x; Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10; WHARTON SA, 1995, EMBO J, V14, P240, DOI 10.1002/j.1460-2075.1995.tb06997.x; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	48	69	70	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42141	42149		10.1074/jbc.M111.254243	http://dx.doi.org/10.1074/jbc.M111.254243			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994935	hybrid, Green Published			2022-12-27	WOS:000298180900025
J	Lee, YS; Tresguerres, M; Hess, K; Marmorstein, LY; Levin, LR; Buck, J; Marmorstein, AD				Lee, Yong S.; Tresguerres, Martin; Hess, Kenneth; Marmorstein, Lihua Y.; Levin, Lonny R.; Buck, Jochen; Marmorstein, Alan D.			Regulation of Anterior Chamber Drainage by Bicarbonate-sensitive Soluble Adenylyl Cyclase in the Ciliary Body	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS-HUMOR SECRETION; MICE; GLAUCOMA; EPITHELIUM; CELLS	Glaucoma is a leading cause of blindness affecting as many as 2.2 million Americans. All current glaucoma treatment strategies aim to reduce intraocular pressure (LOP). LOP results from the resistance to drainage of aqueous humor (AH) produced by the ciliary body in a process requiring bicarbonate. Once secreted into the anterior chamber, AH drains from the eye via two pathways: uveoscleral and pressure-dependent or conventional outflow (C). Modulation of "inflow" and "outflow" pathways is thought to occur via distinct, local mechanisms. Mice deficient in the bicarbonate channel bestrophin-2 (Best2), however, exhibit a lower IOP despite an increase in AH production. Best2 is expressed uniquely in nonpigmented ciliary epithelial (NPE) cells providing evidence for a bicarbonate-dependent communicative pathway linking inflow and outflow. Here, we show that bicarbonate-sensitive soluble adenylyl cyclase (sAC) is highly expressed in the ciliary body in NPE cells, but appears to be absent from drainage tissues. Pharmacologic inhibition of sAC in mice causes a significant increase in LOP due to a decrease in C, with no effect on inflow. In mice deficient in sAC IOP is elevated, and C, is decreased relative to wild-type mice. Pharmacologic inhibition of sAC did not alter LOP or C, in sAC-deficient mice. Based on these data we propose that the ciliary body can regulate C, and that sAC serves as a critical sensor of bicarbonate in the ciliary body regulating the secretion of substances into the AH that govern outflow facility independent of pressure.	[Marmorstein, Alan D.] Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ 85719 USA; [Marmorstein, Lihua Y.] Univ Arizona, Dept Physiol, Tucson, AZ 85719 USA; [Marmorstein, Alan D.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85719 USA; [Tresguerres, Martin; Hess, Kenneth; Levin, Lonny R.; Buck, Jochen] Weill Cornell Coll Med, Dept Pharmacol, New York, NY 10065 USA	University of Arizona; University of Arizona; University of Arizona; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Marmorstein, AD (corresponding author), Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, POB 245216, Tucson, AZ 85719 USA.	amarmorstein@eyes.arizona.edu	Tresguerres, Martin/J-8628-2012; Hess, Kenneth/K-6546-2019	Hess, Kenneth/0000-0003-1377-6070; Tresguerres, Martin/0000-0002-7090-9266; Levin, Lonny/0000-0002-5204-6356	National Institutes of Health [EY13160, GM62328]; American Health Assistance Foundation; Research to Prevent Blindness; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059913] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013160, R56EY013160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY13160 and GM62328. This work was also supported by the American Health Assistance Foundation and an unrestricted grant from Research to Prevent Blindness (to the Department of Ophthalmology and Vision Science at the University of Arizona).	Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P5168, DOI 10.1167/iovs.03-0504; Bakall B, 2008, INVEST OPHTH VIS SCI, V49, P1563, DOI 10.1167/iovs.07-1338; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Civan MM, 2004, EXP EYE RES, V78, P625, DOI 10.1016/j.exer.2003.09.021; Coca-Prados M, 2007, PROG RETIN EYE RES, V26, P239, DOI 10.1016/j.preteyeres.2007.01.002; Do CW, 2004, J MEMBRANE BIOL, V200, P1, DOI 10.1007/s00232-004-0688-5; Dunn TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007877; Escribano J, 2002, MOL VIS, V8, P315; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Farrell J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003251; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Lee DA, 2005, AM J HEALTH-SYST PH, V62, P691, DOI 10.1093/ajhp/62.7.691; Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; MITTAG TW, 1993, AM J PHYSIOL, V264, pF1060, DOI 10.1152/ajprenal.1993.264.6.F1060; Sugrue MF, 1996, J OCUL PHARMACOL TH, V12, P363, DOI 10.1089/jop.1996.12.363; Sugrue MF, 2000, PROG RETIN EYE RES, V19, P87, DOI 10.1016/S1350-9462(99)00006-3; Sun XC, 2003, AM J PHYSIOL-CELL PH, V284, pC1114, DOI 10.1152/ajpcell.00400.2002; Sun Xing Cai, 2004, BMC Physiol, V4, P8, DOI 10.1186/1472-6793-4-8; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Tresguerres M, 2010, PFLUG ARCH EUR J PHY, V460, P953, DOI 10.1007/s00424-010-0865-6; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Yu K, 2010, J CLIN INVEST, V120, P1722, DOI 10.1172/JCI41129; Zhang YW, 2010, MOL VIS, V16, P200; Zhang YW, 2009, INVEST OPHTH VIS SCI, V50, P765, DOI 10.1167/iovs.08-2501	28	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41353	41358		10.1074/jbc.M111.284679	http://dx.doi.org/10.1074/jbc.M111.284679			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994938	Green Published, hybrid			2022-12-27	WOS:000298057500022
J	Douzi, B; Ball, G; Cambillau, C; Tegoni, M; Voulhoux, R				Douzi, Badreddine; Ball, Genevieve; Cambillau, Christian; Tegoni, Mariella; Voulhoux, Rome			Deciphering the Xcp Pseudomonas aeruginosa Type II Secretion Machinery through Multiple Interactions with Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECRETION; CHOLERA-TOXIN; SYSTEM; COMPONENT; DOMAIN; PILUS; IDENTIFICATION; SPECIFICITY; CAMPESTRIS	The type II secretion system enables Gram-negative bacteria to secrete exoproteins into the extracellular milieu. We performed biophysical and biochemical experiments to identify systematic interactions between Pseudomonas aeruginosa Xcp type II secretion system components and their substrates. We observed that three Xcp components, XcpP(C), the secretin XcpQ, and the pseudopilus tip, directly and specifically interact with secreted exoproteins. We established that XcpP(C), in addition to its interaction with the substrate, likely shields the entire periplasmic portion of the secreton. It can therefore be considered as the recruiter of the machinery. Moreover, the direct interaction observed between the substrate and the pseudopilus tip validates the piston model hypothesis, in which the pseudopilus pushes the substrate through the secretin pore during the secretion process. All together, our results allowed us to propose a model of the different consecutive steps followed by the substrate during the type II secretion process.	[Douzi, Badreddine; Cambillau, Christian; Tegoni, Mariella] Aix Marseille Univ, CNRS, AFMB UMR6098, F-13288 Marseille 9, France; [Douzi, Badreddine; Ball, Genevieve; Voulhoux, Rome] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, LISM UPR9027, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Tegoni, M (corresponding author), Aix Marseille Univ, CNRS, AFMB UMR6098, Case 932,163 Ave Luminy, F-13288 Marseille 9, France.	mariella.tegoni@afmb.univ-mrs.fr; voulhoux@ifr88.cnrs-mrs.fr	Voulhoux, Rome/AAT-5333-2021; Douzi, Badreddine/ABA-4540-2021; douzi, Badreddine/Z-5707-2019	Douzi, Badreddine/0000-0003-3140-4713; 	"3D-Pilus" Young Researcher Agence Nationale de Recherches (ANR) [ANR-JC07-183230]	"3D-Pilus" Young Researcher Agence Nationale de Recherches (ANR)(French National Research Agency (ANR))	This work was supported by "3D-Pilus" Young Researcher Agence Nationale de Recherches (ANR) Grant ANR-JC07-183230.	Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Campos M, 2010, P NATL ACAD SCI USA, V107, P13081, DOI 10.1073/pnas.1001703107; Chen Y, 2005, J BIOL CHEM, V280, P42356, DOI 10.1074/jbc.M506843200; Cianciotto NP, 2009, FUTURE MICROBIOL, V4, P797, DOI 10.2217/FMB.09.53; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Douzi B, 2009, J BIOL CHEM, V284, P34580, DOI 10.1074/jbc.M109.042366; Economou A, 2006, MOL MICROBIOL, V62, P308, DOI 10.1111/j.1365-2958.2006.05377.x; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Filloux A, 1998, FEMS MICROBIOL REV, V22, P177, DOI 10.1016/S0168-6445(98)00013-8; Gerard-Vincent M, 2002, MOL MICROBIOL, V44, P1651, DOI 10.1046/j.1365-2958.2002.02991.x; Hu NT, 2002, BIOCHEM J, V365, P205, DOI 10.1042/BJ20020194; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Nunn D, 1999, TRENDS CELL BIOL, V9, P402, DOI 10.1016/S0962-8924(99)01634-7; Patrick M, 2011, J BIOL CHEM, V286, P10378, DOI 10.1074/jbc.M110.167031; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Rich RL, 2002, P NATL ACAD SCI USA, V99, P8562, DOI 10.1073/pnas.142288199; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Sauvonnet N, 1996, MOL MICROBIOL, V22, P1, DOI 10.1111/j.1365-2958.1996.tb02650.x; Sauvonnet N, 2000, J BACTERIOL, V182, P848, DOI 10.1128/JB.182.3.848-854.2000; Shahian T, 2009, NAT CHEM BIOL, V5, P640, DOI 10.1038/nchembio.192; STUER W, 1986, J BACTERIOL, V168, P1070, DOI 10.1128/jb.168.3.1070-1074.1986; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Voulhoux R, 2000, J BACTERIOL, V182, P4051, DOI 10.1128/JB.182.14.4051-4058.2000; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735	31	63	63	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40792	40801		10.1074/jbc.M111.294843	http://dx.doi.org/10.1074/jbc.M111.294843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21949187	Green Published, hybrid			2022-12-27	WOS:000297315400040
J	Sebens, S; Bauer, I; Geismann, C; Grage-Griebenow, E; Ehlers, S; Kruse, ML; Arlt, A; Schafer, H				Sebens, Susanne; Bauer, Iris; Geismann, Claudia; Grage-Griebenow, Evelin; Ehlers, Stefan; Kruse, Marie-Luise; Arlt, Alexander; Schaefer, Heiner			Inflammatory Macrophages Induce Nrf2 Transcription Factor-dependent Proteasome Activity in Colonic NCM460 Cells and Thereby Confer Anti-apoptotic Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-STRESS; ANTIOXIDANT RESPONSE; MOLECULAR-MECHANISMS; ULCERATIVE-COLITIS; ADAPTIVE RESPONSE; CANCER; ACTIVATION; EXPRESSION; SUBUNIT; PATHWAY	Adaptation of epithelial cells to persistent oxidative stress plays an important role in inflammation-associated carcinogenesis. This adaptation process involves activation of Nrf2 (nuclear factor-E2-related factor-2), which has been recently shown to contribute to carcinogenesis through the induction of proteasomal gene expression and proteasome activity. To verify this possible link between inflammation, oxidative stress, and Nr12-dependent proteasome activation, we explored the impact of inflammatory (M1) macrophages on the human colon epithelial cell line NCM460. Transwell cocultures with macrophages differentiated from granulocyte monocyte-colony-stimulating factor-treated monocytes led to an increased activity of Nrf2 in NCM460 cells along with an elevated proteasome activity. This higher proteasome activity resulted from Nrf2-dependent induction of proteasomal gene expression, as shown for the 19 and 20 S subunit proteins S5a and alpha 5, respectively. These effects of macrophage coculture were preceded by an increase of reactive oxygen species in cocultured NCM460 cells and could be blocked by catalase or by the reactive oxygen species scavenger Tiron, whereas transient treatment of NCM460 cells with H2O2 similarly led to Nrf2-dependent proteasome activation. Through the Nrf2-dependent increase of proteasomal gene expression and proteasome activity, the sensitivity of NCM460 cells to tumor necrosis factor-related apoptosis-inducing ligand-or irinotecan-induced apoptosis declined. These findings indicate that inflammatory conditions such as the presence of M1 macrophages and the resulting oxidative stress are involved in the Nrf2-dependent gain of proteasome activity in epithelial cells, e.g. colonocytes, giving rise of greater resistance to apoptosis. This mechanism might contribute to inflammation-associated carcinogenesis, e.g. of the colon.	[Sebens, Susanne; Bauer, Iris; Geismann, Claudia; Grage-Griebenow, Evelin; Kruse, Marie-Luise; Arlt, Alexander; Schaefer, Heiner] Univ Klinikum Schleswig Holstein, Dept Internal Med 1, Lab Mol Gastroenterol & Hepatol, Kiel, Germany; [Sebens, Susanne; Grage-Griebenow, Evelin] Univ Klinikum Schleswig Holstein, Inst Expt Med, Kiel, Germany; [Ehlers, Stefan] Res Ctr Borstel, Leibniz Ctr Med & Biosci, Div Mol Inflammat Med, Borstel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Forschungszentrum Borstel	Schafer, H (corresponding author), Dept Internal Med, I Arnold Heller Str 3,Bldg 6, D-24105 Kiel, Germany.	hschaef@1med.uni-kiel.de	Schäfer, Heiner/C-1055-2011; Ehlers, Stefan/B-4075-2010; Arlt, Alexander/G-7308-2019; Geismann, Claudia/AAX-8158-2021; Sebens, Susanne/C-1222-2010	Arlt, Alexander/0000-0002-6160-1059; Geismann, Claudia/0000-0003-0640-9256; 	Deutsche Forschungsgemeinschaft [SCHA677/9-1]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHA677/9-1 and the Cluster of Excellence "Inflammation at Interfaces."	Akhdar H, 2009, EUR J CANCER, V45, P2219, DOI 10.1016/j.ejca.2009.05.017; Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Arisawa T, 2008, HEPATO-GASTROENTEROL, V55, P394; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Arlt A, 2007, BIOCHEM J, V402, P367, DOI 10.1042/BJ20061072; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bedard K, 2007, PHYSIOL REV, V87, P245; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Chen W, 2009, ONCOL REP, V21, P531, DOI 10.3892/or_00000254; Du ZX, 2011, J CLIN ENDOCR METAB, V96, pE763, DOI 10.1210/jc.2010-2642; Ebert B, 2011, CHEM-BIOL INTERACT, V191, P239, DOI 10.1016/j.cbi.2010.12.026; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714; Gomes-Marcondes MCC, 2002, CANCER LETT, V180, P69, DOI 10.1016/S0304-3835(02)00006-X; Grimm S, 2010, AMINO ACIDS IN PRESS; Han YH, 2009, ONCOL REP, V21, P253, DOI 10.3892/or_00000216; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hellwinkel OJC, 2011, PROSTATE CANCER P D, V14, P38, DOI 10.1038/pcan.2010.48; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Kapeta S, 2010, J BIOL CHEM, V285, P8171, DOI 10.1074/jbc.M109.031575; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Muerkoster S, 2005, CANCER RES, V65, P1316, DOI 10.1158/0008-5472.CAN-04-1626; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; O'Connor PM, 2010, INFLAMM BOWEL DIS, V16, P1411, DOI 10.1002/ibd.21217; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Pi JB, 2003, EXP CELL RES, V290, P234, DOI 10.1016/S0014-4827(03)00341-0; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Purdom-Dickinson SE, 2007, MOL PHARMACOL, V72, P1074, DOI 10.1124/mol.107.035360; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rho JH, 2008, J PROTEOME RES, V7, P2959, DOI 10.1021/pr8000892; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Rushworth SA, 2011, CANCER RES, V71, P1999, DOI 10.1158/0008-5472.CAN-10-3018; Schaedler S, 2010, J BIOL CHEM, V285, P41074, DOI 10.1074/jbc.M110.145862; Shim GS, 2009, FREE RADICAL BIO MED, V47, P1619, DOI 10.1016/j.freeradbiomed.2009.09.006; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Thomas S, 2007, FREE RADICAL BIO MED, V42, P1049, DOI 10.1016/j.freeradbiomed.2007.01.005; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Visconti R, 2009, CURR OPIN DRUG DISC, V12, P240; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wendelsdorf K, 2010, J THEOR BIOL, V264, P1225, DOI 10.1016/j.jtbi.2010.03.027; Xie YM, 2010, CANCER METAST REV, V29, P687, DOI 10.1007/s10555-010-9255-y; Zhao CR, 2010, CANCER EPIDEMIOL, V34, P523, DOI 10.1016/j.canep.2010.06.012	65	32	35	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40911	40921		10.1074/jbc.M111.274902	http://dx.doi.org/10.1074/jbc.M111.274902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21990354	Green Published, hybrid			2022-12-27	WOS:000297315400051
J	Wang, S; Chuang, HH				Wang, Shu; Chuang, Huai-hu			C-terminal Dimerization Activates the Nociceptive Transduction Channel Transient Receptor Potential Vanilloid 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY SENSORY NEURONS; CAPSAICIN RECEPTOR; GATING RING; TRPV1; CYSTEINE; MECHANISM; PHOSPHORYLATION; THERMOSENSATION; DESENSITIZATION; DETERMINANT	Covalent modification of the specific cysteine residue(s) by oxidative stress robustly potentiates transient receptor potential vanilloid 1 (TRPV1) and sensitizes nociception. Here we provide biochemical evidence of dimerization of TRPV1 subunits upon exposure to phenylarsine oxide and hydrogen peroxide (H2O2), two chemical surrogates of oxidative stress. A disulfide bond formed between apposing cysteines ligates two C termini, serving as the structural basis of channel sensitization by oxidative covalent C-terminal modification. Systematic cysteine scanning of the C terminus of a cysteineless TRPV1 channel revealed a critical region within which any cysteine introduced phenylarsine oxide activation to mutant TRPV1. Oxidative sensitization persisted even when this region is substituted with a random peptide linker containing a single cysteine. So did insertion of this region to TRPV3, a homolog lacking the corresponding region and resistant to oxidative challenge. These results suggest that the non-conserved linker in the TRPV1 C terminus senses environmental oxidative stress and adjusts channel activity during cumulative oxidative damage by lowering the activation threshold of gating elements shared by TRPV channels.	[Wang, Shu; Chuang, Huai-hu] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University	Chuang, HH (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.	huai-hu.chuang@cornell.edu			American Heart Association	American Heart Association(American Heart Association)	This work is supported by a Scientist Developmental Grant from the American Heart Association (to H. C.).	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; Kwak J, 2000, J NEUROSCI, V20, P8298, DOI 10.1523/JNEUROSCI.20-22-08298.2000; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2004, J PHYSIOL-LONDON, V560, P627, DOI 10.1113/jphysiol.2004.069054; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Takano M, 1998, J PHYSIOL-LONDON, V512, P395, DOI 10.1111/j.1469-7793.1998.395be.x; Taraska JW, 2007, NAT STRUCT MOL BIOL, V14, P854, DOI 10.1038/nsmb1281; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang S, 2010, J BIOL CHEM, V285, P11547, DOI 10.1074/jbc.M109.058727; Xue Q, 2007, J NEUROCHEM, V101, P212, DOI 10.1111/j.1471-4159.2006.04363.x; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	43	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40601	40607		10.1074/jbc.M111.256669	http://dx.doi.org/10.1074/jbc.M111.256669			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21926175	hybrid, Green Published			2022-12-27	WOS:000297315400020
J	Artsimovitch, I; Svetlov, V; Nemetski, SM; Epshtein, V; Cardozo, T; Nudler, E				Artsimovitch, Irina; Svetlov, Vladimir; Nemetski, Sondra Maureen; Epshtein, Vitaly; Cardozo, Timothy; Nudler, Evgeny			Tagetitoxin Inhibits RNA Polymerase through Trapping of the Trigger Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; ESCHERICHIA-COLI; TRANSCRIPTION TERMINATION; ACTIVE-CENTER; ALPHA-AMANITIN; BETA-SUBUNIT; ELONGATION; STREPTOLYDIGIN; MECHANISM; CATALYSIS	Tagetitoxin (Tgt) inhibits multisubunit chloroplast, bacterial, and some eukaryotic RNA polymerases (RNAPs). A crystallographic structure of Tgt bound to bacterial RNAP apoenzyme shows that Tgt binds near the active site but does not explain why Tgt acts only at certain sites. To understand the Tgt mechanism, we constructed a structural model of Tgt bound to the transcription elongation complex. In this model, Tgt interacts with the beta' subunit trigger loop (TL), stabilizing it in an inactive conformation. We show that (i) substitutions of the Arg residue of TL contacted by Tgt confer resistance to inhibitor; (ii) Tgt inhibits RNAP translocation, which requires TL movements; and (iii) paused complexes and a "slow" enzyme, in which the TL likely folds into an altered conformation, are resistant to Tgt. Our studies highlight the role of TL as a target through which accessory proteins and antibiotics can alter the elongation complex dynamics.	[Artsimovitch, Irina] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Artsimovitch, Irina] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Nemetski, Sondra Maureen; Cardozo, Timothy] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Svetlov, Vladimir; Epshtein, Vitaly; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; New York University; New York University	Artsimovitch, I (corresponding author), Ohio State Univ, Dept Microbiol, 270 Aronoff,318 W 12th Ave, Columbus, OH 43210 USA.	artsimovitch.1@osu.edu; evgeny.nudler@nyumc.org	Artsimovitch, Irina/L-3467-2019	Nudler, Evgeny/0000-0002-8811-3071	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grants (to I. A., E. N., S. M. N., and T. C.).	Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Belogurov GA, 2009, NATURE, V457, P332, DOI 10.1038/nature07510; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; FISHER RF, 1983, J BIOL CHEM, V258, P8146; Hwang W, 2009, CELL BIOCHEM BIOPHYS, V54, P11, DOI 10.1007/s12013-009-9049-4; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; MATHEWS DE, 1990, J BIOL CHEM, V265, P493; MATHEWS DE, 1994, BIOCHEMISTRY-US, V33, P11987, DOI 10.1021/bi00205a038; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Roghanian M, 2011, NUCLEIC ACIDS RES, V39, P4352, DOI 10.1093/nar/gkq1359; STEINBERG TH, 1992, J BIOL CHEM, V267, P20204; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; WEILBAECHER R, 1994, GENE DEV, V8, P2913, DOI 10.1101/gad.8.23.2913; Yidirim Y, 2004, J BIOMOL STRUCT DYN, V22, P267, DOI 10.1080/07391102.2004.10507000; Yuzenkova Y, 2010, P NATL ACAD SCI USA, V107, P10878, DOI 10.1073/pnas.0914424107; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732; Zhu R, 2008, THEOR CHEM ACC, V120, P479, DOI 10.1007/s00214-008-0440-9	33	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40395	40400		10.1074/jbc.M111.300889	http://dx.doi.org/10.1074/jbc.M111.300889			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21976682	hybrid, Green Published			2022-12-27	WOS:000296925700070
J	Vaubel, RA; Rustin, P; Isaya, G				Vaubel, Rachael A.; Rustin, Pierre; Isaya, Grazia			Mutations in the Dimer Interface of Dihydrolipoamide Dehydrogenase Promote Site-specific Oxidative Damages in Yeast and Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; MITOCHONDRIAL IRON HOMEOSTASIS; DISEASE-CAUSING MUTATIONS; LIPOAMIDE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; LIPOIC ACID; PYRUVATE-DEHYDROGENASE; SELECTIVE INACTIVATION; MOONLIGHTING PROTEINS; PROTEOLYTIC ACTIVITY	Dihydrolipoamide dehydrogenase (DLD) is a multifunctional protein well characterized as the E3 component of the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes. Previously, conditions predicted to destabilize the DLD dimer revealed that DLD could also function as a diaphorase and serine protease. However, the relevance of these cryptic activities remained undefined. We analyzed human DLD mutations linked to strikingly different clinical phenotypes, including E340K, D444V, R447G, and R460G in the dimer interface domain that are responsible for severe multisystem disorders of infancy and G194C in the NAD(+)-binding domain that is typically associated with milder presentations. In vitro, all of these mutations decreased to various degrees dihydrolipoamide dehydrogenase activity, whereas dimer interface mutations also enhanced proteolytic and/or diaphorase activity. Human DLD proteins carrying each individual mutation complemented fully the respiratory-deficient phenotype of yeast cells lacking endogenous DLD even when residual dihydrolipoamide dehydrogenase activity was as low as 21% of controls. However, under elevated oxidative stress, expression of DLD proteins with dimer interface mutations greatly accelerated the loss of respiratory function, resulting from enhanced oxidative damage to the lipoic acid cofactor of pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase and other mitochondrial targets. This effect was not observed with the G194C mutation or a mutation that disrupts the proteolytic active site of DLD. As in yeast, lipoic acid cofactor was damaged in human D444V-homozygous fibroblasts after exposure to oxidative stress. We conclude that the cryptic activities of DLD promote oxidative damage to neighboring molecules and thus contribute to the clinical severity of DLD mutations.	[Vaubel, Rachael A.; Isaya, Grazia] Mayo Clin, Dept Pediat, Rochester, MN 55905 USA; [Vaubel, Rachael A.; Isaya, Grazia] Mayo Clin, Dept Adolescent Med, Rochester, MN 55905 USA; [Vaubel, Rachael A.; Isaya, Grazia] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Rustin, Pierre] Hop Robert Debre, INSERM, U676, F-75019 Paris, France; [Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, IFR02, Paris, France	Mayo Clinic; Mayo Clinic; Mayo Clinic; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Isaya, G (corresponding author), Mayo Clin, Dept Pediat, 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health from NIA [AG15709]; National Institutes of Health from NHLBI [F30 HL099036]; National Institutes of Health from NIGMS [T32 GM 65841]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL099036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health from NIA; National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15709 from NIA (to G. I.), Grant F30 HL099036 from NHLBI (to R. A. V.), and Grant T32 GM 65841 from NIGMS. A technology used in this study, "Recombinant Mature Form of Human Frataxin Protein," has been licensed to a commercial entity. Mayo Clinic, but not the investigators, has received royalties from the licensing of this technology.	Ambrus A, 2011, HUM MOL GENET, V20, P2984, DOI 10.1093/hmg/ddr202; Ambrus A, 2009, J NEUROCHEM, V109, P222, DOI 10.1111/j.1471-4159.2009.05942.x; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Argyrou A, 2003, BIOCHEMISTRY-US, V42, P2218, DOI 10.1021/bi020654f; Babady NE, 2007, P NATL ACAD SCI USA, V104, P6158, DOI 10.1073/pnas.0610618104; Branda SS, 1999, HUM MOL GENET, V8, P1099, DOI 10.1093/hmg/8.6.1099; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Bulteau AL, 2005, P NATL ACAD SCI USA, V102, P5987, DOI 10.1073/pnas.0501519102; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Cameron JM, 2006, AM J MED GENET A, V140A, P1542, DOI 10.1002/ajmg.a.31313; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; DAUM G, 1982, J BIOL CHEM, V257, P3028; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gazaryan IG, 2002, J BIOL CHEM, V277, P10064, DOI 10.1074/jbc.M108264200; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; Hong YS, 2003, J INHERIT METAB DIS, V26, P816, DOI 10.1023/B:BOLI.0000010004.12053.5b; Hong YS, 1997, BBA-MOL BASIS DIS, V1362, P160, DOI 10.1016/S0925-4439(97)00073-2; Hong YS, 1996, HUM MOL GENET, V5, P1925, DOI 10.1093/hmg/5.12.1925; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Igamberdiev AU, 2004, FEBS LETT, V568, P146, DOI 10.1016/j.febslet.2004.05.024; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jiang YF, 2005, J BIOL CHEM, V280, P2244, DOI 10.1074/jbc.M408612200; KAEBERLEIN M, 2001, SCI AGING KNOWLEDGE, pPE1; Kareyeva AV, 2011, FEBS LETT, V585, P385, DOI 10.1016/j.febslet.2010.12.019; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kim G, 2002, MUTAGENESIS, V17, P375, DOI 10.1093/mutage/17.5.375; KIM H, 1992, J BIOL CHEM, V267, P5128; Klyachko NL, 2005, J BIOL CHEM, V280, P16106, DOI 10.1074/jbc.M414285200; Lanterman MM, 1996, HUM MOL GENET, V5, P1643, DOI 10.1093/hmg/5.10.1643; MASSEY V, 1961, BIOCHIM BIOPHYS ACTA, V48, P33, DOI 10.1016/0006-3002(61)90512-1; McLain AL, 2011, FREE RADICAL RES, V45, P29, DOI 10.3109/10715762.2010.534163; MISAKA E, 1965, J BIOCHEM, V58, P436, DOI 10.1093/oxfordjournals.jbchem.a128223; Odievre MH, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9319; Parrella E, 2008, METHODS, V46, P256, DOI 10.1016/j.ymeth.2008.10.004; Petrat F, 2003, J BIOL CHEM, V278, P46403, DOI 10.1074/jbc.M305291200; Quintana E., 2011, J INHERIT M IN PRESS; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; RINALDO P, 2005, TIETZ TXB CLIN CHEM, P2207; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Robinson BH, 2001, METABOLIC MOL BASES, P2275; Sadek HA, 2002, ARCH BIOCHEM BIOPHYS, V406, P222, DOI 10.1016/S0003-9861(02)00446-0; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Shaag A, 1999, AM J MED GENET, V82, P177, DOI 10.1002/(SICI)1096-8628(19990115)82:2<177::AID-AJMG15>3.3.CO;2-0; Shany E, 1999, BIOCHEM BIOPH RES CO, V262, P163, DOI 10.1006/bbrc.1999.1133; SIKORSKI RS, 1989, GENETICS, V122, P19; SRERE PA, 1967, SCIENCE, V158, P936, DOI 10.1126/science.158.3803.936; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Taylor NL, 2002, J BIOL CHEM, V277, P42663, DOI 10.1074/jbc.M204761200; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; TSAI CS, 1981, ARCH BIOCHEM BIOPHYS, V206, P77, DOI 10.1016/0003-9861(81)90068-0; Xia L, 2001, EUR J BIOCHEM, V268, P1486, DOI 10.1046/j.1432-1327.2001.02013.x; Youn H, 2000, FEBS LETT, V472, P57, DOI 10.1016/S0014-5793(00)01437-X; Zundorf G, 2009, NEUROSCIENCE, V158, P610, DOI 10.1016/j.neuroscience.2008.10.015	63	28	29	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40232	40245		10.1074/jbc.M111.274415	http://dx.doi.org/10.1074/jbc.M111.274415			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21930696	Green Published, hybrid			2022-12-27	WOS:000296925700055
J	Ye, F; Lemieux, H; Hoppel, CL; Hanson, RW; Hakimi, P; Croniger, CM; Puchowicz, M; Anderson, VE; Fujioka, H; Stavnezer, E				Ye, Fang; Lemieux, Helene; Hoppel, Charles L.; Hanson, Richard W.; Hakimi, Parvin; Croniger, Colleen M.; Puchowicz, Michelle; Anderson, Vernon E.; Fujioka, Hisashi; Stavnezer, Ed			Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Mediates a Ski Oncogene-induced Shift from Glycolysis to Oxidative Energy Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; ALAMAR BLUE; TUMOR-GROWTH; DNA-BINDING; IN-VIVO; CELLS; DIFFERENTIATION; REPRESSION	Overexpression of the Ski oncogene induces oncogenic transformation of chicken embryo fibroblasts (CEFs). However, unlike most other oncogene-transformed cells, Ski-transformed CEFs (Ski-CEFs) do not display the classical Warburg effect. On the contrary, Ski transformation reduced lactate production and glucose utilization in CEFs. Compared with CEFs, Ski-CEFs exhibited enhanced TCA cycle activity, fatty acid catabolism through beta-oxidation, glutamate oxidation, oxygen consumption, as well as increased numbers and mass of mitochondria. Interestingly, expression of PPAR gamma, a key transcription factor that regulates adipogenesis and lipid metabolism, was dramatically elevated at both the mRNA and protein levels in Ski-CEFs. Accordingly, PPAR gamma target genes that are involved in lipid uptake, transport, and oxidation were also markedly up-regulated by Ski. Knocking down PPAR gamma in Ski-CEFs by RNA interference reversed the elevated expression of these PPAR gamma target genes, as well as the shift to oxidative metabolism and the increased mitochondrial biogenesis. Moreover, we found that Ski co-immunoprecipitates with PPAR gamma and co-activates PPAR gamma-driven transcription.	[Ye, Fang; Hanson, Richard W.; Hakimi, Parvin; Anderson, Vernon E.; Stavnezer, Ed] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Lemieux, Helene; Hoppel, Charles L.; Fujioka, Hisashi] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Croniger, Colleen M.; Puchowicz, Michelle] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Croniger, Colleen M.; Puchowicz, Michelle] Case Western Reserve Univ, Sch Med, Mouse Metab Phenotyping Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Stavnezer, E (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	ed.stavnezer@case.edu	Hakimi, Parvin/AAB-1643-2021	Anderson, Vernon Emmett/0000-0002-1699-7621	National Institutes of Health from NCI [U54CA116867]; National Sciences and Engineering Research Council of Canada;  [U24 DK76169];  [DK58620]; NATIONAL CANCER INSTITUTE [U54CA116867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058620, U24DK076169] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant U54CA116867 (TREC grant) from NCI (to E. S.), Grant U24 DK76169 (to C. M. C.), and DK58620 (to R. W. H.). This work was also supported by the National Sciences and Engineering Research Council of Canada (to H. L.).	Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; CARROLL RC, 1978, P NATL ACAD SCI USA, V75, P5015, DOI 10.1073/pnas.75.10.5015; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen DH, 2009, PIGM CELL MELANOMA R, V22, P761, DOI 10.1111/j.1755-148X.2009.00603.x; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; Dahl R, 1998, P NATL ACAD SCI USA, V95, P11187, DOI 10.1073/pnas.95.19.11187; DEFRIES R, 1995, J CLIN LAB ANAL, V9, P89, DOI 10.1002/jcla.1860090203; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fugier C, 2006, J BIOL CHEM, V281, P11553, DOI 10.1074/jbc.M512554200; Gnaiger E., 2000, MITOCHONDRIA COLD, P431; Gnaiger E, 2007, MITOCHONDRIAL PATHWA; Gonzalez RJ, 2001, TOXICOL IN VITRO, V15, P257, DOI 10.1016/S0887-2333(01)00014-5; Guitart M, 2009, MITOCHONDRION, V9, P266, DOI 10.1016/j.mito.2009.03.007; Gutmann I, 1974, METHOD ENZYMAT AN, P1464; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Heider TR, 2007, ANN SURG, V246, P61, DOI 10.1097/SLA.0b013e318070cafa; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495; JOMAIN M, 1969, J LIPID RES, V10, P674; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lana DP, 1996, DEV DYNAM, V205, P13, DOI 10.1002/(SICI)1097-0177(199601)205:1<13::AID-AJA2>3.0.CO;2-8; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leong GM, 2010, INT J OBESITY, V34, P524, DOI 10.1038/ijo.2009.265; LEVINTOW L, 1961, ANNU REV BIOCHEM, V30, P605, DOI 10.1146/annurev.bi.30.070161.003133; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; NAGASE T, 1990, NUCLEIC ACIDS RES, V18, P337, DOI 10.1093/nar/18.2.337; Nicol R, 1999, CELL GROWTH DIFFER, V10, P243; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Perera RJ, 2006, GENE, V369, P90, DOI 10.1016/j.gene.2005.10.021; Presley AD, 2003, J CHROMATOGR B, V793, P141, DOI 10.1016/S1570-0232(03)00371-4; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Savage David B., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405008793; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Stavnezer E., 1988, ONCOGENE HDB, P393; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Sutrave P, 2000, GENE, V241, P107, DOI 10.1016/S0378-1119(99)00461-8; Takahata M, 2009, J BIOL CHEM, V284, P3334, DOI 10.1074/jbc.M808989200; Ueki N, 2008, ONCOGENE, V27, P300, DOI 10.1038/sj.onc.1210654; Ueki N, 2004, MOL CELL BIOL, V24, P10118, DOI 10.1128/MCB.24.23.10118-10125.2004; Walczak R, 2002, J LIPID RES, V43, P177; Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208; Warburg O, 1924, BIOCHEM Z, V152, P319; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zaripheh S, 2006, J NUTR, V136, P932, DOI 10.1093/jn/136.4.932; Zhang H., 2009, THESIS CASE W RESERV, P87; Zhang H, 2009, J BIOL CHEM, V284, P2867, DOI 10.1074/jbc.M807526200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zheng GX, 1997, ONCOGENE, V15, P459, DOI 10.1038/sj.onc.1201205	65	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40013	40024		10.1074/jbc.M111.292029	http://dx.doi.org/10.1074/jbc.M111.292029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21917928	Green Published, hybrid			2022-12-27	WOS:000296925700034
J	Cazanave, SC; Mott, JL; Bronk, SF; Werneburg, NW; Fingas, CD; Meng, XW; Finnberg, N; El-Deiry, WS; Kaufmann, SH; Gores, GJ				Cazanave, Sophie C.; Mott, Justin L.; Bronk, Steven F.; Werneburg, Nathan W.; Fingas, Christian D.; Meng, X. Wei; Finnberg, Niklas; El-Deiry, Wafik S.; Kaufmann, Scott H.; Gores, Gregory J.			Death Receptor 5 Signaling Promotes Hepatocyte Lipoapoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; FACTOR-INDUCED APOPTOSIS; TRAIL-INDUCED APOPTOSIS; NONALCOHOLIC STEATOHEPATITIS; CARCINOMA-CELLS; LIPID RAFTS; CASPASE INHIBITOR; LYSOSOMAL PATHWAY; OXIDATIVE STRESS	Nonalcoholic steatohepatitis is characterized by hepatic steatosis, elevated levels of circulating free fatty acids (FFA), endoplasmic reticulum (ER) stress, and hepatocyte lipoapoptosis. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor 5 (DR5) is significantly elevated in patients with nonalcoholic steatohepatitis, and steatotic hepatocytes demonstrate increased sensitivity to TRAIL-mediated cell death. Nonetheless, a role for TRAIL and/or DR5 in mediating lipoapoptotic pathways is unexplored. Here, we examined the contribution of DR5 death signaling to lipoapoptosis by free fatty acids. The toxic saturated free fatty acid palmitate induces an increase in DR5 mRNA and protein expression in Huh-7 human hepatoma cells leading to DR5 localization into lipid rafts, cell surface receptor clustering with subsequent recruitment of the initiator caspase-8, and ultimately cellular demise. Lipoapoptosis by palmitate was not inhibited by a soluble human recombinant DR5-Fc chimera protein suggesting that DR5 cytotoxic signaling is ligand-independent. Hepatocytes from murine TRAIL receptor knock-out mice (DR-/-) displayed reduced palmitate-mediated lipotoxicity. Likewise, knockdown of DR5 or caspase-8 expression by shRNA technology attenuated palmitate-induced Bax activation and apoptosis in Huh-7 cells, without altering induction of ER stress markers. Similar observations were verified in other cell models. Finally, knockdown of CHOP, an ER stress-mediated transcription factor, reduced DR5 up-regulation and DR5-mediated caspase-8 activation upon palmitate treatment. Collectively, these results suggest that ER stress-induced CHOP activation by palmitate transcriptionally up-regulates DR5, likely resulting in ligand-independent cytotoxic signaling by this death receptor.	[Cazanave, Sophie C.; Mott, Justin L.; Bronk, Steven F.; Werneburg, Nathan W.; Fingas, Christian D.; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Meng, X. Wei; Kaufmann, Scott H.] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA; [Finnberg, Niklas; El-Deiry, Wafik S.] Univ Penn, Sch Med, Philadelphia, PA 19103 USA	Mayo Clinic; Mayo Clinic; University of Pennsylvania	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 1st St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266; Mott, Justin/0000-0002-2927-6962; Kaufmann, Scott/0000-0002-4900-7145	National Institutes of Health [DK41876, DK069757, DK079875, CA69008, CA123258, P30DK084567]; NATIONAL CANCER INSTITUTE [R01CA123258, R01CA069008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R29DK041876, K01DK079875, R01DK041876, R37DK041876, R01DK069757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK41876 (to G. J. G.), DK069757 (to M. C. R.), DK079875 (to J. L. M.), CA69008 (to S. H. K.), CA123258 (to W. S. E.-D.), and P30DK084567 (to Optical Microscopy Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology and the Mayo Foundation).	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Akazawa Y, 2009, GASTROENTEROLOGY, V136, P2365, DOI 10.1053/j.gastro.2009.02.071; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2010, J HEPATOL, V53, P542, DOI 10.1016/j.jhep.2010.03.016; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; Engels IH, 2005, MOL CELL BIOL, V25, P2808, DOI 10.1128/MCB.25.7.2808-2818.2005; Farrell GC, 2009, J GASTROEN HEPATOL, V24, P443, DOI 10.1111/j.1440-1746.2009.05785.x; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Finnberg N, 2005, MOL CELL BIOL, V25, P2000, DOI 10.1128/MCB.25.5.2000-2013.2005; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Higuchi H, 2003, AM J PHYSIOL-GASTR L, V284, pG734, DOI 10.1152/ajpgi.00491.2002; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Kahraman A, 2010, HEPATOLOGY, V51, P92, DOI 10.1002/hep.23253; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Lee DH, 2009, BRIT J PHARMACOL, V157, P1189, DOI 10.1111/j.1476-5381.2009.00245.x; Li N, 2008, BIOCHEM SOC T, V36, P930, DOI 10.1042/BST0360930; Lim SC, 2011, CARCINOGENESIS, V32, P723, DOI 10.1093/carcin/bgr038; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Muhlenbeck F, 2000, J BIOL CHEM, V275, P32208, DOI 10.1074/jbc.M000482200; Ostrom Rennolds S., 2006, V332, P181; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Pockros PJ, 2007, HEPATOLOGY, V46, P324, DOI 10.1002/hep.21664; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ribeiro A, 1999, HEPATOLOGY, V30, P1490, DOI 10.1002/hep.510300620; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Rossin A, 2009, BIOCHEM J, V419, P185, DOI 10.1042/BJ20081212; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Tiwary R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011865; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wei YR, 2009, MOL CELL BIOCHEM, V331, P31, DOI 10.1007/s11010-009-0142-1; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200	56	84	85	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39336	39348		10.1074/jbc.M111.280420	http://dx.doi.org/10.1074/jbc.M111.280420			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21941003	Green Published, hybrid			2022-12-27	WOS:000296759800052
J	Chakraborty, S; Sivaraman, J; Leung, KY; Mok, YK				Chakraborty, Smarajit; Sivaraman, J.; Leung, Ka Yin; Mok, Yu-Keung			Two-component PhoB-PhoR Regulatory System and Ferric Uptake Regulator Sense Phosphate and Iron to Control Virulence Genes in Type III and VI Secretion Systems of Edwardsiella tarda	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; DNA-BINDING DOMAIN; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; FUNCTIONAL-ANALYSIS; VIBRIO-VULNIFICUS; YERSINIA-PESTIS; FUR; EXPRESSION	Inorganic phosphate (P-i) and iron are essential nutrients that are depleted by vertebrates as a protective mechanism against bacterial infection. This depletion, however, is sensed by some pathogens as a signal to turn on the expression of virulence genes. Here, we show that the PhoB-PhoR two-component system senses changes in P-i concentration, whereas the ferric uptake regulator (Fur) senses changes in iron concentration in Edwardsiella tarda PPD130/91 to regulate the expression of type III and VI secretion systems (T3SS and T6SS) through an E. tarda secretion regulator, EsrC. In sensing low P-i concentration, PhoB-PhoR autoregulates and activates the phosphate-specific transport operon, pstSCAB-phoU, by binding directly to the Pho box in the promoters of phoB and pstS. PhoB also binds with EsrC simultaneously on the promoter of an E. tarda virulence protein, evpA, to regulate directly the transcription of genes from T6SS. In addition, PhoB requires and interacts with PhoU to activate esrC and suppress fur indirectly through unidentified regulators. Fur, on the other hand, senses high iron concentration and binds directly to the Fur box in the promoter of evpP to inhibit EsrC binding to the same region. In addition, Fur suppresses transcription of phoB, pstSCAB-phoU, and esrC indirectly via unidentified regulators, suggesting negative cross-talk with the Pho regulon. Physical interactions exist between Fur and PhoU and between Fur and EsrC. Our findings suggest that T3SS and T6SS may carry out distinct roles in the pathogenicity of E. tarda by responding to different environmental factors.	[Chakraborty, Smarajit; Sivaraman, J.; Mok, Yu-Keung] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117543, Singapore; [Leung, Ka Yin] Trinity Western Univ, Dept Biol, Fac Nat & Appl Sci, Langley, BC V2Y 1Y1, Canada	National University of Singapore; Trinity Western University	Mok, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsmokh@nus.edu.sg	Sivaraman, J/H-8028-2012; Mok, Yu Keung/H-8019-2012	Mok, Yu Keung/0000-0002-2829-4878; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore [07/1/21/19/495]; Ministry of Education [R-154-000-498-112]	Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Education	This work was supported by Grant 07/1/21/19/495 from the Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore and Ministry of Education Tier 1 Grant R-154-000-498-112 (to Y.-K. M.).	Aguena M, 2002, MOL GENET GENOMICS, V268, P518, DOI 10.1007/s00438-002-0764-4; Anisimov R, 2005, INT J MED MICROBIOL, V295, P19, DOI 10.1016/j.ijmm.2004.11.007; Arribas-Bosacoma R, 2007, J MOL BIOL, V366, P626, DOI 10.1016/j.jmb.2006.11.038; Baek JH, 2007, FEMS MICROBIOL LETT, V277, P254, DOI 10.1111/j.1574-6968.2007.00965.x; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Buckles EL, 2006, MICROBIOL-SGM, V152, P153, DOI 10.1099/mic.0.28281-0; Carroll RK, 2009, J BIOL CHEM, V284, P12008, DOI 10.1074/jbc.M806261200; Chakraborty S, 2010, J BIOL CHEM, V285, P38876, DOI 10.1074/jbc.M110.179150; Cheng C, 2009, INFECT IMMUN, V77, P1936, DOI 10.1128/IAI.01246-08; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Dortay H, 2006, FEBS J, V273, P4631, DOI 10.1111/j.1742-4658.2006.05467.x; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; JANDA JM, 1993, CLIN INFECT DIS, V17, P742, DOI 10.1093/clinids/17.4.742; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Lamarche MG, 2008, J BACTERIOL, V190, P5256, DOI 10.1128/JB.01536-07; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lavrrar JL, 2003, J BACTERIOL, V185, P2194, DOI 10.1128/JB.185.7.2194-2202.2003; Lee HJ, 2003, J BACTERIOL, V185, P5891, DOI 10.1128/JB.185.19.5891-5896.2003; Lee HJ, 2007, J BACTERIOL, V189, P2629, DOI 10.1128/JB.01791-06; Liu JY, 2005, J BIOL CHEM, V280, P15960, DOI 10.1074/jbc.M414117200; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; Long J, 2008, SURGERY, V144, P189, DOI 10.1016/j.surg.2008.03.045; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Oganesyan V, 2005, J BACTERIOL, V187, P4238, DOI 10.1128/JB.187.12.4238-4244.2005; Pratt JT, 2010, MOL MICROBIOL, V77, P1595, DOI 10.1111/j.1365-2958.2010.07310.x; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rice CD, 2009, APPL ENVIRON MICROB, V75, P573, DOI 10.1128/AEM.01046-08; Rodgers ME, 2009, PROTEINS, V77, P202, DOI 10.1002/prot.22431; Schlenker C, 2009, BEST PRACT RES CL GA, V23, P89, DOI 10.1016/j.bpg.2008.11.014; SCHOLTEN M, 1993, MOL MICROBIOL, V8, P269, DOI 10.1111/j.1365-2958.1993.tb01571.x; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; STEED PM, 1993, J BACTERIOL, V175, P6797, DOI 10.1128/jb.175.21.6797-6809.1993; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Tan YP, 2002, INFECT IMMUN, V70, P6475, DOI 10.1128/IAI.70.11.6475-6480.2002; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Wang F, 2008, J MICROBIOL, V46, P350, DOI 10.1007/s12275-008-0038-x; Wang F, 2009, J MICROBIOL BIOTECHN, V19, P765, DOI 10.4014/jmb.0810.574; Wang QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007646; Wang X, 2009, FISH SHELLFISH IMMUN, V27, P469, DOI 10.1016/j.fsi.2009.06.013; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Zheng J, 2005, INFECT IMMUN, V73, P4127, DOI 10.1128/IAI.73.7.4127-4137.2005; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	56	94	98	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39417	39430		10.1074/jbc.M111.295188	http://dx.doi.org/10.1074/jbc.M111.295188			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21953460	Green Published, hybrid			2022-12-27	WOS:000296759800059
J	Guo, LW; Gao, LQ; Rothschild, J; Su, B; Gelman, IH				Guo, Li-Wu; Gao, Lingqiu; Rothschild, Julian; Su, Bing; Gelman, Irwin H.			Control of Protein Kinase C Activity, Phorbol Ester-induced Cytoskeletal Remodeling, and Cell Survival Signals by the Scaffolding Protein SSeCKS/GRAVIN/AKAP12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; GROWTH-FACTOR RECEPTOR; INDUCED APOPTOSIS; ONCOGENIC TRANSFORMATION; BINDING PROTEIN; SMOOTH-MUSCLE; CYCLIN-D; IN-VIVO; SUBSTRATE; SSECKS	The product of the SSeCKS/GRAVIN/AKAP12 gene ("SSeCKS") is a major protein kinase (PK) C substrate that exhibits tumor-and metastasis-suppressing activity likely through its ability to scaffold multiple signaling mediators such as PKC, PKA, cyclins, calmodulin, and Src. Although SSeCKS and PKC alpha bind phosphatidylserine, we demonstrate that phosphatidylserine-independent binding of PKC by SSeCKS is facilitated by two homologous SSeCKS motifs, EG(I/V)(T/S)-XWXSFK(K/R)(M/L)VTP(K/R)K(K/R)X(K/R)XXXEXXXE(E/D) (amino acids 592-620 and 741-769). SSeCKS binding to PKC alpha decreased kinase activity and was dependent on the two PKC-binding motifs. SSeCKS scaffolding of PKC was increased in confluent cell cultures, correlating with significantly increased SSeCKS protein levels and decreased PKC alpha activity, suggesting a role for SSeCKS in suppressing PKC activation during contact inhibition. SSeCKS-null mouse embryo fibroblasts displayed increased relative basal and phorbol ester (phorbol 12-myristate 13-acetate)-induced PKC activity but were defective in phorbol 12-myristate 13-acetate-induced actin cytoskeletal reorganization and cell shape change; these responses could be rescued by the forced expression of full-length SSeCKS but not by an SSeCKS variant deleted of its PKC-binding domains. Finally, the PKC binding sites in SSeCKS were required to restore cell rounding and/or decreased apoptosis in phorbol ester-treated LNCaP, LNCaP-C4-2, and MAT-LyLu prostate cancer cells. Thus, PKC-mediated remodeling of the actin cytoskeleton is likely regulated by the ability of SSeCKS to control PKC signaling and activity through a direct scaffolding function.	[Guo, Li-Wu; Gao, Lingqiu; Rothschild, Julian; Su, Bing; Gelman, Irwin H.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Gelman, IH (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	irwin.gelman@roswellpark.org			National Institutes of Health [CA94108, CA116430]; Comprehensive Cancer Center from the NCI [P30-CA016056]; United States Department of Defense [PC074228, PC101210]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA094108, R01CA116430, R55CA094108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center from the NCI; United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA94108 and CA116430 (to I. H. G.) and Comprehensive Cancer Center Grant P30-CA016056 from the NCI.; Supported by United States Department of Defense Grants PC074228 and PC101210.	Akakura S, 2008, CANCER RES, V68, P5096, DOI 10.1158/0008-5472.CAN-07-5619; Akakura S, 2010, CELL CYCLE, V9, P4656, DOI 10.4161/cc.9.23.13974; BAE VL, 1994, INT J CANCER, V58, P721, DOI 10.1002/ijc.2910580517; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; Bogatcheva NV, 2003, AM J PHYSIOL-LUNG C, V285, pL415, DOI 10.1152/ajplung.00364.2001; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Chapline C, 1996, J BIOL CHEM, V271, P6417, DOI 10.1074/jbc.271.11.6417; Chapline C, 1998, J BIOL CHEM, V273, P19482, DOI 10.1074/jbc.273.31.19482; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Diviani D, 2001, J CELL SCI, V114, P1431; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Garzotto M, 1998, CANCER RES, V58, P2260; Gelman IH, 1998, CELL MOTIL CYTOSKEL, V41, P1; Gelman IH, 2002, FRONT BIOSCI-LANDMRK, V7, pD1782, DOI 10.2741/gelman; Gelman Irwin H, 2010, Genes Cancer, V1, P1147, DOI 10.1177/1947601910392984; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Henttu P, 1998, BIOCHEM BIOPH RES CO, V244, P167, DOI 10.1006/bbrc.1998.8238; Ho A, 2001, CANCER RES, V61, P474; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hornia A, 1999, MOL CELL BIOL, V19, P7672; HYATT SL, 1994, CELL GROWTH DIFFER, V5, P495; IGARASHI K, 1995, J BIOL CHEM, V270, P29075, DOI 10.1074/jbc.270.49.29075; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; Koren R, 2004, ONCOL REP, V11, P321; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Leitges M, 2007, BIOCHEM SOC T, V35, P1018, DOI 10.1042/BST0351018; Lin XY, 2000, MOL CELL BIOL, V20, P7259, DOI 10.1128/MCB.20.19.7259-7272.2000; Lin XY, 1996, J BIOL CHEM, V271, P28430, DOI 10.1074/jbc.271.45.28430; Lin XY, 2002, BIOCHEM BIOPH RES CO, V290, P1368, DOI 10.1006/bbrc.2002.6357; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Moissoglu K, 2003, J BIOL CHEM, V278, P47946, DOI 10.1074/jbc.M302720200; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Nelson PJ, 1999, J CELL SCI, V112, P361; Nelson PJ, 1997, MOL CELL BIOCHEM, V175, P233, DOI 10.1023/A:1006836003758; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Piontek J, 2003, J BIOL CHEM, V278, P38970, DOI 10.1074/jbc.M306749200; SELKIRK JK, 1971, CANCER RES, V31, P27; SINGER HA, 1990, J PHARMACOL EXP THER, V252, P1068; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Stewart JR, 2005, MOL CANCER THER, V4, P726, DOI 10.1158/1535-7163.MCT-05-0013; Streb JW, 2004, J BIOL CHEM, V279, P56014, DOI 10.1074/jbc.M408828200; Su B, 2006, CANCER RES, V66, P5599, DOI 10.1158/0008-5472.CAN-05-4123; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Turbedsky K, 1997, BIOCHEMISTRY-US, V36, P2063, DOI 10.1021/bi9624651; VENEMA RC, 1993, BIOCHEM J, V294, P401, DOI 10.1042/bj2940401; Weber LP, 2000, BIOCHEM J, V352, P573, DOI 10.1042/0264-6021:3520573; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Xia W, 2001, CANCER RES, V61, P5644; Yamazaki Kosuke, 1995, In Vivo (Attiki), V9, P427; Yan XH, 2009, EXP CELL RES, V315, P1247, DOI 10.1016/j.yexcr.2008.12.026; YOUNG CYF, 1994, ONCOL RES, V6, P203	55	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38356	38366		10.1074/jbc.M111.258830	http://dx.doi.org/10.1074/jbc.M111.258830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21903576	Green Published, hybrid			2022-12-27	WOS:000296594200049
J	Xie, Q; Cvekl, A				Xie, Qing; Cvekl, Ales			The Orchestration of Mammalian Tissue Morphogenesis through a Series of Coherent Feed-forward Loops	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE REGULATORY NETWORKS; FACTOR C-MAF; FIBER CELL-DIFFERENTIATION; TRANSCRIPTION FACTOR PAX6; EMBRYONIC STEM-CELLS; PAIRED DOMAIN; LENS DEVELOPMENT; DNA-BINDING; MOUSE LENS; NASAL DEVELOPMENT	Tissue morphogenesis requires intricate temporal and spatial control of gene expression that is executed through specific gene regulatory networks (GRNs). GRNs are comprised from individual subcircuits of different levels of complexity. An important question is to elucidate the mutual relationship between those genes encoding DNA-binding factors that trigger the subcircuit with those that play major "later" roles during terminal differentiation via expression of specific genes that constitute the phenotype of individual tissues. The ocular lens is a classical model system to study tissue morphogenesis. Pax6 is essential for both lens placode formation and subsequent stages of lens morphogenesis, whereas c-Maf controls terminal differentiation of lens fibers, including regulation of crystallins, key lens structural proteins required for its transparency and refraction. Here, we show that Pax6 directly regulates c-Maf expression during lens development. A 1.3-kb c-Maf promoter with a 1.6-kb upstream enhancer (CR1) recapitulated the endogenous c-Maf expression pattern in lens and retinal pigmented epithelium. ChIP assays revealed binding of Pax6 and c-Maf to multiple regions of the c-Maf locus in lens chromatin. To predict functional Pax6-binding sites, nine novel variants of Pax6 DNA-binding motifs were identified and characterized. Two of these motifs predicted a pair of Pax6-binding sites in the CR1. Mutagenesis of these Pax6-binding sites inactivated transgenic expression in the lens but not in retinal pigmented epithelium. These data establish a novel regulatory role for Pax6 during lens development, link together the Pax6/c-Maf/crystallin regulatory network, and suggest a novel type of GRN subcircuit that controls a major part of embryonic lens development.	[Xie, Qing; Cvekl, Ales] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cvekl, A (corresponding author), 1300 Morris Pk Ave,Ullmann 123, Bronx, NY 10461 USA.	ales.cvekl@einstein.yu.edu	Cvekl, Ales/B-2427-2013		National Institutes of Health [EY012200, EY014237, EY014237S7]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY014237, R01EY012200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012200, EY014237, and EY014237S7. This work was also supported by an unrestricted grant from Research to Prevent Blindness.	Ali RR, 2011, NATURE, V472, P42, DOI 10.1038/472042a; Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chauhan BK, 2004, INVEST OPHTH VIS SCI, V45, P385, DOI 10.1167/iovs.03-0968; Chen Q, 2002, J BIOL CHEM, V277, P24081, DOI 10.1074/jbc.M201821200; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Civil A, 2002, NUCLEIC ACIDS RES, V30, P975, DOI 10.1093/nar/30.4.975; Collinson JM, 2001, P NATL ACAD SCI USA, V98, P9688, DOI 10.1073/pnas.161144098; Cvekl A, 2010, HEREDITY, V105, P135, DOI 10.1038/hdy.2010.16; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Donner AL, 2007, DEV BIOL, V303, P784, DOI 10.1016/j.ydbio.2006.10.047; Dressler GR, 2009, ORGANOGENESIS, V5, P73, DOI 10.4161/org.5.2.8930; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Duncan MK, 2000, J CELL SCI, V113, P3173; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Gunhaga L, 2011, PHILOS T R SOC B, V366, P1193, DOI 10.1098/rstb.2010.0175; Harada T, 2007, GENE DEV, V21, P367, DOI 10.1101/gad.1504307; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jun S, 1996, DEVELOPMENT, V122, P2639; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Kozmikova I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014650; Kusakabe M, 2011, BLOOD, V118, P1374, DOI 10.1182/blood-2010-08-300400; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Liu SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017904; Liu W, 2006, EMBO J, V25, P5383, DOI 10.1038/sj.emboj.7601398; MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5; Medina-Martinez O, 2007, DEVELOPMENT, V134, P1455, DOI 10.1242/dev.000117; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Nomura T, 2007, DEV GROWTH DIFFER, V49, P683, DOI 10.1111/j.1440-169x.2007.00965.x; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Rani A, 2011, J IMMUNOL, V187, P3721, DOI 10.4049/jimmunol.1002354; Ring BZ, 2000, DEVELOPMENT, V127, P307; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Sakai M, 2001, NUCLEIC ACIDS RES, V29, P1228, DOI 10.1093/nar/29.5.1228; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Shimoda Y, 2002, J BIOL CHEM, V277, P2033, DOI 10.1074/jbc.M108495200; Shoval O, 2010, CELL, V143, P326, DOI 10.1016/j.cell.2010.09.050; Singh S, 2002, P NATL ACAD SCI USA, V99, P6812, DOI 10.1073/pnas.102691299; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Suzuki A, 2005, ONCOGENE, V24, P6936, DOI 10.1038/sj.onc.1208844; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wolf LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004159; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Yang CB, 2010, FASEB J, V24, P3274, DOI 10.1096/fj.10-157255; Yang Y, 2004, J MOL BIOL, V344, P351, DOI 10.1016/j.jmb.2004.07.102; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114	80	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43259	43271		10.1074/jbc.M111.264580	http://dx.doi.org/10.1074/jbc.M111.264580			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21998302	Green Published, hybrid			2022-12-27	WOS:000298351300046
J	Lay, CS; Ludlow, LE; Stapleton, D; Bellamy-McIntyre, AK; Ramsland, PA; Drummer, HE; Poumbourios, P				Lay, Chan-Sien; Ludlow, Louise E.; Stapleton, David; Bellamy-McIntyre, Anna K.; Ramsland, Paul A.; Drummer, Heidi E.; Poumbourios, Pantelis			Role for the Terminal Clasp of HIV-1 gp41 Glycoprotein in the Initiation of Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; ALPHA-HELIX PROPENSITY; ENVELOPE GLYCOPROTEIN; ENTRY INHIBITORS; MONOCLONAL-ANTIBODIES; ATOMIC-STRUCTURE; MEDIATED FUSION; 6-HELIX BUNDLE; GP120	The binding by HIV-1 gp120 to CD4 and a chemokine receptor activates the membrane fusion glycoprotein, gp41. The fusion function of gp41 involves the refolding of its core into a 6-helix bundle, which apposes the lipophilic termini (the fusion peptide and transmembrane domain) and the associated cell and viral membranes, leading to their fusion. In this study, we examined the functional role of the polar segment and membrane proximal external region (MPER), which link the fusion peptide and transmembrane domain, respectively, to the core domain and interact to form a terminal clasp adjacent to the core. Limited proteolysis indicated that the terminal clasp is destabilized by simultaneous I535A/V539G; mutations within the polar segment and mutations within the MPER. The destabilizing effects of I535A/V539G correlated with defective cell-cell fusion, viral entry, and viral replication. By using lipophilic and cytoplasmic fluorescent dye transfer assays, we found that terminal clasp destabilization is linked to a block in the lipid mixing/hemifusion phase of the membrane fusion cascade. Because the biosynthesis of the prefusion gp120-gp41 complex did not appear to be affected by I535A/V539G, we infer that the hemifusion block is due to a specific effect on the trimer of hairpins conformation of gp41. By contrast, the decreased fusion function of the MPER mutants correlated with a decrease in the interfacial hydropathy of the MPER sequence, suggesting that the prefusion Ens' complex had been adversely affected in these cases. These findings reveal a novel conserved functional target for the discovery of fusion inhibitors.	[Lay, Chan-Sien; Bellamy-McIntyre, Anna K.; Ramsland, Paul A.; Drummer, Heidi E.; Poumbourios, Pantelis] Burnet Inst, Virus Fus Lab, Melbourne, Vic 3004, Australia; [Stapleton, David] Univ Melbourne, Dept Physiol, Melbourne, Vic 3010, Australia; [Ludlow, Louise E.; Drummer, Heidi E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Bellamy-McIntyre, Anna K.; Drummer, Heidi E.; Poumbourios, Pantelis] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg Austin Hlth, Heidelberg, Vic 3084, Australia	Burnet Institute; University of Melbourne; University of Melbourne; Monash University; Monash University; Austin Research Institute; University of Melbourne	Poumbourios, P (corresponding author), GPO Box 2284, Melbourne, Vic 3001, Australia.	apoumbourios@burnet.edu.au		Ramsland, Paul/0000-0002-2107-2738; Drummer, Heidi/0000-0002-0042-6277	National Health and Medical Research Council [543125, 433929]; Australian Centre for HIV and Hepatitis Virology Research	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Virology Research	This work was supported by National Health and Medical Research Council Grants 543125 and 433929 and the Australian Centre for HIV and Hepatitis Virology Research.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; Bjorndal A, 1997, J VIROL, V71, P7478; BLABER M, 1994, J MOL BIOL, V235, P600, DOI 10.1006/jmbi.1994.1016; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Center RJ, 2002, J VIROL, V76, P7863, DOI 10.1128/JVI.76.15.7863-7867.2002; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Ghaffari G, 2005, J VIROL, V79, P13250, DOI 10.1128/JVI.79.21.13250-13261.2005; HATCH WC, 1992, J IMMUNOL, V148, P3055; Hill MK, 2003, J VIROL, V77, P8329, DOI 10.1128/JVI.77.15.8329-8335.2003; Huang W, 2008, J VIROL, V82, P5584, DOI 10.1128/JVI.02676-07; Ji H, 1999, J VIROL, V73, P8578, DOI 10.1128/JVI.73.10.8578-8586.1999; Kilgore NR, 2003, J VIROL, V77, P7669, DOI 10.1128/JVI.77.13.7669-7672.2003; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lay CS, 2004, FEBS LETT, V567, P183, DOI 10.1016/j.febslet.2004.04.054; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Musich T, 2011, J VIROL, V85, P2397, DOI 10.1128/JVI.02187-10; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; PAGE KA, 1992, J VIROL, V66, P524, DOI 10.1128/JVI.66.1.524-533.1992; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Reeves JD, 2005, DRUGS, V65, P1747, DOI 10.2165/00003495-200565130-00002; Root MJ, 2004, CURR PHARM DESIGN, V10, P1805, DOI 10.2174/1381612043384448; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sackett K, 2003, J MOL BIOL, V333, P47, DOI 10.1016/j.jmb.2003.07.008; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Saez-Cirion A, 2003, BIOPHYS J, V85, P3769, DOI 10.1016/S0006-3495(03)74792-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; STEIN BS, 1990, J BIOL CHEM, V265, P2640; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Takikawa S, 2000, J VIROL, V74, P5066, DOI 10.1128/JVI.74.11.5066-5074.2000; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	62	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41331	41343		10.1074/jbc.M111.299826	http://dx.doi.org/10.1074/jbc.M111.299826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21976663	hybrid, Green Published			2022-12-27	WOS:000298057500020
J	Koster, S; Pavkov-Keller, T; Kuhlbrandt, W; Yildiz, O				Koester, Stefan; Pavkov-Keller, Tea; Kuehlbrandt, Werner; Yildiz, Oezkan			Structure of Human Na+/H+ Exchanger NHE1 Regulatory Region in Complex with Calmodulin and Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATED STRUCTURE SOLUTION; TARGET RECOGNITION; DIFFRACTION DATA; HEART-FAILURE; H+ EXCHANGER; BINDING; ACTIVATION; DOMAIN; PH; KINASE	The ubiquitous mammalian Na+/H+ exchanger NHE1 has critical functions in regulating intracellular pH, salt concentration, and cellular volume. The regulatory C-terminal domain of NHE1 is linked to the ion-translocating N-terminal membrane domain and acts as a scaffold for signaling complexes. A major interaction partner is calmodulin (CaM), which binds to two neighboring regions of NHE1 in a strongly Ca2+-dependent manner. Upon CaM binding, NHE1 is activated by a shift in sensitivity toward alkaline intracellular pH. Here we report the 2.23 angstrom crystal structure of the NHE1 CaM binding region (NHE1(CaMBR)) in complex with CaM and Ca2+-F. The C- and N-lobes of CaM bind the first and second helix of NHE1(CaMBR), respectively. Both the NHE1 helices and the Ca2+-bound CaM are elongated, as confirmed by small angle x-ray scattering analysis. Our x-ray structure sheds new light on the molecular mechanisms of the phosphorylation-dependent regulation of NHE1 and enables us to propose a model of how Ca2+ regulates NHE1 activity.	[Koester, Stefan; Pavkov-Keller, Tea; Kuehlbrandt, Werner; Yildiz, Oezkan] Max Planck Inst Biophys, Dept Struct Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany; [Pavkov-Keller, Tea] Graz Univ, Dept Struct Biol, Inst Mol Biosci, A-8010 Graz, Austria	Max Planck Society; University of Graz	Yildiz, O (corresponding author), Max Planck Inst Biophys, Dept Struct Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	Oezkan.Yildiz@biophys.mpg.de	Pavkov-Keller, Tea/K-9234-2015; Yildiz, Ozkan/P-9207-2016	Pavkov-Keller, Tea/0000-0001-7871-6680; Kuhlbrandt, Werner/0000-0002-2013-4810; Yildiz, Ozkan/0000-0003-3659-2805				Allen DG, 2003, CARDIOVASC RES, V57, P934, DOI 10.1016/S0008-6363(02)00836-2; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Ben Ammar Y, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Chen L, 2001, J PHARMACOL EXP THER, V298, P469; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Drum CL, 2000, J BIOL CHEM, V275, P36334, DOI 10.1074/jbc.M004778200; Engelhardt S, 2002, CIRC RES, V90, P814, DOI 10.1161/01.RES.0000014966.97486.C0; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Garnovskaya MN, 2003, J BIOL CHEM, V278, P16908, DOI 10.1074/jbc.M209883200; Goswami P, 2011, EMBO J, V30, P439, DOI 10.1038/emboj.2010.321; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Halling DB, 2009, J BIOL CHEM, V284, P20041, DOI 10.1074/jbc.M109.013326; Ikeda T, 1997, J BIOCHEM-TOKYO, V121, P295; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lee SH, 2008, BIOCHEM BIOPH RES CO, V369, P320, DOI 10.1016/j.bbrc.2008.01.168; Lefler D, 2003, ASSAY DRUG DEV TECHN, V1, P281, DOI 10.1089/15406580360545099; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Phan VN, 1997, HYPERTENSION, V29, P1265, DOI 10.1161/01.HYP.29.6.1265; POUYSSEGUR J, 1985, FEBS LETT, V190, P115, DOI 10.1016/0014-5793(85)80439-7; SANYAL G, 1988, BIOCHEMISTRY-US, V27, P6229, DOI 10.1021/bi00417a006; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Turner JH, 2007, J PHARMACOL EXP THER, V320, P314, DOI 10.1124/jpet.106.112581; Vertessy BG, 1998, BIOCHEMISTRY-US, V37, P15300, DOI 10.1021/bi980795a; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; Zaun HC, 2008, J BIOL CHEM, V283, P12456, DOI 10.1074/jbc.M800267200; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	55	44	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40954	40961		10.1074/jbc.M111.286906	http://dx.doi.org/10.1074/jbc.M111.286906			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21931166	hybrid, Green Published			2022-12-27	WOS:000297315400055
J	Le Nours, J; Bulloch, EMM; Zhang, Z; Greenwood, DR; Middleditch, MJ; Dickson, JMJ; Baker, EN				Le Nours, Jerome; Bulloch, Esther M. M.; Zhang, Zhening; Greenwood, David R.; Middleditch, Martin J.; Dickson, James M. J.; Baker, Edward N.			Structural Analyses of a Purine Biosynthetic Enzyme from Mycobacterium tuberculosis Reveal a Novel Bound Nucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE MONOPHOSPHATE CYCLOHYDROLASE; TRANSFORMYLASE-IMP CYCLOHYDROLASE; AVIAN AICAR TRANSFORMYLASE; CRYSTAL-STRUCTURE; RIBONUCLEOTIDE TRANSFORMYLASE; PROTEIN-PRODUCTION; MECHANISM; INHIBITORS; PURIFICATION; COMPLEX	Enzymes of the de novo purine biosynthetic pathway have been identified as essential for the growth and survival of Mycobacterium tuberculosis and thus have potential for the development of anti-tuberculosis drugs. The final two steps of this pathway are carried out by the bifunctional enzyme 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase (ATIC), also known as PurH. This enzyme has already been the target of anti-cancer drug development. We have determined the crystal structures of the M. tuberculosis ATIC (Rv0957) both with and without the substrate 5-aminoimidazole-4-carboxamide ribonucleotide, at resolutions of 2.5 and 2.2 angstrom, respectively. As for other ATIC enzymes, the protein is folded into two domains, the N-terminal domain (residues 1-212) containing the cyclohydrolase active site and the C-terminal domain (residues 222-523) containing the formyltransferase active site. An adventitiously bound nucleotide was found in the cyclohydrolase active site in both structures and was identified by NMR and mass spectral analysis as a novel 5-formyl derivative of an earlier intermediate in the biosynthetic pathway 4-carboxy-5-aminoimidazole ribonucleotide. This result and other studies suggest that this novel nucleotide is a cydohydrolase inhibitor. The dimer formed by M. tuberculosis ATIC is different from those seen for human and avian ATICs, but it has a similar similar to 50-angstrom separation of the two active sites of the bifunctional enzyme. Evidence in M. tuberculosis ATIC for reactivity of half-the-sites in the cyclohydrolase domains can be attributed to ligand-induced movements that propagate across the dimer interface and may be a common feature of ATIC enzymes.	[Bulloch, Esther M. M.; Greenwood, David R.; Middleditch, Martin J.; Dickson, James M. J.] Univ Auckland, Sch Biol Sci, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand	University of Auckland	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Auckland Mail Ctr, Private Bag 92019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz	Greenwood, David R/D-2375-2016	Greenwood, David R/0000-0001-5280-042X; Bulloch, Esther/0000-0002-4262-1791; Baker, Edward/0000-0003-2456-7661; Le Nours, Jerome/0000-0002-2221-7636	Foundation for Research, Science, and Technology of New Zealand; Health Research Council of New Zealand; Tertiary Education Commission through Maurice Wilkins Centre of Molecular Biodiscovery; Maurice Wilkins Centre for Molecular Biodiscovery; National Institutes of Health [P4IRR001209]; NCRR; NIGM; Department of Energy Office of Biological and Environmental Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Foundation for Research, Science, and Technology of New Zealand(New Zealand Foundation for Research, Science and Technology); Health Research Council of New Zealand(Health Research Council of New Zealand); Tertiary Education Commission through Maurice Wilkins Centre of Molecular Biodiscovery; Maurice Wilkins Centre for Molecular Biodiscovery; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGM; Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the Foundation for Research, Science, and Technology of New Zealand, the Health Research Council of New Zealand, and the Tertiary Education Commission through funding of the Maurice Wilkins Centre of Molecular Biodiscovery.; Supported by a doctorate scholarship from the Maurice Wilkins Centre for Molecular Biodiscovery. Present address: Biology Dept., Brookhaven National Laboratory, Upton, NY 11973.; Acknowledgments We thank Michael Schmitz for help with NMR spectroscopy and Patrick O'Connor for help with the calculations on CFAIR isomers, X-ray data were collected at the Stanford Synchrotron Radiation Lightsource, a Directorate of, SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science, Stanford University, The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by National Institutes of Health Grant P4IRR001209 from NCRR, Biomedical Technology Program, and NIGM and by the Department of Energy Office of Biological and Environmental Research.	Axelrod HL, 2008, PROTEINS, V71, P1042, DOI 10.1002/prot.21967; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Boger DL, 1997, BIOORGAN MED CHEM, V5, P1817, DOI 10.1016/S0968-0896(97)00120-X; Bricogne G, 2011, AUTO BUSTER VERSION; Cheong CG, 2004, J BIOL CHEM, V279, P18034, DOI 10.1074/jbc.M313691200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Ducati RG, 2011, CURR MED CHEM, V18, P1258; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDO T, 1983, J BACTERIOL, V155, P169, DOI 10.1128/JB.155.1.169-179.1983; Firestine SM, 2009, BIOORGAN MED CHEM, V17, P3317, DOI 10.1016/j.bmc.2009.03.043; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Greasley SE, 2001, NAT STRUCT BIOL, V8, P402, DOI 10.1038/87555; Groziak MP, 1997, J MED CHEM, V40, P3336, DOI 10.1021/jm970301s; GROZIAK MP, 1988, P NATL ACAD SCI USA, V85, P7174, DOI 10.1073/pnas.85.19.7174; Jackson RC., 1981, NUCLEOSIDES CANC TRE, P18; Kang YN, 2007, BIOCHEMISTRY-US, V46, P5050, DOI 10.1021/bi061637j; Kappock TJ, 2000, CURR OPIN CHEM BIOL, V4, P567, DOI 10.1016/S1367-5931(00)00133-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li CL, 2004, J MED CHEM, V47, P6681, DOI 10.1021/jm049504o; LITCHFIELD GJ, 1971, J CHEM SOC C, P817, DOI 10.1039/j39710000817; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; MUELLER WT, 1981, BIOCHEMISTRY-US, V20, P337, DOI 10.1021/bi00505a017; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rayl EA, 1996, J BIOL CHEM, V271, P2225, DOI 10.1074/jbc.271.4.2225; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scalmani G, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3359469; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SZABADOS E, 1994, BIOCHEMISTRY-US, V33, P14237, DOI 10.1021/bi00251a036; Tsuchiya Y, 2006, PROTEIN ENG DES SEL, V19, P421, DOI 10.1093/protein/gzl026; Vergis JM, 2004, BIOCHEMISTRY-US, V43, P1184, DOI 10.1021/bi035139b; Vergis JM, 2001, J BIOL CHEM, V276, P7727, DOI 10.1074/jbc.M009940200; Wall M, 2000, BIOCHEMISTRY-US, V39, P11303, DOI 10.1021/bi0007268; Wolan DW, 2004, BIOCHEMISTRY-US, V43, P1171, DOI 10.1021/bi030162i; Wolan DW, 2003, BIOCHEMISTRY-US, V42, P10904, DOI 10.1021/bi030106h; Wolan DW, 2002, BIOCHEMISTRY-US, V41, P15505, DOI 10.1021/bi020505x; Xu L, 2004, J BIOL CHEM, V279, P50555, DOI 10.1074/jbc.M406801200; Xu L, 2007, J BIOL CHEM, V282, P13033, DOI 10.1074/jbc.M607293200	42	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40706	40716		10.1074/jbc.M111.291138	http://dx.doi.org/10.1074/jbc.M111.291138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956117	Green Published, hybrid			2022-12-27	WOS:000297315400031
J	Soty, M; Visa, M; Soriano, S; Carmona, MD; Nadal, A; Novials, A				Soty, Maud; Visa, Montse; Soriano, Sergi; del Carmen Carmona, Maria; Nadal, Angel; Novials, Anna			Involvement of ATP-sensitive Potassium (K-ATP) Channels in the Loss of Beta-cell Function Induced by Human Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; STIMULATED INSULIN-SECRETION; ENDOPLASMIC-RETICULUM STRESS; HUMAN PANCREATIC-ISLETS; COMMON MECHANISM; MITOCHONDRIAL DYSFUNCTION; MEMBRANE DISRUPTION; DIABETES-MELLITUS; OLIGOMERS IMPLIES; FIBRIL FORMATION	Islet amyloid polypeptide (IAPP) is a major component of amyloid deposition in pancreatic islets of patients with type 2 diabetes. It is known that IAPP can inhibit glucose-stimulated insulin secretion; however, the mechanisms of action have not yet been established. In the present work, using a rat pancreatic beta-cell line, INS1E, we have created an in vitro model that stably expressed human IAPP gene (hIAPP cells). These cells showed intracellular oligomers and a strong alteration of glucose-stimulated insulin and IAPP secretion, Taking advantage of this model, we investigated the mechanism by which IAPP altered beta-cell secretory response and contributed to the development of type 2 diabetes. We have measured the intracellular Ca2+ mobilization in response to different secretagogues as well as mitochondrial metabolism. The study of calcium signals in hIAPP cells demonstrated an absence of response to glucose and also to tolbutamide, indicating a defect in ATP-sensitive potassium (K-ATP) channels. Interestingly, hIAPP showed a greater maximal respiratory capacity than control cells. These data were confirmed by an increased mitochondrial membrane potential in hIAPP cells under glucose stimulation, leading to an elevated reactive oxygen species level as compared with control cells. We concluded that the hIAPP overexpression inhibits insulin and IAPP secretion in response to glucose affecting the activity of K-ATP channels and that the increased mitochondrial metabolism is a compensatory response to counteract the secretory defect of beta-cells.	[Novials, Anna] Hosp Clin Barcelona, IDIBAPS, Diabets & Obes Lab, CEK, E-08036 Barcelona, Spain; [Soriano, Sergi; Nadal, Angel] Univ Miguel Hernandez, Inst Bioingn, Elche 03202, Spain; [Soty, Maud; Visa, Montse; Soriano, Sergi; Nadal, Angel; Novials, Anna] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08017, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Novials, A (corresponding author), Hosp Clin Barcelona, IDIBAPS, Diabets & Obes Lab, CEK, Planta 5,Calle Rossello 149-153, E-08036 Barcelona, Spain.	anovials@clinic.ub.es	Nadal, Angel/G-6721-2014; Soriano, Sergi/M-5255-2017; Visa, Montse/AAQ-8529-2021	Nadal, Angel/0000-0003-4178-2152; Soriano, Sergi/0000-0001-9844-7027; Novials, Anna/0000-0003-0465-2949	Fondo de Investigaciones Sanitarias (FIS) [PI08/0088]; Sarda Farriol Research Program; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); initiative of the Instituto de Salud Carlos III (ISCIII; Ministerio de Ciencia e Innovacion)	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Sarda Farriol Research Program; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); initiative of the Instituto de Salud Carlos III (ISCIII; Ministerio de Ciencia e Innovacion)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Fondo de Investigaciones Sanitarias (FIS) Grant PI08/0088, the Sarda Farriol Research Program, and CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), which is an initiative of the Instituto de Salud Carlos III (ISCIII; Ministerio de Ciencia e Innovacion).	Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Ahren B, 1998, DIABETOLOGIA, V41, P1374, DOI 10.1007/s001250051079; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BETSHOLTZ C, 1990, DIABETES, V39, P118, DOI 10.2337/diabetes.39.1.118; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; CLARK A, 1987, LANCET, V2, P231; COORDT MC, 1995, P SOC EXP BIOL MED, V209, P213; Craig TJ, 2008, J GEN PHYSIOL, V132, P131, DOI 10.1085/jgp.200709874; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Flanagan SE, 2007, DIABETES, V56, P1930, DOI 10.2337/db07-0043; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Gasa R, 1997, AM J PHYSIOL-ENDOC M, V272, pE543, DOI 10.1152/ajpendo.1997.272.4.E543; Gasa R, 1997, REGUL PEPTIDES, V68, P99, DOI 10.1016/S0167-0115(96)02109-X; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Gloyn AL, 2005, HUM MOL GENET, V14, P925, DOI 10.1093/hmg/ddi086; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hiddinga HJ, 1999, AM J PATHOL, V154, P1077, DOI 10.1016/S0002-9440(10)65360-6; Hull RL, 2009, DIABETOLOGIA, V52, P1102, DOI 10.1007/s00125-009-1329-4; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Li XL, 2011, INT J BIOCHEM CELL B, V43, P525, DOI 10.1016/j.biocel.2010.12.008; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MATTSON MP, 1995, BRAIN RES, V676, P219, DOI 10.1016/0006-8993(95)00148-J; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Novials A, 2004, DIABETOLOGIA, V47, P1167, DOI 10.1007/s00125-004-1439-y; NOVIALS A, 1993, DIABETES, V42, P1514, DOI 10.2337/diabetes.42.10.1514; OHSAWA H, 1989, BIOCHEM BIOPH RES CO, V160, P961, DOI 10.1016/0006-291X(89)92529-1; Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131; Pertusa JAG, 2002, DIABETES, V51, P2552, DOI 10.2337/diabetes.51.8.2552; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ravnskjaer K, 2005, ENDOCRINOLOGY, V146, P3266, DOI 10.1210/en.2004-1430; Ronner P, 2001, DIABETES, V50, P291, DOI 10.2337/diabetes.50.2.291; SALAS M, 1995, DIABETES METAB, V21, P269; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Sohal R S, 1985, Basic Life Sci, V35, P75; Soriano S, 2010, ENDOCRINOLOGY, V151, P3543, DOI 10.1210/en.2010-0008; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003235; Zhao HL, 2009, TRANSL RES, V153, P24, DOI 10.1016/j.trsl.2008.10.009; Zhu TH, 2011, DIABETES-METAB RES, V27, P28, DOI 10.1002/dmrr.1140; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x	60	28	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40857	40866		10.1074/jbc.M111.232801	http://dx.doi.org/10.1074/jbc.M111.232801			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21984830	Green Published, hybrid			2022-12-27	WOS:000297315400046
J	Walter, GM; Smith, MC; Wisen, S; Basrur, V; Elenitoba-Johnson, KSJ; Duennwald, ML; Kumar, A; Gestwicki, JE				Walter, Gladis M.; Smith, Matthew C.; Wisen, Susanne; Basrur, Venkatesha; Elenitoba-Johnson, Kojo S. J.; Duennwald, Martin L.; Kumar, Anuj; Gestwicki, Jason E.			Ordered Assembly of Heat Shock Proteins, Hsp26, Hsp70 Hsp90, and Hsp104, on Expanded Polyglutamine Fragments Revealed by Chemical Probes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP104; HEAT-SHOCK-PROTEIN-70 HSP70; PRION; AGGREGATION; HUNTINGTIN; TOXICITY; ATPASE; SUP35; DISAGGREGATION; ELIMINATION	In Saccharomyces cerevisae, expanded polyglutamine (polyQ) fragments are assembled into discrete cytosolic aggregates in a process regulated by the molecular chaperones Hsp26, Hsp70, Hsp90, and Hsp104. To better understand how the different chaperones might cooperate during polyQ aggregation, we used sequential immunoprecipitations and mass spectrometry to identify proteins associated with either soluble (Q25) or aggregation-prone (Q103) fragments at both early and later times after induction of their expression. We found that Hsp26, Hsp70, Hsp90, and other chaperones interact with Q103, but not Q25, within the first 2 h. Further, Hsp70 and Hsp90 appear to be partially released from Q103 prior to the maturation of the aggregates and before the recruitment of Hsp104. To test the importance of this seemingly ordered process, we used a chemical probe to artificially enhance Hsp70 binding to Q103. This treatment retained both Hsp70 and Hsp90 on the polyQ fragment and, interestingly, limited subsequent exchange for Hsp26 and Hsp104, resulting in incomplete aggregation. Together, these results suggest that partial release of Hsp70 may be an essential step in the continued processing of expanded polyQ fragments in yeast.	[Walter, Gladis M.; Smith, Matthew C.; Wisen, Susanne; Kumar, Anuj; Gestwicki, Jason E.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Walter, Gladis M.; Smith, Matthew C.; Wisen, Susanne; Basrur, Venkatesha; Elenitoba-Johnson, Kojo S. J.; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Kumar, Anuj] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Duennwald, Martin L.] Boston Biomed Res Inst, Watertown, MA 02472 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Boston Biomedical Research Institute	Gestwicki, JE (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	gestwick@umich.edu	Smith, Matthew/B-6787-2011	Smith, Matthew/0000-0001-8939-0161; Kumar, Anuj/0000-0002-8923-297X; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	NIH [NS059690, AG000114]; AFAR; Wood Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFAR; Wood Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Grant NS059690 (to J. E. G.) and grants from AFAR and the Wood Foundation (to M. L. D.).; Supported by NIH Predoctoral Fellowship AG000114.	Bagriantsev SN, 2008, MOL BIOL CELL, V19, P2433, DOI 10.1091/mbc.E08-01-0078; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Moosavi B, 2010, YEAST, V27, P167, DOI 10.1002/yea.1742; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patury S, 2009, CURR TOP MED CHEM, V9, P1337, DOI 10.2174/156802609789895674; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Reidy M, 2010, MOL CELL BIOL, V30, P3542, DOI 10.1128/MCB.01292-09; Rikhvanov EG, 2007, PRION, V1, P217, DOI 10.4161/pri.1.4.5058; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; Sherman MY, 2003, NEUROMOL MED, V4, P133, DOI 10.1385/NMM:4:1-2:133; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Song YT, 2005, J BIOL CHEM, V280, P34178, DOI 10.1074/jbc.M505420200; Summers DW, 2009, PRION, V3, P59, DOI 10.4161/pri.3.2.9062; Urakov VN, 2010, PRION, V4, P45, DOI 10.4161/pri.4.1.11074; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wiederhold E, 2010, MOL CELL PROTEOMICS, V9, P431, DOI 10.1074/mcp.R900002-MCP200; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wisen S, 2008, BIOORG MED CHEM LETT, V18, P60, DOI 10.1016/j.bmcl.2007.11.027; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Wiwatwattana N, 2007, NUCLEIC ACIDS RES, V35, pD810, DOI 10.1093/nar/gkl1000; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200	54	21	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40486	40493		10.1074/jbc.M111.284448	http://dx.doi.org/10.1074/jbc.M111.284448			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969373	Green Published, hybrid			2022-12-27	WOS:000297315400008
J	Yang, XY; Zhang, XD; Heckmann, BL; Lu, X; Liu, J				Yang, Xingyuan; Zhang, Xiaodong; Heckmann, Bradlee L.; Lu, Xin; Liu, Jun			Relative Contribution of Adipose Triglyceride Lipase and Hormone-sensitive Lipase to Tumor Necrosis Factor-alpha (TNF-alpha)-induced Lipolysis in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RELATED KINASE; TNF-ALPHA; PERILIPIN-A; STIMULATED LIPOLYSIS; MEDIATED LIPOLYSIS; 3T3-L1 ADIPOCYTES; PROTEIN; TISSUE; ACTIVATION; OVEREXPRESSION	TNF-alpha potently stimulates basal lipolysis in adipocytes, which may contribute to hyperlipidemia and peripheral insulin resistance in obesity. Recent studies show that adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) act sequentially in catalyzing the first two steps of adipose lipolysis in response to beta-adrenergic stimulation. Here, we sought to determine their functional roles in TNF-alpha-induced lipolysis. Silencing of ATGL expression in adipocytes almost completely abolished basal and TNF-alpha-induced glycerol release. In comparison, the glycerol release under the same conditions was only partially decreased upon reduction in expression of either HSL or the ATGL coactivator CGI-58. Interestingly, overexpression of ATGL restored the lipolytic rates in cells with silenced HSL or CGI-58, indicating a predominant role for ATGL. While expression of ATGL, HSL and CGI-58 remains mostly unaffected, TNF-alpha treatment caused a rapid abrogation of the ATGL inhibitory protein G0S2. TNF-alpha drastically decreased the level of G0S2 mRNA, and the level of G0S2 protein could be maintained by inhibiting proteasomal protein degradation using MG-132. Furthermore, coexpression of G0S2 was able to significantly decrease TNF-alpha-stimulated lipolysis mediated by overexpressed ATGL or CGI-58. We propose that the early reduction in G0S2 content is permissive for TNF-alpha-induced lipolysis.	[Yang, Xingyuan; Zhang, Xiaodong; Heckmann, Bradlee L.; Liu, Jun] Mayo Clin, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; [Yang, Xingyuan; Zhang, Xiaodong; Heckmann, Bradlee L.; Liu, Jun] Mayo Clin, Mayo ASU Ctr Metab & Vasc Biol, Scottsdale, AZ 85259 USA; Univ Kentucky, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Mayo Clinic; Mayo Clinic Phoenix; University of Kentucky	Liu, J (corresponding author), MCCRB 3-054,13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	liu.jun@mayo.edu		Heckmann, Bradlee/0000-0002-3271-7183	National Institutes of Health [DK089178]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089178, R56DK089178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK089178. This work was also supported by a Junior Faculty Award from the American Diabetes Association (to J. L.).	Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Fortier M, 2004, AM J PHYSIOL-ENDOC M, V287, pE282, DOI 10.1152/ajpendo.00203.2003; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Green A, 2004, DIABETES, V53, P74, DOI 10.2337/diabetes.53.1.74; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; Greenberg CC, 2003, J BIOL CHEM, V278, P30835, DOI 10.1074/jbc.M303846200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Landstrom TR, 2000, BIOCHEM J, V346, P337, DOI 10.1042/bj3460337; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lien CC, 2009, ENDOCRINOLOGY, V150, P4892, DOI 10.1210/en.2009-0403; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Okazaki H, 2002, DIABETES, V51, P3368, DOI 10.2337/diabetes.51.12.3368; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Plomgaard P, 2008, J CLIN ENDOCR METAB, V93, P543, DOI 10.1210/jc.2007-1761; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; Ren TT, 2006, J MOL ENDOCRINOL, V37, P175, DOI 10.1677/jme.1.02061; RIZACK MA, 1964, J BIOL CHEM, V239, P392; Ryden M, 2004, BIOCHEM BIOPH RES CO, V318, P168, DOI 10.1016/j.bbrc.2004.04.010; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Unger R. H, 2010, BIOCHIM BIOPHYS ACTA, V1801, P209; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VAUGHAN M, 1964, J BIOL CHEM, V239, P401; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; YEAMAN SJ, 1994, ADV ENZYME REGUL, V34, P355, DOI 10.1016/0065-2571(94)90022-1; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479	55	75	76	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40477	40485		10.1074/jbc.M111.257923	http://dx.doi.org/10.1074/jbc.M111.257923			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969372	Green Published, hybrid			2022-12-27	WOS:000297315400007
J	Du, JX; Hagos, EG; Nandan, MO; Bialkowska, AB; Yu, B; Yang, VW				Du, James X.; Hagos, Engda G.; Nandan, Mandayam O.; Bialkowska, Agnieszka B.; Yu, Bing; Yang, Vincent W.			The E3 Ubiquitin Ligase SMAD Ubiquitination Regulatory Factor 2 Negatively Regulates Kruppel-like Factor 5 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; TRANSCRIPTIONAL ACTIVATION; CELLULAR PROLIFERATION; DEPENDENT DEGRADATION; NEURONAL POLARITY; SMURF2; DOMAIN; ESTABLISHMENT; TARGETS; BINDING	The zinc finger transcription factor Kruppel-like factor 5 (KLF5) is regulated posttranslationally. We identified SMAD ubiquitination regulatory factor 2 (SMURF2), an E3 ubiquitin ligase, as an interacting protein of KLF5 by yeast two-hybrid screen, coimmunoprecipitation, and indirect immunofluorescence studies. The SMURF2-interacting domains in KLF5 were mapped to its carboxyl terminus, including the PY motif of KLF5 and its zinc finger DNA-binding domain. KLF5 protein levels were reduced significantly upon overexpression of SMURF2 but not catalytically inactive SMURF2-C716A mutant or SMURF1. SMURF2 alone reduced the protein stability of KLF5 as shown by cycloheximide chase assay, indicating that SMURF2 specifically destabilizes KLF5. In contrast, KLF5(1165), a KLF5 amino-terminal construct that lacks the PY motif and DNA binding domain, was not degraded by SMURF2. The degradation of KLF5 by SMURF2 was blocked by the proteasome inhibitor MG132, and SMURF2 efficiently ubiquitinated both overexpressed and endogenous KLF5. In contrast, knocking down SMURF2 by siRNAs significantly enhanced KLF5 protein levels, reduced ubiquitination of KLF5, and increased the expression of cyclin D1 and PDGF-A, two established KLF5 target genes. In consistence, SMURF2, but not the E3 ligase mutant SMURF2-C716A, significantly inhibited the transcriptional activity of KLF5, as demonstrated by dual luciferase assay using the PDGF-A promoter, and suppressed the ability of KLF5 to stimulate cell proliferation as measured by BrdU incorporation. Hence, SMURF2 is a novel E3 ubiquitin ligase for KLF5 and negatively regulates KLF5 by targeting it for proteasomal degradation.	[Du, James X.; Nandan, Mandayam O.; Bialkowska, Agnieszka B.; Yu, Bing; Yang, Vincent W.] Emory Univ, Sch Med, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA; [Yang, Vincent W.] Emory Univ, Sch Med, Dept Hematol & Oncol, Atlanta, GA 30322 USA; [Hagos, Engda G.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA	Emory University; Emory University; Colgate University	Yang, VW (corresponding author), SUNY Stony Brook, Sch Med, Dept Med, HSC-T16,Rm 020, Stony Brook, NY 11794 USA.	vincent.yang@stonybrook.edu	yu, bing/B-3078-2009; , ehagos/AAY-8486-2020; Yu, Bing/AAF-9459-2019	yu, bing/0000-0002-7259-8190; Yu, Bing/0000-0002-7259-8190; Mandayam, Nandan/0000-0002-4061-9348	National Institutes of Health [DK052230, DK064399, CA084197]; NATIONAL CANCER INSTITUTE [R01CA084197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK052230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052230, DK064399, and CA084197.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chong PA, 2006, J BIOL CHEM, V281, P17069, DOI 10.1074/jbc.M601493200; Conkright MD, 2001, J BIOL CHEM, V276, P29299, DOI 10.1074/jbc.M103670200; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Swamynathan Shivalingappa K., 2010, Human Genomics, V4, P263; Wilson VG, 2008, EXPERT REV PROTEOMIC, V5, P121, DOI 10.1586/14789450.5.1.121; Xie P, 2011, BIOCHEM BIOPH RES CO, V407, P254, DOI 10.1016/j.bbrc.2011.03.016; Zhang QB, 2005, GENE, V348, P25, DOI 10.1016/j.gene.2004.12.050; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	32	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40354	40364		10.1074/jbc.M111.258707	http://dx.doi.org/10.1074/jbc.M111.258707			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953463	hybrid, Green Published			2022-12-27	WOS:000296925700066
J	Parathath, S; Dogan, S; Joaquin, VA; Ghosh, S; Guo, L; Weibel, GL; Rothblat, GH; Harrison, EH; Fisher, EA				Parathath, Saj; Dogan, Snjezana; Joaquin, Victor A.; Ghosh, Snigdha; Guo, Liang; Weibel, Ginny L.; Rothblat, George H.; Harrison, Earl H.; Fisher, Edward A.			Rat Carboxylesterase ES-4 Enzyme Functions as a Major Hepatic Neutral Cholesteryl Ester Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ACYL-COA; ACYLTRANSFERASE INHIBITION; LIVER CARBOXYLESTERASES; REDUCES ATHEROSCLEROSIS; DENSITY-LIPOPROTEIN; APOLIPOPROTEIN B100; MOLECULAR-CLONING; FOAM CELL; EXPRESSION	Although esterification of free cholesterol to cholesteryl ester in the liver is known to be catalyzed by the enzyme acyl-coenzyme A: cholesterol acyltransferase, ACAT, the neutral cholesteryl ester hydrolase (nCEH) that catalyzes the reverse reaction has remained elusive. Because cholesterol undergoes continuous cycling between free and esterified forms, the steady-state concentrations in the liver of the two species and their metabolic availability for pathways, such as lipoprotein assembly and bile acid synthesis, depend upon nCEH activity. On the basis of the general characteristics of the family of rat carboxylesterases, we hypothesized that one member, ES-4, was a promising candidate as a hepatic nCEH. Using under-and overexpression approaches, we provide multiple lines of evidence that establish ES-4 as a bona fide endogenous nCEH that can account for the majority of cholesteryl ester hydrolysis in transformed rat hepatic cells and primary rat hepatocytes.	[Parathath, Saj; Dogan, Snjezana; Joaquin, Victor A.; Guo, Liang; Fisher, Edward A.] NYU, Med Ctr, Dept Med, New York, NY 10016 USA; [Parathath, Saj; Dogan, Snjezana; Joaquin, Victor A.; Guo, Liang; Fisher, Edward A.] NYU, Med Ctr, Marc & Ruti Bell Vasc Biol Program, New York, NY 10016 USA; [Ghosh, Snigdha; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [Weibel, Ginny L.; Rothblat, George H.] Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA	New York University; New York University; University System of Ohio; Ohio State University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Fisher, EA (corresponding author), NYU, Med Ctr, Dept Med, New York, NY 10016 USA.	edward.fisher@nyumc.org	Fisher, Edward/ABE-7469-2020; Parathath, Saj/ABE-2183-2021; Harrison, Earl H/AAN-5378-2021	Parathath, Sajesh/0000-0003-3431-297X; Fisher, Edward/0000-0001-9802-143X; Guo, Liang/0000-0003-1633-1544	National Institutes of Health [DK44498, HL58541]; Post-doctoral Fellowship [F32-HL087627-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL087627, R01HL058541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Post-doctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44498 (to E. H. H. and E. A. F.), HL58541 (to E. A. F.) and by Post-doctoral Fellowship F32-HL087627-1 (to S. P.). We would also like to thank Lisa Grauer and Courtney Blachford for expert technical assistance.	BEAUFAY H, 1974, J CELL BIOL, V61, P188, DOI 10.1083/jcb.61.1.188; BERNARD DW, 1990, ARTERIOSCLEROSIS, V10, P135, DOI 10.1161/01.ATV.10.1.135; BLACKHART BD, 1990, J BIOL CHEM, V265, P8358; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brewer HB, 2000, J CLIN INVEST, V105, P703, DOI 10.1172/JCI9664; BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1184-58; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; Camarota LM, 2004, J BIOL CHEM, V279, P27599, DOI 10.1074/jbc.M402946200; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Christian AE, 1997, J LIPID RES, V38, P2264; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; DURHAM LA, 1984, J BIOL CHEM, V259, P7433; Ghosh S, 1995, BBA-LIPID LIPID MET, V1259, P305, DOI 10.1016/0005-2760(95)00184-0; Ghosh S, 1998, AM J PHYSIOL-GASTR L, V274, pG662, DOI 10.1152/ajpgi.1998.274.4.G662; Ghosh S, 2000, PHYSIOL GENOMICS, V2, P1, DOI 10.1152/physiolgenomics.2000.2.1.1; GLICK JM, 1987, ATHEROSCLEROSIS, V64, P223, DOI 10.1016/0021-9150(87)90250-4; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; HAJJAR DP, 1983, J LIPID RES, V24, P1176; HAJJAR DP, 1983, J BIOL CHEM, V258, P192; HARRISON EH, 1990, J LIPID RES, V31, P2187; HOEG JM, 1982, BIOCHIM BIOPHYS ACTA, V711, P59, DOI 10.1016/0005-2760(82)90009-1; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Kraemer FB, 2002, ENDOCRINOLOGY, V143, P801, DOI 10.1210/en.143.3.801; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kusunoki J, 2001, CIRCULATION, V103, P2604; Liang JJ, 2004, J BIOL CHEM, V279, P44938, DOI 10.1074/jbc.M408507200; Linke T, 2005, J BIOL CHEM, V280, P23287, DOI 10.1074/jbc.M413585200; MENTLEIN R, 1987, BIOCHIM BIOPHYS ACTA, V913, P27, DOI 10.1016/0167-4838(87)90228-7; MENTLEIN R, 1988, BIOCHIM BIOPHYS ACTA, V964, P319, DOI 10.1016/0304-4165(88)90032-3; MINOR LK, 1989, J LIPID RES, V30, P189; MUKHERJEE JJ, 1993, BIOCHEM J, V295, P81, DOI 10.1042/bj2950081; NISHIDE T, 1985, TOHOKU J EXP MED, V146, P123, DOI 10.1620/tjem.146.123; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Poole M, 2001, TOXICOLOGY, V165, P109, DOI 10.1016/S0300-483X(01)00416-4; Riccalton-Banks L, 2003, MOL CELL BIOCHEM, V248, P97, DOI 10.1023/A:1024184826728; Robbi M, 1996, BIOCHEM J, V313, P821, DOI 10.1042/bj3130821; Rong JX, 2005, ARTERIOSCL THROM VAS, V25, P122, DOI 10.1161/01.ATV.0000148202.49842.3b; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Sanghani SP, 2002, EUR J BIOCHEM, V269, P4387, DOI 10.1046/j.1432-1033.2002.03121.x; Sekiya M, 2008, J LIPID RES, V49, P1829, DOI 10.1194/jlr.M800198-JLR200; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; van Bennekum AM, 1999, BIOCHEMISTRY-US, V38, P4150, DOI 10.1021/bi981680+; Vogel S, 2000, J LIPID RES, V41, P882; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485; ZOLFAGHARI R, 1993, J BIOL CHEM, V268, P13532	48	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39683	39692		10.1074/jbc.M111.258095	http://dx.doi.org/10.1074/jbc.M111.258095			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21937439	Green Published, hybrid			2022-12-27	WOS:000296925700002
J	Proto, WR; Castanys-Munoz, E; Black, A; Tetley, L; Moss, CX; Juliano, L; Coombs, GH; Mottram, JC				Proto, William R.; Castanys-Munoz, Esther; Black, Alana; Tetley, Laurence; Moss, Catherine X.; Juliano, Luiz; Coombs, Graham H.; Mottram, Jeremy C.			Trypanosoma brucei Metacaspase 4 Is a Pseudopeptidase and a Virulence Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; ARABIDOPSIS-THALIANA; OLIGOPEPTIDASE-B; EXPRESSION; PROTEINS; SYSTEM; IDENTIFICATION; PARASITEMIA; ACTIVATION; APOPTOSIS	Metacaspases are caspase family cysteine peptidases found in plants, fungi, and protozoa but not mammals. Trypanosoma brucei is unusual in having five metacaspases (MCA1-MCA5), of which MCA1 and MCA4 have active site substitutions, making them possible non-enzymatic homologues. Here we demonstrate that recombinant MCA4 lacks detectable peptidase activity despite maintaining a functional peptidase structure. MCA4 is expressed primarily in the bloodstream form of the parasite and associates with the flagellar membrane via dual myristoylation/palmitoylation. Loss of function phenotyping revealed critical roles for MCA4; rapid depletion by RNAi caused lethal disruption to the parasite's cell cycle, yet the generation of MCA4 null mutant parasites (Delta mca4) was possible. Delta mca4 had normal growth in axenic culture but markedly reduced virulence in mice. Further analysis revealed that MCA4 is released from the parasite and is specifically processed by MCA3, the only metacaspase that is both palmitoylated and enzymatically active. Accordingly, we have identified that the multiple metacaspases in T. brucei form a membrane-associated proteolytic cascade to generate a pseudopeptidase virulence factor.	[Proto, William R.; Castanys-Munoz, Esther; Black, Alana; Tetley, Laurence; Moss, Catherine X.; Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Juliano, Luiz] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, BR-04044020 Sao Paulo, Brazil; [Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 ORE, Lanark, Scotland	University of Glasgow; Universidade Federal de Sao Paulo (UNIFESP); University of Strathclyde	Mottram, JC (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	jeremy.mottram@glasgow.ac.uk	Complexos, INCT Fluidos/H-9172-2013; Juliano, Luiz/D-7204-2012	Juliano, Luiz/0000-0002-5589-2822; Mottram, Jeremy/0000-0001-5574-3766; Hamilton, Alana/0000-0001-5704-2293	Medical Research Council [G9722968, G0000508, G0700127]; MRC [G0000508, G0700127, G9722968] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants G9722968, G0000508, and G0700127.	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Ambit A, 2008, CELL DEATH DIFFER, V15, P113, DOI 10.1038/sj.cdd.4402232; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Bastin P, 1999, J CELL SCI, V112, P3769; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Burleigh BA, 1997, J CELL BIOL, V136, P609, DOI 10.1083/jcb.136.3.609; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Emmer BT, 2010, EUKARYOT CELL, V9, P934, DOI 10.1128/EC.00086-10; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; Field MC, 2004, MICROSC MICROANAL, V10, P621, DOI 10.1017/S1431927604040942; Geiger A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-20; Grebaut P, 2009, INT J PARASITOL, V39, P1137, DOI 10.1016/j.ijpara.2009.02.018; Helms MJ, 2006, J CELL SCI, V119, P1105, DOI 10.1242/jcs.02809; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Lee REC, 2010, P NATL ACAD SCI USA, V107, P13348, DOI 10.1073/pnas.1006610107; Lee REC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002956; Liu W, 2010, MOL BIOCHEM PARASIT, V169, P20, DOI 10.1016/j.molbiopara.2009.09.004; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; Morty RE, 2001, INFECT IMMUN, V69, P2757, DOI 10.1128/IAI.69.4.2757-2761.2001; Moss CX, 2007, FEBS LETT, V581, P5635, DOI 10.1016/j.febslet.2007.11.009; Mottram JC, 2003, TRENDS PARASITOL, V19, P182, DOI 10.1016/S1471-4922(03)00038-2; Munday JC, 2011, MOL BIOCHEM PARASIT, V175, P49, DOI 10.1016/j.molbiopara.2010.09.003; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Sarkany Z, 2003, BIOCHEMISTRY-US, V42, P516, DOI 10.1021/bi027004w; Silverman JM, 2011, CELL MICROBIOL, V13, P1, DOI 10.1111/j.1462-5822.2010.01537.x; Sundstrom JF, 2009, NAT CELL BIOL, V11, P1347, DOI 10.1038/ncb1979; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Webb H, 1997, J CELL BIOL, V139, P103, DOI 10.1083/jcb.139.1.103; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106; Zalila H, 2011, MOL MICROBIOL, V79, P222, DOI 10.1111/j.1365-2958.2010.07443.x; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	45	52	54	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39914	39925		10.1074/jbc.M111.292334	http://dx.doi.org/10.1074/jbc.M111.292334			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949125	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000296925700025
J	Hannibal, L; Somasundaram, R; Tejero, J; Wilson, A; Stuehr, DJ				Hannibal, Luciana; Somasundaram, Ramasamy; Tejero, Jesus; Wilson, Adjele; Stuehr, Dennis J.			Influence of Heme-Thiolate in Shaping the Catalytic Properties of a Bacterial Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOS-LIKE PROTEIN; DEINOCOCCUS-RADIODURANS; ELECTRON-TRANSFER; OXYGENASE DOMAIN; TRYPTOPHAN; INTERMEDIATE; PARAMETERS; REACTIVITY; NITRATION; OXIDATION	Nitric-oxide synthases (NOS) are heme-thiolate enzymes that generate nitric oxide (NO) from L-arginine. Mammalian and bacterial NOSs contain a conserved tryptophan (Trp) that hydrogen bonds with the heme-thiolate ligand. We mutated Trp(66) to His and Phe (W66H, W66F) in B. subtilis NOS to investigate how heme-thiolate electronic properties control enzyme catalysis. The mutations had opposite effects on heme midpoint potential (-302, -361, and -427 mV for W66H, wild-type (WT), and W66F, respectively). These changes were associated with rank order (W66H < WT < W66F) changes in the rates of oxygen activation and product formation in Arg hydroxylation and N-hydroxyarginine (NOHA) oxidation single turnover reactions, and in the O-2 reactivity of the ferrous heme-NO product complex. However, enzyme ferrous heme-O-2 autoxidation showed an opposite rank order. Tetrahydrofolate supported NO synthesis by WT and the mutant NOS. All three proteins showed similar extents of product formation (L-Arg -> NOHA or NOHA -> citrulline) in single turnover studies, but the W66F mutant showed a 2.5 times lower activity when the reactions were supported by flavoproteins and NADPH. We conclude that Trp(66) controls several catalytic parameters by tuning the electron density of the heme-thiolate bond. A greater electron density (as in W66F) improves oxygen activation and reactivity toward substrate, but decreases heme-dioxy stability and lowers the driving force for heme reduction. In the WT enzyme the Trp(66) residue balances these opposing effects for optimal catalysis.	[Hannibal, Luciana; Somasundaram, Ramasamy; Tejero, Jesus; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Wilson, Adjele] CEA IBITEC S, LSOD, F-91191 Gif Sur Yvette, France	Cleveland Clinic Foundation; CEA; UDICE-French Research Universities; Universite Paris Saclay	Stuehr, DJ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Tejero, Jesus/G-3953-2017; Hannibal, Luciana/AAY-7689-2021	Tejero, Jesus/0000-0003-3245-9978; Hannibal, Luciana/0000-0002-0911-5758; Wilson, Adjele Flore/0000-0003-2622-3600	National Institutes of Health [CA53914, GM51491, HL76491]; American Heart Association [11POST650034]; NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53914, GM51491, and HL76491 (to D. J. S.) and American Heart Association Postdoctoral Fellowship Grant 11POST650034 (to L. H.).	Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; ADMAN E, 1975, P NATL ACAD SCI USA, V72, P4854, DOI 10.1073/pnas.72.12.4854; Agapie T, 2009, P NATL ACAD SCI USA, V106, P16221, DOI 10.1073/pnas.0908443106; Bird LE, 2002, STRUCTURE, V10, P1687, DOI 10.1016/S0969-2126(02)00911-5; Brunel A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.195446; Buddha MR, 2005, J BIOL CHEM, V280, P31965, DOI 10.1074/jbc.M501568200; Buddha MR, 2004, J BIOL CHEM, V279, P49567, DOI 10.1074/jbc.C400418200; Buddha MR, 2004, P NATL ACAD SCI USA, V101, P15881, DOI 10.1073/pnas.0405483101; CARTER CW, 1977, J BIOL CHEM, V252, P7802; CHANG CK, 1973, J AM CHEM SOC, V95, P8477, DOI 10.1021/ja00806a062; Chartier FJM, 2004, BIOPHYS J, V87, P1939, DOI 10.1529/biophysj.104.042119; Chartier FJM, 2007, J BIOL CHEM, V282, P20877, DOI 10.1074/jbc.M701800200; Chartier FJM, 2007, BIOCHEM J, V401, P235, DOI 10.1042/BJ20060913; CHOUDHURY K, 1994, J BIOL CHEM, V269, P20239; Clark JP, 2006, J INORG BIOCHEM, V100, P1075, DOI 10.1016/j.jinorgbio.2005.11.020; Couture M, 2001, J BIOL CHEM, V276, P38280; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Crane BR, 2010, ANNU REV BIOCHEM, V79, P445, DOI 10.1146/annurev-biochem-062608-103436; Crane BR, 2008, BIOCHEM SOC T, V36, P1149, DOI 10.1042/BST0361149; Davydov R, 2009, J AM CHEM SOC, V131, P14493, DOI 10.1021/ja906133h; DEMONTIGNY P, 1987, ANAL CHEM, V59, P1096, DOI 10.1021/ac00135a007; Gautier C, 2006, NITRIC OXIDE-BIOL CH, V15, P312, DOI 10.1016/j.niox.2006.03.010; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI [DOI 10.2147/DDDT.S165440, 10.1002/cber.187901201117., DOI 10.1002/CBER.187901201117]; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; HANSON LK, 1979, INT J QUANTUM CHEM, V16, P73; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; Kabir M, 2008, BIOCHEMISTRY-US, V47, P12389, DOI 10.1021/bi801491e; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kinloch RD, 2010, J INORG BIOCHEM, V104, P357, DOI 10.1016/j.jinorgbio.2009.12.014; Lang J, 2009, J INORG BIOCHEM, V103, P1102, DOI 10.1016/j.jinorgbio.2009.05.011; Marechal A, 2010, FEBS J, V277, P3963, DOI 10.1111/j.1742-4658.2010.07786.x; Matsumura H, 2008, BIOCHEMISTRY-US, V47, P4834, DOI 10.1021/bi800142v; Montgomery HJ, 2010, BIOCHEM RES INT, V2010, DOI 10.1155/2010/489892; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13430, DOI 10.1021/bi010717e; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Pant K, 2005, J MOL BIOL, V352, P932, DOI 10.1016/j.jmb.2005.07.070; Ray SS, 2007, BIOCHEMISTRY-US, V46, P11857, DOI 10.1021/bi700803p; Reece SY, 2009, BIOCHEMISTRY-US, V48, P5483, DOI 10.1021/bi900385g; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Santolini M, 2006, BIOCHEMISTRY-US, V45, P1480, DOI 10.1021/bi051710q; Sudhamsu J, 2006, J BIOL CHEM, V281, P9623, DOI 10.1074/jbc.M510062200; Sudhamsu J, 2009, TRENDS MICROBIOL, V17, P212, DOI 10.1016/j.tim.2009.02.003; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Tejero J, 2011, BIOCHEM J, V433, P163, DOI 10.1042/BJ20101353; Ueyama N, 1996, INORG CHEM, V35, P6473, DOI 10.1021/ic9604324; VALENTINE JS, 1979, P NATL ACAD SCI USA, V76, P1009, DOI 10.1073/pnas.76.3.1009; Wang ZQ, 2007, J BIOL CHEM, V282, P2196, DOI 10.1074/jbc.M608206200; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; Wang ZQ, 2002, J BIOL CHEM, V277, P12830, DOI 10.1074/jbc.M111967200; Wei CC, 2003, BIOCHEMISTRY-US, V42, P1969, DOI 10.1021/bi026898h; Wilson DJ, 2001, BIOCHEM BIOPH RES CO, V287, P126, DOI 10.1006/bbrc.2001.5559; Yoshioka S, 2000, J INORG BIOCHEM, V81, P141, DOI 10.1016/S0162-0134(00)00097-0	63	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39224	39235		10.1074/jbc.M111.286351	http://dx.doi.org/10.1074/jbc.M111.286351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21921039	Green Published, hybrid			2022-12-27	WOS:000296759800041
J	Ramachandran, G; Udgaonkar, JB				Ramachandran, Gayathri; Udgaonkar, Jayant B.			Understanding the Kinetic Roles of the Inducer Heparin and of Rod-like Protofibrils during Amyloid Fibril Formation by Tau Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; THIOFLAVIN-T BINDING; FULL-LENGTH TAU; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; IN-VITRO; SULFATE PROTEOGLYCANS; MOLECULAR-MECHANISM; MICROTUBULE-BINDING; ALPHA-SYNUCLEIN	The aggregation of the natively disordered protein, Tau, to form lesions called neurofibrillary tangles is a characteristic feature of several neurodegenerative tauopathies. The polyanion, heparin, is commonly used as an inducer in studies of Tau aggregation in vitro, but there is surprisingly no comprehensive model describing, quantitatively, all aspects of the heparin-induced aggregation reaction. In this study, rate constants and extents of fibril formation by the four repeat domain of Tau (Tau4RD) have been reproducibly determined over a full range of heparin and protein concentrations. The kinetic role of heparin in the nucleation-dependent fibril formation reaction is shown to be limited to participation in the initial rate-limiting steps; a single heparin molecule binds two Tau4RD molecules, forming an aggregation-competent protein dimer, which then serves as a building block for further fibril growth. Importantly, the minimal kinetic model that is proposed can quantitatively account for the characteristic bell-shaped dependence of the aggregation kinetics on the stoichiometry of protein to heparin. Very importantly, this study also identifies for the first time short and thin, rod-like protofibrils that are populated transiently, early during the time course of fibril formation. The identification of these protofibrils as bona fide off-pathway species has implications for the development of therapies for tauopathies based on driving fibril formation as a means of protecting the cell from smaller, putatively toxic aggregates.	[Ramachandran, Gayathri; Udgaonkar, Jayant B.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Udgaonkar, JB (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.	jayant@ncbs.res.in			Tata Institute of Fundamental Research; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India; Government of India	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Government of India	This work was funded by the Tata Institute of Fundamental Research and by the Department of Biotechnology, Government of India.; Recipient of the SP Mukherjee Fellowship from the Council of Scientific and Industrial Research, Government of India.; Recipient of the JC Bose National Fellowship from the Government of India.	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Bazar E, 2010, CHEMBIOCHEM, V11, P1997, DOI 10.1002/cbic.201000207; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chang E, 2011, BBA-PROTEINS PROTEOM, V1814, P388, DOI 10.1016/j.bbapap.2010.10.005; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Csokova N, 2004, PROTEIN EXPRES PURIF, V35, P366, DOI 10.1016/j.pep.2004.01.012; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Fersht A., 1999, STRUCTURE MECH PROTE, P191; FRIEDEN C, 1983, BIOCHEMISTRY-US, V22, P5836, DOI 10.1021/bi00294a023; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Ginsberg SD, 1997, ANN NEUROL, V41, P200, DOI 10.1002/ana.410410211; Goedert M, 1999, AM J PATHOL, V154, P1, DOI 10.1016/S0002-9440(10)65242-X; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Inouye H, 2006, BIOPHYS J, V90, P1774, DOI 10.1529/biophysj.105.070136; Jain S, 2008, J MOL BIOL, V382, P1228, DOI 10.1016/j.jmb.2008.07.052; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; King ME, 1999, BIOCHEMISTRY-US, V38, P14851, DOI 10.1021/bi9911839; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Konno T, 2004, BIOCHEMISTRY-US, V43, P13613, DOI 10.1021/bi048549o; Kumar S, 2010, CURR SCI INDIA, V98, P639; Kumar S, 2009, BIOCHEMISTRY-US, V48, P6441, DOI 10.1021/bi900682w; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; MAGNUS JH, 1991, SCAND J IMMUNOL, V34, P63, DOI 10.1111/j.1365-3083.1991.tb01521.x; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Paudel HK, 1999, J BIOL CHEM, V274, P8029, DOI 10.1074/jbc.274.12.8029; Perez M, 1996, J NEUROCHEM, V67, P1183; PERRY G, 1991, J NEUROSCI, V11, P3679; Peterson DW, 2008, BIOCHEMISTRY-US, V47, P7393, DOI 10.1021/bi702466a; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pickhardt M, 2007, BIOCHEMISTRY-US, V46, P10016, DOI 10.1021/bi700878g; POLLANEN MS, 1994, AM J PATHOL, V144, P869; Rentzeperis D, 1999, NAT STRUCT BIOL, V6, P569; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; SNOW AD, 1992, J HISTOCHEM CYTOCHEM, V40, P105, DOI 10.1177/40.1.1370306; Spillantini MG, 1999, ACTA NEUROPATHOL, V97, P585, DOI 10.1007/s004010051034; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; SU JH, 1992, NEUROSCIENCE, V51, P801, DOI 10.1016/0306-4522(92)90521-3; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107; Wyman J, 1990, BINDING LINKAGE FUNC; Xu SH, 2010, ALZHEIMERS DEMENT, V6, P110, DOI 10.1016/j.jalz.2009.06.002; Yao TM, 2003, J BIOCHEM, V134, P91, DOI 10.1093/jb/mvg116; Yin HS, 2006, FEBS LETT, V580, P211, DOI 10.1016/j.febslet.2005.11.077; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	107	97	96	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38948	38959		10.1074/jbc.M111.271874	http://dx.doi.org/10.1074/jbc.M111.271874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21931162	hybrid, Green Published			2022-12-27	WOS:000296759800014
J	Ritchie, TK; Kwon, H; Atkins, WM				Ritchie, Tasha K.; Kwon, Hyewon; Atkins, William M.			Conformational Analysis of Human ATP-binding Cassette Transporter ABCB1 in Lipid Nanodiscs and Inhibition by the Antibodies MRK16 and UIC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN MULTIDRUG TRANSPORTER; HUMAN P-GLYCOPROTEIN; MONOCLONAL-ANTIBODY; DRUG-BINDING; DIFFERENTIAL IMMUNOREACTIVITY; NUCLEOTIDE-BINDING; CATALYTIC CYCLE; RESISTANCE; MECHANISM; VANADATE	The human ATP-binding cassette (ABC) transporter, P-glycoprotein (P-gp; ABCB1), mediates the ATP-dependent efflux of a variety of drugs. As a result, P-gp plays a critical role in tumor cell drug resistance and the pharmacokinetic properties of most drugs. P-gp exhibits extraordinary substrate and inhibitor promiscuity, resulting in a wide range of possible drug-drug interactions. Inhibitory antibodies have long been considered as a possible strategy to modulate P-gp-dependent cancer cell drug resistance, and it is widely suggested that the antibodies MRK16 and UIC2 inhibit P-gp by capturing a single isoform and preventing flux through the catalytic cycle. Although the crystal structures of many bacterial whole transporters, as well as isolated nucleotide-binding domains, have been solved, high resolution structural data for mammalian ABC transporters are currently lacking. It has been extremely difficult to determine the detailed mechanism of transport of P-gp, in part because it is difficult to obtain purified protein in well defined lipid systems. Here we exploit surface plasmon resonance (SPR) to probe conformational changes associated with these intermediate states for P-gp in lipid bilayer nanodiscs. The results indicate that P-gp in nanodiscs undergoes functionally relevant ligand-dependent conformational changes and that previously described inhibitory antibodies bind to multiple nucleotide-bound states but not the ADP-VO4-trapped state, which mimics the post-hydrolysis state. The results also suggest that the substrate drug vinblastine is released at stages that precede or follow the post-hydrolysis ADP-PO4 center dot P-gp complex.	[Ritchie, Tasha K.; Kwon, Hyewon; Atkins, William M.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Atkins, WM (corresponding author), Univ Washington, Dept Med Chem, Box 357610, Seattle, WA 98195 USA.	winky@u.washington.edu			National Institutes of Health [GM 32165, 62284]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062284, P01GM032165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 32165 and 62284 (to W. M. A.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P492; Bucher K, 2007, PHARM RES-DORDR, V24, P1993, DOI 10.1007/s11095-007-9326-0; Callaghan R, 2006, FEBS LETT, V580, P1056, DOI 10.1016/j.febslet.2005.11.083; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Crowley E, 2010, FEBS J, V277, P3974, DOI 10.1111/j.1742-4658.2010.07789.x; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Druley TE, 2001, BIOCHEMISTRY-US, V40, P4312, DOI 10.1021/bi001371v; GEORGES E, 1993, J BIOL CHEM, V268, P1792; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Goda K, 2002, EUR J BIOCHEM, V269, P2672, DOI 10.1046/j.1432-1033.2002.02929.x; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hsiao P, 2008, DRUG METAB DISPOS, V36, P481, DOI 10.1124/dmd.107.018176; HUNTER J, 1993, J BIOL CHEM, V268, P14991; HUNTER J, 1993, PHARMACEUT RES, V10, P743, DOI 10.1023/A:1018972102702; Jeynes B, 2011, NEUROSCI LETT, V487, P389, DOI 10.1016/j.neulet.2010.10.063; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kimura Y, 2007, CANCER SCI, V98, P1303, DOI 10.1111/j.1349-7006.2007.00538.x; KOBAYASHI Y, 1994, BIOCHEM PHARMACOL, V48, P1641, DOI 10.1016/0006-2952(94)90209-7; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2005, BIOCHEM BIOPH RES CO, V329, P419, DOI 10.1016/j.bbrc.2005.01.134; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Ruth A, 2001, BIOCHEMISTRY-US, V40, P4332, DOI 10.1021/bi001373f; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; SCHINKEL AH, 1993, INT J CANCER, V55, P478, DOI 10.1002/ijc.2910550326; Takeuchi T, 2006, PHARM RES, V23, P1460, DOI 10.1007/s11095-006-0285-7; Taub ME, 2005, DRUG METAB DISPOS, V33, P1679, DOI 10.1124/dmd.105.005421; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Zhou Y, 1999, ARCH BIOCHEM BIOPHYS, V367, P74, DOI 10.1006/abbi.1999.1221; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	49	54	55	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39489	39496		10.1074/jbc.M111.284554	http://dx.doi.org/10.1074/jbc.M111.284554			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937435	Green Published, hybrid			2022-12-27	WOS:000296759800066
J	Das, S; Rericha, EC; Bagorda, A; Parent, CA				Das, Satarupa; Rericha, Erin C.; Bagorda, Anna; Parent, Carole A.			Direct Biochemical Measurements of Signal Relay during Dictyostelium Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; COLLECTIVE CELL-MIGRATION; CYCLIC 3',5'-AMP RELAY; CHEMOATTRACTANT RECEPTOR; MEDIATED ACTIVATION; ADENYLYL-CYCLASE; DOWN-REGULATION; CAMP RECEPTOR; INDUCED PHOSPHORYLATION; DISCOIDEUM	Upon starvation, individual Dictyostelium discoideum cells enter a developmental program that leads to collective migration and the formation of a multicellular organism. The process is mediated by extracellular cAMP binding to the G protein-coupled cAMP receptor 1, which initiates a signaling cascade leading to the activation of adenylyl cyclase A (ACA), the synthesis and secretion of additional cAMP, and an autocrine and paracrine activation loop. The release of cAMP allows neighboring cells to polarize and migrate directionally and form characteristic chains of cells called streams. We now report that cAMP relay can be measured biochemically by assessing ACA, ERK2, and TORC2 activities at successive time points in development after stimulating cells with subsaturating concentrations of cAMP. We also find that the activation profiles of ACA, ERK2, and TORC2 change in the course of development, with later developed cells showing a loss of sensitivity to the relayed signal. We examined mutants in PKA activity that have been associated with precocious development and find that this loss in responsiveness occurs earlier in these mutants. Remarkably, we show that this loss in sensitivity correlates with a switch in migration patterns as cells transition from streams to aggregates. We propose that as cells proceed through development, the cAMP-induced desensitization and down-regulation of cAMP receptor 1 impacts the sensitivities of chemotactic signaling cascades leading to changes in migration patterns.	[Das, Satarupa; Bagorda, Anna; Parent, Carole A.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Rericha, Erin C.] Univ Maryland, Inst Res Elect & Appl Phys, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park	Parent, CA (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37,Rm 2066, Bethesda, MD 20892 USA.	parentc@mail.nih.gov		Das, Satarupa/0000-0002-4217-9972	National Institutes of Health NCI of the Center for Cancer Research; Burroughs Wellcome fund; NATIONAL CANCER INSTITUTE [ZIABC010418] Funding Source: NIH RePORTER	National Institutes of Health NCI of the Center for Cancer Research; Burroughs Wellcome fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health NCI Intramural Research Program of the Center for Cancer Research.; Recipient of a Career Award at the Scientific Interface from the Burroughs Wellcome fund.	Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Bader S, 2007, BIOCHEM J, V402, P153, DOI 10.1042/BJ20061153; Bagorda A, 2009, J CELL SCI, V122, P3907, DOI 10.1242/jcs.051987; BRENNER M, 1984, DEV BIOL, V101, P136, DOI 10.1016/0012-1606(84)90124-6; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; Brzostowski JA, 2006, MOL BIOL CELL, V17, P4220, DOI 10.1091/mbc.E06-05-0376; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; CATERINA MJ, 1995, J BIOL CHEM, V270, P4418, DOI 10.1074/jbc.270.9.4418; CATERINA MJ, 1995, J BIOL CHEM, V270, P8667, DOI 10.1074/jbc.270.15.8667; Charest PG, 2010, DEV CELL, V18, P737, DOI 10.1016/j.devcel.2010.03.017; Chen MY, 1997, GENE DEV, V11, P3218, DOI 10.1101/gad.11.23.3218; Comer FI, 2006, MOL BIOL CELL, V17, P357, DOI 10.1091/mbc.E05-08-0781; DEVREOTES PN, 1979, J CELL BIOL, V80, P300, DOI 10.1083/jcb.80.2.300; DINAUER MC, 1980, J CELL BIOL, V86, P545, DOI 10.1083/jcb.86.2.545; DINAUER MC, 1980, J CELL BIOL, V86, P537, DOI 10.1083/jcb.86.2.537; Garcia GL, 2008, J MICROSC-OXFORD, V231, P529, DOI 10.1111/j.1365-2818.2008.02066.x; Garcia GL, 2009, MOL BIOL CELL, V20, P3295, DOI 10.1091/mbc.E09-03-0223; HERELD D, 1994, J BIOL CHEM, V269, P7036; JOHNSON RL, 1991, BIOCHEMISTRY-US, V30, P6982, DOI 10.1021/bi00242a025; JOHNSON RL, 1992, J BIOL CHEM, V267, P4600; JOHNSON RL, 1993, GENE DEV, V7, P273, DOI 10.1101/gad.7.2.273; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kriebel PW, 2008, J CELL BIOL, V183, P949, DOI 10.1083/jcb.200808105; LACOMBE ML, 1986, J BIOL CHEM, V261, P6811; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laub MT, 1998, MOL BIOL CELL, V9, P3521, DOI 10.1091/mbc.9.12.3521; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Luttrell Louis M., 2006, V332, P3; Maeda M, 1996, J BIOL CHEM, V271, P3351; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Mann SKO, 1997, DEV BIOL, V183, P208, DOI 10.1006/dbio.1996.8499; McCann CP, 2010, J CELL SCI, V123, P1724, DOI 10.1242/jcs.060137; McMains VC, 2008, AGEING RES REV, V7, P234, DOI 10.1016/j.arr.2008.04.003; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; PARENT CA, 1995, J BIOL CHEM, V270, P22693, DOI 10.1074/jbc.270.39.22693; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Shaulsky G, 1998, DEVELOPMENT, V125, P691; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Thomason PA, 1999, J BIOL CHEM, V274, P27379, DOI 10.1074/jbc.274.39.27379; VANHAASTERT PJM, 1987, J BIOL CHEM, V262, P7700; VANHAASTERT PJM, 1994, BIOCHEM J, V303, P539, DOI 10.1042/bj3030539; WANG M, 1988, DEV BIOL, V128, P72, DOI 10.1016/0012-1606(88)90268-0; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xiao Z, 1999, J BIOL CHEM, V274, P1440, DOI 10.1074/jbc.274.3.1440; Zhang H, 2003, EUKARYOT CELL, V2, P62, DOI 10.1128/EC.2.1.62-75.2003; Zhang N, 2001, MOL BIOL CELL, V12, P3204, DOI 10.1091/mbc.12.10.3204	50	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38649	38658		10.1074/jbc.M111.284182	http://dx.doi.org/10.1074/jbc.M111.284182			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911494	hybrid, Green Published			2022-12-27	WOS:000296594200077
J	Shi, Q; Padmanabhan, R; Villegas, CJ; Gu, SM; Jiang, JX				Shi, Qian; Padmanabhan, Rugmani; Villegas, Carla J.; Gu, Sumin; Jiang, Jean X.			Membrane Topological Structure of Neutral System N/A Amino Acid Transporter 4 (SNAT4) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOGENIC SIGNALS; MOLECULAR-BIOLOGY; HUMAN PLACENTA; EXPRESSION; IDENTIFICATION; SUPERFAMILY; PREDICTIONS; MECHANISM; SEQUENCE; ISOFORM	Members of system N/A amino acid transporter (SNAT) family mediate transport of neutral amino acids, including L-alanine, L-glutamine, and L-histidine, across the plasma membrane and are involved in a variety of cellular functions. By using chemical labeling, glycosylation, immunofluorescence combined with molecular modeling approaches, we resolved the membrane topological structure of SNAT4, a transporter expressed predominantly in liver. To analyze the orientation using the chemical labeling and biotinylation approach, the "Cys-null" mutant of SNAT4 was first generated by mutating all five endogenous cysteine residues. Based on predicted topological structures, a single cysteine residue was introduced individually into all possible nontransmembrane domains of the Cys-null mutant. The cells expressing these mutants were labeled with N-biotinylaminoethyl methanethiosulfonate, a membrane-impermeable cysteine-directed reagent. We mapped the orientations of N- and C-terminal domains. There are three extracellular loop domains, and among them, the second loop domain is the largest that spans from amino acid residue similar to 242 to similar to 335. The orientation of this domain was further confirmed by the identification of two N-glycosylated residues, Asn-260 and Asn-264. Together, we showed that SNAT4 contains 10 transmembrane domains with extracellular N and C termini and a large N-glycosylated, extracellular loop domain. This is the first report concerning membrane topological structure of mammalian SNAT transporters, which will provide important implications for our understanding of structure-function of the members in this amino acid transporter family.	[Shi, Qian; Padmanabhan, Rugmani; Villegas, Carla J.; Gu, Sumin; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Shi, Qian/C-5962-2013	Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY12085]; Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R29EY012085, R01EY012085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported, in whole or in part, by National Institutes of Health Grant EY12085. This work was also supported by Welch Foundation Grant AQ-1507.	Ahmed Rezwan, 2010, Journal of Bioinformatics and Computational Biology, V8, P39, DOI 10.1142/S0219720010004501; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Broer S, 2009, J BIOL CHEM, V284, P25823, DOI 10.1074/jbc.M109.031013; Castagna M, 1997, J EXP BIOL, V200, P269; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Devoto A, 1999, J BIOL CHEM, V274, P34993, DOI 10.1074/jbc.274.49.34993; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gu SM, 2003, BIOCHEM J, V371, P721, DOI 10.1042/BJ20030049; Gu SM, 2001, GENOMICS, V74, P262, DOI 10.1006/geno.2001.6567; Gu SM, 2001, J BIOL CHEM, V276, P24137, DOI 10.1074/jbc.M009003200; Gu SM, 2000, P NATL ACAD SCI USA, V97, P3230, DOI 10.1073/pnas.050318197; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Hatanaka T, 2001, BBA-BIOMEMBRANES, V1510, P10, DOI 10.1016/S0005-2736(00)00390-4; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; LOO TW, 1995, J BIOL CHEM, V270, P19345, DOI 10.1074/jbc.270.33.19345; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Malandro MS, 1996, ANNU REV BIOCHEM, V65, P305; Nilsson J, 2000, FEBS LETT, V486, P267, DOI 10.1016/S0014-5793(00)02321-8; Novak D, 2006, BIOCHIMIE, V88, P39, DOI 10.1016/j.biochi.2005.07.002; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wang HP, 2000, BIOCHEM BIOPH RES CO, V273, P1175, DOI 10.1006/bbrc.2000.3061; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u; Zhang Z, 2011, BIOCHEM J, V434, P287, DOI 10.1042/BJ20100507; Zhang Z, 2009, J BIOL CHEM, V284, P25314, DOI 10.1074/jbc.M109.038422; Zheng WJ, 2004, COMPUT BIOL CHEM, V28, P265, DOI 10.1016/j.compbiolchem.2004.07.002	43	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38086	38094		10.1074/jbc.M111.220277	http://dx.doi.org/10.1074/jbc.M111.220277			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917917	Green Published, hybrid			2022-12-27	WOS:000296594200021
J	Xue, L; Aihara, E; Wang, TC; Montrose, MH				Xue, Lin; Aihara, Eitaro; Wang, Timothy C.; Montrose, Marshall H.			Trefoil Factor 2 Requires Na/H Exchanger 2 Activity to Enhance Mouse Gastric Epithelial Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER; TARGETED DISRUPTION; BARRIER HOMEOSTASIS; MUCOSAL RESTITUTION; RABBIT PARIETAL; ACID-SECRETION; CELL-MIGRATION; MUCOUS CELLS; SURFACE PH; IN-VIVO	Trefoil factor (TFF) peptides are pivotal for gastric restitution after surface epithelial damage, but TFF cellular targets that promote cell migration are poorly understood. Conversely, Na/H exchangers (NHE) are often implicated in cellular migration but have a controversial role in gastric restitution. Using intravital microscopy to create microscopic lesions in the mouse gastric surface epithelium and directly measure epithelial restitution, we evaluated whether TFFs and NHE isoforms share a common pathway to promote epithelial repair. Blocking Na/H exchange (luminal 10 mu M 5-(N-ethyl-N-isopropyl) amiloride or 25 mu M HOE694) slows restitution 72-83% in wild-type or NHE1(-/-) mice. In contrast, HOE694 has no effect on the intrinsically defective gastric restitution in NHE2(-/-) mice or TFF2(-/-) mice. In TFF2(-/-) mice, NHE2 protein is reduced 23%, NHE2 remains localized to apical membranes of surface epithelium, and NHE1 protein amount or localization is unchanged. The action of topical rat TFF3 to accelerate restitution in TFF2(-/-) mice was inhibited by AMD3100 (CXCR4 receptor antagonist). Furthermore, rat TFF3 did not rescue restitution when NHE2 was inhibited [TFF2(-/-) mice +HOE694, or NHE2(-/-) mice]. HOE694 had no effect on pH at the juxtamucosal surface before or after damage. We conclude that functional NHE2, but not NHE1, is essential for mouse gastric epithelial restitution and that TFFs activate epithelial repair via NHE2.	[Xue, Lin; Aihara, Eitaro; Montrose, Marshall H.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Wang, Timothy C.] Columbia Univ, Med Ctr, Div Digest & Liver Dis, New York, NY 10032 USA	University System of Ohio; University of Cincinnati; Columbia University	Montrose, MH (corresponding author), Univ Cincinnati, Dept Mol & Cellular Physiol, ML 0576,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	mhm@uc.edu		Wang, Timothy/0000-0001-5730-3019	National Institutes of Health [DK54940, DK060758, DK050594]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054940, R01DK060758, R01DK050594, R37DK050594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54940 (to M. H. M.), DK060758 (to T. C. W.) and DK050594 (Dr. Gary E. Shull).	Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P489, DOI 10.1053/gast.1996.v110.pm8566596; Bachmann O, 1998, AM J PHYSIOL-GASTR L, V275, pG1085, DOI 10.1152/ajpgi.1998.275.5.G1085; Baumgartner HK, 2002, J PHYSIOL-LONDON, V544, P871, DOI 10.1113/jphysiol.2002.024620; Behne MJ, 2002, J BIOL CHEM, V277, P47399, DOI 10.1074/jbc.M204759200; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Boivin GP, 2000, COMPARATIVE MED, V50, P511; Chu JS, 2002, AM J PHYSIOL-CELL PH, V283, pC358, DOI 10.1152/ajpcell.01380.2000; Chu SY, 1999, J CLIN INVEST, V103, P605, DOI 10.1172/JCI5217; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Demitrack ES, 2010, AM J PHYSIOL-GASTR L, V299, pG255, DOI 10.1152/ajpgi.00037.2010; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dubeykovskaya Z, 2009, J BIOL CHEM, V284, P3650, DOI 10.1074/jbc.M804935200; Farrell JJ, 2002, J CLIN INVEST, V109, P193, DOI 10.1172/JCI200212529; Furukawa O, 1999, J PHARMACOL EXP THER, V288, P620; Guan YF, 2011, AM J PHYSIOL-CELL PH, V300, pC1404, DOI 10.1152/ajpcell.00270.2010; Hagen SJ, 2004, AM J PHYSIOL-GASTR L, V286, pG596, DOI 10.1152/ajpgi.00390.2002; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Ilic D, 2007, AM J PATHOL, V170, P2055, DOI 10.2353/ajpath.2007.061277; JEFFREY GP, 1994, GASTROENTEROLOGY, V106, P336, DOI 10.1016/0016-5085(94)90590-8; Joutsi T, 1996, DIGEST DIS SCI, V41, P2187, DOI 10.1007/BF02071399; Kirchhoff P, 2003, AM J PHYSIOL-GASTR L, V285, pG1242, DOI 10.1152/ajpgi.00165.2003; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; LACY ER, 1984, LAB INVEST, V51, P573; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Moeser AJ, 2008, AM J PHYSIOL-GASTR L, V295, pG791, DOI 10.1152/ajpgi.00538.2007; Moeser AJ, 2006, AM J PHYSIOL-GASTR L, V291, pG885, DOI 10.1152/ajpgi.00380.2005; Musch MW, 2009, J PHARMACOL EXP THER, V330, P818, DOI 10.1124/jpet.109.151910; Nowak P, 2004, INT J MOL MED, V14, P175; Park SL, 2010, BRAIN RES, V1366, P189, DOI 10.1016/j.brainres.2010.09.077; Pizzonia JH, 1998, AM J PHYSIOL-RENAL, V275, pF510, DOI 10.1152/ajprenal.1998.275.4.F510; Rossmann H, 2001, AM J PHYSIOL-GASTR L, V281, pG447, DOI 10.1152/ajpgi.2001.281.2.G447; Schultheis PJ, 1998, J CLIN INVEST, V101, P1243, DOI 10.1172/JCI1249; Starodub OT, 2008, AM J PHYSIOL-CELL PH, V294, pC223, DOI 10.1152/ajpcell.00395.2006; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; STUARTTILLEY A, 1994, AM J PHYSIOL, V266, pC559, DOI 10.1152/ajpcell.1994.266.2.C559; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; THIM L, 1995, BIOCHEMISTRY-US, V34, P4757, DOI 10.1021/bi00014a033; Xue L, 2010, GUT, V59, P1184, DOI 10.1136/gut.2009.205625; Yanaka A, 2002, AM J PHYSIOL-GASTR L, V282, pG866, DOI 10.1152/ajpgi.00150.2001; YU FH, 1993, J BIOL CHEM, V268, P25536	43	43	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38375	38382		10.1074/jbc.M111.268219	http://dx.doi.org/10.1074/jbc.M111.268219			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900251	hybrid, Green Published			2022-12-27	WOS:000296594200051
J	Chandran, S; Li, H; Dong, WX; Krasinska, K; Adams, C; Alexandrova, L; Chien, A; Hallows, KR; Bhalla, V				Chandran, Sindhu; Li, Hui; Dong, Wuxing; Krasinska, Karolina; Adams, Chris; Alexandrova, Ludmila; Chien, Allis; Hallows, Kenneth R.; Bhalla, Vivek			Neural Precursor Cell-expressed Developmentally Down-regulated Protein 4-2 (Nedd4-2) Regulation by 14-3-3 Protein Binding at Canonical Serum and Glucocorticoid Kinase 1 (SGK1) Phosphorylation Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; UBIQUITIN LIGASE NEDD4-2; SODIUM-CHANNEL; FUNCTIONAL REGULATION; SURFACE EXPRESSION; LIDDLES-SYNDROME; ENAC REGULATION; ALDOSTERONE; INHIBITION; DEGRADATION	Regulation of epithelial Na+ channel (ENaC)-mediated transport in the distal nephron is a critical determinant of blood pressure in humans. Aldosterone via serum and glucocorticoid kinase 1 (SGK1) stimulates ENaC by phosphorylation of the E3 ubiquitin ligase Nedd4-2, which induces interaction with 14-3-3 proteins. However, the mechanisms of SGK1- and 14-3-3-mediated regulation of Nedd4-2 are unclear. There are three canonical SGK1 target sites on Nedd4-2 that overlap phosphorylation-dependent 14-3-3 interaction motifs. Two of these are termed "minor," and one is termed " major," based on weak or strong binding to 14-3-3 proteins, respectively. By mass spectrometry, we found that aldosterone significantly stimulates phosphorylation of a minor, relative to the major, 14-3-3 binding site on Nedd4-2. Phosphorylation-deficient minor site Nedd4-2 mutants bound less 14-3-3 than did wild-type (WT) Nedd4-2, and minor site Nedd4-2 mutations were sufficient to inhibit SGK1 stimulation of ENaC cell surface expression. As measured by pulse-chase and cycloheximide chase assays, a major binding site Nedd4-2 mutant had a shorter cellular half-life than WT Nedd4-2, but this property was not dependent on binding to 14-3-3. Additionally, a dimerization-deficient 14-3-3 epsilon mutant failed to bind Nedd4-2. We conclude that whereas phosphorylation at the Nedd4-2 major site is important for interaction with 14-3-3 dimers, minor site phosphorylation by SGK1 may be the relevant molecular switch that stabilizes Nedd4-2 interaction with 14-3-3 and thus promotes ENaC cell surface expression. We also propose that major site phosphorylation promotes cellular Nedd4-2 protein stability, which potentially represents a novel form of regulation for turnover of E3 ubiquitin ligases.	[Chandran, Sindhu; Dong, Wuxing; Bhalla, Vivek] Stanford Univ, Div Nephrol, Dept Med, Sch Med, Palo Alto, CA 94304 USA; [Li, Hui; Hallows, Kenneth R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, Pittsburgh, PA 15261 USA; [Krasinska, Karolina; Adams, Chris; Alexandrova, Ludmila; Chien, Allis] Stanford Univ, Mass Spectrometry Facil, Stanford, CA 94305 USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University	Bhalla, V (corresponding author), Stanford Univ, Div Nephrol, Dept Med, Sch Med, 780 Welch Rd,Suite 106, Palo Alto, CA 94304 USA.	vbhalla@stanford.edu	Chandran, Sindhu/AAE-6783-2021	Chandran, Sindhu/0000-0003-4547-3381; Hallows, Kenneth/0000-0002-2964-2440; Bhalla, Vivek/0000-0002-5420-9657; Chien, Allis/0000-0002-4805-2243	National Institutes of Health [T32 DK007357-26, R01 DK075048, K08 DK071648]; National Kidney Foundation [YIB787]; National Center for Research Resources [S10RR027425]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK071648, R01DK075048, R03DK083613, T32DK007357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 DK007357-26 (to S. C.), R01 DK075048 (to K. R. H), and K08 DK071648 (to V. B.). This work was also supported by National Kidney Foundation Young Investigator Grant YIB787 (to V. B.) and by National Center for Research Resources Award S10RR027425 (to the Stanford University Mass Spectrometry Facility).	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Hallows KR, 2010, J BIOL CHEM, V285, P21671, DOI 10.1074/jbc.M109.084731; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Itani OA, 2005, AM J PHYSIOL-RENAL, V289, pF334, DOI 10.1152/ajprenal.00394.2004; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Liang XB, 2010, MOL BIOL CELL, V21, P2024, DOI 10.1091/mbc.E10-01-0042; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	31	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37830	37840		10.1074/jbc.M111.293233	http://dx.doi.org/10.1074/jbc.M111.293233			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900244	Green Published, hybrid			2022-12-27	WOS:000296542400077
J	Lin, YS; Huang, LD; Lin, CH; Huang, PH; Chen, YJ; Wong, FH; Lin, CC; Fu, SL				Lin, Yong-Shiang; Huang, Li-De; Lin, Chao-Hsiung; Huang, Po-Hsiung; Chen, Yu-Jen; Wong, Fen-Hwa; Lin, Chun-Cheng; Fu, Shu-Ling			In Vitro and in Vivo Anticancer Activity of a Synthetic Glycolipid as Toll-like Receptor 4 (TLR4) Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE ACTIVATION; TUMOR-REGRESSION; DENDRITIC CELLS; BONE-MARROW; COMBINATION; GENE; LIPOPOLYSACCHARIDE; RECOGNITION; EXPRESSION; DIFFERENTIATION	Activation of Toll-like receptor 4 (TLR4) triggers the innate immune response and leads to the induction of adaptive immunity. TLR4 agonists are known to function as immunostimulants and exhibit promising therapeutic potential for cancer immunotherapy. We have previously developed a synthetic serine-based glycolipid (designated as CCL-34) that can activate TLR4-dependent signaling pathways. In this study, the anticancer immunity of CCL-34 was further demonstrated. CCL-34-activated macrophages induced cancer cell death via the apoptotic pathway, and this cytotoxicity was significantly inhibited by N-G-monomethyl-L-arginine (an inducible NOS inhibitor). Notably, conditioned medium collected from CCL-34-treated splenocytes also induced cytotoxicity toward cancer cells. Furthermore, CCL-34 treatment suppressed tumor growth and increased the survival rate in TLR4-functional C3H/HeN mice but not in TLR4-defective C3H/HeJ mice. Increased apoptosis, the induction of cytokines (IFN-gamma and IL-12) and chemokines (CXCL9 and CXCL10), and the elevation of leukocyte markers (CD11b, CD11c, CD4, and CD8) were detected at tumor sites in C3H/HeN mice but not in C3H/HeJ mice. Structure-and-activity relationship analysis of CCL-34 and its structural analogs revealed that a sugar moiety is essential for its activity. However, the substitution of the galactose in CCL-34 with glucose or fucose did not reduce its activity. Altogether, this study reveals the anticancer activity of a new synthetic TLR4 agonist and broadens the molecular basis of TLR4-activating glycolipids.	[Huang, Li-De; Lin, Chun-Cheng] Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan; [Lin, Yong-Shiang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 11221, Taiwan; [Lin, Yong-Shiang; Fu, Shu-Ling] Acad Sinica, Taipei 11221, Taiwan; [Lin, Yong-Shiang; Fu, Shu-Ling] Natl Yang Ming Univ, Program Mol Med, Taipei 11221, Taiwan; [Lin, Chao-Hsiung; Wong, Fen-Hwa] Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan; [Lin, Chao-Hsiung; Wong, Fen-Hwa] Natl Yang Ming Univ, Inst Genome Sci, Taipei 11221, Taiwan; [Huang, Po-Hsiung] Natl Yang Ming Univ, Inst Tradit Med, Taipei 11221, Taiwan; [Chen, Yu-Jen] Mackay Mem Hosp, Dept Radiat Oncol, Taipei 10449, Taiwan	National Tsing Hua University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital	Lin, CC (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.	cclin66@mx.nthu.edu.tw; slfu@ym.edu.tw			National Science Council [NSC 99-2320-B-010-009-MY3, 98-2323-B-007-001]; Ministry of Education [95A-C-D01-PPG-03]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education	This work was supported in part by National Science Council Grants NSC 99-2320-B-010-009-MY3 and 98-2323-B-007-001 and Ministry of Education, Aim for the Top University Plan, Grant 95A-C-D01-PPG-03.	Akazawa T, 2004, CANCER RES, V64, P757, DOI 10.1158/0008-5472.CAN-03-1518; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chen SA, 2000, CLIN CANCER RES, V6, P4381; Cluff CW, 2009, ADV EXP MED BIOL, V667, P111, DOI 10.1007/978-1-4419-1603-7_10; D'Agostini C, 2005, INT IMMUNOPHARMACOL, V5, P1205, DOI 10.1016/j.intimp.2005.02.013; Garay RP, 2007, EUR J PHARMACOL, V563, P1, DOI 10.1016/j.ejphar.2007.02.018; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Ho MY, 2010, CANCER SCI, V101, P2411, DOI 10.1111/j.1349-7006.2010.01691.x; Huang LD, 2011, ORG BIOMOL CHEM, V9, P2492, DOI 10.1039/c0ob00990c; Hung LC, 2007, BIOCHEM PHARMACOL, V73, P1957, DOI 10.1016/j.bcp.2007.03.006; Kamat AM, 2009, CANCER RES, V69, P8958, DOI 10.1158/0008-5472.CAN-09-2045; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lee CF, 2004, CANCER GENE THER, V11, P194, DOI 10.1038/sj.cgt.7700658; Lee CH, 2008, CLIN CANCER RES, V14, P1905, DOI 10.1158/1078-0432.CCR-07-2050; Liao HF, 2005, LIFE SCI, V77, P400, DOI 10.1016/j.lfs.2004.10.080; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mei K, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-63; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Okamoto M, 2003, JNCI-J NATL CANCER I, V95, P316, DOI 10.1093/jnci/95.4.316; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Persing DH, 2002, TRENDS MICROBIOL, V10, pS32, DOI 10.1016/S0966-842X(02)02426-5; Pfannes SDC, 2001, J LEUKOCYTE BIOL, V69, P590; Spadiut O, 2010, J AGR FOOD CHEM, V58, P3465, DOI 10.1021/jf9040047; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Thompson BS, 2005, J LEUKOCYTE BIOL, V78, P1273, DOI 10.1189/jlb.0305172; Udagawa M, 2006, CLIN CANCER RES, V12, P7465, DOI 10.1158/1078-0432.CCR-06-1840; Umansky V, 2001, ADV CANCER RES, V82, P107, DOI 10.1016/S0065-230X(01)82004-2; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312	34	19	24	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					43782	43792		10.1074/jbc.M111.285171	http://dx.doi.org/10.1074/jbc.M111.285171			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21949133	Green Published, hybrid			2022-12-27	WOS:000298402300021
J	Llanos, S; Royer, C; Lu, M; Bergamaschi, D; Lee, WH; Lu, X				Llanos, Susana; Royer, Christophe; Lu, Min; Bergamaschi, Daniele; Lee, Wen Hwa; Lu, Xin			Inhibitory Member of the Apoptosis-stimulating Proteins of the p53 Family (iASPP) Interacts with Protein Phosphatase 1 via a Noncanonical Binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPP; E2F; REGION	Background: Regulatory subunits confer substrate specificity to protein phosphatases. Results: iASPP, unlike ASPP2, interacts with protein phosphatase 1 (PP1) via a noncanonical binding motif within its SH3 domain. Conclusion: iASPP is a new PP1-binding partner. Significance: The identification of all ASPP family members as PP1-binding partners extends our understanding of how PP1 activity may be regulated in vivo.	[Llanos, Susana; Royer, Christophe; Lu, Min; Bergamaschi, Daniele; Lu, Xin] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res Ltd, Oxford OX3 7DQ, England; [Llanos, Susana] Spanish Natl Canc Res Ctr, E-28029 Madrid, Spain; [Bergamaschi, Daniele] Barts & London Queen Marys Sch Med & Dent, Ctr Cutaneous Res, Blizard Inst, London E1 2AT, England; [Lee, Wen Hwa] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England	Ludwig Institute for Cancer Research; University of Oxford; Centro Nacional de Investigaciones Oncologicas (CNIO); University of London; Queen Mary University London; University of Oxford	Lu, X (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res Ltd, Old Rd,Campus Res Bldg, Oxford OX3 7DQ, England.	xin.lu@ludwig.ox.ac.uk	lu, min/E-5407-2014; Lee, Wen Hwa/GZA-8183-2022; Lee, Wen Hwa/G-1250-2013; , Susana/AAA-9282-2019	Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225; Lu, Xin/0000-0002-6587-1152; Royer, Christophe/0000-0002-9882-7676; Bergamaschi, Daniele/0000-0002-3955-1091	Ludwig Institute for Cancer Research; Structural Genomics Consortium (SGC); Canadian Institutes for Health Research [1097737]; Canada Foundation for Innovation, Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Research and Innovation; Pfizer; Wellcome Trust	Ludwig Institute for Cancer Research; Structural Genomics Consortium (SGC); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation, Genome Canada(Genome CanadaCanada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Pfizer(Pfizer); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Ludwig Institute for Cancer Research.; Supported by the Structural Genomics Consortium (SGC). The SGC is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Research and Innovation, Pfizer, and the Wellcome Trust.	Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Fogal V, 2005, CELL DEATH DIFFER, V12, P369, DOI 10.1038/sj.cdd.4401562; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Helps NR, 1995, FEBS LETT, V377, P295, DOI 10.1016/0014-5793(95)01347-4; HELPS NR, 1994, FEBS LETT, V340, P93, DOI 10.1016/0014-5793(94)80179-7; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Robinson RA, 2008, STRUCTURE, V16, P259, DOI 10.1016/j.str.2007.11.012; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Slee EA, 2004, ONCOGENE, V23, P9007, DOI 10.1038/sj.onc.1208088; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015	22	23	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43039	43044		10.1074/jbc.M111.270751	http://dx.doi.org/10.1074/jbc.M111.270751			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21998301	hybrid, Green Published			2022-12-27	WOS:000298351300024
J	Misra, J; Chanda, D; Kim, DK; Li, TG; Koo, SH; Back, SH; Chiang, JYL; Choi, HS				Misra, Jagannath; Chanda, Dipanjan; Kim, Don-kyu; Li, Tiangang; Koo, Seung-Hoi; Back, Sung-Hoon; Chiang, John Y. L.; Choi, Hueng-Sik			Curcumin Differentially Regulates Endoplasmic Reticulum Stress through Transcriptional Corepressor SMILE (Small Heterodimer Partner-interacting Leucine Zipper Protein)-mediated Inhibition of CREBH (cAMP Responsive Element-binding Protein H)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER STRESS; HEPATIC GLUCONEOGENESIS; CREB/ATF-FAMILY; GENE-EXPRESSION; CELLS; KINASE; ZHANGFEI; LKB1; ATF6; PHOSPHORYLATION	Curcumin (diferuloylmethane), a major active component of turmeric (Curcuma longa), is a natural polyphenolic compound. Herein the effect of curcumin on endoplasmic reticulum (ER) stress responsive gene expression was investigated. We report that curcumin induces transcriptional corepressor small heterodimer partner-interacting leucine zipper protein (SMILE) gene expression through liver kinase B1 (LKB1)/adenosine monophosphate-activated kinase (AMPK) signaling pathway and represses ER stress-responsive gene transcription in an ER-bound transcription factor specific manner. cAMP responsive element-binding protein H (CREBH) and activating transcription factor 6 (ATF6) are both ER-bound bZIP family transcription factors that are activated upon ER stress. Of interest, we observed that both curcumin treatment and SMILE overexpression only represses CREBH-mediated transactivation of the target gene but not ATF6-mediated transactivation. Knockdown of endogenous SMILE significantly releases the inhibitory effect of curcumin on CREBH transactivation. Intrinsic repressive activity of SMILE is observed in the Gal4 fusion system, and the intrinsic repressive domain is mapped to the C terminus of SMILE spanning amino acid residues 203-269, corresponding to the basic region leucine zipper (bZIP) domain. In vivo interaction assay revealed that through its bZIP domain, SMILE interacts with CREBH and inhibits its transcriptional activity. Interestingly, we observed that SMILE does not interact with ATF6. Furthermore, competition between SMILE and the coactivator peroxisome proliferator-activated receptor alpha (PGC1 alpha) on CREBH transactivation has been demonstrated in vitro and in vivo. Finally, chromatin immunoprecipitation assays revealed that curcumin decreases the binding of PGC-1 alpha and CREBH on target gene promoter in a SMILE-dependent manner. Overall, for the first time we suggest a novel phenomenon that the curcumin/LKB1/AMPK/SMILE/PGC1 alpha pathway differentially regulates ER stress-mediated gene transcription.	[Misra, Jagannath; Chanda, Dipanjan; Kim, Don-kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Li, Tiangang; Chiang, John Y. L.] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, Gyeonggi Do, South Korea; [Back, Sung-Hoon] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju 501746, South Korea	Chonnam National University; Northeast Ohio Medical University (NEOMED); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); University of Ulsan; Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Ctr Nucl Receptor Signals, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Chiang, John Y. L./G-2658-2011; Chanda, Dipanjan/AAU-3996-2021; Koo, Seung-Hoi/E-2763-2015; Misra, Jagannath/AAW-8774-2021	Chiang, John Y. L./0000-0001-9360-7650; Chanda, Dipanjan/0000-0003-0685-187X; Koo, Seung-Hoi/0000-0001-8769-2879; Misra, Jagannath/0000-0001-9713-0298	National Institutes of Health [DK58379, DK44442]; Korean Ministry of Education, Science, and Technology [20110018305]; Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A100588]; National Research Foundation of Korea [20100019512]; Ministry of Education, Science, and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044442, R01DK058379, R56DK044442, R37DK058379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK58379 and DK44442 (to J. Y. L. C.). This work was supported by National Creative Research Initiatives Grant 20110018305 from the Korean Ministry of Education, Science, and Technology, Ministry for Health, Welfare, and Family Affairs, Republic of Korea, Korea Healthcare Technology R&D Project Grant A100588, and National Research Foundation of Korea Future-based Technology Development Program (BIO Fields) Grant 20100019512, funded by the Ministry of Education, Science, and Technology (to H.-S. C.).	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Akhova O, 2005, J VIROL, V79, P14708, DOI 10.1128/JVI.79.23.14708-14718.2005; Bush JA, 2001, EXP CELL RES, V271, P305, DOI 10.1006/excr.2001.5381; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Chin KT, 2005, NUCLEIC ACIDS RES, V33, P1859, DOI 10.1093/nar/gki332; Gomez G, 2007, BIOCHEM BIOPH RES CO, V364, P561, DOI 10.1016/j.bbrc.2007.10.024; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hogan MR, 2006, FEBS LETT, V580, P58, DOI 10.1016/j.febslet.2005.11.046; Howells LM, 2007, ACTA PHARMACOL SIN, V28, P1274, DOI 10.1111/j.1745-7254.2007.00690.x; Kamiya T, 2011, FREE RADICAL RES, V45, P692, DOI 10.3109/10715762.2011.567985; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Lim HW, 2009, BIOCHEM BIOPH RES CO, V389, P187, DOI 10.1016/j.bbrc.2009.08.121; Lu R, 2000, NUCLEIC ACIDS RES, V28, P2446, DOI 10.1093/nar/28.12.2446; Na LX, 2011, NUTR METAB CARDIOVAS, V21, P526, DOI 10.1016/j.numecd.2009.11.009; Nedumaran B, 2009, J BIOL CHEM, V284, P27511, DOI 10.1074/jbc.M109.034660; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Pizzo P, 2010, J CELL MOL MED, V14, P970, DOI [10.1111/j.1582-4934.2008.00681.x, 10.1111/j.1582-4934.2009.00681.x]; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Shishodia S, 2007, ADV EXP MED BIOL, V595, P127; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wang L, 2011, MOL CANCER THER, V10, P461, DOI 10.1158/1535-7163.MCT-10-0812; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	38	37	39	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41972	41984		10.1074/jbc.M111.274514	http://dx.doi.org/10.1074/jbc.M111.274514			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994947	Green Published, hybrid			2022-12-27	WOS:000298180900008
J	Chang, JR; Mukerjee, R; Bagashev, A; Del Valle, L; Chabrashvili, T; Hawkins, BJ; He, JJ; Sawaya, BE				Chang, J. Robert; Mukerjee, Ruma; Bagashev, Asen; Del Valle, Luis; Chabrashvili, Tinatin; Hawkins, Brian J.; He, Johnny J.; Sawaya, Bassel E.			HIV-1 Tat Protein Promotes Neuronal Dysfunction through Disruption of MicroRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NERVE GROWTH-FACTOR; TRANSACTIVATING PROTEIN; CELLULAR MICRORNA; TUMOR-SUPPRESSOR; RNA INTERFERENCE; REQUIRE FUNCTION; TRANSCRIPTION; TYPE-1; INVOLVEMENT	Over the last decade, small noncoding RNA molecules such as microRNAs (miRNAs) have emerged as critical regulators in the expression and function of eukaryotic genomes. It has been suggested that viral infections and neurological disease outcome may also be shaped by the influence of small RNAs. This has prompted us to suggest that HIV infection alters the endogenous miRNA expression patterns, thereby contributing to neuronal deregulation and AIDS dementia. Therefore, using primary cultures and neuronal cell lines, we examined the impact of a viral protein (HIV-1 Tat) on the expression of miRNAs due to its characteristic features such as release from the infected cells and taken up by noninfected cells. Using microRNA array assay, we demonstrated that Tat deregulates the levels of several miRNAs. Interestingly, miR-34a was among the most highly induced miRNAs in Tat-treated neurons. Tat also decreases the levels of miR-34a target genes such as CREB protein as shown by real time PCR. The effect of Tat was neutralized in the presence of anti-miR-34a. Using in situ hybridization assay, we found that the levels of miR-34a increase in Tat transgenic mice when compared with the parental mice. Therefore, we conclude that deregulation of neuronal functions by HIV-1 Tat protein is miRNA-dependent.	[Chang, J. Robert; Mukerjee, Ruma; Bagashev, Asen; Chabrashvili, Tinatin; Sawaya, Bassel E.] Temple Univ, Sch Med, Dept Neurol, Mol Studies Neurodegenerat Dis Lab, Philadelphia, PA 19140 USA; [Del Valle, Luis] Louisiana State Univ, Stanley S Scott Canc Ctr, Sch Med, Dept Med,Sect Hematol Oncol, New Orleans, LA 70112 USA; [Del Valle, Luis] Louisiana State Univ, Stanley S Scott Canc Ctr, Sch Med, Dept Pathol, New Orleans, LA 70112 USA; [Hawkins, Brian J.] Univ Washington, Mitochondria & Metab Ctr, Seattle, WA 98109 USA; [He, Johnny J.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Ctr AIDS Res, Indianapolis, IN 46202 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Louisiana State University System; Louisiana State University System; University of Washington; University of Washington Seattle; Indiana University System; Indiana University-Purdue University Indianapolis	Sawaya, BE (corresponding author), Temple Univ, Sch Med, Dept Neurol, Mol Studies Neurodegenerat Dis Lab, 3420 N Broad St, Philadelphia, PA 19140 USA.	sawaya@temple.edu	Xie, Huangming/B-2260-2012; Bagashev, Asen/D-2913-2011; Del Valle, Luis/J-4085-2015	Bagashev, Asen/0000-0001-9900-8106; Del Valle, Luis/0000-0003-3894-9206	National Institutes of Health from NINDS [R01-NS059327]; National Institutes of Health from NIMH [R01-MH093331]; Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health) [UL1 RR 025758]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL094536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092673, U01MH083545, R01MH093331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059327, R01NS076402] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; National Institutes of Health from NIMH; Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS059327 from NINDS and R01-MH093331 from NIMH (to B. E. S. and R. M.). This work was also supported by Harvard Catalyst, the Harvard Clinical and Translational Science Center (supported by National Institutes of Health Award UL1 RR 025758), and by Harvard University and its affiliated academic health care centers.	Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Brailoiu E, 2006, J NEUROVIROL, V12, P17, DOI 10.1080/13550280500516427; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Carter CC, 2011, CELL HOST MICROBE, V9, P223, DOI 10.1016/j.chom.2011.02.005; Cheng J, 1998, NEUROSCIENCE, V82, P97, DOI 10.1016/S0306-4522(97)00174-7; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Del Valle L, 2000, J NEUROVIROL, V6, P221, DOI 10.3109/13550280009015824; Del Valle L, 2006, FRONT BIOSCI-LANDMRK, V11, P718, DOI 10.2741/1830; Deshmane SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016148; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Eletto D, 2008, J CELL PHYSIOL, V216, P764, DOI 10.1002/jcp.21452; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; EVERALL I, 1995, J NEUROVIROL, V1, P126, DOI 10.3109/13550289509111017; Everall IP, 2002, MOL CELL NEUROSCI, V21, P493, DOI 10.1006/mcne.2002.1196; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Fitting S, 2008, BRAIN RES, V1232, P139, DOI 10.1016/j.brainres.2008.07.032; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Han Y, 2007, NAT MED, V13, P1138, DOI 10.1038/nm1007-1138; Hassan SS, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.016; Haughey NJ, 1999, J NEUROCHEM, V73, P1363, DOI 10.1046/j.1471-4159.1999.0731363.x; Hawkins BJ, 2007, MOL CELL BIOL, V27, P7582, DOI 10.1128/MCB.00493-07; HAYMAN M, 1993, NEUROSCIENCE, V53, P1, DOI 10.1016/0306-4522(93)90278-N; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Kriz J, 2000, BRAIN RES, V885, P32, DOI 10.1016/S0006-8993(00)02899-7; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Lau P, 2010, SEMIN CELL DEV BIOL, V21, P768, DOI 10.1016/j.semcdb.2010.01.009; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Li WX, 2009, NEUROTOX RES, V16, P205, DOI 10.1007/s12640-009-9047-8; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; Maggirwar SB, 1999, J NEUROCHEM, V73, P578, DOI 10.1046/j.1471-4159.1999.0730578.x; Maragos WF, 2003, NEUROSCIENCE, V117, P43, DOI 10.1016/S0306-4522(02)00713-3; Moser JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013445; Mukerjee R, 2008, CELL CYCLE, V7, P2682, DOI 10.4161/cc.7.17.6450; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Nohata N, 2011, ONCOTARGET, V2, P29; Norman JP, 2007, J IMMUNOL, V178, P869, DOI 10.4049/jimmunol.178.2.869; Norman JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003731; Peruzzi F, 2002, J NEUROVIROL, V8, P91, DOI 10.1080/13550280290167885; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Prendergast MA, 2002, BRAIN RES, V954, P300, DOI 10.1016/S0006-8993(02)03360-7; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Rom I, 2009, BRAIN RES, V1275, P81, DOI 10.1016/j.brainres.2009.03.024; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SABATIER JM, 1991, J VIROL, V65, P961, DOI 10.1128/JVI.65.2.961-967.1991; Sanders VJ, 2000, J NEUROSCI RES, V59, P671, DOI 10.1002/(SICI)1097-4547(20000301)59:5<671::AID-JNR10>3.0.CO;2-B; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Self RL, 2004, BRAIN RES, V995, P39, DOI 10.1016/j.brainres.2003.09.052; Shahabi HN, 2009, J NEURAL TRANSM, V116, P567, DOI 10.1007/s00702-009-0221-1; Singh IN, 2005, NEUROSCIENCE, V135, P781, DOI 10.1016/j.neuroscience.2005.05.028; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Watts PM, 1998, NEUROSCIENCE, V86, P511, DOI 10.1016/S0306-4522(97)00649-0; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Yamaguchi A, 1999, J CELL BIOL, V147, P1195, DOI 10.1083/jcb.147.6.1195; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yuan SH, 2009, P NATL ACAD SCI USA, V106, P2909, DOI 10.1073/pnas.0805555106; Zauli G, 2001, FASEB J, V15, P483, DOI 10.1096/fj.00-0354com; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131; Zieg J, 2008, CELL, V134, DOI 10.1016/j.cell.2008.09.010	79	60	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41125	41134		10.1074/jbc.M111.268466	http://dx.doi.org/10.1074/jbc.M111.268466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956116	Green Published, hybrid			2022-12-27	WOS:000297315400071
J	Eades, G; Yang, MH; Yao, Y; Zhang, YS; Zhou, Q				Eades, Gabriel; Yang, Muhua; Yao, Yuan; Zhang, Yongshu; Zhou, Qun			miR-200a Regulates Nrf2 Activation by Targeting Keap1 mRNA in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; OXIDATIVE STRESS; POSTTRANSCRIPTIONAL REGULATION; DNA METHYLATION; FEEDBACK LOOP; EXPRESSION; MICRORNAS; PROLIFERATION; MECHANISMS; CARCINOGENESIS	NE-E2-related factor 2 (Nrf2) is an important transcription factor that activates the expression of cellular detoxifying enzymes. Nrf2 expression is largely regulated through the association of Nrf2 with Kelch-like ECH-associated protein 1 (Keap1), which results in cytoplasmic Nrf2 degradation. Conversely, little is known concerning the regulation of Keap1 expression. Until now, a regulatory role for microRNAs (miRs) in controlling Keap1 gene expression had not been characterized. By using miR array-based screening, we observed miR-200a silencing in breast cancer cells and demonstrated that upon re-expression, miR-200a targets the Keap1 3'-untranslated region (3'-UTR), leading to Keap1 mRNA degradation. Loss of this regulatory mechanism may contribute to the dysregulation of Nrf2 activity in breast cancer. Previously, we have identified epigenetic repression of miR-200a in breast cancer cells. Here, we find that treatment with epigenetic therapy, the histone deacetylase inhibitor suberoylanilide hydroxamic acid, restored miR-200a expression and reduced Keap1 levels. This reduction in Keap1 levels corresponded with Nrf2 nuclear translocation and activation of Nrf2-dependent NAD(P)H-quinone oxidoreductase 1 (NQO1) gene transcription. Moreover, we found that Nrf2 activation inhibited the anchorage-independent growth of breast cancer cells. Finally, our in vitro observations were confirmed in a model of carcinogen-induced mammary hyperplasia in vivo. In conclusion, our study demonstrates that miR-200a regulates the Keap1/Nrf2 pathway in mammary epithelium, and we find that epigenetic therapy can restore miR-200a regulation of Keap1 expression, therefore reactivating the Nrf2-dependent antioxidant pathway in breast cancer.	[Eades, Gabriel; Yang, Muhua; Yao, Yuan; Zhang, Yongshu; Zhou, Qun] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Zhou, Q (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu			National Institutes of Health, NCI [NCI T32]; FAMRI; Maryland Stem Cell Fund; NATIONAL CANCER INSTITUTE [T32CA154274, P30CA134274] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FAMRI; Maryland Stem Cell Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Training Grant NCI T32 in cancer biology (to G. E.). This work was also supported by grants from FAMRI (to Q. Z.) and the Maryland Stem Cell Fund (to Q. Z.).	Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Aoki Y, 2007, CANCER RES, V67, P5643, DOI 10.1158/0008-5472.CAN-06-3355; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bolton JL, 2008, CHEM RES TOXICOL, V21, P93, DOI 10.1021/tx700191p; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Fields WR, 1999, CARCINOGENESIS, V20, P1121, DOI 10.1093/carcin/20.6.1121; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Hsieh TC, 2010, ANTICANCER RES, V30, P4169; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kovalchuk O, 2007, CELL CYCLE, V6, P2010, DOI 10.4161/cc.6.16.4549; Lee S, 2011, CELL MOL LIFE SCI, V68, P325, DOI 10.1007/s00018-010-0457-9; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Loignon M, 2009, MOL CANCER THER, V8, P2432, DOI 10.1158/1535-7163.MCT-08-1186; Mense SM, 2008, TOXICOL APPL PHARM, V232, P78, DOI 10.1016/j.taap.2008.06.007; Muscarella LA, 2011, EPIGENETICS-US, V6, P317, DOI 10.4161/epi.6.3.14408; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Rachakonda G, 2010, ONCOGENE, V29, P3703, DOI 10.1038/onc.2010.118; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Santini V, 2007, CURR DRUG METAB, V8, P383, DOI 10.2174/138920007780655397; Sarkar S, 2011, ANTICANCER RES, V31, P2723; Sato Y, 2001, LEUKEMIA, V15, P1193, DOI 10.1038/sj.leu.2402188; Shin DH, 2010, FREE RADICAL BIO MED, V48, P1051, DOI 10.1016/j.freeradbiomed.2010.01.021; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Tsai KW, 2009, EPIGENETICS-US, V4, P587, DOI 10.4161/epi.4.8.10230; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Voorhoeve PM, 2007, BBA-REV CANCER, V1775, P274, DOI 10.1016/j.bbcan.2006.11.003; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Yao YA, 2010, BREAST CANCER RES TR, V124, P585, DOI 10.1007/s10549-010-1023-8; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Yu SW, 2007, CURR CANCER DRUG TAR, V7, P416; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589; Zhou H, 2010, NUCLEIC ACIDS RES, V38, P3619, DOI 10.1093/nar/gkq084; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	52	224	237	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40725	40733		10.1074/jbc.M111.275495	http://dx.doi.org/10.1074/jbc.M111.275495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21926171	Green Published, hybrid			2022-12-27	WOS:000297315400033
J	Ueyama, T; Nakakita, J; Nakamura, T; Kobayashi, T; Kobayashi, T; Son, J; Sakuma, M; Sakaguchi, H; Leto, TL; Saito, N				Ueyama, Takehiko; Nakakita, Junya; Nakamura, Takashi; Kobayashi, Takeshi; Kobayashi, Toshihiro; Son, Jeonghyun; Sakuma, Megumi; Sakaguchi, Hirofumi; Leto, Thomas L.; Saito, Naoaki			Cooperation of p40(phox) with p47(phox) for Nox2-based NADPH Oxidase Activation during Fc gamma Receptor (Fc gamma R)-mediated Phagocytosis MECHANISM FOR ACQUISITION OF p40(phox) PHOSPHATIDYLINOSITOL 3-PHOSPHATE (PI(3)P) BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; R-MEDIATED PHAGOCYTOSIS; SRC HOMOLOGY-3 DOMAINS; PROTEIN-KINASE-C; SUBCELLULAR-LOCALIZATION; SH3 DOMAIN; PX DOMAINS; PHYSIOLOGICAL SIGNAL; CRYSTAL-STRUCTURE; MEMBRANE	During activation of the phagocyte (Nox2-based) NADPH oxidase, the cytoplasmic Phox complex (p47(phox)-p67(phox) p40(phox) translocates and associates with the membrane-spanning flavocytochrome b(558). It is unclear where (in cytoplasm or on membranes), when (before or after assembly), and how p40(phox) acquires its PI(3)P-binding capabilities. We demonstrated that in addition to conformational changes induced by H2O2 in the cytoplasm, p40(phox) acquires PI(3)P-binding through direct or indirect membrane targeting. We also found that p40(phox) is essential when p47(phox) is partially phosphorylated during Fc gamma R-mediated oxidase activation; however, p40(phox) is less critical when p47(phox) is adequately phosphorylated, using phosphorylation-mimicking mutants in HEK293(Nox2/Fc gamma RIIa) and RAW264.7(P40/P47KD) cells. Moreover, PI binding to p47(phox) is less important when the autoinhibitory PX-PB1 domain interaction in p40(phox) is disrupted or when p40(phox) is targeted to membranes. Furthermore, we suggest that high affinity PI(3)P binding of the p40(phox) PX domain is critical during its accumulation on phagosomes, even when masked by the PB1 domain in the resting state. Thus, in addition to mechanisms for directly acquiring P I(3)P binding in the cytoplasm by H2O2, p40(phox) can acquire PI(3)P binding on targeted membranes in a p47(phox)-dependent manner and functions both as a "carrier" of the cytoplasmic Phox complex to phagosomes and an "adaptor" of oxidase assembly on phagosomes in cooperation with p47(phox), using positive feedback mechanisms.	[Ueyama, Takehiko; Nakakita, Junya; Nakamura, Takashi; Son, Jeonghyun; Sakuma, Megumi; Saito, Naoaki] Kobe Univ, Mol Pharmacol Lab, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Kobayashi, Takeshi] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4668550, Japan; [Kobayashi, Toshihiro] Kobe Int Univ, Dept Phys Therapy, Kobe, Hyogo 6580032, Japan; [Sakaguchi, Hirofumi] Kyoto Prefectural Univ Med, Dept Otolaryng Head & Neck Surg, Kyoto 6028566, Japan; [Leto, Thomas L.] NIAID, Mol Def Sect, Lab Host Def, NIH, Rockville, MD 20852 USA	Kobe University; Nagoya University; Kyoto Prefectural University of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ueyama, T (corresponding author), Kobe Univ, Mol Pharmacol Lab, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan.	tueyama@kobe-u.ac.jp; naosaito@kobe-u.ac.jp	Saito, Nagahiro/I-6113-2014	Saito, Nagahiro/0000-0001-8757-3933	National Institutes of Health, NIAID; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science and Hungarian Academy of Sciences; Naito Foundation; Suzuken Memorial Foundation; Takeda Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23612002] Funding Source: KAKEN	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science and Hungarian Academy of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Suzuken Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the National Institutes of Health, NIAID, Intramural Research Program. This work was also supported in part by Grants-in-aid for scientific research; on the Global Center of Excellence Program, on Priority Areas "Transportsome," on Innovative Areas 'Fluorescence Live Imaging" and (C), from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was also supported by the "Japan-Hungary Research Cooperative Program" grant from the Japan Society for the Promotion of Science and Hungarian Academy of Sciences, by a grant from the Naito Foundation, by a grant from the Suzuken Memorial Foundation, and by a grant from the Takeda Science Foundation.	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; Alloul N, 2001, BIOCHEMISTRY-US, V40, P14557, DOI 10.1021/bi0117347; Bissonnette SA, 2008, J BIOL CHEM, V283, P2108, DOI 10.1074/jbc.M706639200; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; BOLSCHER BGJM, 1989, J CLIN INVEST, V83, P757, DOI 10.1172/JCI113954; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Boussetta T, 2010, BLOOD, V116, P5795, DOI 10.1182/blood-2010-03-273094; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Chen J, 2007, J BIOL CHEM, V282, P30273, DOI 10.1074/jbc.M704416200; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Chessa TAM, 2010, BLOOD, V116, P6027, DOI 10.1182/blood-2010-08-300889; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; deMendez I, 1996, EMBO J, V15, P1211, DOI 10.1002/j.1460-2075.1996.tb00462.x; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Ellson CD, 2001, CURR BIOL, V11, P1631, DOI 10.1016/S0960-9822(01)00447-X; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Fan LM, 2009, ARTERIOSCL THROM VAS, V29, P1651, DOI 10.1161/ATVBAHA.109.191502; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Furutani M, 2006, ANAL BIOCHEM, V355, P8, DOI 10.1016/j.ab.2006.05.014; Gillooly DJ, 2001, J CELL BIOL, V155, P15, DOI 10.1083/jcb.200109001; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Grandvaux N, 2001, BIOCHEM BIOPH RES CO, V287, P1009, DOI 10.1006/bbrc.2001.5665; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Kutateladze TG, 2007, PROG LIPID RES, V46, P315, DOI 10.1016/j.plipres.2007.06.001; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; Larsen EC, 2002, J CELL BIOL, V159, P939, DOI 10.1083/jcb.200205140; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Malkova S, 2006, BIOCHEMISTRY-US, V45, P13566, DOI 10.1021/bi061133l; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Miyano K, 2001, BIOCHEMISTRY-US, V40, P14089, DOI 10.1021/bi010882u; Ohmori S, 1998, MOL CELL BIOL, V18, P5263, DOI 10.1128/MCB.18.9.5263; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; Sathyamoorthy M, 1997, J BIOL CHEM, V272, P9141; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; SEGAL AW, 1985, NATURE, V316, P547, DOI 10.1038/316547a0; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Ueyama T, 2005, J IMMUNOL, V175, P2381, DOI 10.4049/jimmunol.175.4.2381; Ueyama T, 2004, J IMMUNOL, V173, P4582, DOI 10.4049/jimmunol.173.7.4582; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Ueyama T, 2007, FREE RADICAL BIO MED, V42, P180, DOI 10.1016/j.freeradbiomed.2006.08.024; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Umada-Kajimoto S, 2006, BIOCHEM BIOPH RES CO, V341, P101, DOI 10.1016/j.bbrc.2005.12.161; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wientjes FB, 2001, BIOCHEM BIOPH RES CO, V289, P382, DOI 10.1006/bbrc.2001.5982	73	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40693	40705		10.1074/jbc.M111.237289	http://dx.doi.org/10.1074/jbc.M111.237289			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21956105	hybrid, Green Published			2022-12-27	WOS:000297315400030
J	Galeazzi, L; Bocci, P; Amici, A; Brunetti, L; Ruggieri, S; Romine, M; Reed, S; Osterman, AL; Rodionov, DA; Sorci, L; Raffaelli, N				Galeazzi, Luca; Bocci, Paola; Amici, Adolfo; Brunetti, Lucia; Ruggieri, Silverio; Romine, Margaret; Reed, Samantha; Osterman, Andrei L.; Rodionov, Dmitry A.; Sorci, Leonardo; Raffaelli, Nadia			Identification of Nicotinamide Mononucleotide Deamidase of the Bacterial Pyridine Nucleotide Cycle Reveals a Novel Broadly Conserved Amidohydrolase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPETENCE-INDUCED OPERON; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; NAD METABOLISM; DIPHOSPHOPYRIDINE NUCLEOTIDE; PROTEIN; BIOSYNTHESIS; RECA; ENZYMES	The pyridine nucleotide cycle is a network of salvage and recycling routes maintaining homeostasis of NAD(P) cofactor pool in the cell. Nicotinamide mononucleotide (NMN) deamidase (EC 3.5.1.42), one of the key enzymes of the bacterial pyridine nucleotide cycle, was originally described in Enterobacteria, but the corresponding gene eluded identification for over 30 years. A genomics-based reconstruction of NAD metabolism across hundreds of bacterial species suggested that NMN deamidase reaction is the only possible way of nicotinamide salvage in the marine bacterium Shewanella oneidensis. This prediction was verified via purification of native NMN deamidase from S. oneidensis followed by the identification of the respective gene, termed pncC. Enzymatic characterization of the PncC protein, as well as phenotype analysis of deletion mutants, confirmed its proposed biochemical and physiological function in S. oneidensis. Of the three PncC homologs present in Escherichia coli, NMN deamidase activity was confirmed only for the recombinant purified product of the ygaD gene. A comparative analysis at the level of sequence and three-dimensional structure, which is available for one of the PncC family member, shows no homology with any previously described amidohydrolases. Multiple alignment analysis of functional and nonfunctional PncC homologs, together with NMN docking experiments, allowed us to tentatively identify the active site area and conserved residues therein. An observed broad phylogenomic distribution of predicted functional PncCs in the bacterial kingdom is consistent with a possible role in detoxification of NMN, resulting from NAD utilization by DNA ligase.	[Galeazzi, Luca; Bocci, Paola; Amici, Adolfo; Brunetti, Lucia; Ruggieri, Silverio; Sorci, Leonardo; Raffaelli, Nadia] Univ Politecn Marche, Dept Mol Pathol & Innovat Therapies, Biochem Sect, I-60131 Ancona, Italy; [Osterman, Andrei L.; Rodionov, Dmitry A.; Sorci, Leonardo] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Romine, Margaret; Reed, Samantha] Pacific NW Natl Lab, Richland, WA 99352 USA	Marche Polytechnic University; Sanford Burnham Prebys Medical Discovery Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Raffaelli, N (corresponding author), Dipt Patol Mol Terapie Innovat, Sez Biochim, Via Ranieri, I-60131 Ancona, Italy.	n.raffaelli@univpm.it	SORCI, LEONARDO/AAD-7395-2019; Amici, Adolfo/C-5342-2012; Rodionov, Dmitry/V-2688-2018	SORCI, LEONARDO/0000-0002-4356-8873; Amici, Adolfo/0000-0002-1081-7749; Romine, Margaret/0000-0002-0968-7641; Rodionov, Dmitry/0000-0002-0939-390X	Italian Minister of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese"; U.S. Department of Energy, Office of Biological and Environmental Research	Italian Minister of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese"; U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was partly supported by the Italian Minister of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese." The research at the Pacific Northwest National Laboratory and Sanford Burnham Institute was supported by the U.S. Department of Energy, Office of Biological and Environmental Research, as part of the Genomic Science Program. Their contribution originates from the Genomic Science Program Foundational Scientific Focus Area at the Pacific Northwest National Laboratory.	ARNEZ JG, 1995, EMBO J, V14, P4143, DOI 10.1002/j.1460-2075.1995.tb00088.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berge M, 2001, MOL MICROBIOL, V39, P1651, DOI 10.1046/j.1365-2958.2001.02359.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen LF, 2007, TRENDS BIOTECHNOL, V25, P343, DOI 10.1016/j.tibtech.2007.06.001; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FOSTER JW, 1982, J BACTERIOL, V149, P368, DOI 10.1128/JB.149.1.368-371.1982; FOSTER JW, 1980, J BACTERIOL, V142, P1032, DOI 10.1128/JB.142.3.1032-1035.1980; FOSTER JW, 1979, J BACTERIOL, V138, P957, DOI 10.1128/JB.138.3.957-961.1979; FRIEDMANN HC, 1973, BIOCHEM BIOPH RES CO, V50, P54, DOI 10.1016/0006-291X(73)91062-0; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Grose JH, 2005, J BACTERIOL, V187, P4521, DOI 10.1128/JB.187.13.4521-4530.2005; Grose JH, 2005, J BACTERIOL, V187, P2774, DOI 10.1128/JB.187.8.2774-2782.2005; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; IMAI T, 1973, J BIOCHEM-TOKYO, V73, P139; Kaimer C, 2010, ARCH MICROBIOL, V192, P549, DOI 10.1007/s00203-010-0583-7; KINNEY DM, 1979, J BACTERIOL, V140, P607, DOI 10.1128/JB.140.2.607-611.1979; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Maggio-Hall LA, 2003, MICROBIOL-SGM, V149, P983, DOI 10.1099/mic.0.26040-0; MANLAPAZ.P, 1973, J BIOL CHEM, V248, P5150; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Masure HR, 1998, MOL MICROBIOL, V27, P845, DOI 10.1046/j.1365-2958.1998.00732.x; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Mortier-Barriere I, 1998, MOL MICROBIOL, V27, P159, DOI 10.1046/j.1365-2958.1998.00668.x; OLIVERA BM, 1968, COLD SPRING HARB SYM, V33, P27, DOI 10.1101/SQB.1968.033.01.008; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; PARK UE, 1989, J BACTERIOL, V171, P2173, DOI 10.1128/jb.171.4.2173-2180.1989; PEARCE BJ, 1995, J BACTERIOL, V177, P86, DOI 10.1128/jb.177.1.86-93.1995; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rodionov DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-494; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sorci L, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P213; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; ZIMMERMA.SB, 1967, P NATL ACAD SCI USA, V57, P1841, DOI 10.1073/pnas.57.6.1841	43	41	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40365	40375		10.1074/jbc.M111.275818	http://dx.doi.org/10.1074/jbc.M111.275818			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953451	Green Published, hybrid			2022-12-27	WOS:000296925700067
J	Salussolia, CL; Corrales, A; Talukder, I; Kazi, R; Akgul, G; Bowen, M; Wollmuth, LP				Salussolia, Catherine L.; Corrales, Alexandra; Talukder, Iehab; Kazi, Rashek; Akgul, Gulcan; Bowen, Mark; Wollmuth, Lonnie P.			Interaction of the M4 Segment with Other Transmembrane Segments Is Required for Surface Expression of Mammalian alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL DOMAIN; PROTEIN-PROTEIN INTERACTIONS; LIGAND-BINDING DOMAINS; GATED ION CHANNELS; GLUTAMATE-RECEPTOR; NMDA RECEPTOR; ENDOPLASMIC-RETICULUM; KAINATE RECEPTORS; POINT MUTATION; SUBUNIT	Ionotropic glutamate receptors (GluRs) are ligand-gated ion channels with a modular structure. The ion channel itself shares structural similarity, albeit an inverted membrane topology, with P-loop channels. Like P-loop channels, prokaryotic GluR subunits (e. g. GluR0) have two transmembrane segments. In contrast, eukaryotic GluRs have an additional transmembrane segment (M4), located C-terminal to the ion channel core. However, the structural/functional significance of this additional transmembrane segment is poorly defined. Although topologically similar to GluR0, mammalian AMPA receptor (GluA1) subunits lacking the M4 segment do not display surface expression. This lack of expression is not due to the M4 segment serving as an anchor to the ligand-binding domain because insertion of an artificial polyleucine transmembrane segment does not rescue surface expression. Specific interactions between M4 and the ligand-binding domain are also unlikely because insertion of polyglycines into the linker connecting them has no deleterious effects on function or surface expression. However, tryptophan and cysteine scanning mutagenesis of the M4 segment, as well as recovery of function in the polyleucine background, defined a unique face of the M4 helix that is required for GluR surface expression. In the AMPA receptor structure, this face forms intersubunit contacts with the transmembrane helices of the ion channel core (M1 and M3) from another subunit within the homotetramer. Thus, our experiments show that a highly specific interaction of the M4 segment with an adjacent subunit is required for surface expression of AMPA receptors. This interaction may represent a mechanism for regulating AMPA receptor biogenesis.	[Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Neurobiol & Behav, Ctr Mol Med, Stony Brook, NY 11794 USA; [Wollmuth, Lonnie P.] SUNY Stony Brook, Ctr Nervous Syst Disorders, Stony Brook, NY 11794 USA; [Kazi, Rashek; Bowen, Mark] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Salussolia, Catherine L.; Talukder, Iehab; Kazi, Rashek] SUNY Stony Brook, Grad Program Neurosci, Stony Brook, NY 11794 USA; [Corrales, Alexandra] SUNY Stony Brook, Grad Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Akgul, Gulcan] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wollmuth, LP (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Ctr Mol Med, Stony Brook, NY 11794 USA.	lwollmuth@notes.cc.sunysb.edu	Akgül, Gülcan/AAE-1418-2019	Akgül, Gülcan/0000-0003-1590-6350; Salussolia, Catherine/0000-0003-0168-3205; Wollmuth, Lonnie/0000-0002-8179-1259; Bowen, Mark/0000-0002-9525-6986	National Institutes of Health from NIMH [MH066892, MH081923]; National Institutes of Health from NEI [EY01697905]; NRSA [NS073382]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081923, R01MH066892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS073382] Funding Source: NIH RePORTER	National Institutes of Health from NIMH; National Institutes of Health from NEI; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants MH066892 (to L. P. W.) and MH081923 (to M. B.) from NIMH, Grant EY01697905 (to L. P. W.) from NEI, and NRSA NS073382 (to C. L. S.).	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Arvola M, 1996, J BIOL CHEM, V271, P15527, DOI 10.1074/jbc.271.26.15527; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Bjerrum O. J., 1986, ANAL ELECTROPHORESIS; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Caputo GA, 2004, BIOCHEMISTRY-US, V43, P8794, DOI 10.1021/bi049696p; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dingledine R, 1999, PHARMACOL REV, V51, P7; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gill MB, 2009, J BIOL CHEM, V284, P14503, DOI 10.1074/jbc.M900510200; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Janovjak H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1231; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Oswald RE, 2007, CURR DRUG TARGETS, V8, P573, DOI 10.2174/138945007780618526; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Ren H, 2003, J BIOL CHEM, V278, P276, DOI 10.1074/jbc.M209486200; Ren H, 2008, J BIOL CHEM, V283, P8250, DOI 10.1074/jbc.M705933200; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schmid SM, 2007, J NEUROSCI, V27, P12230, DOI 10.1523/JNEUROSCI.3175-07.2007; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Suzuki E, 2005, MOL CELL NEUROSCI, V29, P1, DOI 10.1016/j.mcn.2005.01.004; Talukder I, 2010, J NEUROSCI, V30, P11792, DOI 10.1523/JNEUROSCI.5382-09.2010; Terhag J, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00117; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	56	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40205	40218		10.1074/jbc.M111.268839	http://dx.doi.org/10.1074/jbc.M111.268839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21930708	Green Published, hybrid			2022-12-27	WOS:000296925700053
J	Toledo, D; Ramon, E; Aguila, M; Cordomi, A; Perez, JJ; Mendes, HF; Cheetham, ME; Garriga, P				Toledo, Darwin; Ramon, Eva; Aguila, Monica; Cordomi, Arnau; Perez, Juan J.; Mendes, Hugo F.; Cheetham, Michael E.; Garriga, Pere			Molecular Mechanisms of Disease for Mutations at Gly-90 in Rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; CONGENITAL NIGHT BLINDNESS; COUPLED-RECEPTOR RHODOPSIN; CONSTITUTIVE ACTIVATION; INTRADISCAL DOMAIN; BOVINE RHODOPSIN; POINT MUTANTS; SCHIFF-BASE; OPSIN; MODEL	Two different mutations at Gly-90 in the second transmembrane helix of the photoreceptor protein rhodopsin have been proposed to lead to different phenotypes. G90D has been classically associated with congenital night blindness, whereas the newly reported G90V substitution was linked to a retinitis pigmentosa phenotype. Here, we used Val/Asp replacements of the native Gly at position 90 to unravel the structure/function divergences caused by these mutations and the potential molecular mechanisms of inherited retinal disease. The G90V and G90D mutants have a similar conformation around the Schiff base linkage region in the dark state and same regeneration kinetics with 11-cis-retinal, but G90V has dramatically reduced thermal stability when compared with the G90D mutant rhodopsin. The G90V mutant also shows, like G90D, an altered photobleaching pattern and capacity to activate Gt in the opsin state. Furthermore, the regeneration of the G90V mutant with 9-cis-retinal was improved, achieving the same A(280)/A(500) as wild type isorhodopsin. Hydroxylamine resistance was also recovered, indicating a compact structure around the Schiff base linkage, and the thermal stability was substantially improved when compared with the 11-cis-regenerated mutant. These results support the role of thermal instability and/or abnormal photoproduct formation in eliciting a retinitis pigmentosa phenotype. The improved stability and more compact structure of the G90V mutant when it was regenerated with 9-cis-retinal brings about the possibility that this isomer or other modified retinoid analogues might be used in potential treatment strategies for mutants showing the same structural features.	[Toledo, Darwin; Ramon, Eva; Aguila, Monica; Garriga, Pere] Univ Politecn Cataluna, Ctr Biotecnol Mol, Dept Engn Quim, Terrassa 08222, Spain; [Cordomi, Arnau] Univ Autonoma Barcelona, Lab Med Computac, Unitat Bioestad, Fac Med, Cerdanyola Del Valles 08193, Spain; [Perez, Juan J.] Univ Politecn Cataluna, Ctr Biotecnol Mol, Dept Engn Quim, ES-08034 Barcelona, Spain; [Mendes, Hugo F.; Cheetham, Michael E.] UCL, Inst Ophthalmol, London EC1V 9EL, England	Universitat Politecnica de Catalunya; Autonomous University of Barcelona; Universitat Politecnica de Catalunya; University of London; University College London	Garriga, P (corresponding author), Univ Politecn Cataluna, Ctr Biotecnol Mol, Dept Engn Quim, Terrassa 08222, Spain.	pere.garriga@upc.edu	Cordomí, Arnau/A-1686-2009; Garriga, Pere/C-1949-2017; Perez, Juan J/E-3710-2010	Cordomí, Arnau/0000-0002-3848-2928; Garriga, Pere/0000-0003-4234-8382; Perez, Juan J/0000-0002-0748-8147; Cheetham, Michael/0000-0001-6429-654X	Ministerio de Investigacion, Ciencia e Innovacion [SAF2008-04943-C02-02]; Universitat Politecnica de Catalunya; British Retinitis Pigmentosa Society; Instituto de Salud Carlos III	Ministerio de Investigacion, Ciencia e Innovacion; Universitat Politecnica de Catalunya; British Retinitis Pigmentosa Society; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Ministerio de Investigacion, Ciencia e Innovacion Grants SAF2008-04943-C02-02 (to P. G.) and SAF2008-04943-C02-02 (to J. J. P.), a Universitat Politecnica de Catalunya fellowship (to D. T.), a Formacion de Personal Investigador fellowship from the Ministerio de Investigacion, Ciencia e Innovacion (to M. A.), a grant from the British Retinitis Pigmentosa Society (to M. E. C.), and a contract grant from the Instituto de Salud Carlos III (to A. C.).	Andres A, 2003, BIOCHEM BIOPH RES CO, V303, P294, DOI 10.1016/S0006-291X(03)00328-0; Benned-Jensen T, 2009, Curr Mol Pharmacol, V2, P140; Bosch-Presegue L, 2011, FEBS J, V278, P1493, DOI 10.1111/j.1742-4658.2011.08066.x; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; DeLano D. L., 2010, PYMOL MOL GRAPHICS S; Deupi X, 2007, CURR TOP MED CHEM, V7, P991, DOI 10.2174/156802607780906799; Dizhoor AM, 2008, J NEUROSCI, V28, P11662, DOI 10.1523/JNEUROSCI.4006-08.2008; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Filipek S, 2003, ANNU REV BIOPH BIOM, V32, P375, DOI 10.1146/annurev.biophys.32.110601.142520; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2002, DOI 10.1021/bi020612r; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Hwa J, 2001, P NATL ACAD SCI USA, V98, P4872, DOI 10.1073/pnas.061632798; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kosmaoglou M, 2009, J CELL SCI, V122, P4465, DOI 10.1242/jcs.055228; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Manyosa J, 2003, MED CLIN-BARCELONA, V121, P153, DOI 10.1157/13049792; Matsuyama T, 2010, J BIOL CHEM, V285, P8114, DOI 10.1074/jbc.M109.063875; McAlear SD, 2010, ADV EXP MED BIOL, V664, P263, DOI 10.1007/978-1-4419-1399-9_30; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Neidhardt J, 2006, INVEST OPHTH VIS SCI, V47, P1630, DOI 10.1167/iovs.05-1317; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Ramon E, 2003, J BIOL CHEM, V278, P6427, DOI 10.1074/jbc.M210929200; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Saliba RS, 2002, J CELL SCI, V115, P2907; Sekharan S, 2007, J AM CHEM SOC, V129, P1052, DOI 10.1021/ja066970p; SIEVING PA, 1995, P NATL ACAD SCI USA, V92, P880, DOI 10.1073/pnas.92.3.880; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Surguchev A, 2010, BRAIN RES BULL, V81, P12, DOI 10.1016/j.brainresbull.2009.09.015; Vogel R, 2006, J AM CHEM SOC, V128, P10503, DOI 10.1021/ja0627848; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Yan ECY, 2003, P NATL ACAD SCI USA, V100, P9262, DOI 10.1073/pnas.1531970100; Zeitz C, 2008, INVEST OPHTH VIS SCI, V49, P4105, DOI 10.1167/iovs.08-1717; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; Zvyaga TA, 1996, BIOCHEMISTRY-US, V35, P7536, DOI 10.1021/bi960391n	53	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39993	40001		10.1074/jbc.M110.201517	http://dx.doi.org/10.1074/jbc.M110.201517			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21940625	Green Published, hybrid			2022-12-27	WOS:000296925700032
J	Case, N; Thomas, J; Sen, B; Styner, M; Xie, ZH; Galior, K; Rubin, J				Case, Natasha; Thomas, Jacob; Sen, Buer; Styner, Maya; Xie, Zhihui; Galior, Kornelia; Rubin, Janet			Mechanical Regulation of Glycogen Synthase Kinase 3 beta (GSK3 beta) in Mesenchymal Stem Cells Is Dependent on Akt Protein Serine 473 Phosphorylation via mTORC2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; INTEGRIN-LINKED KINASE; MAMMALIAN TARGET; RAPAMYCIN MTOR; AMINO-ACIDS; IN-VIVO; ACTIVATION; INSULIN; STRAIN; COMPLEX	Mechanical signals can inactivate glycogen synthase kinase 3 beta (GSK3 beta), resulting in stabilization of beta-catenin. This signaling cascade is necessary for the inhibition of adipogenesis in mesenchymal stem cells (MSC) that is produced by a daily strain regimen. We investigated whether Akt is the mechanically activated kinase responsible for phosphorylation and inactivation of GSK3 beta in MSC. Mechanical strain (2% magnitude, 0.17 Hz) induced phosphorylation of Akt at Ser-473 and Thr-308 in parallel with phosphorylation of GSK3 beta at Ser-9. Inhibiting Akt (Akt1/2 kinase inhibitor treatment or Akt knockdown) prevented strain-induced phosphorylation of GSK3 beta at Ser-9. Inhibition of PI3K prevented Thr-308 phosphorylation, but strain-induced Ser-473 phosphorylation was measurable and induced phosphorylation of GSK3 beta, suggesting that Ser-473 phosphorylation is sufficient for the downstream mechanoresponse. As Rictor/mTORC2 (mammalian target of rapamycin complex 2) is known to transduce phosphorylation of Akt at Ser-473 by insulin, we investigated whether it contributes to strain-induced Ser-473 phosphorylation. Phosphorylation of Ser-473 by both mechanical and insulin treatment in MSC was prevented by the mTOR inhibitor KU0063794. When mTORC2 was blocked, mechanical GSK3 beta inactivation was prevented, whereas insulin inhibition of GSK3 beta was still measured in the absence of Ser-473 phosphorylation, presumably through phosphorylation of Akt at Thr-308. In sum, mechanical input initiates a signaling cascade that is uniquely dependent on mTORC2 activation and phosphorylation of Akt at Ser-473, an effect sufficient to cause inactivation of GSK3 beta. Thus, mechanical regulation of GSK3 beta downstream of Akt is dependent on phosphorylation of Akt at Ser-473 in a manner distinct from that of growth factors. As such, Akt reveals itself to be a pleiotropic signaling molecule whose downstream targets are differentially regulated depending upon the nature of the activating input.	[Case, Natasha; Thomas, Jacob; Sen, Buer; Styner, Maya; Xie, Zhihui; Galior, Kornelia; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Case, N (corresponding author), Univ N Carolina, Dept Med, 5030 Burnett Womack,CB 7170, Chapel Hill, NC 27599 USA.	ncase@med.unc.edu	Styner, Maya/I-2044-2019	Styner, Maya/0000-0001-9790-8645	National Institutes of Health [AR042360, AR056655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042360, R01AR056655, R56AR042360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR042360 and AR056655 (to J. R.).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Armstrong JL, 2001, J BIOL CHEM, V276, P952, DOI 10.1074/jbc.M004812200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bullard TA, 2007, CAN J PHYSIOL PHARM, V85, P243, DOI 10.1139/Y07-023; CARVALHO RS, 1994, J BONE MINER RES, V9, P999; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Case N, 2010, J ORTHOP RES, V28, P1531, DOI 10.1002/jor.21156; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kleiman E, 2009, BIOCHEM BIOPH RES CO, V388, P554, DOI 10.1016/j.bbrc.2009.08.063; Liao Y, 2010, AM J TRANSL RES, V2, P19; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Menuki K, 2008, BONE, V43, P613, DOI 10.1016/j.bone.2008.04.022; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Sampson SR, 2006, MOL GENET METAB, V89, P32, DOI 10.1016/j.ymgme.2006.04.017; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Sen B, 2009, J BIOL CHEM, V284, P34607, DOI 10.1074/jbc.M109.039453; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	38	69	72	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39450	39456		10.1074/jbc.M111.265330	http://dx.doi.org/10.1074/jbc.M111.265330			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21956113	hybrid, Green Published			2022-12-27	WOS:000296759800062
J	Iyengar, PV; Hirota, T; Hirose, S; Nakamura, N				Iyengar, Prasanna Vasudevan; Hirota, Tsuyoshi; Hirose, Shigehisa; Nakamura, Nobuhiro			Membrane-associated RING-CH 10 (MARCH10 Protein) Is a Microtubule-associated E3 Ubiquitin Ligase of the Spermatid Flagella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; MITOCHONDRIAL INHERITANCE; 26S PROTEASOME; FIBROUS SHEATH; CAUSES DEFECTS; EXPRESSION; COMPONENT; SPERMATOGENESIS; SPERMIOGENESIS; PROTEOLYSIS	Spermiogenesis is a complex and dynamic process of the metamorphosis of spermatids into spermatozoa. There is a great deal that is still unknown regarding the regulatory mechanisms for the formation of the sperm flagellum. In this study, we determined that the membrane-associated RING-CH 10 (March10) gene is predominantly expressed in rat testis. We isolated two March10 isoforms encoding MARCH10a and MARCH10b, which are generated by alternative splicing. MARCH10a is a long RING finger protein, and MARCH10b is a short RING finger-less protein. Immunohistochemical staining revealed that the MARCH10 proteins are specifically expressed in elongating and elongated spermatids, and the expression is absent in epididymal spermatozoa. MARCH10 immunoreactivity was observed in the cytoplasmic lobes as well as the principal piece and annulus of the flagella. When overexpressed in COS7 cells, MARCH10a was localized along the microtubules, whereas MARCH10b was distributed throughout the cytoplasm. An in vitro microtubule cosedimentation assay showed that MARCH10a is directly associated with microtubules. An in vitro ubiquitination assay demonstrated that the RING finger domain of MARCH10a exhibits an E3 ubiquitin ligase activity along with the E2 ubiquitin-conjugating enzyme UBE2B. Moreover, MARCH10a undergoes proteasomal degradation by autoubiquitination in transfected COS7 cells, but this activity was abolished upon microtubule disassembly. These results suggest that MARCH10 is involved in spermiogenesis by regulating the formation and maintenance of the flagella in developing spermatids.	[Iyengar, Prasanna Vasudevan; Hirota, Tsuyoshi; Hirose, Shigehisa; Nakamura, Nobuhiro] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Nakamura, N (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259-B-19 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	nnakamur@bio.titech.ac.jp	Iyengar, Prasanna/G-2939-2018; Nakamura, Nobuhiro/C-4265-2015	Iyengar, Prasanna/0000-0002-6495-137X; Nakamura, Nobuhiro/0000-0002-0249-2665	Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [21026010];  [22370029];  [22770123]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; 	This work was supported by Grants-in-aid for Scientific Research 21026010, 22370029, and 22770123 and the 21st Century and Global Center of Excellence Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aihara T, 2009, BIOL REPROD, V80, P762, DOI 10.1095/biolreprod.108.074013; Baarends WM, 2003, MOL CELL BIOL, V23, P1151, DOI 10.1128/MCB.23.4.1151-1162.2003; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Chao HCA, 2010, J ASSIST REPROD GEN, V27, P299, DOI 10.1007/s10815-010-9409-4; Eddy E M, 2007, Soc Reprod Fertil Suppl, V65, P45; Escalier D, 2003, MOL REPROD DEV, V65, P298, DOI 10.1002/mrd.10290; Escalier D, 2003, BIOL REPROD, V69, P373, DOI 10.1095/biolreprod.103.015719; Fukuda H, 2006, J BIOCHEM, V139, P137, DOI 10.1093/jb/mvj012; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P320, DOI 10.1002/jemt.20784; Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066; IRONS MJ, 1982, ANAT RECORD, V202, P463, DOI 10.1002/ar.1092020405; IRONS MJ, 1982, AM J ANAT, V165, P121, DOI 10.1002/aja.1001650204; Kato A, 2004, DEV BIOL, V269, P196, DOI 10.1016/j.ydbio.2004.01.026; Kierszenbaum AL, 2000, MOL REPROD DEV, V57, P109, DOI 10.1002/1098-2795(200010)57:2<109::AID-MRD1>3.3.CO;2-0; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Koken MHM, 1996, DEV BIOL, V173, P119, DOI 10.1006/dbio.1996.0011; Kwitny S, 2010, BIOL REPROD, V82, P669, DOI 10.1095/biolreprod.109.079566; Lin YH, 2009, AM J PATHOL, V174, P1857, DOI 10.2353/ajpath.2009.080955; Metcalfe SM, 2005, FEBS LETT, V579, P609, DOI 10.1016/j.febslet.2004.12.027; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Mochida K, 2000, MOL REPROD DEV, V57, P176, DOI 10.1002/1098-2795(200010)57:2&lt;176::AID-MRD9&gt;3.0.CO;2-O; Morokuma Y, 2007, J BIOL CHEM, V282, P24806, DOI 10.1074/jbc.M700414200; Muthukumarana PADS, 2006, INT IMMUNOPHARMACOL, V6, P1993, DOI 10.1016/j.intimp.2006.09.015; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; Nakamura N, 2008, MOL BIOL CELL, V19, P1903, DOI 10.1091/mbc.E07-11-1103; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Nathan JA, 2009, EXP CELL RES, V315, P1593, DOI 10.1016/j.yexcr.2008.10.026; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Oko R., 1990, P3; OKO R, 1989, ANAT REC, V225, P46, DOI 10.1002/ar.1092250108; OKO RJ, 1991, ANN NY ACAD SCI, V637, P203, DOI 10.1111/j.1749-6632.1991.tb27311.x; Ren Y, 2003, J NEUROSCI, V23, P3316; Rivkin E, 1997, MOL REPROD DEV, V48, P77, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;77::AID-MRD10&gt;3.0.CO;2-T; Rodriguez CI, 2007, DEV BIOL, V312, P501, DOI 10.1016/j.ydbio.2007.09.053; Roest HP, 1996, CELL, V86, P799, DOI 10.1016/S0092-8674(00)80154-3; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Steels JD, 2007, CELL MOTIL CYTOSKEL, V64, P794, DOI 10.1002/cm.20224; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Sutovsky P, 2000, INT REV CYTOL, V195, P1; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Yang F, 2005, J BIOL CHEM, V280, P17154, DOI 10.1074/jbc.M500843200; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zavacki AM, 2009, MOL CELL BIOL, V29, P5339, DOI 10.1128/MCB.01498-08	53	29	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39082	39090		10.1074/jbc.M111.256875	http://dx.doi.org/10.1074/jbc.M111.256875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937444	Green Published, hybrid			2022-12-27	WOS:000296759800027
J	Jawhar, S; Wirths, O; Bayer, TA				Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.			Pyroglutamate Amyloid-beta (A beta): A Hatchet Man in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN GLUTAMINYL CYCLASE; TRANSGENIC MOUSE MODEL; PLAQUE CORE PROTEIN; PEPTIDES IN-VITRO; SENILE PLAQUE; DOWNS-SYNDROME; BIOLOGICAL SIGNIFICANCE; PRECURSOR PROTEIN; MAJOR COMPONENT; SYNDROME BRAINS	Pyroglutamate-modified amyloid-beta (A beta(pE3)) peptides are gaining considerable attention as potential key participants in the pathology of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity. Transgenic mice that produce high levels of A beta(pE3-42) show severe neuron loss. Recent in vitro and in vivo experiments have proven that the enzyme glutaminyl cyclase catalyzes the formation of A beta(pE3).In this minireview, we summarize the current knowledge on A beta(pE3), discussing its discovery, biochemical properties, molecular events determining formation, prevalence in the brains of AD patients, Alzheimer mouse models, and potential as a target for therapy and as a diagnostic marker.	[Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.] Univ Gottingen, Dept Mol Psychiat, Univ Med Gottingen, D-37075 Gottingen, Germany	University of Gottingen	Bayer, TA (corresponding author), Univ Gottingen, Dept Mol Psychiat, Univ Med Gottingen, D-37075 Gottingen, Germany.	tbayer@gwdg.de	Wirths, Oliver/C-7342-2019	Wirths, Oliver/0000-0002-4115-0334	Competence Network Degenerative Dementias of the German Federal Ministry of Education and Research	Competence Network Degenerative Dementias of the German Federal Ministry of Education and Research	This work was supported by the Competence Network Degenerative Dementias of the German Federal Ministry of Education and Research. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	ALLSOP D, 1983, BRAIN RES, V259, P348, DOI 10.1016/0006-8993(83)91273-8; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; Breyhan H, 2009, ACTA NEUROPATHOL, V117, P677, DOI 10.1007/s00401-009-0539-7; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Christensen DZ, 2008, ACTA NEUROPATHOL, V116, P647, DOI 10.1007/s00401-008-0451-6; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Drew SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015875; FISCHER WH, 1987, P NATL ACAD SCI USA, V84, P3628, DOI 10.1073/pnas.84.11.3628; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOREVIC PD, 1986, J NEUROPATH EXP NEUR, V45, P647, DOI 10.1097/00005072-198611000-00004; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Hartlage-Rubsamen M, 2009, INT J DEV NEUROSCI, V27, P825, DOI 10.1016/j.ijdevneu.2009.08.007; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Jawhar S, 2011, J BIOL CHEM, V286, P4454, DOI 10.1074/jbc.M110.185819; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lemere CA, 2009, PROG BRAIN RES, V175, P83, DOI 10.1016/S0079-6123(09)17506-4; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis H, 2006, NEUROPATH APPL NEURO, V32, P103, DOI 10.1111/j.1365-2990.2006.00696.x; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Marcello A, 2011, NEUROBIOL AGING, V32, P1379, DOI 10.1016/j.neurobiolaging.2009.08.011; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Milton NGN, 2001, NEUROREPORT, V12, P3839, DOI 10.1097/00001756-200112040-00047; MORI H, 1994, TOHOKU J EXP MED, V174, P251, DOI 10.1620/tjem.174.251; MORI H, 1992, J BIOL CHEM, V267, P17082; Munson GW, 2000, BIOCHEMISTRY-US, V39, P16119, DOI 10.1021/bi0017475; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Naslund J, 1996, J NEUROCHEM, V67, P294; NIKAIDO T, 1971, ARCH NEUROL-CHICAGO, V25, P198, DOI 10.1001/archneur.1971.00490030024002; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Pan WH, 2002, EXP BIOL MED, V227, P609, DOI 10.1177/153537020222700808; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; Racke MM, 2005, J NEUROSCI, V25, P629, DOI 10.1523/JNEUROSCI.4337-04.2005; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Russo C, 2000, NATURE, V405, P531, DOI 10.1038/35014735; Russo C, 1997, FEBS LETT, V409, P411, DOI 10.1016/S0014-5793(97)00564-4; Russo C, 2001, NEUROBIOL DIS, V8, P173, DOI 10.1006/nbdi.2000.0357; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2003, J BIOL CHEM, V278, P49773, DOI 10.1074/jbc.M309077200; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schilling S, 2011, J BIOL CHEM, V286, P14199, DOI 10.1074/jbc.M111.229385; Schilling S, 2008, J NEUROCHEM, V106, P1225, DOI 10.1111/j.1471-4159.2008.05471.x; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Shin RW, 1997, J NEUROSCI, V17, P8187; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; TABATON M, 1994, BIOCHEM BIOPH RES CO, V200, P1598, DOI 10.1006/bbrc.1994.1634; Tabaton M, 2005, INT J EXP PATHOL, V86, P139, DOI 10.1111/j.0959-9673.2005.00428.x; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Tekirian TL, 1999, J NEUROCHEM, V73, P1584, DOI 10.1046/j.1471-4159.1999.0731584.x; Thompson AJ, 1999, RAPID COMMUN MASS SP, V13, P2348, DOI 10.1002/(SICI)1097-0231(19991215)13:23<2348::AID-RCM797>3.0.CO;2-J; TOMIYAMA T, 1994, J BIOL CHEM, V269, P10205; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Wirths O, 2008, NEUROBIOL AGING, V29, P891, DOI 10.1016/j.neurobiolaging.2006.12.004; Wirths O, 2007, NEUROBIOL AGING, V28, P1689, DOI 10.1016/j.neurobiolaging.2006.07.021; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5; Youssef I, 2008, NEUROBIOL AGING, V29, P1319, DOI 10.1016/j.neurobiolaging.2007.03.005	96	152	160	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38825	38832		10.1074/jbc.R111.288308	http://dx.doi.org/10.1074/jbc.R111.288308			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21965666	Green Published, hybrid			2022-12-27	WOS:000296759800001
J	Kim, KH; Aulakh, S; Paetzel, M				Kim, Kelly H.; Aulakh, Suraaj; Paetzel, Mark			Crystal Structure of beta-Barrel Assembly Machinery BamCD Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED BACTERIAL PROTEIN; OUTER-MEMBRANE; ESCHERICHIA-COLI; RESONANCE ASSIGNMENTS; SECONDARY STRUCTURE; ESSENTIAL COMPONENT; BIOGENESIS; FOLD; RECOGNITION; SUPERFAMILY	The beta-barrel assembly machinery (BAM) complex of Escherichia coli is a multiprotein machine that catalyzes the essential process of assembling outer membrane proteins. The BAM complex consists of five proteins: one membrane protein, BamA, and four lipoproteins, BamB, BamC, BamD, and BamE. Here, we report the first crystal structure of a Bam lipoprotein complex: the essential lipoprotein BamD in complex with the N-terminal half of BamC (BamC(UN) (Asp(28)-Ala(217)), a 73-residue-long unstructured region followed by the N-terminal domain). The BamCD complex is stabilized predominantly by various hydrogen bonds and salt bridges formed between BamD and the N-terminal unstructured region of BamC. Sequence and molecular surface analyses revealed that many of the conserved residues in both proteins are found at the BamC-BamD interface. A series of truncation mutagenesis and analytical gel filtration chromatography experiments confirmed that the unstructured region of BamC is essential for stabilizing the BamCD complex structure. The unstructured N terminus of BamC interacts with the proposed substrate-binding pocket of BamD, suggesting that this region of BamC may play a regulatory role in outer membrane protein biogenesis.	[Kim, Kelly H.; Aulakh, Suraaj; Paetzel, Mark] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Paetzel, M (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	mpaetzel@sfu.ca		Kim, Kelly Hyojin/0000-0002-1360-2778; Paetzel, Mark/0000-0002-7408-5487	Canadian Institutes of Health Research; National Science and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; Canadian Foundation of Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Foundation of Innovation(Canada Foundation for Innovation)	This work was supported in part by the Canadian Institutes of Health Research (to M. P.), the National Science and Engineering Research Council of Canada (to M. P.), the Michael Smith Foundation for Health Research (to M. P.), and the Canadian Foundation of Innovation (to M. P.).	Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Albrecht R, 2010, ACTA CRYSTALLOGR F, V66, P1586, DOI 10.1107/S1744309110034160; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim KH, 2011, BIOCHEMISTRY-US, V50, P1081, DOI 10.1021/bi101659u; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2010, BIOMOL NMR ASSIGN, V4, P179, DOI 10.1007/s12104-010-9236-7; Knowles TJ, 2009, BIOMOL NMR ASSIGN, V3, P203, DOI 10.1007/s12104-009-9175-3; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misra R, 2007, ACS CHEM BIOL, V2, P649, DOI 10.1021/cb700212p; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Renault M, 2011, J AM CHEM SOC, V133, P4175, DOI 10.1021/ja109469c; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sampathkumar P, 2008, J MOL BIOL, V381, P867, DOI 10.1016/j.jmb.2008.05.089; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Vanini MMT, 2008, PROTEINS, V71, P2051, DOI 10.1002/prot.21886; Voulhoux R, 2004, RES MICROBIOL, V155, P129, DOI 10.1016/j.resmic.2003.11.007; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Warner LR, 2011, J MOL BIOL, V411, P83, DOI 10.1016/j.jmb.2011.05.022; Zhang H, 2011, ACTA CRYSTALLOGR F, V67, P734, DOI 10.1107/S1744309111014254	40	59	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39116	39121		10.1074/jbc.M111.298166	http://dx.doi.org/10.1074/jbc.M111.298166			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937441	Green Published, hybrid			2022-12-27	WOS:000296759800030
J	Papakosta, M; Dalle, C; Haythornthwaite, A; Cao, LS; Stevens, EB; Burgess, G; Russell, R; Cox, PJ; Phillips, SC; Grimm, C				Papakosta, Marianthi; Dalle, Carine; Haythornthwaite, Alison; Cao, Lishuang; Stevens, Edward B.; Burgess, Gillian; Russell, Rachel; Cox, Peter J.; Phillips, Stephen C.; Grimm, Christian			The Chimeric Approach Reveals That Differences in the TRPV1 Pore Domain Determine Species-specific Sensitivity to Block of Heat Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR TRPV1; ION-CHANNEL; MOLECULAR-BASIS; IN-VIVO; ANTAGONISTS; TURRET	The capsaicin-, heat-, and proton-activated ion channel TRPV1, a member of the transient receptor potential cation channel family is a polymodal nociceptor. For almost a decade, TRPV1 has been explored by the pharmaceutical industry as a potential target for example for pain conditions. Antagonists which block TRPV1 activation by capsaicin, heat, and protons were developed by a number of pharmaceutical companies. The unexpected finding of hyperthermia as an on-target side effect in clinical studies using polymodal TRPV1 antagonists has prompted companies to search for ways to circumvent hyperthermia, for example by the development of modality-selective antagonists. The significant lack of consistency of the pharmacology of many TRPV1 antagonists across different species has been a further obstacle. JYL-1421 for example was shown to block capsaicin and heat responses in human and monkey TRPV1 while it was largely ineffective in blocking heat responses in rat TRPV1. These findings suggested structural dissimilarities between different TRPV1 species relevant for small compound antagonism for example of heat activation. Using a chimeric approach (human and rat TRPV1) in combination with a novel FLIPR-based heat activation assay and patch-clamp electrophysiology we have identified the pore region as being strongly linked to the observed species differences. We demonstrate that by exchanging the pore domains JYL-1421, which is modality-selective in rat can be made modality-selective in human TRPV1 and vice-versa.	[Papakosta, Marianthi; Dalle, Carine; Cao, Lishuang; Stevens, Edward B.; Burgess, Gillian; Cox, Peter J.; Phillips, Stephen C.; Grimm, Christian] Pfizer Global Res & Dev, Pain Res Unit, Sandwich CT13 9NJ, Kent, England; [Russell, Rachel] Pfizer Global Res & Dev, Primary Pharmacol Grp, Sandwich CT13 9NJ, Kent, England; [Haythornthwaite, Alison] Nan Technol GmbH, D-80636 Munich, Germany	Pfizer; Pfizer	Papakosta, M (corresponding author), Pfizer Global Res & Dev, Pain Res Unit, Sandwich CT13 9NJ, Kent, England.	thouli23@yahoo.co.uk; christian_grimm@yahoo.de	Grimm, Christian/ABF-9121-2020	Grimm, Christian/0000-0002-0177-5559	Pfizer Ltd. Global RD	Pfizer Ltd. Global RD	This work was supported by Pfizer Ltd. Global R&D.	Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Baez-Nieto D, 2011, ADV EXP MED BIOL, V704, P469, DOI 10.1007/978-94-007-0265-3_26; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Chung MK, 2011, ADV EXP MED BIOL, V704, P615, DOI 10.1007/978-94-007-0265-3_33; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Garami A, 2010, J NEUROSCI, V30, P1435, DOI 10.1523/JNEUROSCI.5150-09.2010; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hanazawa T., 2006, PCT Int. Appl., Patent No. 2006097817; Jakab B, 2005, EUR J PHARMACOL, V517, P35, DOI 10.1016/j.ejphar.2005.05.002; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Khairatkar-Joshi N, 2009, TRENDS MOL MED, V15, P14, DOI 10.1016/j.molmed.2008.11.004; Kym PR, 2009, BIOCHEM PHARMACOL, V78, P211, DOI 10.1016/j.bcp.2009.02.014; Lazar J, 2009, EXPERT OPIN DRUG DIS, V4, P159, DOI 10.1517/17460440802681300; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reubish DS, 2009, BIOTECHNIQUES, V47, pIII, DOI 10.2144/000113198; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Wang Y, 2002, MOL PHARMACOL, V62, P947, DOI 10.1124/mol.62.4.947; Wong GY, 2009, BRAIN RES REV, V60, P267, DOI 10.1016/j.brainresrev.2008.12.006; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2010, P NATL ACAD SCI USA, V107, pE125, DOI 10.1073/pnas.1008272107; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39663	39672		10.1074/jbc.M111.273581	http://dx.doi.org/10.1074/jbc.M111.273581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21911503	Green Published, hybrid			2022-12-27	WOS:000296759800083
J	Bahaie, NS; Kang, BN; Frenzel, EM; Hosseinkhani, MR; Ge, XN; Greenberg, Y; Ha, SG; Demetriou, M; Rao, SP; Sriramarao, P				Bahaie, Nooshin S.; Kang, Bit Na; Frenzel, Elizabeth M.; Hosseinkhani, M. Reza; Ge, Xiao Na; Greenberg, Yana; Ha, Sung Gil; Demetriou, Michael; Rao, Savita P.; Sriramarao, P.			N-Glycans Differentially Regulate Eosinophil and Neutrophil Recruitment during Allergic Airway Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE ORGANIZATION; NECROSIS-FACTOR-ALPHA; ADHESION MOLECULE; BIOLOGICAL FUNCTIONS; EPITHELIAL-CELLS; BONE-MARROW; L-SELECTIN; ASTHMA; GLYCOSYLATION; MICE	Allergic airway inflammation, including asthma, is usually characterized by the predominant recruitment of eosinophils. However, neutrophilia is also prominent during severe exacerbations. Cell surface-expressed glycans play a role in leukocyte trafficking and recruitment during inflammation. Here, the involvement of UDP-N-acetylglucosamine:alpha-6-D-mannoside beta 1,6-N-acetylglucosaminyltransferase V (MGAT5)-modified N-glycans in eosinophil and neutrophil recruitment during allergic airway inflammation was investigated. Allergen-challenged Mgat5-deficient (Mgat5(-/-)) mice exhibited significantly attenuated airway eosinophilia and inflammation (decreased Th2 cytokines, mucus production) compared with WT counterparts, attributable to decreased rolling, adhesion, and survival of Mgat5(-/-) eosinophils. Interestingly, allergen-challenged Mgat5(-/-) mice developed airway neutrophilia and increased airway reactivity with persistent elevated levels of proinflammatory cytokines (IL-17A, TNF alpha, IFN gamma)). This increased neutrophil recruitment was also observed in LPS- and thioglycollate (TG)-induced inflammation in Mgat5(-/-) mice. Furthermore, there was significantly increased recruitment of infused Mgat5(-/-) neutrophils compared with WT neutrophils in the peritoneal cavity of TG-exposed WT mice. Mgat5(-/-) neutrophils demonstrated enhanced adhesion to P-selectin as well as increased migration toward keratinocyte-derived chemokine compared with WT neutrophils in vitro along with increased calcium mobilization upon activation and expression of elevated levels of CXCR2, which may contribute to the increased neutrophil recruitment. These data indicate an important role for MGAT5-modified N-glycans in differential regulation of eosinophil and neutrophil recruitment during allergic airway inflammation.	[Bahaie, Nooshin S.; Kang, Bit Na; Frenzel, Elizabeth M.; Hosseinkhani, M. Reza; Ge, Xiao Na; Greenberg, Yana; Ha, Sung Gil; Rao, Savita P.; Sriramarao, P.] Univ Minnesota, Lab Allerg Dis & Inflammat, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Sriramarao, P.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Demetriou, Michael] Univ Calif Irvine, Inst Immunol, Dept Neurol Microbiol & Mol Genet, Irvine, CA 92697 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Irvine	Sriramarao, P (corresponding author), Univ Minnesota, Lab Allerg Dis & Inflammat, Dept Vet & Biomed Sci, 1971 Commonwealth Ave, St Paul, MN 55108 USA.	psrao@umn.edu		Demetriou, Michael/0000-0002-2224-7798; Rao, Srirama/0000-0001-9082-1029	National Institutes of Health [AI35796, U19-AI70535, HL0793041, AI053331]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI035796, R01AI053331, U19AI070535, R01AI035796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI35796, U19-AI70535, and HL0793041 (to P. Sriramarao) and AI053331 (to Michael Demetriou).	Abbitt KB, 2009, J LEUKOCYTE BIOL, V85, P55, DOI 10.1189/jlb.0507305; Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Broide DH, 2002, AM J PHYSIOL-LUNG C, V282, pL259, DOI 10.1152/ajplung.00214.2001; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 2002, BBA-GEN SUBJECTS, V1573, P414, DOI 10.1016/S0304-4165(02)00411-7; Deshpande DA, 2004, AM J RESP CELL MOL, V31, P36, DOI 10.1165/rcmb.2003-0313OC; Dong L, 2008, J ASTHMA, V45, P648, DOI 10.1080/02770900802126941; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Eynott PR, 2002, EUR J PHARMACOL, V452, P123, DOI 10.1016/S0014-2999(02)02237-9; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; FEIKEN E, 1995, J INVEST DERMATOL, V105, P120, DOI 10.1111/1523-1747.ep12313429; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Ge XN, 2010, J IMMUNOL, V185, P1205, DOI 10.4049/jimmunol.1000039; Granovsky M, 2000, NAT MED, V6, P306; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; Gu NB, 2010, AM J PHYSIOL-LUNG C, V298, pL290, DOI 10.1152/ajplung.90612.2008; Guo HB, 2009, GLYCOBIOLOGY, V19, P547, DOI 10.1093/glycob/cwp023; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Louahed J, 2001, BLOOD, V97, P1035, DOI 10.1182/blood.V97.4.1035; MARLEY SB, 1994, INFECT IMMUN, V62, P4304, DOI 10.1128/IAI.62.10.4304-4309.1994; Miller M, 2001, J IMMUNOL, V167, P2292, DOI 10.4049/jimmunol.167.4.2292; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; MIYAKE K, 1991, J CELL BIOL, V114, P557, DOI 10.1083/jcb.114.3.557; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Nocker RET, 1999, INT ARCH ALLERGY IMM, V119, P45, DOI 10.1159/000024174; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Rao SP, 2007, J IMMUNOL, V179, P7800, DOI 10.4049/jimmunol.179.11.7800; Simon SI, 2009, CLIN EXP PHARMACOL P, V36, P217, DOI 10.1111/j.1440-1681.2008.05083.x; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; SRIRAMARAO P, 1994, J IMMUNOL, V153, P4238; Sriramarao P, 2000, BLOOD, V95, P592, DOI 10.1182/blood.V95.2.592; SUZUKI H, 1994, J BIOL CHEM, V269, P18263; Suzuki T, 1996, AM J RESP CRIT CARE, V153, P1405, DOI 10.1164/ajrccm.153.4.8616573; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Taube C, 2003, CHEST, V123, p410S, DOI 10.1378/chest.123.3_suppl.410S; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Tomkinson A, 2001, AM J RESP CRIT CARE, V163, P721, DOI 10.1164/ajrccm.163.3.2005010; Zuberi RI, 2009, J IMMUNOL, V183, P3971, DOI 10.4049/jimmunol.0901604	51	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38231	38241		10.1074/jbc.M111.279554	http://dx.doi.org/10.1074/jbc.M111.279554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911487	hybrid, Green Published			2022-12-27	WOS:000296594200037
J	Liu, J; Liu, MY; Fu, L; Zhu, GA; Yan, ECY				Liu, Jian; Liu, Monica Yun; Fu, Li; Zhu, Gefei Alex; Yan, Elsa C. Y.			Chemical Kinetic Analysis of Thermal Decay of Rhodopsin Reveals Unusual Energetics of Thermal Isomerization and Hydrolysis of Schiff Base	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-BOND NETWORK; RETINITIS-PIGMENTOSA; MOLECULAR-MECHANISM; WATER-MOLECULES; DIM-LIGHT; ACTIVATION; STABILITY; EVOLUTION; ORIGIN; RODS	The thermal properties of rhodopsin, which set the threshold of our vision, have long been investigated, but the chemical kinetics of the thermal decay of rhodopsin has not been revealed in detail. To understand thermal decay quantitatively, we propose a kinetic model consisting of two pathways: 1) thermal isomerization of 11-cis-retinal followed by hydrolysis of Schiff base (SB) and 2) hydrolysis of SB in dark state rhodopsin followed by opsin-catalyzed isomerization of free 11-cis-retinal. We solve the kinetic model mathematically and use it to analyze kinetic data from four experiments that we designed to assay thermal decay, isomerization, hydrolysis of SB using dark state rhodopsin, and hydrolysis of SB using photoactivated rhodopsin. We apply the model to WT rhodopsin and E181Q and S186A mutants at 55 degrees C, as well as WT rhodopsin in H2O and D2O at 59 degrees C. The results show that the hydrogen-bonding network strongly restrains thermal isomerization but is less important in opsin and activated rhodopsin. Furthermore, the ability to obtain individual rate constants allows comparison of thermal processes under various conditions. Our kinetic model and experiments reveal two unusual energetic properties: the steep temperature dependence of the rates of thermal isomerization and SB hydrolysis in the dark state and a strong deuterium isotope effect on dark state SB hydrolysis. These findings can be applied to study pathogenic rhodopsin mutants and other visual pigments.	[Liu, Jian; Liu, Monica Yun; Fu, Li; Zhu, Gefei Alex; Yan, Elsa C. Y.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Yan, ECY (corresponding author), 225 Prospect St, New Haven, CT 06520 USA.	elsa.yan@yale.edu	Liu, Jian/A-9302-2013	Zhu, Gefei/0000-0002-0255-2664; Yan, Elsa/0000-0002-3583-1627; Liu, Monica Yun/0000-0003-3936-9377	National Science Foundation [MCB-0955407]; Anderson Postdoctoral Fellowship; Yale College; Yale-HHMI	National Science Foundation(National Science Foundation (NSF)); Anderson Postdoctoral Fellowship; Yale College; Yale-HHMI	This work is supported by National Science Foundation Career Grant MCB-0955407.; Recipient of an Anderson Postdoctoral Fellowship.; Recipient of a Yale College Dean's Research Fellowship.; Recipient of a Yale-HHMI Future Scientists Fellowship.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BELL RP, 1974, CHEM SOC REV, V3, P513, DOI 10.1039/cs9740300513; Berson EL, 1996, P NATL ACAD SCI USA, V93, P4526, DOI 10.1073/pnas.93.10.4526; BIRGE RR, 1990, ANNU REV PHYS CHEM, V41, P683, DOI 10.1146/annurev.pc.41.100190.003343; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Bowmaker JK, 2006, CURR BIOL, V16, pR484, DOI 10.1016/j.cub.2006.06.016; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; COOPER A, 1987, J AM CHEM SOC, V109, P7254, DOI 10.1021/ja00258a002; Corley SC, 2011, BIOPHYS J, V100, P2946, DOI 10.1016/j.bpj.2011.05.015; Del Valle LJ, 2003, CELL MOL LIFE SCI, V60, P2532, DOI 10.1007/s00018-003-3113-9; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HUBBARD R, 1958, J GEN PHYSIOL, V42, P259, DOI 10.1085/jgp.42.2.259; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; Kalloniatis Michael, 2004, Clin Exp Optom, V87, P65; Kennan A, 2005, TRENDS GENET, V21, P103, DOI 10.1016/j.tig.2004.12.001; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; Lamb TD, 1996, P NATL ACAD SCI USA, V93, P566, DOI 10.1073/pnas.93.2.566; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu J, 2011, J BIOL CHEM, V286, P27622, DOI 10.1074/jbc.M111.233312; Liu J, 2009, J AM CHEM SOC, V131, P8750, DOI 10.1021/ja903154u; Lorenz-Fonfria VA, 2010, J AM CHEM SOC, V132, P5693, DOI 10.1021/ja907756e; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; McAlear SD, 2010, ADV EXP MED BIOL, V664, P263, DOI 10.1007/978-1-4419-1399-9_30; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Orban T, 2010, BIOCHEMISTRY-US, V49, P827, DOI 10.1021/bi901889t; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; Ranaghan MJ, 2010, J PHYS CHEM B, V114, P14064, DOI 10.1021/jp106633w; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SHASTRY BS, 1994, AM J MED GENET, V52, P467, DOI 10.1002/ajmg.1320520413; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; Soubias O, 2006, J BIOL CHEM, V281, P33233, DOI 10.1074/jbc.M603059200; SREBRO R, 1972, J PHYSIOL-LONDON, V224, P349, DOI 10.1113/jphysiol.1972.sp009899; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; Yan ECY, 2007, J PHYS CHEM C, V111, P8843, DOI 10.1021/jp067172o; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228	53	10	10	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38408	38416		10.1074/jbc.M111.280602	http://dx.doi.org/10.1074/jbc.M111.280602			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21921035	hybrid, Green Published			2022-12-27	WOS:000296594200055
J	Newell-Caito, JL; Laha, M; Tharp, AC; Creamer, JI; Xu, H; Maddur, AA; Tans, G; Bock, PE				Newell-Caito, Jennifer L.; Laha, Malabika; Tharp, Anthony C.; Creamer, Jonathan I.; Xu, Hong; Maddur, Ashoka A.; Tans, Guido; Bock, Paul E.			Notecarin D Binds Human Factor V and Factor V-a with High Affinity in the Absence of Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-PATHWAY INHIBITOR; NOTECHIS-SCUTATUS-SCUTATUS; COAGULATION FACTOR-XA; ACTIVATED PROTEIN-C; PEPTIDE CHLOROMETHYL KETONES; REGULATORY EXOSITE I; BOVINE FACTOR-V; PROTHROMBINASE COMPLEX; THROMBIN GENERATION; PHOSPHOLIPID-VESICLES	Notecarin D (NotD) is a prothrombin (ProT) activator in the venom of the tiger snake, Notechis scutatus, and a factor Xa (FXa) homolog. NotD binds specifically to the FXa binding site expressed on factor V (FV) upon activation to factor Va (FVa) by thrombin. NotD active site-labeled with 5-fluorescein ([5F]FFR-NotD) binds FV and FVa with remarkably high affinity in the absence of phospholipids (K-D 12 and <= 0.01 nM, respectively). In the presence of membranes, the affinity of [5F]FFR-NotD for FVa is similar, but increased similar to 55-fold for FV. Binding of FXa active site-labeled with Oregon Green to FV and FVa in the presence of phospholipids is similar to 5,000- and similar to 80-fold weaker than [5F]FFR-NotD, respectively. NotD reports FVa and not FV binding by a 3-fold increase in tripeptide substrate hydrolysis, demonstrating allosteric regulation by FVa. The NotD.FVa.membrane complex activates ProT with K-m(app) similar to prothrombinase, and similar to 85-fold weaker without membranes. Active site-blocked NotD exhibits potent anticoagulant activity in plasma thrombin generation assays, representing inhibition of productive prothrombinase assembly and possible disruption of FXa inhibition by the tissue factor pathway inhibitor. The results show that high affinity binding of NotD to FVa is membrane-independent, unlike the strict membrane dependence of FXa for high affinity FVa binding.	[Newell-Caito, Jennifer L.; Laha, Malabika; Tharp, Anthony C.; Creamer, Jonathan I.; Xu, Hong; Maddur, Ashoka A.; Bock, Paul E.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Tans, Guido] Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands	Vanderbilt University; Maastricht University	Bock, PE (corresponding author), C3321A Med Ctr N, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			National Institutes of Health from the NHLBI [HL038779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038779, R01HL038779] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL038779 (to P. E. B.) from the NHLBI.	Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Baugh RJ, 1998, J BIOL CHEM, V273, P4378, DOI 10.1074/jbc.273.8.4378; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; BILLY D, 1995, J BIOL CHEM, V270, P26883, DOI 10.1074/jbc.270.45.26883; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BOCK PE, 1993, METHOD ENZYMOL, V222, P478; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; BROAD AJ, 1979, TOXICON, V17, P661, DOI 10.1016/0041-0101(79)90245-9; BROZE GJ, 1988, BLOOD, V71, P335; BROZE GJ, 1995, ANNU REV MED, V46, P103, DOI 10.1146/annurev.med.46.1.103; Buddai SK, 2010, J BIOL CHEM, V285, P5212, DOI 10.1074/jbc.M109.049833; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Bukys MA, 2005, J BIOL CHEM, V280, P27393, DOI 10.1074/jbc.M503435200; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; FRANCIS B, 1993, TOXICON, V31, P447, DOI 10.1016/0041-0101(93)90180-Q; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; JOBIN F, 1966, NATURE, V211, P873, DOI 10.1038/211873b0; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; KANE WH, 1981, J BIOL CHEM, V256, P1002; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; Lu YF, 1996, BIOCHEMISTRY-US, V35, P8201, DOI 10.1021/bi960281g; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Nicolaes GAF, 2010, J BIOL CHEM, V285, P22888, DOI 10.1074/jbc.M110.131029; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Petersen LC, 1996, EUR J BIOCHEM, V235, P310, DOI 10.1111/j.1432-1033.1996.0310f.x; Pierre LS, 2005, MOL BIOL EVOL, V22, P1853, DOI 10.1093/molbev/msi181; PRYZDIAL ELG, 1991, J BIOL CHEM, V266, P8969; Rao VS, 2003, BIOCHEM J, V369, P635, DOI 10.1042/BJ20020889; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2004, J BIOL CHEM, V279, P48262, DOI 10.1074/jbc.M409964200; ROSING J, 1986, J BIOL CHEM, V261, P4224; ROSING J, 1980, J BIOL CHEM, V255, P274; Rudolph AE, 2001, J BIOL CHEM, V276, P5123, DOI 10.1074/jbc.M006961200; Salzman, 2001, HEMOSTASIS THROMBOSI, P157; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Talbot K, 2010, BBA-PROTEINS PROTEOM, V1804, P723, DOI 10.1016/j.bbapap.2009.11.011; TANS G, 1985, J BIOL CHEM, V260, P9366; Thorelli E, 1998, THROMB HAEMOSTASIS, V80, P92, DOI 10.1055/s-0037-1615145; Tibballs J, 1998, ANAESTH INTENS CARE, V26, P529, DOI 10.1177/0310057X9802600510; Tibballs J, 1998, ANAESTH INTENS CARE, V26, P536; TIBBALLS J, 1991, MED J AUSTRALIA, V154, P275, DOI 10.5694/j.1326-5377.1991.tb121091.x; Toso R, 2006, J BIOL CHEM, V281, P8773, DOI 10.1074/jbc.M511419200; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; YE J, 1995, BIOCHEMISTRY-US, V34, P6448, DOI 10.1021/bi00019a026; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	70	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38286	38297		10.1074/jbc.M111.247122	http://dx.doi.org/10.1074/jbc.M111.247122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21911491	Green Published, hybrid			2022-12-27	WOS:000296594200042
J	Stoll, EA; Cheung, W; Mikheev, AM; Sweet, IR; Bielas, JH; Zhang, J; Rostomily, RC; Horner, PJ				Stoll, Elizabeth A.; Cheung, Willy; Mikheev, Andrei M.; Sweet, Ian R.; Bielas, Jason H.; Zhang, Jing; Rostomily, Robert C.; Horner, Philip J.			Aging Neural Progenitor Cells Have Decreased Mitochondrial Content and Lower Oxidative Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; COMPLEX-I INHIBITION; SUBVENTRICULAR ZONE; DOPAMINERGIC NEUROTOXICITY; AGED RATS; MUTATIONS; BRAIN; MICE; P53; DNA	Although neurogenesis occurs in discrete areas of the adult mammalian brain, neural progenitor cells (NPCs) produce fewer new neurons with age. To characterize the molecular changes that occur during aging, we performed a proteomic comparison between primary-cultured NPCs from the young adult and aged mouse forebrain. This analysis yielded changes in proteins necessary for cellular metabolism. Mitochondrial quantity and oxygen consumption rates decrease with aging, although mitochondrial DNA in aged NPCs does not have increased mutation rates. In addition, aged cells are resistant to the mitochondrial inhibitor rotenone and proliferate in response to lowered oxygen conditions. These results demonstrate that aging NPCs display an altered metabolic phenotype, characterized by a coordinated shift in protein expression, subcellular structure, and metabolic physiology.	[Stoll, Elizabeth A.; Horner, Philip J.] Univ Washington, Neurobiol & Behav Program, Seattle, WA 98109 USA; [Cheung, Willy] Univ Washington, Dept Comp Sci, Seattle, WA 98109 USA; [Mikheev, Andrei M.; Rostomily, Robert C.] Univ Washington, Dept Neurol Surg, Seattle, WA 98109 USA; [Sweet, Ian R.] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Sweet, Ian R.] Univ Washington, Diabet Endocrine Res Ctr, Seattle, WA 98109 USA; [Bielas, Jason H.] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Bielas, Jason H.; Zhang, Jing] Univ Washington, Dept Pathol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Horner, PJ (corresponding author), 815 Mercer St, Seattle, WA 98109 USA.	phorner@uw.edu	Horner, Philip J./AAF-7012-2021	Rostomily, Robert/0000-0003-1431-162X	National Institutes of Health [AG029406, NSO46724, DK17047]; University of Washington [NIH T32 HDO7183-28]; University of Washington Retirement Association; American Foundation for Aging Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG029406, R21AG038305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); University of Washington Retirement Association; American Foundation for Aging Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG029406 (to R. C. R. and P. J. H.) NSO46724 (to P. J. H.), and DK17047 (to I. R. S. and the Diabetes Endocrinology Research Center).; Supported by the University of Washington Developmental Biology Training Grant (NIH T32 HDO7183-28), the University of Washington Retirement Association Fellowship in Aging Biology, and the American Foundation for Aging Research.	Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Caporaso GL, 2003, MOL CELL NEUROSCI, V23, P693, DOI 10.1016/S1044-7431(03)00103-9; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Dani MA, 2010, MED HYPOTHESES, V74, P1021, DOI 10.1016/j.mehy.2010.01.005; Dienel GA, 2006, NEUROCHEM INT, V48, P586, DOI 10.1016/j.neuint.2006.01.004; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Hajieva P, 2009, J NEUROCHEM, V110, P118, DOI 10.1111/j.1471-4159.2009.06114.x; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mclaughlin P, 2006, GLIA, V53, P567, DOI 10.1002/glia.20294; Medrano S, 2009, NEUROBIOL AGING, V30, P483, DOI 10.1016/j.neurobiolaging.2007.07.016; Mikheev AM, 2009, AGING CELL, V8, P499, DOI 10.1111/j.1474-9726.2009.00494.x; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Petit A, 2007, P NATL ACAD SCI USA, V104, P17837, DOI 10.1073/pnas.0703240104; Popa-Wagner A, 2007, ACTA NEUROPATHOL, V113, P277, DOI 10.1007/s00401-006-0164-7; Radad K, 2008, TOXICOL IN VITRO, V22, P68, DOI 10.1016/j.tiv.2007.08.015; Richardson JR, 2007, TOXICOL SCI, V95, P196, DOI 10.1093/toxsci/kfl133; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; ROSE SPR, 1967, BIOCHEM J, V102, P33, DOI 10.1042/bj1020033; Sheng HM, 2009, CURR MED CHEM, V16, P1561, DOI 10.2174/092986709788186255; Siwak-Tapp CT, 2007, NEUROBIOL LEARN MEM, V88, P249, DOI 10.1016/j.nlm.2007.05.001; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; WARBURG O, 1956, SCIENCE, V124, P269; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Yu DS, 2002, CHEM RES TOXICOL, V15, P832, DOI 10.1021/tx010177m	38	52	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38592	38601		10.1074/jbc.M111.252171	http://dx.doi.org/10.1074/jbc.M111.252171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900249	Green Published, hybrid			2022-12-27	WOS:000296594200072
J	Davies, C; Hogarth, LA; Dietrich, PA; Bachmann, PS; Mackenzie, KL; Hall, AG; Lock, RB				Davies, Carwyn; Hogarth, Linda A.; Dietrich, Philipp A.; Bachmann, Petra S.; Mackenzie, Karen L.; Hall, Andrew G.; Lock, Richard B.			p53-independent Epigenetic Repression of the p21(WAF1) Gene in T-cell Acute Lymphoblastic Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITOR GENES; DNA METHYLATION; P53 MUTATIONS; EXPRESSION; APOPTOSIS; CANCER; INACTIVATION; PROMOTER; PATHWAY; HYPERMETHYLATION	The p53 protein is a primary mediator of cellular apoptosis and growth arrest after exposure to DNA-damaging agents. Previous work has shown that the majority of childhood acute lymphoblastic leukemia (ALL) cases express a wild type p53 gene, although the functionality of the p53 pathway has rarely been validated. In the present study, the integrity of the p53 pathway was investigated in a panel of ALL cell lines and xenografts established from direct patient explants in immune-deficient mice. A focused real-time quantitative reverse transcription PCR array of known p53-regulated genes identified p21(WAF1) (CDKN1A) as the highest ranked gene to be differentially expressed between B-cell precursor (BCP)-ALL and T-ALL xenografts following exposure to the DNA-damaging drug etoposide. Lack of p21(WAF1) induction was observed in six of seven T-ALL xenograft lines, as well as primary T-ALL cells following irradiation exposure, despite an otherwise functional p53 response. Repression of p21(WAF1) in T-ALL cells was associated with decreased acetylated H3K9 localized at its promoter compared with BCP-ALL cells, together with increased CpG methylation within the first exon and intron. Although the histone deacetylase inhibitor vorinostat failed to induce p21(WAF1) in T-ALL samples, the combination of vorinostat and the demethylating agent decitabine reactivated expression of the silenced p21(WAF1) gene in the Molt-4 T-ALL cell line. Considering the known anti-apoptotic function of p21(WAF1), our findings have significant implications for the responses of T-versus BCP-ALL cells to chemotherapeutic drugs that induce p21(WAF1).	[Davies, Carwyn; Dietrich, Philipp A.; Bachmann, Petra S.; Mackenzie, Karen L.; Lock, Richard B.] Univ New S Wales, Childrens Canc Inst Australia Med Res, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Hogarth, Linda A.; Hall, Andrew G.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; Newcastle University - UK	Lock, RB (corresponding author), Univ New S Wales, Childrens Canc Inst Australia Med Res, Lowy Canc Res Ctr, POB 81, Randwick, NSW 2031, Australia.	rlock@ccia.unsw.edu.au	Lock, Richard/G-4253-2013; MacKenzie, Karen/N-5849-2019; Mackenzie, Karen/F-1310-2011	Lock, Richard/0000-0002-3436-9071; MacKenzie, Karen/0000-0003-2996-1617	Children's Cancer Institute Australia for Medical Research; Australian National Health and Medical Research Council; JGW Patterson Foundation (Newcastle upon Tyne, UK)	Children's Cancer Institute Australia for Medical Research; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); JGW Patterson Foundation (Newcastle upon Tyne, UK)	This work was supported by the Children's Cancer Institute Australia for Medical Research, a senior research fellowship (to R. B. L.) from the Australian National Health and Medical Research Council, an Australian postgraduate award (to C. D.), a university postgraduate award (to P. S. B.) and the JGW Patterson Foundation (Newcastle upon Tyne, UK) (to L. A. H.). The Children's Cancer Institute Australia for Medical Research is affiliated with the University of New South Wales and Sydney Children's Hospital.	Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Bachmann PS, 2007, CANCER RES, V67, P4482, DOI 10.1158/0008-5472.CAN-06-4244; Bachmann PS, 2010, BLOOD, V116, P3013, DOI 10.1182/blood-2010-05-284968; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Blau O, 1997, LEUKEMIA RES, V21, P721, DOI 10.1016/S0145-2126(97)80032-X; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Brown JM, 1999, CANCER RES, V59, P1391; Chang PY, 2006, MOL CANCER RES, V4, P101, DOI 10.1158/1541-7786.MCR-05-0259; Chen B, 2000, CANCER RES, V60, P3290; Chim CS, 2005, AM J HEMATOL, V80, P282, DOI 10.1002/ajh.20503; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Holleman A, 2003, BLOOD, V102, P4541, DOI 10.1182/blood-2002-11-3612; Irving J, 2009, HAEMATOL-HEMATOL J, V94, P870, DOI 10.3324/haematol.2008.000414; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Javelaud D, 2002, J BIOL CHEM, V277, P37949, DOI 10.1074/jbc.M204497200; Jung C, 2003, CLIN CANCER RES, V9, P6052; Kimura AP, 2004, MOL ENDOCRINOL, V18, P1018, DOI 10.1210/me.2003-0468; Lazzarini R, 2008, CLIN CANCER RES, V14, P5099, DOI 10.1158/1078-0432.CCR-08-0255; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Mahyar-Roemer M, 2001, ONCOGENE, V20, P3387, DOI 10.1038/sj.onc.1204440; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Marks DI, 1996, BLOOD, V87, P1155, DOI 10.1182/blood.V87.3.1155.bloodjournal8731155; Meng L, 2003, PLANT MOL BIOL, V53, P327, DOI 10.1023/B:PLAN.0000006942.00464.e3; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Min DJ, 2006, APOPTOSIS, V11, P1977, DOI 10.1007/s10495-006-0081-1; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Peterson LF, 2007, BLOOD, V109, P4392, DOI 10.1182/blood-2006-03-012575; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rokudai S, 2009, J BIOL CHEM, V284, P237, DOI 10.1074/jbc.M805101200; Roman-Gomez J, 2002, BLOOD, V99, P2291, DOI 10.1182/blood.V99.7.2291; Scott SA, 2004, LEUKEMIA RES, V28, P1293, DOI 10.1016/j.leukres.2004.03.019; Shen LL, 2002, BLOOD, V100, P3432, DOI 10.1182/blood-2002-07-1990; Shin JY, 2000, CANCER RES, V60, P262; SHIOHARA M, 1994, BLOOD, V84, P3781, DOI 10.1182/blood.V84.11.3781.bloodjournal84113781; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tian H, 2000, CANCER RES, V60, P679; WADA M, 1993, BLOOD, V82, P3163; Watanabe M, 2010, J VIROL, V84, P6966, DOI 10.1128/JVI.00073-10; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Ying JM, 2004, BLOOD, V103, P743, DOI 10.1182/blood-2003-09-3193; Zhang W, 1995, CLIN CANCER RES, V1, P1051; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	54	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37639	37650		10.1074/jbc.M111.272336	http://dx.doi.org/10.1074/jbc.M111.272336			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903579	Green Published, hybrid			2022-12-27	WOS:000296542400061
J	Singh, SK; Roberts, SA; McDevitt, SF; Weichsel, A; Wildner, GF; Grass, GB; Rensing, C; Montfort, WR				Singh, Satish K.; Roberts, Sue A.; McDevitt, Sylvia F.; Weichsel, Andrzej; Wildner, Guenter F.; Grass, Gregor B.; Rensing, Christopher; Montfort, William R.			Crystal Structures of Multicopper Oxidase CueO Bound to Copper(I) and Silver(I) FUNCTIONAL ROLE OF A METHIONINE-RICH SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; RESISTANCE PROTEIN; MOLECULAR-MECHANISMS; ANGSTROM RESOLUTION; COPRINUS-CINEREUS; FULL COMPLEMENT; CUPROUS OXIDASE; LACCASE; SITE; HOMEOSTASIS	The multicopper oxidase CueO oxidizes toxic Cu(I) and is required for copper homeostasis in Escherichia coli. Like many proteins involved in copper homeostasis, CueO has a methionine-rich segment that is thought to be critical for copper handling. How such segments function is poorly understood. Here, we report the crystal structure of CueO at 1.1 angstrom with the 45-residue methionine-rich segment fully resolved, revealing an N-terminal helical segment with methionine residues juxtaposed for Cu(I) ligation and a C-terminal highly mobile segment rich in methionine and histidine residues. We also report structures of CueO with a C500S mutation, which leads to loss of the T1 copper, and CueO with six methionines changed to serine. Soaking C500S CueO crystals with Cu(I), or wild-type CueO crystals with Ag(I), leads to occupancy of three sites, the previously identified substrate-binding site and two new sites along the methionine-rich helix, involving methionines 358, 362, 368, and 376. Mutation of these residues leads to a similar to 4-fold reduction in k(cat) for Cu(I) oxidation. Ag(I), which often appears with copper in nature, strongly inhibits CueO oxidase activities in vitro and compromises copper tolerance in vivo, particularly in the absence of the complementary copper efflux cus system. Together, these studies demonstrate a role for the methionine-rich insert of CueO in the binding and oxidation of Cu(I) and highlight the interplay among cue and cus systems in copper and silver homeostasis.	[Singh, Satish K.; Roberts, Sue A.; Weichsel, Andrzej; Wildner, Guenter F.; Montfort, William R.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Rensing, Christopher] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; [McDevitt, Sylvia F.] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Grass, Gregor B.] Bundeswehr Inst Microbiol, D-80937 Munich, Germany	University of Arizona; University of Arizona; Skidmore College; Bundeswehr Institute of Microbiology (IMB)	Montfort, WR (corresponding author), 1041 E Lowell St, Tucson, AZ 85721 USA.	montfort@email.arizona.edu	Singh, Satish/G-4401-2012; Rensing, Christopher/D-3947-2011; Grass, Gregor/A-9981-2009	Rensing, Christopher/0000-0002-5012-7953; Grass, Gregor/0000-0002-8002-7718	National Institutes of Health [HL062969]; International Copper Association; Department of Energy, Office of Biological and Environmental Research; Biomedical Technology Program; NIGMS; United States Department of Energy [W-31-109-Eng-38]; National Institutes of Health, National Center for Research Resources [RR07707]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Copper Association; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL062969 (to W. R. M.) and grants from the International Copper Association (to G. B. G. and C. R.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the U.S. Dept. of Energy, Office of Basic Energy Sciences, and at Argonne National Laboratory.; The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the NIGMS. Diffraction data were also measured at BioCARS Sector 14, Advanced Photon Source, Argonne National Laboratory, supported by the United States Department of Energy under Contract W-31-109-Eng-38. BioCARS is supported by the National Institutes of Health, National Center for Research Resources Grant RR07707.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; COOKSEY DA, 1994, FEMS MICROBIOL REV, V14, P381, DOI 10.1016/0168-6445(94)90056-6; Djoko KY, 2010, J AM CHEM SOC, V132, P2005, DOI 10.1021/ja9091903; Ducros V, 2001, ACTA CRYSTALLOGR D, V57, P333, DOI 10.1107/S0907444900013779; Ducros V, 1998, NAT STRUCT BIOL, V5, P310, DOI 10.1038/nsb0498-310; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes AS, 2007, J INORG BIOCHEM, V101, P849, DOI 10.1016/j.jinorgbio.2007.01.013; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Galli I, 2004, J BIOL INORG CHEM, V9, P90, DOI 10.1007/s00775-003-0501-4; Garavaglia S, 2004, J MOL BIOL, V342, P1519, DOI 10.1016/j.jmb.2004.07.100; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; Kataoka K, 2007, J MOL BIOL, V373, P141, DOI 10.1016/j.jmb.2007.07.041; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Lee SM, 2002, BIOCHEM BIOPH RES CO, V295, P616, DOI 10.1016/S0006-291X(02)00726-X; Li X, 2007, BIOCHEM BIOPH RES CO, V354, P21, DOI 10.1016/j.bbrc.2006.12.116; Loftin IR, 2005, BIOCHEMISTRY-US, V44, P10533, DOI 10.1021/bi050827b; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Loftin IR, 2009, J BIOL INORG CHEM, V14, P905, DOI 10.1007/s00775-009-0503-y; Lok CN, 2008, J PROTEOME RES, V7, P2351, DOI 10.1021/pr700646b; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musci G, 1996, J BIOL CHEM, V271, P1972, DOI 10.1074/jbc.271.4.1972; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Peariso K, 2003, J AM CHEM SOC, V125, P342, DOI 10.1021/ja028935y; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Singh SK, 2004, J BACTERIOL, V186, P7815, DOI 10.1128/JB.186.22.7815-7817.2004; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Stout JE, 2003, INFECT CONT HOSP EP, V24, P563, DOI 10.1086/502251; Stoyanov JV, 2003, FEBS LETT, V546, P391, DOI 10.1016/S0014-5793(03)00640-9; Stoyanov JV, 2001, MOL MICROBIOL, V39, P502, DOI 10.1046/j.1365-2958.2001.02264.x; Vachette P, 2002, J BIOL CHEM, V277, P40823, DOI 10.1074/jbc.M207188200; Wernimont AK, 2003, J BIOL INORG CHEM, V8, P185, DOI 10.1007/s00775-002-0404-9	47	70	72	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37849	37857		10.1074/jbc.M111.293589	http://dx.doi.org/10.1074/jbc.M111.293589			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903583	Green Published, hybrid			2022-12-27	WOS:000296542400079
J	Liszczak, G; Arnesen, T; Marmorstein, R				Liszczak, Glen; Arnesen, Thomas; Marmorstein, Ronen			Structure of a Ternary Naa50p (NAT5/SAN) N-terminal Acetyltransferase Complex Reveals the Molecular Basis for Substrate-specific Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEIN; YEAST; MECHANISM; IDENTIFICATION; EXPRESSION; HARD1; NATA; SAN	The co-translational modification of N-terminal acetylation is ubiquitous among eukaryotes and has been reported to have a wide range of biological effects. The human N-terminal acetyltransferase (NAT) Naa50p (NAT5/SAN) acetylates the alpha-amino group of proteins containing an N-terminal methionine residue and is essential for proper sister chromatid cohesion and chromosome condensation. The elevated activity of NATs has also been correlated with cancer, making these enzymes attractive therapeutic targets. We report the x-ray crystal structure of Naa50p bound to a native substrate peptide fragment and CoA. We found that the peptide backbone of the substrate is anchored to the protein through a series of backbone hydrogen bonds with the first methionine residue specified through multiple van der Waals contacts, together creating an alpha-amino methionine-specific pocket. We also employed structure-based mutagenesis; the results support the importance of the alpha-amino methionine-specific pocket of Naa50p and are consistent with the proposal that conserved histidine and tyrosine residues play important catalytic roles. Superposition of the ternary Naa50p complex with the peptide-bound Gcn5 histone acetyltransferase revealed that the two enzymes share a Gcn5-related N-acetyltransferase fold but differ in their respective substrate-binding grooves such that Naa50p can accommodate only an alpha-amino substrate and not a side chain lysine substrate that is acetylated by lysine acetyltransferase enzymes such as Gcn5. The structure of the ternary Naa50p complex also provides the first molecular scaffold for the design of NAT-specific small molecule inhibitors with possible therapeutic applications.	[Liszczak, Glen; Marmorstein, Ronen] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Liszczak, Glen; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Arnesen, Thomas] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway	The Wistar Institute; University of Pennsylvania; University of Bergen; University of Bergen; Haukeland University Hospital	Marmorstein, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	marmor@wistar.org	Arnesen, Thomas/J-7139-2017; Arnesen, Thomas/Q-8117-2019	Arnesen, Thomas/0000-0002-3005-147X; Arnesen, Thomas/0000-0002-3005-147X	National Institutes of Health [GM060293, GM071339, CA010815]; Research Council of Norway; Norwegian Cancer Society; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293, T32GM071339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060293 (to R. M.) and Training Grant GM071339 (to G. L.). This work was also supported by the Research Council of Norway and the Norwegian Cancer Society (to T. A.).; We acknowledge the use of the Wistar Proteomics Core facility, which is supported in part by National Institutes of Health Grant CA010815. We also acknowledge Mike Brent, Marc Holbert, and Rolf Sternglanz for helpful discussions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnesen T, 2006, ONCOGENE, V25, P4350, DOI 10.1038/sj.onc.1209469; Arnesen T, 2006, GENE, V371, P291, DOI 10.1016/j.gene.2005.12.008; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Braman J, 1996, Methods Mol Biol, V57, P31; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Furdas SD, 2011, BIOORGAN MED CHEM, V19, P3678, DOI 10.1016/j.bmc.2011.01.063; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Hou FJ, 2007, J CELL BIOL, V177, P587, DOI 10.1083/jcb.200701043; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pimenta-Marques A, 2008, DEV BIOL, V323, P197, DOI 10.1016/j.ydbio.2008.08.021; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Ren TT, 2008, CANCER LETT, V264, P83, DOI 10.1016/j.canlet.2008.01.028; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Seo JH, 2010, CANCER RES, V70, P4422, DOI 10.1158/0008-5472.CAN-09-3258; Starheim Kristian K, 2009, BMC Proc, V3 Suppl 6, pS3, DOI 10.1186/1753-6561-3-S6-S3; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Van Damme P., 2011, MOL CELL PROTEOMICS, V10; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; Wu J, 2011, BIOORG CHEM, V39, P53, DOI 10.1016/j.bioorg.2010.11.003; Yu M, 2009, CANCER INVEST, V27, P978, DOI 10.3109/07357900902769723	37	70	71	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					37002	37010		10.1074/jbc.M111.282863	http://dx.doi.org/10.1074/jbc.M111.282863			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21900231	Green Published, hybrid			2022-12-27	WOS:000296538300078
J	Narayanan, S; Arthanari, H; Wolfe, MS; Wagner, G				Narayanan, Saravanakumar; Arthanari, Haribabu; Wolfe, Michael S.; Wagner, Gerhard			Molecular Characterization of Disrupted in Schizophrenia-1 Risk Variant S704C Reveals the Formation of Altered Oligomeric Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGENITOR PROLIFERATION; CORTICAL DEVELOPMENT; NEURONAL MIGRATION; NEURITE OUTGROWTH; DISC1; ASSOCIATION; BINDING; PROTEIN; GENES; NUDEL	DISC1 ((D) under bar isrupted (i) under barn schizophrenia-(1) under bar) plays essential roles in neuronal proliferation, neuronal migration and axon guidance and has been implicated in schizophrenia and related psychiatric disorders. DISC1 forms a functional complex with nuclear distribution element-like protein-1 (NDEL1), a key component that regulates microtubule organization during cell division and neuronal migration. DISC1 polymorphisms at the binding interface of DISC1-NDEL1 complex have been implicated in schizophrenia. However, it is unknown how schizophrenia risk polymorphisms perturb its interaction with NDEL1 and how they change the inherent biochemical properties of DISC1. Here, we characterize the oligomerization and binding property of DISC1 and its natural schizophrenia risk variant, S704C. Our results show that DISC1 forms octamers via dimers as building blocks and directly interacts with tetramers of NDEL1. The schizophrenia risk variant S704C affects the formation of octamers of DISC1 and exhibits higher-order self-oligomerization. However, the observed formation of new oligomeric species did not influence its binding with NDEL1. These results suggest that the improper oligomeric assembly of DISC1-S704C may underlie the observed phenotypic variation due to the polymorphism.	[Narayanan, Saravanakumar; Arthanari, Haribabu; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wolfe, Michael S.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Bldg C1,Rm 107,240 Longwood Ave, Boston, MA 02115 USA.	Gerhard_wagner@hms.harvard.edu		Arthanari, Haribabu/0000-0002-7281-1289	National Institutes of Health [P01-GM047467]; Foundation for Neurologic Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Neurologic Diseases; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Grant P01-GM047467. M. S. W. acknowledges the funding from the Foundation for Neurologic Diseases.	Bakken TE, 2011, ARCH GEN PSYCHIAT, V68, P781, DOI 10.1001/archgenpsychiatry.2011.81; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Brandon NJ, 2005, MOL CELL NEUROSCI, V28, P613, DOI 10.1016/j.mcn.2004.11.003; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Burdick KE, 2008, HUM MOL GENET, V17, P2462, DOI 10.1093/hmg/ddn146; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Di Giorgio A, 2008, EUR J NEUROSCI, V28, P2129, DOI 10.1111/j.1460-9568.2008.06482.x; Eastwood SL, 2010, HUM MOL GENET, V19, P2487, DOI 10.1093/hmg/ddq130; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Leliveld SR, 2009, BIOCHEMISTRY-US, V48, P7746, DOI 10.1021/bi900901e; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mathieson I, 2011, MOL PSYCHIAT; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Nicodemus KK, 2010, HUM GENET, V127, P441, DOI 10.1007/s00439-009-0782-y; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sawa A, 2005, SCIENCE, V310, P1128, DOI 10.1126/science.1121114; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Taylor Ian A, 2004, Methods Mol Biol, V261, P119; Tomppo L, 2009, BIOL PSYCHIAT, V65, P1055, DOI 10.1016/j.biopsych.2009.01.014; Young-Pearse TL, 2010, J NEUROSCI, V30, P10431, DOI 10.1523/JNEUROSCI.1445-10.2010	35	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44266	44276		10.1074/jbc.M111.271593	http://dx.doi.org/10.1074/jbc.M111.271593			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21998303	Green Published, hybrid			2022-12-27	WOS:000298402300066
J	DeRouchey, JE; Rau, DC				DeRouchey, Jason E.; Rau, Donald C.			Role of Amino Acid Insertions on Intermolecular Forces between Arginine Peptide Condensed DNA Helices IMPLICATIONS FOR PROTAMINE-DNA PACKAGING IN SPERM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; NUCLEOPROTAMINE STRUCTURE; HYDRATION FORCES; COMPLEXES; FRAGMENTATION; AGGREGATION; SPERMATOZOA; POLYAMINES; MOLECULES; CHROMATIN	In spermatogenesis, chromatin histones are replaced by arginine-rich protamines to densely compact DNA in sperm heads. Tight packaging is considered necessary to protect the DNA from damage. To better understand the nature of the forces condensing protamine-DNA assemblies and their dependence on amino acid content, the effect of neutral and negatively charged amino acids on DNA-DNA intermolecular forces was studied using model peptides containing six arginines. We have previously observed that the neutral amino acids in salmon protamine decrease the net attraction between protamine-DNA helices compared with the equivalent homo-arginine peptide. Using osmotic stress coupled with x-ray scattering, we have investigated the component attractive and repulsive forces that determine the net attraction and equilibrium interhelical distance as a function of the chemistry, position, and number of the amino acid inserted. Neutral amino acids inserted into hexa-arginine increase the short range repulsion while only slightly affecting longer range attraction. The amino acid content alone of salmon protamine is enough to rationalize the forces that package DNA in sperm heads. Inserting a negatively charged amino acid into hexa-arginine dramatically weakens the net attraction. Both of these observations have biological implications for protamine-DNA packaging in sperm heads.	[DeRouchey, Jason E.] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Rau, Donald C.] NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA	University of Kentucky; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	DeRouchey, JE (corresponding author), Univ Kentucky, Dept Chem, 125 Chem Phys Bldg, Lexington, KY 40506 USA.	derouchey@uky.edu	DeRouchey, Jason/C-5907-2011	DeRouchey, Jason/0000-0002-3624-4432	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Eunice Kennedy Shriver Intramural Research Program.	Andrabi SMH, 2007, J ASSIST REPROD GEN, V24, P561, DOI 10.1007/s10815-007-9177-y; Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Blanc NS, 2001, J STRUCT BIOL, V134, P76, DOI 10.1006/jsbi.2001.4365; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Bloomfield VA, 1996, CURR OPIN STRUC BIOL, V6, P334, DOI 10.1016/S0959-440X(96)80052-2; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; Brewer LR, 2011, INTEGR BIOL-UK, V3, P540, DOI 10.1039/c0ib00128g; Castillo J, 2011, J ANDROL, V32, P324, DOI 10.2164/jandrol.110.011015; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; DeRouchey J, 2005, EUR PHYS J E, V16, P17, DOI 10.1140/epje/e2005-00003-4; DeRouchey J, 2010, BIOPHYS J, V99, P2608, DOI 10.1016/j.bpj.2010.08.028; FEUGHELMAN M, 1955, NATURE, V175, P834, DOI 10.1038/175834a0; FITA I, 1983, J MOL BIOL, V167, P157, DOI 10.1016/S0022-2836(83)80039-4; GREEN GR, 1994, MOL REPROD DEV, V37, P255, DOI 10.1002/mrd.1080370303; Hud NV, 2001, P NATL ACAD SCI USA, V98, P14925, DOI 10.1073/pnas.261560398; HUD NV, 1994, BIOCHEMISTRY-US, V33, P7528, DOI 10.1021/bi00190a005; Kornyshev AA, 1999, PHYS REV LETT, V82, P4138, DOI 10.1103/PhysRevLett.82.4138; Kornyshev AA, 2007, REV MOD PHYS, V79, P943, DOI 10.1103/RevModPhys.79.943; LEIKIN S, 1993, ANNU REV PHYS CHEM, V44, P369, DOI 10.1146/annurev.pc.44.100193.002101; Lewis JD, 2003, CHROMOSOMA, V111, P473, DOI 10.1007/s00412-002-0226-0; MUDD CP, 1987, REV SCI INSTRUM, V58, P2110, DOI 10.1063/1.1139472; Muratori M, 2006, FRONT BIOSCI-LANDMRK, V11, P1491, DOI 10.2741/1898; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; PARSEGIAN VA, 1986, METHOD ENZYMOL, V127, P400; Pelta J, 1996, J BIOL CHEM, V271, P5656, DOI 10.1074/jbc.271.10.5656; PERREAULT SD, 1984, DEV BIOL, V101, P160, DOI 10.1016/0012-1606(84)90126-X; Prieto MC, 1997, BIOCHEMISTRY-US, V36, P11944, DOI 10.1021/bi971061l; Qiu XY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.228101; Raspaud E, 2005, BIOPHYS J, V88, P392, DOI 10.1529/biophysj.104.040113; Raspaud E, 1998, BIOPHYS J, V74, P381, DOI 10.1016/S0006-3495(98)77795-1; RAU DC, 1992, BIOPHYS J, V61, P246, DOI 10.1016/S0006-3495(92)81831-3; Raukas E, 1999, BIOESSAYS, V21, P440, DOI 10.1002/(SICI)1521-1878(199905)21:5<440::AID-BIES11>3.0.CO;2-V; SCHELLMAN JA, 1984, J MOL BIOL, V175, P313, DOI 10.1016/0022-2836(84)90351-6; STANLEY C, 2011, CURR OPIN C IN PRESS; SUAU P, 1977, J MOL BIOL, V117, P909, DOI 10.1016/S0022-2836(77)80005-3; SUWALSKY M, 1972, BIOPOLYMERS, V11, P2223, DOI 10.1002/bip.1972.360111103; Teif VB, 2005, BIOPHYS J, V89, P2574, DOI 10.1529/biophysj.105.063909; TODD BA, 2007, WILEY ENCY CHEM BIOL; Todd BA, 2008, BIOPHYS J, V94, P4775, DOI 10.1529/biophysj.107.127332; Vilfan ID, 2004, J BIOL CHEM, V279, P20088, DOI 10.1074/jbc.M312777200; WIDOM J, 1983, BIOPOLYMERS, V22, P1595, DOI 10.1002/bip.360220612	42	21	24	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					41985	41992		10.1074/jbc.M111.295808	http://dx.doi.org/10.1074/jbc.M111.295808			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994948	Green Published, hybrid			2022-12-27	WOS:000298180900009
J	Ruminski, DJ; Webb, CHT; Riccitelli, NJ; Luptak, A				Ruminski, Dana J.; Webb, Chiu-Ho T.; Riccitelli, Nathan J.; Luptak, Andrej			Processing and Translation Initiation of Non-long Terminal Repeat Retrotransposons by Hepatitis Delta Virus (HDV)-like Self-cleaving Ribozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-LTR RETROTRANSPOSON; RIBOSOMAL-RNA GENES; DROSOPHILA-MELANOGASTER; REVERSE-TRANSCRIPTASE; CATALYTIC CORE; HAMMERHEAD RIBOZYMES; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; SATELLITE DNA; HDV RIBOZYME	Many non-long terminal repeat (non-LTR) retrotransposons lack internal promoters and are co-transcribed with their host genes. These transcripts need to be liberated before inserting into new loci. Using structure-based bioinformatics, we show that several classes of retrotransposons in phyla-spanning arthropods, nematodes, and chordates utilize self-cleaving ribozymes of the hepatitis delta virus (HMI) family for processing their 5' termini Ribozyme-terminated retrotransposons include rDNA-specific R2, R4, and R6, telomere-specific SAW, and Baggins and RTE. The self-scission of the R2 ribozyme is strongly modulated by the insertion site sequence in the rDNA, with the most common insertion sequences promoting faster processing. The ribozymes also promote translation initiation of downstream open reading frames in vitro and in vivo. In some organisms HDV-like and hammerhead ribozymes appear to be dedicated to processing long and short interspersed elements, respectively. HDV-like ribozymes serve several distinct functions in non-LTR retrotransposition, including 5' processing, translation initiation, and potentially trans-templating.	[Ruminski, Dana J.; Webb, Chiu-Ho T.; Luptak, Andrej] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Riccitelli, Nathan J.; Luptak, Andrej] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Luptak, Andrej] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Luptak, A (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	aluptak@ucl.edu			National Institutes of Health [GM094929]; University of California, Irvine; Pew Trusts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Irvine(University of California System); Pew Trusts; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094929. This work was also supported by the University of California, Irvine, and the Pew Trusts.	BEEN MD, 1992, BIOCHEMISTRY-US, V31, P11843, DOI 10.1021/bi00162a024; Belfort Marlene, 2002, P761; Berry KE, 2010, RNA, V16, P1559, DOI 10.1261/rna.2197210; Bibillo A, 2004, J BIOL CHEM, V279, P14945, DOI 10.1074/jbc.M310450200; Bibillo A, 2002, J MOL BIOL, V316, P459, DOI 10.1006/jmbi.2001.5369; Blesa D, 2001, MOL BIOL EVOL, V18, P585, DOI 10.1093/oxfordjournals.molbev.a003839; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Bryan MB, 2005, MOL ECOL, V14, P3757, DOI 10.1111/j.1365-294X.2005.02716.x; Burke WD, 2002, MOL BIOL EVOL, V19, P619, DOI 10.1093/oxfordjournals.molbev.a004121; Burke WD, 1998, NATURE, V392, P141, DOI 10.1038/32330; BURKE WD, 1995, NUCLEIC ACIDS RES, V23, P4628, DOI 10.1093/nar/23.22.4628; Burke WD, 1999, MOL BIOL EVOL, V16, P502, DOI 10.1093/oxfordjournals.molbev.a026132; Cech T. R., 1993, RNA WORLD; Chadalavada DM, 2000, J MOL BIOL, V301, P349, DOI 10.1006/jmbi.2000.3953; Chen JH, 2010, BIOCHEMISTRY-US, V49, P6508, DOI 10.1021/bi100670p; Christensen SM, 2006, P NATL ACAD SCI USA, V103, P17602, DOI 10.1073/pnas.0605476103; De la Pena M, 2003, EMBO J, V22, P5561, DOI 10.1093/emboj/cdg530; de la Pena M, 2010, RNA, V16, P1943, DOI 10.1261/rna.2130310; de la Pena M, 2010, EMBO REP, V11, P711, DOI 10.1038/embor.2010.100; Duhamel J, 1996, NUCLEIC ACIDS RES, V24, P3911, DOI 10.1093/nar/24.20.3911; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; EPSTEIN LM, 1987, CELL, V48, P535, DOI 10.1016/0092-8674(87)90204-2; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; George JA, 1999, INSECT MOL BIOL, V8, P3, DOI 10.1046/j.1365-2583.1999.810003.x; Ghesini S, 2011, J MOL EVOL, V72, P296, DOI 10.1007/s00239-011-9430-y; GREEN B, 1993, MOL BIOL EVOL, V10, P732; Han JS, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-15; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; JAKUBCZAK JL, 1991, P NATL ACAD SCI USA, V88, P3295, DOI 10.1073/pnas.88.8.3295; JAMRICH M, 1984, EMBO J, V3, P1541, DOI 10.1002/j.1460-2075.1984.tb02008.x; Jeong S, 2003, BIOCHEMISTRY-US, V42, P7727, DOI 10.1021/bi034627g; Jimenez RM, 2011, J BIOL CHEM, V286, P7737, DOI 10.1074/jbc.C110.209288; Kamoshita N, 2009, MOL CELL, V35, P181, DOI 10.1016/j.molcel.2009.05.024; Kawaoka S, 2008, INSECT BIOCHEM MOLEC, V38, P1058, DOI 10.1016/j.ibmb.2008.03.007; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; KIDD SJ, 1981, J MOL BIOL, V151, P645, DOI 10.1016/0022-2836(81)90428-9; Kierzek E, 2009, J MOL BIOL, V390, P428, DOI 10.1016/j.jmb.2009.04.048; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Kojima KK, 2003, MOL BIOL EVOL, V20, P351, DOI 10.1093/molbev/msg031; Kubo Y, 2001, MOL BIOL EVOL, V18, P848, DOI 10.1093/oxfordjournals.molbev.a003866; Kurzynska-Kokorniak A, 2007, J MOL BIOL, V374, P322, DOI 10.1016/j.jmb.2007.09.047; Legiewicz M, 2006, NUCLEIC ACIDS RES, V34, P1270, DOI 10.1093/nar/gkl018; Liu F, 2011, PROTEIN CELL, V2, P351, DOI 10.1007/s13238-011-1045-y; LONG EO, 1981, MOL GEN GENET, V182, P377, DOI 10.1007/BF00293925; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Luptak A., 2007, RIBOZYMES RNA CATALY, P130; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; McFarlane CT, 2009, CONSERV GENET RESOUR, V1, P377, DOI 10.1007/s12686-009-9087-7; Mourier Tobias, 2009, Briefings in Functional Genomics & Proteomics, V8, P493, DOI 10.1093/bfgp/elp036; Nehdi A, 2006, NUCLEIC ACIDS RES, V34, P584, DOI 10.1093/nar/gkj463; Nishikawa F, 1999, NUCLEIC ACIDS RES, V27, P403, DOI 10.1093/nar/27.2.403; Perreault J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002031; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Rezende-Teixeira P, 2009, CHROMOSOME RES, V17, P455, DOI 10.1007/s10577-009-9038-x; Riccitelli NJ, 2010, METHODS, V52, P133, DOI 10.1016/j.ymeth.2010.06.005; ROIHA H, 1981, NATURE, V290, P749, DOI 10.1038/290749a0; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; Salehi-Ashtiani K, 2001, NATURE, V414, P82, DOI 10.1038/35102081; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Sanchez-Luque FJ, 2011, NUCLEIC ACIDS RES, V39, P8065, DOI 10.1093/nar/gkr478; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Tang J, 2000, P NATL ACAD SCI USA, V97, P5784, DOI 10.1073/pnas.97.11.5784; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; Warren AM, 1997, MOL GEN GENET, V254, P505, DOI 10.1007/s004380050445; Webb CHT, 2011, RNA BIOL, V8, P719, DOI 10.4161/rna.8.5.16226; Webb CHT, 2009, SCIENCE, V326, P953, DOI 10.1126/science.1178084; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Yang J, 1999, P NATL ACAD SCI USA, V96, P7847, DOI 10.1073/pnas.96.14.7847; Zhu JY, 2011, P NATL ACAD SCI USA, V108, P1839, DOI 10.1073/pnas.1018582108	74	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41286	41295		10.1074/jbc.M111.297283	http://dx.doi.org/10.1074/jbc.M111.297283			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21994949	Green Published, hybrid			2022-12-27	WOS:000298057500016
J	Fenstermacher, KJ; DeStefano, JJ				Fenstermacher, Katherine J.; DeStefano, Jeffrey J.			Mechanism of HIV Reverse Transcriptase Inhibition by Zinc FORMATION OF A HIGHLY STABLE ENZYME-(PRIMER-TEMPLATE) COMPLEX WITH PROFOUNDLY DIMINISHED CATALYTIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DNA-POLYMERASE; VIRUS; BINDING; HOMEOSTASIS; MUTATIONS; MAGNESIUM; CALCIUM; CELLS; IONS; VIVO	Several physiologically relevant cations including Ca2+, Mn2+, and Zn2+ have been shown to inhibit HIV reverse transcriptase (RT), presumably by competitively displacing one or more Mg2+ ions bound to RT. We analyzed the effects of Zn2+ on reverse transcription and compared them to Ca2+ and Mn2+. Using nucleotide extension efficiency as a readout, Zn2+ showed significant inhibition of reactions with 2 mM Mg2+, even when present at only similar to 5 mu M. Mn2+ and Ca2+ were also inhibitory but at higher concentrations. Both Mn2+ and Zn2+ (but not Ca2+) supported RT incorporation in the absence of Mg2+ with Mn2+ being much more efficient. The maximum extension rates with Zn2+, Mg2+, and Mg2+ were similar to 0.1, 1, and 3.5 nucleotides per second, respectively. Zinc supported optimal RNase H activity at similar to 25 mu M, similar to the optimal for nucleotide addition in the presence of low dNTP concentrations. Surprisingly, processivity (average number of nucleotides incorporated in a single binding event with enzyme) during reverse transcription was comparable with Zn2+ and Mg2+, and single RT molecules were able to continue extension in the presence of Zn2+ for several hours on the same template. Consistent with this result, the half-life for RT-Zn2+-(primer-template) complexes was 220 +/- 60 min and only 1.7 +/- 1 min with Mg2+, indicating similar to 130-fold more stable binding with Zn2+. Essentially, the presence of Zn2+ promotes the formation of a highly stable slowly progressing RT-(primer-template) complex.	[Fenstermacher, Katherine J.; DeStefano, Jeffrey J.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	DeStefano, JJ (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, 413 Biosci Res Bldg, College Pk, MD 20742 USA.	jdestefa@umd.edu		Fenstermacher, Katherine/0000-0003-1139-3711	NIGM, National Institutes of Health [GM051140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051140, R01GM051140] Funding Source: NIH RePORTER	NIGM, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGM, National Institutes of Health Grant GM051140 (to J. J. D.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Bolton EC, 2002, MOL CELL, V9, P879, DOI 10.1016/S1097-2765(02)00495-1; BREWER GJ, 1979, AM J HEMATOL, V7, P53, DOI 10.1002/ajh.2830070107; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cristofaro JV, 2002, BIOCHEMISTRY-US, V41, P10968, DOI 10.1021/bi025871v; Delva P, 2004, J MEMBRANE BIOL, V199, P163, DOI 10.1007/s00232-004-0686-7; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P7423; DESTEFANO JJ, 1992, BIOCHIM BIOPHYS ACTA, V1131, P270, DOI 10.1016/0167-4781(92)90025-U; Dubben S, 2010, J LEUKOCYTE BIOL, V87, P833, DOI 10.1189/jlb.0409241; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Filler AG, 1997, AIDS RES HUM RETROV, V13, P291, DOI 10.1089/aid.1997.13.291; FRIDLENDER B, 1978, VIROLOGY, V84, P551, DOI 10.1016/0042-6822(78)90274-X; GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817; Goldschmidt V, 2006, NUCLEIC ACIDS RES, V34, P42, DOI 10.1093/nar/gkj411; Herschhorn A, 2010, CELL MOL LIFE SCI, V67, P2717, DOI 10.1007/s00018-010-0346-2; Honscheid A, 2012, J NUTR BIOCHEM, V23, P18, DOI 10.1016/j.jnutbio.2010.10.007; Hou EW, 2004, PROTEIN EXPRES PURIF, V34, P75, DOI 10.1016/j.pep.2003.10.018; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ilouz R, 2002, BIOCHEM BIOPH RES CO, V295, P102, DOI 10.1016/S0006-291X(02)00636-8; Irimia A, 2006, BIOCHEMISTRY-US, V45, P5949, DOI 10.1021/bi052511+; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; LEVINSON W, 1973, P NATL ACAD SCI USA, V70, P164, DOI 10.1073/pnas.70.1.164; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; MULLEN GP, 1990, J BIOL CHEM, V265, P14327; Olimpo JT, 2010, NUCLEIC ACIDS RES, V38, P4426, DOI 10.1093/nar/gkq169; PALAN PR, 1978, MOL CELL BIOCHEM, V21, P67; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; Sambrook J., 2001, MOL CLONING LAB MANU; SCHATZ O, 1989, FEBS LETT, V257, P311, DOI 10.1016/0014-5793(89)81559-5; Schultz SJ, 2008, VIRUS RES, V134, P86, DOI 10.1016/j.virusres.2007.12.007; Siberry GK, 2002, NUTR RES, V22, P527, DOI 10.1016/S0271-5317(02)00364-0; SLABY I, 1984, BIOCHEM BIOPH RES CO, V122, P1410, DOI 10.1016/0006-291X(84)91248-8; TAN CK, 1991, BIOCHEMISTRY-US, V30, P2651, DOI 10.1021/bi00224a013; TEVELTHUIS AJW, 2010, PLOS PATHOG, V0006; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Walther UI, 2000, IN VITRO MOL TOXICOL, V13, P145, DOI 10.1089/109793300440730; Wang M, 2009, BIOCHEMISTRY-US, V48, P2075, DOI 10.1021/bi801627h; Wang S, 2002, ARCH PATHOL LAB MED, V126, P947; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yarrington RM, 2007, J VIROL, V81, P9004, DOI 10.1128/JVI.02502-06	47	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40433	40442		10.1074/jbc.M111.289850	http://dx.doi.org/10.1074/jbc.M111.289850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21953456	Green Published, hybrid			2022-12-27	WOS:000297315400003
J	Johnston, WA; Hunter, DJB; Noble, CJ; Hanson, GR; Stok, JE; Hayes, MA; De Voss, JJ; Gillam, EMJ				Johnston, Wayne A.; Hunter, Dominic J. B.; Noble, Christopher J.; Hanson, Graeme R.; Stok, Jeanette E.; Hayes, Martin A.; De Voss, James J.; Gillam, Elizabeth M. J.			Cytochrome P450 Is Present in Both Ferrous and Ferric Forms in the Resting State within Intact Escherichia coli and Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIN-STATE; ELECTRON-TRANSFER; DRUG-METABOLISM; RESONANCE RAMAN; WATER BINDING; ACTIVE-SITE; KINETICS; EXPRESSION; P450; REDUCTION	Cytochrome P450 enzymes (P450s) are exceptionally versatile monooxygenases, mediating hydroxylations of unactivated C H bonds, epoxidations, dealkylations, and N- and S-oxidations as well as other less common reactions. In the conventional view of the catalytic cycle, based upon studies of P450s in vitro, substrate binding to the Fe(III) resting state facilitates the first 1-electron reduction of the heme. However, the resting state of P450s in vivo has not been examined. In the present study, whole cell difference spectroscopy of bacterial (CYP101A1 and CYP176A1, i.e. P450cam and P450cin) and mammalian (CYP1A2, CYP2C9, CYP2A6, CYP2C19, and CYP3A4) P450s expressed within intact Escherichia coli revealed that both Fe(III) and Fe(II) forms of the enzyme are present in the absence of substrates. The relevance of this finding was supported by similar observations of Fe(II) P450 heme in intact rat hepatocytes. Electron paramagnetic resonance (EPR) spectroscopy of the bacterial forms in intact cells showed that a proportion of the P450 in cells was in an EPR-silent form in the native state consistent with the presence of Fe(II) P450. Coexpression of suitable cognate electron donors increased the degree of endogenous reduction to over 80%. A significant proportion of intracellular P450 remained in the Fe(II) form after vigorous aeration of cells. The addition of substrates increased the proportion of Fe(II) heme, suggesting a kinetic gate to heme reduction in the absence of substrate. In summary, these observations suggest that the resting state of P450s should be regarded as a mixture of Fe(III) and Fe(II) forms in both aerobic and oxygen-limited conditions.	[Hunter, Dominic J. B.; Stok, Jeanette E.; De Voss, James J.; Gillam, Elizabeth M. J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Johnston, Wayne A.; Gillam, Elizabeth M. J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Noble, Christopher J.; Hanson, Graeme R.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [Hayes, Martin A.] AstraZeneca R&D, Cardiovasc & Gastrointestinal Innovat Med, Drug Metab & Pharmacokinet, SE-43183 Molndal, Sweden	University of Queensland; University of Queensland; University of Queensland; AstraZeneca	Gillam, EMJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	e.gillam@uq.edu.au	/C-3940-2008; Hunter, Dominic/R-8894-2016; GILLAM, ELIZABETH/D-1011-2016; Hunter, Dominic/Q-4226-2019; Hunter, Dominic/H-7955-2019; Johnston, Wayne/D-2095-2017	/0000-0003-0306-4360; Hunter, Dominic/0000-0002-1826-6902; GILLAM, ELIZABETH/0000-0003-0378-793X; Hunter, Dominic/0000-0002-1826-6902; Stok, Jeanette/0000-0002-8759-3931; Johnston, Wayne/0000-0002-7485-8363	Australian Research Council (ARC) [DP0210635, LP0560595]; AstraZeneca RD	Australian Research Council (ARC)(Australian Research Council); AstraZeneca RD(AstraZeneca)	This work was supported in part by Australian Research Council (ARC) Discovery Project Grant DP0210635 (to E. M. J. G. and J. J. D. V.) and ARC Linkage Project Grant LP0560595 funded in partnership with AstraZeneca R&D (to E. M. J. G., J. J. D. V., and M. A. H.).	BACKES WL, 1982, BIOCHEMISTRY-US, V21, P1324, DOI 10.1021/bi00535a034; Cryle M. J., 2007, UBIQUITOUS CYTOCHROM, V3, P397; Cuttle L, 2000, DRUG METAB DISPOS, V28, P945; Das A, 2007, J AM CHEM SOC, V129, P13778, DOI 10.1021/ja074864x; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Denisov IG, 2006, J BIOL CHEM, V281, P23313, DOI 10.1074/jbc.M605511200; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P241, DOI 10.1016/0005-2728(71)90092-2; EBEL RE, 1977, ARCH BIOCHEM BIOPHYS, V183, P317, DOI 10.1016/0003-9861(77)90445-3; FISHER CW, 1992, FASEB J, V6, P759, DOI 10.1096/fasebj.6.2.1537466; FISHER MT, 1985, J AM CHEM SOC, V107, P5018, DOI 10.1021/ja00303a045; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; Goldfarb D, 1996, J AM CHEM SOC, V118, P2686, DOI 10.1021/ja951307e; Guengerich F. Peter, 1994, P1259; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003; Hawkes DB, 2010, CHEMBIOCHEM, V11, P1107, DOI 10.1002/cbic.201000119; Hawkes DB, 2002, J BIOL CHEM, V277, P27725, DOI 10.1074/jbc.M203382200; Hlavica P, 2007, CURR DRUG METAB, V8, P594; HOLMAN DA, 1994, J PHYS CHEM-US, V98, P13300, DOI 10.1021/j100101a032; Honeychurch MJ, 1999, FEBS LETT, V451, P351, DOI 10.1016/S0014-5793(99)00610-9; Huang W, 2007, ARCH BIOCHEM BIOPHYS, V467, P193, DOI 10.1016/j.abb.2007.08.023; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; JENKINS CM, 1994, J BIOL CHEM, V269, P27401; Johnston WA, 2008, J BIOMOL SCREEN, V13, P135, DOI 10.1177/1087057107312780; KOGA H, 1986, J BACTERIOL, V166, P1089, DOI 10.1128/jb.166.3.1089-1095.1986; Kumar D, 2011, FARADAY DISCUSS, V148, P373, DOI 10.1039/c004950f; LAMBETH DO, 1973, J BIOL CHEM, V248, P6095; Lochner M, 2003, ADV SYNTH CATAL, V345, P743, DOI 10.1002/adsc.200303011; Luthra A, 2011, ARCH BIOCHEM BIOPHYS, V507, P26, DOI 10.1016/j.abb.2010.12.008; Mak PJ, 2008, BIOCHEMISTRY-US, V47, P3950, DOI 10.1021/bi800034b; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Nelson DR, 2011, BBA-PROTEINS PROTEOM, V1814, P14, DOI 10.1016/j.bbapap.2010.08.008; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Nouri-Nigjeh E, 2011, CURR DRUG METAB, V12, P359, DOI 10.2174/138920011795202929; OMURA T, 1962, J BIOL CHEM, V237, P1375; Otey Christopher R., 2003, V230, P137; Parikh A, 1997, NAT BIOTECHNOL, V15, P784, DOI 10.1038/nbt0897-784; Peterson JA, 1986, CYTOCHROME P 450 STR, P89; RINKER RG, 1960, J PHYS CHEM-US, V64, P573, DOI 10.1021/j100834a015; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shaik S, 2010, CHEM REV, V110, P949, DOI 10.1021/cr900121s; SONO M, 1982, J BIOL CHEM, V257, P5496; Soucek P, 1999, ARCH BIOCHEM BIOPHYS, V370, P190, DOI 10.1006/abbi.1999.1388; THOMANN H, 1995, J AM CHEM SOC, V117, P8243, DOI 10.1021/ja00136a023; Tomita T, 2001, J BIOL CHEM, V276, P36261, DOI 10.1074/jbc.M104932200; Yim SK, 2010, J MICROBIOL BIOTECHN, V20, P712, DOI 10.4014/jmb.0910.10043; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	48	21	20	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40750	40759		10.1074/jbc.M111.300871	http://dx.doi.org/10.1074/jbc.M111.300871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21976668	hybrid, Green Published			2022-12-27	WOS:000297315400036
J	Li, CL; Li, J; Cai, XY; Sun, HL; Jiao, JJ; Bai, T; Zhou, XW; Chen, XW; Gill, DL; Tang, XD				Li, Changlin; Li, Jing; Cai, Xiangyu; Sun, Haili; Jiao, Jinjin; Bai, Ting; Zhou, Xing Wang; Chen, Xiongwen; Gill, Donald L.; Tang, Xiang D.			Protein Kinase D3 Is a Pivotal Activator of Pathological Cardiac Hypertrophy by Selectively Increasing the Expression of Hypertrophic Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTONE DEACETYLASES; HEART-FAILURE; GENE-EXPRESSION; RAT-HEART; DELTA; MEF2; DYSFUNCTION; RECRUITMENT; INHIBITORS; CHANNELS	Fetal cardiac gene reactivation is a hallmark of pathological cardiac hypertrophy (PCH) driven by cardiac transcription factors (TFs) such as nuclear factor of activated T-cells (NFATs). Nuclear import of dephosphorylated NFATs catalyzed by calcineurin (CaN) is a well-established hypertrophic mechanism. Here we report that NFATc4 expression is also up-regulated by newly expressed protein kinase D3 (PKD3) to induce PCH. In both in vitro and in vivo cardiac hypertrophic models, the normally undetectable PKD3 was profoundly up-regulated by isoproterenol followed by overt expression of cardiac TFs including NFATc4, NK family of transcription factor 2.5 (Nkx2.5), GATA4 and myocyte enhancer factor 2 (MEF2). Using gene silencing approaches, we demonstrate PKD3 is required for increasing the expression of NFATc4, Nkx2.5, and GATA4 while PKD1 is required for the increase in MEF2D expression. Upstream induction of PKD3 is driven by nuclear entry of CaN-activated NFATc1 and c3 but not c4. Therefore, PKD3 is a pivotal mediator of the CaN-NFATc1/c3-PKD3-NFATc4 hypertrophic signaling cascade and a potential new drug target for the PCH.	[Li, Changlin; Li, Jing; Cai, Xiangyu; Sun, Haili; Jiao, Jinjin; Bai, Ting; Tang, Xiang D.] Nankai Univ, Sch Med, Dept Pharmacol, Tianjin 300071, Peoples R China; [Tang, Xiang D.] Nankai Univ, Sch Med, MOE Key Lab Bioact Mat, Tianjin 300071, Peoples R China; [Zhou, Xing Wang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Chen, Xiongwen] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Nankai University; Nankai University; Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Li, J (corresponding author), Nankai Univ, Sch Med, Dept Pharmacol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	stellarli@nankai.edu.cn; stang@nankai.edu.cn	zhou, xt/GWZ-9212-2022; Chen, Xiongwen/D-5988-2012	Chen, Xiongwen/0000-0002-3829-5815	National Institutes of Health [HL55426, AI058173]; Tianjin Science and Technology [08ZCKFSH04500]; Tianjin Natural Science Foundation [10JCYBJC14800]; NSFC [30871011, 81072629, 30870988]; Project "973" grant [2010CB945001]; Chinese Ministry of Education (MOE) [200800550036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088243, R01HL055426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tianjin Science and Technology; Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); NSFC(National Natural Science Foundation of China (NSFC)); Project "973" grant; Chinese Ministry of Education (MOE)(Ministry of Education, China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants (HL55426 and AI058173, to D. L G.), grants from the Tianjin Science and Technology Support Project (08ZCKFSH04500, to X. D. T.), Tianjin Natural Science Foundation (10JCYBJC14800, to J. L), NSFC Grants (30871011, to X. D. T.; 81072629 to J. L; 30870988, to X. W. Z.), The Project "973" grant (2010CB945001, to X. D. T.), and Chinese Ministry of Education (MOE) Doctorial Training Funds (200800550036, to X. D. T.).	Ago T, 2010, J CARDIOVASC TRANSL, V3, P304, DOI 10.1007/s12265-010-9182-x; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Barrick D, 2006, CELL, V124, P883, DOI 10.1016/j.cell.2006.02.028; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Ellwanger K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-47; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Goodall MH, 2010, J BIOL CHEM, V285, P41686, DOI 10.1074/jbc.M110.179648; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Heather LC, 2009, J PHYSIOL PHARMACOL, V60, P31; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Jepsen K, 2002, J CELL SCI, V115, P689; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Li CL, 2011, BIOCHEM BIOPH RES CO, V409, P125, DOI 10.1016/j.bbrc.2011.04.128; Luedde Mark, 2006, Recent Pat Cardiovasc Drug Discov, V1, P1, DOI 10.2174/157489006775244290; MacDonald MR, 2008, EUR HEART J, V29, P1224, DOI 10.1093/eurheartj/ehn156; Mathew J, 2001, CIRCULATION, V104, P1615, DOI 10.1161/hc3901.096700; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Nishida W, 2002, J BIOL CHEM, V277, P7308, DOI 10.1074/jbc.M111824200; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Putt ME, 2009, CIRC-CARDIOVASC GENE, V2, P212, DOI 10.1161/CIRCGENETICS.108.816686; Sambrano GR, 2002, NATURE, V420, P712, DOI 10.1038/nature01306; Schug J, 2008, CURR PROTOC BIOINFOR, V21, P261, DOI DOI 10.1002/; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200	41	20	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40782	40791		10.1074/jbc.M111.263046	http://dx.doi.org/10.1074/jbc.M111.263046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21971046	Green Published, hybrid			2022-12-27	WOS:000297315400039
J	Tortosa, E; Montenegro-Venegas, C; Benoist, M; Hartel, S; Gonzalez-Billault, C; Esteban, JA; Avila, J				Tortosa, Elena; Montenegro-Venegas, Carolina; Benoist, Marion; Hartel, Steffen; Gonzalez-Billault, Christian; Esteban, Jose A.; Avila, Jesus			Microtubule-associated Protein 1B (MAP1B) Is Required for Dendritic Spine Development and Synaptic Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN DEVELOPMENT; ACTIN DYNAMICS; RHO-GTPASES; POSTSYNAPTIC DENSITIES; HIPPOCAMPAL-NEURONS; LIM-KINASE; MORPHOLOGICAL PLASTICITY; CYTOSKELETAL DYNAMICS; MOLECULAR-MECHANISMS; PROTEOMIC ANALYSIS	Microtubule-associated protein 1B (MAP1B) is prominently expressed during early stages of neuronal development, and it has been implicated in axonal growth and guidance. MAP 1B expression is also found in the adult brain in areas of significant synaptic plasticity. Here, we demonstrate that MAP 1B is present in dendritic spines, and we describe a decrease in the density of mature dendritic spines in neurons of MAP1B-deficient mice that was accompanied by an increase in the number of immature filopodia-like protrusions. Although these neurons exhibited normal passive membrane properties and action potential firing, AMPA receptor-mediated synaptic currents were significantly diminished. Moreover, we observed a significant decrease in Rac1 activity and an increase in RhoA activity in the postsynaptic densities of adult MAP1B(+/-) mice when compared with wild type controls. MAP1B(+/-) fractions also exhibited a decrease in phosphorylated cofilin Taken together, these results indicate a new and important role for MAP1B in the formation and maturation of dendritic spines, possibly through the regulation of the actin cytoskeleton. This activity of MAP1B could contribute to the regulation of synaptic activity and plasticity in the adult brain.	[Montenegro-Venegas, Carolina; Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Lab Cell & Neuronal Dynam, Dept Biol, Santiago, Chile; [Montenegro-Venegas, Carolina; Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Inst Cell Dynam & Biotechnol, Santiago, Chile; [Tortosa, Elena; Montenegro-Venegas, Carolina; Benoist, Marion; Esteban, Jose A.] Univ Autonoma Madrid, Dept Neurosci, Ctr Biol Mol Severo Ochoa CSIC UAM, E-28049 Madrid, Spain; [Hartel, Steffen] Univ Chile, Lab Sci Image Anal SCIANLab, Santiago 1027, Chile; [Tortosa, Elena; Avila, Jesus] Ctr Enfermedades Neurodegenerativas CIBERNED, Madrid 28031, Spain	Universidad de Chile; Universidad de Chile; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de Chile; CIBERNED	Gonzalez-Billault, C (corresponding author), Univ Chile, Fac Sci, Lab Cell & Neuronal Dynam, Dept Biol, Santiago, Chile.	chrgonza@uchile.cl	Binacua, Elena Tortosa/AAA-1114-2020; Härtel, Steffen/AAA-2336-2020; Avila, Jesus/I-2610-2015; Gonzalez-Billault, Christian/P-2393-2019; Esteban, Jose/L-4944-2014	Härtel, Steffen/0000-0002-8913-1757; Avila, Jesus/0000-0002-6288-0571; Esteban, Jose/0000-0002-3759-3300; Tortosa, Elena/0000-0003-3910-2314				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; AVILA J, 1994, INT J DEV BIOL, V38, P13; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BLOOM GS, 1985, P NATL ACAD SCI USA, V82, P5404, DOI 10.1073/pnas.82.16.5404; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; COHEN RS, 1977, J CELL BIOL, V74, P181, DOI 10.1083/jcb.74.1.181; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cueille N, 2007, BRAIN RES BULL, V71, P610, DOI 10.1016/j.brainresbull.2006.12.003; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; Dehmelt L, 2005, GENOME BIOL, V6; DENNY JB, 1991, J NEUROCYTOL, V20, P627, DOI 10.1007/BF01187065; Diaz-Nido J., 1990, J NEUROCHEM, V54, P211; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; DiTella MC, 1996, J CELL SCI, V109, P467; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; FISCHER I, 1990, J NEUROCHEM, V55, P328, DOI 10.1111/j.1471-4159.1990.tb08855.x; GARNER CC, 1990, J NEUROCHEM, V55, P146, DOI 10.1111/j.1471-4159.1990.tb08832.x; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Gonzalez-Billault C., 2001, BIO CELL, V12, P2087; Goold RG, 1999, J CELL SCI, V112, P3373; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Gu Jiaping, 2009, Open Neurosci J, V3, P128; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Kawakami SI, 2003, CELL MOL NEUROBIOL, V23, P887, DOI 10.1023/B:CEMN.0000005317.79634.27; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MATUS A, 1986, ANN NY ACAD SCI, V466, P167, DOI 10.1111/j.1749-6632.1986.tb38393.x; MATUS A, 1991, J CELL SCI, P61; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Moreno FJ, 1999, MOL CELL BIOCHEM, V191, P201, DOI 10.1023/A:1006836211318; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nothias F, 1996, J COMP NEUROL, V368, P317, DOI 10.1002/(SICI)1096-9861(19960506)368:3<317::AID-CNE1>3.0.CO;2-8; NOVAK M, 1991, P NATL ACAD SCI USA, V88, P5837, DOI 10.1073/pnas.88.13.5837; Pedrotti B, 1996, FEBS LETT, V388, P131, DOI 10.1016/0014-5793(96)00520-0; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Pilpel Y, 2004, EUR J NEUROSCI, V19, P3151, DOI 10.1111/j.0953-816X.2004.03380.x; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Riederer BM, 2007, BRAIN RES BULL, V71, P541, DOI 10.1016/j.brainresbull.2006.11.012; RIEDERER BM, 1990, EUR J MORPHOL, V28, P347; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Seog DH, 2004, BIOSCI BIOTECH BIOCH, V68, P1808, DOI 10.1271/bbb.68.1808; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tashiro A, 2008, METHOD ENZYMOL, V439, P285, DOI 10.1016/S0076-6879(07)00421-1; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; TUCKER RP, 1988, DEV BIOL, V130, P423, DOI 10.1016/0012-1606(88)90338-7; TUCKER RP, 1988, J COMP NEUROL, V271, P44, DOI 10.1002/cne.902710106; TUCKER RP, 1987, DEVELOPMENT, V101, P535; ULLOA L, 1994, GLIA, V10, P266, DOI 10.1002/glia.440100405; ULLOA L, 1993, J NEUROCHEM, V61, P961, DOI 10.1111/j.1471-4159.1993.tb03609.x; Utreras E, 2008, DEV NEUROSCI-BASEL, V30, P200, DOI 10.1159/000109863; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; VIERECK C, 1989, J NEUROSCI, V9, P3547; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; Wittmann T, 2001, J CELL SCI, V114, P3795; Yang N, 1998, EXP CELL RES, V241, P242, DOI 10.1006/excr.1998.4053; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020	82	67	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40638	40648		10.1074/jbc.M111.271320	http://dx.doi.org/10.1074/jbc.M111.271320			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21984824	Green Published, hybrid			2022-12-27	WOS:000297315400025
J	Aranda-Orgilles, B; Rutschow, D; Zeller, R; Karagiannidis, AI; Kohler, A; Chen, CW; Wilson, T; Krause, S; Roepcke, S; Lilley, D; Schneider, R; Schweiger, S				Aranda-Orgilles, Beatriz; Rutschow, Desiree; Zeller, Raphael; Karagiannidis, Antonios I.; Koehler, Andrea; Chen, Changwei; Wilson, Timothy; Krause, Sven; Roepcke, Stefan; Lilley, David; Schneider, Rainer; Schweiger, Susann			Protein Phosphatase 2A (PP2A)-specific Ubiquitin Ligase MID1 Is a Sequence-dependent Regulator of Translation Efficiency Controlling 3-Phosphoinositide-dependent Protein Kinase-1 (PDPK-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPITZ-SYNDROME GENE; MESSENGER-RNA; GBBB SYNDROME; EXPRESSION; ALPHA-4; PHOSPHORYLATION; SUBUNIT; TARGETS; BINDING; MTOR	We have shown previously that the ubiquitin ligase MID1, mutations of which cause the midline malformation Opitz BBB/G syndrome (OS), serves as scaffold for a microtubule-associated protein complex that regulates protein phosphatase 2A (PP2A) activity in a ubiquitin-dependent manner. Here, we show that the MID1 protein complex associates with mRNAs via a purine-rich sequence motif called MIDAS (MID1 association sequence) and thereby increases stability and translational efficiency of these mRNAs. Strikingly, inclusion of multiple copies of the MIDAS motif into mammalian mRNAs increases production of the encoded proteins up to 20-fold. Mutated MID1, as found in OS patients, loses its influence on MIDAS-containing mRNAs, suggesting that the malformations in OS patients could be caused by failures in the regulation of cytoskeleton-bound protein translation. This is supported by the observation that the majority of mRNAs that carry MIDAS motifs is involved in developmental processes and/or energy homeostasis. Further analysis of one of the proteins encoded by a MIDAS-containing mRNA, namely PDPK-1 (3-phosphoinositide dependent protein kinase-1), which is an important regulator of mammalian target of rapamycin/PP2A signaling, showed that PDPK-1 protein synthesis is significantly reduced in cells from an OS patient compared with an age-matched control and can be rescued by functional MID1. Together, our data uncover a novel messenger ribonucleoprotein complex that regulates microtubule-associated protein translation. They suggest a novel mechanism underlying OS and point at an enormous potential of the MIDAS motif to increase the efficiency of biotechnological protein production in mammalian cells.	[Karagiannidis, Antonios I.; Koehler, Andrea; Schneider, Rainer] Univ Innsbruck, Inst Biochem, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; [Aranda-Orgilles, Beatriz; Krause, Sven; Roepcke, Stefan; Schneider, Rainer; Schweiger, Susann] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Rutschow, Desiree; Zeller, Raphael; Chen, Changwei; Schweiger, Susann] Univ Dundee, Div Med Sci, Ninewells Hosp, Dundee DD1 9SY, Scotland; [Wilson, Timothy; Lilley, David] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Innsbruck; Max Planck Society; University of Dundee; University of Dundee	Schneider, R (corresponding author), Univ Innsbruck, Inst Biochem, Ctr Mol Biosci Innsbruck, Peter Mayr Str 1A, A-6020 Innsbruck, Austria.	rainer.schneider@uibk.ac.at			Deutsche Forschungsgemeinschaft [SFB 577, A6]; Austrian Science Fund [FWF-SFB021, 03, TRP233-B18]; Tyrolean Future Foundation; Tenovus Scotland; AtaxiaUK; Austrian Science Fund (FWF) [TRP 233] Funding Source: researchfish; Cancer Research UK [11722] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); Tyrolean Future Foundation; Tenovus Scotland; AtaxiaUK; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Cancer Research UK(Cancer Research UK)	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB 577 (Project A6, to S. S.), Austrian Science Fund Grants FWF-SFB021 (Project 03) and TRP233-B18 (to R. S.), the Tyrolean Future Foundation (to R. S.), Tenovus Scotland (to S. S.), and AtaxiaUK (to S. S.). Patent application pending (EP 07015280.6).	Aranda-Orgilles B, 2008, HUM GENET, V123, P163, DOI 10.1007/s00439-007-0456-6; Ashique AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000602; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Berthier CC, 2008, NEPHROL DIAL TRANSPL, V23, P880, DOI 10.1093/ndt/gfm697; Berti C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-9; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Canedo CS, 2010, AM J PHYSIOL-ENDOC M, V298, pE761, DOI 10.1152/ajpendo.00421.2009; Cao WL, 2009, BIOL REPROD, V80, P124, DOI 10.1095/biolreprod.108.068882; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Clark MR, 2011, MOL IMMUNOL, V48, P1281, DOI 10.1016/j.molimm.2010.10.024; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Felschow DM, 2000, BIOCHEM BIOPH RES CO, V273, P294, DOI 10.1006/bbrc.2000.2887; Grech G, 2008, BLOOD, V112, P2750, DOI 10.1182/blood-2008-01-133140; HERRLICH P, 1974, P NATL ACAD SCI USA, V71, P1088, DOI 10.1073/pnas.71.4.1088; Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Iskandar K, 2010, AM J PHYSIOL-ENDOC M, V298, pE787, DOI 10.1152/ajpendo.00512.2009; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Lancioni A, 2010, J NEUROSCI, V30, P2880, DOI 10.1523/JNEUROSCI.4196-09.2010; Landgren S, 2009, BRAIN RES, V1305, pS72, DOI 10.1016/j.brainres.2009.08.026; Lijnen HR, 2011, J PHARMACOL EXP THER, V337, P457, DOI 10.1124/jpet.110.178046; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Lonyai A, 2008, IMMUNOL CELL BIOL, V86, P301, DOI 10.1038/icb.2008.6; Luo T, 2007, DEVELOPMENT, V134, P1279, DOI 10.1242/dev.02813; McDonald WJ, 2010, J CELL BIOCHEM, V110, P1123, DOI 10.1002/jcb.22624; Muller YL, 2010, DIABETES, V59, P2080, DOI 10.2337/db09-1593; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Oganesian L, 2007, BIOESSAYS, V29, P155, DOI 10.1002/bies.20523; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; ROBIN NH, 1995, NAT GENET, V11, P459, DOI 10.1038/ng1295-459; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schram K, 2011, ENDOCRINOLOGY, V152, P2037, DOI 10.1210/en.2010-1166; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; So J, 2005, AM J MED GENET A, V132A, P1, DOI 10.1002/ajmg.a.30407; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Tsatsos NG, 2008, ENDOCRINOLOGY, V149, P5155, DOI 10.1210/en.2008-0215; Wauman J, 2008, MOL ENDOCRINOL, V22, P965, DOI 10.1210/me.2007-0414; Wilhelm JE, 2005, BIOL CELL, V97, P235, DOI 10.1042/BC20040097; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Wu HJ, 2009, J CLIN IMMUNOL, V29, P12, DOI 10.1007/s10875-008-9264-6	52	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39945	39957		10.1074/jbc.M111.224451	http://dx.doi.org/10.1074/jbc.M111.224451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21930711	hybrid, Green Published			2022-12-27	WOS:000296925700028
J	Morrow, KA; Das, S; Metge, BJ; Ye, KQ; Mulekar, MS; Tucker, JA; Samant, RS; Shevde, LA				Morrow, K. Adam; Das, Shamik; Metge, Brandon J.; Ye, Keqiang; Mulekar, Madhuri S.; Tucker, J. Allan; Samant, Rajeev S.; Shevde, Lalita A.			Loss of Tumor Suppressor Merlin in Advanced Breast Cancer Is due to Post-translational Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF2 GENE; AKT PHOSPHORYLATION; MDA-MB-435 CELLS; M14 MELANOMA; OSTEOPONTIN; GROWTH; METASTASIS; ACTIVATION; EXPRESSION; INHIBITION	Unlike malignancies of the nervous system, there have been no mutations identified in Merlin in breast cancer. As such, the role of the tumor suppressor, Merlin, has not been investigated in breast cancer. We assessed Merlin expression in breast cancer tissues by immunohistochemistry and by real-time PCR. The expression of Merlin protein (assessed immunohistochemically) was significantly decreased in breast cancer tissues (although the transcript levels were comparable) simultaneous with increased expression of the tumor-promoting protein, osteopontin (OPN). We further demonstrate that the loss of Merlin in breast cancer is brought about, in part, due to OPN-initiated Akt-mediated phosphorylation of Merlin leading to its proteasomal degradation. Restoring expression of Merlin resulted in reduced malignant attributes of breast cancer, characterized by reduced invasion, migration, motility, and impeded tumor (xenograft) growth in immunocompromised mice. The possibility of developing a model using the relationship between OPN and Merlin was tested with a logistic regression model applied to immunohistochemistry data. This identified consistent loss of immunohistochemical expression of Merlin in breast tumor tissues. Thus, we demonstrate for the first time a role for Merlin in impeding breast malignancy, identify a novel mechanism for the loss of Merlin protein in breast cancer, and have developed a discriminatory model using Merlin and OPN expression in breast tumor tissues.	[Morrow, K. Adam; Das, Shamik; Metge, Brandon J.; Samant, Rajeev S.; Shevde, Lalita A.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Mulekar, Madhuri S.] Univ S Alabama, Dept Math & Stat, Mobile, AL 36604 USA; [Tucker, J. Allan] Univ S Alabama, Dept Pathol, Mobile, AL 36604 USA; [Ye, Keqiang] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	University of South Alabama; University of South Alabama; University of South Alabama; Emory University	Shevde, LA (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA.	lsamant@usouthal.edu		Samant, Rajeev/0000-0001-5681-4976	National Institutes of Health [CA138850, CA140472]; Mayer Mitchell Award; University of South Alabama (USA) Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA140472, R01CA138850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayer Mitchell Award; University of South Alabama (USA) Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA138850 (to L. A. S.) and CA140472 (to R. S. S.). This work was also supported by the Mayer Mitchell Award (to L. A. S.) and a grant from the University of South Alabama (USA) Mitchell Cancer Institute.	ARAKAWA H, 1994, HUM MOL GENET, V3, P565, DOI 10.1093/hmg/3.4.565; Bai Y, 2007, ONCOGENE, V26, P836, DOI 10.1038/sj.onc.1209849; Begnami MD, 2007, HUM PATHOL, V38, P1345, DOI 10.1016/j.humpath.2007.01.027; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; CRAIG AM, 1988, BIOCHEM BIOPH RES CO, V157, P166, DOI 10.1016/S0006-291X(88)80028-7; Dai JL, 2004, ONCOGENE, V23, P8681, DOI 10.1038/sj.onc.1207962; Das R, 2003, J BIOL CHEM, V278, P28593, DOI 10.1074/jbc.M303445200; Fouladi M, 2003, CANCER-AM CANCER SOC, V98, P2232, DOI 10.1002/cncr.11783; Furger Kara A., 2001, Current Molecular Medicine (Hilversum), V1, P621, DOI 10.2174/1566524013363339; Gao CJ, 2007, J IMMUNOL, V178, P1870, DOI 10.4049/jimmunol.178.3.1870; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Kim H, 2002, MOL CELLS, V14, P108; Kim Youn Wha, 1998, Journal of Korean Medical Science, V13, P652; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Lacroix M, 2009, CANCER CHEMOTH PHARM, V63, P567, DOI 10.1007/s00280-008-0776-9; Lasota J, 2003, LAB INVEST, V83, P1361, DOI 10.1097/01.LAB.0000087591.29639.E3; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Metge BJ, 2008, CLIN EXP METASTAS, V25, P753, DOI 10.1007/s10585-008-9187-x; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Muranen T, 2007, HUM MOL GENET, V16, P1742, DOI 10.1093/hmg/ddm122; Nunes F, 2005, CANCER GENET CYTOGEN, V162, P135, DOI 10.1016/j.cancergencyto.2005.04.003; Okada M, 2009, CANCER RES, V69, P4043, DOI 10.1158/0008-5472.CAN-08-3931; Philip S, 2004, GLYCOCONJUGATE J, V21, P429, DOI 10.1007/s10719-004-5533-7; Poulikakos PI, 2006, ONCOGENE, V25, P5960, DOI 10.1038/sj.onc.1209587; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rangaswami H, 2006, GLYCOCONJUGATE J, V23, P221, DOI 10.1007/s10719-006-7927-1; Robertson BW, 2010, EXP CELL RES, V316, P1, DOI 10.1016/j.yexcr.2009.10.012; Rodrigues LR, 2007, CANCER EPIDEM BIOMAR, V16, P1087, DOI 10.1158/1055-9965.EPI-06-1008; Rudland PS, 2002, CANCER RES, V62, P3417; Rushing EJ, 2007, J NEURO-ONCOL, V85, P297, DOI 10.1007/s11060-007-9411-6; Sainio M, 1997, J CELL SCI, V110, P2249; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Singhal H, 1997, CLIN CANCER RES, V3, P605; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tuck AB, 1998, INT J CANCER, V79, P502, DOI 10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3; Tuck AB, 2001, J MAMMARY GLAND BIOL, V6, P419, DOI 10.1023/A:1014734930781; Wallace AJ, 2004, GENET TEST, V8, P368, DOI 10.1089/gte.2004.8.368; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; YAEGASHI S, 1995, JPN J CANCER RES, V86, P929, DOI 10.1111/j.1349-7006.1995.tb03003.x; Yang YL, 2009, CANCER SCI, V100, P24, DOI 10.1111/j.1349-7006.2008.01013.x; Ye KQ, 2007, CELL ADHES MIGR, V1, P196, DOI 10.4161/cam.1.4.5192; Zhang GX, 2003, MOL CELL BIOL, V23, P6507, DOI 10.1128/MCB.23.18.6507-6519.2003	45	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40376	40385		10.1074/jbc.M111.250035	http://dx.doi.org/10.1074/jbc.M111.250035			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21965655	hybrid, Green Published			2022-12-27	WOS:000296925700068
J	Wang, D; Wengrod, J; Gardner, LB				Wang, Ding; Wengrod, Jordan; Gardner, Lawrence B.			Overexpression of the c-myc Oncogene Inhibits Nonsense-mediated RNA Decay in B Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATED STRESS-RESPONSE; PROTEIN-SYNTHESIS; TARGET GENE; IN-VIVO; TUMORIGENESIS; EXPRESSION; REPRESSION; DISEASE; CELLS; P53	The Myc transcription factor plays a vital role in both normal cellular physiology and in many human cancers. We have recently demonstrated that nonsense-mediated RNA decay (NMD), a mechanism that rapidly degrades select mRNAs, is inhibited by the stress-induced phosphorylation of translation initiation factor eIF2 alpha, and this inhibition stabilizes many transcripts necessary for tumorigenesis. Here, we demonstrate that NMD is inhibited by high Myc expression. We show that the phosphorylation of eIF2 alpha, likely due to the ability of Myc to generate reactive oxygen species and augment endoplasmic reticulum stress, is necessary for the inhibition of NMD by Myc. The inhibition of NMD both stabilizes and up-regulates multiple Myc targets, suggesting that the inhibition of NMD may play an important role in the dynamic regulation of genes by Myc.	[Gardner, Lawrence B.] NYU, Div Hematol & Med Oncol, Sch Med, Dept Med, New York, NY 10016 USA; [Wengrod, Jordan; Gardner, Lawrence B.] NYU, Dept Pharmacol, Sch Med, New York, NY 10016 USA; [Gardner, Lawrence B.] NYU, New York Univ Canc Inst, Sch Med, New York, NY 10016 USA	New York University; New York University; New York University	Gardner, LB (corresponding author), NYU, Div Hematol & Med Oncol, Sch Med, Dept Med, 550 1st Ave, New York, NY 10016 USA.	lawrence.gardner@nyumc.org		Gardner, Lawrence/0000-0003-0191-0172	National Institutes of Health [DK08164, 5T32GM066704]; Feldstein Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feldstein Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK08164. This work was also supported by the Feldstein Medical Foundation (to L. B. G.) and National Institutes of Health Grant 5T32GM066704 (to J. W.).	Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Ruiz-Vela A, 2008, BLOOD, V111, P1665, DOI 10.1182/blood-2007-09-110601; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang D, 2011, MOL CELL BIOL, V31, P3670, DOI 10.1128/MCB.05704-11; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	24	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40038	40043		10.1074/jbc.M111.266361	http://dx.doi.org/10.1074/jbc.M111.266361			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21969377	Green Published, hybrid			2022-12-27	WOS:000296925700036
J	Wang, ZF; Lin, S; Li, JLJ; Xu, ZH; Yao, H; Zhu, X; Xie, D; Shen, Z; Sze, J; Li, K; Lu, G; Chan, DTM; Poon, WS; Kung, HF; Lin, MCM				Wang, Zifeng; Lin, Sheng; Li, Julia Jun; Xu, Zhenhua; Yao, Hong; Zhu, Xiao; Xie, Dan; Shen, Zan; Sze, Johnny; Li, Kui; Lu, Gang; Chan, Danny Tat-Ming; Poon, Wai Sang; Kung, Hsiang-fu; Lin, Marie Chia-mi			MYC Protein Inhibits Transcription of the MicroRNA Cluster MC-let-7a-1 similar to let-7d via Noncanonical E-box	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; C-MYC; TUMOR SUPPRESSORS; PROMOTES TRANSFORMATION; DOWN-REGULATION; LET-7 MICRORNA; IN-VITRO; CANCER; EXPRESSION; LIN28	The human microRNA cluster MC-let-7a-1 similar to let-7d, with three members let-7a-1, let-7f-1, and let-7d, is an important cluster of the let-7 family. These microRNAs play critical roles in regulating development and carcinogenesis. Therefore, precise control of MC-let-7a-1 similar to let-7d level is critical for cellular functions. In this study, we first showed that the expression of these three members was significantly reduced in human hepatocellular carcinoma HepG2 cells as compared with the immortalized human liver L02 cells. We demonstrated that the MC-let-7a-1 similar to let-7d cluster was encoded by a single polycistronic transcript driven by a 10-kb upstream promoter, with two MYC-binding sites. Importantly, MYC inhibited MC-let-7a-1 similar to let-7d promoter activity via binding to the noncanonical E-box 3 downstream of the transcription start sites, whereas it enhanced promoter activity by binding to the canonical E-box 2 upstream of the transcription start sites. We found that although the binding affinity of MYC to E-box 2 was stronger than E-box 3, the binding quantum of MYC to E-box 3 was significantly higher in cancerous HepG2 cells as compared with the noncancerous L02 cells. In addition, forced expression of let-7 could reverse the MYC-mediated cell proliferation. These findings suggested that in L02 cells with a low level of MYC, MYC binds mainly to E-box 2 to enhance MC-let-7a-1 similar to let-7d expression. However, in HepG2 cells with an elevated MYC, the extra MYC could bind to E-box 3 to suppress the transcription of MC-let-7a-1 similar to let-7d and thus enable HepG2 cells to maintain a high level of MYC and a low level of let-7 microRNAs simultaneously.	[Wang, Zifeng; Lin, Sheng; Li, Kui; Kung, Hsiang-fu] Sun Yat Sen Univ, Lab Integrated Biosci, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Sheng; Li, Julia Jun; Xu, Zhenhua; Sze, Johnny; Lu, Gang; Chan, Danny Tat-Ming; Poon, Wai Sang; Lin, Marie Chia-mi] Chinese Univ Hong Kong, Dept Surg, Brain Tumour Ctr, Shatin, Hong Kong, Peoples R China; [Lin, Sheng; Li, Julia Jun; Xu, Zhenhua; Sze, Johnny; Lu, Gang; Chan, Danny Tat-Ming; Poon, Wai Sang; Lin, Marie Chia-mi] Chinese Univ Hong Kong, Dept Surg, Div Neurosurg, Shatin, Hong Kong, Peoples R China; [Yao, Hong] Kunming Med Univ, Kunming, Peoples R China; [Zhu, Xiao] Guangdong Med Coll, Inst Biochem & Mol Biol, Key Lab Mol Diag, Dongguan, Peoples R China; [Xie, Dan; Kung, Hsiang-fu] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Zan] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Oncol, Shanghai 200030, Peoples R China; [Kung, Hsiang-fu] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong; Chinese University of Hong Kong; Kunming Medical University; Guangdong Medical University; Sun Yat Sen University; Shanghai Jiao Tong University; Chinese University of Hong Kong	Kung, HF (corresponding author), Sun Yat Sen Univ, Lab Integrated Biosci, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	hkung@cuhk.edu.hk; mcllin@surgery.cuhk.edu.hk	Lin, Sheng/AAC-9465-2022; Poon, Wai S/HGD-3084-2022; Poon, Wai Sang/F-1558-2011		National Basic Research Program of China (973 Program) [2010CB529400, 2010CB912800]; National Natural Science Foundation of China [81001023]; Research Grants Council of Hong Kong [467109]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by National Basic Research Program of China (973 Program) Grants 2010CB529400 and 2010CB912800, National Natural Science Foundation of China Grant PC: 81001023, and Research Grants Council of Hong Kong Grant 467109.	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Diao S, 2010, PROTEOMICS, V10, P3723, DOI 10.1002/pmic.201000050; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Lan FF, 2011, INT J CANCER, V128, P319, DOI 10.1002/ijc.25336; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Muller DW, 2008, ONCOGENE, V27, P6698, DOI 10.1038/onc.2008.282; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Simile MM, 2004, CARCINOGENESIS, V25, P333, DOI 10.1093/carcin/bgh014; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wu YF, 2002, ONCOGENE, V21, P1518, DOI 10.1038/sj.onc.1205208; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883; Zhu YM, 2010, WORLD J GASTROENTERO, V16, P3325, DOI 10.3748/wjg.v16.i26.3325	60	54	57	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39703	39714		10.1074/jbc.M111.293126	http://dx.doi.org/10.1074/jbc.M111.293126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21903590	Green Published, hybrid			2022-12-27	WOS:000296925700004
J	Biswas, M; Phan, D; Watanabe, M; Chan, JY				Biswas, Madhurima; Phan, Diane; Watanabe, Momoko; Chan, Jefferson Y.			The Fbw7 Tumor Suppressor Regulates Nuclear Factor E2-related Factor 1 Transcription Factor Turnover through Proteasome-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE; ENDOPLASMIC-RETICULUM; UBIQUITIN LIGASES; NRF1; DEGRADATION; MECHANISMS; PROTEINS; FAMILY; NF-E2; GENE	Nuclear factor E2-related factor 1 (Nrf1) is a basic leucine zipper transcription factor that plays important roles in cellular stress response and development. Currently, the mechanism regulating Nrf1 expression is poorly understood. We report here that Nrf1 is a short-lived protein that is targeted by F-box protein Fbw7, which is the substrate-specifying component of SCF (Skp1-Cul1-Fbox protein-Rbx1)-type ubiquitin ligase for degradation via the ubiquitin-proteasome pathway. We show that Fbw7 directly binds Nrf1 through a Cdc4 phosphodegron and that enforced expression of Fbw7 promotes the ubiquitination and degradation of Nrf1. Conversely, depletion of endogenous Fbw7 leads to decreased Nrf1 ubiquitination and accumulation of Nrf1 protein. Accordingly, expression of Fbw7 leads to down-regulation of antioxidant response element-driven gene activation, whereas disruption of Fbw7-mediated destabilization of Nrf1 leads to increased antioxidant response element-driven gene expression. Together, these data identify Fbw7 as a regulator of Nrf1 expression and reveal a novel function of Fbw7 in cellular stress response.	[Biswas, Madhurima; Phan, Diane; Watanabe, Momoko; Chan, Jefferson Y.] Univ Calif Irvine, Dept Lab Med & Pathol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Chan, JY (corresponding author), Univ Calif Irvine, Dept Lab Med & Pathol, Irvine, CA 92697 USA.	jchan@uci.edu			National Institutes of Health [CA091907]; NATIONAL CANCER INSTITUTE [R56CA091907, R01CA091907, P30CA062203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA091907.	ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHAN JY, 1995, HUM GENET, V95, P265; Crusio KM, 2010, ONCOGENE, V29, P4865, DOI 10.1038/onc.2010.222; Floyd ZE, 2001, J BIOL CHEM, V276, P22468, DOI 10.1074/jbc.M009388200; Fujii Y, 2006, CANCER SCI, V97, P729, DOI 10.1111/j.1349-7006.2006.00239.x; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lenk U, 2000, J BIOL CHEM, V275, P39403, DOI 10.1074/jbc.M006949200; Minella AC, 2005, CELL CYCLE, V4, P1356, DOI 10.4161/cc.4.10.2058; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Myhrstad MCW, 2001, BBA-GENE STRUCT EXPR, V1517, P212, DOI 10.1016/S0167-4781(00)00276-1; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhao R, 2011, ENVIRON HEALTH PERSP, V119, P56, DOI 10.1289/ehp.1002304	33	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39282	39289		10.1074/jbc.M111.253807	http://dx.doi.org/10.1074/jbc.M111.253807			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21953459	Green Published, hybrid			2022-12-27	WOS:000296759800046
J	McKenney, RJ; Weil, SJ; Scherer, J; Vallee, RB				McKenney, Richard J.; Weil, Sarah J.; Scherer, Julian; Vallee, Richard B.			Mutually Exclusive Cytoplasmic Dynein Regulation by NudE-Lis1 and Dynactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS ENDS; TUG-OF-WAR; INTERMEDIATE CHAIN; ASPERGILLUS-NIDULANS; NEURONAL MIGRATION; LISSENCEPHALY GENE; NUCLEAR MIGRATION; BINDING DOMAIN; LIS1; NUDEL	Cytoplasmic dynein is responsible for a wide range of cellular roles. How this single motor protein performs so many functions has remained a major outstanding question for many years. Part of the answer is thought to lie in the diversity of dynein regulators, but how the effects of these factors are coordinated in vivo remains unexplored. We previously found NudE to bind dynein through its light chain 8 (LC8) and intermediate chain (IC) subunits (1), the latter of which also mediates the dynein-dynactin interaction (2). We report here that NudE and dynactin bind to a common region within the IC, and compete for this site. We find LC8 to bind to a novel sequence within NudE, without detectably affecting the dynein-NudE interaction. We further find that commonly used dynein inhibitory reagents have broad effects on the interaction of dynein with its regulatory factors. Together these results reveal an unanticipated mechanism for preventing dual regulation of individual dynein molecules, and identify the IC as a nexus for regulatory interactions within the dynein complex.	[McKenney, Richard J.; Weil, Sarah J.; Scherer, Julian; Vallee, Richard B.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University	Vallee, RB (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Columbia Univ Phys & Surg Bldg,Room 15-409 630 W, New York, NY 10032 USA.	rv2025@columbia.edu			National Institutes of Health [GM47434, HD40182]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047434, R37GM047434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM47434 and HD40182 (to R. B. V.).	Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Bolhy S, 2011, J CELL BIOL, V192, P855, DOI 10.1083/jcb.201007118; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Grabham PW, 2007, J NEUROSCI, V27, P5823, DOI 10.1523/JNEUROSCI.1135-07.2007; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Hebbar S, 2008, J CELL BIOL, V182, P1063, DOI 10.1083/jcb.200803071; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lightcap CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006025; MA S, 1995, MOL BIOL CELL, V6, P899; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Moore JK, 2009, P NATL ACAD SCI USA, V106, P5147, DOI 10.1073/pnas.0810828106; Myers KR, 2007, J NEUROSCI RES, V85, P2640, DOI 10.1002/jnr.21213; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Paschal B. M., 1991, METHOD ENZYMOL, V196, P192; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Roghi C, 1999, J CELL SCI, V112, P4673; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Steffen W, 1997, MOL BIOL CELL, V8, P2077, DOI 10.1091/mbc.8.10.2077; Steffen W, 1996, J STRUCT BIOL, V117, P227, DOI 10.1006/jsbi.1996.0087; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan KT, 1999, J CELL SCI, V112, P1437; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Yi J., 2011, J CELL BIOL IN PRESS; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	65	72	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39615	39622		10.1074/jbc.M111.289017	http://dx.doi.org/10.1074/jbc.M111.289017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21911489	Green Published, hybrid			2022-12-27	WOS:000296759800078
J	Patel, M; Chiang, TC; Tran, V; Lee, FJS; Cote, JF				Patel, Manishha; Chiang, Tsai-Chen; Tran, Viviane; Lee, Fang-Jen S.; Cote, Jean-Francois			The Arf Family GTPase Arl4A Complexes with ELMO Proteins to Promote Actin Cytoskeleton Remodeling and Reveals a Versatile Ras-binding Domain in the ELMO Proteins Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CELL-MIGRATION; DOWNSTREAM ACTIVATION; NUCLEOTIDE EXCHANGE; APOPTOTIC CELLS; PLASMA-MEMBRANE; DOCK180; RAC1; RHOG; PATHWAY; FUSION	The prototypical DOCK protein, DOCK180, is an evolutionarily conserved Rac regulator and is indispensable during processes such as cell migration and myoblast fusion. The biological activity of DOCK180 is tightly linked to its binding partner ELMO. We previously reported that autoinhibited ELMO proteins regulate signaling from this pathway. One mechanism to activate the ELMO-DOCK180 complex appears to be the recruitment of this complex to the membrane via the Ras-binding domain (RBD) of ELMO. In the present study, we aimed to identify novel ELMO-interacting proteins to further define the molecular events capable of controlling ELMO recruitment to the membrane. To do so, we performed two independent interaction screens: one specifically interrogated an active GTPase library while the other probed a brain cDNA library. Both methods converged on Arl4A, an Arf-related GTPase, as a specific ELMO interactor. Biochemically, Arl4A is constitutively GTP-loaded, and our binding assays confirm that both wild-type and constitutively active forms of the GTPase associate with ELMO. Mechanistically, we report that Arl4A binds the ELMO RBD and acts as a membrane localization signal for ELMO. In addition, we report that membrane targeting of ELMO via Arl4A promotes cytoskeletal reorganization including membrane ruffling and stress fiber disassembly via an ELMO-DOCK1800-Rac signaling pathway. We conclude that ELMO is capable of interacting with GTPases from Rho and Arf families, leading to the conclusion that ELMO contains a versatile RBD. Furthermore, via binding of an Arf family GTPase, the ELMO-DOCK180 is uniquely positioned at the membrane to activate Rac signaling and remodel the actin cytoskeleton.	[Chiang, Tsai-Chen; Lee, Fang-Jen S.] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 100, Taiwan; [Patel, Manishha; Tran, Viviane; Cote, Jean-Francois] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Patel, Manishha; Cote, Jean-Francois] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Chiang, Tsai-Chen; Lee, Fang-Jen S.] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan; [Cote, Jean-Francois] McGill Univ, Div Expt Med, Montreal, PQ H3A 1A3, Canada	National Taiwan University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; National Taiwan University; National Taiwan University Hospital; McGill University	Lee, FJS (corresponding author), Natl Taiwan Univ, Inst Mol Med, Coll Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.	fangjen@ntu.edu.tw; jean-francois.cote@ircm.qc.ca		LEE, FANG-JEN/0000-0002-2167-2426	Canadian Institutes of Health Research; National Science Council, Taiwan [NSC-100 2325-B-022-028]; National Taiwan University Hospital [99P21-1]; Canadian Institutes of Health Research-Institut de Recherches Cliniques de Montreal; Universite de Montreal-Comite d'Organisation du Programme des Stagiaires d'Ete; Pfizer Canada; Fonds de la Recherches en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); Canadian Institutes of Health Research-Institut de Recherches Cliniques de Montreal(Canadian Institutes of Health Research (CIHR)); Universite de Montreal-Comite d'Organisation du Programme des Stagiaires d'Ete; Pfizer Canada(Pfizer); Fonds de la Recherches en Sante du Quebec	This work was funded by a Canadian Institutes of Health Research operating grant (to J.-F.C.). This work was also supported by grants from the National Science Council, Taiwan, (NSC-100 2325-B-022-028), and National Taiwan University Hospital (99P21-1, to F.-J.S.L.).; Recipient of a Canadian Institutes of Health Research-Institut de Recherches Cliniques de Montreal training studentship.; Recipient of a Universite de Montreal-Comite d'Organisation du Programme des Stagiaires d'Ete undergraduate studentship funded by Pfizer Canada.; Recipient of a Canadian Institutes of Health Research New Investigator Award and currently holds a Fonds de la Recherches en Sante du Quebec Junior 2 career award.	Bartel P. L., 1993, CELLULAR INTERACTION, P153; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Jacobs S, 1999, FEBS LETT, V456, P384, DOI 10.1016/S0014-5793(99)00759-0; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Meller J, 2008, J CELL SCI, V121, P1981, DOI 10.1242/jcs.025130; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; White DT, 2010, MOL BIOL CELL, V21, P562, DOI 10.1091/mbc.E09-03-0217; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	39	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38969	38979		10.1074/jbc.M111.274191	http://dx.doi.org/10.1074/jbc.M111.274191			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930703	Green Published, hybrid			2022-12-27	WOS:000296759800016
J	Yang, CH; Yue, JM; Pfeffer, SR; Handorf, CR; Pfeffer, LM				Yang, Chuan He; Yue, Junming; Pfeffer, Susan R.; Handorf, Charles R.; Pfeffer, Lawrence M.			MicroRNA miR-21 Regulates the Metastatic Behavior of B16 Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; KAPPA-B; SURVIVAL; EXPRESSION; TARGETS; MODULATION; ACTIVATION; INVASION; ONCOMIR; TUMORS	MicroRNA-21 (miR-21) is overexpressed in many human tumors and has been linked to various cellular processes altered in cancer. miR-21 is also up-regulated by a number of inflammatory agents, including IFN, which is of particular interest considering the close relationship between inflammation and cancer. Because miR-21 appears to be overexpressed in human melanoma, we examined the role of miR-21 in cancer development and metastasis in B16 mouse melanoma cells. We found that miR-21 is a member of an IFN-induced miRNA subset that requires STAT3 activation. To characterize the role of miR-21 in melanoma behavior, we transduced B16 cells with lentivirus encoding a miR-21 antagomir and isolated miR-21 knockdown B16 cells. miR-21 knockdown or IFN treatment alone inhibited B16 cell proliferation and migration in vitro, and in combination they had an enhanced effect. Moreover, miR-21 knockdown sensitized B16 cells to IFN-induced apoptosis. In B16 cells miR-21 targeted tumor suppressor (PTEN and PDCD4) and antiproliferative (BTG2) proteins. To characterize the role of miR-21 in vivo, empty vector- and antagomiR-21-transduced B16 melanoma cells were injected via tail vein into syngeneic C57BL/6 mice. Although empty vector-transduced B16 cells produced large lung metastases, miR-21 knockdown cells only formed small lung lesions. Importantly, miR-21 knockdown tumor-bearing mice exhibited prolonged survival compared with empty vector tumor-bearing mice. Thus, miR-21 regulates the metastatic behavior of B16 melanoma cells by promoting cell proliferation, survival, and migration/invasion as well as by suppressing IFN action, providing important new insights into the role of miR-21 in melanoma.	[Yang, Chuan He; Pfeffer, Susan R.; Handorf, Charles R.; Pfeffer, Lawrence M.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Yue, Junming] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Yang, Chuan He; Yue, Junming; Pfeffer, Susan R.; Handorf, Charles R.; Pfeffer, Lawrence M.] Univ Tennessee, Ctr Hlth Sci, Ctr Adult Canc Res, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Pfeffer, LM (corresponding author), Canc Res Bldg,Rm 154,19 S Manassas St, Memphis, TN 38163 USA.	lpfeffer@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA133322, RHL095957]; University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA133322] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA133322 (to L. M. P.) and RHL095957 (to J. Y.). This work was also supported by the Muirhead Chair Endowment of the University of Tennessee Health Science Center (to L. M. P.).	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; NICOLSON GL, 1978, CANCER RES, V38, P4105; NICOLSON GL, 1979, SCI AM, V240, P66, DOI 10.1038/scientificamerican0379-66; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pfeffer LM, 1998, CANCER RES, V58, P2489; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; POSTE G, 1982, CANCER RES, V42, P2770; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Yang C., 2010, P IEEE WICOM C, P1; Yang CH, 2005, J BIOL CHEM, V280, P31530, DOI 10.1074/jbc.M503120200; Yang CH, 2000, P NATL ACAD SCI USA, V97, P13631, DOI 10.1073/pnas.250477397; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	32	137	145	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39172	39178		10.1074/jbc.M111.285098	http://dx.doi.org/10.1074/jbc.M111.285098			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940630	Green Published, hybrid			2022-12-27	WOS:000296759800036
J	Paul, S; Dansithong, W; Jog, SP; Holt, I; Mittal, S; Brook, JD; Morris, GE; Comai, L; Reddy, S				Paul, Sharan; Dansithong, Warunee; Jog, Sonali P.; Holt, Ian; Mittal, Saloni; Brook, J. David; Morris, Glenn E.; Comai, Lucio; Reddy, Sita			Expanded CUG Repeats Dysregulate RNA Splicing by Altering the Stoichiometry of the Muscleblind 1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; MYOTONIC-DYSTROPHY; TRIPLET-REPEAT; CHLORIDE CHANNEL; BINDING PROTEIN; STEADY-STATE; CTG REPEAT; GENE; MBNL1; IDENTIFICATION	To understand the role of the splice regulator muscleblind 1 (MBNL1) in the development of RNA splice defects in myotonic dystrophy I (DM1), we purified RNA-independent MBNL1 complexes from normal human myoblasts and examined the behavior of these complexes in DM1 myoblasts. Antibodies recognizing MBNL1 variants (MBNL1(CUG)), which can sequester in the toxic CUG RNA foci that develop in DM1 nuclei, were used to purifyMBNL1(CUG) complexes from normal myoblasts. In normal myoblasts, MBNL1(CUG) bind 10 proteins involved in remodeling ribonucleoprotein complexes including hnRNP H, H2, H3, F, A2/B1, K, L, DDX5, DDX17, and DHX9. Of these proteins, only MBNL1(CUG) colocalizes extensively with DM1 CUG foci (> 80% of foci) with its partners being present in < 10% of foci. Importantly, the stoichiometry of MBNL1(CUG) complexes is altered in DM1 myoblasts, demonstrating an increase in the steady state levels of nine of its partner proteins. These changes are recapitulated by the expression of expanded CUG repeat RNA in Cos7 cells. Altered stoichiometry of MBNL1(CUG) complexes results from aberrant protein synthesis or stability and is unlinked to PKC alpha function. Modeling these changes in normal myoblasts demonstrates that increased levels of hnRNP H, H2, H3, F, and DDX5 independently dysregulate splicing in overlapping RNA subsets. Thus expression of expanded CUG repeats alters the stoichiometry of MBNL1(CUG) complexes to allow both the reinforcement and expansion of RNA processing defects.	[Comai, Lucio] Univ So Calif, Inst Med Genet, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Paul, Sharan; Dansithong, Warunee; Jog, Sonali P.; Reddy, Sita] Univ So Calif, Inst Med Genet, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Holt, Ian; Morris, Glenn E.] Robert Jones & Agnes Hunt Orthoped Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry SY10 7AG, Shrops, England; [Holt, Ian; Morris, Glenn E.] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England; [Mittal, Saloni; Brook, J. David] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England	University of Southern California; University of Southern California; Keele University; University of Nottingham	Comai, L (corresponding author), Univ So Calif, Inst Med Genet, Dept Mol Microbiol & Immunol, 2250 Alcazar St,CSA 240, Los Angeles, CA 90033 USA.	comai@usc.edu; sitaredd@usc.edu	Comai, Lucio/H-9524-2019; Comai, Lucio/L-5905-2019	Comai, Lucio/0000-0003-3109-1841; Brook, John David/0000-0002-5946-6740	National Institutes of Health [5R01NS050861, 1R01NS060839]; Medical Research Council [G0802629] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050861, R01NS060839] Funding Source: NIH RePORTER; MRC [G0802629] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01NS050861 and 1R01NS060839. This work was also supported by a gift from Don Hauschnecht.	BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Dansithong W, 2011, EMBO REP, V12, P735, DOI 10.1038/embor.2011.86; Dansithong W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003968; Dhaenens CM, 2008, EXP NEUROL, V210, P467, DOI 10.1016/j.expneurol.2007.11.020; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fox JT, 2009, J BIOL CHEM, V284, P31085, DOI 10.1074/jbc.M109.035576; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Guha M, 2009, MOL BIOL CELL, V20, P4107, DOI 10.1091/mbc.E09-04-0296; Harper PS, 2001, MYOTONIC DYSTROPHY; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Holt I, 2007, GENES CELLS, V12, P1035, DOI 10.1111/j.1365-2443.2007.01112.x; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Li H, 2010, J BIOL CHEM, V285, P17789, DOI 10.1074/jbc.M109.082057; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Van Dusen CM, 2010, MOL CELL BIOL, V30, P2552, DOI 10.1128/MCB.00230-09; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Warf MB, 2009, P NATL ACAD SCI USA, V106, P9203, DOI 10.1073/pnas.0900342106; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	38	45	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38427	38438		10.1074/jbc.M111.255224	http://dx.doi.org/10.1074/jbc.M111.255224			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900255	Green Published, hybrid			2022-12-27	WOS:000296594200057
J	Ning, B; Liu, G; Liu, YY; Su, XF; Anderson, GJ; Zheng, X; Chang, Y; Guo, MZ; Liu, YF; Zhao, YL; Nie, GJ				Ning, Bo; Liu, Gang; Liu, Yuanyuan; Su, Xiufen; Anderson, Gregory J.; Zheng, Xin; Chang, Yanzhong; Guo, Mingzhou; Liu, Yuanfang; Zhao, Yuliang; Nie, Guangjun			5-Aza-2 '-deoxycytidine Activates Iron Uptake and Heme Biosynthesis by Increasing c-Myc Nuclear Localization and Binding to the E-boxes of Transferrin Receptor 1 (TfR1) and Ferrochelatase (Fech) Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ACUTE MYELOID-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; DNA-METHYLATION; TERMINAL DIFFERENTIATION; ERYTHROLEUKEMIA-CELLS; EPIGENETIC REGULATION; ERYTHROID PRECURSORS; TARGET GENES; FACTOR EKLF	The hypomethylating agent 5-aza-2'-deoxycytidine (5-aza-CdR) and its derivatives have been successfully used for the treatment of myelodysplastic syndromes, and they frequently improve the anemia that usually accompanies these disorders. However, the molecular mechanisms underlying this action remain poorly understood. In this study, we used two erythroid models, murine erythroid leukemia cells and erythroid burst-forming unit-derived erythroblasts, to show that 5-aza-CdR induced erythroid differentiation and increased the expression of transferrin receptor 1 (TfR1) and ferrochelatase (Fech), thereby increasing iron uptake and heme biosynthesis. We have identified new regulatory E-boxes that lie outside of CpG islands in the TfR1 and Fech promoters, and the methylation status of these sites can be altered by 5-aza-CdR treatment. This in turn altered the binding of the transcription factor c-Myc to these promoter elements. Furthermore, 5-aza-CdR promoted the nuclear translocation of c-Myc and its binding to Max to form functional complexes. The coordinated actions of 5-aza-CdR on the methylation status of the target genes and in stimulating the nuclear translocation of c-Myc provide new molecular insights in to the regulation of E-boxes and explain, at least in part, the increased erythroid response to 5-aza-CdR treatment.	[Ning, Bo; Liu, Gang; Zhao, Yuliang; Nie, Guangjun] Chinese Acad Sci, Key Lab Biol Effects Nanomat & Nanosafety, Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China; [Liu, Yuanyuan; Su, Xiufen] Jilin Univ, Affiliated Hosp 1, Changchun 130021, Jilin Province, Peoples R China; [Anderson, Gregory J.] Queensland Inst Med Res, Iron Metab Lab, Brisbane, Qld 4092, Australia; [Zheng, Xin; Chang, Yanzhong] Hebei Normal Univ, Coll Life Sci, Lab Mol Iron Metab, Shijiazhuang 050016, Hebei Province, Peoples R China; [Guo, Mingzhou] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, Beijing 100853, Peoples R China; [Ning, Bo; Liu, Yuanfang] Peking Univ, Dept Chem Biol & Appl Chem, Coll Chem & Mol Engn, Beijing 100190, Peoples R China; [Ning, Bo; Liu, Gang] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Jilin University; QIMR Berghofer Medical Research Institute; Hebei Normal University; Chinese People's Liberation Army General Hospital; Peking University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Nie, GJ (corresponding author), Chinese Acad Sci, Key Lab Biol Effects Nanomat & Nanosafety, Natl Ctr Nanosci & Technol, 11 Zhongguancun Beiyitiao, Beijing 100190, Peoples R China.	niegj@nanoctr.cn	Anderson, Gregory J/G-4148-2013; Nie, Guangjun/A-9954-2011; liu, yuanyuan/GWZ-5838-2022	Anderson, Gregory J/0000-0002-8814-5866; nie, guangjun/0000-0001-5040-9793	National Basic Research Program of China (973 program) [2012CB934000, 2011CB933400, 2010CB912802]; National Natural Science Foundation of China [30900278, 10979011]; National Health and Medical Research Council of Australia; Chinese Academy of Science	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (973 program) Grants 2012CB934000, 2011CB933400, and 2010CB912802 and National Natural Science Foundation of China Grants 30900278 and 10979011.; Recipient of a Senior Research Fellowship from the National Health and Medical Research Council of Australia.; Supported by the Chinese Academy of Science Hundred Talents Program.	Angst E, 2010, PANCREAS, V39, P675, DOI 10.1097/MPA.0b013e3181c8b476; Aul C, 1998, HAEMATOLOGICA, V83, P71; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bowen H, 2002, J BIOL CHEM, V277, P34997, DOI 10.1074/jbc.M204232200; CHRISTMAN JK, 1980, J CELL BIOL, V86, P366, DOI 10.1083/jcb.86.2.366; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Dang CV, 1999, MOL CELL BIOL, V19, P1; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Fandy TE, 2009, BLOOD, V114, P2764, DOI 10.1182/blood-2009-02-203547; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; GUSELLA JF, 1980, BLOOD, V56, P481; Hofmann WK, 2005, ANNU REV MED, V56, P1, DOI 10.1146/annurev.med.56.082103.104704; HUMPHRIES RK, 1985, J CLIN INVEST, V75, P547, DOI 10.1172/JCI111731; Jadersten M, 2010, EXP CELL RES, V316, P1390, DOI 10.1016/j.yexcr.2010.02.043; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; LASKEY JD, 1986, J CELL PHYSIOL, V129, P185, DOI 10.1002/jcp.1041290209; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mills KI, 2009, BLOOD, V114, P1063, DOI 10.1182/blood-2008-10-187203; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Okazaki F, 2010, CANCER RES, V70, P6238, DOI 10.1158/0008-5472.CAN-10-0184; OSHIRO S, 1994, J BIOCHEM-TOKYO, V115, P849, DOI 10.1093/oxfordjournals.jbchem.a124428; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; PERKINS AC, 1995, NATURE, V375, P318; PINTO A, 1984, BLOOD, V64, P922; PONKA P, 1985, J BIOL CHEM, V260, P4717; Ponka P, 1997, BLOOD, V89, P1; Quintas-Cardama A, 2010, NAT REV CLIN ONCOL, V7, P433, DOI 10.1038/nrclinonc.2010.87; Schmelz K, 2005, LEUKEMIA, V19, P103, DOI 10.1038/sj.leu.2403552; Sinclair P. R., 2001, CURRENT PROTOCOLS TO, P831; Soriano AO, 2007, BLOOD, V110, P2302, DOI 10.1182/blood-2007-03-078576; Sridhar K, 2009, BLOOD, V114, P4847, DOI 10.1182/blood-2009-08-236422; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Valdez BC, 2010, LEUKEMIA RES, V34, P364, DOI 10.1016/j.leukres.2009.08.014; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676	43	17	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37196	37206		10.1074/jbc.M111.258129	http://dx.doi.org/10.1074/jbc.M111.258129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21903580	hybrid, Green Published			2022-12-27	WOS:000296542400020
J	von der Malsburg, A; Abutbul-Ionita, I; Haller, O; Kochs, G; Danino, D				von der Malsburg, Alexander; Abutbul-Ionita, Inbal; Haller, Otto; Kochs, Georg; Danino, Dganit			Stalk Domain of the Dynamin-like MxA GTPase Protein Mediates Membrane Binding and Liposome Tubulation via the Unstructured L4 Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH ENDOPLASMIC-RETICULUM; ANTIVIRAL ACTIVITY; BHK CELLS; OLIGOMERIZATION; ACTIVATION; FAMILY; PHOSPHOINOSITIDES; PHOSPHOLIPIDS; CONSTRICTION; ENDOCYTOSIS	The human MxA protein is an interferon-induced large GTPase with antiviral activity against a wide range of viruses, including influenza viruses. Recent structural data demonstrated that MxA oligomerizes into multimeric filamentous or ring-like structures by virtue of its stalk domain. Here, we show that negatively charged lipid membranes support MxA self-assembly. Like dynamin, MxA assembled around spherical liposomes inducing liposome tubulation. Cryo-transmission electron microscopy revealed that MxA oligomers around liposomes have a "T-bar" shape similar to dynamin. Moreover, biochemical assays indicated that the unstructured L4 loop of the MxA stalk serves as the lipid-binding moiety, and mutational analysis of L4 revealed that a stretch of four lysine residues is critical for binding. The orientation of the MxA molecule within the membrane-associated oligomer is in agreement with the proposed topology of MxA oligomers based on crystallographic data. Although oligomerization of wild-type MxA around liposomes led to the creation of helically decorated tubes similar to those formed by dynamin, this lipid interaction did not stimulate GTPase activity, in sharp contrast to the assembly-stimulated nucleotide hydrolysis observed with dynamin. Moreover, MxA readily self-assembles into rings at physiological conditions, as opposed to dynamin which self-assembles only at low salt conditions or onto lipids. Thus, the present results indicate that the oligomeric structures formed by MxA critically differ from those of dynamin.	[von der Malsburg, Alexander; Haller, Otto; Kochs, Georg] Univ Freiburg, Dept Virol, Inst Microbiol, D-79104 Freiburg, Germany; [Abutbul-Ionita, Inbal; Danino, Dganit] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel	University of Freiburg; Technion Israel Institute of Technology	Kochs, G (corresponding author), Hermann Herder Str 11, D-79104 Freiburg, Germany.	georg.kochs@uniklinik-freiburg.de; dganitd@techunix.technion.ac.il	Danino, Dganit/D-6832-2016	Danino, Dganit/0000-0002-9782-4940; Ionita, Inbal/0000-0001-7359-0142	German-Israeli-Research Foundation [GIF-841/04]; Deutsche Forschungsgemeinschaft [Ko1579/8-1]; Israel Science Foundation [ISF-530/03]	German-Israeli-Research Foundation(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation)	This work was supported by German-Israeli-Research Foundation Grant GIF-841/04 (to D. D., O. H., and G. K.), Deutsche Forschungsgemeinschaft Grant Ko1579/8-1 (to G. K.), Israel Science Foundation Grant ISF-530/03 (to D. D.). and by financial support to the Russell Berrie Nanotechnology Institute (RBNI) for the cryo-TEM experiments.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Allan D, 1996, MOL MEMBR BIOL, V13, P81, DOI 10.3109/09687689609160580; Barylko B, 1998, J BIOL CHEM, V273, P3791, DOI 10.1074/jbc.273.6.3791; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; BERNASCONI D, 1995, J INTERF CYTOK RES, V15, P47, DOI 10.1089/jir.1995.15.47; BROTHERUS J, 1977, BIOCHIM BIOPHYS ACTA, V486, P243, DOI 10.1016/0005-2760(77)90020-0; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Danino D, 2001, COLLOID SURFACE A, V183, P113, DOI 10.1016/S0927-7757(01)00543-X; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Haller O, 2010, J BIOL CHEM, V285, P28419, DOI 10.1074/jbc.R110.145839; He B, 2010, MOL BIOL CELL, V21, P610, DOI 10.1091/mbc.E09-05-0440; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kochs G, 2005, METHOD ENZYMOL, V404, P632, DOI 10.1016/S0076-6879(05)04055-3; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Low HH, 2010, CURR OPIN STRUC BIOL, V20, P791, DOI 10.1016/j.sbi.2010.09.011; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; RICHTER MF, 1995, J BIOL CHEM, V270, P13512, DOI 10.1074/jbc.270.22.13512; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; TUMA PL, 1993, J BIOL CHEM, V268, P17240; van der Bliek AM, 2010, DEV CELL, V18, P687, DOI [10.1016/j.devcel.2010.05.001, 10.1016/j.devce1.2010.05.001]; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	45	52	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37858	37865		10.1074/jbc.M111.249037	http://dx.doi.org/10.1074/jbc.M111.249037			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900240	Green Published, hybrid			2022-12-27	WOS:000296542400080
J	Das, S; Jena, S; Levasseur, DN				Das, Satyabrata; Jena, Snehalata; Levasseur, Dana N.			Alternative Splicing Produces Nanog Protein Variants with Different Capacities for Self-renewal and Pluripotency in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL NETWORK; SUSTAINING FACTOR; GENE-EXPRESSION; X-INACTIVATION; MOUSE EPIBLAST; OCT4; CLONING; IDENTIFICATION; DERIVATION; LINES	Embryonic stem (ES) cells are distinguished by their ability to undergo unlimited self-renewal although retaining pluripotency, the capacity to specify cells of all germ layers. Alternative splicing contributes to these biological processes by vastly increasing the protein coding repertoire, enabling genes to code for novel variants that may confer different biological functions. The homeodomain transcription factor Nanog acts collaboratively with core factors Oct4 and Sox2 to govern the maintenance of pluripotency. We have discovered that Nanog is regulated by alternative splicing. Two novel exons and six subexons have been identified that extend the known Nanog gene structure and protein coding capacity. Alternative splicing results in two novel Nanog protein variants with attenuated capacities for self-renewal and pluripotency in ES cells. Our previous results have implicated the C-terminal domain, including the tryptophan-rich (WR) domain of Nanog, to be important for the function of Nanog (Wang, J., Levasseur, D.N., and Orkin, S.H. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 6326-6331). Using point mutation analyses, serine 2 (Ser-2) of Nanog has been identified as critical for ES cell self-renewal and for stabilizing a pluripotent gene signature. An inducible conditional knock-out was created to test the ability of new Nanog variants to genetically complement Nanog null ES cells. These results reveal for the first time an expanded Nanog protein coding capacity. We further reveal that a short region of the N-terminal domain and a single phosphorylatable Ser-2 is essential for the maintenance of self-renewal and pluripotency, demonstrating that this region of the protein is highly regulated.	[Das, Satyabrata; Jena, Snehalata; Levasseur, Dana N.] Univ Iowa, Dept Internal Med, Roy J & A Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Levasseur, Dana N.] Univ Iowa, Program Mol & Cellular Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Levasseur, DN (corresponding author), 285 Newton Rd,Carver Biomed Res Bldg,Rm 3270C, Iowa City, IA 52242 USA.	dana-levasseur@uiowa.edu	Das, Satyabrata/J-2629-2019		Department of Internal Medicine; March of Dimes [5-FY10-45]	Department of Internal Medicine; March of Dimes(March of Dimes)	This work was supported by the Department of Internal Medicine and a Basil O'Connor Starter Scholar Research Award Grant 5-FY10-45 from the March of Dimes.	Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunarso G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-155; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Nagy A., 2002, MANIPULATING MOUSE E; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Oh JH, 2005, EXP MOL MED, V37, P250, DOI 10.1038/emm.2005.33; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pan GJ, 2003, CELL RES, V13, P499, DOI 10.1038/sj.cr.7290193; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang J, 2007, P NATL ACAD SCI USA, V104, P20850, DOI 10.1073/pnas.0710565105; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang SH, 2003, GENE EXPR PATTERNS, V3, P99, DOI 10.1016/S1567-133X(03)00005-X; Wang X, 2009, STEM CELLS, V27, P1265, DOI 10.1002/stem.58; Wang Z, 2008, J BIOL CHEM, V283, P4480, DOI 10.1074/jbc.M706009200; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yates A, 2005, BIOCHEM SOC T, V33, P1518, DOI 10.1042/BST0331518; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	63	52	57	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42690	42703		10.1074/jbc.M111.290189	http://dx.doi.org/10.1074/jbc.M111.290189			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21969378	Green Published, hybrid			2022-12-27	WOS:000298180900076
J	Costa, R; Speretta, E; Crowther, DC; Cardoso, I				Costa, Rita; Speretta, Elena; Crowther, Damian C.; Cardoso, Isabel			Testing the Therapeutic Potential of Doxycycline in a Drosophila melanogaster Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID BETA-PEPTIDE; PARKINSONS-DISEASE; MOUSE MODEL; A-BETA; HUNTINGTONS-DISEASE; LATERAL-SCLEROSIS; RAT MODEL; IN-VITRO; MINOCYCLINE; TETRACYCLINES	Therapies for Alzheimer disease that reduce the production of pathogenic amyloid beta (A beta) peptides have been associated with a range of unwanted effects. For this reason, alternative strategies that promote the clearance of the peptide by preventing its aggregation and deposition in the brain have been favored. In this context we have studied doxycycline, a member of the tetracycline family of antibiotics that has shown neuroprotective effects in a number of models of neurodegenerative disease. We investigated the neuroprotective potential of doxycycline in a Drosophila model of A beta toxicity and sought to correlate any effects with the aggregation state of the peptide. We found that administration of doxycycline to A beta 42-expressing flies did not improve their lifespan but was able to slow the progression of their locomotor deficits. We also measured the rough eye phenotype of transgenic flies expressing the E22G variant of A beta 42 and showed that doxycycline administration partially rescued the toxicity of A beta in the developing eye. We correlated these in vivo effects with in vitro observations using transmission electron microscopy, dynamic light scattering, and thioflavin T binding. We found that doxycycline prevents A beta fibrillization and favors the generation of smaller, non-amyloid structures that were nontoxic as determined by the lack of caspase 3 activation in a neuroblastoma cell line. Our confirmation that doxycycline can prevent amyloid beta toxicity both in vitro and in vivo supports its therapeutic potential in AD.	[Costa, Rita; Cardoso, Isabel] IBMC, Mol Neurobiol Unit, P-4150180 Oporto, Portugal; [Speretta, Elena; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Speretta, Elena; Crowther, Damian C.] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Cardoso, Isabel] Escola Super Tecnol Saude Porto, Inst Politecn Porto, P-4400330 Vila Nova De Gaia, Portugal	Universidade do Porto; University of Cambridge; University of Cambridge; Polytechnic Institute of Porto	Cardoso, I (corresponding author), IBMC, Mol Neurobiol Unit, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	icardoso@ibmc.up.pt	Costa, Ana Rita AR/G-6341-2016; Cardoso, Isabel/K-3903-2013	Costa, Ana Rita AR/0000-0002-2855-0472; Cardoso, Isabel/0000-0003-2472-7055; Speretta, Elena/0000-0003-1506-7438	Portuguese Foundation for Science and Technology (FCT) [POCI/SAU-NEU/64593/2006]; FCT [SFRH/BD/41799/2007]; MRC [G0700990]; POCI (Programa Operacional Ciencia e Inovacao); MRC [MC_G1000734] Funding Source: UKRI; Alzheimers Research UK [ART-SRF2010-2] Funding Source: researchfish; Medical Research Council [MC_G1000734, G0700990] Funding Source: researchfish	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); POCI (Programa Operacional Ciencia e Inovacao); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) Grants POCI/SAU-NEU/64593/2006 and POCI 2010 (Programa Operacional Ciencia e Inovacao 2010) and with the participation of the European Communitarian Fund FEDER. This work was also supported by FCT PhD Scholarship SFRH/BD/41799/2007 (to R. C.) and by MRC Grant G0700990 (to D. C. C.).	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Airoldi C, 2011, ORG BIOMOL CHEM, V9, P463, DOI 10.1039/c0ob00303d; Cardoso I, 2006, FASEB J, V20, P234, DOI 10.1096/fj.05-4509com; Cardoso I, 2003, FASEB J, V17, P803, DOI 10.1096/fj.02-0764com; Cardoso I, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-74; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Corti O, 1999, P NATL ACAD SCI USA, V96, P12120, DOI 10.1073/pnas.96.21.12120; Costa R, 2008, FEBS LETT, V582, P936, DOI 10.1016/j.febslet.2008.02.034; Crowther DC, 2006, METHOD ENZYMOL, V412, P234, DOI 10.1016/S0076-6879(06)12015-7; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; DaSilva KA, 2010, EXP NEUROL, V223, P311, DOI 10.1016/j.expneurol.2009.08.032; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Epis R, 2008, EUR J PHARMACOL, V597, P51, DOI 10.1016/j.ejphar.2008.09.001; Faust K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-109; Forloni G, 2002, P NATL ACAD SCI USA, V99, P10849, DOI 10.1073/pnas.162195499; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; Franco C, 2006, AM J PATHOL, V168, P1697, DOI 10.2353/ajpath.2006.050613; Freeman M, 1997, DEVELOPMENT, V124, P261; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hersch S, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.21891; Kelly KJ, 2004, AM J PHYSIOL-RENAL, V287, pF760, DOI 10.1152/ajprenal.00050.2004; KLEIN NC, 1995, MED CLIN N AM, V79, P789, DOI 10.1016/S0025-7125(16)30039-6; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Loeb MB, 2004, J AM GERIATR SOC, V52, P381, DOI 10.1111/j.1532-5415.2004.52109.x; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Thomas M, 2003, CLIN NEUROPHARMACOL, V26, P18, DOI 10.1097/00002826-200301000-00005; Tickoo S, 2002, CURR OPIN PHARMACOL, V2, P555, DOI 10.1016/S1471-4892(02)00206-0; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	45	58	62	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41647	41655		10.1074/jbc.M111.274548	http://dx.doi.org/10.1074/jbc.M111.274548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21998304	Green Published, hybrid			2022-12-27	WOS:000298057500049
J	Crouch, E; Nikolaidis, N; McCormack, FX; McDonald, B; Allen, K; Rynkiewicz, MJ; Cafarella, TM; White, M; Lewnard, K; Leymarie, N; Zaia, J; Seaton, BA; Hartshorn, KL				Crouch, Erika; Nikolaidis, Nikolaos; McCormack, Francis X.; McDonald, Barbara; Allen, Kimberly; Rynkiewicz, Michael J.; Cafarella, Tanya M.; White, Mitchell; Lewnard, Kara; Leymarie, Nancy; Zaia, Joseph; Seaton, Barbara A.; Hartshorn, Kevan L.			Mutagenesis of Surfactant Protein D Informed by Evolution and X-ray Crystallography Enhances Defenses against Influenza A Virus in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL ACTIVITY; LIGAND-BINDING; LECTIN DOMAINS; RECOGNITION; HEMAGGLUTININ; GLYCOSYLATION; COLLECTINS; CLEARANCE; INSIGHTS; OPSONIN	The recognition of influenza A virus (LAY) by surfactant protein D (SP-D) is mediated by interactions between the SP-D carbohydrate recognition domains (CRD) and glycans displayed on envelope glycoproteins. Although native human SP-D shows potent antiviral and aggregating activity, trimeric recombinant neck + CRDs (NCRDs) show little or no capacity to influence IAV infection. A mutant trimeric NCRD, D325A/R343V, showed marked hemagglutination inhibition and viral neutralization, with viral aggregation and aggregation-dependent viral uptake by neutrophils. D325A/R343V exhibited glucose-sensitive binding to Phil82 hemagglutinin trimer (HA) by surface plasmon resonance. By contrast, there was very low binding to the HA trimer from another virus (PR8) that lacks glycans on the HA head. Mass spectrometry demonstrated the presence of high mannose glycans on the Phi182 HA at positions known to contribute to LAY binding. Molecular modeling predicted an enhanced capacity for bridging interactions between HA glycans and D325A/R343V. Finally, the trimeric D325A/R343V NCRD decreased morbidity and increased viral clearance in a murine model of IAV infection using a reassortant A/WSN/33 virus with a more heavily glycosylated HA. The combined data support a model in which altered binding by a truncated mutant SP-D to LAY HA glycans facilitates viral aggregation, leading to significant viral neutralization in vitro and in vivo. These studies demonstrate the potential utility of homology modeling and protein structure analysis for engineering effective collectin antivirals as in vivo therapeutics.	[Crouch, Erika; McDonald, Barbara; Allen, Kimberly] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Nikolaidis, Nikolaos; McCormack, Francis X.; Lewnard, Kara] Univ Cincinnati, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45267 USA; [Leymarie, Nancy; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Spectrometry, Boston, MA 02118 USA; [Rynkiewicz, Michael J.; Cafarella, Tanya M.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Phys & Biophys, Boston, MA 02118 USA; [White, Mitchell; Hartshorn, Kevan L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Washington University (WUSTL); University System of Ohio; University of Cincinnati; Boston University; Boston University; Boston University	Crouch, E (corresponding author), WA Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	crouch@path.wustl.edu	McCormack, Francis X./ABE-8398-2020; Zaia, Joseph/U-7850-2019	McCormack, Francis X./0000-0001-7168-9464; Zaia, Joseph/0000-0001-9497-8701; Rynkiewicz, Michael/0000-0002-4717-5700; Seaton, Barbara/0000-0003-4654-7709; Hartshorn, Kevan/0000-0002-7196-7433	National Institutes of Health [AI083222, HL069031, P41RR10888, S10RR020946]; Veterans Administration Merit Award; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020946, P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI083222 (to B. A. S.), HL069031 (to K. L H.), and P41RR10888 and S10RR020946 (to J. Z.). This work was also supported by a Veterans Administration Merit Award (to F. X. M.).	Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Carlson TK, 2009, GLYCOBIOLOGY, V19, P1473, DOI 10.1093/glycob/cwp122; Crouch E, 2005, J BIOL CHEM, V280, P17046, DOI 10.1074/jbc.M413932200; Crouch E. C., 2006, ENCY RESP MED, V4, P152; Crouch E, 2007, BIOCHEMISTRY-US, V46, P5160, DOI 10.1021/bi700037x; Crouch E, 2006, J BIOL CHEM, V281, P18008, DOI 10.1074/jbc.M601749200; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Crouch EC, 2006, AM J RESP CELL MOL, V35, P84, DOI 10.1165/rcmb.2005-0462OC; Duverger E, 2010, METHODS MOL BIOL, V627, P157, DOI 10.1007/978-1-60761-670-2_10; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hartshorn KL, 2010, SCAND J IMMUNOL, V72, P22, DOI 10.1111/j.1365-3083.2010.02409.x; Hartshorn KL, 2010, AM J PHYSIOL-LUNG C, V298, pL79, DOI 10.1152/ajplung.00223.2009; Hartshorn KL, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-65; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; HARTSHORN KL, 1993, J IMMUNOL, V151, P6265; Hartshorn KL, 2002, BIOCHEM J, V366, P87, DOI 10.1042/BJ20011868; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Hawgood S, 2004, J VIROL, V78, P8565, DOI 10.1128/JVI.78.16.8565-8572.2004; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; LeVine AM, 2004, AM J RESP CELL MOL, V31, P193, DOI 10.1165/rcmb.2003-0107OC; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Lin KW, 2010, J IMMUNOL, V184, P6343, DOI 10.4049/jimmunol.0901947; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Perlman DH, 2009, CIRC RES, V104, P796, DOI 10.1161/CIRCRESAHA.108.187005; Reading PC, 1998, J GEN VIROL, V79, P2255, DOI 10.1099/0022-1317-79-9-2255; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Shrive AK, 2009, J MOL BIOL, V394, P776, DOI 10.1016/j.jmb.2009.09.057; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Smee DF, 2008, ANTIVIR RES, V80, P266, DOI 10.1016/j.antiviral.2008.06.003; Tecle T, 2008, BIOCHEM J, V412, P323, DOI 10.1042/BJ20071663; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; Wear MA, 2005, ANAL BIOCHEM, V345, P214, DOI 10.1016/j.ab.2005.06.037; White M, 2008, J IMMUNOL, V181, P7936, DOI 10.4049/jimmunol.181.11.7936; White MR, 2010, J INNATE IMMUN, V2, P267, DOI 10.1159/000272313; Whitsett JA, 2005, BIOL NEONATE, V88, P175, DOI 10.1159/000087580; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Zhang LQ, 2002, J BIOL CHEM, V277, P22453, DOI 10.1074/jbc.M201632200	45	34	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40681	40692		10.1074/jbc.M111.300673	http://dx.doi.org/10.1074/jbc.M111.300673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21965658	Green Published, hybrid			2022-12-27	WOS:000297315400029
J	Singh, MK; Lu, MM; Massera, D; Epstein, JA				Singh, Manvendra K.; Lu, Min Min; Massera, Daniele; Epstein, Jonathan A.			MicroRNA-processing Enzyme Dicer Is Required in Epicardium for Coronary Vasculature Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; NEURAL CREST; PROGENITOR CELLS; MOUSE DEVELOPMENT; ARTERY FORMATION; CHICK-EMBRYOS; HEART; MUSCLE; DIFFERENTIATION; CARDIOMYOCYTE	The epicardium is a sheet of epithelial cells covering the heart during early cardiac development. In recent years, the epicardium has been identified as an important contributor to cardiovascular development, and epicardium-derived cells have the potential to differentiate into multiple cardiac cell lineages. Some epicardium-derived cells that undergo epithelial-to-mesenchymal transition and delaminate from the surface of the developing heart subsequently invade the myocardium and differentiate into vascular smooth muscle of the developing coronary vasculature. MicroRNAs (miRNAs) have been implicated broadly in tissue patterning and development, including in the heart, but a role in epicardium is unknown. To examine the role of miRNAs during epicardial development, we conditionally deleted the miRNA-processing enzyme Dicer in the proepicardium using Gata5-Cre mice. Epicardial Dicer mutant mice are born in expected Mendelian ratios but die immediately after birth with profound cardiac defects, including impaired coronary vessel development. We found that loss of Dicer leads to impaired epicardial epithelial-to-mesenchymal transition and a reduction in epicardial cell proliferation and differentiation into coronary smooth muscle cells. These results demonstrate a critical role for Dicer, and by implication miRNAs, in murine epicardial development.	[Singh, Manvendra K.; Massera, Daniele; Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Singh, Manvendra K.; Lu, Min Min; Epstein, Jonathan A.] Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Singh, MK (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, 1139 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	masingh@mail.med.upenn.edu; epsteinj@mail.med.upenn.edu	Singh, Manvendra K./AHE-0676-2022	Epstein, Jonathan/0000-0001-8637-4465; Massera, Daniele/0000-0002-9499-6456; Singh, Manvendra K./0000-0002-2884-0074	National Institutes of Health [U01 HL100405]; Spain for cardiovascular regenerative biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spain for cardiovascular regenerative biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 HL100405. This work was also supported by the Grant from Spain for cardiovascular regenerative biology (to J. A. E.).	Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Major Robert J, 2007, Drug Discov Today Dis Models, V4, P219, DOI 10.1016/j.ddmod.2007.09.002; Manner J, 2005, DEV DYNAM, V233, P1454, DOI 10.1002/dvdy.20487; MANNER J, 1993, ANAT EMBRYOL, V187, P281; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pan YQ, 2011, BIOCHEM BIOPH RES CO, V408, P369, DOI 10.1016/j.bbrc.2011.02.119; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Saxena A, 2010, P NATL ACAD SCI USA, V107, P87, DOI 10.1073/pnas.0912870107; Singh MK, 2008, ENDOCRINOLOGY, V149, P3933, DOI 10.1210/en.2008-0109; Singh MK, 2010, J BIOL CHEM, V285, P1765, DOI 10.1074/jbc.M109.038539; Singh MK, 2005, MECH DEVELOP, V122, P131, DOI 10.1016/j.mod.2004.10.011; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2003, CURR OPIN GENET DEV, V13, P365, DOI 10.1016/S0959-437X(03)00088-1; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Wu MF, 2010, DEV CELL, V19, P114, DOI 10.1016/j.devcel.2010.06.011; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zamora M, 2007, P NATL ACAD SCI USA, V104, P18109, DOI 10.1073/pnas.0702415104; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zhou L, 2009, P NATL ACAD SCI USA, V106, P10266, DOI 10.1073/pnas.0811119106	60	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41036	41045		10.1074/jbc.M111.268573	http://dx.doi.org/10.1074/jbc.M111.268573			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969379	Green Published, hybrid			2022-12-27	WOS:000297315400063
J	Tharmalingam, S; Daulat, AM; Antflick, JE; Ahmed, SM; Nemeth, EF; Angers, S; Conigrave, AD; Hampson, DR				Tharmalingam, Sujeenthar; Daulat, Avais M.; Antflick, Jordan E.; Ahmed, Syed M.; Nemeth, Edward F.; Angers, Stephane; Conigrave, Arthur D.; Hampson, David R.			Calcium-sensing Receptor Modulates Cell Adhesion and Migration via Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY-THYROID CARCINOMA; METABOTROPIC GLUTAMATE-RECEPTOR; PROTEIN-COUPLED RECEPTORS; EXTRACELLULAR CALCIUM; CA2+-SENSING RECEPTOR; FUNCTIONAL EXPRESSION; PARATHYROID-HORMONE; KINASE INHIBITION; CA2+ RECEPTOR; CANCER-CELLS	The calcium-sensing receptor (CaSR) is a family C G protein-coupled receptor that is activated by elevated levels of extracellular divalent cations. The CaSR couples to members of the G(q) family of G proteins, and in the endocrine system this receptor is instrumental in regulating the release of parathyroid hormone from the parathyroid gland and calcitonin from thyroid cells. Here, we demonstrate that in medullary thyroid carcinoma cells, the CaSR promotes cellular adhesion and migration via coupling to members of the integrin family of extracellular matrix-binding proteins. Immunopurification and mass spectrometry, co-immunoprecipitation, and co-localization studies showed that the CaSR and beta 1-containing integrins are components of a macromolecular protein complex. In fibronectin-based cell adhesion and migration assays, the CaSR-positive allosteric modulator NPS R-568 induced a concentration-dependent increase in cell adhesion and migration; both of these effects were blocked by a specific CaSR-negative allosteric modulator. These effects were mediated by integrins because they were blocked by a peptide inhibitor of integrin binding to fibronectin and beta 1 knockdown experiments. An analysis of intracellular signaling pathways revealed a key role for CaSR-induced phospholipase C activation and the release of intracellular calcium. These results demonstrate for the first time that an ion-sensing G protein-coupled receptor functionally couples to the integrins and, in conjunction with intracellular calcium release, promotes cellular adhesion and migration in tumor cells. The significance of this interaction is further highlighted by studies implicating the CaSR in cancer metastasis, axonal growth, and stein cell attachment, functions that rely on integrin-mediated cell adhesion.	[Tharmalingam, Sujeenthar; Daulat, Avais M.; Antflick, Jordan E.; Ahmed, Syed M.; Nemeth, Edward F.; Angers, Stephane; Hampson, David R.] Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada; [Conigrave, Arthur D.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Toronto; University of Sydney	Hampson, DR (corresponding author), Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, 144 Coll St, Toronto, ON M5S 3M2, Canada.	d.hampson@utoronto.ca	Ahmed, Mukhtar/ABE-8477-2020; Ahmed, Mukhtar/HIR-3483-2022; Angers, Stephane/E-1432-2014	Angers, Stephane/0000-0001-7241-9044; Daulat, Avais/0000-0002-3076-2132; Ahmed, Syed Mukhtar/0000-0002-9183-9957; Conigrave, Arthur/0000-0002-7232-3891	Natural Sciences and Engineering Research Council of Canada; National Health and Medical Research Council of Australia	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Natural Sciences and Engineering Research Council of Canada and by the National Health and Medical Research Council of Australia.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Ahmed SM, 2011, METHODS MOL BIOL, V756, P357, DOI 10.1007/978-1-61779-160-4_22; Ahmed SM, 2010, J BIOL CHEM, V285, P6538, DOI 10.1074/jbc.M109.069948; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bergholm U, 1997, CANCER-AM CANCER SOC, V79, P132, DOI 10.1002/(SICI)1097-0142(19970101)79:1<132::AID-CNCR19>3.0.CO;2-5; Bouschet T, 2007, J CELL SCI, V120, P2489, DOI 10.1242/jcs.03469; Broadhead GK, 2011, J BIOL CHEM, V286, P8786, DOI 10.1074/jbc.M110.149724; Brown E M, 2000, Rev Endocr Metab Disord, V1, P307, DOI 10.1023/A:1026570518919; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Brust-Mascher I, 1998, BIOPHYS J, V75, P1669, DOI 10.1016/S0006-3495(98)77609-X; CLARK MS, 1995, J NEUROSCI, V15, P6167; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2010, PHARMACOL THERAPEUT, V127, P252, DOI 10.1016/j.pharmthera.2010.04.007; Davies SL, 2006, AM J PHYSIOL-CELL PH, V290, pC1543, DOI 10.1152/ajpcell.00482.2005; Doyle AD, 2002, BIOTECHNIQUES, V33, P358, DOI 10.2144/02332rr02; Fafet P, 2008, ENDOCRINOLOGY, V149, P4475, DOI 10.1210/en.2008-0253; FAJTOVA VT, 1991, AM J PHYSIOL, V261, pE151, DOI 10.1152/ajpendo.1991.261.1.E151; GAGEL RF, 1980, ENDOCRINOLOGY, V107, P516, DOI 10.1210/endo-107-2-516; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Hampson David R., 2008, P363, DOI 10.1007/978-1-59745-055-3_9; Hauache OM, 2000, ENDOCRINOLOGY, V141, P4156, DOI 10.1210/en.141.11.4156; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang CF, 2004, AM J PHYSIOL-CELL PH, V286, pC22, DOI 10.1152/ajpcell.00229.2003; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Kuang DH, 2003, J BIOL CHEM, V278, P42551, DOI 10.1074/jbc.M307120200; Lam BS, 2011, BLOOD, V117, P1167, DOI 10.1182/blood-2010-05-286294; Lester RD, 2005, J BIOL CHEM, V280, P39273, DOI 10.1074/jbc.M509446200; Liao JH, 2006, CANCER RES, V66, P9065, DOI 10.1158/0008-5472.CAN-06-0317; Lin B, 2003, J NEUROPHYSIOL, V89, P2874, DOI 10.1152/jn.00783.2002; Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200; McNeil SE, 1998, J BIOL CHEM, V273, P1114, DOI 10.1074/jbc.273.2.1114; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Modigliani E, 1998, CLIN ENDOCRINOL, V48, P265, DOI 10.1046/j.1365-2265.1998.00392.x; Moley JF, 1999, ANN SURG, V229, P880, DOI 10.1097/00000658-199906000-00016; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Saidak Z, 2009, EXP CELL RES, V315, P2072, DOI 10.1016/j.yexcr.2009.03.003; Saidak Z, 2009, ENDOCR REV, V30, P178, DOI 10.1210/er.2008-0041; Sjaastad MD, 1996, MOL BIOL CELL, V7, P1025, DOI 10.1091/mbc.7.7.1025; Takaoka S, 2010, HORM METAB RES, V42, P627, DOI 10.1055/s-0030-1255091; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Valeyev Najl V., 2006, In Silico Biology, V6, P545; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Vorup-Jensen T, 2007, BBA-PROTEINS PROTEOM, V1774, P1148, DOI 10.1016/j.bbapap.2007.06.014; Vyleta NP, 2011, J NEUROSCI, V31, P4593, DOI 10.1523/JNEUROSCI.6398-10.2011; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Wong R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-15; Yao Y, 2003, J NEUROCHEM, V86, P947, DOI 10.1046/j.1471-4159.2003.01906.x; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	68	48	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40922	40933		10.1074/jbc.M111.265454	http://dx.doi.org/10.1074/jbc.M111.265454			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21969374	Green Published, hybrid			2022-12-27	WOS:000297315400052
J	Peng, Y; Clark, C; Luong, R; Tu, WH; Lee, J; Johnson, DT; Das, A; Carroll, TJ; Sun, ZJ				Peng, Yue; Clark, Curtis; Luong, Richard; Tu, William H.; Lee, Jane; Johnson, Daniel T.; Das, Amrita; Carroll, Thomas J.; Sun, Zijie			The Leucine Zipper Putative Tumor Suppressor 2 Protein LZTS2 Regulates Kidney Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIAS-LIKE PROTEIN; BETA-CATENIN; MICE; GENE; EXPRESSION; MORPHOGENESIS; EPITHELIUM; LAPSER1; BRAIN; GDNF	Members of the leucine zipper putative tumor suppressor (LZTS) family play crucial roles in transcription modulation and cell cycle control. We previously demonstrated that LZTS2 functions as a novel beta-catenin-interacting protein and represses beta-catenin-mediated transcription on T-cell factor/lymphoid enhancing factor. Here, we investigate the biological role of LZTS2 using newly established Lzts2 KO mice. Homozygosity for loss-of-function of the Lzts2-targeted allele resulted in severe kidney and urinary tract developmental defects, including renal/ureteral duplication, hydroureter, and hydronephrosis, which were visible prenatally. Altered ureteric bud outgrowth was identified in Lzts2 null embryos. Further analysis indicated that beta-catenin subcellular localization was altered in fibroblasts isolated from Lzts2 null embryos. In addition, Wnt growth factor-induced beta-catenin-mediated transcriptional activity was increased in Lzts2 null fibroblasts, suggesting a direct role for Lzts2 in the Wnt signaling pathway. These data demonstrate a critical role of LZTS2 in renal development and implicate LZTS2 as a critical regulator of beta-catenin-mediated nephrogenesis.	[Peng, Yue; Clark, Curtis; Tu, William H.; Lee, Jane; Johnson, Daniel T.; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Peng, Yue; Lee, Jane; Johnson, Daniel T.; Sun, Zijie] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; [Das, Amrita; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Nephrol, Dallas, TX 75390 USA; [Das, Amrita; Carroll, Thomas J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, S287,Grant Bldg, Stanford, CA 94305 USA.	zsun@stanford.edu		Johnson, Daniel/0000-0003-4669-037X	NATIONAL CANCER INSTITUTE [R01CA070297, R01CA151623] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA151623, R01 CA070297] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P6707, DOI 10.1038/sj.onc.1204866; Chen F, 2009, PEDIATR NEPHROL, V24, P1621, DOI 10.1007/s00467-008-1072-y; Cho HH, 2008, BBA-MOL CELL RES, V1783, P419, DOI 10.1016/j.bbamcr.2007.08.005; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; DRESSLER GR, 1993, NATURE, V362, P65, DOI 10.1038/362065a0; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Iglesias DM, 2007, AM J PHYSIOL-RENAL, V293, pF494, DOI 10.1152/ajprenal.00416.2006; Kerecuk L, 2008, NAT CLIN PRACT NEPHR, V4, P312, DOI 10.1038/ncpneph0807; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; Marose TD, 2008, DEV BIOL, V314, P112, DOI 10.1016/j.ydbio.2007.11.016; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Peng Y, 2010, J BIOL CHEM, V285, P11465, DOI 10.1074/jbc.M109.079327; Percy B. S., 2007, MOUSE; Peters CA, 2001, PRENATAL DIAG, V21, P917, DOI 10.1002/pd.211; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rosenthal A, 1999, NEURON, V22, P201, DOI 10.1016/S0896-6273(00)81077-6; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Sainio K, 1997, DEVELOPMENT, V124, P4077; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Sudo H, 2008, HUM MOL GENET, V17, P2524, DOI 10.1093/hmg/ddn153; Sudo H, 2007, FASEB J, V21, P2086, DOI 10.1096/fj.06-7254com; Teufel A, 2005, ONCOL REP, V14, P547; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Vecchione A, 2001, CLIN CANCER RES, V7, P1546; Vecchione A, 2007, CANCER CELL, V11, P275, DOI 10.1016/j.ccr.2007.01.014; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370	39	13	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40331	40342		10.1074/jbc.M111.302059	http://dx.doi.org/10.1074/jbc.M111.302059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21949185	hybrid, Green Published			2022-12-27	WOS:000296925700064
J	Singh, SK; Bhardwaj, R; Wilczynska, KM; Dumur, CI; Kordula, T				Singh, Sandeep K.; Bhardwaj, Reetika; Wilczynska, Katarzyna M.; Dumur, Catherine I.; Kordula, Tomasz			A Complex of Nuclear Factor I-X3 and STAT3 Regulates Astrocyte and Glioma Migration through the Secreted Glycoprotein YKL-40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACIDIC PROTEIN GENES; FACTOR-I; ONCOSTATIN-M; TRANSCRIPTIONAL REGULATION; ARTICULAR CHONDROCYTES; BRAIN-DEVELOPMENT; CARTILAGE GP-39; NFIA CONTROLS; JC VIRUS; C-FOS	Nuclear factor I-X3 (NFI-X3) is a newly identified splice variant of NFI-X that regulates expression of several astrocyte-specific markers, such as glial fibrillary acidic protein. Here, we identified a set of genes regulated by NFI-X3 that includes a gene encoding a secreted glycoprotein YKL-40. Although YKL-40 expression is up-regulated in glioblastoma multiforme, its regulation and functions in nontransformed cells of the central nervous system are widely unexplored. We find that expression of YKL-40 is activated during brain development and also differentiation of neural progenitors into astrocytes in vitro. Furthermore, YKL-40 is a migration factor for primary astrocytes, and its expression is controlled by both NFI-X3 and STAT3, which are known regulators of gliogenesis. Knockdown of NFI-X3 and STAT3 significantly reduced YKL-40 expression in astrocytes, whereas overexpression of NFI-X3 dramatically enhanced YKL-40 expression in glioma cells. Activation of STAT3 by oncostatin M induced YKL-40 expression in astrocytes, whereas expression of a dominant-negative STAT3 had a suppressive effect. Mechanistically, NFI-X3 and STAT3 form a complex that binds to weak regulatory elements in the YKL-40 promoter and activates transcription. We propose that NFI-X3 and STAT3 control the migration of differentiating astrocytes as well as migration and invasion of glioma cells via regulating YKL-40 expression.	[Singh, Sandeep K.; Bhardwaj, Reetika; Wilczynska, Katarzyna M.; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Massey Canc Ctr, Richmond, VA 23298 USA; [Dumur, Catherine I.] Virginia Commonwealth Univ, Dept Pathol, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Kordula, T (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Massey Canc Ctr, Richmond, VA 23298 USA.	tkordula@vcu.edu	Dumur, Catherine/AAH-9489-2020		National Institutes of Health [R01NS044118, R21NS063283]; Virginia Commonwealth University [2009 FPP-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063283, R01NS044118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS044118 and R21NS063283. This work was also supported by Massey Cancer Pilot Project no 2009 FPP-02 from Virginia Commonwealth University (to T. K.).	AMEMIYA K, 1992, J BIOL CHEM, V267, P14204; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Benjamini H, 1995, J R STAT SOC B, V57, P289; Bhat KP, 2008, FEBS LETT, V582, P3193, DOI 10.1016/j.febslet.2008.08.010; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Dumur CI, 2008, DIAGN MOL PATHOL, V17, P200, DOI 10.1097/PDM.0b013e318169bfaf; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Gopalan SM, 2006, J BIOL CHEM, V281, P13126, DOI 10.1074/jbc.M601194200; Gopalan SM, 2006, J BIOL CHEM, V281, P1956, DOI 10.1074/jbc.M510935200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kasza A, 2002, J NEUROCHEM, V83, P696, DOI 10.1046/j.1471-4159.2002.01163.x; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kordula T, 1998, J BIOL CHEM, V273, P4112, DOI 10.1074/jbc.273.7.4112; Kzhyshkowska J., 2007, INSIGHTS, V2, P128; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; MUCKE L, 1993, FASEB J, V7, P1226, DOI 10.1096/fasebj.7.13.8405808; Muller K, 2000, J BIOL CHEM, V275, P1645, DOI 10.1074/jbc.275.3.1645; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Nishikawa KC, 2003, EXP CELL RES, V287, P79, DOI 10.1016/S0014-4827(03)00069-7; Nishikawa T, 2008, J IMMUNOL, V180, P3492, DOI 10.4049/jimmunol.180.5.3492; Paugh BS, 2009, J BIOL CHEM, V284, P3408, DOI 10.1074/jbc.M807170200; Piper M, 2011, J COMP NEUROL, V519, P3532, DOI 10.1002/cne.22721; Piper M, 2010, J NEUROSCI, V30, P9127, DOI 10.1523/JNEUROSCI.6167-09.2010; Plachez C, 2008, J COMP NEUROL, V508, P385, DOI 10.1002/cne.21645; Ravichandran V, 2006, J VIROL, V80, P10506, DOI 10.1128/JVI.01355-06; Recklies AD, 2005, J BIOL CHEM, V280, P41213, DOI 10.1074/jbc.M510146200; Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200; Schuringa JJ, 2001, CYTOKINE, V14, P78, DOI 10.1006/cyto.2001.0856; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Singh SK, 2011, J BIOL CHEM, V286, P7315, DOI 10.1074/jbc.M110.152421; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tanwar MK, 2002, CANCER RES, V62, P4364; Underhill-Day N, 2006, CANCER RES, V66, P10891, DOI 10.1158/0008-5472.CAN-06-1766; Wang W, 2007, J NEUROSCI, V27, P6115, DOI 10.1523/JNEUROSCI.0180-07.2007; Wilczynska KM, 2009, STEM CELLS, V27, P1173, DOI 10.1002/stem.35; Yanagisawa M, 1999, NEUROSCI LETT, V269, P169, DOI 10.1016/S0304-3940(99)00447-4; Yang J, 2005, CANCER RES, V65, P939; Zhang L, 2002, J MOL BIOL, V317, P225, DOI 10.1006/jmbi.2001.5350; Zhao LH, 2005, ACTA BIOCH BIOPH SIN, V37, P440, DOI 10.1111/j.1745-7270.2005.00061.x	56	57	58	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39893	39903		10.1074/jbc.M111.257451	http://dx.doi.org/10.1074/jbc.M111.257451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21953450	hybrid, Green Published			2022-12-27	WOS:000296925700023
J	Krachler, AM; Orth, K				Krachler, Anne Marie; Orth, Kim			Functional Characterization of the Interaction between Bacterial Adhesin Multivalent Adhesion Molecule 7 ( MAM7) Protein and Its Host Cell Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEINS; PHOSPHATIDIC-ACID; YERSINIA-PSEUDOTUBERCULOSIS; STREPTOCOCCUS-PYOGENES; CONTACT; MEMBRANE; MODULATION; MATRIX; FIBRILLOGENESIS; PHAGOCYTOSIS	The ability of a pathogen to rapidly form a stable interaction with the host cell surface is key to its success. Bacterial pathogens use a repertoire of virulence factors, but their efficient use relies on close contact between the host and the pathogen. We have recently identified a constitutively expressed MAM7(multivalent adhesion molecule 7), which is widely distributed in Gram-negative pathogens and enables them to establish initial contact with the host cell. Here, we describe the dissection of the MAM7 interaction with the host cell surface into two distinct binding events, involving the host protein fibronectin and the membrane phospholipid phosphatidic acid. We analyzed which domains within MAM7 and fibronectin are necessary for complex formation. We further studied phosphatidic acid binding by MAM7 using site-directed mutagenesis and liposome association assays and demonstrated that a specific distribution of basic charge on MAM7 is required for high affinity binding. Finally, we showed that fibronectin and phosphatidic acid binding to MAM7 are not mutually exclusive and that the three molecules likely assemble into a tripartite complex on the host cell surface.	[Krachler, Anne Marie; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Kim.Orth@utsouthwestern.edu	Krachler, Anne-Marie/C-8645-2014; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Krachler, Anne Marie/0000-0002-0936-0016	National Institutes of Health NIAID [R01-AI056404, R01-AI087808]; Welch Foundation [I-1561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087808, R01AI056404] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health NIAID Grants R01-AI056404 and R01-AI087808. This work was also supported by Welch Foundation Grant I-1561.	Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Boekema BKHL, 2004, INFECT IMMUN, V72, P691, DOI 10.1128/IAI.72.2.691-700.2004; Burdette DL, 2009, MOL MICROBIOL, V73, P639, DOI 10.1111/j.1365-2958.2009.06798.x; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Chitale S, 2001, CELL MICROBIOL, V3, P247, DOI 10.1046/j.1462-5822.2001.00110.x; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Couturier MR, 2008, CAN J MICROBIOL, V54, P537, DOI [10.1139/W08-042, 10.1139/w08-042]; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; HORMANN H, 1987, BIOL CHEM H-S, V368, P669, DOI 10.1515/bchm3.1987.368.1.669; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Krachler AM, 2011, P NATL ACAD SCI USA, V108, P11614, DOI 10.1073/pnas.1102360108; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Matsuka YV, 2003, BIOCHEMISTRY-US, V42, P14643, DOI 10.1021/bi035239h; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Rosenshine I, 1996, EMBO J, V15, P2613, DOI 10.1002/j.1460-2075.1996.tb00621.x; ROSQVIST R, 1988, INFECT IMMUN, V56, P2139, DOI 10.1128/IAI.56.8.2139-2143.1988; Saini NK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-200; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; SIMONET M, 1990, INFECT IMMUN, V58, P841, DOI 10.1128/IAI.58.3.841-845.1990; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; TRAN VN, 1993, EMBO J, V12, P1887; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; VOELKER DR, 1991, MICROBIOL REV, V55, P543, DOI 10.1128/MMBR.55.4.543-560.1991; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WORTH HGJ, 1977, CLIN CHEM, V23, P1995; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026	43	49	54	6	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38939	38947		10.1074/jbc.M111.291377	http://dx.doi.org/10.1074/jbc.M111.291377			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21937438	hybrid, Green Published			2022-12-27	WOS:000296759800013
J	Rediger, A; Piechowski, CL; Yi, CX; Tarnow, P; Strotmann, R; Gruters, A; Krude, H; Schoneberg, T; Tschop, MH; Kleinau, G; Biebermann, H				Rediger, Anne; Piechowski, Carolin L.; Yi, Chun-Xia; Tarnow, Patrick; Strotmann, Rainer; Grueters, Annette; Krude, Heiko; Schoeneberg, Torsten; Tschoep, Matthias H.; Kleinau, Gunnar; Biebermann, Heike			Mutually Opposite Signal Modulation by Hypothalamic Heterodimerization of Ghrelin and Melanocortin-3 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CONSTITUTIVE ACTIVITY; THYROTROPIN RECEPTOR; CRYSTAL-STRUCTURE; FOOD-INTAKE; CROSS-TALK; IDENTIFICATION; ACTIVATION; WEIGHT; SYSTEM	Interaction and cross-talk of G-protein-coupled receptors (GPCRs) are of considerable interest because an increasing number of examples implicate a profound functional and physiological relevance of homo-or hetero-oligomeric GPCRs. The ghrelin (growth hormone secretagogue receptor (GHSR)) and melanocortin-3 (MC3R) receptors are both known to have orexigenic effects on the hypothalamic control of body weight. Because in vitro studies indicate heterodimerization of GHSR and MC3R, we investigated their functional interplay. Combined in situ hybridization and immunohistochemistry indicated that the vast majority of GHSR-expressing neurons in the arcuate nucleus also express MC3R. In vitro coexpression of MC3R and GHSR promoted enhanced melanocortin-induced intracellular cAMP accumulation compared with activation of MC3R in the absence of GHSR. In contrast, agonist-independent basal signaling activity and ghrelin-induced signaling of GHSR were impaired, most likely due to interaction with MC3R. By taking advantage of naturally occurring GHSR mutations and an inverse agonist for GHSR, we demonstrate that the observed enhanced MC3R signaling capability depends directly on the basal activity of GHSR. In conclusion, we demonstrate a paradigm-shifting example of GPCR heterodimerization allowing for mutually opposite functional influence of two hypothalamic receptors controlling body weight. We found that the agonistin dependent active conformation of one GPCR can determine the signaling modalities of another receptor in a heterodimer. Our discovery also implies that mutations within one of two interacting receptors might affect both receptors and different pathways simultaneously. These findings uncover mechanisms of important relevance for pharmacological targeting of GPCR in general and hypothalamic body weight regulation in particular.	[Rediger, Anne; Piechowski, Carolin L.; Tarnow, Patrick; Grueters, Annette; Krude, Heiko; Kleinau, Gunnar; Biebermann, Heike] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Yi, Chun-Xia; Tschoep, Matthias H.] Univ Cincinnati, Metab Dis Inst, Dept Internal Med, Cincinnati, OH 45267 USA; [Strotmann, Rainer; Schoeneberg, Torsten] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University System of Ohio; University of Cincinnati; Leipzig University	Biebermann, H (corresponding author), Charite, Inst Expt Pediat Endocrinol, Augustenburger Pl 1, D-13353 Berlin, Germany.	heike.biebermann@charite.de	Tschoep, Matthias H/I-5443-2014; Kleinau, Gunnar/GPX-6330-2022; Yi, Chun-Xia/J-4068-2016	Yi, Chun-Xia/0000-0003-1184-4615; Biebermann, Heike/0000-0002-2024-7778; Tschoep, Matthias/0000-0002-4744-371X	Deutsche Forschungsgemeinschaft [BI 893/2-1, KL2334/2-1]; Graduate School [TP1]; Bundesministerium fur Bildung und Forschung NGFN [01GS825]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School; Bundesministerium fur Bildung und Forschung NGFN(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft Grants BI 893/2-1 and KL2334/2-1 and Graduate School 1208 Hormonal Regulation of Energy Metabolism, Body Weight and Growth, TP1, and Bundesministerium fur Bildung und Forschung NGFN-Plus Grant 01GS825.	Barnes PJ, 2006, J CLIN INVEST, V116, P1210, DOI 10.1172/JCI28535; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Bradaia A, 2009, P NATL ACAD SCI USA, V106, P20081, DOI 10.1073/pnas.0906522106; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; Cai MY, 2005, J MED CHEM, V48, P1839, DOI 10.1021/jm049579s; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chollet C, 2009, J PEPT SCI, V15, P711, DOI 10.1002/psc.1177; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Elsner A, 2006, PEPTIDES, V27, P372, DOI 10.1016/j.peptides.2005.02.027; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Goldstein J. L., 2011, COLD SPRING IN PRESS; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Hoist B, 2006, J CLIN INVEST, V116, P637, DOI 10.1172/JCI27999; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kleinau G, 2008, CELL MOL LIFE SCI, V65, P3664, DOI 10.1007/s00018-008-8450-2; Kleinau G, 2011, J BIOL CHEM, V286, P25859, DOI 10.1074/jbc.M110.196980; Krishna R, 2009, CLIN PHARMACOL THER, V86, P659, DOI 10.1038/clpt.2009.167; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Marks DL, 2006, PEPTIDES, V27, P259, DOI 10.1016/j.peptides.2005.01.025; McGraw DW, 2006, J CLIN INVEST, V116, P1400, DOI 10.1172/JCI25840; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Piscione F, 2008, J AM COLL CARDIOL, V52, P1381, DOI 10.1016/j.jacc.2008.07.034; Rached M, 2004, BBA-MOL BASIS DIS, V1689, P229, DOI 10.1016/j.bbadis.2004.03.009; Rediger A, 2009, OBESITY FACTS, V2, P80, DOI 10.1159/000209862; Romero A, 2010, EUR J ENDOCRINOL, V163, P1, DOI 10.1530/EJE-10-0099; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Schellekens H, 2010, NEUROPHARMACOLOGY, V58, P2, DOI 10.1016/j.neuropharm.2009.06.024; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Shaw AM, 2005, PEPTIDES, V26, P1720, DOI 10.1016/j.peptides.2004.12.026; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Tao YX, 2004, J CLIN ENDOCR METAB, V89, P3936, DOI 10.1210/jc.2004-0367; Tarnow P, 2008, OBESITY FACTS, V1, P155, DOI 10.1159/000138251; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wang HJ, 2004, J CLIN ENDOCR METAB, V89, P157, DOI 10.1210/jc.2003-031395; Wilson SJ, 2007, BIOCHEM BIOPH RES CO, V352, P397, DOI 10.1016/j.bbrc.2006.11.040; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Yarnitzky T, 2010, CURR OPIN DRUG DISC, V13, P317; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	56	76	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39623	39631		10.1074/jbc.M111.287607	http://dx.doi.org/10.1074/jbc.M111.287607			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21940628	Green Published, hybrid			2022-12-27	WOS:000296759800079
J	Kim, JY; Oh, MH; Bernard, LP; Macara, IG; Zhang, HY				Kim, Jeong-Yoon; Oh, Mi Hee; Bernard, Laura P.; Macara, Ian G.; Zhang, Huaye			The RhoG/ELMO1/Dock180 Signaling Module Is Required for Spine Morphogenesis in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RHO-GTPASES; NEURITE OUTGROWTH; SYNAPSE FORMATION; APOPTOTIC CELLS; RAC; DOCK180; ACTIVATION; DOMAIN; PROTEINS	Dendritic spines are actin-rich structures, the formation and plasticity of which are regulated by the Rho GTPases in response to synaptic input. Although several guanine nucleotide exchange factors (GEFs) have been implicated in spine development and plasticity in hippocampal neurons, it is not known how many different Rho GEFs contribute to spine morphogenesis or how they coordinate the initiation, establishment, and maintenance of spines. In this study, we screened 70 rat Rho GEFs in cultured hippocampal neurons by RNA interference and identified a number of candidates that affected spine morphogenesis. Of these, Dock180, which plays a pivotal role in a variety of cellular processes including cell migration and phagocytosis, was further investigated. We show that depletion of Dock180 inhibits spine morphogenesis, whereas overexpression of Dock180 promotes spine morphogenesis. ELMO1, a protein necessary for in vivo functions of Dock180, functions in a complex with Dock180 in spine morphogenesis through activating the Rac GTPase. Moreover, RhoG, which functions upstream of the ELMO1/Dock180 complex, is also important for spine formation. Together, our findings uncover a role for the RhoG/ELMO1/Dock180 signaling module in spine morphogenesis in hippocampal neurons.	[Kim, Jeong-Yoon; Oh, Mi Hee] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Coll Biosci & Biotechnol, Taejon 305764, South Korea; [Bernard, Laura P.; Zhang, Huaye] Univ Med & Dent New Jersey, Dept Neurosci & Cell Biol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Macara, Ian G.] Univ Virginia Hlth Syst, Ctr Cell Signaling, Charlottesville, VA 22908 USA	Chungnam National University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Virginia	Zhang, HY (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes La W, Piscataway, NJ 08854 USA.	zhang29@umdnj.edu		Kim, Jeong-Yoon/0000-0001-5873-2069	National Institutes of Health [GM070902, NS065183]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Chungnam National University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS065183, K99NS065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Chungnam National University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM070902 (to I. G. M.) and NS065183 (to H. Z.). This work was also supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award (to H. Z.).; Recipient of financial support from Chungnam National University during sabbatical leave at the University of Virginia.	Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fujimoto S, 2009, MOL BIOL CELL, V20, P4941, DOI 10.1091/mbc.E09-03-0200; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Ma XM, 2008, J NEUROSCI, V28, P12368, DOI 10.1523/JNEUROSCI.4269-08.2008; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Meller J, 2008, J CELL SCI, V121, P1981, DOI 10.1242/jcs.025130; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Node-Langlois R, 2006, J CELL SCI, V119, P4986, DOI 10.1242/jcs.03273; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	49	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37615	37624		10.1074/jbc.M111.268029	http://dx.doi.org/10.1074/jbc.M111.268029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21900250	Green Published, hybrid			2022-12-27	WOS:000296542400059
J	Dmitriev, P; Petrov, A; Ansseau, E; Stankevicins, L; Charron, S; Kim, E; Bos, TJ; Robert, T; Turki, A; Coppee, F; Belayew, A; Lazar, V; Carnac, G; Laoudj, D; Lipinski, M; Vassetzky, YS				Dmitriev, Petr; Petrov, Andrei; Ansseau, Eugenie; Stankevicins, Luiza; Charron, Sebastien; Kim, Elena; Bos, Tomas Jan; Robert, Thomas; Turki, Ahmed; Coppee, Frederique; Belayew, Alexandra; Lazar, Vladimir; Carnac, Gilles; Laoudj, Dalila; Lipinski, Marc; Vassetzky, Yegor S.			The Kruppel-like Factor 15 as a Molecular Link between Myogenic Factors and a Chromosome 4q Transcriptional Enhancer Implicated in Facioscapulohumeral Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FSHD CANDIDATE GENE; MUSCULAR-DYSTROPHY; DNA REARRANGEMENTS; OXIDATIVE STRESS; EXPRESSION; PROTEIN; KLF15; MUSCLE; REPRESSOR; SEQUENCE	Facioscapulohumeral muscular dystrophy (FSHD), a dominant hereditary disease with a prevalence of 7 per 100,000 individuals, is associated with a partial deletion in the subtelomeric D4Z4 repeat array on chromosome 4q. The D4Z4 repeat contains a strong transcriptional enhancer that activates promoters of several FSHD-related genes. We report here that the enhancer within the D4Z4 repeat binds the Kruppel-like factor KLF15. KLF15 was found to be up-regulated during myogenic differentiation induced by serum starvation or by overexpression of the myogenic differentiation factor MYOD. When over-expressed, KLF15 activated the D4Z4 enhancer and led to overexpression of DUX4c (Double homeobox 4, centromeric) and FRG2 (FSHD region gene 2) genes, whereas its silencing caused inactivation of the D4Z4 enhancer. In immortalized human myoblasts, the D4Z4 enhancer was activated by the myogenic factor MYOD, an effect that was abolished upon KLF15 silencing or when the KLF15-binding sites within the D4Z4 enhancer were mutated, indicating that the myogenesis-related activation of the D4Z4 enhancer was mediated by KLF15. KLF15 and several myogenesis-related factors were found to be expressed at higher levels in myoblasts, myotubes, and muscle biopsies from FSHD patients than in healthy controls. We propose that KLF15 serves as a molecular link between myogenic factors and the activity of the D4Z4 enhancer, and it thus contributes to the overexpression of the DUX4c and FRG2 genes during normal myogenic differentiation and in FSHD.	[Dmitriev, Petr; Petrov, Andrei; Stankevicins, Luiza; Kim, Elena; Robert, Thomas; Lazar, Vladimir; Lipinski, Marc; Vassetzky, Yegor S.] Univ Paris 11, CNRS, UMR8126, Inst Cancerol Gustave Roussy, F-94805 Villejuif, France; [Turki, Ahmed; Carnac, Gilles; Laoudj, Dalila] Univ Montpellier I, INSERM, U1046, F-34295 Montpellier, France; [Ansseau, Eugenie; Charron, Sebastien; Coppee, Frederique; Belayew, Alexandra] Univ Mons, Mol Biol Lab, B-7000 Mons, Belgium; [Bos, Tomas Jan] Vrije Univ, Myeloma Ctr, Lab Hematol & Immunol, B-1090 Brussels, Belgium; [Petrov, Andrei] IBC Generium, Moscow 127006, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Mons; Vrije Universiteit Brussel	Vassetzky, YS (corresponding author), Univ Paris 11, CNRS, UMR8126, Inst Cancerol Gustave Roussy, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	vassetzky@igr.fr	Vassetzky, Yegor/M-3383-2019; Lazar, Vladimir/AAQ-2086-2020; Lazar, Vladimir/AAV-2087-2020; BELAYEW, Alexandra/D-5205-2013; Stankevicins, Luiza/K-1858-2014; Vassetzky, Yegor S/C-6447-2008; Laoudj-Chenivesse, dalila/N-7097-2018; Carnac, Gilles/N-6744-2018	Vassetzky, Yegor/0000-0003-3101-7043; BELAYEW, Alexandra/0000-0001-5115-2424; Vassetzky, Yegor S/0000-0003-3101-7043; Turki, Ahmed/0000-0003-4559-3105; Laoudj-Chenivesse, dalila/0000-0003-4356-9187; Carnac, Gilles/0000-0002-3518-8774	Association Francaise Contre les Myopathies; Fondation pour la Recherche Medicale; Onderzoerksraad Vrije Universiteit Brussel; Vlaamse Liga tegen Kanker-Stichting Emmanuel van der Schueren	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Onderzoerksraad Vrije Universiteit Brussel; Vlaamse Liga tegen Kanker-Stichting Emmanuel van der Schueren	This work was supported by grants from the Association Francaise Contre les Myopathies (to Y. S. V., D. L., and A. B.).; Supported by a postdoctoral fellowship from the Fondation pour la Recherche Medicale.; Supported by the Onderzoerksraad Vrije Universiteit Brussel and the Vlaamse Liga tegen Kanker-Stichting Emmanuel van der Schueren.	Adachi H, 2002, J BIOL CHEM, V277, P24014, DOI 10.1074/jbc.M201854200; Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Arashiro P, 2009, P NATL ACAD SCI USA, V106, P6220, DOI 10.1073/pnas.0901573106; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Cabianca DS, 2010, J CELL BIOL, V191, P1049, DOI 10.1083/jcb.201007028; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; CHEN QK, 1995, COMPUT APPL BIOSCI, V11, P563; Coppee F., 2004, FACIOSCAPULOHUMERAL, P1; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Hsu DKW, 1996, J BIOL CHEM, V271, P13786, DOI 10.1074/jbc.271.23.13786; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Leenders JJ, 2010, J BIOL CHEM, V285, P27449, DOI 10.1074/jbc.M110.107292; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNT PW, 1991, J MED GENET, V28, P655, DOI 10.1136/jmg.28.10.655; Luo SW, 2009, EMBO J, V28, P2568, DOI 10.1038/emboj.2009.178; McDonald J., 2009, HDB BIOL STAT, P1; Meijer AH, 1998, YEAST, V14, P1407, DOI 10.1002/(SICI)1097-0061(199811)14:15<1407::AID-YEA325>3.0.CO;2-M; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394; Otteson DC, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-15; Otteson DC, 2004, INVEST OPHTH VIS SCI, V45, P2522, DOI 10.1167/iovs.04-0072; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petrov A, 2003, RUSS J GENET+, V39, P147, DOI 10.1023/A:1022471523757; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Uchida S, 2000, MOL CELL BIOL, V20, P7319, DOI 10.1128/MCB.20.19.7319-7331.2000; Uchida S, 2001, KIDNEY INT, V60, P416, DOI 10.1046/j.1523-1755.2001.060002416.x; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Vinals F, 1997, J BIOL CHEM, V272, P12913, DOI 10.1074/jbc.272.20.12913; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	56	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44620	44631		10.1074/jbc.M111.254052	http://dx.doi.org/10.1074/jbc.M111.254052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21937448	Green Published, hybrid			2022-12-27	WOS:000298645500033
J	Garbers, C; Thaiss, W; Jones, GW; Waetzig, GH; Lorenzen, I; Guilhot, F; Lissilaa, R; Ferlin, WG; Grotzinger, J; Jones, SA; Rose-John, S; Scheller, J				Garbers, Christoph; Thaiss, Wolfgang; Jones, Gareth W.; Waetzig, Georg H.; Lorenzen, Inken; Guilhot, Florence; Lissilaa, Rami; Ferlin, Walter G.; Groetzinger, Joachim; Jones, Simon A.; Rose-John, Stefan; Scheller, Juergen			Inhibition of Classic Signaling Is a Novel Function of Soluble Glycoprotein 130 (sgp130), Which Is Controlled by the Ratio of Interleukin 6 and Soluble Interleukin 6 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BIOLOGICAL FUNCTION; DESIGNER CYTOKINE; EPITHELIAL-CELLS; TH17 CELLS; IL-6; INFLAMMATION; RESPONSES; BLOCKADE; CANCER	Background: IL-6 trans-signaling plays a critical role in chronic inflammation and cancer. Results: The trans-signaling inhibitor sgp130(Fc) also inhibits classic signaling depending on IL-6/sIL-6R ratios. Conclusion: The additional function of sgp130(Fc) suggests that in vivo only low therapeutic concentrations guarantee blockade of trans-signaling but not classic signaling. Significance: The demonstration that the trans-signaling inhibitor can also inhibit classic signaling is central for the field of IL-6 biology.	[Garbers, Christoph; Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Thaiss, Wolfgang; Lorenzen, Inken; Groetzinger, Joachim; Rose-John, Stefan] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Jones, Gareth W.; Jones, Simon A.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Waetzig, Georg H.] CONARIS Res Inst AG, D-20498 Kiel, Germany; [Guilhot, Florence; Lissilaa, Rami; Ferlin, Walter G.] NovImmune SA, CH-1228 Geneva, Switzerland	Heinrich Heine University Dusseldorf; University of Kiel; Cardiff University; NovImmune SA	Scheller, J (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Thaiss, Wolfgang/ABH-9299-2020; Scheller, Jürgen/K-5290-2015; Garbers, Christoph/D-9932-2015; Waetzig, Georg/AAV-7486-2021; Rose-John, Stefan/A-7998-2010; Jones, Simon Arnett/Q-7017-2018	Garbers, Christoph/0000-0003-4939-6950; Rose-John, Stefan/0000-0002-7519-3279; Jones, Simon Arnett/0000-0001-7297-9711; Guilhot, Francois/0000-0001-7222-487X; Jones, Gareth/0000-0002-0125-4841	Deutsche Forschungsgemeinschaft [SFB877, A1, A2]; Cluster of Excellence "Inflammation at Interfaces"; Versus Arthritis [18286] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; Versus Arthritis(Versus Arthritis)	This work was funded by Deutsche Forschungsgemeinschaft Grant SFB877 of Projects A1 and A2 and by the Cluster of Excellence "Inflammation at Interfaces."	AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Barkhausen T, 2011, CRIT CARE MED, V39, P1407, DOI 10.1097/CCM.0b013e318211ff56; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; CASTELL JV, 1988, EUR J BIOCHEM, V177, P357, DOI 10.1111/j.1432-1033.1988.tb14384.x; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Dominitzki S, 2007, J IMMUNOL, V179, P2041, DOI 10.4049/jimmunol.179.4.2041; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Gaillard JP, 1999, EUR CYTOKINE NETW, V10, P337; GAILLARD JP, 1993, EUR J IMMUNOL, V23, P820, DOI 10.1002/eji.1830230408; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Lissilaa R, 2010, J IMMUNOL, V185, P5512, DOI 10.4049/jimmunol.1002015; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Melton L, 2008, NAT BIOTECHNOL, V26, P957, DOI 10.1038/nbt0908-957; MITSUYAMA K, 1995, GUT, V36, P45, DOI 10.1136/gut.36.1.45; Mitsuyama K, 2006, GUT, V55, P1263, DOI 10.1136/gut.2005.079343; Montero-Julian FA, 2001, CELL MOL BIOL, V47, P583; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; MULLBERG J, 1993, FEBS LETT, V332, P174, DOI 10.1016/0014-5793(93)80507-Q; Muller-Newen G, 1998, J IMMUNOL, V161, P6347; Peters M, 1997, J EXP MED, V185, P755, DOI 10.1084/jem.185.4.755; Peters M, 1998, J IMMUNOL, V161, P3575; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; SATO K, 1993, CANCER RES, V53, P851; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Tenhumberg S, 2008, J BIOL CHEM, V283, P27200, DOI 10.1074/jbc.M803694200; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; ZOHLNHOFER D, 1992, FEBS LETT, V306, P219, DOI 10.1016/0014-5793(92)81004-6	45	116	122	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42959	42970		10.1074/jbc.M111.295758	http://dx.doi.org/10.1074/jbc.M111.295758			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21990364	Green Published, hybrid			2022-12-27	WOS:000298351300017
J	Su, J; Cao, X; Wang, KW				Su, Jun; Cao, Xu; Wang, KeWei			A Novel Degradation Signal Derived from Distal C-terminal Frameshift Mutations of KCNQ2 Protein Which Cause Neonatal Epilepsy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE; PROTEASOMAL DEGRADATION; CONVULSIONS; CHANNELS; GENE; EXPRESSION; SUBUNIT; CELLS; BRAIN	Background: The mechanism underlying incomplete dominance of KCNQ2 channel mutations, which causes epilepsy, remains unknown. Results: We have identified a novel degradation signal with a key five-amino acid (RCXRG) motif from distal C-terminal frameshift mutations of KCNQ2. Conclusion: The novel degradation signal accelerates degradation of surface mutant proteins through ubiquitin-independent proteasome machinery. Significance: Our findings reveal a mechanism by which mutant KCNQ2 proteins cause epilepsy.	[Su, Jun; Cao, Xu; Wang, KeWei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Neurosci Res Ctr, Beijing 100191, Peoples R China; [Wang, KeWei] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100191, Peoples R China	Peking University; Peking University	Wang, KW (corresponding author), Peking Univ, Sch Med, 38 Xueyuan Rd, Beijing 100091, Peoples R China.	wangkw@bjmu.edu.cn	Cao, Xu/G-6209-2015	Cao, Xu/0000-0003-1796-2735	National Science Foundation of China [30630017, 30970919]; Ministry of Science Technology of China [2007CB512100]; Ministry of Education of China [B07001]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Science Foundation of China Research Grants 30630017 and 30970919, the Ministry of Science Technology of China "973 Program" 2007CB512100, and the Ministry of Education of China, 111 Project China (B07001) (to K. W. W.).	Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Doi N, 2005, PROTEIN ENG DES SEL, V18, P279, DOI 10.1093/protein/gzi034; Doi N, 1998, CELL MOL LIFE SCI, V54, P394, DOI 10.1007/s000180050169; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Jentsch TJ, 2000, EPILEPSIA, V41, P1068, DOI 10.1111/j.1528-1157.2000.tb00302.x; Jow F, 2000, MOL BRAIN RES, V80, P269, DOI 10.1016/S0169-328X(00)00146-7; Kamsteeg EJ, 2003, J CELL BIOL, V163, P1099, DOI 10.1083/jcb.200309017; Komaru K, 2005, FEBS J, V272, P1704, DOI 10.1111/j.1742-4658.2005.04597.x; Kurepa J, 2008, PLANT SIGNAL BEHAV, V3, P386, DOI 10.4161/psb.3.6.5376; Lerche H, 1999, ANN NEUROL, V46, P305, DOI 10.1002/1531-8249(199909)46:3<305::AID-ANA5>3.0.CO;2-5; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Psenka TM, 1996, SEIZURE, V5, P243, DOI 10.1016/S1059-1311(96)80044-6; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; RONEN GM, 1993, NEUROLOGY, V43, P1355, DOI 10.1212/WNL.43.7.1355; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Soldovieri MV, 2006, J BIOL CHEM, V281, P418, DOI 10.1074/jbc.M510980200; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Volkers L, 2009, NEUROSCI LETT, V462, P24, DOI 10.1016/j.neulet.2009.06.064; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Yamauchi A, 1998, FEBS LETT, V421, P147, DOI 10.1016/S0014-5793(97)01552-4	39	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					42949	42958		10.1074/jbc.M111.287268	http://dx.doi.org/10.1074/jbc.M111.287268			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21937445	hybrid, Green Published			2022-12-27	WOS:000298351300016
J	Cheetham, J; MacCallum, DM; Doris, KS; Dantas, AD; Scorfield, S; Odds, F; Smith, DA; Quinn, J				Cheetham, Jill; MacCallum, Donna M.; Doris, Kathryn S.; Dantas, Alessandra da Silva; Scorfield, Susan; Odds, Frank; Smith, Deborah A.; Quinn, Janet			MAPKKK-independent Regulation of the Hog1 Stress-activated Protein Kinase in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL BIOSYNTHESIS; FISSION YEAST; OXIDATIVE-STRESS; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTIONAL RESPONSE; CHLAMYDOSPORE FORMATION; SIGNALING PATHWAYS; MITOTIC REGULATOR; IN-VIVO	The Hog1 stress-activated protein kinase regulates both stress responses and morphogenesis in Candida albicans and is essential for the virulence of this major human pathogen. Stress-induced Hog1 phosphorylation is regulated by the upstream MAPKK, Pbs2, which in turn is regulated by the MAPKKK, Ssk2. Here, we have investigated the role of phosphorylation of Hog1 and Pbs2 in Hog1-mediated processes in C. albicans. Mutation of the consensus regulatory phosphorylation sites of Hog1 (Thr-174/Tyr-176) and Pbs2 (Ser-355/Thr-359), to non-phosphorylatable residues, resulted in strains that phenocopied hog1 Delta and pbs2 Delta cells. Consistent with this, stress-induced phosphorylation of Hog1 was abolished in cells expressing non-phosphorylatable Pbs2 (Pbs2(A)A). However, mutation of the consensus sites of Pbs2 to phosphomimetic residues (Pbs2(DD)) failed to constitutively activate Hog1. Furthermore, Ssk2-independent stress-induced Hog1 activation was observed in Pbs2(DD) cells. Collectively, these data reveal a previously uncharacterized MAPKKK-independent mechanism of Hog1 activation in response to stress. Although Pbs2(DD) cells did not exhibit high basal levels of Hog1 phosphorylation, overexpression of an N-terminal truncated form of Ssk2 did result in constitutive Hog1 activation, which was further increased upon stress. Significantly, both Pbs2(AA) and Pbs2(DD) cells displayed impaired stress resistance and attenuated virulence in a mouse model of disease, whereas only Pbs2(AA) cells exhibited the morphological defects associated with loss of Hog1 function. This indicates that Hog1 mediates C. albicans virulence by conferring stress resistance rather than regulating morphogenesis.	[Cheetham, Jill; Doris, Kathryn S.; Dantas, Alessandra da Silva; Scorfield, Susan; Smith, Deborah A.; Quinn, Janet] Newcastle Univ, Fac Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [MacCallum, Donna M.; Odds, Frank] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen AB25 2ZD, Scotland	Newcastle University - UK; University of Aberdeen	Quinn, J (corresponding author), Newcastle Univ, Fac Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	janet.quinn@ncl.ac.uk	da Silva Dantas, Alessandra/B-9151-2015; Quinn, Janet/AAR-9957-2021; MacCallum, Donna M./D-7897-2011	MacCallum, Donna M./0000-0003-4833-0378; Quinn, Janet/0000-0002-8732-7676	Biotechnology and Biological Sciences Research Council; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust.	ALFA CE, 1993, METHOD CELL BIOL, V37, P201, DOI 10.1016/S0091-679X(08)60251-4; Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Arana DM, 2005, MICROBIOL-SGM, V151, P1033, DOI 10.1099/mic.0.27723-0; Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Blackwell C, 2003, YEAST, V20, P1235, DOI 10.1002/yea.1036; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Cheetham J, 2007, MOL BIOL CELL, V18, P4603, DOI 10.1091/mbc.E07-06-0581; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; MacCallum DM, 2010, ANTIMICROB AGENTS CH, V54, P1476, DOI 10.1128/AAC.01645-09; MacCallum DM, 2009, EUKARYOT CELL, V8, P373, DOI 10.1128/EC.00387-08; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Navarro-Garcia F, 2005, MICROBIOL-SGM, V151, P2737, DOI 10.1099/mic.0.28038-0; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; Nikolaou E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-44; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; PIPER PW, 1988, NUCLEIC ACIDS RES, V16, P1333, DOI 10.1093/nar/16.4.1333; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Rodaki A, 2009, MOL BIOL CELL, V20, P4845, DOI 10.1091/mbc.E09-01-0002; Roman E, 2005, MOL CELL BIOL, V25, P10611, DOI 10.1128/MCB.25.23.10611-10627.2005; Samejima I, 1998, MOL BIOL CELL, V9, P2325, DOI 10.1091/mbc.9.8.2325; SanJose C, 1996, J BACTERIOL, V178, P5850, DOI 10.1128/jb.178.19.5850-5852.1996; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shieh JC, 1998, MOL BIOL CELL, V9, P311, DOI 10.1091/mbc.9.2.311; Shiozaki K, 1997, MOL BIOL CELL, V8, P409, DOI 10.1091/mbc.8.3.409; Shiozaki K, 1998, MOL BIOL CELL, V9, P1339, DOI 10.1091/mbc.9.6.1339; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Smith DA, 2010, FEMS MICROBIOL LETT, V306, P1, DOI 10.1111/j.1574-6968.2010.01937.x; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; Tripathi G, 2002, EMBO J, V21, P5448, DOI 10.1093/emboj/cdf507; Vylkova S, 2007, EUKARYOT CELL, V6, P1876, DOI 10.1128/EC.00039-07; Walker LA, 2009, FUNGAL GENET BIOL, V46, P210, DOI 10.1016/j.fgb.2008.10.012; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Wysong DR, 1998, INFECT IMMUN, V66, P1953, DOI 10.1128/IAI.66.5.1953-1961.1998; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x	54	40	51	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42002	42016		10.1074/jbc.M111.265231	http://dx.doi.org/10.1074/jbc.M111.265231			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994942	hybrid, Green Published			2022-12-27	WOS:000298180900011
J	Wortmann, A; He, YW; Christensen, ME; Linn, M; Lumley, JW; Pollock, PM; Waterhouse, NJ; Hooper, JD				Wortmann, Andreas; He, Yaowu; Christensen, Melinda E.; Linn, Mayla; Lumley, John W.; Pollock, Pamela M.; Waterhouse, Nigel J.; Hooper, John D.			Cellular Settings Mediating Src Substrate Switching between Focal Adhesion Kinase Tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) Tyrosine 734	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY KINASES; SIGNAL-TRANSDUCTION; PKC-DELTA; CARCINOMA-CELLS; GROWTH-FACTOR; CANCER-CELLS; PHOSPHORYLATION; MIGRATION; BINDING; FAK	Reciprocal interactions between Src family kinases (SFKs) and focal adhesion kinase (FAK) are critical during changes in cell attachment. Recently it has been recognized that another SFK substrate, CUB-domain-containing protein 1 (CDCP1), is differentially phosphorylated during these events. However, the molecular processes underlying SFK-mediated phosphorylation of CDCP1 are poorly understood. Here we identify a novel mechanism in which FAK tyrosine 861 and CDCP1-Tyr-734 compete as SFK substrates and demonstrate cellular settings in which SFKs switch between these sites. Our results show that stable CDCP1 expression induces robust SFK-mediated phosphorylation of CDCP1-Tyr-734 with concomitant loss of p-FAK-Tyr-861 in adherent HeLa cells. SFK substrate switching in these cells is dependent on the level of expression of CDCP1 and is also dependent on CDCP1-Tyr-734 but is independent of CDCP1-Tyr-743 and -Tyr-762. In HeLa CDCP1 cells, engagement of SFKs with CDCP1 is accompanied by an increase in phosphorylation of Src-Tyr-416 and a change in cell morphology to a fibroblastic appearance dependent on CDCP1-Tyr-734. SFK switching between FAK-Tyr-861 and CDCP1-Tyr-734 also occurs during changes in adhesion of colorectal cancer cell lines endogenously expressing these two proteins. Consistently, increased p-FAK-Tyr-861 levels and a more epithelial morphology are seen in colon cancer SW480 cells silenced for CDCP1. Unlike protein kinase C delta, FAK does not appear to form a trimeric complex with Src and CDCP1. These data demonstrate novel aspects of the dynamics of SFK-mediated cell signaling that may be relevant during cancer progression.	[Wortmann, Andreas; He, Yaowu; Christensen, Melinda E.; Waterhouse, Nigel J.; Hooper, John D.] Mater Med Res Inst, Brisbane, Qld 4101, Australia; [Wortmann, Andreas; Linn, Mayla; Pollock, Pamela M.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Lumley, John W.] Wesley Med Ctr, Auchenflower, Qld 4066, Australia	Mater Research; Queensland University of Technology (QUT); Wesley Hospital	Hooper, JD (corresponding author), Mater Med Res Inst, Aubigny Pl, Brisbane, Qld 4101, Australia.	jhooper@mmri.mater.org.au	Waterhouse, Nigel/B-2498-2012; Wortmann, Dr Andreas/D-2074-2012; Waterhouse, Nigel/I-9813-2016; Hooper, John/C-1481-2016	Hooper, John/0000-0003-1054-8486; Pollock, Pamela/0000-0001-8420-1026; HE, Yaowu/0000-0002-7828-263X	National Health and Medical Research Council of Australia [339732]; Cancer Council Queensland; Wesley Research Institute [2008/06]; Cancer and Bowel Research Trust; Australian Research Council [FT0991446]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Wesley Research Institute; Cancer and Bowel Research Trust; Australian Research Council(Australian Research Council)	This work was supported by a National Health and Medical Research Council of Australia Fellowship 339732 (to J. D. H.), a Cancer Council Queensland grant (to J. D. H.), Wesley Research Institute Grant 2008/06 (to J. D. H.), a Ph.D. scholarship from the Cancer and Bowel Research Trust (to A. W.), and an Australian Research Council Futures Fellowship FT0991446 (to N. J. W.).	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boyer B, 2002, ONCOGENE, V21, P2347, DOI 10.1038/sj.onc.1205298; BROOKS PC, 1993, J CELL BIOL, V122, P1351, DOI 10.1083/jcb.122.6.1351; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Ikeda JI, 2006, J PATHOL, V210, P75, DOI 10.1002/path.2026; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Lunn JA, 2007, J BIOL CHEM, V282, P10370, DOI 10.1074/jbc.M607780200; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Myoui A, 2003, CANCER RES, V63, P5028; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Playford MP, 2008, EXP CELL RES, V314, P3187, DOI 10.1016/j.yexcr.2008.08.010; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Sedelies KA, 2008, CELL DEATH DIFFER, V15, P708, DOI 10.1038/sj.cdd.4402300; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Spassov DS, 2011, CELL CYCLE, V10, P1225, DOI 10.4161/cc.10.8.15343; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Spassov DS, 2009, AM J PATHOL, V174, P1756, DOI 10.2353/ajpath.2009.080890; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Xing LZ, 2000, MOL CELL BIOL, V20, P7363, DOI 10.1128/MCB.20.19.7363-7377.2000; Yadav SS, 2007, CANCER LETT, V257, P116, DOI 10.1016/j.canlet.2007.07.012; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013	56	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42303	42315		10.1074/jbc.M111.227462	http://dx.doi.org/10.1074/jbc.M111.227462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21994943	hybrid, Green Published			2022-12-27	WOS:000298180900040
J	Kim, JK; Lee, E; Shin, S; Jeong, KW; Lee, JY; Bae, SY; Kim, SH; Lee, J; Kim, SR; Lee, DG; Hwang, JS; Kim, Y				Kim, Jin-Kyoung; Lee, Eunjung; Shin, Soyoung; Jeong, Ki-Woong; Lee, Jee-Young; Bae, Su-Young; Kim, Soo-Hyun; Lee, Juneyoung; Kim, Seong Ryul; Lee, Dong Gun; Hwang, Jae-Sam; Kim, Yangmee			Structure and Function of Papiliocin with Antimicrobial and Anti-inflammatory Activities Isolated from the Swallowtail Butterfly, Papilio xuthus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-DEFENSE PEPTIDES; GRAM-NEGATIVE BACTERIA; CELL-FREE IMMUNITY; NF-KAPPA-B; NMR-SPECTROSCOPY; ANTIBACTERIAL PEPTIDES; HYALOPHORA-CECROPIA; ESCHERICHIA-COLI; INSECT IMMUNITY; INNATE IMMUNITY	Papiliocin is a novel 37-residue cecropin-like peptide isolated recently from the swallowtail butterfly, Papilio xuthus. With the aim of identifying a potent antimicrobial peptide, we tested papiliocin in a variety of biological and biophysical assays, demonstrating that the peptide possesses very low cytotoxicity against mammalian cells and high bacterial cell selectivity, particularly against Gram-negative bacteria as well as high anti-inflammatory activity. Using LPS-stimulated macrophage RAW264.7 cells, we found that papiliocin exerted its anti-inflammatory activities by inhibiting nitric oxide (NO) production and secretion of tumor necrosis factor (TNF)-alpha and macrophage inflammatory protein (MIP)-2, producing effects comparable with those of the antimicrobial peptide LL-37. We also showed that the innate defense response mechanisms engaged by papiliocin involve Toll-like receptor pathways that culminate in the nuclear translocation of NF-kappa B. Fluorescent dye leakage experiments showed that papiliocin targets the bacterial cell membrane. To understand structure-activity relationships, we determined the three-dimensional structure of papiliocin in 300 mm dodecylphosphocholine micelles by NMR spectroscopy, showing that papiliocin has an alpha-helical structure from Lys(3) to Lys(21) and from Ala(25) to Val(36), linked by a hinge region. Interactions between the papiliocin and 1,PS studied using tryptophan blue-shift data, and saturation transfer difference-NMR experiments revealed that Trp(2) and Phe(5) at the N-terminal helix play an important role in attracting papiliocin to the cell membrane of Gram-negative bacteria. In conclusion, we have demonstrated that papiliocin is a potent peptide antibiotic with both anti-inflammatory and antibacterial activities, and we have laid the groundwork for future studies of its mechanism of action.	[Kim, Jin-Kyoung; Lee, Eunjung; Shin, Soyoung; Jeong, Ki-Woong; Lee, Jee-Young; Kim, Yangmee] Konkuk Univ, BMIC, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Bae, Su-Young; Kim, Soo-Hyun] Konkuk Univ, Coll Med, Inst Biomed Sci & Technol, Lab Cytokine Immunol, Seoul 143701, South Korea; [Lee, Juneyoung; Lee, Dong Gun] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Kim, Seong Ryul; Hwang, Jae-Sam] Natl Acad Agr Sci, Rural Dev Adm, Suwon 441100, South Korea	Konkuk University; Konkuk University; Konkuk University Medical Center; Kyungpook National University; Rural Development Administration (RDA)	Kim, Y (corresponding author), Konkuk Univ, BMIC, Dept Biosci & Biotechnol, Seoul 143701, South Korea.	ymkim@konkuk.ac.kr			Rural Development Administration, Republic of Korea [20080401-034-017]; Basic Science Research Program [2011-0022873]; Priority Research Center through the National Research Foundation of Korea [2009-0093824]; Ministry of Education, Science and Technology	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Basic Science Research Program; Priority Research Center through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by BioGreen21 Program Grant 20080401-034-017 from the Rural Development Administration, Republic of Korea, and by Basic Science Research Program Grant 2011-0022873 and Priority Research Centers Program Grant 2009-0093824 through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; Blondelle SE, 1999, BBA-BIOMEMBRANES, V1462, P89, DOI 10.1016/S0005-2736(99)00202-3; BOMAN HG, 1985, DEV COMP IMMUNOL, V9, P551, DOI 10.1016/0145-305X(85)90018-7; BOMAN HG, 1991, EUR J BIOCHEM, V201, P23, DOI 10.1111/j.1432-1033.1991.tb16252.x; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cole AM, 2000, ANTIMICROB AGENTS CH, V44, P2039, DOI 10.1128/AAC.44.8.2039-2045.2000; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; Dimarcq JL, 1998, BIOPOLYMERS, V47, P465, DOI 10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-#; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gennis R.B., 1989, BIOMEMBRANES MOL STR, p[20, 154]; Ghiselli R, 2004, ANN SURG, V239, P251, DOI 10.1097/01.sla.0000108673.25385.03; Ghosh AK, 1997, BIOCHEMISTRY-US, V36, P14291, DOI 10.1021/bi971933j; Goddard T. D. and Kneller D. G ., 2002, SPARKY; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gregory SM, 2008, BIOPHYS J, V94, P1667, DOI 10.1529/biophysj.107.118760; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P7620, DOI 10.1021/bi00420a008; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Jeon YJ, 1999, IMMUNOPHARMACOLOGY, V43, P1, DOI 10.1016/S0162-3109(99)00032-6; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Kim SR, 2010, MOL CELLS, V29, P419, DOI 10.1007/s10059-010-0050-y; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Liang YL, 2006, DEV COMP IMMUNOL, V30, P249, DOI 10.1016/j.dci.2005.04.005; Lopez L, 2003, INSECT BIOCHEM MOLEC, V33, P439, DOI 10.1016/S0965-1748(03)00008-0; Marassi FM, 1999, BIOPHYS J, V77, P3152, DOI 10.1016/S0006-3495(99)77145-6; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; MORISHIMA I, 1990, COMP BIOCHEM PHYS B, V95, P551, DOI 10.1016/0305-0491(90)90019-P; Mueller M, 2004, J BIOL CHEM, V279, P26307, DOI 10.1074/jbc.M401231200; Nell MJ, 2006, PEPTIDES, V27, P649, DOI 10.1016/j.peptides.2005.09.016; Nijnik A, 2009, Emerg Health Threats J, V2, pe1, DOI 10.3134/ehtj.09.001; Otvos L, 2000, J PEPT SCI, V6, P497; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; PIERS KL, 1994, ANTIMICROB AGENTS CH, V38, P2311, DOI 10.1128/AAC.38.10.2311; PLISKA V, 1981, J CHROMATOGR, V216, P79, DOI 10.1016/S0021-9673(00)82337-7; Porcelli F, 2006, BIOCHEMISTRY-US, V45, P5793, DOI 10.1021/bi0601813; QU XM, 1982, EUR J BIOCHEM, V127, P219, DOI 10.1111/j.1432-1033.1982.tb06858.x; Ramamoorthy A, 2010, BBA-BIOMEMBRANES, V1798, P223, DOI 10.1016/j.bbamem.2009.08.012; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Saito A, 2005, COMP BIOCHEM PHYS B, V142, P317, DOI 10.1016/j.cbpb.2005.08.001; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Silvestro L, 2000, ANTIMICROB AGENTS CH, V44, P602, DOI 10.1128/AAC.44.3.602-607.2000; Silvestro L, 1997, BIOCHEMISTRY-US, V36, P11452, DOI 10.1021/bi9630826; SIPOS D, 1992, EUR J BIOCHEM, V209, P163, DOI 10.1111/j.1432-1033.1992.tb17273.x; Srisailam S, 2000, BBA-PROTEIN STRUCT M, V1479, P275, DOI 10.1016/S0167-4838(00)00008-X; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Teng WY, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/473276; Wang L, 2007, COMP BIOCHEM PHYS B, V148, P417, DOI 10.1016/j.cbpb.2007.07.010; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wu JM, 2009, PEPTIDES, V30, P839, DOI 10.1016/j.peptides.2009.02.004; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P130; Xiao YJ, 2006, FEBS J, V273, P2581, DOI 10.1111/j.1742-4658.2006.05261.x; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yu K, 2000, J PEPT RES, V55, P51, DOI 10.1034/j.1399-3011.2000.00146.x; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	86	83	89	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41296	41311		10.1074/jbc.M111.269225	http://dx.doi.org/10.1074/jbc.M111.269225			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965682	hybrid, Green Published			2022-12-27	WOS:000298057500017
J	Li, YM; Jaramillo-Lambert, A; Hao, J; Yang, Y; Zhu, WG				Li, Yongming; Jaramillo-Lambert, Aimee; Hao, Jing; Yang, Yi; Zhu, Wenge			The Stability of Histone Acetyltransferase General Control Non-derepressible (Gcn) 5 Is Regulated by Cullin4-RING E3 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-ASSOCIATED PROTEIN; DNA-DAMAGE RESPONSE; HUMAN STAGA COMPLEX; CELL-CYCLE; S-PHASE; REQUIRES TRRAP; REPLICATION; ACETYLATION; DEGRADATION; DESTRUCTION	Histone acetyltransferases play important roles in the regulation of chromatin structure and gene transcription. As one of the most important histone acetyltransferases, general control non-derepressible (Gcn) 5 has been linked to diverse cellular processes and tumorigenesis as well. We have recently identified a functional link between Gcn5 and acidic nucleoplasmic DNA-binding protein 1 (And-1) that is elevated in multiple cancer cells and is essential for Gcn5 protein stability. However, the mechanism by which And-1 regulates Gcn5 protein stability remains unknown. Here we show that the ablation of Cullin4-RING E3 ubiquitin ligase (CRL4) leads to the stabilization of Gcn5 in cells with depleted And-1, and Cdc10-dependent transcript 2 (Cdt2) serves as a substrate receptor protein of CRL4. Overexpression of Cdt2 reduces the Gcn5 protein levels, and CRLCdt2 is sufficient to ubiquitinate Gcn5 both in vivo and in vitro. And-1 stabilizes Gcn5 by impairing the interaction between Gcn5 and CRLCdt2 and thereby preventing Gcn5 ubiquitination and degradation. The degradation of Gcn5 is not dependent on proliferating cell nuclear antigen, an important player involved in CRLCdt2-mediated protein degradation. Thus, CRLCdt2 and And-1 play an essential role in the regulation of Gcn5 protein stability. This study provides us with the mechanistic basis to develop alternative approaches to inhibit Gcn5 activity for cancer therapy.	[Li, Yongming; Jaramillo-Lambert, Aimee; Hao, Jing; Yang, Yi; Zhu, Wenge] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Zhu, WG (corresponding author), George Washington Univ, Sch Med, Dept Biochem & Mol Biol, 2300 Eye St NW, Washington, DC 20037 USA.	bcmwxz@gwumc.edu	li, yong/HDN-3885-2022	Jaramillo-Lambert, Aimee/0000-0001-7697-8580	National Institutes of Health [4R00CA136555]; NATIONAL CANCER INSTITUTE [R00CA136555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 4R00CA136555 (to W. Z.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kikuchi H, 2011, BIOCHEM BIOPH RES CO, V405, P657, DOI 10.1016/j.bbrc.2011.01.088; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Li J, 2009, BRIT J CANCER, V101, P691, DOI 10.1038/sj.bjc.6605202; Li Y., 2011, ONCOGENE        0704, DOI DOI 10.1038/ONC.2011.261; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Pan HW, 2006, CELL CYCLE, V5, P2676, DOI 10.4161/cc.5.22.3500; Rekowski MV, 2010, BBA-GENE REGUL MECH, V1799, P760, DOI 10.1016/j.bbagrm.2010.05.006; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Toyota M, 2005, SEMIN ONCOL, V32, P521, DOI 10.1053/j.seminoncol.2005.07.003; Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	42	19	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41344	41352		10.1074/jbc.M111.290767	http://dx.doi.org/10.1074/jbc.M111.290767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21987584	Green Published, hybrid			2022-12-27	WOS:000298057500021
J	Mohamed, TMA; Oceandy, D; Zi, M; Prehar, S; Alatwi, N; Wang, YW; Shaheen, MA; Abou-Leisa, R; Schelcher, C; Hegab, Z; Baudoin, F; Emerson, M; Mamas, M; Di Benedetto, G; Zaccolo, M; Lei, M; Cartwright, EJ; Neyses, L				Mohamed, Tamer M. A.; Oceandy, Delvac; Zi, Min; Prehar, Sukhpal; Alatwi, Nasser; Wang, Yanwen; Shaheen, Mohamed A.; Abou-Leisa, Riham; Schelcher, Celine; Hegab, Zeinab; Baudoin, Florence; Emerson, Michael; Mamas, Mamas; Di Benedetto, Giulietta; Zaccolo, Manuela; Lei, Ming; Cartwright, Elizabeth J.; Neyses, Ludwig			Plasma Membrane Calcium Pump (PMCA4)-Neuronal Nitric-oxide Synthase Complex Regulates Cardiac Contractility through Modulation of a Compartmentalized Cyclic Nucleotide Microdomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART; CA2+; OVEREXPRESSION; TRANSPORT; ATPASE; HEALTH; SIGNAL; CAMP	Identification of the signaling pathways that regulate cyclic nucleotide microdomains is essential to our understanding of cardiac physiology and pathophysiology. Although there is growing evidence that the plasma membrane Ca2+/calmodulinde-pendent ATPase 4 (PMCA4) is a regulator of neuronal nitricoxide synthase, the physiological consequence of this regulation is unclear. We therefore tested the hypothesis that PMCA4 has a key structural role in tethering neuronal nitric-oxide synthase to a highly compartmentalized domain in the cardiac cell membrane. This structural role has functional consequences on cAMP and cGMP signaling in a PMCA4-governed microdomain, which ultimately regulates cardiac contractility. In vivo contractility and calcium amplitude were increased in PMCA4 knock-out animals (PMCA4(-/-)) with no change in diastolic relaxation or the rate of calcium decay, showing that PMCA4 has a function distinct from beat-to-beat calcium transport. Surprisingly, in PMCA4(-/-), over 36% of membrane-associated neuronal nitric-oxide synthase (nNOS) protein and activity was delocalized to the cytosol with no change in total nNOS protein, resulting in a significant decrease in microdomain cGMP, which in turn led to a significant elevation in local cAMP levels through a decrease in PDE2 activity (measured by FRET-based sensors). This resulted in increased L-type calcium channel activity and ryanodine receptor phosphorylation and hence increased contractility. In the heart, in addition to subsarcolemmal calcium transport, PMCA4 acts as a structural molecule that maintains the spatial and functional integrity of the nNOS signaling complex in a defined microdomain. This has profound consequences for the regulation of local cyclic nucleotide and hence cardiac (beta-adrenergic signaling.	[Mohamed, Tamer M. A.; Oceandy, Delvac; Zi, Min; Prehar, Sukhpal; Alatwi, Nasser; Wang, Yanwen; Shaheen, Mohamed A.; Abou-Leisa, Riham; Schelcher, Celine; Hegab, Zeinab; Baudoin, Florence; Mamas, Mamas; Lei, Ming; Cartwright, Elizabeth J.; Neyses, Ludwig] Univ Manchester, Cardiovasc Med Res Grp, Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England; [Mohamed, Tamer M. A.] Zagazig Univ, Fac Pharm, Dept Biochem, Zagazig 44519, Egypt; [Emerson, Michael] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Platelet Biol Grp, London SW7 2AZ, England; [Di Benedetto, Giulietta] Venetian Inst Mol Med, I-35100 Padua, Italy; [Zaccolo, Manuela] Univ Glasgow, Inst Neurosci & Psychol, Glasgow G12 8QQ, Lanark, Scotland	University of Manchester; Egyptian Knowledge Bank (EKB); Zagazig University; Imperial College London; Veneto Institute Molecular Medicine; University of Glasgow	Neyses, L (corresponding author), Univ Manchester, Cardiovasc Med Res Grp, Manchester Acad Hlth Sci Ctr, Room 1,302 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Ludwig.Neyses@cmft.nhs.uk	Neyses, Ludwig/AGY-7446-2022; Mamas, Mamas Andreas/A-2549-2019; Di Benedetto, Giulietta/L-9842-2019; Wang, Yanwen/I-1654-2015; Lei, Ming/S-7209-2016; Oceandy, Delvac/G-9911-2015; Zaccolo, Manuela/AAP-6706-2020	Mamas, Mamas Andreas/0000-0001-9241-8890; Di Benedetto, Giulietta/0000-0002-1489-3896; Wang, Yanwen/0000-0002-7986-4500; Lei, Ming/0000-0002-0928-341X; Oceandy, Delvac/0000-0002-6242-6491; Zaccolo, Manuela/0000-0002-0934-3662; Hegab, Zeinab/0000-0001-7381-4425; Baudoin, Florence/0000-0002-2300-1490; Prehar, Sukhpal/0000-0002-4334-7931; Cartwright, Elizabeth/0000-0002-6836-7795	Medical Research Council (MRC) [G0200020, G0500025, G0802004]; British Heart Foundation (BHF) [PG/05/082]; National Institute for Health Research, Manchester Biomedical Research Centre; Egyptian Postgraduate Research Scholarships; MRC [G0500025, G0802004] Funding Source: UKRI; Medical Research Council [G0802004, G0200020, G0500025] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation (BHF)(British Heart Foundation); National Institute for Health Research, Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Egyptian Postgraduate Research Scholarships; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (MRC) International Appointee Grant (G0200020), MRC Programme/Research Grants (G0500025 and G0802004) (to L N.), and a British Heart Foundation (BHF) Project Grant (PG/05/082) (to D. O. and E. J. C.).; Supported by a BHF Intermediate Basic Science Research Fellowship (FS/09/046).; We acknowledge the bioimaging and electron microscopy facilities in the University of Manchester for help and advice. We thank Dr. Yatong Li, University of Manchester for help during the manuscript preparation. We thank Dr. Martin Lohse for providing the Epac I FRET plasmid, The L. Neyses laboratory is supported by the National Institute for Health Research, Manchester Biomedical Research Centre Funding Scheme.; Recipients of Egyptian Postgraduate Research Scholarships.	Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Beigi F, 2009, NITRIC OXIDE-BIOL CH, V21, P226, DOI 10.1016/j.niox.2009.09.005; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; BERS DM, 1993, CARDIOVASC RES, V27, P1772, DOI 10.1093/cvr/27.10.1772; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bito V, 2008, CARDIOVASC RES, V77, P315, DOI 10.1093/cvr/cvm063; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; Burkard N, 2007, CIRC RES, V100, pE32, DOI 10.1161/01.RES.0000259042.04576.6a; CARAFOLI E, 1990, PROG CLIN BIOL RES, V332, P181; Cartwright EJ, 2005, J MOL CELL CARDIOL, V39, P403, DOI 10.1016/j.yjmcc.2005.04.007; Cartwright EJ, 2007, ANN NY ACAD SCI, V1099, P247, DOI 10.1196/annals.1387.007; Chang KC, 2008, P NATL ACAD SCI USA, V105, P4477, DOI 10.1073/pnas.0709118105; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Gros R, 2003, CIRC RES, V93, P614, DOI 10.1161/01.RES.0000092142.19896.D9; Hammes A, 1998, CIRC RES, V83, P877; Hammes A, 1996, J BIOL CHEM, V271, P30816, DOI 10.1074/jbc.271.48.30816; Hare JM, 1999, NAT MED, V5, P273, DOI 10.1038/6486; HAYAKAWA K, 1994, J MOL BIOL, V235, P357, DOI 10.1016/S0022-2836(05)80039-7; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lee D, 2010, BMB REP, V43, P151, DOI 10.5483/BMBRep.2010.43.3.151; Mohamed TMA, 2009, J BIOL CHEM, V284, P12091, DOI 10.1074/jbc.M809112200; Molkentin JD, 2006, J CLIN INVEST, V116, P623, DOI 10.1172/JCI27824; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oceandy D, 2007, CIRCULATION, V115, P483, DOI 10.1161/CIRCULATIONAHA.106.643791; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Saraiva RM, 2006, CURR OPIN CARDIOL, V21, P221, DOI 10.1097/01.hco.0000221584.56372.dc; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Schuh K, 2003, J BIOL CHEM, V278, P41246, DOI 10.1074/jbc.M307606200; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Sears CE, 2004, PHILOS T R SOC B, V359, P1021, DOI 10.1098/rstb.2004.1477; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Xu KY, 2003, J BIOL CHEM, V278, P41798, DOI 10.1074/jbc.M306865200; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798	45	63	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41520	41529		10.1074/jbc.M111.290411	http://dx.doi.org/10.1074/jbc.M111.290411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21965681	Green Published, hybrid			2022-12-27	WOS:000298057500038
J	Rajamohan, F; Marr, E; Reyes, AR; Landro, JA; Anderson, MD; Corbett, JW; Dirico, KJ; Harwood, JH; Tu, MH; Vajdos, FF				Rajamohan, Francis; Marr, Eric; Reyes, Allan R.; Landro, James A.; Anderson, Marie D.; Corbett, Jeffrey W.; Dirico, Kenneth J.; Harwood, James H.; Tu, Meihua; Vajdos, Felix F.			Structure-guided Inhibitor Design for Human Acetyl-coenzyme A Carboxylase by Interspecies Active Site Conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; COA CARBOXYLASE; CARBOXYLTRANSFERASE DOMAIN; A CARBOXYLASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; DRUG DISCOVERY; MUTANT MICE; 2 ISOFORMS; OBESITY	Inhibition of acetyl-CoA carboxylases (ACCs), a crucial enzyme for fatty acid metabolism, has been shown to promote fatty acid oxidation and reduce body fat in animal models. Therefore, ACCs are attractive targets for structure-based inhibitor design, particularly the carboxyltransferase (CT) domain, which is the primary site for inhibitor interaction. We have cloned, expressed, and purified the CT domain of human ACC2 using baculovirus-mediated insect cell expression system. However, attempts to crystallize the human ACC2 CT domain have not been successful in our hands. Hence, we have been using the available crystal structure of yeast CT domain to design human ACC inhibitors. Unfortunately, as the selectivity of the lead series has increased against the full-length human enzyme, the potency against the yeast enzyme has decreased significantly. This loss of potency against the yeast enzyme correlated with a complete lack of binding of the human-specific compounds to crystals of the yeast CT domain. Here, we address this problem by converting nine key active site residues of the yeast CT domain to the corresponding human residues. The resulting humanized yeast ACC-CT (yCT-H9) protein exhibits biochemical and biophysical properties closer to the human CT domain and binding to human specific compounds. We report high resolution crystal structures of yCT-H9 complexed with inhibitors that show a preference for the human CT domain. These structures offer insights that explain the species selectivity of ACC inhibitors and may guide future drug design programs.	[Rajamohan, Francis; Marr, Eric; Reyes, Allan R.; Landro, James A.; Anderson, Marie D.; Corbett, Jeffrey W.; Dirico, Kenneth J.; Harwood, James H.; Tu, Meihua; Vajdos, Felix F.] Pfizer Global Res & Dev, Groton, CT 06340 USA	Pfizer	Rajamohan, F (corresponding author), Pfizer Inc, Eastern Point Rd,MS 8118A-2095, Groton, CT 06340 USA.	francis.rajamohan@pfizer.com; felix.vajdos@pfizer.com		Vajdos, Felix/0000-0002-8256-2087				Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; ABUELHEIGA L, 1995, P NATL ACAD SCI USA, V92, P4011, DOI 10.1073/pnas.92.9.4011; AbuElheiga L, 1997, J BIOL CHEM, V272, P10669; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Corbett JW, 2010, BIOORG MED CHEM LETT, V20, P2383, DOI 10.1016/j.bmcl.2009.04.091; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Harwood HJ, 2005, EXPERT OPIN THER TAR, V9, P267, DOI 10.1517/14728222.9.2.267; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Lenhard JM, 2002, ADV DRUG DELIVER REV, V54, P1199, DOI 10.1016/S0169-409X(02)00092-3; Madauss KP, 2009, ACTA CRYSTALLOGR D, V65, P449, DOI 10.1107/S0907444909008014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rajamohan F, 2010, PROTEIN EXPRES PURIF, V73, P189, DOI 10.1016/j.pep.2010.04.022; TANABE T, 1975, EUR J BIOCHEM, V57, P15, DOI 10.1111/j.1432-1033.1975.tb02272.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Zhang HL, 2004, STRUCTURE, V12, P1683, DOI 10.1016/j.str.2004.07.009; Zhang HL, 2004, P NATL ACAD SCI USA, V101, P5910, DOI 10.1073/pnas.0400891101; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	30	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41510	41519		10.1074/jbc.M111.275396	http://dx.doi.org/10.1074/jbc.M111.275396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21953464	hybrid, Green Published			2022-12-27	WOS:000298057500037
J	Atianand, MK; Harton, JA				Atianand, Maninjay K.; Harton, Jonathan A.			Uncoupling of Pyrin-only Protein 2 (POP2)-mediated Dual Regulation of NF-kappa B and the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NOD-LIKE RECEPTORS; DEATH-DOMAIN-FOLD; CASPASE-1 ACTIVATION; NEGATIVE REGULATOR; CUTTING EDGE; INTERLEUKIN-1-BETA; RECRUITMENT; ASC; INHIBITOR	Activation of transcription factor NF-kappa B and inflammasome-directed caspase-1 cleavage of IL-1 beta are key processes in the inflammatory response to pathogen or host-derived signals. Pyrin-only proteins (POPs) are restricted to Old World monkeys, apes, and humans and have previously been shown to impair inflammasome assembly and/or NF-kappa B p65 transcriptional activity in transfected epithelial cells. However, the biological role of POP2 and the molecular basis for its observed functions are not well understood. In this report we demonstrate that POP2 regulates TNF alpha and IL-1 beta responses in human monocytic THP-1 cells and in stable transfectants of mouse J774A.1 macrophages. Deletion analysis of POP2 revealed that the first a-helix (residues 1-19) is necessary and sufficient for both inflammasome and NF-kappa B inhibitory functions. Further, key acidic residues Glue, Asps, and Glum, believed critical for Pyrin/Pyrin domain interaction, are important for inflammasome inhibition. Moreover, these mutations did not reduce the effect of POP2 upon NF-kappa B, indicating that the inflammasome and NF-kappa B inhibitory properties of POP2 can be uncoupled mechanistically. Collectively, these data demonstrate that POP2 acts as a regulator of inflammatory signals and exerts its two known functions through distinct modalities employed by its first a-helix.	[Atianand, Maninjay K.; Harton, Jonathan A.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	Harton, JA (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, 47 New Scotland Ave,MC 151, Albany, NY 12208 USA.	hartonj@mail.amc.edu	Harton, Jonathan A/AAW-5283-2021; Atianand, Maninjay/AAF-7823-2019; Harton, Jonathan/F-2848-2010	Harton, Jonathan A/0000-0002-0350-1877; Atianand, Maninjay/0000-0003-4135-2515; Harton, Jonathan/0000-0002-0350-1877	National Institutes of Health [R01AI072259]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI072259 (to J. A. H.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Atianand MK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-56; Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Bewry NN, 2007, J BIOL CHEM, V282, P26178, DOI 10.1074/jbc.M611747200; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bruey JM, 2004, J BIOL CHEM, V279, P51897, DOI 10.1074/jbc.M406741200; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dinarello CA, 1997, J BIOL REG HOMEOS AG, V11, P91; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Dorfleutner A, 2007, VIRUS GENES, V35, P685, DOI 10.1007/s11262-007-0141-9; Dorfleutner A, 2007, INFECT IMMUN, V75, P1484, DOI 10.1128/IAI.01315-06; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Fairbrother WJ, 2001, PROTEIN SCI, V10, P1911, DOI 10.1110/ps.13801; Fiorentino L, 2002, J BIOL CHEM, V277, P35333, DOI 10.1074/jbc.M200446200; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Freundt EC, 2008, CELL, V133, P401, DOI 10.1016/j.cell.2008.04.017; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lamkanfi M, 2004, J BIOL CHEM, V279, P51729, DOI 10.1074/jbc.M407891200; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; Li NX, 2000, METHOD ENZYMOL, V319, P273; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu T, 2003, PROTEIN SCI, V12, P1872, DOI 10.1110/ps.0359603; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Rahman MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000635; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Su JM, 2009, J INNATE IMMUN, V1, P164, DOI 10.1159/000158541; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	79	29	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40536	40547		10.1074/jbc.M111.274290	http://dx.doi.org/10.1074/jbc.M111.274290			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21976665	Green Published, hybrid			2022-12-27	WOS:000297315400013
J	Liu, J; Nussinov, R				Liu, Jin; Nussinov, Ruth			Flexible Cullins in Cullin-RING E3 Ligases Allosterically Regulate Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOCS-BOX; CUL5-RBX2 MODULES; STRUCTURAL BASIS; COMPLEX REVEALS; PROTEIN; RECOGNITION; SPECIFICITY; CUL2-RBX1; INSIGHTS; DOMAINS	How do the cullins, with conserved structures, accommodate substrate-binding proteins with distinct shapes and sizes? Cullin-RING E3 ubiquitin ligases facilitate ubiquitin transfer from E2 to the substrate, tagging the substrate for degradation. They contain substrate-binding, adaptor, cullin, and Rbx proteins. Previously, we showed that substrate-binding and Rbx proteins are flexible. This allows shortening of the E2-substrate distance for initiation of ubiquitination or increasing the distance to accommodate the polyubiquitin chain. However, the role of the cullin remained unclear. Is cullin a rigid scaffold, or is it flexible and actively assists in the ubiquitin transfer reaction? Why are there different cullins, and how do these cullins specifically facilitate ubiquitination for different substrates? To answer these questions, we performed structural analysis and molecular dynamics simulations based on Cull, Cul4A, and Cu15 crystal structures. Our results show that these three cullins are not rigid scaffolds but are flexible with conserved hinges in the N-terminal domain. However, the degrees of flexibilities are distinct among the different cullins. Of interest, Cull flexibility can also be changed by deletion of the long loop (which is absent in Cul4A) in the N-terminal domain, suggesting that the loop may have an allosteric functional role. In all three cases, these conformational changes increase the E2-substrate distance to a specific range to facilitate polyubiquitination, suggesting that rather than being inert scaffold proteins, cullins allosterically regulate ubiquitination.	[Liu, Jin; Nussinov, Ruth] NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program,NIH, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Sackler Inst Mol Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; Sackler Faculty of Medicine	Nussinov, R (corresponding author), NCI, Basic Sci Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program,NIH, Frederick, MD 21702 USA.	ruthnu@helix.nih.gov		Nussinov, Ruth/0000-0002-8115-6415; Liu, Jin/0000-0002-1067-4063	National Institutes of Health from NCI [HHSN261200800001E]; National Cancer Institute Center for Cancer Research of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010441, ZIABC010440] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Center for Cancer Research of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN261200800001E from NCI and the National Cancer Institute Center for Cancer Research Intramural Research Program of the National Institutes of Health.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bergeron JRC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000925; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Liu J, 2008, P NATL ACAD SCI USA, V105, P901, DOI 10.1073/pnas.0707401105; Liu J, 2010, BIOPHYS J, V99, P736, DOI 10.1016/j.bpj.2010.05.021; Liu J, 2010, J MOL BIOL, V396, P1508, DOI 10.1016/j.jmb.2010.01.022; Liu J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000527; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Marcsisin SR, 2010, J MOL BIOL, V402, P892, DOI 10.1016/j.jmb.2010.08.026; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Skaar JR, 2007, CANCER RES, V67, P2006, DOI 10.1158/0008-5472.CAN-06-3241; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Wriggers W, 1997, PROTEINS, V29, P1; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	40	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40934	40942		10.1074/jbc.M111.277236	http://dx.doi.org/10.1074/jbc.M111.277236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21937436	hybrid, Green Published			2022-12-27	WOS:000297315400053
J	Tanabe, N; Wheal, BD; Kwon, J; Chen, HH; Shugg, RPP; Sims, SM; Goldberg, HA; Dixon, SJ				Tanabe, Natsuko; Wheal, Benjamin D.; Kwon, Jiyun; Chen, Hong H.; Shugg, Ryan P. P.; Sims, Stephen M.; Goldberg, Harvey A.; Dixon, S. Jeffrey			Osteopontin Signals through Calcium and Nuclear Factor of Activated T Cells (NFAT) in Osteoclasts A NOVEL RGD-DEPENDENT PATHWAY PROMOTING CELL SURVIVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MATRIX PROTEINS; IN-VITRO; KAPPA-B; POSTTRANSLATIONAL MODIFICATIONS; TRANSCRIPTION FACTORS; RAT OSTEOCLASTS; SMOOTH-MUSCLE; INTEGRIN; RESORPTION; RECEPTORS	Osteopontin (OPN), an integrin-binding extracellular matrix glycoprotein, enhances osteoclast activity; however, its mechanisms of action are elusive. The Ca2+-dependent transcription factor NFATc1 is essential for osteoclast differentiation. We assessed the effects of OPN on NFATc1, which translocates to nuclei upon activation. Osteoclasts from neonatal rabbits and rats were plated on coverslips, uncoated or coated with OPN or bovine albumin. OPN enhanced the proportion of osteoclasts exhibiting nuclear NFATc1. An RGD-containing, integrin-blocking peptide prevented the translocation of NFATc1 induced by OPN. Moreover, mutant OPN lacking RGD failed to induce translocation of NFATc1. Thus, activation of NFATc1 is dependent on integrin binding through RGD. Using fluorescence imaging, OPN was found to increase the proportion of osteoclasts exhibiting transient elevations in cytosolic Ca2+ (oscillations). OPN also enhanced osteoclast survival. The intracellular Ca2+ chelator 1,2-bis(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) suppressed Ca2+ oscillations and inhibited increases in NFATc1 translocation and survival induced by OPN. Furthermore, a specific, cell-permeable peptide inhibitor of NFAT activation blocked the effects of OPN on NFATc1 translocation and osteoclast survival. This is the first demonstration that OPN activates NFATc1 and enhances osteoclast survival through a Ca2+-NFAT-dependent pathway. Increased NFATc1 activity and enhanced osteoclast survival may account for the stimulatory effects of OPN on osteoclast function in vivo.	[Dixon, S. Jeffrey] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Chen, Hong H.; Goldberg, Harvey A.] Univ Western Ontario, Dept Dent, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Wheal, Benjamin D.] Univ Western Ontario, Grad Program Neurosci, London, ON N6A 5C1, Canada; [Tanabe, Natsuko] Nihon Univ, Sch Dent, Tokyo 1010062, Japan	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Nihon University	Dixon, SJ (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	jeff.dixon@schulich.uwo.ca	Sims, Stephen/G-4510-2013; Goldberg, Harvey/B-5742-2015; Dixon, S. Jeffrey/G-3657-2013	Dixon, S. Jeffrey/0000-0001-9162-1686	Canadian Institutes of Health Research (CIHR); Sato Fund; Sato Fund, Nihon University School of Dentistry, Tokyo, Japan	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Sato Fund(Sato Fund); Sato Fund, Nihon University School of Dentistry, Tokyo, Japan	This work was supported by the Canadian Institutes of Health Research effects in multiple cell types. (CIHR).; Supported in part by the Sato Fund, Nihon University School of Dentistry, Tokyo, Japan.; Recipient of a Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHR.	Anborgh PH, 2010, J CELL MOL MED, V14, P2037, DOI 10.1111/j.1582-4934.2010.01115.x; Asou Y, 2001, ENDOCRINOLOGY, V142, P1325, DOI 10.1210/en.142.3.1325; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boss V, 1998, J BIOL CHEM, V273, P19664, DOI 10.1074/jbc.273.31.19664; Chellaiah MA, 2003, CALCIFIED TISSUE INT, V72, P197, DOI 10.1007/s00223-002-1025-6; da Silva APB, 2009, LAB INVEST, V89, P1169, DOI 10.1038/labinvest.2009.80; Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011; Diao HY, 2008, P NATL ACAD SCI USA, V105, P15884, DOI 10.1073/pnas.0806089105; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; Gramoun A, 2010, J CELL BIOCHEM, V111, P350, DOI 10.1002/jcb.22705; Grohe B, 2009, LANGMUIR, V25, P11635, DOI 10.1021/la901145d; Grol MW, 2009, PURINERG SIGNAL, V5, P205, DOI 10.1007/s11302-009-9139-1; HEINEGARD D, 1995, ANN NY ACAD SCI, V760, P213, DOI 10.1111/j.1749-6632.1995.tb44632.x; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Ikeda F, 2006, J IMMUNOL, V177, P2384, DOI 10.4049/jimmunol.177.4.2384; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Katayama Y, 1998, J CELL PHYSIOL, V176, P179, DOI 10.1002/(SICI)1097-4652(199807)176:1<179::AID-JCP19>3.3.CO;2-M; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; Korcok J, 2005, J BIOL CHEM, V280, P16909, DOI 10.1074/jbc.M410764200; Kovac JR, 2008, AM J PHYSIOL-GASTR L, V294, pG88, DOI 10.1152/ajpgi.00305.2007; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Lapierre DM, 2010, J BIOL CHEM, V285, P25792, DOI 10.1074/jbc.M110.109322; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; Naemsch LN, 2001, J BIOL CHEM, V276, P39107, DOI 10.1074/jbc.M105881200; Nakamura I, 2001, J CELL BIOL, V152, P361, DOI 10.1083/jcb.152.2.361; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; PANICCIA R, 1993, AM J PHYSIOL, V265, pC1289, DOI 10.1152/ajpcell.1993.265.5.C1289; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Razzouk S, 2002, BONE, V30, P40, DOI 10.1016/S8756-3282(01)00637-8; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; SHANKAR G, 1995, EXP CELL RES, V219, P364, DOI 10.1006/excr.1995.1240; SHANKAR G, 1993, J CELL SCI, V105, P61; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Sitara D, 2010, IMMUNOL REV, V233, P286, DOI 10.1111/j.0105-2896.2009.00849.x; Tanaka S, 2006, ANN NY ACAD SCI, V1068, P180, DOI 10.1196/annals.1346.020; Teti A, 1998, J BONE MINER RES, V13, P50, DOI 10.1359/jbmr.1998.13.1.50; Vejda S, 2005, BRIT J HAEMATOL, V128, P711, DOI 10.1111/j.1365-2141.2004.05355.x; Velupillai P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000733; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156	58	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39871	39881		10.1074/jbc.M111.295048	http://dx.doi.org/10.1074/jbc.M111.295048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21940634	Green Published, hybrid			2022-12-27	WOS:000296925700021
J	Atianand, MK; Duffy, EB; Shah, A; Kar, S; Malik, M; Harton, JA				Atianand, Maninjay K.; Duffy, Ellen B.; Shah, Aaloki; Kar, Supriya; Malik, Meenakshi; Harton, Jonathan A.			Francisella tularensis Reveals a Disparity between Human and Mouse NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE VACCINE STRAIN; NF-KAPPA-B; INNATE IMMUNE RECOGNITION; LISTERIA-MONOCYTOGENES; NALP3 INFLAMMASOME; CASPASE-1 ACTIVATION; MURINE MACROPHAGES; SIGNALING PATHWAYS; AIM2 INFLAMMASOME; VIRULENT-STRAINS	Pathogen-triggered activation of the inflammasome complex leading to caspase-1 activation and IL-1 beta production involves similar sensor proteins between mouse and human. However, the specific sensors used may differ between infectious agents and host species. In mice, Francisella infection leads to seemingly exclusive activation of the Aim2 inflammasome with no apparent role for Nlrp3. Here we examine the IL-1 beta response of human cells to Francisella infection. Francisella strains exhibit differences in IL-1 beta production by influencing induction of IL-1 beta and ASC transcripts. Unexpectedly, our results demonstrate that Francisella activates the NLRP3 inflammasome in human cells. Francisella infection of THP-1 cells elicits IL-1 beta production, which is reduced by siRNA targeting of NLRP3. Moreover, in reconstituted 293T cells, Francisella triggers assembly of the NLRP3 inflammasome complex. In addition, inhibitors of reactive oxygen species, cathepsin B, and K+ efflux pathways, known to specifically influence NLRP3, substantially but not completely impair the Francisella-elicited IL-1 beta response, suggesting the involvement of another inflammasome pathway. Finally, shRNA targeting of NLRP3 and AIM2 reveals that both pathways contribute to the inflammasome response. Together these results establish NLRP3 as a cytosolic sensor for Francisella in human cells, a role not observed in mouse.	[Atianand, Maninjay K.; Duffy, Ellen B.; Shah, Aaloki; Kar, Supriya; Malik, Meenakshi; Harton, Jonathan A.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Dept Arts & Sci, Albany, NY 12208 USA	Albany Medical College; Albany College of Pharmacy & Health Sciences	Harton, JA (corresponding author), 47 New Scotland Ave,MC-151, Albany, NY 12208 USA.	hartonj@mail.amc.edu	Atianand, Maninjay/AAF-7823-2019; Harton, Jonathan/F-2848-2010; Harton, Jonathan A/AAW-5283-2021; Malik, Meenakshi/F-1501-2015	Atianand, Maninjay/0000-0003-4135-2515; Harton, Jonathan/0000-0002-0350-1877; Harton, Jonathan A/0000-0002-0350-1877; Malik, Meenakshi/0000-0003-0051-4485	National Institutes of Health [R21AI075250, P01AI056320, R01AI072259]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075250, P01AI056320, R01AI072259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI075250 (to M. M.) and P01AI056320 and R01AI072259 (J. A. H.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Choubey D, 2010, J INTERF CYTOK RES, V30, P371, DOI 10.1089/jir.2009.0096; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P39, DOI 10.1016/S0882-4010(02)00194-8; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; GAVRILIN MA, 2011, FRONT MICROBIOL, V2, P1; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harton JA, 2002, HUM IMMUNOL, V63, P588, DOI 10.1016/S0198-8859(02)00400-7; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kahlenberg JM, 2004, J LEUKOCYTE BIOL, V76, P676, DOI 10.1189/jlb.0404221; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; Noah CE, 2010, INFECT IMMUN, V78, P1797, DOI 10.1128/IAI.01135-09; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Santic M, 2010, CELL MICROBIOL, V12, P129, DOI 10.1111/j.1462-5822.2009.01400.x; Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shen H, 2004, VACCINE, V22, P2116, DOI 10.1016/j.vaccine.2003.12.003; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Williams KL, 2003, J IMMUNOL, V170, P5354, DOI 10.4049/jimmunol.170.11.5354; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	62	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39033	39042		10.1074/jbc.M111.244079	http://dx.doi.org/10.1074/jbc.M111.244079			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930705	Green Published, hybrid			2022-12-27	WOS:000296759800022
J	Bate, C; Williams, A				Bate, Clive; Williams, Alun			Amyloid-beta-induced Synapse Damage Is Mediated via Cross-linkage of Cellular Prion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; PHOSPHOLIPASE A(2); CYTOSOLIC PHOSPHOLIPASE-A(2); NATURAL OLIGOMERS; MOLECULAR-BASIS; PEPTIDE; A-BETA(1-42); DYSFUNCTION; ACTIVATION	The cellular prion protein (PrPC), which is highly expressed at synapses, was identified as a receptor for the amyloid-beta (A beta) oligomers that are associated with dementia in Alzheimer disease. Here, we report that A beta oligomers secreted by 7PA2 cells caused synapse damage in cultured neurons via a PrPC-dependent process. Exogenous PrPC added to Prnp knock-out((0/0)) neurons was targeted to synapses and significantly increased A beta-induced synapse damage. In contrast, the synapse damage induced by a phospholipase A(2)-activating peptide was independent of PrPC. In Prnp wild-type((+/+)) neurons A beta oligomers activated synaptic cytoplasmic phospholipase A(2) (cPLA(2)). In these cells, the addition of A beta oligomers triggered the translocation of cPLA(2) in synapses to cholesterol dense membranes (lipid rafts) where it formed a complex also containing A beta and PrPC. In contrast, the addition of A beta to Prnp((0/0)) neurons did not activate synaptic cPLA(2), which remained in the cytoplasm and was not associated with A beta. Filtration assays and non-denaturing gels demonstrated that A beta oligomers cross-link PrPC. We propose that it is the cross-linkage of PrPC by A beta oligomers that triggers abnormal activation of cPLA(2) and synapse damage. This hypothesis was supported by our observation that monoclonal antibody mediated cross-linkage of PrPC also activated synaptic cPLA(2) and caused synapse damage.	[Bate, Clive] Royal Vet Coll, Dept Pathol & Infect Dis, N Mymms AL9 7TA, Herts, England; [Williams, Alun] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of London; University of London Royal Veterinary College; University of Cambridge	Bate, C (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hawkshead Lane, N Mymms AL9 7TA, Herts, England.	cbate@rvc.ac.uk						Anfuso CD, 2004, BBA-MOL CELL BIOL L, V1686, P125, DOI 10.1016/j.bbalip.2004.09.006; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bate C, 2007, NEUROPHARMACOLOGY, V53, P222, DOI 10.1016/j.neuropharm.2007.05.003; Bate C, 2011, J BIOL CHEM, V286, P8752, DOI 10.1074/jbc.M110.186833; Bate C, 2010, J ALZHEIMERS DIS, V21, P985, DOI 10.3233/JAD-2010-100528; Bate C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-13; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Brown DR, 2001, TRENDS NEUROSCI, V24, P85, DOI 10.1016/S0166-2236(00)01689-1; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Gaudreault SB, 2004, J BIOL CHEM, V279, P356, DOI 10.1074/jbc.M304777200; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Jeng CJ, 1998, J CELL BIOL, V140, P685, DOI 10.1083/jcb.140.3.685; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Manzoni C, 2009, AMYLOID, V16, P71, DOI 10.1080/13506120902879848; MOSKOWITZ N, 1982, SCIENCE, V216, P305, DOI 10.1126/science.6278597; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Tanzi RE, 2005, NAT NEUROSCI, V8, P977, DOI 10.1038/nn0805-977; Thais ME, 2006, BRAIN RES, V1075, P13, DOI 10.1016/j.brainres.2005.12.045; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang SSS, 2001, J BIOL CHEM, V276, P42027, DOI 10.1074/jbc.M102834200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	52	76	78	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37955	37963		10.1074/jbc.M111.248724	http://dx.doi.org/10.1074/jbc.M111.248724			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900234	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000296594200008
J	Hanzelmann, P; Schindelin, H				Haenzelmann, Petra; Schindelin, Hermann			The Structural and Functional Basis of the p97/Valosin-containing Protein (VCP)-interacting Motif (VIM) MUTUALLY EXCLUSIVE BINDING OF COFACTORS TO THE N-TERMINAL DOMAIN OF p97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA ATPASE P97/VCP; INCLUSION-BODY MYOPATHY; P97; UBIQUITIN; DISEASE; BINDING; INSIGHTS; UBXD1; COFACTORS; INTERACTS	The AAA (ATPase associated with various cellular activities) ATPase p97, also referred to as valosin-containing protein (VCP), mediates essential cellular processes, including ubiquitin-dependent protein degradation, and has been linked to several human proteinopathies. p97 interacts with multiple cofactors via its N-terminal (p97N) domain, a subset of which contain the VCP-interacting motif (VIM). We have determined the crystal structure of the p97N domain in complex with the VIM of the ubiquitin E3 ligase gp78 at 1.8 angstrom resolution. The alpha-helical VIM peptide binds into a groove located in between the two subdomains of the p97N domain. Interaction studies of several VIM proteins reveal that these cofactors display dramatically different affinities, ranging from high affinity interactions characterized by dissociation constants of similar to 20 nM for gp78 and ANKZF1 to only weak binding in our assays. The contribution of individual p97 residues to VIM binding was analyzed, revealing that identical substitutions do not affect all cofactors in the same way. Taken together, the biochemical and structural studies define the framework for recognition of VIM-containing cofactors by p97. Of particular interest to the regulation of p97 by its cofactors, our structure reveals that the bound alpha-helical peptides of VIM-containing cofactors overlap with the binding site for cofactors containing the ubiquitin regulatory X (UBX) domain present in the UBX protein family or the ubiquitin-like domain of NPL4 as further corroborated by biochemical data. These results extend the concept that competitive binding is a crucial determinant in p97-cofactor interactions.	[Haenzelmann, Petra; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	University of Wurzburg	Hanzelmann, P (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	petra.haenzelmann@virchow.uni-wuerzburg.de	Schindelin, Hermann/Q-2697-2019		Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine) [FZ 82]	Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine, FZ 82) (to H. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Haines Dale S, 2010, Genes Cancer, V1, P753; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2010, HUM MOL GENET, V19, pR38, DOI 10.1093/hmg/ddq157; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Morreale G, 2009, FEBS J, V276, P1208, DOI 10.1111/j.1742-4658.2008.06858.x; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Rich RL, 2007, ANAL BIOCHEM, V361, P1, DOI 10.1016/j.ab.2006.10.040; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104; Zhao G, 2009, P NATL ACAD SCI USA, V106, P16197, DOI 10.1073/pnas.0908321106	46	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38679	38690		10.1074/jbc.M111.274506	http://dx.doi.org/10.1074/jbc.M111.274506			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21914798	hybrid, Green Published			2022-12-27	WOS:000296594200080
J	Zhuang, CM; Tang, HX; Dissanaike, S; Cobos, E; Tao, YX; Dai, ZH				Zhuang, Chunmei; Tang, Hongxing; Dissanaike, Sharmila; Cobos, Everardo; Tao, Yunxia; Dai, Zonghan			CDK1-mediated Phosphorylation of Abi1 Attenuates Bcr-Abl-induced F-actin Assembly and Tyrosine Phosphorylation of WAVE Complex during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; C-ABL; MITOTIC PHOSPHORYLATION; POLARIZED DISTRIBUTION; TRANSFORMING ACTIVITY; REGULATORY COMPLEX; SIGNALING COMPLEX; TARGET PROTEINS; KINASE; ACTIVATION	Coordinated actin remodeling is crucial for cell entry into mitosis. The WAVE regulatory complex is a key regulator of actin assembly, yet how the WAVE signaling is regulated to coordinate actin assembly with mitotic entry is not clear. Here, we have uncovered a novel mechanism that regulates the WAVE complex at the onset of mitosis. We found that the Bcr-Abl-stimulated F-actin assembly is abrogated during mitosis. This mitotic inhibition of F-actin assembly is accompanied by an attenuation of Bcr-Abl-induced tyrosine phosphorylation of the WAVE complex. We identified serine 216 of Abi1 as a target of CDK1/cyclin B kinase that is phosphorylated in cells at the onset of mitosis. The Abi1 phosphorylated on serine 216 displayed greatly reduced tyrosine phosphorylation in the hematopoietic cells transformed by Bcr-Abl. Moreover, a phosphomimetic mutation of serine 216 to aspartic acid in Abi1 was sufficient to attenuate Bcr-Abl-induced tyrosine phosphorylation of the WAVE complex and F-actin assembly. Ectopic expression of Abi1 with serine 216 mutations interfered with cell cycle progression. Together, these data show that CDK1-mediated phosphorylation of serine 216 in Abi1 serves as a regulatory mechanism that may contribute to coordinated actin cytoskeleton remodeling during mitosis.	[Zhuang, Chunmei; Tang, Hongxing; Cobos, Everardo; Tao, Yunxia; Dai, Zonghan] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Amarillo, TX 79106 USA; [Dissanaike, Sharmila] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Amarillo, TX 79106 USA; [Cobos, Everardo; Dai, Zonghan] Texas Tech Univ, Hlth Sci Ctr, Stem Cell Transplant Program, Amarillo, TX 79106 USA; [Zhuang, Chunmei] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Shandong University	Dai, ZH (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, 1406 Coulter St, Amarillo, TX 79106 USA.	zonghan.dai@ttuhsc.edu			National Institutes of Health from NCI [R01 CA094921, R21 CA133597]; National Institutes of Health from NIDDK [K01 DK067191]; When Everyone Survives Foundation; NATIONAL CANCER INSTITUTE [R21CA133597, R01CA094921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK067191] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from NIDDK; When Everyone Survives Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA094921 and R21 CA133597 (to Z. D.) from NCI and Grant K01 DK067191 (to Y. T.) from NIDDK. This work was also supported by a grant from the When Everyone Survives Foundation (to Z. D.).	Ardern H, 2006, CELL MOTIL CYTOSKEL, V63, P6, DOI 10.1002/cm.20101; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Courtney KD, 2000, MOL CELL NEUROSCI, V16, P244, DOI 10.1006/mcne.2000.0865; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Dai ZH, 1998, GENE DEV, V12, P1415, DOI 10.1101/gad.12.10.1415; Dai ZH, 2001, J BIOL CHEM, V276, P28954, DOI 10.1074/jbc.M101170200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Juang JL, 1999, ONCOGENE, V18, P5138, DOI 10.1038/sj.onc.1202911; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; KIPREOS ET, 1990, SCIENCE, V248, P217, DOI 10.1126/science.2183353; Kondylis V, 2007, DEV CELL, V12, P901, DOI 10.1016/j.devcel.2007.03.008; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Li YZ, 2007, J CELL SCI, V120, P1436, DOI 10.1242/jcs.03430; Lin TY, 2004, J BIOMED SCI, V11, P902, DOI 10.1159/000081837; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; McWhirter JR, 1997, ONCOGENE, V15, P1625, DOI 10.1038/sj.onc.1201342; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Mistry SJ, 2001, J BIOL CHEM, V276, P31209, DOI 10.1074/jbc.M011654200; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Salgia R, 1997, J CLIN INVEST, V100, P46, DOI 10.1172/JCI119520; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Skourides PA, 1999, ONCOGENE, V18, P1165, DOI 10.1038/sj.onc.1202407; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Sun X, 2008, LEUKEMIA, V22, P1053, DOI 10.1038/sj.leu.2404990; Sun XL, 2009, CARCINOGENESIS, V30, P2109, DOI 10.1093/carcin/bgp251; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Woodring PJ, 2005, J BIOL CHEM, V280, P10318, DOI 10.1074/jbc.M410658200; Yu WD, 2008, CARCINOGENESIS, V29, P1717, DOI 10.1093/carcin/bgn098	43	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38614	38626		10.1074/jbc.M111.281139	http://dx.doi.org/10.1074/jbc.M111.281139			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21900237	Green Published, hybrid			2022-12-27	WOS:000296594200074
J	Guo, JP; Coppola, D; Cheng, JQ				Guo, Jian-Ping; Coppola, Domenico; Cheng, Jin Q.			IKBKE Protein Activates Akt Independent of Phosphatidylinositol 3-Kinase/PDK1/mTORC2 and the Pleckstrin Homology Domain to Sustain Malignant Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; PROMOTES CELL-SURVIVAL; BREAST-CANCER ONCOGENE; KAPPA-B ACTIVATION; IKK-EPSILON; KINASE-B; PROSTATE-CANCER; PHOSPHORYLATION; INHIBITOR; AKT/PKB	Serine/threonine kinase Akt regulates key cellular processes such as cell growth, proliferation, and survival. Activation of Akt by mitogenic factor depends on phosphatidylinositol 3-kinase (PI3K). Here, we report that IKBKE (also known as IKK epsilon and IKKi) activates Akt through a PI3K-independent pathway. IKBKE directly phosphorylates Akt-Thr308 and Ser473 independent of the pleckstrin homology (PH) domain. IKBKE activation of Akt was not affected by inhibition of PI3K, knockdown of PDK1 or mTORC2 complex. Further, this activation could be inhibited by Akt inhibitors MK-2206 and GSK690693 but not the compounds (perifosine and triciribine) targeting the PH domain of Akt. Expression of IKBKE largely correlates with activation of Akt in breast cancer. Moreover, inhibition of Akt suppresses IKBKE oncogenic transformation. These findings indicate that IKBKE is an Akt-Thr308 and -Ser473 kinase and directly activates Akt independent of PI3K, PDK1, and mTORC2 as well as PH domain. Our data also suggest that Akt inhibitors targeting the PH domain have no effect on the tumors in which hyperactive Akt resulted from elevated IKBKE.	[Guo, Jian-Ping; Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Coppola, Domenico] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Cheng, JQ (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org			National Institutes of Health [CA137041]; Florida James & Esther King Biomedical Research Program [1KG02, 10KD-04]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA137041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida James & Esther King Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA137041 and Florida James & Esther King Biomedical Research Program 1KG02 (to J. Q. C.) and 10KD-04 (to J.-P. G.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arkan MC, 2011, CURR TOP MICROBIOL, V349, P159, DOI 10.1007/82_2010_97; Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Dan HC, 2007, CANCER RES, V67, P6263, DOI 10.1158/0008-5472.CAN-07-1232; Dan HC, 2004, ONCOGENE, V23, P706, DOI 10.1038/sj.onc.1207171; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garrett CR, 2011, INVEST NEW DRUG, V29, P1381, DOI 10.1007/s10637-010-9479-2; Ghobrial IM, 2010, CLIN CANCER RES, V16, P1033, DOI 10.1158/1078-0432.CCR-09-1837; Gonzalez-Angulo AM, 2011, MOL CANCER THER, V10, P1093, DOI 10.1158/1535-7163.MCT-10-1089; Guan HY, 2011, J PATHOL, V223, P436, DOI 10.1002/path.2815; Guo JP, 2010, J BIOL CHEM, V285, P3676, DOI 10.1074/jbc.M109.078212; Guo JP, 2009, AM J PATHOL, V175, P324, DOI 10.2353/ajpath.2009.080767; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hixon ML, 2010, REV RECENT CLIN TRIA, V5, P189, DOI 10.2174/157488710792007329; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lindsley CW, 2010, CURR TOP MED CHEM, V10, P458, DOI 10.2174/156802610790980602; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Ozes ON, 1999, NATURE, V401, P82; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Porta C, 2009, IMMUNOBIOLOGY, V214, P761, DOI 10.1016/j.imbio.2009.06.014; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Salh B, 1998, J IMMUNOL, V161, P6947; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Yang CH, 2001, J BIOL CHEM, V276, P13756, DOI 10.1074/jbc.M011006200; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yuan ZQ, 2002, J BIOL CHEM, V277, P29973, DOI 10.1074/jbc.M203636200	48	75	77	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37389	37398		10.1074/jbc.M111.287433	http://dx.doi.org/10.1074/jbc.M111.287433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21908616	Green Published, hybrid			2022-12-27	WOS:000296542400039
